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LAPAROSCOPIC CHOLECYSTECTOMY: 
BEGINNERS EXPERIENCES
S. Kumar, D. Singh, J. K. Kushwaha
CSM (Erstwhile King George's) Medical University, 
General Surgery, Department Of Surgery,  CSMMU, 
Lucknow 22600, India
Introduction: Cholecystectomy is one of the commonest 
surgeries performed Laparoscopically. Less pain faster 
recovery and early return to work are some of its advantages. 
Training of surgeons to perform this procedure during post-
graduate curriculum is inadequate in most of the Northern 
India teaching hospitals and is believed to be the important 
reason for majority of complications during learning curve. 
We present our data of outcome of patients of laparoscopic 
cholecystectomy performed by beginner.
Methods: 62 conventional laparoscopic cholecystectomies 
(including conversion to open) performed by presenting 
author from 15 October 2009 to 6 December 2010 were 
retrospectively analyzed for operating time, outcome, com-
plications and conversion to open cholecystectomy.
Results: All the patients had chronic cholecystitis with 
cholelithiasis. 77% (48/62) were female patients and rest 
were males. The average age in both the group was 41 and 
48 years. The mean time of surgery in female patients was 
42 minutes as compared to 76 minutes in male. None of the 
patients had common bile duct (CBD) stone. Diffi cult dis-
section of Calot`s was encountered in 9 (14.5%) female 
patients and 8 (57%) male patients with 4 and 5 patients in 
both group requiring conversion. None of our patients had 
complications like intestinal, CBD and vascular injury. Stone 
spillage was seen in 5 patients however none of them required 
conversion. The average postoperative admission time was 
48 hrs and all the patients returned to work on an average.
Conclusion: Laparoscopic cholecystectomy offers the sub-
stantial advantage of markedly decreased pain and disability, 
without apparent increased mortality or overall morbidity. 
The results of laparoscopic cholecystectomy are greatly 
infl uenced by the skills and experience of the surgeon per-
forming the procedure and refl ect a rapid acquisition of 
appropriate technical skills. However, it is a safe procedure 
even in the hands of beginners provided all its basic princi-
ples are followed.
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OUTCOME OF FLUOROSCOPICALLY-
GUIDED LAPAROSCOPIC 
CHOLEDOCHOTOMY IN 
214 EGYPTIAN PATIENTS
A. Elgeidie
Gastroenterology Surgical Center, Jehan Street, Mansoura, 
Dakahlia, 35516 Mansoura, Egypt
Introduction: Laparoscopic bile duct exploration (LBDE) 
is well established although the results via choledochotomy 
performed under fl uoroscopic guidance without utilizing 
choledochoscopy are relatively poorly documented. This 
report evaluates the results achieved by a single surgeon 
operating in one institution on an unselected group of 
Egyptian patients.
Methods: Over a 5-year period, 214 consecutive patients 
with preoperative diagnosis of common bile duct stones 
(CBDS) and CBD diameter over 10 mm were included. 
Patients were diagnosed preoperatively by clinical examina-
tion, liver function tests, abdominal ultrasound and magnetic 
resonance cholangiography. They underwent LBDE via 
choledochotomy under fl uoroscopic guidance without utiliz-
ing fl exible choledochoscopy.
Results: 35 patients (16%) had undergone failed ERCP. 
Sixteen patients (7%) had failed CBDS extraction laparo-
scopically. Another 5 patients had no stones at intraoperative 
cholangiography. For the remaining 193 patients, primary 
closure was done in 98 patients (51%), T-tubes in 63 patients 
(33%), choledochoduodenostomy in 12 patients (6%), retro-
grade stent in 7 patients (4%), and antegrade stent in 6 
patients (3%). Postoperative complications occurred in 9 
patients (5%) (bile leak n = 5, internal hemorrhage n = 1, 
mild pancreatitis n = 1, and wound infection n = 2). Retained 
CBD stones were observed in 7 patients (3.6%) The median 
operative time was 67 minutes and the median hospital stay 
was 2.4 days. The median follow-up was 24.2 weeks with 
no strictures.
Conclusion: LBDE under fl uoroscopic guidance has a 
success/failure rate and a complication rate similar to 
those published for LBDE done via choledochotomy. 
Fluoroscopically-guided LBDE is safe and effective but 
there is a defi nite morbidity rate.
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SUPPORTED BY THE PROJECT 
(MINISTRY OF DEFENCE, CZECH 
REPUBLIC), A LONG-TERM 
ORGANIZATION DEVELOPMENT 
PLAN 1011
P. Lochman1, Z. Subrt1, J. Paral1 and P. Hoffmann2
1Faculty of Military Health Sciences, University of 
Defence, Hradec Kralove, Czech Republic; 2Department of 
Radiology, University Hospital, Hradec Kralove, Czech 
Republic
Faculty of Military Health Sciences, University of Defence, 
Department of Field Surgery, Trebesska 157550001 Hradec 
Kralove, Czech Republic
Supported by the Project (Ministry of Defence, Czech 
Republic) ‘A long-term organization development plan 
1011’.
Introduction: Situs viscerum inversus totalis is a rare dis-
order presented by complete transposition of thoracic and 
abdominal viscera. It is associated with certain organ anoma-
lies, but it is not a predisposing factor to cholecystolithiasis. 
Up to these days fewer than 100 cholecystectomies in 
patients with situs inversus were published worldwide.
Methods: We report a case of 75-year-old female referred 
to our hospital with abdominal pain in the left hypochon-
drium. Situs inversus totalis and acute calculous cholecystitis 
were diagnosed and successfully conservatively treated with 
antibiotics. Patient underwent elective laparoscopic chole-
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cystectomy 3 months later. The procedure and postoperative 
course were uneventful and patient recovered well.
Results: The clinical presentation of these patients with 
cholecystolithiasis may be confusing, vague and the right 
diagnosis delayed. Laparoscopic cholecystectomy is the gold 
standard in the treatment even though the operation requires 
some modifi cations in operating theatre settlement and posi-
tion of surgical team. The most surgeons are right-handed 
and to operate laparoscopically in „mirror image’ anatomic 
situation using mainly left hand for dissection may be stress-
ful, uncomfortable and more time demanding. Some recom-
mendations to overcome this issue were published. In 
conclusion, the above mentioned anomaly may cause some 
risk and delay of exact diagnosis, but it is not dangerous in 
itself.
Conclusion: Laparoscopic cholecystectomy is a safe proce-
dure, even in case of acute cholecystitis, if performed by 
experienced laparoscopic surgeon. The most dangerous is 
always an incautious and too self-confi dent surgeon.
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MANAGEMENT OF PATIENTS 
PRESENTING WITH LARGE HEPATIC 
ABSCESS ALONG WITH 
CHOLELITHIASIS AND 
CHOLEDOCHOLITHIASIS
N. N. Ganguly
Ochsner A, DeBakey M, Murray S. Pyogenic Abscess of the 
Liver II. An Analysis of Forty-Seven Cases with Review of 
the Literature. Am J Surg. 1938;XL:292–319.
Gauhati Medical College, Guwahati, Assam, IndiaSurgery 
‘NAMAN’, 12 J.P.Agarwala Bye Lane, Bishnurabha Path
Beltola, 78102 Guwahati/Assam, India
Introduction: Bacterial abscess of the liver is relatively 
rare. It has been described since the time of Hippocrates (400 
BC), with the fi rst published review by Bright appearing in 
1936. In 1938, Ochsner’s classic review heralded surgical 
drainage as the defi nitive therapy; however, despite the more 
aggressive approach to treatment, the mortality rate remained 
at 60–80%.
Occasionally patients present with large intrahepatic 
abscess along with cholelithiasis for surgery. This causes 
confusion. Should the patient be operated? If operated then 
what should be the approach to the Hepatic abscess? We have 
treated 12 such cases who presented with acute cholecystitis 
along with large intra hepatic abscess/abscesses successfully 
over the last two years. We present herewith our experience 
in managing such patients. So far we could not confi rm 
perforation of the gall bladder into the liver conclusively and 
these cases can be considered as Neimeier’s type II 
diseases.
All though the primary therapy of liver abscess being 
guided drainage after the 70s, there are reports of laparo-
scopic approach and its superiority over conservative therapy.
Materials and method: 12 patients presented as acute 
abdomen in our OPD/Emergency services in the last two 
years. Presentations were similar. Acute pain abdomen for 
over 5 days with fever, vomiting and anorexia. 8 were female 
aged between 40–56 years and 4 were male, aged between 
45–58 years. Only two of them were from urban background. 
Initial workup suggested presence of cholelithiasis in 10, 
choledocholithiasis with obstructing features in one and 
without obstructing features in one. 9 patients had edema of 
the gall bladed or that of the CBD. Only two had Jaundice. 
All had leucocytosis above 10,000 and a left Shift. One had 
a pleural collection on the right side. CECT scans were 
undertaken in all cases and Neimeier’s type II was 
considered.
Patients were put on hydration, antibiotics, analgesics and 
stabilized for 24–48 hours in the ward. They had pig tail (one 
multiple and 11 single) drains inserted under USG Guidance. 
Two underwent ERC Clearance and stenting of the CBD 
after the pig tail were inserted in the hepatic abscess cavities. 
Antibiotics and Hydration continued from 7–16 days and 
oral nourishment increased progressively. The empyema tho-
racis patient needed a closed chest drainage inserted and it 
was removed after the content regressed after the pig tail 
drainage of the hepatic abscess cavity. Patients were dis-
charged from the ward when stable with the pig tail drainage 
in situ. They were advised appropriate dietary restrictions 
and attend SOPD for surgery after 6 weeks. 4 patients could 
be operated and it was found that within 6 weeks of drainage 
all of these cavities shrunk and the drainage could be 
removed. 8 of the patients are refusing surgery for various 
reasons like festival, weakness etc. But all of them are in 
contact and are directed to attend the emergency service as 
soon as ready for Surgery.
Results: All of these patients have behaved comfortably. All 
are surviving. No one needed extensive surgeries and those 
who have undergone cholecystectomies (5 lap, 1 Open) are 
free from any restrictions.
Pyogenic liver abscess is considered to be the commonest 
cause of liver abscess followed by amoebic and fungal. After 
the late 1970s, the treatment of liver abscess is primarily 
being aspiration of the content by a needle or catheter. 
Neimeier’s type III need surgery. Open or Laparoscopic 
depends on the available expertise. The result of Lap explo-
ration is better as reported by some researchers. However 
Catheter drainage and subsequent cholecystectomy have 
shown good promise. The treatment needed some time to get 
completed but these patients could be managed with minimal 
mortality. That our small series has no mortality speaks 
volumes of the success of the therapy.
Conclusion: The patients presented themselves in various 
stages of crisis. It was scary at the beginning to think of 
operating them as emergency cases. However as the number 
of patients increased so did our confi dence in managing them 
in a simple way. And presently the standard of treatment 
offered by us for such condition is the same way which is 
presented here.
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MINIMALLY INVASIVE APPROACHES 
TO INTRAHEPATIC AND 
EXTRAHEPATIC 
CHOLANGIOCARCINOMA
A. Gumbs1, N. Jarufe2, J. Salinas2 and B. Gayet3
1Summit Medical Group, Berkeley Heights, NJ, USA; 
2Digestive Surgery Department, School of Medicine 
Pontifi cia Universidad Católica, Santiago, Chile; 3Institut 
Mutualiste Montsouris, Paris, France
Summit Medical Group, Surgical Oncology, Bensley 
Pavilion, 4th Floor, 1 Diamond Hill Rd. 7922 Berkeley 
Heights, USA
Introduction: Due to the perceived diffi culty in dissecting 
hilar cholangiocarcinomas off of the portal structures and in 
performing complex biliary reconstructions, very few centers 
have used minimally invasive techniques for these tumors.
Methods: Because of this, a review was undertaken by 
combining the experience of 3 international centers with 
expertise in complex minimally invasive hepatobiliary 
surgery. Patients were divided into hilar cholangiocarcino-
mas and intrahepatic cholaniocarcinomas. The Bismuth clas-
sifi cation was used to stratify the hilar cholangiocarcinomas. 
From December 2002–June 2011, a total of 14 patients were 
resected laparoscopically for cholangiocarcinoma.
Results: Nine patients had an intrahepatic lesion. The mean 
estimated blood loss (EBL) was 233 mL (range = 
100–400 mL). Six out of 9 patients are currently alive with 
a median follow-up of 28 months. Five patients had a hilar 
lesion, their mean age was 73 years (range = 66–79 years). 
Their mean EBL was 240 mL (range = 0–400 mL). All 
patients are currently alive with a median follow up of 11 
months (range = 3–18 months). No patients required reopera-
tion, but 2 patients developed bile leaks and a fi nal patient 
developed a pulmonary embolism for an overall morbidity 
rate of 21%. The overall conversion rate was 7%. There were 
no mortalities at 30 or 90 days.
Conclusion: Minimally invasive approaches for both intra-
hepatic and hilar cholangiocarcinomas appear feasible and 
safe. There is no increased rate of port site recurrences when 
cholangiocarcinomas are removed laparoscopically. Although 
short term results seem similar to the published open experi-
ence, longer-term follow-up is needed to see how disease 
free and overall survival is affected.
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MULTICENTER STUDY OF MINIMALLY 
INVASIVE APPROACHES TO PRE AND 
POST-OPERATIVELY DIAGNOSED 
GALLBLADDER CANCER
A. Gumbs1, J. Nicolas2, J. Salinas2 and B. Gayet3
1Summit Medical Group, Berkeley Heights, NJ, USA; 
2Digestive Surgery Department, School of Medicine 
Pontifi cia Universidad Católica, Santiago, Chile; 3Institut 
Mutualiste Montsouris, Paris, France
Summit Medical Group, Surgical Oncology, Bensley 
Pavilion, 4th Floor, 1 Diamond Hill Rd. 7922 Berkeley 
Heights, USA
Introduction: Laparoscopic removal of gallbladder 
cancer limited to the lamina propria (Stage IA) is currently 
considered the standard of care, however, most centers with 
patients that have greater than T1A lesions are treated with 
hepatic parenchymal resection of the gallbladder bed and 
hepatoduodenal lymphadenectomy via an open approach. A 
review of 3 centers that perform laparoscopic radical chole-
cystectomy was undertaken to see if the minimally invasive 
approach is feasible and safe for this disease.
Methods: The experience at 3 international centers with 
surgeons with expertise in advanced laparoscopic hepato-
biliary techniques that perform laparoscopic hepatectomy 
and hepatoduodenal lymphadenectomy was reviewed. 
Patients were entered into a database retrospectively. All 
patients that underwent attempted minimally invasive resec-
tion were analyzed.
Results: A total of 15 patients underwent attempted mini-
mally invasive surgery for both pre- and post-operatively 
diagnosed gallbladder cancer. The female to male ratio is 
2 : 1, mean age is 61 (range = 35–79), the mean estimated 
blood loss is 160 mL (range = 0–400 mL), the mean operat-
ing room time is 220 minutes (range = 120–480 minutes) and 
mean length of stay is 4 days (range = 2–8). An mean of 4 
lymph nodes (range = 1–11) were retrieved and all patients 
had an R0 resection. Ten patients underwent initial laparo-
scopic radical cholecystectomy and 5 patients underwent 
laparoscopic completion radical cholecystectomy after 
routine laparoscopic cholecystectomy. No patient developed 
a bile leak, required drainage, re-operation or died at 90 days.
Conclusion: Minimally invasive approaches for both intra-
hepatic and hilar cholangiocarcinomas appear feasible and 
safe. Although short term results seem similar to the pub-
lished open experience, longer-term follow-up is needed.
026
CONTRAST-ENHANCED 
ULTRASONOGRAPHY AS FOLLOW-UP 
EXAMINATION OF GALLBLADDER 
LESIONS DETECTED BY 
MASS SCREENING
K. Inui, J. Yoshino, H. Miyoshi, T. Kobayashi and 
S. Yamamoto
Department of Gastroenterology, Second Teaching 
Hospital, Fujita Health University
Second Teaching Hospital, Fujita Health University, 
Gastroenterology, 3-6-10, Otobashi, Nakagawa, 454 
Nagoya, Japan
Introduction: Gallbladder cancer prevalence in mass 
screening of a healthy population was 0.01%, while gallblad-
der polyp was about 7%. Endosonography (EUS) and multi-
detector-row CT (MDCT) are useful for differential diagnosis 
of lesions detected by screening, but are somewhat invasive. 
Contrast-enhanced ultrasonography (CEUS) shows diagnos-
tic promise. We investigated differential diagnosis of gall-
bladder lesions with CEUS using a new contrast agent, 
perfl ubutane microbubbles (Daiichi-Sankyo, Tokyo).
Methods: We treated 30 patients with gallbladder lesions 
detected by mass screening, including adenocarcinoma (2), 
chronic cholecystitis (3), debris (2), benign polyp (12), and 
adenomyomatosis (11). Four patients were diagnosed by his-
tologic examination of resected specimens: adenocarcinoma, 
2, adenomyomatosis, 1, and hyperplastic polyp, 1. Other 
patients were diagnosed by EUS, MDCT, magnetic reso-
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nance cholangiopancreatography (MRCP), and/or 12-month 
clinical follow-up. When contrast was scattered with a 
uniform and small fl ow image, we diagnosed benign polyps. 
When such fi ndings were absent or staining was continuous, 
(suggesting hypervascularity), we performed EUS, MDCT, 
and/or MRCP.
Results: In 2 patients with debris, CEUS showed no stain-
ing. In 10 with polypoid lesions, staining was scattered with 
uniform, small fl ow image. In 7 with adenomyomatosis, 
CEUS disclosed cystic areas in lesions. No further examina-
tion was required in 19 patients (63%). We performed EUS 
in 5 patients, MDCT in 8, and MRCP in 3. Of these 11 
patients, 7 were followed-up, while 4 (13%) patients had 
surgery to rule out cancer. In 2 patients, whose diagnosis was 
adenocarcinoma in situ, CEUS showed fl owing images des-
ignated irregular rolling sign or eruption sign.
Conclusion: We can diagnose benign polyps, when contrast 
is scattered with a uniform and small fl ow image. We can 
diagnose adenomyomatosis, when fl ow direction is constant 
and cystic areas were seen in lesions. When fl owing images, 
designated irregular rolling sign or eruption sign are seen, 
we can diagnose gallbladder carcinoma. CEUS using per-
fl ubutane microbubbles could limit follow-up gallbladder 
imaging to diagnose abnormal screening results.
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PREOPERATIVE IMAGING FINDINGS 
CONCERNING FOR GALLBLADDER 
MALIGNANCY: IS INITIAL 
LAPAROSCOPIC APPROACH 
REASONABLE?
G. Wright1, A. Siripong1, E. Mitchell1, M. Winton2 
and M. Chung3
1Grand Rapids Medical Education Partners/Michigan State 
University General Surgery Residency, Grand Rapids, MI; 
2Michigan State University College of Human Medicine, 
Grand Rapids, MI; 3Spectrum Health Medical Group, 
Grand Rapids, MI
Grand Rapids Medical Education Partners, Department of 
Surgery, 1000 Monroe NW 49503 Grand Rapids, MI, USA
Introduction: Gallbladder cancer is the most common 
biliary malignancy. This is most often an incidental fi nding 
following cholecystectomy. There are currently no guide-
lines for the treatment of patients with preoperative imaging 
concerning for gallbladder malignancy. We investigated 
these patients to determine the incidence of pathology-
confi rmed malignancy in this population and to discover 
factors that may be used to determine which patients may be 
initially managed laparoscopically.
Methods: All patients referred to a hepatobiliary focused 
surgical oncologist with preoperative imaging concerning for 
gallbladder malignancy who underwent cholecystectomy 
from 2005 to 2011 were reviewed. Retrospective chart 
review was used to record variables including demographic 
data, type of imaging used, operative fi ndings, and fi nal 
pathology. These were analyzed to determine factors predic-
tive of pathology-confi rmed malignancy.
Results: A total of 4,474 patients with gallbladder pathology 
were evaluated. Twenty-nine patients met criteria for study, 
including 15 females and 14 males with a median age of 70 
(23–90). Preoperative imaging included computed tomogra-
phy, ultrasound, and magnetic resonance imaging in 25, 11, 
and 9 patients respectively. Twelve patients had multiple 
imaging studies. Eight patients (27.6%) were initially 
managed laparoscopically with 3 conversions to an open 
procedure. A total of 14 patients (48.3%) had pathology-
confi rmed malignancy. Benign fi ndings included chronic 
cholecystitis (34.5%), adenomyoma (10.3%) and gallbladder 
diverticulum (6.9%). Age, sex, BMI, and performance 
of MRI were not statistically signifi cant predictors of 
malignancy.
Conclusion: Our results demonstrate that over one half of 
patients with preoperative imaging fi ndings concerning for 
gallbladder malignancy had benign pathology following sur-
gical resection. These fi ndings suggest that initial laparo-
scopic approach in selected patients may be appropriate. A 
multi-institutional prospective designed study would be ben-
efi cial in determine the effi cacy of such an approach.
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A RETROSPECTIVE REVIEW OF THE 
DIFFERENT TREATMENT STRATEGIES 
FOR RECURRENT PYOGENIC 
CHOLANGITIS IN CHANGI 
GENERAL HOSPITAL
Y. X. Koh, A. Chiow, L. S. Lee, S. S. Tan and 
S. Ibrahim
Changi General Hospital, Department of General Surgery
Changi General Hospital, Department of General Surgery, 
2 Simei Street 3, Singapore 52988952988SGSG
Introduction: Recurrent pyogenic cholangitis is a condition 
with repeated infection of the biliary system with the forma-
tion of biliary stones and strictures in the biliary system.
This study aims to review and identify the optimal man-
agement option in patients with Recurrent Pyogenic 
Cholangitis treated at Changi General Hospital (CGH) for 
the past 10 years from the period 1st Jan 2002–1st Oct 2011.
Methods: This is a retrospective review of a prospectively 
maintained database of patients with recurrent pyogenic 
cholangitis for the past 10 years.
Firstly, the presence of cholangitis defi ned by clinical 
picture suggestive of cholangitis. Secondly, the patient has 
imaging investigations showing the presence of intra hepatic 
stones, intrahepatic biliary strictures, ectatic dilated intrahe-
patic ducts, liver atrophy, liver abscess. Thirdly, exclusion of 
alternate diagnoses of autoimmune, congenital, neoplastic 
and postoperative causes.
Statistical Analysis was performed with SPSS version 
17.0, Fisher’s exact test was used to compare the proportions 
of treatment failure between the groups.
Results: Initial failure rate in terms of residual stone of 
operative compared with non-operative treatment was 10.2% 
vs 32.3% and this was statistically signifi cant (p = 0.0193).
Long term failure rates for operative compared with non-
operative treatment was 20.4% vs 61.3%, and this was sta-
tistically signifi cant (p = 0.0003). Median time to failure was 
12 months for non-operative group vs 34 months for the 
operative group. Log rank test p < 0.001.
Conclusion: Considering all the treatment modalities, there 
was a much higher rate of failure in the non-operative treat-
ment group vs that of the operative treatment group. This 
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demonstrates that the selection of cases to undergo non-
operative therapy remains to be defi ned.
From the Kaplan Meier curve, it can be observed that 
operative procedures are generally more durable than non-
operative methods. Although less durable, non-operative 
treatment methods can still be employed as temporizing 
procedures.
036
THERAPEUTIC STRATEGY FOR 
ELDERLY ACUTE CHOLECYSTITIS 
ACCORDING TO THE 
TOKYO GUIDELINES
K. Asa, M. Watanabe, S. Kusachi, H. Matsukiyo, 
T. Saito, H. Kodama, Y. Saida and J. Nagao
Department of Surgery, Toho University Ohashi Medical 
Center
Toho University Ohashi Medical Center, Department of 
Surgery, 2-17-6 Ohashi, Meguro-ku, 153 Tokyo, Japan
Introduction: We focused on the therapeutic strategy for 
elderly acute cholecystitis (AC) according to the Tokyo 
guidelines.
Methods: Between January 1998 and September 2010, 233 
patients who underwent cholecystectomy for AC at our 
department were enrolled in the study. The cases were clas-
sifi ed as follows: Mild 111 cases (47.6%); Moderate 120 
cases (51.5%); Severe 2 cases (0.9%). In regard to ages, 
elderly AC was defi ned as age ≥ 75 years, and younger AC 
was less than 75 years. Elderly AC included 53 patients 
(22.7%), and young AC included the remaining 180 patients 
(77.3%).
Results: In the elderly AC, the severity classifi cation was as 
follows: Mild 17 cases (32.1%); Moderate 36 cases (67.9%); 
Severe 0 cases. While, in the younger AC, the severity clas-
sifi cation was as follows: Mild 94 cases (52.2%); Moderate 
84 cases (46.7%); Severe 2 cases (1.1%). The elderly AC 
showed signifi cantly higher severity grade on admission. 
Furthermore, signifi cant differences in the presence of co-
morbidity, body temperature, white blood cell count, and 
serum C-reactive protein were between the elderly AC and 
younger AC groups found. In addition, signifi cant difference 
in the frequency of bactibilia and postoperative complica-
tions were also observed.
Conclusion: Physicians should always keep in mind that 
morbidity rates are signifi cantly higher in elderly patients, 
those also have a signifi cantly higher risk of severe local 
cholecystitis. Comorbidity itself may not be a contraindica-
tion of early laparoscopic cholecystectomy for high risk 
patients. Considering high morbidity rates, however, high-
risk patients should be managed carefully depending accord-
ing to their status.
043
EVALUATION OF THE HJORTSJO 
CROOK SIGN IN THE DELINEATION 
OF THE RIGHT POSTERIOR BILE 
DUCT ANATOMY
H. Alghamdi
University of Dammam, General surgery, 
Po Box 4002031952 Alkhobar, Saudi Arabia
Introduction: It is well recognized that most hilar bile ducts 
anatomical variations stem from different right posterior duct 
origin. Nakamura’s classifi es the supraportal right posterior 
duct into the most commonly type I (65%: in which the right 
posterior and anterior join to form a single right hepatic 
duct), type II (9.2:, the right posterior duct joins the confl u-
ence, forming trifurcation) the infraportal right posterior duct 
as type III (8.3%), type IV (15.8%, the right posterior duct 
joins the left hep.
Methods: Prospective study involve recruiting patient 
undergoing indicated ERCP from 1st of March 2010 to 30th 
of May 2011, without a history of liver resection or biliary 
instrumentation.
Results: Around 123 ERCPs done in the study period. Only 
86 were eligible to be included in the study. We found that 
Hjortsjo Crook sign is positive in 45%. Type 1 4%, type II: 
5%, type III: 2.5%, type IV: 15%. Conclusion sign is not a 
commonly fi nd sign but if positive it’s strongly correlated to 
type I.
044
PREOPERATIVE BILIARY DRAINAGE 
FOR DISTAL BILIARY OBSTRUCTION 
AND POST-OPERATIVE INFECTIOUS 
COMPLICATIONS
M. Jones, W. S. Ngu, C. P. Neal, A. R. Dennison, 
M. S. Metcalfe and G. Garcea
University Hospital of Leicester
University Hospital of Leicesterfl at 27, 55 Watkin road, 
Leicester LE2 7, United Kingdom
Introduction: Preoperative biliary drainage (PBD) of distal 
biliary obstruction may increase post-operative complica-
tions. This study examined the effect of PBD on positive bile 
culture rates (PBC) and complications after biliary bypass or 
pancreaticoduodenectomy. Bilirubin levels in the non-PBD 
cohort were also analysed to determine the impact on 
outcome.
Methods: A retrospective case-note analysis from 2003 to 
the present day was undertaken. Statistical analysis was 
undertaken using Students t-test, Chi-squared test, Receiver 
Operator Characteristics, correlation coeffi cient, relative risk 
ratios and logistic regression.
Results: Four hundred and twenty-two patients were identi-
fi ed. PBD resulted in a signifi cantly higher risk of both infec-
tious complications and PBC rates (RR 1.3 and RR 3.0 
respectively; P < 0.05). PBC was associated with a signifi -
cantly longer HDU stay (2 days versus 1 day) and a higher 
risk of infectious complications (RR of 1.4; P < 0.05). PBC 
was found to be an independent risk factor for infectious 
complications postoperatively (Odds ratio of 6.3: CI 1.8 to 
22.0: P = 0.003). Bilirubin levels in the non-PBD cohort did 
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not correlate or predict length of stay, HDU stay, mortality 
or complication rate.
Conclusion: There seems to be little value in PBD for 
patients with distal biliary obstruction. For most HPB units, 
avoidance of PBD will prove logistically impossible. 
Liberating HPB centres from their emergency general surgi-
cal commitments and operating as ‘stand alone’ units may 
be the only viable way of meeting this service need.
050
GNAS CODON 201 MUTATIONS ARE 
UNCOMMON IN INTRADUCTAL 
PAPILLARY NEOPLASMS OF THE BILE 
DUCT (IPNB) ARISING FROM THE 
INTRA- AND EXTRAHEPATIC 
BILIARY TREE
H. Matthaei1, J. Wu2, N. V. Adsay3, D. S. Klimstra4, 
R. D. Schulick2, B. Vogelstein2, R. H Hruban2 and 
A. Maitra2
1University of Bonn; 2Johns Hopkins University; 3Emory 
University; 4Memorial Sloan-Kettering Cancer Center
University of Bonn, General, Visceral, Thoracic and 
Vascular Surgery, Sigmund-Freud-Str. 2553105 Bonn, 
Germany
Introduction: Activating point mutations in GNAS codon 
201 have been detected in more than 50% of Intraductal 
Papillary Mucinous Neoplasms (IPMNs) of the pancreas. 
Biliary papillomatosis (BP) is characterized by multifocal 
Intraductal Papillary Neoplasms of the Bile duct (IPNBs) 
arising from the biliary tree and BP morphologically resem-
bles pancreatic IPMNs. Thus, we sought to assess the muta-
tional status of GNAS at codon 201 in IPNBs.
Methods: Thirty-four patients with BP from three institu-
tions were included. DNA from microdissected lesions was 
subjected to an ultrasensitive PCR/ligation method for the 
detection of GNAS mutations at codon 201 as well as of 
KRAS mutations at codon 12. Mutational status was com-
pared with clinical and pathologic data.
Results: The IPNBs of patients included had a median 
maximum diameter of 3.5 cm (range, 0.7–21.1 cm) and were 
located intrahepatically (N = 6, 18%), extrahepatically (N = 
13, 38%), both intra- and extrahepatically (N = 4, 12%), or 
in the gallbladder (N = 11, 32%). A majority exhibited the 
pancreatobiliary epithelial subtype (N = 20, 59%), had high-
grade dysplasia (N = 26, 77%), and had an associated inva-
sive adenocarcinoma (N = 20, 59%). Analysis of GNAS at 
codon 201 revealed only one mutation (2.9%) in a multifocal 
intestinal subtype intrahepatic IPNB with high-grade dyspla-
sia. In another six patients (17.6%) a KRAS codon 12 muta-
tion was detected.
Conclusion: GNAS codon 201 mutations are uncommon in 
IPNB in contrast to pancreatic IPMNs. A more comprehen-
sive molecular profi ling is needed to uncover the pathways 
involved in the development of BP.
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A COMPARATIVE STUDY OF 
SURGERY AND ENDOSCOPY FOR 
THE TREATMENT OF BILE 
DUCT STRICTURE IN 
CHRONIC PANCREATITIS
J.-M. Regimbeau, D. Fuks, E. Bartoli, M. Fumery, 
A. Hanes, T. Yzet and R. Delcenserie
Federation of medico-surgical digestive diseases. Amiens 
University Hospital, Amiens, France
Amiens University Hospital, Amiens, France, Federation of 
medico-surgical digestive diseases, Place Victor Pauchet, 
80000 Amiens, France
Introduction: To compare the outcomes of endoscopic 
treatment (ET) and surgical treatment (ST) for common bile 
duct (CBD) stricture in chronic pancreatitis (CP).
Methods: From 2004 to 2009, 39 patients (35 men, 4 
women; median age: 52 (range 38–66)) were referred to our 
centre for CBD stricture in CP. Thirty-three (85%) patients 
underwent primary ET (with tube exchange every 6 months 
or in the event of obstruction) and 6 underwent primary ST. 
Treatment success was defi ned in both groups as the absence 
of signs of recurrence with normal serum bilirubin and alka-
line phosphatase levels, after permanent stent removal in ET 
group. The follow-up was >12 months in all patients. For 
patients treated with ET, the mean number of biliary proce-
dures was 3 (1–10) per patient and the mean number of stents 
used was 1.2 per procedure. The mean duration of stent 
intubation was 11 months.
Results: Although overall morbidity was higher in ST 
group, the frequency of complications requiring invasive 
procedures was signifi cantly higher in the ET group (7 vs. 1, 
p = 0.04). In intention to treat, the success rates of ST and 
ET did not differ signifi cantly (83% vs. 76%; p = 0.08). 
Seventeen patients required ST after ET due to failure. 
Event-free survival was signifi cantly greater in the ST group 
(16.9 vs. 5.8 months; p = 0.01). The actuarial success rates 
at 6, 12 and 24 months were respectively 74%, 74% and 65% 
in the ST group and 75%, 69% and 12% in the ET group (p 
= 0.01). After more than 3 endoscopic procedures, the 
success rates at 6 and 18 months were 27% and 18%, 
respectively.
Conclusion: For bile duct stricture in chronic pancreatitis, 
surgery is associated with better long-term outcomes than 
endoscopic therapy. After more than 3 endoscopic proce-
dures, the success rate is low.
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CONTRIBUTION OF MOLECULAR 
ADSORBENT RECIRCULATING SYSTEM 
DIALYSIS (MARS®) IN THE 
PREOPERATIVE MANAGEMENT OF 
JAUNDICED PATIENTS WITH HILAR 
CHOLANGIOCARCINOMA
J.-M. Regimbeau, E. Chapuis-Roux, D. Fuks, T. Yzet, 
R. Delcenserie, E. Lobjois, E. N’Guyen-Khac and 
J.-M. Regimbeau
Federation of medico-surgical digestive diseases. Amiens 
University Hospital, Amiens, France
Amiens University Hospital, Amiens, France, Federation of 
medico-surgical digestive diseases, Place Victor Pauchet 
80000 Amiens, France
Introduction: The preoperative management of hilar 
cholangiocarcinoma (HC) with jaundice focuses on the 
decrease of serum total bilirubin levels (TBL) by biliary 
drainage (BD). However, the time to obtain acceptable TB 
is about 6–8 weeks. The objective of this preliminary study 
was to evaluate the impact of MARS dialysis in association 
with BD on the decrease of TBL.
Methods: The study protocol was approved by the local 
institutional review board and written, informed consent was 
provided by all patients at enrollment. From January 2009 
and January 2011, we prospectively selected all jaundiced 
patients admitted to our university medical center with 
resectable right-sided HC, requiring a BD prior a major hepa-
tectomy. The BD was followed by 3 procedures MARS 
dialysis over a period of 72 hours. The collected parameters 
were the decrease of TBL, serum creatinine, prothrombin 
index, serum albumin, platelets count, pruritus and the spe-
cifi c complications of MARS.
Results: Among 26 patients treated with curative intent, 2 
patients were included (sex ratio 1, median age: 68 years) 
with HC (Bismuth-Corlette IIIa). The initial TBL was 328 
and 242 µmol/L, respectively. After 3 procedures of MARS 
dialysis, the TBL decreased of 30% and 52%. At the end of 
each procedure, there was a rebound of TBL of 10 µmol/L. 
The MARS improves the serum creatinine, decreased plate-
lets count and prothrombin index and does not infl uence the 
value of serum albumin. The pruritus disappeared after 1 and 
2 procedures. MARS-related morbidity included hypoten-
sion (n = 1), tachycardia (n = 1), thrombocytopenia (n = 2) 
and anemia (n = 1).
Conclusion: In association with BD, MARS dialysis 
appears to accelerate the decrease in TBL which would 
reduce the delay before surgery.
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RECURRENT ACUTE PANCREATITIS 
ASSOCIATED WITH CHOLEDOCHAL 
CYST MIXED TYPE (TYPE I AND II) AND 
ANOMALOUS PANCREATOBILIARY 
JUNCTION
D. Palafox1, J. R. Zacarías-Ezzat1, O. Chapa-Azuela2, 
D. Palafox3, A. Etchegaray-Dondé4, A. Rodríguez-Báez4, 
H. Garza-Flores4, G. Miranda-Devora3 and G. Rodríguez3
1Surgery Resident. Hospital General de Mexico; 2Surgery 
Service. Unit 305. Unit Chief. Hospital General de 
Mexico; 3Surgery Resident. Hospital General de Mexico; 
4Surgery Service. Unit 305. Hospital General de Mexico
Hospital General de Mexico, Surgery, San Francisco Street 
#7. Col. Del Valle. Del. Benito Juárez. 03103 Mexico City, 
México
Introduction: Choledochal cysts have an incidence in 
western societies of 1 in 100,000 to 150,000. Mixed choledo-
chal cysts type I and II are extremely rare and account 1.1%. 
To our knowledge there are only 6 cases reported worldwide. 
Clinical signifi cance is the risk of malignancy ranging from 
10–30%. Choledochal cysts are associated with anomalous 
pancreaticobiliary ductal union in 0.08 to 3.2% of the cases. 
We present a case of a patient with the aforementioned 
disease treated successfully with surgery.
Methods: The patient is a 20 year old male with recurrent 
acute pancreatitis treated with medical management. He was 
referred to our unit with an acute episode. Ultrasonography 
revealed intra and extrahepatic biliary dilatation, choledochal 
cyst and pancreatitis. CT-scan and Cholangio MRI revealed 
no further information but biliary dilatation up to ampular 
area. After medical management surgery was planned. An 
exploratory laparotomy was performed. An aberrant cystic 
duct draining into a choledochal diverticulum (2 × 2 × 1 cm) 
was encountered, as well as choledochal dilatation up to 
2.5 cm, Cholecystectomy, diverticulectomy and choledoco-
raphy were performed, T-tube placement and biliary drainage 
were also performed.
Results: 2 months after surgery, the patient had and 
acute episode and Endoscopic Retrograde Cholangio-
Pancreato graphy was performed along with sphinterotomy, 
further studies such as cytologic fl uid analysis revealed pan-
creatobiliary refl ux and surgery was performed. Roux-en-Y 
hepato-jejunal anastomosis was successfully performed. 4 
months after surgery, no further acute pancreatitis episodes 
have been encountered.
Conclusion: Pancreatobiliary junction malformations are 
often associated with malignant transformation, the rate is 
high ranging from 10–30%. It is of outmost importance to 
prepare an early surgical protocol in order to perform a suc-
cessful procedure and minimize associated risks. Long term 
survival rate in patients with biliary neoplasms arising from 
choledochal cysts is 6–21 months without early medical and 
surgical treatment. Long term follow up of this patients is 
mandatory.
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HEPATIC ARTERY PSEUDOANEURYSM 
FOLLOWING LAPAROSCOPIC 
CHOLECYSTECTOMY
K. Selvaraju and P. Shetty
Kasturba Medical College, Manipal University, 
Department of General Surgery, Agalya Nursinghome, 
Salem Main road
Mecheri, Salem Dt – 636453.63645 Salem, India
Introduction: Laparoscopic cholecystectomy is the treat-
ment of choice for symptomatic cholelithiasis. Despite its 
many advantages when compared to open procedure, there 
is an increase in the incidence of 0.3%–1.0% of biliary and 
vascular injuries. Hepatic artery pseudoaneurysm is a rare 
but serious late complication associated with laparoscopic 
cholecystectomy and bile duct injury. This poster depicts a 
rare but life threatening complication of laparoscopic chole-
cystectomy, its prevention and management.
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COMMON BILE DUCT EXPLORATION 
VIA CYSTIC DUCT WITH A SPECIAL 
REFERENCE TO SEPTUM-LIKE 
STRUCTURE AT THE JUNCTION: 
A SURGICAL PEARL TO AVOID BILE 
DUCT STRICTURE
A. Shimizu, M. Hyodo, Y. Sakuma, T. Fujiwara, 
H. Sasanuma, M. Koizumi, N. Sata and Y. Yasuda
Department of Surgery, Jichi Medical University
Jichi Medical University, Department of Surgery, Gion 
3-2-24, Shimotsuke, 329 Tochigi, Japan
Introduction: Choledochotomy is employed to surgically 
remove choledocal stones. In a case with a non-dilated bile 
duct, however, even if technically feasible, there remains a 
concern about postoperative stricture after primary closure. 
T-tube or C-tube is often used. Still once incised, benign 
biliary stricture could occur as a late complication. Cystic 
duct approach with septum opening has been applied for 
these cases with excellent outcome.
Methods: The gallbladder is removed from the hepatic bed 
in a fundus-downward fashion, followed by dissection of the 
cystic duct. Next the lateral side of the cystic duct is incised 
longitudinally up to the junction of the common bile duct to 
identify the opening into the bile duct. A septum-like struc-
ture, a fused abutment of the cystic duct and the common 
hepatic duct is recognized. This is opened without jeopard-
izing the free wall of the bile duct. Thereafter lithotomy is 
performed followed by cholangioscopy to ensure no calculus 
left. Then the cystic duct is closed with intermittent 5-0 
absorbable sutures. With this technique, incision to the 
common bile duct can be avoided and therefore theoretically 
stricture will not ensue.
Results: During the past three years, fi ve cases with gall-
bladder and/or choledochal stones were treated with this 
technique. No postoperative bile leak, no narrowing of the 
bile duct was noted. This method can also be applied to a 
diffi cult cystic duct cannulation case performing intraopera-
tive cholangiography.
Conclusion: Common bile duct exploration using this 
cystic duct approach is useful to avoid postoperative stricture 
especially in a case with a non-dilated bile duct.
072
ANASTOMOTIC LEAKAGE 
OF INTRAHEPATIC 
CHOLANGIOJEJUNOSTOMY 
FOLLOWING EXTENSIVE 
HEPATOBILIARY RESECTION
T. Noji, S. Hirano, E. Tanaka, T. Shichinohe, 
M. Miyamoto, T. Tsuchikawa, K. Kato and J. Matsumoto
Department of Gastrointestinal Surgery II, Graduate 
school of Medicine, Hokkaido University, Hokkaido, 
Japan
Graduate school of Medicine, Hokkaido University, 
Department of Gastrointestinal Surgery IIKita15 Nishi7, 
Kita-ku, 6086 Sapporo, Japan
Introduction: Intrahepatic cholangiojejunostomy is techni-
cally diffi cult. Few studies have reported result of intrahe-
patic cholangiojejunostomy following hepatobiliary 
resection. The purpose of this study was fi rstly to evaluate 
the incidences of anastomotic leakage after intrahepatic 
cholangiojejunostomy with extensive hepatobiliary resec-
tion, secondly to reveal risk factors for this specifi c 
complication.
Methods: Between September 1998 and December 2010, 
220 patients with biliary carcinoma underwent intrahepatic 
cholangiojejunostomy following hepatobiliary resection at 
the Second Department of Surgery, Hokkaido University 
Hospital, Japan. They consists of 140 patients with extra-
hepatic bile duct cancer, 45 patients with intrahepatic cholan-
gio carcinoma and 35 patients with gallbladder carcinoma. 
There were 146 men and 74 women, and median age was 68 
(range 41–81) years.
Data collected from pre-operative and operative fi ndings 
to evaluate the risk for anastomosis leakage included age, 
gender, diabetes, body mass index, pre-operative serum 
albumin, pre-operative biliary drainage, preoperative cholan-
gitis, preoperative portal vein embolism, the number.
Results: The incidence of anastomotic leakage was 13/220 
(5.9%). Univariate and multivariate analysis revealed that 
the risk factor of anastomotic leakage was platelet count less 
than 100,000 (/mm3) on post operative day 3. This risk factor 
was related with operative blood loss, operation time, and 
preoperative liver dysfunction. (ICGR15min > 15%).
Conclusion: The incidences of anastomotic leakage after 
intrahepatic cholangiojejunostomy with extensive hepatobil-
iary resection was 5.9%. The risk factor of anastomotic 
leakage was platelet counts less than 100,000 on post opera-
tive day 3.
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SILC FOR SILC: SINGLE INSTITUTION 
LEARNING CURVE FOR SINGLE-
INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY
C. W. Tay1, L. Shen2, I. G. Shridhar1, K. Madhavan1 
and S. K. Chang1
1Division of HPB Surgery, Department of Surgery, National 
University Health System Singapore, Singapore; 2Division 
of Biostatistics, Yoong Loo Lin School of Medicine, 
National University of Singapore, Singapore
National University Health System Singapore, Division of 
HPB Surgery, Department of Surgery, National University 
Hospital, 1E, Kent Ridge Road, NUHS Tower Block, Level 
8, 119228 Singapore 11922 Singapore, Singapore
Introduction: Single-incision laparoscopic cholecystec-
tomy (SILC) has been increasingly performed for benign 
gallbladder disease. No publication up to date has addressed 
the learning issues of this new technique.
We report the SILC learning experience of 2 HPB sur-
geons, studying the factors that could potentially infl uence 
the learning curve of SILC.
Methods: Patients who underwent SILC by Surgeon A and 
B over the period of 28 months were studied retrospectively. 
Operating time, conversion rate and reason for conversion of 
individual surgeons were recorded. Identity of fi rst assistants 
and their experience with previous laparoscopic cholecystec-
tomy (LC) experience were analysed for the effects of these 
factors.
Conversion is defi ned as adding extra working port(s) or 
laparotomy. CUSUM analysis is used to identify learning 
curve of SILC, T-test is used to compare continuous 
variable.
Results: 119 patients who underwent SILC were studied. 
100 and 19 cases performed by Surgeon A and B respec-
tively. 8 cases required additional working port, no laparot-
omy was required. In CUSUM analysis, most conversion 
occurred during the fi rst 20 cases.
Mean operating time were signifi cantly lower (63 vs 
91 min, p = 0.04) and lower conversion rate (2.5% vs 21%, 
p = 0.36) after the learning curve has been overcome. 
Operating times decrease as the experience increase for both 
surgeon.
Most common conversion is due to adhesion at Calot’s 
triangle. Acute cholecystitis, patients’ BMI and previous 
surgery do not seem to infl uence conversion rate. Mean oper-
ating times of cases assisted by assistant with and without 
LC experience were 48 and 74 minutes respectively (p = 
0.004).
Conclusion: About 19 cases are needed to overcome the 
learning curve, comparable conversion rate and shorter oper-
ating time were observed after learning curve has been over-
come. Team work, assistant with conventional laparoscopic 
cholecystectomy experience and appropriate equipment and 
technique are the important factors at the beginning stage of 
performing SILC.
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APPLICATION OF EVIDENCE BASED 
MEDICINE IN THE GALLSTONES 
SURGERY
S. Loudjedi, N. Meziane, F. Ghirane and M. Kherbouche
Department of Surgery B University Abou Bekr Belkaid
University Abou Bekr Belkaid, Surgey B15 rue 
Commandnat Djaber Tllemcen, 13000 Tlemcen, Algeria
Introduction: Evidence based medicien is the application 
of the best of the evidence in the management of patients
1. formulation of the clinical question
2. search in pubmed
3. analysis of results critical reading
4. application to patients.
Methods: We have 150 patients with gallstone disease we 
have applicated the different steps of Evidence Based 
Medicine to support these patients.
We consider our work a feasibility study.
The various issues involved gallstones and lithiasis of the 
bile duct.
Results: Of 25 questions asked on cholelithiasis we have 
found 45 articles on pubmed (meta-analysis, randomized 
trials) and we asked experts in biliary surgery.
About the practical application, 88 patients underwent 
laparoscopic cholecystectomy for cholelithiasis, 22 patients 
underwent a sphictérotomie for lithiasis of the bile duct and 
13 patients underwent laparoscopic cholecystectomy for 
acute cholecystitis in three days after the fi rst crisis.
Conclusion: Phenomenon with a weighting of three tripods 
of evidence-based medicine (documentary research, clinical 
situation and values of patients) we were able to apply evi-
dence-based medicine to surgery of gallstones.
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SURGICAL REVISION OF 
HEPATICOJEJUNOSTOMY 
STRICTURE AFTER FAILURE 
OF METAL ENDOPROTHESIS
S. Ammar
Assiut University Hospitals- Assiut -Egypt
Assiut University Hospital, Surgery department, Assiut 
University Hospital, General Surgery Department, 71516 
Assiut, Egypt
Introduction: Hepaticojejunostomy stricture could lead to 
long-term complication such as hepaticodocholithiasis, 
cholangitis, liver abscess formation, secondary biliary cir-
rhosis and portal hypertension. The objective of this study is 
to evaluate feasibility and safety of revision hepaticojejunos-
tomy after failure of metal stent.
Methods: Revision of hepaticojejunostomy stricture after 
failure of metal endoprothesis was done for 16 patients from 
February 2004 to May 2010. All patients presented by recur-
rence of symptoms and signs of biliary obstruction after 
percutanous management.
Results: The study group consisted of 12 females and 4 
males. The mean age was 35.4 (range 22–60) years. The 
duration of metal stent prior to attempted revision was ranged 
from 6 to 36 months. Fourteen patients were followed up for 
a mean period of 32.6 (range 12–60) months. Twelve patients 
had excellent results; they never had jaundice or cholangitis. 
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Two patients had good results with attacks of cholangitis at 
13, 16 months after operation and both of them respond to 
conservative management within 72 hours.
Conclusion: Surgical revision of hepaticojejunostomy after 
failure of metal endoprothesis is feasible and safe. Surgical 
revision is recommended from the start in such benign condi-
tion to avoid complication of metal stents.
1000
CHOLEDOCHAL CYST: ANALYSIS OF 436 
PATIENTS FROM AN INDIAN CENTRE
A. K. Agarwal
Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi 110002, India
Background/aim: Choledochal Cyst (CDC) or congenital 
bile duct cyst is a rare disorder affecting the biliary system. 
Prospective database of choledochal cyst was analysed to 
ascertain the clinical presentation, cyst morphology & com-
plications of choledochal cysts.
Material and methods: Study group included patients of 
choledochal cysts presenting to the surgical Clinic over a 
period of 11 years (January 2001 to May 2011) at our teach-
ing tertiary referral centre. Result: A total of 436 cases of 
choledochal cyst were managed during January 2001 to May 
2011. There were 63 (14.44%) paediatric and 373 (85.55%) 
adult patients. Male to female ratio was 1 : 4.1. Pain abdomen 
was most common presenting complaint followed by jaun-
dice, cholangitis, abdominal lump and pancreatitis. A history 
of prior biliary surgery was found in 44 (10.09%) patients. 
Two hundred and seventy patients (49.7%) had Type I CDC, 
158 had Type IVa (36.2%), 3 had Type V, and 2 had Type II. 
One patient each had Type III, IVb and VI (Todani’s modi-
fi cation of Alonso Lej classifi cation). Malignancy in form of 
gallbladder cancer & cholangiocarcinoma was present in 
7.79% cases and portal hypertension in 4.12%. Patients with 
Type I, II and IV CDC underwent excision of the extrahe-
patic portion of the Choledochal cyst with Roux-en-Y 
Hepaticojejunostomy. Two patients of Type V cyst under-
went left hepatectomy. One patient of T type VI cyst under-
went laparoscopic cholecystectomy. Thirty day mortality 
was 0.22%.
Conclusion: Type I was the most common type of CDC. 
Malignancy was present in 7.79% cases and Portal hyperten-
sion in 4.12%. Choledochal cyst excision with bilioenteric 
anastomosis is a safe procedure and should be performed 
early.
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OUTCOME OF FLUOROSCOPICALLY-
GUIDED LAPAROSCOPIC 
CHOLEDOCHOTOMY IN 
214 EGYPTIAN PATIENTS
A. Elgeidie
Gastroenterology Surgical Center, Jehan Street, Mansoura, 
Dakahlia, 35516 Mansoura, Egypt
Introduction: Laparoscopic bile duct exploration (LBDE) 
is well established although the results via choledochotomy 
performed under fl uoroscopic guidance without utilizing 
choledochoscopy are relatively poorly documented. This 
report evaluates the results achieved by a single surgeon 
operating in one institution on an unselected group of 
Egyptian patients.
Methods: Over a 5-year period, 214 consecutive patients 
with preoperative diagnosis of common bile duct stones 
(CBDS) and CBD diameter over 10 mm were included. 
Patients were diagnosed preoperatively by clinical examina-
tion, liver function tests, abdominal ultrasound and magnetic 
resonance cholangiography. They underwent LBDE via 
choledochotomy under fl uoroscopic guidance without utiliz-
ing fl exible choledochoscopy.
Results: 35 patients (16%) had undergone failed ERCP. 
Sixteen patients (7%) had failed CBDS extraction laparo-
scopically. Another 5 patients had no stones at intraoperative 
cholangiography. For the remaining 193 patients, primary 
closure was done in 98 patients (51%), T-tubes in 63 patients 
(33%), choledochoduodenostomy in 12 patients (6%), retro-
grade stent in 7 patients (4%), and antegrade stent in 6 
patients (3%). Postoperative complications occurred in 9 
patients (5%) (bile leak n = 5, internal hemorrhage n = 1, 
mild pancreatitis n = 1, and wound infection n = 2). Retained 
CBD stones were observed in 7 patients (3.6%) The median 
operative time was 67 minutes and the median hospital stay 
was 2.4 days. The median follow-up was 24.2 weeks with 
no strictures.
Conclusion: LBDE under fl uoroscopic guidance has a 
success/failure rate and a complication rate similar to 
those published for LBDE done via choledochotomy. 
Fluoroscopically-guided LBDE is safe and effective but 
there is a defi nite morbidity rate.
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BILE DUCT INJURIES ASSOCIATED 
WITH OPEN AND LAPAROSCOPIC 
CHOLECYSTECTOMY
O. J. M. Torres1, J. M. M. Junior2 and R. F. Neiva2
1Federal University of Maranhao – Professor of 
Gastrointestinal Surgery; 2Cancer Center Maranhao 
State – Surgeon
Federal University of Maranhao, Department of Surgery, 
Rua dos Bicudos 14/600 Ed. Aspen Renascença II65075 
Sao Luis, Brazil
Introduction: Major bile duct injury following cholecystec-
tomy is a serious complication having a considerable long-
term morbidity and occasional mortality. This is aggravated 
by delayed recognition of injury or a failed initial repair. 
Major bile duct injury can occur due to open or laparoscopic 
cholecystectomy. The aim of this analysis was to identify the 
possible differences between major bile duct injury associ-
ated with open and laparoscopic cholecystectomy.
Methods: This retrospective review includes 16 consecu-
tive major bile duct injuries following cholecystectomy, 
undergoing management in a single unit at our hospital, 
which is a tertiary care referral centre between March 2004 
and April 2008. Major bile duct injury was defi ned as occlu-
sion of the common bile duct either by transection or devel-
opment of a stricture or major segmental ducts injured at the 
porta hepatic. The patient profi le, time of presentation, and 
primary management were recorded. There were 14 female 
(87.5%) and two male (12.5%) with a mean age of 44.1 ± 
16.4 years. Thirteen patients (81.2%) were referred from 
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outside our institute and one patient with history of prior 
repair.
Results: Nine patients (56.3%) underwent open cholecys-
tectomy. Four of the injuries (25.0%) were recognized 
intra-operatively. The other twelve injuries (75.0%) were 
diagnosed postoperatively and manifested as biliary perito-
nitis and emergency surgery (two patients – 16.7%), bile 
leakage (three patients – 25.0%), or jaundice (seven patients 
– 58.3%). The diagnosis was confi rmed by abdominal ultra-
sound, computed tomography, magnetic resonance cholangi-
ography or endoscopic retrograde cholangiograms. The 
Bismuth’s classifi cation was Type II in 9 patients. Surgical 
management in all patients consisted of Roux-en-Y hepati-
cojejunostomy. The mean postoperative length of stay was 
11 days (range 5–42 days). There was one death (6.25%).
Conclusion: Major bile duct injuries remain a signifi cant 
problem in biliary surgery. When the fi rst repair is performed 
by surgeon experienced in hepatobiliary surgery, the success 
rate is high. There was no difference between laparoscopic 
and open cholecystectomy in terms of outcome and 
complications. 
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CLINICAL IMPACT OF 18-FDG PET-CT 
IN AMPULLA OF VATER CANCER
S.-P. Yun and H.-I. Seo
Department of Surgery, Postgraduate School of Medicine, 
Pusan National University, Busan, Republic of Korea
Postgraduate School of Medicine, Pusan National 
University, Department of Surgery, 305 Gudeok-Ro, 
Seo-Gu, Busan, 602-739 Korea 602 Busan, Republic of 
Korea
Introduction: 18-fl uorodeoxyglucose positron emission 
tomography/computed tomography (18-FDG PET/CT) has 
been a useful tool for the diagnosis of malignant lesions and 
the determination of stages. This study was performed to 
evaluate the signifi cance of 18-FDG PET/CT in the preop-
erative diagnosis of Ampulla of Vater cancer.
Methods: From October 2009 to June 2011, fi fteen patients 
who underwent whole body 18-FDG PET/CT imaging for 
differential diagnosis of Ampulla of Vater cancer were 
included, and the imaging study were carried out before the 
biliary biopsy and endoscopic intervention would be per-
formed. The fi ndings were counted positive when the value 
of SUV was over 2.5. The average value of SUV at Ampulla 
of Vater cancer was 8.1. Among 15 patients, fourteen showed 
over 2.5 of SUV, and another one had false negative result 
(sensitivity 93%). 10 were diagnosed as invasive carcinoma 
(SUV 6.5) and 5 as adenoma (SUV 11.4) in preoperative 
tissue biopsies. Fourteen patients underwent pancreaticoduo-
denectomy, and one underwent bypass surgery due to multi-
ple liver metastases.
Results: Among fourteen patients who underwent pancrea-
ticoduodenectomy, one was adenoma (SUV 2.6), 6 were pT1 
(average SUV 5.4), 3 were pT2 (average SUV 12.7), and four 
were pT3 (average SUV 9.3). Five patients had lymph node 
metastases (LN(−) : LN(+) = 7 : 10.4), and the average 
number of dissected lymph node was 18.1 (9–46). The 
patients whose multiple liver metastases were found was not 
diagnosed with preoperative 18-FDG PET/CT preoperative. 
The average size of tumor was 2.4 cm (1–5.3 cm), 6 were 
under 2 cm (average SUV 3.8) and 8 were over 2 cm (average 
SUV 11.0). 3 showed negative CK7 test, 8 positive CK7 test 
(SUV 10.1). 8 showed negative CK20 test (average SUV 
10.3), 3 positive CK20 test (average SUV 6.1), and positive 
CK19 test were shown in all 11 cases.
Conclusion: 18-FDG PET/CT could be very sensitive for 
preoperative diagnosis of Ampulla of Vater cancer, but not 
more superior to conventional imaging modalities, probably 
due to the low number of patients. The average values of 
SUV were detected highly when the size of cancer was over 
2 cm, metastatic lymph nodes, positive CK7 tests and nega-
tive CK20 tests. Evaluation for signifi cance of 18-FDG PET/
CT should be performed more precisely observing the 
changes of the amount of preoperative metabolism.
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INTRAHEPATIC 
CHOLANGIOCARCINOMA IN PATIENT 
WITH POLYCYSTIC LIVER DISEASE
M. Filauro, S. Cappato, F. Belli and A. Barberis
Ospedale GallieraDepartment of General Surgery and G.I 
diseases, General and Biliopancreatic Surgery Unit, Via 
Mura Delle Cappuccine 14, 16128 Genova, Italy
Introduction: Video presentation: Intrahepatic cholangi-
ocarcinoma is a malignant cancer arising from the neoplas-
tic transformation of cholangiocytes of intra-hepatic bile 
ducts. [1]
This tumor represents the second most common primary 
malignancy and several studies have shown that incidence 
and mortality rates are increasing worldwide, it’s account 
10–20% of the deaths for hepato-biliary malignancy. [2]
This tumor usually appears as a mass-forming lesion 
within the liver, which is mostly confused with metastatic.
Methods: We present a case of a male patient of 77 years 
old with intrahepatic cholangiocarcinoma in polycystic liver 
disease.
The patient’s personal history include diabetes mellitus II 
and primary hypertension.
He was admitted in our Department with abdominal pain, 
with no temperature and without sign of peritonitis.
Laboratory tests showed only an increasing of tumoral 
markers (CA 19,9 445 U/ml and CEA 16.2 ng/ml) and a CT 
scan demonstrated polycystic liver and kidney disease and a 
disomogeneus mass on the second and the third liver segment, 
this mass caused dilatation of intrahepatic bile ducts and 
involved left hepatic vein.
The patient underwent surgery on May 2010. After 
Makuuchi’s laparotomy, we found polycystic liver disease 
and a mass inv.
Results: Tumor resection is the only potential cure for 
cholangiocarcinoma. The median survival of patients with 
unresectable disease is 6–12 months [12].
All patients with resectable intrahepatic cholangiocarci-
noma, hilar cholangiocarcinoma, and the majority of patients 
with extrahepatic-cholangiocarcinoma, require partial hepa-
tectomy to increase the chances of negative resection 
margins. Preoperative evaluation includes an extensive 
assessment of patient fi tness for major surgery, the absence 
of any metastatic disease and the possibility of resection 
margins free from cancer. If any of these conditions are not 
satisfi ed, surgical therapy is not indicated and palliative 
modalities should be recommended [13–14].
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GAINING NEW INSIGHTS INTO THE 
MOLECULAR MECHANISMS 
UNDERLYING THE 
CHOLANGIOCARCINOMA
S. Di Filippo1, F. Goeman2, V. Canu2, A. Sacconi2, 
A. Scarinci1, G. Castagnola1, G. Blandino2 and G. L. Grazi1
1Department of General and Hepatobiliary, pancreatic 
surgery Regina Elena Cancer Institute Rome; 2Department 
of Pathology (Translational Oncogenomics Unit) Regina 
Elena Cancer Institute Rome
Regina Elena Cancer Institute Rome, General and 
Hepatobiliary, pancreatic surgery, Via Elio Chianesi, 
53144 Rome, Italy
Introduction: Currently, Cholangiocarcinoma (CC) is the 
second most common primary hepatic tumor and has over-
taken hepatocellular carcinoma as the main cause of death 
from a primary liver tumor. The only cure for CC remains 
surgical resection. Chemotherapy does not signifi cantly 
increase survival. So far the molecular mechanisms of CC 
oncogenesis and progression are poorly understood.
Methods: We selected a group of patients differing in grade 
and site of the tumor and extracted total RNA from biopsies 
deriving from normal and tumoral tissue. All samples were 
reviewed by a pathologist to verify the presence of malignant 
transformation and a percentage of tumor cells of at least 
60–70%. We hybridized the RNA samples on microRNA 
microarrays containing probes for 1205 different human and 
144 human viral microRNAs. To further characterize the 
gene expression signatures characteristic of CC we per-
formed with a subset of samples genome-wide microarrays 
for mRNAs.
Results: We identifi ed several microRNAs differently regu-
lated in tumor versus normal tissue in cholangiocarcinoma. 
Some of them were confi rmed in real-time analysis. Each 
microRNA has hundreds of putative mRNA targets and vice 
versa, each mRNA is regulated by several microRNAs. An 
in silico analysis using microRNA target prediction algo-
rithms like TargetScan, PicTar and miRanda combined with 
a bioinformatics analysis of the microRNA together with the 
mRNA microarrays enabled us to identify microRNA/mRNA 
modules. Therefore, combining microRNA and mRNA 
microarrays allowed us to identify potentially regulatory 
microRNA/mRNA clusters.
Conclusion: Our broad microRNA expression analysis 
revealed new microRNAs deregulated in cholangiocarci-
noma. The co-analysis of expression changes of microRNAs 
and mRNAs enabled us to draw conclusions about the mir-
coRNA/mRNA regulatory network characteristic for the 
cholangiocarcinoma which should contribute to an improved 
understanding of the molecular mechanisms driving the 
cholangiocarcinogenesis process.
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ENDOSCOPIC MANAGEMENT FOR 
LARGE AND MULTIPLE COMMON BILE 
DUCT PIGMENT STONES
A. Krishnan1, R. Ramakrishnan2 and J. Venkataraman3
1Special trainee; 2Assistant Professor; 3Professor & Head
Stanley medical college, Department of Gastroenterology 
and Hepatology, Old jail road, Royapuram 60001 chennai, 
India
Introduction: Different endoscopic modalities are available 
for the extraction of common bile duct stones. However, 
there is no clear consensus on the better therapeutic approach. 
The aim is to analyze the effectiveness of ‘interim’ plastic 
biliary stent deployment in diffi cult pigment stones.
Methods: Patients who had co-morbid illness and elderly 
patients who are not fi t for surgery were included. Endoscopic 
plastic biliary stenting was performed in 35 patients with 
large and/or multiple common bile duct stones or those dif-
fi cult to extract with conventional endoscopic therapy. Bile 
duct drainage and endoscopic placement of 7 Fr plastic 
biliary stents were established in all patients. The diameters 
of the CBD stones were measured on the radiographs before 
and after stenting.
Results: In this 11 patients has multiple CBD stones (>3) 
and 26 patients had large stones (>2 cms). Stone retrieval 
was possible, after a median of 24 days (19–38 days). All 
patients had reductions in the stone number and/or stone size. 
In 6 patients there was spontaneous clearance of the stones 
from the CBD. The median number and size of stones per 
patient was signifi cantly reduced after biliary stenting com-
pared with before {5 (3) vs 2.0 (1.0) [P < 0.0001]} and {2.8 
(1.5) to 2.0 (1.0) [P < 0.001]} respectively. All the stones 
were black and amorphous in consistency.
Conclusion: Plastic biliary stenting may fragment common 
bile duct stones and decrease stone sizes. Unlike the reports 
from the West, shorter period of deployment is suffi cient for 
pigment stones, because these are either black or mixed and 
are amorphous, unlike the hard cholesterol stones reported 
from the West.
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USE THE DUODENUM, IT’S ALREADY 
THERE: A RETROSPECTIVE COHORT 
STUDY COMPARING BILIARY 
RECONSTRUCTION TO THE EITHER 
THE JEJUNUM OR DUODENUM
J. Rose, T. Biehl and J. Ryan
Virginia Mason Medical Center
Virginia Mason Medical Center, Graduate Medical 
Education, 1100 9th Ave, 98101 Seattle, USA
Introduction: Surgical reconstruction of the biliary system 
is required for a variety of reasons. Roux-en-Y jejunal anas-
tomosis (RJA) is the current gold standard for repair. Direct 
duodenal anastomosis (DDA) is a less common approach, 
however it has the benefi t of operative simplicity and ease 
of postoperative endoscopic evaluation. We compared the 
outcomes of non-palliative DDA to RJA.
Methods: A retrospective cohort study was performed at a 
single tertiary care center comparing DDA to RJA between 
the years 2000 and 2010. Standard patient demographics, 
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complications rates, mortality rates, need for endoscopic or 
radiologic interventions, and long term outcomes were 
compared.
Results: A total of 105 non palliative biliary reconstructions 
were performed between 2000 and 2010. 67 DDA and 38 
RJA reconstructions were performed in an end-to-side 
fashion for bile duct injury, cholangiocarcinoma, choledo-
chal cysts, or benign strictures. The groups were similar with 
regard to demographics, preoperative diagnosis, postopera-
tive length of stay, postoperative mortality rates, and overall 
(Grade III or greater) complication rates. However, anasto-
motic related complications (leaks, abscesses/bilomas, or 
strictures) were fewer in the DDA cohort (11.7% vs. 35.3%; 
P = 0.01). And of those developing stricture, 5 of 6 in RJA 
cohort required percutaneous transhepatic access for man-
agement, as opposed to only 1 of 3 in the DDA cohort.
Conclusion: Direct duodenal anastomosis is a safe and 
often preferable method for biliary reconstruction. It may 
have decreased anastomotic complication rates and benefi ts 
from easier postoperative endoscopic management.
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TWO-PORT CHOLECYSTECTOMY AS A 
STANDARD OPERATION FOR ANY TYPE 
OF BENIGN GALLBLADDER DISEASES
S.-J. Kim1, D.-G. Kim2 and N. Gun-Hyung3
1Daejeon St. Mary’s hospital, Daeheung-dong, Jung-gu, 
Daejeon, Korea; 2Seoul St. Mary’s hospital, Banpo-dong, 
Seocho-gu, Seoul, Korea; 3Department of Surgery, Seoul 
St. Mary’s hospital, the Catholic University of 
Korea, Seoul
Daejeon St. Mary’s hospital, the Catholic University of 
Korea, Department of Surgery, Daeheung-dong, Jung-gu, 
301 Daejeon, Korea
Introduction: Despite its safety and feasibility, it is not 
completely certain whether 2-port laparoscopic cholecystec-
tomy can be applied to the same indications as 4-port 
cholecystectomy.
Methods: Prospectively collected data of patients who had 
undergone either 4-port (n = 261) or 2-port (n = 148) laparo-
scopic cholecystectomy between March 2007 and May 2010 
were analyzed retrospectively. For 2-port cholecystectomy, 
the authors designed an umbilical port using a wound 
retractor, a surgical glove, and 3 trocars to accommodate 3 
laparoscopic instruments. Another port was inserted in 
epigastrium.
Results: No difference was observed between the two study 
groups in terms of average age, sex ratio, body mass index, 
or preoperative laboratory variables regarding surgical out-
comes. Mean postoperative hospital stay was signifi cantly 
shorter in the 2-port group (4.7 ± 0.3 days vs. 3.8 ± 0.2 days; 
p = 0.021). For 2-port procedures, the factors found to be 
related with a longer operation were, development of an 
intraoperative complication (Odds ratio [OR] 3.42, CI 
1.323–8.820, p = 0.011), insertion of a drain (OR 3.05, CI 
1.284–7.244, p = 0.011), and longer hospital stay (OR 1.26, 
CI 1.005–1.574, p = 0.046).
Conclusion: The fi ndings of this study show that 2-port 
laparoscopic cholecystectomy has the potential to replace 
conventional 4-port laparoscopic cholecystectomy.
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THE FIRST REPORTED SQUAMOUS 
CELL CARCINOMA OF PANCREAS 
IN LATVIA
M. Pavars1, A. Vanags2, I. Strumfa2 and J. Gardovskis2
1Paula Stradins University Hospital; 2Riga Stradins 
University
Paula Stradins University Hospital, General Surgery, 
Pilsonu Street, 131002 Riga, Latvia
Introduction: Primary pancreatic squamous carcinoma 
(PPSC) is a rare morphological variant of pancreatic neo-
plasms with a reported incidence 0.5 to 2%. We present an 
extremely rare case of pure squamous cell carcinoma of the 
head of pancreas showing cystic characteristics. PPSC was 
diagnosed on histopathological examination of the surgical 
biopsy and is the fi rst such reported case in Latvia.
Methods: Physical examination, computed tomography and 
subsequent laparotomy with biopsy were done to establish 
the presence and origin of a cystic mass in the pancreatic 
head. Cytokeratin (CK) profi le including CK5/6; CK7; 
CK20; CK34βE12 as well as p63 was performed by immu-
nohistochemistry to defi ne the exact diagnosis.
Results: A 66-year-old woman was admitted to the hospital 
with a 3-month history of dull upper abdominal pain. On 
physical examination, there was palpable epigastric fullness. 
Computed tomography demonstrated a cystic mass in the 
pancreatic head. No abdominal lymphadenopathy or other 
focal lesions were present. Blood tests were normal. 
The patient underwent laparotomy, but the lesion was 
non-resectable due to the invasion in the celiac trunc. 
A palliative cystojejunostomy was performed and biopsy of 
cyst was done. Histology revealed pure squamous cell 
cancer, by immunohistochemistry CK5/6+; CK7−; CK20−; 
CK34βE12+; p63+. The patient received postoperative radi-
ation therapy, but the survival was only 2 months.
Conclusion: Despite the progress in oncological research 
squamous pancreatic tumours still represent worse survival 
results. Strategies involving non-surgical treatment such as 
chemotherapy and radiotherapy should be tested. More 
detailed studies of the tumour biology could lead to new 
treatment modalities.
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TREATMENT OF BILIARY LEAKAGE 
WITH ENDOSCOPIC STENT BY MEANS 
OF INTERVENTION-GUIDED 
RENDEZVOUS METHOD AFTER 
FAILED CANNULATION
S. Lee and H. Y. Kwak
Department of Surgery, St. Paul’s hospital, The Catholic 
University of Korea, College of Medicine, Seoul, Korea
St. Paul’s hospital, The Catholic University of Korea, 
College of Medicine, Seoul, Korea, Department of Surgery, 
St. Paul’s hospital, The Catholic University of Korea, 
College of Medicine, Jeonnong-dong, Dongdaemoon-gu, 
13070 Seoul, South Korea
Introduction: Biliary leakage is an uncommon but signifi -
cant complication following surgeries handling biliary tract 
including cholecystectomy. Although endoscopic placement 
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of biliary stents is a well-established technique, it requires 
much skill.
A 38-year-old man presented with ascending colon cancer 
with liver metastasis. The patient underwent right colectomy 
with right hepatectomy at the same time. 2 days after opera-
tion, biliary leakage was found.
Methods: We tried endoscopic retrograde cholangiopan-
creatography (ERCP) for decompression twice but failed. 
Intervention was done for percutaneous perihepatic abscess 
drainage and a 10.2 Fr large pigtail drainage catheter was 
placed below the right subdiaphragmatic space and another 
same catheter in its mid-portion, where communicates with 
biliary tree. A 0.035 in angled type Terumo guide has been 
kept with its distal in the duodenal loop via the communicat-
ing hole. Two days later, an endoscopic plastic biliary stent 
& nasobiliary drainage catheter was inserted following the 
guidewire after CBD cannulation by rendezvous method.
Results: Biliary leakage stopped two weeks after endo-
scopic retrograde biliary drainage (ERBD) and the nasobil-
iary drainage catheter was removed. Unfortunately the 
patient experienced another complication this time: entero-
cutaneous fi stula. The patient had adjuvant chemotherapy 
nine times and after follow-up study showed no progression, 
he had segmental resection for enterocutaneous fi stula. The 
patient discharged and currently is followed in stable status.
Conclusion: Biliary leakage stopped two weeks after endo-
scopic retrograde biliary drainage (ERBD) and the nasobil-
iary drainage catheter was removed. Unfortunately the 
patient experienced another complication this time: entero-
cutaneous fi stula. The patient had adjuvant chemotherapy 
nine times and after follow-up study showed no progression, 
he had segmental resection for enterocutaneous fi stula. The 
patient discharged and currently is followed in stable status.
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SYNCHRONOUS DOUBLE CANCER 
OF EXTRAHEPATIC BILIARY TRACT 
AND PANCREAS
J. H. Lee1, J.-W. Hwang1, K.-M. Park1 and Y.-J. Lee2
1Division of Hepatobiliary and Pancreatic Surgery, 
Department of Surgery, Asan Medical Center, Seoul, 
Korea; 2Asan Medical Center, Surgery, 388-1, Poongnap-
dong, Songpa-gu, 138-736, 13873 Seoul, Korea
Introduction: Two or more malignancies may be consid-
ered synchronous when each tumor presents a defi nite picture 
of malignancy, each tumor is distinct, and the possibility that 
one tumor is a metastatic lesion from the other has been ruled 
out. Synchronous malignancies of the extrahepatic biliary 
tract and pancreas are rare. This study aims to clarify clin-
icopathologic characteristics of synchronous cancers of the 
extrahepatic bile duct, gallbladder and pancreas.
Methods: Of the cases of resection for biliary tract and 
pancreas malignancies between 2003 and 2010, 10 patients 
had two separate malignancies. We retrospectively reviewed 
the clinical data and survival using medical records of these 
10 patients. We defi ned synchronous cancers as those occur-
ring within 6 months of the fi rst primary cancer.
Results: These double cancers of biliary tract and pancreas 
were more common in male, and age ranged from 48 to 
83 years (median 63). Of 10 patients, 5 had unexpected 
malignancies on imaging studies. Curative resections were 
performed in 8 patients and 2 patients had microscopic 
tumor-positive margin. Four patients were based on biliary 
or pancreatic intraepithelial neoplasia. Carcinoma-in-situ 
lesion was found in 2 patients. The median size of main 
tumor was 2.5 cm (range 1.2–5.2), and histologic grades of 
main tumor were well- (n = 1), moderately- (n = 7), and 
poorly-differentiated (n = 2). Lymph node metastasis was 
found in 1 patients. Tumor recurrences were developed in 4 
patients, and 1 patient died of lung metastasis at postopera-
tive 8 months.
Conclusion: Multiplicity of primary malignancies itself 
does not seem to indicate poor prognosis. The detection of 
multiple tumors may lead to proper strategy for curative 
resection. Understanding multiplicity and surgical outcomes 
are an important step for successful management.
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BILIARY FISTULAS AND 
LIVER RESECTIONS
F. Antonio and F. Martin
Hepato-Biliary Unit, Department of General Surgery, 
Central Hospital of Bolzano, Bolzano, Italy
Introduction: Standardization of hepatic resection treat-
ment has reduced mortality and morbidity rates. Anatomical 
resection and effective hemostasis have led to a reduction in 
postoperative complication rate (4–7%). One of the most 
fearful complications is the onset of a biliary fi stula, namely 
bile leakage following parenchymal transection. Although 
numerous methods for the intraoperative detection of bile 
leaks have been developed through practice and chemical 
substances have been manufactured for fi stula.
Methods: Our experience began in 1995: we have attempted 
to improve intraoperative biliostasis to minimize the risk of 
postoperative fi stula development by testing different materi-
als. In the early 2005, we began employing the collagen 
sponge coated with fi brinogen and thrombin. The resected 
surface must be cleaned of blood and subsequently the 
sponge, moistened with saline solution, can be applied, 
gently pressing for 3–5 minutes.
Results: In our clinical experience, prior to sponge use, a 
biliary fi stula developed in 3.9% of elective resections (4/103 
cases) and 5.1% of surgical procedures to treat bleeding due 
to hepatic trauma (4/79 cases): conversely, there were no 
postoperative bile leaks in the 14 patients (11 hepatic resec-
tions and 3 traumas) treated with collagen sponge coated 
with fi brinogen and thrombin and the drain was always 
removed 3–5 days after surgery.
Conclusion: Although the limited number of cases do not 
constitute clinical evidence, of note is the fact that hepato-
biliary surgeons can rely on local products for biliostasis, 
enabling them to safely carry out hepatic resection or post-
traumatic liver biliostasis. Absent or reduced biliary fi stula 
incidence has a positive impact on both patients (lower septic 
complication and re-operation rates) and institutions (shorter 
mean hospital stay and reduced costs).
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VARIATION AND CONGENITAL 
ANOMALIES OF HEPATOBILIARY 
SYSTEM: A PROSPECTIVE STUDY ON 
200 CADAVERS
S. Sharda, D. Chaudhary, A. Rai, R. Mankar, S. Kumar, 
A. Shukla, A. S. Kindra and N. Shukla
Gandhi Medical College, Bhopal, India
Gandhi Medical College, Department of Surgery, Gandhi 
Medical College and associated Hamidia Hospital, 1 
Bhopal, India
Introduction: Considerable anatomical variations of the 
hepatobiliary system may exist in a given population and 
knowledge of such anomalies is of utmost importance to the 
surgeon, because failure to recognize them at operation may 
be disastrous.
This study was aimed to inculcate and improvise the prac-
tice of hepatobiliary anatomy and dissection amongst resi-
dents; and to determine the gross anatomical variations and 
congenital anomalies of the hepatobiliary system.
Methods: A prospective study done on 200 cadavers. After 
due permission for autopsy, abdominal exploration was per-
formed to display the gross anatomy of the visceral surface 
of the hepatobiliary system noting the anatomical details as 
per working proforma, observations were formulated.
Results: The classic anatomic description of the origin of 
Common Hepatic artery from the Celiac Trunk was recorded 
in 97% cadavers, origin of Right Hepatic artery from Hepatic 
artery Proper in 89%, origin of Cystic artery from Right 
hepatic artery in 96%. Cystic artery crosses Posterior to 
Common Hepatic duct in 93%. Branching of Proper Hepatic 
artery before it enters Porta Hepatis (within 1 to 4 cms of 
Porta Hepatis) was recorded in 94%. Single gall bladder is 
encountered in all. 83% had angular, 12% had parallel and 
rest 5% had spiral confl uence of cystic duct with Common 
hepatic duct. The median length of Cystic duct, common 
hepatic duct and common bile ducts were 3.2 cms (1–6 cms), 
3.54 cms (1.2–8.5 cms) and 6.45 cms (2.2–10.6 cms) 
respectively.
Conclusion: The classical anatomic description of the 
origin of common hepatic artery was recorded in up to 97%, 
while ductal variations being very few. On the contrary, 
textbook picture suggests an approximately 50% variation in 
normal arterial anatomy. Despite differences in opinion 
regarding incidence of variations, one should have the 
knowledge of all the variants. However, there is no replace-
ment for meticulous dissection and vigilance.
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GALLBLADDER CANCER INCIDENCE 
AND TRENDS IN SETIF, 
(ALGERIA) 1986–2008
Z. Zoubida1, D. Abdellouche2, S. Laouamri1, A. Djemaa3 
and A. Mahnane1
1Cancer registry of Setif – University hospital of Setif; 
2Anatomopathology department – University hospital of 
Setif.; 3Constantine anti-cancer center – University 
hospital of Constantine – Algeria
University hospital of Setif, Cancer registry of Setif, Setif 
19000 Setif, Algeria
Introduction: Gallbladder cancer incidence is higher in 
women than in men in most areas of the world, it is a rela-
tively rare neoplasm, and detection of this is diffi cult because 
symptoms and signs are not specifi c and often appear late in 
the clinical course of the disease. For this reason, diagnosis 
is generally made when the cancer is already in advanced 
stages, and prognosis for survival is less than 5 years in 90% 
of cases. Gallbladder anomalies and cholelithiasis are the 
major risk factor for this cancer other risk factors are obesity 
and selected aspects of diet, linked to gallstones.
This study was designed to provide up-dated incidence 
fi gures for Gallbladder cancer in Setif at the period 1986–
2008 adjusting for the effect of age, sex, and period of diag-
nosis and the geographical distribution of Gallbladder cancer 
at the national international level. These data are compared 
with standardized rates of Cancer Registries in Five 
Continents.
Methods: Cancer registry represents a data source. Cancer 
morphology and topography are coded in accordance of the 
international classifi cation of diseases for oncology manual 
(ICD-O, the third edition).
Results: In setif, Algeria Gallbladder cancer ranked third in 
the female population with the standardized incidence rates 
8.1/100.000 persons year for representing 8.9% of all cases 
among women.
The Gallbladder cancer touch the young woman from the 
age of 35 years to increase gradually with the age and reach 
a maximum in 70–74 years then the incidence increases 
quickly from 85 years with a median age at 62 years old.
Conclusion: Gallbladder cancer is an important public 
health problem in Algeria and most causes of cancer death 
among women. Incidence and mortality have been declining 
in Algeria the last few decades, mainly due to the increasing 
frequency of cholecystectomy.
It is the most common cancer it represents 8, 9% of all 
cancer sites in female population reported in Setif cancer 
registry, more than 50% of new cases are the young women 
whose age is inferior at 50 years. It represents the second 
cause of mortality at women in Algeria it accounts 6000 
deaths each year.
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INCIDENTAL GALLBLADDER 
CARCINOMA (IGC): OUR TEN 
YEARS EXPERIENCE
G. Angelini, A. Barberis, F. Belli and M. Filauro
General and HPB Surgery Unit, Galliera Hospital, Genoa, 
Italy
Galliera Hospital, Genoa, Italy, General and HPB Surgery 
Unit, Mura delle Capuccine 14, 16125 Genoa, Italy
Introduction: Gallbladder carcinoma is a rare but high 
lethal neoplasm; it’s suspected preoperatively in 30% of 
patients, but 70% are incidentally found at the histological 
examination.
The role of radical resection for this disease is still debated 
and little is known about the long-term survival. Different 
recommendation are often drawn based on small groups data. 
The aim of this study was to report our experience with IGC 
and evaluate survival outcomes and prognosis.
Methods: This paper offers a retrospective descriptive anal-
yses of 16 cases of IGC out of 4118 cholecystectomies per-
formed between January 2000 and November 2009 in our 
HPB Unit, according to the most rigorous defi nition where 
IGCs were discovered fi rst by the pathologist; pre- and intra-
operative suspicion of gallbladder cancer, was a exclusion 
criteria.
Oncological follow up was updated through phone call 
interviews and outpatient visits.
Results: On a total of 4118 cholecystectomy (2975 laparo-
scopic and 1143 open), IGC was recognized in 16 patients 
(0.39%), 13 females and 3 males, mean age 66.5 ys 
(43–89 ys) with the following pathological stage, according 
to the American Joint Committee on Cancer (AJCC): 4 
patients had T1a cancer, 5 patients T1b, 4 patients T2 and 3 
patients T3; histological grade was equally represented: well 
differentiated (G1): 6 cases, moderately differentiated (G2): 
4 cases, poorly differentiated (G3): 6 cases.
Radical surgery (hepatic resection and lymphadenectomy) 
was performed in 5 patients: 1 T1b patient, 3 T2 and 1 T3 
patients.
At present 7 patients are still alive and 2 dropped out the 
follow up.
Conclusion: IGC presented a low incidence (0.39%) in our 
ten-years experience, with high mortality. Our behaviour was 
homogeneous in recommending for T2 and T3 patients 
extended resection of hepatic gallbladder bed and regional 
lymphadenectomy.
Although the small number of patients analysed we can 
register as among the 5 still alive and disease free patient, 3 
were T2 patients (60%) and 1 T3.
Prospective studies should be useful to improve our 
knowledge about IGC.
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INDEPENDENT PREDICTORS OF 
SURVIVAL IN GALLBLADDER 
CARCINOMA
V. Mittal1, L. Smithson2, L. Ferguson1, R. Kolachalam1, 
S. Silapaswan1 and M. Jacobs1
1Providence Hospital and Medical Centers, Southfi eld, MI; 
2University at Buffalo – SUNY, Buffalo, NY
Providence Hospital and Medical Centers, Surgery 16001 
W. Nine Mile Rd. 48075 Southfi eld, USA
Introduction: OBJECTIVE: The objective of this study is 
to evaluate the effect of lymph node and tumor stage status 
on survival in gallbladder carcinoma.
Methods: Patients who presented with carcinoma of the 
gallbladder were retrospectively reviewed from 1999 to 
2010. Clinical presentation, laboratory values, time of diag-
nosis, surgical management, and survival were assessed and 
analyzed.
Results: 54 patients with gallbladder carcinoma were found 
among more than 120,000 cholecystectomies done during a 
20 year period. 43 patients had primary carcinoma of the 
gallbladder and 11 patients had metastatic extension of the 
surrounding visceral malignancies. 44% of the patients pre-
sented as acute cholecystitis. Imaging studies (ultrasound 
and CT) yielded fi ndings suggestive of gallbladder carci-
noma in 14% and 65% respectively. Patients with negative 
nodes had a 5-year survival of 50% as compared to 0% 
5-year survival in node positive patients. 5-year survival was 
36% in stage I & II carcinoma of the gallbladder; whereas 
5-year survival was 0% in stage III & IV, though 1-year 
survival was 30% in stage III & IV. 5-year survival was 13%.
Conclusion: Early diagnosis and aggressive treatment for 
gallbladder carcinoma should increase the survival of this 
fatal disease. The lymph node and tumor stage has a direct 
relationship on the outcome and survival. High preoperative 
suspicions including tumor markers and presentations 
could permit early diagnosis and planned curative 
cholecystectomies.
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PHOTODYNAMIC THERAPY FOR 
CHOLANGIOCARCINOMA 
BY PERCUTANEOUS 
TRANSHEPATIC ACCESS
A. Ivanov, V. P. Zemlyanoy, I. P. Savinov, L. L. Drach 
and G. G. Muradov
North-Western State Medical University named after I.I. 
Mechnikov
North-Western State Medical University named after I.I. 
Mechnikov, surgical department, Russia, Saint-Petersburg, 
Kirochnaya ul. 41, Zip Code: 191015 Saint-Petersburg, 
Russia
Introduction: The prognosis of patients with cholangiocar-
cinomas is very poor and the fi rst symptom is mechanical 
jaundice. The percutaneous transhepatic drainage is used in 
the fi rst stage of treatment. It seemed to be an attractive idea 
to deliver light directly through the drainage. For doing that 
it was necessary to determine the possibility of tumor radia-
tion by the semiconductor laser through the catheter wall.
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Methods: The aim of the research was to estimate the 
optimum transmission spectra and measure the radiation 
damping semiconductor lasers (wavelength = 630–700 nm) 
by the wall of biliary catheters. Optical characteristics of the 
most widely used catheters were studied. The measuring of 
catheter wall transmission spectra was taken with monochro-
mator. Measurements of sample absolute transmission were 
taken with the help of photometric sphere.
Results: Our study showed that more effi cient larger radia-
tion wavelength should be used. In particular, quite promis-
ing seems to be the use of red area, in the range of 
600–700 nm. It was shown by the experiment the absolute 
value of catheter transmission coeffi cient is close to one. 
However, our clinical experience showed that during of the 
application of low intensity laser radiation a local thermal 
effect was registered. Consequently the wall of biliary drain-
age was damaged.
Conclusion: Light delivery through transhepatic drainage is 
possible, however, for the delivery of the suffi cient dose of 
light it is necessary to decrease the radiation power, which, 
in its turn, leads to the prolongation of the procedure.
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EXTERNAL PANCREATIC DUCT STENT 
DOES NOT DECREASE THE RATE OF 
PANCREATIC FISTULA AFTER 
PANCREATICODUODENECTOMY
D. Dahiya, S. Nusarat and L. Kaman
Department of General Surgery, Postgraduate Institute of 
Medical Education and Research (PGIMER), 
Chandigarh-160012, India
Postgraduate Institute of Medical Education and Research 
(PGIMER), Chandigarh, India, Surgery Assistant 
Professor, Department of Surgery, PGIMER, Chandigarh 
160012, India
Introduction: Pancreatic fi stula (PF) is the most important 
cause of morbidity and mortality after pancreaticoduodenec-
tomy (PD). In this retrospective study PF rate after PD was 
compared with an external drainage stent versus no stent.
Methods: This study included 53 patients who underwent 
PD by single surgeon at PGIMER, Chandigarh between June 
2000 and October 2010. These patients were divided into 
group A (26) who received external pancreatic duct stent 
across the pancreaticojejunal anastomosis and group B (27) 
where no pancreatic duct stent was placed. Primary study 
end point was PF as per ISGPF defi nition. Grade C pancre-
atic fi stulas were included in this study for evaluating the 
advantage of putting stent across the anastomosis.
Results: Group A and B were comparable in relation to 
demographic data, pathologic diagnosis and preoperative 
biliary drainage. PF rates were similar in both the groups 
(11.5% vs. 14.8%, p = 0.725). Re-exploration was required 
in 3 and 2 patients in group A and group B respectively (p = 
0.60). Only 2 patients in group A and 1 in group B underwent 
re-exploration for PF. There was no signifi cant difference in 
morbidity (p = 0.575), mortality (p = 0.318) and the require-
ment of radiological (p = 0.48) or endoscopic intervention (p 
= 0.969) following PD. Delayed gastric emptying was 
present in 19.2% & 18.5% in group A and B respectively (p 
= 0.094). Postoperative hospital stay was also comparable 
between groups (p = 0.66).
Conclusion: External pancreatic duct stent across after PD 
does not decrease the pancreatic fi stula rate.
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BILIARY ATRESIA SPLENIC 
MALFORMATION SYNDROME WITH 
ABSENCE OF PORTAL VEIN BRANCHES: 
A CASE REPORT
H. Shoriem, O. Hegazy, S. H. Eldeen, S. Saleh, 
I. Tarek, I. Marwan and E. Salah
National Liver Institute, Menoufi a University, Egypt, 
Department of Hepatobiliary surgery and liver 
transplantation, 75 Wageh Abaza st, Wadi Hof, Helwan, 
11142 Cairo, Egypt
Introduction: Although BA is an isolated abnormality in 
most infants, it may be associated with other congenital 
abnormalities such as the polysplenia syndrome in 9% to 
37% of patients. Splenic development anomalies are one of 
the most common components of this syndrome.
Methods: A 45 days old boy was admitted to the national 
liver institute hospital with neonatal cholestasis diagnosed as 
biliary atresia and was scheduled for Kasai procedure at the 
age of 55 days old.
Results: The whole external biliary system was atretic. 
Dissection of porta hepatis revealed large common hepatic 
artery. Surprisingly neither portal vein nor its branches was 
found in porta hepatic. The proximal part of the round liga-
ment towards the umbilicus it was containing a dilated 
umbilical vein close to the umbilicus with short portal trunk 
inserted in it. Anastomoses between the portal trunk and the 
patent part of umbilical vein was done to re-establish portal 
fl ow to the liver. Serum bilirubin gradually decreased and 
became anicteric one month after Kasai portoenterostomy.
Conclusion: We present a rare case of biliary atresia splenic 
malformation syndrome with congenital absence of the 
portal vein and its branches, polysplenia, and intestinal mal-
rotation. Kasai portoenterostomy procedure with construc-
tion of portal vein had been done and the infant became 
anicteric one month later.
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REINTERVENTION AFTER 
PERCUTANEOUS METALLIC STENTING 
FOR PALLIATION OF MALIGNANT 
BILIARY OBSTRUCTION
K. Roberts1, A. Adair1, M. Malaki2, S. Oliff2, D. M. Mirza1, 
R. P. Sutcliffe1 and K. Mangat2
1Department of Liver Surgery, University Hospital 
Birmingham, UK; 2Department of Radiology, University 
Hospital Birmingham, UK
University Hospital Birmingham, Liver Surgery, Queen 
Elizabeth Hospital, West Midlands B15 Birmingham, 
United Kingdom
Introduction: Percutaneous metallic stents are superior to 
plastic stents for palliation of malignant biliary obstruction. 
However, limited information is available on the outcome 
of patients after failed metallic stenting who require 
reintervention. The aim of this study was to evaluate the 
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results of reintervention at a tertiary hepatobiliary centre in 
this group of patients.
Methods: A total of 208 patients who underwent percutane-
ous metallic stenting for malignant biliary obstruction 
between 2007 and 2011 were identifi ed from a prospective 
database. The procedure was performed for proximal (n = 
113) and distal (n = 95) biliary obstruction. The outcome of 
patients with primary (persistent jaundice) and secondary 
(recurrent jaundice) stent failure were analysed. Second 
patency rate was defi ned as the time between second metal 
stent insertion and reintervention or death.
Results: A second procedure was required in 33 patients 
(percutaneous stent n = 24, endoscopic stent n = 3, external 
drainage n = 6).
Primary stent failure occurred in 6 patients at a median of 
26 days. In this group 4 patients underwent a successful 
second percutaneous stenting with a median second patency 
rate of 117 days.
Secondary stent failure occurred in 27 patients at a median 
of 105 days. Successful second percutaneous stenting was 
carried out in 20 patients with a median second patency rate 
of 122 days.
Median length of hospital stay post restenting was 4 days 
with a median drop in bilirubin of 33.5% over this time 
period.
There were no post procedural deaths. Overall survival 
from second stenting was 122 days.
Conclusion: After failed metallic biliary stenting, reinter-
vention can be performed safely in an experienced tertiary 
centre, and achieves effective internal drainage in the major-
ity of patients.
187
TORSION OF THE GALL BLADDER (G.T.)
P. pillay1, A. Jahangiri1, S. Naidu1 and J. Fenwick2
1Dept of surgery; 2Dept of Radiology
University of Queensland and Queensland Health, Surgery, 
level 5 Dept of Surgery, QE11 hospital Kessels R, Coopers 
Plain 4108 Brisbane, Australia
Introduction: Gall bladder torsion (G.T.) is rare and was 
fi rst described by Wendel in 1898. The presentation of 2 
cases within a 3 month period led to this analysis. It is rarely 
diagnosed preoperatively with serious outcomes. About 500 
cases have been described in the literature. The cause is the 
lack of the mesentry of the G.B. which then is free fl oating 
in the abdomen. We present 2 cases and review the 
literature.
Methods: The fi rst patient was thought to have large bowel 
obstruction as the caecum was grossly dilated on CT scan 
and although the gall bladder (G.B.) was enlarged no further 
comment was made. After failure to respond to conservative 
treatment a laparotomy was performed that revealed a 
necrotic and torted gall bladder compressing the transverse 
colon. A cholecystectomy was completed but the patient suc-
cumbed to multiorgan failure.
The second patient presented with severe right upper 
quadrant pain. On this occasion the radiologist was able to 
make the diagnosis based on the C.T fi ndings. Prompt 
surgery gave a favourable result.
Results: Delay in diagnosis resulted in poor outcome whilst 
early diagnosis produced a good outcome. This is the theme 
in most articles. The experience of the fi rst case enabled the 
clinicians to consider the diagnosis in the second case that 
was confi rmed by C.T. The 2 images will be presented.
Conclusion: G.T. is rare and a high index of suspicion is 
needed to treat the condition promptly. Our cases confi rmed 
this.
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LAPAROSCOPIC CHOLECYSTECTOMY 
IN SITUS INVERSUS TOTALIS
V. Borgaonkar, S. Deshpande, V. Kulkarni and 
V. Borgaonkar
Seth Nandalal Dhoot Hospital, Aurangabad, India
Seth Nandalal Dhoot Hospital, Department of Surgery and 
HPB unitPlot no A-1, MIDC, Chikalthana 43121 
Aurangabad, India
Introduction: Situs inversus totalis is a rare condition 
which presents diffi culty in clinical diagnosis as well as 
laparoscopic surgery for cholelithiasis. The mirror image 
anatomy makes the laparoscopic intervention diffi cult even 
for an experienced surgeon. Presenting here a video of 
Laparoscopy in Situs Inversus Totalis. Technical aspects of 
this mirror image condition and diffi culties faced during the 
procedure will be highlighted.
Methods: A middle aged lady presented with pain in left 
hypochondrium of 15 days duration. She was haemodynami-
cally stable. Her total leucocyte count was raised. 
Ultrasonography of abdomen revealed Cholelithiasis with 
Cholecystitis. Her X-Ray chest showed dextrocardia and 
Situs Inversus Totalis was confi rmed on Computerised 
Tomography examination. She was taken up for Laparoscopic 
Cholecystectomy.
O. R. arrangement – mirror image of routine laparoscopic 
cholecystectomy positions used in our department. 
Anaesthetist was at the head end, monitor was placed on the 
patient’s left side and surgeon with camera assistant was on 
the right side of the patient. Port position was a mirror image 
of standard four port lap-cholecystectomy.
Results: Laparoscopy in Situs Inversus Totalis is a demand-
ing procedure even in hands of experienced laparoscopic 
surgeon. The mirror image anatomy challenges dexterity of 
operating surgeon. When done with due care the results are 
as good as that of routine Lap cholecystectomy. Hook with 
diathermy was passed from epigastric port and managed with 
right/left hand of surgeon while traction at infundibulum was 
exerted by the assistant. Cystic artery was managed by har-
monic. Cystic duct was clipped and divided after obtaining 
critical view at Calot’s triangle. Dissection at fossa was done 
by surgeon’s right hand at mid clavicular port and gall 
bladder manipulated by surgeon’s left hand through epigas-
tric port.
Conclusion: Situs inversus is a congenital condition. It can 
either be partial or total. Laparoscopic Cholecystectomy has 
been proved to be gold standard even in Situs Inversus. The 
procedure becomes diffi cult because of the fact that the 
anatomy is mirror image of that of routinely seen and most 
surgeons are right handed. This needs alteration in technique 
of cholecystectomy. When about 25% biliary anatomical 
variations are considered, the risk of iatrogenic injuries 
increases.
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THE RADICALITY AND SAFETY OF 
BILE DUCT RESECTION FOR THE 
TREATMENT TO THE BILE 
DUCT CANCER
Y. Kato, M. Konishi, S. Takahashi, T. Kinoshita, 
N. Gotohda and T. Kinoshita
Department of Hepatobiliary Pancreatic Surgery, National 
Cancer Center Hospital East, Kashiwa, Chiba, Japan
National Cancer Center Hospital East, Department of 
Hepatobiliary Pancreatic Surgery, National Cancer Center 
Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 
277-8577, Japan
Introduction: Pancreatoduodenectomy (PD) or hepatobil-
iary resection (HBR; extended either right or left hepatec-
tomy or segmentectomy with caudate lobectomy and hilar 
bile duct resection) is commonly used for the surgical pro-
cedure of extrahepatic bile duct cancer to obtain a suffi cient 
surgical margin from cancer. On the other hand, Bile duct 
resection (BDR) play generally a narrow role for treatment 
to extrahepatic bile duct cancer such as palliative resection 
in recent years.
Methods: The surgical procedures depended on the location 
of the primary tumor. In principle, in the case of tumor invad-
ing obviously to intrapancreatic bile duct, PD was performed; 
to hilar bile duct, HBR. Only in the case that tumor was 
localized to the middle or upper bile duct (Bismuth type I or 
II tumors) and did not infi ltrate to the adjacent organs (Tis, 
T1 and T2), BDR was performed. A total of 161 patients with 
extrahepatic bile duct cancer who underwent resectional 
surgery with curative intent were reviewed retrospectively. 
In this study, the clinicopathological characteristics and sur-
vival outcomes of BDR (n = 34) were investigated and com-
pared with those of PD (n = 61) and HBR (n = 66).
Results: The morbidity, mortality and operative parameters 
such as operative time, operative blood loss, blood transfu-
sion rate, were signifi cantly lower in BDR group than in PD 
and HBR group. Mortality of BDR group was zero. BDR 
was safe procedure for the treatment of bile duct cancer. 
Overall 5-year survival rates were 39.9% (median survival: 
3.6 years) for BDR, 46.2% (median survival: 2.6 years) for 
PD, and 23.8% (median survival: 2.6 years) for HBR, respec-
tively. Among the BDR, PD and HBR group, the differences 
of survival rates were not signifi cant. Similarly, there was no 
signifi cant difference in survival which was adjusted for the 
UICC-TNM stage and the margin status of bile duct 
cut-end.
Conclusion: Performance of HBR or PD increased morbidi-
ties and mortalities compared to BDR, but the type of pro-
cedure did not have signifi cant impact on the long-term 
survivals of patients, if applied according to our intention-
to-treat strategy. So, we concluded that BDR is a safety 
procedure for the treatment of extrahepatic bile duct cancer. 
In the cases that tumor is localized to the middle or proximal 
third bile duct (Bismuth type I or II tumors) and does not 
infi ltrate to the adjacent organs.
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AGGRESSIVE SURGERY TO 
GALLBLADDER CANCER – EXTEND 
RESECTION FOR ADVANCED 
GALLBLADDER CANCER IN 
A SINGLE CENTER EXPERIENCE
T. Niguma, T. Kojima and T. Mimura
Okayama Saiseikai General Hospital
Okayama Saiseikai General Hospital, Surgery 1-17-18 
Kitaku Ifukuchou 70085O kayama, Japan
Introduction: For curative operation, advanced gallbladder 
(Gb) cancer with peri-pancreatic nodal involvement and/or 
hilar bile duct invasion is required extended operation such 
as pancreatoduodenectomy (PD) and/or lobular hepatectomy 
(LH) with bile duct resection. The benefi t of extended resec-
tion is still controversial because of unestimated prognosis 
and mortality.
Methods: The aim of this study is to report the result of 
extended operation for advanced Gb cancer. From 1980 to 
2010, 223 patients underwent laparotomy for Gb cancer in 
Okayama Saiseikai General Hospital. 210 patients under-
went Gb resection, while 13 patients were palliative. 124 
patients were pathologically curative, but 73 patients were 
non-curative. 48 cases had extended operations, including 25 
PD and 26 LH (3 PD with right LH). PD group includes 8 
peri-Gb partial hepatectomy, 14 central lower segmentec-
tomy, 3 right LH, 4 portal vein resection and 1 hepatic artery 
resection. All LH group underwent bile duct resection (3 PD) 
and lymph node dissection of hepatoduodenal ligament, 
further including 4 portal vein and 1 hepatic artery 
resection.
Results: Median survival (MS) of curative resection was 
49.6 months while non-curative resection was 7.0 months. 
Disease specifi c 5 year survival rate of curative resection is 
96.3% in pT1, 60.8% in pT2, and 28.4% in pT3 and pT4. In 
the extended resection group, curative resection rate is 62.5% 
(30/48). MS of extended curative resection was 28.1 months, 
while non-curative was 8.8 months. There was one mortality 
in PD group in the early 90’s. 13 patients survive more than 
3 years, and 6 patients survive more than 5 years without 
recurrence. Nodal involvement rates are 88.0% (22/25) and 
61.5% (16/26) in PD and LH group respectively. MS of 
extended curative resection are 23.0 months and 34.6 months 
in PD and LH group respectively.
Conclusion: These results suggest that extended operation 
for Gb cancer is feasible and have survival benefi t if patho-
logically curative operation is achieved.
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A CASE OF PRIMARY HEPATIC 
CARCINOSARCOMA WITH 
INTRABILIARY PAPILLARY 
GROWTH COMPONENT
T. Okuno, G. Honda, M. Kurata, S. Kobayashi, 
Y. Okuda and K. Tsuruta
Dept of Surgery, Tokyo Metropilitan Cancer and infectious 
Diseases Center Komagome Hospital
Tokyo Metropilitan Cancer and infectious Diseases Center 
Komagome Hospital, Surgery 3-18-22 Honkomagome, 
Bunkyo-ku, 11386 Tokyo, Japan
Introduction: Primary hepatic carcinosarcoma is a rare 
malignant tumor that consists of an intimate mixture of car-
cinomatous (either hepatocellular or cholangiocellular) ele-
ments and differentiated sarcomatous elements. We present 
here a case of primary hepatic carcinosarcoma with intrabil-
iary papillary growth component (IPC).
Methods: An 82-year-old man was referred to our hospital 
for abnormal liver function test. He had no history of viral 
hepatitis or alcoholism. CT showed a low density mass of 
3 cm with peripheral ring enhancement, dilated bile ducts of 
the left lobe and stenosis of the left hepatic artery and left 
portal vein. On DIC-CT images, no bile duct of the left lobe 
was observed and stenosis of the right main branch of the 
hepatic duct (RHD) and the common hepatic duct (CHD) 
were revealed in spite of no jaundice. We diagnosed a hilar 
cholangiocarcinoma developing from the left hepatic duct, 
which had a superfi cial spreading component. We performed 
extended left hepatectomy with excision of the extrahepatic 
bile duct and regional lymph node dissection.
Results: The gross fi ndings revealed a white-solid tumor of 
3 cm in Segment 2 close to the hilum with IPC, which had 
occupied most of peripheral branches of the left hepatic duct 
and had extended up to the RHD and CHD. Histologically, 
the main tumor was comprised of a sarcomatous element that 
included rhabdomyoblasts and a hepatocellular carcinoma 
element that existed as several smaller nodules. The majority 
of the tumor was a sarcomatous element and the fi ndings of 
transition between these elements were unclear. IPC con-
sisted of a sarcomatous element alone. Immunohistochemical 
fi ndings of the sarcomatous element were positive. His post-
operative course was uneventful and he is doing well without 
recurrence for 33 months after surgery.
Conclusion: Within the range of our reference, 42 cases of 
primary hepatic carcinosarcoma have been reported. The 
outcomes of these cases except for several cases that under-
went curative resection were very poor, and this case is the 
longest survivor. Tumors with intrabiliary papillary growth 
components are very rare and have been reported in only 2 
cases, including this case. Here we report this case and 
review the associated literature.
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USE OF ANTIBIOTICS IN ACUTE 
CALCULOUS CHOLECYSTITIS – AN 
AUDIT OF OUR PRACTICES
H. Bari and R. Khan
Aga Khan University Hospital, Surgery, 36, 9th 
Commercial Street, Phase IV, Defence Housing Authority, 
7500 Karachi, Pakistan
Introduction: To audit our practices of antibiotic usage in 
patients with acute calculous cholecystitis and compare them 
with international standard guidelines.
Methods: A retrospective proforma based study was per-
formed by reviewing the medical records of all patients with 
the diagnosis of acute calculous cholecystitis, admitted at 
Aga Khan University Hospital, Karachi from January 2009 
to December 2009. Data was recorded regarding patient’s 
demographics, clinical features, hematological and radio-
logical investigations & empiric antibiotics used (mono-
therapy – single antibiotic, combination therapy – more than 
one antibiotic). Patients were classifi ed according to Tokyo 
guidelines and our practices of antibiotic usage were com-
pared. Data were analyzed using Statistical Package for the 
Social Sciences (SPSS version 16.0).
Results: A total of 120 patients were admitted with diagno-
sis of acute calculous cholecystitis, and 96 patients met the 
inclusion criteria. The patients were classifi ed into grade I (n 
= 50), grade II (n = 40) and grade III (n = 6). The combina-
tion therapy was used in 65% of grade I patients where a 
monotherapy is recommended by the guidelines. Flagyl was 
concomitantly used in 67% and 61% patients in grade I and 
II, respectively, where it is not recommended by the guide-
lines. Early cholecystectomy was performed in 97%, 95% 
and 100% of patients with grade I, II and III respectively.
Conclusion: Grading of severity of acute cholecystitis is 
helpful for guiding management strategies. Empiric antibiot-
ics should be used according to disease severity and suscep-
tibility patterns. Monotherapy should be the fi rst priority for 
mild & moderate cases and combination therapy for severe 
cases. Use of Flagyl should be more selective, especially in 
early cases.
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COMBINED CAVERNOUS HEMANGIOMA 
IN INTRAHEPATIC BILIARY 
CYSTADENOMA OF THE LIVER
K. Jung-Chul, H.-jong Kim, C.-K. Cho, Y.-S. Koh, 
Y.-H. Hur, H.-H. Kim, H.-J. Kim and B.-G. Choi
Division of Hepato-Pancreato-Biliary Surgery, Department 
of Korea, 42, Jebong-ro, Dong-gu
Chonnam National University Medical School, 501-7 
Gwang-ju, Republic of Korea
Introduction: Cavernous hemangiomas are the most 
common benign tumors of the liver. Intrahepatic biliary cys-
tadenoma is a rare cystic tumor that occurs with the liver 
parenchyma or, less frequently, in the extrahepatic bile ducts. 
By the way, combined cavernous hemangioma and intrahe-
patic biliary cystadenoma is extremely rare, which has been 
reported in less than 10 cases. Especially, any case of cavern-
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ous hemangioma in intrahepatic biliary cystadenoma has not 
reported in the English literature until now.
Methods: A 57-year-old woman visited our hospital com-
plaining of abdominal discomfort. Abdominal computed 
tomography revealed a 17.5 × 15 cm well-circumscribed 
cystic lesion with 5 × 3.4 cm-sized intracystic delayed 
enhancing solid portion in the right hepatic lobe. After 9 
months, the follow-up abdominal computed tomography 
demonstrated slightly increased size of cystic lesion (19 × 
16 cm) with intracystic solid portion (7.5 × 4.5 cm). Liver 
magnetic resonance imaging showed huge cystic lesion (15.7 
× 14.3 × 18.4 cm) with enhancing solid portion (7.6 × 4.6 × 
7.7 cm) in right hepatic lobe and S4. The laboratory data 
revealed that liver and renal function were within normal 
limits, and tumor markers including CEA and CA 19-9 were 
normal.
Results: The initial impression was biliary cystadenoma 
with hemangioma of the liver. Right hemihepatectomy was 
performed. The macroscopic examination of the specimen 
showed a 13 × 10-cm cystic lesion with 10 × 5.5 cm heman-
gioma in the cyst. The histopathology helped make the diag-
nosis of combined cavernous hemangioma in intrahepatic 
biliary cyatadenoma of the liver. The patient had an unevent-
ful postoperative course.
Conclusion: Here, we present a case of combined cavern-
ous hemangioma in intrahepatic biliary cystadenoma of the 
liver.
242
GALL BLADDER CANCER IN A 
SEVENTEEN YEAR OLD FEMALE: 
A RARE DISEASE
D. Singh, S. Kumar and J. K. Kushwaha
CSM (Erstwhile King George's) Medical University, 
Department of Surgery, Lucknow, India
Introduction: The incidence of gall bladder cancer (GBC) 
in India ranges from 1.01 per 100000 for males to 10.1 per 
100000 for females and the actual number may even be much 
more in endemic zone. The disease is common with advanc-
ing age and the youngest case reported in the literature is a 
22 years male.
Methods: We report a case of gall bladder cancer in a 17 
years old female.
Results: Case history: A 17 years female patient presented 
to us with history of right upper abdominal pain for 4 months 
and lump from past 3 months it was associated with signifi -
cant weight loss and anorexia. She had no signifi cant family 
and personal history. On examination she had satisfactory 
general condition with no lymphenoadenopathy and clinical 
jaundice. On abdominal examination hard, mildly tender 
hepatomegaly was seen. CECT scan of the abdomen revealed 
thickened, irregular gall bladder wall with 11 × 7 cms iso to 
hypodense space occupying lesion with ill defi ned margins 
in the right lobe of liver with portal and paraortic lymphad-
enopathy. The FNAC from liver confi rmed the diagnosis of 
metastasis from adenocarcinoma of gall bladder.
Conclusion: GBC is a disease of elderly age group however 
it may occur even in a young female from endemic zone and 
having large gall stone.
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LAPAROSCOPIC RESECTION OF HILAR 
CHOLANGIOCARCINOMA
M. A. Machado, M. Mochizuki, R. Surjan and F. Makdissi
University of Sao Paulo
University of Sao Paulo, Gastroenterology, Rua Dona 
Adma Jafet 74 cj 1021308 Sao Paulo, Brazil
Introduction: Surgical resection is the only curative treat-
ment for hilar cholangiocarcinoma. Laparoscopic hepatec-
tomy has been used to treat several types of liver neoplasms. 
However, technical issues have limited the adoption of lapar-
oscopy for the treatment of hilar cholangiocarcinoma. So far, 
there is only one report of minimally invasive procedure for 
hilar cholangiocarcinoma in the literature.
The aim of this video is to show a laparoscopic resection 
of hilar cholangiocarcinoma.
Methods: A 43-year-old female with progressive jaundice 
due to left-sided hilar cholangiocarcinoma was referred for 
treatment. Based on our previous experience with advanced 
laparoscopic liver resections, including central and extended 
resections, we decided to perform a totally laparoscopic left 
hemihepatectomy with radical lymphadenectomy and resec-
tion of extrahepatic bile ducts. Biliary reconstruction was 
performed using the hybrid method.
Results: Operative time was 300 minutes with minimum 
blood loss and no need for blood transfusion. Recovery was 
uneventful and the patient was discharged on the 7th post-
operative day. Pathology revealed a well-differentiated 
cholangiocarcinoma with negative lymph nodes and clear 
surgical margins. The patient is well with no signs of the 
disease 12 months after the procedure.
Conclusion: Laparoscopic left hemihepatectomy extended 
to segment 1 with extensive lymphadenectomy is safe and 
feasible in selected patients and by surgeons with expertise 
in both liver surgery and minimally invasive techniques. The 
use of hybrid method may be needed for biliary reconstruc-
tion, especially in cases with a very small caliber bile duct. 
Further studies are still needed to confi rm the benefi t 
of this approach over conventional surgery for hilar 
cholangiocarcinoma.
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AN EVALUATION OF THE SINGLE 
INCISIONAL CLIP LESS LC PROCEDURE 
USING THE LAPAROSCOPIC SUTURE 
AND LIGATURE PROCEDURE
M. Yamazaki, K. Koda, M. Suzuki, T. Tezuka, C. Kosugi, 
K. Imai, A. Hirano and H. Yasuda
Department of Surgery Teikyo University Chiba Medical 
Center, Ichihara city, Chiba, Japan
Teikyo University Chiba Medical Center, Surgery 3426-3 
Anesaki Ichihara city, Chiba, 299 Ichihara, Japan
Introduction: In the case of the laparoscopic cholecystot-
omy (LC), it is commonly performed to close a cystic artery 
and a cystic duct with metal clips. For a long time and 
although being rare, complications such as a lithogenesis or 
the bile duct stricture by clips after an operation are reported. 
We introduced the single incisional clip less LC (SICL-LC) 
for the purpose of preventing the complication caused by the 
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metal clip. We evaluate this operative method with clinical 
outcomes.
Methods: Between Nov. 2009 and Jul. 2011, 40 patients 
with a diagnosis of Cholecystolithiasis and polyps were 
assigned to SICL-LC (ligature group, n = 20) or to the single 
incisional clip LC (clip group, n = 20). LC was performed 
using the SILSTM port or wound retractor, which was 
inserted through a 2.5-cm-long umbilical skin incision. The 
cystic artery and gall bladder (GB) were ligated and dis-
sected by an energy device (mainly SonosurgR). The cystic 
duct was ligated by metal clips in clip group and by two 
times of knots including transfi xing suture in ligature group, 
using a curved forceps. The GB was hoisted by a 2 mm 
looped wire (mini-loop retractorR) or a thread. A 2 mm 
forceps was added in cases of diffi culty.
Results: There was no difference in operating times (clip, 
117 min vs ligature, 118 min), bleeding value (9.3 ml vs 
9.6 ml) and postoperative hospital stay (3.6 vs 3.7 days). 
There was no postoperative complication and conversion in 
both groups. However, SICL-LC was not performed in two 
patients. Worrying about the knot insuffi ciency of a cystic 
duct and bleeding from a big cystic artery, we added a clip 
for safety.
Conclusion: SICL-LC could be performed safely, and it 
seemed that SICL-LC was useful for the prevention of com-
plication due to a clip.
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SURGICAL OUTCOME AND 
PROGNOSTIC FACTORS OF DISTAL 
BILE DUCT CANCER
G. Yunome1, H. Shimamura1, S. Ishiyama2, Y. Narushima1 
and K. Takeda1
1Department of Surgery, Sendai Medical center; 
2Department of Surgery, Sendai Kosei Hospital
Sendai Medical Center, Department of Surgery 2-8-8 
Miyagino, Miyagino-ku, Sendai, Miyagi pref 98385 Sendai, 
Japan
Introduction: Distal bile duct cancer, comparing with 
Klatskin tumor or gallbladder cancer, seems to have rela-
tively higher respectability and curability. Though, once pro-
gressed beyond the bile duct, prognosis of this malignancy 
turns to be poor. Here we report our single institute experi-
ence and surgical results of distal bile duct cancer, and 
explore prognostic factors of this neoplasm.
Methods: Forty-eight patients were diagnosed as distal bile 
duct cancer, and operated in our institute between 1998 and 
2010. We performed pancreaticoduodenectomy (PD) for 38, 
and bile duct resection only for one of them. Two pts resulted 
in palliative operation. One patient died of gastrointestinal 
bleeding and following DIC after PD (mortality 2.6%). 
Except for this, remaining 37 pts were retrospectively 
reviewed about prognostic factors such as lymph node (LN) 
met, perineural invasion or chemotherapy effect. Survival 
rates were calculated using Kaplan-Meier method, and com-
pared by Generalized Wilcoxon or Logrank test.
Results: According to the UICC staging, 5-y survival of the 
pts in stage 1B was more than 60% (MST: 104M), whereas 
the prognosis of the pts in stage 2A or higher was very poor. 
When pts were compared from a LN met point of view, 
prognosis of the pts with LN met was signifi cantly worse 
than without LN met. There also was signifi cant difference 
of overall survival between the groups of positive and nega-
tive for pancreas invasion, whereas no signifi cant difference 
was observed for perineural invasion. Pts with positive 
resected margin seemed to have bad prognosis. We used 
gemcitabine and/or S-1 as adjuvant chemotherapy. But, 
adding chemotherapy after surgery had not so far improved 
overall survival comparing to surgery alone.
Conclusion: Positive LN met and pancreas invasion were 
independent prognostic factors for distal bile duct cancer. 
Since using gemcitabine and S-1 as adjuvant chemotherapy 
could not improve surgical outcome, applying other chemo-
therapeutic drugs or new combination is urgent.
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THE PROGNOSTIC FACTORS AFTER 
CURATIVE RESECTION IN DISTAL 
COMMON BILE DUCT CANCER; 
FOCUSING ON THE SIGNIFICANCE OF 
PERINEURAL INVASION AND 
LYMPHOVASCULAR INVASION
H. J. Kim, B. G. Choi, S. H. Cho, C. Y. Kim, Y. H. Hur, 
J. C. Kim, H. J. Kim and C. K. Cho
Chonnam National University Medical School, Gwangju, 
Korea
Chonnam National University Medical School, Surgery 
160, Baekseo-ro, Dong-gu, Department of Surgery, 
Chonnam National University Medical School, Gwangju, 
501-757, Korea
Introduction: Recently perineural invasion (PNI) and lym-
phovascular invasion (LVI) have been known to be important 
prognostic factors in peripheral cholangiocarcinoma and 
hilar cholangiocarcinoma, but, in distal common bile duct 
cancer (distal CBD Ca) it is not clear until now. The purpose 
of this study was to evaluate the factors that infl uence recur-
rence and long-term survival and especially the signifi cance 
of PNI and LVI as the prognostic factor after curative resec-
tion (R0) of distal CBD Ca.
Methods: We examined the patients with distal CBD Ca 
who underwent radical surgery at Chonnam National 
University Hospital between March 2006 and June 2010. 
Retrospective analysis was performed for 64 patients of 
distal CBD Ca with R0 resection confi rmed by pathologic 
results. We examined clinicopathologic features, recurrence 
and survival rate, and evaluated the prognostic factors affect-
ing survival. Survival curves were analyzed using the 
Kaplan-Meier method, and for the evaluation of prognostic 
factors, log-rank test was used for univariate analysis and 
Cox proportional hazards model was used for multivariate 
analysis. A p-value < 0.05 was considered to be statistically 
signifi cant.
Results: Overall survival rates for 1, 3, and 5 years were 
78%, 43%, and 35% respectively. In the univariate analysis, 
the prognostic factors infl uencing survival were histologic 
differentiation, lymph node metastasis, and TNM stage. 
Among them, lymph node metastasis was identifi ed to be 
only independent prognostic factor for overall survival in 
multivariate analysis. As for the PNI, the 5-year survival rate 
is higher in PNI-negative group than in PNI-positive group, 
but there was no statistical signifi cance. And also the LVI 
was not signifi cantly associated with long-term survival.
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Conclusion: Lymph node metastasis was only signifi cant 
prognostic factor affecting survival after curative resection 
of distal CBD Ca. As for the PNI and LVI those are recently 
thought to be signifi cant prognostic factors in cholangiocar-
cinoma, our study did not show any signifi cant relationship 
with long-term survival after curative (R0) resection of distal 
CBD Ca. We think that further larger scaled studies should 
be necessary to identify the prognostic signifi cance of PNI 
and LVI in distal CBD Ca.
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VASCULAR INVASION OF PERIHILAR 
CHOLANGIOCARCINOMA; DOES 
THE SITE OR HORIZONTAL 
EXTENSION MATTER?
Y. Kishi, K. Shimada, S. Oguro, S. Nara, M. Esaki and 
T. Kosuge
Hepatobiliary and Pancreatic Surgery Division, National 
Cancer Center Hospital
National Cancer Center Hospital, Hepatobiliary and 
Pancreatic Surgery Division 5-1-1, Tsukiji, Chuo-ku 104 
Tokyo, Japan
Introduction: Staging specifi c for perihilar cholangiocarci-
noma was developed in the 7th Union Internationale Contre 
Le Cancer (UICC) TNM classifi cation. In this staging, 
hepatic parenchymal invasion is classifi ed as T2b, and 
hepatic artery or portal vein invasion as T3 or T4 according 
to the site or horizontal extension. In the staging by Japanese 
Society of Biliary Surgery (JSBS), hepatic invasion less than 
5 mm in depth is defi ned as T3 and deeper hepatic invasion 
or any vascular invasion is defi ned as T4.
Methods: To evaluate which T category better discriminates 
patients’ prognosis, prognosis of 91 patients who underwent 
surgical resection for hilar cholangiocarcinoma with patho-
logically confi rmed hepatic or vascular invasion were evalu-
ated based on the UICC and JSBS staging.
Results: By the UICC, 42, 37, and 12 patients were classi-
fi ed as T2b, T3, and T4, respectively. There was no differ-
ence in the incidence of lymph node metastases (T2b vs. T3 
vs. T4; 60% vs. 62% vs. 58%; P = 0.96). Five-year survival 
rate of each group was 38%, 21%, and 20%, respectively (P 
= 0.24). By the JSBS, 24 and 67 patients were included in 
T3 and T4 category, and there was no signifi cant difference 
in the incidence of lymph node metastases (T3 vs. T4; 45% 
vs. 66%; P = 0.09). Five-year survival rate of each group was 
52% and 20%, respectively (P < 0.01).
Conclusion: Vascular invasion is associated with poor sur-
vival irrespective of the site or horizontal extension. Further, 
the infl uence of hepatic invasion on postoperative prognosis 
seems underestimated by the UICC staging.
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A CASE OF CONGENITAL AGENESIS OF 
THE GALLBLADDER (CAGB) WITH 
THE HYPOGENETIC CYSTIC DUCT 
DEFINITELY DIAGNOSED BY 
PERORAL CHOLANGIOSCOPY
K. Sasaki
National Health Insurance Kawasaki Hospital
National Health Insurance Kawasaki Hospital, Department 
of Internal Medicine, 23-1, Kitahara, Maekawa, Kawaski, 
Shibata, Miyagi, 98915 Kawasaki, Japan
Introduction: CAGB is a rare anomaly, which is, in adults, 
serendipitously detected at autopsy or laparotomy in most 
cases. Though per se usually poses no problems, it some-
times complicates cases exhibiting biliary symptoms, defying 
diagnosis: it still remains exceedingly diffi cult to correctly 
make the preoperative diagnosis. Though it is usually associ-
ated with the absence of the cystic duct, only four cases of 
CAGB have been reported in the world, so far, to be accom-
panied by the hypogenetic cystic duct.
Methods: A 59-year-old woman presented with a few-day 
history of abdominal pain, nausea, vomiting, icterus and 
fever. Her previous and family histories were non-
contributory. Laboratory data showed elevated hepatic and 
pancreatic enzymes, hyperbilirubinemia and leukocytosis. 
Computed tomography (CT) demonstrated the dilated biliary 
tree obstructed by a stone in the distal part and the swollen 
pancreas with the enhanced peripancreatic adipose tissue. No 
entopic or ectopic gallbladder was detected by ultrasonogra-
phy, CT or magnetic resonance cholangiopancreatography. 
Though failed to visualize the organ, endoscopic retrograde 
cholangiography showed a stone in the distal and a short, 
thin, blind tube arising from the mid extrahepatic biliary tree.
Results: Lack of past history of biliary diseases and too 
short a duration of the present symptoms excluded the pos-
sibility of the scleroatrophic gallbladder. She underwent 
endoscopic sphincterotomy and choledocholithotomy under 
the diagnosis of CAGB with the hypogenetic cystic duct 
complicated with choledocholithiasis triggering pancreatitis. 
Peroral cholangioscopy revealed the tube to be a crescent-
folded cul-de-sac running parallel to and draining into the 
common hepatic duct, the rudimentary primordium which 
should have developed into the cystic duct and gallbladder, 
confi rming the diagnosis. No other fi ndings were detected in 
the papillary orifi ce through the bifurcation of the hepatic 
ducts. She kept an uneventful postoperative course.
Conclusion: This is the fi fth case of CAGB with the hypo-
genetic cystic duct and the fi rst in the world, in which the 
diagnosis is established by peroral fi ndings fulfi lling the 
strict diagnostic criteria proposed by Frey et al. This report 
emphasizes the importance of awareness of the anomaly and 
the crucial role of peroral cholangioscopy in diagnosing 
CAGB and consequently obviating unnecessary, potentially 
dangerous exploration through the non-natural orifi ces in 
quest of the phantom gallbladder.
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TREATMENT OF BILIARY 
COMPLICATIONS AFTER 
CHOLECYSTECTOMY NARJIS.Y, 
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GASTROENTEROLOGY, MOHAMED 
VI UNIVERSITARY HOSPITAL, CADI 
AYYAD UNI
Y. Narjis1, K. Rabbani1, N. Ihfa1, Z. Semlani2, A. Diffaa2, 
A. Louzi1, R. Benelkhaiat1 and B. Finech1
1Service de chirurgie viscérale, CHU Mohamed VI, Faculté 
de médecine et de pharmacie de Marrakech, Université 
Cadi Ayyad, Marrakech; 2Service de gastro-entérologie, 
CHU Mohamed VI, Faculté de médecine et de pharmacie 
de Marrakech, Université Cadi Ayyad, Marrakech
CHU Mohamed VI, Universite Cadi Ayyadchirurgie 
Visceralebp: 7010, Sidi Abbad 40000 Marrakech, Morocco
Introduction: Biliary complications of cholecystectomy 
are rare but serious. Their mortality rate can reach 9%. 
The purpose of the study was to describe the management 
of biliary complications after cholecystectomy in our 
department.
Methods: We analyzed the management of 18 patients (all 
women) with a mean age of 53 years (18–92 years). The 
complications found were wounds of the common bile duct 
(CBD) (n = 16, 60%), stenosis of the common bile duct (n 
= 5, 18.5%), fi stulas by dropping the cystic stump (n = 4, 
15%) and fi stulas of an aberrant biliary duct (n = 2, 7.5%).
Results: Acute cholecystitis was present in 40% of cases (n 
= 11). Intraoperative cholangiography was performed in 9 
patients (44%). We deplored one death. The wounds of the 
VBP was diagnosed intraoperatively in 43% of cases (n = 5) 
or within an average of 11.2 days in 57% of cases (n = 9). 
Secondary stenosis of the CBD were diagnosed within an 
average of 95 days. The trauma of the VBP were treated with 
biliary-digestive anastomoses 11 and 7 drains Kehr. Fistulas 
by dropping the cystic stump were diagnosed within 14.8 
days. Fistulas of aberrant canal were diagnosed intraopera-
tively. Fistulas were treated by the establishment of a clip on 
the cystic duct (n = 1), a drain of Kehr (n = 1), and the closure 
of the aberrant duct (n = 2).
Conclusion: the trauma of CBD (sores or stenosis) post 
cholecystectomy are serious because they require often 
a biliary-digestive anastomosis unlike other biliary 
complications.
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MINIMUM INVASIVE SURGERY IS GOOD 
INDICATION FOR ADENOMA AND 
EARLY CANCER OF THE AMPULLA 
OF VATER
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H. Kajiyama2, T. Yazawa2, N. Takeshita3 and 
M. Yamamoto2
1Department of Surgery, Institute of Gastroenterology, 
Tokyo women’s Medical University, Yachiyo Medical 
Center; 2Department of Surgery, Institute of 
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3Department of Surgery, Ebara Hospital
Tokyo women’s Medical University, Yachiyo Medical 
Center, Surgery, Institute of Gastroenterology, 477-96 
Oowadashinden Yachiyo-shi chiba-ken 276 Chiba-ken, 
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Introduction: PancreatoDuodenectomy (PD) or Pylorus 
Preserving PancreatoDuodenectomy (PPPD) for tumors of 
the Ampulla of Vater were performed as the standard opera-
tion. Therefore, it may be possible that local excision is 
performed for the early stage carcinoma of Ampulla of Vater 
if the clinical diagnosis would be precisely provided. So far, 
we have performed minimum invasive surgery. We sought to 
examine treatment results of Minimum Invasive Surgery at 
this time.
Methods: From January 1989 through December 2009, 130 
patients with tumors of the Ampulla of Vater were surgically 
treated. Of these, 21 and 97 underwent Minimum Invasive 
Surgery and PD/PPPD, respectively. 20 out of 97 patients, 
who underwent PD/PPPD, had early cancer of the Ampulla 
of Vater. We examined whether this method is appropriate 
or not, by comparing treatment results of PD/PPPD with 
Minimum Invasive Surgery in terms of curability, operation 
time, a total amount of bleeding under operation, postopera-
tive complications and the average postoperative hospitaliza-
tion days.
Results: Local excision of the Ampulla of Vater and resec-
tion of duodenum as Minimum Invasive Surgery were per-
formed in 16 and 5 patients, respectively.
The average operation time was 173 minutes in local exci-
sion, 206 minutes in resection of duodenum and 308 minutes 
in PPPD/PD (StageI). The average a mount of bleeding under 
operation was 190 ml in local excision, 339 ml in resection 
of duodenum and 986 ml in PPPD/PD (StageI).
The average postoperative hospitalization was 19 days in 
local excision, 41 days in resection of duodenum and 37 days 
in PPPD/PD (StageI). The mortality was 0% in minimum 
Invasive Surgery and 10% in PPPD/PD (StageI).
Of 20 patients who underwent Minimum Invasive Surgery, 
all of them still survive without recurrence.
Conclusion: Minimum Invasive Surgery for tumors of the 
Ampulla of Vater is best indication for adenoma. It is thought 
that this operation procedure is very effective in patients with 
carcinoid and carcinoma if infi ltration border of malignant 
cells in the deepest part remains up to the Oddi’s sphincter. 
But it is essential to precisely diagnose the depth of 
infi ltration.
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Introduction: Cancer of the gallbladder is the most common 
cancer of the bile ducts and is the fi fth largest digestive 
cancer. Its diagnosis is often delayed and often done at a step 
of non-resecability. The objective of this study is to focus on 
a different epidemiological, clinical, paraclinical and prog-
nosis of this disease.
Methods: In this retrospective study, we report forty-three 
cases of cancer of the gallbladder between January 2002 and 
December 2009. The average age of patients was 57 years 
with extremes of 34 and 80 years. The patient was a female 
in 75% of cases. The gallstones were present in 55% of cases. 
The clinical symptomatology was dominated by the right 
upper quadrant pain (89% of cases), vomiting (61%) and 
jaundice (35% of cases).
Results: A right upper quadrant mass was found in 7 patients 
(17% of cases). Ultrasound and CT have to suspect the diag-
nosis, respectively 45% and 58% of cases. Twenty-eight 
patients were operated (65% of cases). The treatment was 
curative in 10 patients (36% of cases), palliative in 9 patients 
(32%) and no treatment in 9 patients (32%). Adjuvant chem-
otherapy alone was performed in 26 patients (61% of cases). 
No patient received radiotherapy. Operative mortality was 
zero with a median survival after diagnosis of less than six 
months.
Conclusion: Cancer of the gallbladder remains serious. 
Surgery is the only curative treatment.
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COMPLICATED LIVER HYDATID CYST: 
A COMPARATIVE STUDY OF 
SURGICAL MANAGEMENT AND 
LONG-TERM OUTCOME
F. Duek, J. Lendoire, L. Gil, F. Duek, C. Quarin, V. Garay, 
G. Raffi n, M. Rivaldi and O. Imventarza
Hospital Cosme Argerich
Hospital Cosme Argerich, Liver & transplant division, 
Almirante Brown, 2401155 Buenos Aires, Argentina
Introduction: Echinococcosis is a health problem in certain 
endemic areas of Argentina. The appropriate management of 
complicated liver hydatid cyst is still a matter of discussion. 
The aim of this study is to analyze the impact of complica-
tions in the surgical management and outcome of patients 
treated with liver hydatid cysts (LHC).
Methods: Between 1996–2011 61 patients underwent 
radical surgical treatment for LHC at our unit. Diagnosis was 
performed by US, CT and hydatid serology. A comparative 
analysis with non-complicated LHC was performed.
Results: 57.4% female, age 46.7. Symptomatic 100%. 
Localization: right lobe (65.6%), left (27.9%) bilateral 
(6.6%). Mean size 8.9 cm (r: 4–25), 37.7% > 10 cm. Fifteen 
patients presented with complicated cysts (24.6%): jaundice 
(8.2%), abscess (8.2%), cholangitis (6.6%). Intrabiliary 
rupture was verifi ed in 10 (16.3%). Surgical approach was 
conventional in 98.4%. All patients were treated by radical 
surgery: total pericystectomy 44.3%, subtotal pericystec-
tomy (>85%) 44.3% and liver resection 11.4%. Morbidity 
31.1% Clavien I 9 (47.3%), II 6 (31.5%), IIIa 3 (15.7%) 
grade IIIb 1 (5.2%). In univariate comparative analysis ICU 
stay (p = 0.04), length of hospital stay (p = 0.03), biliary 
fi stula (p < 0.001), bile duct drainage (p < 0.001) and po 
complications (p = 0.03) were statistically signifi cant.
Conclusion: One fourth of patients with liver hydatid cysts 
develop complications. Radical surgical treatment is the best 
approach, with a higher rate of hospital stay and morbidity 
in the complicated cyst. The most relevant parameter is 
the presence of a biliary fi stula and its therapeutic 
management.
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MANAGING THE KLATSKIN TUMORS IN 
THE 3RD MILLENNIUM: RELEVANCE 
OF PREOPERATIVE OPTIMIZATION 
AND MAJOR HEPATIC RESECTION IN 
OUTCOME IMPROVEMENT
F. Ratti, F. Ferla, F. Cipriani, L. Aldrighetti and G. Ferla
Department of General Surgery – Hepatobiliary Surgery 
Unit. IRCCS H San Raffaele, Vita-Salute San Raffaele 
University, Milan, Italy
IRCCS H San Raffaele, Hepatobiliary Surgery Unit, 
General Surgery Department, Via Olgettina 6020132 
Milano, Italy
Introduction: The diagnosis and treatment of hilar tumours 
requires a multidisciplinary approach based on the synergy 
of radiologists, surgeons, oncologists and gastroenterolo-
gists. Klatskin tumour is a relatively rare disease with a poor 
prognosis: currently the only possible treatment is repre-
sented by the removal of the tumour associated with radical 
surgery; outcome is closely related to a proper preoperative 
management of the patient.
Methods: The aim of this study was to evaluate the short-
and long-term outcome of patients undergoing surgery. From 
January 2004 to December 2011, 94 patients with preopera-
tive diagnosis of Klastkin tumours were candidated to 
surgery at the Hepatobiliary Surgery Unit of the Hospital San 
Raffaele in Milan. The data of all patients were prospectively 
collected and retrospectively reviewed. The outcome was 
evaluated in terms of perioperative morbidity and mortality 
and overall and disease-free survival. Outcome predictors 
were also evaluated.
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Results: Of 94 patients undergoing surgery, 80 underwent 
hepatic and biliary Carrefour resection. Fourteen patients 
were considered unresectable due to the presence of perito-
neal carcinomatosis or advanced disease seen during staging 
laparoscopy or at laparotomy and were therefore excluded 
from the analysis. Seventy-fi ve (93.7%) patients underwent 
major liver resections: in 14 of these, surgery was performed 
at a distance of 30–40 days from PVE. In 55 patients biliary 
drainage was preoperatively placed for palliation of obstruc-
tive jaundice. The postoperative morbidity rate was 52.1% 
and mortality 6.8%. The most frequent cause of death was 
postoperative liver failure. 5 years survival rate was 29%. 
Recurrent disease was found in 75% of patients.
Conclusion: Klatskin tumour still remains a disease associ-
ated with poor prognosis, but a correct preoperative diagnos-
tic and therapeutic management provides tools to perform 
this type of surgery with acceptable morbidity and mortality, 
improving long term results.
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UNSUSPECTED GALLBLADDER 
CARCINOMA AFTER LAPAROSCOPIC 
CHOLECYSTECTOMY
H. Matsukiyo, W. Manabu, A. Koji, S. Tomoaki, 
K. Hajime, H. Osahiko, N. Jiro and K. Shinya
Toho University Ohashi Medical Center Department of 
Surgery
Toho University Ohashi Medical Center, Surgery, 2-17-6, 
Ohashi Meguro-ku, zip code: 153-8515153 Tokyo, Japan
Introduction: The introduction of laparoscopic surgery is 
known associated benefi ts of decreased discomfort, short-
ened hospital stay and rapid return to normal activity.
Gallbladder cancer (GBC) has been detected in 0.3–2.9% 
of laparoscopic cholecystectomy (LC). 15–30% of patients 
with GBC show no preoperative or intraoperative evidence 
of malignancy, and unsuspected GBCs have been found 
occasionally after LC.
We retrospectively reviewed our cases, especially patients 
with a pT1a tumor (limited to mucosa).
Methods: Of 1472 patients who underwent LC from January 
1991 to May 2010, 7 (0.48%) with unsuspected GBC that 
had a pT1a tumor (limited to mucosa) were reviewed.
Results: These 9 patients consisted of 3 men and 4 women, 
whose ages ranged from 60 to 85 years, with a median age 
of 73 years. All of patients with a pT1a tumor (limited to 
mucosa). The preoperative diagnosis was chronic cholelithi-
asis in 4 patients, gallbladder poly in 4 patients. One patient 
with positive margin of cystic duct, subsequently underwent 
bile duct resection. All of patients have been doing well 
range 15–160 months after LC without recurrence.
Conclusion: The LC procedure does not adversely affect 
the prognosis of unsuspected GBC, regardless of whether it 
is detected after LC.
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1Professor, Gastrointestinal Surgery, Dayanand Medical 
College & Hospital, Ludhiana, India; 2Professor, 
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Introduction: Bowel injuries during laparoscopic cholecys-
tectomy (LC) are rare. But they may be associated with 
disastrous consequences if not recognised and managed 
early.
Methods: 14 patients with bowel injury secondary to LC 
were reviewed retrospectively. All the patients were operated 
elsewhere and referred to us for management.
Results: Of 14 patients, 6 patients had duodenal, 4 patients 
had jejunal, 3 ileal and one patient had transverse colon 
injury. Only in 4 cases injury was recognised intra-opera-
tively. In duodenal injury patients, primary closure was done 
in 4 patients, duodeno-pancreatectomy in one and pyloric 
exclusion in another patient. In patients with jejunal & ileal 
injury, perforation closure was done in 5 patients, resection 
anastomosis in one and loop ileostomy in one. Diversion 
colostomy was done for colonic injury. In 4 patients with 
jejunal injury, who were referred with peritonitis, there was 
no discharge in the subhepatic drain suggestive of bowel 
injury. 10 patients presented within 72 hours. All 4 patients 
presenting after 72 hours of injury expired.
Conclusion: Bowel injuries during LC that are nor recog-
nised and managed promptly are associated with high 
morbidity and mortality. The subhepatic drain after cholecys-
tectomy in these patients may not be a useful guide to bowel 
injury as it may fail to drain effectively a localised collection 
in the infracolic compartment.
284
SYMPTOMATIC GALLSTONES 
DURING PREGNANCY
S. Gupta1, M. Singla2 and S. Kumar3
1Associate Professor, Dept. of Gynaecology & Obstetrics, 
Dayanand Medical College & Hospital, Ludhiana; 
2Consultant, Dept. of Gynaecology & Obstetrics, Singla 
Maternity Hospital, Ludhiana; 3Associate Professor, Dept 
of Surgery, Dayanand Medical College & Hospital, 
Ludhiana, India
Dayanand Medical College & Hospital, Dept of Obstetrics 
& Gynaecology, Civil Lines 14100 Ludhiana, India
Introduction: Gallstone disease is not an unusual cause of 
pain abdomen during pregnancy. If not managed promptly, 
it may be associated with adverse foetal and maternal 
outcome. We present our experience with 20 patients with 
symptomatic gallstones during pregnancy.
Methods: We reviewed our data of 20 patients with symp-
tomatic gallstones retrospectively.
Results: Out of 20 patients, 4 presented during fi rst trimes-
ter, 14 during 2nd trimester and one during 3rd trimester. 8 
patients were managed conservatively and remained asymp-
tomatic throughout pregnancy. 5 patients who presented with 
acute severe cholecystitis were operated laparoscopically at 
presentation. 6 patients, who were initially managed con-
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servatively, underwent laparoscopic cholecystectomy elec-
tively during pregnancy as they remained symptomatic. One 
patient with recurrent pain, who had earlier refused surgery, 
presented with gall stone pancreatitis needing induction of 
delivery at 34 weeks of gestation. However there was no 
foetal or maternal mortality. None of the patients required 
tocolytics.
Conclusion: Laparoscopic cholecystectomy is a safe thera-
peutic option for symptomatic gall stones during pregnancy. 
Patients with symptomatic gallstones managed conserva-
tively during pregnancy remain at risk for high maternal & 
foetal morbidity.
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ROLE OF CD151 EXPRESSION IN 
GALLBLADDER CARCINOMA
N. Matsumoto, M. Shimada, T. Utsunomiya, Y. Morine, 
S. Imura, T. Ikemoto, J. Hanaoka and H. Miyake
Department of Surgery, the University of Tokushima, Japan
The University of Tokushima, Japan, Department of 
Surgery, 3-18-15 Kuramoto cho 770 Tokushima, Japan
Introduction: CD151 widely expressed in several cell 
types, including epithelial, endothelial, muscle and haemat-
opoietic cells, and involved in several pathological activities 
associated with tumor progression, including metastasis and 
angiogenesis. Resulted in, over-expression of CD151 in 
tumor tissues is associated with poor prognosis. The aim of 
this study is to clarify the clinical role of CD151 expression 
in gallbladder carcinoma (GBC).
Methods: Forty-fi ve patients with GBC who underwent sur-
gical treatment were included. CD151 (ab33315, Abcam 
Inc., UK) expressions were determined immunohistochemi-
cally. The intensity of staining (weak; 1, moderate; 2, strong; 
3) and the staining area (%) were analyzed. The positive 
expression was defi ned if the staining index (intensity of 
staining × area) was more than 100. Clinicopathological vari-
ables including Ki67 (ab66155 Abcam Inc., UK) and MMP9 
(ab76003, Abcam Inc., UK) were compared between the two 
groups.
Results: CD151 positive expression was 57.8%, and signifi -
cantly correlated with poorer prognosis (5 y survival; 29.2% 
vs. 77.7%). CD151 expressions signifi cantly correlated with 
lymphatic invasion and tended to be correlated with lymph 
nodes metastasis (LN meta). CD151 expression positively 
correlated to MMP9 expression with signifi cance, though 
Ki67 labeling index was similar between two groups. 
Multivariate analysis revealed that CD151 positive expres-
sion and LN meta were independent prognostic indicators 
(CD151; p < 0.0001, LN meta; p = 0.034).
Conclusion: Those fi ndings suggested that CD151 is a pos-
sible prognostic factor of GBC, and might be a molecular 
target through the regulation of metastasis.
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LAPAROSCOPIC OPERATION FOR 
SUSPECTED EARLY-STAGE 
GALLBLADDER CANCER
H. Kasugai1, S.-pei Mukai1, Y. Takehara1, J.-ichi Tanaka1, 
S.-ei Kudo1, Y. Sugiyama2 and T. Yamakawa2
1Digestive Disease Center, Showa University Northern 
Yokohama Hospital, Yokohama, Japan; 2Department of 
Surgery, Teikyo University Mizonokuchi Hospital, 
Kawasaki, Japan
Showa University Northern Yokohama Hospital, Digestive 
Disease Center 35-1, Chigasaki-Chuo, Tsuzuki-Ku 22485 
Yokohama, Japan
Introduction: The purpose of this study was to evaluate the 
feasibility of the laparoscopic approach for suspected early-
stage gallbladder cancers and to establish the strategy of the 
treatment for those lesions.
Methods: Thirty-two patients who underwent laparoscopic 
cholecystectomy were diagnosed to have gallbladder cancer 
histologically between May 1990 and December 2011 at the 
two institute. The numbers of case according to the histologi-
cal cancer invasion were pT1a(m) in 13, pT1b(mp) in 1, pT2 
(ss) in 17, pT3 (se) in1. A retrospective review of the medical 
records for the clinico-pathological features and the outcome 
was performed.
Results: The 5-year survival rate for pT1a and pT1b patients 
were 100%, whereas for pT2 patients was 77.4%. Ten out of 
17 cases of pT2 underwent the additional resection. Liver 
bed and D2 lymph node dissection was performed in all ten 
cases, in 2 cases bile duct resection was added, and in one 
case with liver metastasis, partial hepatectomy was com-
bined. Two patients without additional operation and one 
patient with second operation died of the recurrence. The 
patient of pT3 also died of the recurrence 6 months after 
second operation. Twenty cases could be suspected gallblad-
der cancer (pT1a;11, pT1b;1, pT2;8) preoperatively, and 
5-year survival rate of that suspected group (93.3%) was 
signifi cantly better than that of unsuspected group (72.7%).
Conclusion: The outcome of the cases in which laparo-
scopic operation was performed for gallbladder cancer was 
acceptable, and laparoscopic approach was appropriate. We 
believe that laparoscopic approach for suspected early gall-
bladder cancer should be selected fi rst. If the lesion is limited 
within the early stage, it is not necessary to do the additional 
treatment. However if the lesion is already progressed 
advanced stage, the adequate extended operation should be 
performed by open procedure.
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PROGNOSTIC FACTORS IN RESECTED 
ADENOARCINOMA OF THE AMPULLA 
OF VATER
A. Urakami, Y. Hirabayashi, M. Higashida, K. Tsutsumi, 
H. Nakashima, K. Yamashita, T. Hirai and M. Nakamura
Department of Digestive Surgery, Kawasaki Medical 
School, Kurashiki, Japan
Kawasaki Medical School, Digestive Surgery, 577 
Matsushima 701 Kurashiki, Japan
Introduction: The adenocarcinoma of the ampulla of Vater 
is a type of periampullary tumor with a better prognosis than 
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pancreatic cancer and bile duct cancer. Earlier detection, high 
resectability rates and less aggressive tumor characteristics 
have been the main factors related to longer survival. 
However, clinicopathological factors to predict tumor recur-
rence and survival are still controversial.
Methods: The aim of this study was to evaluate the prog-
nostic signifi cance of clinicopathological factors, using uni-
variate and multivariate analysis. We reviewed the medical 
records of 31 patients with surgically treated adenocarci-
noma of the ampulla of Vater between 1998 and 2010. Age, 
gender, tumor location, diameter, depth of invasion, pancre-
atic invasion (panc), duodenal invasion (du), surgical margin 
(em), lymph node metastasis (n), histological differentiation, 
tumor infi ltration (INF), lymphatic invasion (ly), venous 
invasion (v), perineural invasion (pn), nervous plexus inva-
sion (pl), CEA, CA19-9 were investigated.
Results: The 31 patients (21 males, 10 females) reviewed 
had a mean age of 67.7 years old (51–81). The total 50% 
mean survival time was 90 months, and the fi ve-year survival 
rate was 55.7%. Four factors, including panc (p = 0.0290), 
n (p = 0.0085), CEA (p = 0.0085), CA19-9 (p < 0.0001) were 
analyzed as being signifi cant by univariate analysis. Those 
four factors were reanalyzed by multivariate analysis. The 
lymph node metastasis (n) (p = 0.0373, hazard ratio = 8.617) 
was found to be the signifi cant prognostic factors.
Conclusion: In our study, the median survival time was 90 
months, and the 5-year survival rate was 55.7%. 38.7% of 
patients had lymph node metastasis. Our results showed the 
lymph node metastasis to be the most signifi cant prognostic 
factors for resected adenocarcinoma of the ampulla of Vater. 
These fi ndings may be useful in predicting life expectancy 
and determining treatment strategies after operation.
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CYSTIC DUCT CANCER 
PRESENTING HEMOBILIA
H. Baba1, T. Sanada1, H. Kuwabara1, N. Goseki1, 
S. Arii2 and H. Ishida3
1Shuwa General Hospital; 2Tokyo Medical and Dental 
University; 3Saitama Medical Center, Saitama Medical 
University
Shuwa General Hospital, Surgery, 1200 Yaharashinden 344 
Kasukabe, Japan
Introduction: Primary cancer of the cystic duct is rare, 
accounting less than 5% of all biliary tract cancers. It is well 
known that Farrar fi rst proposed the defi nition of cystic duct 
cancer but advanced cancer could not meet his criteria. Later, 
Ozedn advocated new criteria for surgically resected 
advanced cancer. We herein present an unusual case patho-
logically confi rmed advanced cystic duct cancer presenting 
hemobilia.
Methods: A 68-year-old Japanese female experienced a 
slight epigastralgia in the morning hours and gradually wors-
ened. She visited our emergency room for diagnosis and 
treatment. CT scan revealed a thickening of the gallbladder 
wall at the neck and mass formation was recognized suggest-
ing gallbladder cancer. Endoscopic retrograde cholangiogra-
phy was carried out for further diagnosis and encountered 
bleeding from the ampulla of Vater. Cholangiogram showed 
fi lling defect within the common bile duct. Contrast medium 
did not enter the gallbladder. With no evidence of distant 
metastasis, right trisegmentectomy along with caudate lobec-
tomy and lymph node dissection were scheduled following 
portal embolization.
Results: Her postoperative course was uneventful that she 
was discharged on the 12th postoperative day. Macroscopically, 
the center of the tumor located next to the neck of the gall-
bladder. Cystic duct was severely stenotic at the center of the 
tumor. Microscopically, poorly differentiated adenocarci-
noma was confi rmed. Despite massive bleeding at diagnosis, 
no evidence of coagulation or red blood cell accumulation 
was found that the pathogenesis of hemobilia was not con-
fi rmed. Two out of six nodes were positive for cancer, pTMN 
being pT3N1M0 StageIIB. Adjuvant chemotherapy by 
Gemcitabine and S-1 was continued for two years. Three and 
a half years have past since the initial operation and she is 
well.
Conclusion: Cystic duct cancer with hemobilia is reported. 
Massive liver resection can be achieved by preoperative 
portal embolization. Curative resection as well as adjuvant 
chemotherapy may play an important role in maintaining 
disease free period.
290
AGGRESSIVE SURGICAL TREATMENT 
OF KLATSKIN TUMOR
O. Kotenko, D. Fedorov, A. Grinenko, A. Popov, 
A. Korshak, M. Grigoryan, A. Gusev and I. Petrishe
National Institute of surgery and transplantology
National Institute of surgery and transplantology, Liver 
surgery and transplantology, 30 Geroev Sevastopolya str. 
3680 Kiev, Ukraine
Introduction: Surgical treatment of Klatskin tumour is one 
of the most diffi cult and not till the end of the resolved 
problems of modern surgical hepathology. Despite essential 
progress in diagnostics, to introduction of innovative tech-
nologies preoperative preparation, to modern methods of a 
transsection of a parenchyma and liver transplantation, 
results of surgical treatment remain unsatisfactory. Special 
complexity is represented by cases with a tumor invasion of 
a portal vein and a hepatic artery.
Methods: The purpose of the present research was studying 
of results of surgical treatment of Klatskin a tumor with 
invasion of the main vessels. Between 2002 and 2009 in unit 
of transplantation and liver surgery extensive and expanded 
resections of the liver to 71 patients with peripheral, perichil-
lar cholangiocarcinomas and Klatskin tumors are made. We 
study results of surgical treatment of 35 patients with a 
cholangiocarcinoma of confl uence bile ducts.
Results: 35 patients underwent resection for proximal 
cholangiocarcinoma.
Median age was 60 ± 12 years. Five tumors were classifi ed 
as Bismuth Type 2, fourteen Type 3a, nine Type 3b and seven 
Type 4, respectively. More than in 45% of cases there was a 
necessity of a separate drainage of three sections of a liver. 
From 35 patients in 22 cases have executed a resection of a 
portal vein with the subsequent reconstruction. At 4 patients 
it is made hepathoduodenoligamentectomy with resection 
and reconstruction of portal vein and hepatic artery. At preva-
lence of tumoral process on intrapancreatic part of choledoch 
at 6 patients is executed hepathopancreatoduodenectomy. 
The postoperative lethality has made 14.2%, 5-year survival 
rate – 25%.
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Conclusion: Aggressive surgical treatment for cholangi-
ocarcinoma the confl uence of bile duct with hepatic artery 
and portal vein resection can be performed safely with 
acceptable lethality and long term survival rate.
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LAPAROSCOPIC CHOLECYSTECTOMY 
IN CARDIAC PATIENTS
N. P. Jain2 and S. Kumar1
1Associate Professor, Dept. of Surgery, Dayanand Medical 
College & Hospital, Ludhiana; 2Associate Professor, Dept. 
of Internal Medicine, Dayanand Medical College & 
Hospital, Ludhiana
Dayanand Medical College & Hospital, Dept of Internal 
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Introduction: There is ever increasing number of cardiac 
patients with increasing age and associated medical illness, 
who present high risk for anaesthesia. We present our experi-
ence with 72 patients with symptomatic gallstones with 
cardiac disease.
Methods: Data of 72 patients with cardiac disease, who 
underwent laparoscopic cholecystectomy were reviewed ret-
rospectively. All patients were assessed by anaesthetist, car-
diologist and physicians before surgery. Transthoracic 
echocardiography was done in all the patients to evaluate the 
cardiac status.
Results: The mean age of the patients was 55 years (30–70 
years). Left ventricular ejection fraction, recorded by tran-
sthoracic echocardiography, was 20–30% in 39 (52%) and 
30–40% in rest 33 (48%). 15 patients (21%) had regional 
wall motion abnormalities, 27 patients (37%) had cardiomy-
opathy, 18 patients (25%) had valvular heart disease where 
as 12 patients (17%) had prior cardiac intervention. Intra-op 
arrhythmias were noted in 12 (17%). One patient died post-
operatively due to acute myocardial infarction.
Conclusion: Our study concludes that patients with symp-
tomatic gall stones and cardiac dysfunction should not be 
denied laparoscopic cholecystectomy. Thus proper evalua-
tion of cardiac status, administration of balanced anaesthesia 
and low pressure pneumoperitoneum reduces the chances of 
life threatening complications.
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LAPAROSCOPIC APPROACH FOR 
CHOLECYSTO-DUODENO FISTULA 
IN ASSOCIATION WITH 
CHOLECYSTOLITHIASIS: A REPORT 
OF THREE CASES
Y. Kando, G. Honda, M. Kurata, S. Kobayashi, Y. Okuda 
and K. Tsuruta
Dept of Surgery, Tokyo Metropolitan Cancer and Infectious 
diseases Center Komagome Hospital
Tokyo Metropolitan Cancer and Infectious diseases Center 
Komagome Hospital, Surgery 18-22, Honkomagome 3 
chome, Bunkyo-ku, Tokyo 11386, Japan
Introduction: Recently, almost all cholecystolithiasis cases 
can be managed by laparoscopic cholecystectomy (LC). But 
for the management of cholecysto-enteric fi stula, open chole-
cystectomy is still more common than LC. Here, we report 
3 cases of cholecysto-duodeno fi stula (CDF) that were 
managed successfully via laparoscopic approach. We 
describe methods to complete the surgery precisely and 
safely, and consider the indication and the timing for CDF, 
with a literature review.
Methods: The study comprised one male and two female 
patients with ages ranging from 62 to 82. Two patients had 
abdominal pain but one patient had no subjective complaint. 
Surgery was performed under general anesthesia using 4 
ports in the same way of the American-style conventional 
LC. Dissection around the gallbladder and duodenum was 
carefully performed prior to division of the fi stula. During 
division of CDF using a stapler, we inserted a gastroscope 
into the duodenum through the mouth to prevent duodenal 
stenosis and to check leakage. After division, we removed 
the gallbladder by conventional methods.
Results: In two patients, CDF was diagnosed by detecting 
the stone in the intestine, and by detecting air in the gallblad-
der and the fi stula in another one. Duration from onset to 
surgery was 10, 26 and 45 days. All three patients underwent 
LC with the described procedure. Mean operative duration 
was 199 minutes and the blood loss was little in every 
patient. We were unable to close the duodenal wall com-
pletely using the stapler in the patient who was operated on 
10 days after the onset, because CDF had yet to become 
suffi ciently fi rm by fi brotic change. We completed the repair 
using the greater omentum fi lling in the same way as the 
procedure for duodenal perforation caused by peptic ulcer. 
There was no postoperative leakage in any patient.
Conclusion: It was not diffi cult to expose and encircle the 
CDF via laparoscopic approach. By putting a gastroscope in 
the duodenum, we closed the CDF with the stapler without 
stenosis. Early treatment may result in incomplete closure, 
because the CDF is still edematous or has yet to become 
suffi ciently fi rm. Considering that the stone moves into the 
duodenum and produces CDF with acute infl ammation, we 
recommend surgery after stabilizing the patient’s condition 
with antibiotics or other treatments.
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INCREASED LIVER STIFFNESS IN 
EXTRAHEPATIC CHOLESTASIS
A. Pesce
A.O.U. Policlinico-Vittorio EmanueleSurgical sciences, 
organ transplantation and advanced technologies, Via 
Plebiscito 62895100 Catania, Italy
Introduction: Transient elastography is a non invasive tool 
to measure liver stiffness (LS), which has been reported to 
correlate with the stage of liver fi brosis. Extrahepatic 
cholestasis was reported to cause elevated LS, which is con-
sidered to be attributed to the increased hydrostatic pressure 
in the liver. In the present study the correlation of LS with 
laboratory data was investigated in extrahepatic cholestasis. 
The change of liver stiffness after successful biliary drainage 
was also assessed.
Methods: LS was measured in 15 patients with extrahepatic 
cholestasis due to malignant lesions in 8 cases and non neo-
plastic diseases of biliary tract or pancreas in 7 cases. Liver 
stiffness measurement was also assessed after 30 days by 
biliary drainage (stones removal or stenting at ERCP). Serum 
bilirubin levels and liver stiffness were correlated.
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Results: The mean value of LS in all patients was 10.6 kPa 
before biliary drainage. LS signifi cantly correlated with 
serum bilirubin levels (p < 0.0002). Biliary drainage led to 
a reduction of bilirubin by 15 to 0.8 mg/dl which was sig-
nifi cantly correlated with a reduction of LS by 10.6 kPa to 
4 kPa (p < 0.05).
Conclusion: Extrahepatic cholestasis should be excluded 
before assessing liver fi brosis by transient elastography in 
chronic liver diseases.
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A CHOLANGIOCARCINOMA 
DEVELOPING AFTER CHOLEDOCHAL 
CYST-DUODENO ANASTOMOSIS 
FOR CONGENITAL BILIARY 
DILATATION IN THE ABSENCE OF 
PANCREATICOBILIARY MALJUNCTION
Y. Kume1, G. Honda1, M. Kurata1, S. Kobayashi1, 
Y. Okuda1, Y. Tateishi2 and K. Tsuruta1
1Dept of Surgery, Tokyo Metropolitan Cancer and 
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Introduction: Recently, choledochal cyst-duodeno anasto-
mosis is considered a contraindication for congenital biliary 
dilatation regardless of concomitance of pancreaticobiliary 
maljunction, because cholangiocarcinoma develops in the 
dilated bile duct at a high rate. Generally, the cause of car-
cinogenesis is considered to be the continuous refl ux of pan-
creatic juice. However, pancreaticobiliary maljunction did 
not exist in this case.
Methods: A 41-year-old female, who underwent choledo-
chal cyst-duodeno anastomosis for congenital biliary dilata-
tion in the absence of pancreaticobiliary maljunction at the 
age of 3 months, was referred to our hospital for recurrent 
cholangitis. Contrast enhanced CT showed a high density 
tumor of 5 cm located in the superior and middle part of the 
common bile duct. MRI showed a high intensity tumor on 
diffusion-weighted image. Although the biopsy did not 
detect malignant cells, in light of the size of the tumor, we 
strongly suspected the tumor had already developed into 
cholangiocarcinoma in the dilated common bile duct. 
Therefore, we performed pylorus preserving pancreatoduo-
denectomy with regional lymph node dissection.
Results: The gross fi ndings revealed multiple semi-pedun-
culated tumors of 4 cm in largest diameter in the superior 
and middle part of the dilated bile duct. Histopathology fi nd-
ings revealed that the tumors were adenoma containing 
several components of very well differentiated adenocarci-
noma, which were all in-situ carcinoma. The fi nal diagnosis 
was TisN0M0 Stage0. Her postoperative course was une-
ventful and she was discharged on postoperative day 16. She 
is now doing well without recurrence for 1 year and 5 months 
after surgery.
Conclusion: We experienced a case of cholangiocarcinoma 
developing after choledochal cyst-duodeno anastomosis for 
congenital biliary dilatation in the absence of pancreaticobil-
iary maljunction. In this case, the cause of carcinogenesis 
was not the continuous refl ux of the pancreatic juice to the 
bile duct. This suggests that choledochal cyst-duodeno anas-
tomosis itself induces carcinogenesis of the dilated bile duct.
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APPLICATION OF EVIDENCE 
BASED MEDICINE IN THE 
GALLSTONES SURGERY
S. Loudjedi, N. Meziane, A. Bereksi and M. Kherbouche
University Abou Bekr Belkaid Tlemcen Surgery, B15 rue 
Commandant Djaber 13000 Tlemcen, Algeria
Introduction: Evidence-based medicine is the conscien-
tious and judicious use of best research evidence to support 
a given patient.
We tried to apply the different steps of this approach for 
surgery of gallstones.
Methods: Our experimental diagram was a feasibility study 
about 100 patients with simple and complicated cholelithi-
asis and cholecystitis in lithiasis of the bile duct.
We fi rst formulate clinical questions and literature search 
and analysis of results (critical reading) fi nally practical.
Results: We found the response to our fi ndings on PubMed 
and the Cochrane collaboration and we do a critical reading 
of these articles and we could apply the results in about 45% 
of cases.
Conclusion: Evidence based medicine is applicable in gall-
stones surgery has provided you use a phenomenon weight-
ing between the three pillars of this one: the documentary 
research, clinical situations, the surgeon’s experience and 
also values of the patient.
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ARE HISTOLOGIC MUCOSAL 
CHANGES A PARAMETER TO 
PREVENT GALLBLADDER 
CANCER APPEARANCE?
P. Sisco, N. Perrone, G. Pagliarino, M. J. Jaroslavsky, 
I. Alvarez and J. Devoto
Pirovano Hospital – Surgical Department – Buenos Aires 
– Argentina
Pirovano Hospital, Surgical Department, Giribone 
12511427 Buenos Aires, Argentina
Introduction: The similarity of the clinical features between 
benign and malignant gallbladder diseases as well as between 
early and advanced cancer stages lead to a late diagnosis of 
gallbladder cancer with poor prognosis and a high mortality 
index. The lithiasic chronic infl ammation is considered a risk 
factor due to the appearance of histologic mucosal changes 
– metaplasia (MTP) – dysplasia (DY) – a previous step in 
the development of gallbladder cancer.
Methods: Between January 2003 and June 2011, 1764 
anatomopathological reports belonging to patients with gall-
stones who underwent open or laparoscopic cholecystectomy 
were analyzed.
All the specimens were evaluated macroscopically; sec-
tions from fundus, body, neck and cystic duct were obtained 
for microscopic evaluation. The specimen was submitted to 
a complete study when suspicion of lesion existed.
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The presence of metaplasia, dysplasia and cancer in gall-
bladder wall was analyzed.
The A.J.C.C. staging system – 7 TH Ed. 2010 – was 
applied to classify early or advanced cancer.
Clinical features and outcome in patients with different 
stages of cancer were reviewed.
Results: In relation to gender, 1130 patients (64%) were 
female and 634 patients were male (36%) – range between 
45 and 92 years – mean age 69.
In all the cases, the underlying pathology was a sympto-
matic chronic calculous cholecystitis.
Metaplasia was present in 95 patients (5.4%): pyloric 
metaplasia (PMTP) 80 (4.5%) and intestinal type (IMTP) in 
15 (0.8%). DY was evidenced in 7 cases (0.4%).
Cancer was diagnosed in 20 cases (1.13%): 16 females 
(80%) and 4 males (20%) – range between 39 and 88 years 
– mean age 65. Fifteen patients presented advanced stages 
(75%) and 5 early stages which constituted a postoperative 
fi nding in the pathological report.
The comparative analysis of clinical features at admission 
revealed to be similar in patients with.
Conclusion: 1 – MTP and DY showed to be associated with 
cancer development in the specimens analyzed, even in cases 
when carcinoma originated from an adenoma.
2 – None of the study resources revealed the existence of 
mucosal changes.
3 – Cholecystectomy proved to be the only procedure to 
evidence histological changes in gallbladder wall in chronic 
calculous cholecystitis.
4 – The study of MTP and DY in a retrospective revision 
allowed us to conclude that cholecystectomy is the unique 
option to prevent cancer.
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IS SUBCUTANEOUS LOOP 
IN BILIOENTERIC 
ANASTOMOSIS EFFECTIVE?
V. Carrillo-Maciel, J. E. Carrillo-Maciel, 
O. M. Solorzano-Pineda, A. L. A. S., J. A. Leal-Martinez, 
S. Ramos-Linaje, R. Rangel-Rodarte and P. Cano-Rios
Social Security 71
Social Security 71, Department of Surgery, Calle Lobo No. 
224 Fracc. Los Viñedos 27016 Torreon, Mexico
Introduction: Karl Langenbuch performed the fi rst elective 
cholecystectomy on July 15, 1882. There was a possibility 
of biliary duct injury. Today the ratio is 0.2–0.6%. The opera-
tion of choice to repair the bile duct through there exist in 
13–30% risk of stricture. Subsequent re-operation present 
increased morbidity and mortality. For 14 years we have used 
a subcutaneous loop by mean of endoscopic access if devel-
oped stricture and resolve it with local anesthesia.
Methods: Objective: To demonstrate the effectiveness of 
the subcutaneous loop in patients with stricture bilioenteric 
anastomosis.
Methods: We reviewed 100 cases with bile duct injuries 
in the past fourteen years. They were divided into two 
groups: Group I: traditional reconstruction with bilioenteric 
anastomosis Roux-en-Y and group II: subcutaneous loop.
Data analysis: ‘Statistical analysis system’ Windows 
version 6.12. For categorical pre and postsurgical variables, 
‘Prog frequency’, for pre and postsurgical continuous vari-
ables ‘Prog Genial Linear Models.’
Descriptive statistics for measures of central tendency, 
mean, median, and mode and measures of dispersion, stand-
ard deviation, epidemiologic profi le.
Results: In group I there were no stenosis and in group II 
there are three. Those were resolved with hydrostatic 
dilatation.
Conclusion: Use of subcutaneous loop is effective and we 
recommend it for young patients with Bismuth type II, III, 
or IV.
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HEPATIC FIBROSIS DUE TO BILIARY 
OBSTRUCTION IS UNDER 
APPRECIATED AT THE TIME OF 
PANCREATICODUODENECTOMY: 
A WORD OF CAUTION
T. Winston, V. Siripurapu, E. Liu, R. D. Jeyarajah and 
T. L. Winston
Methodist Dallas Medical Center, Cancer Administration, 
1441 N. Beckley Avenue, 75203 Dallas, US
Introduction: Chronic obstruction of the biliary system 
may cause hepatic fi brosis, secondary biliary cirrhosis, and 
possible liver failure. We aim to detect the state of underlying 
liver fi brosis caused from biliary obstruction for patient’s 
undergoing a pancreaticoduodenectomy (PD).
Methods: Retrospective data was collected and reviewed on 
patients undergoing PD from September 2010 through 
December 2011. Each patient had a core needle biopsy per 
protocol performed at the time of surgery by a dedicated 
hepatobiliary surgeon at a tertiary care center.
Results: Out of twenty patients identifi ed, 9 (45%) were 
diagnosed with liver fi brosis. Superimposed on the fi brosis 
in these patients, 2 (10%) were diagnosed with liver steato-
sis, 2 (10%) were diagnosed with liver cirrhosis, and 4 were 
diagnosed with cholestasis consistent with bile obstruction. 
Eight of the nine patients (89%) had pancreatic adenocarci-
noma and one patient had pancreatic intraepithelial neoplasm 
(PanINa) (11%). Five of nine patients had stage 1–2 fi brosis, 
one of nine patients had stage 2–3 fi brosis, two of nine 
patients had stage 3–4, and one patient had stage 4 fi brosis 
(cirrhosis). One patient with diagnosed cirrhosis did not have 
the PD performed.
Conclusion: Based on the data collected, an astonishing 
45% of the patient’s were diagnosed with stage 1–4 liver 
fi brosis. This is highly suggestive that a patient with chronic 
biliary obstruction should have a liver biopsy performed at 
baseline at the time of PD. This may aid in determining an 
intra-operative predictor for patients morbidity and subse-
quent patient care.
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OUTCOMES OF EARLY LAPAROSCOPIC 
CHOLECYSTECTOMY AFTER 
ENDOSCOPIC SPHINCTEROTOMY: 
A CHANGE OF POLICY
J. S. K. Reinders1, D.-J. Gouma2 and D. Boerma1
1Department of Surgery, St. Antonius Hospital, 
Nieuwegein; 2Department of Surgery, Academic Medical 
Center, Amsterdam
St. Antonius Hospital, Department of Surgery, 
Koekoekslaan 1, 3430 EM3430 Nieuwegein, Netherlands
Introduction: Endoscopic retrograde cholangiography 
(ERCP) with endoscopic sphincterotomy (ES) followed by 
laparoscopic cholecystectomy (LC) in patients with com-
bined choledochocystolithiasis is treatment of choice in 
many countries. In a recent RCT we demonstrated that LC 
within 72 hours is safe and recurrent biliary events are being 
avoided. The aim of the present study was to assess the 
feasibility and outcome of early LC after ES a policy-change 
on timing of LC after ES in our hospital.
Methods: From June 2009 – October 2011, all consecutive 
patients who underwent ERCP with ES and were deemed fi t 
for subsequent LC were reviewed. Epidemiologic factors, 
operative outcome and complications were recorded.
Results: In total 98 patients underwent LC after ES. Median 
time between ES and LC was 2 days (range 1–55). Over 70% 
of all patients were operated within 3 days and 85% within 
1 week (during the same hospital admission). Of 15% of 
LC’s performed after 1 week or longer (n = 14), 8 (57%) 
were delayed because of (post-ERCP) pancreatitis or cholan-
gitis and two were delayed because of patients preference. 
For the remaining 4 patients reason for postponing was 
unknown. Fifteen patients (15%) had an acute cholecystitis 
at the time of surgery. Median length of LC was 60 mins. 
Conversion rate was 4%, procedure related morbidity was 
0%. One patient had minor common bile duct; two patients 
had a cystic stump leakage. Median postoperative hospital 
stay was 1 day.
Conclusion: Early LC after ES is feasible and safe. Of all 
patients who underwent ES for bile duct stones, 85% under-
went LC within one week thereafter. The reason for postpon-
ing LC in the remaining 15% of patients was more often of 
medical than of organizational origin. At the time of surgery 
15% of patients already had signs of acute cholecystitis. 
Procedure related morbidity was low, although a cystic 
stump leakage percentage of 2% may mandate closing the 
stump with a loop rather than a clip.
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BILIARY TRACT RECONSTRUCTION 
USING JEJUNAL TUBE: AN 
EXPERIMENTAL STUDY IN DOGS
E. Crema1, E. A. Trentini1, L. A. Magna2, L. S. Leonardi2, 
J. C. LIanos2 and M. M. Lerco2
1Federal University of Triângulo Mineiro. Digestive 
Surgery; 2São Paulo State University
Federal University of Triângulo Mineiro, Digestive 
Surgery, Rua Marcos Lombardi, 305, Santa Maria, CEP: 
38050–17038100 Uberaba – MG, Brasil
Introduction: The Roux-en-Y reconstruction is not ana-
tomical, both diagnostic and therapeutic endoscopic access 
to the biliary tract. To physiologically reconstruct the biliary 
tract, Crema et al suggested the application of the Monti 
principle to the biliary tract, already used in humans for the 
urinary tract. With this technique, a jejunal segment is trans-
versely retubularized. This study aimed to evaluate the effi -
cacy of jejunal tube interposition between the common bile 
duct and duodenum in dogs.
Methods: Thirteen dogs underwent a laparoscopic common 
bile duct ligature, followed by a biliodigestive connection by 
jejunal tube interposition (bile duc-tube-duodenum) after one 
week. The tube was built from a jejunal loop an antime-
senteric section was made longitudinally along the entire 
extent of the jejunal segment. Afterwards, a vascularized 
rectangular fl ap measuring 4×1.5 cm was obtained. A con-
tinuous inverting Schmieden’s suturing was then performed 
with resorbable monofi lament 3.0 suture, involving the entire 
wall. The levels of glutamic-pyruvic and glutamic-oxalacetic 
transaminases, total bilirubins, alkaline phosphatase and 
gamma-glutamyltransferase were assessed before surgery 
and thereafter weekly.
Results: Data on 9 dogs were analyzed statistically. The 
dogs presented with obstructive jaundice after common bile 
duct ligature, as confi rmed by biochemical examination, we 
found that the tube interposition caused biliary tract opening, 
because TB and canalicular enzymes presented high values 
one week after common bile duct ligature (4.39 mg/dl; 
3251.7 U/L; 66.1 U/L), and gradually decreased until the 
completion of the study (0.11 mg/dl; 323.1 U/L; 10.7 U/L), 
respectively). A statistically signifi cant reduction in cholesta-
sis after biliodigestive connection by jejunal tube interposi-
tion and were healthy until the end of the experiment.
Conclusion: After induction of acute obstructive jaundice 
by laparoscopic ligation of the common bile duct, biliodiges-
tive connection with common bile duct-duodenal interposi-
tion of a jejunal tube is effective for biliary tract 
decompression, and diagnostic and therapeutic endoscopic 
access to the biliary tract becomes possible. The results are 
encouraging, but long-term studies are required to compare 
the biliary reconstruction with a jejunal tube and the Roux-
en-Y jejunal loop techniques.
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SINGLE INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY WITH 
ABDOMINAL WALL LIFTING 
USING BY MUSCLE HOOK
Y. Shindo, Y. Tanaka, Y. Saito, M. Onuki, Y. Kobayashi, 
A. Yamaguchi, N. Yokoyama and H. Sasaki
Nakadori General Hospital Gastroenterological Surgery
Nakadori General Hospital, Gastroenterological Surgery, 
3-15 Misono-cho Minamidori 1085 Akita, Japan
Introduction: Four trocars laparoscopic cholecystectomy 
(LC) is standard operation. In recent years, the Single 
Incision Laparoscopic cholecystectomy (SILC) was spread 
and we performed the SILC from April, 2010. But, the opera-
tion method was changed to SILC with abdominal wall using 
by Muscal hook (SILCMH) from the following reasons.
1. Insertion of trocar is unexpectedly diffi cult.
2. Endoscopic dissectors and trocars interfere out of the 
abdominal cavity.
3. Hole of trocar can’t close fi nely.
Methods: Then, SILC was compared with SILCMH. SILC 
was performed with three trocars under pneumoperitoneum 
of 8 mmHg. Method of SILSMH is as follows. A umbilicus 
is fi rst cut open 2.5~3 cm. A umbilical wound is equipped 
with wound protector (no trocar). Abdominal wall is lifted 
by muscle hook connected fi xed bar, and operation working 
space was made. Cholecystectomy was performed through 
this umbilical wound by endoscopic dissector, scissors, elec-
trocauterizer and ultrasound coagulating shears etc. SILC 
cases and SILCMH cases from April, 2010 were compared 
about operation time, the amount of bleeding, complications, 
the difference of the cost of materials and the median length 
of post operative stay.
Results: SILC are 13 cases, SILCMH are 11 cases. The 
SILC/SILCMH average age was 59.7/57.9 years old. Average 
operation time of SILC/SILCMH are 126 ± 29.6/141 ± 41.5 
minutes. Average amount of bleeding of SILC/SILCMH are 
25.1/31.6 ml. Complications in particular did not accept. The 
cost of SILCMH was cheap 55,000 yen compared with the 
cost of SILC because of no trocar and pneumoperitoneum. 
SILC/SILCMH’ median length of post operative stay was 
6.6/5.2 days. Other advantage SILCMH operation method is 
as follows.
1. Trocar is unnecessary and operativity is good.
2. There is little load to heart and lung function because of 
no pneumoperitotoneum.
3. Operation near a laparotomy can be performed. Usual 
laparoscopic suction system and gauze could be used.
Conclusion: Single Incision Laparoscopic Cholecystectomy 
with abdominal wall lifting using by Muscle hook is feasible 
and provides good cost performance.
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TEMPERATURE DEPENDENCE OF 
INDOCYANINE GREEN CLEARANCE
M. Dirkes, I. C. J. H. Post, M. Heger and T. M. van Gulik
Surgical Laboratory, Department of Surgery, Academic 
Medical Center, University of Amsterdam, The Netherlands
Academic Medical Center, Amsterdam, Department of 
Surgery, Meibergdreef 9, 1105 AZ Amsterdam, The 
Netherlands
Introduction: Indocyanine green (ICG) clearance is widely 
used as a quantitative dynamic liver function test. The clear-
ance rate is dependent on hepatic blood fl ow and the func-
tionality of hepatic transporters OATP1B3 and NTCP. These 
ICG transporters function independently of ATP but transport 
activity is dependent on temperature. The aim of this study 
was to determine to which extent the clearance rate of ICG 
is dependent on temperature in a porcine model.
Methods: Female Landrace pigs (n = 12, mean weight of 
49 ± 2 kg) were subjected to two ICG clearance tests under 
general anesthesia. At t = 0 h and t = 4 h, liver blood fl ow 
by means of cardiac output and ICG clearance rate were 
measured. ICG (25 mg/5 mL/pig) was injected via the ear 
vein and the plasma disappearance rate (PDR) was measured 
with a dye densitogram analyzer using pulse oximetry on the 
tail. Cardiac output and core body temperature (Tb) were 
measured by a Swan-Ganz thermodilution catheter. During 
the 4-h interval the pig was allowed to cool passively in an 
ambient temperature of 20.7 ± 0.6°C. Statistics were per-
formed using a t-test. Regression analysis was performed in 
Matlab.
Results: During 4 hours of ambient cooling, Tb fell from 
37.5 ± 0.4°C at t = 0 h to 33.7 ± 1.1°C at t = 4 h (p < 0.001). 
Over this period the cardiac output remained unaltered 
(4.7 L/min at t = 0 h to 4.3 L/min at t = 4 h, p = 0.142), but 
the ICG PDR exhibited a reduction from 0.212 ± 0.027 unit/
min at t = 0 h to 0.152 ± 0.019 unit/min at t = 4 h (p < 0.001). 
Based on exponential regression analysis (RSQ = 0.78), the 
infl uence of temperature can be approximated by PDR = 
0.0077e^ (0.0883Tb). This suggests an 8.5% decline in ICG-
clearance when the Tb lowers from 37°C to 36°C.
Conclusion: Measurement of ICG clearance is dependent 
on both hepatic blood fl ow and Tb. One degree lowering of 
Tb can lower the ICG PDR by as much as 8.5%. ICG clear-
ance tests which are performed at lower Tb, such as during 
perioperative measurements, should therefore be corrected 
for Tb to accurately refl ect liver function.
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LAPAROSCOPIC VS. OPEN LIVER 
RESECTION FOR HCC LESS THAN 5CM
S. Y. Yoon and K. hun Kim
Asan Medical Center, University of Ulsan College of 
Medicine, Seoul, South Korea, Department of hepatobiliary 
pancreas surgery and liver transplantation, 82 Seoul, 
South Korea
Introduction: By comparing laparoscopic liver resection 
for hepatocellular carcinoma versus to open hepatectomy, 
purpose of this study was to evaluate the short-term result of 
laparoscopic liver resection about the HCC. The comparison 
to the open liver resection was done for the HCC (less than 
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5 cm) during 4 years. The laparoscopic liver resection was 
done by a single surgeon.
Methods: The retrospective study was performed received 
hepatectomy for the HCC between July 2007 and August 
2011 in our institution. 1050 patient of HCC was received 
operation during 4 years. Above them, Patient whose never 
received TACE or RFA before surgery was selected for this 
study.
Results: The 318 patients was under the Open liver resec-
tion (OLR: HCC less than 5 cm), And the 74 cases was under 
Laparoscopic liver resection (LLR: HCC less than 5 cm).
There was no signifi cant difference in hospital mortality 
and morbidity. Return to normal diet was relatively good in 
the group of laparoscopic liver resection. The 48 months 
overall and disease-free survival rates were also signifi cantly 
no different.
Conclusion: This procedure is developing and safe tech-
nique in a select group of patients including those with 
malignancies, resulting in short hospital stays, rapid return 
to normal diet, full mobility and minimal morbidity with 
acceptable oncological parameter. It can be a optimal method 
for the hepatectomy in HCC (<5 cm).
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OUR STRATEGY TO REDUCE THE RISK 
OF POSTOPERATIVE MORBIDITY IN 
PATIENTS WITH HILAR 
CHOLANGIOCARCINOMA
A. Kobayashi, T. Yokoyama, A. Shimizu, H. Motoyama, 
K. Kubota, N. Furusawa, T. Kitagawa and 
S.-ichi Miyagawa
First Department of Surgery, Shinshu University School of 
Medicine
Shinshu University School of Medicine, First Department 
of Surgery, 3-1-1 Asahi 39086 Matsumoto, Japan
Introduction: Despite advancement of surgical techniques 
and perioperative care, surgical resection still carries a sub-
stantial risk of postoperative morbidity in patients with hilar 
cholangiocarcinoma (HC). Since 2001, we have applied a 
strategy to reduce postoperative morbidity, consisting of (a) 
meticulous surgical procedure to reduce blood loss and (b) 
extensive peritoneal lavage with warm saline: 2–3 litter 
whenever operative fi eld was contaminated with bile and >10 
litter before abdominal closure.
Methods: The aim of this study is to clarify the effect of our 
strategy on short-term outcomes after surgical resection 
for HC.
Method: Perioperative data of 133 patients were analyzed 
according to two different time periods: 1990 to 2000 (group 
1, n = 72) and 2001 to 2010 (group 2, n = 61). There was 
one in-hospital death in each group.
Results: Median blood loss (mL) was signifi cantly reduced 
in group 2 compared with group 1 (1040 vs. 800, P < 0.0001). 
Although the incidence of microorganisms in the preopera-
tive bile cultures was signifi cantly higher in group 2 than in 
group 1 (71% vs. 92%, P = 0.01), the incidence of contami-
nated fl uid from the abdominal drain, examined at postopera-
tive day 7 (68% vs. 31%, P = 0.0005), the number of patients 
with matching cultures {9 (28%) vs. 4 (9%), P = 0.03}, and 
the morbidity rate (71% vs. 52%, P = 0.03) were signifi cantly 
lower in group 2. There was a tendency toward lower surgi-
cal site infection (SSI) rate in group 2 (26% vs. 13%, P = 
0.06). An independent risk factor associated with SSI was 
blood loss > 900 mL (OR, 3.09; 95% CI, 1.04–9.17).
Conclusion: Our strategy, including meticulous surgical 
procedure to minimize blood loss and extensive peritoneal 
lavage, has a benefi cial effect on reducing postoperative mor-
bidity after resection for HC.
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STAGING, RESECTABILITY, AND 
OUTCOME IN PATIENTS WITH 
GALLBLADDER CARCINOMA
A. El-Gendi1, S. Bessa1, M. Sharaan1 and P. Vavra2
1Department Of Surgery, Faculty Of Medicine, Alexandria 
University, 440 El-Horreya Street, Roushdy 21311, 
Alexandria, Egypt; 2Department of Surgery, University 
Hospital Ostrav, Ostrava, Czech Republic
Introduction: Carcinoma of gallbladder (GB) is the most 
common biliary tract malignancy. Unfortunately it usually 
presents late in an advance stage. The prognosis hence 
remains poor, as radical surgical treatment is achievable in a 
small number of them. It is generally accepted that curative 
resection with tumor free resection margins is the only 
chance for long term-survival. The authors analyze and 
assess the management and outcome in patients with gall-
bladder cancer in a single tertiary referral center.
Methods: Between 2004 and 2008, a prospectively main-
tained database for 31 patient with gallbladder cancer treated 
at our institution was developed. Demographics, results of 
imaging studies, pathology, and survival were analyzed. 
Biliary drainage was achieved by endoscopic stenting and/
or percutaneous transhepatic drains in all jaundiced patients. 
To assess the resectability, when CT scan and MRI were not 
conclusive, selective angiogram was done. Patients, who 
were unresectable, were treated with chemotherapy and 
metallic stent if jaundiced. Curative resections included 
extended cholecystectomy (wedge resection of GB bed), 
more extensive hepatectomy (segmentectomy IVa and V or 
right hepatectomy) and extra-hepatic biliary ducts excision.
Results: 18 patients had unresectable disease. 2 patients 
were treated with just laparoscopic cholecystectomy. 11 liver 
resections have been performed. No post-operative mortality 
has been recorded. The median survival for patients who 
underwent surgery was 25 months, which was signifi cantly 
longer than that for not-operated patients (P < 0.003). Depth 
of tumor invasion (T) signifi cantly affected survival (P < 
0.01). The 1- and 3-year survival rates for T1/T2, and T3/T4 
were 100%, 69% and 67% and 0% respectively. In absence 
of lymph node metastasis (N0) the 1-and 3-year survival 
were 100% and 49% respectively. Chemotherapy offers sig-
nifi cant benefi t in term of survival in patients who were 
unresectable and managed by palliative care.
Conclusion: Although much progress has been made in the 
diagnosis and management of gallbladder carcinoma, the 
long-term outlook for most patients is still dismal. Only 
complete tumor resection, including hepatic resection, 
enables long-term survival for patients. Chemotherapy has a 
signifi cant benefi t in term of survival rate compared with no 
treatment.
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PROGNOSTIC FACTORS AND 
RECURRENCE PATTERNS OF T2 
GALLBLADDER CANCER AFTER 
SURGICAL RESECTION
K. K. Choi, M. J. Kim, H. Park, J. S. Heo, D. W. Choi and 
S. H. Choi
Department of Surgery, Samsung Medical Center, 
Sungkyunkwan University School of Medicine
Samsung Medical Center, Sungkyunkwan University School 
of Medicine, Department of Surgery, 50 Irwon-dong, 
Gangnam-gu, Seoul 135-710, South Korea
Introduction: Depth of tumor invasion is one of crucial 
prognostic factor for Gall bladder (GB) cancer. The aim of 
the current study was to elucidate the clinicopathological 
prognostic factors and recurrence patterns of T2 GB cancer.
Methods: The clinicopathological data of 153 patients who 
underwent a surgical treatment for T2 GB cancer between 
January 2000 and December 2011 were investigated retro-
spectively. The patients had R1 or R2 resection margin were 
excluded in this study. Kaplan-Meier analysis, and Cox 
regression hazard ratio was used for univariate and multivari-
ate study respectively.
Results: The overall survival rates were 60.8% at 5 years. 
The absence of lymph node metastasis (P = 0.05), perineural 
invasion (P = 0.02) and preoperative CA19-9 > 35 U/ml (P 
= 0.02) were signifi cant risk factors for overall survival in 
the multivariate analysis. Recurrence occurred in 35 patients 
(22.9%). Eleven patients had locoregional recurrences and 
24 patients had distant metastasis. The absence of lymph 
node metastasis (P < 0.01) was the only signifi cant risk factor 
for disease-free survival by multivariate study.
Conclusion: The lymph node metastasis is the single most 
important risk factor for GB cancer after surgical resection. 
However, more thorough analysis is needed for elucidate 
prognostic factors for GB cancer.
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RESULTS OF LAPAROSCOPIC COMMON 
BILE DUCT EXPLORATION IN ELDERLY
J. Wong, D. Tam, W. Chu, T.-P. Fung and S.-H. Lam
Division of Hepatobiliary and Pancreatic Surgery, 
Department of Surgery, United Christian Hospital, Hong 
Kong SAR
United Christian Hospital, Department of Surgery, 5/F, 
Block G, United Christian Hospital, 130 Hip Wo Street, 
Kwun Tong, Hong Kong SAR
Introduction: Common bile duct (CBD) stone is a common 
disease in elderly patients. Endoscopic retrograde cholangio-
pancreaticogram (ERCP) is a commonly used method for 
CBD stone extraction. However, ERCP imposes signifi cant 
risk to the elderly patients especially for those who require 
repeated sessions. Laparoscopic common bile duct explora-
tion (LCBDE) has shown to be an effective treatment for 
CBD stone. Nevertheless, the effi cacy and safety of LCBDE 
in elderly patients are unknown.
Methods: Patients who underwent LCBDE from January 
2007 to December 2011 were included for analysis. The 
peri-operative data for the elderly patients (age 65 years old 
or above) were retrospectively collected and analyzed. For 
the operative details, laparoscopic cholecystectomy was rou-
tinely performed before LCBDE. CBD stones extraction was 
performed by choledochoscope or stone extraction balloon 
under fl uoroscopy screening. Choledochotomy site was 
closed by interrupted suture with or without T-tube insertion. 
For patients with T-tube insertion, cholangiogram would be 
performed 10 days after operation and the T-tube would be 
removed at clinic 6 weeks after operation. The primary out-
comes were the complication rate and stone recurrence rate.
Results: Total 20 male and 16 female elderly patients under-
went LCBDE during the inclusion period. The median age 
was 78 years old with the median ASA score 2. The mean 
operative time was 199 ± 44 minutes with median blood loss 
of 50 ml. The median diameter of CBD was 1.5 cm and 
T-tube was inserted in 31 patients. The overall complication 
rate was 11.1%. Complications included three bile leakage 
and one intra-abdominal abscess; which were managed by 
endoscopic stenting with or without percutaneous drainage. 
The complication rate was signifi cantly lower in patients 
with T-tube insertion (6.5% versus 40%, P = 0.03). During 
the median follow up period of 9 months, four patients devel-
oped recurrent CBD stones, which were subsequently cleared 
by ERCP.
Conclusion: LCBDE is a safe and effective treatment for 
CBD stone in elderly patients. The complication rate was 
signifi cantly lower in patients with T-tube insertion. T-tube 
insertion should be recommended after LCBDE for the 
elderly patients.
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GALLBLADDER CARCINOMA: LIVER 
INVOLVEMENT IS A MAJOR 
PROGNOSTIC FACTOR
F. Vandenbroucke-Menu1, M. D’Hondt2, Z. Benamira2, 
R. Lapointe1, M. Plasse1, R. Letourneau1, M. Dagenais1 
and A. Roy1
1Hopital Saint Luc – CRCHUM – Université de Montréal; 
2Hopital Saint Luc – CHUM
Hopital Saint Luc – CHUM, Service de Chirurgie 
Hépatobiliaire et pancréatique, 1058 rue Saint Denis 
H2X3J4 Montreal, Qc, Canada
Introduction: The aim of this study was the evaluation of 
survival rate and prognostic factors of patients who were 
found to have gallbladder cancer (GBC) incidentally discov-
ered at laparoscopic cholecystectomy compared with patients 
with initial presentation of GBC.
Methods: A retrospective review of a prospectively col-
lected database of all patients with GBC at our tertiary aca-
demic hospital between January 1998 and December 2008 
was performed. Among 102 GBC patients, were included 69 
women and 33 men (median age: 65.5 years). Forty-fi ve 
patients presented with incidental gallbladder cancer (IGC) 
and 58 with nonincidental cancer (NIGC).
Results: The curative surgery rate was 84.4% for IGC and 
29.8% for NIGC (p < 0.001). The 5-year actuarial survival 
rate was 63.2% for patients with curative intent surgery and 
0% for patients with palliative approach. Patients in IGC 
have a longer survival rate compared to patients with NIGC 
(median: 25.8 vs 4.4 months, p < 0.0001) For patients with 
radical resection, there was no difference between IGC and 
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NIGC. The incidence of liver involvement was respectively 
0%, 20.8%, 58.3%, 100% for pT1, pT2, pT3 and pT4 tumor. 
Univariate analysis showed that survival rate was signifi -
cantly affected by perineural invasion, T, N and M-stage, R0 
resection, liver involvement, CA-19.9. In multivariate analy-
sis, liver involvement was the only independent factor.
Conclusion: For patients with surgery for GBC, liver 
involvement was a major independent indicator for the sur-
vival. Therefore, all patients with IGC and a pT2 or more 
disease should undergo a second radical resection.
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INCIDENTAL GALLBLADDER CANCER 
AFTER LAPAROSCOPIC 
CHOLECYSTECTOMY: TREATMENT 
AND SURVEILLANCE POLICIES IN THE 
UNITED KINGDOM – RESULT 
OF A SURVEY
G. Marangoni, A. Hakeem, G. Toogood, J. P. Lodge and 
R. Prasad
St James’ Hospital, HPB and Transplant Unit, Beckett 
Street, LS9 7TF Leeds, UK
Introduction: Increasingly diagnosis of early gallbladder 
cancer (GBC) is incidentally made after laparoscopic chole-
cystectomy (LC). T stage correlates with nodal metastases 
and potential for residual disease. Although there is no con-
troversy in the treatment of T1a and T2 tumours, there is still 
no agreement on what constitutes optimal management for 
pT1b and the extent of lymphadenectomy for pT2 tumours. 
Staging, timing of surgery after LC and treatment of the 
extrahepatic biliary tree are not standardized.
Methods: The aim of this study was to assess the treatment, 
staging and surveillance protocols of incidentally found 
GBC after LC among hepatobiliary and upper GI surgeons 
in the United Kingdom in the light of the current published 
literature. A questionnaire on incidental GBC was devised 
and sent to the Consultant Surgeons members of the 
Association of Upper GI Surgeons (AUGIS) of Great Britain 
and Ireland after approval from the AUGIS Committee. 
There were 13 questions regarding treatment protocols 
according to T category (pT1a/pT1b, pT2), treatment of pre-
vious port sites, staging protocols, surveillance policies, 
timing of surgery after LC, extent of lymphadenectomy and 
management of the extrahepatic biliary tree.
Results: There were 48 completed questionnaires. Over 
80% would consider simple LC an adequate treatment for 
T1a tumours. 30% do not advocate radical surgery for T1b 
and 50% would not perform regional lymphadenectomy. 5% 
would not further treat T2 tumours and 23% would not add 
regional lymphadenectomy. Over 50% would not resect port 
sites. About 50% would consider chest and abdomen CT only 
for staging. About 30% and 80% would recommend surveil-
lance for CT or MRI for 2–5 years for T1 and T2 tumours 
after extended resection respectively. 72% would advocate 
surgery as soon as possible. 22.5% and 20% would perform 
coeliac trunk lymphadenectomy if staging confi rms positive 
nodes and routinely excise the extrahepatic biliary tree 
respectively.
Conclusion: The only chance of cure for GBC is complete 
tumour excision. There is heterogeneity among UK surgeons 
regarding treatment, staging and surveillance policies. 
According to the survey, UK practice does not fully comply 
with published evidence for T1a and T2 categories. Although 
there is increased evidence that T1b tumours would benefi t 
from extended resection only 50% would perform a regional 
lymphnode dissection. Clear guidelines would help stand-
ardization of staging and surveillance policies.
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VALUE OF LYMPH NODE DISSECTION 
IN PATIENTS WITH INTRAHEPATIC 
CHOLANGIOCARCINOM UNDERWENT 
HEPETECTOMY-IMPACT ON LONG 
TERM SURVIVAL
Y.-Y. Jan, T.-S. Yeh and M.-F. Chen
Department of Surgery, Chang Gung Memorial Hospital, 
Chang Gung University, Taoyuan, Taiwan
Chang Gung Memorial Hospital, Chang Gung University, 
Department of Surgery, 5 Fu-Hsing Street, Kwei-Shan 
Shiang, Taoyuan 333 Taoyuan, Taiwan
Introduction: Hepatectomy with lymph node dissection is 
a clinical concern for improving the long term survival in 
patients with intrahepatic cholangiocarcinoma (ICC). This 
study to evaluate the affi cancy of lymph node dissection to 
improving the surgical outcome 92 hepatectomy without 
lymph node dissection was group I and another 73 hepatec-
tomy as group II.
Methods: 165 patients with ICC who underwent hepatec-
tomy were retrospective analysis for investigated the value 
of lymph node dissection between Jan 1998 and Dec 2008. 
92 hepatectomy without lymph node dissection was group I 
and another 73 hepatectomy with lymph node dissection as 
group II.
Results: The 3-and 5-Y survival rates were 36.6% and 
25.8% in group I patients and 32.1% and 24.6% in group II, 
respectively (P: 0.657). The 3- and 5-year survival rates were 
52.9% and 47% in patients of group II with lymph node 
metastasis and 15.6% and 9.4% in patients of group II 
without lymph node metastasis (P < 0.0001).
TNM staging were I (55.4%), II (9.8%), III (34.8%) in 
group I patients without lymph node dissection and I (15.1%), 
II (4.1%), III (80.8%) in group I patients with lymph node 
dissection, respectively (P < 0.0001).
Conclusion: The long term survival in patients with intra-
hepatic cholangiocarcinoma underwent hepatectomy with 
lymph node dissection is not improved than without lymph 
node dissection group. Under staging of TNM was found in 
patients with ICC under went hepatectomy without lymph 
node dissection. Prognosis is poor in patients with ICC 
underwent hepatectomy with lymph node dissection associ-
ated with lymph node metastasis.
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RISK OF CARCINOGENESIS IN THE 
BILIARY EPITHELIUM IN PATIENTS 
WITH PANCREATICOBILIARY 
MALJUNCTION THROUGH BOTH 
EPIGENETIC AND GENETIC PATHWAY
H. Mori, H. Ishibashi, T. Utsunomiya, S. Imura, Y. Morine, 
T. Ikemoto, H. Miyake and M. Shimada
Department of Surgery, The University of Tokushima, 
Japan
The University of Tokushima, Department of Surgery, 
3-18-15 Kuramotocho, Tokushima 770-8503, Japan
Introduction: Pancreaticobiliary maljunction (PBM) is a 
high risk factor for biliary tract cancer because of the regur-
gitation of pancreatic and bile juice. We previously reported 
PBM had the possibility of carcinogenesis through epige-
netic pathway regarding as Histone deacetylase. The purpose 
of this study was to investigate the expression of genetic 
carcinogenesis genes, especially AID (activation-induced 
cytidine deaminase) which had the activity of gene mutation, 
in the biliary epithelium in PBM patients.
Methods: Thirteen PBM patients without biliary cancer 
who was performed extrahepatic bile duct resection were 
enrolled. Ten out of 13 patients with PBM were in Dilated 
group (D) and three out of them were in Non-dilated group 
(ND). Four patients without biliary cancer performed pan-
creaticoduodenectomy were selected as a control group (C). 
The expression of K-ras and AID in the gallbladder and bile 
duct epithelium was evaluated by immunohistochemistry. 
More than 10% of K-ras and AID expression was evaluated 
as a positive staining.
Results: In the gallbladder epithelium, the expression 
of K-ras in the Dilated group signifi cantly increased com-
pared to those in control group (C : D : ND = 
25.0% : 90.0% : 66.7%). In the bile duct epithelium, the 
expression of K-ras in the Non-Dilated group signifi cantly 
increased compared to those in control group (C : D : ND = 
25.0% : 70.0% : 100%). In the gallbladder epithelium, the 
expression of AID in the Dilated group signifi cantly increased 
compared to those in control group (C : D : ND = 
0% : 70.0% : 66.7%). In the bile duct epithelium, the expres-
sion of AID in the Non-dilated group signifi cantly increased 
compared to those in control group (C : D : ND = 
0% : 40.0% : 66.7%).
Conclusion: Patients with PBM had the high expression of 
AID in the biliary epithelium in both the Dilated and Non-
dilated group. These fi ndings suggested that patients with 
PBM in both Dilated and Non-dilated type had a possibility 
of malignant potentials for bile tract cancer through both 
epigenetic and genetic pathways.
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LIVER BED POCKET SCORE IS USEFUL 
AS ADJACENT TOOL FOR 
PREOPERATIVE ASSESSMENT OF THE 
DIFFICULTY OF LAPAROSCOPIC 
CHOLECYSTECTOMY
K. Shinozaki, T. Ajiki, K. Ueno, H. Sawa, S. Murakami, 
Y. Yoshida, I. Matsumoto and Y. Ku
Kobe University, Department of Surgery, Division of 
Hepatic-Biliary-Pancreatic surgery, Kobe, Japan
Kobe University, Department of Surgery, Division of 
Hepatic-Biliary-Pancreatic surgery, 7-5-2 Kusunoki-cho, 
Chuo-ku, 650 Kobe, Japan
Introduction: Laparoscopic cholecystectomy (Lap-C) is 
now a standard surgery for gallbladder stone and acute/
chronic cholecystitis. There are some reports discussing the 
preoperative assessment of the diffi culty of Lap-C by the 
severity of cholecystitis or the confi guration of cystic duct, 
but there are few reports discussing the diffi culty of liver bed 
dissection. We would like to propose a new method, liver 
bed pocket score, for preoperative assessment of the diffi -
culty of liver bed dissection in Lap-C.
Methods: Forty-six cases that underwent Lap-C from 2006 
to 2011 at our hospital and affi liated institutions were ana-
lyzed. Before operation we perform CT and get reconstructed 
coronal and sagital section images. We measured the width; 
a, and height; b of the liver bed at each slices, and we defi ned 
the liver bed pocket score (LBPS) as the maximum value of 
b/a. Relationships between LBPS and the time to dissect 
gallbladder from the liver bed were analyzed.
Results: There are 29 male and 17 female and average age 
55.7 years old. Their preoperative diagnoses were gallblad-
der stone in 45 patients and gallbladder polyp in one patient. 
Twenty-two patients had the past acute or chronic cholecys-
titis. The average gallbladder dissecting time was 17.2 
minutes, and the average of LBPS was 0.45 in coronal 
section and 0.58 in sagital section, respectively. The correla-
tion coeffi cient in linear approximation of the LBPS and the 
gallbladder dissecting time was 0.59 (p < 0.0001) in coronary 
section and 0.55 (p = 0.00017) in sagital section, which had 
signifi cant correlations.
Conclusion: Liver bed pocket score is one of the useful 
adjacent tools for preoperative assessment of the diffi culty 
of liver bed dissection in Lap-C.
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KANDIL TECHNIQUE: STILL RELEVANT
M. Z. Kherrour, H. Meghraoui, D. Rahal and 
M. Boubekeur
Emergency service, Hospital-Universiter Center of Sidi Bel 
Abbes, Faculte de Medecine TALEB Mouradmedecine 09 
rue Rafai Mahi Cite 20 aout (Cite Police) 22000 Sidi Bel 
Abbes, Algeria
Introduction: Biliary surgery can put us in the face of dra-
matics situations, the defect of the biliary ducts is almost 
impossible to repair. Kandil technic’s is an epiploplasty of 
the common bilary duct, initially described by Pr. Kandil 
Snouci for seven patients. On extreme cases it was the only 
therapeutic chance of our patients.
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Methods: we received the patient B.Y 80 years old the 
28/05/2011, discharged from a service of the interior of the 
country for an acute abdomen.
The patient is monitored for congestive heart failure. nine 
days before his evac, it is supported for cholangitis, the 
symptomatology do not regress despite medical treatment. 
the day of his discharge, the patient’s general condition dete-
riorates hence its orientation at our level and his hospitaliza-
tion at our service.
Defense abdominal net is found in a jaundiced patient: 
‘tan’ and febrile: 39.5°C. diagnosis of peritonitis biliar is 
retained and the patient is taken him to the operating room.
Results: an incision above ombilcale Medan with a right 
cross is recasts practiced, under the liver there is a purulent 
collection, bilary duct breaks throughout the cholédoc and 
infected with walls.
After washing the peritoneum, we found ourselves at a 
loss of bilary duct substance to be repaired, we set up the 
biggest drain of Kehr we had, and was sutured around 
épiplon taking our points on the peritoneum of the hepatic 
pedicle. the operation is terminated by a drain down the liver.
Contrary to our expectations the postoperative course was 
good, the control of cholongiography made d15 post surgery 
not shown any abnormalities, the patient is put out to d16, 
and the drain is removed at the second months after surgery.
Conclusion: this case with a large defect of bilary duct, 
where the walls presence infected and suppurative against a 
collection showing the sutures-biliary-digestion, according 
epiploplastie Kandil is a technique for the treatment of such 
situations.
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PROPOSAL OF A STEP-DOWN 
APPROACH FOR ANTIBIOTIC THERAPY 
IN PREOPERATIVELY STENTED 
PATIENTS WITH DISTAL BILE 
DUCT OBSTRUCTION
M. Erkan1, D. Sauliunaite1, A. Herner2, C. Reiser-Erkan1, 
C. W. Michalski1, T. Miethke3, H. Friess1 and J. Kleeff1
1Department of Surgery, Klinikum rechts der Isar, 
Technische Universität München, Munich, Germany; 
22nd Department of Internal Medicine, Klinikum rechts der 
Isar, Technische Universität München, Munich, Germany; 
3Institute of Medical Microbiology, Immunology and 
Hygiene, Technische Universität München, Munich, 
Germany
Klinikum rechts der Isar, Technische Universitaet 
Muenchen, Surgery, Ismaningerstrasse 1281675 Munich, 
Germany
Introduction: Preoperative stenting of the bile duct in 
patients with biliary obstruction increases postoperative 
infectious complications. A step-down antibiotic therapy 
may reduce infectious complications and hospital stay.
Methods: 198 patients who underwent pancreatic head 
resection due to distal bile duct obstruction between July 
2007 and February 2010 were analyzed retrospectively. All 
patients received a single dose (3 g) of ampicillin/sulbactam 
30 minutes before the operation. Complications were 
assessed according to the Clavien-Dindo classifi cation.
Results: 90 patients (45%) underwent preoperative ERCP-
stenting due to obstructive jaundice. Intraoperative bile 
cultures were signifi cantly more often contaminated in the 
stented patients (100% vs. 34.8%, p = 0.03) and were more 
often polymicrobial (85.7% vs. 78.3%, p = 0.048). 
Piperacillin/tazobactam or imipenem would have covered 
87% and 94% of the bacterial spectrum, respectively. Postop. 
complications were more often in stented patients (52% vs. 
34%, p = 0.27). The average hospital stay of patients with 
postoperative complications was signifi cantly longer than of 
patients without complications (28.4 vs. 15.6 days, p < 
0.0001), which also increased signifi cantly in patients with 
complications if they were preoperatively stented (24.1 vs. 
32.7 d, p = 0.03).
Conclusion: Preoperative biliary stenting increases postop-
erative complications and hospital stay signifi cantly in 
patients undergoing pancreatic head resections. Due to the 
high prevalence of resistant bacteria, perioperative broad-
spectrum antibiotic therapy and a culture oriented step-down 
approach instead of the standard culture oriented escalation 
therapy may reduce morbidity.
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OUTCOMES OF CHOLECYSTECTOMY 
FOR ACUTE CHOLECYSTITIS 
IN OCTOGENARIANS
D. Yeo, M. Perini, M. Fink, V. Muralidharan, G. Starkey, 
R. Jones, C. Christophi and M. Nikfarjam
University of Melbourne Department of Surgery, Austin 
Health, Heidelberg, Victoria, Australia
University of Melbourne/Austin Health, Department of 
Surgery, Austin Health, Lance Townsend Building, Level 8, 
145 Studley Rd, Heidelberg, Victoria 3084 Melbourne, 
Australia
Introduction: Acute cholecystitis in the elderly is an 
increasingly surgically managed problem. It is recognized 
that elderly patients have greater comorbidities which 
increase the risk of surgical complications. Whether advanced 
aged is as independent risk factor for morbidity and mortality 
in a contemporary group of patients treated by early chole-
cystectomy is undetermined.
Methods: Patients with histologically confi rmed acute 
cholecystitis treated in a specialized unit in a tertiary hospital 
between November 2005 and March 2011 were identifi ed 
from a prospectively maintained database. Elderly patients 
defi ned as those aged 80 years and older were compared to 
all others.
Results: 411 patients had histology proven acute cholecys-
titis, of which 71 (17%) were 80 years and older. Elderly 
patients were more likely to have comorbidities and be 
febrile at presentation (41% vs 19%; p < 0.001). They were 
more commonly converted from laparoscopic surgery (20% 
vs 7%; p = 0.001) and were more likely to have gangrenous 
cholecystitis (44% vs 31%; p = 0.001) and choledocholithi-
asis (27% vs 17%; p = 0.048). Elderly patients had more 
complications (31% vs 13%; p < 0.001), a higher mortality 
rate (4% vs 1%; p = 0.038) and a longer length of stay (7 
days vs 3 days; p < 0.001). Age over 80 (p = 0.004), diabetes 
(p = 0.026), fever at presentation (p = 0.023), and haemo-
globin less than or equal to 10 g/L (0.033) were independent 
risk factors for complications.
Conclusion: Age 80 years and older is independently asso-
ciated with increased morbidity and mortality following 
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cholecystectomy. Elderly patients are also more likely to 
have gangrenous pathology and common bile duct stones.
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POST CHOLECYSTECTOMY BILE DUCT 
INJURIES: OUTCOME ANALYSIS
P. Mishra1, S. Saluja1, M. Nayeem1, B. Sharma2 and 
R. Rajalingam1
1Department of Gastrointestinal surgery G B Pant Hospital 
and Maulana Azad Medical college; 2Department of 
Gastroenterology G B Pant Hospital and Maulana azad 
Medical College
GB Pant Hospital and Maulana Azad Medical College, 
Gastrointestinal Surgery, Room No 219, Academic block, 
GB Pant Hospital, 2 JLN Marg, New Delhi 1100022, India
Introduction: Despite advances in speciality care, mortality 
and morbidity remain an important issue in management of 
bile duct injuries. We analysed the management of bile duct 
injuries to assess the outcomes.
Methods: Of 150 patients with bile duct injuries managed, 
13 patients who presented with stricture hepaticojejunos-
tomy were excluded. The record of remaining 137 patients 
was analyzed for presentation, initial and defi nitive manage-
ment and follow-up.
Results: Of 137 injuries, 88 were open and 49 were laparo-
scopic. The presentations include acute bile duct injury (n = 
5), bile collection (n = 45), external biliary fi stula (n = 46) 
and stricture (n = 41). After initial management 3 patients 
died (sepsis n = 2, pseudoaneurysmal bleed n = 1). Of 107 
patients who underwent defi nitive repair, 3 died (portal 
hypertension n = 2, sepsis n = 1). At 1 year follow-up 100 
patients had good outcome and only four had bad outcome 
as per Mac Donald grading.
Conclusion: Late diagnosis with peritonitis and sepsis in 
the early phase and portal hypertension and cirrhosis in the 
late phase are main causes of mortality. These patients should 
be referred to specialist hepatobiliary centres at the earliest 
to decrease morbidity and mortality. Successful management 
can limit the morbidity in more than 90% cases.
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UNDIFFERENTIATED CARCINOMA 
IN GALLBLADDER
H. Park, D. W. Choi, J. S. Heo, S. H. Choi, M. J. Kim 
and K. G. Choi
Samsung Medical Center, Sungkyunkwan University School 
of Medicine
Samsung Medical Center, Sungkyunkwan University School 
of Medicine, Department of surgery, Ilwon-dong 50 
samsung medical center, Kangnam-gu, 0 Seoul, Republic of 
Korea
Introduction: Undifferentiated carcinoma is rarely seen in 
the gallbladder, there are very little case reports. We reported 
the 8 cases of patients with undifferentiated carcinoma in 
gallbladder that also have a characteristic feature.
Methods: We retrospectively reviewed the charts of all 
patients operated to the Samsung medical canter between 
October 1994 and March 2009 with cancer of gallbladder. 
Eight cases of pathologically proven undifferentiated carci-
noma were found among 404 cases of gallbladder cancer. We 
examined the characteristics of undifferentiated carcinoma 
and compared survival rates in adenocarcinoma patients by 
log-rank test after 1 : 5 fi xed matching with age and sex.
Results: The 8 cases included 7 women and 1 man of 
median age 57.5 years (range 45–69 years). Follow up 
periods ranged from 4.3 to 47.2 months (median, 7.3 months). 
The fi ve patients underwent radical cholecystectomy and 2 
patients underwent right trisectionectomy. One patient was 
operated palliatively cholecystectomy and segmental resec-
tion of transverse colon.
The eight patients were classifi ed by pathology stage and 
the results were: stage lb in two, stage lla in two, stage llb 
in three and stage lll in one. Patients in undifferentiated 
carcinoma showed signifi cantly poor overall survival than 
patients in adenocarcinoma of gallbladder (1-years survival 
rate 42.9% vs 76.8%, p = 0.036).
Conclusion: In our study, we examined the characteristics 
of undifferentiated carcinoma and concluded the survival of 
undifferentiated carcinoma in gallbladder was signifi cantly 
lower in patients than in those with adenocarcinoma in gall-
bladder. But further research with a larger sample size is 
needed to understand the characteristic of this tumor.
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SUCCESSFUL TREATMENT OF 
MALIGNANT BILIARY-CUTANEOUS 
FISTULA USING A T-TUBE
Y. C. Yoon, S. K. Park and S. M. Park
Department of Surgery, Incheon St. Mary’s Hospital, The 
Catholic University of Korea, Incheon, Republic of Korea
Introduction: Biliary-cutaneous fi stulas are uncommon but 
can be a source of signifi cant morbidity after hepato-biliary 
surgery. Residual malignancy may be associated with the 
development of postoperative fi stula. Conservative treatment 
and invasive treatment including surgery is considered. We 
report a case of post operative biliary-cutaneous fi stula which 
was successfully treated by resection of fi stula tract including 
wide excision of hepaticojejunostomy site with T-tube 
insertion.
Methods: Case report.
Results: Right hepatectomy with Roux-en-Y hepaticojeju-
nostomy was performed for a 78-year-old man with Klatskin 
tumor Bismuth type IIIA. Postoperative 4 weeks, bilious 
discharge was found in the wound and CT showed biliary-
cutaneous fi stula. The liver function sustained normal so we 
decided to observe. To 1 month after the development of 
fi stula, closure of the fi stula was not found so we performed 
percutaneous transhepatic biliary drainage but closure did 
not occur. Thus, we performed resection of fi stula tract 
including wide excision around the hepaticojejunostomy site 
and T-tube insertion. Malignancy was found in the fi stula 
tract, and T-tube was removed after 2 months. No recurrence 
was found for 12 months after the fi rst operation.
Conclusion: Postoperative biliary-cutaneous fi stula was 
successfully treated with resection of fi stula tract including 
wide excision of hepaticojejunostomy site and T-tube inser-
tion. There may be possibility of malignancy in cases of 
biliary-cutaneous fi stula which is not successfully treated 
with conservative treatment, so wide excision of hepaticoje-
junostomy site should be included in the surgery for postop-
erative biliary-cutaneous fi stula and this treatment strategy 
may increase the curative potential.
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PSEUDOANEURYSMS OF THE CYSTIC 
ARTERY AFTER CHOLECYSTECTOMY
C. Lamb, S. Travis and A. Brooks
Queens Medical Centre campus, Nottingham University 
Hospitals Trust, Nottingham, United Kingdom
Queens’s Medical Centre, Hepatobiliary Surgery, 9, James 
Lambert Drive, Leics, LE13 0SPLE13 Melton Mowbray, 
United Kingdom
Introduction: Pseudoaneurysm of the cystic artery after 
cholecystectomy is a rarely reported phenomenon, with 
fewer than 10 cases reported in the world literature. It usually 
presents with bleeding from the GI tract, secondary to 
haemobilia, or with intra-abdominal haemorrhage. We 
present two patients who developed pseudoaneurysms of the 
cystic artery after cholecystectomy.
Methods: Patient data was obtained through case note 
review for both patients. Radiological images were obtained 
from the hospital’s electronic database and reporting system.
Results: The fi rst patient was a 74 year old female who 
underwent laparoscopic cholecystectomy followed by ERCP 
for choledocholithiasis. 24 hours after ERCP she presented 
with GI bleeding and an OGD showed haemobilia. 
Angiography revealed a pseudoaneurysm of the cystic artery 
with active haemorrhage. The aneurysm sac was thrombosed 
with Tisseal® injection and the artery embolised with micro-
coils. Follow up imaging showed no fl ow in the aneurysm 
and a patent right hepatic artery.
The second patient was a 69 year old male who underwent 
open cholecystectomy for xanthogranulomatous cholecysti-
tis. He became acutely unwell post operatively and a CT scan 
revealed a pseudoaneurysm of the cystic artery which was 
successfully embolised with cyanoacrylate glue.
Conclusion: Pseudoaneurysm of the cystic artery is a rare 
complication of cholecystectomy. The mainstay of treatment 
in the reported literature is increasingly based around inter-
ventional radiological techniques and our experience has 
confi rmed that this is a successful strategy for such patients, 
even in the context of signifi cant ongoing bleeding. Most 
cases present with haemobilia but the diagnosis should not 
be discounted in the absence of GI bleeding.
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SURGICAL TREATMENT OF INJURY 
BILIARY TRACT, FACILITATED BY 
INTERVENTIONAL RADIOLOGY. 
REPORT OF 3 CASES
P. Amaral1, E. Ettinger1, R. Santana1, F. Silano2, 
P. V. Soares3 and S. Leite3
1Staff of Digestive Surgery, Hospital São Rafael, Salvador, 
Brazil; 2Medical Resident of Digestive Surgery, Hospital 
São Rafael, Salvador, Brazil; 3Medical Resident of General 
Surgery, Hospital São Rafael, Salvador, Brazil
Hospital São Rafael, Digestive Surgery, Av. São Rafael, 
2152, São Marcos. 41253 Salvador, Brazil
Introduction: The approach to iatrogenic biliary tract injury 
demands expertise and time to the surgeon. Therefore the 
objective of this study is to analyze the results and benefi ts 
of trans-parieto-hepatic drain placement by interventional 
radiology in preoperative surgical reconstruction of the iatro-
genic biliary injury.
Methods: We evaluated the records of patients undergoing 
this procedure being taken in consideration: type of biliary 
injury (partial or total), damage or not of the right hepatic 
artery, duration of the drain placement procedure, rates of 
failure and complications, position of the drain in the abdom-
inal cavity, type of drain and the time between the placement 
of the drain and the surgery. It was also considered: the facil-
ity of locating the drain in the abdominal cavity, cavity 
aspect, type of reconstruction and surgical time, post opera-
tive complications and the drain current situation.
Results: There was a complete section of the choledochus 
in all cases. There were no lesions associated on the right 
hepatic artery. A pigtail drain was used in all cases. The mean 
procedure time was 2:30 hours and there were no complica-
tions. The drain was placed in the lesion topography with 
exit to the abdominal cavity, remaining in this location until 
the surgery was held after seven days. In all cases the drain 
was located with ease. The reconstruction of the biliary tract 
was made by hepaticojejunostomy in roux-y, with mean 
operative time of 2:45 hours. Patients had no postoperative 
complications. Two other patients remained with the drain, 
one of them for 4 months and the other for 2 months.
Conclusion: In these report cases the use of trans-parieto-
hepatic drain was proven useful as a intra-operatory guide 
and as a cast for choledocojejosnostomy.
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DELAYED RIGHT HEMIHEPATECTOMY 
FOLLOWED BY RIGHT-HEPATIC 
VASCULAR CONTROL BOTH BY 
DA VINCI ROBOTIC SURGERY 
TO A PATIENT OF HILAR 
CHOLANGIOCARCINOMA WITH 
DEEP JAUNDICE
N. Zhou
Institute of Hepatobiliary and Gastrointestinal Disease of 
PLA Second Artillery
Institute of Hepatobiliary and Gastrointestinal Disease of 
PLA Second Artillery, Institute of Hepatobiliary and 
Gastrointestinal Disease of PLA Second Artillery, No. 16, 
Xinjiekouwai Avenue, Xicheng District, Beijing 10008, 
China
Introduction: To explore and fi nd a new method to treat 
hilar cholangiocarcinoma with deep jaundice operated by da 
Vinci robotic surgery.
Methods: A hilar cholangiocarcinoma patient of type 
Bismuch IIIa was found with deep jaundice (total bilirubin 
TB: 635 µmol/L). On the fi rst admission, we did da Vinci 
robotic surgery including drainage of left hepatic duct and 
dissection of right hepatic vessels (right portal vein and right 
hepatic artery) and placement of vascular control device. 3 
weeks later on the second admission when the jaundice dis-
appeared we controlled right hepatic vascular discontinu-
ously for 6 days and then sustained later. On the third 
admission after 3 weeks of right hepatic vascular control, the 
right hemihepatectomy was performed by da Vinci robotic 
surgery for the second time.
Results: The future liver remnant (FLR) after the right 
hepatic vascular control increased from 35% to 47%. The 
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volume of left lobe was increased by 368 ml. When the TB 
and liver function were all normal, the right hemihepatec-
tomy was performed by da Vinci robotic surgery 10 weeks 
after the fi rst operation. The removal of atrophic right hepatic 
lobe with tumor in bile duct was found with no pathological 
cancer remaining in the margin.
Conclusion: Under Da Vinci robotic surgical system, a pro-
grammed treatment can be achieved: fi rst, gradually control-
ling the port of hepatic vascular together with biliary 
drainage, which results in the liver’s partially atrophy and 
compensatory hyperplasia in the other part and then followed 
by radical hepatectomy. Such programmed hepatectomy pro-
vides a new treatment for patients of hilar cholangiocarci-
noma with deep jaundice who have the possibility of radical 
heptolobectomy.
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HEPATOPANCREATICODUODENECTOMY 
FOR BILIARY CANCER: 
46 CONSECUTIVE CASES WITH 
ZERO MORTALITY
T. Aoki, K. Hasegawa, Y. Sakamoto, Y. Sugawara and 
N. Kokudo
Division of HBP Surgery, Department of Surgery, 
University of Tokyo, Tokyo, Japan
University of Tokyo, Division of HBP Surgery, Department 
of Surgery, 7-3-1 Hongo, Bunkyo-ku 113 Tokyo, Japan
Introduction: Despite recent advances in surgical tech-
niques and perioperative managements, hepatopancreati-
coduodenectomy (HPD) for biliary cancer remains a 
challenge for surgeons, and this procedure has been reported 
to be associated with relatively high mortality and morbidity 
in the previous studies. In the present study, we reviewed our 
experience of 46 consecutive HPDs and assessed the short- 
and long-term outcomes in a retrospective fashion.
Methods: The clinocopathological data (patient character-
istics, operative results, pathological results, morbidity, mor-
tality, and long-term survival) of 46 patients undergoing 
HPD for biliary cancer were reviewed. The cohort patients 
consisted of 31 males and 15 females, with a mean age of 
68 years. In case of obstructive jaundice, the patients fi rst 
received biliary drainage for future remnant liver. After the 
serum total bilirubin level became under 5.0 mg/dL, portal 
vein embolization (PVE) was performed if the volume of the 
future remnant liver is supposed to be lower than 40% of the 
total liver volume. About 2 weeks after the PVE, HPD was 
performed.
Results: The diagnosis was bile duct cancer in 34, and gall-
bladder cancer in 11. The indications for HPD was extensive 
horizontal cancer spread in 30, invasion to the adjacent 
organs in 12, and lymph node metastasis in 6. In 6 cases, the 
procedure was changed to HPD intraoperatively because of 
positive surgical margins. The extent of liver resection was 
extended right liver in 34, extended left liver in 2 and others 
in 10. In all cases, two-staged pancreatico-jejunostomy was 
selected. The median operative time was 832 minutes and 
median blood loss was 1370 g. The morbidity rate was 82%, 
15% of which were major complications; however, there was 
no operative death. The 2- and 5-year overall survival rate 
was 51% and 43%, respectively.
Conclusion: HPD could be performed with zero mortality 
using perioperative treatments and managements, although 
this procedure was associated with long operation time, 
much intraoperative bleeding and high morbidity rate. The 
extensive horizontal spread of bile duct cancer and invasion 
to the adjacent organs of the gallbladder cancer were good 
indications for HPD. If a curative resection becomes possible 
using this extensive procedure, long-term survival can be 
expected.
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LAPAROSCOPIC CBD EXPLORATION 
IN PATIENT WITH SITUS 
INVERSUS TOTALIS
S.-jone Han, K.-sik Chun and I.-sang Song
Chungnam National University Hospital, Department of 
Surgery, 33 Munhwaro, Jung-Gu 30172 Daejoen, Korea
Introduction: Laparosopic common bile duct (CBD) explo-
ration is relatively common procedure for CBD stones now, 
but some technical diffi culties are still exist such as severe 
adhesion due to previous upper abdominal operation, severe 
infl ammation due to combined acute cholecystitis or cholan-
gitis, impacted far distal common bile duct stones and ana-
tomical variations.
Situs inversus totalis is a rare disease and can cause some 
technical diffi culties due to mirror image of normal anatomy.
Methods: A 71-year old female was admitted for epigastric 
pain and fever. Her initial chest X-ray showed a right-sided 
heart. On abdominal CT scan, multiple gallbladder and CBD 
stones were diagnosed with situs inversus totalis. She prima-
rily underwent ERCP but the procedure was failed because 
of technical diffi culty from her anatomical variation. Then 
laparoscopic CBD exploration was performed. Ports were 
introduced in a mirror image of conventional setups, except 
the 10 mm-port which was located at the lower epigastric 
area. After ligation of the cystic artery and duct, choledo-
chotomy was done as the same manners of conventional 
procedure. The whole CBD was inspected with a video 
choledochoscopy and there was no remnant stone.
Results: The operation time was 129 minutes and there was 
no intraoperative complication. The patient was discharged 
at the 5th postoperative day without any postoperative 
complications.
Conclusion: Situs inversus totalis poses a problem due to 
mirror image of anatomy which can make the surgeon feel 
to be unfamiliar. But laparoscopic CBD exploration can be 
performed safely with carefulness.
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OPERATIVE AND DIAGNOSTIC 
STRATEGY FOR THE SUSPECTED 
GALLBLADDER CANCER AND THE 
OPTIMAL CASES FOR LAPAROSCOPIC 
CHOLECYSTECTOMY
H. Katagiri, K. Ishii, H. Kawamata, H. Tajima, H. Kamata, 
Y. Kumamoto and M. Watanabe
Department of Surgery, Kitasato University, School of 
Medicine
Kitasato University, School of Medicine, Department of 
Surgery 1-15-1, Kitasato, Sagamihara, Japan
Introduction: The surgical procedure for gallbladder cancer 
is still diffi cult to improve a prognosis. Otherwise, laparo-
scopic cholecystectomy (LC) is possible to get complete cure 
in some cases of early cancer. The present study aims to 
clarify the appropriate case for LC by evaluating the preop-
erative suspected gallbladder cancer and its clinicopathologi-
cal fi nding.
Methods: We performed a retrospective analysis of patients 
with gallbladder cancer who underwent cholecystectomy 
from 1981 to 2010 at Kitasato university east hospital in 
Japan. The histopathological fi nding clarifi ed the horizontal 
carcinomatous spread and invasion depth in the 53 cases 
precisely. We classifi ed those macroscopic confi guration and 
the characteristic. Long-term survival was calculated using 
the Kaplan-Meier method, and differences in group of sur-
vivors were compared by the log-rank test. In preoperative 
diagnosis, we used Doppler ultrasonography and analysed 
maximum blood fl ow velocities (Vmax) in the mural cystic 
artery of the gallbladder.
Results: 43 cases with protruding lesion and 10 with fl at 
invasive lesion (WT) were defi ned. The protruding lesions 
were classifi ed into 3 subclass, such as pedicle type (PD, n 
= 7), nodular type (ND, n = 25) and papillary type (PP, n = 
11). The cancer nest was localized in the basal point with 
PD. The area of cancer spread in ND, PP, WT were 3 to 6 
times of the protruding part. The frequency of case beyond 
pT2 was 0% (PD), 91% (ND), 82.8% (PP), 90% (WT). 
Diagnostic Vmax was high in 14 cases of gallbladder cancer. 
The ROC analysis of the differential diagnosis by Vmax 
against the cut-off value of 35.2 cm/s was: AUC 0.929, 
sensitivity 85.7% and specifi city 88.2%. Patients with pT1 
who underwent no additional surgery, are alive without 
recurrence.
Conclusion: Also the regional lymphadenectomy is neces-
sary for the cases of pT2 cancer. There is much frequency of 
advanced cancer with sessile lesion and fl at lesion. However, 
all cases with macroscopic pedicle type were pT1 cancer. 
Thus, the case with pedicle lesion is optimal for the laparo-
scopic cholecystectomy. And the Doppler ultrasonography is 
useful for diagnosis of gallbladder cancer.
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POLYARTERITIS NODOSA PRESENTED 
BY IHD DILATATION WITH 
HEPATOLITHIASIS – A CASE REPORT-
J.-W. Choi, D. H. Ryu, H. Y. Yun, L.-C. Jang and 
Y. J. Song
Chungbuk National University, College of Medicine and 
Medical Research Institute Surgery, 62 Gaesin-dong 361 
Cheongju, Korea
Introduction: Polyarteritis Nodosa (PAN) is a systemic 
necrotizing vasculitis of medium-sized or small arteries in 
multi organ systems, but a rare vasculitis. Deposition Ag-Ab 
complexes in the vessel walls leads to infl ammation, edema 
and eventually necrosis of the tunica intima and media. It is 
characterized by fi brinoid necrosis and infi ltration predomi-
nantly by polymorphonuclear leukocutes. GI involvement 
occurs in 14~65% of patients with PAN, where small bowel 
or gallbladder are most commonly affected.
Methods: A 53-year-old male patient visited the OPD, 
because of poor oral intake that started one month earlier. 
Initial physical examination, did not show any specifi c fi nd-
ings. Lt. IHD dilatation was shown on abdominal US fi nd-
ings. The patient did not have a hepatitis history but had mild 
fever (37.3°C) on V/S. Diagnostic abdominal CT fi ndings 
showed Lt. IHD dilatation with hepatolithiasis and chronic 
cholecystitis, and the possibility of intrahepatic cholangi-
ocarcinoma could not be ruled out.
After conservative managements, surgery was performed 
for diagnostic and therapeutic purposes.
Results: After undergoing cholecystectomy and Lt. hepate-
ctomy, the specimen did not show any evidence implying 
cancer and IHD stenosis and cholecystitis with hepatolithi-
asis was seen, and the surgery was brought to an end. During 
the postoperative recovery period, after the patient felt 
numbness on his feet, the symptoms worsened. The fi nal 
pathology reported to be Polyarteritis nodosa with hepato-
lithiasis on liver, Polyarteritis nodosa with chronic chole-
cystits on GB. The patient was transferred to rheumatology 
and was further treated with prednisolone. Thereafter the 
numbness on his feet disappeared and PD maintenance 
therapy was continued. After being discharged the patient is 
currently under OPD f/u in the rheumatology department.
Conclusion: The authors report a case presented by Lt. IHD 
dilatation with hepatolithiasis on abdominal CT fi ndings 
without any evidence of systemic disease, and was histologi-
cally diagnosed as Polyarteritis nodosa.
490
ACTIVE RESECTION FOR 
HETEROCHRONIAL TRIPLE 
CHOLANGIOCELLAR CARCINOMAS
D. Teraoku, M. Shimada, T. Utsunomiya, I. Satoru, 
Y. Morine, T. Ikemoto, M. Kanamoto and H. Miyake
Department of Digestive and Transplant Surgery, 
Tokushima University
Tokushima University, Department of Digestive and 
Trasnplant Surgery, 2-50-1 Kuramoto-cho 77000 
Tokushima, Japan
Introduction: It is rare that heterochronial or recurrent 
cholangiocellar carcinoma (CCC) for radical resection, espe-
330 Poster Presentation Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 288–699
cially triple cancers. Just two reported that twice major 
hepatectomies after pancreatoduodenectomy (PD) for hete-
rochronial CCC. Here we show a case whose cholangiocellar 
carcinoma was resected twice after PD for cancer of the 
middle bile duct, as a curative resection.
Methods: 60 years old male, with distal gastrectomy for 
perforative duodenal ulcer in 1994, underwent PD for middle 
bile duct cancer (papillary adenocarcinoma) in 1997 at other 
hospital. He received segmentectomy (S6) which was diag-
nosed as metastatic recurrent tumor of the liver (S6, solitary 
4 cm) from middle bile duct cancer in 2005 at our institute 
(Total bleeding; 140 ml, Op. time; 6 h 7 min). Pathological 
examination revealed that diagnosis was poorly differenti-
ated cholangiocelluar carcinoma, thus it was considered that 
double cancers.
Results: During out-patients follow-ups, repeated cholangi-
tis were observed in short time, CT revealed obstructive 
jaundice due to hilar mass formation. He was diagnosed as 
hilar cholagioma, thus another hepatectomy and hepaticoje-
junostomy were undergone (Total bleeding; 380 ml, Op. 
time; 8 h 16 min.) despite of surgical diffi culties due to 
severe adhesions and re-anastmosis. Pathological examina-
tion revealed that diagnosis was well differentiated cholan-
giocelluar carcinoma, thus it was considered that triple 
cancers. He has survived 10 months after the previous opera-
tion without recurrence and a new lesion.
Conclusion: Our case is extremely rare because heteroch-
ronial triple cholangiocellar carcinoma that were resected 
radially in each time. Active resections for cholangiocellar 
carcinoma considered as recurrence or metastasis may be a 
strong therapeutic option.
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COMBINED TREATMENT OF PATIENTS 
WITH KLATSKIN TUMOR
A. Polikarpov, P. Tarazov, D. Granov, A. Kozlov 
and V. Popov
Russian Scientifi c Centre of Radiology and Surgical 
Technologies, St. Petersburg, Russia, Leningradskaja 70, 
Pesochny 19775 St. Petersburg, Romania
Introduction: To evaluate results of combined, surgical and 
interventional radiological, treatment of pts with Klatskin 
tumor.
Methods: Between 2000 and 2010, 33 pts with histologi-
cally verifi ed cholangiocarcinoma of Bismuth III-IV were 
treated (22 men, 11 women, aged 35–70 years). All patients 
had obstructive jaundice with 80–760 (mean 430 + 120) 
µmol/L total bilirubin level. Percutaneous transhepatic 
biliary drainage (PTBD) or stenting was the fi rst step of 
treatment.
After bilirubin decreasing <50 µmol/L, 11 patients 
received surgery (left hepatectomy = 7, right hepatectomy = 
3, hepatic duct bifurcation resection = 1) with following 
adjuvant regional celiac artery infusion (CAI) (group A). 
22 pts had contraindication for surgery because of signifi cant 
vascular invasion. Of them, 8 were treated by repeated CAI 
(1–8, mean 3 cycles) with ADM, 5-FU and Gemcitabine 
(Group B), while 14 had symptomatic therapy (group C).
Results: Complications of PTBD (n = 7; 21%) were: drain-
age migration (n = 4), hemobilia (n = 2), cholangitis (n = 1). 
Hemobilia was successfully treated by right hepatic artery (n 
= 1) or gastroduodenal artery (n = 1) embolization. Other 
complications were managed conservatively.
Surgical mortality rate in group A was 9% (n = 1). At 
present, 5 patients are alive 3, 6, 18, 24 and 48 mo. The mean 
survival of 5 pts who died was 27 mo, with 2-yr survival 
100%. In group B, 2 pts are alive for 9 and 21 mo, 6 pts died 
(mean survival 18 mo and 2-yr survival 25%). In group C, 
all pts died in 2–23 (mean 10.5) mo.
Conclusion: PTBD/stenting is relatively safe and effective 
method for correction of malignant obstructive jaundice and 
when successful gives a good chance for specifi c therapy. 
Both surgery and regional chemotherapy help to increase 
survival in pts with Klatskin tumor.
509
COMPLETION CHOLECYSTECTOMY – A 
COMPLICATION DURING THE 
LAPAROSCOPIC ERA
C. Wilson, J. French, D. Manas and S. White
Hepatobiliary and Transplant Unit, The Freeman Hospital, 
Newcastle-upon-Tyne, United Kingdom
The Freeman Hospital, HPB and Transplantation, Freeman 
Road, High Heaton, NE7 7 Newcastle-upon-Tyne, United 
Kingdom
Introduction: Laparoscopic cholecystectomy (LC), because 
of its minimal invasiveness, has become the gold standard 
approach for removing the gallbladder (GB). As a result, the 
number of cholecystectomies performed in the UK has 
rapidly increased since its inception. However, in those 
patients with signifi cant infl ammation LC can be challenging 
and when Calot’s triangle is hostile some advocate partial 
cholecystectomy (PC) in order to avoid an open operation 
and potentially a bile duct injury.
Methods: We reviewed the experience of completion chole-
cystectomy (CC) in a specialist tertiary HPB unit with a 
referral population of over 3 million during a 1 year period 
(November 2010–2011). The specialist unit performs over 
200 LC a year for benign gallbladder disease as well as 
defi nitive treatment for GB cancer.
Results: 3 cases of CC were identifi ed during the study 
period. 2 of the cases had re-presented with persistent RUQ 
pain and one recurrent biliary pancreatitis secondary to 
microlithiasis. All patients were presumed to have had a LC 
but after further imaging by MRI/EUS or ERCP, all were 
found to have a signifi cant gallbladder remnant. All patients 
underwent a completion cholecystectomy (2 via an open 
procedure). In all of the cases clips or surgical ties had been 
placed on either Hartmann’s pouch or the gallbladder fundus, 
leaving a signifi cant remnant.
Conclusion: LC is in most cases an effective and straight 
forward operation. Despite the perceived effectiveness and 
ease of the laparoscopic approach, PC is not without com-
plications and attention to the length of the cystic duct stump 
or gallbladder remnant is critical to avoid recurrent 
problems.
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LIVER RESECTIONS FOR NON 
TUMORAL HEPATIC DISEASES. 
MULTICENTRIC EXPERIENCE 
IN ARGENTINA
J. Pekolj1, A. Dietrich1, M. Moro2, G. Stork2, N. Bucich3, 
R. Russi3, P. B. schelotto4 and E. de Santibañes1
1Service of HPB surgery, Hospital Italiano of Buenos 
Aires; 2Service of General Surgery, Hospital Dr Penna, 
Bahia Blanca; 3Service of HPB surgery, Hospital Naval of 
Buenos Aires; 4Service of HPB surgery, Favaloro 
Foundation University Hospital
Hospital Italiano of Buenos Aires, HPB surgery, Hospital 
Italiano de Buenos Aires, Perón 4190, 1181 Buenos Aires, 
Argentina
Introduction: The role of Liver resection (LR) in patients 
with non-tumoral hepatic diseases (NTHD) remains 
controversial.
Methods: A retrospective analysis in a multicentric data 
base was performed.
Outcome measures were incidence of postoperative 
cholangitis, infectious and non-infectious complications, 
hospital stay and overall mortality.
Post-operative complications were recorded using the 
Dindo-Clavien classifi cation.
Results: Seventy-seven patients underwent LR due to 
NTHD from January 2001 to November 2011. Thirteen 
patients presented complex bile duct injuries (CBDI), 17 
intra-hepatic lithiasis (IL), 20 liver hydatid cyst (LHC), 10 
with polycystic liver disease (PLD), 6 with sclerosing 
cholangitis (SC) and 10 other NTHD.
Twenty fi ve patients presented history of previous treat-
ments, either percutaneous or endoscopic.
Thirty patients underwent major hepatectomy and forty-
seven underwent liver segmentectomy or atypical liver 
resection.
Liver resections included a right hepatectomy in 19 
patients, left hepatectomy in 6, right tri-segmentectomy in 3 
and left lateral segmentectomy with right posterior segmen-
tectomy in 2 patients. Minor hepatectomy included a left.
Conclusion: LR is a radical and effective procedure to treat 
benign non tumoral liver diseases, instead of other surgical 
or percutaneous procedures, avoiding multiple sessions of 
treatment and high post procedure complications rates.
514
SIGNIFICANCE OF PORTAL VEIN 
EMBOLIZATION IN PATIENTS WITH 
BILIARY MALIGNANCIES WHO 
UNDERWENT EXTENDED 
HEPATECTOMY. TO WHAT EXTENT 
SHOULD WE PERFORM PVE? -SINGLE 
INSTITUTIONAL RESULT
R. Higuchi1, T. Ota1, T. Araida2, H. Kajiyama1, T. Yazawa1, 
K. Onuki1, S. Uemura1 and M. Yamamoto1
1Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University; 2Department of 
Gastroenterology, Tokyo Women’s Medical University, 
Yachiyo Medical Center
Gastroenterology, Tokyo Women’s Medical University, 
Surgery, 8-1 Kawada-cho, Shinjuku-ku, 16286 Tokyo, 
Japan
Introduction: Portal vein embolization (PVE) is often rou-
tinely performed preoperatively in patients with biliary 
malignancies who undergo extended hepatectomy. However, 
PVE is sometimes performed in cases which it is unneces-
sary. So we study an appropriate standard indication of PVE.
Methods: The subjects were 95 patients who underwent 
extended hepatectomy (right hepatectomy, right trisegmen-
tectomy) combined with extra-hepatic bile duct resection for 
biliary malignancies in our institute between 1997 and 2010. 
PVE was generally indicated when a future remnant liver 
(FRL) volume was estimated to be less than 30%. Fifteen 
patients underwent PVE (Group A) and 80 patients didn’t 
undergo PVE before extended hepatectomy (Group B).
Results: Right trisegmentectomy was signifi cantly often 
performed in group A (4/15) than group B (4/80, P = 0.019), 
but, in a ratio of combination of PD, reconstruction of the 
portal vein and hepatic artery were not. The FRL volume 
before PVE was signifi cantly smaller in group A (26%) than 
group B (35%, P = 4.50 × 10−7). And, there was signifi cant 
increase in the FRL volume after PVE (7.0%, P = 0.001). 
There was no signifi cant deference in the postoperative mor-
bidity (A: 67% vs B: 51%) and mortality (A: 0% vs B: 2.5%) 
between the two groups. The length of hospital stay was 
signifi cantly longer in group A (73 days) than group B (52 
days, P = 0.0095).
Conclusion: In conclusion, preoperative PVE may contrib-
ute to improve surgical outcome of extended hepatectomy 
for biliary malignancies when the FLR volume of the patient 
is less than 30% of the estimated total liver volume.
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EFFECT OF PREOPERATIVE 
NEUTROPHIL-LYMPHOCYTE RATIO 
AND LACTATE DEHYDROGENASE ON 
THE SURGICAL OUTCOMES OF DISTAL 
BILE DUCT CARCINOMA
Y. Iso, M. Ishizuka, T. Sawada and K. Kubota
Department of Gastroenterological Surgery, Dokkyo 
Medical University
Dokkyo Medical University, Department of 
Gastroenterological Surgery, 880 Mibu, Tochigi 32102, 
Japan
Introduction: The current standard treatment for the distal 
bile duct carcinoma (DBC) remains surgical resection as no 
alternative effective treatment exists. However, in resected 
cases, the long-term prognosis is still poor. The use of infl am-
matory markers based on differential white-cell counts, such 
as the neutrophil/lymphocyte ratio (NLR) and lactate dehy-
drogenase (LDH), may be simple and readily available 
biomarkers. This study aimed to determine whether the NLR 
and LDH are predictors of surgical outcomes in patients with 
DBC.
Methods: We enrolled 75 DBC patients who had undergone 
pancreatoduodenectomy (PD) at a single institution between 
April 2000 and November 2011. In 10 patients, PD with 
extended hepatectomy was performed because carcinoma 
invaded hilar bile ducts. And 5 patients underwent PD with 
portal vein resection due to portal invasion. The NLR and 
LDH were estimated as described previously. Briefl y, patients 
with both an elevated NLR (>5) and LDH level (>250 U/L) 
were allocated a score of 2 (N-L score 2). Patients in whom 
only one of the biochemical abnormalities was present were 
allocated a score of 1 (N-L score 1). Patients in whom neither 
of these abnormalities was present were allocated a score of 
0 (N-L score 0).
Results: Of these 75 patients, 45 patients had N-L score 0, 
27 patients had N-L score 1, and 3 patients had N-L score 2. 
Patients with N-L score 2 had a signifi cantly worse overall 
survival (OS) than did patients with a N-L score 1 and 0. Cox 
regression analysis revealed that elevated N-L score 2 was 
an independent predictor of OS (P = 0.01).
Conclusion: The N-L score 2 is an independent predictor of 
OS in patients with DBC. Preoperative NLR and LDH meas-
urement in DBC patients may be a simple method for iden-
tifying patients with a poor prognosis who can be enrolled 
in further trials of surgical resection.
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OUTCOME OF EXTENDED RIGHT 
HEPATIC LOBECTOMY WITH PORTAL 
VEIN RESECTION FOR ADVANCED 
KLATSKIN TUMOR
Y. Iso, T. Sawada and K. Kubota
Department of Gastroenterological Surgery, Dokkyo 
Medical University
Dokkyo Medical University, Department of 
Gastroenterological Surgery, 880 Mibu, Tochigi 32102, 
Japan
Introduction: Hilar cholangiocarcinoma (also known as 
‘Klatskin tumor’), occasionally requires concurrent extended 
right hepatic lobectomy with portal vein resection (ERHL 
with PV), depending on the manner of progression and ana-
tomical characteristics. In the present study, we reviewed the 
cases of ERHL with PV performed at our department.
Methods: In our department, ERHL for Klatskin tumor is 
performed after transileocolic right portal vein embolization 
(TIPE) and involves D2 lymphadenectomy (dissection of the 
lymph nodes of the hepatoduodenal ligament). Between 
April 2000 and November 2011, liver resections for 67 cases 
of Klatskin tumor were performed at our department. Of 
these, 43 cases underwent TIPE-ERHL. Patients were 
divided to 2 groups; ERHL with PV resection (PV group, n 
= 6), and ERHL without PV resection (non-PV group, n = 
37). Clinicopathological data were compared between the 
two groups. Data were expressed as PV group to non-PV 
group in order.
Results: Mean ages were 71.3 and 68.8 years old, mean 
operation times were 659.3 and 614.7 minutes (P = 0.28), 
operative blood losses was 877.8 and 1002.4 ml (P = 0.53), 
post-operative hospital stays were 62.8 days and 51.4 days 
(P = 0.65), and mean survival periods was 28.9 months and 
20.8 months (P = 0.43), respectively.
Conclusion: Since PV resection does not increase the risk 
of surgery, PV resection should be performed with ERHL if 
PV invasion is suspected.
546
ANALYSIS OF PREDICTORS FOR NON-
INVASIVE BILIARY IMAGING FOR 
SUSPECTED CHOLEDOCHOLITHIASIS 
PRIOR TO CHOLECYSTECTOMY
N. Doctor and R. Gomes
Department of Surgical Gastroenterology Jaslok Hospital 
and Research Centre, 15, dr g Deshmukh Marg, Mumbai, 
Maharashtra, India 400026
Jaslok Hospital and Research Centre, 15, dr g Deshmukh 
Marg, Mumbai, Maharashtra India -400 026 Department 
of Surgical Gastroenterology 9, Dani Sadan, 113 
Walkeshwar Road, Mumbai Maharashtra, 40000640000 
Mumbai, India
Introduction: Selective non invasive imaging with MRCP 
or EUS or CT is routinely performed prior to preoperative 
ERCP in patients with symptomatic gallstone disease with 
clinical, biochemical and sonographic criteria suggesting 
coexistent CBD stones to give a low frequency of false-
negative ERCP results. Our aim was to identify predictors 
for selection of a preoperative diagnostic technique for 
patients with symptomatic gallstone disease with suspected 
choledocholithiasis.
Methods: This study prospectively included 69 who had 
undergone MRCP/EUS/CT and/or ERCP before LC among 
212 patients with LC for symptomatic gallstones between 
October 2010 to September 2011. Preoperative evaluation 
included abdominal sonography and serum biochemistry 
(total bilirubin, aspartate aminotransferase, alanine ami-
notransferase, glutamyl transferase, alkaline phosphatase, 
amylase and lipase). MRCP/EUS/CT and/or ERCP was per-
formed if suspected choledocholithiasis. Choice between 
MRCP/EUS/CT and ERC was according to clinical/labora-
tory fi ndings and personal preference. No selection criteria 
was used. CBD stones were confi rmed by ERCP/IOC and 
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considered absent if stone-related symptoms absent during 3 
month follow-up with normal laboratory fi ndings.
Results: 69 patients had abnormal biochemical and/or sono-
graphic criteria suggesting coexistent CBD stones. 52 under-
went either an MRCP/CT/EUS. 30 patients underwent an 
ERCP of which 17 underwent prior MRCP/CT/EUS. 2 
underwent an IOC. No stones detected on IOC and no stone 
detected one case of ERCP. 26 patients were detected to have 
CBD stones (12.3%) treated preoperatively by ERCP. CBD 
stones were detected in 18 of 55 patients with deranged 
LFTs, 24 of 42 patients with a dilated CBD on sonography, 
11 of 13 patients with a visualized stone on sonography, 21 
of 36 with deranged LFTs and a dilated CBD and in none 
with deranged LFTs and a non dilated CBD. 40 with no stone 
detected on MRCP/CT/EUS were followed up for 3 month 
and had no biliary symptoms.
Conclusion: ERCP can be used in high risk patients for 
coexistent CBD stones based on biochemical and sono-
graphic predictive criteria without prior use of non invasive 
imaging. Non invasive imaging can be used selectively 
before laparoscopic cholecystectomy.
550
PAPILLARY CARCINOMAS OF THE 
BILIARY SYSTEM: CHARACTERISTICS 
OF A DISTINCT SUBSET
C. Tampi1 and J. Palepu2
1Dept of Histopathology, Lilavati Hospital and Research 
Centre, Mumbai, India; 2Dept of Surgical Oncology, 
Lilavati Hospital and Research Centre, Mumbai, India
Lilavati Hospital and Research Centre, Histopathology, 
Cons. Histopathologist, Dept of Histopathology, Lilavati 
Hospital and Research centre, Bandra-W, Mumbai -400 
05040005 Mumbai, India
Introduction: Within biliary tract carcinomas the papillary 
carcinomas are a better behaved biological subset. Their 
survival is however marred by recurrences, often amenable 
to curative resections. Two such re operated cases are pre-
sented. Though resurgeries are rare, an analysis of all suc-
cessfully reoperated biliary tract cancers reported, reveal all 
of them to be papillary adenocarcinomas substantiating the 
need to understand the characteristics of this small subset.
Methods: Three patients were operated for adenocarcino-
mas of the ampulla and left hepatic duct, respectively. The 
histology was papillary adenocarcinoma, and resection was 
R0. The cancers recurred after 16–24 months, two at the 
anastomotic site, which was at some distance away from the 
primary tumor and one as metachronous cystic ovarian 
tumors. Two of the patients underwent successful re resec-
tions and the histology of the recurrences was identical low 
stage well differentiated, papillary carcinomas, in both cases.
Analysis of reports of successful reoperations for recurrent 
bile duct cancers reveal that the histology in all the reoper-
ated cases, both in the primary and in the recurrent tumor 
was identical, that is papillary adenocarcinomas.
Results: Papillary adenocarcinomas have a predominant 
exophytic, intraluminal component. They are well to moder-
ately differentiated. They present as early TNM stage tumors, 
and are amenable to R0 resections.
They have long survival but are prone to recurrences. 
These recurrences are often far from the primary site, and 
are sometimes metachronous cancers along the biliary tree. 
They recur frequently at the bilio-enteric anastomotic site. 
Distant metastasis is also seen, as in our case. These recur-
rences are also papillary tumors, well differentiated and low 
stage. These recurrences are remarkable in that they are often 
amenable to successful re resections.
Conclusion: Papillary adenocarcinomas of the biliary 
system have distinct biological characteristics.
1) They are low stage low-grade tumors. 2) They are prone 
to recurrences either at anastomotic site, as metachronous 
tumors or as distant metastasis 3). The recurrences are also 
papillary, well-differentiated and are amenable to curative 
surgery.
Identifi cation of this subset and its molecular signature, if 
any, would help better prognostication for these patients.
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LAPAROSCOPIC VERSUS OPEN 
PANCREATICODUODENECTOMY: 
ONCOLOGICAL OUTCOMES USING 
LEEDS PATHOLOGY PROTOCOL 
(LEEPP) – A MATCHED-PAIR ANALYSIS
A. Hakeem, A. Aldouri, A. Smith and K. Menon
Department of Hepato-Pancreato-Biliary Surgery, St 
James’s University Hospital NHS Trust
Leeds Teaching Hospital NHS Trust, Department of 
Hepato-Pancreato-Biliary Surgery, St James’s University 
Hospital NHS Trust, Beckett Street, LS97T Leeds, United 
Kingdom
Introduction: Laparoscopic Pancreaticoduodenectomy 
(LPD) has been shown to be a technically safe procedure. 
Oncological safety of LPD is still a matter for debate. 
Currently, there is limited evidence for cancer outcomes 
following LPD, especially in comparison to Open 
Pancreaticoduodenectomy (OPD). The aim of this study is 
to compare the adequacy of cancer resection and outcome 
following LPD and OPD.
Methods: Between November 2005 and April 2009, 12 
LPD’s (9 ampullary and 3 distal CBD tumours) were carried 
out in a tertiary referral centre. A cohort of 12 patients who 
underwent OPD from November 2003 to Feb 2007 were 
matched for age, sex, site of tumour origin and tumour size. 
Histology was assessed using previously validated Leeds 
Pathology Protocol (LEEPP). The primary aim was to evalu-
ate margin involvement and mean number of lymph nodes 
excised. The secondary endpoints were complications, high-
dependency unit (HDU) stay, length of hospital stay (LOS), 
recurrence and mortality rate. The median follow-up was 
46.8 months for LPD and 56.0 months for OPD.
Results: LPD and OPD were matched for age (67.0 Vs 66.3 
years, p = 0.868), male gender (8 Vs 8, p = 1.000), tumour 
origin (9 ampullary and 3 CBD both groups, p = 1.000) and 
tumour size (19.8 Vs 19.2 mm, p = 0.870). R0 resection was 
achieved in 9 LPD Vs 8 OPD (p = 1.000). The mean number 
of lymph node excised for LPD Vs OPD (20.7 Vs 18.5, p = 
0.534). Clavien grade I/II complications (5 Vs 8), Clavien 
grade III/IV complications (2 Vs 6) and pancreatic leak (2 
Vs 1) were statistically not signifi cant (LPD Vs OPD). The 
mean HDU stay was longer in OPD group (3.7 Vs 1.4 days, 
p < 0.000), but LOS was no different (14.9 Vs 14.9 days, p 
= 1.000). There were 2 recurrences each in LPD and OPD 
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(p = 1.000). There was no difference in the recurrence-related 
mortality (2 Vs 2, p = 1.000).
Conclusion: Compared to open procedure, in patients with 
tumour size less than 2 cm, laparoscopic pancreaticoduo-
denectomy achieves similar rate of R0 resection, lymph 
node harvest and long-term recurrence. LPD patients have 
signifi cantly shorter high-dependency stay and lesser post-
operative complications. Though technically challenging, 
laparoscopic pancreaticoduodenectomy is safe and does not 
compromise oncological outcome.
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A CASE OF LARGE INTRADUCTAL 
PAPILLARY MUCINOUS NEOPLASM OF 
BILE DUCT MANAGED BY PORTAL VEIN 
EMBOLIZATION AND RIGHT 
TRISECTIONECTOMY
C. Bunchaliew, R. Chanwat and T. Khuhaprema
National Cancer Institute, Thailand
National Cancer Institute, Surgical Oncology, 268/1 Rama 
VI Road, Rajathevi 10140 Bangkok, Thailand
Introduction: Surgical management is the cornerstone of 
treatment for intraductal papillary mucinous neoplasm of 
bile duct. In some cases, the large tumor involving multiple 
segments of liver may cause surgical problem. We reported 
a case that portal vein embolization can be helpful in this 
situation.
Methods: A 45 year-old man suffered from abdominal pain 
for 2 years. His abdominal MRI revealed a large cystic-
papillary tumor which involved segment IV, V, VI, VII and 
VIII of liver. Initially, functional liver volume of the left 
lateral segment was estimated to be 25%. Right portal vein 
embolization was done and CT Volumetry in the following 
3 weeks reported volume of left lateral segment was increased 
to 35%.
Results: The right trisectionectomy was performed in this 
patient. During operation, negative right bile duct margin 
was reported by frozen section. On section of the liver speci-
men revealed 17 × 11 × 11 cm cystic mass with numerous 
papillary projection and mucin containing inside. Post-
operative course was uneventful. Patient was discharged on 
7th post-operative day. Pathological report revealed intraduc-
tal papillary mucinous neoplasm of bile duct with invasive 
component and free resection margin.
Conclusion: Hepatectomy is an only one curative procedure 
for intraductal papillary mucinous neoplasm of bile duct. 
Portal vein embolization can be an adjunct procedure for 
management in case of large tumor.
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LARGE CELL NEUROENDOCRINE 
CARCINOMA OF THE AMPULLA OF 
VATER: A CASE REPORT AND REVIEW 
OF THE LITERATURE
K. D. Kim, H. C. Kim, J. C. Chung, G.-S. Choi and 
H.-J. Lee
Soonchunhyang University College of Medicine, 
Soonchunhyang University Bucheon Hospital, Department 
of Surgery 1174 Jung-dong, Wonmi-gu 42767 Bucheon-si, 
Korea
Introduction: Primary neuroendocrine carcinoma of the 
ampulla of Vater is very rare. The clinical course presents an 
appearance of extremely aggressive behavior and frequent 
liver metastasis. The effective adjuvant chemotherapy for 
large cell neuroendocrine carcinoma (LCNEC) is not estab-
lished as yet. We report a rare case of LCNEC of the ampulla 
of Vater.
Methods: A 58 year old man presented with epigastric dis-
comfort and dyspepsia. All laboratory fi ndings were within 
normal limits. PET-CT scan showed a focal FDG uptake in 
the head of pancreas. Endoscopic biopsy specimen of duo-
denal papilla revealed a diffuse infi ltration of atypical cell, 
consistent with poorly differentiated malignant tumor.
Results: The patient underwent pylorus preserving pancrea-
ticoduodenectomy. Histopathologic fi ndings were suitable 
for LCNEC. Immunohistochemical studies revealed positiv-
ity for chromogranin A, synaptophycin. The patient was 
undertaken chemotherapy (cisplatin and etoposide). Six 
months after surgery, a metastatic hepatic nodule was found 
at segment 7 and was treated by radiofrequency abration. The 
patient was received six courses of additional chemotherapy 
(cisplatin, doxorubicin and cyclophosphamide; CAP).
Conclusion: Twenty-one months after the surgery, the 
patient is alive and no other metastatic lesion is found. CAP 
chemotherapy was effective. For early detection of liver 
metastasis, short term follow up by using radiologic imaging 
is essential.
557
CLINICAL SIGNIFICANCE OF 
TRANSDUODENAL AMPULLECTOMY IN 
THE ERA OF ENDOSCOPIC 
PAPILLECTOMY
H.-J. Lee, H. C. Kim, J. C. Chung and G.-S. Choi
Soonchunhyang University College of Medicine, 
Soonchunhyang University Bucheon Hospital, Department 
of Surgery, 1174 Jung-dong, Wonmi-gu 42767 Bucheon-si, 
Korea
Introduction: Ampullary adenomas seem to follow the 
adenoma-to-carcinoma sequence. Recently, endoscopic 
papillectomy has been used to manage ampullary adenomas, 
but curative surgical resection of the tumor remains the treat-
ment of choice. Transduodenal ampullectomy has been 
reported that is associated with less complication rate and 
hospitalization than Pancreaticoduodenectomy. So, the goal 
of this study was to reestablish the scope of transduodenal 
ampullectomy.
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Methods: We retrospectively reviewed the medical records 
of 65 patients treated for ampullary tumors between January 
2002 and November 2011.
Results: In this study, the indication of transduodenal 
ampullectomy was ampullary tumor with low-grade dyspla-
sia (>2 cm), high-grade dysplasia, carcinoma in situ and T1 
cancer. Twenty endoscopic papillectomies, 5 transduodenal 
ampullectomies and 40 pancreaticoduodenectomies were 
performed. One patient underwent transduodenal ampullec-
tomy after endoscopic papillectomy due to a remnant tumor. 
Depending on the results of frozen biopsy, immediate intra-
operative conversion from transduodenal ampullectomy to 
pancreaticoduodenectomy was performed in one patient. 
During follow up, recurrence was found in one patient (20%) 
after transduodenal ampullectomy and four patients (20%) 
after endoscopic papillectomy. The mean follow up was 36.7 
months (range, 15 days–111 months).
Conclusion: Although endoscopic papillectomy can be 
applied in ampullary adenoma with low-grade dysplasia and 
size of less than 2 cm, transduodenal ampullectomy is the 
best treatment an alternative to radical surgery in ampullary 
tumor with high-grade dysplasia, carcinoma in situ and T1 
adenocarcinoma.
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GALLBLADDER POLYPS; IS 
SURVEILLANCE FOLLOWED BY 
CHOLECYSTECTOMY RISK AND 
COST-EFFECTIVE?
G. Garcea, V. Cairns, C. Neal, A. Dennison and 
A. Dennison
Department of Hepatobiliary and Pancreatic Surgery, 
University Hospitals of Leicester
University Hospitals of Leicester, Department of 
Hepatobiliary and Pancreatic Surgery, Leicester General 
Hospital, Gwendolen Road, Leicester LE5 4, United 
Kingdom
Introduction: The management of true neoplastic gallblad-
der polyps remains nebulous due the lack of knowledge 
regarding their natural history. This study attempted to ascer-
tain risk factors for neoplasia and the best management 
options for patients presenting with gallbladder polyps.
Methods: Patients with gallbladder polyps were identifi ed. 
Demographic data, size and number of polyps were recorded 
as well size increase and histology. Detection rates for 
potentially neoplastic and frankly neoplastic polyps were 
recorded and compared with complication rates from chole-
cystectomy. Cost-effectiveness of USS surveillance was 
examined.
Results: 986 patients were identifi ed. Only 6.6% of polyps 
exhibited an increase in size over the surveillance period. 
The median size of polyps of demonstrating an increase in 
size was signifi cantly greater than those not increasing 7 
versus 5 mm respectively (P < 0.05). Only 3.7% of resected 
polyps had malignant or potentially malignant histology. 
Size above 10 mm and increase in size during surveillance 
predicted neoplastic potential.
Conclusion: Surveillance ± selective surgery policy could 
potentially detect and prevent 5.4 gallbladder cancers per 
1000 individuals per year with a cost-saving of over £130,000 
per year. Cancer prevention benefi ts would exceed the risk-
ratios from cholecystectomy complications. Polyps greater 
than 10 mm should be resected, those between 5 to 10 mm 
should be under USS surveillance.
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BILIARY INJURY AFTER 
LAPAROSCOPIC CHOLECYSTECTOMY: 
OUR EXPERIENCE AND 
LITERATURE REVIEW
S. Vaccarisi1, E. Bonaiuto1, V. Pellegrino1, V. Crocco1, 
N. Spadafora1, A. N. Garrini1, G. Cavallari2 and B. Nardo1
1Hepato-Biliary-Pancreatic and Transplant Organs Unit, 
Department of Surgery, Annunziata Hospital, Cosenza, 
Italy; 2Department of Surgery and Transplantation, S.
Orsola-Malpighi Hospital, University of Bologna, Italy
Annunziata Hospital, Surgery, Hepato-Biliary-Pancreatic 
and Transplant Organs Unitvia F. Migliori 87100 Cosenza, 
Italy
Introduction: In recent years, iatrogenic bile duct injuries 
(IBDI) after laparoscopic cholecystectomy (LC) have pre-
sented an increase in their incidence, which ranges from 0.4 
to 0.6%. The risk factors are well known: anatomic anoma-
lies, gallbladder infl ammation, surgical adhesion and sur-
geon’s experience. Despite numerous data in literature and 
the learning curve, the percentage of IBDI remains high 
resulting in important consequences on the quality of life of 
the patient.
Methods: From December 2007 to December 2011, 9 
patients with IBDI after LC were treated in our 
Hepatobiliarypancreatic Unit. Seven were referred to us from 
other hospitals. Two patients were subjected to LC by our 
surgical team among 484 LCs (0.4%). Patients were 4 males 
and 5 females. The median age was 53.2 years (34–79 years). 
The IBDI were grouped according to Strasberg classifi cation: 
A 1 patient, D 1 patient, E1 5 patients, E2 1 patient, E3 1 
patient. Only in one patient operated by us the correction was 
intra-operative, while the other patients underwent surgery 
after a mean period of 19.6 days (4–78 days).
Results: In 7 patients we performed a Roux-en-Y hepatico-
jejunostomy, one patient was treated with endoscopic biliary 
stenting and laparoscopic drainage, the other one was sub-
mitted to T tube biliary drainage and external drainage of the 
cavity. The mean days of hospitalization were 10.7 (range 
7–21). In the postoperative period two patients (E1) had low-
fl ow biliary fi stula treated with conservative therapy. After a 
median follow-up of 12.6 months (range 1–23) all patients 
have good clinical condition and normal values of bilirubin 
and liver enzymes. In one patient, after onset of jaundice due 
to cicatricial stenosis of the common bile duct, we had to 
run, a new Roux-en-Y epaticojejunostomy after 137 days.
Conclusion: The choice of treatment (surgery, radiology, 
endoscopic or combined) should be decided according 
to the type of lesion and the specifi c experience of the 
surgeons. The reoperations are burdened by high morbidity 
and mortality, so it is important to direct the patient to a 
hepatobiliary center of reference as soon as possible because 
early detection of iatrogenic injury signifi cantly increases the 
chances of successful repair.
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INTRAHEPATIC 
CHOLANGIOCARCINOMA: IMPACT OF 
GENETIC HEMOCHROMATOSIS ON 
OUTCOME AND OVERALL SURVIVAL OF 
AFTER SURGICAL RESECTION
L. Sulpice1, M. Rayar1, E. Boucher2, F. Pele3, B. Meunier1 
and K. Boudjema1
1Service de chirurgie hépatobiliaire et digestive- CHU 
Pontchaillou, Université de Rennes 1, France; 
2Département d’oncologie médicale, CRLCC Rennes, 
Université de Rennes 1, France; 3Département 
d’épidémiologie- CHU Pontchaillou, Université de Rennes 
1, France
CHU Pontchaillou- Rennes, Université de Rennes 1, 
France, Service de chirurgie hépatobiliaire et digestive, 2 
rue Henri Le Guilloux 35033 Rennes cedex, France
Introduction: Intrahepatic cholangiocarcinoma (ICC) is of 
increasing incidence and liver resection has been shown to 
improve survival. Impact of underlying liver disease on post-
operative survival is still debated. Indeed, while the cirrhosis 
seems to worsen the prognosis after resection, the infl uence 
of genetic hemochromatosis (GH) has never been evaluated. 
The aim of this study was to establish the clinical signifi -
cance of GH for prognosis in patients with ICC.
Methods: All patients with ICC who underwent surgical 
resection between January 1997 and August 2011 were ana-
lysed retrospectively. 87 patients were analysed, 16 (18.4%) 
had GH (GH group) and 71 (81.6%) were allocated in non 
GH group (51 and 19 (21.8%) had normal or cirrhotic paren-
chyma, respectively). Prognosis signifi cance of clinicopatho-
logic factors including GH was assed by univariate and 
multivariate analysis. Univariate analysis of overall survival 
(OS) and disease free survival (DFS) were estimated by 
Kaplan-Meier method and compared by the log rank test. 
Factors with a p < 0.1 in univariate analysis were included 
in subsequent multivariate analysis by the Cox multiple 
regression model.
Results: R0 resection was performed in 65 patients (74.7%). 
Overall median survival time was 32.5 months, with 1-, 3- 
and 5 year actuarial rates of 78.7%, 46.8% and 30.5% respec-
tively. There was no signifi cant difference in survival 
between our 2 groups. In non GH group, survival between 
cirrhotic and non cirrhotic patients was similar. Univariate 
analysis showed that major hepatectomy (p = 0.012), intra-
operative blood infusion (p = 0.007), tumor size > 5 cm 
(0.006), nodule > 1 (p < 0.001), microvascular invasion (p = 
0.04) were signifi cantly associated with poor survival. 
Multivariate analysis showed that Intraoperative blood infu-
sion (HR 0.37; 95 IC [0.19; 0.71], p = 0.003) and nodule > 
1 (HR 2.5; 95 IC [1.06;5.8], p = 0.037) were associated with 
lower survival.
Conclusion: While the incidence of GH is high in our 
series, its presence does not affect overall and disease free 
survival after liver resection for ICC.
565
THE SURVIVAL OUTCOME AND 
PROGNOSTIC FACTORS FOR 
EXTRAHEPATIC BILE DUCT 
CANCER FOCUSED ON MIDDLE 
BILE DUCT CANCER
K. J. Kang1, K. S. Ahn1, Y. H. Kim1, T. J. Lim1 and 
Y. I. Choi2
1Department of Surgery, Keimyung University School of 
Medicine, Daegu, Korea; 2Department of Surgery, 
Bongseng Hospital, Busan, Korea
Keimyung University, School of Medicine, Surgery, 
Department of Surgery, Keimyung university Dongsan 
Hospital, 56 Dalsung-ro, Jung-gu 700 Daegu, Republic of 
Korea
Introduction: There is a question about appropriate surgical 
procedure for the extrahepatic bile duct cancer confi ned to 
the middle bile duct (MBD) that is in the extrahepatic-
supraduodenal area. In order to get R0 resection for curative 
goal, combined hepatectomy or radical pancreaticoduo-
denectomy (PD) may be necessary. The aim of this study is 
compare survival between segmental resection group for 
mid-BD and radical PD group for the distal bile duct (DBD) 
cancer for analysis of oncologic feature of MBD ca.
Methods: From July 2000 to November 2011, 87 patients 
underwent resection for extrahepatic bile duct cancer. In 19 
patients of them, tumor was confi ned in the MBD and seg-
mental resection of bile duct (BDR) was performed (BDR 
group) and remaining 67 patients underwent pancreaticoduo-
denectomy for DBD cancer (PD group). We analyzed retro-
spectively clinicopathological characteristics and survival 
outcomes of two groups in terms of pattern of progression 
and prognosis.
Results: The rate of advanced T stage (T3) was signifi cantly 
lower (10.5% Vs 61.2%), and lymph node invasion (52.6% 
Vs 20.9%, P = 0.010) and the rate of R1 resection (42.1% 
Vs 11.9%, P = 0.006) were signifi cantly higher in BDR group 
than PD group. The 3 year survival rates were signifi cantly 
lower in BDR group (59.8% Vs 15.7%, P = 0.05). When we 
compared overall survival rates in patients of BDR group, 
there was no signifi cant difference between R0 and R1 resec-
tion. However, in PD group, patients with R0 resection 
showed signifi cant longer survival rates than those of R1 
resection. in multivariate analysis, margin status and lymph 
node invasion were signifi cant independent prognostic 
factors of extrahepatic bile duct cancer.
Conclusion: In MBD cancer, although T stage is lower than 
DBD cancer, rates of lymph node invasion is higher and 
showed poor survival rates than DBD cancer regardless of 
margin status.
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THE VALUE OF PREOPERATIVE 
MAGNETIC RESONANCE 
CHOLANGIOPANCREATOGRAPHY 
(MRCP) TO PREVENT BILE DUCT 
INJURY IN PATIENTS WHO WILL 
PERFORM LAPAROSCOPIC 
CHOLECYSTECTOMY
T. J. Lim1, Y. H. Kim1, K. S. Ahn1, K. J. Kang1, Y. I. Choi2 
and T. J. Park1
1Department of Surgery, Keimyung University School of 
Medicine, Daegu, Korea; 2Department of Surgery, 
Bongseng Hospital, Busan, Korea
Keimyung University School of Medicine, Surgery, 
Department of Surgery, Keimyung University Dongsan 
Hospital, 56 Dalsung-ro, Jung-gu 700 Daegu, Republic of 
Korea
Introduction: The aim of this study is to evaluate the value 
of preoperative MRCP prior to cholecystectomy by analyz-
ing the rate of clinically inapparent common bile duct stone 
or duct anomaly and postoperative complication.
Methods: Between 2009.12 and 2010.12, 283 patients 
underwent laparoscopic cholecystectomy due to benign 
biliary disease. Among these patients, 125 were performed 
MRCP preoperatively and classifi ed as MRCP group. 
Remaining 158 patients who were not taken MRCP were 
classifi ed as non MRCP group. We analyzed preoperative 
common bile duct (CBD) stone and biliary anomaly based 
on MRCP and postoperative complications such as bile duct 
injury in both group.
Results: In MRCP group, pre-operative MRCP screening 
revealed clinically silent CBD stones in 5 patients (4.0%), 
bile duct anomalies 17 patients (13.6%). Although, 2 cases 
of bile duct injury were occurred in non MRCP group in 
contrast with no bile duct injury in MRCP group, there was 
no signifi cant statistical difference of postoperative compli-
cation in both groups. MRCP may be useful to evaluate bile 
duct anomaly and reveal hidden bile duct stones. However, 
this modality did not show statistical benefi ts for reducing 
bile duct injury in laparoscopic cholecystectomy.
Conclusion: Our results showed that routine MRCP scan 
for cholecystectomy may not be justifi ed.
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STRATEGIES OF THE REPAIR FOR 
INTRAOPERATIVE BILE DUCT INJURY
T. Yazawa, Y. Takehisa, O. Takehiro, H. Ryota, K. Hideki, 
O. Kenitiro, U. Syuitiro and Y. Masakazu
Department of Surgery, Institute of Gastroenterology, 
Tokyo Woman’s Medical University
Department of Surgery, Institute of Gastroenterology, 
Tokyo Woman’s Medical University, 8-1 Kawada tyo 
Shinjyuku-ku, 162 Tokyo, Japan
Introduction: Intraoperative bile duct injury (BDI) and 
postoperative bile duct stricture were serious complication. 
The choice of treatment is diffi cult. We investigated the treat-
ment of 56 patients diagnosed as BDI in our institute.
Methods: From 1971 to 2007, 56 patients with BDI or post 
bile duct stricture underwent treatment in our institute. 
Clinicopathological features and outcomes were analyzed 
retrospectively.
Results: 20 patients (35.7%) had their original surgery at 
our institute, 36 patients (64.3%) at other institute.
18 patients were managed by hepaticojejunostomy, 12 
patients by end to end ductal repair, 3 patients by 
Choledocoduodenostomy, jejuna interposition, simple ductal 
repair, respectively. T tube drainage was performed 8 
patients, and other procedures were performed in 4.6 patients 
were managed by non-surgical repair. In most patients who 
underwent hepaticojejunostomy and in re-operated case, 
obstruction was more than Bismuth type III. In end to end 
ductal repair cases, 10 patients was Bismuth type II, 11 cases 
(91.7%) showed a good prognosis.
Conclusion: In Bismuth type I and II, we choiced end to 
end ductal repair possibly. In more than Bismuth type III or 
re-operated cases, we will performed hepaticojejunostomy.
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CASE REPORT: PRIMARY LYMPHOMA 
OF BILE DUCT
V. H. Torres-Cueva1, E. Anchante-Castillo2, 
C. Yeren-Paredes3, O. Becerra4, E. Cordero5, J. Nuñez6, 
J. Sumire7 and J. Delgado7
1Chief Hepatobiliary Surgery Service ‘G. Almenara 
National Hospital-Lima-PERU; 2Chairman Department of 
surgery ‘G. Almenara National Hospital-Lima-PERU; 
3Staff Hepatobiliary Surgery Service ‘G. Almenara 
National Hospital-Lima-PERU; 4Staff Hepatobiliary 
Surgery Service ‘G. Almenara National Hospital-Lima-
PERU; 5Staff Hepatobiliary Surgery Service ‘G. Almenara 
National Hospital-Lima-PERU; 6Staff Hepatobiliary 
Surgery Service ‘G. Almenara National Hospital-Lima-
PERU; 7Staff Department of Patology ‘G. Almenara 
National Hospital-Lima-PERU
‘Guillermo Almenara National Hospital’-EsSalud Lima-
PERU, Hepatobiliary Surgery Service- Department of 
Surgery, Calle Guayaquil 132- la Molina-Lima-PERU, 
Lima, Lima, Peru
Introduction: We report an extremely rare case of Primary 
Lymphoma of Bile duct, in a 58 years old female patient; 
who was operated of gallstones in another hospital, the 
surgeon performed an open cholecystectomy plus common 
Bile Duct exploration with biopsy of bile duct thickened ant 
T tube drain. The histological fi ndings shows an 
Adenocarcinoma of bile duct and reactive hyperplasia. The 
patient received six months of chemotherapy as adjuvant 
therapy.
Methods: Six months after the patient was transfered to 
hepatobiliary Surgery Service of G. Almenara National 
Hospital where we Follow up. At this time the patient 
was asyntomatic with (LFTs) and Ca 19-9 negative. Our 
Pathologists reviewed the slides of the fi rst operation 
and they found that the patient had Primary Lymphoma 
of Bile Duct instead of Adenocarcinoma and the 
Immunohistochemistry (CD45:+, CD20:+, CD3:); confi rmed 
the Diagnosis of B Cell Lymphoma.
The cholangiography by T tube showed slight narrowing 
distal bile duct without dilatation, so we tried to pull out the 
T Tube without success and producing Cholangitis two 
weeks after. At the admission the patient has abdominal pain, 
Choluria an jaundice. Laboratory and images showed.
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Results: Alkaline Phosphate: 233 U/L; GGTP: 530 U/L; 
ASAT: 1002 U/L; ALAT: 782 U/L; Total Bilirrubin: 2.06 mg/
dl; Ca19.9: 4.45 U/ml. MRI showed intrahepatic Bile ducts 
dilated with an impacted stone in common bile duct. The 
patient underwent to an second abdominal surgery and we 
performed a resection of bile duct and reconstruction in an 
old fashioned ‘Roux in Y Hepaticojejunostomy’ plus nodular 
biopsy of retrocholedocian nodule. The Pathology result of 
this nodule and common bile duct was benign without evi-
dence of malignancy. the patient was discharge and follow 
up in the out patient clinic; she was been well, without evi-
dence of tumor recurrence a year after second surgery.
Conclusion: Primary Lymphoma of Bile Duct is extremely 
rare case, could be present with clinical features mimicking 
cholangiocarcinoma or Adenocarcinoma as we reviewed in 
the literature collected, so it should be considered in the 
Differential diagnosis of patients with obstructive jaundice 
and bile duct tumors as in the present case. If the diagnosis 
is made before surgery, chemotherapy may be the primary 
therapy. Surgical resection should be reserved to complica-
tions of biliary obstruction.
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SINGLE INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY: INITIAL 
EXPERIENCE IN A PUBLIC HOSPITAL
E. Murguia, A. Duro, F. Rodriguez and H. Mayorga
Bernardo Houssay Hospital. Florida. Buenos Aires. 
Argentina
Bernardo Houssay Hospital, Department of Surgery, 
Hipolito Yrigoyen 1757, 1602 Florida. Buenos Aires, 
Argentina
Introduction: Single incision laparoscopic cholecystec-
tomy (SILS) has gained wide popularity, because of the 
improved cosmesis associated with this technique. The fun-
damental idea is to have a single port to hold all the instru-
ments into the abdominal cavity. We present our initial 
experience in SILS in a public hospital.
Methods: From August 2010 to October 2011, thirty two 
patients (28 female and 4 male) with symptomatic gallstone 
disease underwent cholecystectomy using single incision. 
We excluded the patients with acute cholecystitis or con-
comitant choledocholithiasis. Only one longitudinal umbili-
cal 2.0 cm in length incision was made for accessing the 
abdominal cavity. The single port device used was SILS port 
(Coviden, USA). Intraabdominal visualization is obtained 
with a 5 mm. laparoscope. Only two other instruments were 
used for the performance the cholecystectomy. All the regular 
steps of laparoscopic cholecystectomy were followed.
Results: The mean age of the patients was 39 years (21–64). 
The mean body mass index (BMI) was 22.69 kg/m2 (Range: 
18.59–26.21). The mean operative time was 83.49 min. 
(61–138). No conversion to standard laparoscopic cholecys-
tectomy was done. No intraoperative complications occurred. 
No postoperative complications occurred. To date no wound 
infection and no hernias have developed.
Conclusion: Single incision laparoscopic cholecystectomy 
is a feasible and safe alternative to standard laparoscopic 
cholecystectomy. It makes an excellent cosmetic result. 
Further evaluation with randomization and a larger sample 
population is necessary.
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PERIOPERATIVE AND LONG FOLLOW 
UP EVALUATION OF LAPAROSCOPIC 
SUBTOTAL CHOLECYSTECTOMY
A. Tamura, Y. Otsuka, M. Tsuchiya, T. Maeda, T. Katagiri, 
J. Ishii, Y. Kubota and H. Kaneko
Toho University medical center Omori hospital, Tokyo, 
Japan
Toho University medical center Omori hospital, 
Gastroenterological surgery, 6-11-1 omori-nishi, ota-ku 
143 Tokyo, Japan
Introduction: Laparoscopic subtotal cholecystectomy 
(LSC) is conducted in patients with severe, generally gan-
grenous, acute, or chronic infl ammatory changes in triangle 
of Calot.
Methods: We investigated the safety and complications of 
LSC for severe cholecystitis in perioperative and follow up 
period during 3 to 7 years.
Laparoscopic cholecystectomy (LC) was performed in 
827 patients during a period of 2004 to 2010. In 23 of the 
patients (2.8%), LSC was performed.
Results: In the LSC group, one patient was converted to 
open subtotal cholecystectomy. The average operation time 
for LSC was 162 minutes, estimated operative blood loss was 
42 ml. The average postoperative hospital stay was 8.7 days. 
In the LC group, 57 patients were converted to open chole-
cystectomy. The average operation time for LC was 117 
minutes, estimated operative blood loss was 22 ml. The 
average postoperative hospital stay was 4.7 days. There was 
no bile duct injury or mortality in either group.
During 3 to 7 years follow up periods, 2 patients were 
detected new gall stone in residual gallbladder.
Conclusion: Although LSC has disadvantage in term of 
operating time, blood loss and hospital stay compared with 
LC, LSC is utilized operative technique in complicated 
cholecystitis.
It is considered the procedure is relatively safe with an 
acceptably low morbidity rate.
In addition, LSC technique has considered to reduce the 
conversion rate to open surgery, and may be helpful in 
decrease of biliary duct injury complications.
Further study is needed for incidence of recurrence gall-
bladder stone, although less incidence was observed.
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A CASE OF CHYLURIA, A RARE 
COMPLICATION AFTER SURGERY FOR 
CANCER OF THE GALLBLADDER
R. Higuchi1, T. Ota1, H. Kajiyama1, T. Yazawa1, 
M. Hamano2, T. Araida2, T. Furukawa3 and M. Yamamoto3
1Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University, Kawada-cho, 
Shinjuku-ku, Tokyo, Japan; 2Department of 
Gastroenterology, Tokyo Women’s Medical University, 
Yachiyo Medical Center, Kawada-cho, Shinjuku-ku, Tokyo, 
Japan; 3Institute for Integrated Medical Sciences, Tokyo 
Women’s Medical University, Kawada-cho, Shinjuku-ku, 
Tokyo, Japan
Introduction: A 58-year-old woman underwent right lobec-
tomy with resection and reconstruction of the bile duct and 
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portal vein after percutaneous transhepatic portal vein 
embolization for gallbladder cancer with infi ltration to the 
right hepatic artery, portal vein and bile duct.
Methods: She was discharged on postoperative day (POD) 
26 without major complications, but was readmitted for 
dehydration, electrolyte imbalance and chyluria on POD 50. 
The patient was discharged once again after symptomatic 
therapy, but was readmitted for shortness of breath and appe-
tite loss. Split renal function study showed normal left kidney 
function but protein 2+/glucose 2+ in the right pelvic urine, 
and cystoscopy revealed milky urine fl owing from the right 
ureteral orifi ce. Filarial antibodies were negative.
Results: Based on a diagnosis of chyluria occurring from 
lymphorrhea at the level of the right pelvis associated with 
of surgery for gallbladder cancer, she underwent unilateral 
stripping of the right renal pedicle. Postoperatively, 
hyponatremia, proteinuria and cloudy urine became normal, 
and ascites and edema improved.
Conclusion: To the best of our knowledge, reports on chy-
luria after biliary and abdominal surgery in the English lit-
erature are very rare, and we therefore report this case.
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OUR LOCAL EXPERIENCE IN 
AGGRESSIVE MANAGEMENT OF 
GALLBLADDER CARCINOMA
L. S. Lee, Y. X. Koh, W. L. L. Ong, S. S. Tan 
and S.-M. Tan
Changi General Hospital, Singapore
Changi General Hospital, General Surgery, 2, Simei Street 
3, 52988952988 Simei, Singapore
Introduction: Gallbladder carcinoma (GBCA) accounted 
for only 2% of all cancer. It has poor prognosis due to lack 
of early signs and symptoms. However, R0 resection with 
aggressive management has proven to achieve a better sur-
vival. We aim to determine the outcome of the patients after 
the aggressive management of GBCA in our centre.
Methods: All the GBCA patients who had surgery at Changi 
General Hospital, Singapore, from 2001 to 2011, were retro-
spectively reviewed. Those who had palliative surgery for 
non-resectable tumour and those with stage T1 tumour were 
excluded. Patients were classifi ed in to 2 groups. Group 1 
patients had aggressive management with resection of liver 
segment 4b/5, lymphadenectomy, and with or without con-
current resection of the surrounding organs and Group 2 
patients had less aggressive management with only wedge 
resection of the gallbladder fossa of the liver or no liver 
resection. Comparison were analysed using SPSS.
Results: Twenty seven patients had undergone surgery. 
There were 17 patients in Group 1, of which 9 had bile duct 
resection, 2 had concurrent Whipple’s procedure, and 3 had 
right colectomy. R0 was achieved in all the 17 patients. Two 
patients (11.7%) had complications that required interven-
tions in Group 1. In Group 2, four patients had wedge resec-
tion of the gallbladder fossa, of which 2 (20%) had 
complications requiring intervention. There are 10 disease 
recurrences in Group 1 and all patients in Group 2 had 
disease recurrence. Average duration of survival in Group 1 
and Group 2 were 28.8 months and 11.1 months respectively. 
There were 8 (47%) survival in Group 1, whilst none survive 
in Group 2.
Conclusion: GBCA is a rare and highly lethal disease. 
Aggressive management in GBCA does not seem to have a 
high complication rate. High index of suspicion and early 
diagnosis of the disease in earlier stages is essential in 
improving survival.
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ANALYSIS OF PROGNOSTIC FACTORS 
OF THE MIDDLE OR LOWER BILE 
DUCT CARCINOMA
Y. Yamamoto, I. Hisashi, M. Ryo, F. Hitoshi, O. Kazuma, 
O. Toshiya, K. Yukihito and O. Eigo
Division of Digestive Surgery, Department of Surgery, 
Kyoto Prefectural University of Medicine
Kyoto Prefectural University of Medicine, Division of 
Digestive Surgery, Department of Surgery, 465 Kajii-cho, 
Kamigyo-ku, Kyoto 6020841, Japan
Introduction: Recent advances in imaging modalities and 
surgical procedures have improved the outcome of the surgi-
cal treatment for middle or lower bile duct carcinoma, 
however, surgical outcome cannot be satisfi ed. The aim of 
this study was to investigate the clinicopathological charac-
teristics and surgical outcomes of middle or lower bile duct 
carcinoma.
Methods: The clinical records of 33 patients that underwent 
macroscopic curative resection for middle or lower bile duct 
carcinoma between January 2001 and December 2009 were 
reviewed retrospectively. Twenty-nine patients underwent 
pancreaticoduodenectomy, 1 underwent extrahepatic bile 
duct resection, and 3 underwent hepatectomy with extrahe-
patic bile duct resection, respectively. Nineteen clinicopatho-
logic factors, including radial margin and ductal margin, 
were investigated using univariate and multivariate analysis 
in these patients.
Results: The overall 5-year survival rate was 47.6%, and 
median survival time was 37.5 months. In the univariate 
analysis, positive radial margin (p < 0.01), serosal invasion 
(p < 0.01), and neural invasion (p = 0.03) were signifi cantly 
predictors of a poor outcome. Multivariate survival analysis 
showed that positive radial margin (p = 0.049) and serosal 
invasion (p < 0.001) were independently associated with a 
poorer prognosis. One in 3 patients with positive mucosal 
ductal margin has remained free of recurrence for 58 months, 
however, there were no long survivor in 4 patients with posi-
tive submucosal ductal margin.
Conclusion: Securing a negative radial margin, rather than 
obtaining a negative ductal margin, had a signifi cant impact 
on survival.
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SURGICAL OUTCOMES AND 
PROGNOSTIC FACTORS FOR 
EXTRAHEPATIC 
CHOLANGIOCARCINOMA IN 
EXTREMELY OLD PATIENTS AGED 
OVER 80 YEARS IN A SINGLE 
ACADEMIC INSTITUTE
Y. Katayose1, K. Nakagawa1, K. Fukase2, M. Mizuma2, 
F. Motoi2, T. Rikiyama2, S. Egawa2 and M. Unno2
1Integrated Surgery and Oncology, Tohoku Graduate 
School of Medicine, Seiryomachi, Aobaku, Sendai, Japan; 
2Department of Surgery, Tohoku Graduate School of 
Medicine, Seiryomachi, Aobaku, Sendai, Japan
Introduction: The safety and effi cacy of surgical treatment 
for extrahepatic cholangiocarcinoma in extremely old 
patients aged over 80 years are not evaluated enough. The 
aim of this study was to compare the peri-operative safety 
and effi cacy after surgery between younger (below 64), 
young-old (65–74), old-old (75–80), and extremely old (over 
80) patients at a single university hospital.
Methods: 234 consecutive patients who underwent surgical 
resection for extrahepatic cholangiocarcinoma in 10 years 
from 2001 to 2010 in our institute were retrospectively ana-
lyzed in the study. In 234 cases, younger, young-old, old-old, 
and extremely old patients were 76, 110, 35, 13 cases, 
respectively. Hilar bile duct cases were 148, and distal bile 
duct cases were 86. In hilar bile duct cases, younger, young-
old, old-old, and extremely old patients were 53, 71, 17, 7 
cases, respectively. In distal bile duct cases, younger, young-
old, old-old, and extremely old patients were 23, 39, 18, 6 
cases, respectively.
Results: Operative procedures, R0-resection rate, blood 
loss, and operative duration were not different between each 
group. And, hospital stay after surgery, hospital death, surgi-
cal site infection, liver failure, and anastomotic leakage were 
also not different between each group. But only 3 cases 
(3/13, 23.1%) of extremely old patients were received adju-
vant chemotherapy. The other patients were received adju-
vant chemotherapy in 53.8%. The rate of adjuvant therapy 
for extremely old patients were signifi cant low compared 
with the other patients (p = 0.044). Over all survival (OS) 
were different between old-old and extremely old patients (p 
= 0.046). Then, adjuvant therapy and postoperative treatment 
seemed to be related with OS.
Conclusion: From this retrospective study, we tended not to 
apply adjuvant therapy for extremely old patients. However, 
surgical outcomes of peri-operative factors were not differ-
ent. There was no demerit for radical resection for extremely 
old patients. Therefore, we could try adjuvant therapy for 
extremely old patients to improve prognosis in safety.
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IMAGING MODALITY OF 
REFORMATTED LONGITUDINAL 
IMAGE BY MULTI-DETECTOR ROW 
CT IN THE DIAGNOSIS FOR 
GALLBLADDER CANCER
A. Iwama, T. Tadatoshi, Y. Mituka, M. Mamamichi, 
H. Tokio and Y. Shintaro
Department of Digestive Surgery, Nihon University School 
of Medicine
Nihon University School of Medicine, Department of 
Digestive Surgery, ZIP 173-8610, 30-1 Ohyaguchikami-
machi Itabashi-ku, 8610 Tokyo, Japan
Introduction: The gallbladder cancer (GBC) is one of the 
poorest prognostic cancers. The only available option to offer 
long time survival is radical resection with a negative surgi-
cal margin. Thus, only way contributing to prognosis is to 
diagnose in early stage GBC. Recent advancement of multi-
detector row CT (MDCT) enables to detect early change of 
gallbladder cancer. However, the diagnostic value of early 
GBC and optimal plane of multi-planner reformat image on 
the diagnosis is unsettled.
Methods: The gallbladder cancer (GBC) is one of the 
poorest prognostic cancers. The only available option to offer 
long time survival is radical resection with a negative surgi-
cal margin. Thus, only way contributing to prognosis is to 
diagnose in early stage GBC. Recent advancement of multi-
detector row CT (MDCT) enables to detect early change of 
gallbladder cancer. However, the diagnostic value of early 
GBC and optimal plane of multi-planner reformat image on 
the diagnosis is unsettled. The 54 patients who were preop-
eratively diagnosed gallbladder neoplasm and were under-
gone cholecystectomy with liver resection were included. 
They were pathologically divided to the malignant group (n 
= 30) and benign group (n = 24) after operation. The diag-
nostic value obtained from longitudinal image of gallbladder 
was assessed with preoperative variables.
Results: The mucosal line was disrupted in 28 patients 
(93%) of malignant group and in only 3 patients (13%) 
benign group (P < 0.001). The wall thickness of maximum 
(9.3 mm [4.2–24.8] vs. 7.0 [2.4–22.6], p = 0.07) and 
minimum (1.2 mm [1.0–2.4] vs. 1.3 [1.0–2.6], p = 0.23) in 
one plane of longitudinal image of gallbladder did not differ 
between two groups whereas the maximum/minimum ratio 
of wall thickness was signifi cantly differ between two groups 
(6.8 [1.92–20.7] vs. 5.8 [2.33–8.69], p = 0.04). The partial 
liver bed enhancement around the tumor was more frequent 
in malignant group than that in benign group (40.0% [12/30] 
vs. 12.5% [3/24], p = 0.03). The disruption of the mucosal 
line was the independent predictor for diagnosis (Odds ratio: 
28.5, 95% CI [5.99–228.1], p = 0.001). Longitudinal image 
enable to diagnose the hepatic-invasion of GBC.
Conclusion: The reformatted longitudinal image of MDCT 
has the best modality in the diagnosis for GB.
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IS ROUTINE INSERTION OF 
NASOGASTRIC TUBE REALLY 
NECESSARY IN ELECTIVE 
PANCREATODUODENECTOMY?: 
A PROSPECTIVE RANDOMIZED 
CONTROLLED TRIAL
H. Kwon1, S. Kim1, J. Chun2, Y. Hwang1 and Y.K. Yun2
1Department of Surgery, Kyungpook National University 
Medical Center; 2Department of Surgery, Kyungpook 
National University School of Medicine
Kyungpook National University Medical Center, 
Department of Surgery, 807 Hogukno, Buk-gu, Daegu 
Metropolitan City, Republic of Korea
Introduction: The objective of this study was to investigate 
the effi cacy of inserting nasogastric (NG) tube after pancrea-
toduodenectomy (PD) by comparing clinicopathological 
factors and complications of between patients with and 
without a NG tube in the patient who underwent elective PD.
Methods: 72 patients were enrolled in this trial from 
September 2009 to June 2011. The patients were randomly 
assigned to the with NG tube group (Group 1, n = 36) and 
without NG tube group (Group 2, n = 36). Clinicopathological 
factors and surgical outcomes such as length of hospital 
stay after PD, delayed gastric emptying (DGE), postopera-
tive hemorrhage (PPH), postoperative pancreatic fi sula 
(POPF), pulmonary complications, cardiovascular complica-
tions, wound complications, and mortality compared 
prospectively.
Results: There was no difference in terms of age, gender, 
operating time, pathological diagnosis, time to fl atus, length 
of hospital stay after PD between two groups. Postoperative 
complication rates, including DGE (Grade A and B) (38.9% 
vs 27.8%, respectively; p = 0.454), POPF (Grade A and B) 
(30.6% vs 30.6%, respectively; p = 1.000), PPH (Grade A 
and B) (11.1% vs 5.6%, respectively; p = 0.674), pulmonary 
complications (63.9% vs 66.7%, respectively; p = 1.000), 
and cardiovascular complications (5.6% vs 2.7%, respec-
tively; p = 1.000), were similar in each group. There was no 
leakage of duodenojejunostomy in both groups. A case of 
mortality due to myocardial infarction occurred in Group 1 
but the difference was not statistically signifi cant.
Conclusion: Routine insertion of NG tube offers no benefi t 
in preventing postoperative complications after elective PD 
and does not shorten length of hospital stay after PD. 
Therefore, routine use of a nasogastric tube is not required 
in elective PD.
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CLINICOPATHOLOGICAL FEATURES OF 
INTRADUCTAL PAPILLARY NEOPLASM 
OF THE BILE DUCTS WITH 
EXTRACELLULAR MUCIN SECRETION
M. Mizuma1, T. Morikawa1, K. Ishida2, F. Motoi1, 
T. Rikiyama1, Y. Katayose3, S. Egawa1 and M. Unno1
1Division of Hepato-Biliary-Pancreatic Surgery, 
Department of Surgery, Tohoku University Graduate 
School of Medicine, Sendai, Japan; 2Department of 
Pathology, Tohoku University Hospital, Sendai, Japan; 
3Division of Integrated Surgery and Oncology, Department 
of Surgery, Tohoku University Graduate School of 
Medicine, Sendai, Japan
Tohoku University Graduate School of Medicine, Division 
of Hepato-Biliary-Pancreatic Surgery, Department of 
Surgery, 1-1 Seiryomachi, Aoba-ku, Sendai 980–8574, 
Japan
Introduction: Recently, intraductal papillary neoplasm of 
the bile ducts (IPNB) was proposed as a new disease entity. 
Although some reports have discussed whether IPNB is the 
biliary counterpart of intraductal papillary mucinous neo-
plasm of the pancreas (IPMN), including cases with poor 
mucin secretion in IPNB is not fi t for the features of IPMN. 
The purpose of this study is to elucidate the clinicopathologi-
cal features of IPNB with extracellular mucin secretion, 
compared with absence of that.
Methods: Between January 1999 and August 2011, a total 
of 27 consecutive cases with pathologically diagnosed IPNB 
were surgically resected at the Tohoku University Hospital. 
Mean age was 69.0 years old (range 50–82). 19 and 8 cases 
were diagnosed with IPNB in males and females, respec-
tively. These cases were divided into two groups. One is 
IPNB with extracellular mucin secretion grossly or micro-
scopically (IPNBm(+)) and the other is IPNB without extra-
cellular mucin secretion (IPNBm(−)). 19 cases were allocated 
to IPNBm(+) and 8 to IPNBm(−). Clinicopathological fea-
tures were reviewed in each group.
Results: All cases of IPNB were histologically diagnosed 
with malignancy. Tumors confi ned to the mucosa included 
15 of 19 cases (79.0%) and 1 of 8 cases (12.5%) in IPNBm(+) 
and IPNBm(−), respectively (p = 0.0013). Incidence of extra-
biliary malignant neoplasms was signifi cantly higher in 
IPNBm(+) than IPNB(−) (26.3% vs 0%, p = 0.0462). Overall 
5-year survival was 87.1% for IPNBm(+) and 47.6% for 
IPNBm(−). The survival rate of IPNBm(+) was higher than 
that of IPNB(−) though it was not signifi cant.
Conclusion: IPNBm(+) appears more indolent than 
IPNBm(−). IPNB might be categorized according to extra-
cellular mucin secretion. Since clinicopathological features 
of IPNBm(+) are similar to those of IPMN, IPNBm(+) might 
be considered the biliary counterpart of IPMN.
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OPERATIVE OUTCOME OF HEPATIC 
RESECTION COMBINED WITH PORTAL 
VEIN RESECTION FOR HILAR 
CHOLANGIOCARCINOMA
T. Ajiki, K. Ueno, H. Sawa, K. Shinozaki, M. Kido, 
I. Matsumoto, T. Fukumoto and Y. Ku
Department of Surgery, Division of Hepato-Biliary-
Pancreatic Surgery, Kobe University Graduate School of 
Medicine
Kobe University Graduate School of Medicine, Department 
of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, 
7-5-1 Kusunoki-cho, Chuo-ku 65017 Kobe, Japan
Introduction: Curative resection for hilar cholangiocarci-
noma remains diffi cult in spite of recent advances of opera-
tive techniques. The main reasons for irresectability in hilar 
cholangiocarcinoma are local extensive invasion to major 
vessels such as the hepatic artery (HA) and the portal vein 
(PV). The aim of this study is to outline of our experience 
with hepatic resection combined with PV and HA resection 
for hilar cholangiocarcinoma and to evaluate the clinical 
signifi cance of this aggressive resection.
Methods: Between 1996 and 2011, a total of 52 patients 
with hilar cholangiocarcinoma underwent surgical resection 
at our institute. Operative procedures were 48 hepatic resec-
tions (30 left-sided hepatectomy (LH) and 18 right-sided 
hepatectomy (RH)) and 4 bile duct resections. Preoperative 
PV embolization was performed in 2 cases. Combined PV 
resection and reconstruction was carried out in 11 patients 
(21%). We examined prognostic factors in our experienced 
cases with hilar cholangiocarcinoma, and the operative out-
comes were compared between cases with and without PV 
resection. In this series, we had no experiences of HA resec-
tion and reconstruction. Therefore, we examined details of 
cases that HA invasion infl uenced R2 resection.
Results: R0, 1, 2 resection was achieved in 29, 12, and 11 
cases, respectively. Signifi cant univariate and multivariate 
prognostic factors were R0 resection. Eleven cases with 
combined PV resection consisted of 6 LH and 5 RH, 8 R0 
and 3 R1, 2, respectively. Results of pathological invasion to 
PV were 1 PV0, 6 PV1 (adventitia), 3 PV2 (media) and 1 
PV3 (intima) (actual pathological PV invasion were 91%). 
Survival rates of 1, 3, and 5 years in R0 resection cases were 
85, 51 and 43%, respectively. There was no signifi cant dif-
ference between cases with and without combined PV resec-
tion (p = 0.75). HA invasion infl uenced R2 resection in 7 
cases, in which another factors such as surgical margins or 
peritoneal metastasis were also positive.
Conclusion: Our experiences indicated that R0 resection is 
most important in resection for hilar cholangiocarcinoma, 
and combined PV resection could achieve R0 resection. 
However, cases requiring HA resection were almost so 
advanced, and HA resection should be performed in the 
selected cases.
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THE DIAGNOSIS AND 
MANAGEMENT OF SPHINCTER 
OF ODDI DYSFUNCTION: 
A SYSTEMATIC REVIEW
T. Hall, A. Dennison and G. Garcea
Department of Hepatobiliary and Pancreatic Surgery
Department of Hepatobiliary and Pancreatic Surgery, 
Leicester General Hospital, Gwendolen Road, Leicester, 
Leicestershire, LE5 4PWLE5 4 Leicester, United Kingdom
Introduction: Sphincter of Oddi dysfunction (SOD) is a 
benign pathological syndrome. The clinical manifestations 
may be a consequence of an anatomical stenosis or sphincter 
dysmotility. Manometry is invasive and has an associated 
morbidity. Non-invasive investigations have been evaluated 
to ameliorate risk but have unknown effi cacy. The review 
aims to critically appraise current evidence for the diagnosis 
and management of SOD.
Methods: A systematic review of articles containing rele-
vant search terms was performed. Inclusion criteria were any 
fully published study relating to the diagnosis and manage-
ment of SOD. Search limits were English language manu-
scripts only. All articles retrieved had the references 
cross-checked to ensure capture of cited pertinent articles.
Results: Manometry is the current gold standard in select-
ing which patients are likely to benefi t from endoscopic 
sphincterotomy (ES). It can however, be misleading. Several 
non-invasive investigations were identifi ed. These have poor 
sensitivities and specifi cities compared to manometry. There 
is a paucity of data examining the investigation’s specifi c 
ability to select patients for ES.
Outcomes of ES for Type I SOD are favourable irrespec-
tive of manometry. Types II and III SOD may respond to an 
initial trial of medical therapy. Manometry may predict 
response to ES in Type II SOD, but not in Type III.
Conclusion: Non-invasive investigations currently lack suf-
fi cient sensitivities and specifi cities for routine use in diag-
nosing SOD. Type I SOD should be treated with ES without 
manometry. Manometry may be useful for Type II SOD. 
However, whilst data is lacking a therapeutic trial of Botox 
or trial stenting may bean alternative. Careful and thorough 
patient counselling is essential. Type III SOD is associated 
with high complications from manometry and poor outcomes 
from ES.
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SINGLE INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY: A SYSTEMATIC 
REVIEW
T. Hall, A. Dennison, D. Bilku, M. Metcalfe and G. Garcea
Department of Hepatobiliary and Pancreatic Surgery, 
Leicester General Hospital, Gwendolen Road, Leicester, 
UK
Introduction: Single incision laparoscopic cholecystec-
tomy (SILC) is a novel concept designed to improve patient 
satisfaction and minimise surgical trauma. Whilst technically 
feasible, concerns exist over its safety and cost-effectiveness. 
A review of the existing literature was undertaken with 
specifi c reference to morbidity, pain, cosmesis and cost-
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effectiveness of SILC when compared to standard laparo-
scopic cholecystectomy (SLC).
Methods: All studies identifi ed through MEDLINE until 
July 2011 were included. References were cross-checked to 
ensure capture of cited pertinent articles. Case reports and 
series of less than 4 were excluded.
Results: In total 49 studies were analysed, including 2336 
patients. There were 7 randomised trials and 11 case-matched 
control (to SLC) series. The technical aspects of SILC were 
not standardised. Median follow-up time was 4 weeks, 
although 55% of studies reported no follow-up. The overall 
median complication rate was 7.37% (range 0–28.6) and the 
overall rate of biliary duct complications was 0.39%.
Post-operative pain was similar or worse in SILC com-
pared to SLC in 76.9% (n = 10) of articles reporting pain 
outcomes. Six articles investigated cosmesis after SILC com-
pared to SLC. Three articles demonstrated signifi cantly 
improved cosmesis after SILC.
Conclusion: The perceived benefi ts of SILC over SLC are 
improved cosmesis and reduced surgical trauma. There is no 
defi nitive evidence that such improvements can be gained by 
the single-incision. Complications are more common, may 
be underestimated due to the lack of suffi cient follow-up and 
may be associated with the shift from safe practice.
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PARENCHYMA-PRESERVING 
HEPATECTOMY FOR PERIHILAR 
CHOLANGIOCARCINOMA
H.-W. Park, H. Shin, C.-S. Park, J.-M. Namgoon, 
Y.-H. Park, G.-C. Park, D.-H. Jung and S.-G. Lee
Department of Surgery, Asan Medical Center, University of 
Ulsan College of Medicine, Seoul, Korea
Asan Medical Center, University of Ulsan College of 
Medicine, Department of Surgery, 388-1 Poongnap-dong, 
Songpa-gu 13873, Seoul Korea
Introduction: Both curative resection and acceptably low 
perioperative mortality offer the chance of long-term sur-
vival in patients with hilar cholangiocarcinoma. The resecta-
bility rate for hilar cholangiocarcinoma has increased through 
concurrent major hepatectomies, but these procedures are 
technically demanding and often associated with serious 
complications. Parenchyma-preserving limited hepatectomy 
(PPLH) has a defi nite merit on patient safety, but surgical 
procedure becomes more complex.
Methods: PPLH was performed in 13 patients with advanced 
perihilar cholangiocarcinoma by a single surgeon. Their 
medical records were analyzed retrospectively.
Results: The types of PPLH included resection of S4 + 1 (n 
= 8), S5 + 4a + 1 (n = 2), S5 + 4 + 1 (n = 2) and isolated S1 
(n = 1). R0 resection was achieved in 10 patients. Pylorus-
preserving pancreatectomy and extended bile duct resection 
with excavation of the intrapancreatic bile duct was per-
formed in 3 and 4 cases, respectively. There was neither 
mortality nor major morbidity, but prolongation of minor bile 
leak up to 1 month was observed in 3 patients. Their 5-year 
survival rate was around 40%, which is quite similar to 47% 
in our R0 major hepatectomy group (n = 214). Two signifi -
cant risk factors affecting survival after resection were lymph 
node metastasis and curability of surgery.
Conclusion: Major hepatectomy offers an improved sur-
vival with a higher possibility of curative resection than 
PPLH, but it still carries a risk of non-negligible major mor-
bidity and mortality. Less extensive procedures can be con-
ducted safely and benefi cially for old-aged patients with poor 
general condition and less advanced tumor stage if tumor-
free resection margins are obtainable.
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A CASE OF ADENOSQUAMOUS 
CARCINOMA OF THE EXTRAHEPATIC 
BILE DUCT
H. Ando, Y. Kishida, S. Oota, H. Seko, T. Ikeyama, 
S. Makita and Y. Akita
Gifu social insurance Hospital
Gifu social insurance hospital, Surgery 1221-5 dota Kani 
city Gifu prefecture, Japan, Kani, Japan
Introduction: Most malignant tumors originating from the 
biliary tract are adenocarcinomas, and adenosquamous car-
cinoma of the extrahepatic bile duct is very rare fi ndings.
We report a case of adenosquamous cell carcinoma of the 
extrahepatic bile duct which had a good prognosis after 
radical resection.
Methods: A 67-year-old man was admitted to our hospital 
because of jaundice.
The abdominal enhanced computed tomography (CT) and 
ultrasound (US) revealed the dilation of the bile duct and the 
tumor in the lower bile duct. After percutaneous transhepatic 
biliary drainage (PTBD), biopsy was performed via percuta-
neous transhepatic cholangioscopy. The histopathologic fi nd-
ings showed adenocarcinoma.
Pancreatoduodenectomy was performed under the diagno-
sis of carcinoma of the lower bile duct.
Results: Pathologically, the resected tumor was diagnosed 
as adenosquamous carcinoma of the lower bile duct.
Conclusion: This patient has survived recurrence-free for 
30 months after radical resection without adjuvant therapy.
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OUTCOME OF SURGICAL TREATMENT 
OF HILAR CHOLANGIOCARCINOMA 
WITH PRECISE HEPATECTOMY: 
PERSONAL EXPERIENCE FROM 
SINGLE CENTER
X. Li, S. Jian, C. Feng, W. Ke, P. Liyong and W. Xuehao
Liver Transplantation Center, Department of Surgery, The 
First Affi liated Hospital of Nanjing Medical University, 
300 GuangZhou Road, Nanjing, 210029, China
The First Affi liated Hospital of Nanjing Medical 
University, Liver Transplantation Center, Department of 
Surgery, 300 GuangZhou Road, 21002 Nanjing, China
Introduction: Hilar resection in combination with hepatec-
tomy has resulted in a higher rate of R0 resections and 
increased survival in patients with hilar cholangiocarcinoma 
(HCCA). This aggressive surgical approach is, however, 
associated with high rates of operative morbidity and mortal-
ity. In this study, we assessed the outcome of the radical 
approach for the management of hilar cholangiocarcinoma 
with precise hepatectomy techniques.
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Methods: From 2004 until June 2010, 67 consecutive 
patients underwent resection on the suspicion of HCCA. We 
conducted a retrospective single-center study. Preoperative 
diagnosis and staging was based on ultrasound, computed 
tomography, MRI and selective percutaneous cholangiogra-
phy. Surgery was radical and included en-bloc liver, 
extrahepatic bile duct and hilar lymph nodes resection, fol-
lowed by biliary reconstruction with hepaticojejunostomy. 
Outcomes of resection were evaluated.
Results: Eighty-nine patients underwent preoperative eval-
uation and 67 cases underwent radical resection containing 
Bismuth-Corlette type IIIA (n = 11), IIIB (n = 11) and IV (n 
= 29). Preoperative biliary drainage was undertaken in 10 
(14.90%). The surgical procedures included 20 extrahepatic 
bile duct resections, 34 left hemihepatectomies, 4 left triseg-
mentectomies, 6 right hemihepatectomies and 3 parenchyma-
preserving hepatectomies (all extended to the caudate lobe). 
Portal vein and hepatic artery resection were performed in 5 
and 2 patients, respectively. The R0 resection rate was 
89.5%. One (1.49%) patient who underwent HA and PV 
reconstruction was dead of liver failure. The overall 1- and 
5-year survival is 68% and 25% respectively.
Conclusion: Surgery for hilar cholangiocarcinoma is chal-
lenging and technically demanding, but can be performed 
with acceptable mortality. Achieving complete margin nega-
tive resection remains the goal in selected patients. Precise 
surgical technique and careful preoperative evaluation is the 
key measures to obtain better clinical outcome with low 
complication morbidity and perioperative mortality.
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AUTOIMMUNE CHOLANGIOPATHY – A 
RARE CAUSE OF HILAR STRICTURE 
MIMICKING HILAR 
CHOLAMGIOCARCINOMA
S. Singh1, R. Hannavar1, C. Bihari2, A. Rastogi2 
and P. Deka1
1Department of GI Oncosurgery & Liver transplantation, 
Rajiv Gandhi Cancer Institute, Delhi, India; 2Department 
of Pathology, Institute of Liver & Biliary Sciences, Delhi, 
India
Rajiv Gandhi Cancer Institute, Delhi, India, GI 
Oncosurgery & Liver Transplantation, Sector 5, Rohini 85 
Delhi, India
Introduction: Ig G4 related disease is a unique systemic 
infl ammatory condition characterized by tumorous swelling 
of affected organs and high serum IgG4 concentrations. 
Autoimmune pancreatitis is a prototype of IgG4 disease. 
IgG4 related disease can involve a variety of organs includ-
ing the salivary glands, lacrimal glands and retroperitoneum 
(retroperitoneal fi brosis). The bile duct lesion is called 
autoimmune cholangiopathy or IgG4-related sclerosing 
cholangitis.
Methods: A 63 yr old hypertensive male presented with 
pain in right upper abdomen and pruritus for 1 month. He 
was evaluated at Kathmandu, Nepal where CT scan and 
MRCP were done which was suggestive of hilar block 
Cause hilar cholangiocarcinoma Type 3a with bilateral 
pelviureteric obstruction cause ? retroperitoneal fi brosis. 
Subsequently, the patient was referred to us for further 
management.
His had serum bilirubin of 3.3 mg% with raised SGOT 
(241 IU), SGPT (402IU) and alkaline phosphatase (357IU). 
His serum creatinine was mildly elevated (1.7 mg%) and 
CA19-9 was 26.6.
He was initially planned for surgery suspecting hilar 
cholangiocarcinoma. So, CECT abdomen was repeated with 
the aim of assessing vascular involvement and liver 
volumetry.
Results: CT showed bilateral retroperitoneal mass with 
hilar mass cause. Hilar mass was similar to the retroperito-
neal mass encasing the ureters and it was also similarly 
encasing and extending along the bile duct. So possibility of 
same pathology affecting the retroperitoneum as well as liver 
hilum was kept. Hence USG guided FNA of perinephric 
mass and biopsy from renal mass was done. His biopsy from 
retroperitoneal mass was suggestive of Ormond’s disease. 
Absolute eosinophil count and serum IgG4 were also done 
and both were found to be signifi cantly elevated. So possibil-
ity of autoimmune cholangiopathy as a cause of hilar block 
was kept and steroid trial was planned. He was started on 
wysolone 40 mg OD and ursodeoxycholic acid 300 mg BD.
Conclusion: LFT was repeated after 1 month and it showed 
signifi cant improvement. MRCP was repeated after 1 month 
and it showed no evidence of any hilar block or any IHBRD. 
LFT as well as creatinine almost normalized. Wysolone was 
gradually tapered and he is doing well with normal LFT & 
KFT at 6 months.
Autoimmune cholangiopathy should be kept as a possible 
cause for hilar block if there is associated retroperitoneal 
fi brosis and a trial of steroid therapy should be given in these 
cases.
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BILE DUCT INJURIES IN THE ERA OF 
LAPAROSCOPIC CHOLECYSTECTOMY
B. O. Al-Jiffry1, M. Hatem2, H. Makhzangy3 
and Y. Alnemary1
1Department of Surgery, Taif University, Taif, Saudi 
Arabia; 2Ain Shames University, Cairo, Egypt; 
3Department of Gastroenterology, AlHada Military 
Hospital, Taif, Saudi Arabia
Introduction: Laparoscopic cholecystectomy (LC) is the 
standard of care for symptomatic cholelithiasis, but it is 
associated with a higher incidence of bile duct injury than 
the open approach. The management of these injuries remains 
a challenge. A multidisciplinary approach is recommended 
for appropriate management.
Forty eight patients suffered bile duct injury after LC were 
treated in AL-Hada Armed Forces Hospital (Taif-Saudi 
Arabia) and Ain Shams university Hospitals (Egypt) from 
April 2006 to Aug 2010.
Methods: If the injury was suspected intraoperatively, 
Intraoperative cholangiography (IOC) was done and if con-
fi rmed, immediate laparotomy was performed with primary 
repair or bilioenteric anastmoses. Cases presented postopera-
tively was subjected to full evaluation and endoscopic 
cholangiopancreatography (ERCP) to diagnose the type of 
injury based on the Strasberg classifi cation. Cases proved to 
be stage A would be managed endoscopically, however more 
advanced cases were managed by open surgery. Postoperative 
follow up was done for all patients.
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There were 30 females (62.5%) and 18 males (37.5%) 
with mean age of 45 years (range: 18–90). Six patients were 
discovered intraoperatively (12.5%), of which 2 cases were 
Strasberg stage C and primary repair.
Results: were done with internal stenting. The other 4 
patients were; one E2, two E3 and one E4, Roux-en-Y hepa-
ticojejunostomy (H-J) was done. Forty two patients (87.5%) 
presented postoperatively mainly by referral. In the postop-
erative group there were 18 (37.5%) patients of stage A, one 
E1 (2.1%), eight E2 (16.6%), fi ve E3 (10.4%), two E4 
(4.2%), eight E5 (16.6%). Patients with stage A were 
managed by ERCP and stenting, however in 6 patients 
(12.5%) endoscopic removal of retained stone(s) were added. 
The total number of H-J performed were 28 (58.3%), of 
which 4 patients (14.2%) developed subsequent anastomotic 
strictures and were treated with percutaneous transhepatic 
balloon dilatation. There were no mortalities with a Mean 
follow up of 34 months.
Conclusion: Complex bile duct injury can be readily dis-
covered and managed intraoperatively if the surgeon is expe-
rienced enough to expect and manage it and IOC well 
confi rm the diagnosis. In cases presented postoperatively 
multidisciplinary approach is advocated for diagnosis and 
appropriate management, however endoscopic management 
will be successful in stage A injuries while higher injuries 
will require surgical intervention by an experienced HPB 
surgeon to yields the best results.
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USEFULNESS OF PET IN 
GALLBLADDER CANCER
D. S. Yoon, J. K. Kim, H. J. Lee, J. S. Park, H. S. Chi and 
B. R. Kim
Department of Surgery, Gangnam Severance Hospital, 
Yonsei University Health System, Seoul, Korea
Gangnam Severance Hospital, Yonsei University Health 
System, Surgery, 211 Eunjoro Gangnam-gu, 135–7 Seoul, 
Republic of Korea
Introduction: The accurate evaluation is mandatory for 
appropriate planning of treatment in gallbladder cancer. 
Various imaging studies have been used to differentiate 
between benign and malignant lesion and to determine 
resectability and distant metastasis. The purpose of this study 
is to report the role of fl udeoxy glucose-positron emission 
tomography (FDG-PET) in differential diagnosis, evaluation 
of respectability.
Methods: We used the clinical database registry system of 
the Gangnam Severance Hospital, Yonsei University Health 
System for these analyses from Jan 2005 to Dec 2011. A total 
of 103 patients underwent PET scan with GB pathology. We 
included subjects who underwent PET scan either for sus-
pected GB cancer or for other malignancy with pathologi-
cally confi rmed GB pathology other than GB cancer to 
reduce the risk of selection bias for evaluating the accuracy 
of diagnosis of PET using the maximum standardized uptake 
value (SUV max).
Results: Of 103 patients, 44 (42.7%) were benign and 59 
(57.3%) had GB cancer. Among 59 patients with GB cancer, 
PET scanning was used for preoperative evaluation in 45 
patients and in 6 patients with incidentally diagnosed GB 
cancer. The preoperative sensitivity was 86.1% and specifi -
city was 94.6%. For postoperative surveillance, 7 patients 
were followed up with PET scan. The receiver operating 
characteristic (ROC) curve demonstrated an area under the 
curve of 0.938 (95% CI [0.861 to 0.979]). SUV max of 3.9 
was the best cutoff value for differentiating benign and 
malignant lesions in patient with suspected GB cancer. Time 
to progression and overall survival rate in the low SUV max 
(<4) group were higher than in the high SUV max (>4) 
group.
Conclusion: SUV max can differentiate benign and malig-
nant lesions in patients with GB pathology. PET scans refl ect 
tumor differentiation in GB cancer. A low SUV max (≤4) was 
a good prognostic predictor in univariate analysis, but further 
studies are needed to assess the signifi cance.
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P16 AND MGMT HYPERMETHYLATION 
PREDICTS SURGICAL OUTCOMES
D. S. Yoon, J. S. Park, J. K. Kim, H. J. Lee, H. S. Chi and 
B. R. Kim
Department of Surgery, Gangnam Severance Hospital, 
Yonsei University Health System, Seoul, Korea
Gangnam Severance Hospital, Yonsei University Health 
System, Surgery, 211 Eunjoro Gangnam-gu135-7 Seoul, 
Republic of Korea
Introduction: Extrahepatic bile duct cancer is a primary 
malignancy arising from epithelium of extrahepatic biliary 
tract. We aimed to evaluate the potential role of DNA pro-
moter methylation of gene involved in a variety of cellular 
function including adhesion (CDH1), cell division (p16) and 
survival (DAPK), to predict disease free survival (DFS) and 
overall survival (OS) in curative resected mid/distal bile duct 
cancer.
Methods: Sixty-fi ve mid/distal bile duct carcinoma speci-
mens obtained at Severance Hospital of Yonsei University 
College of Medicine from January 2000 to December 2006. 
Methylation of interest loci was confi rmed using 
pyrosequencing.
Results: The signifi cant methylation frequencies (MtI > 
5%) of the 3 gene analyzed were 17% for P16, 54% for 
DAPK, 60% for E-cadherin. P16 and DAPK MtI status cor-
related with perineural invasion and tumor depth, respec-
tively. In 65 patients, the 3-year and 5-year overall survival 
was 54.9% and 48.4%, respectively. In multivariate analysis 
of overall survival, presence of lymph node metastasis and 
P16 methylation status were identifi ed as an independent 
prognostic factors for overall survival. In patient with 
unmethylated of P16, the 3- and 6-year survival rates were 
60.8% and 54.9%, respectively. In patients with a hyper-
methylated of P16, the 3- and 6-year survival rates were 
27.3% and 0.0%, respectively.
Conclusion: P16 hypermethylation can predict overall sur-
vival in curative resected mid/distal bile duct cancer. 
Classifi cation of mid/distal bile duct cancer by both genetic 
and epigenetic profi les may improve the capability of pre-
dicting prognosis and of applying tailored therapy in mid/
distal cancer.
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SURGICAL OUTCOMES AND 
PREDICTING FACTORS OF CURATIVE 
RESECTION IN PATIENTS WITH HILAR 
CHOLANGIOCARCINOMA: 10-YEAR 
SINGLE INSTITUTION EXPERIENCE
K. S. Hoon1, M. S. Cho1, S. W. Park2, S. B. Choi3, 
G. H. Choi1, J. S. Park1, J. B. Chung2 and K. SiK Kim1
1Department of Surgery, Yonsei University College of 
Medicine; 2Department of Internal Medicine, Yonsei 
University College of Medicine; 3Department of Surgery, 
Korea University College of Medicine
Yonsei University College of Medicine, Department of 
Surgery, 50, Yonsei-ro, Seodaemun-gu, Seoul 120-752, 
Korea
Introduction: The surgical resection of hilar cholangiocar-
cinoma is extremely challenging because the tumor is closely 
related with the complicated hilar structures. We investigated 
to identify the outcomes for patients who underwent surgical 
resection and to identify the parameters that infl uenced 
radical resection.
Methods: From January 2000 to December 2009, 105 
patients underwent surgical resection for hilar cholangiocar-
cinoma. The clinicopathological parameters and surgical 
outcomes were retrospectively analyzed.
Results: There were 15 operative mortalities (14.3%). 
Seventy four patients underwent curative resection (70.5%). 
The median overall survival time for R0, R1 and R2 were 
58 months, 28 months and 19 months, respectively. Caudate 
lobectomy (p = 0.044; Odds ratio [OR], 4.386) and perineural 
invasion (p = 0.01; OR, 0.062) were correlated with curative 
resection. Total bilirubin levels of more than 3 g/dl just 
before the operation (p = 0.042; hazard ratio [HR], 2.109) 
and extent of resection (R1 & 2 vs R0; p = 0.05; HR, 2.309) 
were selected as signifi cant factors affecting overall survival 
on the multivariate analysis.
Conclusion: Though the signifi cance and proper levels of 
liver optimization needs to be validated by a prospective 
study, liver optimization using preoperative biliary drainage 
and caudate lobectomy to achieve curative resection may be 
thought of as adjustable territories according to the surgeon’s 
efforts.
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WHICH SURGICAL STRATEGY IS 
OPTIMAL IN PATIENTS WITH T2 
GALLBLADDER CANCER
L. J. Hong, S. H. Kim, G. H. Choi, C. M. Kang, 
J. S. Choi, W. J. Lee and K. S. Kim
Department of Surgery, Yonsei University College of 
Medicine, Yonsei-ro, Seodaemun-gu, Seoul, Korea
Introduction: Incidental fi nding of gallbladder cancer 
(GBCA) has been dramatically increased as an initial pres-
entation because of the expansion of laparoscopic cholecys-
tectomy. However, the management of incidental T2 GBCA 
is debate issue. Therefore, we compared between our 10-year 
experience and consensus based surgical strategy of T2 
GBCA.
Methods: 155 patients underwent operation because of 
GBCA with stage more than T2 from Jan. 2000 to Dec. 2009 
at Severance Hospital, Yonsei University Health System, 
Seoul, Korea. The medical records of 70 patients with T2 
GBCA were retrospectively reviewed.
Results: Radical cholecystectomy was performed in only 32 
(45.8%) patients. In T2 GBCA with positive LN, overall 
survival between cholecystectomy with LN dissection and 
radical cholecystectomy or between D1 and D2 LN dissec-
tion did not show a signifi cant difference. Twenty patients 
experienced recurrence during follow-up period. Among 
eleven patients underwent cholecystectomy with liver resec-
tion, only two (18.2%) patients had intrahepatic recurrence. 
Among nine patients underwent cholecystectomy without 
liver resection, three (33.3%) patients had intrahepatic recur-
rence. However, Recurrences at gallbladder bed were one 
and two patients, respective and it was not signifi cant differ-
ence (p = 0.438).
Conclusion: There was a large gap between clinical prac-
tices and treatment guidelines. Though patients to enroll in 
this study and experience recurrence were a small, cholecys-
tectomy and LN dissection without liver resection showed a 
similar survival and recurrence patterns compared with that 
of radical cholecystectomy. To be accordance between clini-
cal practices and treatment guidelines, the roles of limited 
resection in T2 lesion will be needed to evaluate more.
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HEPATECTOMY FOR NON PRIMARY 
INTRA HEPATIC LITHIASIS: WHEN 
AND HOW?
M. Gaillard1, L. Plard1, E. Salame2 and L. Chiche1
1Hepatobiliary and Transplantation Unit, CHU Caen, 
Caen, France; 2Hepatobiliary and Transplantation Unit, 
CHU Tours, Tours, France
CHU de Caen Service de chirurgie hépato-biliaire et 
transplantation, Avenue de la Côte de Nacre 14000 Caen, 
France
Introduction: Hepatolithiasis in Western countries is a rare 
complication of gallstones. Its management is often diffi cult 
and requires different procedures including hepatectomy.
The aim of the study is to precise the indications of liver 
resection in that pathology, to determine the best preopera-
tive evaluation and to study the specifi cities and results of 
these hepatectomies.
Methods: A retrospective monocentric study of 20 consecu-
tive hepatic resections between 1995 and 2011 for secondary 
intra hepatic lithiasis is reported. Presentation, preoperative 
(ultrasound, MRCP and CT scan) and operative (ultra sound 
and cholangiography) data are analyzed, focusing on the 
performance of the different radiological investigations. 
Operative procedures are studied. Short term and long term 
results are analyzed.
Results: Between 1995 and 2011, 1169 hepatectomies were 
done in our center. 20 (1.7%) patients with median age of 52 
years presenting cholangitis (13/20) or isolated pain (5/20) 
underwent liver resection for hepatolithiasis because of liver 
atrophy, abcesses or untreatable biliary strictures. Lithiasis 
was revealed by ultrasonography (88%), MRCP (63%) and 
CT Scan (38%). Surgical procedures included cholangiogra-
phy, ultrasonography and endoscopy and consisted in ana-
tomical liver segmentectomy associated with iterative 
bilio-digestive anastomosis or biliary clearance. No mortal-
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ity was observed. Severe morbidity concerned 6 patients 
Clavien III, with a mean hospital stay of 12.5 days. 
Considering a mean follow up of 26 months, we report 4 
recurrences.
Conclusion: Hepatectomy in complicated secondary hepa-
tolithiasis is a safe and effi cient procedure. But this type of 
liver resection has to fulfi ll different conditions: precise 
preoperative evaluation, complete operative exploration, 
anatomical resection and adequate biliary clearance and 
drainage. Postoperative management has also some specifi ci-
ties, that’s why liver resection in that indication has to be 
referred to specialized hepatobiliary centers.
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MAJOR HEPATIC RESECTION 
COMBINED WITH PORTAL VEIN OR 
HEPATIC ARTERIAL RECONSTRUCTION 
FOR ADVANCED BILIARY CARCINOMA 
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Introduction: Biliary malignancies arise in the hepatic 
hilum invaded to portal vein and hepatic artery are required 
vascular resection and reconstruction for resecting tumor. 
Especially, hepatectomy with vascular reconstruction (VR) 
for biliary malignancy remains controversial in terms of its 
complications and outcome. We evaluated whether hepatec-
tomy with VR for biliary carcinoma is justifi ed or not.
Methods: Sixty-six patients with hilar cholangiocarcinoma 
(n = 55) and gallbladder carcinoma (n = 11) who underwent 
over bi-sectionectomy and biliary reconstruction were 
enrolled. Right hemihepatectomy (n = 40; four with pancrea-
ticoduodenectomy), left hemihepatectomy (n = 16), right 
trisectionectomy (n = 4), left trisectionectomy (n = 2) and 
right anterior and left medial sectionectomy (n = 4) were 
performed. Preoperative portal vein embolization was per-
formed on 36 of 44 patients underwent right side hepatec-
tomy. VR was required on 19 of these 66 (28.8%) patients 
(portal vein reconstruction, n = 13; hepatic artery reconstruc-
tion, n = 4; portal vein and hepatic artery reconstruction, 
n = 2).
Results: There were signifi cant differences between non-VR 
and VR group in operation time (non-VR vs. VR: 590 ± 138 
vs. 709 ± 181 min) but no differences in blood loss. 
Postoperative liver failure (serum T.bil > 5 mg/dl after opera-
tion) occurred 18 patients (non-VR, n = 11; VR, n = 7) but 
not resulted in lethal. Early and late vascular complications 
as thrombosis and stenosis were not observed postopera-
tively. Mortality case include hospital death was not recorded. 
Pathological surgical margins negative percentages were 
62.8% in non-VR group, and 55.6% in VR group (N.S.). The 
3- and 5-year survival rates were 52.9 and 39.4% in the 
non-VR group and 50.8 and 10.6% in the VR group, respec-
tively (p = 0.23, log-rank test).
Conclusion: We conclude hepatectomy with VR for biliary 
carcinoma is acceptable operative procedure in terms of 
operative complications and early outcome. In spite of their 
3-year survival rate, VR group showed severe prognosis 
compared with non-VR group. Effective adjuvant therapies 
should be established to improve survival.
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MANAGEMENT OF CYSTIC DUCT 
STUMP LEAKS AFTER LAPAROSCOPIC 
CHOLECYSTECTOMY
S. Gavini, I. Mohammed, S. Subramanian, K. Sreenivasan, 
S. Velavan, R. Niranjan, S. Elavarasan and B. Elangovan
Sri Ramachandra University
Sri Ramachandra University, Surgical Gastroenterology, 
D2 OPD, Room No 10, Department of Surgical 
Gastroenterology, Sri Ramachandra University, Porur, 
60011 Chennai, India
Introduction: Laparoscopic cholecystectomy is the gold 
standard for symptomatic cholelithiasis. Bile leak from 
cystic duct stump is a preventable morbidity. The aim of this 
study is to evaluate patients treated with cystic duct stump 
leaks after laparoscopic cholecystectomy.
Methods: Between Jan 2005 -Dec 2011, 13 patients with 
cystic duct stump leaks after laparoscopic cholecystectomy 
were treated at a university hospital. Medical records of these 
patients were retrospectively analyzed with respect to clini-
cal presentation, diagnosis and management. In this 13 
patients, 6 patients had acute cholecystitis, 1 patient had 
empyema gallbladder, 1 patient had Mirrizi’s (type 1) and 5 
patients had chronic cholecystitis.
Results: 13 patients (10 male and 3 female, mean age 47.5 
years) developed cystic duct stump leak at a mean of 7.1 days 
(12 hrs–28 days). Commonest presentation was bile leak 
through drain (n = 8). Pain abdomen (n = 7), abdominal 
distension (n = 4), fever (n = 3) and biliary peritonitis (n = 
2) were the other features. Endoscopic retrograde cholangi-
ogram demonstrated leak in all patients and no distal bile 
duct obstruction. Defi nitive treatment with stenting was 
achieved in 7 patients. Ultrasound guided catheter drainage 
(n = 3), laparoscopy and drainage (n = 2) and exploratory 
laparotomy (n = 1) were required in some cases. Bile 
leak subsided at a median duration of 10 days (3–21 days). 
In a median follow-up of 4 yrs, all the patients are 
asymptomatic.
Conclusion: Acute cholecystitis is the commonest cause of 
cystic duct leak. Early ERCP should be done to establish the 
site of leak, rule out bile duct injury and distal obstruction. 
Endoscopic stenting is a safe and effective method of treat-
ment of cystic duct stump leaks. Additionally, drainage of 
intra-abdominal bile collections by ultrasound guidance, 
relaparoscopy or laparotomy may be required in uncon-
trolled leak.
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Uijeongbu St. Mary’s Hospital, The Catholic University of 
Korea, Surgery, #65-1, Gumo-dong 48071 Uijeongbu, 
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Introduction: Limited retraction has been an obstacle in the 
advancement of pure single incision cholecystectomy. 
Adequate retraction is necessary to perform a safe cholecys-
tectomy. We reviewed the results of a single institution with 
respect of single incision cholecystectomy with a single 
2 mm needlescopic instrument and snake retractor to aid in 
obtaining a critical view of safety to identify the ideal surgi-
cal strategy of single incision laparoscopic cholecystectomy 
in disease of biliary tree.
Methods: Between October 2010 and December 2011, 120 
patients underwent single incision laparoscopic cholecystec-
tomy with needle scopic infundibular retraction for gallblad-
der disease in single institute by one surgeon, Uijeongbu St. 
Mary’s hospital. 120 patients with a mean age 50.1 years 
(range 14 to 82) were identifi ed. We used a hand-made Glove 
port or SILSTM (Covidien, Tyco health Medical) single-port 
device for operation. Single port device was placed through 
umbilicus. A (2 mm) needlescopic retractor (Stryker, San 
Jose, CA) was placed in the right fl ank region directly 
through the abdominal wall for retraction of the gallbladder 
infundibulum in an anterior and cephalad direction. And 
snake retractor was used for liver retraction.
Results: Patient all had a pathologic diagnosis of acute and 
chronic cholecystitis. ASA class averaged 1.62 (range 1 to 
2). Operative times averaged 65.5 minutes (range 28 to 188 
minutes). Postoperative hospital stays averaged 2.4 days. 
There were no instances of bile leak, soft tissue infection, 
abscess, hernia or bile duct injury.
Conclusion: Single incision cholecystectomy with a single 
needlescopic instrument is safe for acute and chronic chole-
cystitis even in suppurative cholecystitis. Liver retraction 
using a snake retractor is very useful in easy and diffi cult 
gallbladder disease. We believe that surgeons practicing 
single incision laparoscopic cholecystectomy techniques 
should be aware of this potential injury and should exercise 
caution to avoid it.
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EARLY MANAGEMENT OF BILE 
DUCT INJURIES AT A TERTIARY 
CARE CENTRE
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Introduction: Bile duct injury following cholecystectomy 
is an iatrogenic catastrophe associated with signifi cant peri-
operative morbidity and mortality, increased hospital costs, 
reduced quality of life and high rates of subsequent litigation. 
The aim of this study is to evaluate the management of bile 
duct injury detected on-table or in the early postoperative 
period (4 wks) at a tertiary care centre (university teaching 
hospital).
Methods: In a retrospective analysis of a prospectively 
maintained database all patients with bile duct injuries 
managed between January 2005 and December 2011 were 
included in the study. Patients were divided into two groups- 
Group A- injuries detected on table and Group B- injury 
manifested in the perioperative period (4 weeks). Out of 36 
patients (acute and chronic cholecystitis, n = 18 each), Group 
A had 6 patients and Group B had 30 patients. The medical 
records of these patients were analysed to identify the pre-
disposing factor/s, mode of presentation, management and 
outcome. Bile duct injuries were classifi ed according to 
Strasberg classifi cation.
Results: Group A patients underwent primary repair (n = 4) 
and hepaticojejunostomy (HJ) (n = 2) for incomplete and 
complete injury respectively during the same laparotomy. In 
Group B, the injury distribution was type A (n = 13), type C 
(n = 1) and type D (n = 2). These patients underwent endo-
scopic retrograde cholangiogram or magnetic resonance 
cholangiogram and endoscopic biliary stenting. 14 patients 
had type E injury. Treatment offered to them were as follows: 
removal of ligature and T tube drainage in 2, HJ in 2, creation 
of controlled external biliary fi stula and HJ after 6 weeks in 
10 patients. Complications were minor postoperative bile 
leak (n = 3) and recurrent stricture (n = 1). Remaining 
patients, in a mean follow-up of 3 yrs (6 mo–6 yrs) are 
asymptomatic.
Conclusion: In our series, patients with acute and chronic 
cholecystitis were at equal risk for bile duct complications. 
Injury detected during cholecystectomy can be treated appro-
priately in the same sitting. Strasberg type A to D injuries 
can be treated with endoscopic interventions and bilioma 
drainage. For type E injuries, early HJ can be offered selec-
tively. Majority, however, require creation of controlled 
biliary fi stula and delayed HJ. Good outcomes can be attrib-
uted to following an appropriate strategy.
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LONG-TERM ANASTOMOTIC 
COMPLICATIONS AFTER TOTAL 
PANCREATECTOMY: A PROSPECTIVE 
STUDY WITH ULTRASONOGRAPHIC 
ASSESSMENT
C. Neal, G. Garcea, C. Pollard, Y. Rees, M. Metcalfe 
and A. Dennison
Leicester General Hospital
Leicester General Hospital, Department of HPB Surgery, 
Gwendolen Road, Leicester LE54P, United Kingdom
Introduction: The incidence and outcome of long-term 
anastomotic complications following pancreatic resection is 
poorly documented due to the limited outlook in patients 
undergoing even potentially curative procedures for malig-
nant disease. The aim of this study was to determine long-
term anastomotic integrity in a population who underwent 
pancreatic resection for benign disease and were subject 
to long-term clinical follow-up and ultrasonic hepatico-
jejunostomy surveillance.
Methods: An analysis of all patients who underwent total 
pancreatectomy (TP) for benign disease over a 12 year 
period (1996–2008) was performed using a prospectively 
maintained database (updated August 2011). Patients under-
went regular postoperative clinical review, with ultrasound 
surveillance of the hepaticojejunostomy at six-monthly inter-
vals for the fi rst year and yearly thereafter. Clinical and 
radiological evidence of stricture formation as well as sub-
sequent management strategies, were noted.
Results: Ninety patients underwent TP for benign disease 
over the study period, with simultaneous islet autotransplan-
tation in 54. Six patients (6.7%) had duodenum-preserving 
pancreatectomy and 81 (90%) had spleen-preserving surgery. 
There were 3 post-operative deaths (3.3%). Median radio-
logical follow-up was 107 months (range 10–179 months). 
Clinically apparent hepaticojejunostomy strictures devel-
oped in 2 patients (2.2%), developing at 12 months and 117 
months respectively. These were both treated by dilatation 
and stenting with good result. No other patient demonstrated 
clinical or radiological evidence of hepatico-jejunostomy 
stricture formation. Neither gastro-jejunostomy nor entero-
enterostomy strictures were detected in any patient.
Conclusion: Biliary stricture formation is an infrequent 
occurrence after TP for chronic pancreatitis and can be 
managed successfully with percutaneous biliary dilatation 
and stenting. Hepaticojejunostomy formation in these 
patients is generally facilitated, however, by signifi cant bile 
duct dilatation.
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‘AMYLASE LEVELS IN DIAGNOSING 
POST ERCP PANCREATITIS’; IS IT A 
SIGNIFICANT INDICATOR WITHOUT 
ABDOMINAL PAIN?
C. Liyanage1, N. M. M. Nawaratne2, N. Fernandopulle2, 
D. M. G. C. Wijesundara1 and N. J. Nawaratne1
1Department of Hepatobiliary surgery, University of 
Kelaniya Medical School, Ragama, Sri Lanka; 
2Department of Gastroenterology and Hepatology. National 
Hospital of Sri Lanka, Colombo, Sri Lanka
University of Kelaniya, Hepatobiliary surgery, Department 
of Surgery, Thalagolla Road, 1 Ragama, Sri lanka
Introduction: ERCP is an invasive pancreatico-biliary 
investigation. A common complication following ERCP is 
pancreatitis. In some units post ERCP amylase and lipase 
levels are done to diagnose post ERCP pancreatitis.
Objectives:
To ascertain whether Amylase levels were raised in major-
ity of patients following ERCP even when they did not 
develop post procedural pancreatitis.
Methods: 40 consecutive patients who underwent ERCP at 
the National hospital Sri Lanka and North Colombo Teaching 
hospital over a period of 2 months were included in this 
preliminary study. Pre and serial post procedural pain scores 
and amylase levels at 24 hrs and 48 hrs, alkaline phos-
phatase, bilirubin, raised body temperature, icterus, and 
special ERCP fi ndings were included. Patients who had 
ERCP for pancreatitis were not included. Statistical analysis 
was done using MINITAB statistical software.
Results: A majority of patients (60.71%) had a raised serum 
amylase level at 24 hrs after ERCP. In 91.66% of patients 
the amylase levels regressed at 48 hours post procedure. 
However, a comparatively small percentage of patients 
(13.33%) complained of a worsening abdominal pain post 
procedure. Therefore a comparative analysis failed to show 
any association between worsening of abdominal pain and a 
raised serum amylase level (p value 0.523). However all 
patients with a worsening of abdominal pain had a raised 
serum amylase and were later confi rmed by ultrasound scan 
as acute pancreatitis.
Conclusion: 1. Amylase levels were raised in majority of 
patients following ERCP and the levels regressed at 48 hrs.
2. A raised amylase levels with signifi cant abdominal pain 
score was present in patients who went on to develop 
pancreatits.
3. An isolated raise in amylase levels are not a reliable 
indicator of pancreatitis and amylase levels should not be 
tested routinely on post ERCP patients, unless they have a 
worsening of abdominal pain’
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CLINICAL OUTCOMES FROM THE 
DEVELOPMENT OF A SURGICAL 
CENTRE FOR THE TREATMENT OF 
HILAR CHOLANGIOCARCINOMA
A. Siriwardena, S. Jegatheeswaran, J. Lim, T. Satyadas 
and A. Sheen
Regional Hepatobiliary Surgery Unit, Manchester Royal 
Infi rmary
Manchester Royal Infi rmary, Regional Hepatobiliary 
Surgery Unit, Oxford Road, Manchester M13 9WLM139W, 
United Kingdom
Introduction: Hilar cholangiocarcinoma is a rare tumour of 
poor prognosis. As management requires complex multi-
modality care, patient-centred outcomes and cost of care is 
likely best addressed by centralisation of treatment. This study 
looks at clinical outcomes from the development of a surgical 
centre for the treatment of hilar cholangiocarcinoma (HC).
Methods: This academic medical centre (serving a popula-
tion of 1.5 million) invested in the development of a modern, 
comprehensive (non-transplant) hepato-pancreato-biliary 
service in 1999 and the fi rst liver resection for HC was 
undertaken in 2001. Data were collected prospectively on 
patients undergoing liver resection for HC over the subse-
quent decade. 22 patients constitute the dataset (from 406 
undergoing hepatic resection). The median (range) age was 
62 ± 11 years, male: female ratio was 13 : 9. During this 
period a further 51 patients, median age 73 ± 11, presented 
with inoperable hilar cholangiocarcinoma. Multidisciplinary 
management utilised pre-operative external biliary drainage 
and magnetic resonance scan. Outcome data are reported.
Results: Of 22 undergoing resection, 16 underwent radical 
portal lyphadenectomy (10 with positive nodes), 14 under-
went concomitant caudate resection and 9 achieved an his-
tological R0 resection. In-patient mortality after resection 
was 23% (compared to 32% in patients with non-resectable 
disease). 5-year survival rate after R0 resection was 30%.
Conclusion: Surgical management of hilar cholangiocarci-
noma is intensive, requires complex multidisciplinary care 
and achieves good outcomes in only a small number of 
patients with this rare disease. Nonetheless, given that excel-
lent 5-year survival can be achieved for a carefully-selected 
cohort of patients (in the absence of other modalities of care), 
modern surgical programmes should continue to stage and 
resect patients with HC.
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IS ADJUVANT CHEMOTHERAPY USEFUL 
FOR R0 RESECTABLE GALLBLADDER 
CARCINOMA? PRESENTATION OF A 
MONOCENTRIC CLINICAL TRIAL
C. Bouzid, K. Bentabak, K. Cherchar, S. A. Faraoun, 
H. A. Kaci, M. W. Boubnider, N. Kheidri and A. Graba
Pierre and Marie Curie Centeroncologic Surgery ‘‘A’’ 
Place du 1 er Mai 16000 Algiers, Algeria
Introduction: Gallbladder carcinoma has bad prognosis, 
only 10% survival at 5 years all stages taken together. The 
incidence in Algeria is 9/100000 inhabitants. It’s the highest 
incidence in the world next to India, Pakistan, Chile and 
Equador. Surgery remains the only curative treatment. To 
improve its prognosis and reduce the recurrence. Different 
therapies were suggested without any advantage. That’s why 
palliative chemotherapy is recognized for advanced and 
metastatic unresectable gallbladder carcinoma.
Methods: it’s a prospective, comparative and randomized 
study with 2 groups: a group with radical surgery R0 alone 
(cholecystectomy, bisegmentectomy IV b + V or even right 
hepatectomy extended to IVb with lymphadenectomy with 
skeletonization of the hepatic pedicle, common hepatic 
artery to the coeliac trunk and peripancreatic lymphadenec-
tomy with or without main bile duct resection) versus surgery 
plus adjuvant chemotherapy (gemcitabine 1250 mg/m² at 
day 1 and day 8 + cisplatine 70 mg/m² at day 1. all 21 days. 
06 cycles.
74 patients must be included.
From January 2010 to December 2011, 40 patients who 
underwent radical surgery R0 for gallbladder carcinoma 
were included. The mean age is 57.78 y [27–78], 34 women 
and 6 men.
Results: 36 bisegmentectomy, 2 trisegmentectomy and 2 
right hepatectomy extended to IV b, 6 main bile duct 
resection.
Patients were classifi ed with TNM 2009
6 T1b, 24 T2 and 10 T3, 25 N0, 13 N1, 2 N2, 5 patients 
were M1 (1 local carcinomatosis node near gallbladder bed), 
the average of lymph nodes resected is 10. 5 [3–20].
19 patients were randomized in group with chemotherapy, 
21 in group with surgery alone.
Mean follow up is 13.4 months [01–24], 04 recurrences at 
08, 12, 17 and 22 months.
04 patients died, one at month 3 (pulmonary embolism), 
one at month 9 (recurrence), one at month 14 (brain stroke) 
and the last one at month 21 (pulmonary embolism).
Conclusion: The trial is on going, the fi nal result can 
confi rm the advantage of surgery associated to adjuvant 
chemotherapy and the improvement of the prognosis.
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SQUAMOUS VARIANT OF GALL 
BLADDER CANCER: IS IT DIFFERENT 
FROM ADENOCARCINOMA?
A. K. Agarwal
Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi 110002, India
Introduction: Adenosquamous carcinoma (ASC) and squa-
mous cell carcinoma (SCC) of gallbladder are rare histologi-
cal variants of gall bladder cancer (GBC). This study was 
undertaken to analyze the clinicopathological variables and 
surgical outcomes in patients with ASC/SCC of gallbladder 
and compare them with adenocarcinoma (AC).
Methods: Retrospective analysis of operated GBC patients 
between August 2009 & March 2011.
Patients with ASC/SCC on fi nal histopathology were com-
pared with AC group for clinical presentation, tumor size, 
locoregional extent, lymph node involvement and survival.
Results: One hundred and forty one patients of GBC were 
taken up for surgery (excluding Incidental Gall bladder 
cancer) during the period. Of the 80 patients who underwent 
surgical resection with a curative intent, Nine patients had 
ASC (n = 6) or SCC (n = 3; group A) while 71 had adeno-
carcinoma (Group B). Abdominal pain was the most common 
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symptom, vomiting was signifi cantly more common in group 
A compared to group B (55.56% vs. 15.49%, p = 0.01). The 
median tumor size was signifi cantly higher in group A 
(7.8 cm vs. 5.1 cm, p = 0.01). Extrahepatic adjacent organ 
involvement requiring adjacent organ resection was also 
more common in Group A (88.89% vs. 29.57%, p = 0.001). 
In spite of the higher T stage, the majority of patients in 
group A had a node negative disease (55.56% vs. 19.4%, p 
= 0.023). All the 52 patients found to have metastatic disease 
on laparoscopy/exploration had AC on histopathological 
examination. During median follow up period of 11 months 
(range 2–21 months) there was no signifi cant difference in 
the overall survival between the 2 groups (77.78% (7/9) 
versus 80.28% (57/71), p = 1.0).
Conclusions: ASC and SCC presented at an advanced T 
stage, however the incidence of nodal involvement and 
distant metastasis was less common compared to AC. Despite 
being locally advanced malignancy requiring more extensive 
resection survival in these patients was comparable to 
patients with adenocarcinoma.
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EXPERIENCE OF EARLY REPAIR IN 
POST CHOLECYSTECTOMY ACUTE 
BILE DUCT INJURY
A. K. Agarwal
Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi 110002, India
Background: An immediate repair is considered optimal in 
acute bile duct injury presenting early, however these are 
technically challenging and not many reports are available 
in the literature. We herein report our experience of manag-
ing acute bile duct transection referred to us early.
Aims and objectives: To analyze our experience of the 
repair of bile duct injuries, in the acute setting.
Materials and methods: Retrospective analyses of the pro-
spective database of post cholecystectomy bile duct injury 
referred early. Details of the intraoperative records were 
obtained & after initial resuscitation all patients were taken 
up for an urgent surgery. At exploration extent of injury was 
ascertained. Proximal healthy duct at the hilum was prepared 
with fi lleting onto the left duct to obtain a good sized well 
vascularised duct for performing hepatico-jejunostomy.
Results: Between January 2000 and December 2009, of the 
440 patients of bile duct injury managed, 8 (1.8%) were 
taken up for defi nitive repair in acute setting (within 48 hrs 
of the cholecystectomy). The median interval between the 
index surgery and the referral was 27.5 ± 10.3 hours. All 
patients had an apparent segmental ductal loss. There was no 
associated vascular injury in any patient. Variant biliary 
anatomy was present in 2 patients. For reconstruction, Roux 
en Y Hepatico jejunostomy using the left duct approach was 
adopted. A mean anastomotic diameter of 1.5 ± 0.6 cm was 
achieved. The mean operative time was 4.6 ± 1.7 hours and 
a stented anastamosis was performed in 6 patients. There was 
no major post operative morbidity. On median follow up of 
42 months (10–108 months) for 7 patients none of them 
developed an anastomotic complication.
Conclusion: Good results can be achieved for repair of bile 
duct injuries in the acute setting. Early repair also allays 
patient’s anxiety & apprehension and results in reduced 
patient morbidity. Prompt repair should be undertaken in 
patient of biliary transaction referred early.
667
COMMON BILE DUCT TRANSECTED, 
GALL BLADDER STILL IN SITU: 
WHAT NEXT?
A. K. Agarwal
Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi 110002, India
Introduction: Classical laparoscopic bile duct injury during 
cholecystectomy occurs when the common bile duct (CBD) 
is mistaken as cystic duct and is clipped and divided, however 
it is recognised only later while separating gallbladder (GB) 
from liver bed or post operatively. More extensive damage 
is caused at the time of removal of the GB from its bed 
resulting in resection of CBD and part of common hepatic 
duct thereby increasing the magnitude of the injury. The 
present report discusses a scenario wherein the operating 
surgeon realized the transection of the CBD (having mis-
taken it for a cystic duct) prior to the dissection of the GB 
from its bed.
Methods: Retrograde case report.
Results: A 44 year old lady was taken up for laparoscopic 
cholecystectomy for symptomatic gall stones at a city hos-
pital. Intraoperatively CBD was clipped and transected inad-
vertently due to misidentifi cation CBD as the cystic duct. 
Having realized soon after, the operating surgeon contacted 
us. He was advised not to attempt removing the gall bladder 
and close the abdomen after ensuring hemostasis and putting 
a drain. The patient was promptly transferred and within 7 
hours (since index surgery) was taken up for a re-exploration 
at our centre. The CBD had been clipped at the lower end 
(Strassburg E1), the GB was in place and the cystic duct was 
still in continuity with the CBD. The CBD was transected 
above and the incision extended onto the Left hepatic duct 
and a stented Roux en Y hepatico-jejunstomy was performed. 
The postoperative course was uneventful and the patient was 
discharged on sixth postoperative day. At a follow-up of 1 
year, the patient is asymptomatic with normal liver function 
tests.
Conclusion: Removal of the gall bladder (with re transac-
tion of the CBD high up) further compounds a classical 
laparoscopic bile duct injury. If recognized intraoperatively 
surgeon should resist the temptation to complete the chole-
cystectomy if not trained enough to perform hepatico-
jejunostomy and should drain and refer instead with the GB 
in situ. This limits the extent of biliary injury (more complex 
& higher injury), decreases the patient morbidity & anxiety/
apprehension with a resultant excellent outcome.
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OUTCOMES OF PATIENTS WITH 
HISTOLOGICALLY PROVEN ACUTE 
ACALCULOUS CHOLECYSTITIS
K. Manya, M. Nikfarjam, M. Fink, V. Muralidharan, 
G. Starkey, R. Jones and C. Christophi
University of Melbourne, Department of Surgery, Austin 
Health
Austin Health, Surgery, University of Melbourne, 8 
Shiralee Court, Wheelers Hill 3150 Melbourne, Australia
Introduction: Acute acalculous cholecystitis (AAC) is tra-
ditionally described in the setting of critical illness, where 
the diagnosis is based on clinical assessment and imaging 
criteria. Some of the co-morbid medical conditions associ-
ated with AAC include hypertension, diabetes and cardiovas-
cular disease. The aims of the study were to determine the 
overall prevalence of AAC in our hospital, to identify 
features and outcomes of AAC in patients treated by 
cholecystectomy.
Methods: Patients with histologically confi rmed acute 
cholecystitis treated in a specialized unit in a tertiary hospital 
between 2005 and 2011 were identifi ed from prospectively 
maintained database. Retrospective review of data was 
undertaken and patients with AAC, defi ned by an absence of 
stones on imaging and histology were identifi ed and com-
pared to those patients with acute cholecystitis and confi rmed 
gallstones.
Results: AAC was identifi ed in 35 of 412 (8.5%) cases of 
acute cholecystitis. These patients tended to be older (69 
years versus 61 years; p = 0.004) and more likely to be febrile 
(46% versus 21%; p = 0.001) and hypotensive (23% versus 
5%; p < 0.001) at initial presentation. There was a higher 
incidence of chronic obstructive airway disease (COAD) in 
the AAC group (26% versus 6%; p < 0.011). Other comor-
bidities were similar between the groups. Operative out-
comes were similar between the groups. There were no 
overall differences in complications between the AAC and 
calculous acute cholecystitis group (17% versus 16%; p = 
0.063). The post-operative length of stay was however higher 
in the AAC group (5 days versus 3 days; p = 0.026).
Conclusion: The overall prevalence of AAC was consistent 
with previous studies. The patients with AAC were older, 
unwell at initial presentation and their hospital admission 
longer than those with acute calculous cholecystitis. The only 
medical condition strongly associated with AAC was COAD. 
The operative outcomes and complications of AAC treated 
by cholecystectomy were similar to cases of acute calculous 
cholecystitis.
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THE ROLE OF INTRAPERITONEAL 
ANAESTHETIC IN LAPAROSCOPIC 
CHOLECYSTECTOMY
C. Jones, A. McBrearty and B. Clements
Department of Surgery, Royal Victoria Hospital, Belfast
Royal Victoria Hospital, Belfast Health and Social Care 
Trust, Department of Surgery, 10 Breezemount Park BT32 
Banbridge, Northern Ireland
Introduction: Post-operative pain following laparoscopic 
cholecystectomy can delay discharge. Shoulder tip pain may 
be a result of diaphragmatic stretching due to the creation of 
the pneumoperitoneum. The use of local anaesthetic intra-
peritoneally may therefore reduce this reaction, and the 
overall post-operative pain. This review aimed to evaluate 
the role of intraperitoneal local anaesthetic infi ltration in the 
management of post-operative pain following laparoscopic 
cholecystectomy.
Methods: A literature search was carried out using the fol-
lowing databases – Pubmed, Athens, Medline and Google 
scholar search engine. The following key words were used 
– laparoscopic cholecystectomy, post-operative pain man-
agement, intraperitoneal, and local anaesthetic, singly or in 
combination. To ensure an up-to-date literature search, the 
search initially restricted to the last six years. To maximize 
this search, backward chaining of reference lists from 
retrieved papers was also undertaken. The search was limited 
to the English language. A total of 15 papers were originally 
identifi ed, 6 were excluded due to date or content, leaving a 
total of 9 papers.
Results: Five randomised control trials supported the use of 
intraperitoneal local anaesthetic to control post-operative 
pain following laparoscopic cholecystectomy. Evidence sup-
ported the combined use of pre-incisional and intraperitoneal 
local anaesthetic, and confi rmed the benefi t of bupivacaine 
intraperitoneal instillation prior to the creation of the pneu-
moperitoneum. Evidence also supported the use of nebulised 
intraperitoneal local anaesthetic. Contrary to this, Paech et 
al, 2008 did not demonstrate any benefi t on the use of intra-
peritoneal analgesia. Akinci et al, 2008 found the lowest 
post-operative pain score was in the group receiving intrave-
nous analgesia (tramadol) rather than intraperitoneal 
analgesia.
Conclusion: Overall, the majority of randomised control 
trials supported the use of intraperitoneal local anaesthetic to 
reduce post-operative pain following laparoscopic cholecys-
tectomy. The use of pre-incisional local anaesthetic appears 
synergistic. Importantly, this should be used in conjunction 
with other methods of pain control and may allow a greater 
number of patients to undergo laparoscopic cholecystectomy 
as a day case procedure.
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HEPATOPANCREATODUODENECTOMY 
FOR GALLBLADDER CANCER
A. Belli, P. Limongelli, L. Cioffi , G. Russo, A. D’Agostino, 
C. Fantini and G. Belli
Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital
S.M. Loreto Nuovo Hospital, Department of General and 
Hepato-Pancreato-Biliary Surgery, Via A. Vespucci 80142 
Naples, Italy
Introduction: Hepatopancreatoduodenectomy is a major 
surgical procedure previously reported for the treatment of 
hepatobiliary malignancies. This video illustrates, step by 
step an open hepatopancreatoduodenectomy.
Methods: A right hepatectomy with en –bloc pancreatoduo-
denectomy was carried out.
Results: There were no intraoperative complications but 
one intraoperative and two perioperative blood transfusions. 
Operating time was 360 minutes. The patient had a compli-
cated postoperative course characterized by postoperative 
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collection and fever but discharged on the twenty-third post-
operative day. Patient was alive at one year follow up.
Conclusion: This technique may achieve complete surgical 
resection in the treatment of advanced gallbladder carcinoma 
but its impact on long term outcome is to be further 
evaluated.
706
MIRIZZI SYNDROME IN 
LAPAROSCOPIC ERA
L. Cioffi , P. Limongelli, A. Belli, G. Russo, A. D’agostino, 
C. Fantini and G. Belli
Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital
S.M. Loreto Nuovo Hospital, Department of General and 
Hepato-Pancreato-Biliary Surgery, Department, Via A. 
Vespucci, 80142 Naples, Italy
Introduction: In the laparoscopic era a early approach to 
gallstones has increased the rate of diagnosis of Mirizzi 
Syndrome (MS), in particular when presenting before fi stula 
formation. In literature less than about two hundred of cases 
of MS treated with a laparoscopic approach were reported.
In this report we report our experience of laparoscopic 
treatment for MS and discuss surgical options, technical 
tricks and clinical outcomes as complication and conversion 
rate.
Methods: According to a recent classifi cation we identifi ed 
two types of MS: type I, without colecystocholedochal 
fi stula, and type II, with fi stula. Patients with MS were surgi-
cally treated with a laparoscopic approach.
Results: Nine patients with MS were treated with laparo-
scopic approach. In 5 type I pts we performed laparoscopic 
cholecystectomy (LC) with only one conversion to lapatot-
omy. In 4 type II pts we carried out LC with T-tube biliary 
drain (1 pts), subtotal LC (1 pts), open biliodigestive anas-
tomosis (conversion of LC in 2 pts).
One patient type II treated with LC + T-tube had mild 
biliary leak. One type I patient fi rst intentionally treated with 
LC was converted to open cholecystectomy; 2 type II patients 
fi rst intentionally treated with LC, were treated with open 
biliodigestive anastomosis.
Conclusion: According to previous reports complication 
rate seems to be not different between open and laparoscopic 
approach. Laparoscopic treatment can be a promising option 
in the treatment of MS with or without colecystocholedochal 
fi stula carrying notorious advantages in terms of periopera-
tive outcomes of a mininvasive approach. Attempt to lapar-
oscopy is suggested providing all the surgical steps of the 
open approach are to be safely and thoroughly performed.
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SINGLE INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY: A SINGLE 
CENTER EXPERIENCE
H. Tranchart, P. Lainas, G. Pourcher, G. Di Giuro, 
S. Ferretti, D. Tzanis, N. Devaquet and I. Dagher
Department of Abdominal and Minimally Invasive Surgery, 
Antoine Beclere Hospital, AP-HP, Clamart, F-92140, 
France
Antoine Beclere Hospital, AP-HP, Department of 
Abdominal and Minimally Invasive Surgery, 157 rue de la 
Porte de Trivaux 92141 Clamart, France
Introduction: Single incision laparoscopic cholecystec-
tomy (SILC) was developed in the late 1990s in order to 
improve the outcomes of four-port laparoscopic cholecystec-
tomy. Benefi ts of SILC have been suggested by few small 
series but the possibility of standardization of this technique 
is still under investigation. The aim of our study was to report 
our experience of standardized SILC and to examine the 
short and long-term benefi ts associated with this procedure.
Methods: Patients with an indication for a cholecystectomy, 
with a body mass index (BMI) inferior to 40, no history of 
liver disease and no prior upper abdominal surgery were 
considered for SILC. Thirty-two patients (20 women and 12 
men) underwent SILC from June to October 2011 in our 
department. Data concerning all patients who underwent 
SILC in our unit were prospectively collected. Operative and 
perioperative outcomes were analyzed.
Results: Indications were stones in 28 patients and polyps 
in 4 patients. Mean BMI was 25.5 kg/m2 (range 17.5–38.2 kg/
m2), mean operating time was 69.5 min (range 30–130 min) 
and blood loss was minimal. There were no conversions to 
open surgery; 10 patients required one additional trocar and 
3 patients two additional trocars. These were needed for 
better exposition and never in emergency conditions. 
Perioperative minor complications (12.5%) included two 
hemorrhages easily managed by bipolar coagulation and two 
gallbladder perforations requiring laparoscopic lavage. 
Postoperative complications (9%) included a case of respira-
tory distress after gastric fl uid inhalation, treated by antibiot-
ics during ICU hospitalization. No biliary leakage was 
reported.
Conclusion: Standardization of SILC is possible with 
excellent outcomes.
708
HEPATIC TUBERCULOSIS MIMICKING 
KLATSKIN TUMOR
M. Soufi , T. E. Harroudi and M. Bouziane
Oujda Department of Surgery, Faculty of Medicine, 
University Mohammed First Morocco
faculty of Medicine, University Mohammed First Morocco, 
Oujda Department of Surgery, Bp 4847 Oujda Université 
60049 Oujda, Morocco
Introduction: Hepatic tuberculosis is rare disease and 
usually occurs in association with pulmonary tuberculosis. 
Isolated tuberculosis of liver is very rare but its not so excep-
tional in endemic country like morocco.
Methods: We report the case of a 45-year-old man present-
ing with features of obstructive jaundice and a clinico-
354 Poster Presentation Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 288–699
radiological picture highly suggestive of a perihilar 
cholangiocarcinoma Klatskin tumor.
Results: External biliary derivation was done because we 
don't have diagnosis and all biopsy in preoperative were 
negative. The biopsies of pseudotumoral tumor in hepatic 
hilar confi rmed tuberculosis. After nine months of chemo-
therapy of antituberculosis, the patient is well at one year of 
postoperative rate.
Conclusion: We review the literature on this unusual pres-
entation, highlight the considerable diagnostic challenge 
such cases can pose, and also emphasize the need to consider 
tuberculosis in differential diagnosis of lesions klatskin 
tumor, particularly in areas endemic for the disease.
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IMPACT OF RESECTION MARGIN 
ON SURVIVAL AND RECURRENCE 
IN INTRAHEPATIC 
CHOLANGIOCARCINOMA
E. Alqarqaz1 and M. Johann2
1The Hashemite University, 13115 Zarqa, Jordan; 2Hopital 
Bon Secours, 57038 Metz, France
The Hashemite University, Department of Surgery, Faculty 
of medicine, The Hashemite University, P.O. Box 150459, 
13115 Zarqa, Jordan
Introduction: Intrahepatic cholangiocarcinoma (IHC) is a 
rare primary liver tumor. Recently it is being diagnosed more 
frequently with its incidence increasing worldwide. Although 
many of the patients are diagnosed at late stage of the disease, 
surgical resection remains the only potential modality to 
improve survival for patients with this disease. Little is 
known about the impact of hepatic resection margin on recur-
rence and survival in patients operated, with intent for cure, 
with this disease.
Methods: Retrospective analysis of the data collected from 
medical and radiological records of the patients who under-
went liver resection for IHC between the periods January 
2002 until April 2010 at Hôpital Bon Secours, Metz, France, 
and from June 2010 until December 2011 at Hospital Prince 
Hamza Hospital, Amman, Jordan.
Results: Eighteen patients underwent surgery for IHC. 
Grossly, all resections were R0, but microscopically, in 3 
patients the margin was involved (R1). In the R0 group, the 
margin was >1 cm (wide margin WM) in 10 patients, and 
<1 cm (narrow margin NM) in 5. Median follow up time was 
28 months. Recurrence occurred in 10 patients (55.6%). The 
difference of recurrence free survival time between R1 and 
R0 groups showed better prognostic impact for the R0 group 
(P value = 0.085) while it did not show any better prognostic 
impact between the WM and NM groups (P value = 0.63). 
The difference of survival rate between R1 and R0 groups 
was statistically signifi cant (P value = 0.0014) while between 
the WM and NM groups it was not signifi cant (P value = 
0.99).
Conclusion: Negative hepatic resection margin (R0) for 
patient with IHC showed favorable infl uence on survival and 
recurrence when compared to positive margin (R1), the dif-
ference was statistically signifi cant, while WM (>1 cm) of 
resection did not show favorable impact on survival or recur-
rence when compared to NM (<1 cm).
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EMERGENCY CHOLECYSTECTOMY; 
AN ECONOMIC EVALUATION OF 
PRACTICE AT A REGIONAL 
HEPATOBILIARY CENTRE
N. Misra1, V. Kaliyaperumal1, N. Grimes2, R. Jones2, 
D. Dunne1, G. Poston1, S. Fenwick1 and H. Malik1
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Introduction: The debate as to how to best manage patients 
presenting acutely with complications of gallstones contin-
ues – whether to consider early emergency surgery on the 
index admission or to discharge the patient, who is then to 
be placed on a waiting list. Perceptions of increased risk and 
greatly increased cost still persist about the early approach. 
Although in patients with acute severe pancreatitis the rec-
ommendation from a clinical viewpoint is to perform an 
early cholecystectomy, we analysed whether the same strat-
egy can be applied in patients presenting with other compli-
cations of gallstones e.g. cholecystitis. We report on our 
experience from a regional hepatobiliary centre.
Methods: A retrospective study was conducted of all 
patients admitted with acute biliary symptoms, and who 
underwent emergency cholecystectomy on the index admis-
sion, at University Hospital Aintree, Liverpool, by the hepa-
tobiliary team, between January 2008 and August 2011. The 
comparison group used was that of all patients who had a 
delayed cholecystectomy, i.e. who were discharged after 
initial medical treatment for bilary disease and were then 
placed on the surgical waiting list during this period. Costing 
data were calculated for each patient on an individual basis, 
including all theatre consumables, drugs and calculated cost 
for length of stay on a surgical ward. A decision tree roll back 
analysis was conducted, using input data derived from the 
clinical study as well as the individual patient level costs, in 
order to calculate the overall costs for both the early and 
delayed cholecystectomy arm of the study. Statistical analy-
sis was conducted using the Chi squared test.
Results: Of the 1888 patients who had a laparoscopic chole-
cystectomy during this period, 89 patients had an emergency 
or early laparoscopic cholecysytectomy (eLC) and 310 
patients presented acutely with biliary disease and then went 
on to have a delayed cholecystectomy (dLC). Overall median 
length of stay (LoS) for the eLC group was 6 days, and for 
the delayed group was 7 days (p = NS), including the primary 
admission for medical treatment.
The risk of emergency readmissions for all patients on the 
waiting list was 13% with a median stay of this emergency 
admission of 4.5 days. Post-operative readmission rates were 
equivalent for both eLC (8%) and dLC (9%) − p = NS. Mean 
operating time was longer in the eLC group than the dLC 
group – 120 minutes vs. 60 minutes (p < 0.05). Post operative 
ERCP rates were 3% for the eLC group and 0% for the dLC 
group (p = NS), post operative fl uid collections requiring 
intervention were 6% for the eLC group as opposed to 0% 
for the dLC group (p = NS). The mean baseline cost per 
patient for eLC was composed of £265.95 for theatre con-
sumables, £780 for operating theatre time, £26.89 for drugs 
and £1590 for the overall ward inpatient cost including staff-
ing costs, leading to a total of £2663. The cost for dLC was 
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calculated at £2513, leading to a baseline cost difference 
between the eLC and dLC of around £150 (€180) more 
expensive for the eLC group. But after complications and 
readmission costs were calculated and inputted into the deci-
sion tree analysis, this difference decreased to a cost of £52 
(€62) – more expensive for the eLC pathway.
Conclusion: Early cholecystectomy on the index admission 
appears to be safe, with an overall length of stay slightly 
shorter for the early cholecystectomy pathway rather than 
that of a delayed pathway. The difference in costs between 
the early and delayed cholecystectomy pathway was minimal 
per patient, with both patients pathways being essentially 
cost equivalent. But with NHS tariff (i.e. income derived by 
the institution) being around £3197 (€3836) for a eLC and 
£1390 (€1668) for a dLC, the difference in net monetary 
benefi t per patient was around £1755 (€2106) per patient, 
which would be the income gained per patient by changing 
to a policy of early versus delayed cholecystectomy for acute 
biliary disease. In a hospital conducting around 200 chole-
cystectomies per year on patients for acute biliary disease in 
the National Health Service, this could translate to a cost 
saving of over £350,000 per year, or €420,000.
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HILAR CHOLANGIOPLASTY USING 
OMENTUM FOR DUCTAL DEFECT 
IN BILIOBILIARY FISTULA: 
A CASE REPORT
T. Ebata, Y. Yokoyama, T. Igami, G. Sugawara, 
Y. Takahashi and M. Nagino
Division of Surgical Oncology, Nagoya University 
Graduate School of Medicine
Nagoya University Graduate School of Medicine, Division 
of Surgical Oncology, 65 Tsurumaicho Showaku Nagoya, 
46685 Nagoya, Japan
Introduction: Non-circumferential defect of the biliary 
system is occasionally faced at surgery for biliobiliary fi stula. 
The condition represents an uncommon but important com-
plication of gallstone disease. Although direct closure or 
patch repair using the gallbladder cuff are recommended as 
fi rst-line treatments, these procedures are sometimes techni-
cally diffi cult in active infl ammation. The authors, herein, 
present a novel procedure denoted as hilar cholangioplasty, 
which utilizes the pedicled omentum.
Methods: An 80-year-old man was referred to our hospital 
because of cholangitis. Endoscopic retrograde cholangiogra-
phy demonstrated that a large gallstone astride the common 
hepatic duct with upstream biliary dilation, indicating bilio-
biliary fi stula. On laparotomy, after removal of the gallstones 
and the gallbladder, a large defect, 2 × 3 cm in size, was 
found at the right side of the common hepatic duct just below 
the hepatic bifurcation. The bile duct and the surrounding 
tissue were extensively erosive and thickened with dense 
fi brosis, such that conventional repair methods could not be 
performed. Alternatively, cholangioplasty using the pedicled 
omentum as an autologous graft was performed, followed by 
T-tube placement for biliary decompression.
Results: Histologic examination of the resected specimen 
showed chronic cholecystitis. He had a satisfactory postop-
erative course and was discharged on 16 days after surgery. 
Cholangioscopy via the T-tube sinus tract on 37 days after 
surgery demonstrated a yellow polypoid mass below the 
bifuracation. Histology of the biopsy samples demonstrated 
that a monolayer biliary epithelium overlaid the omentum. 
The patient has remained well after 3 years’ follow-up and 
CT visualized slight thickness of the grafted omentum 
without dilatation of the intrahepatic tree.
Although a single experience, the results provide a histo-
logic evidence of early transformation into a neo-bile duct 
and indicate a long-term safety of this method.
Conclusion: Hilar cholangioplasty using pedicled omentum 
is simple, easy, and reproducible. We believe that the present 
procedure is a promising surgical option for non-circumfer-
ential ductal defect.
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METASTATIC BREAST CARCINOMA IN 
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Introduction: The development of secondary implants in 
bile ducts is a rare event in breast cancer. Its incidence is less 
than 2% of metastatic cases, and the development of symp-
toms is observed in less than 1% of patients.
Methods: Case report: a 62-year-old female patient under-
went left mastectomy with lymph node dissection and 
chemo/radiotherapy 12 years ago, and right hepatectomy for 
metastases 4 years ago with good outcomes. Attended our 
hospital with complaints of itching, showing progressive 
cholestasis translated by the gradual increase of alkaline 
phosphatase and gamma-glutamyl transferase. Magnetic 
resonance imaging of the abdomen and magnetic resonance 
cholangiopancreatography showed a lesion of about 1 cm in 
diameter causing left hepatic duct stenosis and upstream 
dilatation.
Results: The patient underwent liver IVB segmentectomy, 
with resection of the extrahepatic biliary tree and reconstruc-
tion through a Roux-en-Y cholangiojejunostomy at the con-
fl uence of ducts of liver segments II and III. This anastomosis 
was tutored by trans-hepatic tubes. The patient recovered 
well postoperatively, no anastomotic fi stula was observed 
and remained asymptomatic during follow-up.
Conclusion: The appearance of jaundice in a patient with 
a history of breast cancer is usually secondary to liver 
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metastases. However, the differential diagnosis of biliary 
cholestasis due to extrinsic compression by lymph nodes or 
metastatic intraductal lesions without involvement of the 
hepatic parenchyma must be considered due to their better 
prognosis and the possibility of palliative treatment with 
symptomatic relief and improved survival.
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SECONDARY BILIARY STENTING 
FOR MALIGNANCY
T. Nakamura1, Y. Kon2, T. Akao1, H. Nogawa1, A. Sano1 
and Y. Fukai1
1Gunma Prefectural Cancer Center, Ota, Gunma, Japan; 
2Ota General Hospital, Ota, Gunma, Japan
Gunma Prefectural Cancer Center, Surgical Oncology, 
617-1 Takahayashi-Nishicho 373 Ota, Gunma, Japan
Introduction: Biliary tracts are often involved by several 
malignancies, especially upper abdominal cancers. They 
induce obstructive jaundice, hepatic dysfunction, or cholan-
gitis. They make treatment process deteriorate. Although 
biliary stenting improves those complications, that function 
is not permanent. We evaluate secondary stentings to biliary 
stent dysfunction.
Methods: We analyzed biliary stentings from April 2006 to 
Dec 2011 and evaluated secondary stentings at Gunma 
Prefectural Cancer Center in Japan.
Results: 42 cases (22.2%) had secondary stentings for their 
stent dysfunctions among 189 cancer patients with metallic 
stents for their malignant biliary stenoses. Two patients died 
from gastrointestinal bleeding after stenting and three 
patients suffered from cholecystitis. 37 patients (88%) were 
discharged home and 15 cases (35.7%) could have anti-
cancer treatment after secondary stentings. 28 secondary 
stents (66.7%) were patent until patients expired.
Conclusion: Although a few serious complications could 
happen, secondary stenting should be considered to biliary 
metallic stents dysfunctions for malignancy because they can 
not only improve the quality of life to many patients but also 
make some patients be able to continue their anti-cancer 
treatment.
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VARIATIONS OF BILE DUCT ANATOMY 
ON OPERATIVE CHOLANGIOGRAPHY 
WITH FOCUS ON THE DISTRIBUTION 
OF COMMON HEPATIC DUCT LENGTH
K.-Y. Lee, W. P. Cho, W. Y. Shin, S.-I. Ahn and 
K.-C. Hong
Department of Surgery, Inha University School of Medicine
Inha University School of Medicine, Surgery, 7-206, 3-Ga 
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Introduction: On performing laparoscopic cholecystec-
tomy, the dissection of Calot triangle is of utmost importance 
because most cases of bile duct injury occur at this stage. 
Theoretically, the shorter the common hepatic duct length 
becomes, the narrower of the area of Calot triangle, and 
hence the higher the chance of bile duct injury. This study 
was performed to examine the distribution of common 
hepatic dust lengths, as well as the variation of the bile duct 
branching pattern via operative cholangiogram.
Methods: 1277 consecutive operative cholangiograms 
taken between November 2002 and March, 2011 were 
reviewed. The length of the common hepatic dust was meas-
ured on the operative cholangiography, and the types of bile 
duct variation classifi ed. The relevance of bile duct injury to 
the variation of bile duct anatomy was studied.
Results: The median length of common hepatic duct was 
22 mm (range, 0 ~ 69 mm) on operative cholangiography. In 
about 3% of the cases, the common hepatic duct length was 
0 mm. There were 12 cases (0.9%) of bile duct injuries. The 
chance of bile duct injury was higher when the common 
hepatic duct was shorter, especially the right hepatic or right 
posterior hepatic duct injury. The variation of intrahepatic 
bile duct was similar to the variations reported in the litera-
ture. The distribution of common hepatic duct length was 
bimodal, with peaks in 0 and 20 mm, respectively.
Conclusion: There are patients whose common hepatic duct 
is very short, and care should be taken in these patients to 
avoid the possible bile duct injury during cholecystectomy. 
The distribution pattern of common hepatic duct length sug-
gested that there may be at least two different mechanisms 
governing the cystic duct budding process during the embry-
onic development.
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PERCUTANEOUS CHOLECYSTOSTOMY 
IN PATIENTS WITH SUSPECTED 
MIRIZZI SYNDROME
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Introduction: Detailed reports of percutaneous cholecysto-
stomy (PC) in patients with suspected Mirizzi Syndrome 
(MS) are lacking. Many studies indicate that acute cholecys-
tectomy (CY) in poor risk patients conveys a relatively high 
morbidity and mortality. Also, bile duct injury is reported 
with laparoscopic CY in MS. Therefore, this study aims to 
assess outcome following initial PC for acute cholecystitis 
(AC) both with and without suspected MS.
Methods: We reviewed patients undergoing PC at the Royal 
Adelaide Hospital between April 2007 and October 2011 
using an automated web-based prospective data collection 
system. Patient demographics, blood and imaging results at 
presentation, PC technique (60% transperitoneal, 40% tran-
shepatic) and complications, total length of hospital stay 
(LOS) and outcome from subsequent CY was analysed.
Results: PC was recorded in 60 poor risk patients. Group 1 
comprised 39 suspected MS – based on clinical presentation 
suggesting AC, raised serum bilirubin and liver enzymes 
with no bile duct stones nor distal dilatation on imaging. MS 
was confi rmed on cholangiography in 6/39 (15%) which 
involved ERCP in 3 (7.7%). Group 2 comprised 21 with AC 
alone. Complications from PC included: tube dislodgements 
– 8 (13.3%), tube blockages – 2 (3.3%) and cholangitis – 1 
(1.7%). In Group 1, late CY at median 47 (4–598) days was 
performed in 21/39 (54%): 14 laparoscopic [1 converted] and 
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7 open. No confi rmed MS patient was converted. In Group 
2, 13/21 (62%) underwent late CY at median 87 (19–167) 
days (p = 0.08): 12 laparoscopic [4 converted] and 1 open. 
1 minor bile leak, resolved with endoscopic stenting, in 
Group 1. There was no difference in median LOS between 
2 groups (p < 0.14-Fisher) and no mortality.
Conclusion: We concluded that PC is a potentially safe, 
effective initial method to manage patients with clinically 
suspected MS. Late laparoscopic CY had a low conversion 
rate with no bile duct injury. Stringent measures are required 
to prevent tube dislodgement. PC may obviate ERCP.
750
SINGLE INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY WITH STANDARD 
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Introduction: Single incision laparoscopic surgery (SILS) 
has been spreading across the globe largely due to the 
improved aesthetics and reduced post-operative pain. 
Although the fi rst SILS cholecystectomy was described by 
Navarra in 1997, there have been no reports on SILS chole-
cystectomy originating from the Caribbean. We performed a 
three year retrospective multi-centre audit of SILS cholecys-
tectomy techniques being used in all hospitals across the 17 
countries comprising the English speaking Caribbean.
Methods: Independent investigators in each of the 17 coun-
tries interviewed OT staff and examined OT records from 
January 2009–2012. The records of patients who had SILS 
cholecystectomy were retrieved. The data extracted included 
demographics, indications for surgery, operative details, sur-
gical techniques, specialized equipment, conversions, mor-
bidity and mortality. A SILS cholecystectomy was considered 
one in which all instruments were passed through a single 
incision. A conversion was present when an additional inci-
sion was required – whether for open access or additional 
ports. Any procedure requiring <24 hours hospitalization 
was considered an ambulatory procedure in keeping with 
the standardized defi nition from the US based SPARCS 
Committee.
Results: The fi rst SILS cholecystectomy was performed in 
Jamaica (2010) with straight instruments. Overall, there were 
13 procedures performed across the region, all in females at 
a mean age of 37.4 ± 8.5 years. The mean operative time was 
68 ± 10.5 minutes. A variety of access ports were used: SILS 
port (8); Gelport (3); and 5 mm reusable ports (2). A com-
plication was recorded in 1 (7.7%) case. This was a bile leak 
from to an injury believed to be due to faulty instrumentation 
(sheared insulation from cautery hook). There were no other 
complications noted. 11 (84.6%) patients had ambulatory 
procedures, with an average duration of hospitalization of 
10.8 ± 5 hours (Mean ± SD). One patient required hospitali-
zation for 6 days after a bile leak.
Conclusion: Most hospitals in this region operate with 
limited resources. Therefore, SILS cholecystectomy with 
curved instruments and specialized access ports may not 
always be feasible. Nevertheless experienced surgeons can 
complete this procedure using conventional instruments. It 
is important to audit our techniques in order to balance safety 
and effi cacy while maintaining affordability. Careful case 
selection is paramount and surgeons should maintain a low 
threshold to convert to standard laparoscopy.
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RIGHT HEPATIC AND SECTORAL DUCT 
INJURIES AT LAPAROSCOPIC 
CHOLECYSTECTOMY
S. I. Ahn, K.-Y. Lee and W. Y. Shin
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School of Medicine, Inha University, Department of 
Surgery, 7-206, Shinheung-dong 3, ga, jung-gu, 400-
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Introduction: Injuries to right hepatic and right posterior 
sectoral duct (RPSD) during laparoscopic cholecystectomy 
occur relatively infrequently, but may be the cause of serious 
complications. Right posterior sectoral bile duct variations 
are seen in about 4–8% of the population and are particularly 
vulnerable to injury during laparoscopic cholecystectomy. 
The data on the management of bile duct injuries at out 
center were discussed in this study.
Methods: There were a total of 7 patients with right hepatic 
duct and RPSD injuries between 2007 and 2011. The data 
gathered include demographics, pre-operative diagnosis, 
type of injury, diagnostic tools, mode of treatment after 
injury, average length of post-operative hospital stay, and 
morbidity. The patient data were retrospectively reviewed.
Results: Of the 7 patients, 3 were men and their mean age 
was 52. The pre-op. diagnosis were acute cholecystitis (2), 
GB stone (4), and GB polyp (1). There were 4 cases of rt.
hepatic duct injury and 3 cases of RPSD injury. In 6 patients, 
the bile duct injury was identifi ed intraoperatively, whereas 
in 1 patient the injury was suspected on day 3 due to bile 
leak. Intraop. cholangiogram was performed for 4 patients to 
identify duct injury. As for the management, 6 patients 
underwent surgeries (2 choledochojejunostomies, 3 primary 
repair, and 1 proximal ligation), and 1 patient received con-
servative treatment. The average length of post-operative 
hospital stay was 16 days. In terms of morbidity, 2 patients 
suffered cholangitis, treated conservatively.
Conclusion: The right hepatic and RPSD injuries are not 
common but diffi cult complications to manage. Prompt sur-
gical repair is most important. However, conservative man-
agement including proximal ligation seems to be feasible in 
cases with RPSD injuries. Further studies with larger number 
of cases are needed.
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Introduction: Vascular invasion of colorectal liver metasta-
sis following liver resection has a detrimental effect on 
patient outcome. However there are few studies specifi cally 
looking at the signifi cance of biliary invasion in colorectal 
liver metastasis (CRLM). The aim of this study was therefore 
to evaluate the presence of biliary invasion and patient out-
comes in those having liver resection for CRLM.
Methods: All patients having liver resection for colorectal 
liver metastasis during an 11 year period up to 2011 were 
identifi ed from a prospectively maintained database. The unit 
follows standardised pathological reporting for CRLM where 
biliary and vascular invasion are assessed and documented. 
Missing information was specifi cally crosschecked with a 
separate histopathology database. Univariate and subsequent 
multivariate analysis were carried out for biliary and vascular 
invasion individually and in combination with other prog-
nostic variables to assess their clinical signifi cance. Survival 
was assessed using Kaplan-Meir plots and log rank tests for 
signifi cance (p < 0.05) using SPSS vs. 19.
Results: 432 patients (67% male, mean age 64.5 years, 
range 29–86) underwent liver resection for CRLM during 
this time period. Primary tumours were either colonic (54%) 
or rectal (46%). Seventy patients (16.3%) had positive biliary 
invasion on tumour histopathology whereas 137 (32%) had 
vascular invasion. Overall 155 (36%) patients had both 
biliary and vascular invasion (BVI). Overall 5 year survival 
was 43% in this series. On univariate analysis 5 year survival 
in those patients with biliary invasion was 39.9% compared 
to 42.5% in those without biliary invasion (p = 0.866). 
Results were similar in those patients with or without vascu-
lar invasion respectively (40.4% vs. 43.2%, p = 0.65). Also 
combined BVI failed to infl uence OS (39.2% vs. 42.2%, 
p = 0.856).
Conclusion: In our series, bilary invasion of CRLM does 
not affect overall survival rates in patients having liver 
resection.
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Introduction: Under the rising demand of health services, 
the critical pathway (CP) which standardizes the practice 
guideline was introduced as a means to provide quality 
healthcare service. Critical pathway may increase the 
patient’s satisfaction rate by providing with the systematic 
and consistent service. Therefore, it is to evaluate the signifi -
cance of critical pathway by developing and applying critical 
pathway to the patient who underwent Laparoscopic 
Cholecystectomy.
Methods: From June 2010 to Oct 2011, 70 patients in the 
CP applied group and 106 patients in the non-CP applied 
group among the total number of 176 patients who under-
went elective laparoscopic cholecystectomy were examined 
and the followings were compared. Number of days of hos-
pitalization, total costs of medical service, total insurance 
and non-insurance costs, charging fees for selecting a doctor, 
total costs of individual charges and hospitalization, the costs 
of private ward, patient’s satisfaction rate, rates of readmis-
sion. The patients admitted through the emergency room and 
the patients underwent cooperative surgery from the different 
department were not included in this study. The date analysis 
used the T-test.
Results: CP application rate was 98.5% (69 of 70). The 
gender was 34 male and 36 female patients in the CP applied 
group. 16 male and 90 female in non-CP applied group. The 
mean age was 40.5 years old in CP applied group and 49.8 
years old in non-CP applied group. The number of days of 
admission and the medical costs in all categories of CP 
applied group showed a signifi cant reduction level compared 
to the non-CP applied group. (Number of days of hospitaliza-
tion: 1 day vs. 2.62 days (p < 0.000), Total cost of medical 
service: 1781 Euro vs. 2229 Euro (p < 0.000), total costs of 
individual charges: 906.6 euro vs 1188 euro (p < 0.000), The 
satisfaction rate in CP applied group scored for 8 points out 
of the perfect score of 10, re-admission rate was 0%.
Conclusion: The critical pathway should be broadly applied 
as it led to the decreased number of days of hospitalization 
and the medical costs, and increased patient’s satisfaction 
rate after its application. Therefore, the comparative large-
scale study is necessary in order to widen its adaptation of 
CP application.
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AGGRESSIVE HEPATECTOMY FOR THE 
CURATIVE TREATMENT OF BILOBAR 
INVOLVEMENT OF TYPE IV-A BILE 
DUCT CYST
J. Donf, S. Yang and Z. Huang
Hospital & Institute of Hepatobiliary Surgery, Chinese 
PLA General Hospital
Hospital & Institute of Hepatobiliary Surgery, Chinese 
PLA General Hospital, Fuxing road, 2810085 Beijing, 
China
Introduction: To analyze the risk and benefi t of aggressive 
hepatectomy for curative purpose in the treatment of bilobar 
involvement of type IV-A bile duct cysts (BDC).
Methods: Between January 2006 and December 2011, 28 
bilobar BDC patients who underwent an aggressive hepate-
ctomy were identifi ed from a prospective database, and 
perioperative and long-term outcomes were compared with 
18 bilobar BDC patients receiving conventional surgical 
treatment.
Results: Aggressive hepatectomy included 9 trisectionecto-
mies, 8 extended hemihepatectomies, 5 hemihepatectomies, 
3 mesohepatectomies and 3 special hepatectomies. 
Postoperative morbidity (57.1% vs. 22.2%, P = 0.020) in 
aggressive hepatectomy but not mortality (3.6% vs. 0%, P = 
1.000) was signifi cantly increased compared with conven-
tional surgical treatment. 27 (96.4%, 27/28) achieved symp-
tom-free status after aggressive hepatectomy during a mean 
follow up of 31 months. While, 7 patients (38.9%, 7/18) 
remained free of biliary symptoms after conventional one 
during a mean follow up of 37 months. The results was 
signifi cantly different (P < 0.001). In addition, no malignant 
transformation happened after aggressive hepatectomy. 
However, 4 patients receiving conventional surgical treat-
ment were found unresectable cholangiocarcinoma.
Conclusion: Aggressive hepatectomy is both a challenging 
procedure and an effi cient treatment for some selected 
patients with bilobar BDC of type IV-A. The role of aggres-
sive hepatectomy in the treatment of bilobar BDC of type 
IV-A should be paid particular attention in the future.
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LAPAROSCOPIC COMMON BILE DUCT 
EXPLORATION OF COMMON BILE 
DUCT STONES
I. Y. Park, Y. J. Kim, E. Y. Kim, Y. H. Eom, J. H. Lee, 
J. M. Baek, G. Y. Sung and D. S. Lee
Department of Surgery, Bucheon St. Mary Hospital, 
Catholic University of Korea
Bucheon St. Mary Hospital, Catholic University of Korea, 
Surgery, Sosa-Dong, Wonmi-Gu 420–7 Bucheon, Republic 
of Korea
Introduction: Common bile duct (CBD) stones are found 
in 10% of patients with symptomatic gallstones. Recently, 
endoscopic retrograde cholangiopancreatography and papil-
lary sphicterotomy are widely performed. However laparo-
scopic CBD exploration is a single stage technique and more 
cost-effective treatment.
Methods: We reviewed cases with laparoscopic common 
bile duct exploration (LCBDE) by several techniques. From 
January 1999 to December 2011, we underwent 47 cases of 
LCBDE by following approaches such as trans-cystic tech-
nique, choledochotomy and primary closure with or without 
biliary stent.
Results: 16 males and 31 females were studied. The mean 
age was 58 years old. The mean postoperative hospital stay 
was 9.3 days. We underwent trans-cystic approach (3), only 
primary closure of CBD (25), primary closure with antegrade 
stent (5), T-tube insert (14). Antegrade stent was inserted 
through the choledochotomy site. We tried primary closure 
in 35 cases. However, 5 cases were re-operated due to bile 
leakage (4) and retained stone (1). In the re-operations, 2 
cases were laparoscopic T-tube choledocholithotomy and 3 
cases were open T-tube choledocholithotomy.
Conclusion: LCBDE is a successful and cost effective treat-
ment of CBD stones. Especially, primary closure with or 
without stent was more effective and safe method by the 
skilful surgeon in the selected cases.
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LONG-TERM OUTCOME OF 
HEPATECTOMY FOR PRIMITIVE 
HEPATOLITHIASIS
P. Bucur1, E. Vibert3, G. Pittau1, O. Ciacio1, L. Ricca1, 
R. Adam2 and D. Castaing1
1AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 
F-94800 Villejuif, France; 2Univ Paris-Sud, Faculté de 
Médecine, F-94270 Le Kremlin Bicêtre, France; 3Inserm, 
Unité 785, F-94800 Villejuif, France
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire, 
12-14 avenue Paul Vaillant Couturier 94800 Villejuif, 
France
Introduction: Primitive hepatolithiasis (PHL) is very rare 
in western countries. Percutaneous and endoscopic stone 
extraction, extracorporeal lithotripsy (non-surgical proce-
dures, NSP), hepatico-jejunostomy and hepatectomy are the 
main procedures used for the treatment of hepatolithiasis. 
The aim of this study is to evaluate immediate and long-term 
results of hepatectomy as a treatment for hepatolithiasis.
Methods: From 1980 to 2007, 23 patients (16 women and 
7 men, mean age 45 ± 13 years) had a hepatectomy in our 
hospital for PHL. PHL was made of cholesterol stones in 11 
patients and of brown pigment stones in 12 patients. Stones 
were localized in one side of the liver in 16 patients and 
bilateral in 7. Extrahepatic stones were present in 12 patients. 
Before hepatectomy, 8 patients had NSP and/or hepatico-
jejunostomy. There were 10 major and 13 minor hepatic 
resections.
Results: Mortality and morbidity were 0% and 30.4%. 
Mean hospital stay was 14 ± 4 days. Median follow-up was 
8 years (range 2–19). At 1, 3, 5 and 10 years 82, 72, 65 and 
56% of patients were asymptomatic. The 8 patients that had 
recurrence were treated with NSP and/or antibiotics. These 
complementary treatments were successful in 2 patients. At 
last follow-up 17 patients were free of symptoms and 6 
needed on-off antibiotic treatment. One patient had a liver 
transplantation. The only preoperative factor associated with 
increase in recurrence rate was right liver localization.
Conclusion: Hepatectomy is a safe and effective treatment 
for PHL in Europe with low morbidity and an acceptable 
long-term recurrence rate, especially for stones localized in 
the left side of the liver.
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AN ANALYSIS OF THE OPERATIVE 
OUTCOME OF AN EXTRA-HEPATIC 
BILIARY TRACT CANCER AND OF THE 
ADJUVANT CHEMOTHERAPY OF 
GEMCITABINE
H. Kawamata, K. Ishii, K. Yamashita, H. Katagiri, 
Y. Takahashi, K. Furuta, Y. Kumamoto and M. Watanabe
Department of Surgery, Kitasato University School of 
Medicine
Kitasato University School of Medicine, Department of 
Surgery, 1-15-1 Kitasato Minami-ku, Sagamihara-shi 
Kanagawa-ken, 252-032925200 Sagamihara, Japan
Introduction: An aggressive operation is necessary to cure 
the biliary tract cancer. However an argument is left what 
kind of factor infl uences prognosis of the patient. In biliary 
tract cancer, even though recurrence rate after resection is 
high, postoperative adjuvant therapy is not still established. 
In this study, we aimed to disclose prognostic factors inde-
pendent of stage, and to analyse the outcome of chemo-
therapy using gemcitabine.
Methods: Of 112 patients with the extra-hepatic biliary tract 
cancer, including ampulla of vater, who underwent the opera-
tion in the Kitasato University Hospital from 1986 to 2010, 
89 patients were multivariate analysis ability for all clinico-
pathological factors. The postoperative chemotherapy was 
performed in 68 of 89 patients, and gemcitabine was given 
to 24 patients.
Results: Five year disease specifi c survival rate (5-yr DSS) 
was 58.4%. Independent predictor were such as the histologi-
cal differentiation degree (P = 0.045), high levels of preop-
erative serum CEA (P = 0.003), and CA19-9 (P = 0.011), 
lymphatic vessel invasion (P = 0.014), portal venous inva-
sion (P < 0.0001), lymph node metastasis (P = 0.011), 
perineural invasion (P < 0.0001), distal cut-end margin (P = 
0.009), positive for tumor exposure on abrasion side (P = 
0.0147), operation methods (P = 0.0005) in a univariate 
manner. Multivariate analysis revealed that the perineural 
invasion (P = 0.049) and preCEA (P = 0.025) were independ-
ent predictor. 5-yr DSS of the population who received gem-
citabine postoperative course was 75.0%, and the progression 
free survival was 34.9 months on average.
Conclusion: We newly identifi ed that the presence of 
perineural invasion and the levels of serum preCEA are inde-
pendent prognostic factors in the patients with extra-hepatic 
biliary tract cancers. Patients who received gemcitabine in 
adjuvant chemotherapy, 5-yr DSS and progression free sur-
vival rate were tended to be higher than the other therapeutic 
groups. We introduce this identifi cation into clinical strategy 
after operation, and can expect elongation of survival rate by 
taking adjuvant chemotherapy.
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DAY CARE LAPAROSCOPIC 
CHOLECYSTECTOMY IN A 
DEVELOPING COUNTRY
R. Patta1, J. Ramas2, U. Dhus3 and M. Rao4
1Senior consultant GI Surgery; 2Associate consultant GI 
Surgery; 3Senior consultant Gastroenterology; 
4Senior consultant Anaesthesiology
Apollo Hospitals, Department of Surgical 
Gastroenterology, 21, Greams Lane, Off Greams Road, 
Nungambakkam 60000 Chennai, India
Introduction: Laparoscopic method of cholecystectomy 
became the gold standard in a very short period since the 
advent of laparoscopic surgery 2 decades ago. Presently this 
procedure is done as a day surgery safely in a majority of 
centers around the world. In India it is rather diffi cult to 
convince patients to consent for a day care laparoscopic 
cholecystectomy as this is not considered a minor surgical 
procedure. We present our experience with this option in a 
tertiary care hospital in southern India.
Methods: Between December 2010 and December 2011 we 
performed 62 day care laparoscopic cholecystectomy proce-
dures. Apart for 5 patients with acute cholecystitis all others 
are with no acute infl ammation. Age ranged from 16–56 
years. There were 48 women and 14 men. We carefully 
avoided patients with co-morbidities like cardiac dysfunction 
or COPD. Well controlled diabetes mellitus, hypertension 
and thyroid dysfunction were not considered a contra-
indication. These patients are taken up for laparoscopic 
cholecystectomy under a general anesthetic in the morning 
hours. This procedure is performed by the standard 4 port 
technique. For post op analgesia we used US guided inter-
costal nerve block which worked very well.
Results: All the 62 procedures could be performed without 
any diffi culty. Three patient had an additional procedure in 
the form of ovarian cystectomy and appendectomy. No pro-
cedure was converted to open surgery. There was no instance 
of uncontrolled intra-operative bleeding or any bile leak. No 
abdominal drain was inserted in any of them. They were 
discharged from the hospital about 6–8 hours after surgery. 
No patient had to stay overnight in the hospital and none of 
them were re-admitted. They were reviewed in the out 
patient department the following day. None of them had any 
issues in the follow-up period. Control of pain and post-
operative nausea was excellent. patient satisfaction levels 
were very good.
Conclusion: With proper selection of cases, day-care lapar-
oscopic cholecystectomy is a safe procedure. Proper surgical 
technique, adequate control of nausea and pain in the post-
operative period and proper pre-operative counselling helps 
in achieving good results. In developing countries where 
availability of hospital beds is a premium, day care laparo-
scopic cholecystectomy is a very possible and feasible 
option.
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HAEMATOCRIT LEVEL DECREASE 
AFTER LAPAROSCOPIC 
CHOLECYSTECTOMY. A 
PERSPECTIVE STUDY
I. Gerogiannis1, A. Kambaroudis1, P. Petras1, A. Milonas2 
and T. Gerasimidis1
15th Department of Surgery, Medical School, Aristotle 
University of Thessaloniki, Hippokratio Hospital, 
Thessaloniki, Greece; 2Anaesthesiology Department, 
Hippokratio Hospital, Thessaloniki, Greece
Medical School, Aristotle University of Thessaloniki, 
Hippokratio Hospital, Thessaloniki, Greece, 5th 
Department of Surgery, Hippokratio Hospital of 
Thessaloniki, Konstantinoupoleos Street, 54642 
Thessaloniki, Greece
Introduction: Laparoscopic cholecystectomy (LC) is the 
treatment of choice for symptomatic cholelithiasis. 
Nonetheless, in most of cases postoperatively (postop), there 
is an unusual decrease of haematocrit (Hct) level combined 
with oligouria, without the evidence of blood loss. This often 
lead us to unnecessary postop imaging studies.
Our aim is to investigate the factors that affect patient’s 
haemodynamic condition and discuss the role of physiologi-
cal mechanisms during and after LC.
Methods: We collected data from patients who underwent 
LC for symptomatic cholelithiasis, during a 2 year period 
(2009–2011). In this study 68 (26 male) patients were included 
with a median age of 58.3 yo. The ASA score was 1–2. A 
specifi c protocol based analysis was performed after each 
patient’s admission and involved patient’s medical history, 
physical status, clinical examination and specifi c laboratory 
tests preop, 6 and 24 hours postop. Laboratory blood tests 
included Hct and haemoglobin (Hgb) values and electrolytes 
(K+, Na+). Furthermore, aldosterone levels were measured in 
patient’s plasma preop and 24 h postop. Patient’s haemody-
namic values were also recorded and included MAP, ECG 
and fl uid balance estimation pre-, intra- and post-op.
Results: Hct and Hgb levels decreased postoperatively in 
all patients. An average of Hct level decrease 3.27% was 
found the fi rst postoperative day. Aldosterone level values 
were also decreased (average value: 4.43 pg/dl) postop. 
Furthermore, urine output, postoperatively, was low or zero.
Conclusion: The decrease of Hct level postop, in patients 
who underwent a LC, is due to many factors. If blood loss 
incidence is excluded, changes in aldosterone plasma level 
follow changes of intravascular volume (IVV). Major causes 
of increased IVV are administration of crystalloid fl uids and 
haemodynamic changes including renal function due to 
pneumoperitoneum. Understanding these mechanisms and 
combined with absence of clinical signs of haemorrhage, we 
can avoid unnecessary postop imaging studies.
778
INITIAL REPORT OF THE 
HEPATOBILIARY ACTIVITY, IN THE 
UNIVERSITY HOSPITAL OF IOANNINA, 
NORTH WEST GREECE
G. Glantzounis1, H. Harisis1, M. Mitsis1, G. Georgiou1, 
P. Nicolopoulos2, G. Papadopoulos3, C. Katsios1 and 
M. Fatouros1
1Department Of Surgery, University Hospital Of Ioannina, 
Greece; 2Department Of Radiology, University Hospital Of 
Ioannina, Greece; 3Department Of Anesthesiology, 
University Hospital Of Ioannina, Greece
University Hospital of Ioannina University, Department of 
Surgerymedical School, University of Ioannina, 
Department of Surgery, 45110 Ioannina, Greece
Introduction: Surgical management of the primary and 
metastatic tumours of the hepato-biliary tract has improved 
signifi cantly over the last years and the indications are con-
tinuously extended. The aim of this study is to present our 
early experience with the management of patients with hepa-
tobiliary tumours in North West Greece.
Methods: During the period October 2009 – November 
2011, 38 patients with hepatic or bilary tract tumours 
underwent intervention. The median age was 65 years 
(range, 33–80 years). 25 patients underwent liver resec-
tion (3 hepatocellular carcinomas (HCCs), 5 intrahepatic 
cholangiocarcinomas, 1 gallbladder carcinoma, 4 hilar 
cholangiocarcinomas, 10 metastatic tumours, 2 benign 
lesions). 3 patients with unresectable tumours underwent 
radiofrequency ablation through laparotomy and 10 
patients with inoperable HCCs underwent hepatic artery 
chemoembolization.
Results: Patients with resectable liver tumours underwent 
11 major liver resections and 14 minor resections. The 
median hospital stay was 10 days (range, 5–35 days). There 
was no postoperative mortality and the morbidity was 36%. 
R0 resection was achieved in 24 of the 25 hepatectomies. 
There was no postoperative morbidity or mortality for 
the patients who underwent RFA or transarterial 
chemoembolization.
Conclusion: Our early postoperative results in the manage-
ment of patients with hepatobiliary tumours are comparable 
with the results in the literature and this encourages us to 
continue the HPB activity. It seems that there is a high pro-
portion of carcinomas of the biliary tree, in North West 
Greece, (especially intrahepatic cholangiocarcinomas), 
fi nding which requires further investigation.
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GALLBLADDER PERFORATIONS 
SUCCESSFULLY MANAGED WITHOUT 
EMERGENCY CHOLECYSTECTOMY
C. H. Tan1, S. W. K. Mak1, J. Su2 and Y. L. Cheah1
1Khoo Teck Puat Hospital, Singapore; 2National University 
of Singapore
Khoo Teck Puat Hospital, General Surgery, 90 Yishun 
Central, Singapore 7688280, Singapore
Introduction: Gallbladder perforation is a rare complica-
tion of acute cholecystitis. Due to it’s high mortality and 
morbidity, prompt surgical intervention is the standard of 
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care for perforated gallbladders. We review our experience 
of gallbladder perforations successfully managed without 
emergency cholecystectomy.
Methods: 14 consecutive patients were diagnosed with gall-
bladder perforation on radiological imaging or intra-
operative fi ndings from July 2010 to Dec 2011 in a single 
institution. Mean follow up was 3.5 months. Patient demo-
graphics, clinical presentation, radiological fi ndings, opera-
tive data, length of hospital stay, morbidity and mortality 
rates were analyzed retrospectively. Gallbladder perforations 
were divided into 3 types using Neimeier’s classifi cation 
system.
Results: 11 males and 3 females with a mean of age 67 years 
had gallbladder perforation. 1 patient was excluded from 
analysis as his gallbladder perforated due to carcinoma. 
Majority of patients presented with abdominal pain, fever 
and had raised white cell counts (92%) and deranged liver 
function tests (69%). 9 patients required emergency chole-
cystectomy with a post-op morbidity rate of 11% and no 
mortality. 4 remaining patients were managed without emer-
gency cholecystectomy: all received IV antibiotics; 2 under-
went interval elective cholecystectomy, 1 had a percutaneous 
cholecystostomy tube insertion, and 1 underwent ERCP for 
a CBD stone retrieval. These 4 patients had type 2 perfora-
tions with no morbidity and mortality from conservative 
treatment.
Conclusion: Early diagnosis, recognition and emergency 
surgical intervention are of crucial importance in the treat-
ment of perforations of gallbladder. There may, however, be 
a select group of patients who can be treated successfully 
without emergency cholecystectomy.
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GALLBLADDER CANCER AND 
MIRIZZI SYNDROME IN SITUS 
INVERSUS VISCERUM
L. Cioffi , A. Belli, P. Limongelli, G. Russo, A. D’Agostino, 
C. Fantini, G. Belli
Department of General and Hepato-Pancreato-Biliary
Surgery S.M. Loreto Nuovo Hospital, Naples, Italy
Introduction: Situs inversus viscerum (SI) is a rare condi-
tion, occurring in 1 : 5000–1 : 10000 hospital admission. 
Herein we report technical and iconographic features of a 
case of a 76- year-old female with total SI and intraoperative 
diagnosis of gallbladder cancer (GBC) associated with 
Mirizzi syndrome (MS).
Methods: A 76-year-old female was admitted in our Unit 
with jaundice and hemobilia. Enhanced computed tomogra-
phy of the abdomen was suggestive for acute cholecystitis 
with a big stone between biliary tract and gallbladder as in 
Mirizzi syndrome. Serum levels of Ca 19.9 were in normal 
range despite presence of jaundice. Under the impression of 
a complicated infl ammatory disease of biliary tract patient 
underwent a laparotomy. During intervention a mass was 
palpated between gallbladder and loggia hepatis.
Results: Surgical resection en bloc of gallbladder, IVb-V 
segments of the liver, extrahepatic bile duct with a dissection 
of regional lymph nodes, was performed with intention to 
treat a GBC infi ltrating liver. Before biliary reconstruction 
by Roux-en-Y hepaticojejunostomy, intrahepatic biliary 
washing was performed to remove biliary magma. Histologic 
fi ndings reported a poorly differentiated gallbladder cholan-
giocarcinoma T1bN1, with infl ammatory cholecystocholedo-
cal fi stula. Postoperative course was uncomplicated.
Conclusion: Patients with SI present with a mirror image of 
their abdominal anatomy. Special care must be exercised to 
identify the presence of several associated anatomic abnor-
malities, such as a midline gallbladder or liver, rotational 
abnormalities of the small and large intestine, interruption of 
the inferior vena cava or ipsilateral location of the aorta and 
IVC. Despite the rarity of SI, in these patients hepatic resec-
tion with reconstruction of biliary tract can be safely and 
successfully performed.
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A CONTRIBUTION TO THE STUDY OF 
SUPRADUODENAL HUMAN 
CHOLEDOCHAL ELASTIC SYSTEM: 
NORMAL AND WITH LITHIASIS
F. Waechter1, J. Sampaio2, U. Teixeira3, T. Passarin4, 
P. Fontes5, M., N.6, L. Pereira-Lima7 and J. Diedrich8
1Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS – Brazil; 2Professor of 
Surgery, Universidade Federal de Ciências da Saúde de 
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Surgery Resident, Universidade Federal de Ciências da 
Saúde de Porto Alegre, RS – Brazil; 4Hepato-Pancreato-
Biliary Surgery Resident, Universidade Federal de 
Ciências da Saúde de Porto Alegre, RS – Brazil; 
5Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS – Brazil; 6Professor of 
Surgery, Universidade Federal de Ciências da Saúde de 
Porto Alegre, RS – Brazil; 7Professor of Surgery, 
Universidade Federal de Ciências da Saúde de Porto 
Alegre, RS – Brazil; 8Surgery Resident, Universidade 
Federal de Ciências da Saúde de Porto Alegre, RS – Brazil
Universidade Federal de Ciências da Saúde de Porto 
Alegre, Hepato-Pancreato-Biliary Surgery, Rua Sarmento 
Leite, 245. Zipcode: 90050-170, 90050 Porto Alegre, 
Brazil
Introduction: Several studies about the histology of differ-
ent vital organs and components of the human body have 
been conducted over the years. Among these, the histology 
of the choledocal wall was detailed in both normal and patho-
logical conformation. However, literature lacks specifi c work 
about the choledocal elastic system wall. So, we aimed to 
identify the elastic system of the human supraduodenal 
common bile duct, as well as to evaluate possible structural 
changes in the presence of choledocholithiasis.
Methods: Biopsies of normal and dilated common bile 
ducts were performed, which were stained by selective tech-
niques for elastic fi bers, and specifi c technique for collagen 
fi bers, in addition to the classic hematoxylin-eosin staining.
Results: The study revealed the presence of constant histo-
logical pattern and the existence of a well-marked elastic 
system in normal common bile duct wall. In choledocholithi-
asis, we observe structural changes of chronic infl ammatory 
nature, as well as hyperplasia of the elastic system and its 
neoformation in areas previously devoid of fi bers of this 
system.
Conclusion: The normal human supraduodenal common 
bile duct has a well-marked elastic system; there is hyper-
plasia of this system in choledocholithiasis; and the elastic 
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fi brosis is not isolated, being accompanied by types I and III 
collagen fi brosis.
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LONG-TERM RESULTS OF 
LAPAROSCOPIC TRANSCYSTIC 
COMMON BILE DUCT EXPLORATION
C. ORourke1, E. Sieling2 and N. ORourke3
1University of Queensland, Brisbane, Australia; 2Hospital 
Italiano de Buenos Aires, Buenos Aires, Argentina; 3Royal 
Brisbane Hospital, Brisbane, Australia
University of Queensland, 79 Outlook Crescent Bardon 
4065 Brisbane, Australia
Introduction: The aim of this paper was to evaluate the 
long-term results of Laparoscopic Transcystic Common Bile 
Duct Exploration (LTCBDE).
Methods: 124 consecutive private patients of one surgeon 
(NO’R) undergoing this procedure over 14 years were 
enrolled in this study. The presenting author (CO’R) 
attempted to contact all patients.
Results: 109 patients were able to be contacted. Of these 
109, 73 were females with an age range of 16–88, with a 
mean of 49. Mean follow up was 5 years. Of these 109 
patients, 13 underwent a planned ERCP within 5 days of 
LTCBDE. Of the remaining 96 who underwent LTCBDE 
alone, the length of hospital stay ranged from 0 to 28 days, 
with a median of one day. After discharge, one patient devel-
oped transient pancreatitis on day three and no intervention 
was required. Two patients of the 93 had had documented 
episodes of pain requiring ERCP, sphincterotomy and 
common bile duct stone clearance, one at 6 months and one 
at 12 months following the initial LTCBDE.
Conclusion: When deemed successful at time of surgery, 
LTCBDE alone has excellent long-term results with apparent 
successful stone clearance of 98% (94 from 96) in this group.
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POST CHOLECYSTECTOMY BILIARY 
STRICTURE: OUR EXPERIENCE IN A 
SINGLE SURGICAL UNIT
P. Puneet, D. Kumar, S. Singh, S. Tiwary and A. Khanna
Department of Surgery, Institute of Medical Sciences, 
Banaras Hindu University, Varanasi-221005, India
Institute of Medical Sciences, Banaras Hindu University, 
Varanasi-221005, India, Department of Surgery, 
Department of Surgery, Institute of Medical Sciences, 
Banaras Hindu University, Varanasi-221005, India
Introduction: Benign biliary strictures commonly occur 
after cholecystectomy and are challenging condition. Studies 
show incidence following lap cholecystectomy 0.2–0.7% 
and open cholecystectomy 0.1–02%.
Methods: It is a retrospective study includes 43 patients 
with post cholecystectomy biliary stricture. Demographic, 
clinical, radiological and operative data were collected from 
hospital record from august 2006 to august 2011 and ana-
lyzed. All cases were referred from other hospital with 
history of cholecystectomy done outside. The mean age of 
the patients was 40.8 years with male: female ratio of 1 : 4. 
The mean duration of symptoms was 6 months. The present-
ing symptoms included recurrent jaundice (79%), pain 
abdomen (65%), itching (48%).
Results: Common clinical fi ndings included icterus (91%), 
abdominal tenderness (46%), ascites (5%). Out of all cases 
of biliary stricture, 77% had open cholecystectomy while 
23% had laparoscopic cholecystectomy in the past. Median 
time taken from cholecystectomy to clinical presentation was 
3 months (range: 0.6–60 months). Most common form of 
biliary stricture was type II (44%) followed by type I (25%), 
type III (21%), type IV (12%) [Bismuth- Corlette classifi ca-
tion]. Roux-en-Y hepaticojejunostomy was done in 36 
patients while ERCP and stenting in 7 patients. Follow up of 
4 month–5 year were done based on clinical and biochemical 
parameters. Outcomes were graded as per categories defi ned 
by Mc Donald et al. Grade A (84%) followed by grade B 
(12%).
Conclusion: Good outcome with minimal morbidity and 
mortality can be achieved in the subgroup of benign biliary 
strictures managed in dedicated unit with expert HPB sur-
geons and follow-up.
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PERCUTANEOUS MANAGEMENT OF 
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1Department of Surgical Gastroenterology, Asian Institute 
of Gastroenterology, Hyderabad, India; 2Department of 
Interventional Radiology, ASIAN institute of 
Gastroenterology, Hyderabad, India; 3Department of 
Medical Gastroenterology, Asian Institute of 
Gastroenterology, Hyderabad, India
Asian Institute of Gastroenterology, Dept of GI Surgery, 
6-3-661, Somajiguda, Sangeeth Nagar 50082 Hyderabad, 
India
Introduction: Benign HJ strictures are a diffi cult clinical 
scenario to manage. The results of revision surgery deterio-
rate with each attempt. Percutaneous transhepatic biliary 
drainage (PTBD) is a minimally invasive procedure, done 
for benign HJ strictures. In this study, the effectiveness and 
safety of this technique was evaluated.
Methods: Between March 2007 to December 2011, 44 
patients with benign HJ strictures underwent PTBD. Average 
age was 39 years (15–92), with 20 males, and 24 females. 
HJ was for post cholecystectomy biliary injury in 37 patients, 
for post choledochal cyst excision in 5, and post CBD exci-
sion in 2 patients. Sequential balloon dilatation was done 
from 10 to 18 mm, followed by placement and upgradation 
of the catheter every 3 months, till the end of 1 year, when 
the catheter was removed, after confi rming free fl ow of 
contrast across the anastomosis. 20 patients had PTBD on 
the right, 9 on the left, and 13 patients had bilateral PTBD. 
Segment 3 and segment 8 were the preferred segments.
Results: Technical success for transhepatic cannulation and 
negotiation of the stricture was 95% (42/44). On an average 
4 exchanges were required before catheter removal which 
could be achieved in 32 patients (76%) at the end of their 1 
year. The average time for PTBD removal was 360 days. 
Average f/up was 27 months and longest f/up was 56 months. 
One patient underwent revision HJ as he was unwilling for 
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a long term catheter. Remaining 10 (24%) patients are in 
various stages of follow up. Pain was signifi cant in 9 (22%), 
transient bleeding in 4 (10%) patients. There was no 30 day 
mortality, 1 patient died 3 months post intervention due to 
cardiac cause. 1 patient had recurrent stricture after 15 
months of 1 year treatment.
Conclusion: Thus 39/42 (93%) patients could be managed 
successfully by percutaneous technique. Post HJ strictures 
can be effectively managed with PTBD and balloon dilata-
tion. It has minimal morbidity and no mortality, and should 
be the fi rst line of management in benign post HJ 
strictures.
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DIFFICULT LAPAROSCOPIC 
CHOLECYSTECTOMY: CURRENT 
EVIDENCE AND STRATEGIES 
OF MANAGEMENT
M. A. Uzun2, E. Altinli1, E. Eroglu3, A. S. Senger4, 
A. Sumer5, A. Celik6, R. Kurt7 and O. Yucel8
1Asc. Prof. Dr. of General Surgery; 2Asc. Prof. Dr. of 
General Surgery; 3General Surgeon; 4General Surgeon; 
5Assis. Prof. Dr. of General Surgery; 6General Surgeon; 
7General Surgeon; 8Asc. Prof. Dr. of General Surgery
Haydarpasa Numune Training and Research Hospital, 2nd 
General Surgery Unit, Hamidiye Mahallesi Gürbüz Sok. 
No:118/12, Cekmekoy 34782 Istanbul, Turkey
Introduction: Laparoscopic cholecystectomy is the treat-
ment of choice for gall bladder stone disease. Diffi cult chole-
cystectomy is associated with serious complications and a 
high conversion rate. The aim of this study was to review the 
current strategies to manage diffi cult cholecystectomy.
Methods: A retrospective search was conducted to review 
all diffi cult laparoscopic cholecystectomy through 2010 to 
2012 in our unit. 284 patients were included in this study. 
Frozen triangle of Callot, fi brotic and contracted gallbladder, 
previous abdominal operations, morbid obesity, gallbladder 
gangrene, acute cholecystitis, gallbladder empyema, Mirizzi 
syndrome, liver cirrhosis, cholecystogastric and choledo-
choduodenal fi stula formation presentations are equivocal 
for diffi cult laparoscopic cholecystectomy.
Results: 41 cases were defi ned as diffi cult laparoscopic 
cholecystectomy. 21 cases had previous abdominal opera-
tions as; 5 cases had Graham patch for peptic ulcer perfora-
tion, 6 had umbilical mesh hernia repair, 6 had TAH-BSO, 2 
had small bowel surgery for benign reasons, and 2 had BTV 
plus a kind of stomach resection. 7 patients had BMI > 40, 
6 cases had contracted and fi brotic gallbladder and 3 cases 
had Mirizzi syndrome. 3 cases had liver cirrhosis and 1 case 
had gallbladder cancer. Laparoscopy was abandoned in only 
4 cases and open procedure was done due to two Mirizzi 
syndrome, two acute cholecystitis with bile leakage and 
massive cystic artery hemorrhage. All patients with previous 
abdominal operations and morbid obesity were successfully 
opera.
Conclusion: No consensus is found among surgeons on 
how to manage diffi cult laparoscopic cholecystectomy. 
Iatrogenic injuries and conversion rate can be reduced 
depending on the surgeon’s experience. Subtotal cholecys-
tectomy, antegrade or fundus fi rst techniques, and periopera-
tive cholangiogram may reduced the complications and 
conversion rate.
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DUODENUM PRESERVING PANCREATIC 
HEAD RESECTION IN SOLID 
PSEUDOPAPILLARY TUMOR
J. H. Lee1, H. W. Kim1, S. H. Kim1, J. H. Lim1, 
H. K. Kim2, J. B. Chung3 and K. S. Kim1
1Dept. of Surgery, Severance Hospital, Yonsei University 
College of Medicine; 2Dept. of pathology, Severance 
Hospital, Yonsei University College of Medicine; 3Dept. of 
Internal Medicine, Severance Hospital, Yonsei University 
College of Medicine
Severance Hospital, Yonsei University College of Medicine, 
Surgery, 50 Yonsei Ro Seodaemoon Ku 12075 Seoul, Korea
Introduction: Solid pseudopapillary tumor (SPT) is a rare 
primary neoplasm of the pancreas with low-grade malignant 
potential. Classifi ed by the World Health Organization in 
2010, SPT even with angioinvasion, perineural invasion, or 
deep invasion of the surrounding acinar tissue do not indicate 
an accelerated malignant behavior.
Methods: The treatment is a complete surgical resection 
including adjacent organs and areas of metastasis if possible. 
Literature review shows patients may still experience long-
term survival despite metastasis or locally advanced disease.
Results: A 26-year-old female was admitted with a 10 cm 
cystic and solid mass in the pancreatic head. In the operating 
room, a well capsulated cystic lesion was observed without 
adjacent organ invasion or reactive lymph nodes. A duode-
num-preserving pancreatic head resection (DPPHR) was 
performed. On pathology review, a SPT was confi rmed with 
less than 5% of cytologic atypia and atypical mitosis. Upon 
immunohistochemical staining, β-catenin was found to be 
positive for nuclear pattern. Due to the low-grade malignant 
potential, quality of life should not be overlooked. In DPPHR, 
the duodenum is preserved; it is signifi cantly more protective 
of pancreatic exocrine and endocrine functions compared 
with a Whipple or a pylorus-preserving resection.
Conclusion: Currently, the major application of DPPHR is 
in patients with chronic pancreatitis or cystic neoplasms, 
mainly intraductal papillary mucinous neoplasm or muci-
nous cystic neoplasm. DPPHR is not readily performed in 
patients with SPT due to its rare occurrence, however it 
as an alternative surgical method. Preoperative prediction 
of malignancy is imperative prior to surgical method 
selection.
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PRIMARY DUCT CLOSURE AFTER 
LAPAROSCOPIC BILE DUCT 
EXPLORATION FOR 
CHOLEDOCHOLITHIASIS IS A SAFE 
AND EFFECTIVE APPROACH
Y. Khaled, D. Malde, C. De Suza, A. Kalia and B. Ammori
The University of Manchester and the Department of 
Hepato-Pancreato-Biliary Surgery, North Manchester 
General Hospital, Delaunays Road, Crumpsall, 
Manchester, M8 5RB, UK
North Manchester General Hospital, Department of 
Hepato-Pancreato-Biliary Surgery, Delaunays Road, 
Crumpsall, M85RB Manchester, UK
Introduction: The common bile duct is traditionally 
managed with T-tube drainage after choledochotomy and 
removal of common bile duct (CBD) stones, but this approach 
carries an associated tube-related morbidity rate, including 
bile leak, of 10.5–20%. This study examines the safety and 
effectiveness of laparoscopic CBD exploration (LCBDE) 
followed by primary duct closure.
Methods: This is a retrospective analysis of 88 consecutive 
patients (26 male) undergoing LCBDE between October 
2002 and December 2011. The duct was primarily closed in 
all patients. The results shown represent the median (range).
Results: All procedures were completed laparoscopically. 
Transcystic exploration was employed in 12 patients. The 
biliary tree was clear at the end of exploration with no sub-
sequent evidence of missed stones in 86 patients (97.7%). 
The operating time was 120 (22–395) minutes. Four patients 
(4.5%) had bile leak and were managed successfully with 
re-laparoscopy (n = 3) and conservatively (n = 1). The mor-
bidity rate was 8%. There were no operative deaths, and the 
postoperative hospital stay was 1 (0–51) day. At a follow up 
of 50.7 (48–82) months, 92.1% of patients had no biliary 
symptoms, one underwent endoscopic extraction of a retained 
stone, another had endoscopic balloon dilatation of bile duct 
stricture, and four patients were lost to follow up.
Conclusion: Primary duct closure following LCBDE is 
safe, and can be employed as an alternative to T-tube inser-
tion with short hospital stay and lower morbidity rate.
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GASTRODUODENOPANCREATECTOMY 
FOR NEOPLASM OF THE AMPULLA OF 
VATER: ADJUVANTTREATMENT – IS 
THERE A REAL BENEFIT?
F. Waechter1, U. Teixeira2, J. Sampaio3, L. Pereira-Lima4, 
P. Fontes5, M. Nectoux6, T. Passarin7 and J. Diedrich8
1Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS – Brazil; 2Hepato-
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Universidade Federal de Ciências da Saúde de Porto 
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Leite, 245, ZipCode: 90050-17090050, Porto Alegre, Brazil
Introduction: Assessing the impact of adjuvant chemo-
radiotherapy on survival of patients undergoing gastroduo-
denopancreatectomy (DPT) for cancer of the ampulla of 
Vater.
Methods: Retrospective analysis of a series of patients 
undergoing DPT for adenocarcinoma of the duodenal papilla 
in our institution between 1999 and 2008.
Results: So far, 24 patients were analyzed. The mortality at 
30 days was null. 12.5% underwent adjuvant treatment, with 
median survival of 27.66 months. 87.5% had surgery as an 
exclusive treatment, with median survival of 51.09 months. 
The longest survival reported to date is 10 years.
Conclusion: Through analysis of this group, adjuvant treat-
ment seems to affect the outcome of these patients, because 
the median survival in the adjuvant treatment group was 
lesser than in the no adjuvant therapy group.
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ELECTIVE CHOLECYSTECTOMY: 
IS THERE A WAY TO PREDICT 
ASYMPTOMATIC 
CHOLEDOCHOLITHIASIS?
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Introduction: Several criteria have been suggested for pre-
dicting choledocholithiasis in patients undergoing elective 
cholecystectomy (EC). Among these, we can mention the 
echographic changes, the liver function tests (LFT) and total 
bilirubin (TB), alkaline phosphatase (ALP), alanine ami-
notransferase (ALT), aspartate aminotransferase (AST) and 
gamma-glutamyl transpeptidase (GGT). Objective: To study 
the value of the above indicators as a way to predict choledo-
colithiasis in patients undergoing EC.
Methods: A prospective analysis of 2228 patients that 
underwent EC between May 1996 and December 2008 by 
the same team of Digestive Tract Surgery. All patients were 
included in a specifi c protocol of our service. Intraoperative 
cholangiography was performed in 1835 patients, and this 
was considered the gold standard in the diagnosis of choledo-
cholithiasis. Changes in pre-operative tests were compared 
to cholangiography.
Results: Unexpected choledocholithiasis was found in 120 
(5.38%) patients. The sensitivity, specifi city, positive predic-
tive value and negative predictive value, respectively, for 
each preoperative indicator was: ALT (26.7%, 95.2%, 24%, 
95.8%), AST (35.8%, 82.6%, 10.5%, 95.8%), alkaline phos-
phatase (40%, 93%, 24.2%, 96.5%), GGT (34%, 89%, 15%, 
96%), BT (38.3%, 94.6%, 28.8%, 96.4%), abdominal ultra-
sound suggesting choledocholithiasis (26.7%, 95%, 24%, 
95.8%).
Conclusion: Both total abdominal ultrasound and labora-
tory tests have no validity and are not cost-effective in the 
preoperative evaluation of these patients in order to detect 
choledocholithiasis.
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SINGLE INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY AND 
CHOLEDOTHOLITHOTOMY WITH 
PRIMARY CLOSURE OF THE CBD IN 
PATIENTS WITH GB AND CBD STONE
K.-H. Kim1, C.-H. An1, Y.-K. You2, J.-S. Kim1, I.-Y. Park3 
and D.-G. Kim2
1Uijeongbu St. Mary’s Hospital, The Catholic University of 
Korea; 2Seoul St. Mary’s Hospital, The Catholic University 
of Korea; 3Bucheon St. Mary’s Hospital, The Catholic 
University of Korea
Uijeongbu St. Mary’s Hospital, The Catholic University of 
Korea, Surgery, #65-1, Gumo-dong 48071 Uijeongbu, 
Republic of Korea
Introduction: Traditionally, the CBD is closed with T-tube 
drainage after choledochotomy and removal of CBD stones. 
Surgeons have tried to minimize the scars and reduce the port 
sites and achieve this. We believe that primary closure can 
be as safe as closure with T-tube drainage. We reviewed the 
our experiences to demonstrate the safety and feasibility of 
primary closure of the CBD after laparoscopic choledochot-
omy in patients with CBD stones using single port access.
Methods: Between November 2011 and December 2011, 4 
patients underwent single incision laparoscopic cholecystec-
tomy and choledocholithotomy with needle scopic infundib-
ular retraction for gallbladder disease in single institute by 
one surgeon, Uijeongbu St. Mary’s hospital. 4 patients with 
a mean age 64.5 years (range 42 to 76) were identifi ed. We 
used a SILS (Covidien, Tyco health Medical) single-port 
device for operation. Single port device was placed through 
umbilicus. A (2 mm) needlescopic retractor (Stryker, San 
Jose, CA) was placed in the right fl ank region directly 
through the abdominal wall for retraction of the gallbladder 
infundibulum in an anterior and cephalad direction. And 
snake retractor was used for liver retraction.
Results: Patient all had a pathologic diagnosis of acute gan-
grenous and chronic cholecystitis. ASA class averaged 1.75 
(range 1 to 2). Operative times averaged 267.5 minutes 
(range 143 to 365 minutes). Postoperative hospital stays 
averaged 5.5 days. There were no instances of bile leak, soft 
tissue infection, abscess, hernia or bile duct injury.
Conclusion: Single incision cholecystectomy and choledo-
cholithotomy with primary closure of the CBD is safe and 
feasible for acute and chronic cholecystitis even in suppura-
tive cholecystitis. Liver retraction using a snake retractor is 
very useful in obtaining a critical view of safety.
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BILIARY PERITONITIS AS A RESULT OF 
RUPTURE OF DISTENDED 
INTRAHEPATIC BILE DUCTS DUE TO 
LEFT HEPATIC DUCT 
CHOLANGIOCARCINOMA. REPORT OF 
A RARE CASE
G. Glantzounis1, G. Lianos1, G. Georgiou1, A. Tsili2, 
R. Doumos1, C. Tsitsipanis1, V. Tatsis1 and M. Fatouros1
1Department Of Surgery, University Hospital Of Ioannina, 
Ioannina, Greece; 2Department Of Radiology, University 
Hospital Of Ioannina, Ioannina, Greece
Introduction: Spontaneous biliary peritonitis is an unusual 
cause of acute epigastric pain. We report the case of a patient 
who presented with the clinical picture of acute abdomen, as 
a result of intraperitoneal rupture of subcapsular intrahepatic 
bile ducts of the left liver lobe, caused by an obstructive 
cholangiocarcinoma in the left main bile duct.
Methods: A 79-year-old female patient presented to another 
hospital due to acute epigastric pain. Abdominal U/S and CT 
scan showed a mass in the left liver lobe and dilated left 
intrahepatic biliary tree; fi ndings suggestive of an intrahe-
patic cholangiocarcinoma. The patient was referred to our 
hospital for further investigation and treatment. Abdominal 
MRI/MRCP showed a liver lesion of 53 mm in diameter in 
segment IV and a second lesion (8 mm) which was obstruct-
ing the left hepatic duct. It showed also a large localized fl uid 
collection in the upper abdomen. which was drained percu-
taneously under CT guidance. Biochemical analysis of the 
greenish fl uid showed to be pure bile. An ERCP was 
attempted with no success and a laparotomy was decided.
Results: During laparotomy, a small tumor (<10 mm) was 
found which was caused complete obstruction of the left 
hepatic duct and located 10 mm above its confl uence with 
the right duct. It caused dilatation and rupture of the subcup-
sular bile vessels of segment III. Along with these, a large 
tumour (5 cm) was found in segment IVb. A typical left 
hepatectomy was performed. Histological examination 
showed a left hepatic duct cholangiocarcinoma expanding 
along the course of the intrahepatic bile duct and causing also 
a intrahepatic left liver lobe cholangiocarcinoma. Resection 
margins were free of tumour (R0 resection). The patient 4 
months after the operation is in good health, disease free.
Conclusion: Biliary peritonitis due to rupture of dilated int-
rahepatic bile ducts from an obstructive cholangiocarcinoma 
of the left main duct is an extremely rare entity. Good diag-
nostic work-up, drainage of collection, improvement of 
patient’s general condition and aggressive surgery are impor-
tant steps for the effective management of such complicated 
cases.
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THE SURVIVAL OUTCOME AND 
PROGNOSTIC FACTORS FOR 
GALLBLADDER CANCER FOLLOWING 
R0 OR R1 SURGICAL RESECTION
J. H. Lim, S. H. Kim, S. W. Park, G. H. Choi, J. S. Choi, 
W. J. Lee, K. S. Kim and B. R. Kim
Deparment of Surgery & Department of Internal Medicine, 
Severance Hospital, Yonsei University College of Medicine, 
250 Seongsnano, Seodaemon-Ku, Seoul, Korea
Introduction: The prognosis of gallbladder cancer is 
dismal. Recently an aggressive surgical resection for gall-
bladder cancer has been widely accepted. The objective of 
this study was to analyze the survival outcome and the clin-
icopathologic factors that infl uence survival and recurrence 
of gallbladder cancer after R0 or R1 resection.
Methods: From January 200 to June 2011, 92 patients 
underwent R0 or R1 resection for gallbladder cancer. The 
clinicopathological characteristics and survival outcomes 
were reviewed retrospectively.
Results: Of the 92 patients, 71 patients (77.2%) underwent 
R0 resection for gallbladder cancer, and 21 patients (22.8%) 
underwent R1 resection. Overall survival rates were 86.6% 
at 1 year, 65.8% at 3 years and 60.2% at 5 years. Above T3 
status, N2 stage of Lymph node metastasis, lymphovascular 
invasion were signifi cant independent predictors of poor 
prognosis by multivariate analysis. Recurrence occurred in 
26 patients (28.2%). Disease-free survival rates were 79.4% 
at 1 year, 69.8% at 3 year and 66.1% at 5 years. Above T3 
status, N2 stage of lymph node metastasis were found to be 
signifi cant independent predictors of recurrence by multi-
variate analysis.
Conclusion: In patients who high tumor status, Lymphnode 
metastasis, and lymphovascular invasion after R0 or R1 
resection for Gallbladder cancer, the adjuvant therapy will 
be needed to enhance the survival.
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SURGICAL RESECTION OF HILAR 
CHOLANGIOCARCINOMA: 
EXPERIENCE FROM A 
REGIONAL CENTRE
A. Balakrishnan, S. Jamdar, N. V. Jamieson, E. L. Huguet, 
A. Jah and R. K. Praseedom
Hepatopancreaticobiliary Unit, Addenbrooke’s Hospital, 
Cambridge, United Kingdom
Addenbrooke’s Hospital, Cambridge, 
Hepatopancreaticobiliary Unit, Addenbrooke’s Hospital,
Hills Road, CB2 Cambridge, United Kingdom
Introduction: Hilar cholangiocarcinoma (HC) is a rare 
malignancy with a dismal prognosis and surgery remains the 
only option for long-term survival. We examined our experi-
ence of HC to identify factors affecting overall survival and 
recurrence-free survival following surgical resection.
Methods: The electronic hospital patient administration 
system was retrospectively interrogated to identify patients 
who underwent surgical resection of hilar cholangiocarcino-
mas (extended hemihepatectomy with or without portal vein 
excision and reconstruction) between 1995 and 2011. Patient 
records were reviewed to determine demographic data, oper-
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ative procedure, perioperative management and histological 
fi ndings in order to identify factors contributing to periopera-
tive morbidity and mortality, recurrence-free survival and 
overall survival in HC.
Results: 18 patients had surgical resection (median age 61, 
range 45–71) for HC. All resections barring one tumour in 
situ showed evidence of microvascular and perineural inva-
sion and 11 patients had either radial or cut edge positive 
margins (R1 resections). Four HCs had arisen on a back-
ground of previously undiagnosed primary sclerosing 
cholangitis noted histologically. No patients were lost to 
follow-up; median follow-up was 15 months (range 3–116). 
There was one perioperative mortality (6%). Overall median 
survival was 25 months (range 5 days to 127 months) with 
20% Kaplan-Meier 5-year survival. There was no signifi cant 
difference in the 5-year survival of patients with positive 
(R1) or negative (R0) resection margins (p = 0.45).
Conclusion: Management of HC in the form of extended 
hemihepatectomy with or without portal vein excision and 
reconstruction yielded perioperative mortality, median sur-
vival and 5-year survival rates in our unit comparable with 
that quoted in the existing literature, confi rming surgical 
resection as a safe and feasible option for the treatment of 
patients with HC. Positive microscopic resection margins did 
not infl uence overall 5-year survival.
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ROLE OF STAGING LAPAROSCOPY IN 
GALL BLADDER CANCER IN THE ERA 
OF 18F-FDG PET-CT
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Introduction: Gall bladder cancer (GBC) is an aggressive 
disease with dismal prognosis. Most patients present in 
advanced stage. Staging laparoscopy is a recommended 
modality to prevent nontherapeutic laparotomy. PET/CT 
imaging has the potential to improve preoperative staging 
and identify unresectable cases. This study was designed to 
evaluate role of staging laparoscopy in the era of FDG PET; 
whether FDG PET would be able to replace staging 
laparoscopy.
Methods: Between January 2011 and December 2011, 
patients with suspected GBC deemed resectable on MDCT, 
underwent FDG PET/CT scan. Twenty patients were staged 
using laparoscopy after excluding extra abdominal metasta-
sis on PET/CT. Ascitic fl uid, when present, was sent for 
malignant cytology. Biopsy specimens taken from perito-
neum, omentum and liver nodules suspected of metastasis 
were subjected to frozen section and histopathology. Standard 
liver resection and lymph node dissection was done for 
resectable cases. Data were prospectively collected and ana-
lyzed. PET/CT and laparoscopy were assessed for their 
ability to detect peritoneal and liver surface metastasis. Role 
of PET/CT vis-à-vis MDCT was assessed in detection of 
lymph node metastasis.
Results: In detecting surface metastases PET/CT and 
staging laparoscopy had sensitivity, specifi city and accuracy 
of 60%, 100%, 90% and of 75%, 100%, 94.7% respectively. 
When used in combination, sensitivity, specifi city and accu-
racy were 80%, 100% and 95% respectively (p = 0.001). 
PET/CT and staging laparoscopy each detected unresectable 
disease in three out of six patients (accuracy 50%). Their 
combined use detected unresectable disease in four out of six 
patients (66.6%) and prevented nontherapeutic laparotomy 
in 20% patients. MDCT accurately staged lymph nodes in 
eight (57.1%) patients (n = 14) while PET/CT was useful in 
eleven (78.6%) patients who underwent curative resection.
Conclusion: Staging laparoscopy and PET/CT have roles 
complementary to each other in the staging and management 
of GBC. PET/CT holds an edge over MDCT in detecting 
lymph node metastasis. Our small series confi rms the fact 
that FDG PET can’t be used as replacement to staging lapar-
oscopy rather it is complementary.
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INCREASE THE SURVIVAL IN 
ADVANCED GALLBLADDER CANCER?
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Introduction: In advanced gallbladder cancer, the surgical 
resection is the only treatment for cure. However, there is no 
consensus for common bile duct resection during radical 
surgery. The aims of this study were to identify predictors of 
survival and assess the necessity of common bile duct (CBD) 
resection in advanced gallbladder cancer.
Methods: We reviewed the medical records of 64 patients 
with advanced gallbladder cancer who underwent cholecys-
tectomy except R2 resection and D0 lymph node dissection 
from March 2000 through June 2011 at Severance hospital, 
Yonsei University College of Medicine, Seoul, Korea. The 
survival outcomes and clinicopathological characteristics 
were reviewed between the CBD resection group and the 
non-CBD resection group.
Results: Of the 64 patients, 34 patients (53.1%) underwent 
common bile duct resection. Overall survival rates did not 
differ signifi cantly between the CBD and non-CBD resection 
groups (at 1 year: 79% vs 88%, at 3 years: 53% vs 68% and 
at 5 years: 53% vs 58% respectively; P = 0.461). However, 
the CBD resection group had a shorter recurrence-free sur-
vival (at 1 year: 60% vs 82%, at 3 years: 58% vs 79% and 
at 5 years: 49% vs 76%: P = 0.057). The numbers of acquired 
lymph nodes, tumor invaded lymph nodes and Lymph nodes 
around hepatoduodenal ligament were more in CBD resec-
tion group. Because the pathological staging was higher (P 
= 0.02), the survival was poorer in CBD resection group.
Conclusion: Although CBD resection didn’t increase the 
survival, CBD resection may be needed for more accurate 
nodal status evaluation.
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PERIHILAR RESECTION IN THE 
TREATMENT OF HILAR 
CHOLANGIOCARCINOMA
J. H. Dong and X. C. Hong
Hospital & Institute of Hepatobiliary Surgery, Chinese 
PLA General Hospital, Beijing, China
Hepatobiliary Surgery, 28 Fu Xing Road, 10085 Bei Jing, 
China
Introduction: The hilar bile duct cancer can not only spread 
longitudinally along the biliary tree, but also vertically 
invade the bile duct and adjacent vessels and hepatic paren-
chyma. Considering the clinicopathological character of 
hilar cholangiocarcinoma, we began to use perihilar resec-
tion as our basis of radical resection for this intractable 
disease fi ve years ago. This article is to investigate the thera-
peutic effect of the Perihilar resection in the treatment of 
hilar cholangiocarcinoma.
Methods: From April, 2006 to April, 2011, 50 patients suf-
fered from hilar cholangiocarcinoma received Perihilar 
resection or combined hepatectomy in our department. The 
extent of perihilar resection includes removal of gallbladder, 
resection of extrahepatic bile duct and adjacent liver paren-
chyma and regional lymphadenectomy. As for the bile duct 
resection, the distal margin is at the upper edge of head of 
pancreas while the proximal margin is at the bifurcation of 
the second-order biliary ducts bilaterally. The parenchyma 
resection includes caudate lobectomy and the inferior area of 
segment 4 and 5, and the distance between the bile duct. If 
needed, major liver resection such as hemihepatectomy or 
reconstruction of involved vessels was added.
Results: Among the 50 patients, there were 28 males and 
22 females. With respect to Bismuth type, the number of 
Bismuth 2, Bismuth 3A Bismuth 3B, Bismuth 4 was 10, 10, 
23, 7 respectively. Perihilar resection alone was used for the 
patients of Bismuth 2; if the tumor was more advanced 
(Bismuth 3/4), major resection was combined. So the number 
of Perihilar resection alone, combined right hepatectomy, left 
hepatectomy, left trisectionectomy and right trisectionec-
tomy was 10, 10, 23, and 7 respectively. The mean operation 
time was 700 mins and the mean bleeding was 500 ml. The 
R0 resection rate was 80%, and complication rate of one 
person is 1.43. The morality in hospital is 3%. The 3-year 
survival is 42%.
Conclusion: Our preliminary result revealed that perihilar 
resection is effective and it should be the fundamental treat-
ment of hilar cholangiocarcinoma.
842
ROLE OF FDG PET/CT IN DECIDING 
RESECTABILITY IN GALL 
BLADDER CANCER
T. D. Yadav1, U. Zambare1, A. P. Maurya1, A. l.2, 
A. Bhattacharya3 and G. Singh1
1Department of General Surgery, PGIMER, Chandigarh, 
India; 2Department of Radiodiagnosis, PGIMER, 
Chandigarh, India; 3Department of Nuclear Medicine, 
PGIMER, Chandigarh, India
Post Graduate Institute of Medical Education and 
Research, Chandigarh, India, Department of General 
Surgery, H. No. 1165, Sector no. 24, 16001 Chandigarh, 
India
Introduction: Gall bladder cancer (GBC) is a rare disease 
with dismal prognosis. Most patients of gall bladder cancer 
present in advanced stage. Surgery does not offer any sur-
vival benefi t in the presence of metastasis. Preoperative 
imaging is critical. MDCT is inseparable part of preoperative 
work up. While PET/CT has a potential to change the course 
of management in many cancers, its role in GBC is being 
defi ned. This study aimed to determine role of PET/CT in 
deciding resectability of GBC.
Methods: From July 2009 to November 2011, patients sus-
pected to be suffering from GBC underwent routine work up 
including MDCT. Only those patients who were deemed 
resectable on MDCT included in the study. All such patients 
underwent F18-FDG PET/CT after ruling out diabetes mel-
litus. Patients with evidence of distant metastasis were sub-
jected to FNAC for confi rmation of the diagnosis. Data were 
prospectively collected. PET/CT assessed for determining 
malignant nature of disease and for distant metastasis. 
Results of PET/CT analyzed in comparison with MDCT.
Results: Forty patients were included in the study. Twenty 
nine (72.5%) patients explored with intent of curative resec-
tion. Resection could be completed in 24 (60%) patients. 11 
(27.5%) patients did not undergo exploration due to identi-
fi cation of distant metastasis. Diagnosis was confi rmed using 
histopathology or cytology as gold standard. In determining 
malignant nature of disease, PET-CT had sensitivity, PPV 
and accuracy of 94.1%, 91.4% and 87.5% respectively. In 
determining resectability PET-CT had sensitivity, PPV and 
accuracy of 100%, 87.5% and 87.5% respectively. PET-CT 
fi ndings resulted in change in management in 27.5% patients 
deemed resectable by standard work-up.
Conclusion: We found PET-CT to be important in detecting 
distant metastasis which is missed by conventional imaging. 
Our study proves that FDG PET-CT has an impact on the 
management of gall bladder cancer.
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A SAFE EARLY LAPAROSCOPIC 
CHOLECYSTECTOMY AFTER ERCP IN 
CHOLEDOCO-CHOLECYSTOLITHIASIS: 
A CASE REPORT
A. Nugroho and B. Philippi
Digestive Division, Department of Surgery, Faculty of 
Medicine University of Indonesia Cipto Mangunkusumo 
Hospital
Digestive Division, Department of Surgery, Faculty of 
Medicine University of Indonesia Cipto Mangunkusumo 
Hospital, Jl. Diponegoro 71, Central Jakarta, 10430 
Jakarta, Indonesia
Introduction: Laparoscopic cholecystectomy (LC) follow-
ing endoscopic retrograde cholangio-pancreaticography 
(ERCP) is a well accepted treatment strategy for cholelithi-
asis with secondary choledocholithiasis. However, the timing 
of the second procedure is usually postponed due to the 
ERCP related complication, namely pancreatitis.
Methods: We report a case of a 60-yrs old male with 
choledoco-cholecystolithiasis who had an ERCP followed by 
a LC 48 hours after the fi rst procedure. There were no sign 
of pancreatitis after ERCP and there was also no sign of 
severe infl ammation in the operative fi eld during LC. The 
patient was discharge 2 days after the surgery with minimal 
discomfort.
Results: Post-ERCP pancreatitis is frequently associated 
with an increase in serum amylase level greater then twice 
the normal limit at 3 h after ERCP with an elevation at 6 h. 
A normal amylase level consistent with a good clinical con-
dition is a good predictive marker for a safe early LC. 
Moreover, infl ammation which usually occur after 72 h 
makes the operation more diffi cult in patients who undergo 
preoperative ERCP. Early LC after ERCP is preferred than 
delayed cholecystectomy because it has low conversion rate, 
short operative time, short hospital stay and low rate of 
postoperative complications.
Conclusion: A safe early LC after ERCP is feasible in 
patients with normal amylase and a good clinical condition 
after the fi rst procedure.
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SURGICAL TREATMENT OF 
CHOLEDOCHAL CYSTS IN CHILDREN 
AND ADULTS: A SINGLE-CENTER 
EXPERIENCE IN 83 PATIENTS
Y. El-Massoudi, M. Bieze, J. Wilde, O. Busch, D. Gouma 
and T. van Gulik
Academic Medical Center, Amstedam, the Netherlands
Academic Medical Center, Department of Surgery, P.O. 
Box 22660, 1100 DD Amsterdam, 100dd Amsterdam, the 
Netherlands
Introduction: Choledochal cysts (CdC) are congenital dila-
tations of the bile ducts that are considered pre-malignant. 
Todani’s classifi cation is mostly used to characterize CdC. 
Treatment consists of complete excision of the cystic dilata-
tion with Roux-en-Y hepaticojejunostomy (HJ). For type IVa 
and V cysts excision combined with a hemihepatectomy is 
commonly advised. This study evaluates symptoms of 
patients with CdC and treatment in patients with Type IVa 
and V CdC without liver resection.
Methods: Retrospective analysis of 83 patients who had 
undergone resection of CdC from January 1973 to January 
2011 (41 children, 42 adults; 22 male, 61 female).
Results: Children presented with abdominal pain (75%), 
jaundice (63%), nausea/vomiting (39%), hepatomegaly 
(34%) and gallstones (34%). Symptoms in adults were 
abdominal pain (100%) and jaundice (17%). CdC was clas-
sifi ed as: Type I: 62 patients, Type II: 2, Type III: 2, Type 
IVa: 12 and Type V: 5 patients. All patients underwent ext-
rahepatic cyst resection including 16 patients with type IVa 
or type V CdC with no additional hemihepatectomy. Mean 
follow-up of the patients with type IVa and type V CdC was 
4.9 years (1–10 years). In these patients, no signs of tumor 
formation were detected. Postoperative morbidity was 10.8% 
among 42 adults and 4.8% in 41 children. There were two 
postoperative deaths (2.4%) in the children and adult group, 
respectively.
Conclusion: Children with CdC more often presented with 
jaundice, gallstones and hepatomegaly. Cyst excision with 
biliary reconstruction is safe treatment in children and adults. 
Malignant transformation was not found in CdC with intra-
hepatic extension (type IVa and V) treated by excision of 
only the extrahepatic component without liver resection, 
with a mean follow-time of 5 years.
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DEGREE OF LIVER INJURY IN 
OBSTRUCTIVE JAUNDICE BASED ON 
ITS MORPHOLOGIC FEATURE
A. Nugroho and T. Lalisang
Department of Surgery, Faculty of Medicine University of 
Indonesia Cipto Mangunkusumo Hospital
Digestive Division, Department of Surgery, Faculty of 
Medicine University of Indonesia Cipto Mangunkusumo 
Hospital, Jl. Diponegoro 71, Central Jakarta, 10430 
Jakarta, Indonesia
Introduction: Functional changes in severe obstructive 
jaundice are thought to be the result of changes in liver 
morphology. Attempt to quantify the degree of liver injury 
based on its morphologic feature could be benefi cial to help 
predict the course of this disease. The aim of this study was 
to investigate the changes in liver morphology in severe 
obstructive jaundice patients in order to formulate a scoring 
system to quantify the degree of liver injury in obstructive 
jaundice.
Methods: We did a descriptive study of 31 liver biopsy 
specimens taken during open biliary drainage surgery to 
relieve obstructive jaundice. The biopsy specimens stained 
with Hematoxylin Eosin were scored with the use of a scale 
previously validated in a study of the treatment of primary 
biliary cirrhosis. Liver morphology was assessed with regard 
to fi brosis, periportal infl ammation, ductal proliferations and 
cholestasis. Each of the item was graded 0 (none was 
observed) to 3 (severe). A serum total bilirubin of more than 
20 mg/dl is classifi ed as severe obstructive jaundice.
Results: There were 21 male and 10 female included in this 
study. The mean age was 49.45 ± 12.17 years old. Severe 
obstructive jaundice patients had a 66.7% moderate fi brosis, 
58.3% moderate periportal infl ammation, 66.7% severe 
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ductal proliferation, and 73.3% severe cholestasis. The mean 
total histopathology score in severe obstructive jaundice was 
higher (7.82 ± 2.298) compared to the mild-moderate 
obstructive jaundice (6.79 ± 2.607), although there were not 
statistically signifi cant.
Conclusion: Changes in liver morphology is evident in 
severe obstructive jaundice with a tendency of a higher total 
histopathology score compared to mild-moderate jaundice.
852
THE INCIDENCE OF CONCOMITANT 
VASCULAR INJURY IN IATROGENIC 
BILIARY INJURY CASES, ITS IMPACT 
ON CLINICAL PRESENTATION AND 
SHORT-TERM OUTCOME AFTER 
DEFINITIVE TREATMENT
T. P. Ramchurn, T. Yadav and R. Singh
Postgraduate Institute of Medical Education and 
Research, Ministry of Health, Royal Road, Khoyratty, 
Pamplemousses, Mauritius, Chandigarh, India
Introduction: In an era where laparoscopic cholecystec-
tomy is the standard of care for symptomatic gallstone 
disease, the entity of vascolobiliary injury cannot be over-
looked. Such complex injuries can be life-threatening and are 
very challenging to manage. The present study reports the 
incidence of concurrent biliovascular injury (BVI) cases at a 
tertiary referral centre, their presentation and management 
and evaluates their outcome after defi nitive treatment.
Methods: Between January 2009 to June 2010 (inclusive), 
all patients treated for iatrogenic biliary injuries were thor-
oughly evaluated. The biliary tree was imaged and CT angi-
ography was routinely done. The patients were managed by 
multiple modalities. All the bilioenteric anastomoses were 
done by 2 senior surgeons and a liver biopsy was always 
taken. Vascular reconstruction was not attempted in any case.
Results: The incidence of concomitant vascular injury was 
20% (6 out of 30) and 67% of these were right hepatic artery 
injuries. A signifi cant association (P < 0.05) was found 
between BVI and isolated biliary tract injury (IBTI) groups 
with regard to a fi nding of liver abscess and Atrophy/
Hypertrophy complex. In 27 cases, presentation was delayed 
by a mean of 516 days. Of the 18 patients who underwent 
defi nitive repair, 11 showed fi brosis on histopathology and 1 
showed cirrhotic features. There was a lack of infl uence of 
concurrent vascular injury over overall morbidity. At a mean 
follow-up of 11 months, the success rate was 100% in BVI 
group and 83% in the IBTI group.
Conclusion: The incidence of vascular injury is high and 
there is a delay in referal by the operating surgeon. The 
occurrence of liver abscess, Atrophy/Hypertrophy complex 
and a fi nding of fi brosis on liver biopsy were signifi cantly 
higher in BVI group. However, concomitant vascular injury 
had no signifi cant effect on short-term outcome after defi ni-
tive treatment. Continued vigilance after cholecystectomy 
and timely referal to a multispeciality centre are the key to 
successful management of biliary injuries.
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HYPERSPLENISM IN SCHISTOSOMATIC 
PORTAL HYPERTENSION
V. Resende3, A. Petroianu1 and A. E. Oliveira2
1Andy Petroianu; 2Antônio Eustáquio Oliveira; 
3Vivian Resende
Alfa Institute of Gastroenterology, Hospital of Clinics of 
the Federal University of Minas Gerais, Surgical, Rua 
Sergipe 67/24013010 Belo Horizonte, Brazil
Introduction: For many years, the hematologic changes 
occurring in hepatosplenic Manson’s schistosomiasis have 
been defi ned as hypersplenism. Initially, the belief was that 
removal of the spleen would normalize the hematologic 
values. However, hematimetric normalization was observed 
in surgeries for the treatment of portal hypertension in which 
the spleen was preserved.
Methods: For many years, the hematologic changes occur-
ring in hepatosplenic Manson’s schistosomiasis have been 
defi ned as hypersplenism. Initially, the belief was that 
removal of the spleen would normalize the hematologic 
values. However, hematimetric normalization was observed 
in surgeries for the treatment of portal hypertension in which 
the spleen was preserved. In view of these fi ndings, it is 
necessary to verify the clinical and laboratory profi le of 
these patients in order to defi ne the real presence of 
hypersplenism.
Results: In all operated groups, hematimetric values, leuko-
cyte counts, platelet number and prothrombin time were 
higher during the postoperative period. With respect to the 
immunoglobulins, the postoperative values of IgM, IgG and 
IgA were normal.
Conclusion: Patients with schistosomatic portal hyperten-
sion and peripheral cytopenia cannot be classifi ed as having 
hypersplenism, but rather as having pancytopenia due 
to splenomegaly caused by diffi culty on portal blood 
drainage.
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HAEMOSTASIA OF LIVER, SPLEEN AND 
BONE, USING ELECTROCAUTERY 
GREASED WITH LIDOCAINE GEL
V. Resende and A. Petroianu
Alfa Institute of Gastroenterology, Hospital of Clinics of 
the Federal University of Minas Gerais, Surgical, Rua 
Sergipe 67/240130130 Belo Horizonte, Brazil
Introduction: Despite the advances on surgical technique, 
the hemostasia of liver, spleen and bone continues to be a 
challenge for surgeons in trauma and major procedures on 
these organs. This communication presents a new device for 
parenchymatous hemostasia by using the electocautery 
greased with lidocaine gel.
Methods: After previous good results in experimental 
studies and approval by the ethic committee, electrocautery 
greased with lidocaine gel was used for hemostasia in 36 
procedures as follows: 6 multisegmental hepatectomies to 
remove hepatic tumors, 10 partial hepatectomies to perform 
hepatojejunostomy in presence of intrahepatic biliary 
obstruction, and 4 laparoscopic liver biopsies; 8 subtotal 
splenectomies (portal hypertension – 5 cases, splenic 
ischemia – 2 laparoscopic cases and Gaucher’s disease – 1 
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case) and 1 laparoscopic splenic biopsy; 7 bone resections 
(pelvic-femoral – 6 cases, and rectal tumor invading the 
coccyx – 1 case).
Results: This procedure was easy to be preformed, and 
complete hemostasia of the minor blood vessels was achieved 
in all cases. No postoperative bleeding occurred in these 
patients and their follow-up curse was satisfactory.
Conclusion: The electrocautery greased with lidocaine gel 
is an unexpensive, easily available and effi cacious method to 
achieve the hemostasia of minor vessels in hepatic, splenic 
and bone operative procedures.
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MIRIZZI SYNDROME IN ASSOCIATION 
WITH SERUM CA 19-9 GREATER THAN 
20,000: IS IT POSSIBLE?
F. Waechter1, U. Teixeira2, T. Passarin3, J. Sampaio4, 
P. Fontes5, L. Pereira-Lima6, M. Nectoux7 and P. Famer8
1Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS – Brazil; 2Hepato-
Pancreato-Biliary Surgery Resident, Universidade Federal 
de Ciências da Saúde de Porto Alegre, RS – Brazil; 
3Hepato-Pancreato-Biliary Surgery Resident, Universidade 
Federal de Ciências da Saúde de Porto Alegre, RS – 
Brazil; 4Professor of Surgery, Universidade Federal de 
Ciências da Saúde de Porto Alegre, RS – Brazil; 
5Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS – Brazil; 6Professor of 
Surgery, Universidade Federal de Ciências da Saúde de 
Porto Alegre, RS – Brazil; 7Professor of Surgery, 
Universidade Federal de Ciências da Saúde de Porto 
Alegre, RS – Brazil; 8General Surgery Resident, 
Universidade Federal de Ciências da Saúde de Porto 
Alegre, RS – Brazil
Universidade Federal de Ciências da Saúde de Porto 
AlegreHepato-Pancreato-Biliary Surgery, Rua Sarmento 
Leite, 245. ZipCode: 90050-170, 90050 Porto Alegre, 
Brazil
Introduction: Elevated levels of plasma glycoprotein 
CA19-9 are associated with pancreatic and biliary tract 
cancer, and levels above 120 are strongly associated with 
malignancy. We report a case of patient with plasma levels 
of CA19-9 above 20.000 U/ml in the presence of benign 
pathology.
Methods: A 83-year-old female patient, admitted for inves-
tigation of progressive jaundice, dark urine, hipocolia, 
itching and weight loss. MRI and MRCP of the abdomen 
showed dilatation of intrahepatic biliary tree and a lesion in 
the topography of the common hepatic duct suggestive of 
cholangiocarcinoma. Among preoperative laboratory tests, 
stood out BT 26.1 mg/dl and CA 19-9 24.800 U/ml.
Results: Laparotomy showed Mirizzi syndrome. The 
pathology of the surgical specimen confi rmed the diagnosis 
of chronic cholecystitis and no neoplasia. Postoperatively, 
after the resolution of the cholestatic pattern, we measured 
again the plasma level of CA19-9, which showed a signifi -
cant decrease. Following 18 months, the patient was in good 
general condition, without evidence of malignant disease and 
with serum CA19-9 levels within normal limits.
Conclusion: Jaundiced patients should have their serum CA 
19-9 remeasured after relief of cholestatic pattern, since 
jaundice alone can raise levels of this antigen. Elevated 
levels of CA19-9 does not indicate the presence of malig-
nancy in absolute and can not be used as a single indicator 
to differentiate between benign and malignant disease.
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XANTHOGRANULOMATOUS 
CHOLECYSTITIS: PERSPECTIVE 
FROM A EUROPEAN CENTRE 
WITH SPECIALIST 
MULTIDISCIPLINARY REVIEW
K. Roberts1, M. Hale1, N. Scott2, R. Prasad1, P. Lodge1 and 
G. Toogood1
1Dept of Liver Surgery, St James Hospital, Leeds, UK; 
2Dept of Pathology, St James Hospital, Leeds, UK
St James University Hospital, Liver surgery, 77 Three 
Acres Lane, Dickens Heath, Shirley, B90 1NZB90 Shirley, 
United Kingdom
Introduction: Xanthogranulomatous cholecystitis (XGC) is 
a rare chronic infl ammatory disease of the gall bladder (GB). 
It is frequently mistaken for, and may predispose to, GB 
cancer. Almost all published cases originate from the middle 
or Far East where 14–66% of cases undergo open resection 
for suspected carcinoma. The outcome of XGC within a 
European cohort of patients is unclear. The study aimed to 
assess the management of XGC in patients treated by a dedi-
cated HPB team and multidisciplinary meeting.
Methods: Cases of XGC were identifi ed from the pathology 
database at a specialist HPB unit in the United Kingdom. 
Each case was reviewed to identify presenting features, 
preoperative investigations and diagnosis, management and 
outcome.
Results: Forty two cases of XGC were identifi ed over 66 
months (0.8% of cholecystectomy specimens; 25 females; 
median age 58, range 27–85). A preoperative suspicion of 
GB cancer was raised in 10 cases but only 2 (5%) underwent 
planned open cholecystectomy ± GB bed resection. 26% of 
the remaining cases were converted from laparoscopic to 
open procedures due to procedural diffi culty. There was no 
postoperative diagnosis of GB cancer.
Conclusion: XGC presents a diagnostic challenge to 
European surgeons. However, the low rate of planned open 
cholecystectomy ± bed resection suggests that despite a fre-
quent suspicion of preoperative GB cancer the majority of 
cases are correctly identifi ed as infl ammatory by a specialist 
HPB MDT. With no cases, we question the association of 
XGC with GB cancer in European patients.
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PREOPERATIVE IMAGING IN PATIENTS 
WITH GALLSTONES AND SUSPECTED 
CBD STONES: LEARNING FROM THE 
LAPAROENDOSCOPIC RENDEZ-VOUS
M. Sofi a, A. Ricotta, S. Latteri, R. Lombardo, M. Di Blasi, 
S. Puleo, D. Russello and G. L. Greca
Department of Surgical Sciences Organs Transplantations 
and Advanced Technologies
University of Catania, Department of Surgical Sciences 
Organ Transplantations and Advanced Technologies, via, 
del Bosco 32495125 Catania, Italy
Introduction: In patients with suspected common bile duct 
(CBD) stones, their identifi cation before cholecystectomy 
plays an important role in planning the best surgical option. 
The aim of the present study was to analyze the results of 
preoperative investigations, intraoperative cholangiography 
(IOC), the fi ndings of intraoperative ERCP and endoscopic 
sphinterotomy (ES) with CBD clearance in patients with 
suspected CBD stones, to fi nd clinical suggestions and infl u-
ences in the surgical decision making.
Methods: In the period between September 2008–November 
2011, 47 patients with suspected CBD stones were enrolled 
in the study. As preoperative imaging they were submitted 
to abdominal ultrasound, CT scan, and MRI. They were 
scheduled for laparoscopic cholecystectomy plus IOC and 
laparoendoscopic rendez-vous (RV) according to our pre-
ferred treatment in more than 150 cases. Patient characteris-
tics, preoperative imaging reports, whether the IOC was 
successful, interpretation of the IOC imaging, and the 
fi nal outcome of surgery together with combined endoscopic 
procedures, morbility and mortality were reported 
prospectively.
Results: Preoperative imaging were: 23 (48.9%) MRI, 20 
(42.5%) CT, 4 (8.5%) US. RV procedure was complete in 36 
patients, one RV failed, 2 cases converted in choledochot-
omic exploration, 3 cases converted in open surgery. In 5 
cases the procedure was limited to LC due to negative IOC. 
Overall sensitivity and specifi city of MRI was 73.3% and 
75%, and in the RV group it was 75% and 60%. In 8 cases 
with negative preoperative imaging for stones, ES during RV 
revealed biliary sludge or microlithiasis. In these patients the 
indications to ES were: unclear IOC, history of pancreatitis 
or jaundice. Morbility in RV was: 1 (2.7%) postoperative 
mild acute pancreatitis, 3 (8.3%) postoperative amylase 
increasing and 1 (2.7%) intraoperative bleeding. Mortality 
was nihil.
Conclusion: MRC can identify CBD stones pre-operatively 
and can help surgeons plan safe procedures. However the 
low specifi city of MRI suggests in patients with high suspi-
cion of CBD stones a properly evaluation of biliary tree. 
Only intraoperative IOC followed by ES, during RV, can be 
the solution for bile fl ow obstruction due to biliary sludge 
and/or stenosis of the papilla or sphincter of Oddi’s dysfunc-
tion. Our analysis shows that in patients with unclear IOC, 
sludge or microlithiasis are always found.
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PERI-OPERATIVE AND LONG TERM 
OUTCOMES FOLLOWING 
TRISECTIONECTOMY FOR HILAR 
CHOLANGIOCARCINOMA
A. Williams, J. Lordan and A. Khan
Royal Marsden NHS Foundation Trust, Upper GI Surgery, 
Fulham Road, SW3 6 London, UK
Introduction: Hilar cholangiocarcinoma is associated with 
poor long term survival and a low resectability rate. Studies 
have shown that improvements in diagnosis and staging, 
along with improved surgical techniques, translate into better 
long term survival. This study was designed to assess 
outcome following adjuvant chemotherapy and radical tri-
sectionectomy for hilar cholangiocarcinoma.
Methods: Consecutive patients (n = 10), who underwent 
liver resection for hilar cholangiocarcinoma, were included 
in the study. All patients received computerised tomography 
(CT) and magnetic resonance imaging, but only selected 
patients underwent positron emission tomography (PET). 
Patients’ demographics, peri-operative and long term out-
comes were recorded. Univariate and multivariate analyses 
were used to identify independent risk factors for mortality. 
Patients received adjuvant gemcitabine alone (n = 1), with 
capecitabine (n = 1) or with cisplatin (n = 4).
Results: The median age was 63 years (range, 41–79 years), 
and patients had an ASA of 2 (n = 4) or 3 (n = 6). Six patients 
underwent pre-operative ERCP and 2 underwent PTC. Six 
patients received staging laparoscopy. Patients underwent 
extended left hepatectomy (n = 5), right trisectionectomy (n 
= 4) or right trisectionectomy and pancreaticoduodenectomy 
(n = 1). The median intensive care stay was 2 days (range, 
1–8 days) and the median hospital stay was 17.5 days (range, 
7–51 days) and 3 patients had R1 resection margins. Five 
patients received peri-operative blood transfusions. Four 
patients had peri-operative complications (grade III n = 2) 
and no deaths. The 1-year DFI was 57% (SE 3.1;95% CI 
1.5–36.3) and the OS was 87.5% (SE 2.72; 95% CI 
14.58–31.18).
Conclusion: Aggressive parenchymal liver resection for 
hilar cholangiocarcinoma is safe and may confer medium 
and long term benefi t.
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IS THE PANCREATICODUODENECTOMY 
FEASIBLE IN RECURRENT REMNANT 
BILE DUCT CANCER FOLLOWING 
SEGMENTAL RESECTION OF 
BILE DUCT?
J. G. Lee1, J. H. Lim1, S. H. Kim1, J. S. Park2, D. S. Yoon2, 
W. J. Lee1 and K. S. Kim1
1Dept. of Surgery, Severance Hospital, Yonsei University 
College of Medicine; 2Dept. of Surgery, Kangnam 
Severance Hospital, Yonsei University College of Medicine
Severance Hospital, Yonsei University College of Medicine, 
Surgery, 50 Yonsei Ro, Seodaemoon Ku 12570 Seoul, 
Korea
Introduction: The prognosis of bile duct cancer is poor, and 
the effective therapy sometimes is not available. In clinical 
setting, the local recurrence following a curative resection is 
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in dilemma. As the surgical techniques and intensive sup-
portive managements have been developed, recently the sur-
gical indication is widely expanded. We experienced 6 
patients who underwent pancreaticoduodenectomy (PD) 
after the bile duct surgery.
Methods: A 59-year male patient had a recurrent distal 
common bile duct (CBD) cancer 78 month after segmental 
resection for mid CBD cancer. After PD, the lymph nodes 
were invaded and the chemotherapy was performed. 
Unfortunately the mortality was occurred due to chemo-
therapy induced cytotoxities. A 71-year male patient had a 
recurrent CBD cancer. 73 month ago, he underwent Lt. hemi-
hepatectomy with caudate lobectomy because of Klatskin 
tumor type IIIb. He is in NED status for 39 month. 22 month 
ago, a 58-year male patient underwent segmental resection 
of CBD due to CBD cancer. He experienced the recurrent 
CBD caner and underwent PD. For 65 month, there is no 
meaningful event.
Results: A 68-year female patient underwent PD because of 
recurrent CBD cancer 57 month after bile duct resection. The 
lesion is early (pT1) and so the further treatment is not 
needed. A 64-year male patient underwent PD 7 month after 
segmental resection for mid CBD cancer. A 66-year male 
patient underwent Lt. hemihepatectomy with caudate lobec-
tomy for Klatskin tumor IIIb. 98 month after, the distal 
remnant CBD cancer was found and the PD was performed. 
He is being well for 10 month.
Conclusion: After the exhaustive imaging studies, the 
active surgical approach is possible in selected patient with 
recurrent remnant CBD cancer.
890
SINGLE CENTER EXPERIENCE IN 
TREATMENT OF BILIARY 
CYSTADENOMAS
M. Efanov, V. Vishnevsky, R. Ikramov, O. Zhavoronkova, 
N. Vetsheva, P. Usyaky and A. Zhao
Vishnevsky Institute of Surgery, Hepatopancreatobiliary, 
Bolshaya Serpuchovskaya, 27 Moscow, Russia
Introduction: When observing resent publications on 
biliary cystadenoma (CAd) it seems the incidence of the 
disease is increasing during the last two years.
Aim: To analyze the common features of biliary CAd.
Methods: Twenty six patients underwent radical surgical 
procedures for biliary CAd and two for biliary cystadenocar-
cinomas (CAdC) since 2000. CT and transabdominal ultra-
sonography were included in the routine examination in all 
patients. The treatment of choice in patients with biliary CAd 
was cystectomy while in patients with CAdC it was a hemi-
hepatectomy. Four patients were operated for residual CAd. 
Seventeen patients were evaluated for CEA and CA 19-9 
level in plasma and six patients – in cystic fl uid. All patients 
were followed up for relapse of the desease. All the patients 
with biliary cystic tumors were female and all of them had 
the single lesion in the liver. Mean age was 51 ± 2 years. The 
women with CAdC were 58 and 75 years old.
Results: Mean diameter of cystic adenomas was 91 ± 
6.2 cm. In 19 (68%) patients CAd localized in segment 4 of 
the liver. The intracystic septation was revealed in 8 patients 
(31%) with Cad and in one patient with CAdC. The mean 
levels of CEA and CA 19-9 in plasma were 2.1 ± 0.65 ng/
ml and 680 ± 575 U/ml while in cystic fl uid they were and 
40.1 ± 7.6 ng/ml and 202234 ± 198968 U/ml respectively in 
patients with CAd. The levels of CEA and CA 19-9 in plasma 
were 6.0 ng/ml and 128 U/ml while in cystic fl uid they were 
and 3269 ng/ml and 24526 U/ml respectively in one patient 
with CAd. Robotic assisting cystectomy in two patients with 
CAd of segment 4 were performed operated with uneventful 
postoperative course. There was no relapse of the disease in 
any patients with CAd after cystectomy. In both patients the 
CAdC were giant (>30 cm), and only palliative hemihepate-
ctomy was available to be performed.
Conclusion: Biliary CAd should be considered in women 
with single cyst localized in segment 4 of the liver. Elevated 
plasma level and especially markedly elevated cystic fl uid 
level of CEA and CA 19-9 contribute to diagnose of CAd.
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THE QUEST FOR LUSCHKA’S DUCT
E. Boonstra, K. Lorenz and R. Porte
University Medical Centre Groningen, The Netherlands, 
Department of Hepatobiliary Surgery and Liver 
Transplantation
UMCG Hepatobiliary Surgery and Liver Transplantation, 
Hanzeplein 1, Postbus 30.001, 9700 RB Groningen 9700R, 
Netherlands
Introduction: The German anatomist Hubert von Luschka 
gave name to several structures in the human body. One of 
great discussion is the duct of Luschka, part of the biliary 
system.
Methods: Questioning whether this eponym is appropri-
ately applied we have read his anatomical disquisition about 
the human body and reviewed the available literature.
Results: We were unable to fi nd such a subvesical or hepa-
tocystic duct illustrated by Luschka. An explanation for the 
arousal of such a misconception might be the peribiliary 
glands which have been discussed in detail by him.
Conclusion: It seems that the reason why several approaches 
concerning this anatomical structure are present is the fact 
that Luschka maybe never described this duct. The use of 
this eponym in medical communication is confusing and 
hampers scientifi c discussion since different structures are 
meant and should be abandoned.
896
HEPATICOJEJUNOSTOMY WITH ‘THE 
HAND FAN TECHNIQUE’
S. Pekmezci1, K. Saribeyoglu1, E. Aytac1 and B. Serdar2
1Istanbul University, Cerrahpasa Medical Faculty, 
Department of General Surgery, Istanbul, Turkey; 2Istanbul 
University, Cerrahpasa Medical Faculty, Department of 
Medical Education, Istanbul, Turkey
Istanbul University, Cerrahpasa Medical Faculty, 
Department of General Surgery, Istanbul, Turkey, 
Cerrahpasa Tip Fakultesi Genel Cerrahi Anabilim Dali, 
Fatih 34098 Istanbul, Turkey
Introduction: Hepaticojejunostomy (HJ) is performed to 
maintain the bile fl ow in to the small bowel after extra 
hepatic bile duct resection. Although various techniques have 
been described for HJ procedure, leaks and strictures after 
HJ are still serious problems for surgeons. In this study, we 
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have presented our Roux en Y hepaticojejunostomy tech-
nique (the Hand fan technique) with the outcomes of the 
patients who had been operated for benign diseases.
Methods: Between July 2004- June 2011, the patients who 
underwent Roux en Y hepaticojejunostomy with (the Hand fan 
technique) for benign etiologies were included in the study.
Results: There were 31 (11 males) patients. Median age was 
51. The indications for hepaticojejunostomy: bile duct injury 
during laparoscopic cholecystectomy (n = 22), hepaticojeju-
nostomy stenosis (n = 4), benign biliary stenosis (n = 3), bile 
duct cyst (n = 1), biliary stricture after surgery (n = 1). Median 
follow up time and hospital stay were 32.5 months and 7 days 
respectively. Postoperative complications were wound infec-
tion (n = 2) and intraabdominal fl uid collection (n = 1). A 
patient underwent a mesh repair surgery for an incisional 
hernia one year after HJ. However, obstructive jaundice was 
occurred in same patient a year after mesh repair. The jejunal 
segment, which was prepared for the biliodigestive anasto-
mosis, was obstructed by adhesions in this case.
Conclusion: The Hand fan technique is a safe and feasible 
approach for maintaining continuity between the bile duct and 
intestine with acceptable postoperative morbidity. The Hand 
fan technique could ease application of HJ in the cases which 
have small the diameter of the remnant bile duct and when the 
level of HJ is adjacent to or in the liver parenchyma.
[Correction added after online publication on 2 July 2012: 
Authors’ names should read in this order: S. Pekmezci, 
K. Saribeyoglu, E. Aytac and B. Serdar, not K. Saribeyoglu, 
S. Pekmezci, E. Aytac and B. Serdar.]
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NEW INTERNATIONAL REGISTRY FOR 
PERIHILAR CHOLANGIOCARCINOMA: 
THE SOLUTION FOR MOST 
CONTROVERSIES ON STAGING AND 
THERAPIES FOR THIS DISEASE
M. De Oliveira1, Y. Nimura2, R. Schulick3, C. Rosen4, 
G. Gores5, P. Neuhaus6 and P.-A. Clavien1
1Department of Surgery, Swiss HPB Center, University 
Hospital Zurich, Switzerland; 2Department of Surgery, 
Aichi Cancer Center, Nagoya, Japan; 3Department of 
Surgery, Johns Hopkins Medical Center, Baltimore, USA; 
4Department of Surgery, Mayo Clinic and Foundation, 
Rochester, MN, USA; 5Department of Medicine, Mayo 
Clinic and Foundation, Rochester, MN, USA; 6Department 
of Surgery, University Hospital Charité, Berlin, Germany
University of Zurich, Surgery & Transplantation, 
Raemistrasse 1008091 Zurich, Switzerland
Introduction: Perihilar cholangiocarcinoma (PHC) remains 
a challenging and controversial disease. The major barrier to 
compare results among centers and identify the best therapies 
according the type and extend of the disease is the lack of a 
reliable staging system. Bismuth-Corlette classifi cation is 
widely used, but it does not include critical data. Other 
systems are restricted to centre’s experience and do not 
provide enough information for guiding therapy, including 
liver transplantation.
Methods: To introduce a new terminology and classifi cation 
system to gather large scale data through an international 
registry. The long-term goal is to develop a relevant staging 
system guiding therapy including surgery and liver 
transplantation.
Results: We critically reviewed all available staging systems 
and designed a novel and simple classifi cation system for 
PHC based on tumor type and size, extension along the 
biliary system, vascular and lymph nodes involvement, also 
considering putative remnant liver volume after resection, 
underlying liver disease, as well as assessment for LT. A new 
registry was made available to gather data from all around 
the world. (www.cholangioca.org).
Conclusion: The use of common terminology and classifi -
cation system for PHC, made available in a worldwide reg-
istry, offers a new tool to gather relevant data to enable 
comparison among centers and the identifi cation of best 
therapies based on objective and reproducible information.
908
MIRIZZI SYNDROME AND INCIDENCE 
OF GALLBLADDER CANCER: A SINGLE 
INSTITUTION’S EXPERIENCE
M. H. Goh and J. K. Low
Department of General Surgery, Tan Tock Seng Hospital, 
Singapore
Tan Tock Seng Hospital, Department of General Surgery, 
11 Jalan Tan Tock Seng, Singapore 30843330843, 
Singapore
Introduction: Mirizzi Syndrome is a rare complication due 
to long term gallstone disease, whereby the patient presents 
with obstructive jaundice secondary to external compression 
of the common hepatic duct by gallstones impacted at the 
gallbladder neck or cystic duct. The chronic infl ammation 
due to gallstones may have a role to play in gallbladder 
carcinoma pathogenesis. The aim of this study is to look at 
the incidence of gallbladder carcinoma in patients with 
Mirizzi Syndrome in our institution.
Methods: This is a retrospective study, looking at data from 
1st January 2005 to 31st July 2011. We looked at the demo-
graphics, clinical fi ndings, laboratory results, diagnostic 
studies, operative notes, pathological results and outcome of 
patients who presented with obstructive jaundice during this 
period of time. Only patients with proven Mirizzi Syndrome 
(that is diagnosed on radiological investigations, diagnostic 
procedures or intra-operative fi ndings) are included in this 
study.
Results: 165 patients presented with obstructive jaundice 
between January 2005 and July 2011.17 out of 165 patients 
were found to have Mirizzi Syndrome. Amongst the 17 
patients, the mean age was 64 years old; 8 patients were 
female and 9 were male. 3 out of the 17 (17.6%) patients 
were found to have gallbladder carcinoma. 2 of the patients 
were diagnosed to have gallbladder carcinoma upon histol-
ogy results, after cholecystectomy was done for gallstone 
disease. The 3rd patient was suspected to have gallbladder 
carcinoma based on the computed tomography (CT) fi ndings 
and underwent oncological resection for gallbladder carci-
noma. The 3 patients died within 12 months of diagnosis of 
gallbladder carcinoma.
Conclusion: Gallbladder carcinoma is highly associated 
with Mirizzi Syndrome. Diagnosis of gallbladder carcinoma 
was made on fi nal histology for these patients. However, the 
diagnosis of gallbladder carcinoma, or the differentiation 
between gallbladder carcinoma and Mirizzi Syndrome based 
on radiological studies is still very diffi cult. The diagnosis 
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for gallbladder carcinoma can be confi rmed with histology 
and further surgery can then be planned for proper oncologi-
cal clearance.
910
MANAGEMENT OF 
CHOLANGIOCARCINOMA – OUR 
EXPERIENCE
N. Kolev, A. Tonev, G. Ivanov, K. Ivanov and V. Ignatov
University Hospital ‘St. Marina’, Varna, Bulgaria
University Hospital ‘St. Marina’, Department of General 
and Operative Surgery, 1, Hristo Smirnensky str.9000 
Varna, Bulgaria
Introduction: Cholangiocarcinoma is the second most 
common primary liver cancer behind hepatocellular cancer. 
Although it is an uncommon malignancy, several reports 
have documented a signifi cant rise in incidence worldwide. 
As a result, interest in understanding the presentation, diag-
nosis, natural history, and effi cacy of various treatment 
modalities has increased. Cholangiocarcinoma (CC) is a 
highly fatal disease with limited therapeutic options.
Methods: We compared CC patients receiving different 
therapies between 2000 and 2010 with univariate and multi-
variate analyses.
Results: Sixty-two cases were included. The mean age at 
diagnosis was 59 years. Only 6.3% received surgical resec-
tion, 65.5% received palliative interventions (16% surgical, 
44% endoscopic), 24.4% received only chemo whereas 3.8% 
did not receive any treatment. The median survival was 19 
months for surgical resection, 9 months for surgical pallia-
tion, and 4 months for endoscopic palliation.
Conclusion: Only a minority of patients with CC receives 
potentially curative therapy. Young age is the strongest pre-
dictor of receiving potentially curative treatment. Older 
patients and those diagnosed in recent time periods are more 
likely to receive endoscopic palliation. Surgical resection 
was associated with improved survival. Only the multidisci-
plinary team management of these suffering patients includ-
ing gastroenterologist, hepatologist, hepatomorphologist and 
sometimes a surgeon will lead to increasing of the therapeu-
tic results.
911
BENIGN BILIARY STRICTURES: REPAIR 
AND OUTCOME WITH THE USE OF 
SILASTIC TRANSHEPATIC 
TRANSANASTOMOTIC STENTS
F. Waechter1, U. Teixeira2, J. Sampaio3, P. Fontes4, 
L. Pereira-Lima5, M. Nectoux6, T. Passarin7 and C. Kruse8
1Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS – Brazil; 2Hepato-
Pancreato-Biliary Surgery Resident, Universidade Federal 
de Ciências da Saúde de Porto Alegre, RS – Brazil; 
3Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS – Brazil; 4Professor of 
Surgery, Universidade Federal de Ciências da Saúde de 
Porto Alegre, RS – Brazil; 5Professor of Surgery, 
Universidade Federal de Ciências da Saúde de Porto 
Alegre, RS – Brazil; 6Professor of Surgery, Universidade 
Federal de Ciências da Saúde de Porto Alegre, RS – 
Brazil; 7Hepato-Pancreato-Biliary Surgery Resident, 
Universidade Federal de Ciências da Saúde de Porto 
Alegre, RS – Brazil; 8General Surgery Resident, 
Universidade Federal de Ciências da Saúde de Porto 
Alegre, RS – Brazil
Universidade Federal de Ciências da Saúde de Porto 
Alegre, Hepato-Pancreato-Biliary Surgery, Rua Sarmento 
Leite, 245, ZipCode: 90050-17090050, Porto Alegre, Brazil
Introduction: Laparoscopic cholecystectomy most dreaded 
complication, iatrogenic major bile duct injury, is rising in 
the last years, despite the learning curve, and stabilized in a 
level higher than that experienced in open cholecystectomy. 
Among the features which can bring to this event a good 
outcome is the use of transhepatic transanastomotic tubes in 
association with the corrective hepaticojejunostomy.
Methods: To report a 20 years experience on biliary recon-
struction of bile duct injuries with the use of transhepatic 
transanastomotic tubes. Data were analysed from 338 
patients who underwent operation for major bile duct injuries 
between January 1988 and December 2009.
Results: All the 338 patients were submitted to Roux-en-Y 
hepaticojejunostomy (Hepp-Couinaud approach) or distinct 
cholangiojejunostomies, all with the use of transhepatic 
transanastomotic silastic tubes. A successful long-term result 
was achieved in 240 (92.9%) of 338 patients, including those 
who required subsequent procedures.
Conclusion: Benign bile duct strictures near the hepatic 
duct confl uence remains a surgical challenge. The use of 
silastic transhepatic transanastomotic tubes in high biliary 
tract reconstruction is an option which can provides a suc-
cessful repair of bile duct injuries with low complication 
rates.
 Poster Presentation Abstracts 377
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 288–699 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
912
SURGICAL TREATMENT FOR 
ADVANCED GALLBLADDER 
CARCINOMA
M. A. Uzun1, M. Tilki1, G. C. Okuyan1, N. Koksal2, 
O. Yucel1, E. Altinli1, A. S. Celik1 and G. Kilicoglu3
1Haydarpasa Numune Training and Research Hospital, 
Department of General Surgery, Istanbul, Turkey; 
2University of Kafkas Medical School, Department of 
General Surgery, Kars, Turkey; 3Haydarpasa Numune 
Training and Research Hospital, Department of Radiology, 
Istanbul, Turkey
Haydarpasa Numune Training and Research Hospital, 
Istanbul, Turkey, Department of General Surgery, 
Hamidiye Mah. Gurbuz Sok. No:118/12, Cekmekoy 34782 
Istanbul, Turkey
Introduction: Due to the aggressive nature of gallbladder 
cancer, especially in patients with advanced stage; have poor 
prognosis which prevails a traditional pessimism. However, 
the long survival with aggressive surgery in suitable cases 
are reported in the literature. We evaluated the results of our 
approach for these cases.
Methods: We retrospectively reviewed the medical records 
of 40 gallbladder cancer patients. Clinicopathologic charac-
teristics of patients, surgical procedures, hospital mortality, 
morbidity and survival rates were evaluated.
Results: The median age of the patients was 67.5 years and 
24 (60%) were female. According to latest AJCC staging 
system 35 (87.5%) patients were in Stage 3 and 4. 23 (57.5%) 
out of 40 patients had surgery – one extended hepatectomy, 
one portal vein resection, two hepatopancreatoduodenec-
tomy, six extrahepatic bile duct resection, eleven radical 
cholecystectomy and three simple cholecystectomy. Two 
patients died (one from bleeding and one from sepsis) post-
operatively. Eleven patients survived for one year, three sur-
vived for three years and two survived for fi ve years. One of 
our patients is still alive and healthy after 104 months from 
the surgery. None of the 16 advanced stage patients survived 
more than a year in whom surgery could not be applied.
Conclusion: The only chance of curative treatment for 
advanced stage gallbladder cancer is stil surgery. Good 
results are reported with surgery, including extensive resec-
tions, for this disease. Our results are also promising in these 
patients.
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RIGHT SECTORAL BILE BUCT 
INJURY POST LAPAROSCOPIC 
CHOLECYSTECTOMY: 
TO OPERATE OR TO CONSERVE?
S. Saleh, H. Abdelmaged, O. Hegazy and B. Hegab
National Liver Institute, Menuofi ya University, Egypt, 
Hepatobiliary & Liver Transplantation Surgery, 
Hepatobiliary & Liver Transplantation Surgery 
Department
National Liver Institute, Menuofi ya University, Menoufi ya, 
Egypt
Introduction: Right posterior sectoral hepatic duct anoma-
lies are seen in about 6–8% of the population. Management 
strategies are still controversial. This study aimed at studying 
results of right posterior sectoral bile duct injuries in a spe-
cialized center after laparoscopic cholecystectomy.
Methods: Ten cases were treated in National Liver Institute, 
Menuofi ya University, Egypt between 2005 and 2010 for 
injuries of right posterior sectoral bile duct injuries and were 
followed up for a median of 20 month (range, 12–60 months). 
Demographic data, clinical presentation, management and 
outcome were reviewed.
Results: Bile duct injury were discovered during primary 
surgery in 3 cases, 2 were converted from laparoscopic to 
open laparotomy, with attempt to do bilioenteric anastmosis 
in one case. The mean time of referral from index surgery 
was 12 days. The major presentation on referral was bile leak 
in 7 cases (70%), 2 cases (20%) with biliary peritonitis, and 
a case with ascending cholangitis. Post referral management 
used ERCP, percutaneous drainage and surgery. In one case 
(10%) ERCP could identify the sectoral bile duct injury. 8 
cases (80%) MRCP were done and could identify sectoral 
and right duct injury. Six cases (60%) were managed primary 
by ERCP and stenting. Four of these cases (67%) needed no 
further management. Four cases (40%) needed bilioenteric 
anastmosis as fi nal cure. Six cases (60%) did well without 
surgical bilioenteric anastmosis, The mean follow-up time 
was 20 months. No signifi cant morbidity or mortality apart 
from one case of incisional hernia.
Conclusion: successful management of right isolated 
segmental duct injury after laparoscopic injury requires 
adequate identifi cation of the lesion and multidisciplinary 
treatment. 60% of the cases can be treated successfully with 
proper drainage and non surgical procedures.
926
LATROGENIC BILE DUCT INJURY 
ASSOCIATED WITH ANOMALIES OF 
THE RIGHT HEPATIC SECTIONAL 
DUCTS FOLLOWING LAPAROSCOPIC 
CHOLECYSTECTOMY
H. J. Jang, J. H. Kwak, K. J. Cheon, J. H. Ahn and 
J. H. Lee
University of Ulsan, Gangneung Asan Hospital, Surgery, 
415 Bandong-ri Sacheon-myeon, Gangneung-si, Gangwon- 
do 210-711, 21071 Gangneung, Korea
Introduction: Bile duct injuries remain one of the most 
devastating complications of both open and laparoscopic 
cholecystectomy (LC). Although laparoscopic cholecystec-
tomy has been widely accepted as the standard operation, it 
continues to have a high complication rate than open chole-
cystectomy. Bile duct injury with LC has often been attrib-
uted to surgical inexperience, but it is also clear that aberrant 
bile ducts are present in a signifi cant number of patients who 
sustain biliary injuries during these procedures.
Methods: We performed 3120 LC from 2000 to 2011. We 
present six cases (0.2%) of right sectoral duct injuries, two 
of which had right posterior sectoral duct (RPSD) injuries 
noted on intraoperative cholangiogram, while three of right 
anterior sectoral duct (RASD) and one of RPSD injuries 
noted on postoperative percutaneous transhepatic cholangi-
ography (PTC).
Results: In the fi rst two cases, Intraop cholangiogram dem-
onstrated aberrant biliary anatomy and injuries to low-lying 
RPSDs drain to cystic duct. Both cases was successfully 
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recognized and repaired immediately by hepaticojejunos-
tomy. Three of RASD and one of RPSD injuries noted on 
postoperative period. One case of RASD injury was per-
formed delayed hepaticojejunostomy after PTBD. The post-
operative course of these patients was uncomplicated. The 
other cases were successfully performed intrahepatic bile 
duct ablation using coiling, fi brin glue and alcohol for 7, 22 
and 25 times.
Conclusion: We present six cases (0.2%) of right hepatic 
duct injuries which occurred during LC for 11 years. If 
RHSD injury noted on postoperative period, Although a 
repeat procedure may be necessary, the obliteration of bile 
ducts is a safe procedure with excellent results in patients 
with complications from isolated segmental ducts.
929
A CASE OF SPINDLE CELL CARCINOMA 
OF THE HILAR BILE DUCT
R. Higuchi1, T. Ota1, N. Takeshita1, HI. Kajiyama1, 
T. Yazawa1, K. Onuki1, T. Furukawa2 and M. Yamamoto1
1Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University; 2Institute for 
Integrated Medical Sciences, Tokyo Women’s Medical 
University
Gastroenterology, Tokyo Women’s Medical University, 
Surgery, 8-1 Kawada-cho, Shinjuku-ku, 162 Tokyo, Japan
Introduction: This patient is a 62 year old woman with bile 
duct cancer. She presented with brown urine and itching, so 
she went a local hospital. She underwent endoscopic naso-
biliary drainage (ENBD) for jaundice. Cholangiography 
shows a stenosis of the superior bile duct. Irregularity of the 
right and left hepatic duct were also seen.
Methods: Cytology of the bile juice yielded a diagnosis of 
class V. CT showed the tumor made contact with the right 
hepatic artery and portal vein. Base on the diagnosis of hilar 
bile duct cancer with the right hepatic artery and portal vein, 
we performed right and caudate lobectomy with resection 
and reconstruction of the bile duct and PV. Pathological 
examination showed pat Bsm, nodular type, 2.5 × 2 × 2 cm, 
infγ, ly1, v2, pn1, ss, t4, pN0, stage IVa, pHM2 (cis), pDM0, 
pEM1, Curability C.
Results: Tumor cells were a spindle shaped and invasive, 
spread out from bile duct wall to surrounding tissue. 
Immunostaining showed AE1/AE3 (+), CK7 (+), CK19 (+), 
EMA (+), cKIT (−), CD34 (−) and Vimentin (−). Thought 
she was discharged postoperative day 25 for chylous ascites 
and underwent adjuvant chemotherapy postoperatively, she 
died 12 months after operation due to recurrence.
Conclusion: To the best of our knowledge, reports on 
spindle cell carcinoma of the bile duct in the English litera-
ture are rare, so we therefore report this case.
932
COMPLICATED LIVER HYDATID 
DISEASE IN THE ERA OF 
ENDOSCOPIC RETROGRADE 
CHOLANGIO-PANCREATOGRAPHY
D. Symeonidis1, G. Koukoulis1, G. Christodoulides1, 
V. Kouritas2, I. Mamaloudis1, I. Chatzinikolaou1 and 
K. Tepetes1
1Department of General Surgery, University Hospital of 
Larisa, Greece; 2Department of Thoracic Surgery, 
Evangelismos General Hospital, Athens, Greece
University Hospital of Larisa, Department of General 
Surgery, Mezourlo 41110 larisa, Greece
Introduction: The purpose of the present report was to 
investigate the proper diagnostic work up of liver hydatid 
disease focusing especially on the role of certain interven-
tional procedures such as endoscopic retrograde cholangio-
pancreatography (ERCP) in the fi nal treatment algorithm.
Methods: The medical records of eighteen patients who 
underwent surgery for complicated liver hydatid disease 
were retrospectively reviewed. Collected data included age, 
gender, clinical presentation, past medical history, laboratory 
fi ndings, imaging investigation, preoperative interventions, 
length of hospital stay, type of surgery and incidence and 
severity of post-op complications.
Results: Among the eighteen patients included in the study, 
twelve patients were diagnosed with a cyst-biliary tree com-
munication, two patients developed broncho-biliary fi stula, 
two patients had a liver abscess while in two patients a free 
rupture in the peritoneal cavity was the indication for imme-
diate surgical intervention. Pain in the upper right quadrant 
was the main presenting symptom in the majority of the 
cases studied. In four patients a diagnosis of acute cholangitis 
was established after the initial work-up. ERCP in the 
preoperative setting was performed in six patients while 
eight patients were submitted to ERCP due to bile leakage 
postoperatively.
Conclusion: Whenever a communication is strongly sus-
pected in the preoperative setting based on data extracted 
from laboratory results and imaging modalities, a preopera-
tive ERCP should be contemplated. This interventional 
modality besides its diagnostic value can effectively lower 
the pressures within the biliary tree and seems to decrease 
the incidence and severity of postoperative bile leak.
938
BILIARY ANATOMY: CORRECT 
ASSESSMENT FROM 465 CONSECUTIVE 
INTRAOPERATIVE 
CHOLANGIOGRAPHY
M. Massani, B. Pauletti, C. Ruffolo, E. Caratozzolo, 
R. Bonariol, L. Boanriol and N. Bassai
IV Dpt Surgery, Regional Center for HPS Surgery, 
Regional Hospital, Piazza Ospedale, Treviso 31100, Italy
Introduction: Biliary anatomy was described by many 
authors but the classifi cation proposed by Coinuad is the 
most popular and used one. According to this classifi cation 
the most common variation is the confl uence of posterior 
duct directly in the left main duct; followed by real trifurca-
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tion and by the confl uence of the posterior duct in the main 
biliary duct.
Methods: In our institution, as proposed by many authors, 
we used to take an intraoperative cholangiography to prevent 
biliary damage. Aim of this study was to prospectively study 
biliary anatomy in a consecutive number of 484 patients, 
all operated for gallstone disease, from January 2008 to 
December 2010 at our center for liver and pancreas surgery.
The same equip, after the laparoscopic cholecistectomy, 
re-evaluated all the intraoperative cholangiography looking 
for biliary anatomy variations. We studied data from 484 
elective or urgent consecutive cholecistectomy, 224 male and 
260 female, age range from 21 to 96 years. Images were 
judged suitable for the study only if the second biliary order 
ducts were well defi ned.
Results: 465 intraoperative cholangiography matched the 
inclusion criteria. 67.3% (313 pts) had the classical anatomy, 
with a bifurcation of right and left duct; 13.8% (64 pts) had 
posterior right duct coming from the main left duct; 6.5% 
(30 pts) had a trifurcation (common confl uence of posterior 
anterior and left ducts); 5.8% (27 pts) had the posterior duct 
coming directly from the main duct and 1.3% (6 pts) had an 
accessory posterior duct coming from the main duct; 1.01% 
(7 pts) shows coexisting multiple variations All the other 
variants were occasionally.
Conclusion: Our study includes a non selected, numerous, 
group of patients and this is the main difference with the 
majority of the previous published study in which included 
patients were candidate for liver or pancreas resection. The 
sample is consistent and our results confi rm the validity of 
the Coinaud biliary classifi cation.
950
NOTCH SIGNALLING IS UPREGULATED 
IN CHOLANGIOCARCINOMA WHILST 
PATHWAY INHIBITION ENHANCES 
CHEMOSENSITIVITY
A. Robson1, R. Guest1, L. Boulter1, J. Iredale2 and 
S. Forbes1
1Scottish Centre for Regenerative Medicine, University of 
Edinburgh; 2Centre for Infl ammation Research, University 
of Edinburgh
University of Edinburgh, Department of Surgery, 128/6 
Viewforth, Edinburgh EH10 4LNUK, UK
Introduction: Intrahepatic cholangiocarcinoma (ICC) is an 
aggressive malignancy of biliary epithelium with increasing 
global mortality. The Notch signalling pathway is important 
in embryonic cholangiocyte specifi cation and adult biliary 
homeostasis. Notch plays oncogenic and tumour suppressive 
roles in haematological and solid tumours but its role in ICC 
remains unclear. We aim to defi ne the contribution of Notch 
signalling to the ICC malignant phenotype and evaluate its 
potential as a therapeutic target.
Methods: The Notch pathway was characterised immuno-
histochemically, by gene array and with quantitative real 
time polymerase chain reaction (qrtPCR) in Human ICC 
specimens, a multi-step thioacetamide-induced rat model of 
ICC and in human cholangiocarcinoma cell lines. The Notch 
pathway was pharmacologically inhibited in vitro using 
DAPT (a gamma secretase inhibitor) and also inhibited 
with small interfering RNA against Notch receptors and 
mediators of the Notch pathway. Effects on proliferation and 
chemoresistance (5-FU, cisplatin, gemcitabine) were exam-
ined using the MTT assay.
Results: The Notch pathway and its target effectors are 
active in both human and rat tissue. The Notch 3 receptor is 
particularly upregulated (97 fold in human; p < 0.05 and in 
rat pooled samples 6.5 fold). In both Human ICC and Rat 
models Jagged-1 ligand is supplied by tumour-associated 
myofi broblasts which form close associations with malignant 
cholangiocytes that express Notch-3, suggesting a function-
ally intact Notch pathway within the tumour. Notch up-
regulation occurs progressively in the rat model with 
increasing expression from healthy liver to fi brosis and 
fi nally malignancy. In vitro pathway ablation with gamma-
secretase inhibition and RNA interference reduced prolifera-
tion and enhanced chemosensitivity of cancer cell lines.
Conclusion: In ICC the Notch pathway is progressively up-
regulated in human and rat, with a tumour-associated myofi -
broblast-derived signal activating the Notch 3 receptor on 
malignant epithelium, likely acting through HeyL. Moreover 
Notch signal appears to be tumour promoting in vitro with 
pathway inhibition restricting proliferation and enhancing 
chemosensitivity. As such Notch pathway inhibitors repre-
sent a potential therapeutic option in this aggressive 
malignancy.
959
A RARE COMPLICATION OF 
CHOLELITHIASIS
B. Serji, S. Ahmimech, M. Elabsi, M. Amraoui, 
A. Rougani and R. Chkoff
University Mohamed V Department of the Emergency 
Surgery (UCV) Ibn Sina Hospital Rabat Morocco
Faculty of Medecine and Pharmacy of Rabatservice des 
UCV125, Amal 6, Hay El Montalak, CYM10150 Rabat, 
Morocco
Introduction: Cholecysto-enteric fi stula complicates 0.3–
0.5% of patients with cholithiasis. However, more than 80% 
of these stones are so small that they are passed into the 
stools without causing obstruction, only 6% of the cases 
develop clinical intestinal obstruction.
Methods: A 51 year-old woman, diabetic on insulin with a 
history of epigastric pain presented 3 days before her admis-
sion an occlusive syndrome. The physical examination 
revealed a distended abdomen.
The scan showed a distended small bowel obstruction with 
a pneumobilia and sclero-atrophic gallbladder.
Results: The patient underwent surgery. At laparotomy, a 
gallstone was discovered in the last ileal loop. It was extracted 
by the means of a longitudinal enterotomy which was then 
closed transversely. We discovered a cholecysto-duodenal 
fi stula, it was left intact. The surgical follow up was simple.
The principal goal in management of gallstone ileus is a 
quick effective relief of mechanical bowel obstruction. Most 
authors favour enterolithotomy alone, followed by cholecys-
tectomy at a later date, because of its lower morbidity.
Conclusion: The gallstone ileus, although rare, remains a 
serious complication of cholelithiasis. Laparoscopic approach 
can be used to manage both the iléus and the cholecystec-
tomy at a later date.
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INTRAHEPATIC SARCOMATOID 
CHOLANGIOCARCINOMA
J. H. Kim, H. J. Jang, J. H. Kwak, K. J. Cheon, J. H. Ahn 
and D. U. Um
University of Ulsan, Gangneung Asan Hospital, Surgery, 
Gangneung Asan Hospital
415 Bandong-ri Sacheon-myeon, Gangneung-si, Gangwon- 
do 210-711, 21071 Gangneung, Korea
Introduction: Sarcomatoid features are occasionally seen 
in various types of epithelial tumors, and it is sometimes 
diffi cult to differentiate between sarcomatoid carcinoma and 
true sarcoma.
Most sarcomatoid carcinomas in the liver are thought to 
be sarcomatoid hepatocellular carcinomas. Recently, there 
have been reports demonstrating sarcomatous changes in 
cholangiocarcinomas. This type of tumor is defi ned as ‘sar-
comatous intrahepatic cholangiocarcinoma’ in the WHO 
classifi cation of tumors.
Methods: We report herein a patient with intrahepatic sar-
comatous cholangiocarcinoma who underwent a hepatic 
resection. The main part of the tumor consisted of pleomor-
phic spindle and giant cells.
Results: A 63-year-old male patient presented with a liver 
mass. Computed tomography revealed a well-demarcated, 
low-attenuated mass in the left lobe of the liver. On laparot-
omy, 3 and 4 segmentectomies were performed. The 
tumor was 3×4 cm in size. Microscopically, the tumor 
cells were contained in the sarcomatous component, and 
adenocarcinoma component on histological mapping. 
Immunohistochemical staining for cytokeratin was positive 
in the sarcomatous components. The diagnosis confi rmed a 
sarcomatoid cholangiocarcinoma. 4 months after surgery, the 
patient died of pneumonia.
Conclusion: To the best of our knowledge, only 17 cases of 
intrahepatic sarcomatoid cholangiocarcinoma have been 
reported in the English-language literature.
It has been reported that the prognosis for intrahepatic 
sarcomatoid cholangiocarcinoma is worse than that for int-
rahepatic cholangiocarcinoma.
We report herein a patient with intrahepatic sarcomatoid 
cholangiocarcinoma who underwent a hepatic resection. The 
main part of the tumor consisted of pleomorphic spindle and 
giant cells.
961
SAFE RESECTION FOR HILAR 
CHOLANGIOCARCINOMA IN THE 
ABSENCE OF PORTAL VEIN 
EMBOLIZATION OF PERCUTANEOUS 
TRANSHEPATIC BILIARY DRAINAGE
H. Ramesh, S. Rather, M. Wani and B. Abraham
Department of GI surgery, Lakeshore Hospital, Cochin, 
Kerala, India
31/543, Subash Nagar, Edappally, 68202 Cochin, India
Introduction: Resection of hilar cholangiocarcinoma is 
complicated by the presence of jaundice, and the need for 
major liver resection. Many centers perform both PTBD and 
PVE to decrease jaundice and increase the functioning liver 
remnant. This paper describes the results with resection in 
the absence of either PVE or PTBD.
Methods: 124 cases were resected over a 15 year period. 
There were 11 extended right hepatectomies, 23 right hepa-
tectomies, 37 left hepatectomies, 7 extended left hepatecto-
mies, and 48 parenchyma conserving liver resections. 
Bilirubin levels ranged from 1.2 to 16 mgs% and 65 patients 
had co-morbid illness. Patients age ranged between 37 and 
85 years. 55 patients presented with lobar atrophy necessitat-
ing resection of that lobe.
Results: 9 patients died (4 of hepatic failure, 2 of ARDS, 2 
of septicemia, and 1 due to irreversible shock secondary to 
intraoperative hypotension. Median survival was 25 months. 
Factors affecting mortality were a) intraoperative blood loss, 
prolonged hypotension and combined venous and hepatic 
resection. Factors affecting survival were a) curative resec-
tion, b) lymph node positivity and c) perineural infi ltration.
Conclusion: Resection for Hilar cholangiocarcinoma can be 
performed safely in the absence of PVE or PTBD.
967
EVALUATION OF CAUSES AND 
TREATMENT OF SURGICAL 
JAUNDICE AT TERTIARY CARE 
HOSPITAL IN PAKISTAN
S. A. Razaque and D. lakhiani
Liaquat University of Medical Health & Sciences 
Jamshoro Pakistan
Liaquat University of Medical Health & Sciences 
Jamshoro Pakistan, Surgery, FNo 208 Tayab complex 
cantt. saddar Hyderabad Paskistan, 91000 Hyderabad, 
Pakistan
Introduction: surgical jaundice is a common problem in 
Pakistan but the causes differ from the western countries and 
the management is also different due to lack of latest modali-
ties of treatment.
Methods: prospective study of 80 case of surgical jaundice 
from January 2008 to December 2008 conducted at Liaquat 
University of Medical Health & Sciences Jamshoro Pakistan. 
All the patients above the age of 15 years of both sexes 
having surgical jaundice diagnosed on the basis of clinical 
grounds and supported by LFT and ultrasonography.
Results: average age of presentation was 45 years with 
female to male ratio 1.5 : 1. Seventy percent of the case were 
due to malignancy. the most common cause was carcinoma 
head of pancreas in 27 (33.75%) cases followed by bile duct 
stone disease in 24 (30%) cases. The common bile duct 
stones were managed by choledochotomy and the malignant 
case were managed by biopsy alone in 30 (37.5%), bypass 
in 20 (25%) and curative resection in 6Cases (7.5%). The 
mortality was 11.25%. Maximum survival for carcinoma of 
pancreas was 9 months.
Conclusion: the malignancy is the most common cause of 
the surgical jaundice and is more common in females in our 
area. Due to lack of modern modalities of treatment the 
common bile duct stones were managed by open cholecys-
tectomy and supraduodenal choledochotomy. Due to 
advanced nature of malignancy the internal biliary drainage 
was the best option.
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SURGICAL MANAGEMENT OF 
THORACO-OMPHALOPAGUS 
TWINS: HEPATO-PANCREATICO-
BILIARY ISSUES
C. Moir, D. Nagorney, J. Matsumoto, T. Vrtiska, J. Dearani 
and R. Clay
Mayo Clinic, Rochester
Mayo Clinic, Pediatric Surgery, 200 1st ST SW55905 
Rochester, MN, USA
Introduction: Surgical management of conjoined twins is 
complex and requires a multidisciplinary team. In Thoraco-
omphalopagus twins (TOTs), co-existent conjoining of 
hepato-pancreatico-biliary and duodeno-jejunal anatomy are 
major factors affecting operative timing, approach and 
outcome. The aims of this study were to defi ne the frequency 
of HPB/DJ abnormalities, to defi ne a preferred imaging 
approach and to briefl y overview our outcomes.
Methods: We retrospectively reviewed the clinical records 
of 6 TOTs. HPB and DJ anatomical abnormalities were 
detailed, imaging approaches reviewed and outcomes inclu-
sive of growth and development (G&D) assessed. Mortality 
and morbidity was based on the expectation of 12 separated 
children. Pre-operative planning for separation was through 
a multidisciplinary team of surgeon, anesthesiologists, nurses 
and para-medical personnel.
Results: Median age of separation was 112 days. Conjoined 
anatomical structures were: Manubrium/sternum/xyphoid in 
5, pericardium – 5, liver – 5, bile duct – 3, pancreas – 3, 
duodenum/jejunum – 3 and omphalocele – 6. Congenital 
heart disease and pulmonary hypertension occurred in 4 
TOTs and 1 child respectively. Contrast enhanced CT of each 
TOT child best defi ned HPB and DJ anatomy. One child died 
(pulmonary hypertension). Liver function was normal post-
separation. Bile fl ow was maintained through CBD in 9 
children and hepatico-jejunostomy – 3. Single DJs were 
separated in 6. Omphaloceles were closed in 5 TOTs. One 
bile leak resolved with percutaneous drainage. There were 
no late HPB complications. G&D has progressed normally 
in 11 of 12 children.
Conclusion: HPB and DJ anatomic abnormalities are 
common in TOTs. Contrast enhanced CT imaging inclusive 
of CT cholangiography accurately defi nes abnormalities and 
provides an anatomic framework for planning separation 
through a multidisciplinary surgical team. Separation of 
TOTs can be safe, provide durable repair of HPB/DJ abnor-
malities and lead to normal childhood growth and 
development.
972
POST-TREATMENT OUTCOMES 
FOR INTRAHEPATIC 
CHOLANGIOCARCINOMA
M. House, A. Golas, B. Rapp, M. Johnson, A. Nakeeb and 
H. Pitt
Indiana University School of Medicine
Indiana University School of Medicine, Surgery, 545 
Barnhill Drive, Emerson Hall, 52946202 Indianapolis, 
United States
Introduction: The incidence of intrahepatic cholangiocar-
cinoma (ICC) is increasing worldwide. Complete operative 
resection represents the only potentially curative treatment 
option for ICC; however, many patients present with 
advanced stage, unresectable disease. The aim of this study 
was to analyze the outcomes for patients with ICC treated 
with resection or hepatic artery embolization.
Methods: Patients with ICC were reviewed at a single insti-
tution between January 2003 and May 2010. Clinical and 
pathologic data were collected retrospectively for pts who 
underwent either non-transplant resection (n = 36, median 
age = 62 yrs) or hepatic artery embolization (n = 12, median 
age = 65 yrs). Standard or extended right hepatectomy was 
performed in 16 pts. Overall survival was calculated from 
the date of operation or fi rst treatment to the date of last 
follow-up or death.
Results: Median tumor diameter was 6.5 cm (range, 1.8–
18.2 cm). A margin-negative (R0) resection was accom-
plished in 11 pts (30%). Median length of hospital stay was 
10 days (5–28 d). Two postoperative deaths were recorded, 
and postoperative morbidity was observed in 23 pts (64%). 
Seven pts (19%) were staged as LN positive, and 8 pts (22%) 
had multifocal disease on fi nal pathology. Actuarial median 
overall survival (OS) after resection was 28 mos (0.5–96 m), 
and 8 pts died of hepatic recurrences less than 12 mos after 
operation. Twelve pts, 5 with locally unresectable and 7 with 
limited metastatic disease underwent hepatic artery emboli-
zation with downsizing effect. Actual median OS after fi rst 
embolization treatment was 10 mos (0.6–20 m).
Conclusion: Outcomes after hepatectomy for ICC can be 
improved by better patient selection and reducing postopera-
tive morbidity. Liver-directed therapies can achieve reliable 
tumor downsizing effect, which in the neoadjuvant setting, 
could increase the R0 resection rate for patients undergoing 
resection for intrahepatic cholangiocarcinoma.
973
CYSTOPERICYSTECTOMY – WHEN AND 
WHY, OUR EXPERIANCE
D. P. Vasavada, S. Mehta, A. Mehta and H. P. Trivedi
Department of Surgery, M P Shah Medical College, 
Jamnagar, Gujarat, India 361008
M P Shah Medical College, Jamnagar, Gujarat, INDIA 
361008, Department of Surgery, Head of Department, 
Department of Surgery, M P Shah Medical College, 36100 
Jamnagar, India
Introduction: To evaluate scope for major liver resection 
against the conventional partial cytectomies for hydatid cysts 
of liver at general surgical department.
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Methods: we are presenting study of last 10 years of liver 
hydatid cysts managed surgically at our secondary health 
care center of district level hospital. patients were of 6 years 
to 65 years of age and some of them were having co-morbid 
conditions like diabetes, COPD, IHD etc. Out of 542 patients 
included in study, 470 were managed by conventional partial 
cystectomies and 72 were managed by cystopericystectomy 
as we have started this at our centre since last two and half 
years. The operative time, ease of surgery, requirement of 
blood transfusion, recurrence, morbidity and mortality were 
compared between both groups.
Results: We found that for the cyst clearance both of the 
procedures were equally effective and we have seen recur-
rence rate less than 1 percent in both of the procedure. 
However for operative times, ease of surgery and blood 
transfusion requirement, the partial cystectomy was having 
an upper edge. We had 3 biliary fi stula in this group. Out of 
72 cystopericystectomies, we had 2 deaths due to massive 
haemorrhage from middle hepatic veins.
Conclusion: we found that cystopericystectomy can be kept 
reserved for infected hydatid cysts where biliary communi-
cation is diffi cult to handle in partial cystectomies. It can also 
chosen in patients fi t for major liver resections and without 
any co-morbid conditions. Moreover cystopericystectomy 
need higher level surgical skill and setup which might not 
possible for every hospital of developing contry.
999
LAPAROSCOPIC RADICAL 
CHOLECYSTECTOMY FOR T3 
GALLBLADDER CARCINOMA
A. K. Agarwal
Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi 110002, India
Background: Traditionally laparoscopic surgery has been 
contraindicated in patients with suspected gall bladder cancer 
(GBC). Recently however safety and feasibility of laparo-
scopic surgery has been reported in a few patients with early 
(T1 and T2) GBC. This study was done to determine safety 
and feasibility of laparoscopic radical cholecystectomy 
(LRC) for T3 GBC.
Methods: Prospective study performed at our institute 
between June and November 2011. Patients with GBC with 
limited liver infi ltration were considered for LRC. Patients 
with extensive liver infi ltration, jaundice and extrahepatic 
adjacent organ involvement were excluded. The procedure 
was performed using fi ve ports with the patient in the supine 
position with leg split. Standard radical cholecystectomy 
(resection of segments IVB and V) was performed with 
standard lymphadenectomy (clearance of nodes from the 
hepatoduodenal ligament, skeletonizing the vascular struc-
tures and the bile ducts with clearance of nodes anterior and 
posterior to the head of the pancreas and the hepatic artery 
till its origin from the celiac axis).
Results: Four patients underwent LRC during the study 
period. Median operating time was 290 min (range 
240–340 min). Median blood loss was 150 ml (range 
100–300 mL). Small subhepatic collection with wound 
infection occurred in one patient which resolved with single 
time aspiration of subhepatic collection. Median post-
operative hospital stay was 5 days (range 3–16 days). On 
fi nal histopathology all patients had T3 GBC. Median (indi-
vidual cases yield) lymph node yield was 10 (7, 9, 11, 13). 
All patients received adjuvant chemotherapy. During median 
follow up of 4 months (range 1–5 months) all patients were 
alive without any evidence of recurrence or metastasis.
Conclusion: Laparoscopic radical cholecystectomy is safe 
and feasible in selected patients with T3 GBC.
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PRE RESECTION PORTAL VEIN 
EMBOLIZATION DOES NOT AGGRAVATE 
RECURRENCE OF COLO-RECTAL LIVER 
METASTASES IN THE REMNANT LIVER. 
A CASE-CONTROL STUDY
M. Ben-Haim1, Y. Goykhman1, N. Lubezky1, I. Kori2, 
E. Shacham-Shmueli3, I. Nachamany1, R. Nakache1 and 
J. Klausner1
1Surgery, Tel Aviv Medical Center; 2IR, Tel Aviv Medical 
Center; 3Oncology, Tel Aviv Medical Center
Tel Aviv Medical Center, Surgery, 6 Weizman st. 64239 Tel 
Aviv, Israel
Introduction: Selective portal vein embolization (PVE) is 
applied frequently before resection of colorectal liver 
metastases (CRLM). Theoretically, induction of atrophy-
hypertrophy may exacerbate recurrence in the remnant liver.
Methods: a case control study. Patients with CRLM who 
were treated in a curative intent with surgery and chemo-
therapy are included. Each patient in the PVE group was 
paired with a control patient who was also treated by surgery 
and chemotherapy, adjusted by age and clinical risk predic-
tors (number and size of lesions, synchronicity, nodal 
involvement and MSKCC-CS). Incidence and pattern of 
recurrence were compared.
Results: PVE was performed prior to 21/370 (6%) resec-
tions of CRLM (2003–2010). 5 cases are excluded due to 
inadequate hypertrophy (2), Extra hepatic metastases (2) and 
perioperative death (1). The PVE- and control groups were 
comparable: Mean age, 62.9 vs. 60.3; Original tumor site, 
colon, 12 and rectum, 4 in both; number of lesions, solitary, 
2 vs. 3, 2–6, 10 in both, >6, 4 vs. 3; synchronicity, 75% vs. 
62.5%; R0 resection, 94% vs. 88% and mean MSKCC-CS, 
2.5 vs. 2.7. Bi lobar spread was more frequent in the PVE 
group, 75% vs. 37% and types of resections were different 
accordingly. The mean follow up after resection was 20.7 
months vs. 20.2 respectively. Liver only recurrence was 37% 
in the PVE group vs. 31% in the control.
Conclusion: Induction of hepatic hypertrophy by PVE 
before resection of CRLM appears to be safe and does not 
aggravate liver remnant recurrence.
018
HEPATECTOMY AND RESECTION OF 
CONCOMITANT EXTRAHEPATIC 
DISEASE FOR COLORECTAL LIVER 
METASTASES – A SYSTEMATIC REVIEW
T. Chua, A. Saxena, W. Liauw, F. Chu and D. Morris
St George Hospital, Surgery, Hepatobiliary and Surgical 
Oncology Unit, UNSW Department of Surgery, Level 3 
Pitney Building, St George Hospital, Kogarah 2217 
Sydney, Australia
Introduction: Recent data suggests that hepatectomy for 
patients with colorectal liver metastases (CLM) with con-
comitant extrahepatic disease (EHD) achieve encouraging 
survival result. The authors examine the clinical effi cacy of 
this treatment approach through a systematic review of the 
published literature.
Methods: Electronic search of the MEDLINE and PubMed 
databases (January 2000 to January 2011) to identify studies 
reporting outcomes of hepatectomy for CLM with resection 
of EHD was undertaken. Two reviewers independently 
appraised each study using a predetermined protocol. Clinical 
effi cacy was synthesized through a narrative review with full 
tabulation of results of all included studies.
Results: Twenty-two studies were examined. This com-
prised of 1142 patients. The median disease-free survival 
was 12 (range, 4 to 22) months, median overall survival was 
30 (range, 14 to 44) months and median 5-year survival rate 
was 19% (range, 0 to 42%). Median 5-year survival of 
patients with R0 hepatectomy with resection of EHD was 
25% (range, 19% to 36%). Survival based on site of EHD 
include lung; median survival (M/S) was 41 (range, 32 to 46) 
months, porto-caval lymph node; M/S was 25 (range, 19 to 
48) months, peritoneal metastases; M/S was 25 (range, 18 to 
32) months.
Conclusion: In the era of effective systemic therapies, sur-
gical resection of CLM and concomitant EHD in carefully 
selected patients may achieve survival results superior to 
non-surgically treated patients. This treatment strategy may 
be considered appropriate especially when a R0 hepatectomy 
and complete resection of EHD may be achieved.
027
PATIENTS WITH MULTIPLE 
SYNCHRONOUS COLONIC CANCER 
HEPATIC METASTASES BENEFIT FROM 
THEIR ENROLMENT IN A ‘LIVER FIRST 
APPROACH’ PROTOCOL
D. Kardassis1, A. Ntinas1, A. Kofokotsios2, K. Papazisis3, 
C. Karanikiotis4, D. Miliaras5, A. L. Kelekis6 and 
D. Vrochides1
1Center of Hepato-Pancreato-Biliary Surgery, ‘Euromedica 
Geniki Kliniki’ General Hospital; 2Department of 
Gastroenterology, ‘Euromedica Geniki Kliniki’ General 
Hospital; 3Department of Medical Oncology, ‘Euromedica 
Geniki Kliniki’ General Hospital; 4Department of Medical 
Oncology, ‘Euromedica Kyanous Stavros’ General 
Hospital; 5Department of Pathology, ‘Euromedica Geniki 
Kliniki’ General Hospital; 6Department of Radiology, 
‘Euromedica Geniki Kliniki’ General Hospital
‘Euromedica Geniki Kliniki’ General Hospital, Center of 
Hepato-Pancreato-Biliary Surgery, 2, Gravias Str.54645 
Thessaloniki, Greece
Introduction: This study was conducted in order to assess 
the ‘reverse’ strategy (liver fi rst approach) when treating 
patients with multiple synchronous colonic (not rectal) 
cancer hepatic metastases that are initially not resectable in 
one stage.
Methods: A retrospective review of prospectively recorded 
data was undertaken. Patients who were enrolled in the pro-
tocol (ECOG performance status 0) suffered from colon 
cancer and synchronous multiple liver metastases (type II or 
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III), with no indication of extrahepatic disease. All patients 
were treated with curative intent. Complete preoperative 
staging (incl. PET-CT) was performed. In case of an immi-
nent bowel obstruction, an intraluminal stent was placed 
endoscopically. Subsequently, patients received neo-
adjuvant chemotherapy. Provided a positive response, they 
initially underwent one or two hepatectomies followed by 
the colectomy. In between, disease re-staging was performed 
to exclude progression and chemotherapy regimens were 
administered.
Results: Data from 10 consecutive patients (7 men) with a 
mean age of 64.8 (SD ± 15.8) years were studied. The 
median observation period was 9.5 (6–18) months. An intra-
luminal stent had to be placed in 5 patients. Four patients 
completed all planned surgical operations, on average 2.7 
procedures. Their median overall survival period was 15.6 
(95% CI 13.5–17.6) months and their median disease-free 
survival period, after completing the protocol, was 5.3 (95% 
CI 0.7–9.8) months. Patients who were not able to undergo 
all scheduled operations due to disease progression achieved 
a median overall survival period of 9.6 (95% CI 7.0–11.9) 
months. There was no need for a palliative colectomy.
Conclusion: In cases of extensive liver metastatic disease 
originating from colon cancer, the ‘reverse’ therapeutic 
approach within a protocol is feasible. It probably ensures 
that all patients will receive chemotherapy and avoids unnec-
essary surgery. Conclusions concerning possible overall sur-
vival prolongation can be drawn only after validation of 
these results by a further follow-up and preferably by a pro-
spective randomized trial.
028
SUMMARY OUTCOMES OF TWO-STAGE 
RESECTION FOR ADVANCED 
COLORECTAL LIVER METASTASES
T. Chua1, F. Chu1, W. Liauw2 and D. Morris1
1Hepatobiliary and Surgical Oncology Unit, UNSW 
Department of Surgery, St George Hospital, Sydney, 
Australia; 2Cancer Care Centre, Department of Medical 
Oncology, St George Hospital, Sydney, Australia
St George Hospital, Sydney, Australia, Hepatobiliary and 
Surgical Oncology Unit, UNSW Department of Surgery, 
Level 3 Pitney Building, Hepatobiliary and Surgical 
Oncology Unit, UNSW Department of Surgery, St George 
Hospital, Sydney, 2217 Kogarah, Australia
Introduction: Surgical resection is associated with 
improved long-term survival in patients with colorectal liver 
metastases (CLM). However, majority of patients have unre-
sectable bilobar advanced liver metastases. Two-stage resec-
tion (TSR) allows selected patients to achieve complete 
resection of metastases through surgery combined with 
chemotherapy and interventional radiological procedures.
Methods: Electronic search of the MEDLINE and PubMed 
databases (January 2000 to October 2011) to identify studies 
examining the outcomes of the surgical approach of TSR of 
advanced CLM was undertaken. Clinical effi cacy and predic-
tive factors was compiled and synthesized through a narra-
tive review with full tabulation of results of all included 
studies.
Results: Twelve studies were examined. This comprised of 
488 patients. A median of 77% (range, 64% to 100%) com-
pleted TSR. The most common failure to complete TSR was 
due to disease progression in a median of 100% (range, 56% 
to 100%). Second-stage resection appeared to be more 
morbid compared to fi rst-stage resection with higher compli-
cation rate (33% vs. 14%) and requiring more blood transfu-
sion (3 units vs. 1 unit). Completed TSR achieved a median 
survival of 37 (range, 18 to 66) months, median 3-year sur-
vival rate was 60% (range, 45% to 84%) and median 5-year 
survival rate was 48% (range, 32% to 70%). In patients who 
failed TSR, the median survival was 16 (range, 10 to 29) 
months.
Conclusion: In carefully selected candidates with advanced 
bilobar CLM, the TSR approach achieves long-term survival 
in patients who would traditionally be only considered for 
palliative chemotherapy. Failure to complete TSR did not 
appear to adversely affect outcome in patients who only 
underwent fi rst-stage resection.
042
RELATIONSHIP BETWEEN 
PERIOD OF SURVIVAL AND 
CLINICOPATHOLOGICAL 
CHARACTERISTICS IN PATIENTS WITH 
COLORECTAL LIVER METASTASIS
A. Nanashima, T. Abo, T. Sawai, T. Yasutake and 
T. Nagayasu
Division of Surgical Oncology, Department of Surgery, 
Nagasaki University Hospital
Nagasaki University Hospital, Division of Surgical 
Oncology and Department of Surgery, 1-7-1 Sakamoto 852 
Nagasaki, Japan
Introduction: Cancer death in the early period after hepa-
tectomy still remains in patients with colorectal liver metas-
tasis (CLM). We examined the relationship between 
clinicopathological parameters and survival periods in 130 
CLM patients who underwent hepatectomy.
Methods: Patients were divided into four groups: Group 1 
(5-year survivors without tumor relapse), Group 2 (survivors 
at 2–5 years), Group 3 (cancer death at 2–5 years), and Group 
4 (cancer death within 2 years).
Results: A short surgical margin was frequent in Group 4 
compared to Group 1 (31 vs 78%, p < 0.05). Primary node-
positive status, absence of fi brous pseudo-capsular forma-
tion, higher Clinical Risk Score, and tumor recurrence within 
12 months were frequent in Group 4 (p < 0.05). Multivariate 
analysis revealed a short surgical margin (HR; 3.5) and early 
tumor relapse (HR; 5.9) as independently signifi cant related 
parameters (p < 0.05).
Conclusion: A suffi cient surgical margin, or careful follow-
up for early tumor relapse may be important to improve 
outcomes after surgery in CLM patients.
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048
THORACIC SURGICAL MANAGEMENT 
OF COLORECTAL LUNG METASTASES: 
A QUESTIONNAIRE SURVEY OF 
MEMBERS OF THE SOCIETY FOR 
CARDIOTHORACIC SURGERY IN GREAT 
BRITAIN AND IRELAND
A. Siriwardena1, S. Jegatheeswaran1, A. Sheen1, 
T. Satyadas1 and T. Treasure2
1Regional Hepatobiliary Surgical Unit, Manchester Royal 
Infi rmary, Manchester, United Kingdom; 2Clinical 
Operational Research Unit, University College London, 
United Kingdom
Manchester Royal Infi rmary, Regional Hepatobiliary 
Surgery Unit, Oxford Road, Manchester M139W, United 
Kingdom
Introduction: Distant metastases to liver and lung are not 
uncommon in colorectal cancer. Resection of metastases is 
widely accepted as standard of care. However there is no fi rm 
evidence base for this. This questionnaire survey was carried 
out to assess the current practice preferences of cardiotho-
racic surgeons of Great Britain and Ireland.
Methods: An online questionnaire survey was emailed to 
cardiothoracic surgeons in Great Britain and Ireland. The 
survey was live for 12 weeks. Responses were collated on 
SurveyMonkey®.
Results: Of 75 respondents [>75% of UK thoracic sur-
geons], 62 indicated thoracic surgery as a specialist interest. 
Sixty-eight used thoracic CT for staging; 48 (70%) added 
liver CT and 35 (51%) added pelvic CT. FDG-PET was used 
by 59 (86%). The most frequent indication for pulmonary 
resection was solitary lung metastasis without extra-thoracic 
disease. Video-assisted thoracoscopic surgery (VATS) was 
used by (85%). In addition, thoracotomy was used by 63 
(96%). Twenty-two (33%) used radiofrequency ablation 
(RFA). Synchronous liver and lung resection was contrain-
dicated for 83%. Fifty-two (77% of 68) thought that scientifi c 
equipoise presently exists over the risk: benefi t ratio for lung 
resection for colorectal lung metastases but only 2.
Conclusion: The results confi rm that the majority of 
respondents utilize conventional cross-sectional imaging and 
use either VATS or formal thoracotomy for resection. The 
results emphasize the continuing need for formal randomized 
trials to provide evidence of any survival benefi t from pul-
monary metastasectomy for colorectal lung metastases.
051
STRATEGY FOR SYNCHRONOUS AND 
MULTIPLE LIVER METASTASIS
S. Osada, H. Imai, Y. Sasaki and K. Yoshida
Surgical Oncology, Gifu University School of Medicine, 
1-1, Yanagido, 501 Gifu, Japan
Introduction: Surgical indications for resection of synchro-
nous metastasis from colorectal cancer (CRC) and the 
optimal timing of hepatectomy are still controversial and 
widely debated. In present, we will argue the strategy for 
synchronous and multiple liver metastasis from CRC.
Methods: Synchronous and multiple metastatic liver tumors 
were detected in 57 since May/2005. Our treatment policy 
has been to perform hepatectomy fi rst, if the resection can 
be done with no limit on size and number of tumors. However, 
if curative resection is not, chemotherapy is begun fi rst and 
timing for the possibility of a radical operation is planned 
immediately. In 37 patients whose tumors were located only 
in the liver, primary tumor resection was performed fi rst in 
16 patients, and after tumor-decreasing by chemotherapy, 
operation was performed in 7 patients. In 20 patients in 
whom chemotherapy was performed fi rst, hepatectomy was 
performed in 3 patients, and staged hepatectomy was per-
formed in 10 patients.
Results: 1) Recurrence was detected after hepatectomy in 
75.0% of simultaneous resection cases and in 70.0% of 
staged cases. In the recurrence cases, early detection (within 
6 months) after tumor resection occurred in 58.3% of the 
simultaneous and 14.2% of the staged. 2) No differences in 
results of pre- and postoperative liver function tests were 
found, and duration of hepatectomy and blood loss were also 
similar. 3) Median survival time (MST) and 2-year survival 
rate were signifi cantly better in the hepatic resection cases 
than in the non-operated cases. There was no signifi cant dif-
ference in MST or 2-year survival rate between simultaneous 
and staged cases. 4) In 10 staged cases, length of chemo-
therapy had no effect on patient condition.
Conclusion: The present data show that neoadjuvant chem-
otherapy does not increase the risk of postoperative compli-
cations or the surgical diffi culties of hepatectomy for 
colorectal metastases.
055
EVALUATION OF TUMOUR MARKERS 
AS HELPFUL DIFFERENTIAL 
DIAGNOSTIC TOOL IN PATIENTS WITH 
SUSPECTION AT BREAST CANCER 
LIVER METASTASES
V. LISKA1, V. Treska1, L. Holubec2, J. Vrzalova3, 
T. Skalicky1, O. Vycital1, J. Bruha1 and O. Topolcan3
1Department of Surgery, Medical School and Teaching 
Hospital Pilsen, Charles University Prague, Czech 
Republic; 2Department of Oncology, Medical School and 
Teaching Hospital Pilsen, Charles University Prague, 
Czech Republic; 3Central Isotopic Laboratory, Medical 
School and Teaching Hospital Pilsen, Charles University 
Prague, Czech Republic
Teaching Hospital and Medical School Pilsen, Charles 
University Prague, Department of Surgery, Alej svobody 
80, 30400 Pilsen, Teská republika
Introduction: The tumour markers were demonstrated as 
useful auxiliaries in follow up of patients with breast cancer, 
in detection of recurrence and in control of oncologic therapy 
effect, but no study was performed to distinguish benign liver 
lesions from breast cancer metastases. The aim of this study 
was therefore to evaluate the importance of tumour markers 
(CEA, CA19-9, TK, TPA, TPS and CYFRA 21-1) in dif-
ferential diagnosis between benign liver lesions and liver 
metastases of breast cancer.
Methods: The study includes 3 groups: I. 22 patients with 
breast cancer liver metastases and II. Group of patients with 
benign diagnosis (intrahepatic: 39 patients with benign liver 
lesions (hemangiomas, focal nodular hyperplasia, liver cysts, 
hepatocellular adenomas) and III. Group of healthy control: 
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21 patients without any liver disease or lesion that were 
operated for benign extrahepatic diseases (groin hernias, 
varices of lower limbs). The serum levels of tumour markers 
were assessed by means of immunoanalytical methods.
Results: We proved that preoperative serum levels of 
CYFRA 21-1, TPA, TPS and CEA were increased in patients 
with liver metastases of breast cancer in contrary to healthy 
controls and patients with benign liver lesions (p-value < 
0.05). On the other hand serum levels CA19-9 and TK were 
increased in the malignant patients in comparison with 
benign controls and healthy patients but these differences 
were not statistically signifi cant.
Conclusion: We demonstrated that tumour markers (CEA, 
CYFRA21-1, TPA and TPS) could be recommended as a 
good diagnostic tool for differential diagnosis of breast 
cancer liver metastases from benign liver lesions.
This project was supported by grant IGA MZ CR NR 
12025 and 10240.
064
RADIOFREQUENCY ABLATION FOR 
COLORECTAL LIVER METASTASES – 
CURRENT INDICATIONS 
AND OUTCOMES
D. Gomez1, D. Gomez1, A. De Rosa1, A. Addison1, 
W. K. Dunn2, A. Brooks1 and I. C. Cameron1
1Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust, Nottingham, United Kingdom; 
2Department of Radiology, Queen’s Medical Centre, 
Nottingham University Hospitals NHS Trust, Nottingham, 
United Kingdom
Queen’s Medical Centre, Department of Hepatobiliary and 
Pancreatic Surgery, E Floor, West Block, Queen’s Medical 
Centre, Derby Road, Nottingham NG7 2UHNG72U, United 
Kingdom
Introduction: With the increasing availability of radiofre-
quency ablation (RFA) in various centres, more patients are 
being offered this treatment modality, including patients with 
colorectal liver metastasis (CRLM). The aim of the current 
study was to evaluate the clinical indications and current 
outcomes following RFA treatment in patients with CRLM.
Methods: Relevant articles were reviewed from the pub-
lished literature using the Medline database. The search was 
performed using the keywords ‘colorectal cancer’, ‘liver 
metastases’, ‘liver resection’ and ‘radiofrequency ablation’.
Results: Six non-randomised studies were identifi ed from 
2004. Most studies assessing the effi cacy of RFA in CRLM 
have included patients unfi t for surgery. Patients treated with 
RFA had a worse disease-free survival, with most recur-
rences located in the liver. Published 5-year survival rates 
were 14% to 55% and local tumour recurrence rates were 
3.6% to 60%. Prognostic factors that infl uenced outcome 
following RFA include tumour burden, CEA level and extra-
hepatic disease. Currently, patients unfi t for surgery and 
patients requiring combination therapy are offered RFA. 
There is insuffi cient evidence to suggest RFA as an alterna-
tive to liver resection for patients with resectable CRLM.
Conclusion: There are no established selection criteria for 
patients with CRLM for RFA. The outcome of RFA treatment 
is dependent on tumour burden, disease location, number 
of ablations performed per tumour and the use of 
chemotherapy.
067
RADIOEMBOLIZATION AND 
CHEMOEMBOLIZATION FOR 
UNRESECTABLE NEUROENDOCRINE 
LIVER METASTASES – A 
SYSTEMATIC REVIEW
T. Chua, T. Yang and D. Morris
Hepatobiliary and Surgical Oncology Unit, UNSW 
Department of Surgery, St George Hospital, Kogarah, 
Sydney, NSW 2217, Australia
Introduction: A number of therapeutic modalities have 
been explored to improve the outcome of patients with neu-
roendocrine tumour liver metastases (NETLM), in particular 
the use of hepatic artery chemoembolization and intra-arte-
rial radioembolization. This review examines its clinical 
effi cacy and safety.
Methods: Literature search of databases (Medline and 
Pubmed) to identify published studies of the use of hepatic 
artery chemoembolization and radioembolization of NETLM 
was undertaken. Response to treatment and survival outcome 
was examined as endpoints of this review.
Results: Twenty fi ve studies (seven studies – radioemboli-
zation, 18 studies – chemoembolization) comprising 1138 
patients were reviewed. For patients who underwent radi-
oembolization, the rate of partial and complete response 
ranged from 12.5% to 66% (median = 55%), the median 
overall survival ranged from 14 to 70 mths (median = 
26.5 mths), and the 5-year survival ranged from 46% to 55% 
(median = 50.5%). For patients who underwent chemoem-
bolization, the rate of partial and complete response ranged 
from 11.1% to 78% (median = 49%), the median overall 
survival ranged from 15 months to 69 months (median = 39 
months), and the 5-year survival ranged from 11.1% to 
65.4% (median = 31%).
Conclusion: Both chemoembolization/bland embolization 
and radioembolization appear to be equally effective strate-
gies to manage unresectable or treatment refractory NETLM. 
Further investigation into the long term outcome and pro-
spective clinical trials to examine the relative effi cacy and 
safety are warranted.
073
LIVER REMNANT HYPERTROPHY 
INDUCTION – HOW OFTEN DO WE 
NEED IT IN THE TIME OF COMPUTER 
ASSISTED SURGERY?
G. A. Stavrou, M. Donati, K. J. Oldhafer and 
G. A. Stavrou
Department of General and Visceral Surgery, Asklepios 
Hospital Barmbek, Ruebenkamp 220, Hamburg 22291, 
Germany
Introduction: To evaluate the signifi cance of the hypertro-
phy concept in patients requiring extended liver resections 
in the time of computer assisted surgery.
Methods: Analysis of patient collective between 01/2005 
and 12/2009 undergoing major liver surgery. 2D CT, 3D 
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CAS with Fraunhofer MeVis Sofware. PVE, PVL as 1. Stage 
operative procedure.
Results: 2D CT data identifi ed 29 patients to be at risk for 
liver failure after resection. After 3D CAS analysis and 
virtual operation planning only 7/29 were at true risk and 
were submitted to PVO. Another 5 patients were submitted 
to the hypertrophy concept for intraoperative fi nding of 
insuffi cient parenchyma quality. In total 12 patients under-
went PVO (6 PVE/6PVL). 9/12 patients went to stage 2 and 
were successfully operated. There was no difference in 
FRLV gain or waiting time to step 2 between the groups, 
though survival was better in the PVE group.
Conclusion: PVO is an effective approach if the patients 
FRL is too small on 2D CT volumetry. 3D CAS has great 
impact on the analysis of FRL capacity and in augmenting 
resectability – in our experience only patients with insuffi -
cient FRLV on the virtual resection plan have to take the risk 
of PVO to maintain the chance of liver resection.
074
NOVEL NAVIGATION SURGERY FOR 
ULTRASONOGRAPHY – INVISIBLE 
HEPATIC TUMOR
K. Kasuya
Tokyo Medical University Hospital Surgery, 6-7-1 
Nishishinjuku Shinjukuku 160-0 Tokyo, Japan
Introduction: Resection of hepatic tumors is determined on 
the basis of intraoperative ultrasonography (US) fi ndings. To 
visualize hepatic tumors which are invisible on conventional 
intraoperative contrast-enhanced US, diagnostic MRI images 
were incorporated into the procedure using real-time virtual 
sonography (RVS). The purpose of this study was to estab-
lish a novel surgical method for US-invisible hepatic tumors 
using RSV with indocyanine green (ICG) navigation while 
observing the fl uorescence.
Methods: The site of the tumor as a target was marked 
employing a US-guided puncture method using ICG, allow-
ing the observation of fl uorescence using an infrared camera 
(the Photodynamic Eye [PDE]). Case 1: Four months later 
from colectomy, MRI indicated metastasis in the S7 region 
of the liver. Contrast-enhanced US did not yield visualization 
of the S7 region after preoperative chemotherapy. Surgical 
method: After general anesthesia, a 23-G PEIT needle was 
percutaneously inserted into the lesion, visualized using 
MPR image data of the MRI under the guidance of RSV. 
Subsequently, 200 l of an ICG-ethanol mixture was injected 
into the liver. During liver resection, the presence/absence of 
fl uorescence on the cut liver surface was observed.
Results: The pathological examination showed that the 
hepatic tumor in the S7 region was a metastatic lesion (3 mm 
in diameter) containing viable cancer cells. We thereafter 
performed this method for similar cases. We conclude that 
advances in preoperative chemotherapy and CT or MRI for 
unresectable liver metastasis have presented new challenges 
concerning surgical techniques in the intraoperative 
US-guided resection of US-invisible hepatic tumors, namely, 
US-guided hepatic resection. The 2nd case was also a 
US-invisible tumor following chemotherapy. Histologically, 
the tumor diameter was 2 mm. The ICG ethanol had spread 
only a little. In contrast, the fl uorescent area was widely 
visible. The distance from the ICG ethanol to the tumor was 
only 5 mm.
Conclusion: Advances in preoperative chemotherapy and 
CT or MRI for unresectable liver metastasis have presented 
new problems concerning the surgical techniques for the 
intraoperative US-guided resection of US-invisible hepatic 
tumors, i.e., US-guided hepatic resection. In this study, our 
method of US-invisible hepatic tumor resection under RVS 
navigation with ICG was helpful in resecting such a scar 
level of the tumor after chemotherapy.
076
OUTCOMES FOLLOWING RADIO-
FREQUENCY ABLATION FOR 
COLORECTAL LIVER METASTASES: 
SINGLE CENTRE EXPERIENCE
A. De Rosa1, S. Shore1, D. Gomez1, W. K. Dunn2, 
A. Brooks1 and I. C. Cameron1
1Department of Hepatobiliary and Pancreatic Surgery, 
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust; 2Department of Radiology, Queen’s Medical 
Centre, Nottingham University Hospitals NHS Trust
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust, Department of Hepatobiliary and Pancreatic 
Surgery, E Floor, West Block, Queen’s Medical Centre, 
Derby Road, Nottingham NG7 2UHNG72U, United 
Kingdom
Introduction: The aim of this study was to evaluate the 
outcomes of patients with colorectal liver metastases 
(CRLM) following radio-frequency ablation (RFA) therapy.
Methods: Patients with CRLM that were treated with RFA 
between August 2001 and July 2011 were included. Data 
collated included demographics, details of CRLM treatment 
and survival outcomes.
Results: 20 patients with CRLM underwent RFA. All 
patients had a solitary metastasis, with a median size of 
26 mm. The metastases were metachronous in 11 patients 
and 19 patient had disease confi ned to the liver. Percutaneous 
RFA was performed in 90% (n = 18) of cases and intra-
operatively in 2 cases. RFA was the primary treatment 
modality in 5 (25%) patients deemed unfi t for surgery. RFA 
with liver resection was performed in 3 patients. RFA was 
used for the treatment of recurrent disease post-resection in 
12 patients. Ten patients with recurrence had received adju-
vant chemotherapy, and 3 patients had a second hepatectomy 
prior to RFA. The median time to liver recurrence post-
resection was 15 months. The median overall survival was 
30 (8–101) months.
Conclusion: In patients with unresectable and recurrent 
CRLM, RFA is a suitable alternative treatment modality in 
selected cases.
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OUTCOME OF CETUXIMAB THERAPY 
IN METASTATIC COLORECTAL CANCER 
– THE FUTURE FRONTIER?
D. Gomez, A. De Rosa, A. Addison, A. Brooks and 
I. C. Cameron
Department of Hepatobiliary and Pancreatic Surgery, 
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust, Department of Hepatobiliary and Pancreatic 
Surgery, Department of Hepatobiliary and Pancreatic 
Surgery, E Floor, West Block, Queen’s Medical Centre, 
Derby Road, Nottingham NG7 2UHNG72U, United 
Kingdom
Introduction: To review the current outcomes following 
cetuximab therapy in patients with metastatic colorectal 
cancer in the palliative setting as well as in down-staging 
programmes.
Methods: Relevant articles were reviewed from the pub-
lished literature using the Medline database. The search 
was performed using the keywords ‘colorectal cancer’, 
‘cetuximab’, ‘liver metastases’, ‘liver resection’ and 
‘hepatectomy’.
Results: Published data have observed that cetuximab may 
be benefi cial in the palliative setting and in down-staging 
programmes. In the palliative setting, cetuximab has benefi -
cial effects by increasing tumour response and survival. 
Although not all studies have observed a signifi cant increase 
in overall survival following the addition of cetuximab, the 
time to tumour progression were signifi cantly higher in the 
majority of studies. With the addition of cetuximab to current 
neo-adjuvant chemotherapy, more patients with metastatic 
KRAS wild-type colorectal cancer that were initially deemed 
to have unresectable disease are being offered surgery. 
However, the majority of published studies tend to report 
minimal surgical data and lack outcome data.
Conclusion: Current evidence suggests that cetuximab may 
be considered for unresectable disease in patients with meta-
static colorectal cancer. The addition of cetuximab in con-
ventional chemotherapy regimens has improved the effi cacy 
of down-staging programmes, leading to more patients being 
offered potentially curative resection.
078
THE ‘LIVER-FIRST’ APPROACH FOR 
SYNCHRONOUS COLORECTAL LIVER 
METASTASES: SINGLE CENTRE 
EXPERIENCE
A. De Rosa1, D. Gomez1, J. Mills2, I. J. Beckingham1, 
A. Brooks1 and I. C. Cameron1
1Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust; 2Department of Oncology, Queen’s 
Medical Centre, Nottingham University Hospitals NHS 
Trust
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust, Department of Hepatobiliary Surgery and 
Pancreatic Surgery, Department of Hepatobiliary and 
Pancreatic Surgery, E Floor, West Block, Queen’s Medical 
Centre, Derby Road, Nottingham NG7 2UHNG72U, United 
Kingdom
Introduction: In patients with synchronous colorectal liver 
metastases, there is a risk of disease progression in the liver, 
during treatment of the primary, precluding curative treat-
ment. The aim of this study was to evaluate the outcomes in 
patients managed by resection of CRLM prior to resection 
of the primary tumour.
Methods: Patients that underwent resection of synchronous 
CRLM prior to surgery for their primary tumour between 
July 2010 and December 2011 were included. Data collated 
included demographics, details of neoadjuvant therapy, mor-
bidity and mortality rates and survival outcomes.
Results: Six patients were included, and the rectum was the 
primary site in 3 cases. Prior to liver resection, three patients 
underwent chemoradiotherapy plus neoadjuvant chemother-
apy and two received neoadjuvant chemotherapy alone. One 
patient had liver resection without chemotherapy but under-
went chemoradiotherapy followed by chemotherapy post-
operatively. R0 resection rate was 17%, with no post-operative 
deaths and morbidity of 67% (n = 4). Three patients (50%) 
subsequently underwent resection of the primary tumour a 
median of 14 (6–39) weeks later. The median disease free 
survival was 11 (3–26) weeks, and all 3 patients developed 
recurrence (liver and lung n = 2 and para-aortic lymph nodes 
n = 1). The other 3 patients are awaiting primary resection.
Conclusion: Long term outcome following the reverse 
treatment approach is still to be determined.
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RESECTION OF COLORECTAL LIVER 
METASTASES FOLLOWING DOWN-
STAGING CHEMOTHERAPY 
AND CETUXIMAB
A. De Rosa1, D. Gomez1, J. Mills2, I. J. Beckingham1, 
A. Brooks1 and I. C. Cameron1
1Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust; 2Department of Oncology, Queen’s 
Medical Centre, Nottingham University Hospitals NHS 
Trust
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust, Department of Hepatobiliary Surgery and 
Pancreatic Surgery, Department of Hepatobiliary and 
Pancreatic Surgery, E Floor, West Block, Queen’s Medical 
Centre, Derby Road, Nottingham NG7 2UHNG72U, United 
Kingdom
Introduction: The aim of this study was to evaluate the 
outcomes of patients with colorectal liver metastases 
(CRLM) following down-staging with chemotherapy and 
cetuximab.
Methods: Patients with CRLM that underwent down-stag-
ing with combination of chemotherapy and cetuximab from 
May 2010–June 2011 were included. Data collated included 
demographics, surgery, morbidity and mortality rates and 
survival outcome.
Results: Of the 13 patients that underwent down-staging 
therapy for synchronous CRLM, seven (54%) patients under-
went hepatic resection after a median of 8 (2–16) cycles of 
5-fl uorourail, folinic acid and oxaliplatin (FOLFOX) and 
cetuximab. Five patients (38%) failed down-staging and 1 
patient died during cetuximab treatment. Hepatic resection 
was complete (R0) in 29% (n = 2). There were no post-
operative deaths and the morbidity rate was 45% (n = 3). Of 
the patients that underwent hepatic resection, the median 
disease-free survival was 4 (1–7) months. Two patients 
(29%) had disease recurrence at 3 and 7 months. Median 
overall survival for CRLM patients that underwent surgery 
from diagnosis was 12 (11–17) months.
Conclusion: The addition of cetuximab to neo-adjuvant 
chemotherapy regimens increases the down-staging response, 
increasing potentially curative resection in CRLM patients. 
Survival benefi t following resection in this patient group 
remains to be determined.
082
NEUROENDOCRINE LIVER 
METASTASES: OPTIONS IN THE 
MANAGEMENT AND OUTCOMES OF A 
COMBINED APPROACH
V. Velayutham, J. Sathyanesan, S. Ramaswamy, 
R. palaniappan and S. Rajagopal
Institute of Surgical Gastroenterology, Government Stanley 
Medical College and Hospital, Chennai, India
Government Stanley Medical College and Hospital, Dept 
of Surgical Gastroenterology and Liver Transplantation, 
A1, ceedeeyes apts, 33/12, VOC main road, Kodambakkam, 
Chennai, 60001, India
Introduction: Many neuroendocrine tumors (NETs) have a 
tendency to metastasize to the liver. In case of limited number 
of metastases, liver surgery or radiofrequency ablation (RFA) 
may result in apparently total clearance of metastases. 
However, it is not clear whether such therapy will provide 
symptom reduction or increased survival. Our objective was 
to analyse the options in the management of neuroendocrine 
tumours with liver metastases and we also sought to deter-
mine the effect of surgical resection.
Methods: Between January 2004 and May 2010, 42 Patients 
undergoing operations or interventions for neuroendocrine 
liver metastases from any primary were identifi ed from a 
prospective liver database. Recorded data and medical record 
review were used to analyse the type of procedure, length of 
hospital stay, peri-operative morbidity, tumour recurrence, 
progression, and survival.
Results: The median age was 40.8 years (range 16–64 
years). 48.3% of patients were female. 42 patients included 
28 carcinoids, 12 islet cell tumors, 2 nonfunctioning tumors 
from unknown origin. Thirty-six patients underwent surgical 
therapy, including anatomical liver resection (n = 22), abla-
tion (n = 4), or combined resection and ablation (n = 10). 
Hepatic artery embolization was performed in 6 patients. No 
difference was noted in the percentage of liver involved with 
tumor between the 2 groups. An association of improved 
survival was noted in patients treated surgically, with a 
3-year survival of 83% for patients treated by surgical 
resection alone or in combination, compared with 31% in 
patients treated with medical therapy or embolization. No 
difference.
Conclusion: Early and aggressive surgical management of 
hepatic metastases from neuroendocrine tumours is associ-
ated with signifi cant long-term survival rates. Radiofrequency 
ablation either alone or in combination with surgery is a 
reasonable option if a lesion is unresectable.
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LAPAROSCOPIC RADIOFREQUENCY 
THERMAL ABLATION OF LIVER 
METASTASES FROM BREAST CANCER: 
A 15-YEAR EXPERIENCE
E. Berber, Y. Tasci, O. Agcaoglu, S. Aliyev and 
A. Siperstein
Department of General Surgery, Cleveland Clinic, 
Cleveland, Ohio
Cleveland Clinic, General Surgery, 9500 Euclid Avenue/
F2044195 Ceveland, United States of America
Introduction: Introduction: Liver metastasis from breast 
cancer (LMBC) is challenging. There are limited data on the 
role of laparoscopic radiofrequency thermal ablation (RFA) 
for these patients. The aim of this study is to analyze the 
survival after laparoscopic RFA of LMBC.
Methods: Methods: The medical records of patients with 
LMBC who underwent laparoscopic RFA between 1996 
and 2011 were reviewed from an IRB-approved prospective 
database. Survival was calculated using Kaplan-Meier anal-
ysis. All data are expressed as mean ± standard error of the 
mean.
Results: There were a total of 24 female patients with a 
mean age of 50 ± 2 years who underwent 35 laparoscopic 
RFA sessions. The dominant tumor size was 3.8 ± 0.4 cm 
(range 1–10) and number of tumors per patient 2.4 ± 0.4 
(range 1–9). Tumors were unilobar in 59% and bilobar 41%. 
Seven patients (29%) had limited amounts of extrahepatic 
disease (EHD). Hospital stay was 1 day and morbidity/mor-
tality zero. During a median follow-up of 19.5 months, 41% 
of the patients developed local liver recurrence at the site of 
ablation, 63% new liver disease and 37% EHD. Local recur-
rence per lesion was 19%. Median disease-free survival was 
9 months and overall survival 2.8 years after RFA. Five-year 
actual survival was 20%.
Conclusion: Conclusion: To our knowledge, this is the 
largest experience with laparoscopic RFA of LMBC. Our 
results show that laparoscopic RFA can provide long-term 
survival with minimal morbidity in a subset of patients with 
predominantly liver disease.
094
COULD PREOPERATIVE 
CHEMOTHERAPY FOR COLORECTAL 
LIVER METASTASES CONTRIBUTE 
TO PRESERVE MAJOR VESSELS IN 
LIVER RESECTION?
K. Hiramatsu, N. Seiji and T. Kato
Department of General Surgery Toyohashi Municipal 
Hospital
Toyohashi Municipal Hospital, General Surgery, 50 
Hakken Nishi Aotake-cho, 44185 Toyohashi, Japan
Introduction: Current chemotherapy might amplify the 
chance of curative hepatectomy for colorectal liver metas-
tases. Once the resection is scheduled, tumor major vessel 
involvement often limits the extent of liver resection. The 
aim of this study is to observe the effects of chemotherapy 
for colorectal liver metastases in perivascular area of major 
vessels which is major limiting factor in liver resection.
Methods: Among 91 cases of liver resections for colorectal 
liver metastases since January 2006 till November 2011, 
because of tumor involvement, liver resections with major 
vessels, including three major stems of hepatic veins (HV) 
and central (more than segmental) glissonean pedicles (GP), 
were investigated. The effects of chemotherapy were 
reviewed on comparing computed tomography images (CT) 
with histological effects. Tumor regressions were observed 
on CT after chemotherapy. Also the distances between 
tumors and targeting major vessels before and after chemo-
therapy were measured on CT. The histological residual 
tumor existence and tumor regression effects were observed. 
The regression effects were classifi ed into 4 grades according 
to Dworak et al.
Results: Suffi cient pathological observations were possible 
in 10 cases. Observed major vessels were 2 right anterior GP, 
2 left lateral superior segmental GP, one right anterior supe-
rior GP, one left GP, 2 right HV, 2 left HV and 2 middle HV. 
Effects of regression of tumor size on CT were no CR case, 
2 cases in PR, 1 case in NC, 2 cases in PD. The number of 
patients of each histological tumor regression were grade 4, 
0 and grade 3, 1, grade 2, 1, grade 1, 4, and grade 0, 4. 
Patients with major vessel invasion were considered apart 
before and after chemotherapy in 5 cases of 10 overall on 
CT. However, pathologically residual tumor nests were still 
seen in contact with major vessels in 4 of these 5 cases.
Conclusion: Tumor regressions of colorectal liver metasta-
sis involving major vessels after chemotherapy on CT might 
not necessarily mean possible preservation of major vessels. 
Therefore, the way of liver resection for colorectal liver 
metastasis, which is limited by major vessel involvement, 
could be decided mostly at fi rst imaging diagnosis before 
chemotherapy even in the era of strong agents of 
chemotherapy.
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SURGICAL TREATMENT OF LIVER 
METASTASES (LM) FROM COLORECTAL 
CANCER (CRC). INFLUENCE OF AGE ON 
THE POSTOPERATIVE RESULTS
N. Belev, M. Slavchev, P. Rusev and A. Trifonov
Clinic of Surgery at Military Medical Academy, Plovdiv, 
Bulgaria
Military Medical Academy – Plovdiv, Clinic of Surgery, 81, 
Hristo Botev blvd., 4000 Plovdiv, Bulgaria
Introduction: Because of the population ageing, 25% of 
Europeans will be over 65 years in 2030. 76% of patients 
with newly diagnosed CRC are between 65 and 85 years. 
4418 newly diagnosed cases for 2008 in Bulgaria, 2882 
(65%) of them are over 65 years. Liver metastases occur in 
28–50% of all patients. Radical liver resection is the only 
curative option. Today liver resection is a safe procedure 
with low morbidity and mortality of only 0–11% irrespective 
of age.
Methods: For the period 01.03.2009–30.08.2011 in our 
clinic, 63 patients undergo surgery for CRCLM. 40 (63%) of 
them are over 65 years. Radical surgery was performed in 
31 (49%) cases, 20 (69%) of them are >65 years. The fol-
lowing procedures are performed – right hemihepatectomy 
– 4, left lateral sectionectomies – 3, two stage resection – 1, 
bisegmentectomies – 2, segmentectomies – 7, metastasecto-
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mies – 1. Simultaneous resections in 8 elderly patients 
(40%). The radical operations in patients <65 are 11 (39%). 
4 of them are simultaneous resections. In 7 cases meta-
chronous metastases are resected.
Results: Complications are registered in 5 patients over 65 
(12.5%) (biloma; anastomotic leak with peritonitis; stress-
ulcer GI bleeding; infected bile collection with peritonitis; 
hemorrhagic shock) and in two patients under 65 years 
(8.7%) (internal pancreatic fi stula with operative wound sup-
puration; biloma). Perioperative mortality is 1.6% (one 
patient in the >65 group).
Conclusion: Age is not a limiting factor for radical treat-
ment of CRC LM. Regardless of the signifi cantly larger 
number of comorbidities in elderly patients, liver resections 
can be performed successfully with a postoperative compli-
cations rate comparable to those of patients under 65 years.
123
TRENDS IN THE SURGICAL 
MANAGEMENT OF COLORECTAL 
LIVER METASTASES: 
A CONTEMPORARY 
SINGLE-CENTER EXPERIENCE
E. Berber, O. Agcaoglu, S. Aliyev, F. Aucejo, K. Karabulut, 
C. Miller and A. Siperstein
Department of General Surgery, Cleveland Clinic, 
Cleveland, Ohio, USA
Cleveland Clinic, General Surgery, 9500 Euclid Avenue/
F2044195 Cleveland, United States of America
Introduction: In the 2000s, newer chemotherapy regimens 
and ablation technologies have been introduced into the 
treatment of patients with colorectal liver metastases. 
Recently, the concept of aggressive liver resection (LR) has 
been reinforced. The aim of this study is to analyze the trends 
observed at our institution in the surgical treatment of color-
ectal liver metastases.
Methods: Between 2000 and 2009, 459 patients with color-
ectal liver metastases underwent surgical treatment (LR, n = 
181 or RFA, n = 278) at an academic center. Demographic, 
clinical, peri-operative and oncologic outcomes of patients 
treated before and after 2005 were compared using t-test, chi 
square and Kaplan Meier survival analyses. Data were 
obtained from prospective IRB-approved databases.
Results: After 2005, tumors became smaller (3.6 vs 4.1 cm) 
and fewer (2 vs 3) compared to before 2005. Over time, 
comorbidities and use of chemotherapy increased. LR 
patients comprised 14% of the surgical cases in 2000 and 
72% in 2009. After 2005, number of major LRs increased 
from 6% to 28%, with more preop portal vein embolizations, 
but morbidity didn’t rise. Laparoscopic LRs also saw a tem-
poral increase over time: 9% of the LRs were done laparo-
scopically in 2006 and 28% in 2009. Both disease-free (16 
vs 10 months) and overall (5-year 38% vs 24%) survival 
increased after 2005, compared to before 2005. This increase 
in overall-survival after 2005, compared to before 2005, was 
seen in both LR (5-year 67% vs 52%) and RFA (5-year 23% 
vs 17%) patients.
Conclusion: This study shows that our patients have wit-
nessed a similar global trend in the surgical management of 
colorectal liver metastases with a temporal increase in the 
utilization of chemotherapy and more aggressive LR. With a 
multidisciplinary aggressive treatment approach, we have 
seen an improved survival of all patient subgroups in our 
series over time.
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SURGICAL TREATMENT OF LIVER AND 
LUNGS COLORECTAL METASTASES
D. Ionkin, A. Vishnevsky, V. Vishnevsky and M. Pikunov
A.V. Vishnevsky Institute of Surgery, Russiageneral Surgery, 
B. Serpuchovskaya 2711799, Moscow, Russia
Introduction: Aim: Improvement the results of treatment of 
patients with liver and lungs colorectal metastases.
Methods: Investigation and treatment of 88 patients with 
colorectal metastases was carried in institute during the last 
fi ve years. Primary bowel tumor was surgically removed in 
all cases. In 59% of patients lungs and liver metastases were 
detected in one stage with large intestine tumor and at 41% 
of patients – in 6 and more months after operation on large 
intestine. All patients had adjuvant therapy. 50 (56.8%) 
patients had surgically procedures about secondary com-
bined lungs and liver lesions. From them colorectal metas-
tases were in 35 cases in liver and in one lung; and in 15 
cases in liver and in both lungs. Middle age was 51.2 years 
(25–69 years).
Results: The sequence of operations was following: 1. One-
stage hepatectomy and metastasectomy from lung – 6 (12%) 
patients; 2. hepatectomy, then in 2–3 weeks from one lung 
– 27 (54%); 3. hepatectomy, then from both lungs in one-
stage – 8 (16%); 4. hepatectomy, then-from one lung and 
then-from contralateral lung – 8 (16%); 5. Resection of right 
lung, then -hepatectomy – 1 (2%). The extent liver resection 
about metastases was following: hemihepatectomies – 25 
(50%), extended hemihepatectomies – 10 (20%), 2–3-seg-
mentectomy – 15 (30%). The extent lung resection about 
metastases was following: precision (laser, coagulation) 
metastasectomy – 23 (46%), atypical sublobar lung resection 
– 15 (30%), lobectomy – 4 (8%), thoracoscopic resection – 8 
(16%).
Conclusion: The best results of treatment of liver and lungs 
colorectal metastases are reached in the group of patients 
underwent liver resection and metastasectomy from lungs in 
2–3 weeks, especially at those patients when the secondary 
tumors have been detected only after 6 and more months 
after surgically removal of a primary tumor. The kind of 
surgical intervention on lungs had no value on the forecast 
of disease. More propitious for patients were bilateral lung 
resections through mini appro.
392 Poster Presentation Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 288–699
139
SURGICAL OUTCOMES IN PATIENTS 
WITH RECTAL CANCER AND 
SYNCHRONOUS METASTASES
J.-M. Regimbeau1, T. Ravololoniaina1, C. Sabbagh1, 
B. Chauffert2 and J.-P. Joly3
1Department of Digestive and Metabolic Surgery, Amiens; 
2Department of Oncology, Amiens; 3Department of 
Hepatology and Gastroenterology, Amiens
North Hospital, Digestive and Metabolic Surgery, Place 
Victor Pauchet, 80054 Amiens, France
Introduction: Treatment of rectal cancer with synchronous 
metastases in a diffi cult situation that needed to associate 
surgery, radiotherapy and chemotherapy. Three strategies can 
be used and need to be evaluate (classical stages, simultane-
ous approach and liver-fi rst approach). The aim of this study 
was to evaluate these strategies in the treatment of rectal 
cancer with synchronous metastases.
Methods: From January 2003 to December 2010, all 
patients with rectal cancer and synchronous metastases in a 
curative approach were included in this retrospective study. 
Epidemiological (gender, age, BMI), surgical and survival 
data were studied. Risk factors of incomplete resection of 
both rectum and liver were analysed.
Results: Of 36 patients (67.6% of men, mean age 63.7 
years, mean BMI 25), 21 had classical stages, 9 had a syn-
chronous approach and 6 had a liver-fi rst approach. Clinical 
risk score was not different between groups (p = 0.8). Overall 
postoperative complications rate was 5.5% (n = 2) after liver 
resection and 41.6% after rectal resection (n = 15). The rate 
of overall complications was 38.1% after classical stages, 
55.6% after simultaneous approach and 66.7% after liver-
fi rst approach (p = 0.3). The median survival in the classical 
approach was 63 months, the median survival in the simul-
taneous approach was 26 months and in the liver-fi rst 
approach 63 months (p = 0.8). Surgical strategies was not a 
risk factor for incomplete resection.
Conclusion: No difference for postoperative morbidity and 
long-term survival outcomes between the three strategies 
groups. According to oncological emergency of either the 
rectal tumor or metastases, the three strategies may be used. 
No risk factor for incomplete resection has been found.
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INTRAOPERATIVE ULTRASOUND-
GUIDED LIVER RESECTION FOR 
INVISIBLE, NON-PALPABLE 
METASTATIC COLORECTAL CANCER
A. Chiappa, E. Bertani, C. Corbellini, P. D. Vigna, 
G. Bonomo, M. Venturino, M. Marino and B. Andreoni
Unit of Hepatobiliary Pancreatic Surgery-European 
Institute of Oncology and University of Milano
European Institute of Oncology-University of Milano, Unit 
of Hepato-Biliary-Pancreatic Surgery, Via G. Ripamonti, 
43520141 Milano, Italy
Introduction: There is considerable evidence to show that 
hepatic metastases from colorectal cancer (CRC) are fre-
quently missed at operation by simple inspection and palpa-
tion, even when correctly identifi ed by preoperative imaging. 
The role of intraoperative ultrasonography (IOUS) in the 
detection and localization of non-visible, impalpable meta-
static hepatic nodules in patients with CRC was evaluated in 
this study as well as the impact of IOUS on metastasis 
excision.
Methods: In a series of 83 histologically-confi rmed CRC-
related liver metastases, resection was performed using 
IOUS in 67 patients. Resections included formal hepatecto-
mies, segmentectomies, subsegmentectomies and non-
anatomical hepatic wedge resections.
Results: IOUS demonstrated the presence and the location 
of 8 (10%) non-visible and impalpable lesions, with success-
ful resection in each case. Of 22 lesions <1 cm in maximal 
diameter, 5 (23%) were occult to surgical evaluation, as were 
3/39 (8%) of nodules between 1–5 cm in maximal diameter. 
All 22 tumors > 5 cm in maximal diameter were palpable. 
Amongst patients with solitary CRC liver metastases, 5/57 
(9%) of nodules were detected only by IOUS, as compared 
with 2/10 (20%) when there were multiple liver metastases 
present.
Conclusion: The detection of non-visible and impalpable 
CRC liver metastases with IOUS is recommended, particu-
larly for the diagnosis and localization of small metastases, 
avoiding blind resections and permitting a more selective 
resectional approach.
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PATTERN OF RECURRENCE 
FOLLOWING RESECTION OF 
COLORECTAL LIVER METASTASES: 
DOES MARGIN MATTER?
D. Gomez1, D. Kamali1, W. K. Dunn2, A. Brooks1 and 
I. C. Cameron1
1Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust, Nottingham, United Kingdom; 
2Department of Radiology, Queen’s Medical Centre, 
Nottingham University Hospitals NHS Trust, Nottingham, 
United Kingdom
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust, Nottingham, United Kingdom, Department of 
Hepatobiliary and Pancreatic Surgery, Department of 
Hepatobiliary and Pancreatic Surgery, E Floor, West 
Block, Queen’s Medical Centre, Derby Road, Nottingham 
NG7 2UHNG72U, United Kingdom
Introduction: The aim of this study was to assess the 
pattern of recurrence in patients who underwent hepatic 
resection for colorectal liver metastases (CRLM) with 
respect to their resection margin.
Methods: Patients undergoing CRLM resection from 
January 2006 to December 2010 were included. Clinical and 
recurrence disease data was collected. Survival differences 
following liver resection in patients with a R0 or R1 resection 
were determined.
Results: 184 patients were included, of which 145 patients 
had a R0 resection. There were no signifi cant differences 
between the two groups with regards to demographics and 
type of surgery. However, R1 resection was signifi cantly 
higher (p = 0.012) in patients with multiple metastases. The 
majority of patients with recurrent disease had lung 
only recurrence (n = 41, 41%). There were no signifi cant 
differences with respect to pattern of disease recurrence 
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between the R0 and R1 resection groups (p = 0.125). The R1 
resection group did not have a signifi cantly higher liver only 
recurrence compared to patients with a R0 resection (p = 
0.211).
Conclusion: Resection margin does not infl uence the 
pattern of disease recurrence following potentially curative 
resection for CRLM.
153
RATE OF RE-RESECTION AND 
OUTCOMES FOLLOWING RESECTION 
OF COLORECTAL LIVER METASTASES
D. Gomez, D. Kamali, I. J. Beckingham, A. Brooks 
and I. C. Cameron
Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust, Nottingham, United Kingdom
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust, Nottingham, United Kingdom, Department of 
Hepatobiliary and Pancreatic Surgery, Department of 
Hepatobiliary and Pancreatic Surgery, E Floor, West 
Block, Queen’s Medical Centre, Derby Road, Nottingham 
NG7 2UHNG72U, United Kingdom
Introduction: The aim of this study was to assess the re-
resection rate and outcomes of patients who underwent 
hepatic resection for colorectal liver metastases (CRLM).
Methods: Patients undergoing CRLM resection from 
January 2006 to December 2010 were included. Clinical and 
recurrence disease data was collected. Survival following 
liver resection was determined.
Results: Of the 184 patients, 84 patients were disease-free 
at the last follow-up. Of the 100 patients that had recurrent 
disease, 27 patients (27%) had further surgery. With respect 
to site of recurrence of these patients, lung only recurrence 
was observed in 12 patients, followed by liver only recur-
rence (n = 11), liver and lung recurrence (n = 2) and other 
sites (n = 2). Following re-resection, 1 patient died post-
operatively, 4 patients died of recurrence and 11 patients are 
disease-free. The 3 and 5-year overall survival was 84.4% 
and 66.4%, respectively. There were no signifi cant difference 
between the overall survival in patients that had re-resection 
for liver only recurrence compared to other site of recurrence 
[31 (17–56) vs 52 (25–67), p = 0.604].
Conclusion: Patients with recurrent disease following liver 
resection for CRLM should be treated with further surgery 
as this improves overall survival, irrespective of site of 
recurrence.
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INDIVIDUAL QUALITY OF LIFE OF 
PATIENTS WITH COLORECTAL 
LIVER METASTASES
D. Kostov1, D. Tomov2 and G. Kobakov3
1Naval Hospital of Varna, Varna, Bulgaria; 2Medical 
University of Varna, Varna, Bulgaria; 3Specialized Hospital 
for Oncologic Diseases of Varna, Varna, Bulgaria
Naval Hospital of Varna, Varna, Department of Surgery, 3 
Hristo Smirnenski Street, 9002 Varna, Bulgaria
Introduction: Dramatic increase of morbidity and mortality 
rates of hepatic malignancies necessitates further improve-
ment of timely and complex diagnosis, treatment and reha-
bilitation. Maintenance of the individual patient’s quality of 
life (QoL) after multimodal treatment is a serious task for 
the interdisciplinary teams of hepatologists, liver surgeons, 
psychologists, gastroenterologists and care-givers. We aim at 
sharing our experience with QoL assessment in patients with 
colorectal liver metastases (CLM).
Methods: Based on EORTC QOL-LMC21, we elaborated 
a 40-item questionnaire with a fi ve-degree scale for CLM 
patient’s QoL evaluation. It was postoperatively offered to 
155 CLM patients, 96 males and 59 females aged between 
32 and 81 years and hospitalized in the Naval Hospital of 
Varna from 1.I.2000 till 31.XII.2011. Either mono- or biseg-
mentectomy was done in 87 cases while various types 
of major hepatic resection were applied in 68 ones. Data 
were statistically processed by variation and correlation 
analyses.
Results: Three months after multimodal treatment, the 
response rate was high (139 cases or 90%). There were 
certain differences between the scores of both groups con-
cerning all the items. Volume-sparing liver resections war-
ranted a greater extent of QoL improvement as gastrointestinal 
discomfort was statistically reliably diminished after mon-
osegmentectomy than after hemihepatectomy (p < 0.05). 
Reduction of postoperative complications and recurrences 
favourably infl uenced upon most specifi c symptoms, every-
day activities, and resocialization. Contemporary neoadju-
vant chemotherapy did not resulted in a better QoL in the 
patients at stage IV of the disease. The occurrence of dysp-
neic complaints suggested a postoperative respiratory and 
heart failure.
Conclusion: Our results indicated that our enlarged version 
of EORTC QOL-LMC21 was a reliable measure for assess-
ment of patient-reported outcomes after combined treatment 
of CLM. It should be applied in conjunction with the EORTC 
QLQ-C30 questionnaire, too. Future research will focus on 
the dynamic following-up the subjective QoL evaluations by 
the same CLM patients. Thus it will enable a broader appli-
cation of individualized diagnostic and therapeutic proce-
dures and ensure a better patient’s life-style.
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IMPORTANCE OF THROMBOCYTES 
FOR THE HYPERTROPHY RESPONSE 
AFTER PORTAL VEIN EMBOLIZATION 
– A RETROSPECTIVE COHORT STUDY
C. Sturesson1, R. Andersson2, L. Hoekstra1 and 
T. van Gulik1
1Department of Surgery, Academic Medical Centre, 
Amsterdam, The Netherlands; 2Department of Surgery, 
Clinical Sciences Lund, Lund University and Skåne 
University Hospital, Lund, Sweden
Department of Surgery, Academic Medical Centre, IWO-1, 
Meibergdreef 91105 Amsterdam, The Netherlands
Introduction: Thrombocytes have proven important for 
liver regeneration after liver resection in the experimental 
setting. The importance of thrombocytes for liver regenera-
tion in the context of portal vein embolization (PVE) has 
been studied only to a limited extent. The aim of our study 
is to examine the effects of thrombocytes on the volumetric 
liver hypertrophy response after PVE.
Methods: This retrospective cohort study comprised 75 
patients with liver metastases from colorectal cancer sub-
jected to PVE in preparation for major liver resection. All 
patients had normal liver function without cirrhosis. Patients 
were divided into 2 groups depending on if chemotherapy 
was given within 6 weeks before PVE or not. Correlation 
between degree of hypertrophy and level of thrombocytes 
was investigated. In the chemotherapy group, the correlation 
between degree of hypertrophy and the difference in throm-
bocyte levels at the time of PVE and 2 months earlier was 
examined.
Results: The chemotherapy group showed lower levels of 
thrombocytes (p = 0.003) as well as lower degree of hyper-
trophy (p = 0.030) as compared to the group without chemo-
therapy. No correlation within groups between level of 
thrombocytes and degree of hypertrophy was found. 
However, in the chemotherapy group, a positive linear cor-
relation between degree of hypertrophy and the difference in 
thrombocytes between the time points of PVE and 2 months 
preceding PVE was found (p = 0.0006).
Conclusion: Absolute numbers of thrombocytes do not 
infl uence the volumetric regeneration after PVE. For patients 
on preprocedural chemotherapy, PVE at a time when the 
thrombocytes are decreasing is associated with reduced 
regeneration.
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SYNCHRONOUS COLORECTAL 
AND HEPATIC RESECTION OF 
LOCALLY ADVANCED (T3/4) 
METASTATIC DISEASE
L. Andrii, I. Shchepotin, A. Lukashenko, O. Kolesnik 
and V. Priymak
National Cancer Institute, Abdominal Oncology, 
Lomonosova Str. 33/433022 Kiev, Ukraine
Introduction: Approximately 25% of the patients with 
colorectal cancer already have liver metastases (LM) at diag-
nosis. Hepatic resection is the only option offering a potential 
cure for patients with synchronous colorectal cancer LM. 
The optimal timing of hepatic resection is still controversial. 
The purpose of this study was to analyze our initial experi-
ence with this aggressive strategy, and to defi ne the prognosis 
and the surgical indications.
Methods: Fifty-fi ve patients with synchronously recog-
nized locally advanced carcinoma and LM were divided into 
two groups, i.e., 29 patients who underwent hepatectomy at 
the time of colorectal surgery (concurrent group) and 26 
patients who underwent delayed liver resection (staged 
group). The postoperative complications were analyzed 
retrospectively according to the documented records 
(2008–2011).
Results: No signifi cant differences were observed between 
groups in type of colon resection (P = 0.5) or hepatic resec-
tion (P = 0.1), overall operative duration (mean, 400 vs. 360 
minutes), blood loss (mean, 320 vs. 250 ml), disease-free 
survival from date of hepatectomy (median, 11 vs. 11 
months). Overall duration of hospitalization was signifi -
cantly shorter for concurrent group (mean, 24 vs. 11 days; P 
< 0.001). It is noticed, that in concurrent group there is a 
bigger risk of development of postoperative complications 
(52 vs. 31%). There was no mortality in both groups. Overall 
duration of hospitalization was signifi cantly shorter for 
concurrent than for staged resection (mean, 12 vs. 26 days; 
P < 0.05).
Conclusion: Combined rectal and hepatic resection is safe. 
Morbidity and mortality do not preclude concurrent resec-
tion. Simultaneous colon and hepatic resection reduces 
overall hospital stay.
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PROSPECTIVE PHASE II TRIAL ON 
PROPHYLACTIC PERIHEPATIC 
LYMPHADENECTOMY IN PATIENTS 
WITH COLORECTAL CANCER WITH 
LIVER METASTASIS
W.-S. Lee, J. H. Baek, J. N. Lee and K. K. Kuk
Department of Surgery, Gil Medical Center, Gachon 
University School of Medicine, Incheon, Korea
Gil Medical Center/Gachon University School of Medicine/
Surgery, 1198 Guwol-dong, Namdong-gu, Incheon, 40576, 
Korea
Introduction: Lymph node status is one of the most impor-
tant prognostic factors in oncologic surgery; however, the 
role of prophylactic lymph node dissection remains unclear 
for colorectal cancer with liver metastasis. This study pro-
spectively evaluated the frequency of perihepatic lymph 
nodes, through routine perihepatic lymphadenectomy and 
analysis of lymph node metastases in patients undergoing 
hepatectomy due to colorectal metastasis.
Methods: From Feb 2010 to Nov 2011, a total of 34 patients 
prospectively underwent hepatic resection. Prophylactic 
perihepatic lymphadenectomy was carried out after speci-
men removal. Incidence, site, and complication were 
analyzed.
Results: In average, 6.18 lymph nodes were dissected 
per patient. No mortality was associated to lymphadenec-
tomy. Two postoperative complication (5.9%) (intra-
abdominal bleeding) was related to lymph node excision and 
reoperation. The overall frequency of lymph node metastases 
was 8.9%.
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Number of hepatic metastases, CEA level, size of lesion, 
synchronicity of cancer regards to primary tumor and lymph 
node at the primary site was not signifi cantly related to peri-
hepatic lymph node metastasis (P = 0.65; 0.57; 0.34; 0.74 
and 0.45 respectively).
Conclusion: Prophylactic periheaptic lymphadenectomy is 
a safe procedure after liver resection, and it may be routinely 
applied in patients with colorectal cancer with liver metasta-
sis. Perihepatic lymphadenectomy may allow the detection 
of extrahepatic lymph node metastases, resulting in more 
accurate staging of extrahepatic disease and thus contribute 
in overall survival. However, prospective randomized trial is 
warranted.
197
COMPLICATIONS OF INTRA-
OPERATIVE RADIOFREQUENCY 
ABLATION OF LIVER METASTASES: 
A SINGLE CENTRE 10-YEARS 
EXPERIENCE
G. Desolneux1, S. Evrard1, T. Razafi ndratsira1, V. Brouste2, 
M. Fonck3, D. Bechade3 and Y. Becouarn3
1Department of Oncological Surgery, Institut Bergonié; 
2Clinical Research and Epidemiology Unit, Institut 
Bergonié; 3Department of Medical Oncology, Institut 
Bergonié
Institut Bergonié, Digestive Tumours Unit, Oncological 
Surgery, 229, cours de l’Argonne 33076 Bordeaux, France
Introduction: Intraoperative radiofrequency ablation is 
now commonly used to treat liver metastases, in addition to 
resection, allowing an increasing number of patients eligible 
to an hepatic clearance of the metastatic disease. However, 
there is a lack of data reporting specifi c complications of this 
technique. Our study was designed to assess mortality and 
morbidity of this procedure.
Methods: From 2000 to 2010, all patients treated by intraop-
erative radiofrequency ablation of liver metastases were identi-
fi ed from our prospective database. Surgical resection or 
thermoablation decision was made intraoperatively after liver 
mobilisation and intraoperative ultrasound examination. 
Postoperative course and complications were reported accord-
ing to Dindo and Clavien classifi cation. Statistical analysis were 
performed using SPSS 18.0. The Chi-squared test and Fisher 
test were used to determine predictive factors of complications. 
This study was approved by the local ethic committee.
Results: From 2000 to 2010, 430 liver metastases in 151 
consecutive patients were treated by intraoperative radiofre-
quency ablation by a single surgeon, with or without associ-
ated liver resection and/or other surgical procedures. Global 
mortality rate was 2.7%: 9.5% for patients with extrahepatic 
associated procedures versus 0% in patients with liver 
surgery only. Global morbidity rate was 45.1%. Severe com-
plications (Dindo > 3) occurred in 19.5%. 63% of the com-
plications were intraabdominal. Univariate analysis identifi ed 
associated extra-hepatic surgery, Gastro-intestinal tract 
opening and duration of surgery >4 hours as risk factors for 
complications of grade >3.
Conclusion: Specifi c mortality rate of intraoperative radiof-
requency ablation is low. It adds only few specifi c complica-
tions to liver surgery. As risk factors are duration of surgery 
and associated septic procedures, these should be delayed if 
possible. With these limits and those already published (size 
< 30 mm, location far from main biliary duct) intraoperative 
radiofrequency ablation leads to a good benefi t/risk ratio for 
patients with complex liver metastatic disease.
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LOCAL RECURRENCE AFTER TOTAL 
MESORECTAL EXCISIONAL
N. A. Benamar, M. L. Achab, Z. Belkaid, I. Haddam, 
F. M. Boudia, M. Haoues, A. Mahindad and A. A. Benamar
Algiers Medical Institute, Medical Department, Bachir 
Ibrahimi Street, Colonne Voirol, Hydra, 1630 Algiers, 
Algeria
Introduction: It is well known that local recurrence of 
rectal carcinoma plays an important role in its prognosis. 
Patients with rectal cancer are at high risk of local recurrence 
despite considerable improvements in the multidisciplinary 
treatment. Since the introduction of total mesorectal excision 
(TME) and preoperative radio chemotherapy, local recur-
rence is widely reduced in 5 to 10% of patients. The aim of 
the study was to evaluate the local recurrence after total 
mesorectal excision.
Methods: Between January 2000 and December 2009, 99 
patients with rectum cancer including 10 rectocolic polypo-
sis, underwent surgical treatment by TME. Median age was 
52 years (range 21–86 years). Topography of tumors was low 
rectum (n = 76), median rectum (n = 18) and high rectum (n 
= 5). 59 patients had locally advanced rectal cancer (Stage 2 
and 3), 14 patients had a cancer with synchronous metastatic 
(stage 4). 69% of patients underwent preoperative radio-
therapy. Median size of tumor was 4 cm. The operations 
performed were 51 abdominoperineal resection, 38 anterior 
resection with transanal anastomosis, 3 coloproctectomy 
with ileoanal anastomosis and 7 coloproctectomy with defi n-
itive ileostomy. Circumferential Margin Resection (CMR) 
was evaluated in 24%.
Results: The local recurrence was observed in 21.7% (n = 
20/92). 75% of local recurrence had occurred within 2 years. 
A higher local recurrence rate was seen at all distances from 
the anal verge (p = 0.83). After curative surgery, local recur-
rence rate was 13.5% in patients underwent preoperative 
chemo- radiotherapy and reached at 23.5% after surgery 
alone (p = 0.09). Also, there is no local recurrence for 
responders to neoadjuvant treatment. The local recurrence 
was associated with increasing invasion depth (p = 0.01). It 
was respectively 11% and 20% in stage I, II and raised to 
28.5% when there were metastatic nodes (p = 0.3). In the-
other hand, mucinous histology and poor differentiation 
were both associated with a poor prognosis of local control 
(p = 0.004).
Conclusion: In this study, most of patients have a locally 
advanced rectum carcinoma. To reduce a local recurrence, 
rectal cancer should be cured by short course preoperative 
radiotherapy which be selected by modern stagging, includ-
ing preoperative magnetic resonance imaging and/or ultra-
sound, adequate surgery in agreement with histopathological 
analysis considering the margins of the resected tissue.
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LIVER RESECTION FOR METASTATIC 
BREAST CANCER: DOES IT 
IMPROVE SURVIVAL?
M. Scotté1, L. Lacaze1, J. Lubrano1, L. Schwarz1, 
S. Tarrab2, B. Resch2 and L. Marpeau2
1Department of Digestive Surgery, Rouen University 
Hospital; 2Department of Gynecology and Obstetrics, 
Rouen University Hospital
Service de chirurgie digestive, Hopital charles nicolle, 1, 
rue de Germont 76000 Rouen, France
Introduction: Breast cancer liver metastases (BCLM) are 
usually associated with a poor survival. The results of liver 
surgery for colorectal metastases have made it possible to 
apply the principles of liver resection in patients presenting 
with BCLM. The aim of our study was to analyse the 
outcome and prognosis factors of liver surgery for metastatic 
breast cancer.
Methods: Over a period of 5 years, 19 patients with BCLM 
were referred to our institution for surgical treatment. None 
of them had extrahepatic disease, as assessed by preoperative 
radiological examinations. Indications for surgery were non 
evolutive or isolated BCLM in patients previously treated 
using chemotherapy. The median age was 53 years (38–68) 
and the median disease-free interval (time between treatment 
of the primary and diagnosis of liver metastases) was 56 
months (7–120). The mean tumor size was 40 mm (range 
10–100). Because of extrahepatic disease found in 4 women 
during laparotomy, only 15 patients underwent liver resec-
tion (8 major and 7 minor hepatectomies).
Results: There was no postoperative death. The overall sur-
vival rate at 1, 3, and 5 years was 100%, 65.6% and 35.3%, 
respectively. The median survival rate was 48 months. The 
univariate analysis showed that type of hepatectomy, number 
of metastasis and age of patients strongly infl uenced survival 
rate. On the contrary the survival rate was not infl uenced by 
disease free interval, hormone receptor status, stage of breast 
cancer, size of tumor, and blood transfusions. In multivariate 
analysis, no independent prognostic factor was identifi ed in 
the Cox’s proportional hazard model.
Conclusion: These results suggest that long term survival 
can be achieved in highly selected patients by performing 
liver resection for BCLM.
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LIVER RESECTION FOR MULTIPLE 
COLORECTAL LIVER METASTASES 
WITH SURGERY UP-FRONT APPROACH: 
BI-INSTITUTIONAL ANALYSIS OF 
CONSECUTIVE 736 CASES
A. Saiura1, J. Yamamoto2, K. Hasegawa3, R. Koga1, 
Y. Sakamoto3, S. Hata3, M. Makuuchi4 and K. Norihiro3
1Department of Gastroenterological Surgery, Cancer 
Institute Ariake Hospital, Japanese Foundation for Cancer 
Research; 2Department of Surgery, National Defense 
Medical College; 3Division of Hepato-Biliary-Pancreatic 
Surgery, Department of Surgery, Graduate School of 
Medicine, University of Tokyo; 4Division of Hepato-
Biliary-Pancreatic Surgery, Japanese Red Cross Medical 
Cente
Cancer Institute Ariake Hospital, Japanese Foundation for 
Cancer Research, Department of Gastroenterological 
Surgery, 3-10-6 Ariake, Koto-ku, Tokyo 135-8500, Japan
Introduction: Preoperative chemotherapy has become 
more common in the management of multiple resectable 
colorectal liver metastases (CLM), however, the benefi t is 
unclear. In this period, preoperative chemotherapy was used 
only in patients with unresectable CRLMs. This study exam-
ined clinical outcomes following liver resection for multiple 
colorectal liver metastases with the surgery up-front 
approach.
Methods: Data collected prospectively over a 16-year 
period for 736 patients undergoing hepatic resection at two 
different centers were reviewed. Demographic data, labora-
tory tests, the number and size of the metastases, lobar 
involvement, the status of the histological margins, the type 
of resection, pre- and postoperative chemotherapy, recur-
rence, and date of death were recorded for all patients. 
Patients were divided into three groups depending on the 
number of tumors as follows: Group A, between one and 
three tumors (n = 493); Group B, between four and seven 
tumors (n = 141); and Group C, eight or more tumors 
(n = 102).
Results: Of the 736 liver resections, 159 patients (22%) 
underwent major hepatectomy (right hemihepatectomy or 
more n = 103; left hemihepatectomy n = 56) and 577 patients 
(78%) underwent minor hepatectomy (sectionectomy n = 65; 
segmentectomy n = 19; non-anatomical minor hepatectomies 
n = 493). The 5-year overall and recurrence-free survival 
rates were 51% and 21%, respectively, for the entire patient 
cohort, 56% and 29% in Group A, 41% and 12% in Group 
B, and 33% and 1.7% in Group C. Multivariate analysis 
showed that decreased survival was associated with positive 
lymph node metastasis of the primary tumor, the presence of 
extrahepatic tumors, a maximum size of the liver tumor 
>5 cm, and tumor exposure during liver resection.
Conclusion: In patients with multiple liver metastases, the 
number of liver metastases has less impact on the prognosis 
than other prognostic factors. Complete resection with repeat 
metastasectomy offers a chance of cure even in patients with 
numerous colorectal liver metastases (i.e. those with eight or 
more nodules). A further prospective study is necessary to 
clarify the optimal setting of preoperative chemotherapy.
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CHANGES IN HEPATIC VOLUMES AND 
RATIOS AFTER LONG -TERM (BIO)
CHEMOTHERAPY FOR TYPE II-III 
LIVER METASTASIS FROM 
COLORECTAL CANCER
D. Sommacale, E. L. Tamby, E. Palladino, O. Bouche, 
M. D. Diebold and R. Kianmanesh
Hospital University, Digestive Surgery, avenue du general 
koenig 51100 Reims, France
Introduction: Drugs delivered for liver metastasis from 
colorectal cancer (LMCRC) are effi cient but hepatotoxic. 
The aim of this study was to evaluate the potential changes 
induced by long-term (bio)chemotherapy on the liver 
volumes and ratios.
Methods: CT-scans of 57 patients (20F), with type II-III 
LMCR were prospectively studied. The mean age was 62 
(41–84), mean BMI 24 (16–65). The population included 
79% colon primaries, 9% peritoneal carcinomatosis and 61% 
synchronous LM. Secondary liver reaction was performed in 
42% of the patients (50% major). Morbidity rate was 42%. 
One patient died of liver failure. Median number of drug 
therapy cycles was 12 (4–74). Therefore, 2 groups were 
studied: Gp < 12 cycles (n = 33) and Gp > 12 cycles (n = 
24). Liver volumes and ratios, left liver (LL), right liver 
(RL), whole liver (WL) were estimated by angulometry 
(92% accuracy to volumetry).
Results: The univariate analysis revealed statistical differ-
ences concerning age (62 vs 68, p < 0.001), number of sec-
ondary liver resections (50% vs 20%, p < 0.01). No difference 
was found for BMI and post liver resection morbidity. All 
patients who underwent reaction in Gp > 12 cycles had liver 
steatosis (range 30 to 75%). Before drug therapy, WL 
volumes were not statistically different between the two 
groups. After drug therapy, RL volume and the ratio between 
RL/LL was signifi cantly decreased in the Gp > 12 cycles (p 
< 0.03).
Conclusion: These preliminary results showed a slight ten-
dency to right liver atrophy and an decrease in the LR/LL 
ratio in patients who received a prolonged drug therapy 
(more than 12 cycles). Further analyses including the type of 
administrated drugs and immune-histochemical induced 
liver lesions could help to better understand these results.
330
LIVER RESECTION FOR 
HEPATIC METASTASIS FROM 
SUPRARENAL CARCINOMA
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5Division of Hepato-Pancreatic-Biliary Surgery, 
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6Department of Surgery, Complejo Hospitalario de Jaen
Complejo Hospitalario de Jaen, Division of Hepato-
Pancreatic-Biliary Surgery, Department of Surgery, Avda. 
del Ejercito Español, 10, 23007 Jaen, Spain
Introduction: Adrenocortical carcinoma is a very rare 
tumor, with an incidence of 0.5–2 cases per million popula-
tion each year. Liver metastases are even more rare, since 
only about 50 cases have been reported in the literature. The 
majority of these cases have been discussed in association 
with other noncolorectal nonneuroendocrine liver metas-
tases. There is no clear indications for surgery, but even if 
there is extrahepatic disease.
Methods: A 24 years-old woman underwent laparoscopic 
right adrenalectomy for adrenocortical carcinoma in January 
2008 (pT3N0M0, stage III). She did not receive adjuvant 
chemotherapy. In May 2011 an abdominal control CT 
showed two liver masses of 6 and 2.5 cm in segments six 
and three, respectively. A whole-body FDG-PET-CT showed 
two intense hypermetabolism areas in the same location. 
Liver metastases from adrenal carcinoma, even though very 
rare, was strongly suspected. Surgery was decided in the 
oncology committee.
Results: Intraoperatively, metastasis in segment six was 
confi rmed, but the mass located in segment three was a 
diaphragmatic implant doing mark in the liver. Segmentectomy 
of the six and section of implant was carried out. The patient 
was discharged on the fi fth postoperative day without com-
plications. Histopathological examination revealed a single 
hepatic lesion of 6 cm compatible with metastasis of adreno-
cortical carcinoma and a diaphragmatic implant of 2.3 cm 
with the same diagnosis. Currently free of disease after adju-
vant chemotherapy with cisplatin + etoposide.
Conclusion: Adrenal carcinoma is a rare malignancy with 
a poor prognosis. The basis of treatment is the complete 
surgical ablation of the tumor and of the local or metastatic 
recurrence. Hepatic metastases are very rare. The best results 
are in patients with metachronous metastases developed after 
a disease-free survival > 1 year in which a complete resection 
was performed. The patients with synchronous metastases 
have poor results, recurrence occur rapidly and the survival 
is short. Mitotane can be used.
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MORBIDITY AND MORTALITY AFTER 
HEPATIC RESECTION
V. Resende1, J. B. Rezende-Neto2, C. Xavier-Lima3, 
J. S. Fernandes4, J. Salisi5 and J. R. Cunha-Melo6
Alfa Institute of Gastroenterology, Hospital of Clinics of 
the Federal University of Minas Gerais, Surgical, Rua 
Sergipe 67/2401, Funcionários 30130 Belo Horizonte, 
Brazil
Introduction: Perioperative care associated with modern 
techniques for dissection of the hepatic parenchyma had an 
impact on reducing operative morbidity and mortality, partly 
as a result of reduced blood transfusion. As a result there was 
an increase in surgical indications, especially in the treatment 
of liver metastasis.
Methods: All patients that underwent hepatic resections 
from 2007 to 2011 were included in the study (n = 100). 
Resections were performed using monopolar electrocautery, 
argon beam scalpel and kellyclasia. We analysed diagnosis, 
types of resection, hospital length of stay, perioperative 
blood transfusion, morbidity and mortality. The Fisher’ s 
exact test were used for statistical analysis.
Results: Thirty (30%) major hepatectomies were performed, 
20 (20%) right and 10 left (10%). 70 (70%) minor hepatec-
tomies, 52 segmentectomies and 18 non-anatomical resec-
tions. The most common diagnosis were metastasis in 54 
(54%) patients, mostly due to colorectal cancer. Hepatocellular 
was the most common hepatic cancer followed by cholangi-
ocarcinoma. There were 20 (20%) hepatic resections for 
benign diseases mainly due to intra-hepatic lithiasis and giant 
hemangioma. Eight patients (11.43%) developed postopera-
tive complications. Six patients (8.57%) received periopera-
tive blood transfusion. There were 6 postoperative deaths 
(8.57%), 4 (5.71%) were patients with HCC. The average 
hospital length of stay was 4 days.
Conclusion: The most common diagnosis for the proce-
dures were colorectal adenocarcinoma metastasis. Segmental 
resections were more commonly performed. Although low 
morbidity was observed, mortality was high among patients 
that had pre-operative cirrhosis and underwent hepatic resec-
tion for hepatocellular carcinoma.
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THE ROLE OF MULTISLICE 
COMPUTERISED TOMOGRAPHIC 
ARTERIAL PORTOGRAPHY IN THE 
DETECTION OF COLORECTAL LIVER 
METASTASES, AND THE FACTORS 
INFLUENCING PERFUSION DEFECTS
C. Jones1, S. A. Badger1, B. E. Kelly2, M. Love2 and 
P. T. Kennedy2
1Department of HPB Surgery, Mater Hospital, Belfast; 
2Department of Radiology, Royal Victoria Hospital, Belfast
Mater Hospital, Belfast Health and Social Care Trust, 
HPB Surgery, 10 Breezemount Park, BT32 Banbridge, 
Northern Ireland
Introduction: Accurate imaging of colorectal liver metas-
tases is essential. Computerised Tomographic Arterial 
Portography (CTAP), a method of liver imaging, has not 
being extensively used in clinical practice. This study there-
fore aimed to assess CTAP accuracy, and determine factors 
infl uencing the uptake of arterial contrast.
Methods: Consecutive metastatic colorectal cancer patients 
underwent CTAP. Two blinded individuals reported the 
scans. Contrast density in Hounsfi eld units was recorded at 
portal vein, hepatic vein, inferior and superior liver paren-
chyma. Correlations between perfusion defects, number of 
metastases, and contrast density were calculated. For surgical 
patients, CTAP was compared with histology. Ethical 
approval and written consent were obtained.
Results: 55 patients from September 2002 to May 2004 
were included. For surgical patients (n = 19), CTAP had an 
accuracy of 86.0%, sensitivity of 89.2% and specifi city of 
84.4%. There was a positive correlation (r = 0.53; p = 0.03) 
between the difference between superior and inferior con-
trast, and number of perfusions defects. For the non-surgical 
group (n = 35), CTAP reported 184 lesions, 115 were con-
sidered metastatic, with 47 perfusion abnormalities. A nega-
tive correlation (r = −0.41; p = 0.01) between perfusion 
defects and ratio of contrast in hepatic : portal vein was 
noted. No correlation with the number of metastases was 
noted.
Conclusion: CTAP can distinguish between metastatic 
lesions and perfusion defects, while mapping arterial vascu-
lar anatomy. In homogenous liver parenchyma there are 
fewer perfusion defects, while the smaller the hepatic : portal 
vein ratio more perfusion defects were detected. Further 
work is justifi ed regarding the timing of contrast and the use 
of bolus tracking technology to control the scan initiation 
time to optimise liver perfusion.
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A CASE REPORT OF THE LIVER 
METASTASIS OF COLON CANCER WITH 
THE TUMOR THROMBUS IN THE 
INTRAHEPATIC BILE DUCT
S. Takamatsu1, H. Nagano1, S. Ootsukasa1, Y. Kawachi1, 
H. Maruyama1 and K. Taki2
1Department of Surgery, Musashino Red Cross Hospital; 
2Department of Pathology, Musashino Red Cross Hospital
Musashino Red Cross Hospital, Surgery, Kyonan-cho 
1-26-1, Musashino-Shi 180-8 Tokyo, Japan
Introduction: Liver metastasis of the colorectal cancer has 
been one of the most frequently encountered liver tumors. 
The invasion to the bile duct and the formation of the tumor 
thrombus in the intrahepatic bile duct was considered to be 
rare. We experienced a metastatic tumor of the colon cancer, 
which was one of the multiple liver metastases, with the 
macroscopic tumor thrombus in the intrahepatic bile duct.
Methods: The patient was a 72-year-old female who was 
previously underwent surgery for the descending colon 
cancer with direct invasion to left diaphragm at our hospital. 
The computed tomography (CT) before the operation showed 
the multiple liver tumors considered to be the metastatic 
tumors. Since she had symptoms that were caused by the 
obstruction of the colon, we removed only the colon cancer 
initially. At three months after the surgery, intrahepatic bile 
duct of the segment 6, which was continued from the largest 
tumor of the liver metastases, was dilated on the CT. That 
tumor existed in the peripheral of the segment 6, therefore, 
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the fi ndings of the CT suggested the existence of the tumor 
thrombus in the bile duct.
Results: We performed the hepatectomy for the liver metas-
tases at four months after the resection of colon cancer. Six 
tumors of all were detected in the liver on the intraoperative 
ultrasonography. We underwent the anatomical resection of 
the segment 6 for two tumors, which one of them had the 
macroscopic tumor thrombus in the intrahepatic bile duct, 
and the partial resections for four tumors respectively. The 
postoperative course was uneventful, and the patient has 
been alive with no evidence of recurrence. On pathologically, 
six of all tumors were diagnosed as the metastatic tumors of 
the colon cancer, and the tumor thrombus in the intrahepatic 
bile duct of the segment 6 was confi rmed.
Conclusion: We reported a rare case of the liver metastasis 
of the colon cancer with the macroscopic tumor thrombus in 
the intrahepatic bile duct. Although the partial resection of 
the liver has been generally considered to be enough for the 
surgical treatment of the liver metastasis of colorectal cancer, 
our case suggested that it was necessary to undergo the ana-
tomical resection such as segmentectomy for the metastatic 
tumors with invasion to either intrahepatic blood vessels or 
bile duct.
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CLINICAL OUTCOME OF 
HEPATECTOMY FOR COLORECTAL 
LIVER METASTASIS AFTER 
FOLFOX CHEMOTHERAPY
Y. Shimizu, T. Sano, Y. Senda and Y. Nimura
Department of Gastroenterological Surgery Aichi Cancer 
Center Hospital, Nagoya, Japan
Aichi Cancer Center Hospital, Gastroenterological 
Surgery, Kanokoden 1-1, Chikusa-ku 46486 Nagoya, Japan
Introduction: The FOLFOX new-type chemotherapeutic 
regimen serves to improve patient’s survival and extend the 
indication for hepatectomy. The safety and management of 
peri-hepatectomy for post-chemotherapeutic patients remain 
to be completely established. Thus, we evaluated colorectal 
liver metastasis in our cases who underwent hepatectomy 
after FOLFOX chemotherapy.
Methods: Between 2006 and September 2011, a total of 36 
patients who underwent hepatectomy at Aichi Cancer Center 
Hospital for colorectal liver metastasis after FOLFOX-based 
chemotherapies included 27 cases of synchronous metastasis 
and 9 cases of metachronous metastasis (age 39–78 y.o.; 
median age 64 y.o.). We evaluated the number of FOLFOX 
cycles, surgical outcome and prognosis.
Results: The median maximum tumor size and number of 
metastases before chemotherapy were 4.1 cm and 4, respec-
tively, FOLFOX cycles were 8, and median chemotherapy 
withdrawal before hepatectomy was 41 days. There were 14 
cases of partial hepatectomy, 8 of segmentectomy and 14 of 
lobectomy or more major hepatectomy. Operative time 
ranged 70–550 minutes (median 218) and blood loss ranged 
10–1350 ml (median 292). 30 cases were free of carcinoma 
and the 6 other retained carcinoma extrahepatically. 
Postoperative hospitalization ranged 6–28 days (median 11). 
Postoperative complications were wound infection in 3 
cases, bile leakage in 2, major pleural effusion in 2. The 
overall survival of 36 cases ranged 70–1819 days with a 
median of 695 days and 9 died.
Conclusion: Although segmentectomy or more major hepa-
tectomy was performed in 61% of all cases after median 8 
FOLFOX cycles of chemotherapy, the operative time, blood 
loss, complications, hospitalization days and 695 days of 
median overall survival were an acceptable outcome of sur-
gical treatment for advanced colorectal liver metastasis. In 
conclusion, major hepatectomy after FOLFOX chemother-
apy is safe, and the indications for hepatectomy involving 
colorectal liver metastasis can be extended.
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SIMULTANEOUS LAPAROSCOPIC 
RESECTION OF COLORECTAL 
CANCER AND SYNCHRONOUS 
LIVER METASTASES
Y. Kaneko, Y. Inoue, Y. Takahashi, S. Katagiri, Y. Kotera, 
A. Shunichi, T. Oki and M. Yamamoto
Department of Surgery Institute of Gastroenterology Tokyo 
Women’s Medical University
Tokyo Women’s Medical University, Department of Surgery 
Institute of Gastroenterology, 8-1 Kawadacho 
Shinjyuku-ku, 162 Tokyo, Japan
Introduction: The fi eld of laparoscopic colon resection has 
rapidly evolved, and laparoscopic hepatic resection has been 
reported to provide the benefi ts of small incisions and less 
trauma. Simultaneous resection of colorectal tumors and 
liver metastases has been advocated because of the benefi ts 
of avoiding a second operation and making the same incision 
twice.
Methods: Four patients underwent simultaneous laparo-
scopic colectomy and liver resection.
Results: The primary tumor location was in the sigmoid 
colon in one patient and the rectum in three. There was no 
need to convert to open surgery in any of the patients. The 
median total operating time was 316 (range 209–387) 
minutes. The median total estimated blood loss was 35.8 
(range 13–70) ml. The median postoperative hospital stay 
was 12.5 (range 8–18) days. There were abscesses at the edge 
of the liver that required drainage in two patients.
Conclusion: Patients who underwent simultaneous laparo-
scopic resection of colorectal tumor and liver metastases had 
less blood loss, shorter length of hospital stay and quicker 
recovery. This report suggests that laparoscopic simultane-
ous resection for colorectal cancer and liver metastases is a 
safe and feasible procedure in selected patients.
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ONCOLYTIC VACCINIA VIRUS FOR THE 
TREATMENT OF LIVER TUMOURS
R. Dave1, F. Errington-Mais2, E. West2, G. Toogood1 
and A. Melcher2
1Department of HPB and Transplant Surgery, St James 
University Hospital, Leeds, UK; 2Section of Oncology & 
Clinical Research, University of Leeds, Leeds, UK
St James University Hospital, Leeds, UK, Department of 
HPB and Transplant Surgery, Beckett Street, Leeds LS97T, 
United Kingdom
Introduction: Liver resection for colorectal liver metas-
tases (CRLM) has a reported success rate of 50% 5-year 
survival. However, recurrence rates are reported as 50% 
within 2 years. Tumour cells are able to proliferate as they 
evade immunosurveillance. Activating the body’s immune 
system in the tumour environment may enhance tumour cell 
death. This may be achieved by lysing the tumour using a 
targeted oncolytic virus, releasing tumour associated anti-
gens, and activating Natural Killer (NK) cells.
Methods: Using a double-stranded enveloped pox virus 
backbone, the Vaccinia virus (VV) has been genetically 
manipulated to encode for granulocyte macrophage colony 
stimulating factor (GM-CSF). Enzyme Linked 
Immunoabsorbent Assay (ELISA) was used to confi rm pro-
duction of GMCSF when CRC cell lines and primary CRLM 
tissue were infected with Vaccinia. ELISA was used to 
measure pro- and anti-infl ammatory cytokines (IL6, IL10). 
Induction of the innate immune response was measured by 
levels of degranulation of NK cells following viral treatment, 
and the cytotoxic ability of activated PBMCs when exposed 
to CRC targets.
Results: VV is able to produce large quantities of GMSCF 
(2,000 pg/ml by 72 hours). This is a cytokine that can stimu-
late stem cells to produce granulocytes and macrophages, 
which can be recruited to the tumour environment. More than 
50% of the NK cells become activated in response to the 
viral treatment with surface expression of CD69. We also 
demonstrate ‘arming’ of NK cells with an up-regulation of 
surface expression of CD107; this indicates the release of 
granzymes that can induce apoptosis of virally infected 
tumour cells. On exposing activated NK cells to CRC targets 
we have demonstrated a 40–50% lysis of the tumour cells in 
24 hours. VV also causes an up-regulation of pro-infl amma-
tory cytokines.
Conclusion: Harnessing the immune system using an onco-
lytic virus such as VV may provide a useful adjunct to the 
treatment of disseminated malignancy. Tumour-specifi c 
innate immunity means that it may be a more directed 
therapy than current modalities, and may be able to target 
tumours that remain undetectable to imaging and 
immunosurveillance.
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SAFETY AND FEASIBILITY OF ONE 
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MAJOR LIVER RESECTION PLUS 
COLECTOMY FOR COLORECTAL 
NEOPLASM WITH SYNCHRONOUS 
LIVER METASTASIS
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Introduction: Simultaneous surgery for primary colorectal 
tumour with synchronous liver metastasis has been showed 
to be safe and effective. One stage totally laparoscopic color-
ectal and minor liver resections have been reported but there 
are no data regarding simultaneous major hepatectomies and 
colorectal surgery. The aim is to evaluate safety, feasibility 
and outcome of a small cohort of highly selected patients 
treated by a one stage totally laparoscopic major hepatec-
tomy and colorectal resection.
Methods: From January 2009 to June 2011 fi ve patients (3 
Female and 2 Male) with primary colorectal neoplasm and 
synchronous mono-lobar liver metastasis requiring a major 
hepatectomy underwent one stage totally laparoscopic 
approach following neo-adjuvant chemotherapy. A retro-
spective analysis of prospective collected data was per-
formed. All values are presented as percentage (%) and 
median (range).
Results: Liver procedures were: 4 rights and 1 left hepate-
ctomy. Colonic procedures were 4 sigmoid colectomies and 
1 anterior resection of the rectum. Conversion rate was zero. 
Total operative time was 500 (380–600) min. Estimate blood 
loss was 500 (300–1200) ml. Total hospital stay was 6 (5–10) 
days. All liver resections but one were performed without 
infl ow vascular clamping. Morbidity rate was 40% and peri-
operative mortality was zero. Oncologically, an R0 resection 
was always achieved with a liver clear margin distance of 
1.1 (0.4–1.8) cm and a number of colonic lymph-node 
retrieved of 18 (16–25). At 19 (6–34) months follow up all 
patients are alive and 1 patient had a recurrence observed in 
the remnant liver.
Conclusion: In highly selected patients a one stage totally 
laparoscopic approach is a feasible and safe option to treat 
primary colorectal neoplasm with synchronous liver metas-
tasis requiring major hepatectomies. This approach is 
expected to give fewer adhesions making redo liver surgery 
easier to be performed. Indeed, this happened in the patient 
who experienced a recurrence of a single liver metastasis and 
was treated by a redo laparoscopic resection. Larger studies 
are needed to validate these results.
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FIRST-STAGE HEPATECTOMY 
COMBINED WITH RESECTION 
OF THE PRIMARY TUMOUR FOR 
SYNCHRONOUS BILOBAR 
COLORECTAL LIVER METASTASES
M. Barabino, E. Opocher, R. Santambrogio, A. Gatti, 
E. De Nicola and N.’ M. Mariani
Hepato-biliary-pancreatic Surgery Unit San Paolo Hospital
Hepato-Biliary-Pancreatic Surgery Unit, San Paolo 
Hospitalvia di Rudinì 8, 20142 Milan, Italy
Introduction: This study assessed the feasibility and out-
comes of combined colorectal and hepatic resection as the 
fi rst step of two-stage hepatectomy (TSH) in patients with 
bilobar synchronous colorectal liver metastases (CLM).
Methods: Between January 2004 and January 2011, all 
patients with synchronous initially unresectable CLM were 
enrolled to TSH. Fulfi lling criteria were an unresected 
primary colorectal tumour and bilobar liver metastases 
potentially totally removable by two sequential resections. 
Feasibility and outcome were prospectively evaluated.
Results: Among 71 patients with synchronous CLM, ten 
patients (14%) were planned for combined colorectal resec-
tion and partial clearance of liver metastases as fi rst step 
hepatectomy, of whom 5 by laparoscopic approach. TSH was 
completed in 9/10 patients. Chemotherapy was delivered 
before (50%), in between (70%) and after (88%) the 2 hepa-
tectomies. Mean delay before the fi rst and between the fi rst 
and second operation was respectively 2.8 and 4.7 months. 
Post-operative morbidity increased according to steps (20% 
versus 44%). No mortality occurred. Median follow-up from 
the fi rst stage was 29.3 months. Overall and disease free 
survival rates for patients who completed the procedure were 
70% and 42% respectively at 3 years and 41% and 19% at 
5 years.
Conclusion: Combined fi rst step hepatectomy and colorec-
tal resection can be safely proposed within the two-stage 
strategy plan even in laparoscopy, in order to shrink the 
tumour clearance and optimize time for chemotherapy.
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SIMULTANEOUS COLORECTAL 
SURGERY AND MAJOR HEPATECTOMY 
IN PATIENTS WITH SYNCHRONOUS 
COLORECTAL LIVER METASTASES. 
INSTITUT JEAN PAOLI ET IRENE 
CALMETTES AT MARSEILLE, FRANCE. 
‘15 YEARS OF EXPERIENCE’
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Introduction: Perioperative morbidity due to Simultaneous 
Resection of Colorectal Cancer and Major Hepatectomy in 
patients with synchronous colorectal liver metastases 
(SCRLM) is under estimated, the vast majority of published 
series do not stratify complications by severity according to 
a comprehensible, accessible, well established and validated 
classifi cation system, making diffi cult to clearly establish the 
relation of this combined surgical strategy with the severity 
of postoperative complications.
Methods: We designed a cohort, descriptive, retrospective 
study. A search through the Surgery Department of the 
Institute Jean Paoli et Irene Calmettes at Marseille, France 
medical records identifi ed 12 major liver resections com-
bined with primary colorectal surgery in SCRLM patients 
from 1994 to 2010. Clavien-Dindo Classifi cation of surgical 
complications to establish morbidity by severity and mortal-
ity was used.
We included consecutive patients only at an ‘elective 
scenario’.
Results: 58% were male, 50% were more than 60 y, 83% 
received neo chemotherapy, 67% had comorbidity, 17% had 
an ASA score of 3, 17% were treated with rectum resection, 
mean number of liver mets was 3.58, 58% had bilobular liver 
mets, 42% were taken to right hepatectomy and 25% to right 
extended, in 42% any hepatic pedicle clamping technique 
was used, 33% received perioperative blood transfusion, 
mean surgical time was 536 min, and mean ICU/total stay 
was 9.5/20 d respectively. Overall morbidity was 75%, peri-
operative (60 d) mortality was 0%. No Complication was 
reported in 3 (25%) pts. Low Severity Complications were 
reported in 8 (89%) High Severity Complication reported 
only in 1 (11%) Reintervention due to anastomotic dehis-
cence) The most common was a LSC: Anemia.
Conclusion: Complications are present more often than 
generally reported in literature. We observed that complica-
tions related to liver surgery were the most often reported, 
but those associated to bowel surgery were the most severe. 
This complex, combined, radical surgical procedure to treat 
the SCRLM is feasible, with acceptable rate of High Severity 
Complications and Mortality in centres with an experienced 
team. A statistically designed, multicentric, prospective, con-
trolled and randomized trial is needed.
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MODIFIED FOLFOX6 AND 
BEVACIZUMAB AS NEOADJUVANT 
CHEMOTHERAPY FOR PATIENTS WITH 
POTENTIALLY CURABLE BILOBAR 
LIVER METASTASES FROM 
COLORECTAL CANCER
A. Maeda, Y. Kaneoka, Y. Takayama and M. Isogai
Department of Surgery, Ogaki Municipal Hospital, Gifu, 
Japan
Ogaki Municipal Hospital, Department of Surgery, 4-86, 
Minaminokawa, Ogaki, 503-8502, 503 Gifu, Japan
Introduction: Even though patients with colorectal cancer 
(CRC) and liver metastases have a poor prognosis, they can 
benefi t from perioperative chemotherapy and complete extir-
pation of the disease. Oxaliplatin based chemotherapy with 
bevacizumab has been widely reported to improve outcomes 
with metastatic CRC. However, its impact on surgical com-
plications and survival benefi t after liver resection remains 
to be determined.
Methods: Sixteen patients with potentially curable bilobar 
metastases from CRC were eligible for this single-center, 
nonrandomized trial. The study group consisted of 12 men 
and 4 women, with median age of 61 (range 52 to 73) years. 
Eligible criteria included synchronous liver metastases and 
metastatic liver disease developed within one year after 
resection of the primary lesions. Patients received biweekly 
oxaliplatin, 5-fl uorouracil, and folic acid (FOLFOX6) plus 
bevacizumab therapy. The sixth cycle of neoadjuvant chemo-
therapy (NAC) did not include bevacizumab, resulting in 4 
weeks window-time between the last administration of beva-
cizumab and hepatectomy.
Results: Synchronous liver diseases were observed in 13 
(81%). Although objective response to NAC was achieved 
in 5 patients (32%), 15 patients (94%) underwent liver resec-
tion. The liver surgery included 4 hemihepatecitomies, 2 
sectorectomies, and 9 partial resections of the liver with 
median operative time of 212 minutes and median blood loss 
of 340 mL without blood transfusion. Any postoperative 
morbidity or morbidity was observed. Among the hepatect-
omized, 9 patients (60%) developed recurrence with median 
relapse free time of 16.6 months. Initial recurrent deposits 
were observed in remaining liver in 4 patients, lung in 3, 
lymphnodes in 3, and peritoneum in 1. Two patients were 
deceased of primary disease with survival time of 33 and 24 
months.
Conclusion: Our data suggest that FOLFOX6 and bevaci-
zumab can be safely administered until 4 weeks before liver 
resection in patients with liver metastases from CRC without 
increasing perioperative complications. Further study is 
needed to defi ne the survival benefi t of NAC with FOLFOX6 
plus bevacizumab in patients with potentially curable syn-
chronous bilobar metastases from CRC.
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OUTCOME OF LIVER RESECTION FOR 
NON-COLORECTAL AND NON-
NEUROENDOCRINE LIVER 
METASTASES (NCRNNE)
R. Dave, A. Cockbain, E. Hidalgo, K. R. Prasad, P. Lodge 
and G. Toogood
Department of HPB and Transplant Surgery, St James 
University Hospital, Leeds, UK
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Introduction: The liver is a frequent site for tumor metas-
tases, and surgery for colorectal liver metastases (CRLM) is 
well established, with survival rates accepted to be 50% in 
5 years. However, surgery for NCRNNE has been approached 
with caution. We aimed to report the outcomes of surgery for 
NCRNNE in our unit, and to determine the patterns of 
disease presentation, recurrence and survival.
Methods: We identifi ed 78 patients who had liver resection 
from NCRCNNE primary tumours from 28/12/92 to 02/08/11 
using a prospectively maintained database; Breast (N = 19), 
Melanoma (N = 4), Renal (N = 10), Anal Squamous Cell 
Carcinoma (N = 5), Lung (N = 3), Sarcoma (N = 15), GIST 
(N = 13), Squamous-other (cervix, bile duct, oropharynx) (N 
= 6) and Gastric Adenocarcinoma (N = 3). The electronic 
records of all these patients were then retrospectively 
reviewed. We obtained data on patient demographics, pres-
entation of disease, pathological data, recurrence and sur-
vival. Data was analysed using ANOVA and Kaplan-Meir 
tests.
Results: The age at diagnosis varied with tumour type; 
sarcoma at 46 years and gastric at 67 years. The progression 
to detectable liver disease was quickest with anal SCC 
metastases (172 days), which had a 60% recurrence rate 
within a mean of 192 days. Malignant melanomas had a 
100% recurrence rate, which occurred at a mean of 321 days. 
Breast metastases were the least likely (33%) and slowest 
(468 days) to recur. The 1-, 3- and 5-year survival after 
NCRCNNE metastectomy was 88%, 56% and 47% respec-
tively, compared with 86%, 58% and 46% after CRLM 
metastectomy. 5-year survival was poorest with malignant 
melanomas (0%) and best with GIST (47%). Survival did not 
correlate with size of tumour (largest; sarcoma 67 cm, small-
est; melanoma 28 cm).
Conclusion: Liver Resection is an effective treatment for 
metastases from NCRCNNE tumours in highly selective 
patients. In the right patient, surgery offers similar survival 
rates to resection of CRC metastases, but some tumour types 
do better than others, and a decision to proceed with resec-
tion should take into account the histological diagnosis, and 
an understanding of the behavior of that tumour type.
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INDETEMINATE HEPATIC LESIONS FOR 
COLORECTAL CANCER PATIENTS
J. H. Kim, H.-S. Han, Y.-S. Yoon, J. Y. Cho, D. W. Hwang 
and Y. Kwon
Seoul National University Bundang Hospital, Department 
of Surgery, Seoul National University College of Medicine, 
Korea
Seoul National University Bundang Hospital, Department 
of Surgery, Bundang Hospital, 166 Gumi-ro, Bundang-Gu, 
Seongnam-Si, Gyeonggi-Do, 463-707, 467-7 Seongnam, 
South Korea
Introduction: The initial abdominal CT scan for patients 
with colorectal cancer may reveal indeterminate hepatic 
lesions. The signifi cance of these lesions is often unknown 
at the time of diagnosis. This study evaluates the indetermi-
nate hepatic lesions on abdominal CT scan and the diagnostic 
accuracy of MRI.
Methods: Between January 2009 and December 2009, data 
were collected retrospectively. All colorectal cancer patients 
with hepatic lesions less than 1 cm on initial staging CT scan 
were included. These hepatic lesions were formally reported 
as equivocal lesions. MRI was performed in case of the 
patients with equivocal hepatic lesions, after initial CT scan. 
The cyst, hemangioma, and colorectal cancer with liver 
metastasis were excluded which were defi nitely diagnosed 
by the radiologists.
Results: 73 patients in the enrolled colorectal cancer patients 
had the equivocal hepatic lesions. Total 121 indeterminate 
hepatic lesions were analyzed. 16 lesions (13.2%) were 
proved to be metastasis, and the other 105 lesions (86.8%) 
were benign stable lesions. Sensitivity, specifi city, positive 
predictive value, negative predictive value and positive like-
lihood ratio for these indeterminate lesions for MRI were 
68.7%, 95.2%, 76.1%, 100% and 14.3, respectively.
Conclusion: Indeterminate hepatic lesions may require 
further evaluation and can be clarifi ed by MRI which is 
useful diagnostic tool.
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BIPOLAR VS UNIPOLAR RFA OF LIVER 
EFFECTS OF BLOOD FLOW
D. Morris, M. Habin, J. Akhter and K. Pilla
University of New South Wales St George Hospital
University of New South Wales, Department of Surgery, St 
George Hospital, Short Street, Kogarah 2217 Sydney, 
Australia
Introduction: RFA has high local recurrence rates in liver, 
these experiments seek to clarify the effects of vascular heat 
sink on monopolar and bipolar RFA.
Methods: 1. Bovine liver perfused at 1 L/min at room 
temperature.
2. Bovine liver with 5 mm PTFE graft transversing it 
perfused at 1 L/min. Unipolar and bipolar (RFA Medical) 
RFA probes. Calculation of volume of ablation by bidirec-
tional measurements.
Results: 1. Perfusion reduced ablation volume from 8.2 cc 
to 0.1 cc monopolar 100 w, 5 min 3 cm probe with 52 to 
5.9 cc bipolar. Increasing power to 150 watts returned this 
to 65 cc.
2. 5 cm probe adjacent to large vesel 5 cc 150 watts 
monopolar 35 cc bipolar.
Conclusion: Bipolar RFA is far more effi cient than unipolar 
in a perfused liver model.
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LIVER METASTASIS FROM 
ADRENOCORTICAL CANCER – 
SURGERY CAN HELP
B. Patel, R. Bryant and N. O’Rourke
Royal Brisbane Hospital
Royal Brisbane Hospital, Ned Hanlon Building, Level 8, 
4008 Brisbane, Australia
Introduction: Adrenocortical carcinoma is a rare tumour 
with variable survival statistics. Long term survival after 
resection of liver metastases is occasionally reported. We 
would like to report on 4 liver resections in 3 patients with 
good medium term outcomes and one important histologic 
misdiagnosis.
Methods: We reviewed three patients from our liver resec-
tion database. All had undergone resection of liver tumours 
in the setting of a previously resected primary tumour of the 
adrenal cortex.
Results: R0 resection of an 8 cm left adrenal primary. 8 
years later a 3 cm lesion in segment 4B was resected in a 
non anatomic fashion with clear margins. Histology sug-
gested Focal Nodular Hyperplasia (FNH). 10 years later, a 
12 cm tumour in the right lobe was detected. Laparoscopic 
biopsy suggested metastasis from adrenocortical carcinoma, 
confi rmed following right hepatectomy, although immune-
phenotyping was needed to exclude a primary hepatic lesion. 
Disease free at 3 months.
R0 resection of a 10 cm left adrenal primary, 18 months 
later 3 large liver metastases, extended R0 right hepatectomy, 
disease free at 12 months.
18 cm primary left adrenocortical carcinoma with a syn-
chronous 3 cm secondary tumour in segment 6 was observed 
for 3 months.
Conclusion: Long term survival is possible in some patients, 
following resection of liver metastases from adrenocortical 
cancers. The histology can be confusing and immunohisto-
chemistry is recommended.
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CHEMOTHERAPY ASSOCIATED LIVER 
INJURY: A SYSTEMATIC REVIEW AND 
META-ANALYSIS
S. Robinson1, C. Wilson2, A. Burt1, D. Manas2 and 
S. White1
1Institute of Cellular Medicine, Newcastle University, 
Framlington Place, Newcastle upon Tyne, NE2 4HH, UK; 
2Department of HPB and Transplant Surgery, Freeman 
Hospital, High Heaton, Newcastle upon Tyne, NE7 7DN, 
UK
Newcastle University, Institute of Cellular Medicine, 
Framlington Place, Newcastle upon Tyne NE24H, UK
Introduction: Chemotherapy associated liver injury (CALI) 
has been associated with increased morbidity and mortality 
in patients undergoing major hepatectomy to treat colorectal 
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liver metastases (CRLM). In addition a link has recently been 
made between CALI and poorer long term disease specifi c 
outcome.
The aim of this review was to determine the pathological 
effect of specifi c chemotherapy regimens on the hepatic 
parenchyma as well as surgical morbidity, mortality and 
overall survival.
Methods: A literature search of MEDLINE, EMBASE and 
the Cochrane Library identifi ed 14,619 potentially relevant 
reports. Of these 37 full text reports which included patients 
only with CRLM and provided either histological data 
or patient outcome data were considered suitable for 
inclusion.
For each report data relating to study design characteris-
tics, histological scoring of the liver parenchyma and 
peri-operative outcomes were extracted. Study quality 
was assessed using the Newcastle-Ottawa score for non-
randomised studies and graded using the Oxford centre for 
Evidence Based Medicine scale.
A meta-analysis was performed utilising a random effects 
model. Results are reported as relative risk (±95% CI). 
Statistical signifi cance was set at p < 0.05.
Results: No association could be demonstrated between the 
use of pre-operative chemotherapy and the development of 
hepatic steatosis > 30%. The presence of steatohepatitis was 
associated with the use of pre-operative Irinotecan based 
chemotherapy (RR 3.45; 95% CI 1.12–10.62; p = 0.03). 
Calculating the number needed to harm suggests that 1 in 
every 12 patients treated with Irinotecan based chemother-
apy could be expected to develop steatohepatitis.
Oxaliplatin based chemotherapy regimens are associated 
with grade 2 or greater sinusoidal injury (RR 4.36; 95% CI 
1.12–10.62; p = 0.03) with a number needed to harm of 8. 
The use of Bevacizumab alongside Oxaliplatin reduces the 
risk of grade 2 or greater sinusoidal injury.
Conclusion: The use of pre-operative chemotherapy is 
associated with an increased risk of injury to the liver paren-
chyma in patients with CRLM. This injury occurs in a 
regimen specifi c manner with Irinotecan being associated 
with steatohepatitis whereas Oxaliplatin is associated with 
sinusoidal injury. This injury may have implications on the 
functional reserve of the liver following major hepatic 
resection.
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CLINICAL AND EXPERIMENTAL 
INVESTIGATION OF HEPATIC 
STEATOSIS AFTER FOLFOX 
CHEMOTHERAPY FOR CRLM
S. Robinson1, J. Mann1, A. Burt1, D. Manas2, D. Mann1 
and S. White1
1Institute of Cellular Medicine, Newcastle University, 
Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK; 
2Department of HPB and Transplant Surgery, Freeman 
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Introduction: Chemotherapy associated liver injury (CALI) 
is a signifi cant concern in patients requiring liver resection 
for colorectal liver metastases (CRLM). Although more com-
monly associated with sinusoidal obstruction syndrome 
some reports suggest that Oxaliplatin can predispose to 
hepatic steatosis/steatohepatitis. The aim of this study was to 
evaluate the development of steatosis/steatohepatitis after 
Oxaliplatin based chemotherapy.
Methods: C57Bl/6 mice (n = 6) were treated with intra-
peritoneal FOLFOX weekly for 4 weeks. One week after the 
fi nal dose animals were culled and livers harvested. 
Representative samples of liver were formalin fi xed for his-
tological analysis. Hepatic triglyceride content was meas-
ured in tissue lysates using a colorimetric assay.
H&E stained tissue sections of 50 patients (mean age 
64.2 yrs; 37M : 13F) who had previously undergone liver 
resection for colorectal liver metastases, all of whom had 
received pre-operative chemotherapy, were reviewed and the 
degree of hepatic steatosis was scored (mild, moderate and 
severe). The presence of infl ammatory infi ltrates and bal-
looning degeneration of hepatocytes was also assessed.
Results: Histological review of FOLFOX treated mice did 
not demonstrate any evidence of hepatic steatosis or associ-
ated infl ammation. Similarly hepatic triglyceride content did 
not differ between control and FOLFOX treated animals 
(11.96 nmol vs 11.78 nmol; p = 0.467).
All patients in our cohort had received chemotherapy prior 
to surgery (5-FU/Capecitabine n = 12; Oxaliplatin based n = 
20 or Irinotecan based n = 18). Others received a combina-
tion of both Oxaliplatin and Irinotecan. The incidence of 
hepatic steatosis was similar in those receiving 5FU alone 
(58.3%; n = 7); oxaliplatin (57.9%; n = 11; p = 0.37) or 
irinotecan (41.7%; n = 5; p = 0.42). There was no evidence 
of steatohepatitis in any group.
Conclusion: The addition of Oxaliplatin to traditional 5-FU 
based chemotherapy is not associated with a higher incidence 
of hepatic steatosis in either our experimental model or in 
patients treated with Oxaliplatin based chemotherapy. 
Discussion of the toxicity of Oxaliplatin based regimens 
should rather focus on sinusoidal obstruction syndrome and 
not hepatic steatosis.
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UNPICKING THE PATHOGENESIS OF 
FOLFOX INDUCED SINUSOIDAL 
OBSTRUCTION SYNDROME
S. Robinson1, J. Mann1, D. Manas2, A. Burt1, D. Mann1 and 
S. White1
1Institute of Cellular Medicine, Newcastle University, 
Framlington Place, Newcastle upon Tyne, NE2 4HH, UK; 
2Department of HPB and Transplant Surgery, Freeman 
Hospital, High Heaton, Newcastle upon Tyne NE7 7DN, 
UK
Newcastle University, Institute of Cellular 
MedicineFramlington Place, Newcastle upon Tyne NE24H, 
UK
Introduction: Sinusoidal obstruction syndrome (SOS) fol-
lowing Oxaliplatin based chemotherapy is a cause for major 
concern when undertaking liver resection for colorectal liver 
metastases. To date no relevant experimental models of 
Oxaliplatin induced SOS have been described. The aim of 
this project was to establish such a model which could be 
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utilised to identify potential therapeutic strategies to prevent 
the development of SOS.
Methods: C57Bl/6 mice were treated with intra-peritoneal 
FOLFOX (n = 10), or vehicle (n = 10), weekly for fi ve weeks 
and culled one week following fi nal treatment. Representative 
biopsies of the liver and spleen were fi xed in formalin and 
paraffi n embedded for histological analysis.
RNA and protein were extracted from snap frozen biopsies 
of the liver and subject to biochemical, analysis by qRT-PCR 
and western blot respectively, for markers of matrix remodel-
ling, vascular dysfunction/endothelial damage, DNA damage 
and cellular proliferation. Serum was separated from whole 
blood and markers of liver injury (i.e. ALT, AST and Alk 
Phos) were also measured. Statistical signifi cance was 
assessed with Mann-Whitney U Test.
Results: FOLFOX treatment was associated with the devel-
opment of sinusoidal dilatation and peri-venular hepatocyte 
atrophy on H&E stained sections of the liver in keeping with 
SOS. This was associated with an elevated serum ALT and 
AST (p < 0.05). Immunohistochemistry for γH2AX demon-
strated the presence of DNA damage in the sinusoidal 
endothelium.
In the liver of FOLFOX treated animals there was up-
regulation of key genes associated with matrix remodelling 
such as MMP9 (p < 0.001), MMP2 (p < 0.001), Pro-Collagen 
I (p < 0.001) and TGFβ (p < 0.001). There was evidence of 
endothelial damage and a subsequent pro-thrombotic state 
with up-regulation of PAI-1 (p < 0.001), vWF (p < 0.01) and 
Factor X (p < 0.001).
Conclusion: We have developed the fi rst reproducible 
model of chemotherapy induced SOS that refl ects the patho-
genesis of this disease process in patients. Through analysis 
of this model we have gained insights into the molecular 
changes that underpin the development of SOS and are now 
able to test potential therapeutic strategies to prevent it.
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CAUDATE LOBE RESECTION FOR 
COLORECTAL LIVER METASTASES – A 
MATCHED PAIR ANALYSIS
G. Marangoni, A. Hakeem, G. Toogood, R. Prasad and 
J. P. Lodge
James’ Hospital, HPB and Transplant Unit, Leeds, UK
St James’ Hospital, HPB and Transplant Unit, Beckett 
Street, LS9 7TF Leeds, United Kingdom
Introduction: Tumours located in the caudate lobe can be 
challenging due to the anatomical relation of segment I with 
the inferior vena cava (IVC), the presence of multiple small 
caudate veins, variable bile ducts anatomy and diffi cult expo-
sure during surgery. Some groups reported increased morbid-
ity, smaller resection margins and inferior outcomes. Aim of 
the study was to compare the group of patients who under-
went caudate lobe resection (CLR) with a group of patients 
without caudate lobe excision (NCLR).
Methods: Over a 16 year period, from November 1994 to 
November 2010, 1295 consecutive liver resections for color-
ectal liver metastases (CRLM) were performed at our 
Institution. The cohort of caudate resection patients were age 
(±1 year), sex and number of resected segments matched 
with an exact number of other hepatic resection patients that 
did not include the caudate lobe. Seventy-fi ve patients had 
CLR. Six patients who had isolated caudate lobe resection 
were excluded leaving 69 cases from analysis.
Results: ASA score, comorbidity, number of bilateral resec-
tions, steatosis and fi brosis did not differ among the cohorts 
(p = NS). Similarly the number of tumours, size of the largest 
tumour and resection margins (R0 vs R1) did not differ 
among the two groups (p = NS). Post-operative stay (13.5 vs 
10.9 days), ICU admissions (16 vs 7), morbidity (sepsis, bile 
leak, cardio-vascular, respiratory; 26 vs 27), number of 
patients transfused (7 vs 5), hepatic failure (7 vs 6) and 
60-days mortality (1 vs 2) were not signifi cant (CLR vs 
NCLR, p = NS). Overall survival at 1, 3 and 5 years were 
85%, 57% and 48% for CLR and 95%, 61% and 50% for 
NCLR respectively. Disease-free survival at 1, 3, and 5 years 
were 75%, 47% and 47% for CLR and 85%, 63% and 53% 
respectively.
Conclusion: Although caudate lobe involvement adds to the 
technical complexity of hepatic resection, it does not appear 
to carry increased morbidity and mortality when associated 
to major liver surgery. The rate of R0 resection and overall 
and disease-free survival does not differ between CLR and 
NCLR.
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DIAGNOSIS OF COLORECTAL HEPATIC 
METASTASES AFTER NEOADJUVANT 
CHEMOTHERAPY BY GD-EOB-DTPA 
ENHANCED MR IMAGING
K. Toda, S. Takahashi, Y. Kato, N. Gotohda, T. Kinoshita, 
M. Konishi and T. Kinoshita
Department of Digestive Surgery, National Cancer Center 
Hospital East
National Cancer Center Hospital East, Department of 
Surgery, 6 5 1 Kashiwanoha, Kashiwa, 2778577, 277 
Kashiwa, Japan
Introduction: Purpose: We evaluated the usefulness of 
enhanced magnetic resonance imaging (MRI) using a hepa-
tocyte-specifi c contrast agent, gadolinium-ethoxybenzyl-
diethlenetriamine pentaacetic acid (Gd-EOB-DTPA), in the 
diagnosis of colorectal hepatic metastases (CHM) after neo-
adjuvant chemotherapy.
Methods: Material and method: Twenty-eight patients with 
CHM after neoadjuvant chemotherapy underwent MRI 
including dynamic and hepatobiliary phase EOB-MRI. 
Metastases were either confi rmed by pathological fi ndings of 
resected specimen or imaging fi ndings at four months after 
surgery when the lesion had not been resected at operation. 
Pathologically, we considered the lesions which showed any 
cancer cell microscopically as metastasis. Enlargement of the 
lesion confi rmed by imaging diagnosis after surgery also 
indicated malignancy.
Results: Results: We compared the fi ndings of enhanced 
MRI with Gd-EOB-DTPA and fi nal results by pathology or 
follow-up imaging diagnosis in 117 lesions of 28 patients. 
One hundred and seven lesions were resected. Ten lesions 
(8.5%) which were not detected by EOB-MRI were resected 
with suspicion of metastases during an operation. Six lesions 
(5.1%) which were detected by EOB-MRI showed complete 
response by the histological examination. Six lesions (5.1%) 
which were detected by EOB-MRI, located in deep area of 
liver, were not recognizable during an operation. Three out 
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of the 6 lesions showed progressed in a postoperative 
4-months image. Sensitivity and positive predictive value of 
EOB-MRI were 90% and 80%, respectively.
Conclusion: Conclusions: Enhanced MRI with Gd-EOB-
DTPA can detect small CHM in a high sensitivity even after 
neoadjuvant chemotherapy. However, EOB-MRI might not 
be useful for evaluating tumor viability in patients with CHM 
after chemotherapy.
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HEPATIC RESECTION FOR METASTATIC 
NEUROENDOCRINE TUMOURS: AN 
ASIAN EXPERIENCE
L. S. Yee1, J. Y. Teo2, P. C. Cheow1, Y. F. Chung2, 
K. P. Goh2, J. S. Wong2, K. H. Chow2 and P. J. Ooi1
1Department of Surgical Oncology, National Cancer 
Centre, 11 Hospital Drive, Singapore; 2Department of 
General Surgery, Singapore General Hospital, Singapore
Introduction: Gastrointestinal neuroendocrine tumours are 
rare and their clinical management is challenging. They have 
a strong predilection for metastasis to the liver. Almost 10% 
of all liver metastases are neuroendocrine in origin. While 
liver resection for colorectal metastases is well established, 
the exact role of liver resections for metastatic neuroendo-
crine tumours is less well-defi ned. This is further compli-
cated by the fact that a signifi cant majority of patients have 
diffuse, bilobar disease.
Methods: We reviewed all patients who underwent liver 
resection for metastatic neuroendocrine tumours over a 
10-year period at our institution from a prospective database, 
and compared the clinical, pathological and survival 
characteristics.
Results: 253 patients underwent liver resection for meta-
static lesions to the liver, of which 10 are for metastatic 
neuroendocrine tumours. 4 patients underwent synchronous 
resection of the liver metastases together with the primary; 
one patient underwent resection for presumed hepatocellular 
carcinoma followed by resection of the primary neuroendo-
crine tumor after further investigations, while the remainder 
underwent resection of metastases with curative intent. The 
median overall survival was 45.5 months (range 1–138 
months) with fi ve of the ten patients still alive, after a median 
follow-up period of 67 months. We achieved R0 resection in 
all cases. Of these, four remain disease-free. There was only 
one perioperative mortality in our series.
Conclusion: Liver resection for metastatic neuroendocrine 
cancer has a low mortality and morbidity and confer excel-
lent overall and disease-free survival in selected patients.
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TWO-STAGE SURGERY FOR 
UNRESECTABLE COLORECTAL LIVER 
METASTASES: RESULTS AND 
PROGNOSTIC FACTORS
N. Bagmet, O. Skipenko, G. Shatveryan, L. Polishuk, 
A. Biryukov and V. Khovrin
FSBI Petrovsky National Research Center of Surgery 
RAMS, Moscow, Russia
FSBI Petrovsky National Research Center of Surgery 
RAMS, Department of Liver, Bile Duct and Pancreas 
Surgery, Abrikosovskii pereulok, 211999 Moscow, Russia
Introduction: Two-stage liver surgery (TSLS) is modern 
strategy to improve survival in patients (pts) with initially 
unresectable colorectal liver metastases (CLM) in order to 
minimize the risk of postoperative liver failure and fi nally 
achieve a curative R0 resection.
Methods: From 2007 to 2011, 52 pts underwent two-stage 
liver surgery. Main indications were bilobar CLM (33) and 
small planned remnant liver volume (19) (PRLV). In order 
to increase of PRLV, portal vein ligation (n = 45) or emboli-
zation (n = 7) was performed in all patients as the fi rst stage 
of the treatment. The early postoperative, long-term out-
comes and prognostic factors were analysed.
Results: 38 pts (73%) had completion of TSLS. 14 pts were 
excluded after the stage I mostly because of disease progres-
sion (11). After stage II mortality was 2.6%, morbidity – 
36%, liver insuffi ciency – 0%. There were no signifi cant 
differences in 3-year survival between pts who completed 
TSLS vs. pts treated with planned single-stage hepatectomy 
(65% vs 80%, p = 0.331). By multivariable analysis only 
extrahepatic extrapulmonary colorectal metastases were 
independent prognostic factor infl uenced failure to complete 
stage II (p = 0.013, Odds ratio 0.085) and poor long-term 
outcomes (p = 0.014, Odds ratio 0.097). In this group 3-year 
survival was 38% vs. 76% in pts without extrahepatic 
extrapulmonary lesions (p = 0.0002).
Conclusion: The completion of two-stage surgery gives a 
good chance for long-term survival to the patients with ini-
tially unresectable colorectal liver metastases. Extrahepatic 
extrapulmonary colorectal metastases can predict failure of 
two-stage approach and poor long-term outcomes.
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THE CELLULAR AND CLINICAL 
IMPLICATIONS OF CETUXIMAB IN THE 
MANAGEMENT OF COLORECTAL 
LIVER METASTASES
C. Jones and M. A. Taylor
Department of HPB Surgery, Mater Hospital, Belfast
Mater Hospital, Belfast Health and Social Care Trust, 
Department of HPB Surgery, 10 Breezemount Park, BT32 
Banbridge, Northern Ireland
Introduction: Recent advancements in the management of 
colorectal liver metastases, with new targeted therapies, have 
resulted in an improvement in survival. Novel biomarkers 
such as KRAS may be of prognostic and diagnostic value. 
KRAS mutations potentially predict the response of biologi-
cal therapies such as Cetuximab (Erbutix, Merck Serono). 
This review aimed to evaluate the role of KRAS testing and 
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the use of Cetuximab in the fi rst line management of color-
ectal liver metastases.
Methods: An electronic literature search was performed of 
publications within the past 6 years. The key words – KRAS, 
Cetuximab, metastatic colorectal cancer, colorectal liver 
metastases, singly or in combination, were used. All rand-
omized controlled trials and cohort studies in the defi ned 
time period were included. Limitations included the English 
language and human participants. A total of 7 studies relating 
to KRAS only were retrieved, while a further 15 studies 
relating to the clinical application of Cetuximab as a fi rst line 
treatment of colorectal liver metastases were included.
Results: Studies related to the role of KRAS testing dem-
onstrated a positive concordance of KRAS status between 
primary colorectal cancer and their subsequent metastases; 
and suggested KRAS mutational status is a prognostic indi-
cator in metastatic colorectal cancer. With regard to the clini-
cal application of Cetuximab, seven studies included 
sub-group analysis of KRAS mutational status. Until the 
MRC COIN trial, the evidence consistently demonstrated 
cetuximab signifi cantly improved progression free survival, 
overall survival and surgical resection rates, especially in 
KRAS wild-type tumours. However, the MRC COIN trial, 
the largest prospective trial, found Cetuximab had no addi-
tional benefi t when combined with standard chemotherapy.
Conclusion: The literature does not support the routine use 
of Cetuximab as the standard fi rst-line treatment of colorectal 
liver metastases. It highlights the need for the optimization 
of treatment on an individual basis, especially in KRAS wild-
type tumours only. In this setting, Cetuximab has been shown 
to improve outcome and increase respectability, especially 
when combined with FOLFIRI. The cost-effectiveness of 
Cetuximab also needs to be considered in detail.
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PLACEMENT OF ARTERIAL HEPATIC 
CATHETER DURING MAJOR 
HEPATECTOMY: IS IT SAFE?
L. Benhaim, D. Goere, S. Bonnet, F. Dumont, 
F. Deschamps, T. de Baere, C. Honore and D. Elias
Institut Gustave Roussy, Department de Chirurgie, 
Oncologique, 114, Rue Edouard Vaillant 94805 Villejuif 
Cedex, France
Introduction: Adjuvant hepatic arterial infusion (HAI) of 
chemotherapeutic agent could improve survival after resec-
tion of colorectal liver metastases (CRLM). The aim of this 
study was to analyze the postoperative course after insertion 
of a catheter into the gastroduodenal artery during a major 
hepatectomy.
Methods: Adjuvant HAI was performed for patients at high 
risk of hepatic recurrence (i.e. with more than 4 CRLM, after 
repeat hepatectomy, with disappeared CRLM). Patients who 
underwent a major hepatectomy (3 segments or more) for 
CRLM were selected from a prospective database. From 
2000 to 2010, 22 patients underwent a major hepatectomy 
associated with the insertion of a catheter. They were com-
pared to 25 patients who underwent a major hepatectomy for 
more than 4 CRLM, during the same period.
Results: The 2 groups were comparable regarding age, 
BMI, ASA score, and mean number of preoperative systemic 
chemotherapy (11 ± 5). The operating time was comparable 
295 ± 85 min with and 288 ± 55 min without catheter inser-
tion (p = 0.75). Complications were slightly more frequent 
after catheter insertion (64%) than after major hepatectomy 
alone (51%), but the difference did not reach signifi cance (p 
= 0.06) and occurrence of major complications (Clavien-
Dindo 3 or more) was comparable (p = 0.8). However, 2 
patients died postoperatively, both after an extended hepate-
ctomy associated to a catheter insertion. Causes of death 
could be related to a liver insuffi ciency due to a small 
remnant liver volume, complicated by a portal and an arterial 
thrombosis.
Conclusion: The placement of a catheter into the gastroduo-
denal artery during a major hepatectomy is feasible and does 
not increase signifi cantly the rate of postoperative complica-
tions. However, in case of an extended hepatectomy, the 
catheter placement should be delayed and performed 
percutaneously.
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THE ROLE OF CARCINOEMBRYONIC 
ANTIGEN AS A MARKER FOR 
COLORECTAL LIVER METASTASES
C. Jones, S. A. Badger, L. D. McKie, T. Diamond and 
M. A. Taylor
Department of HPB Surgery, Mater Hospital, Belfast
Mater Hospital, Belfast Health and Social Care Trust, 
Department of HPB Surgery, 10 Breezemount Park, BT32 
Banbridge, Northern Ireland
Introduction: Carcinoembryonic Antigen (CEA) can 
monitor disease progression, and treatment response in 
colorectal adenocarcinoma. This study aimed to determine 
the accuracy of CEA in the detection of colorectal liver 
metastases, and as a marker of subsequent resectability.
Methods: Patients with primary colorectal cancer were 
identifi ed and = divided into three groups: resectable hepatic 
metastases (group 1), unresectable metastases (group 2), and 
disease free (group 3). CEA was recorded pre- and post-
hepatectomy in group 1 and upon radiological confi rmation 
of disease state in groups 2 and 3. CEA was expressed as 
median (95% CI), and the correlation with pathological 
parameters was assessed by Spearman rank correlation.
Results: Group 1 (n = 141) had a median pre-operative CEA 
of 8.9 (4.6–13.1), with 38.1% being normal. Maximum 
tumour diameter correlated with CEA level (r = 0.41, p < 
0.0001). Post-hepatectomy CEA was 2.3 (1.9–2.7; p < 
0.0001), with 81.1% being normal. Group 2 (n = 158) had 
CEA of 20.6 (9.4–31.9). Group 3 (n = 361) had CEA of 2.0 
(1.8–2.2). Sensitivity of CEA pre- and post-hepatectomy was 
61.2% and 69.3% respectively, while specifi city was 79.8% 
for both groups.
Conclusion: CEA concentration was elevated in hepatic 
colorectal metastases, but was not found to be a marker of 
resectability. A CEA reduction post-resection indicates CEA 
may be used as an indicator of treatment response, while 
CEA is increased by tumour burden and lesion size.
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LIVER RESECTION FOR COLORECTAL 
METASTASES (CRM). RESULTS AFTER 
10 YEARS OF FOLLOW UP
J. Lubrano, N. Bouviez, B. Heyd and G. Mantion
University Hospital, Besancon, France
University Hospital, Visceral Surgery, 1 Boulevard 
Fleming, 25030 Besançon, France
Introduction: Actual 5-year survival after resection for 
CRM is actually 25 to 35%. Few studies analysed more long-
term follow up. The aim of the study is to analyse actual 
10-year follow up results and prognosis factors in one center.
Methods: All liver resection for CRM data performed 
between 1990 and 2000 were retrospectively analysed. 
Patients with incomplete data or operated on out of our center 
for a fi rst liver resection were excluded. Statistical study did 
not examine multivariate Cox regression analyse due to the 
number of survivors. A total of 89 consecutive patients 
underwent curative-intent liver resection and were analysed. 
Mean age was 64 years. CRM were synchronous for 24 
patients and metachronous for 65; major liver resection was 
performed in 50 patients, and peri operative chemotherapy 
in 33 patients. 11 patients had repeat hepatectomies. One 
patient experienced operative mortality and 2 patients were 
lost to follow up before 10 years.
Results: There were 37 actual 5-year survivors (43%) and 
19 actual 10-year survivors (22%), among them 16 were 
disease free. Poor prognosis factors were: a disease free 
interval less than 1 year, a non anatomical resection, Fong 
Clinical Risk Score (CRS) > 2, segment 1 CRM location, 
peritumoral lymphangitis. Good prognosis factors were: a 
mucinous component in the CR tumor, CRM right location 
and CRS < or = 2.
Conclusion: Risk of recurrence is real 5 years after liver 
resection for CRM, but survival seems to be stable after 10 
years and 10 year survival patients must be considered as 
cured. Poor prognosis factors may be take into account to 
indicate and to intensify post operative treatments.
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THE ROLE OF LAPAROSCOPY IN TWO-
STAGE HEPATECTOMY FOR BILOBAR 
COLORECTAL LIVER METASTASES
M. A. Hilal, F. Di Fabio, R. N. Whistance, N. W. Pearce 
and J. N. Primrose
Hepatobiliary and Pancreatic Surgical Unit, Southampton 
University Hospitals NHS Foundation Trust, Southampton, 
UK
Southampton University Hospitals NHS Foundation Trust, 
Southampton, UK, Hepatobiliary and Pancreatic Surgical 
Unit, Tremona Road, SO16 Southampton, UK
Introduction: The role of laparoscopy in the management 
of patients with bilateral colorectal liver metastases (CRLMs) 
has not yet been investigated.
Methods: We reviewed a prospectively collected database 
of patients undergoing two-stage hepatectomy at our institu-
tion between April 2007 and April 2011.
Results: Nine patients (male n = 7, median age 62) under-
went two-stage hepatectomy for bilobar CRLMs with laparo-
scopic fi rst-stage. The fi rst stage consisted of laparoscopic 
clearance of the left lobe with no postoperative morbidity 
and mortality. Two patients underwent portal vein ligation 
during fi rst-stage hepatectomy, and six patients underwent 
portal vein embolization after surgery. Second-stage hepate-
ctomy with right lobar clearance (open n = 6, laparoscopic 
n = 2, and laparoscopic to open = 1) was associated with no 
mortality and a postoperative morbidity rate of 56%. 
Complications included intra-abdominal collection (n = 4), 
and bleeding requiring re-operation (n = 1). During second-
stage surgery adhesions in the operating fi eld were minimal 
or absent.
Conclusion: The well recognized advantages of laparos-
copy (e.g.: less intra-abdominal adhesions and faster recov-
ery) may play a favourable role in the aggressive management 
of patients with bilobar CRLMs who are candidates for a 
two-stage resection. Laparoscopic fi rst-stage clearance of the 
left lobe should progressively become the ‘gold standard’. 
Laparoscopic second-stage hepatectomy is a feasible but 
challenging procedure requiring accurate patient selection.
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SURGICAL RESECTION FOR LIVER 
METASTASIS FROM GASTRIC 
ADENOCARCINOMA
S. B. Kim1, K. S. Bum1, Y. T. Koh2, E.-H. Cho1 
and C.-S. Lim3
1Department of Surgery, Korea Cancer Center Hospital; 
2Department of Surgery, National Police Hospital; 
3Gastrointestinal Cancer Center, Dongnam Institution of 
Radiological & Medical Sciences
Korea Cancer Center Hospital, Surgery, 75 Nowon-gil 
(215-4-Gongneung-dong), Nowon-gu, 139-7 Seoul, 
Republic of Korea
Introduction: This study was performed to analyze the 
clinical outcome of surgical resection for liver metastases 
from gastric adenocarcinoma.
Methods: From January 1991 to December 2010, total of 
8723 curative gastrectomies for gastric adenocarcinomas 
were performed in department of surgery of Korea Cancer 
Center Hospital, Seoul, Korea. Among them, liver metastasis 
was found in 120 patients (11.9% of recurrent patients) and 
curative hepatectomy was performed in 11 patients (respect-
ability 9.2%). Clinical outcome of the patients who under-
went hepatectomy was analyzed retrospectively.
Results: Among the patients, 10 patients were male. Median 
age was 58 years old. Median duration between gastrectomy 
and liver metastasis was 10.7 months. Median follow up 
period was about 10 months. No operative complication or 
operative mortality occurred in the patients. Synchronous 
resection was performed in 3 patients, and metachronous 
resection was performed in 8 patients. One year over all 
survival rate was 27.8% and fi ve year survival rate was 9.1% 
in all patients. No patients survived for 1 year in synchronous 
patients. In metachronous patients, one-year survival rate 
was 37.5%, and fi ve-year survival rate was 12.5%.
Conclusion: Candidate for surgical resection of liver metas-
tasis from gastric cancer is few and Prognosis after hepate-
ctomy of metastases is disappointing. But In selected cases 
long-term survivors do exist.
 Poster Presentation Abstracts 409
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 288–699 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
489
GENE EXPRESSION IN OXALIPLATIN 
RELATED SINUSOIDAL 
OBSTRUCTION SYNDROME
S. Robinson1, M. Jelena1, M. Derek2, M. Derek1 
and W. Steve1
1Institute of Cellular Medicine, Newcastle University, 
Framlington Place, Newcastle upon Tyne, NE2 4HH, UK; 
2Department of HPB and Transplant Surgery, Freeman 
Hospital, High Heaton, Newcastle upon Tyne, NE7 7DN, 
UK
Newcastle University, Institute of Cellular Medicine, 
Framlington Place, Newcastle upon Tyne NE24H, UK
Introduction: Sinusoidal Obstruction Syndrome (SOS) is 
associated with Oxaliplatin based chemotherapy in patients 
with colorectal liver metastases (CRLM) and is a cause of 
concern when undertaking major liver resection.
The pathogenesis of SOS is poorly understood however a 
variety of candidate genes have been identifi ed which may 
play a role in activating various molecular pathways involved. 
The aim of this study was to validate these gene expression 
changes in an independent cohort of patients.
Methods: Patients undergoing liver resection for CRLM, 
were identifi ed for inclusion and appropriate informed 
consent obtained. Full clinical information was recorded for 
each patient including pre-operative chemotherapy use. A 
biopsy of the non-tumour bearing liver was obtained, prior 
to parenchymal transection, and stored in RNA later. 
Histopathology was reviewed to identify those with SOS.
Hepatic gene expression was compared in chemotherapy 
naive patients (controls) with no evidence of underlying 
liver disease (n = 10) and those who received pre-operative 
Oxaliplatin either with (n = 13) or without (n = 9) evidence 
of SOS by qRT-PCR. Mann-Whitney U-test was used to 
assess statistical signifi cance.
Results: The interval between cessation of chemotherapy 
and surgery was similar for all patient groups (p = 0.45). In 
contrast to previous studies we were unable to identify 
changes in extracellular matrix remodelling genes (MMP2, 
MMP9, TIMP1, TGFβ) thought to be involved in SOS. 
However there was up regulation of angiogenesis related 
VEGF-C (1.6 fold, p < 0.05) along with the hypoxia induced 
HIF1a (1.98 fold; p < 0.01) in those with SOS.
It is suggested that SOS is associated with a pro-throm-
botic tendency and in keeping with this there was a non-
signifi cant trend towards increased expression of vWF (2.5 
fold; p = 0.06). We also confi rmed up-regulation of CCL20 
in those with SOS (3.8 fold; p < 0.05) which is chemotactic 
for colorectal cancer cells.
Conclusion: We were able to confi rm up-regulation of 
genes involved in angiogenesis, hypoxia and thrombogenesis 
in patients with SOS. It is likely that changes in extracellular 
matrix re-modelling genes occur early in the development of 
SOS and but have returned to baseline levels if there is a 
reasonable duration between stopping chemotherapy and 
surgical resection.
Increased expression of CCL20 may account for the 
recently reported poorer disease specifi c survival in patients 
with SOS.
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EXISTENCE OF VESICULAR INVASION 
OF LIVER TUMOR ON COLORECTAL 
LIVER METASTASIS (CRLM) PATIENTS 
MAY HAVE A ROLE OF EARLY RELAPSE 
AFTER HEPATECTOMY
Y. Kotera, Y. Takahasi, T. Kato, G. Yoneda, A. Oomori, 
S. Arizumi, S. Katagiri and M. Yamamoto
Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University
Tokyo Women’s Medial University, Surgery, 8-1, 
Kawadacyo, Shinjyuku 162 Tokyo, Japan
Introduction: Background: Colorectal Liver Metastasis 
(CRLM) were frequently relapsed even after curative opera-
tion. It is very important to predict whether tumor relapse or 
not. In this study, we focus on the vesicular invasion (portal 
vein invasion or venous invasion) of Metastatic liver tumor 
itself. Then We try to fi gure out the vesicular invasion has 
any role of relapse tumor.
Methods: Patients: 90 cases of CRLM patients who under-
went curative operation (hepatectomy) during the period of 
2001–2008 were chosen. 48 patients (53.3%) were men. 43 
patients (47.7%) were the synchronous metastasis cases. 
Methods: All tumors of 90 patients were checked existence 
of vesicular invasion pathologically after curative operation. 
Clinical outcome were examined and also tumor free sur-
vival and overall survival were examined on both vesicular 
invasion positive group (positive group) and vesicular inva-
sion negative group (negative group).
Results: 51 cases out of 90 cases (56.6%) had vesicular 
invasion on their tumors. 3 years survival rate after hepate-
ctomy was 85% on vesicular invasion negative group, 56% 
on positive group. Positive group had signifi cantly poor 
outcome after hepatectomy (p = 0.004) 79 cases out of 90 
patients underwent chemo therapy after hepatectomy. On 
positive group, chemo therapy using mFOLFOX6 prolonged 
overall survival rate.
Conclusion: Tumors which had vesicular invasion easily 
relapsed after curative operation for CRLM. Based on the 
results of this study, First we should check the existence of 
vesicular invasions then decide which patient should perform 
chemo therapy after hepatectomy or not.
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REPEATED LIVER RESECTIONS FOR 
COLORECTAL CANCER METASTASES
V. Visokai, L. Lipska, M. Mracek and M. Levy
Surgical Department, Thomayer Hospital, First Faculty of 
Medicine, Charles University
Thomayer Hospital, First Medical Faculty, Charles 
University Prague, Surgical Department, Videnska 
80014059 Prague 4, Czech Republic
Introduction: Liver metastases will appear approximately 
in 40% of patients with colorectal carcinoma, synchronous 
metastases are present at time of diagnosis of CRC in 
15%–20% of patients, in another 20% of patients will 
develop metachronous metastases (most often within 2 
years) after resection of primary CRC. Surgery remains the 
only option for curative radical treatment for liver metastases 
for colorectal carcinoma.
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Methods: The aim of the study was to evaluate results of 
repeated liver resections for colorectal cancer metastases. 
There were 119 patients operand for CRLM between 1996 
and 2011 at our surgery. Of these 21 patients were operated 
repeatedly.
Results: Morbidity in all patients operated for CRLM was 
26.1%, mortality 2.5, 5-year survival is 40%, median follow 
up 3.5 year. Repeatedly operated were 21 patients, 16 two 
times, 3 three times, 2 patients four times together 28 
repeated operations were performed. Limited resections were 
preferred (10 times, together 34 nonanatomical resections), 
segmentectomy was performed in 9 cases, bisegmentectomy 
in 3 cases and right hepatectomy in 3 cases.
Morbidity was in all patients 25% in group repeatedly 
operated was 28.6% (p = 0.66), mortality 2.6% vers. 0%, 
mean blood loos was 6632 ml vers. 835 ml (p = 0.14). 
Relapse of cancer was in 60% of all cases, in the group of 
repeatedly operated in 61% cases. Survival in both groups 
was similar (p = 0.856).
Conclusion: Our results confi rmed that morbidity, mortal-
ity, DFI and survival is similar in patients who underwent 
repeated liver resections compared with those with one 
resection. Indication for repeated liver resection are the same 
as for fi rst resection. Patient should be well aware of prob-
ability of repeated liver resection at the time of fi rst hepate-
ctomy. Liver preserving resection should be preferred.
522
STRATEGIES IN LIVER METASTATIC 
DISEASE – OUR EXPERIENCE
N. Kolev, A. Tonev, K. Ivanov, V. Ignatov and G. Ivanov
University Hospital ‘St. Marina’, Varna, Bulgaria
University Hospital, Department of General and Operative 
Surgery, 1, Hristo Smirnensky str, Varna 9000, Bulgaria
Introduction: Recent advances in chemotherapy, combined 
with traditional clinicopathological factors should used to 
indicated otherwise unresectable patients from surgery.
Methods: We present our statistically analyzed experience 
and some novel tendencies in the management of patients 
with metastatic disease from gastrointestinal cancer.
Results: Portal vein embolization and two-stage operation 
with ablative therapy and preoperative chemotherapy should 
be considered for potentially resectable liver metastases 
located in a liver remnant that is at the minimum volume 
required for survival. Some recent trials regarding preopera-
tive chemotherapy for resectable liver mets have failed to 
demonstrate a clear signifi cant advantage. However, patients 
with a low clinical risk score for the recurrence, such as 
several metastases of less than 4 cm, and who are fi t candi-
dates for liver resection are often offered immediate surgery.
Conclusion: For defi nitely unresectable liver metastatic 
disease there are treatment options in face of novel triple 
combination in biologics systemic therapy, radiosurgery and 
etc. The treatment paradigm for liver mets is rapidly chang-
ing with the development of newer anticancer agents. Stem 
cells diagnostics will reveal some future benefi ts.
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SELECTIVE INTERNAL RADIATION 
THERAPY (SIRT) PRIOR TO LIVER 
RESECTION FOR COLORECTAL 
LIVER METASTASES
M. R. Schoen1, D. Kant1, J. Dietrich1, D. Gaertner1, 
P. Reimer2, M. Binnenhei3, M. Bentz3 and K. Tatsch4
1Department of Surgery, Klinikum Karlsruhe, Germany; 
2Department of Radiology, Klinikum Karlsruhe, Germany; 
3Department of Oncology, Klinikum Karlsruhe, 
Germany; 4Department of Nuclear Medicine, Klinikum 
Karlsruhe, Germany
Klinikum Karlsruhe, Department of Surgery, Moltkestr. 
9076133 Karlsruhe, Germany
Introduction: Current advances in the fi eld of hepatobiliary 
surgery including portal vein embolization, radiofrequency 
ablation of small lesions and two-stage hepatectomy have 
enabled surgeons to take a more aggressive approach to 
surgical management of liver malignancies. A treatment 
option with good tolerability that would control local tumor 
growth and allow for lobular hypertrophy could further 
enhance resectability and provide for even better clinical 
results.
Methods: 3 patients with irresectable colorectal liver metas-
tases refractory to chemotherapy underwent SIRT with 
yttrium-90 resin microspheres followed by major hepatic 
resection. Case 1: 51-year-old woman, large metastases in 
segments 2, 3, 5 and 8. First stage left lateral liver resection 
was followed by SIRT to the right liver, followed by right 
hepatectomy. Case 2: 78-year-old man with a large tumor 
mass in segments 4, 5 and 8. Superselective SIRT was carried 
out to the central liver segments followed by extended right 
hepatectomy. Case 3: 77-year-old man with a large tumor 
mass in segments 2, 3, 4, 5 and 8. SIRT was carried out to 
the left side of the liver and selectively to the branches of 
seg. 5 and 8 followed by extended left hepatectomy.
Results: SIRT treatment was well tolerated by all patients. 
Except for minor nausea no side effects occurred. Serial 
FDG-PET/CT scans revealed in all cases a decrease in size 
and metabolic status of the tumors. A signifi cant decrease of 
the tumor marker CEA was measured. Further, an increase 
of volume in liver segments not treated with SIRT was cal-
culated in all cases by CT or MRI scans. Major hepatic 
resection was uneventful in all patients. Histology of resected 
liver tissue revealed Y-90 microspheres deposition predomi-
nantly at tumor sites. A signifi cant tumor regression and 
fi brosis of liver tissue from segments treated with SIRT 
occurred.
Conclusion: As demonstrated by regression in CT scans, 
decrease of metabolic activity in FDG-PET scans, decrease 
of tumor markers and tumor regression in histology we 
would like to conclude that SIRT is highly effective in local 
tumor control. Further, SIRT was followed by hypertrophy 
of the untreated liver segments thus allowing for safe 
extended liver resection. We believe that SIRT deservers 
further evaluation in controlled studies not only in palliative 
settings but prior to liver resection.
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HEPATIC RESECTION FOR METASTATIC 
MALIGNANT MELANOMA: 
A SYSTEMATIC REVIEW
J.-M. Aubin, J. Rekman, R. Fairfull-Smith, R. Mimeault, 
F. Balaa and G. Martel
Liver and Pancreas Surgery Unit, Division of General 
Surgery, The Ottawa Hospital, University of Ottawa, 
Ottawa, ON, Canada
The Ottawa Hospital, Civic CampusLiver and Pancreas 
Unit, 1053 Carling, CPC Suite 305, K1Y 4E9, Ontario, 
K1Y4E Ottawa, Canada
Introduction: The recent decades have seen an increase in 
hepatic resections for non-colorectal metastatic disease. 
Though only small series have been published, hepatic resec-
tions for metastatic melanoma have been carried out. The 
objective of this review was to evaluate the safety and ade-
quacy of oncologic outcomes of liver resection for metastatic 
melanoma.
Methods: Two authors reviewed the literature from 
MEDLINE, Embase and The Cochrane Library and inde-
pendently screened qualifying articles. Studies with a 
minimum of ten patients with metastatic melanoma undergo-
ing liver resection were included. Included outcomes of 
overall survival and/or disease-free survival were abstracted 
and synthesized.
Results: A total of 369 de-duplicated studies were screened. 
Seventeen studies were included, for 797 patients (1.4–44% 
of patients with melanoma metastatic to the liver). Median 
follow-up was 9–59 months (0–258 months). Median dis-
ease-free survival post-resection was 8.3–23 months. Median 
overall survival post-resection was 8.4–28 months (R0 resec-
tion: 23–28 months; R1: 16–22 months; R2: 8.4–16 months). 
Documented overall survival was 60–77% at 1 year, 30–53% 
at 3 years, and 0–29% at 5 years. Median overall survival 
with a solitary metastasis was 37–81 months, and 7–30 
months for multiple metastases. Although poorly reported, 
best supportive care yielded a median overall survival of 
3–12 months, with a 5-year survival of 4–6%.
Conclusion: Hepatic resection appears to improve survival 
in selected patients with metastatic melanoma, particularly 
so with low metastatic burden and R0 resection. Given the 
certain selection bias, these fi ndings should be confi rmed in 
a multi-institutional clinical trial.
539
SIMULTANEOUS LAPAROSCOPIC LIVER 
RESECTION FOR COLON CANCER 
LIVER METASTASIS
Y. Kwon, H.-S. Han, Y.-S. Yoon, J. Y. Cho, D. W. Hwang 
and K.-W. Jung
Department of Surgery, Seoul National University Bundang 
Hospital, Seoul National University College of Medicine
Seoul National University Bundang Hospital, Department 
of Surgery, 82, Gumi-ro 173, Beon-gil 46370 Seongnam, 
R.O. Korea
Introduction: The liver is the most common organ for the 
metastasis of colorectal cancer and hepatectomy for the 
metastatic lesion is regarded as the standard and only poten-
tial curative treatment. Increasing numbers of study report 
the effi cacy and safety of combined colorectal and liver 
resection and the feasibility and safety of laparoscopic hepa-
tectomy is proved in numerous journals. In the present study, 
we evaluated clinical outcomes of combined laparoscopic 
colorectal and liver surgery.
Methods: Six patients who underwent combined laparo-
scopic colorectal surgery and laparoscopic hepatectomy for 
colon cancer and synchronous liver metastasis were retro-
spectively analyzed.
Results: Five cases of tumorectomy and one left hemihepa-
tectomy were performed for the colon cancer with hepatic 
metastasis and every liver resection was done by totally 
laparoscopic method. The median operative time was 267.5 
minutes while median time for hepatic resection was 125 
minutes and for colorectal resection was 165 minutes. There 
was no open conversion or immediate postoperative compli-
cation. Median blood loss was 350 ml (50–700). One patient 
received reoperation due to anastomotic leakage one week 
after the surgery. Cancer recurred in only one patient 8 month 
after the surgery. This patient received radiofrequency abla-
tion for recurred metastasis in liver and wedge resection for 
metastasis in lung.
Conclusion: Combined laparoscopic liver resection for 
colon cancer liver metastasis is feasible procedure.
564
ONE-STAGE SURGICAL RESECTION OF 
17 SYNCHRONOUS MULTIPLE BILOBAR 
LIVER METASTASIS FROM 
COLORECTAL CANCER: CASE REPORT 
AND REVIEW OF LITERATURE
C. Veronica1, N. Spadafora1, E. Bonaiuto1, A. N. Garrini1, 
S. Vaccarisi1, V. Pellegrino1, G. Cavallari2 and B. Nardo1
1Hepato-Biliary-Pancreatic and Transplant Organs Unit, 
Department of Surgery, Annunziata Hospital, Cosenza, 
Italy; 2Department of Surgery and Transplantation, S.
Orsola-Malpighi Hospital, University of Bologna, Italy
Annunziata Hospital, Surgery, Hepato-Biliary-Pancreatic 
and Transplant Organs Unitvia F. Migliori 87100 Cosenza, 
Italy
Introduction: The surgical indication and the optimal 
timing for surgical resection for synchronous metastasis 
(SM) have long been controversial. Neoadjuvant chemo-
therapy has been found to be effective not only for initially 
non-resectable metastasis but also for resectable SM. Some 
studies recommended staged operation with initial resection 
of the colorectal cancer followed by hepatic resection 2–6 
months later. Two-stage hepatectomy is the most widely used 
surgical treatment of multiple bilobar metastases.
Methods: We reported our experience about a 1-stage oper-
ative time in a patient with rectal cancer and synchronous 
multiple hepatic bilobar metastasis. In April 2010, a 59 
years-old man was admitted in our department for 
Adenocarcinoma of the rectum and multiple hepatic bilobar 
metastasis. General conditions were good and the preopera-
tive imaging, abdominal ultrasonography (US), computer 
total body tomography (CT) no showed extra-hepatic disease. 
We performed intraoperative ultrasonography (IOUS) that 
showed 17 hepatic metastases and we decided to proceed to 
1-stage operative time of anterior resection of the rectum, 
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ileostomy and IOUS guided wedge resections of all hepatic 
bilobar metastases.
Results: The immediate post operative time was regular. 
Patient underwent adjuvant chemotherapy. At 20 months 
follow-up the general conditions are good and there is no 
evidence of recurrence.
Conclusion: In our experience one-stage operative treat-
ment of rectum tumor and hepatic bilobar metastasis resec-
tions is a good strategy in selected patients and specialized 
centers in agreement with literature data.
662
LIVER RESECTION FOR NON 
COLORECTAL NON NEUROENDOCRINE 
(NCNNE) CANCER LIVER METASTASES. 
EXPERIENCE FROM 22 CASES
N. Quezada, R. Yanez, J. Varas, F. Crovari, J. F. Guerra, 
S. Guzman, N. Jarufe and J. Martinez
Digestive Surgery Department, Pontifi cia Universidad 
Católica De Chile, Cirugia Digestiva, Marcoleta 350, 
patio Interior. Edifi cio de Division de Cirugia, 83200 
Santiago, Chile
Introduction: It has been well established that colorectal 
cancer and neuroendocrine tumour liver metastases treated 
by hepatic resection offers a survival benefi t. Nevertheless, 
it is not clear if this is true for other tumours histology. The 
aim of this study is to report the outcomes of patients submit-
ted to liver metastases resection from primaries origin other 
than colorectal or neuroendocrine cancer.
Methods: Retrospective analysis of our prospective elec-
tronic database. Twenty two patients with mean age of 59.1 
± 14 y (range: 22–78) were identifi ed. Demographic data, 
diagnosis, previous treatments, surgical procedure per-
formed, complications, median survival time, morbidity and 
mortality were recorded.
Results: There were 9 sarcomas, 5 GI adenocarcinomas 
(adCA), 3 breast adCA, 1 melanoma, 1 gastric GIST, 1 lung 
squamous cell CA, 1 adrenal CA, 1 ovarian cancer. Nine 
patients received pre-operative chemotherapy. There were 18 
anatomical resections and 4 wedge resections. There were 2 
histological positive margins. Mean hospitality stay was 7.5 
± 3 days, and there was only one early complication (femoral 
vein thrombosis). There was no mortality in this series. 
Median follow up time was 18 months (range 9–72). One, 2 
and 5 years overall survivals were 85, 51 and 26%, respec-
tively, and all patients died because of cancer recurrence. 
Four patients with resection of adenocarcinomas metastases, 
are alive after 3 years of follow-up.
Conclusion: This series shows that long-term survival is 
possible for patients with otherwise lethal diagnosis. In this 
experience, there were no serious complications neither mor-
tality after liver resections for this controversial indication. 
Liver resection could be an alternative in highly selected 
patient with NCNNE metastases.
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LAPAROSCOPIC RESECTION OF 
COLORECTAL LIVER METASTASES: 
A SINGLE CENTER CASE-CONTROL 
MATCHED-PAIRS ANALYSIS
R. Montalti, B. V. den Bossche, D. Cavaniglia, 
G. Castagnola, S. Laurent, K. Geboes, B. de Hemptinne 
and R. I. Troisi
Dept. of General & Hepato-Biliary Surgery, Liver 
Transplantation Service, Ghent University Hospital and 
Medical School, De Pintelaan 185, 9000 Ghent, Belgium
Ghent University Hospital and Medical School, Dept. of 
General & Hepato-Biliary Surgery, Liver Transplantation 
Service, De Pintelaan 185, 9000 Ghent, Belgium
Introduction: This study is to evaluate overall results of 
liver surgery for colorectal liver metastases (CRLM) by com-
paring the open approach (OS) with the laparoscopic (LS) in 
a case-control matched pair analysis.
Methods: Between January 2005 and September 2009 a 
total 533 liver resections were performed in our institution. 
During this period laparoscopic liver resection of CRLM was 
increasingly performed in 40 cases. Data from the LS group 
were compared with those obtained from a control group 
undergoing open surgery for a similar indication in a 
matched-pair analysis. Pairs were matched as closely as pos-
sible for age and gender, type of resection, location of the 
tumoral lesions and surgery date. Endpoints were: overall 
morbidity, R0 resection rates, recurrence rates and hospital 
stay.
Results: The median follow-up was of 15.6 m for LS and 
23.4 for OS (p = 0.02). The median age was of 69 y in the 
LS group and 23.4 in OS. Conversion to laparotomy was 
required in 3 (7.5%) out of 40 laparoscopic cases due to 
uncontrolled bleeding. In both groups 8 (20%) major and 32 
(80%) minor hepatectomies were performed. The overall 
morbidity in the LS group was 0.5% (2/40) and 3% (11/40) 
respectively in LS and OS groups. Similar R0 resection rates 
were found between LS and OS groups: 35/40 (87.5%) cases 
vs. 32/40 (80%) cases respectively. The recurrence rate was 
of 15% (6/40) in the LS group and 40% (16/40) in the OS 
group respectively (p = 0.02). The median hospital stay was 
shorter in the LS group: 7 days (P = 0.01).
Conclusion: According to this experience, laparoscopic 
resection of colorectal liver metastases can be considered as 
a good even preferable alternative when possible to open 
surgery. The overall morbidity and hospital stay were signifi -
cantly lesser in the laparoscopic approach, whereas mid-term 
oncological outcomes were similar.
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LIVER FIRST IN THE SYNCHRONOUS 
LIVER METASTASIS: OUR EXPERIENCE 
IN ONE YEAR
A. Serrablo1, L. Ligorred2 and C. Hörndler3
1HPB Surgical Unit. Miguel Servet University Hospital; 
2Colorectal Unit Miguel Servet University Hospital; 
3Pathology Department Miguel Servet University Hospital
Miguel Servet University Hospital, General and Digestive 
Surgery, Lasierra Purroy 25, 3ºD50007 Zaragoza, Spain
Introduction: An increasing number of patients with syn-
chronous colorectal liver metastases (CLM) are candidates 
for resection. The optimal treatment sequence in these 
patients has not been defi ned but in case of huge liver metas-
tasis or vascular involvement is preferable to removed fi rst 
CLM because any complication after colorectal surgery may 
make it impossible to subsequent rescue.
Methods: We operated on fi rst reverse case in 2006. Up to 
now this procedure is more and more common. Data on 12 
consecutive patients with synchronous resectable CLM and 
intact primary, who were underwent to liver fi rst procedure 
in 2011, were reviewed. All patients after preoperative chem-
otherapy were evaluated in HPB Committee. Postoperative 
morbidity and mortality rates and colorectal posterior rescue, 
number of metastases, size of liver met, chemotherapy were 
analyzed.
Results: All patients (100%) had resection of all disease 
without liver or extrahepatic disease before colorectal 
surgery. Nine patients had rectum cancer (75%). Median 
numbers of CLMs were 4. Four patients (33%) was under-
gone IVC resection. Minimum number of segments resected 
was 4. Postoperative mortality rates was 8.3% (1 patient for 
postoperative liver failure) in the liver surgery and 0% in the 
colorectal procedure. 4 patient had some complication: one 
postoperative ascites, two surgical wound infection and one 
bowel occlusion after hepatectomy. One or two month after 
hepatectomy all patient were operated on colorectal tumour 
(two right colectomies, one left colectomy, one Milles and 8 
anterior rectal resection. Overall hospital stay were 17 days.
Conclusion: Reverse surgical strategies in patients with 
synchronous presentation of CLM are one approach more 
with acceptable mobidity and mortality. The reverse strategy 
can be considered as an alternative option in patients with 
advanced CLM and an asymptomatic primary.
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SIMULTANEOUS RESECTION OF 
COLORECTAL LUNG AND LIVER 
METASTASES: FEASIBILITY AND 
PRELIMINARY RESULTS
M. Rayar1, L. Sulpice1, B. De Latour2, B. Meunier1 and 
K. Boudjema1
1Service de chirurgie Hepatobiliaire et Digestive, CHU 
pontchaillou, Rennes, France; 2Service de chirurgie 
Cardiothoracique et vasculaire, CHU pontchaillou, 
Rennes, France
CHU Pontchaillou, Service de chirurgie hepatobiliaire et 
digestive, 2 rue Henri Le Guilloux 35033 Rennes, France
Introduction: Lung and liver are the two most frequent 
sites for colorectal cancer metastases (CRCM). The simulta-
neous presence of these two locations usually requires a 
sequential surgical approach, which expose to tumour devel-
opment between the two sequences, and to delay chemo-
therapy due to surgical morbidity. These problems could be 
avoided by performing both surgical steps during the same 
procedure.
The aim of our study was to evaluate the feasibility of 
simultaneous resection of liver and lung CRCM.
Methods: Since January 2009, 15 patients (sex ratio: 3/2, 
median age: 61 (range 41–72) years) with resectable liver 
and lung metastases were proposed for simultaneous resec-
tion. Exclusion criteria were: age > 75 years, pulmonary 
function tests or a clinical condition not compatible with 
surgery. The surgical approach started with an abdominal 
laparotomy for the liver resection followed with a posterior 
thoracotomy (video assisted if needed) for the thoracic time.
Both surgical steps were radical or were part of a com-
bined strategy in case of bilateral lung localization or bilobar 
liver localization.
Results: Lesions were synchronous in 26.7% (n = 4) and 
metachronous in 73.3% (n = 11, with 5 recurrences). Median 
hospital duration was 8 days (range 7–21). Mortality was 
6.7% (n = 1, due to postoperative pneumonia). Severe com-
plications (grade > 2 of Dindo-Clavien classifi cation) 
occurred in 5 (33.3%) patients. Specifi c abdominal compli-
cations were: bile leakage (n = 2), abdominal collection (n = 
1), acute liver failure (n = 1). Specifi c thoracic complications 
were: pneumonia (n = 5), acute respiratory failure (n = 3), 
pulmonary embolism (n = 1).
Mean follow up was 12.6 months. Overall survival was 
24.1 months (3 (20%) patients died), and disease free sur-
vival was 12.5 months (6 (40%) patients had recurrence and 
6 (40%) patients were still in remission).
Conclusion: Simultaneous resection of lung and liver 
metastases is feasible in properly selected patients. A longer 
follow-up is necessary to evaluate the result of this aggres-
sive treatment of colorectal cancer metastases, before recom-
mending this strategy.
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PROGNOSIS OF LONG-TERM RESULTS 
FOR COLORECTAL LIVER METASTASES
Y. Kovalenko, A. Zhao and A. Chugunov
N.V. Sklifosovsky Institute of Emergency Medicine, Liver 
Surgery and Transplantation Department, 12909 Bolshaya 
Suharevskaya Square, 3/512909 Moscow, Romania
Introduction: Objectives: Recently advances in surgical 
treatment and molecular biology have improved survival rate 
in patients with colorectal liver metastases.
Purpose: The aim of this study was to identify predictors 
of long-term results and to develop prognostic scoring 
system in patients who had undergone liver resection.
Methods: Methods: We reviewed the medical records of 69 
patients underwent liver resection for colorectal liver metas-
tases. The effect independent clinicopathologic and molecu-
lar predictors on outcome were tested using univariate and 
multivariate analyses by the Cox regression. This study 
evaluated immunohistochemical expression ck 20, β-cat, 
Ki-67, MUC2, MUC5 A in 12 surgically resected specimens 
of liver metastases. The level of 3 prognostic molecules 
(β-cat, Ki-67, ck 20) were signifi cantly associated with sur-
vival rate and recurrence after hepatic resection. The value 
414 Poster Presentation Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 288–699
each independent risk factor was assessed dependent on type 
and extent hepatectomy. The data was applied to our pro-
posed prognostic score.
Results: Overall and recurrence-free survival rates in 
patients with colorectal metastases after hepatic resection 
was analyzed. Survival was estimated using the Kaplan-
Meier analysis. The overall and recurrence-free 5-year sur-
vival rates were 31% and 14%, respectively. 5-year survival 
rates were 19% and 50% for anatomical and nonanatomical 
resections. 5-year survival rates were 28% and 34% for 
major and minor resections. Histological differentiation and 
molecular markers β-cat, Ki-67, CK 20 were the major deter-
minants of survival and recurrence for total patient popula-
tion. The probability of recurrence by risk scoring system at 
any site was evaluated at 2 years after liver resection.
Conclusion: Conclusions: We hope, that prediction of long-
term outcome will allow have adequate selection of patients 
for surgical treatment. The proposed prognostic scoring 
system has clinical value, however need further studies and 
analyses molecular markers for patients with colorectal liver 
metastases.
670
SURGICAL RESECTION OF 
COLORECTAL CANCER LIVER 
METASTASES IN ROUTINE CLINICAL 
PRACTICE: A POPULATION-BASED 
OUTCOMES STUDY
S. Nanji1, G. Li2, W. Mackillop3 and C. Booth3
1Department of Surgery, Queens University, Kingston, 
Canada; 2Division of Cancer Care and Epidemiology, 
Queens University, Kingston, Canada; 3Department of 
Oncology, Queens University, Kingston, Canada
Queens University, Surgery, 151 Earl Street, Kingston, 
Ontario, K7L 2H3K7L2H Kingston, Canada
Introduction: Resection of liver metastases has emerged as 
an important treatment option for patients with advanced 
colorectal cancer (CRC). Most of the existing literature in 
this fi eld describes outcomes of highly selected patients 
treated at a small number of high volume institutions. Here 
we report the results of a registry-based study to describe the 
outcome of patients with resected CRC liver metastases in 
the general population of Ontario, Canada.
Methods: All cases of CRC in Ontario who underwent sur-
gical resection of liver metastases in 2002–2009 (n = 1711) 
were identifi ed using the population-based Ontario Cancer 
Registry (OCR). The OCR captures diagnostic and demo-
graphic information on ~98% of all incident cancer cases in 
Ontario. We linked electronic records of treatment to the 
registry and requested pathology reports held at OCR. 
Surgical pathology reports were identifi ed for 943 (55%) of 
cases. We describe surgical procedures, pathologic fi ndings, 
and outcomes for those cases for which pathology reports 
were available. Overall survival (OS) was determined using 
the Kaplan-Meier technique.
Results: Five year OS for all cases was 47% (95% CI 44%–
50%) and 49% (95% CI 45%–53%) for cases with pathology 
reports. Margins were involved with microscopic (R1) 
disease in 8% (75/943) of cases and survival was inferior 
compared to RO cases (5-year OS 27% vs 51%, p < 0.0001). 
Structures adjacent to the liver were resected en bloc in 38 
(4%) cases of which 29% (11/38) were found to contain 
invasive disease. Survival was comparable in patients with 
or without evidence of invasive disease (5-year OS 57% vs 
65%, p = 0.810). Peri-portal lymph nodes were resected in 
129 cases and were involved with metastatic disease in 14 
(11%); survival was inferior among cases with positive nodal 
disease compared to cases with negative nodes (5-year OS 
25% vs 50%, p = 0.009).
Conclusion: Resection of CRC liver metastases among 
unselected cases in the general population is associated with 
survival outcomes that are comparable to those reported in 
institution-based studies. Positive surgical margins (R1) and 
peri-portal nodal metastases are associated with inferior 
survival.
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WHAT OFFERS LONG TERM SURVIVAL 
AFTER RESECTION OF COLORECTAL 
LIVER METASTASES? – AN ANALYSIS 
OF ACTUAL 10 YEAR FOLLOW UP
M. Takahashi, K. Hasegawa, M. Oba, T. Aoki, 
Y. Sakamoto, Y. Sugawara and N. Kokudo
Hepato-Biliary-Pancreatic Surgery Division, Department 
of Surgery, University of Tokyo
University of Tokyo, Hepato-Biliary-Pancreatic Surgery 
Division, Department of Surgery, 7-3-1 Hongo, Bunkyo-Ku, 
113 Tokyo, Japan
Introduction: Surgical resection has been considered the 
only curable treatment for colorectal liver metastases (CLM). 
However, the 5-year disease-free survival rates after hepatic 
resection has been around 30%. And some reports found that 
a signifi cant number of patients experience recurrence after 
5 years. Therefore 5-year survival rates may be insuffi cient 
as an indication of cure. This study aimed to analyze long-
term results and prognostic factors in liver resection for CLM 
with 10-year follow-up data.
Methods: Clinicopathologic data of patients treated with 
liver resection for CLM in our institution were retrospec-
tively reviewed. Overall survival rates were calculated. And 
prognostic factors for 10-year survival were analyzed using 
univariate and multivariate analysis.
Results: There were 131 consecutive patients identifi ed 
with 10-year follow-up. Five-and 10-year overall survival 
rates were 42.4% and 27.7%, respectively. Survival curve 
reached a plateau after 10 years from the time of hepatic 
resection. There were 33 (25.2%) actual 10-year survivors. 
Of those, 19 patients (57.5%) experienced recurrence and 
underwent re-resection. Only two patients experienced dis-
ease-specifi c death after 10 years of survival. Multivariate 
analysis evidenced two independent negative prognostic 
factors of 10-year survival: male sex (P = 0.003) and non-
wedge resection (P = 0.016).
Conclusion: 10-year survival after initial hepatectomy 
should be defi ned as cure. On investigation of prognostic 
factors, parenchymal preserving hepatectomy offers long-
term survive. With the advance of perioperative chemother-
apy and aggressive surgical policy, parenchymal preserving 
hepatectomy will be emphasized more and more.
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A UNIQUE CASE OF RECTAL 
NEUROENDOCRINE TUMOR WITH 
HUGE LIVER METASTASIS
B. O. Al-jiffry, O. AlMalki, A. AlMalki, A. AlMalki
Department Of Surgery, Taif University, Taif, Saudi Arabia
Introduction: Small cell carcinomas (SCC) are malignan-
cies deriving from neuroendocrine tissue and although the 
gastrointestinal tract contains the largest population of neu-
roendocrine cells, these malignancies are rare.
The colorectal SCC accounts for 0.2% to 1.5% of all 
colonic cancers and is considered to be an aggressive neo-
plasm with rapid growth and poor prognosis. There are only 
three cases reported with liver metastasis, non of them had 
surgical treatment to the liver.
Methods: 46-year old male referred from another hospital 
in Dec 08, with a huge liver lesion. He was complaining of 
RUQ pain and palpable mass for 4 months, bleeding per 
rectum for 2 months. O/E he was cachectic, with huge 
hepatomegaly and DRE showed a fi rm tender mass 2 cm 
above the anal verge. CT showed a 13 cm in the right 
hemiliver abutting the middle hepatic vein. He opted to go 
to another center for a second opinion. He was told after full 
investigation ‘we can not offer you any treatment’. In Feb 
09, he presented to our ER with the same complaints in addi-
tion to delirium. Colonoscopy revealed an ulcerating mass. 
A repeat CT showed progress of the liver lesion to 17 cm 
and no change in the pelvis. The fi nal pathology report 
showed anaplastic SCC.
Results: Multidesplinary team discussed the case and 
agreed for two-stage procedure. He underwent an extended 
right liver resection in Feb followed by APR in April 09. 
Intra-operatively, a single peritoneal seeding in the pelvis 
was excised and sent for frozen section, it was positive for 
malignancy. Final histopathology showed SCC arising at the 
ano-rectal junction and measuring 4 × 2 cm. Distal and 
proximal margins are free. The tumor is invading the full 
thickness of the wall (T4). No lymphovascular invasion. 
Multiple lymph nodes were negative for malignancy. In Aug 
09, the patient received 13 cycles of chemotherapy then 
somatostatin 20 mg IM once monthly till now. CT scan in 
Sep and PET scan in Dec 11 was reported negative. He is 32 
month disease free.
Conclusion: Most available literature on this condition 
exists in the form of case reports and retrospective studies. 
We report the fi rst case of SCC of the rectum with a large 
liver metastasis and a unique approach, as we offered the 
patient a staged surgical approach in which the secondary 
metastatic tumor was resected six weeks prior to the resec-
tion of the primary one because of the rapid liver growth and 
progress liver failure, followed by chemotherapy resulting in 
a long-term disease-free survival.
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THE CENTROSOMAL KINASE NEK2 IS 
OVEREXPRESSED IN PRIMARY AND 
METASTATIC COLORECTAL CANCER
C. Neal1, A. Fry2, C. Mann1, G. Garcea1, M. Masood1, 
A. McGregor1, M. Manson2 and D. Berry3
1Leicester General Hospital; 2University of Leicester; 
3University Hospital of Wales
Leicester General Hospital, Department of HPB Surgery, 
Gwendolen Road, Leicester LE54P, United Kindgom
Introduction: Chromosomal instability (CIN) is a hallmark 
of colorectal cancer (CRC), enabling cancer progression and 
invasion. Centrosome abnormalities are a major cause of 
CIN, yet the causative mechanisms are poorly characterised. 
The mitotic kinase Nek2 (NIMA-related kinase 2) regulates 
centrosome separation, with overexpression resulting in mul-
tiple centrosomes and aneuploidy induction in vitro. This 
study examined Nek2 expression in primary and metastatic 
colorectal malignancy in vitro and in vivo.
Methods: Nek2 protein expression was examined in a panel 
of CRC cell lines using Western blotting and densitometry, 
with protein localisation assessed by immunocytochemistry. 
Nek2 expression was also examined by immunohistochem-
istry in a series of resected CRC (n = 103), as well as their 
matched lymph node and hepatic metastases, using appropri-
ate negative and positive controls. Slides were independently 
scored in a blinded fashion by two observers. Nek2 expres-
sion was correlated with clinicopathological characteristics 
including tumour stage and long-term survival.
Results: Nek2 protein expression was signifi cantly greater 
in all CRC lines examined than in the immortalised colono-
cyte line HCEC (P < 0.05), with highest expression in the 
metastatic line SW620. Cytoplasmic and/or nuclear Nek2 
overexpression (relative to the normal colorectum) was 
present in 86.4% of resected CRC and was associated with 
advancing Dukes stage (P = 0.002), as well as shorter dis-
ease-free (P = 0.029), hepatic disease-free (P = 0.033) and 
cancer-specifi c (P = 0.026) survival. In Nek2-overexpressing 
primary tumours, elevated expression was maintained within 
all matched lymph node and liver metastases examined. 
Nek2 overexpression, both in vitro and in vivo, was accom-
panied by markedly abnormal mitotic centrosomal accumu-
lation of Nek2.
Conclusion: Nek2 overexpression correlates with advanc-
ing stage and poor prognosis in CRC, with expression main-
tained at secondary sites. These data support a role for Nek2 
in CRC progression and show potential for Nek2 inhibitors 
(currently in preclinical development) in the treatment of 
metastatic CRC.
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THE ROLE OF MESENCHYMAL 
CADHERIN AND CATENIN 
ADHESION MOLECULES IN THE 
METASTATIC PROGRESSION OF 
COLORECTAL CANCER
C. Neal1, C. Mann1, G. Garcea1, M. Masood1, 
A. McGregor1, M. Manson2 and D. Berry3
1Leicester General Hospital; 2University of Leicester; 
3University Hospital of Wales
Leicester General Hospital, Department of HPB Surgery, 
Gwendolen Road, Leicester LE54P, United Kingdom
Introduction: Altered native cadherin and catenin adhesion 
molecule expression is implicated in colorectal cancer (CRC) 
progression. ‘Foreign’ cadherins are also upregulated in epi-
thelial malignancies, with in vitro mesenchymal cadherin 
expression associated with expression of isoform 1 of p120, 
a cadherin-stabilising molecule whose isoforms exert differ-
ing effects upon cellular motility via Rho GTPase regulation. 
This study examined foreign cadherin and catenin expression 
in primary and metastatic CRC.
Methods: Expression of E-cadherin, ‘foreign’ cadherins-2, 
-3 and -11, beta-catenin, total p120 and p120 isoform 1 was 
examined in a panel of CRC cell lines using Western blotting 
and densitometry, with protein localisation assessed by 
immunocytochemistry. Protein expression was also exam-
ined by immunohistochemistry in a series of resected CRC 
(n = 103), as well as their matched lymph node and hepatic 
metastases, using appropriate positive and negative controls. 
Slides were independently scored in a blinded fashion by two 
observers. Cadherin and catenin expression was correlated 
with clinicopathological characteristics including tumour 
stage and long-term survival.
Results: Expression of p120 isoform 1 was restricted to 
mesenchymal cadherin-expressing cell lines. Cadherins-2, -3 
and -11 were upregulated in 35.9%, 96.1% and 9.7% of 
primary CRC respectively. P120 isoform 1 neoexpression 
was evident in 34.0% of CRC and associated with both loss 
of tumour E-cadherin expression (P = 0.025) and N-cadherin 
neoexpression (P = 0.022). P120 isoform 1 expression was 
also associated with advancing Dukes stage and independ-
ently associated with shortened cancer-specifi c survival (P < 
0.001). Expression of cadherin-2, cadherin-3 and p120 
isoform 1 was maintained within matched lymph node and 
liver metastases of overexpressing primary tumours (all 
P < 0.05).
Conclusion: These data support a role for mesenchymal 
adhesion molecules in the progression of CRC and support 
their candidature as potential therapeutic targets in metastatic 
CRC. Further studies are underway to determine whether 
p120 isoform 1 also exerts independent prognostic value 
following resection of colorectal liver metastases.
685
HEPATIC SINUSOIDAL INJURY IS 
ASSOCIATED WITH SHORTENED 
LONG-TERM SURVIVAL IN 
PATIENTS UNDERGOING RIGHT 
TRISECTIONECTOMY FOR 
COLORECTAL LIVER METASTASES
C. Neal1, C. Mann1, G. Garcea1, E. Pointen1, 
A. McGregor1, M. Metcalfe1, D. Berry2 and A. Dennison1
1Leicester General Hospital; 2University Hospital of Wales
Leicester General Hospital, Department of HPB Surgery, 
Gwendolen Road, Leicester LE54P, United Kingdom
Introduction: Recent data have suggested that oxaliplatin-
associated sinusoidal injury (SI) in the non-tumour bearing 
liver (NTBL) may be associated with adverse long-term 
outcome following hepatectomy for colorectal liver metas-
tases (CRLM), though this observation may be an epiphe-
nomenon of associations with unfavourable tumour biology. 
This study aimed to assess the impact of NTBL histology 
upon long-term outcome in a series of consecutive patients 
undergoing right hepatic trisectionectomy for CRLM.
Methods: Clinicopathological data for patients undergoing 
right trisectionectomy at a single tertiary referral hepatobil-
iary centre between January 2002 and December 2008 were 
obtained from a prospectively maintained database. Blinded 
NTBL pathological review was conducted by two patholo-
gists using established criteria for SI, steatosis, non-alcoholic 
steatohepatitis (NASH), fi brosis and cholestasis. Univariate 
and multivariable Cox regression analyses were performed 
to correlate perioperative and pathological variables with 
long-term overall and disease-free survival. Postoperative 
deaths (90-day) were excluded from long-term survival 
analyses.
Results: A total of 66 consecutive patients underwent right 
trisectionectomy for CRLM over the study period. 
Preoperative oxaliplatin-based chemotherapy was used in 24 
cases (36.4%, median 6 cycles, range 2–8 cycles). SI was 
noted in 21 cases (31.8%) and was independently associated 
with oxaliplatin use. Five-year overall survival rate was 
28.8%. On multivariable analysis, number of metastases 
resected and SI were independently associated with short-
ened overall survival following trisectionectomy. Number of 
metastases resected, perioperative blood transfusion and SI 
were independently associated with shortened disease-free 
survival following trisectionectomy. Steatosis, NASH, fi bro-
sis and cholestasis showed no association with long-term 
survival.
Conclusion: Short-course oxaliplatin-associated SI is asso-
ciated with adverse prognosis following right trisectionec-
tomy for CRLM. The restriction of this analysis to patients 
undergoing right trisectionectomy, coupled with inclusion of 
traditional clinicopathological variables as covariates, sug-
gests that this fi nding is unlikely to simply be an epiphenom-
enon of associations with unfavourable tumour biology. 
Further studies are necessary to confi rm these fi ndings and 
to explore underlying mechanism(s).
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SINUSOIDAL INJURY IS 
INDEPENDENTLY ASSOCIATED WITH 
BLOOD LOSS DURING RIGHT HEPATIC 
TRISECTIONECTOMY
C. Neal1, C. Mann1, G. Garcea1, E. Pointen1, 
A. McGregor1, D. Berry2 and A. Dennison1
1Leicester General Hospital; 2University Hospital of Wales
Leicester General Hospital, Department of HPB Surgery, 
Gwendolen Road, Leicester LE54P, United Kingdom
Introduction: There is considerable anecdotal evidence 
linking macroscopic liver appearance at time of hepatectomy 
with operative blood loss, particularly in patients who have 
received neoadjuvant chemotherapy. Objective data to 
support these observations are scarce, however. This study 
aimed to evaluate whether histological abnormalities within 
the non-tumour bearing liver (NTBL) are associated with 
blood loss and transfusion requirement in patients undergo-
ing right hepatic trisectionectomy.
Methods: Clinicopathological data for patients undergoing 
right trisectionectomy at a United Kingdom tertiary referral 
hepatobiliary centre between 2002 and 2008 were obtained 
from a prospectively maintained database. Blinded NTBL 
pathological assessment was conducted by two pathologists 
using established criteria for sinusoidal injury (SI), steatosis, 
non-alcoholic steatohepatitis (NASH), fi brosis and cholesta-
sis. Univariate and multivariable binary logistic regression 
analyses were performed to compare intra-operative blood 
loss and perioperative transfusion requirement with patient 
and operative factors, including NTBL histology.
Results: 103 patients underwent right hepatic trisectionec-
tomy over the study period. Median operating time was 300 
minutes (range 130–660 minutes), median operative blood 
loss was 600 ml (range 100–7000 ml) and mean periopera-
tive transfusion requirement was 1.6 units (median 0 units, 
range 0–14 units). Steatosis was noted in 51 patients (49.5%), 
NASH (Kleiner score > 4) in 9 patients (8.7%), fi brosis in 
36 patients (35.0%) and SI (grade 1–2) in 32 patients 
(31.1%). On multivariable analysis, SI was independently 
associated with both blood loss of >1500 ml (P = 0.029, RR 
4.05, 95% CI 1.16–14.16) and transfusion requirement (P = 
0.006, RR 4.62, 95% CI 1.56–13.73). Steatosis, steatohepa-
titis and fi brosis showed no association with either outcome.
Conclusion: In line with anecdotal evidence based on mac-
roscopic observations, these data suggest that sinusoidal 
injury is associated with increased blood loss during right 
hepatic trisectionectomy. This association likely relates to 
the proangiogenic nature of SI, which includes upregulation 
of mediators such as vascular endothelial growth factor 
(VEGF).
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INFLUENCE OF RESECTION MARGIN 
ON SURVIVAL FOLLOWING RESECTION 
OF COLORECTAL LIVER METASTASES
C. Neal, C. Moreman, A. McGregor, C. Mann, V. Cairns, 
M. Metcalfe, A. Dennison and G. Garcea
Leicester General Hospital
Leicester General Hospital, Department of HPB Surgery, 
Gwendolen Road, Leicester LE54P, United Kingdom
Introduction: Surgical margin is an important prognostic 
factor in patients undergoing hepatic resection for colorectal 
liver metastases (CRLM). Although there is consensus that 
positive margins (R1) are associated with worse prognosis 
than negative margins (R0), the optimal size of negative 
margin remains controversial, with individual studies yield-
ing confl icting results. The aim of this study was to further 
examine the infl uence of resection margin size upon survival 
following CRLM resection.
Methods: Clinicopathological data, including the Memorial 
Sloan-Kettering Cancer Centre Clinical Risk Score (MSKCC 
CRS), were obtained from a prospectively maintained data-
base for 170 patients undergoing hepatectomy for CRLM 
between 2001 and 2006. Resection margin status was 
assessed by two pathologists blinded to clinicopathological 
data. Distance of individual metastases from the resection 
margin was assessed for each patient, using the following 
groupings: positive (R1), <1 mm, 1–5 mm, 5.1–10 mm, 
>10 mm. In patients with multiple metastases, the closet 
margin was taken as representative. Univariate and multi-
variable analyses were conducted to compare clinicopatho-
logical factors with overall and disease-free survival 
following hepatectomy.
Results: The R1 resection margin rate was 41.1% (n = 70). 
When compared to patients with microscopically negative 
(R0) resection margins, the presence of an R1 margin was 
signifi cantly associated with both shortened overall and 
disease-free survival following hepatectomy (P = 0.011 and 
P = 0.047, log-rank test), though these associations were not 
maintained on multivariable analyses incorporating the 
MSKCC CRS. Analysis of patients with R0 margins alone, 
however, revealed no signifi cant difference in either overall 
survival or disease-free survival when patients with margins 
of <1 mm, 1–5 mm, 5.1–10 mm and >10 mm were com-
pared, either between individual groups or following regroup-
ing around solitary cut points (1 mm, 5 mm or 10 mm).
Conclusion: In this patient cohort, whilst an involved (R1) 
margin was associated with adverse prognosis, the size of 
negative margin in patients undergoing an R0 resection did 
not infl uence post-operative recurrence or survival. These 
data further support abandonment of the ‘1 cm rule’ for 
CRLM resection. Additional studies are needed to confi rm 
these fi ndings and to determine whether an R1 margin is a 
true independent prognostic factor for CRLM or an epiphe-
nomenon of more aggressive tumour biology.
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BIOLOGICAL FACTORS INFLUENCING 
ANGIOGENESIS AND PROGNOSIS IN 
RESECTED COLORECTAL 
LIVER METASTASES
C. Neal1, C. Sutton1, K. O’Byrne2, G. Garcea1, L. Jones3, 
P. Furness1, G. Poston4 and D. Berry5
1University Hospitals of Leicester; 2University of Dublin; 
3Barts Cancer Institute; 4Royal Liverpool University 
Hospital; 5University Hospital of Wales
Leicester General Hospital, Department of HPB Surgery, 
Gwendolen Road, Leicester LE54P, United Kingdom
Introduction: Angiogenesis is a ‘hallmark’ of cancer, with 
roles in all stages of tumour development and progression. 
Microvessel density (MVD) and proangiogenic factors have 
been shown to exert prognostic value in several tumour 
types, but few studies have examined their value in resect-
able colorectal liver metastases (CRLM). This study assessed 
the prognostic signifi cance of angiogenesis using MVD and 
angiogenesis-modulating factors in a consecutive series of 
patients undergoing liver resection for CRLM.
Methods: Resected CRLM from 182 patients were exam-
ined immunohistochemically for microvessels (via CD34 
staining), vascular endothelial growth factor (VEGF), thymi-
dine phosphorylase (TP), matrix metalloproteinases 2 and 9 
(MMP-2, MMP-9) and p53. Staining was assessed by two 
independent observers blinded to clinicopathological data. 
MVD was measured using a computerised image analysis 
system. MVD and biological factors were correlated using 
the Chi-squared test. Prognostic signifi cance of clinicopatho-
logical and immunohistochemical variables was determined 
by Kaplan–Meier analysis and application of the log-rank 
test, with multivariable analysis performed through Cox pro-
portional hazard regression analysis using a stepwise back-
ward procedure.
Results: High expression of TP correlated with high MVD 
(p = 0.04 for edge hotspots, p = 0.001 for contiguous edge 
vessels). High expression of stromal MMP-9 correlated with 
high edge MVD (p = 0.05) and high intra-tumour MVD (p 
= 0.04). On univariate analysis, bilobar disease (p = 0.003), 
tumour edge hotspot (p = 0.005), lymphocytic TP (p = 0.02), 
absence of tumour cell and stromal VEGF (p = 0.05 and p = 
0.0004 respectively, all log-rank test) signifi cantly correlated 
with poor prognosis. On multivariable analysis, tumour edge 
MVD hotspot, bilobar disease and absence of stromal VEGF 
were independent negative prognostic factors (p = 0.038, 
p = 0.04 and p = 0.002 respectively, Cox regression 
analysis).
Conclusion: Tumour edge hotspot and the absence of 
tumour cell and stromal VEGF were independently associ-
ated with poor survival in patients undergoing liver resection 
for CRLM and may be clinically useful biomarkers in this 
context. Thymidine phosphorylase and stromal MMP-9 were 
themselves signifi cantly associated with microvessel density 
and may represent novel therapeutic targets in patients with 
CRLM.
692
INTRAOPERATIVE CONTRAST-
ENHANCED ULTRASONOGRAPHY: 
ASSESSMENT OF EFFICACY IN 
COLORECTAL LIVER METASTASES 
AFTER PREOPERATIVE 
CHEMOTHERAPY
A. Ruzzenente, A. Valdegamberi, C. Iacono, S. Conci, 
M. De Angelis and A. Guglielmi
Department of Surgery – General Surgery A – GB Rossi 
Hospital-Piazzale A. Scuro, Verona
General Surgery A, Department of Surgery, GB Rossi 
Hospital, Piazzale A. Scuro 1037134 Verona, Italy
Introduction: Liver resection is the only treatment offering 
long-term survival for patients with colorectal liver metas-
tases (CRLM). Preoperative chemotherapy improves resecta-
bility but reduces accuracy of preoperative staging. 
Contrast-enhanced intraoperative ultrasonography (CEIOUS) 
seems to improve detection of liver metastases after preop-
erative chemotherapy. The aim is to evaluate ability of 
CEIOUS to detect intraoperative metastases in patients with 
CRLM underwent preoperative chemotherapy.
Methods: From January 2011 to August 2011 25 patients 
with CRLM, after preoperative chemotherapy, underwent 
IOUS and CE-IOUS during hepatectomy. These fi ndings 
were compared with preoperative staging imaging, per-
formed with contrast-enhanced ultrasonography (CE-US), 
CT and/or MRI.
Results: Preoperative staging imaging detected a total of 40 
metastatic lesions in 25 patients. In 7 patients (28%) 
Intraoperative ultrasonography (IOUS) detected 19 missed 
hepatic nodules for a total of 59 lesions (detection rate higher 
of 47.5% than preoperative imaging). In 9 patients (36%) 
CEIOUS detected further 6 nodules for a total of 65 hepatic 
lesions detected (detection rate higher of 10.2% than preop-
erative imaging and IOUS). All these new detected lesions 
were pathologically diagnosed as metastases. At univariate 
analysis we found three factors signifi cantly related to detec-
tion of new nodules with CEIOUS: more than three metas-
tasis before chemotherapy (p = 0.022), complete response to 
chemotherapy (p = 0.03) and size of nodules less than 20 mm 
after chemotherapy (p = 0.008).
Conclusion: In patients who undergo surgery for CRLM, 
CEIOUS improves the sensitivity of IOUS to detect liver 
metastases enhancing the rate of treatment with curative 
intent. Patients with multiple nodules, patients who achieve 
complete response or with nodule size less than 20 mm after 
chemotherapy can take advantage with use of CEIOUS.
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CHEMOTHERAPY ASSOCIATED LIVER 
INJURY IN HEPATIC RESECTION FOR 
COLORECTAL METASTASES
M. Sofi a1, R. Scilletta1, S. Mongiovì1, A. Pesce1, 
M. Spada2, G. L. Greca1, S. Gruttadauria2 and S. Puleo1
1Department of Surgical Sciences Organ Transplantation 
and advanced Technologies, University of Catania, 
Catania, Italy; 2Department of Abdominal Surgery and 
Organ Transplantation, ISMETT, University of Pittsburgh 
Medical Centre, Palermo, Italy
University of Catania, Department of Surgical Sciences 
Organ Transplantation and Advaced technologies, via del 
Bosco, 32495125 Catania, Italy
Introduction: Preoperative chemotherapy can damage non 
neoplastic liver parenchyma, causing chemotherapy associ-
ated liver injury (CALI). This pathological fi nding may have 
consequences on the postoperative course, increasing post-
operative morbidity. Aim of this work is to report our retro-
spective analysis on the clinical impact of the CALI in 
patients operated of liver resection for hepatic metastases 
from colorectal cancer.
Methods: Between the period 2002–2008, 97 patients 
affected by colorectal liver metastases who underwent liver 
resection into three different department of general surgery 
in the same region, were enrolled in the study. Patients were 
divided in two groups according to the different length of 
period between the end of preoperative chemotherapy and 
day of surgery: Group A) 44 (45.4%) patients, <8 weeks and 
Group B) 53 (54.6%) patients, >8 weeks. In each group age, 
sex, BMI, type of chemotherapy drugs (5FU, oxapliplatin, 
irinotecan), number of cycles of chemotherapy, stages of 
CALI (steatosis, steatohepatitis, sinusoidal obstruction 
syndrome[SOS]) morbidity and mortality were analyzed.
Results: Chemotherapic agents employed were: 95.8% 
5FU, 47.4% oxaliplatino, 24.7% irinotecan. CALI was codi-
fi ed by three different pathologist using the same score 
system: steatosis 88.6%, steatohepatitis 73.1% and 45.4% 
SOS. Patients in the group A had more oxaliplatino based 
chemotherapy than group B (p 0.04). However there were no 
difference in type and incidence of CALI. Mean n° of cycles 
was higher in the group B than A (8.2 vs 6.7: p 0.01) and 
58.5% of patients in the group B had >6 cycles. Overall 
20.4% patients developed complications, of these 35% 
developed complications related to liver impairment, and all 
had steatosis. Morbidity was 11.4% in Group A vs 28.3% in 
Group B (p 0.04). Only one death was recorded in Group B.
Conclusion: In this multicentric retrospective analysis, 
chemotherapy liver damage was enforced by the sum of 
cycles and it was not reversible over time. This should be 
considered when planning hepatic resection in patients sub-
mitted to chemotherapy.
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TUMOUR RESPONSE AND SECONDARY 
RESECTABILITY OF COLORECTAL 
LIVER METASTASES FOLLOWING 
CHEMOTHERAPY WITH CETUXIMAB. A 
CASE OF COMPLETE TUMOR NECROSIS
M. Sofi a, A. Ricotta, S. Latteri, M. Scuderi, R. Lombardo, 
S. Cordio, D. Russello and G. L. Greca
Department of Surgical Sciences Organ Transplantations 
and Advanced Tecnologies, university of Catania, Italy
University of Catania, Department of surgical Sciences 
Organ Transplantations and Advanced Technologiesvia del 
bosco, 32495125 Catania, Italy
Introduction: Surgery is the only curative option for 
patients with liver metastases of colorectal cancer, but few 
patients present with resectable lesions. Chemotherapy is 
increasingly used to downstage initially unresectable disease 
and allow for potentially curative surgery. Standard chemo-
therapy regimens convert 10%–20% of cases to resectable 
disease. To increase the number of candidates eligible for 
surgery is the addition of targeted agents such as cetuximab 
and bevacizumab to standard chemotherapy.
Methods: A 59-year-old male patient was affected by syn-
chronous, multiple, bilobar liver metastases from a right 
colon primary tumor. The primary tumor was resected as fi rst 
due to intestinal obstruction, and the genetic analysis showed 
a wild type k-ras gene. After one month he was scheduled 
for chemotherapy with FOLFIRI and Cetuximab as fi rst line 
treatment. During chemotherapy the patient developed a 
cutaneous side effect involving the whole body. After eight 
cycles of this regimen, he experienced a partial radiographic 
and a complete biochemical response (serum CEA level 
decreased from 673.1 to 2.75 ng/mL and CA19-9 from 5283 
to 15.9 UI/ml).
Results: Liver surgery was planned and a complete removal 
of all visible tumors was performed using a ultrasound-
guided multisegment hepatic resection. Histopathologic 
examination of the specimen showed that all of the six 
resected metastases presented chronic infl ammatory response 
with giant cells and histocytes and no neoplastic cells. He is 
currently alive and free of disease, 17 months after diagnosis 
and 10 months after liver resection.
Conclusion: Cetuximab increases the number of patients 
eligible for secondary hepatic resection, as well as the rate 
of complete resection when combined with fi rst-line treat-
ment with the FOLFIRI regimen. This associated chemo-
therapy allow to obtain a complete histologic response. 
Secondary resection is a valid treatment for selected patients 
with initially unresectable liver metastases and an important 
end point for future clinical trials.
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STAGED LIVER RESECTIONS FOR 
BILOBAR HEPATIC COLORECTAL 
METASTASIS: A SINGLE CENTER 
EXPERIENCE
M. Jamal, M. Hassanain, Y. Yousef, Y. Jozaghi, S. Jabbour, 
M. Al-Jiffry, P. Chaudhury and P. Metrakos
McGill University Health Center, Royal Victoria Hospital, 
HPB and Multi-organ Transplantation
McGill University, HPB and Multi-organ Transplantation, 
Royal Victoria Hopital, S10, Department of Surgery, H3A 1 
Montreal, Canada
Introduction: Bilobar colorectal cancer liver metastasis 
(BCLM) are challenging resection. Given the survival 
advantage for resection a portion of these patients may 
benefi t from a staged liver resection strategy. In this study 
we describe our staged resection experience.
Methods: From January 2003 to January 2011 patients that 
were put on the staged resection pathway were identifi ed 
from the MUHC HPB Database. All patients underwent neo-
adjuvant chemotherapy, liver resection (LR) to clear one side 
of the liver, portal vein embolization of the contralateral side, 
followed by the second stage LR. Those who had only a 
single LR were considered a failed staged resection (FSR), 
while those who completed the second stage were considered 
to have had a successful staged resection (SSR). Survival 
was calculated from the date of diagnosis BCLM. Complete 
follow up and dates of deaths were obtained from the 
Government of Quebec populational database.
Results: A total of 90 patients were identifi ed. 51 patients 
(57%) had an SSR, while 39 patients (43%) had an FSR. The 
overall 5-year survival and median survival were 19% and 
1.8 years respectively for the entire group. The SSR median 
survival was 2.5 years vs. 1.4 years in the FSR group. The 
SSR 5-year survival was 43% vs. 5% in FSR group.
Conclusion: Staged resection for BCLM is feasible and 
offers a survival benefi t.
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MEASURING METABOLIC ACTIVITY OF 
COLORECTAL LIVER METASTASES AND 
ITS RELATIONSHIP WITH TUMOUR 
VOLUME USING PET-CT
C. Jones1, S. A. Badger1, L. D. McKie1, T. Diamond1, 
M. A. Taylor1, R. H. Wilson2 and T. Lynch3
1Department of HPB Surgery, Mater Hospital, Belfast; 
2Department of Oncology, Belfast City Hospital, Belfast; 
3Department of Radiology, Belfast City Hospital, Belfast
Mater Hospital, Belfast Health and Social Care Trust, 
Department of HPB Surgery, 10 Breezemount Park, BT32 
Banbridge, Northern Ireland
Introduction: PET-CT (positron emission tomography) 
scanning combines the metabolic information of FDG PET, 
with the anatomical information of CT. It is routinely per-
formed as an imaging modality in the assessment of color-
ectal liver metastases (CRLM). With the advent of more 
aggressive surgical resection of CRLMs, this study aimed to 
assess the relationship between the metabolic activity and the 
volume of each tumour.
Methods: FDG PET-CT scans from 2007 to 2009 of 79 
patients with potentially resectable CRLMs were analysed. 
The scans were reviewed in detail by 2 experienced, trained 
doctors (one radiologist and one surgeon), and the following 
measurements were taken: Standard Uptake Value – 
SUVmean, SUVpeak, SUVmax, maximal diameter and 
reconstructed volume; along with the anatomical location of 
the tumour. Patient demographics were also recorded. Ethics 
approval was obtained. Values were expressed as median 
(IQR), and correlation calculated with Spearman Rank test.
Results: 79 patients were included, 8 were excluded due to 
incomplete data. The median age was 62.5 years, with 47 
males. The median SUV mean was 4.6 (3.8–5.7), SUV peak 
5.6 (4.3–7.3) and SUV max 7.1 (5.8–9.8). The median 
number of lesions per patient was 2 (1–2), with a median 
diameter of 23.4 mm (15.6–39.3) and volume of 37.5 cm3 
(4.0–39.8). The number of lesions weakly correlated to 
tumour volume (r = 0.26, p = 0.03). There was a positive 
correlation found between tumour volume, and SUV peak (r 
= 0.646, p < 0.0001), SUV max (r = 0.636, p < 0.0001) and 
SUVmean (r = 0.45, p < 0.0001). There was also a signifi -
cantly positive correlation between maximum tumour diam-
eter and SUVpeak (r = 0.643, p < 0.0001), SUVmax (r = 
0.629, p < 0.0001) and SUVmean (r = 0.44, p < 0.0001).
Conclusion: This study demonstrated the direct relationship 
between tumour volume on PET-CT and the metabolic activ-
ity of the tumour as measured by SUVpeak, SUVmax and 
SUVmean, in the setting of colorectal liver metastases. 
Further studies are required to assess the role of PET-CT to 
assess tumour volume and its potential implications for 
future surgical planning, when radical resection with a 
remaining functional liver remnant is required.
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THE USE OF THE FONG SCORE IN THE 
ERA OF PET-CT SCANNING
C. Jones1, S. A. Badger1, T. Diamond1, L. D. McKie1, 
M. A. Taylor1 and T. B. Lynch2
1Department of HPB Surgery, Mater Hospital, Belfast; 
2Department of Radiology, Belfast City Hospital, Belfast
Mater Hospital, Belfast Health and Social Care Trust, 
Department of HPB Surgery, 10 Breezemount Park, BT32 
Banbridge, Northern Ireland
Introduction: The Fong score is a validated prognostic tool 
for patients with colorectal liver metastases (CRLM). 
PET-CT, a pre-operative imaging modality for CRLM, can 
indicate the metabolic activity of the tumour by the maximum 
standard uptake value (SUVmax). Evidence suggests this is 
also prognostic indicator. The aim of this study was to deter-
mine the relationship between these two parameters.
Methods: All patients who underwent a hepatic resection of 
CLM were retrospectively analysed. The 5 parameters of the 
Fong score were collated from laboratory results and the 
local oncology database. The SUVmax was obtained from 
the PET-CT report performed prior to resection. Patients who 
had no pre-operative PET-CT were excluded. Average 
SUVmax was expressed as median (IQR) and compared 
using Kruskal-Wallis test.
Results: A total of 148 patients had hepatic resection 
between 1997 and 2009. 49 were excluded due to missing 
data, leaving 99 in the study cohort. Ten patients had a Fong 
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score of 0, with average SUV of 7.2 (5.5–9.6). 21 had a score 
of 1 and associated SUV of 7.0 (5.7–10.1). Patients with 
Fong score of 2 (n = 38) had SUV of 8.3 (6.5–10.9). 25 
patients had a Fong score of 3, with a SUV of 8.8 (6.7–12.0). 
Only 4 patients had a score of 4 with SUV of 12.2, while 1 
patient had a score of 5, whose SUV was 7.1. There was no 
difference between the groups (p = 0.61).
Conclusion: Although both SUVmax and the Fong score 
help predict the patient outcome, there was no association 
between them. Further prospective studies would be required 
to evaluate this further.
705
LONG-TERM OUTCOMES AFTER 
PORTAL VEIN EMBOLIZATION AND 
MAJOR HEPATECTOMY IN PATIENTS 
WITH EXTENSIVE NEUROENDOCRINE 
LIVER METASTASES
M. Russell, M. Katz, J. Fleming, J. Lee, E. Abdalla, 
S. Curley, J.-N. Vauthey and T. Aloia
The University of Texas M.D. Anderson Cancer Center, 
Houston, Texas, USA
The University of Texas M.D. Anderson Cancer Center, 
Surgical Oncology, 1400 Presser Street, Unit 1484, 
Houston, Tx, 77030 Houston, USA
Introduction: In contrast to colorectal liver metastases, 
neuroendocrine liver metastases (NLM) tend to be numerous 
and bilateral, with frequent recurrences. The purpose of this 
project was to examine outcomes for patients with extensive 
NLM treated with portal vein embolization (PVE) and 
extended hepatectomy.
Methods: From a prospective PVE database containing 309 
cases performed between 2000 and 2011, 24 patients with 
NLM were identifi ed. Primary sites included pancreas – 9 
patients (40.9%), bowel – 10 patients (45.5%), and unknown 
– 3 patients (13.6%). After PVE, 22 of the 24 patients had 
suffi cient future liver remnant (FLR) hypertrophy to undergo 
resection. Clinical factors were examined for association 
with perioperative and long-term outcomes.
Results: In 9 patients (40.9%), PVE was performed between 
staged hepatectomies and in 3 (13.6%) cases hepatectomy 
was combined with primary tumor resection. Preoperative 
therapies included chemotherapy in 10 patients and octre-
otide in 13 patients. Median metastasis size (4.25 cm; range: 
1.2–13 cm) and number (5 lesions; range: 1–18) indicated 
extensive liver involvement. The 90-day postoperative liver 
insuffi ciency, overall morbidity, and mortality rates were 
18%, 55% and 0%, respectively. During a median follow up 
interval of 35.5 months, 12 patients recurred. The 3- and 5- 
year overall survival rates were 88% and 79%, respectively. 
Early recurrence was associated with poor long-term surviv-
als (5-year OS 33% vs 92%).
Conclusion: Extended hepatectomy facilitated by PVE is a 
safe and effective strategy for selected NLM patients. Given 
the relatively poor response rates of NLM patients with 
extensive disease treated with liver transplantation, more 
consideration should be given to multidisciplinary approaches 
involving medical, interventional and surgical strategies.
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CARDIOPULMONARY EXERCISE 
TESTING INCREASES HEPATECTOMY 
RATE IN THE ELDERLY
D. Dunne1, R. Jones1, G. Poston1, H. Malik1, D. Palmer2, 
C. Lacasia3, S. Jack4 and S. Fenwick1
1Northwestern Hepatobiliary Centre, Aintree University 
Hospital; 2Department of Oncology, University of 
Liverpool; 3Department of Anaesthesia, Aintree University 
Hospital; 4Department of Respiratory Medicine, Aintree 
University Hospital
Aintree University Hospital, Northwestern Hepatobiliary 
Centre, 10 Hattons Lane, Liverpool L16 7QSL167Q, UK
Introduction: Hepatectomy offers the only possibility of 
cure to patients with colorectal liver metastases (CRLM) and 
although 50% of CRLM patients are >70, only 25% of those 
undergoing hepatectomy are >70. (due to higher periopera-
tive mortality). Cardiopulmonary exercise testing (CPET) 
can identify patients at higher operative risk. We introduced 
CPET on 1/10/2009. This study assesses its effect on patient 
selection and outcome.
Methods: After 1/10/2009 for all patients undergoing resec-
tion of CRLM meeting one of the following criteria under-
went CPET.
(1) planned extended right/or extended left resection
(2) over 65
(3) signifi cant comorbidities.
Data were collected prospectively. Group (A) 1/10/2009–
21/12/2011 was compared to a published historical series 
1/8/1990 to 1/4/2007 (Group B) from our unit. We also 
compared our results to a recently published series from 
LiverMetSuvey (LMS).
Results: Group A 155 patients, Group B 654 patients. In 
Group A 64 (41%) patients were 70+, Group B 181 (28%) 
patients (p < 0.0001). There was no difference in the over 
70s. in male : female ratio or postoperative complications. 
There was increased use of neoadjuvant chemotherapy in 
Group A 26 patients (40%) vs. 34 patients (19%) Group B 
(p = 0.001). In hospital mortality was 1.6% (1 patient) Group 
A vs. 4.9% (9 patients) group B (p = 0.46).
Comparing Group A to LMS data from 1/1986 to 6/2007 
(7764 resections). Group A 41% aged 70+ vs. 21% LMS (p 
< 0.01). No signifi cant difference in neoadjuvant chemo-
therapy use (Group A 41% vs. LMS 34%) (p = 0.22), or 60 
day mortality (Group A – 1 patient (1.6%) vs. 62 (3.8%) 
LMS) (p = 0.51).
Conclusion: increase in the number of patients over the age 
of 70 proceeding to surgery. There is a trend towards lower 
mortality possibly due to better preoperative assessment. We 
believe that the number of hepatectomies undertaken for 
CRLM in patients aged over 70 would rise if CPET were 
introduced as a standard preoperative assessment tool.
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LAPAROSCOPIC LIVER RESECTION – 
AN EXTENDED LITERATURE REVIEW
C. Jones and M. A. Taylor
Department of HPB Surgery, Mater Hospital, Belfast
Mater Hospital, Belfast Health and Social Care Trust, 
Department of HPB Surgery, 10 Breezemount Park, BT32 
Banbridge, Northern Ireland
Introduction: The benefi ts of laparoscopic surgery are well 
recognised. Initially there was resistance to performing liver 
resections laparoscopically, due to concerns regarding diffi -
cult mobilisation, risks of major haemorrhage and dissemina-
tion of tumour. Despite these concerns, many units are now 
performing laparoscopic liver resection. This study aimed to 
review the clinical benefi ts and cost effectiveness of liver 
resection in colorectal metastases (CRLM), comparing open 
with laparoscopic technique.
Methods: A literature search was carried out using the fol-
lowing databases – Pubmed, Athens, Medline and Google 
scholar search engine. The following key words were used 
– cost effectiveness, liver or hepatic resection, laparoscopic, 
colorectal cancer, colorectal liver metastases – singly or in 
combination. In order to ensure an up-to-date literature 
search, it was restricted to 2000–2009. To maximise this 
search, backward chaining of reference lists from retrieved 
papers was also undertaken. The search was limited to 
English language, but no restriction according to the type of 
study. A total of 34 papers were identifi ed, with 15 papers 
excluded and 19 papers reviewed.
Results: Level 2 evidence supports laparoscopic liver resec-
tion in large volume centres. There was reduced operative 
time, analgesic requirements and blood loss, and a shorter 
hospital stay, with no increased morbidity or mortality. 
Laparoscopic CRLM resection margins are similar to open 
surgery, with no port site or intra-abdominal seedlings. 
Studies with 5-year follow-up showed no difference between 
the 2 techniques. Laparoscopic liver resection is cost effec-
tive. Capital investment in specialised equipment is offset in 
reduced hospital bed days, thus gaining life-years. Evidence 
strongly supports laparoscopic liver resection improving sur-
vival, with a learning curve highlighting the need for ade-
quate training and exposure to this technique.
Conclusion: Literature suggested laparoscopic liver resec-
tion is safe, feasible, oncologically effective and cost effec-
tive in certain circumstances. This is especially the case for 
wedge resections or segmentectomies, with limited data sup-
porting the use of laparoscopic surgery for major resections. 
Prior to a laparoscopic approach becoming gold standard for 
liver resection, larger prospective randomized studies with 
long-term follow-up are required to validate this technique.
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FEASABILITY REPORT OF A PILOT 
STUDY COMBINING MICROARRAY 
MRNA EXPRESSION ANALYSIS WITH 
HIDA SCANNING TO PREDICT THE 
DEVELOPMENT OF CHEMOTHERAPY-
INDUCED HEPATIC INJURY ON 
PREOPERATIVE LIVER BIOPSY
B. Thomson, C. Pilgrim1, P. Alan2, M. William3, L. Emma4, 
S. Marty1, U. Val1, E. Peter1 and B. Simon5
1Hepatopancreaticobiliary Service, Upper Gastrointestinal 
Surgery, The Alfred Hospital, Melbourne, Australia; 
2Department of Pathology, The Alfred Hospital, Melbourne, 
Australia; 3Department of Pathology, Peter MacCallum 
Cancer Centre, Melbourne Australia; 4Centre for 
Biostatistics and Clinical Trials, Peter MacCallum Cancer 
Centre, Melbourne, Australia; 5Division of Cancer Surgery, 
Peter MacCallum Cancer Centre, Melbourne, Australia
Introduction: Chemotherapy induced hepatic injuries 
(CIHI) remain a troubling problem for surgeons & oncolo-
gists increasing perioperative morbidity & interfering with 
planned treatment regimens. CIHI remain unpredictable in 
their development & although similar phenotypic injury pat-
terns attributable to comorbid diseases such as obesity & 
diabetes are well recognized, there is still no way to accu-
rately predict who is at risk of developing severe CIHI fol-
lowing preoperative treatment of colorectal metastases.
Methods: HIDA scanning was performed before and after 
treatment with chemotherapy to detect subtle deteriorations 
in liver function that could herald otherwise unrecognized 
CIHI. Non-tumorous liver was collected prior to chemo-
therapy at either diagnostic laparoscopy or via percutaneous 
ultrasound guided core-biopsy and compared to non-
tumorous liver remote from malignant disease taken at time 
of hepatic resection for colorectal metastases to quantify 
injury extent and to provide a pre-chemotherapy sample for 
microarray mRNA expression analysis to test whether there 
are recognizable genetic signatures that predispose to the 
development of CIHI.
Results: Six patients were recruited to this pilot study. All 
underwent preoperative prechemotherapy HIDA scanning 
successfully and fi ve also gave consent for collection of liver 
tissue prior to treatment. Tissues collected were suitable for 
microarray mRNA expression analysis (mean A260/A280 = 
2.04 and mean RNA integrity number [RIN] = 8.1). There 
was suffi cient tissue to prepare both H&E and Masson 
stained slides for histological examination to grade CIHI. No 
patient developed severe CIHI after treatment with FOLFOX 
when comparing paired samples of non-tumour liver 
histologically.
Conclusion: Collection of preoperative non-tumorous liver 
tissue for microarray mRNA expression analysis prior to 
hepatectomy for colorectal metastases is feasible, and in 
conjunction with baseline HIDA scan parameters may enable 
recognition of patients at risk for developing CIHI.
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METASTATIC NEUROENDOCRINE 
CARCINOMA: FEASIBILITY OF LIVER 
RESECTIONS USING THE 
LAPAROSCOPIC APPROACH
S. Cawich2, N. Pearce1, M. Abu-Hilal1, F. DiFabio1 
and T. Armstrong1
1Southampton University Hospital, Tremona Road
Southampton, SO16 6YD, UK; 2University of the West
Indies, Mona, Kingston 7, Jamaica
Introduction: Medical literature contains few reports of 
laparoscopic liver resections (LLR) for neuroendocrine 
tumour (NET) metastases. Most reports contain few patients 
with NETs in large series of unselected patients or include 
laparoscopic assisted ablation of secondaries. This may be 
due to the perceived diffi culty of LLR due to adhesions, 
tumour desmoplasia, diffi cult disease distribution and fears 
of increased carcinoid crises. We describe our experience 
with LLR in a dedicated cohort of NET patients.
Methods: We identifi ed all LLRs done for NET metastases 
over 9 years. Data were retrospectively collected on patient 
demographics, operative details, estimated blood loss (EBL), 
transfusion requirements and survival. Morbidity was graded 
using Clavien’s grading system for surgical complications, 
where grades I/II were considered mild complications and 
grades III/IV considered severe. Specifi c complications 
included haemorrhage, bile leaks, carcinoid crises, surgical 
site infections, hepatic insuffi ciency, vein thrombosis, pneu-
monia, myocardial infarction and mortality. Post-operative 
mortality was defi ned as death within 30 days of operation. 
Survival was calculated from the date of the fi rst major 
intervention for hepatic metastases.
Results: Of 33 resections for NET, there were 16 open and 
17 (51.5%) LLRs. NET accounted for 8.1% of 210 LLRs for 
all indications. The mean patient age was 62.7 ± 10.9 years. 
5 major (3 simultaneous colectomies) and 12 minor LLRs 
were completed with 1 conversion (adhesions). Major LLRs 
were completed in 331 ± 57.7 minutes (mean ± SD), with 
1090 ± 1655.5 mls (mean ± SD) EBL, 1.6 ± 0.89 days (mean 
± SD) of HDU care and 6.2 ± 3.5 days (mean ± SD) total 
hospitalization. Minor LLRs were completed in 152.9 ± 95.7 
minutes (mean ± SD) of operating time, with 154.2 ± 
167.2 mls (mean ± SD) EBL, 1.3 ± 1.1 days (mean ± SD) 
of HDU care and 5.1 ± 2.6 days (mean ± SD) total hospitali-
zation. There were 2 (11.8%) complications: iatrogenic 
splenic injury (Grade III) and pneumonia (Grade IIa).
Conclusion: Despite adhesions, tumour desmoplasia and 
diffi cult disease distribution, LLR can be performed by expe-
rienced surgeons with 5.9% conversion rates, 11.8% morbid-
ity and no mortality. Despite the theoretic risk of carcinoid 
crises due to the lack of tactile feedback while handling a 
tumour-laden liver with laparoscopic instruments, this was 
not encountered and should not be a contraindication to LLR. 
This is a feasible option in patients with metastatic NET 
disease.
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COLORECTAL LIVER METASTASIS 
(CRLM): INCREASING ROLE OF 
LAPAROSCOPIC LIVER RESECTION- A 
SINGLE UNIT COMPARATIVE ANALYSIS
S. K. P. John, S. Rehman, A. Vallance, S. Robinson, 
J. French, D. Manas and S. White
Hepatobiliary Surgery, Freeman Hospital, Newcastle upon 
Tyne, UK
Freeman Hospital, HPB Surgery, Level 4 Offi ce, High 
Heaton, Newcastle Upon Tyne NE7 7DN, UKNE7 7, 
United Kingdom
Introduction: Laparoscopic liver resection (LLR) is becom-
ing increasingly used to reduce the morbidity of open liver 
resection The aim of this study was to compare outcomes 
after LLR with that of open liver resection.
Methods: From April 2007 onwards all patients who under-
went either left lateral sectionectomy, left hemi-hepatectomy, 
segmentectomy and non-segmental resection for CRLM 
were identifi ed from a prospectively maintained HPB data-
base (open & LLR). Those having right hepatectomy were 
excluded from analysis as there were too few laparoscopic 
procedures for meaningful analysis. Comparisons between 
groups were made in terms of complications (graded using 
the Clavien-Dindo classifi cation), duration of hospital stay 
and overall survival (OS). Statistical analysis was performed 
using Fisher Exact test for categorical variables, Mann 
-Whitney U test for non – parametric continuous variables 
and overall survival (OS) plotted with Kaplan Meir curves 
(SPSS vs. 19).
Results: 78 patients had LLR for various indications (color-
ectal n = 43, non colorectal n = 17, benign n = 18). During 
the same period 94 patients had open equivalent procedures 
for CRLM (including 4 conversions from a lap procedure). 
Female patients were more likely to have a LLR compared 
to open (47% females, 24% males p = 0.01). Grade 3 & 4 
complications were more seen in the open group (8.5% vs. 
4.7%), however grade 1 & 2 complications were slightly 
higher in the laparoscopic group (18.6% vs. 17.1%) Median 
stay was 4 days in LLR group (range 1–23), 7 days (range 
3–95) in open group, p < 0.001. R1 resections were less 
during second era of the study in LLR and comparable to the 
open group. At 3 years 91% of LLR and 72% of open group 
were alive. OS was similar (p = 0.4).
Conclusion: Laparoscopic liver resection has shown bene-
fi ts in terms of lower morbidity in our series when comparing 
it to equivalent open procedures. Long term follow up will 
be needed to see if there is real advantage in OS and outcome.
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CHEMOTHERAPEUTIC REGIMEN TO 
REDUCE THE LIVER DAMAGE BY 
OXALIPLATIN-BASED CHEMOTHERAPY 
AND TO ENHANCE ‘CONVERSION’ IN 
PATIENTS WITH INITIALLY 
UNRESECTABLE COLORECTAL 
LIVER METASTASES
T. Miyatani, M. Shimada, T. Utsunomiya, S. Imura, 
Y. Morine, T. Ikemoto, H. Mori and J. Hanaoka
Tokushima University
Tokushima University, Surgery, Kuramotocho 3-18-15770 
Tokushima, Japan
Introduction: Prognosis in patients with unresectable liver 
metastases from colorectal cancer is known to be very poor. 
However, thanks to progress of chemotherapy including 
molecular-target agents, ‘conversion’ has been sometimes 
seen. The aim of this study is to clarify the impact of current 
chemotherapeutic regimen plus bevacizumab (Bev) on 
‘Conversion’ and inhibition of liver injury by Bev in patients 
with initially unresectable colorectal liver metastases.
Methods: <Study 1> Fifty-six patients with initially unre-
sectable colorectal liver metastases, who received the current 
Cx regimen (FOLFOXIRI plus Bev, et al), were included in 
this study. Completeness and adverse effects were examined 
in FOLFOXIRI plus Bev, and ‘Conversion’ rate was inves-
tigated in detail. Patients, who became resectable after Cx 
(Conv group, n = 16), were compared to those with initially 
resectable colorectal liver metastases (Resect group, n = 45) 
in the short- and long-term prognosis. <Study 2> Sixteen 
patients who became resectable after Cx divided into two 
groups (Bev group, n = 9) and No-Bev group (n = 7), and 
histopathology of the liver tissue, blood chemistry and 
increasing rate of spleen volume were evaluated.
Results: <Study 1> Sixteen out of 56 patients became 
resectable (‘Conv’ rate: 29%), and seven out of 9 patients 
with FOLFOXIRI plus Bev became resectable (‘Conv’ rate: 
78%), except for 2 with multiple lung metastases and bone 
metastasis prior to Cx. All sixteen patients tolerated the 
regimen well (only one patient with diarrhea of Grade3 was 
observed). There was no difference between the Conv and 
the Resect group in terms of the 3-year OS or the post opera-
tive complication rate (13% vs. 11%). <Study 2> The patients 
in the Bev group had no blue liver, and the rate of sinusoidal 
dilatation was lower than that in the No-Bev group (20% vs. 
67%). Serum HA and increasing rate of spleen volume in the 
Bev group decreased compared to those in the No-Bev 
group.
Conclusion: These fi ndings indicated a high ‘Conversion’ 
rate of current regimen (especially, FOLFOXIRI plus Bev) 
and inhibitory effects of Bev on sinusoidal injury in patients 
with initially unresectable colorectal liver metastases.
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TUMOR PROGRESSION AFTER 
PREOPERATIVE PORTAL VEIN 
EMBOLIZATION
L. Hoekstra1, K. van Lienden2, A. Doets1, O. Busch1, 
D. Gouma1 and T. van Gulik1
1Department of Surgery, Academic Medical Center, 
University of Amsterdam, Amsterdam, the Netherlands; 
2Department of Radiology, Academic Medical Center, 
University of Amsterdam, Amsterdam, the Netherlands
Academic Medical Center, University of Amsterdam, 
Amsterdam, the Netherlands, Department of Surgery, 
IWO-A1-132, Meibergdreef 91105 Amsterdam, The 
Netherlands
Introduction: Portal vein embolization (PVE) induces 
atrophy of the embolized liver segments and compensatory 
hypertrophy of the contralateral liver, resulting in increased 
liver volume of the future remnant liver (FRL). Because of 
this induced liver regeneration, tumor growth after PVE is 
potentially enhanced. The aim of the study was to evaluate 
tumor growth in a series of patients undergoing liver resec-
tion after PVE in our department, along with a review of the 
literature on tumor progression after PVE.
Methods: PVE was performed in 28 patients diagnosed 
with colorectal metastases (CRM) between 2004 and 2011 
in our center. Tumor volume (TV) and tumor growth rate 
(TGR) were measured by CT volumetry and compared with 
a non-PVE control group with CRM of whom 30 had two 
CT-scans preoperatively. Also, newly diagnosed tumors in 
the FRL after PVE and after resection were analyzed. A lit-
erature review was performed using MEDLINE with key-
words focusing on PVE and tumor progression.
Results: Mean TV increased signifi cantly after PVE. The 
median TGR of PVE patients was 0.53 mL/day (range 
−4.24–8.00) vs 0.09 mL/day (range −5.01–8.74; p = 0.03) in 
non-PVE patients. TGR was 0.15 (range  3.79–1.00) mL/day 
before PVE, and 0.85 (range  1.46–4.67) mL/day after PVE 
in the same patients (p = 0.08). Seven (25.0%) patients 
showed new tumor lesions in the FRL after PVE. Three of 
these patients (10.7%) were not deemed resectable after PVE 
for this reason. Patients after PVE also showed a signifi cantly 
higher rate (8/19) of recurrent metastases in the remnant liver 
at follow-up after resection. Survival was signifi cantly better 
for non-PVE patients with a 5 year survival rate of 60% 
versus 22% in patients undergoing PVE (p < 0.001).
Conclusion: Literature suggests that PVE induces tumor 
growth after PVE. In the majority of our patients, TV and 
TGR increased after PVE. Our study also showed that PVE 
potentially induces new tumor in the FRL and recurrent 
tumor after resection. Short intervals as well as interval 
chemotherapy between PVE and resection are therefore 
advised.
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THE ORANGE II PLUS – TRIAL: AN 
INTERNATIONAL MULTICENTRE 
RANDOMISED CONTROLLED TRIAL OF 
OPEN VERSUS LAPAROSCOPIC 
HEMIHEPATECTOMIE
E. Wong-Lun-Hing1, B. Topal2, J. N. Primrose3, 
A. Laurent4, B. Edwin5, L. Aldrighetti6, 
C. H. C. Dejong1 and R. M. van D. on behalf of the 
ORANGE II P. study group1
1Maastricht University Medical Centre; 2University 
Hospitals Leuven; 3University Hospital Southampton NHS; 
4Henri Mondor Paris; 5Oslo University Hospital; 
6San Raffaele Hospital Milan
Maastricht University Medical Centre, HPB Surgery, 
Department of Surgery, Maastricht University Medical 
Centre, PO Box 5800, 6202 Maastricht, The Netherlands
Introduction: Developments in liver surgery include the 
introduction of laparoscopy and enhanced recovery path-
ways. Laparoscopic surgery and enhanced recovery pro-
grammes both focus on faster time to recovery and shorter 
LOS. In expert hands median LOS after major hepatic resec-
tion varies between 6–12.5 days for open and 4–8.2 days for 
laparoscopic resection. To optimise postoperative recovery 
and further adopt laparoscopic liver surgery there is a need 
for an RCT comparing open and laparoscopic liver surgery.
Methods: The ORANGE II PLUS – Trial is a prospective 
study with a two armed, randomised double blinded experi-
mental design and parallel registry to determine whether 
laparoscopic surgery is to be preferred over open surgery in 
patients undergoing left or right hemihepatectomy and par-
ticipating in an enhanced recovery programme. A sample 
size of 2 × 86 patients in the randomisation arms can dem-
onstrate a 2 day reduction in time to functional recovery (α 
= 0.05, β = 90%). Patients ineligible for randomisation will 
be included in a prospective registry. In all patients requiring 
hemihepatectomy, the inclusion criteria will be tested at the 
outpatient clinic. Eligible patients will be recruited for ran-
domisation and informed consent will be obtained.
Results: The primary endpoint of the ORANGE II PLUS 
– Trial will be time to functional recovery. Secondary end-
points are hospital length of stay, readmissions, total morbid-
ity, liver specifi c morbidity, quality of life, body image, 
reasons for delay of discharge after functional recovery, 5 
year survival and long term incidence of incisional hernias.
Conclusion: The added value of the laparoscopic hemi-
hepatectomy compared to the open hemihepatectomy has 
never been studied in a randomised controlled setting. 
Therefore, the multicentre international ORANGE II PLUS 
– trial has been constructed and will provide evidence on the 
merits of laparoscopic versus open hemihepatectomy.
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NEW STRATEGIES AIMING 
R0-RESECTION FOR COLORECTAL 
LIVER METASTASIS: HIGH 
ONCOLOGICAL RISK PATIENTS MAY 
BENEFICIATE WITH NO PEJORATIVE 
OVERALL SURVIVAL
A. Dili, J. Lemaire, B. Mansvelt, G. Molle and C. Bertrand
Jolimont Hospital, Oncological Surgery, 159, Rue Ferrer
7100 La Louviere, Belgium
Introduction: The resection of liver metastasis from colo-
rectal cancer (CRLM) is actually the only curative treatment. 
Different artifi ces have been developed to extend the rate of 
R0-resection. The aim of this study is to compare the results 
of these new strategies with a conventional approach, in the 
context of an era of new systemic chemotherapies.
Methods: Prospective consecutive series of 68 patients 
treated between January 2006 and June 2011, by hepatec-
tomy without (group A) and with (group B) new strategies 
in view to extent the R0-rate resection. Were analyzed, the 
number of metastasis, the uni- or bilobar localisation, the 
type of new artifi ce, the rate of iterative hepatectomies (hepa-
tectomy for a recurrent liver disease), and the global survival 
(Kaplan-Meier). Mean age: 64.24 year old (40–89). Mean 
number of metastasis: 7.4 (1–20), synchronous metastatic 
disease: 42 patients (61.7%). Group A: 45p (64.2%): >3 
lesions: 10, bilobar: 14, >3 lesions and/or bilobar: 16 (35.6%). 
Group B: 23p (33.8%): >3 lesions: 14, bilobar: 15, >3 lesions 
and/or bilobar: 19 (82.6%).
Results: Signifi cantly more patients with a high risk disease 
were so treated in the group B (X²: p < 0.01). In the group 
B, 39 artifi ces were used: 14 two-stages hepatectomies 
(61%), 11 portal vein embolisations (47.8%), 7 thermoabla-
tions (30.4%), 7 systemic chemotherapies for unresectable 
liver disease (30.4%). This group represents 33.8% of the 
patients. Iterative hepatectomy for recurrent liver disease 
were performed in 14 patients, 8 in group A (17.7%) and 6 
in group B (26%). Global survival at 1, 3, 5 years was 94, 
60, 56% (group A: 97, 68, 60%/group B: 95, 48 et 48%).
Conclusion: In our experience, the use of new strategies 
with technical artifi ces and iterative hepatectomies in order 
to extend the R0-resection rate permitted an increase of 50% 
the number of resection indications. Despite the fact that 
most of these patients had a signifi cantly higher percentage 
of high-risk hepatic disease, the 5-years overall survival was 
practically similar to the group where complex strategies 
were not necessary. The 5-year survival of the whole serie 
was 56%.
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LIVER METASTASES FROM 
COLORECTAL CANCER: WHICH PRE 
OPERATIVE IMAGING STRATEGY 
SHOULD BE FAVORED?
L. Chiche2, E. Hourna1, L. Plard2, V. L. Pennec1, 
N. Bouvard1 and J. P. Pelage1
1Service of Radiology – University Hospital of Caen – 
France; 2Service of Hepatobiliary and Pancreatic Surgery 
– University Hospital of Caen – France
University Hospital, Hepatobiliary and Pancreatic Surgery, 
Avenue de la cote de Nacre, 14000 Caen, France
Introduction: Liver resection is the best treatment of color-
ectal metastasis if R0 resection is achieved, that why preop-
erative detection of all the lesions is mandatory in order to 
plan the best surgical strategy. The goals of the study were 
to determine the best radiologic strategy before liver resec-
tion for CRM; to compare the diagnostic accuracy of ultra-
sonography (US), contrast-enhanced US (CEUS), CT with 
injection (MDCT), MRI after injection of gadolinium 
(GADO) and superparamagnetic iron oxyde (SPIO).
Methods: A total of 52 candidates for liver resection were 
evaluated. All radiological examinations were reviewed by 
3 readers blinded to fi nal outcomes, including 1 in-training 
radiologist and 2 staff radiologists (with 2 and 15 years of 
experience in abdominal imaging). The sensitivity of each 
individual examination was obtained based on the surgical 
fi ndings and the results of intra operative ultrasonography 
and histopathology. The sensitivity of combined imaging 
evaluation was also considered.
Results: The mean sensitivity of MDCT, MRI with GADO 
and MRI with SPIO were not signifi cantly different (63.4%, 
61.4% and 59.7%, respectively, p > 0.05) but were signifi -
cantly higher than that of US and CEUS (47.1% and 52.2% 
respectively, p < 0.05). The sensitivity of the combination 
MDCT-MRI with GADO was signifi cantly higher than that 
of MDCT-MRI with SPIO (p < 0.0001), MDCT-US (p < 
0.001) and MDCT-CEUS (p = 0.005). There was no signifi -
cant difference between the sensitivity of the combination 
MDCT-MRI with GADO and MDCT-MRI with GADO-US. 
A good correlation between the 3 readers was obtained with 
kappa from 0.75 to 0.77 for the detection of liver 
metastases.
Conclusion: In our study, the association MDCT-MRI with 
GADO was the most sensitive imaging modality for the 
detection of liver metastases from colorectal origin (specially 
for patient with preoperative chemotherapy). Contrast-
enhanced ultrasonography and SPIO-MRI failed to improve 
the preoperative radiologic accuracy.
833
ACCURATE PREDICTION OF RESIDUAL 
LIVER FUNCTION PRIOR 
TO HEPATECTOMY
M. Stockmann, M. Malinowski, J. F. Lock, R. Roehl, 
S.-C. Schmidt and P. Neuhaus
Department of General, Visceral, and Transplantation 
Surgery Campus Virchow Klinikum, Charite 
Universitaetsmedizin Berlin, Germany
Charite Universitaetsmedizin, Campus Virchow Klinikum, 
Department of General, Visceral, and Transplantation 
Surgery, Augustenburger Platz 113353 Berlin, Germany
Introduction: The future remnant liver (FRL) is a limiting 
factor by patients undergoing extended liver resection. Due 
to low predicted FRL volume as many as 80% of the patients 
are unresectable. However i.e. chemotherapy or NASH leads 
to liver function impairment and change of volume/function 
ratio. Thus prediction of FRL function would be extremely 
useful for the patient management prior to liver resection.
Methods: Data was assessed from the prospective observa-
tional study. The preoperative functional capacity of the liver 
was determined by the LiMAx test, based on the cytochrome 
P450 1A2 capacity. Prior to resection virtual hepatectomy 
with volumetric analysis using a 3-dimensional reconstruc-
tion of a 4-phase contrast-enhanced computer tomography 
was performed. FRL function was calculated from preopera-
tive function and predicted FRL volume. This analysis was 
done prior to operation in cooperation with the operating 
surgeon. Directly after operation a CT-scan and LiMAx test 
was performed again. Values in median (IQR).
Results: 12 out of 24 enrolled patients undergone liver 
resection as well as the function/volumetric analysis. 
Indications for surgery were: hepatocellular (n = 6) or 
cholangiocellular carcinoma (n = 2), and colorectal metasta-
sis (n = 4). Predicted FRL volume correlates with measured 
FRL volume (r = 0.972, p < 0.0001). Predicted FRL function 
correlates with measured FRL function (r = 0.622, p = 
0.031). The difference between predicted and measured FRL 
function was −55 (−93, −21) µg/kg/h. Pringle manoeuvre 
was identifi ed as an important factor infl uencing this 
difference.
Conclusion: FRL function analysis using LiMAx test and 
virtual liver resection of the CT-scan has the potential to 
predict residual liver function and could improve the preop-
erative planning. Thus, an increasing number of patients 
might undergo safe liver resection.
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DIFFERENCE IN PATHOLOGICAL 
FEATURES AND RISK FACTORS FOR 
RECURRENCE BETWEEN 
SYNCHRONOUS AND METACHRONOUS 
COLORECTAL LIVER METASTASIS
M.-S. Park1, N.-J. Yi1, H. Kim1, Y.-R. Choi1, G. Hong1, 
K.-B. Lee2, K.-W. Lee1 and K.-S. Suh1
1Seoul National University College of Medicine, 
Department of Surgery; 2Seoul National University College 
of Medicine, Department of Pathology
Seoul National University College of Medicine, Seoul, 
Korea, Department of surgery, Department of Surgery, 
Seoul National University College of Medicine, 101 
Daehak-no, Jongno-gu, Seoul, 110-744, KS013 Seoul, 
Korea
Introduction: Few studies has specifi cally examined about 
difference between synchronous and metachronous colorec-
tal liver metastasis. The aim of this study was to compare 
clinicopathological features and risk factors for recurrence 
after hepatic resection in patients with synchronous and 
metachronous colorectal liver metastases.
Methods: From January 2003 to December 2008, 118 
patients were underwent hepatic resection for colorectal liver 
metastasis at Seoul National University Hospital, Korea. 
Patients were divided into two groups: synchronous (n = 78) 
and metachronous (n = 40) colorectal liver metastasis. 
Patients demographics, the histopathologic characteristics of 
the primary and metastatic tumors, and recurrence pattern 
were analyzed.
Results: The pathological characteristics associated with 
recurrence were more often in patients with synchronous 
metastases concerned an more often regional lymph nodal 
metastasis of primary tumor, multiple hepatic metastasis, a 
worse differentiation and more frequently a tumor budding 
of metastatic lesion. However, there was no statistically 
difference in recurrence rates between two groups. In 
Multivariate analysis, poorly differentiation of primary 
lesion and pre-operative serum CEA level > 200 were inde-
pendent risk factors of recurrence in synchronous group. In 
metachronous group, presence of extrahepatic lesion, infl am-
mation on metastatic lesion, and the size of liver metastasis 
> 3 cm were signifi cant risk factors for recurrence.
Conclusion: Different pathologic features and risk factors 
for recurrence were associated with synchronous and meta-
chronous colorectal liver metastases. This study suggests that 
different screening and adjuvant therapy strategies may be 
needed according to these factors.
847
COMPLICATIONS OF INTRAOPERATIVE 
ABLATION OF LIVER TUMOURS: 
MICROWAVE VERSUS 
RADIOFREQUENCY
M. Mirarchi, S. Dokmak, O. Farger, B. Aussilhou and 
J. Belghiti
Department of HPB Surgery & Liver Transplantation, 
Beaujon Hospital, Clichy, France
Department of HPB Surgery & Liver Transplantation, 
Beaujon Hospital, Clichy, France, U.O. di Chirurgia 
Generale e di Urgenza, Padiglione 5, Policlinico S.
Orsola-Malpighi, Via Massarenti, 940138 Bologna, Italy
Introduction: Intraoperative thermal ablation, often associ-
ated with surgical resection, is poorly described. The aim was 
to compare immediate postoperative results of intraoperative 
ablation using microwave (MWA) ablation versus radiofre-
quency (RFA) for liver tumors.
Methods: Since 2004, 44 patients underwent intraoperative 
ablation therapy (MW in 17 and RFA in 27) of 61 malignant 
liver tumors including colorectal metastases in 21, HCC in 
13 and others in 10. Age, etiology, associated surgical pro-
cedures were similar in the two groups with similar number 
of ablated nodules (2.8 + 1.7 vs 1.8 + 2.1 p = ns) and similar 
mean size (19.8 + 11.4 mm vs 18.7 + 10.0 mm p = ns).
Results: The duration of the procedure was lower in MWA 
group (4.04 + 2.20 vs 6.95 + 3.99 p = 0.013). Presence of 
post-procedure fever was similar (35.2% vs 25.9% p = ns); 
AST and ALT levels on Day 1 was similar (581 + 517 vs 734 
+ 565 and 544+423 vs 789 + 666, respectively). Bilirubine 
level on Day 5 was lower in the MW group (12 + 4 vs 19 + 
12 p = 0.0214). Postoperative complications included biliary 
fi stula in one patient in each group, pleural effusion in 1 vs 
2 patients, ascites in 1 vs 4 in the RFA group, portal throm-
bosis in one after RFA. The rate of overall complications was 
lower in the MW group (11% vs 48% p = 0.021).
Conclusion: This study confi rms the lower duration of 
MWA ablation for liver tumors with a lower rate of complica-
tion when compared to RFA procedure.
851
COMPARISON OF PERI-OPERATIVE 
OUTCOME – LAPAROSCOPIC 
VERSUS OPEN LEFT LATERAL 
LIVER RESECTION
R. Saif, R. Lochan, S. Robinson, R. Charnley, B. Jaques, 
J. French, D. Manas and S. White
Department of Hepatobiliary and Transplant Surgery, 
Freeman Hospital, Newcastle upon Tyne, United Kingdom
Freeman Hospital, Newcastle upon Tyne, UK, Dept of HPB 
and Transplant Surgery, Freeman Hospital, Freeman Road, 
Newcastle upon Tyne NE7 7GBNE77G, United Kingdom
Introduction: Laparoscopic left lateral segmentectomy 
(LLLS) is being increasingly performed to reduce the mor-
bidity of open surgery and is now performed routinely in 
many high-volume centres. Although the safety and effi cacy 
of laparoscopic liver resection is well documented, very few 
studies have compared laparoscopic with open techniques in 
a case-matched study. This case-matched study was designed 
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to compare perioperative outcomes between LLLS and open 
left lateral segmentectomy (OLLS).
Methods: Data was retrospectively reviewed from a pro-
spectively maintained database. With the launch of a laparo-
scopic liver resection program in 2007, 20 patients underwent 
LLLS between April 2007 and October 2011 and compared 
to 20 patients who underwent OLLS from 2004. The two 
groups were broadly matched for patient characteristics, 
indications for resection and size of the lesion.
Results: The indications for LLS were colorectal liver 
metastases, intrahepatic cholangiocarcinoma, HCC, meta-
static neuroendocrine tumour and benign pathology. 2 of the 
fi rst 10 patients in the LLLS group required a hand-port. 
The conversion rate was 10% and both conversions were in 
the fi rst 10 in the LLLS group. There was no difference 
between duration of surgery (222.1 min vs 186.05 min, p > 
0.05). The surgical margin was similar for both groups for 
malignant tumours (R1 = 3.15%). The median postoperative 
length of stay was shorter in the LLLS group compared to 
the OLLS group (5 vs 9 days, p < 0.05). One patient (5%) 
in the LLLS group (Clavien-Dindo Gr I) and 4 patients 
(20%) in the OLLS group (Clavien-Dindo Gr II & III) devel-
oped postoperative complications.
Conclusion: LLLS is a safe and feasible technique in expe-
rienced hands. This is associated with a shorter length of 
hospital stay without compromising the surgical margin or 
increasing morbidity. OLLS is now rarely performed in our 
centre.
856
LIVER RESECTION IN 
METASTATIC GASTROINTESTINAL 
STROMAL TUMORS
A. B. F. Puerta1 and S. S. Mudan2
1Asociacion Española de Cirujanos; 2The Royal Marsden 
Hospital, London
The Royal Marsden Hospital, Academic Surgery, Fulham 
Road, London SW36J, England
Introduction: The benefi t, if any and case selection for 
operation in metastatic GIST has not as yet been evaluated. 
We report our experience with patients undergoing liver 
resection for metastatic GIST.
Methods: From a prospectively held data base spanning 
2000–2011 we identifi ed 12 patients who underwent liver 
resection and cases notes reviewed. Non-parametric statistics 
were applied.
Results: M : F ratio 5 : 7. Median age at diagnosis of 
primary 55 yr (47–71). Primary site: Gastric 6, duodenum 1, 
small intestine 2, colon 2, rectum 1. Liver metastases present 
at diagnosis of primary in 3 cases and underwent synchro-
nous resection. For metachronous presentation median DFI 
was 12 m (2–96). Liver only disease n = 9, 3 with additional. 
Eleven received neoadjuvant chemotherapy TKI inhibitors. 
Median duration of TKI therapy 18 m (10–84). Operation 
performed after plateau of response or evidence of progres-
sion. Liver resections: right extended 1, right 3, left 1, non-
anatomic or segmental 7. Additional visceral resection in 2 
(synchronous primary cases excepted). At a median follow 
up time of 43 m from liver resection the status is: NED 7, 
AWD 3, DOC 1, DOD 1. No 30 day mortality.
Conclusion: The safety of hepatectomy for GIST in the 
imatinib treated patient is demonstrated. Whether resection 
of metastatic disease translates into cure, at least in some 
patients is yet to be proven but it is suggested that the indica-
tions for liver resection for metastatic disease might be 
extended to this disease.
858
KLF6 SPLICE VARIANT 1 IN PATIENTS 
WITH COLORECTAL LIVER 
METASTASIS CORRELATES WITH A 
HIGHER CLINICAL RISK SCORE
K. Y. D. Hui1, S. Robinson2, G. Patman1, D. Manas2, 
H. Reeves1 and S. White3
1Northern Institute of Cancer Research, Newcastle 
University, UK; 2Department of HPB and Transplant 
Surgery, The Freeman Hospital Newcastle Upon Tyne, 
England, UK; 3Institute of Cellular Medicine, Newcastle 
University, England, UK
Newcastle University, Northern Institute for Cancer 
Research, Northern Institute for Cancer Research, Paul 
O’Gorman Building, Medical School, Newcastle 
University, Framlington Place, NE2 4 Newcastle upon 
Tyne, England
Introduction: In its wild type form KLF6 (KLF6-WT) acts 
as a tumour suppressor gene whose expression is lost in a 
variety of human cancers. Conversely, KLF-6 splice variant 
1 (KLF6-SV1) is able to function as an oncogene playing an 
important role in tumour proliferation and invasion. The aim 
of this study was to determine how the expression of these 
two KLF6 variants in patients with colorectal liver metas-
tases (CRLM) correlates with an established prognostic 
scoring system.
Methods: Patients undergoing resection of CRLM over a 2 
year period were identifi ed for inclusion within this study. 
Immunohistochemistry was performed using antibodies 
directed against KLF6-WT and KLF6-SV1 on formalin 
fi xed paraffi n embedded tumour samples and the proportion 
of positively stained nuclei for each was determined using 
an automated computerized image analysis system 
(APERIO). Clinical data was collected and Fong’s Clinical 
Risk Score (CRS) was calculated as a marker of patients 
outcome.
Spearmans correlation coeffi cient was used to determine 
the relationship between nuclear staining of KLF-6 and the 
CRS. Continuous variables were compared with Mann 
Whitney U Test. A p-value < 0.05 was considered 
signifi cant.
Results: Twenty fi ve patients (male 64%) were included in 
this study with a mean age of 69.2 years (range 52–81). The 
distribution of CRS were as follows; CRS score 0 n = 2, CRS 
score 1 n = 6, CRS score 2 n = 3, CRS score 3 n = 10, CRS 
score 4 n = 3, CRS score 5 n = 1. 9 patients developed recur-
rence within 1 year of liver resection. All patients remained 
alive at the end of the study period.
There was a positive correlation between KLF6-SV1 and 
the calculated CRS (Spearman’s correlation effi cient = 0.481, 
p = 0.015) whereas no such correlation existed with KLF6-
WT. In those with a CRS < 3 the mean proportion of positive 
nuclear staining for KLF6-SV1 was 5% compared to 15% in 
those with a CRS ≥ 3 (p < 0.05).
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Conclusion: In this preliminary study, high expression of 
KLF6-SV1 in patients with CRLM correlates with a higher 
clinical risk score. Further long-term follow up data is 
required to determine what affect this has on prognosis and 
overall patient survival.
951
LIVER RESECTIONS IN 60 PATIENTS 
OLDER THAN 80 YEARS
G. Pourcher, H. Tranchart, F. Kanso, D. T. P. Lainas, 
J. Gaillard, D. Franco and I. Dagher
Department of Minimal Invasive Surgery, AP-HP, Antoine 
Béclère Hospital, Clamart, France
Introduction: One of modern hepatic surgery challenges 
with the ageing of the population and the effi cacy of new 
chemotherapy, is the care of patients older than 80 years.
Methods: We retrospectively collected data about patients 
older than 80 years who underwent a liver resection for 
neoplasia or metastasis between May 1995 and April 2009.
Results: Sixty-two liver resections were performed in 60 
consecutive patients. The median age was 81 years (range: 
80–92.) Eighty percent have comorbidity (essential hyper-
tension, diabetics, ...). The majority (57.5%) of liver resec-
tions involved more than two Couinaud’s segments. The 
median operating time was 212 minutes (range: 87–423). No 
transfusion was performed during the surgery. 20% of the 
procedures were realized by laparoscopy. Median hospital 
stay was 13 days (range: 7–21), 23 (38.3%) patients had 
post-operative complications: 6 transfusions after surgery, 7 
auricular fi brillation, 5 urinary tract infections, 2 wound 
infections and 3 sepsis. Overall hospital mortality was 5% (3 
patients). The mean of survival disease free was 21.6 months.
Conclusion: Liver surgery is one of the higher risk surgery. 
Liver surgery in patients older than 80 years old is feasible. 
Post-operative complications were associated with comor-
bidity and not directly to surgery.
984
SIMULTANEOUS COLORECTAL AND 
LIVER RESECTION: INTERMITTENT 
HEPATIC PEDICLE CLAMPING 
HAS NO IMPACT ON 
COLORECTAL ANASTOMOSIS
E. De Raffele, M. Mirarchi, S. Vaccari, S. Palumbo 
and B. Cola
Dipartimento di Emergenza/Urgenza, Chirurgia Generale e 
dei Trapianti. Policlinico S.Orsola-Malpighi. Università 
degli Studi di Bologna. Bologna. Italy
Dipartimento di Emergenza/Urgenza, Chirurgia Generale e 
dei Trapianti. Policlinico S.Orsola-Malpighi. Università 
degli Studi di Bologna. Bologna. Italy. U.O. di Chirurgia 
Generale e di Urgenza, Padiglione 5, Policlinico S.
Orsola-Malpighi, Via Massarenti, 940138 Bologna, Italy
Introduction: Liver resection (LR) has become the stand-
ard treatment for patients with synchronous colorectal cancer 
liver metastases (CRLM). In simultaneous colorectal resec-
tion (CRR) and LR, hepatic pedicle clamping (HPC) is con-
sidered potentially dangerous to colorectal anastomoses. 
This study aimed to determine whether intermittent HPC 
adversely affects the perioperative clinical course of simul-
taneous colorectal and liver resections.
Methods: From July 2005 to December 2011, 89 LRs have 
been performed with curative intent for CRLM in our unit. 
All the pts were included in a prospective cohort of 173 LRs 
performed in the same period. Twenty-two patients under-
went simultaneous CRR and LR for a CRC with synchronous 
CRLM. Fifteen pts required intermittent HPC (GrHPC) and 
7 did not (GrNHPC). The mean ± SD age was 63 ± 6 yrs in 
GrHPC (range 55–77 yrs) and 62 ± 9 yrs in GrHPC (range 
50–71 yrs), respectively (p = NS). There were 10 males and 
5 females in GrHPC and 4 males and 3 females in GrNHPC, 
respectively (p = NS). The primary CRC was in the rectum 
in 7 pts (47%) of GrHPC and in 3 pts (43%) of GrNHPC, 
respectively (p = NS).
Results: The CRLM were biliobar in 9 pts (60%) of GrHPC 
and in 7 (100%) of GrNHPC, respectively (p = NS). A major 
LR was performed in 4 pts (27%) of GrHPC and in 2 (29%) 
of GrNHPC, respectively (p = NS). The mean ± SD duration 
of intermittent HPC was 62 ± 30 mins in GrHPC (range 
15–125 mins). The mean ± SD duration of the surgical pro-
cedure was 600 ± 94 mins in GrHPC (range 438–804 mins) 
and 447 ± 76 mins in GrNHPC (range 330–606 mins), 
respectively (p = 0.001). Minor p.o. complications developed 
in 4 (27%) pts in GrHPC and in 1 pt (14%) in GrNHPC, 
respectively (p = NS). None developed major complications. 
The mean ± SD duration of hospital stay was 12 ± 3 days in 
GrHPC (range 7–19 days) and 11 ± 1 days in GrNHPC 
(range 9–13 days), respectively (p = NS).
Conclusion: Patients with CRC and synchronous CRLM 
should be considered potential candidates to simultaneous 
colorectal and liver resection, eventually after neoadjuvant 
chemo and/or radiotherapy. The resection of the primary 
cancer before LR, especially in case of extraperitoneal rectal 
adenocarcinomas, confi rms that the CRR has been poten-
tially curative and that the subsequent LR is indicated. 
Intermittent HPC has no adverse impact on the perioperative 
clinical course of simultaneous resections.
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EXPERIMENTAL BILOBAR LIVER 
METASTASIS – RADIOLOGICAL 
EVALUATION OF SURGICAL AND 
ONCOLOGICAL PRACTICE
M. Scotté1, L. Schwarz1, E. Vibert2, P. Mulder3, L. Nicol3 
and C. Savoye-Collet4
1Department of Digestive Surgery and INSERM U 1073, 
Rouen University Hospital; 2Department of Surgery, 
Hepato-Pancreato-Biliary Center, Villejuif, France; 
3INSERM U1096, Rouen University, France; 4Department 
of Digestive Imaging, Rouen University Hospital
Digestive Surgery, Charles Nicolle Hospital, 1, rue de 
germont 76000 Rouen, France
Introduction: The usual sequence of surgical treatment of 
bilobar liver metastases, is represented by a fi rst stage of 
portal vein occlusion (PVO) with minor hepatic resection 
and/or radiofrequency ablation. The second stage usually 
consists of major hepatic resection. Although technically 
easier, given recent evidence of the induction of tumor 
growth by PVO in the remaining liver, it is necessary to 
develop surgical models and evaluation methods to compare 
the therapeutic sequences.
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Methods: Bilobar colorectal liver metastases were induced in 
18 BDIX rats (7 w, 250 g) by injection of DHDK12 syngenic 
colon cancer cells. 1 million of DHDK12 were injected 
beneath liver capsule of the left liver lobe to induce a macro-
scopic unique metastases, and 1.5 millions were injected 
through the portal vein after clamping just above the portal 
bifurcation to induce multiple micrometastasis of the right 
liver lobe and caudate lobe. MR imaging of the liver using 4.7 
Tesla magnet was used for in vivo analysis of tumor growth. 
Tumor volumes were measured by semi-automatic method.
Results: The tumours were moderately hypointense on MR 
T1w Flash (Fast-Low-Angle-Shot) and hyperintense on T2w 
RARE (Rapid Acquisition with Relaxation Enhancement). 
The use of gadolinium was unconclusive even for early 
acquisition time. The unique subcapsular tumor had a average 
volume of 0.03 cm3 and 0.085 cm3 the 7 and 14 days after 
injection, respectively. Micrometastases of the caudate and 
right lobes were visible in 45% of cases as a tumoral edging 
at day 7. After confl uence and proliferation, all metastasis 
were detectable using MR imaging, as multiple sub millimet-
ric subcapsular nodules 14 days after injection. The mean 
tumor volume was estimated at 1.1 cm3 at the 14t day.
Conclusion: This rat model of colorectal liver metastasis is 
reproductible and allows effi cient evaluation of various sur-
gical and oncological treatment modalities for liver metasta-
sis. It seems useful to evaluate the risk of tumour progression 
in two-stage liver surgery for advanced synchronous liver 
metastasis.
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REDUCED LENGTH OF STAY 
FOLLOWING LIVER RESECTION – THE 
EFFECT OF SAME DAY ADMISSION
J. Watt1, M. Singh2, K. Mawire2, J. McGhie2, 
A. T. Abraham2, H. Elberm2, R. R. Hutchins2 and 
H. M. Kocher1
1Barts Cancer Institute, London, UK; 2Barts and the 
London HPB Centre, Digestive Diseases CAU, Regional 
Services, Barts and the London NHS Trust, London, UK
Barts Cancer Institute, London, UK, Tumour Biology, Flat 
7, 5 Maples Place, E1 2E London, UK
Introduction: Our centre undertakes approximately 45 liver 
resections annually; the majority (59%) for colorectal liver 
metastases (CRLM). Preoperative assessment and same day 
admission was introduced in 2008. This aimed to assess and 
optimise patients regarding existing medical problems; 
attempting to reduce surgical risk and operative postpone-
ment on medical grounds. We reviewed all CRLM resections 
from 2006 to 2011 comparing complication rates, outcome 
and length of stay before and after same day admission.
Methods: We identifi ed patients undergoing liver resection 
for CRLM between January 2006 and December 2011 from 
a prospectively maintained database of all liver resections 
carried out over the same period. Patients were selected on 
the basis of fi nal histology. Using this database and supple-
mentary information from electronic patient records patient 
demographics, details of surgery, length of stay, postopera-
tive complications and subsequent follow up information 
was collected. Patients operated on prior to the introduction 
of same day admission (early: 2006–8) were compared with 
those undergoing surgery under the current system of admis-
sion and assessment (late: 2009–11) with statistical analysis 
performed using Microsoft Excel.
Results: 145 patients underwent 153 resections between 
2006 and 2011. Median age was 65 years (range 24–90), 95 
(66%) were male. 74 operations were performed in the early 
period, 65% were male, median age was 57 years (range 
39–89). There were 79 later operations, 59% were male, 
median age was 67 (range 24–90) years. The majority, 42 
(57%) and 46 (58%) respectively, of patients in both the early 
and late groups had major resections. 5 patients per group 
had laparoscopic surgery 7% and 5% respectively. Median 
follow up was for 388 (range 10–1823) days. 2 early group 
patients (4%) died within 30 days of surgery compared with 
3 (3%) in the late group. Mean length of stay reduced from 
12.7 days (±1.45) in the early group to 11.6 days (±1.16) in 
the late group.
Conclusion: Case load and patient demographics are 
broadly unchanged over the six year period. There has been 
no change in the number of major resections or laparoscopic 
procedures carried out. The 30 day mortality and number of 
complications both major and minor is also unchanged. 
However there has been a reduction in the length of post 
operative in-patient stay following liver resection since the 
introduction of pre operative assessment and same day 
admission.
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LONG TERM RESULTS OF 
LIVER RESECTION FOR 
HEPATOCELLULAR CARCINOMA IN 
NON-CIRRHOTIC LIVER
W. Faber, S. Sharafi , M. Stockmann, T. Dennecke, 
B. Sinn, G. Puhl, P. Neuhaus and D. Seehofer
Charité – Universitätsmedizin Berlin, Campus Virchow 
Klinikum, Department of General-, Visceral- and 
Transplantation Surgery, Augustenburger Platz, 113353 
Berlin, Germany
Introduction: Hepatocellular carcinoma (HCC) is one of 
the most common malignant tumors worldwide.
Only few data on HCC in non-cirrhotic livers and especially 
without viral hepatitis in Western countries are available. The 
purpose of this study was to defi ne the outcomes and poten-
tial prognostic factors, associated with survival after hepatic 
resection in patients with HCC in the absence of liver cir-
rhosis and hepatitis B or C infection.
Methods: From January 2000 to September 2010, 148 
patients without liver cirrhosis and without extrahepatic 
metastases underwent curative hepatic resection for HCC at 
the Surgical Department of the Charité, Campus Virchow 
Klinikum. The outcome of these patients was retrospectively 
reviewed. Patients with cirrhosis or severe fi brosis, fi brola-
mellar HCC and patients positive for hepatitis B or C were 
excluded.
Results: The overall 1-, 3-, 5- and 7-year OS rates were 
75.4%, 54.7%, 38.9% and 31.8%. The overall 1-, 3-, 5- and 
7-year DFS was 60.3%, 38.0%, 29.1% and 18.1%. In the 
multivariable analysis cumulative survival was decreased by 
patient age, increased operation time, increased preoperative 
GGT and tumor stage. In the subgroup with uninodal disease, 
N0 and R0 status tumor size of >10 cm and tumor differen-
tiation were highly predictive for an impaired survival. An 
unfavorable survival was observed in patients with tumor 
size > 10 cm and/or poor differentiation of the tumor.
Conclusion: The current TNM staging system stratifi ed for 
survival and recurrence. Extension of the current TNM 
staging system by grading and more exactly differentiation 
of tumor size could increase the prognostic accuracy for 
predicting outcome. Preoperative increased urea and GGT 
could be shown as possible new poor prognostic factors.
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HSA-MIR-520D INDUCES HEPATOMA 
CELLS TO FORM NORMAL 
LIVER TISSUES VIA A 
STEMNESS-MEDIATED PROCESS
M. Norimasa1, S. Tsuno1, K. Shomori2 and J. Hasegawa1
1Div. Pharmacotherapeutics, Dept. Pathophysiological and 
therapeutic science, Faculty of Medicine, Tottori 
University; 2Div. Organ pathology, Faculty of Medicine, 
Tottori University
Tottori University, Pharmacotherapeutics, 86 Nishicho, 
683-8 Yonago, Japan
Introduction: The human ncRNA gene RGM249 regulates 
differentiation degree of cancer cells and converts 293FT 
cells to hiPSCs. RGM249 downregulation induces the upreg-
ulation of human ten miRNAs including hsa-mir-520d. We 
examined their involvement in pluripotency or malignant 
level, using two cell lines (293FT and undifferentiated 
hepatoma cell line HLF).
Methods: To determine the underlying factors, we investi-
gated the effect via a mir-520d-expressing lentiviral induc-
tion on 293FT and HLF in vitro. Subsequently, we evaluated 
tumour formation in a xerograft model. Gene expressions in 
either transformed cells or generated tissues were examined 
by immunocytochemistry, immunohistochemistry, Western 
blotting, and RT-PCR using pluripotent markers, cancer 
related genes, epigenetic markers, or cancer stem cell 
markers, for each. To invasive ability of transformed cells, 
migration assay was performed. After cells sorted with 
NANOG and GFP were cultured in undifferentiation-
maintaining condition or not, the tumour formation was esti-
mated by subcutaneous or intraperitoneal injection into 
immunodefi cient mice.
Results: in vitro study, 520d especially induced transformed 
HLF cells both Oct3/4 and NANOG positive within 24 h, 
showed P53 upregulation and both hTERT and AID down-
regulation, and mostly lost the migration ability. After lenti-
viral infection, the 520d-expressing cells were injected into 
mice intraperitoneal cavities (n = 8), resulting in benign 
teratomas (37.5%), absence of tumours (50.0%) and differ-
entiation into benign liver tissues (12.5%) along the insertion 
site after 1 month. HLF cells sorted with NANOG and GFP 
in undifferentiation-maintaining condition for 2 weeks never 
generated any tumour in vivo (n = 8). Furthermore, mir-520d 
induced Huh7 (well-differentiated hepatoma cell) to hiPSC-
like cells with both Oct3/4 and NANOG positive.
Conclusion: We are the fi rst to show loss of malignant prop-
erties of cancer cells in vivo with a single miRNA. This 
molecule successfully converts 293FT and hepatoma cells to 
hiPSC-like cells. Hepatoma, independent of differentiation 
degree, may be converted to hiPSC-like state by only one 
miRNA (mir-520d). Malignancy regulation by mir-520d 
appears to be caused by a conversion to normal stem cells, 
maintaining P53 upregulation and AID downregulation.
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024
METABOLIC SYNDROME AND HEPATIC 
RESECTION: IMPROVING OUTCOME
S. Agrawal1 and C. Daruwala2
1Indraprastha Apollo Hospital, New Delhi, India; 2Temple 
University Hospital, Philadelphia, USA
Indraprastha Apollo Hospital, Hepatobiliary and 
Pancreatic Surgery, Sarita Vihar 76 New Delhi, India
Introduction: MetS and its hepatic manifestation nonalco-
holic fatty liver disease (NAFLD) are associated with an 
increased operative mortality despite signifi cant improve-
ment in perioperative outcome after hepatic resection. A 
review of the perioperative risk associated with hepatic 
resection in patients with metabolic syndrome (MetS) and 
identifi cation of measures for the improvement of cardiomet-
abolic disturbances and liver-related mortality.
Methods: A review of the English literature on MetS, liver 
resection and steatosis was performed from 1980–2011 using 
the MEDLINE and PubMed databases.
Results: MetS is a predictor of NAFLD and patients with 
multiple metabolic risk factors are at risk for harboring non-
alcoholic steatohepatitis (NASH) predictive of operative 
and cardiovascular mortality. Preoperative diagnosis of 
unsuspected NASH with the selective use of liver biopsy 
can modify the operative strategy by limiting the extent 
of hepatic resection, avoiding or altering preoperative 
chemotherapy regimen and utilization of portal vein 
embolization.
Results: Thiazolidinediones are therapeutic for MetS and 
NASH and Vitamin E for active NASH however, their utility 
in improving perioperative outcome after hepatic resection 
is unknown. Short-term regimen for weight loss improves 
postoperative patient and liver-related outcomes in patients 
with >30% steatosis. Cardiovascular disease associated 
with MetS or NAFLD should be managed aggressively. 
Perioperative measures to minimize thrombotic events and 
acute renal injury secondary to the proinfl ammatory, pro-
thrombotic state of MetS may further improve outcome.
Conclusion: Potential candidates for hepatic resection 
should be screened for MetS as the preoperative identifi ca-
tion of NASH, short-term treatment of signifi cant steatosis, 
cardiovascular risk assessment and optimization of each 
component of MetS may improve perioperative outcome in 
this high risk subset of patients.
039
APPLICATION OF REMAXOL INCLUDED 
INTO COMPLEX PRE-AND 
POSTOPERATIVE TREATMENT OF 
PATIENTS WITH HEPATIC CIRRHOSIS
M. Zarivchatskiy, E. Kamenskikh, I. Mugatarov 
and G. Bogatireva
Academy of Medicine named after Academician E.A. 
Wagner, Petropavlovskaya Street, Perm, Russia
Introduction: Complex treatment of hepatic cirrhosis 
(HC) includes pathogenetic therapy based on hepatocyte-
directed drugs. Succinate-containing antioxidant Remaxol 
(‘POLYSAN’ Ltd, St. Petersburg) belongs to them. It is the 
fi rst hepatoprotector stimulating endogenous ademethionine 
synthesis. An active component of Remaxol – siccine acid 
– is a universal energy supplying intermediate. Riboxine, 
nicotinamide, methionine, sodium, magnesium and potas-
sium chlorides are the components of Remaxol.
Methods: Estimation of hepatoprotector and antioxidant 
effi ciency of Remaxol in HC patients complicated by the 
threat or completed esophageal varicose veins (EVV) hemor-
rhage was carried out. The volume of observations was 40 
persons divided into 2 groups (the main and comparison 
groups), 20 persons each. There were 17 women and 23 men 
among the patients. The mean age was 52.4. It was a blind 
placebo-controlled study. Remaxol was used during the 
course of 8 days, 400 ml once a day, intravenously, dropwise 
with the rate of 40–60 drop/min. Effi ciency of therapy was 
assessed by dynamics of clinical manifestations, activity of 
biochemical indicated cytolytic hepatic enzymes and 
cholestasis markers as well as activity of antioxidant status.
Results: Remaxol therapy resulted in statistically signifi cant 
reduction of the manifestation rate of asthenic and dyspeptic 
syndromes. In the main group, statistically signifi cant 
decrease in the total and conjugated bilirubin, AlT, AsT, GGT 
and alkaline phosphatase indices was detected. The initial 
assessment of activity of antioxidant status by the catalase 
level revealed its inhibition to 44.03 ± 14.32 mcat/l in the 
main group and 41.85 ± 7.59 mcat/l in the comparison group. 
After completing the therapy, more marked positive dynam-
ics of the catalase activity in the Remaxol group – to 80.78 
± 43.67 mcat/l versus the comparison group – 49.56 ± 
3.51 mcat/l was fi xed.
Conclusion: Remaxol promoted reduction of the cytolysis 
and cholestasis syndromes, elevation of the antioxidant 
status that correlated with clinical improvement. Hereby, 
the blood serum enzyme reduction ratio was signifi cantly 
higher in patients taking Remaxol compared to placebo-
combined basic therapy used. Remaxol can be recom-
mended as an effective hepatoprotector included into 
complex pre-and postoperative treatment of patients with 
hepatic cirrhosis.
040
MINI-INVASIVE TECHNIQUES 
OF NONPARASITIC HEPATIC 
CYSTS TREATMENT
G. Bogatireva, M. Zarivchatskiy, K. Pankov, I. Mugatarov 
and D. Smetanin
Academy of Medicine named after Academician E.A. 
Wagner
Academy of Medicine named after Academician E.A. 
Wagner, Surgical, 26, Petropavlovskaya Street, 61499 
Perm, Russia
Introduction: Since 1996, when laparoscopic techniques 
began to be applied, mini-invasive methods of cyst treatment 
have been used at Perm Center of Surgical Pathology. Since 
1998 transcutaneous interventions under the USI control 
have been used in treatment of hepatic fl uid formations. The 
objective of the study was to work out indications and to 
assess results of nonparasitic hepatic cysts treatment using 
mini-invasive techniques – laparoscopic and puncture-
aspiration under the USI control.
Methods: Examination of 85 patients with nonparasitic 
hepatic cysts (aged 16–78) including 35 treated with 
laparoscopic technique and 50 – with transcutaneous 
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puncture-aspiration (TPA) was performed. Localization of 
cysts by segments was: I-31, II-35, III-35, IV-44, V-42, 
VI-38, VII-47, VIII-45. Wall fenestration of 6–21 cm diam-
eter cysts on the visceral and diaphragmatic surfaces of the 
liver and 96% ethanol chemical treatment were performed 
under endothracheal anaesthesia. Pipe drainage was brought 
to the cyst for 2–4 days. TPA technique was used in case of 
6–10 diameter cysts. After completing the puncture and 
administrating 96% ethanol for 4–5 minutes in the volume 
equal to ½ of the cyst aspirated content positive effect was 
revealed.
Results: The postoperative period was not complicated. No 
lethal outcomes were fi xed. The duration of hospital staying 
was 5–8 days. Results of treatment were followed up in the 
terms from 2 to 72 months; 3 relapses were noted. Cavities 
with the liquid content up to 80 ml were detected using USI; 
obliteration required single punctures and ethanol de-
epithelization. No marked complications were observed after 
the puncture except for 2 cases of pain syndrome with a 
short-term hyperthermia. Full obliteration was reached in 28 
patients, small sized cysts without a tendency to growth and 
complaints were preserved in 6 patients that permitted us to 
draw a conclusion about the achieved clinical effect.
Conclusion: Thus, while choosing the technique for treat-
ment of nonparasitic hepatic cysts preference should be 
given to mini-invasive surgery accompanied by trivial 
trauma, good nearest and long-term results, essential eco-
nomic effect.
041
APPLICATION OF ENDOSCOPIC 
LIGATION OF ESOPHAGEAL 
VARICOSE VEINS IN PATIENTS WITH 
HEPATIC CIRRHOSIS
I. Mugatarov, E. Kamenskikh, I. Mugatarov, D. Smetanin, 
V. Shchekotov, P. Barlamov and A. Vorobyeva
Academy of Medicine named after Academician E.A. 
Wagner, Perm, Russia
Academy of Medicine named after Academician E.A. 
Wagner, Surgical, 26, Petropavlovskaya Street, 61499 
Perm, Russia
Introduction: During the recent decades hepatic cirrhosis 
morbidity remains stably high and makes 30% of the total 
number of patients with chronic diffuse diseases of the liver 
treated at the specialized hospitals. In 50–85% of patients 
hepatic cirrhosis is complicated by portal hypertension mani-
fested by esophageal varicose veins (EVV) dilatation. Even 
the fi rst episode of esophageal varicose veins hemorrhage 
can lead to lethal outcome in 50–70% of cases.
Methods: The work is based on analysis of the results of 
examination and treatment of 20 hepatic cirrhosis patients 
with the syndrome of portal hypertension treated in 2004–
2010. There were 7 men and 13 women. The mean age was 
51.1. According to Child-Pugh, 3 patients were referred to 
class A, 11- to class B, 6 – to class C. The degree 2 esopha-
geal varicose veins were detected in 6 cases, the degree 3 – in 
14. Endoscopic ligation of EVV was fulfi lled using the nylon 
loops ‘Olympus’ with 5–7 loops applied for 1 course. Control 
endoscopic examination was performed in 10–14 days, then 
– 1, 3, 6, 12 months later during the fi rst year, after that – 
once in 6 months.
Results: Six patients needed additional courses of endo-
scopic ligation. In 12 months after the fi rst course of endo-
scopic ligation, no esophageal varicose veins were fi xed in 
2 patients, the degree 1 EVV – in 13, the degree 2 – in 3. 
Occurrence rate of the degree 3 EVV reduced to 10%. 
Hemorrhage relapsed in 1 patient who had not been per-
formed dynamic endoscopic monitoring. Survival rate 
among the class A and B patients (by Child-Pugh) during 
one-year follow-up was 100%; three-and fi ve-year survival 
rate was 91.0 ± 8.7% and 54.6 ± 20.6%, respectively. One-
year survival rate of the class C patients was 60.0 ± 18.2%, 
three-year – 45.0 ± 18.8%, fi ve-year – 22.5 ± 18.5%.
Conclusion: Prevention of esophageal varicose veins hem-
orrhage in hepatic cirrhosis consists in dynamic endomoni-
toring added by repeated courses of endoscopic ligation. 
Application of mini-invasive methods permits to improve the 
nearest and long-term results of curing patients with hepatic 
cirrhosis complicated by the portal hypertensive syndrome.
046
PURE LAPAROSCOPIC 
HEPATECTOMY FOR HCC PATIENTS 
WITH LIVER CIRRHOSIS
Z. Morise1, A. Sugioka2, N. Kawabe1 and J. Kawase1
1Fujita Health University School of Medicine Banbuntane-
Houtokukai Hospital, Department of Surgery; 2Fujita 
Health University School of Medicine, Department of 
Surgery
Fujita Health University School of Medicine Banbuntane-
Houtokukai Hospital, Surgery, 3-6-10 Otobashi 
Nakagawa-ku, Nagoya AICHI 454-850945485, Japan
Introduction: Not a small number of HCC patients with 
severe liver dysfunction exists who is not able to undergo 
treatment modalities (resection, ablation, TACE) due to liver 
function, tumor size and/or localization, especially after 
repeat treatments for the disease. Furthermore, not a small 
portion of patients need the repeat treatments for multicentric 
metachronous lesions occurred in chronic impaired liver. For 
those patients, ‘less invasive’ pure laparoscopic hepatectomy 
may provide a good option.
Methods: From May 2005, 23 patients with hepatocellular 
carcinoma and liver cirrhosis underwent pure laparoscopic 
hepatectomy. We examine the perioperative course of the 
patients. There were also 6 out of 23 patients had severe liver 
cirrhosis (Child-Pugh B/C and ICG R15 of 40% or above). 
These 6 patients and the other 16 patients (Child A and ICG 
R15 median: 13.4)%, excluded the patient with HCC and 
rectal carcinoma) were compared in perioperative course.
Results: Perioperative course of HCC patients with severe 
liver cirrhosis who underwent pure laparoscopic hepatec-
tomy was favorable and comparable to that of the other HCC 
patients with mild/moderate liver cirrhosis. Also, repeat pure 
laparoscopic hepatectomy for patients with liver cirrhosis 
and multicentric/metachronous HCCs was feasible and safe 
with advantage of less post-operative adhesion. Our experi-
ences suggest that pure laparoscopic hepatectomy for HCC 
patients with severe liver cirrhosis has specifi c advantage of 
minimal postoperative ascite production which leads to 
lower risk of disturbance in water/electrolyte balance and 
hypoproteinemia.
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Conclusion: The procedure minimizes destruction of the 
collateral blood/lymphatic fl ow from laparotomy and mobi-
lization, and mesenchymal injury from compression. Severe 
cirrhotic patients with tumors on the liver surface and/or 
local recurrence after repeat treatment, are the good candi-
dates for this procedure. Furthermore, repeat pure laparo-
scopic hepatectomy for patients with liver cirrhosis and 
multicentric/metachronous HCCs was feasible and safe with 
advantage of less post-operative adhesion.
063
RADIOFREQUENCY ABLATION FOR 
HEPATOCELLULAR CANCER – 
CURRENT INDICATIONS AND 
OUTCOMES
D. Gomez1, A. De Rosa1, A. Addison1, W. K. Dunn2, 
I. J. Beckingham1 and I. C. Cameron1
1Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust, Nottingham, United Kingdom; 
2Department of Radiology, Queen’s Medical Centre, 
Nottingham University Hospitals NHS Trust, Nottingham, 
United Kingdom
Queen’s Medical Centre, Department of Hepatobiliary and 
Pancreatic Surgery, E Floor, West Block, Queen’s Medical 
Centre, Derby Road, Nottingham, NG7 2UHNG72U, 
United Kingdom
Introduction: Recent studies have demonstrated benefi cial 
results in patients with Hepatocellular cancer (HCC) follow-
ing radiofrequency ablation (RFA). The aim of the current 
study was to evaluate the clinical indications and current 
outcomes following RFA treatment in patients with HCC.
Methods: Relevant articles were reviewed from the pub-
lished literature using the Medline database. The search was 
performed using the keywords ‘hepatocellular cancer’, ‘liver 
tumour’, ‘liver resection’, ‘transplantation’ and ‘radiofre-
quency ablation’.
Results: Studies have observed 5-year survival of >50% 
following RFA in patients with early-stage, unresectable 
HCC. Childs status, age and a-FP were prognostic factors. 
Differences in patient selection, techniques employed, 
outcome measures and addition of other treatment modali-
ties, make interpretation of results diffi cult. RFA can be con-
sidered in cirrhotic, non-surgical patients with early-stage 
HCC. Short to medium term survival rates after RFA are 
similar to hepatic resection for HCC < 3 cm. For larger HCC, 
resection may provide better survival than RFA. RFA may 
be an effective treatment modality for patients with advanced 
cirrhosis and unresectable HCC awaiting transplantation, 
with 66% response rate reported.
Conclusion: RFA should be considered in patients with 
HCC < 3 cm in size who are not candidates for liver resec-
tion or transplantation, and also considered as an alternative 
treatment modality in patients with HCC < 3 cm who are 
suitable for resection. RFA can be used as a bridging therapy 
prior to transplantation.
066
LIVER METASTASES FROM 
ADRENOCORTICAL CANCER-SURGERY 
CAN HELP
B. Patel, N. O’Rourke and R. Bryant
Royal Brisbane Hospital
Royal Brisbane Hospital, Division of Surgery, Level 8, Ned 
Hanlon Building, Herston, 4006 Brisbane, Australia
Introduction: Adrenocortical carcinoma is a rare tumour 
with variable survival statistics. Long term survival after 
resection of liver metastases is occasionally reported. We 
would like to report on 4 liver resections in 3 patients with 
good medium term outcomes and one important histological 
misdiagnosis.
Methods: Case 1 – 48 year old male underwent an R0 resec-
tion of an 8 cm left adrenal primary. 8 years later a 3 cm 
lesion in segment 4B resected in a non anatomic fashion with 
clear margins. Histology suggested Focal Nodular 
Hyperplasia (FNH) 10 years later, a 12 cm PET positive 
tumour was detected in the right lobe and Laparoscopic trans 
hepatic biopsy suggested metastasis from well differentiated 
adrenocortical carcinoma, confi rmed after uneventful right 
hepatectomy.
Case 2 – 37 year old female underwent R0 resection of a 
10 cm left adrenal primary. 18 months later 3 large liver 
metastases were detected and she underwent an uneventful 
extended R0 right hepatectomy.
Case 3 – 52 year old female presented with an 18 cm 
primary left adrenal primary and a synchronous 3 cm tumor 
in Segment 6 which was observed for 3 months followed by 
posterior sectionectomy.
Results: Case 1 Histological review of the previous ‘FNH’, 
showed identical features! Alive without disease 3 months 
later.
Case 2 Well and disease free at 12 months follow up.
Case 3 Alive with nodal and lung metastasis at 30 months 
despite adjuvant Mitotane chemotherapy.
Conclusion: Long term survival is possible in some patients, 
following resection of liver metastases from adrenocortical 
cancers. The histology can be confusing and immunohisto-
chemistry is recommended.
070
ONCOLOGIC SAFETY OF 
LAPAROSCOPIC HEPATECTOMY 
VERSUS OPEN HEPATECTOMY IN 
HEPATOCELLULAR CARCINOMA
C. W. Tay1, S. K. Chang1, S. Liang2, W. W. Hlaing1, 
I. G. Shridhar1 and K. Madhavan1
1Division Of Hpb Surgery, Department Of Surgery, 
National University Health System Singapore; 2Division Of 
Biostatistic, Yoong Loo Lin School Of Medicine, National 
University Of Singapore
National University Health System Singapore, Division of 
HPB Surgery, Department of Surgery, National University 
Hospital, 1E, Kent Ridge Road, NUHS Tower Block, Level 
8, 119228 Singapore, Singapore
Introduction: Role of laparoscopic hepatectomy (LH) in 
management of hepatocellular carcinoma (HCC) remains 
controversial, mainly due to concerns rising from achieving 
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adequate oncologic clearance, technical diffi culty in large 
HCC at the posterior aspect of the liver as well as surgical 
haemostasis in cirrhotic liver. Hence, LH is often offered 
only for small, benign, peripheral lesions in non-cirrhotic 
livers.
We aim to compare oncologic outcome of LH versus open 
hepatectomy (OH) in patients who have HCC.
Methods: 30 patients who underwent LH for HCC were 
retrospectively studied. They were matched with 30 patients 
who had OH for HCC with similar age, extend of resection 
and cirrhosis status for comparison.
Patient’s basic data such as age, gender, risk factor of 
HCC, Child’s status, presence of cirrhosis were recorded. 
Oncologic data such as tumour size and location, resection 
margin, histological features, presence of recurrence, time to 
recurrence and follow up period were studied. Surgical 
approach, operative time and length of stay were also studied.
We further analyzed patients who developed recurrence in 
both groups to examine any risk factor of HCC recurrence 
in LH.
Results: 30 patients had LH and 30 patient had OH were 
compared, operating time was similar (288 vs 301 minutes, 
p = 0.15). LH patients had signifi cant short length of stay (7 
vs 11 days, p = 0.01).
Mean tumour size was similar between LH and OH (39.8 
vs 45 mm, p = 0.18). Negative resection margins were 
achieved in 97% of cases in both groups with mean resection 
margin of 9.9 mm and 8.2 mm (p = 0.24) respectively. 8 
(27%) in LH group versus 13 (43%) patients (p = 0.17) in 
OH developed HCC recurrence. Mean follow up period in 
LH and OH were 20 vs 33 months respectively. No signifi -
cant difference in tumour location in LH and OH.
No statistical signifi cance in tumour size, resection margin, 
age, gender, histology and cirrhosis status in patient who had 
HCC recurrence in both groups.
Conclusion: LH is a safe and feasible curative treatment 
option for HCC. It can be performed to remove HCC up to 
12 cm and posteriorly located tumour in cirrhotic liver. 
Oncologic margin clearance was achieved in 97% of all 
patients, recurrence rate is similar with OH group.
Larger study is recommended to further examine the onco-
logical outcomes of LH in HCC patients.
091
DIAGNOSIS OF SMALL HEPATIC 
NODULES IN CIRRHOTIC LIVER: ROLE 
OF CONTRAST-ENHANCED 
ULTRASOUND AND CONTRAST-
ENHANCED MAGNETIC RESONANCE 
IMAGING IN THE VALIDATION OF THE 
NON INVASIVE DIAGNOSTIC CRITERIA 
FOR HEPATO-CELLULAR CARCINOMA
I. Di Carlo2, F. Loria1, G. Loria3, S. Basile4, D. Randazzo5, 
L. Frosina6, A. Haghighi7 and P. Rodoni8
1Dept. of Radiology Palmi Hopsital, ASP 5 Reggio 
Calabria; 2Dept. of Surgical Sciences, University of 
Catania; 3Dept. of Radiology Palmi Hospital, ASP 5 
Reggio Calabria; 4Dept. of Radiology Palmi Hospital, ASP 
5 Reggio Calabria; 5School of Medicine University of 
Messina; 6School of Medicine University of Messina; 
7Dept. of Radiology Mendrisio Hospital, EOC Bellinzona; 
8Dept. of Radiology Mendrisio Hospital EOC Bellinzona
University of Medicine of Catania, Surgical Sciences, 
Cannizaro Hospital, via Messina 82695126 Catania, Italy
Introduction: This study prospectively evaluates the accu-
racy of contrast-enhanced ultrasound (CEUS) and contrast-
enhanced magnetic resonance imaging (CEMRI) for the 
diagnosis of small nodules detected during ultrasound sur-
veillance in cirrhotic patients.
Methods: CEUS and multiphasic CEMRI with a liver spe-
cifi c contrast agent were performed in 89 patients with cir-
rhosis without prior hepatocellular carcinoma (HCC) in 
whom baseline US detected a small (2 cm or smaller) soli-
tary nodule (mean 14 mm). Enhancement patterns were 
studied during arterial, portal and late phase. Fine-needle 
biopsy were performed in all patients.
Intense arterial uptake followed by washout in the venous/
delayed phase was registered as conclusive for HCC. Those 
nodules in which both CEUS and MRI depicted a conclusive 
pattern were classifi ed as American Association Study Liver 
Disease (AASLD) criteria positive. Nodules not displaying 
this coincidental profi le were classifi ed as AASLD criteria 
negative.
Results: 60 (67.4%) patients were diagnosed with HCC, 1 
(1.1%) was diagnosed with cholangiocarcinoma, 24 (27%) 
lesions were classifi ed as regenerative/dysplasic nodules, 3 
(3.4%) as hemangioma and 1 (1.1%) as focal nodular 
hyperplasia.
In the diagnosis of HCC sensitivity, specifi city, positive 
and negative predictive values of conclusive profi le were 
51.7%, 93.1%, 93.9% for CEUS and 61.7%, 96.6%, 97.4% 
and 54.9% for MRI respectively. Values for coincidental 
conclusive fi ndings in both techniques were 33.3%, 100%, 
100%, and 42%. The application of conclusive criteria 
reduced sensitivity and increased specifi city: CEUS accu-
rately diagnosed 31/60 HCC and CEMRI 37/60 (sensitivity: 
CEUS 51.7% CEMRI 61.7%- specifi city: CEUS 93.9%, 
CEMRI 97.4%).
Conclusion: The diagnosis of small HCC can be established 
without a positive biopsy if both CEUS and CEMRI are 
conclusive. However, sensitivity of these noninvasive crite-
ria is 33%, and as occurs with biopsy, absence of a conclu-
sive pattern does not rule out malignancy. These results 
validate the AASLD guidelines.
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LAPAROSCOPIC HEPATECTOMY FOR 
HEPATOCELLULAR CARCINOMA IN 
PATIENTS WITH LIVER CIRRHOSIS
T. Kojima, T. Niguma, T. Mimura, Y. Nishiyama, 
Y. Akazai, M. Kataoka, T. Takahata and T. Ohara
Department of Surgery, Okayama Saiseikai General 
Hospital, Okayama, Japan
Okayama Saiseikai General Hospital, Department of 
surgery, 1-17-18, Ifuku-cho, Kita-ku, Okayama city, 
Okayama prefecture, 70085 Okayama, Japan
Introduction: Laparoscopic hepatectomy seemed as feasi-
ble and safe procedure, indication of this procedure has 
become widely. In this study, we evaluate the advantage of 
laparoscopic hepatectomy for hepatocellular carcinoma in 
patients with cirrhosis.
Methods: From September 2008 to September 2011, 23 
consecutive patients underwent laparoscopic hepatectomy. 
We compared two groups in a case matched retrospective 
analysis: one was laparoscopic hepatectomy (LH) group, and 
the other was open hepatectomy (OH) group. The selection 
criteria for both groups specifi ed small (size 5 cm or smaller) 
tumor located in the left lobe (segment I, II, III b) or periph-
eral right lobe. In all cases, indocyanine green retention rate 
at 15 minutes was over 20% and histologically proven cir-
rhosis. All patients of both groups underwent partial hepate-
ctomy. The two groups were well matched for tumor size and 
location, type of liver resection, and liver function.
Results: No patients in LH group underwent conversion to 
laparotomy. There was no mortality in both group. There was 
no signifi cant difference in operative time. Intraoperative 
blood loss (LH, 1047 ml; OH 127 ml; p = 0.05), the amount 
of perioperative transfusion of fl esh frozen plasma (LH, 0U; 
OH 9.15 U; p = 0.05), and postoperative hospital stay (LH, 
9.3 days; OH 20.8 days; p = 0.04) were signifi cantly smaller 
in LH group. There was no postoperative complication in LH 
groups, whereas fi ve patients had complication. One patient 
experienced biliary fi stula and four patients experienced 
transient postoperative ascitis. All complications were suc-
cessfully controlled with conservative treatment, but they 
required longer hospital stay.
Conclusion: We suspected that postoperative ascites of 
laparoscopic hepatectomy for hepatocellular carcinoma 
located in surface of the liver was smaller by less mobiliza-
tion and manipulation. Laparoscopic hepatectomy may be 
considered as a safe procedure even for cirrhotic patients 
whose liver function is poor, and this procedure offers a 
better postoperative course, shorter hospital stay, and lower 
cost than traditional approach.
126
RADIOFREQUENCY ABLATION FOR 
PRIMARY LIVER CANCER. 
LONG-TERM RESULTS
D. Ionkin, V. Vishnevsky, M. Efanov, O. Zhavoronkova, 
O. Melechina, A. Shurakova and A. Zhao
A.V. Vishnevsky Institute of Surgery, General Surgery, B. 
Serpuhovskaya 2711799 Moscow, Russia
Introduction: Aim: patients with primary liver cancer treat-
ment improvement.
RFA indications: 1) Residual/recurrent tumor after RFA or 
operation; 2) General contraindications for liver resection 
(heavy somatic condition, coagulopathy etc.); 3) Liver mal-
functioning (liver cirrhosis ‘B’ and ‘C’ (by Child-Pugh), 
chemotherapy effects, liver steatosis etc.).
Methods: From 2002 to 2011 a total of 19 patients with 
primary liver cancer underwent ultrasound-guided radiofre-
quency Ablation (RFA). The group of the patients included 
41 males and 56 females; age – 51.6 years (varying from 27 
to 83 years). Of them, 6 patients (31.6%) were in stage II 
(UICC Systems) and 13 (68.4%) in stages III–IV. 13 patients 
(68.4%) had Child-Pugh class B and 6 (31.6%)-class C, 
respectively. 31 RFA were performed in total, among them 
25 percutaneous RFA (PcRFA) and 6 RFA with laparotomy. 
Mean session number (PcRFA) was 1.4 (from 1 to 4). 
Effi ciency control was performed with US, MRI from fi rst 
24 hours after procedure, from 3, 5 days (US) and then from 
1, 3, 6 (MRI), 12 (MRI), 18, 24 (MRI) months.
Results: The ablation success rate after the fi rst RFA based 
on the MRI were 90.3 (28/31). Local tumor recurrence was 
found in 7 (22.5%) patients. 3 patients died (15.8%) within 
fi rst month after the procedure due to liver failure followed 
by multi-organ failure. The occurrence rate of major compli-
cations was 12.9% (4/310. Post-RFA 1-, 2-, 3-, 4- and 5-years 
survival rates were 73.7%; 47.4%; 36.8%; 26.3%; 10.5% 
relatively. Mediana survival- 26 months.
Conclusion: Patients with primary liver cancer treated with 
RFA, as well as operatively develop different results, depend-
ing on the following prognostic factors: metastases identifi -
cation period, localization, liver malfunctioning, tumor 
nodes number and size. Patients are to by dynamically moni-
tored. RFA, especially PcRFA, as a minimally invasive local 
treatment, has become an effective and relatively safe alter-
native for the patients with primary liver cancer.
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CLINICOPATHOLOGIC 
CHARACTERISTICS OF 
RECURRENT HEPATOCELLULAR 
CARCINOMA TREATED WITH 
RADIOFREQUENCY ABLATION
N. Yamamoto, K. Okano, J. Uemura and Y. Suzuki
Department of Gastroenterological Surgery, Faculty of 
Medicine, Kagawa University, Ikenobe, Kita-gun, Miki-
cho, Kagawa, Japan
Introduction: Radiofrequency ablation (RFA) is an effec-
tive local ablation therapy and one of the standard therapies 
for small hepatocellular carcinoma (HCC). However, there 
are some cases presenting a specifi c recurrence pattern such 
as rapid tumor growth with aggressive vascular involvement, 
a lymph node metastases and peritoneal dissemination. 
Therefore, we examined the tumor characteristics and bio-
logical behavior of the HCC after RFA therapy.
Methods: From August 2004 to May 2010, X patients 
received RFA using internally cooled electrode as the sole 
treatment modality for HCC in our hospital. A total of 24 
recurrence lesions in 21 patients after RFA received surgical 
therapy during the same period. The tumor recurrence pattern 
and histopathological characteristics were analyzed. The bio-
logical behavior including immunohistochemical expression 
of Ki-67 Labeling Index in 18 recurrent nodules of 15 
patients after RFA (RFA group) were examined and com-
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pared with that of 118 resected lesions without RFA (Control 
group).
Results: Radical surgical resections were attempt for intra-
hepatic local recurrence in 15 patients (18 nodules), perito-
neal dissemination in 4, lymph node metastasis in 3 and 
adrenal metastasis in 2 patients. Both local and extra-hepatic 
recurrences were found in 2 patients. Ten of 24 lesions (37%) 
were histologically diagnosed as poorly differentiated or sar-
comatous HCC. Tumor diameter was signifi cantly (p = 
0.043) small in RFA group (26 ± 3 mm) compared with 
control group (44 ± 3 mm). Ki-67LI was signifi cantly (p = 
0.002) high in RFA group (34 ± 4%) compared with control 
group (17 ± 1%). Portal involvement was signifi cantly high 
(p = 0.010) in RFA group (72%) compared with control 
group (38%).
Conclusion: The recurrence tumor after RFA has character-
istics of accelerated cell proliferation and aggressive vascu-
lar invasiveness in the stage of the tumor with small 
diameter.
154
SHORT AND LONG-TERM 
OUTCOMES OF SURGICAL 
RESECTION FOR RECURRENT 
HEPATOCELLULAR CARCINOMA
J. Y. Teo
Singapore General Hospital, General Surgery, 15 Evelyn 
Road, Singapore
Introduction: Hepatocellular carcinoma (HCC) is the fi fth 
most common neoplasm worldwide with an incidence of 
500000 to 1000000 new cases annually. Primary resection is 
frequently the treatment of choice due to shortage of organs 
for liver transplant. However, there is a high recurrence rate 
after primary resection. Salvage transplant is the preferred 
treatment for these recurrences, but the problem of scarce 
donor organs remains in many countries. Hence, re-
resections are frequently performed.
Methods: All patients undergoing re-resection for hepato-
cellular carcinoma (HCC) between January 1 2000–
September 30 2011 at the Singapore General Hospital were 
identifi ed from a prospectively-kept database. Patients 
undergoing liver re-resection for other pathologies, patients 
who underwent the original surgery at a different institution, 
patients whose HCC was fi rst treated with radiofrequency 
ablation (RFA) or any method other than surgery, and patients 
undergoing resection for isolated non-hepatic recurrences 
were all excluded from analysis. Data on recurrence and 
survival was collected and analysed using SPPS v. 17.0. 
Survival curves were analysed using the Kaplan-Meier 
method.
Results: 50 patients undergoing re-resection for recurrent 
HCC were identifi ed from our database. The mean age at 
re-resection was 62 years (range 40–78 years). The mean 
time to fi rst recurrence was 34 months (sd ± 27 months). All 
re-resections were minor hepatic resections (less than 3 seg-
ments). 30 patients (60%) had further recurrences, at a mean 
of 15 months after re-resection (sd ± 17 months). All 30 had 
an average of 2 further interventions, including resection, 
RFA, TACE and transplant. The mean overall survival after 
re-resection was 38.8 months (sd ± 26.9 months), with 25 
patients alive with no evidence of recurrence at the time of 
data analysis. The mean survival of these patients was 44.3 
months (sd ± 27.7 months) post re-resection.
Conclusion: Re-resection of recurrent HCC can confer 
good overall and disease-free survival in a selected cohort of 
patients. The implication is that patients with recurrent HCC 
can be adequately treated with re-resection if they are suit-
able candidates, as the shortage of available donor organs 
precludes transplant in many of these cases.
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FEATURES OF TECHNICS OF 
EXTENSIVE RESECTIONS OF THE 
LIVER AT LOCALLY PREVAILING 
FORMS OF MALIGNANT TUMORS
S. Akhmedov1, A. Dustov1, N. Rasulov2, A. Radzhabov2, 
B. Safarov1 and Z. Tabarov1
1Institute of Gastroenterology of Ministry of Health, 
Dushanbe, Tajikistan; 2City Urgent Hospital of Dushanbe, 
Dushanbe, Tajikistan
The Institute of Gastroenterology of the Ministry of Health 
of Tajikistan, Surgery Department, 2, Mayakovsky str. 
73406 Dushanbe, Tajikistan
Introduction: Marked increase in the number of patients 
with extensive and complicated forms of malignant tumors 
of the liver and gall bladder, requiring urgent solutions. 
Rupture of the tumor, cancerous peritonitis and bleeding, are 
directly dependent on the amount and adequacy of surgical 
intervention.
Methods: Experience of 23 extensive resections of a liver 
(RL), urgently performed in the department of Lever’s and 
Pancreas’s Surgery of City Urgent Hospital, till 2010 is pre-
sented. The age of patients varied from 19 to 58; men – 15, 
women – 8. The strategy of surgical treatment of primary 
complicated and disseminated cancer of liver and gallbladder 
with invasion into the liver, included maximizing gentle 
and bloodless removal of the pathological focus, within 
and extraorganic dissemination of tumor cells, a reliable and 
defi nitive hemo- and cholestasis. Husking the big sizes meta-
static tumors were conducted in 2 cases; an anatomic resec-
tion of a liver with thermal handling of a surface of a cut by 
pneumothermocoagulation – 2 patients.
Results: By the end of operation RHHE and ExtRHHE from 
uncontrollable bleeding and air embolism 4 patients have 
died. In the early postoperative period (for 2–8 days) 2 
patients have died from acute liver failure. The intraoperative 
lethality has made 17.3%, postoperative – 8.7%, the general 
– 26%. Within a year after operation are live 12 (70.5%) 
patients, 2 years – 7 (41.0%), more 3 years – 1 (5.8%).
Conclusion: The differentiated surgical tactics directed on 
the maximum removal of a site of disrupted tumor, adequate 
haemo- and cholestasis; active drainage of residual cavity are 
defensible and allow to improve quality of life at patients 
with local – extended and generalized form of cancer of the 
liver and gallbladder.
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GADOXETIC ACID-ENHANCED 
MRI VERSUS MULTIPHASIC MDCT 
IN THE DIAGNOSIS OF 
HEPATOCELLULAR CARCINOMA
I. Di Carlo2, F. Loria1, G. Loria3, L. Frosina4, 
D. Randazzo5, S. Basile6, A. Haghighi7 and P. Rodoni8
1Dept. of Radiology Palmi Hospital, ASP 5 Reggio 
Calabria; 2Dept. of Seurgical Sceinces, University of 
Catania; 3Dept. of Radiology Palmi Hospital, ASP 5 
Reggio calabria; 4School of Medicina, University of 
Messina; 5School of Medicine University of Messina; 
6Dept. of Radiology Palmi Hospital, ASP 5 Reggio 
Calabria; 7Dept. of Radiology Mendrisio Hospital, EOC 
Bellinzona; 8Dept. of Radiology Mendrisio Hospital, EOC 
Bellinzona
Cannizzaro Hospital-University of Catania, Surgical 
Sciences, via Messina 82695126 Catania, Italy
Introduction: Magnetic resonance imaging (MRI) with 
liver specifi c contrast-agents has been found to have 
diagnostic accuracy in the detection of hepatocellular carci-
noma (HCC) similar to that of multi-detector computed-
tomography (MDCT). This study compared the diagnostic 
performance of gadoxetic acid-enhanced MRI and mul-
tiphasic MDCT in the diagnosis of HCC.
Methods: Sixty-two consecutively registered patients with 
83 HCCs underwent triple-phase (arterial, portal and late) 
MDCT and gadoxetic acid-enhanced 1.5 T MRI. The diag-
nosis was confi rmed by surgical resection, biopsy or foolow-
up. Three observers independently and randomly reviewed 
the MR and CT images on a tumor-by-tumor basis. The 
diagnostic accuracy of these techniques in the diagnosis of 
HCC was assessed with alternative free response receiver 
operating characteristic (ROC) analysis. Sensitivity, positive 
and negative predictive values, and sensitivity according to 
tumor size were evaluated.
Results: For each observer, the areas under the ROC curve 
were 0.971, 0.959 and 0.967 for MRI and 0.947, 0.950 and 
0.943 for MDCT. The differences were not statistically sig-
nifi cant between the two techniques for each observer (p > 
0.05). The differences in sensitivity and positive and nega-
tive predictive values between the two techniques for 
each observer were not statistically signifi cant (p > 0.05). 
Among 10 HCCs 1 cm in diameter or smaller, each of 
the observers detected seven tumors with MRI; with MDCT, 
one observer detected fi ve, one observer detected four and 
one observer detected three HCCs with no statistically sig-
nifi cant difference (p > 0.05).
Conclusion: Multiphasic gadoxetic acid-enhanced MRI and 
MDCT have similar diagnostic performance in the diagnosis 
of HCC, but MRI may be better than MDCT in the detection 
of HCC 1 cm in diameter or smaller.
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TRIPLE POSITIVE TUMOR MARKERS 
FOR HEPATOCELLULAR CARCINOMA 
ARE USEFUL PREDICTORS OF A 
POOR SURVIVAL
M. Ueno, S. Kiriyama, S. Hayami, M. Tani, M. Kawai, 
S. Hirono and H. Yamaue
Second Department of Surgery, Wakayama Medical 
University
Wakayama Medical University, Second Department of 
Surgery, 811-1 Kimiidera, 64185 Wakayama City, Japan
Introduction: In Hepatocellular carcinoma (HCC), alpha-
fetoprotein (AFP) is used as a tumor marker in the world and 
lens culinaris agglutinin-reactive fraction of AFP (AFP-L3) 
and des-gamma-carboxy prothrombin (DCP) are also clini-
cally used in Japan. Recently, a tumor marker was reported 
to be able to predict cancer malignancy. The aim of this study 
was to investigate the infl uence of the expression pattern of 
these 3 tumor markers on the prognosis and clinicopathologi-
cal parameters of HCC.
Methods: This retrospective study analyzed 185 patients 
who underwent hepatectomy for HCC. AFP, AFP-L3, 
and DCP were measured at the time of preoperative 
examinations.
Tumor markers that were higher than the upper normal 
range were defi ned as positive markers. Tumors were classi-
fi ed according to the number of positive tumor markers and 
categorized as triple negative, single positive, double posi-
tive or triple positive HCC. The relations between clinical or 
pathological parameters and expression patterns of 3 tumor 
markers were statistically analyzed. Cox proportional hazards 
regression analyses were performed to estimate risk factors 
for recurrence and survival.
Results: Seventy fi ve patients were single positive, 47 
patients were double positive, 39 patients were triple positive 
and 24 patients were triple negative. From clinical parame-
ters, a tumor size larger than 5 cm, the presence of macro-
vascular invasion, and anatomical liver resection were 
related to the expression patterns of 3 tumor markers. 
Multivariate prognostic analyses revealed independent risk 
factors for recurrence or survival to be the Child-Pugh score, 
the presence of multiple tumors, and triple positive tumor 
marker expression. From pathological fi ndings, micro-
vascular invasion and an Edmondson-Steiner classifi cation 
of III or IV were related to the expression patterns of 3 tumor 
markers.
Conclusion: Triple positive tumor markers for HCC showed 
poor prognosis and invasive characteristics in pathological 
fi ndings. Measuring these three tumor markers for HCC; 
AFP, AFP-L3, DCP would be useful for predicting the degree 
of HCC malignancy.
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EVALUATION OF A NOVEL 
BIOCERAMIC DRUG DELIVERY 
SYSTEM FOR TREATING 
HEPATOCELLULAR CARCINOMA 
(HCC) IN VIVO
K. Simo1, J. Swet1, H. Pacheco2, D. Sindram1, D. Iannitti1, 
A. El-Ghannam2, I. McKillop1
1Department of General Surgery, Carolinas Medical 
Center, Charlotte, NC 28203; 2Department of Mechanical 
Engineering, UNC at Charlotte, Charlotte NC 28223
Carolinas Medical Center, General Surgery Research and 
HPB Surgery, 1000 Blythe Blvd, 28203 Charlotte, United 
States
Introduction: Hepatocellular carcinoma is the fi fth most 
commonly diagnosed cancer worldwide while also being 
ranked second amongst cancer related mortality. Most treat-
ment options are ineffective due to late detection and the 
average survival time remains 7–8 months. Treatment of 
HCC utilizing chemotherapeutics is often ineffective, associ-
ated with high morbidity due to renal/hepatic toxicity. This 
study sought to evaluate a silica-calcium-phosphate nano-
composite (SCPC) bioceramic as a drug delivery system.
Methods: SCPC was formulated to 32.9 mol% silica, milled 
to uniform particle size (200–450 µm), and immersed in CIS 
solution (10 mg/ml). SCPC-CIS hybrid was recovered and 
compressed to 5 × 2 mm cylinders. Characterization demon-
strated reproducible CIS release and cytotoxicity against 
cultured HCC cells. An in vivo subcutaneous rat model of 
HCC was established (H4IIEs) and animals treated with a 
cisplatin intraperitoneal (ip) injection (3 mg/Kg/day) or 
SCPC-CIS hybrids placed adjacent or within the tumors. 
Tumor growth, histology, and hepatic/renal toxicity were 
measured.
Results: Following 5 days of treatment SCPC-CIS hybrids 
signifi cantly reduced tumor growth (0.57 ± 0.23 cm3) versus 
untreated (1.70 ± 0.18 cm3). CIS-ip failed to signifi cantly 
affect tumor growth versus untreated. However, CIS-ip treat-
ment led to signifi cantly decreased body weight (14.9 ± 
0.9%), concomitant with increased ALT (168 ± 24 IU), cre-
atinine (2.15 ± 0.22 mg/dL), and BUN (135 ± 6 mg/dL) (p 
< 0.01 versus untreated). Conversely SCPC-CIS did not sig-
nifi cantly affect body weight or markers of hepatic/renal 
function. Histological analysis demonstrated signifi cantly 
increased tumor cell death (apoptotic and necrotic) in CIS-
SCPC treated versus untreated and CIS (ip) treated animals.
Conclusion: SCPC-CIS induces signifi cant HCC cell death 
and inhibits tumor progression in an in vivo model of tumor 
formation in the absence of systemic toxicity. The versatility 
of SCPC to bind a wide range of chemotherapeutics raises 
the possibility of targeted, ‘personalized’ therapy for HCC in 
the absence of systemic toxicity.
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PROLONGED CHEMOTHERAPY DO NOT 
ALTER LIVER REGENERATION AFTER 
MAJOR HEPATECTOMY FOR 
COLORECTAL LIVER METASTASIS
M. Scotté1, L. Schwarz1, D. Fuks2, L. Lacaze1, O. Suaud3, 
J. P. Lestrat3, jean M. Regimbeau2
1Digestive Surgery Department and INSERM U1073, 
Rouen University Hospital; 2Digestive Surgery Department, 
Amiens University Hospital; 3Radiology Unit, Rouen 
University Hospital
Service de Chirurgie Digestive, Hôpital Charles Nicolle, 1, 
rue de germont 76000 Rouen, France
Introduction: Extensive neoadjuvant chemotherapy for 
colorectal cancer may induce hepatic damage and increase 
morbidity after hepatectomy. The lower limit of liver remnant 
volume to ensure safe resection after chemotherapy has not 
been established, but a minimal liver remnant of 30–40% has 
been proposed. The purpose of this study was to evaluate the 
infl uence of prolonged chemotherapy on liver volume after 
major hepatectomy.
Methods: Between 2006 and 2010, 23 patients underwent, 
after preoperative chemotherapy, a major hepatectomy for 
metastases of colorectal cancer, with (n = 16) or without (n 
= 7) portal vein occlusion (PVO). Liver volumes were meas-
ured by semi-automatic method before and 4 to 6 weeks after 
PVO (Total Liver Volume (TLV), Tumour Volume (TV), and 
Future Remnant Liver Volume (FRLV), and 3 months after 
hepatectomy (Remnant Liver Volume (RLV)). The degree of 
hypertrophy were expressed by the relations ((post-PVO 
FRLV − initial FRLV)/initial FRLV) * 100 after PVO and 
((RLV − TLV)/TLV) * 100 after hepatectomy. These results 
were also compared to hypertrophy of the segment I. The 
infl uence of the duration (< or > 6 cycles) of chemotherapy 
was analyzed.
Results: The initial FRLV was 33.2 ± 5.3% and 39.6 ± 9.2% 
in the groups with and without PVO (NS). Three months 
after hepatectomy, the remaining liver was 79.3 ± 10.8% and 
91.6 ± 17.8% of initial TLV, respectively (NS). A correlation 
between FRLV and volume of segment I was found after 
surgery (p = 0.025), and 3 months after hepatectomy (p = 
0.029). An «Over regeneration» following hepatectomy was 
observed after PVO in 5 patients with a lower FRLV (27.1 
± 4.1%) (p = 0.0003). Prolonged preoperative chemotherapy 
and the type of chemotherapy did not affect hypertrophy 
induced by PVO (30.1 ± 48.8% vs. 26.7 ± 17.2%, p = 0.85), 
nor the FRL after hepatectomy (82.1 ± 12.4% vs. 85.8 ± 
18%, p = 0.61).
Conclusion: The preoperative chemotherapy does not infl u-
ence negatively liver regeneration, estimated by liver volum-
etry, 3 months after major hepatectomy, with or without OP. 
Furthermore, an additional regeneration can be observed fol-
lowing hepatectomy in patients presenting with lower hyper-
trophy after PVE. This over regeneration has to be taken into 
account in the estimation of FRLV.
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RESULT OF SURGICAL TREATMENT 
FOR PERITONEAL DISSEMINATION OF 
HEPATOCELLULAR CARCINOMA (HCC)
N. Nakamura, T. Irie, D. Ban, T. Ochiai, A. Kudo, 
S. Tanaka and S. Arii
Department of Hepato-Biliary Pancreatic Surgery, Tokyo 
Medical and Dental University
Tokyo Medical and Dental University, Department of 
Hepato-Biliary Pancreatic Surgery, 1-5-45 Yushima, 
Binkyo-ku, 113 Bunkyo-ku, Tokyo, Japan
Introduction: Even in the patients with advanced stage, 
peritoneal dissemination of HCC is rare. Ruptured HCC 
increases the risk of abdominal dissemination and the prog-
nosis is usually worse than that of non-ruptured HCC. 
Although the recent improvements of the treatment for HCC 
such as surgical operation and radiofrequency ablation are 
remarkable, proper treatment for peritoneal dissemination of 
HCC has not been established. Here, we report surgically 
treated seven cases of peritoneal dissemination.
Methods: 503 cases of HCC were treated from April, 2000 
to October, 2011 in our department of Hepato-biliary pan-
creatic surgery, Tokyo medical and dental university hospi-
tal. The seven cases (7/503; 1.4%) of peritoneal dissemination 
were treated with the surgical operation. Three of seven were 
male and others were female. The average age was 69.7 years 
old. Tumor markers were elevated in all cases. In this paper, 
we would focus on the several cases and discuss on the 
particular features of HCC with peritoneal dissemination.
Results: 6 of 7 cases had previous treatment including 2 
cases of ruptured HCC, one is disease-free and the other has 
multiple resections. Only one case has no previous treatment. 
In 6 cases except for one, there was no intrahepatic lesion at 
time of the surgical procedure for peritoneal disseminations. 
The outcome of that case with intrahepatic lesion was dead 
in two months after operation due to advancing disease. Case 
Report; A 74-year-old male diagnosed with ruptured HCC in 
the right lobe was underwent emergency TACE followed by 
hepatectomy. After initial treatment, repeat hepatectomy was 
performed during two years. In the latest operation, several 
tumors were seen near the terminal ileum and pathologically 
diagnosed as intestinal metastasis.
Conclusion: Even in cases of peritoneal dissemination, 
repeat surgical procedure is also possible and one of the 
effective strategies in case of no intrahepatic lesion. Peritoneal 
dissemination of HCC has clinical features different from 
other GI cancers in terms of slower growth. Peritoneal dis-
semination of HCC has also various characteristics even in 
our 7 cases. It’s diffi cult to be enclosed in a single category. 
Therefore, it is necessary to carefully consider the strategy 
of treatment for each case.
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HYBRID INTRAOPERATIVE US 
DIAGNOSIS FOR SMALL FOCAL LIVER 
LESIONS – AN INITIAL EXPERIENCE 
USING INTRAOPERATIVE SONAZOID 
AND ELASTOGRAPHY
Y. Inoue, K. Hasegawa, K. Omichi, T. Michiro, T. Aoki, 
Y. Sakamoto, Y. Sugawara and N. Kokudo
Hepato-Biliary-Pancreatic Surgery Division, University of 
Tokyo
University of Tokyo, Hepato-Biliary-Pancreatic Surgery 
Division, 7-3-1 Hongo, Bunkyo-ku 113, Tokyo, Japan
Introduction: Although intraoperative ultrasonography 
(IOUS) is useful for precise intraoperative diagnosis, B-mode 
IOUS sometimes fails to depict the clear image of small focal 
liver lesions. Contrast enhanced US (CEUS) and Real-time 
tissue elastography (RTE) can provide clearer contrast than 
B-mode for such lesions by visualizing vascularity and elas-
ticity of the subject. The aim of this study is to investigate 
the effi cacy of hybrid US diagnosis (HUSD) using both 
CEUS and RTE in intraoperative setting.
Methods: Between October 2010 and September 2011, 
intraoperative HUSD (CEUS with Sonazoid and RTE) was 
performed for 70 hepatocellular carcinomas (HCCs), 54 
adenocarcinomas, 19 other malignant tumors (ex. neuroen-
docrine tumor), 13 benign solid tumors (ex. hemangioma), 
and 15 liver cysts, after routine B-mode IOUS during hepa-
tectomy. RTE images were classifi ed into six types, from 
type 1 (even strain) to type 6 (no strain), according to the 
degree of strain contrast with the surrounding liver [modifi ed 
elasticity type of liver tumor (mod.ETLT)]. Then, we exam-
ined the compliance of HUSD for the pathological diagnosis 
or diagnostic imaging. We also compared the diagnostic per-
formance of HUSD with B-mode IOUS.
Results: HUSD could identify all malignant tumors which 
were preoperatively diagnosed. Moreover, HSUD detected 9 
new lesions which were not detected before. According to 
RTE images, HCCs were classifi ed as type 3 or type 4 or 
type 5, with a sensitivity of 83%, a specifi city of 60%, and 
an accuracy of 70%. Meanwhile, adenocarcinomas were 
classifi ed as type 6, with 68%, 96%, and 86%. Additionally, 
benign solid tumors were classifi ed as type 1 or type 2, with 
92%, 92%, and 94%. Sixty-seven lesions were within 1.5 cm 
in diameter. Among them, HUSD clearly depicted 13 lesions 
with obscure contour on B-mode (19%) and 6 undetectable 
lesions on B-mode (10%) successfully with suffi cient 
contrast.
Conclusion: HUSD with CEUS and RTE were useful in the 
screening and differential diagnosis of small focal liver 
lesions. IO-HUSD could assume a large role in future intra-
operative diagnosis.
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MELD SCORE AS A PROGNOSTIC 
FACTOR FOR CIRRHOTIC PATIENTS 
UNDERGOING HEPATECTOMY 
FOR HCC
O. Hegazy, A. Sallam, M. Osman and I. Marwan
National Liver Institute, Meoufi ya University HPB & Liver 
Transplantation Surgery, Zat-Elkoom, Imbaba, Giza, Egypt
Introduction: Surgical resection remains the mainstay of 
treatment, in patients with solitary HCC and good liver func-
tion. The risk of hepatic failure in a cirrhotic patient undergo-
ing hepatectomy still remains high, as a result of compromised 
function of the liver remnant. Recently, the model for end-
stage liver disease (MELD) score has been applied to deter-
mine the outcome of cirrhotic patients undergoing liver 
resection for HCC.
Methods: This is a retrospective analysis of the records of 
60 patients with HCC, who underwent hepatic resection in 
the National Liver Institute, Menoufi ya University, from 
January, 2007 to June, 2010. The analysis includes: demo-
graphic data, preoperative evaluation of the liver function 
and tumor status. The meld score was calculated. Operative 
data, data of postoperative course, complications, Hospital 
stay, Patient’s survival, and recurrence were collected.
Results: MELD score was calculated to all cases with mean 
of 7.6 (range, 6–13). Major resection was done in 11 cases 
(18.4%), while minor resection was performed in 49 cases 
(81.6%). Two cases (3.3%) died from massive perioperative 
bleeding. One case (1.6%) complicated by bile leak, 6 cases 
(10%) had Wound infection, 23 cases (38.3%) had chest 
infection, 14 cases (23.3%) developed ascites not respond to 
treatment, one case (1.6%) developed Hematemesis, 2 cases 
(3.3%) developed encephalopathy, 3 cases (5%) developed 
liver failure and died within 30 days after surgery. These 
complications were recorded in patients with meld score 
above 9. The hospital stay & incidence of recurrence were 
increased in patients with MELD more than 9.
Conclusion: MELD score can accurately predict mortality, 
morbidity and long-term survival in patients with HCC and 
cirrhosis, undergoing hepatic resection.
269
EFFICACY OF COX-2 INHIBITOR, 
MELOXICAM, FOR RECURRENT 
HEPATOCELLULAR CARCINOMA 
AFTER CURATIVE SURGERY
T. Ryu, Y. Takami, M. Tateishi, Y. Wada and H. Saitsu
Department of Hepato-Billiary-Pancreatic Surgery, 
National Hospital Organization Kyushu Medical Center
National Hospital Organization Kyushu Medical Center, 
Department of Hepato-Billiary-Pancreatic Surgery, 1-8-1 
Jigyohama, Chuo-ku, Fukuoka 810-8563, Japan
Introduction: As hepatocellular carcinoma (HCC) has a 
high rate of recurrence even after curative treatment, it is 
likely that chemopreventive agents for recurrent HCC will 
be benefi cial in improving the prognosis of HCC. Recently, 
cyclooxygenase-2 (COX-2) is found to be overexpressed in 
HCC and it is suggested that COX-2 inhibitor may offer a 
chemopreventive and therapeutic approach for HCC. We 
investigated the effects of the clinically used COX-2 inhibi-
tor, for recurrent HCC after curative treatment.
Methods: We have treated 236 patients with meloxicam 
(15 mg/day) for recurrent HCC after curative treatment in 
our institute between December 2006 and December 2010. 
Of these 162 cases that received their curative surgery, 
hepatic resection or microwave coagulo-necrotic therapy 
(MCN), for HCC in our institute, we evaluated the effects of 
meloxicam by MRI according to the RECIST version 1.1 
criteria six months after taking meloxicam and overall 
survival were retrospectively evaluated and statistically 
analyzed.
Results: Of these 162 cases, 3 cases (1.9%) have achieved 
CR, 10 cases (6.3%) have achieved PR, 49 cases (31.0%) 
have achieved SD and 96 cases (60.8%) were PD, and tumor 
control rate (CR + PR + SD) was 39.2%. The average periods 
from starting meloxicam to the retreatment for the recurrent 
HCC were 295 days in PD group and 625 days in CR + PR 
+ SD group (P < 0.0001). Of 114 cases that received their 
curative surgery for HCC in our institute after January 2004; 
overall survival rates at 3-, and 5-years were 88.7% and 
63.3% in the PD group (68 cases), whereas 95.4% and 86.8% 
respectively, in the CR + PR + SD group (46 cases). Overall 
survival tended to be better in the CR + PR + SD group than 
in the PD group (P = 0.0603).
Conclusion: Taking COX-2 inhibitor, meloxicam, for recur-
rent HCC may prolong the time to progression of recurrent 
HCC, and give the better prognosis.
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GIANT HEPATOCELLULAR CARCINOMA 
(GIANT HCC) IN NON-CIRRHOTIC 
LIVER
E. G. A. Castillo1, V. H. T. Cueva2, J. J. N. Ju3, 
C. M. Y. Paredes3, O. B. De la Cruz3, T. E. C. Palomino3 
and J. S. Umeres4
1Chairman Department of Surgery, Guillermo Almenara 
National Hospital, Lima, Peru; 2Chief Hepatobiliary 
Surgery Service, Guillermo Almenara National Hospital, 
Lima, Peru; 3Staff Hepatobiliary Surgery Service, 
Guillermo Almenara National Hospital, Lima, Peru; 
4Staff Department of Patology, Guillermo Almenara 
National Hospital, Lima, Peru
Guillermo Almenara National Hospital, EsSALUD, Av. 
Grau 800, la Victoria, Lima 13, Peru
Introduction: A patient of 31 years old, female with 3 
months of evolution, right upper quadrant pain and palpable 
mass associated with weight loss and hiporexia. On physical 
examination, weight 46 kg. Size: 1.44. No jaundice, abdomen 
with palpable mass occupying the entire abdomen. We report 
a giant hepatocellular carcinoma which was resected com-
pletely in non-cirrhotic liver. The resection of the huge tumor 
was performed because the left lobe of the liver was com-
pensatory hypertrophy and LFTs was normal.
Methods: Abdominal CT shows heterogeneous mass of 
40 cm in diameter occupying segments IV, V, VI, VII, VIII, 
with compression of right portal vein and right hepatic vein. 
Left hepatic pedicle is displaced. Performance status (Zubrod 
1), liver function tests FA: 137, ASAT: 145, ALAT: 66, 
GGTP 115, BT: 0.68, BD: 0.21, BI: 0.47, Alb: 4.51, AFP: 
1534. Viral Hepatitis HBsAg (−).
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She underwent an Extended Right Hepatectomy according 
to Brisbane Classifi cation, resecting a mass of 40 × 35 cm 
around 7 kg, remnant liver segments I, II and III hypertro-
phied. Bleeding: 1500 cc. Postoperative course stable. FA: 
158, ASAT: 20, ALAT: 17, GGTP 25, BT: 0.94, BD: 0.47, 
Alb: 2.55. Weight: 34 kg. She was discharged on day 10.
Results: Pathology: HCC moderately differentiated trabec-
ular pattern. Tumor size of 31.4 cm diameter, Weight: 
6230 g. Complete tumor capsule, tumor necrosis 40%, 
microvascular invasion present (+), no perineural invasion, 
tumor-free liver capsule, surgical margins free of neoplasia. 
Non-neoplastic liver has macrovesicular steatosis. Lymph 
nodes (−).
TAC Abdomen (30 days): hypertrophy of segments II and 
III, no evidence of disease persistence. AFP: 15, 3. Patient 
presents with malnutrition and hypoalbuminemia and ascites 
in treatment. Doppler ultrasound: permeable hepatic vein, 
portal vein left spontaneous fl ow velocity of 20 cm/sec. 
Hepatic artery with fl ow preserved. Hypertrophied left lobe 
associated with steatosis.
Conclusion: In Peru, there is a proportion of young patients 
with giant single tumor with non-cirrhotic liver, may be 
secondary to infection with hepatitis B virus, which exceeds 
all known criteria or scores for HCC. They are tributaries of 
surgical treatment for preserved liver function and their man-
agement has an adequate post-treatment survival. Surgical 
experience is required for the management of these tumors 
and decreases the chance of complications.
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DOES THE PREOPERATIVE LOCO-
REGIONAL THERAPY MAKE ANY 
DIFFERENCE IN LIVER 
TRANSPLANTATION FOR HCC 
OUTCOMES ? – 13 YEARS SINGLE 
CENTRE EXPERIENCE
M. Kocik1, M. Adamec1, L. Janousek1, M. Kucera1, 
P. Trunecka2 and M. Oliverius1
1Transplant Surgery Department, Institute for Clinical and 
Experimental Medicine, Prague, Czech Republic; 
2Department of Hepatogastroenterology, Institute for 
Clinical and Experimental Medicine, Prague, Czech 
Republic
Institute for Clinical and Experimental Medicine (IKEM), 
Transplant Surgery Department, Videnska 1958/914021 
Prague 4, Czech Republic
Introduction: Although a favorable impact of preoperative 
loco-regional therapy on outcome after liver transplantation 
(LTx) for HCC has not been proven, number of patients listed 
for LTx receive such treatment to stabilize or downstage the 
disease. The aim of our study is to compare outcomes fol-
lowing pretransplant tumor ablation versus preoperatively 
untreated patients.
Methods: From May 1998 to March 2011 a total number of 
77 patients underwent LTx for HCC. Some 52 of those were 
diagnosed HCC before listing and another 25 patients were 
diagnosed with incidental HCC from explanted livers. Loco-
regional procedures were TACE, RFA or percutaneous 
ethanol injection and patients were listed for LTx without a 
waiting period to assess tumor progression. All patients were 
retrospectively analyzed for tumor status within Milan and 
UCSF criteria, time on the waiting list and overall (OS) and 
disease free (DFS) survivals. Patients were divided in the 
three groups : Ablated prior to LTx, untreated prior to LTx 
and patients with HCC diagnosed from explanted livers. 
Outcomes of the groups were compared.
Results: 1-year, 3-year and 5-year OS and DFS for the 
whole cohort of patients were 85.6%, 74.6%, 68.7% and 
83.0%, 71.7%, 62.3% resp. The difference in 5-year OS and 
DFS in the three groups of patients was not statistically 
signifi cant (p = 0.28 and p = 0.24). Median times on the 
waiting list for the three groups were 71.5 days (range 
3–539), 52.5 days (range 2–410) and 80 days (range 7–413) 
and the difference was not statistically signifi cant (p = 0.86). 
5-year OS and DFS for patients within Milan criteria were 
77.6% and 72.2% and the difference between treated and 
untreated groups (p = 0.09 and p = 0.36) were not statistically 
signifi cant. Similar results were obtained in patients within 
UCSF criteria (72.8% and 67.6%, p = 0.18 and 0.45).
Conclusion: Our data show no statistically signifi cant dif-
ference in survival of patients after LTx for HCC who had 
loco-regional treatment prior to LTx compared to patients not 
treated before LTx and patients with incidental HCC in 
explanted livers. Similar results were obtained when patients 
outside Milan or UCSF criteria were excluded. Based on our 
data we conclude that in the setting of relatively short waiting 
time (3 months) loco-regional therapy does not bring addi-
tional benefi t for patients.
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A CASE OF SOLITARY MEDIASTINAL 
METASTASIS FROM HEPATOCELLULAR 
CARCINOMA TREATED BY VIDEO-
ASSISTED THORACIC SURGERY
K. Suzumura, T. Hirano, Y. Iimuro, N. Kuroda, T. Okada, 
Y. Asano and J. Fujimoto
Department of Surgery, Hyogo College of Medicine, 
Hyogo, Japan
Hyogo College of Medicine, Department of Surgery, 1-1 
Mukogawa Nishinomiya, 663 Hyogo, Japan
Introduction: Solitary mediastinal metastasis from hepato-
cellular carcinoma (HCC) are extremely rare. We report a 
case of solitary mediastinal metastasis from HCC treated by 
video-assisted thoracic surgery (VATS).
Methods: A 75-year-old man who has undergone hepatic 
resection and transcatheter arterial embolization (TAE) for 
HCC. His protein induced by vitamin K antagonist (PIVKA-
2) level was found to be elevated. Computed tomography 
showed a tumor 2 cm in diameter at the mediastinum. 
18F-fl uorodeoxy-glucose positron emission tomography 
showed slightly uptake in the tumor. VATS was performed. 
The histopathological diagnosis was metastatic hepatocel-
lular carcinoma in the lymph nodes.
Results: Postoperative course was uneventful, with a post-
operative hospital stay of 6 days. There have been no recur-
rence as of 3 months after surgery.
Conclusion: VATS is a minimally invasive and useful 
method for solitary mediastinal metastasis from HCC.
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EXPRESSION PROFILE OF MICRORNA 
200 FAMILY IN HEPATOCELLULAR 
CARCINOMA WITH BILE DUCT TUMOR 
THROMBUS: WHY DO HEPATOMA 
CELLS RUN?
T.-S. Yeh1 and T.-C. Chen2
1Department of Surgery, Chang Gung Memorial Hospital 
Chang Gung University, Taoyuan, Taiwan; 2Department of 
Pahtology, Chang Gung Memorial Hospital Chang Gung 
University, Taoyuan, Taiwan
Chang Gung Memorial Hospital, Chang Gung University, 
Department of General Surgery, 5 Fu-Hsing Street, 
Kwei-Shan Shiang, 333 Taoyuan, Taiwan
Introduction: The issue of hepatocellular carcinoma with 
bile duct tumor thrombi (HCC-BDTT) is clinically challeng-
ing and associated with a dismal prognosis. Most investiga-
tors emphasized preoperative diagnosis and surgical 
management; whereas the in-depth molecular exploration of 
HCC-BDTT is lacking. We herein presented an unique 
expression profi le of miR200 family of HCC-BDTT, as well 
to propose a potential management strategy.
Methods: Thirty patient with HCC-BDTT and 100 patients 
with conventional HCC (cHCC) undergone intended cura-
tive hepatectomy were retrospectively recruited. Their cor-
responding formalin-fi xed paraffi n-embedded (PPFE) 
surgical specimens were used. Five hepatoma cell lines 
(Hu7, Mahlavu, HepG2, SK-HEP-1 and Hep3B) were used 
for in vitro study.
Results: The expression of miR200c and 141 of HCC-
BDTT detected by quantitative real-time PCR was signifi -
cantly lower compared with that of cHCC; whereas the 
expression of miR200a, 200b and 429 in both groups was 
similar. The expression of membranous E-cadherin of HCC-
BDTT detected by immunohistochemistry was decreased 
compared with that of cHCC; whereas the expression of 
ZEB1 and TGFβRII of HCC-BDTT was increased compared 
with those of cHCC. Both proliferation and invasion capacity 
of Mahlavu and SK-HEP-1 were attenuated by treatment of 
pre-miR200b, 200c or 141. Meanwhile, ZEB1 expresson of 
pre-miR-treated hepatoma cells was decreased, in contrast 
E-cadherin expression of pre-miR-treated hepatoma cells 
was increased.
Conclusion: The increased proliferative and invasive phe-
notypes of HCC-BDTT might be contributed to specifi c 
down-regulation of miR200c and 141, which in turn down-
regulates E-cadherin through modulation of ZEB1. miR200 
family emerged as a new target of molecular management 
modality.
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MAY TRANSIENT ELASTOGRAPHY 
(FIBROSCAN®) HAVE A ROLE IN 
DECISION-MAKING OF 
HEPATOCELLULAR CARCINOMA?
A. Pesce
A.O.U. Policlinico-Vittorio Emanuele, Surgical Sciences, 
Organ Transplantation and Advanced Technologies, Via 
Plebiscito, 62895100 Catania, Italy
Introduction: Portal hypertension has been reported as a 
negative prognostic factor and a relative contraindication to 
liver resection. The aim of this study is to consider a possible 
role of fi brosis evaluation by transient elastography 
(Fibroscan®) and its correlation with portal hypertension in 
cirrhotic patients and to consider the use of this technique in 
planning therapeutic options in patients with hepatocellular 
carcinoma (HCC).
Methods: In this study 77 patients with cirrhosis, 42 of 
whom with HCC, were enrolled between 2009–2011. The 
group comprised 46 males and 31 females with a mean age 
of 65.2 years. The main etiology was HCV-related cirrhosis 
(66.2%). Liver function was assessed according to the Child-
Pugh classifi cation. In all patients liver stiffness measure-
ment (LSM) was performed using Fibroscan®. The presence 
of portal hypertension was indirectly defi ned as (1) esopha-
geal varices detectable at endoscopy or (2) splenomegaly 
(increased diameter of the spleen ≥12 cm) or (3) platelet 
count of < 100.000/mm3.
Results: The mean value of liver stiffness in all patients was 
27.9 kPa. Thirty-seven patients (48%) presented portal 
hypertension, while in 40 patients (52%) no portal hyperten-
sion was found. The mean value of liver stiffness in HCC 
patients with portal hypertension was 33.4 kPa versus 
23.2 kPa in patients without portal hypertension (p-value < 
0.04). Liver stiffness measurement was used to implement 
BCLC algorithm in decision-making to treatment.
Conclusion: Conclusions. The evaluation of liver fi brosis 
by transient elastography may be useful in the follow-up of 
cirrhotic patients and direct correlation with portal hyperten-
sion may aid in the evaluation of surgical risk for patients 
with HCC and/or in the choice of alternative therapies.
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THE RESULTS OF LAPAROSCOPIC 
LIVER RESECTION IN 25 PATIENTS
K.-ichiro Ishii, H. Tajima, H. Kamata, H. Katagiri, 
Y. Kumamoto and M. Watanabe
Department of Surgery, Kitasato Univ, Kanagawa, Japan
Kitasato Univ, Surgery 2-1-1 Asamizodai, Sagamihara city, 
Kanagawa, Japan
Introduction: A laparoscopic approach to hepatic disease is 
increasingly performed although its ultimate benefi t is yet 
to be confi rmed. Laparoscopic hepatectomy is gradually 
gaining acceptance as an alternative to open resection in 
selected patients. The aim of this study is to report our initial 
institution experience with laparoscopic hepatectomy.
Methods: We performed 25 hepatectomies by the laparo-
scopic approach. These 25 patients were included in the 
study with varyingly pre-operative diagnosis such as hepa-
tocellular carcinoma (16 patients), hemangioma (2 patients), 
metastatic liver tumor (3 patients), focal nodular hyperplasia 
(2 patient) and hemangiomyolipoma (1 patient). The median 
age was 61.9 years (21–79) with a female to male ratio of 
12:13.
Median number (1) and maximum diameter (38 mm 
(10–100 mm)) were comparable in patients undergoing lapar-
oscopic liver resection. Nineteen left lateral segmentectomy, 
5 local resection and one right lobectomy were performed.
Results: Median intraoperative blood loss was 223 (10–
1950) ml. Median operation time was 180 (67–445) minutes. 
Of the 25 patients, two were converted to an open procedure 
due to an uncertain adhesion and inadequate exposure.
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The length of stay was 9.3 days (3–16). These were no 
morbidities and no mortalities. Of the patients that success-
fully underwent the procedure laparoscopically, and these 
were no morbidities. With a follow up, 22 patients with a 
diagnosis of malignancy have 3 patients of recurrent disease. 
These 3 patients have no local recurrent.
In lateral segmentectomy the amount of bleeding and post 
operative stay in laparoscopic surgery group was signifi -
cantly improved compared with those in open surgery group.
Conclusion: A minimally invasive approach to hepatic 
disease is safe and technically feasible with acceptable 
morbidity.
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COMPARISON OF CONTRAST-
ENHANCED ULTRASONOGRAPHY 
USING BY SONAZOID AND 
HISTPATHOLOGICAL EXAMINATION IN 
HEPATOCELLULAR CARCINOMA
K. Fukuyo, M. Yasunaga, G. Akasu, H. Sakai and 
H. Kinoshita
Department of Surgery, Kurume University School of 
Medicine, Kurume, Japan
Kurume University School of Medicine, Department of 
Surgery, 67 Asahi-machi, Kurume-shi, Fukuoka 83000 
Kurume, Japan
Introduction: We investigated the correlation with Sonazoid 
contrast-enhanced ultrasonography (Sonazoid-CEUS) image 
and histpathological examination in hepatocellular carci-
noma (HCC).
Methods: The subject were 36 HCC nodules less than 3 cm 
which were performed by Sonazoid-CEUS before the opera-
tion. The number of muscular arteries which were immunos-
tained in CD34 and alpha-SMA compared early vascular 
phase image. And the number of kupffer cells which were 
immunostained in CD68 compared kupffer phase image.
Results: In early vascular phase of Sonazoid-CEUS, the 
degree of contrast: (−)2/36, (±)10/36, (+)14/36, (++)10/36. 
Contrasted 34 cases diffusely accepted all the interposition 
of a kind sinusoid cavity and muscular arteries in histpatho-
logical examination. In kupffer phase of Sonazoid-CEUS, 
the degree of perfusion defect: (−)0/36, (±)5/36, (+)31/36. 
All cases diffusely decrease kupffer cells in histpathological 
examination.
Conclusion: Sonazoid-CEUS image refl ected the develop-
ment of the muscular arteries and decrement of Kupffer cells 
objectively.
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HCC MICRO-WAVES ABLATION IN 
CRITICAL PATIENTS WITH HIGH 
DIAMETER LESIONS
A. Percivale1, G. Griseri2, M. Malerba3 and R. Pellicci1
1Department of Surgery, Pietra Ligure, Italia; 2Department 
of Surgery, Savona, Italia; 3University of Study, Genova, 
Italia
Santa Corona Hospital, Department of Surgery, Via XXV 
Aprile 3817011, Pietra Ligure, Savona, Italia
Introduction: Focal ablation techniques such radio fre-
quency are daily used for patients with critical morbidity. 
This technique has limitations in terms of treatment of 
lesions greater than 3 cm, located close to blood vessels, or 
greater than 3 cm where treatment time becomes longer with 
necessity of selective clamping or vascular exclusion, thus 
increasing morbidity and mortality. To overcome these limi-
tations we experienced microwave ablation technique
Methods: From February 2010 6 patients were treated by 
MW, 4 males and 2 females, aged between 64 and 86 years 
with unifocal HCC with a diameter between 35 and 78 mm. 
The microwaves ablation was performed using a 22 cm 
length and 3.7 cm exposed tip Percutaneous Antenna 
(Evident TM MWA 13 Ga – Valleylab) and a MWA Generator 
(Evident MWA System – Valleylab). Microwaves ablations 
was performed in all patients: four treatment were performed 
during a laparotomic procedure and two by percutaneous 
ultrasound guidance. The two bigger lesions were treated 
with two antennas in parallel allowing a more time effi cient 
procedure and obtaining major thermal ablation.
Results: The postoperative course was uneventful with no 
major complications. All patients underwent ultrasound and 
CT contrast agents imaging within one months, three months 
and six months from procedures. Laboratory data including 
aFP dosage were collected within one months, three months 
and six months from procedures. Current follow up was 
negative for recurrence disease in 5 patients. One patients 
was re treated after one year for recurrent disease in the same 
HCC nodule.
Conclusion: MW ablation is an alternative treatment for 
primary major liver lesions even if in patient with critical 
comorbidities. Comparing with radiofrequency, we experi-
enced a direct thermal elliptical injury of about 3 cm around 
the probe, with greater intralesional temperature and greater 
speed of execution. Our data consistent with initial literature 
results confi rm the effectiveness of this technique in terms 
of complete ablation rate, safety, usefulness for patients with 
major comorbidity and necessity of pedicul clamping or vas-
cular occlusion.
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THE DYSFUNCTIONAL AREA AND 
CONGESTIVE AREA AFTER 
HEPATECTOMY WITH MAIN HEPATIC 
VEIN RESECTION
H. Mu, S. Ariizumi, Y. Kotera, Y. Takahashi, S. Katagiri, 
H. Egawa, M. Yamamoto and M. Muhan
Division of Digestive Surgery, Department of Surgery, 
Institute of Gastroenterology, Tokyo Women’s Medical 
University,  Kawada-cho, Shinjuku-ku, Tokyo, Japan
Introduction: To evaluate the function of the congestive 
area after hepatectomy with main hepatic vein (HV) 
resection.
Methods: From November 2010 until May 2011, 12 patients 
underwent hepatectomy including the main hepatic vein 
(HV). Of these, left hepatectomy (LH) with middle hepatic 
vein (MHV) was performed in 8 patients, right hepatectomy 
(RH) with MHV in 3 patients, and posterior sectionectomy 
with right HV in 1 patient. Post-hepatectomy, all patients 
underwent gadoxetic acid disodium enhanced magnetic reso-
nance imaging (EOB-MRI) within 4 weeks. The congestive 
area appeared as a hyper-intense area on T2-weighted 
images. The function of the congestive area was evaluated 
on hepatobiliary phase images. After comparison with the 
intensity of normal liver, the area with low intensity was 
defi ned as dysfunction.
Results: Ten of 12 patients showed a congestive area in the 
remnant liver on T2-weighted images, and the mean conges-
tive area was 9% of the remnant liver (range 1–14%). 
Nevertheless, all patients showed a dysfunctional area, and 
the mean dysfunctional area was 15% of the remnant liver 
(range 2–27%). In 11 of 12 patients the dysfunctional area 
was bigger than the congestive area. According to the surgi-
cal procedure, in 8 patients who underwent left hepatectomy 
with MHV the mean dysfunctional area was 12% of the 
remnant liver, but it was 24% in patients who underwent 
right hepatectomy with MHV. Posterior segmentectomy case 
had an area of liver dysfunction of 19%.
Conclusion: The dysfunctional area was more extended 
than the congestive area after hepatectomy with HV.
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PET/CT USING 
18F-FLUOROMETHYLCHOLINE TO 
DETECT HEPATOCELLULAR 
CARCINOMA AND ASSESS EXTENT OF 
THE DISEASE
M. Bieze1, H.-J. Klumpen2, J. Verheij3, U. Beuers4, 
P. Jansen4, S. Phoa5, T. van Gulik1 and R. Bennink6
1Department of Surgery, Academic Medical Center; 
2Department of Medical Oncology, Academic Medical 
Center; 3Department of Pathology, Academic 
Medical Center; 4Department of Hepatology, 
Academic Medical Center; 5Department of Radiology, 
Academic Medical Center; 6Department of Nuclear 
Medicine, Academic Medical Center
Academic Medical Center, Amsterdam Surgery, 
Meibergdreef 9, IWO 1-A1-132, 1105 Amsterdamthe, the 
Netherlands
Introduction: Diagnosis of HCC primarily involves 
imaging (MR, multiphase-CT, ultrasound). The aim of this 
study was to assess the advantage of 18F-fl uorocholine (18F-
FCH) PET using the tracer for detection of HCC and evalu-
ation of extent of the disease.
Methods: Twenty-one patients (mean age 62 years; range 
47–79 years) with HCC > 1 cm were included since 
December 2010. Fifteen minutes after IV injection of 
18F-FCH a whole-body PET/CT was performed. All patients 
underwent baseline-PET prior to treatment, 3 patients had 
control-PET after treatment, and 2 patients had follow-up 
PET after 3–6 months. Standard of reference were 2 imaging 
studies (MR, CT, or ultrasound) if histopathological diagno-
sis was not obtained. The standardized uptake value (SUV) 
of the lesion and surrounding tissue were assessed, and SUV-
ratios calculated. 18F-FCH PET scan was considered posi-
tive if the SUV-ratio exceeded 1.15.
Results: Standard work-up revealed 38 hepatic HCC in 21 
patients. In 35/38 lesions (92%) 18F-FCH PET was positive 
(SUV-ratio 2.06 ± 0.67). Standard work-up showed 6 suspi-
cious lesions in lung or abdomen (all PET positive. PET 
showed new lesions in 7 patients (hepatic 2, peritoneal 1, 
lymph 1, lung 4, skeletal 4, adrenal gland 2). Treatment after 
PET could have changed in 7/21 (33%) patients: no resection 
(n = 1), extensive resection (n = 1), start of Sorafenib treat-
ment (n = 4), and start Sorafenib and radiotherapy (n = 1). 
Of the 3 patients who underwent follow-up PET, progressive 
disease was detected by 18F-FCH PET in lung and abdomen 
of 2 patients, confi rmed by histopathology or additional 
imaging.
Conclusion: This study shows promising results in detec-
tion of HCC using 18F-FCH PET/CT, with implications for 
staging and possibly on management. Therefore, 18F-FCH 
PET/CT may be of value as additional non-invasive imaging 
tool for evaluation of HCC, including metastatic disease, 
treatment response, and follow-up.
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SIGNIFICANCE OF ANATOMIC 
HEPATECTOMY FOR 
HEPATOCELLULAR 
CARCINOMA PATIENTS
T. Ochiai, H. Ikoma, Y. Yamamoto, D. Ichikawa, 
H. Fujiwara, K. Okamoto, Y. Kokuba and E. Otsuji
Department of Surgery, Kyoto Prefectural University of 
Medicine
Kyoto Prefectural University of Medicine Surgery 465 
Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, 602 Kyoto, 
Japan
Introduction: The signifi cance of anatomic hepatectomy 
for hepatocellular carcinoma (HCC) is controversial. The 
purpose of this study was to clarify the effi cacy of anatomic 
hepatectomy for HCC patients.
Methods: From 1980 to 2011, 303 HCC patients underwent 
anatomic hepatectomy in our department (anat group). A 
total of 118 patients also underwent nonanatomic hepatec-
tomy (nonanat group). We compared the clinicopathology of 
the anat group with that in the nonanat group. We also evalu-
ated favorable conditions of anatomic hepatectomy for HCC 
patients by subset and multivariate analysis.
Results: There was no signifi cant difference between the 
anat (36.4%) and nonanat (30.5%) groups in 5-year disease-
free survival. Moreover, subset analyses revealed that dis-
ease-free survival of the anat group was signifi cantly better 
than that of the nonanat group when HCC patients had an 
UICC T1 tumor, a tumor with venous invasion, a tumor 
located within one subsegment or a surgical margin less than 
10 mm, and they received anatomic hepatectomy (all p < 
0.05).
In HCC patients with an ICG 15 minutes retention rate 
less than 30%, anatomic hepatectomy was an independent 
favorable prognostic factor by multivariate analysis taking 
into consideration 9 other clinical factors, which could be 
determined pre- or intra-operatively.
Conclusion: Anatomic hepatectomy for relatively early 
staged HCC yields favorable results compared with nonana-
tomic hepatectomy. Anatomic hepatectomy should be per-
formed for HCC patients with an ICG 15 minutes retention 
rate less than 30%.
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CLINICOPATHOLOGICAL 
EXAMINATION OF THE POORLY 
DIFFERENTIATED HEPATOCELLULER 
CARCINOMA AND PRIMARY HEPATIC 
NEUROENDOCRINE TUMOR
Y. Nomura1, N. Osamu2, K. Masayoshi1, Y. Hirohisa3 and 
K. Hisafumi4
1Department of Diagnostic Pathology, Kurume Univercity 
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3Department of Pathology, Kurume Univercity School of 
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Kurume Univercity School of Medicine, Fukuoka, Japan
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Pathology 67, Ashahi-machi, Kurume-shi, Fukuoka, 
830-0011, 83000 Kurume, Japan
Introduction: Primary neuroendocrine tumor (NET) and 
neuroendocrine carcinoma of the liver is extremely rare. 
Poorly differentiated hepatocelluler carcinoma (PHCC) 
sometimes transform to HCC with neuroendocrine differen-
tiation. 4 cases of pure NET, 5 cases of HCC with neuroen-
docrine differentiation and 21 cases of poorly differentiated 
HCC including an infant case were found in Kurume univer-
sity and surgical resection was performed. Now we report 
the feature of the clinicopathological fi ndings of these 
tumors.
Methods: Between January 2000 and April 2011, 1064 
hepatic nodules had undergone initial surgical resection at 
the Kurume University School of Medicine, Fukuoka, Japan. 
Clinical and pathological examination and immunohisto-
chemical analysis was performed. We reacted sections with 
HP-1, CK8, CK18, synaptophysin, vimentin, CAM5.2, 
EpCAM, chromograninA, CD56, EMA, CK7, CK19, Ki-67, 
SSTR2, NSE and S100. In 1064 nodules, 4 cases were pure 
well differentiated NET, 5 cases were HCC (poorly differen-
tiated) with neuroendocrine differentiation, and 21 cases 
were poorly differentiated HCC.
Results: In the 4 cases of pure NET comprised 3 males and 
1 female and mean diameter were 53.3 mm ± 14.1 SD × 
40.8 mm ± 12.5 SD and mean age was 45.2 ± 6.3. The cases 
of HCC with neuroendocrine differentiation only males and 
mean diameter were 33.0 mm ± 14.1 SD × 29.3 mm ± 12.1 
SD and mean age was 62.6 ± 6.3. In case of Poorly differenti-
ated HCC also 13 males and 8 females, and 51.9 mm ± 6.7 
SD × 44.6 mm ± 5.9 SD, age was 61.3 ± 3.1 respectively. 
There were no signifi cant different in tumor diameter, but 
NEC has a tend to see in younger age than other 2 kinds of 
tumors. Result of the immunohistochemical analysis, some 
differences were seen in CK8, CK18, CK7 and CK19.
Conclusion: It is unknown that PHCC transform to HCC 
with neuroendocrine differentiation or not. But in our analy-
sis, the immunostaining of HP-1, Synaptophysin, chromo-
graninA and CD56 showed positive in some nodules. Some 
PHCC were thought to have the possibility to transform to 
neuroendocrine tumor or carcinoma. And the differences 
PHCC that showed CK8, CK18, CK7, CK19 positive or not 
seem to indicate some potential to transform.
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VITAMIN K SUPPRESSES MIGRATION 
OF HEPATOCELLULAR CARCINOMA 
CELLS BY BLOCKING THE 
HGF/C-MET PATHWAY
S. Hwang1, H.-N. Hong2, Y.-J. Won2, Y.-H. Park1, 
G.-C. Park1, G.-W. Song1, N.-Y. Kim3 and S.-G. Lee1
1Department of Surgery, Asan Medical Center, University 
of Ulsan College of Medicine, Seoul, Korea; 2Department 
of Cell Biology, University of Ulsan College of Medicine, 
Seoul, Korea; 3Asan Instiute of Life Science, Asan Medical 
Center, Seoul, Korea
Asan Medical Center, University of Ulsan College of 
Medicine, Seoul, Korea; Department of Surgery, 388-1 
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Introduction: Vitamin K (VK) is a fat-soluble vitamin 
involved in blood coagulation and bone metabolism. VK has 
been shown to suppress cancer growth and induce apoptosis 
and differentiation in various cancer cells including hepato-
cellular carcinoma (HCC) cells. In HCC patients, abnormal 
prothrombins (PIVKA-II) are detected at high frequencies in 
the blood as an important tumor marker. There are several 
reports to elucidate the signaling pathways involved in the 
actions of VK.
Methods: In this study, we intended to reveal the migration 
suppression effect of VK through blocking the HGF/c-Met 
pathway. HepG2 cells (HCC cell line) were cultured and then 
treated with hepatocyte growth factor (HGF), in which 
E-cadherin expression were measured by using special 
immunohistochemeical stains and Western Blot and cell 
migration was also measured by scratch tests.
Results: After treatment with different concentrations of 
HGF, E-cadherin expression was weakened reversely accord-
ing to the concentration of HGF. In contrast, concurrent 
treatment with HGF and VK-1 revealed no attenuation in 
E-cadherin expression. Migration of HCC cells were acceler-
ated after HGF treatment, but this effect became much weak-
ened after concurrent treatment with HGF and VK-1. 
Attenuated expression of E-cadherin implicates that cell 
migration for HCC metastasis is facilitated by loss of adhe-
sion molecules.
Conclusion: The results of this study revealed that HGF-
induced HGF/c-Met pathway was inhibited by VK-1. The 
mechanism may take a part on the role of VK-associated 
anti-tumor effect during HCC progression. Further studies 
are necessary to integrate this pathway to the already-
established action mechanisms of VK, including protein 
kinase A, steroid and xenobiotic receptor, extracellular 
signal-regulated kinases, IkB kinase, and others.
413
HCC – OPTIONS AND LIMITS
P. Vavra1, P. Twardzikova2, A. El-Gendi3, M. Vavrova4, 
T. Jonszta4, M. Hasal1, P. Ihnat1 and N. Habib5
1Department of Surgery, Medical Faculty and University 
Hospital Ostrava, Ostrava, Czech Republic; 2Department 
of Oncology, University Hospital Ostrava, Ostrava, Czech 
Republic; 3Department of Surgery, Main Alexandria 
University Hospital, Alexandria, Egypt; 4Department of 
Radiology, University Hospital Ostrava, Ostrava, Czech 
Republic; 5Liver and Pancreas Surgery, Hammersmith 
Hospital, Imperial College London, United Kingdom
Medical Faculty and University Hospital Ostrava, Ostrava, 
Czech Republic; Surgery, Department of Surgery, 
University Hospital Ostrava, 17 Listopadu 1790, 70852 
Ostrava, Czech Republic
Introduction: The hepatocellular carcinoma (the “HCC”) 
features approximately 90% of all primary liver malignity. 
The largest incidence of the HCC is in the eastern Asia 
region, almost 100/100,000 inhabitants, whereas in the North 
America or in Europe the incidence achieves approx. 2 till 
11 cases per 100,000 inhabitants. In 2008 the HCC incidence 
in the Czech Republic achieved 10.9/100,000 per males and 
5.6/100,000 per females.
Methods: TACE-trans arterial chemoembolization with 
drug eluting beads. The method is aimed at delivering anti-
cancer drug directly into the tumor tissue. Liver surgery – the 
combined benefi ts of the hand assisted approach together 
with using radiofrequency energy. Systemic therapy of HCC 
– the majority of patients diagnosed with HCC have advanced 
disease. Based on the results of the clinical trials Sorafenib 
is recommended as category 1 option for selected patients 
with Child-Pugh class A or B liver function. RFA treatment 
– the procedures are performed under CT guidance. The 
RITA needles 10 to 15 cm long, fi rm or fl exible are used. 
Cyber Knife is used for stereotactic ablative radiotherapy of 
moving targets included hepatocelullar carcinomas.
Results: Authors present single-centre results of 
Multidisciplinary team treatment of patients with HCC 
during the years 2009–2011.
Conclusion: The prognosis depends on early diagnosis in 
the preclinical stage. The uncured HCC has survival progno-
sis of approximately 6–9 months, but even the prognosis of 
treated patients in the late stage is not satisfactory. The best 
treatment results are in the Asia. This is clearly connected 
with the quality of early HCC diagnosis and the respective 
treatment strategy.
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ADMINISTRATION OF GRANULOCYTE 
COLONY-STIMULATING FACTOR FOR 
SAFE LIVER RESECTION OF 
HEPATOCELLULAR CARCINOMA 
WITH HYPERSPLENISM
H. Nakayama and T. Takayama
Department of Digestive Surgery, Nihon University School 
of Medicine, Tokyo, Japan
Nihon University School of Medicine, Department of 
Digestive Surgery, 30-1 Oyaguchi-kami-cho, Itabashi-ku 
173 Tokyo, Japan
Introduction: In the development of hepatocellular carci-
noma (HCC) as a result of liver cirrhosis, neutropenia 
accompanying hypersplenism is sometimes seen.
Methods: We report three cases of HCC in which liver 
resection was successful after increasing their neutrophil 
counts with granulocyte colony-stimulating factor (G-CSF).
Results: [Case 1] A 70-year-old woman who suffered from 
edema of the leg, and HCCs were found simultaneously. 
HCV antibody was positive. Her white blood cell count was 
low (2100/μL) with neutropenia. G-CSF was administered, 
and the white blood cell count improved to 3300/µL. The 
Child-Pugh grade was B and the retention of indocyanine 
green at 15 minutes (ICGR15) value was 26.1%. Resection 
of liver segments 8 and 4 was performed. The operation time 
was 370 minutes and the amount of bleeding was 540 g. 
Although minor drain infection and pleural effusion occurred, 
she left hospital vigorously. [Case 2, 3] G-CSF was admin-
istered for them. Their liver resection was performed safely.
Conclusion: Preoperative G-CSF treatment for neutropenia 
is one option for safe liver resection.
418
LIVER RESECTION AND 
POSTOPERATIVE MANAGEMENT FOR 
HEPATOCELLULAR CARCINOMA 
WITH HYPERSPLENISM
H. Nakayama, T. Takayama and T. Higaki
Department of Digestive Surgery, Nihon University School 
of Medicine, Tokyo, Japan
Nihon University School of Medicine, Department of 
Digestive Surgery, 30-1 Oyaguchi-kami-cho, Itabashi-ku 
173 Tokyo, Japan
Introduction: Once hepatocellular carcinoma (HCC) has 
developed with liver cirrhosis, patients may exhibit hyper-
splenism and severe thrombocytopenia. We evaluated the 
factors that affect liver resection and postoperative manage-
ment in HCC with thrombocytopenia.
Methods: Three hundred and sixty-fi ve patients with HCC 
(293 men, 72 women; median age 68 years) who underwent 
liver resection in 2000–2007 were enrolled in this study. The 
patients with platelet counts 100,000/µL or more were clas-
sifi ed into the H group (n = 283) and those with platelet 
counts <100,000/µL were classifi ed into the L group (n = 82). 
The patients’ backgrounds, operation factors, and postopera-
tive prognosis were compared between these groups.
Results: The L group showed a signifi cantly higher inci-
dence of hepatitis C antibody-positivity compared with the 
H group. The L group exhibited worse serum albumin, pro-
thrombin, serum bilirubin, and ICG15 values compared with 
the H group. Many esophageal varices were apparent in the 
L group. The volumes of intraoperative bleeding and platelet 
transfusion in the L group were higher than those in the H 
group. While, there was no signifi cant difference in the 
number of tumors between the groups, the tumor diameter 
was signifi cantly smaller in the L group (median: 2.5 cm) 
compared with the H group (3.5 cm). The L group was com-
prised of many cirrhotic patients. Pleural effusion in the L 
group (38%) was higher than in the H group (20%) (p = 
0.002).
Conclusion: The patients with HCC whose platelet counts 
were less than 100,000/µL had poor liver function, and a 
large volume of intraoperative blood loss. It is important to 
manage such patients with careful attention to pleural effu-
sion among the postoperative complications.
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THE LONG-TERM PROGNOSIS OF 
PATIENTS WITH HEPATOCELLULAR 
CARCINOMA WITH 
HYPOCHOLESTEROLEMIA
H. Nakayama, T. Takayama and Y. Midorikawa
Department of Digestive Surgery, Nihon University School 
of Medicine, Tokyo, Japan
Nihon University School of Medicine, Department of 
Digestive Surgery, 30-1 Oyaguchi-kami-cho, Itabashi-ku, 
173 Tokyo, Japan
Introduction: It has been reported that hypocholesterol-
emia is a prognostic factor for patients with gastrointestinal 
cancer. Hypocholesterolemia occurs as a result of a defect of 
protein synthesis in patients with hepatocellular carcinoma 
(HCC) on the background of liver cirrhosis. This report esti-
mates the long-term prognosis of patients with HCC with 
hypocholesterolemia.
Methods: Five hundred and twenty-seven patients with 
HCC were classifi ed into either the L group (serum-choles-
terol values <120 mg/dl before their operation: n = 61) or the 
H group (≥120 mg/dl: n = 466). The patients’ background 
factors, liver function, operation factors, and prognosis were 
compared between both groups.
Results: Compared with the H group, a higher incidence of 
positivity for HCV antibody, anemia, low blood platelets, 
low serum albumin, low prothrombin, and high indocyanine 
green retention rate at 15 minutes were evident in the L 
group.
No signifi cant differences were observed for the serum 
bilirubin and AFP between groups. The Child-Pugh classifi -
cation was signifi cantly poorer for the L group. In the L 
group, the operation time was shorter and fresh frozen 
plasma transfusion was used more frequently. There was 
no signifi cant difference in the frequency of postoperative 
complications between groups. The fi ve-year cumulative sur-
vival rates of the L group and H group were 26% and 56% 
(p = 0.001).
Conclusion: It may be suggested that serum cholesterol 
level is a prognostic factor for patients with HCC.
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DEVELOPMENT OF A NEW 
ULTRASOUND GUIDED PUNCTURE 
ADAPTER FOR ANATOMICAL 
LIVER RESECTION
H. Nakayama, T. Takayama and O. Aramaki
Department of Digestive Surgery, Nihon University School 
of Medicine, Tokyo, Japan
Nihon University School of Medicine, Department of 
Digestive Surgery, 30-1 Oyaguchi-kami-cho, Itabashi-ku, 
173 Tokyo, Japan
Introduction: The fundamental technique for anatomical 
subsegmetectomy is specifi c dyeing of the feeding portal 
branch for HCC to determine the precise resectable area. We 
developed a puncture adapter for ultrasound guided staining 
to perform simple and fi ne liver resection. These items can 
fi x the needle for the puncture and the dyeing technique 
is performed precisely. We present our experience and 
expertise.
Methods: The patient suffered hepatocellular carcinoma 
(2.5 cm in diameter) located in the paracaval portion of the 
caudate lobe. Since the HCC existed in the backside of the 
root part of the middle hepatic vein, anatomical resection of 
segment 8 + 1 was planned. Puncture of the portal branch of 
segment 8 was carried out using this adapter, and staining 
with indigo-blue was performed. The portal branch of 
segment 6 was dyed with puncture. The border of the poste-
rior segment and caudate lobe of the liver was identifi ed.
Results: Transection of the liver was initiated on the left-
side of segment 8, and the middle hepatic vein was exposed. 
When it arrived at the front of caudate lobe on the backside 
of the middle hepatic vein, transection was turned in the 
direction of the Arantius ligament. The right hepatic vein was 
exposed on the right-side of segment 8, and the border of the 
posterior segment and caudate lobe was also transected. 
Finally the Arantius ligament was divided and the liver resec-
tion was completed. Segments 8 and 1 were extracted en 
bloc. The operation time was 576 minutes and the volume of 
bleeding was 858 ml. No complications occurred and the 
patient left the hospital 19 days after the operation.
Conclusion: The new echo probe and puncture adapter are 
useful for safe anatomical subsegmentectomy of the liver.
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TOTALLY LAPAROSCOPIC 
HEPATECTOMY VS. LAPAROSCOPY-
ASSISTED HEPATECTOMY FOR LIVER 
TUMORS: A COMPARATIVE STUDY
O. Itano1, G. Oshima2, S. Maeda2, N. Chiba2, M. Tanabe1, 
S. Aikou1 and Y. Kitagawa1
1Department of Surgery, Keio University, School of 
Medicine; 2Endoscopic Surgery Center, Eiju General 
Hospital
Keio University, School of Medicine, Department of 
Surgery, 35 Shinanomachi, Shinjuku-ku, 160 Tokyo, Japan
Introduction: This work was designed to compare the oper-
ative, postoperative and midterm outcomes for liver tumor 
of totally laparoscopic hepatectomy (TLH) with and those of 
laparoscopy-assisted hepatectomy (LAH), and clarify the 
advantage and disadvantage of these two methods.
Methods: We retrospectively analyzed clinical outcomes of 
28 patients with liver tumors who had undergone LAH from 
March 2006 to July 2008 (LAH group) and those of patients 
who had undergone TLH from August 2008 to March 2011 
(TLH group). LAH was defi ned combination of laparoscopic 
mobilization of the target liver lobe and open liver resection 
through less than the 12 cm extraction site. Their indications 
and type of liver resection were not modifi ed by the use of 
laparoscopy compared with conventional open hepatectomy. 
There was no signifi cant difference in clinicopathological 
data (patient’s background, tumor data, type of resection) of 
two groups.
Results: The mean operative times were 307 ± 174 min in 
TLH group and 370 ± 105 min in LAH group, respectively 
(p = 0.1). The mean blood loss were signifi cant lower in TLH 
than in LAH group (187 ± 253 vs. 516 ± 482 ml; p = 0.0027). 
There was one conversion to open resection in LAH group, 
but none in TLH group, although 3 conversions to LAH in 
TLH group. Morbidity and mortality rate were similar in the 
two groups (29 and 0% vs. 19 and 4%; p = 0.5). The period 
to diet is signifi cant shorter in TLH than in LAH group (1.4 
± 0.9 vs. 2.7 ± 1.2 days; p < 0.001). The mean postoperative 
stays were 10 ± 12 days in TLH group and 15 ± 10 days in 
LAH group, respectively (p = 0.16). Two-year disease-free 
survival and 2-year overall survival were similar in the two 
groups.
Conclusion: TLH was less invasive than LAH in several 
outcomes, however similar in oncological outcomes. In addi-
tion, LAH played an important role as a backup operation of 
TLH to maintain minimally invasive surgery.
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TUMOR RESPONSE EVALUATION 
ACCORDING TO MRECIST CRITERIA IN 
PATIENTS WITH HEPATOCELLULAR 
CARCINOMA TREATED WITH 
TACE-DRUG ELUTING BEADS
R. Surjan
University of Sao Paulo, School of Medicine, Sao Paulo, 
Brazil
Department of Gastroenterology, Liver Transplantation 
Service, Rua João Moura 956 apto 151 Pinheiros, Zip 
Code – 05412-0015412 São Paulo, Brazil
Introduction: Drug eluting beads (DEB) is an embolizing 
device that slowly releases chemotherapy to decrease sys-
temic toxicity during TACE. Initial studies showed that 
TACE-DEB is superior to conventional TACE regarding 
tumor response and toxicity. There is no study in our popula-
tion that evaluate HCC response to TACE-DEB, according 
to mRECIST criteria. The aim of this study is to evaluate 
tumor response according to mRECIST criteria in patients 
with HCC treated with TACE-DEB.
Methods: In the period of the study, 53 patients with HCC 
were treated with 65 sessions of TACE-DEB loaded with 
doxorubicin 50 mg. Tumor response was evaluated one 
month after the procedure with CT or MRI according to 
mRECIST criteria.
Results: Median age was 62 years and 74% were male. The 
majority of the patients were cirrhotic (89% – CHILD A 65% 
e CHILD B 35%). Etiology of liver disease was HCV in 
27/53 (51%), HBV in 8/53 (15%), alcohol in 10/53 (19%) 
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and NASH in 3/53 (6%). According to BCLC staging system, 
51% was BCLC A and 49% was BCLC B. Most patients had 
one nodule (66%). No patient presented with extrahepatic 
metastasis or macroscopic vascular invasion. Tumor response 
according to mRECIST was possible after 60 procedures. 
Complete response was reached in 12/60 (20%), partial 
response in 31/60 (52%), stable disease in 4/60 (6.5%) and 
progressive disease in 13/60 (21.5%).
Conclusion: In patients with compensated liver cirrhosis 
and HCC, TACE-DEB was effi cient in induce tumor response 
according to mRECIST criteria, and in our study objective 
response (complete response + partial response) was reached 
in 72% of cases. Further studies are necessary to evaluate 
survival and predictors factors of response.
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ANALYSIS OF RESULTS OF 44 CASES OF 
HILAR CHOLANGIOCARCINOMA 
AFTER DA VINCI SURGERY
N. Zhou
Institute of Hepatobiliary and Gastrointestinal Disease of 
PLA Second Artillery
Institute of Hepatobiliary and Gastrointestinal Disease of 
PLA, Second Artillery No. 16, Xinjiekouwai Avenue, 
Xicheng District, Beijing 10008, China
Introduction: Hilar cholangiocarcinoma is the most diffi -
cult area of Hepatobiliary Surgery. Complex anatomy and 
surgery procedure restrict the development of minimally 
invasive surgical in this area. In this paper, through a retro-
spective analysis on 44 cases of “Da Vinci” robotic surgery 
for hilar cholangiocarcinoma, we evaluate the clinical sig-
nifi cance for robotic surgery system in the treatment of hilar 
cholangiocarcinoma.
Methods: From January 2009 to September 2011, 44 
patients with Hilar cholangiocarcinoma underwent robotic 
surgery using da Vinci S system. The clinical data of 44 
patients were analyzed.
Results: 23 cases of hilar cholangiocarcinoma received 
tumor resection, resection rate 52.27% (23/44) (involving 3 
anatomical left hepatectomies, 3 operations of extrahepatic 
bile duct resection and gallbladder-bridge biliary reconstruc-
tion, 16 operations of extrahepatic bile duct resection and 
biliary-enteric Roux-en-Y anastomosis, 1 tumor resection 
and reconstruction of hilar bile duct); 21 cases received pal-
liative biliary external drainage involving 9 cases of pallia-
tive biliary external drainage, 12 cases of Y-type biliary 
internal drainage with T tube). Complications rate is 18.18% 
(8/44), Mortality rate 2.27% (1/44).
Conclusion: Robotic techniques are particularly valuable in 
very challenging hilar biliary surgery such as bile duct explo-
ration, reconstruction and anastomosis. In the minimally 
invasive conditions the full exploration and re-evaluation of 
the tumor could be achieved. For unresectable cases, ade-
quate drainage could be done well.
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ANTITHROMBIN III IS INDEPENDENT 
PROGNOSTIC FACTOR OF 
HEPATECTOMIZED PATIENTS WITH 
HEPATOCELLULAR CARCINOMA
H. Tashiro, H. Iwako, H. Amano, T. Kobayashi, S. Kuroda, 
H. Tazawa, A. Oshita and H. Ohdan
Department of Gastroenterological Surgery, Hiroshima 
University Hospital
Hiroshima University Hospital, Gastroenterological 
Surgery, 1-2-3, Kasumi, Minami-ku 734-8 Hiroshima, 
Japan
Introduction: Antithrombin III (ATIII) is a heparin-binding 
protein and a major inhibitor of coagulation proteases, pri-
marily thrombin and factor Xa. ATIII has been reported to 
effi ciently inhibit tumor angiogenesis in a mouse model. 
However, little data is available on the impact of ATIII on 
outcomes of patients with HCC who underwent hepatec-
tomy. we aimed to investigate the effect of ATIII on survival 
and HCC recurrence in patients who underwent curative 
hepatic resection.
Methods: Between the years 2000 and 2008, 440 patients 
with HCC underwent curative hepatectomy as an initial treat-
ment. The patients were categorized into 2 groups on the 
basis of their preoperative ATIII level: 70% or more than 
70% (group 1, n = 314), and <70% (group 2, n = 126). To 
overcome bias due to the different distribution of covariates 
among patients from the 2 groups, a one-to-one match was 
created using propensity score analysis. The Kaplan-Meier 
method was used for analyses of overall survival and dis-
ease-free survival, whereas comparisons between groups 
were performed using the log-rank test. We performed mul-
tivariate analyses using the Cox proportional hazards model.
Results: Sixty-fi ve of the 314 patients with preoperative 
ATIII levels of 70 or more than 70% were matched with 65 
of the 126 patients with preoperative ATIII levels <70% after 
covariate adjustment. The overall survival rate of patients in 
group 1 was signifi cantly higher than that of patients in group 
2 (P = 0.005): in group 1, 5-year overall survival rates were 
83.4%, whereas in group 2, they were 57.1%. Furthermore, 
the disease-free survival rate of patients in group 1 was 
signifi cantly higher than that of patients in group 2 (P = 
0.012). Multivariate analysis revealed that serum ATIII level, 
serum AFP level, multiple tumors, and microscopic vascular 
invasion were the independent prognostic factors.
Conclusion: One-to-one matching study using propensity 
scores and multivariate analysis showed that the ATIII level 
was the prognostic factor for favorable outcomes in HCC-
patients after curative hepatectomy. We suggest that a new 
modality for increasing ATIII levels could be a novel strategy 
for suppressing HCC recurrence after hepatectomy.
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CLINICAL OUTCOME OF 
INTRAOPERATIVE RADIOFREQUENCY 
ABLATION FOR HCC IN THE CASES OF 
DIFFICULT FOR RESECTION
E.-H. Cho1, S. B. Kim1, S. H. Yoon1, Y. H. K. Kim2 and 
C.-S. Lim3
1Department of Surgery, Korea Cancer Center Hospital; 
2Department of Radiology, Korea Cancer Center Hospital; 
3Gastrointestinal Cancer Center, Dongnam Institution of 
Radiological & Medical Science
Korea Cancer Center Hospital, Surgery, 75 Nowon-gil 
(215-4-Gongneung-dong), Nowon-gu, 139-7 Seoul, 
Republic of Korea
Introduction: The purpose of this study is to analyze the 
outcome of intraoperative radiofrequency ablation (RFA) for 
hepatocellular carcinoma (HCC) in cases of diffi cult for 
resection.
Methods: Two hundred and thirty fi ve patients underwent 
curative surgery for HCC in our institution. Two hundred and 
eleven patents underwent curative hepatic resection only 
(resection group). The remaining twenty four patients under-
went intraoperative RFA with (n = 17) or without (n = 7) 
hepatic resection (RFA group). RFA was performed in 
limited cases for unresectable cases including bilobar mul-
tiple diseases, poor hepatic reserve function. Clinical data 
and outcomes were analyzed and compared between the two 
groups retrospectively.
Results: Postoperative complication rates were not different 
statistically between the two groups (25% in RFA group and 
36% in resection group, p = 0.20). There was no hospital 
mortality in RFA group. Five-year survival rates are not 
statistically different in the two groups (8.3% in RFA group, 
and 14.2% in resection group, p = 0.300). In the subgroup 
analysis with multiple tumors, 5-year recurrence free sur-
vival rates were not statistically different (5.9% in RFA 
group, and 4.3% in resection group, p = 0.059).
Conclusion: Intraoperative RFA is safe and effective treat-
ment option in selected patients with bilobar multiple HCCs 
or poor hepatic reserve function.
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LAPAROSCOPIC (-ASSISTED) 
HEPATECTOMY FOR 
HEPATOCELLULAR CARCINOMA
G. Oshima1, O. Itano2, Y. Shoji1, S. Maeda1, Y. Koyama1, 
S. Aiko1 and Y. Kitagawa2
1Department of Surgery, Eiju General Hospital; 
2Department of Surgery, School of Medicine, Keio 
University
Eiju General Hospital, Surgery, 2-23-16 Higashi-Ueno, 
Taito-ku, Tokyo, Japan
Introduction: Laparoscopic hepatectomy is still not a well-
established treatment modality for hepatocellular carcinoma. 
The purpose of this work was to evaluate the midterm results 
of the laparoscopic liver resections for hepatocellular 
carcinoma.
Methods: From January 2006 to September, there were 53 
laparoscopic (-assisted) liver resection for hepatocellular car-
cinoma carried out at our hospital. The patients comprised 
of 44 males and 9 females with a mean age of 66.1 ± 10.1 
years. Twenty six patients were HCV-positive and 11 were 
HBV-positive. Others without viral infection included 9 alco-
holic hepatitis and 3 NASH. The background of the resected 
livers were 45 Child-Pugh A and 8 Child-Pugh B. 
Laparoscopic-assisted procedures consisted of laparoscopic 
mobilization of the target organs, followed by open resection 
and reconstruction through an 8–12 cm extraction site.
Results: As to 29 limited resections, totally laparoscopic 
methods were performed in 17 cases and laparoscopy-
assisted method in 12 cases. The mean operative time was 
299 ± 95 minutes. The mean blood loss was 244 ± 292 ml. 
Postoperative morbidity rate was 17% and the mortality rate 
was 3%.
As to 24 anatomical resections, there were 4 subsegmen-
tectomies, 7 lateral segmentectomy, one S4 resection, 3 ante-
rior sectionectomies, 4 posterior sectionectomy, 1 left 
hepatectomy, 4 right hepatectomy. Totally laparoscopic 
methods were performed in 14 cases and laparoscopic-
assisted method in 10 cases. The mean operative time was 
420 ± 154 minutes. The mean blood loss was 553 ± 578 ml. 
Postoperative morbidity rate was 20.8% and the mortality 
rate was 0%.
Conclusion: Laparoscopic (-assisted) liver resection for 
hepatocellular carcinoma is feasible and safe. But more data 
may be needed for evaluation of long-term outcome.
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NEW APPROACH FOR EVALUATION OF 
FUNCTIONAL LIVER RESERVE IN 
SURGICAL TREATMENT OF THE 
CIRRHOTIC PATIENTS
V. Syplyviy, O. Petiunin, V. Markovskiy, D. Ievtushenko 
and P. Petiunin
Kharkiv National Medical University, General Surgery, 
235 Lenina Ave., Kharkiv, Ukraine
Introduction: Surgical treatment of a cirrhotic patients is 
connected with high risk of postoperative hepatic failure. 
Hepatic biopsy with morphological examination is a “gold” 
standard in evaluation of functional liver reserve. Modern 
noninvasive methods of examination like Doppler ultrasound 
are also used to achieve this goal. The purpose of our research 
was to defi ne new criteria of functional liver reserve in cir-
rhotic patients in order to improve results of their surgical 
treatment.
Methods: The results of surgical treatment of 137 patients 
with liver cirrhosis were analysed. In 81 cases was performed 
the distal splenorenal shunt by Warren, in 56 – devasculariza-
tion surgery. Morphological examinations with morphometry 
of liver biopsies and Doppler ultrasound of portal blood 
vessels were done.
Results: On the basis of the analysis were determined three 
(A, B, C) types of cirrhosis which statistically signifi cant 
differs by area of unchanged hepatocytes, volume of dividing 
hepatocytes, connective tissue area, stroma to parenchyma 
ratio, volume of hepatocytes in the state of necrosis and/or 
necrobiosis. The results of portal blood vessels Doppler 
ultrasound were different and depends upon morphological 
type of cirrhosis. In A-type patients the diameters of portal 
and splenic veins, linear portal blood velocity, volumic portal 
blood velocity, portal congestion index were like in healthy 
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persons, in B and C-type – the diameters of portal and splenic 
veins, portal congestion index were increased simultane-
ously with decrease of linear portal blood velocity, volumic 
portal blood velocity. Hepatic failure occurred in 52.6% 
patients with B-type and in 77.8% patients with C-type cir-
rhosis at portal vein diameter more than 1.5 cm, linear portal 
blood velocity less than 10 cm/s, portal congestion index 
more than 0.14 cmхs.
Conclusion: Morphological changes in liver are intercom-
municated with disturbances of portal hemodynamics in cir-
rhotic patients. Linear portal blood velocity and portal 
congestion index most exactly refl exes the character of path-
ological changes in liver.
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“EX VIVO” PRETREATMENT WITH 
SONIC HEDGEHOG PATHWAY 
INHIBITOR MITIGATE THE GROWTH 
OF HEPTOMA IN MICE
K.-S. Jeng1, I-S. Sheen2, M.-C. Yu3, H.-H. Tsai3 and 
F.-Y. Chang3
1Departments of Surgery, Far Eastern Memorial Hospital, 
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Chang-Gung Memorial Hospital, LinKou, Taiwan; 
3Department of Medical Research, Far Easten Memorial 
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Far Eastern Memorial Hospital, Departments of Surgery, 
No. 21, Sec. 2, Nanya S. Rd., Banciao Dist 220, New 
Taipei City, Taiwan (R.O.C.)
Introduction: Hepatocellular carcinoma (HCC), one of the 
most malignancies worldwide, rapidly increasing recently in 
the United States, is very prevalent in Taiwan and other Asian 
counties. Previous studies suggested that abnormal activa-
tion of the hedgehog (Hh) signaling pathway contributes to 
hepatocarcinogenesis. It is hypothesized that to inhibit Shh 
activation may inhibit the development of HCC. Therefore, 
we designed this study.
Methods: We do pretreatment of ML-1 cells with SMOH 
inhibitor, cyclopamine, dividing 3 groups with different dose 
(control: untreated; low dose: 5 µm; high dose: 20 µm). We 
explored C57BL/6 mice to implant the untreated ML-1 cell 
HCC cells into the livers of control group A. We implanted 
ML-1 cells treated with low dose and high dose to group B 
and C respectively. Three weeks later, we reexplored all 
groups of mice for harvesting their liver and HCC to study. 
All the harvested HCC tissues were sent for real time-PCR 
for Shh, Ptch-1, Smoh and Gli-1. The data was analyzed by 
SPSS.
Results: The difference of tumor size has statistical signifi -
cance among 3 groups (p = 0.015). The mean values of Shh 
mRNA of group A, B and C are 2.907 ± 4.981; 1.331 ± 0.370; 
and 0.772 ± 0.528. Those of Gli-1 mRNA of group A, B and 
C are 3.865 ± 4.095; 2.525 ± 0.786; and 0. 974 ± 0.675. 
Those of Ptch-1 mRNA of control group A, B and C are 
1.200 ± 1.432; 0.850 ± 0.467; and 0.791 ± 0.356. The mean 
value of Smoh mRNA of group A, B and C are 1.693 ± 1.624; 
1.102 ± 0.390; and 0.811 ± 0.114. The difference of Shh 
mRNA and Gli-1 mRNA among 3 groups has statistical 
signifi cance by univariate analysis (P value = 0.007 and 
0.006 respectively) and multivariate analysis (P value = 
0.007 and 0.005 respectively).
Conclusion: Pretreatment of cyclopamine on the ML-1 
cells may decrease tumor growth in the mice liver and 
changed the Shh mRNA and Gli-1 mRNA signifi cantly. It 
suggests Smoh inhibitor may inhibit the growth of hepatic 
tumor through the blockade of the Shh pathway.
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Introduction: Ten mm as the safety margin of curative 
resection of hepatocellular carcinoma (HCC) is the consen-
sus. A prospective cohort study to investigate the impact of 
5 mm as the narrowest margin on central resection of HCC 
was conducted.
Methods: From January 1994 to July 2010, 196 patients 
with HCC undergoing central resections of liver with cura-
tive potential were divided into two groups (the narrowest 
margin, A: “ >5 mm and < 10 mm”; B: “5 mm”). The out-
comes were compared.
Results: There was no signifi cant differences of recurrence 
rate and overall survival between the two groups. However, 
group B had more perimargin recurrence (50% vs. 0%, P < 
0.001) and a signifi cantly less survival after exclusion of 
those with recurrence within 1 year (P < 0.001).
Conclusion: In the diffi cult central resections, the narrowest 
margin width of 5 mm was the minimal requirement.
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HCC WAS PRESENTED BY 
INTRAHEPATIC BILE DUCT 
OBSTRUCTION – A CASE REPORT
D. H. Ryu, J.-W. Choi, D. H. Kim, H. Y. Yun, L.-C. Jang 
and Y. J. Song
Chungbuk National University, College of Medicine and 
Medical Research Institute, Surgery, 62 Gaesin-dong, 361 
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Introduction: HCC is a common and a major tumor which 
is typical of showing poor prognosis. In most cases patients 
with HCC do not have any specifi c symptoms, but if symp-
toms occur they are mostly presented by RUQ abdominal 
pain, weight loss and palpable mass. It is less commonly 
presented by hypovolemic shock due to rupture of tumor, 
obstructive jaundice, hemobilia, fever, and rarely expressed 
by paraneoplastic syndrome. Diagnosis is made mainly by 
radiologic imaging studies (US, CT & MRI) and tumor 
markers.
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Methods: A 69-year-old female patient visited the ER, 
because of RUQ abdominal pain that started a few hours 
earlier. Initial physical examination, showed positive Murphy 
signs and abdominal pain did not improve. Acute cholecys-
titis and Rt. IHD obstruction were identifi ed on abdominal 
CT fi ndings.
The patient was a HBsAg chronic carrier with liver cir-
rhosis, therefore she was admitted after PTGBD was per-
formed. Radiologic imaging fi ndings, showed that the Rt. 
IHD obstruction was not caused by gallstones, and the pos-
sibility of obstruction due to blood clots or tumors could not 
be ruled out.
Therefore PTBD was attempted, but the catheter failed to 
proceed and bleeding occurred. After conservative manage-
ments, surgery was performed.
Results: After undergoing cholecystectomy and CBD 
exploration, choledochoscopic removal of bile duct tumor 
emboli was performed. Both emboli and proximal IHD 
frozen bx. specimen were suspected of cholangiocarcinoma. 
The guardian of the patient did not want further surgery and 
the surgery was terminated. During the postoperative recov-
ery period, the fi nal pathologic result of the tumor emboli 
was reported to be HCC (moderately differentiated). The 
patient was discharged without further treatment.
Conclusion: The authors report a case presented by RUQ 
pain without any evidence of hepatic masses on abdominal 
CT fi ndings, and was histologically diagnosed as HCC by a 
Rt. IHD tumor emboli.
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Introduction: Objectives and aim: Hepatocellular cancer 
(HCC) patients require multidisciplinary treatment including 
mainly hepatologists, surgeons and oncologists. In Poland 
majority of these patients are treated by non-oncologists, 
however treatment with sorafenib can be administered only 
by the oncologists. There are no existing data on HCC 
patients fl ow between these specialities. LIVer cancer 
patients suitable for sorafenib Evaluation Registry (LIVER) 
was established in order to assess the HCC patients’.
Methods: Patients’ data were collected voluntarily by non-
oncologists (LIVER1) and oncologists (LIVER2) in several 
outpatient clinics in tertiary centers in Poland, according to 
specially designed protocol. Descriptive statistical methods 
and U-Mann-Whitney and Fisher tests were applied.
Results: In the period 2009–2010 – 478 HCC patients were 
included into registry, male gender predominated (70%). 
HCV infection was found in 199 (42%) and HBV in 112 
(24%) patients. Oncologists recorded more patients with 
undetermined HCC aetiology than other physicians (35% vs 
15%). CT scan (80%, ns), US scan (74% in LIVER1 vs 47% 
in LIVER2, p < 0.0001) and biopsy (48% LIVER1 vs 72% 
LIVER2, p < 0.0001) were the most common diagnostic 
tools. Patients with more advanced HCC according to BCLC 
scale and worse performance status were more frequently 
seen by oncologists (LIVER2), similar prevalence in Child-
Pugh status was observed in both groups (p < 0.05 for all). 
Frequency of extrahepatic lesions was different (10% 
LIVER1 vs 42% in LIVER2, p < 0.05).
Conclusion: LIVER is the fi rst attempt in Poland to register 
HCC patients covering the different therapeutic area special-
ists. The registry shows that patients treated by oncologists 
have more advanced HCC and worse performance status (p 
< 0.05). The data obtained show the need of early HCC 
detection multidisciplinary system, allowing to refer these 
patients to the oncologist for earlier targeted treatment.
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Introduction: HCC is the leading cause of cancer related 
mortality worldwide. Emerging evidence suggests aberrant 
activation of an embryological trans-differentiation pro-
gramme termed epithelial-mesenchymal transition (EMT) is 
critical in promoting metastasis in different carcinomas. We 
analyzed the expression of ZEB1, a key transcription factor 
implicated in EMT, by immunohistochemistry (IHC) 
and western blotting in HCC. Additionally, we performed 
migration assays to analyze the consequences of ZEB1 
expression.
Methods: We performed western blotting for ZEB1, 
E-cadherin, vimentin and alpha-tubulin to identify the epi-
thelial-mesenchymal status of 8 primary HCC cell lines. IHC 
was undertaken on paraffi n sections from 40 patients who 
underwent resections for primary HCC between May 1997 
and Nov 2010 and scored by 2 independent pathologists. 
Clinicopathological data was collated retrospectively and 
patient survival calculated using the Kaplan-Meier method. 
We transfected ZEB1 into Huh7 and HepG2 cell lines by 
electroporation and assessed EMT related changes in cell 
motility using Boyden chambers (pore size: 8 µm) and serum 
as chemo-attractant.
Results: Western blotting of proteins from 8 HCC cell lines 
demonstrated reciprocal expression of ZEB1 and E-cadherin, 
suggesting EMT promotes a migratory phenotype in HCC. 
ZEB1 also signifi cantly increased cell motility as a 3 fold 
increase in cell migration was observed after ZEB1 transfec-
tion into Huh7 cells (23 ± 4 vs. 79 ± 5). ZEB1 positivity was 
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detected in 11/40 specimens analysed by IHC. Statistical 
analysis highlighted ZEB1 as an independent prognostic 
marker favouring a signifi cant reduction in cancer specifi c 
(41 vs. 16 months, p < 0.003) and disease free survival (29 
vs. 9 months p < 0.004). Clinico-pathological analysis 
revealed a signifi cant correlation between ZEB1 expression, 
stage, vascular invasion and satellite lesions.
Conclusion: Our results suggest that ZEB1 induced EMT 
promotes tumour progression and metastasis in HCC, and 
that over-expression of ZEB1 may represent an independent 
prognostic biomarker in patients with HCC.
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Introduction: Radioembolization (RE), which enables the 
delivery of high-dose radiation preferentially to liver 
tumours, is used in some specialist centres as part of the 
multimodal treatment of unresectable hepatocellular carci-
noma (HCC) with intermediate and advanced-stage disease. 
This retrospective analysis by the 8 centers comprising the 
European Network on Radioembolization with 90Y micro-
spheres (ENRY) evaluated the impact of prior hepatic-
directed procedures on the outcomes following RE.
Methods: Patients were considered eligible for RE with 
90Y resin microspheres (SIR-Spheres) if they were not suit-
able for surgery (resection, liver transplantation) or ablation 
(PEI, RF, cryo), or had progressed on prior surgery, ablation 
or vascular therapy (TACE/TAE). Consecutive patients (n = 
325) received RE between 09/2003 and 12/2009, were 
mostly Child-Pugh class A (82.5%), with cirrhosis (78.5%) 
and good performance status (ECOG 0–1: 87.7%) but many 
had multinodular (75.9%), bilobar (53.1%), advanced disease 
(BCLC C: 56.3%) and/or portal vein occlusion (23.3%). Of 
these, 143 patients (44.0%) had prior hepatic surgery 
(n = 61; 18.8%), ablation (n = 29; 8.9%) and/or vascular 
procedures (n = 98; 30.2%), mostly as a single procedure (n 
= 101; 31.1%).
Results: The analysis found few differences in baseline 
characteristics between prior treatment groups, except for a 
higher baseline total bilirubin in treatment-naïve patients 
(mean 1.2 vs. 1.0 mg/dL; p = 0.004). A slightly higher activ-
ity was administered to treatment-naïve patients (median 1.7 
vs. 1.5 GBq; p = 0.001) refl ecting the higher target tumour 
volume (median 250 vs. 180 mL). No signifi cant differences 
were observed in overall survival between the prior proce-
dure and treatment-naïve groups (median [95% CI]: 13.1 
[10.9–19.6] vs. 12.5 [10.3–15.9] months; p = 0.289). Analysis 
of clinical and laboratory adverse events found that they 
varied little between patients stratifi ed by any or no prior 
procedure.
Conclusion: Patients who have failed prior procedures can 
be effectively and safely treated with radioembolization and 
had outcomes similar to those who were treatment naïve. 
Radioembolization could be considered as a valuable treat-
ment option for patients who relapse following surgical, 
ablative or vascular procedures and who remain suitable 
candidates for treatment.
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Introduction: A central bisectionectomy of the liver 
removes segments 4, 5, and 8, and this is a technically 
demanding operation because it requires two transection 
planes. For preservation of remnant right posterior and left 
lateral Glissonian pedicles, right and left hepatic vein, exact 
anatomical resection is necessary. However, in large tumor 
which is hanged on hilar area, it is diffi cult to determine 
exact resection plane because of diffi cult to approach the 
Glissonian pedicle.
Methods: From October 2004 to February 2011, 670 
patients underwent liver resection in Keimyung University 
Dong-San Medical Center and ten patients of them (nine of 
hepatocellular carcinoma and one of mass forming cholan-
giocarcinoma), central bisectionectomy was performed. In 3 
patients (group 1), masses were located on hilar area with 
abutting and compromising of right posterior and left lateral 
Glissonian pedicles. Remaining 7 patients (group 2), masses 
were not contact with hilar structure. In all patients of group 
1, preoperative MRCP was taken. We retrospectively ana-
lyzed surgical technique and postoperative outcome in two 
groups.
Results: In group 2, resection line was determined by infl ow 
control of Glisson of right anterior section and S4. In con-
trast, in group 1, infl ow control was impossible due to con-
tacting mass with hilar structure, so resection line was guided 
by hanging maneuver. In both group, mean tumor size (8.8 
vs 7.0 cm), operative time (376.7 min vs 350.5 min), resec-
tion margin (3.0 mm vs 6.4 mm) were not signifi cantly dif-
ferent. In contrast to a case of postoperative complication in 
group 2 (ascites), bile leakage was occurred in all three 
patients of group 1, including a case of transaction of left 
lateral duct (B 2&3).
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Conclusion: Central bisectionectomy with hanging maneu-
ver for giant tumor located on hilar area can guide to transect 
easily and safely with keeping enough resection margin bilat-
erally and posteriorly. However, this procedure can accom-
pany bile duct injury because of diffi culty in differentiation 
of the bile ducts, and because those are not dilated and col-
lapsed by compressing the ducts while hanging. Very careful 
evaluation of the biliary tree and careful transaction is 
demanded (Video clips included).
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Introduction: Reports regarding hepatocellular carcinoma 
in non-viral-related liver disease (NBNC-HCC) are increas-
ing in Japan. We have reported that patients with NBNC-
HCC have a high incidence of diabetes mellitus (DM), 
hypertension (HTN), and body mass index > 25 kg/m2 (BMI 
> 25), and that maximum tumor size (max TS) in NBNC-
HCC was larger than that in B or C type hepatitis-related 
HCC (ILCA 2011). The aim of the study is to clarify the 
factors related to early recurrence and survival in 
NBNC-HCC.
Methods: From January 2000 through March 2010, 136 
patients underwent hepatic resections for primary HCC, of 
whom 41 patients with NBNC-HCC were investigated. 1) 
The patients with NBNC-HCC were classifi ed into two 
groups: the patients who had early recurrence (ER) within 
one year (n = 8) and those who had no recurrence (NR) more 
than one year (n = 33). Between the two groups, the follow-
ing variables were investigated: age, gender, BMI > 25, DM, 
HTN, AST, ALT, T-Bil, albumin, ALP, γ-GT, white blood cell 
count, platelet count, ICGR15, AFP, PIVKA II, max TS, 
portal vein invasion (VP), intrahepatic metastasis (IM), oper-
ation time, blood loss, and blood transfusion (BT). 2) Factors 
related to survival were investigated in NBNC-HCC.
Results: 1) Survival in group ER was signifi cantly worse 
than that in group NR (p < 0.01). Signifi cant factors related 
with group ER included max TS, Alb, and AFP. BT and VP/
IM were also related with group ER. 2) Age, serum albumin, 
and DM were the independent prognostic factors in NBNC-
HCC using uni- and multi-variate analyses.
Conclusion: In NBNC-HCC, factors related with ER 
included max TS, serum albumin, and AFP, and age, serum 
albumin, and DM were the independent prognostic factors in 
NBNC-HCC.
488
RESULTS OF LIVER RESECTION IN 
PATIENTS WITH PORTAL VEIN TUMOR 
THROMBUS COMPLICATING 
HEPATOCELLULAR CARCINOMA
O. Ciacio1, E. Vibert2, M. Khalfallah1, R. Adam3 
and D. Castaing3
1AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire, 
F-94800 Villejuif, France; 2Inserm, Unite 785, F-94800 
Villejuif, France; 3Univ Paris-Sud, Faculté de Médecine, 
F-94270 Le Kremlin Bicêtre, France
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire, 
12-14 Avenue Paul Vaillant Couturier, 94800 Villejuif, 
France
Introduction: Median survival of patients with hepatocel-
lular carcinoma (HCC) complicated by macroscopic portal 
vein tumor thrombus (PVTT) is inferior to 3 months. Aim: 
This study analyses the results of surgical treatment in this 
situation.
Methods: From 1992 to 2009, 31 patients (pts) (ages: 57 ± 
10 years, 10 females/21 males, 27 ASA I-II, 4 ASA III) were 
operated upon, 15 (48%) pts were cirrhotic (Child A-B), 7 
(22%) had a hepatopathy and 9 (29%) a normal liver. Mean 
number and diameter of HCC was 2.2 ± 2.3 and 8.3 ± 4.6 cm, 
respectively, with bilobar extension in 10 (32%) pts. PVTT 
involved a sectorial branch in 6 (19%) pts, a pedicular branch 
in 21 (67%) pts and the portal trunk in 4 (12%) pts. Mean 
bilirubin was 15 ± 9 mmol/L, PT was 75 ± 14%, creatinine 
75 ± 25 µmol/L and platelet count: 241 000 ± 143 000/mm3. 
Median level of AFP was 375 µg/L (Min: 2 – Max: 1 245 377). 
Uni- and multivariate analysis were done for overall survival 
with preoperative data.
Results: These 31 pts have been treated with 3 minor and 
28 major hepatectomies that required liver vascular exclu-
sion in 8 (25%) pts and vascular reconstructions in 2 pts. 
Transfusion rate was 3.1 ± 4.0 unit of packed red cells. 
Resection were R0, R1 and R2 in 8 (25%), 16 (51%) and 7 
(22%) pts, respectively. Two-month post-operative mortality 
was 3/31 (9%). Morbidity rate was 17/31 (51%). Length of 
hospitalization was 17 ± 10 days. The median survival was 
5.7 months. 6-month, 1 and 2 year OS were 62%; 48%, 35% 
(5 pts at risk). In multivariate analysis, preoperative bilirubin 
rate was the only independent predictive factor of OS. In pts 
with normal bilirubin (≤17 µmol/L) (n = 22), 6-month, 1 and 
2 year OS were 68%; 68% and 50% (5 pts at risk), respec-
tively. In pts with bilirubin > 17 µmol/L (n = 9), 6 month OS 
was 31% (2 pts at risk) with no 1-year survivors (log rank, 
p = 0.003).
Conclusion: Liver surgery in patients with portal vein 
tumor thrombus complicating HCC can be performed with 
satisfactory OS rate in patients with strictly normal liver 
function.
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Introduction: The neutrophil to lymphocyte ratio (NLR) 
has been proposed as a prognostic indicator following resec-
tion for hepatocellular carcinoma (HCC). The aim of this 
study was to determine whether the neutrophil to lymphocyte 
ratio is predictive of recurrence after resection in HCC, and 
if cirrhosis or viral hepatitis have any effect on this predictive 
value.
Methods: A retrospective review was performed of all 
patients who underwent resection for HCC at a single institu-
tion between June 2002 and July 2011. A pre-operative NLR 
ratio greater than 5, which has previously been shown to be 
associated with poor prognosis, was considered elevated. 
Recurrence was defi ned as any evidence of disease by com-
puted tomography or biopsy after the time of primary resec-
tion. Primary outcomes were rate of recurrence and 5 year 
survival determined by the Kaplan-Meier log rank method. 
Sub-group analysis was performed for patients with cirrhosis 
and viral hepatitis.
Results: Eighty one patients were identifi ed and a pre-oper-
ative blood count with differential was available for 68 
patients. Of these 68 patients, 34 had known disease recur-
rence. The 1-, 3-, and 5-year overall survival rates were 75%, 
29%, and 16% respectively. Twelve patients had a NLR > 5. 
The rate of recurrence among patients with a NLR > 5 was 
50% (n = 6), and among those with NLR < 5 was 50% (n = 
28, p = 0.75). Five year survival was 50% in NLR > 5 and 
46% in NLR < 5 (p = 0.82). Median survival for NLR > 5 
was 28 months and for < 5 it was 71 months (p = 0.60). 
Subset analysis demonstrated no statistically signifi cant dif-
ferences in recurrence or 5-year survival with elevated NLR 
in patients with cirrhosis or viral hepatitis.
Conclusion: In this series, NLR was not a valuable predic-
tive tool for survival or recurrence after resection for HCC. 
These results were borne out when subset analysis of patients 
with cirrhosis and viral hepatitis was performed. Though the 
host immune response likely plays an important role in long-
term outcomes of cancer patients, this study and several 
others call into question the utility of NLR in predicting 
long-term oncologic outcomes.
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Introduction: Central hepatectomy is a complicated opera-
tion in liver surgery.
Methods: The tertiary branches to S4 from the umbilical 
portion are ligated and divided. The liver parenchyma is dis-
sected along the falciforme ligament and then the middle 
hepatic vein is ligated and divided. The anterior surface of 
the inferior vena cava and the trunk of the right hepatic vein 
are confi rmed. The right anterior Glissonean pedicle is 
ligated and the liver parenchyma is dissected on the border-
line between the right anterior and the posterior section. The 
small branches from the right hepatic vein are divided and 
liver dissection is performed along the main right hepatic 
vein.
Results: We performed central hepatectomy for 57 HCC 
patients from 1990 to 2010. The morbidity and mortality are 
the same as those in other type of sectionectomy or 
hemi-hepatectomy.
Conclusion: Central hepatectomy is a feasible and safe 
operation for tumors located in the central area of the liver.
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Introduction: To evaluate a novel methylene blue staining 
technique for guiding anatomic hepatic resection for hepato-
cellular carcinoma (HCC).
Methods: Between February 2009 and June 2010, hepatic 
segmentectomy was performed in 43 HCC patients using a 
novel sustained methylene blue staining technique. Sustained 
staining was achieved by injecting methylene blue into the 
distal aspect of the portal vein after isolating Glisson’s 
sheath. The hepatic pedicle was immediately ligated, and the 
hepatic parenchymal transection was performed along the 
interface between methylene blue stained tissue and unstained 
tissue.
Results: Anatomic hepatectomy was performed in all 
patients including monosegmentectomy (n = 21), subseg-
mentectomy (n = 7), combined multisegmentecomy (n = 10), 
and hemihepatectomy (n = 5). The portal vein was success-
fully injected with methylene blue in 100% of cases, and 
complete staining of the target hepatic segment was achieved 
in 41/43 (95.3%) cases. Mean intraoperative bleeding was 
300 ± 50 mL, and the postoperative complication rate was 
18.6% (8/43). Surgical margins were all negative on patho-
logic examination. Mean duration of postoperative follow-up 
was 19 months (range, 12 to 28). Eleven patients had intra-
hepatic recurrence, but no recurrence around the surgical 
margin.
Conclusion: This novel technique of achieving sustained 
staining by injecting methylene blue then immediately ligat-
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ing the hepatic pedicle is simple and feasible. It can guide 
the selection of the surgical margin during hepatic paren-
chyma transection to improve the accuracy of anatomic 
hepatectomy for the treatment of HCC.
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Introduction: Spontaneous rupture of HCC is a rare but 
dreadful complication. The exact mechanism leading to it is 
not clearly defi ned: subcapsular location, tumor necrosis and 
rapid growth seem to be predisposing conditions. The treat-
ment is controversial and largely dependent on general con-
ditions of the patient. Some studies have reported better 
survival with staged hepatectomy, but debates still remain 
because of the high operative mortality and poor prognosis 
of non-operative procedures.
Methods: Among 34 patients with HCC who underwent 
hepatic resection between December 2007 and December 
2011 in our Hepato-Biliary-Pancreatic Surgery Unit, two 
patients had ruptured HCC. The fi rst case was a 55-year-old 
male patient who came to our attention for an hemorrhagic 
HCC (3 cm) with mild hemoperitoneum (MELD score 7). 
We performed a wedge resection of S6. The second case was 
a 75-year-old man who presented to our attention for a rup-
tured formation (14 cm) of left liver compatible with HCC 
and hemoperitoneum (MELD score 7). We treated patient 
conservatively with blood derivate transfusion until hemo-
dynamic conditions stabilized (Hb 7.7 mg/dl on admission), 
then we performed a left lobectomy.
Results: Post-operative course was regular in both patients. 
Histological exams demonstrated a trabecular HCC with 
large necrosis areas. The fi rst patient is still alive at 19 fol-
low-up with no disease recurrence or hepatic failure; unfor-
tunately the second one died after 7 months for hepatic 
recurrence and cerebral metastases.
Conclusion: In these patients the primary purpose is to sta-
bilize hypovolemic shock, but the choice of therapeutic 
approach is very important for prognosis. Since surgery is a 
defi nitive treatment, it is the fi rst option. Angiographic embo-
lization (TAE) is an alternative method to achieve hemostasis 
in patients with poor liver function or multifocal HCC and 
it can be a bridge treatment preliminary to surgical resection 
in unstable patients. Our results confi rm poor prognosis of 
this pathology.
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Introduction: We established a preferred postoperative 
drain management rule (“3 × 3 rule”) in liver resection. This 
rule was made in accordance with the association between 
drain fl uid culture and the bilirubin value < 3 mg/dL on 
postoperative day 3. We recommended this rule; drain 
removal if the drain-fl uid bilirubin concentration is < 3 mg/
dL on POD 3. To validate the feasibility and diagnostic value 
of the 3 × 3 rule.
Methods: We analyzed data on 316 abdominal drains in 250 
consecutive patients who underwent liver resection for 
malignancies. Drain-fl uid volumes, bilirubin levels and bac-
teriologic cultures were measured on postoperative days 
(POD) 1, 3, 5, and 7. The drains were removed in accordance 
with the 3 × 3 rule. The actual bile leakage and drain fl uid 
infection rate was measured and the accuracy, false positive 
rate and false negative rate of drain management were retro-
spectively analyzed. We validated those rates two different 
time periods (at the time of established 3 × 3 rule and on 
2009–2011).
Results: There was no signifi cant difference on patients’ 
backgrounds in two time periods. There was no intra-abdom-
inal infection and no needed for additional intervention in 
accordance of 3 × 3 rule. Between 2009 and 2011, the total 
infection rate was 14.0% (35/250). The infection rate was 
comparable to the time when 3 × 3 rule was established 
(16.1% vs. 14.0%, p = 0.86). The median duration of drain 
placement was signifi cantly shortened (6.7 days vs 3.4 days, 
p < 0.01) by 3 × 3 rule. The infection rate within 3 × 3 rule 
(false positive rate) was 2.4% (6/250).
Conclusion: The 3 × 3 rule allows an early removal of 
drainage tube with minimum infection risk and adequate 
information from drains.
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NEITHER BIOLOGICAL REACTIONS 
NOR CLINICAL OUTCOMES WERE 
DIFFER WITH OR WITHOUT 
THORACOTOMY IN LIVER RESECTION
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Introduction: The transthoracic approach in liver resection 
is a useful option for improving the clearance of and access 
to the operation fi eld. However, this approach remains con-
troversial due to the threat of increased respiratory complica-
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tions. The aim of this study was to evaluate the clinical 
outcomes and biological responses of patients who under-
went the transthoracic versus the transabdominal approach 
in liver resection.
Methods: This case-matched cohort study included a total 
of 127 patients who underwent treatment for hepatocellular 
carcinoma, forty-four (34.6%) patients had the transthoracic 
approach of liver resection, and the patients were matched 
on three variables: (1) scale of liver resection, (2) periopera-
tive steroid administration, and (3) pathologically proven 
liver cirrhosis. The patients were divided into two groups 
according to the transthoracic (n = 36) or transabdominal (n 
= 36) approaches. Clinical outcomes (including respiratory 
and overall complications) and biological responses (includ-
ing acute-phase cytokine production and oxygenation) were 
compared between the two different approaches.
Results: The preoperative variables were well matched. 
However, for the transthoracic group relative to the transab-
dominal group, the median operative time was signifi cantly 
longer (median: 402 min [range: 236–661] vs. 330 min 
[range: 178–697], P < 0.001), the ischemia time was shorter 
(65 min [range: 12–223] vs. 76 min [range: 28–247], P = 
0.04), the level of AaDO2 on POD 1 was higher (66.1 vs. 
33.5 Torr, P = 0.04), and the IL-6 level in pleural effusions 
on POD2 was higher (21,900 pg/ml [range: 6,020–123,000] 
vs. 866 pg/ml [range: 389–2,210], P < 0.001). There was no 
postoperative mortality and no signifi cant difference between 
groups in overall morbidity (P = 0.81), overall respiratory 
complications (P = 0.11) and length of postoperative hospital 
stay (P = 0.23).
Conclusion: Because of there was no signifi cant difference 
between transthoracic and transabdominal approaches. It is 
no need for hesitate using the transthoracic approach in liver 
resection when tumor location was suitable.
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Introduction: Metachronous LN metastasis is generally 
found in end-stage disease with multiple intra- and/or extra-
hepatic metastases. The reported one-year survival rate of 
patients with LN metastasis is around 50%; therefore, surgi-
cal treatment is rarely performed for metachronous LN. Few 
reports are available on patients with metachronous LN 
metastases who were successfully treated by surgical resec-
tion but among whom the indication for metastasis dissection 
was limited.
Methods: We performed transarterial chemotherapy with 
80 mg/body of cisplatin powder (IA Call, Kaken, Tokyo) 
with 3 ml of ethiodized oil (Lipiodol) emulsion. This pro-
cedure was initially performed through the common 
hepatic artery and left gastric artery. As the LN metastasis 
was fed by two arteries, blood alternation through coil 
embolization of the left gastric artery was performed to 
provide the LN with a uniform blood supply. This 
approach enabled simultaneous infusion of both the meta-
static LN and the liver.
Trans arterial chemotherapy was performed a total of three 
times to control the LN metastasis and to prevent meta-
chronous intrahepatic recurrence.
Results: The tumor was well controlled, and no new recur-
rent intra- or extrahepatic lesion was observed for 6 months. 
LNs were systematically dissected from the celiac axis to the 
proper hepatic artery. Histopathological examination revealed 
that the metastatic lesion was single and pathologically 
proved metastatic HCC. The postoperative course was 
uneventful, and the patient was discharged from the hospital 
9 days after the operation. The patient remains in good condi-
tion without any recurrence for almost 5 years after the LN 
dissection.
Conclusion: Surgical resection for LN metastases from 
HCC should be strictly limited because of its poor prognosis. 
However, the surgical approach may be ideally suited to 
stably-controlled solitary metachronous LN metastases. 
Careful re-evaluation of the status of a metastatic lesion may 
contribute to an improved patient prognosis.
674
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Introduction: TDM-621, a colorless acidic solution, is a 
newly developed local hemostatic agent. Once it contacts 
with blood, it shows neutralization and gelation resulting 
hemostasis for exudative hemorrhage from the tissue. We 
report a result of prospective trial for the effi cacy and safety 
of TDM-621 in liver resection in this paper.
Methods: A total of 45 patients of Child-Pugh class A, who 
performed an elective open or laparoscopic liver resection 
between August 2010 to April 2011 in 4 institutions, enrolled 
in this study. TDM-621 was uniformly applied to the area 
where has exudative hemorrhage on the hepatic resection 
plane, until the achievement of hemostasis. Effi cacy of 
hemostasis was classifi ed into 4 groups defi ned as excellent; 
in which the hemostasis was completely obtained, effective; 
in which the hemostasis was fi nally gained with repeat appli-
cation of TDM-621, minor effect; in which required other 
modalities for hemostasis, and invalid in which the hemosta-
sis was failed. And post-operative course of these patients 
were evaluated.
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Results: Thirty-nine liver resections in 45 patients had eli-
gible hemorrhage for this study in the total of 89 bleeding 
site. Eighty-two percent of these bleeders (73 sites) were 
hemostasized by TDM-621 without using other modalities, 
and were categorized to be excellent or effective. All surger-
ies were successfully performed. None of these patients had 
post-operative bleeding complication, except 1 patient had a 
conservatively improved hemorrhage from abdominal drains 
at 1 post-operative day. Surgical site infection or other 
adverse events were not observed.
Conclusion: TDM-621 is an absorbable artifi cial composi-
tion without a risk of infectious disease derived from living 
body. Our study suggests that TDM-621 can provide a simple 
and effective hemostasis for exudative hemorrhage in liver 
resection of both open and laparoscopic procedures. 
Otherwise, a long term observation will be required to evalu-
ate an incidence of foreign body reaction.
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Introduction: Recurrence after liver resection for hepato-
cellular carcinoma (HCC) is common. Resection of extrahe-
patic recurrences such as lung metastatectomy (LM) has 
been well documented. Conversely, reports on the long term 
outcome of peritoneal metastatectomy (PM) are lacking. In 
this study, we compare the outcome of lung and peritoneal 
metastatectomy following hepatectomies for HCC in a ter-
tiary institution.
Methods: We retrospectively reviewed the data of 1222 
patients who underwent hepatectomies for HCC in Samsung 
Medical Center in Korea from January 2006 to August 2010. 
We studied the clinicopathological factors between resected 
lung metastasis (LM) and peritoneal metastasis (PM) and 
their long term outcome. Kaplan-Meier analysis was used to 
study the survival outcome.
Results: The recurrence rate of resected HCC in this cohort 
was 41.6% (n = 508). Thirty-two patients with lung metas-
tasis (23.2%) underwent LM while 13 patients (36.1%) of 
patients with peritoneal metastasis underwent PM. Two 
patients underwent PM and LM sequentially. Demographic 
and clinical data between the LM and PM groups were com-
parable. However, the mean prehepatectomy PIVKA-II level 
was signifi cantly higher in the LM group compared to PM 
group (p = 0.029).
On univariate analysis of pathological factors, the median 
tumour size (p = 0.005), proportion of patients with tumor > 
75 mm (p = 0.005) and rate of microvascular invasion (p = 
0.047) were signifi cantly greater in the LM group. The 
median time-to-recurrence in the LM group was 12.0 (4.0–
45.0) months compared to 18.0 (1.0–102.0) months in the 
PM group (p = 0.896). The 1-year, 3-year and 5-year overall 
survival (OS) of patients in the LM group was 92.0%, 55.0% 
& 55.0% while that in the PM group was 90.0%, 75.0% & 
38.0% respectively. The mean OS in the LM was comparable 
to that in the PM group (p = 0.578).
Conclusion: Twenty-three percent (23.2%) of patients with 
lung metastasis and 36.1% of patients with peritoneal metas-
tasis could undergo metastatectomy. The long term survival 
of patients with PM and LM was comparable in this study. 
While LM has been shown to improve survival in patients 
with HCC, we demonstrated favourable outcome for PM 
as well, which in many situations would be considered 
palliative.
679
HEPATIC RESECTIONS USING HOME-
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T.-L. Tam, T.-P. Fung, W. Chu, S.-W. Wong and S.-H. Lam
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Introduction: Saline-linked cautery (tissue-link) is widely 
used in liver surgery and is reported to decrease blood loss 
during liver transection. We would like to evaluate our expe-
rience with our home-made saline linked cautery – UC 
Sealer.
Methods: A retrospective study of 90 liver resections using 
a home-made saline linked cautery was performed. The 
device is assembled with a nasogastric tube, a disposable ball 
tip diathermy and an intravenous fl uid drip set. The dia-
thermy machine power setting is 80 watts in coagulation 
spray mode. The whole device only costs 25 USD.
Results: Between March 2009 and December 2011, 40 
major hepatectomy cases and 50 minor hepatectomy cases 
were performed with the use of this device. The median age 
of patients was 64. Mean blood lost was 336 cc (20–2300), 
the mean transection time was 135 min (45–300). No 
Pringle’s maneuver was used during surgery. No patient died 
during surgery or during the postoperative period.
Conclusion: Our home-made saline linked cautery is easy 
to assemble and use. It provides good hemostasis of the cut 
liver surface, and thus reduces bleeding and necessity for 
Pringle’s maneuvers, with results comparable to the com-
mercially available devices.
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Introduction: The most effective treatment of HCC meeting 
Milan Criteria is liver transplant. Nevertheless, there is no 
clear consensus concerning HCC patients who are not eli-
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gible for transplantation. The aim of this study is to report 
our experience with surgical resection of HCC patients 
falling beyond the Milan criteria.
Methods: From 1990 to 2010 a total of 173 patients under-
went surgical resection for HCC beyond Milan criteria at the 
Henri Mondor General and Liver surgery unit. Data regard-
ing these patients were prospectively recorded. We retrospec-
tively analyzed clinicopathological features as well as overall 
survival and disease free survival of the series.
Furthermore among patients presenting recurrence survival 
rates were compared between the “treated group” (re-hepate-
ctomy, RF, Chemioembolization, Chemiotherapy, salvage 
liver transplant) and “non-treated group (supportive therapy).
Results: The series mean age was 58 (SD 15.6). The histo-
pathologic fi ndings showed a mean tumor size of 113.5 mm 
(SD 47.9) and 104 microscopic vascular invasion. 143 
patients underwent R0 resection, 31 R1. Postoperative mor-
bidity was 39.8% and mortality 9.24%.
The overall survival was 69/38.2/26.1% at 1/3/5 years 
respectively; the overall disease free survival was 33/11.4/4% 
at 1/3/5 years respectively. The overall survival following 
recurrence was 77.9/43.1/28.8% in the “treated group” and 
31.6/17.3/0% in the “non-treated group” at 1/3/5 years 
respectively with p = 0.0057. When comparing recurrence 
treatments, survival outcome for re-hepatectomy was 
77/33/33% at 1/3/5 years; survival was 100% at 22 months 
for salvage transplant (2 patients).
Conclusion: ”Out of Milan” HCC patients can be offered a 
potentially curative liver resection. Recurrent disease should 
be treated whenever possible since it shows better survival 
outcome than supportive therapy. Interestingly if recurrence 
is managed by “re-hepatectomy” survival rates at 3 and 5 
years stabilize around 33%. Salvage liver transplantation for 
recurrent HCC that was primarily non transplantable seems 
to yield good outcomes. Larger series and longer follow-up 
are needed to confi rm these results.
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Introduction: HCC is the most frequent liver malignancy, 
usually developed due to persistent chronic hepatitis. While 
good treatment results after radical resection or liver trans-
plantation in cases with small lesions are predictable, the 
treatment of multifocal, large (more than 5 cm) tumors and 
these ones with infi ltration of IVC or hepatic veins still 
remains a moot question. Sparing of enough remnant liver 
necessitates the utilization of different multimodal strategies 
in the treatment of HCC.
Methods: One hundred and three patients with HCC who 
underwent operative treatment in our department from 2005 
to 2010 were prospectively evaluated. Fifty-four of the 
patients were male and 49 female. The average age was 59.7 
years (vary from 2 to 78). CT volumetric assessment in 
combination with clinical examination and blood biochem-
istry was used for prediction of suffi ciency of remnant liver 
volume before major resection. Three liver transplantations, 
69 radical resections, 6 ligations of the right branch of the 
portal vein (RBPV) and 25 explorations were made. Twenty-
one of the operations were performed laparoscopically, 
including 7 segmental or wedge resections and 2 ligations of 
RBPV.
Results: Viral hepatitis was observed in 37.8% patients. In 
27 cases resection of tumor larger than 5 cm were done. 
Regarding radical resections: 29 of them were major 
anatomical and the remaining 40 were segmental, bi-seg-
mental or wedge resections spearing liver parenchyma. 
Postoperative morbidity was 26.3% (19 cases), 8 patients 
were present with III and IV grade according to Dindo-
Clavien’s classifi cation. Mortality level was 2.7%. Median 
follow up time was 35 months. One- and 3 year survival rates 
for the group underwent major resections were lower than 
this of the group with T1 and T2 tumors, 73% and 48%, and 
91% and 72% respectively, but they were signifi cantly higher 
than that of patients who underwent palliative procedures 
(p = 0.02).
Conclusion: At present, in the era of donor shortage, surgi-
cal resection still remains the most applicable and effective 
treatment of HCC. Satisfactory results were obtained even 
after major resections in non-cirrhotic livers. The utilization 
of multimodal conceptions could increase the rate of resect-
ability. The most important factors infl uencing long-term 
results are related to the tumor size and number, and biologi-
cal features such as vascular invasion and tumor cell 
differentiation.
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1Columbia University of Physicians and Surgeons, New 
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Introduction: Chronic Hepatitis C is a global challenge 
with End stage liver disease and rising Hepatocellular 
Carcinoma. Peg Interferon Alfa and Ribavirin was the back-
bone of therapy. Recently introduced Directly Acting 
Antivirals (DAAs) -protease inhibitor has a promising role 
in escalating Sustained Viral Response (SVR) in Response 
guided therapy in non-responders, partial and relapses. This 
study utilized Nitazoxanide (NTZ) & Telapravir, with SOC 
for 24 weeks in treatment Experienced Patients.
Methods: Fifty (n = 50) patients were divided into Group 
A (n = 12) NTZ 500 mg three times for 12 weeks, Group B 
(n = 12) NTZ 500 mg twice daily for 24 weeks Group C (n 
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= 26) control. All received Peg Interferon Alfa2a 180 mcg 
SQ QOW with fi xed dose of Ribavirin 1200 mg daily for 24 
weeks with Telapravir 750 mg three times daily for 12 
weeks. Viral load was obtained at day 0, 7th day, 14th day, 
4 weeks, 12th week and 24 weeks. Viral kinetics was 
analyzed.
Results: In Group A: 5/12 (42%) non-responder, 6/12 (50%) 
partial responder, 2/12 (16%) relapsers. In Group B: 5/12 
(42%) non-responders, 6/12 (50%) partial responder, 1/12 
relapsers (8%). In Group C: 10/26 (38%) non-responder, 
10/26 (38%) partial responder, 4/26 (15%) relapsers, 2/26 
(8%) unknown.
Conclusion: This quadruple truncated regimen has excelled 
the RVR, ETVR over SOC with DAAs over 13%, without 
any difference between 24 weeks of NTZ over 12. Needs a 
larger trial for validation.
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VEIN RECONSTRUCTION FOR HUGE 
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and J.-M. Namkoong
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Introduction: When advanced huge hepatocellular carci-
noma (HCC) involves segment 5, 7 and 8, Rt. lobectomy is 
usually recommended. However, old aged patient with cir-
rhotic liver and small left lobe volume can not tolerate for 
major hepatectomy such as Rt. lobectomy. Under this situa-
tion, the patient having initially unresectable huge HCC 
occupying the right lobe (segment 5, 7, and 8), we success-
fully performed segment 6 preserving systematic Rt. hepa-
tectomy with Rt. hepatic vein resection and reconstruction.
Methods: The patient was a 71-year-old male having cir-
rhotic liver. He presented with a huge HCC located at 
segment 5, 7 and 8. Indocyanine green 15 minutes retension 
rate was 27.943%. Rt. anterior, posterior and left hepatic 
Glisson pedicles are isolated. The extent of hepatectomy was 
decided by clamping of Rt. anterior Glisson pedicle and 
demarcation between segment 6 and 7 under guidance of 
intraoperative ultrasonography. Hepatectomy was performed 
by Kelley crushing method using intermittent Pringle maneu-
ver. Distal RHV draines segment 6 and RHV stump were 
isolated respectively, and then intervening RHV was resected 
with segment 5, 7, and 8. After bleeding control, RHV was 
reconstructed with fresh iliac vein graft from cadaveric organ 
donor.
Results: His postoperative coarse was uneventful. 
Postoperative peak AST/ALT, total bilirubin and prothrom-
bin level were 532/430 (IU/L), 3.0 mg/dl, and 60.0%, respec-
tively. The liver function test has been improved and nearly 
normalized only a few days after. The patient was recovered 
uneventfully and discharge on postoperative 23 days.
Conclusion: Right hepatic vein resection and reconstruction 
combined with segment 6 preserving systematic Rt. 
lobectomy may selectively offer a chance of curative resec-
tion for a patient in whom right lobectomy is unacceptable 
due to old age, liver cirrhosis and also too small expected 
remaining left liver volume for huge HCC occupying segment 
5, 7 and 8.
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COMPLETE CLINICAL RESPONSE OF A 
PATIENT WITH LYMPH NODE AND 
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Gastroenterology Surgery, 8-1 Kawada-cho, Shinjyuku-ku, 
Tokyo 162, Japan
Introduction: Sorafenib has been demonstrated to prolong 
the overall survival of HCC patients in large-scale clinical 
studies conducted to validate its approval as standard therapy. 
In these previous studies, no complete clinical responders 
were identifi ed. However, complete response (CR) cases 
have been reported occasionally, which has attracted increas-
ing interest regarding the effi cacy of sorafenib against HCC.
Results: The patient was a 74-year-old woman. Based on 
that lymph node metastasis of hepatocellular carcinoma after 
resection was diagnosed. The lesion was a solitary nodule in 
direct contact with aortic wall. Due to these fi ndings, the oral 
administration of sorafenib was started at an initial dose of 
400 mg/day 3 times a week. Because of the adverse reactions 
improved, administration of the therapy was resumed at 
200 mg/day three times a week. Both, lung and lymph node 
metastases disappeared on CT at 5 months of treatment. No 
accumulation of contrast in the peri-aortic lymph node was 
detected on PET-CT at 7 months of therapy. After 12 months 
of therapy, the patient is still in CR on sorafenib at a dose of 
200 mg/day twice a week.
Conclusion: This case is suggested that sorafenib adminis-
tration must be continued when its dose is reduced in indi-
vidual cases as CR may be achieved by continuous low-dose 
therapy. Taken together, this is an important case which 
showed that long-term low-dose sorafenib therapy achieved 
CR in terms of lymph node and pulmonary metastases in a 
patient following surgery for HCC.
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REVALUATION FOR SURGICAL 
INDICATION OF HEPATOCELLULAR 
CARCINOMA BASED ON 
MAKUUCHI CRITERIA
H. Nakayama, T. Takayama and S. Yamazaki
Department of Digestive Surgery, Nihon University School 
of Medicine, Tokyo, Japan
Nihon University School of Medicine, Department of 
Digestive Surgery, 30-1 Oyaguchi kami-cho, Itabashi-ku, 
173 Tokyo, Japan
Introduction: In Japan, indication of liver resection is uni-
versally chosen based on the Makuuchi criteria. The validity 
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of the Makuuchi criteria to hepatocellular carcinoma (HCC) 
is re-verifi ed.
Methods: The liver function, operative factor, and progno-
sis were investigated for 433 patients with HCC that were 
performed curative liver resection in 2001–2008. The 
patients having Child-Pugh A (some B) were enrolled for 
operation. Ascites, serum bilirubin value, and ICGR15 value 
were measured. The area of liver resection was determined 
based on the Makuuchi criteria. Transection of liver was 
carried out using the Pean clamp crushing technique.
Results: In background factor, there were 52 hepatitis B 
surface antigen positive (12%) and 255 HCV antibody-pos-
itive (59%). Median ICGR15 value was 12%. In the factor 
of operation, they were the amount of bleeding of 335 g 
(5–3500), 30 blood transfusions (7%) and 326 minutes of 
operation time (90–1004). In the feature of HCC, 3 cm 
(1–29) in median diameter of cancer was shown, and the 
single cancer was shown on 290 patients (67%). Major post-
operative complications were shown as pleural effusion 
(27%), drain infection (13%), wound infection (11%), and 
bile leakage (7%). Cumulative fi ve-year survival was 60% 
(Stage I: 74%, II: 64%, III: 55%, IV: 38%).
Conclusion: The Makuuchi criteria presents appropriate 
indication of liver resection for HCC, and the Pean clamp 
crushing technique is safe liver transection method.
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SIMULTANEOUS IDENTIFICATION OF 
TWO LIVER CANCERS DURING 
RESECTION OF COLON CANCER
H. Nakayama, T. Takayama and M. Hirabayashi
Department of Digestive Surgery, Nihon University School 
of Medicine, Tokyo, Japan
Nihon University School of Medicine, Department of 
Digestive Surgery, 30-1 Oyaguchi kami-cho, Itabashi-ku, 
173 Tokyo, Japan
Introduction: We encountered a chronic hepatitis C patient 
in whom early colon cancer and 2 liver masses were found 
simultaneously, and the differentiation of the liver tumors 
was diffi cult. Herein, we report the case.
Methods: The patient was a 71-year-old man with colon 
cancer that was found during follow-up for hepatitis C, and 
he underwent endoscopic resection in July 2010. At the same 
time, 2 masses were detected in the liver on CT. A mass 
stained intensely in the S7 region was diagnosed as hepato-
cellular carcinoma, and another mass that was enhanced het-
erogeneously in the S6 region was suspected as colonic 
metastasis to the liver or intrahepatic cholangiocellular 
carcinoma.
Results: Hepatectomy was performed in September 2010. 
On histopathological examination, the former was found to 
be a moderately-differentiated hepatocellular carcinoma 
(HCC). The latter was a moderately-differentiated adenocar-
cinoma that was positive for cytokeratin (CK) 7 and negative 
for CK20 on immunostaining, upon which intrahepatic chol-
angiocellular carcinoma was diagnosed.
Conclusion: For the differentiation of liver tumors in cases 
of colon cancer, immunohistological diagnosis using the CK 
profi le is useful.
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PREVALENCE OF HEPATITIS E IN NEW 
YORK AMONG HIV NEGATIVE 
CHRONIC LIVER DISEASE POPULATION 
“IS IT AN INNOCENT BYSTANDER”
P. Basu1, T. Nair2, S. Farhat2, S. Foustin2, L. Ang2, 
M. Jafri3, K. Mittimani2 and N. J. Shah2
1Columbia University of Physicians and Surgeons, New 
York, USA; 2North Shore University Hospital, Forest Hills, 
New York, USA; 3NYMC Richmond University, Staten 
Island, New York, USA
Columbia University of Physicians and Surgeons, 
Hepatology and Liver Transplant, 5 Station Square, Forest 
Hills 11375 New York, USA
Introduction: Hepatitis E is essentially an oro-fecal infec-
tion with high prevalence in developing countries. There is 
limited data available on its prevalence in Urban US. The 
study evaluates the prevalence of Hepatitis E antibody IgG 
and IgM in New York in patients with chronic liver disease.
Methods: Four hundred forty (n = 440) were divided into 2 
groups: group A; control 140 patients without any stigmata 
of liver disease. Group B, 300 patients with history of liver 
disease including hepatitis B 125/300 (41%), Chronic hepa-
titis C 60/300 (20%), fatty liver 70/300 (23%), Alcoholic 
liver disease 29/300 (10%), HBV HCV co infection 9/300 
(3%), auto immune hepatitis 2/300 (0.6%), PBC/PSC 5/300 
(2%). HEV antibody IGM and IGG were measured with 
HEV genotyping. 22/300 (7%) patients were liver transplant 
recipients, 6/300 (2%) patients were kidney transplant recipi-
ents. 43/300 (14%) patients were Intra venous Drug Abuser. 
20/300 (7%) received Blood products.
Results: Group (A) HEV IgG positive 13% (18/140), Group 
B HEV IgG positive 40.6% (122/300) including 3.7% 
(4/122) having both IgM & IgG positive. The prevalence of 
HEV IgG was 54% (12/22) in the liver transplant recipient 
group and 33% (2/6%) kidney transplant recipient group.
Conclusion: The study demonstrates the prevalence of 
Hepatitis E infection in New York and HEV antibody in 
CLD. Including transplant donors and recipients. Question 
remains the impact and progression of acute or chronic liver 
disease with concomitant HEV in pre, peri, and post liver 
transplant recipient. Larger study needs to validate.
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LIVER RESECTION FOR LOCALLY 
ADVANCED HCC WITH 
CHILD A CIRRHOSIS
S. Sasturkar, N. Kumar and V. Pamecha
Dept. of HPB Surgery, Institute of Liver & Billiary 
Sciences, New Delhi, India
Institute of Liver & Billiary Sciences, New Delhi, India; 
Dept. of HPB Surgery D-1, Vasant Kunj 11007, New Delhi, 
India
Introduction: Liver resection for large HCC with macro-
vascular invasion and/or biliary tract involvement remains a 
clinical challenge in patients with cirrhosis. The indications 
for liver resection for HCC in Child A cirrhosis are expand-
ing. In HCC, whether the tumor volume or tumor biology 
determines treatment outcome remains unclear. Performance 
status is an established independent clinical criterion in treat-
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ment planning. Here we share our experience of liver resec-
tion for locally advanced HCC.
Methods: Four men with Child A cirrhosis (HBV-3, HCV-1) 
with HCC underwent liver resection. The median age 40 yrs 
& mean tumor diameter was 8.3 cm. First patient with left 
lobe HCC (8.8 cm) with multiple nodules and 1.5 cm nodule 
in the segment VI; underwent modifi ed extended left hepa-
tectomy & wedge resection of seg. VI. Second patient with 
tumor (5 cm) involving the right hepatic duct and right pos-
terior branch of portal vein; underwent right hepatectomy, 
CBD excision & hepaticojejunostomy. Third patient; HCC 
(10.1 cm) in right lobe with right portal vein tumor throm-
bus. Right hepatectomy with portal venoplasty was per-
formed. The forth patient with HCC (9.5 cm) in right lobe 
with right posterior portal vein invasion and right hepatec-
tomy was performed.
Results: All patients in our series were with ECOG perfor-
mance status zero. The mean operative time & estimated 
blood loss were 11 hr & 1135 ml respectively. On histopa-
thology all four patients had R-0 resection with moderately 
differentiated Grade II HCC. There was no evidence of meta-
static disease.
All four patients recovered without any decompensation 
of liver function except prolonged ascitic drainage. The mean 
post operative hospital stay was 14 days. Ascites was control-
led with diuretics & albumin therapy (Clavien-Dindo Grade 
1 complication). The median follow up is 6 months (range 
3–9 months). No evidence of recurrent disease or liver 
decompensation on follow up till date. Patients with HBV 
related cirrhosis were started on antiviral therapy.
Conclusion: Liver resection for large & locally advanced 
HCC in patients with Child A cirrhosis and good perfor-
mance status has showed good short term outcome in our 
series.
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SARCOMATOUS HEPATOCELLULAR 
CARCINOMA WITH SOFT 
TISSUE METASTASIS
I. Y. Park1, Y. J. Kim1, Y. H. Eom1, K. Y. Baek2, 
D. D. You3, S. J. Kim4, K. H. Kim5 and J. Kim1
1Department of Surgery, Bucheon St. Mary Hospital, 
Catholic University of Korea; 2Department of Surgery, St. 
Mary Hospital, Catholic University of Korea; 3Department 
of Surgery, St. Vincent Hospital, Catholic University of 
Korea; 4Department of Surgery, Daejeon St. Mary 
Hospital, Catholic University of Korea; 5Department of 
Surgery, Euijongbu St. Mary Hospital, Catholic University 
of Korea
Bucheon St. Mary Hospital, Catholic University of Korea, 
Surgery, Sosa-Dong, Wonmi-Gu 420-7 Bucheon, Republic 
of Korea
Introduction: Sarcomatoid hepatocellular carcinoma is a 
rare variant of hepatocellular carcinoma.
Methods: A 62-year-old man was admitted due to sudden 
severe right upper quadrant abdominal pain which started 2 
weeks ago. He was chronic hepatitis B carrier for 20 years. 
Laboratory fi ndings showed normal liver function test except 
increase gamma-GTP. Alpha-FP was increased to 873.4 U. 
Abdominal CT showed there was a mass diameter of 5.3 cm 
in the segment VI of the liver.
Results: We underwent partial resection of the liver. The 
mass size was 6.6 × 7 cm. The mass had central hemorrhagic 
necrosis and was adhered to the retro-peritoneum. There 
were multiple large lymph nodes around it. On microscopic 
fi ndings, the tumor cells showed marked variation in cellular 
and nuclear shape and size. Immunohistochemically, the 
tumor cell was positive with cytokeratin and Vimentin. It 
reacted slightly with α-FP. He complained of right shoulder 
pain and noticed a shoulder mass one month after operation. 
Mass was biopsied with a true-cut needle. Pathology revealed 
identical result as indicated in the liver. It revealed sarcoma-
toid hepatocellular carcinoma. He died 2 months after opera-
tion due to multiple metastasis.
Conclusion: This case is very aggressive, invasive and 
rapidly deteriorating sarcomatoid hepatocellular carcinoma 
with soft tissue metastasis to shoulder.
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HEPATIC RESECTION FOR INITIALLY 
INOPERABLE HEPATOCELLULAR 
CARCINOMA (HCC); PRETREATED 
HEPATIC ATERIAL INFUSION OF 
CHEMOTHERAPY (HAIC)
G. C. Park, S. G. Lee, D. H. Jung and S. H. Kang
Asan Medical Center, Seoul, Korea
Asan Medical Center, Hepatobiliary and Liver 
Transplantation Surgery, 388-1 Pungnap-2 Dong, 
Songpa-Gu, Seoul 138-736, Korea
Introduction: Treatment of advanced HCC remains a sig-
nifi cant problem for clinicians. Numerous clinical studies 
have shown that HAIC provides moderate therapeutic effi -
cacy with substantially favorable toxicity profi les in selected 
patients groups with advanced HCC. We present our experi-
ence of two patients with initially inoperable advanced HCC 
who underwent hepatic resection after pretreated HAIC.
Methods: First case was 45 year old man who had multiple 
HCC with portal vein tumor thrombus (PVTT) in both lobes 
of liver on Dec. 2009. From Jan. 2010 to Jun. 2010, HAIC 
with 5-FU, mitomycin, epirubicin was performed six cycles 
and transarterial chemoembolization (TACE) once. At Jan. 
2011, he underwent partial hepatectomy uneventfully and 
was discharged well.
Results: Second case was 51 year old woman who had huge 
HCC with PVTT in left lobe on Oct. 2008. She took HAIC 
treatment with 5-FU, cisplatin six cycles till Apr. 2009 in 
spite of favorable toxicity (leukopenia). Left trisectionec-
tomy and caudate lobectomy with PVTT thrombectomy was 
performed successfully. Until now, there is no evidence of 
disease recurrence.
Conclusion: For initially unresectable HCC without liver 
cirrhosis, HAIC may be an effective treatment modality. We 
suggest that more clinical studies should be undertaken to 
explore the use of HAIC for advanced HCC patients.
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EXTENDING THE BOUNDARIES OF 
LAPAROSCOPIC AND OPEN 
LIVER RESECTION FOR 
HEPATOCELLULAR CARCINOMA
C. Kenfi eld, M. Basedow, R. Bryant and N. O’Rourke
Royal Brisbane Hospital
The Royal Brisbane Hospital, Hepatobiliary, Herston, 
Brisbane, Queensland 4029, Australia
Introduction: Liver resection is the best available treatment 
for hepatocellular carcinoma in patients not suitable for 
transplantation. However options for resection are limited by 
the regenerative capacity of the remnant liver, particularly 
where extended or bilateral resections are required. Strategies 
to improve the remnant volume include portal vein embolisa-
tion and staged resections.
Methods: We review a series of four patients undergoing 
extended and staged resections for hepatocellular carcinoma. 
Analysis of the suffi ciency of the expected liver remnant 
included the degree of fi brosis or presence of cirrhosis, 
Child-Pugh score, volumetric measurement of the remnant 
liver, indocyanine green clearance and response to portal 
vein embolisation.
Results: Four patients include a 58 male with cirrhosis sec-
ondary to alcohol with a 3 cm HCC segment 6 and 2.5 cm 
HCC segment 2 (laparoscopic segmentectomy 6, two months 
later underwent second stage laparoscopic left lateral sectio-
nectomy (home day 3 both admissions). A 29 male with 
chronic hepatitis B and F2 fi brosis with a 15 cm multifocal 
HCC right liver and a 6 cm HCC segment 4 (underwent right 
portal vein embolisation followed by trans-arterial chemo-
embolisation to segment 4 with a subsequent extended right 
hepatectomy. Home day 7). A 50 male with chronic hepatitis 
B, large and multifocal HCC right liver and segment 4 (right 
hepatectomy. Home day 9). A 47 female with Alagilles’s 
Syndrome (Laparoscopic left lateral sectionectomy for 
Segment 3 HCC followed by right hemihepatectomy for 
Segment 6 HCC. Home day 3, then day 8).
No patients developed postoperative hepatic insuffi ciency.
Conclusion: Extended and staged liver resections are an 
option for the surgical management of hepatocellular carci-
noma. Patients must be carefully selected by assessment of 
the regenerative capacity of the remnant liver.
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13 YEARS AND THOUSAND HCC 
PATIENTS TREATED IN A SINGLE 
ITALIAN SURGICAL UNIT: CHANGES IN 
TREATMENT STRATEGY
L. Lupo, P. Panzera, R. Memeo, G. Scialandrone, E. Poli 
and V. Memeo
University of Bari, Institute of General Surgery and Liver 
Transplantation
University of Bari, Institute of General Sugery and Liver 
Transplantation, Policlinico di Bari, Piazza Giulio Cesare, 
1170120 Bari, Italy
Introduction: Southern Italy is one of the European region 
with the higher incidence of HCC. From January 1997 to 
December 2010, 985 patients underwent surgical resection 
(RES), radiofrequency ablation (RFA) or Liver Transplantation 
(LT) for HCC in our centre. In 764 cases it was a fi rst diag-
nosis of HCC, in 221 cases a diagnosis of recurrent HCC. In 
this paper were analyzed data about these patients, trying to 
fi nd out changing in patients’ population and treatment 
strategy.
Methods: Patients’ mean age was 65 years (range 25–89). 
The 46.6% had a single nodule, the 28.27% of them 2 
nodules and the remaining 25.13% 3 or more nodules. The 
mean diameter of the main lesion was 34.8 mm (decreasing 
from 46 mm in 1997 to 30.1 mm in 2010). The 66% suffered 
from HCV hepatitis, 19% from HBV hepatitis, 7% from both 
HCV and HBV hepatitis, 8% was HBV and HCV negative.
312 patients underwent liver resection: 297 (95%) for a 
fi rst diagnosis HCC, 15 (5%) for HCC recurrence.
RFA was reserved to 579 patients with poor general condi-
tions or Child class ≥B7, or those class A with small nodes 
whose resection would have sacrifi ced a large amount of 
parenchyma.
Ninety-four patients underwent LT (MELD > 12 or 
“salvage LT”, Age < 65).
Results: During these 13 years there was a decreasing trend 
in the number of RES while there was an increase in the RFA 
group. During years the larger diameter of HCC nodules at 
treatment decreased. There was a prevalence of patients with 
two or more nodules in the LT group (P = 0.003). RES was 
mainly used as fi rst treatment and LT and RFA as second (P 
= 0.001). The OS of all 985 patients at one, three, fi ve and 
ten years was respectively 92.6%, 79%, 67.7% and 37.6%; 
In the RES group it was respectively 94.7%, 73.2%, 63% 
and 41.2%; in the RFA group it was 95.3%, 80%, 64.5% and 
14.4%; in the LT group it was 80%, 73.9%, 73.9% and 
66.4%. The OS correlated to cancer’s mass assessed by the 
sum of the main diameters of HCC nodules at treatment 
(P < 0.001).
Conclusion: During the last 13 years it was noticed an 
increasing use of RFA compared to RES. It may be conse-
quential to an earlier diagnosis of HCC (evidenced as a 
smaller cancer mass at treatment) and to a “Bridge to 
Transplantation” approach.
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TOTALLY ROBOTIC LIVER RESECTION 
FOR HEPATOCELLULAR CARCINOMA 
IN CIRRHOTIC PATIENTS: INITIAL 
EXPERIENCE IN A SINGLE HEPATO-
BILIARY-PANCREATIC AND 
TRANSPLANTATION INSTITUTE. 
CASE-MATCHED ANALYSIS
A. Slim, S. Di Sandro, A. Giacomoni, A. Lauterio, 
I. Mangoni, P. Mihaylov, M. Tripepi and L. De Carlis
Division of General Surgery and Transplantation, 
Niguarda Ca’ Granda Hospital, Milan, Italy
Niguarda Ca’ Granda Hospital, Division of General 
Surgery and Transplantation, Piazza Ospedale Maggiore, 
320162 Milan, Italy
Introduction: Background. Although the diffusion of the 
application of Robotic-Assisted surgery in the urology, gyne-
cology, thoracic, general and cardiac surgery, few studies 
report possibility and advantages of the Robotic-Assisted 
surgery for the liver tumors. Particularly, none author has 
considered before the real benefi t in the application of Totally 
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Robotic LR (TR-LR) into the specifi c setting of the HCC on 
liver cirrhosis.
Methods: Materials and Methods. Since March 2011, 18 
TR-LR were performed at our Institute. Among these, 10 
(56%) patients were treated due to single nodule of HCC 
associated to liver cirrhosis and were considered for the 
study analysis. To expand the signifi cance of study results, 
patients were compared to a series of 10 selected totally 
laparoscopic LR (TL-LR) of HCC on liver cirrhosis (also 
performed in our Institute) by case-matching analysis.
Results: Results. Analysis of the peri-operative data have 
demonstrated signifi cant differences concerning the median 
number of packed red blood cells units transfused (respec-
tively, 0.3 and 0.8 for TR-LR and TL-LR: P-value = .008) 
and of fresh frozen plasma units transfused (respectively, 0.7 
and 1.3 for TR-LR and TL-LR: P-value = .035). Oncological 
features compared between the two groups (TR-LR and 
TL-LR).
Conclusion: Conclusion. In our experience, TR-LR appears 
to be at present the major minimally invasive technique who 
can better reproduce what it could be performed by the open 
liver surgery. TR-LR allows to expose patients at signifi cant 
lower risk of bleeding, transfusion, biliary and vascular com-
plications. Furthermore and probably more important, the 
risk of radical tumor resection appears to be lower for TR-LR 
than TL-LR.
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PORTAL VEIN OCCLUSION PLUS 
PERCUTANEOUS ABLATION AS FIRST 
TREATMENT OF NOT RESECTABLE 
LIVER CANCER
L. Lupo, P. Panzera, R. Memeo, R. Notarnicola, T. Lisco, 
S. Roselli, A. Salerno and V. Memeo
University of Bari, Institute of General Surgery and Liver 
Transplantation, Policlinico di Bari, Piazza Giulio Cesare, 
1170120 Bari, Italy
Introduction: Aim of this paper was to evaluate the effi cacy 
of Portal Vein Embolization (PVE) associated to Trans 
Arterial Chemio Embolization (TACE) and Radiofrequency 
Ablation (RFA) to treat those Liver Cancers not suitable for 
surgical resection because of inadequate Future Remnant 
Liver (FRL).
Methods: In the last 5 years 23 patients with liver cancer, 
not suitable for surgery, underwent PVE associated to RFA 
or TACE (PVE+) as fi rst treatment to make it feasible a 
further hemi-hepatectomy. Fourteen patients were affected 
from HCC, 7 from liver metastases from Colon-Rectal 
Cancer, 1 Cholangiocarcinoma, and 1 Liver Metastasis from 
Gallbladder Cancer. Fifteen had a single tumour, 5 had 2 or 
3 tumours, 3 had more than 3 tumours. The mean size of the 
main tumour was 70 mm (range 50–110 mm), in the 80% of 
cases the prevalent localization was in the middle liver sector 
(IV–V and VIII segment). All patients underwent ipsilateral 
(tumour side) PVE, 5 by surgical ligature, 18 by US guided 
PVE. In 16 cases it was associated RFA, in 7 RFA and TACE.
Results: No death occurred after PVE+ but 2 patients had 
transient acute liver failure, 2 had a liver abscess, 2 had fever. 
Fourteen patients had signifi cant hypertrophy of the contra-
lateral lobe, 7 had a complete necrosis of tumour, 7 had 
scarce effect with cancer progression. In 5 cases with docu-
mented complete tumour necrosis after PVE+ it was consid-
ered not useful any further treatment.
Nine patients underwent liver hemihepatectomy after PVE+ 
(right or left hepatectomy, 3 extended). One patient underwent 
Liver Transplantation. One patient had a further RFA.
Conclusion: PVE associated to RFA or TACE (as fi rst 
approach), in patients affected from Liver Cancer not eligible 
for surgery, enhances the effi cacy of each single treatment, 
obtains both a wider necrosis and the hypertrophy of the 
contralateral healthy lobe. Occasionally it obtains the com-
plete tumour’s necrosis, often it makes feasible a next surgi-
cal resection. Results of this small series look encouraging.
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TOTALLY ROBOTIC CAUDATE 
HEPATECTOMY FOR 
HEPATOCELLULAR CARCINOMA – 
CASE REPORT
K. Chen, Y.-D. Chen, S.-D. Chen, J.-M. Wu, 
K.- H. Cheng and S.-H. Huang
Division of General Surgery, Department of Surgery, 
Far-Eastern Memorial Hospital, New Taipei City, Taiwan
Far-Eastern Memorial Hospital, Division of General 
Surgery, Department of Surgery, No. 21 Nan-Ya S Rd, Sec 
2, Pan-Chiao District 220, New Taipei City, Taiwan
Introduction: Laparoscopic hepatectomy is one of the 
recent advances of minimally invasive surgery. Current indi-
cation includes tumors located in the S2-6 and without vas-
cular invasion. For lesions in the caudate lobe, laparoscopic 
hepatectomy can be technically challenging because of 
limited space between the lesion and great vessels. Through 
the da Vinci robotic surgical system, the surgeon could carry 
on the procedure by improved image, more stable view and 
instruments with better dexterity.
Methods: The patient was placed in modifi ed Tredelenberg 
position with slightly right side up. Four armed da Vinci 
robotic surgical system had been used. The camera port was 
placed in the periumbilical region. Another three 8 mm 
robotic ports were set up (one in RUQ and two in LUQ). A 
12 mm assistant port was placed in the LLQ. After cholecys-
tectomy, the hepatic hilum was dissected and infl ow branches 
to the caudate lobe were identifi ed and divided. Then total 
caudate hepatectomy (including the left Spiegel lobe, para-
caval portion and the right caudate process) was done. 
Harmonic scalpel was used as the primary tool for parenchy-
mal transection. The operation time was 325 minutes and the 
blood loss was 75 ml.
Results: The patient was sent back to the ordinary ward 
after surgery and resumed oral intake on the day after surgery. 
Pathological result confi rmed the diagnosis of hepatocellular 
carcinoma and the margin was free of tumor involvement. 
The patient was discharged home uneventfully on postopera-
tive day 8.
Conclusion: With more stable vision and better dexterity of 
the instruments, da Vinci robotic system may help to per-
formed laparoscopic hepatectomy in limited space for tumors 
in caudate lobe.
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PROPOSAL OF A REFINED STAGING 
SYSTEM FOR PATIENTS WITH 
CURATIVE RESECTION FOR 
HEPATOCELLULAR CARCINOMA
A. Chan, S. T. Fan, R. Poon, S. C. Chan, T. T. Cheung, 
K. Chok and C. M. Lo
Division of Hepatobiliary and Pancreatic Surgery, Liver 
Transplantation, Department of Surgery, Queen Mary 
Hospital, The University of Hong Kong
Division of Hepatobiliary and Pancreatic Surgery, Liver 
Transplantation, Department of Surgery, Queen Mary 
Hospital, The University of Hong Kong, 102 Pokfulam 
Road, Hong Kong
Introduction: There is yet an ideal pathological staging 
system that is applicable to patients with curative resection 
for all forms of hepatocellular carcinoma (HCC). Recent 
studies have shown the inadequacy of the AJCC/TNM 
(aTNM) and the Japanese TNM (jTNM) staging system in 
patient stratifi cation and prognostication. This study aims to 
propose a refi ned staging system (RSS) and to compare its 
accuracy with the aTNM 5th, 6th and 7th edition, and jTNM 
staging system.
Methods: The clinicopathological data of 754 patients who 
received curative hepatectomy for HCC between 1989 and 
2005 were reviewed. All patients were followed up at least 
60 months. Independent prognostic factors were identifi ed 
by multivariable analysis and formed the basis of the RSS. 
The accuracy for prognostic prediction of the RSS was com-
pared with the other two staging systems in a Cox-regression 
model.
Results: The prognostic factors were microvascular inva-
sion (LVI), tumor multiplicity, bilobar disease, and tumor 
size > 5 cm. The RSS is: T1–single tumor ≤5 cm, without 
LVI; T2–single tumor > 5 cm, without LVI, or single tumor 
≤5 cm but LVI +ve; T3–single tumor > 5 cm with LVI +ve, 
or multiple tumor in one lobe with LVI −ve; T4–multiple 
tumors in one lobe but LVI +ve, bilobar tumors, or tumor 
with portal vein invasion, or tumor rupture. This system 
stratifi ed patients into each subgroup with clear survival dif-
ference while the 5th aTNM and jTNM systems failed to 
stratify patients with early HCC, and the 6th and 7th aTNM 
systems failed to stratify patients with advanced HCC. The 
RSS had higher accuracy than aTNM and jTNM staging 
systems (p = 0.03).
Conclusion: The development of this RSS was based on a 
single center experience of hepatectomy for over 15 years 
that was supplemented by a long follow up period in order 
to allow suffi cient time for observation of tumor behavior at 
all stages. This staging system appears to be more appropri-
ate than the aTNM and jTNM to stratify patients with cura-
tive resection for HCC. Nonetheless, further studies are 
needed to validate this staging system in other patient 
population.
884
SIGNIFICANT RESPONSE TO LOCAL 
ABLATIVE BRIDGING TREATMENTS 
FACILITATES ACCEPTABLE RATES OF 
SURVIVAL FOLLOWING LIVER 
TRANSPLANTATION FOR HCC IN 
A UK CENTRE
R. Lochan1, R. Coates1, R. saif1, J. French1, H. Reeves2, 
B. Jaques1, S. White1 and D. Manas1
1Department of HPB and Transplantation Surgery; 
2Department of Hepatology and Liver Transplantation
Freeman Hospital, Department of HPB and 
Transplantation Surgery, High Heaton, Newcastle upon 
Tyne NE7 7DN, United Kingdom
Introduction: Liver Transplantation (LT) is a well-recog-
nised treatment option for selected patients with hepatocel-
lular carcinoma (HCC). However there is always concern 
regarding tumour progression whilst on the waiting list. As 
yet there is no agreed consensus on how to reduce progres-
sion of disease whilst waiting. UK guidelines recommend 
local ablative therapy for all HCC patients being considered 
for LT. We have sought to review this practice and evaluate 
its benefi t.
Methods: All consecutive patients with HCC who have 
undergone LT between 2001 to 2010 were identifi ed from 
our prospectively maintained database. All patients are dis-
cussed at our LT assessment meeting and also at a separate 
HPB MDT for consideration of bridging treatment. Our 
imaging protocol includes 1) triple phase CT to assess the 
number of hyper vascular liver lesions, presence of venous 
washout, or extra-hepatic disease, 2) MRI to re-characterize 
any atypical lesions or 3) CEUS for further characterisation. 
Patients undergo either trans-arterial chemo-embolisation 
(TACE) and/or percutaneous/ laparoscopic radio frequency 
ablation (RFA) whilst on the LT waiting list. The response 
to bridging treatment assessed and intensive surveillance for 
disease progression is also undertaken.
Results: 55 HCC patients underwent LT (M:F = 43:12), 
Childs-Pugh A (n = 9), B (n = 30) and C (n = 16). Bridging 
treatments were either TACE n = 31, RFA n = 28, or both 
treatments n = 4. TACE treatments per patient were 1 (n = 
12), 2 (n = 12), 3 (n = 6) or 4 (n = 1). Six patients did not 
undergo any form of bridging treatment as they rapidly pro-
gressed to LT. The response to bridging treatment was com-
plete (n = 8), good (n = 10), moderate (n = 18), poor (n = 4) 
or no response (n = 15). There were 2 deaths within 100 
post-operative days. At last follow-up, 28 patients had died 
due to recurrent disease, stable recurrent disease n = 4 or 
disease free n = 21. Overall survival [median (95% CI)] was 
62 (53 -71) months. For those with a good response to bridg-
ing treatments it was 67 (55–79) months whilst for those with 
poor/no response it was 53 (42–64) months (log-rank p = 
0.059).
Conclusion: This study demonstrates the feasibility of 
various bridging treatments for patients with HCC who await 
liver transplantation in the UK. In combination with careful 
patient selection and surveillance acceptable rates of survival 
can be achieved.
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EVALUATION OF GENE EXPRESSION 
SIGNATURE OF GLYPICAN-3 
IN HEPATOCELLULAR 
CARCINOMA PATIENTS
A. Nastase1, M. Grigorie2, V. Herlea2, S. Dima2 and 
I. Popescu2
1Rntech Molecular Biology and Tissue Biobanking 
Laboratory, Bucharest, Romania; 2Center of Digestive 
Diseases and Liver Transplantation, Fundeni Clinical 
Institute, Bucharest, Romania
Rntech Molecular Biology and Tissue Biobanking 
Laboratory, Fundeni Avenue No. 258, 22328 Bucharest, 
Romania
Introduction: Hepatocellular carcinoma (HCC) is the fi fth 
cause of cancer and is one of the world’s highest causes of 
cancer-related death. Nowadays, increasing interest is to 
identify new markers that could discriminate between 
patients with or without HCC or to evaluate the post-opera-
tive risk of tumor recurrence or metastasis.
The aim of our study was to explore the potential diagnos-
tic value of glypican-3 (GPC-3) in HCC patients who under-
went liver transplantation or those that underwent liver 
resection.
Methods: GPC-3 expression was evaluated at mRNA level 
by using real-time PCR in 26 HCC patients who underwent 
liver transplantation (LT, n = 14) or liver resection (LR, n = 
12). GPC-3 gene expression was determined in tumoral 
tissue compared with match normal tissue from the same 
patient. The level of each mRNA was normalized to refer-
ence gene 18S (20×). Additionally alpha-fetoprotein (AFP) 
level and relevant clinicopathological data, like tumor size 
and hepatitis B and C viral infection were recorded and the 
relationship with GPC3 level were analyzed.
Results: 46.15% of the patients had hepatitis C virus infec-
tion. The mean level of AFP was 202.82 ng/ml. The GPC3 
gene expression was evaluated and was signifi cantly corre-
lated with tumor size in LT HCC patients (p = 0.01, r = 0.683, 
95%CI: 0.2115–0.8966), respectively LR HCC patients (p = 
0.0349, r = 0.6375, 95%CI: 0.06065–0.8951). Was observed 
that one patient with LT HCC who developed HCC recur-
rence, had a high gene expression of GPC3, associated with 
high AFP level.
No relevant correlation of the mRNA GPC3 level with B 
and C virus infection was observed.
Conclusion: GPC3 was overexpressed in tumoral HCC 
tissue compared with normal matched tissue and there was 
a signifi cant correlation with tumor size.
Because GPC3 can stimulate Wnt signaling there could be 
a positive correlation between GPC3 and stimulation of HCC 
progression. Targeting GPC3 could represent an attractive 
novel HCC therapy. Also with further evaluation GPC3 
could be assessed as a good serological marker for HCC 
recurrence.
Acknowledgements: Study supported from POSDRU 
89/1.5/S/ 60746.
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CAN WE PERFORM SAFETY 
HEPATECTOMIES IN CHILD B AND C 
PATIENTS? RESULTS OF THE USE OF 
BIPOLAR RADIOFREQUENCY 
COLD NEEDLES
F. Waechter1, U. Teixeira2, T. Passarin2, P. Fontes1, 
M. Nectoux1, L. Pereira-Lima1, J. Sampaio1 and P. Famer3
1Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS, Brazil; 2Hepato-Pancreato-
Biliary Surgery Resident, Universidade Federal de 
Ciências da Saúde de Porto Alegre, RS, Brazil; 3General 
Surgery Resident, Universidade Federal de Ciências da 
Saúde de Porto Alegre, RS, Brazil
Universidade Federal de Ciências da Saúde de Porto 
Alegre, Hepato-Pancreato-Biliary Surgery, Rua Sarmento 
Leite, 245 Zip Code: 90050-17090050 Porto Alegre, Brazil
Introduction: The development of techniques and devices 
to transect the liver parenchyma has allowed to reduce bleed-
ing and postoperative hepatic dysfunction, mainly responsi-
ble for the morbidity and mortality of this procedure. 
However, cirrhotic patients, Child B and C, with liver neo-
plasm, often can not benefi t from such techniques due to its 
low hepatic reserves. An alternative and innovative tech-
nique was designed by this team – the use of cold bipolar 
radiofrequency needles.
Methods: Prospective analysis of 23 consecutive cases per-
formed by the same team using cold bipolar radiofrequency 
needles. All patients had Child B cirrhosis (n = 18) or C (n 
= 5) associated with hepatocellular carcinoma. Minor hepa-
tectomies (less than 3 segments) were performed in 16 
patients and major hepatectomies (more than 3 segments) in 
7 patients. Vascular clamping have not been performed. 
Patients were assessed in the amount of trans-operative 
bleeding, need for perioperative transfusion, length of post-
operative hospital stay, complications, recurrence and death.
Results: The overall mean intraoperative bleeding was 
163 ml, 76 ml in minor hepatectomies and 207 ml in major 
hepatectomies. The average hospital stay was 8 days (2–37 
days). No patient required transfusion of packed red blood 
cells. Mortality was null in the fi rst 30 days. No cases of 
tumor recurrence in the liver edge section in the study group 
were observed. As postoperative complications, were 
observed: abscess along the edge of the liver section (n = 1), 
wound infection (n = 3), right pleural effusion (n = 12), 
pneumonia (n = 4), and diffi cult to control ascites (n = 5).
Conclusion: Hepatectomies using bipolar radiofrequency 
are a safe alternative in the treatment of patients with cir-
rhosis Child B and C and hepatocellular carcinoma. This 
technique allows liver resection with low rates of bleeding 
and good hepatic functional tolerance.
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LAPAROSCOPIC ABLATION AND 
SALVAGE TRANSPLANTATION 
IN PATIENTS WITH 
HEPATOCELLULAR CARCINOMA
A. Vitale, F. D’Amico, E. Gringeri, G. Zanus, D. Neri 
and U. Cillo
Hepatobiliary Surgery and Hepatic Transplantation Unit, 
Padua University Hospital, Via Giustiniani, 235128 
Padova, Italy
Introduction: The 5-year intention to treat survival after 
liver transplantation (LT) is about 50%. Laparoscopic abla-
tion (LA) is a potential fi rst line therapy alternative to LT in 
patients with hepatocellular carcinoma (HCC) not eligible 
for resection or percutaneous ablation.
Methods: Enrolment period: 2004–2009. Study group: 
BCLC A patients, age < 70 years, not eligible for resection 
or percutaneous ablation for tumor characteristics (location, 
number and size) or cirrhosis severity (severe portal hyper-
tension, ascites, coagulopathy). Enrolled patients underwent 
to LA by radiofrequency (RF), microwave (MW) and ethanol 
injection (EI). Primary end-point was 5 year survival. 
Secondary end-points: postoperative mortality and 
morbidity.
Results: Eighty-six were enrolled (males = 84%, median 
age 61 years): 58% had RF, 5% had MW, 37% had only EI. 
Median hospital stay was 3 days (1–19), there was not peri-
operative mortality, while morbidity was 29%. Overall sur-
vival at 1, 3, and 5 years was 79%, 69% and 48% respectively. 
Eighteen patients (21%) underwent salvage LT. Perioperative 
mortality of LT was 0%, while 5 year survival of these 
patients was 76%.
Conclusion: LA and eventual subsequent salvage LT repre-
sents a safe and effective therapeutic strategy for the treat-
ment of HCC patients.
933
LAPAROSCOPIC LIVER RESECTION IN 
HEPATOCELLULAR CARCINOMA: 
SINGLE CENTRE EXPERIENCE
A. Takhar, M. A. Hilal, T. Rahman, J. Primrose, 
T. Armstrong and N. Pearce
University Surgical Unit, Southampton General Hospital, 
Southampton, United Kingdom
Southampton General Hospital, Department of Surgery, 
E Level, Tremona Road, SO16 Southampton, United 
Kingdom
Introduction: Laparoscopic resection is increasing being 
employed as the technique of choice in malignant liver 
tumours. However, there is a paucity of data regarding the 
use of this modality in hepatocellular carcinoma (HCC).
Methods: We aimed to evaluate the use of laparoscopic 
liver resection in HCC at our centre by reviewing our pro-
spectively maintained database of all patients undergoing 
resection for malignant disease. Main outcome measures 
were 30 day mortality, tumour free resection margins, intra-
operative blood loss and hospital length of stay. Statistical 
analysis was carried out using the Mann Whitney test for 
non-parametric data; p ≤ 0.05 was considered a signifi cant 
result.
Results: From January 2003 to December 2010 a total of 30 
patients had 31 liver resections for HCC at our centre. Of 
these, 17 (56.6%) patients had 18 laparoscopic liver resec-
tions (LLR) and 13 (43.3%) had open liver resections (OLR). 
Median age and male female ratio was (LLR) 64 years 
(2.4:1) and (OLR) 61 years (1.6:1) respectively. 9/17 (53%) 
patients in the LLR group had liver cirrhosis. 4 (24%) 
patients in the LLR group needed conversion to open proce-
dure. There was one 30 day mortality in each group. One 
patient (5.6%) in the LLR group had an R1 resection. The 
median blood loss was 250 ml and 1500 ml in the LLR and 
OLR groups respectively (p = 0.05). Median post operative 
length of stay was 4 (LLR) and 7 (OLR) days respectively 
(p = 0.002).
Conclusion: Laparoscopic liver resection for HCC is safe, 
feasible and oncologically effi cient in a select group of 
patients even in the presence of established cirrhosis. This 
treatment modality is increasingly being used as an alterna-
tive to open surgery as well as to ablative therapies in patients 
deemed too unfi t for major surgical intervention.
939
SELECTIVE EMBOLISATION OF 
NON-HAEMORRHAGING 
HEPATOCELLULAR ADENOMAS: 
A MULTI-CENTER PILOT STUDY
R. Coelen1, M. de Jong1, J. Stoot2, R. van Dam1 and 
C. Dejong1
1Department of Surgery, Maastricht University Medical 
Centre, Maastricht, The Netherlands; 2Department of 
Surgery, Orbis Medical Centre, Sittard, The Netherlands
Maastricht University Medical Centre, General Surgery, 
P. Debyelaan, 256229 Maastricht, The Netherlands
Introduction: Hepatocellular adenomas (HCAs) are rare 
benign liver tumours for which resection is suggested when 
size reaches 5 cm due to risk of rupture and malignant 
evolvement. Selective arterial embolisation (SAE) of (non-)
haemorrhaging HCAs has been shown to be effective as 
acute treatment and also diminishes tumour size. Applying 
SAE to reduce adenoma size is an attractive concept, but 
the behaviour of HCAs post-embolisation in terms of 
tumour size and remaining vital tumour tissue is currently 
unknown.
Methods: Ten patients with a non-haemorrhaging HCA > 
5 cm will undergo SAE. The procedure will be performed in 
one of three University hospitals in the Netherlands with 
expertise in this technique. Six months post-embolisation, 
the tumour will be resected.
Imaging (MRI scan) is performed at baseline and at two 
follow-up visits (3 and 6 months). Histopathological and 
immunohistochemical analyses of the specimens will focus 
on the presence of vital tumour cells or malignant foci and 
identifi cation of tumour subtypes according to the Bordeaux 
adenoma tumour markers.
Results: Primary outcome measure of this pilot is the per-
centage of tumour shrinkage and the devitalizing potential of 
SAE after six months. Results are expected end of 2012.
Conclusion: This multi-center pilot study will provide 
insights in the effects of elective, selective arterial embolisa-
tion on tumour size and remaining vital tumour tissue in 
non-ruptured, non-haemorrhaging HCAs > 5 cm.
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SMALL EARLY-STAGE 
HEPATOCELLULAR CARCINOMA 
DETECTED BY INTRAOPERATIVE 
ULTRASONOGRAPHY DURING DURING 
SURGERY OF HCC IN LIVER CIRRHOSIS
J. H. Ahn, H. J. Jang, K. J. Cheon and D. U. Um
University of Ulsan, Gangneung Asan Hospital, Radiology 
Gangneung Asan Hospital, 415 Bandong-ri Sacheon-
myeon, Gangneung-si, Gangwon-do 210-711, 20171 
Gangneung, Korea
Introduction: During hepatic resection for hepatocellular 
carcinoma (HCC), intraoperative screening US (IOUS) 
detects new lesions in 13.1% to 30% of cases.
HCC frequently presents a nodular appearance with a 
fi brous capsule, whose presence is regarded as a helpful 
diagnostic clue in diagnostic imaging, particularly ultrasono-
graphic diagnosis, of HCC.
This study was to evaluate the IOUS fi ndings focused on 
the capsule of early-stage small HCCs detected by IOUS 
during surgery for HCC.
Methods: Between January 2007 and December 2010, 120 
patients underwent hepatic resection at our institution. Of 
these 120 patients, 68 nodules in 39 patients, who met the 
study criteria, were included. Of these 68 nodules, 49 nodules 
were pathologically excluded as follows: regenerative 
nodules; suspected intrahepatic metastases; dysplastic 
nodules et al.; Finally, the study group consisted of 12 
nodules in 9 patients diagnosed by synchronous multicentric 
small early-stage HCCs. The diagnosis of capsule was based 
on the general rules for the study of primary liver cancer.
Results: The study cohort comprised of 8 male patients and 
one female. Overall age range was 39–75 years. All patients 
had background liver cirrhosis and had positive fi ndings for 
serum hepatitis B virus antigen. The size of small early-
staged HCCs ranged from 6 to 13 mm (mean, 9 mm). 
Histologically, 12 small early-stage HCC nodules were clas-
sifi ed into 4 vaguely nodular types and 8 distinctly nodular 
types. 4 vaguely nodular HCCs had no tumor capsule. Of 8 
distinctly nodular HCCs, 6 HCCs had incomplete tumor 
capsule measuring more than 50% and two HCCs had com-
plete tumor capsule. The thickness of the capsule at micro-
scopic examination ranged from 0.4 to 0.6 mm. Of 8 tumor 
capsules, tumor capsules were identifi ed as incomplete 
hypoechoic rim (n = 6) and complete hypoechoic rim (n = 
2) on IOUS. The maximum thickness of the hypoechoic rim 
was ranged from 0.8 to 1.2 mm.
Conclusion: To target the small early-stage HCC, this pre-
senting study focused on small early-stage HCC detected as 
synchronous multicentric occurrence in patients with HCC. 
Our results indicates that IOUS could detect the capsules of 
the small early-stage HCCs in spite of the fact that they are 
small in size. We also found that the tumor capsule could be 
identifi ed as an incomplete low echoic rim.
956
CENTRAL BISECTIONECTOMY OF THE 
LIVER USING GLISSONEAN PEDICLE 
TRANSECTION METHOD
S. Katagiri, M. Yamamoto, S.-ichi Ariizumi, Y. Kotera and 
Y. Takahashi
Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University
Institute of Gastroenterology, Tokyo Women’s Medical 
University, Department of Surgery, 8-1, Kawada-cho, 
Shinjyuku, 162 Tokyo, Japan
Introduction: Central bisectionectomy for hepatic tumor is 
the common major operation in liver surgery. This approach 
is widely known as the central hepatectomy by McBride CM 
et al. who described it in 1972. The Glissonean pedicle tran-
section method is a useful and safe technique for hepatec-
tomy. Therefore, liver surgeons should know the fundamental 
surgical concept and technique for central bisectionectomy 
using Glissonean pedicle approach.
Methods: A J-shaped laparotomy is performed in the right 
subcostal area. The Glissonean pedicle approach is per-
formed at the hepatic hilus. After ligation of the some tertiary 
branches of left medial segment, the right anterior Glissonean 
pedicles are encircled and ligated in the extended hepatic 
hilus. After confi rming the borderline between the right ante-
rior and posterior segment, the liver parenchyma is dissected 
from the anterior surface of the liver. The V5 and V8 branches 
of right hepatic veins are divided and liver dissection is 
performed along the main right hepatic vein. The root of the 
middle hepatic vein is fi nally identifi ed in the liver. We 
reviewed the central bisectionectomy of the liver at our 
institute.
Results: We performed 865 patients who underwent hepa-
tectomy from 2005 to 2009. Central bisectionectomy was 
performed 22 cases (2.5%). HCC was performed in 8, meta-
static tumor in 4, ICC in 4, bile duct cancer in 4, others in 2 
cases. We performed two methods for central bisectionec-
tomy. There were 12 cases of controlled method with recon-
struction of bile duct and 10 cases of Glissonean pedicle 
approach. The average of blood loss and operation time 
showed a statistically signifi cant difference between the 2 
methods, with 3360 ± 3488 cc and 485 ± 225 min in con-
trolled method and 1325 ± 752 cc and 235 ± 29.7 min in 
Glissonean pedicle approach, respectively.
Conclusion: Among the techniques used in central bisectio-
nectomy using the Glissonean pedicle approach are consid-
ered to be the most important.
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SURGICAL RESECTION OF BILATERAL 
ADRENAL METASTASIS FROM 
HEPATOCELLULAR CARCINOMA
J. H. Kim1, H. J. Jang2, K. J. Cheon2, J. H. Ahn2 
and D. U. Um2
1Department of Surgery, Seoul National University 
Bundang Hospital, 166 Gumi-ro, Bundang-Gu, 
Seongnam-Si, Gyeonggi-Do, 463-707, South Korea; 
2University of Ulsan, Gangneung Asan Hospital, Surgery, 
415 Bandong-ri Sacheon-myeon, Gangneung-si, 
Gangwondo 210-711, 21071 Gangneung, Korea
Introduction: Hepatocellular carcinoma (HCC) frequently 
metastasizes to the adrenal glands. The surgical strategy for 
HCC associated with bilateral adrenal gland metastasis is 
complicated because of the possibility of adrenal 
insuffi ciency.
Methods: We report a patient with HCC who had bilateral 
adrenal gland metastasis that was treated successfully.
Results: A 71-year-old man with HCC (8 cm in diameter) 
in the right lobe of the liver was admitted to our hospital. 
Right hemihepatectomy was performed. One year after 
surgery, the patient with bilateral adrenal gland metastasis 
(right, 5 cm in diameter; left, 4 cm in diameter) was admitted 
to our hospital. Bilateral adrenalectomy was performed 
simultaneously. Hydrocortisone supplement was given, and 
the postoperative course was uneventful. No recurrence was 
observed during the 6-month follow-up period.
Conclusion: According to our experience, we suggest that 
surgery should be considered as one of the treatment strate-
gies for patients with HCC and bilateral adrenal metastasis, 
to provide safer surgery and longer survival.
971
ANGIOGRAPHIC COMPUTED 
TOMOGRAPHY (DYNA-CT) REDUCE 
FALSE POSITIVITY OF COMPUTED 
TOMOGRAPHY DURING HEPATIC 
ARTERIOGRAPHY AND ARTERIAL 
PORTOGRAPHY FOR DIAGNOSIS OF 
HEPATOCELLULAR CARCINOMA
C. W. Kim1, S. L. Lee2, Y. D. Won2, J. Y. Choi1, 
S. K. Yoon1, S. W. Choi1, Y. S. Lee1 and C. D. Lee1
1Department of Internal Medicine, The Catholic University 
of Korea, Seoul, Korea; 2Department of Radiology, The 
Catholic University of Korea, Seoul, Korea
The Catholic University of Korea, Internal Medicine, 
#65-1, Gumo-dong, Uijeongbu-shi, Gyounggi-do, 
Uijeongbu, South Korea
Introduction: Outstanding advances in hepatic imaging 
techniques have made us to see more small nodular lesions. 
Computed tomography during hepatic arteriography and 
arterial portography (CT-HAAP) is sensitive imaging tech-
nique for HCC but, false positive detection is still problem 
to be solved. Angiographic computed tomography (Dyna-
CT) has recently used for HCC diagnosis after transcatheter 
arterial chemolipiodolization (TACL) but, there is few 
reports for the usefulness of Dyna-CT for HCC diagnosis.
Methods: Total 15 cirrhosis patients with small nodular 
lesions were enrolled. CT-HAAP was performed for diagno-
sis of HCC then TACL with or without embolization was 
performed. In CT-HAAP, bright nodular enhancement during 
arteriogram without enhancement during portogram was 
considered as a possible HCC nodule. Dyna-CT was per-
formed immediately after TACL. In Dyna-CT, white nodular 
lipiodol-uptake was considered as a possible HCC nodule. 4 
weeks after TACL, follow-up CT scan was performed for 
assessment of remaining lipiodol-uptake as a HCC nodule. 
Two of 15 patients were lost during follow-up period after 
TACL.
Results: Except 2 follow-up lost patients, total 23 nodules 
were positive as a possible HCC nodule in CT-HAAP. 14 of 
23 (60.9%) were positive as a possible HCC nodule in Dyna-
CT. After 4 weeks later, 13 of 14 (92.9%) were positive as 
HCC nodules in follow-up CT scan. Among CT-HA positive 
nodules, they can be divided into 4 types:
Type 1: CT-HA (+), Dyna-CT (+), F/up lipiodol CT (+)
Type 2: CT-HA (+), Dyna-CT (+), F/up lipiodol CT (−)
Type 3: CT-HA (+), Dyna-CT (−), F/up lipiodol CT (+)
Type 4: CT-HA (+), Dyna-CT (−), F/up lipiodol CT (−)
Among 23 CT-HA positive nodules, the number of each type 
is 12, 1, 0, 10 respectively. Twenty two (96%) CT-HA posi-
tive nodules are type 1 or 4. Only 1 (4%) CT-HA positive 
nodule is type 2.
Conclusion: Among 23 CT-HA positive nodules, 14 (60.9%) 
were positive as a possible HCC nodules in Dyna-CT. After 
4 weeks later, 13 of 14 (92.9%) were positive as HCC 
nodules in follow-up lipiodol CT scan. Our preliminary 
experience of Dyna-CT in HCC showed that Dyna-CT can 
reduce the false positive detection rate of HCC in CT-HAAP 
markedly but, further investigation is needed to confi rm the 
meaning of Dyna-CT in HCC diagnosis.
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REMNANT LEFT LIVER TORSION 
CAUSING SEVERE OUTFLOW BLOCK 
SYNDROME AFTER RIGHT 
HEPATECTOMY FOR GIANT 
HEPATOCELLULAR CARCINOMA
N. Sato, A. Kenjo, T. Tsuchiya, T. Anazawa, J. Haga, 
T. Sato and M. Gotoh
Department of Hepato-Biliary-Pancreatic and Transplant 
Surgery, Fukushima Medical University
Fukushima Medical University, Department of Hepato-
Biliary-Pancreatic Surgery, 1 Hikarigaoka, Fukushima 
960-1295, Japan
Introduction: Outfl ow block syndrome has recognized as a 
one of lethal complications after left lobe living donor liver 
transplantation, but as a rare complication after liver resec-
tion. It has been reported that remnant left liver after right 
hepatectomy tends to rotate spontaneously into the right sub-
phrenic space, resulting in venous outfl ow impairment. We 
report a case of remnant left liver torsion causing acute 
outfl ow block after right hepatectomy, which was success-
fully treated with early management.
Methods: A-67-year-old man underwent right hepatectomy 
(without division of left triangular ligament and removal of 
middle hepatic vein) for giant hepatocellular carcinoma. On 
the day after surgery, blood biochemical fi ndings showed a 
signifi cant liver dysfunction and a renal dysfunction. Hepatic 
venous fl ow was detected by Doppler US as lower than that 
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of the end of surgery and Doppler waveforms had been 
monophasic. Abdominal CT showed the dislocation of the 
swelling remnant left liver in right subphrenic space and the 
inferior vena cava compression externally. He was diagnosis 
with acute hepatic outfl ow block due to remnant liver torsion, 
necessitating emergency operation.
Results: Operative fi ndings revealed that the remnant left 
liver was found to be markedly congested and swollen. The 
congestion disappeared after replacement of the remnant left 
lobe into its anatomical position in conjunction with an 
immediate improvement in the hemodynamic parameters. In 
addition, the hepatic venous fl ow detected by intraoperative 
Doppler US increased and the Doppler waveforms were 
changed into triphasic pattern. Falciform ligament was 
sutured to the anterior abdominal wall to fi x the remnant left 
liver in anatomical position. His postoperative course was 
uneventful.
Conclusion: The surgical removal of the right lobe of the 
liver altered normal anatomic support of inferior vena cava 
and liver. The remnant left lobe tends to set up a rotational 
force to create torsion of the liver, even if left triangular liga-
ment is preserved. To fi x the remnant liver in the anatomical 
position might be effective method for preventing acute 
outfl ow block after right hepatectomy for giant liver tumor.
ANNULE – 966
COMPARISON OF DOXORUBICIN-
ELUTING BEAD TRANSARTERIAL 
CHEMOEMBOLIZATION AND 
RESECTION FOR EARLY 
HEPATOCELLULAR CARCINOMA
M. Sellers1, H. Pollinger1, K. Kegley1, A. Arepally2, 
S. Citron2, R. Shrestha1, M. Mulloy1 and M. Johnson1
1Piedmont Transplant Institute; 2Piedmont Radiology
Piedmont Transplant Institute, 1968 Peachtree Rd NW, 6th 
Floor, 77 Building, 30309 Atlanta, USA
Introduction: Barcelona Clinic for Liver Cancer (BCLC)-A 
(early) hepatocellular carcinoma (HCC) is traditionally 
treated with resection. According to the BCLC treatment 
algorithm, transarterial chemoembolization (TACE) is 
reserved for patients (pts) with intermediate HCC. 
Doxorubicin-eluting bead TACE compares favorably to con-
ventional TACE in terms of safety effi cacy in intermediate 
HCC pts. A comparison of DEB-TACE with resection in pts 
with early HCC has not been reported.
Methods: We retrospectively compared doxorubicin-elut-
ing bead TACE (n = 16) and segment-oriented open and 
laparoscopic resection (n = 17) in chronic liver disease pts 
(Child-Turcotte-Pugh score 5 or 6) with unifocal HCC and 
good performance status (PS). TACE was performed by stan-
dard techniques; laparoscopic (n = 4) and open (n = 13) 
resections included 8 hemihepatectomies, 3 anatomic mono-
segmentectomies, 2 anatomic central hepatectomies (seg-
ments 5, 8, and/or 4), 3 left lateral sectionectomies and 1 
non-anatomic resection. Recurrence-free and overall sur-
vival were compared with Kaplan-Meier. Length of stay 
(LOS) was compared with a two-tailed t-test.
Results: Median follow-up = 644 days. One TACE pt had 
PS = 1; all others and all resection pts had PS = 0. Nine 
TACE pts had thrombocytopenia (TCP); no resection pt had 
TCP. No pt had ascites or encephalopathy. All TACE pts had 
a complete response by modifi ed RECIST; 3 recurred (19%). 
One resection pt had steatosis without fi brosis; all others had 
fi brosis or cirrhosis; all had negative margins; 9 recurred 
(53%; p = 0.04 by chi-square). Recurrence-free and overall 
survival favored TACE, but neither difference was statisti-
cally signifi cant. Mean LOS was 0.19 ( ± 0.1; range 0–2) 
days for TACE and 5.94 ( ± 0.6; 3–12) days (p < 0.0001). 
There was one perioperative death and no peri-TACE deaths. 
No clinically relevant TACE-related hepatic decompensation 
occurred.
Conclusion: In our cohort, DEB-TACE was as effective as 
resection for patients with HCC in the setting of mild chronic 
liver disease, including in some with hematologic evidence 
of portal hypertension, who are not resection candidates. As 
expected, length of stay, a surrogate for overall resource 
utilization, was signifi cantly lower following DEB-TACE. 
These data argue strongly for a randomized comparison 
between DEB-TACE and resection for early HCC pts.
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A 5-YEAR OVERVIEW OF MELD X 
LIVER TRANSPLANTATION IN A 
UNIVERSITY HOSPITAL IN BRAZIL
E. Tatebe, E. Chaib, M. Shinzato and L. D’Albuquerque
University of São Paulo School of Medicine
University of São Paulo School of Medicine, Rua Eça de 
Queiroz, 58, Vila Mariana, CEP 04011-0304011 São 
Paulo, Brazil
Introduction: The MELD (Model for End-Stage Liver 
Disease) score was adopted as a new criteria for orthotopic 
liver transplantation (OLT) in 2006 in Brazil. We aimed to 
analyze the value of MELD as a predictor of survival after 
OLT.
Methods: We analyzed the data from 329 liver transplants 
performed in the “Hospital das Clínicas” of the University 
of São Paulo School of Medicine from August 2006 to June 
2010. In this period, we had 11 living donors liver transplants 
(LDLT), 6 split-liver transplants (SLT), 24 re-transplants and 
288 OLT. Patients were classifi ed in two groups: Group I 
(MELD < 25) and Group II (MELD > 25). Patients submitted 
to LDLT, SLT and re-transplant were not included. We ana-
lyzed the following data: age, MELD, cold ischemia time 
(CIT) and warm ischemia time (WIT), and mortality rate 
(MR).
Results: Group I: 89 patients and Group II: 199 patients. 
Patients in Group II had a higher mortality rate (31.66%, 
63/199) than patients in Group I (24.72%, 22/89). However, 
patients in Group I had a higher re-transplantation rate 
(7.86%, 7/89) than patients in Group II (5.52%, 11/199). CIT, 
WIT and patient age were similar in both groups.
Conclusion: Although Group I had the highest retransplan-
tation rate, patients in Group II had a higher mortality rate 
after the procedure. Therefore patients with MELD above 25 
or higher have fewer chance of long-term survival after OLT. 
MELD score can be used as a predictor factor of good results.
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EVALUATION OF DONOR HEPATIC 
GRAFT QUALITY AS A PREDICTOR 
OF LONG-TERM SURVIVAL 
AFTER ORTHOTOPIC 
LIVER TRANSPLANTATION
M. Shinzato, E. Chaib, E. Tatebe and L. D’Albuquerque
University of São Paulo School of Medicine
University of São Paulo School of Medicine, Rua Eça de 
Queiroz, 58, Vila Mariana, CEP 04011-0304011 São 
Paulo, Brazil
Introduction: Liver transplantation is the best treatment 
option for patients in hepatic failure. We aimed to evaluate 
the quality of the hepatic graft as a predictor of long-term 
survival after orthotopic liver transplantation (OLT).
Methods: We analyzed the data from 329 liver transplants 
performed in the “Hospital das Clínicas” of the University 
of São Paulo School of Medicine from August 2006 to June 
2010. We retrospectively analyzed data from the donors, 
such as: sex, age, use of alcohol and drugs, serologies, use 
of blood products, vasoactive drugs, infection, use of antibi-
otics, bilirubin, hemogram, platelets, associate diseases and 
urine output. transplants: There were 11 living donor liver 
transplants (LDLT), 6 split-liver transplants (SLT), 24 re-
transplants and 288 OLT. Patients were classifi ed in two 
groups: Group I (MELD < 25) and Group II (MELD > 25). 
Patients submitted to LDLT, SLT and those who had primary 
non-function were not included.
Results: Group I: 89 patients and Group II: 199 patients. 
Patients in Group I had a higher 24 hours urine output 
(4486.31 ml + 3063.61), leukocytes number (20842.86 + 
44723.62) and also were positive for both Anti-HBC 
(22.47%, 20/89) and anti-HBS (26.97%, 24/89). Patients in 
Group II had higher levels of sodium (243.61 mEq/L + 
1226.24), CPK (2486.53 U/L + 9828.55) and gamma GT 
(90.81 U/L + 107.84), were positive for both toxoplasmosis 
(28.64%, 57/199) and cytomegalovirus (45.23%, 90/199). 
They also had higher mortality rate (32.16%, 64/199). All 
other characteristics were similar in both groups.
Conclusion: When we used donor hepatic graft with higher 
levels of sodium in recipients with MELD above 25 we 
found higher mortality rate (32.16%) in the fi rst year after 
OLT than those with MELD below 25. Donor hepatic graft 
with higher level leukocytes in recipients with MELD < 25 
seems to have much better long-term postoperative results 
than those with higher leukocytes number in recipients with 
MELD > 25.
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ASSESSMENT OF HEPATIC 
ARTERIAL ANATOMY PRIOR TO 
ORGAN RECOVERY
K. Roberts1, D. Malde1, B. Adams1, J. Hodson2, 
M. Sheridan1 and E. Hidalgo1
1St James University Hospital Leeds; 2Medical Statistician, 
University Hospitals Birmingham
University Hospital Birmingham, Liver Transplantation, 
Mindlesohn Way, Edgbaston B15 2WB, United Kingdom
Introduction: Iatrogenic hepatic arterial injury during 
organ recovery increases ischaemic times and risk of hepatic 
artery thrombosis. A review of CT imaging prior to organ 
recovery would alert retrieving surgeons to the presence of 
anatomical variants. This study aimed to identify the propor-
tion of donors with coincidental CT scans for review and the 
ability of organ retrieval surgeons to interpret these images.
Methods: Consecutive organ donors with coincidental 
abdominal contrast enhanced CT scans were assessed by 
review of an electronic radiology database. These images, 
with additional cases, were blindly reviewed by organ recov-
ery surgeons to assess their ability to defi ne anatomy.
Results: 13/156 donors had coincidental imaging for review. 
Using 23 CT sequences, the median positive and negative 
predictive value of surgeons to correctly describe right 
hepatic arterial anatomy was 0.83 and 0.94, of the left hepatic 
anatomy was 0.75 and 0.94 respectively.
Conclusion: The availability of CT imaging for review 
prior to donation is low. However, when available, surgeons 
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can correctly defi ne hepatic arterial anatomy in the majority 
of cases. A practice of routinely reviewing available imaging 
prior to organ recovery would be expected to decrease iatro-
genic arterial injury.
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EARLY POSTOPERATIVE 
COMPLICATIONS IN DECEASED 
DONOR LIVER TRANSPLANTATION: 
A CLINICAL PROFILE
A. Krishnan, S. Rajagopal and A. Venkataraman
Department of Gastroenterology and Liver Transplantation 
Unit, Stanley Medical College, Old Jail Road, Royapuram, 
Chennai, India
Introduction: Liver transplant often results in hemody-
namic and biochemical changes in the immediate postopera-
tive period, often causing concern to the treating physician. 
To study the pre-operative clinical profi le, the hematological 
and biochemical changes in the immediate postoperative 
period up to 7 days following DDLT patients.
Methods: A detailed assessment of the patients pre opera-
tive clinical diagnosis, presence of co-morbid illness and 
postoperative hematological, biochemical, microbiological 
and clinical events was made between survivors and those 
who died. Various parameters were compared between two 
groups to understand the various that determined early post-
operative outcome in DDLT patients.
Results: A total of 26 patients, categorized into group I-18 
patients (Survivors) and group II-8 (mortality). There was 
no difference in the fl uctuation of hemoglobin levels 
between the two groups. Early leukocytosis and persistent 
azotemia predicted early morbidity and mortality. A signifi -
cant fall of platelet count predicted mortality. Transaminases 
showed a signifi cant rise between the 2nd and 3rd postop-
erative days and stabilized and showed a downwards 
trends by the 7th–9th postoperative days in both group. 
Hypernatremia predicated early mortality. Cause of death 
was intra-operative events like cardiac arrhythmias, and in 
ischemic cardiac events (2), pulmonary thromboembolism 
(1), and hepatic artery thrombosis (1), sepsis and multior-
gan failure (4).
Conclusion: Pre-operative co-morbid illness, postoperative 
worsening azotemia, persistent leukocytosis, and sepsis and 
cardiac events in the immediate postoperative period predicts 
an outcome post DDLT.
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RESULTS OF INTRAOPERATIVE REAL 
TIME CHOLANGIOGRAPHY AND 
C-TUBE DRAINAGE DURING A DONOR 
HEPATECTOMY IN LIVING-DONOR 
LIVER TRANSPLANTATION
T. Ochiai, H. Ikoma, Y. Yamamoto, Y. Kokuba, 
H. Okajima, N. Yoshimura and E. Otsuji
Department of Surgery, Kyoto Prefectural University of 
Medicine
Kyoto Prefectural University of Medicine, Surgery 465 
Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, 602 Kyoto, 
Japan
Introduction: In living-donor liver transplantation (LDLT), 
biliary tract complications are a serious problem for recipi-
ents and donors. The anatomy of the biliary tract should be 
evaluated in detail before the operation for both the recipi-
ents and donors. However, the preoperative radiological 
diagnostic examination, i.e. endoscopic retrograde cholangi-
ography or percutaneous transhepatic cholangiography, for a 
healthy donor should be limited, because of donor safety.
Methods: Sixty-nine LDLTs were performed at the 
Department of Surgery, Kyoto Prefectural University of 
Medicine, between September 2003 and August 2011. 
Among them, 62 adult-to-adult LDLT cases were studied. 
We applied intraoperative real-time cholangiography 
(IORTC) using a C-arm and/or C-tube drainage to reduce 
biliary tract complications in donor hepatectomy. From 2003 
to 2011, intraoperative real-time cholangiography and C-tube 
drainage was applied to 43 and 23 donor cases, respectively. 
Nineteen donor cases had both procedures. We compared the 
operative courses of 43 donors with IORTC and 19 donors 
without IORTC; subsequently, there were 23 donors with 
C-tube drainage and 38 donors without drainage.
Results: We confi rmed the division line of the hepatic duct 
by visualizing a stricture on the monitor of the C-arm by 
pulling a thread and dissecting the proper site of the bile duct. 
The number of hepatic ducts of the graft to be anastomosed 
was 1 in 11 cases, 2 in 7 cases (36.8%) and 3 in 1 (5.2%) of 
the 19 cases without IORTC (mean, 1.47) and it was 1 in 36 
cases and 2 in 7 (16.3%) of the 43 cases with IORTC (mean, 
1.16) (p = 0.025). Bile leakage from the resection occurred 
in 7 donors without, and in none of those with, C-tube drain-
age (p = 0.031).
Conclusion: In living-donor liver transplantation, intraop-
erative real-time cholangiography enables effective determi-
nation of the precise division line of the hepatic duct. 
Moreover, C-tube drainage is effective for reducing bile 
leakage from the resected surface of the liver of donors.
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IMPACT OF RECIPIENT CO-MORBID 
FACTORS ON OUTCOME OF LIVING-
DONOR LIVER TRANSPLANTATION
O. Hegazy, K. A. El-Ella, T. Ahmed and H. Abdeldayem
National Liver Institute, HPB & Liver Transplantation 
Surgery, Zat-Elkoom, Embaba, Giza, Egypt
Introduction: Liver transplantation has become the treat-
ment of choice for patients with end-stage liver diseases 
(ESLD). Generally recipients with associated risks and co-
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morbid factors such as (smoking, DM, hypertension, obesity, 
previous abdominal surgery, cardiac disease, renal disease, 
pulmonary disease, PVT) were believed to affect the outcome 
of liver transplantation adversely.
Methods: We retrospectively evaluated the records of 116 
LDLT recipients at our center from April 2003 to March 
2011. Forty-two patients were excluded. In the remaining 74 
patients (mean age = 48.2 ± 6.9, BMI = 27.9 ± 5.5, MELD 
score = 22.68 ± 5.5) the outcome measures were packed red 
cell (PRC) transfusion in 48 hours, length of stay (LOS) in 
ICU and the hospital stay, hepatic artery thrombosis (HAT), 
postoperative portal vein thrombosis (PVT), biliary compli-
cations (BC), postoperative bacterial infection (POBI), re-
operation and death.
Results: Postoperative PVT found in 3 (4.1%) patients, 
there was signifi cant correlation with preexisting PVT. 
Biliary complications (BC) developed in 29 (39.2%) patients. 
There was signifi cant increased BC in diabetic patients. 
Postoperative bacterial infection (PBI) found in 42 (61.9%) 
patients, without signifi cant correlation to the co-morbid 
factors. Postoperative mortality occurred in 20 (27%) 
patients, seven were hypertensive, and 12 were diabetic. 
There was signifi cant correlation between postoperative 
mortality and hypertension & DM, The outcome in the pres-
ence of multiple co-morbid factors did not infl uence peri-
operative morbidity, but mortality was signifi cantly increased 
in patient with multiple co-morbid factors.
Conclusion: Presence of co-morbid factors such as hyper-
tension, diabetes mellitus, cardiac disease, and renal disease 
found to increase postoperative morbidity, but did exclude 
the patient from liver transplantation. Patients with multiple 
co-morbid factors require special consideration since peri-
operative mortality is signifi cantly higher.
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DIFFICULTIES OF LDLT FOR HCC 
PATIENTS: EXPERIENCE FROM FIRST 
150 LDLT CASES
H. shoriem, H. E. Soliman, S. Saleh, T. Yaseen, O. Hegazy, 
K. Abuelella, I. Marwan and T. Ibrahiem
National Liver Institute, Menoufi a University, Egypt
Department of Hepatobiliary Surgery and Liver 
Transplantation, National Liver Institute, 75 Wageh Abaza 
st, Wadi Hof, Helwan, 11142 Cairo, Egypt
Introduction: Living donor liver transplantation (LDLT) 
can provide life-saving therapy for many patients with HCC, 
who otherwise would succumb due to tumor progression. 
Offering LDLT to patients with HCC, however, raises 
complex issues for the donor, the recipient, and the medical 
team.
Methods: The records of HCC cases in the 150 patients who 
underwent LDLT in National Liver Institute (NLI), Menoufi ya 
University, Egypt, from April 2003 to October 2011, were 
retrospectively revised. The aim it to answer several ques-
tions: Should we expand the criteria for liver transplantation 
for HCC? What is the response to loco-regional therapy and 
role of tumor downstaging? What are the diffi culties of eval-
uation? Is there especial technique considerations? What 
about the outcome and recurrence?
Results: From the fi rst 150 case of LDLT HCC was the 
indication of LDLT in 35 (23.3%) of cases. Of the total 35 
HCC cases 28 (80%) was within Milan criteria, 4 (11.4%) 
cases had benign portal vein thrombosis, 3 (8.5%) cases had 
recurrent HCC, PET CT done in all HCC two weeks before 
LT to exclude distant HCC metastases. Porta hepatis fi rst and 
exploration fi rst was the used technique.
Conclusion: Transplantation is currently the only life-
saving therapy for patients with unresectable HCC and cir-
rhosis. The Milan criteria remain a valid tool to select 
candidates for LDLT to achieve optimal long-term results. 
Alpha-fetoprotein of 1000 ng/mL or more should be consid-
ered an exclusion criterion for liver transplantation. PET CT 
might be of particular diagnostic value in detecting distant 
HCC metastases. Exploration fi rst and non touch technique 
are recommended in HCC cases.
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POST LIVING DONOR LIVER 
TRANSPLANTATION BILIARY 
COMPLICATIONS: EXPERIENCE 
FROM FIRST 150 CASES
H. shoriem, H. E. Soliman, S. Saleh, H. Osama, T. Yaseen, 
K. Abuelella, B. Marwan and T. Brahiem
National Liver Institute, Menoufi a University, Egypt
Department of Hepatobiliary Surgery and Liver 
Transplantation, National Liver Institute, 75 Wageh Abaza 
st, Wadi Hof, 11142 Cairo, Egypt
Introduction: Living donor liver transplantation (LDLT) is 
becoming a widespread technique with good results. Biliary 
complications, however, still occur frequently after liver 
transplantation and have retained a high risk of signifi cant 
mortality and morbidity. The aim of this work is to review 
the biliary complications, its related problems, and its impact 
on the morbidity and mortality in patients underwent living 
related liver transplantation.
Methods: The records of 150 patients who underwent 
LDLT in National Liver Institute (NLI), Menoufi ya 
University, Egypt, from April 2003 to October 2011, were 
retrospectively revised.
Results: Biliary complications occurred in 34% of recipi-
ents and included bile leak in 24% of cases, anastomotic 
strictures 10% of cases. 30% of cases had biliary leak fol-
lowed by stricture. The number of biliary anastomosis was 
directly proportional to biliary complications. Other poten-
tial risk variables for biliary complications as type of biliary 
reconstruction, cold ischemia time, and CMV infection did 
not affect biliary complications in our study. Endoscopic and 
radiological intervention management is effective in the 
majority of cases. Surgical intervention is obligatory in 
selected cases.
Biliary complications related mortality was 12%.
Conclusion: Biliary complications are one of the most 
serious complications following LDLT and should be diag-
nosed and managed as early as possible to avoid dreadful 
outcome.
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ASSESSMENT OF ACUTE AND CHRONIC 
HEPATIC HEMOSTASIS USING 
VERISET™ HEMOSTATIC PATCH 
VERSUS SURGICEL™ NU-KNIT™ 
ABSORBABLE HEMOSTAT IN A 
PORCINE MODEL
K. Howk1, M. Lisowski2, J. C. Jr.2, S. Rousselle3, 
D. Garlick4 and N. J. Espat5
1Covidien; 2Surpass, Inc.; 3Alizée Pathology; 4Histo-
Scientifi c Research Laboratories; 5Roger Williams Medical 
Center
Covidien PreClinical Affairs, 15 Crosby Drive, 1730 
Bedford, USA
Introduction: Achieving hemostasis during surgical proce-
dures is a common challenge across surgical specialties. 
Conventional methods used for obtaining hemostasis include 
ligature, compression, or cautery. The Veriset™ Hemostatic 
Patch is a polyethylene glycol and oxidized cellulose patch 
that is capable of creating rapid hemostasis at actively bleed-
ing sites. The purpose of this study was to assess the safety 
and hemostatic effectiveness of Veriset™ application 
employing a porcine hepatic resection model.
Methods: Forty domestic swine underwent non-anatomic 
liver resection of a single lobe using conventional methods. 
The resection sites were evaluated for bleeding severity 
before application of either Surgicel™ Nu-Knit™ Absorbable 
Hemostat or the Veriset™ Hemostatic Patch. Effi cacy of 
treatment was defi ned by: 1) the time to achieve hemostasis 
and 2) the need to apply additional hemostat material. The 
safety of applying Veriset™ was monitored via post opera-
tive clinical observations, physical examinations, and clini-
cal pathology assessment. In addition, tissue compatibility 
was assessed by a veterinary pathologist, blinded to treat-
ment type, at 14, 28, 42, 56, and 84 days after treatment. 
Discrete variables were analyzed using 2-sample T-test.
Results: Target bleeding site scores were similar for both 
the Surgicel™ Nu-Knit™ Absorbable Hemostat and 
Veriset™ Hemostatic Patch treatment groups prior to treat-
ment. Hemostasis was achieved in the Veriset™ animals in 
37.3 ± 5.5 seconds (mean ± SEM) and in the Surgicel™ 
Nu-Knit™ animals in 185.9 ± 24.2 seconds (p < 0.01). 
Veriset™ required a single application for all 23 sites; 
however 9 of 17 Surgicel™ Nu-Knit™ sites required mul-
tiple applications. There were no treatment-related adverse 
post operative observations. Histopathologic evaluation of 
the tissue specimens demonstrated comparable healing fea-
tures in both groups and no adverse impact of treatment on 
the progression of the healing process. Infl ammation was 
virtually undetectable at 56 days.
Conclusion: These experimental results demonstrated that 
the application of the Veriset™ Hemostatic Patch to tran-
sected hepatic parenchyma stopped active bleeding with a 
5-fold reduction in the time to achieve hemostasis compared 
to Surgicel™ Nu-Knit™ Absorbable Hemostat. Evaluation 
of the safety of the Veriset™ Hemostatic Patch showed no 
short or long-term adverse effects in terms of infl ammation 
or wound healing.
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SEVOFLURANE PRECONDITIONING 
PLUS POSTCONDITIONING PROTECTS 
THE LIVER AGAINST ISCHEMIA/
REPERFUSION INJURY IN RATS
J. A. R. Filho1, E. R. R. Figueira2, B. B. Schimer3, 
V. O. Andre4, M. F. de S. Buto5, M. J. C. Carmona1, 
P. A. C. Luiz3 and A. C. D’Albuquerque2
1Discipline of Anesthesiology, Department of Surgery, 
Hospital das Clinicas, University of Sao Paulo School of 
Medicine, Sao Paulo, Brazil; 2Discipline of Digestive 
Organ Transplantation – LIM37, Department of 
Gastroenterology, Hospital das Clinicas, University of Sao 
Paulo School of Medicine, Sao Paulo, Brazil; 3Department 
of Visceral and Transplant Surgery, University Hospital of 
Zurich, Switzerland; 4FAPESP 2011/08759-0 Scientifi c 
Initiation, University of Sao Paulo School of Medicine, Sao 
Paulo, Brazil; 5Discipline of Scientifi c Research in 
Medicine, University of Sao Paulo School of Medicine, Sao 
Paulo, Brazil
Discipline of Anesthesiology, Department of Surgery, 
Hospital das Clinicas, University of Sao Paulo School of 
Medicine, Sao Paulo, Brazil; Rua dos Ingleses, 586, apt 
194, CEP 01329-000, Morro dos Ingleses, 1329 Sao Paulo, 
Brazil
Introduction: Preconditioning is a therapeutic strategy 
aimed to increase ischemic tissue tolerance and protection 
against ischemia/reperfusion (IR) injury. Recent studies 
demonstrated that volatile anaesthetics may improve post-
ischemic recovery by an ischemic preconditioning-like 
mechanism. Postconditioning is a new concept that may have 
hepatoprotective effect. We hypothesized that sevofl urane 
preconditioning combined with postconditioning may reduce 
the hepatocellular damage in a rat model of warm liver IR.
Methods: Ten Wistar rats under mechanical ventilation 
were divided into 2 groups of 5; 1) IR: rats subjected to 
45 min of warm liver ischemia of left and median lobes, 
followed by resection of non-ischemic lobes at early reperfu-
sion; and 2) SEVO + IR: rats were exposed to sevofl urane 
2.5% for 15 min, followed by 5 min-washout, before isch-
emia, plus sevofl urane 2.5% for 15 min at reperfusion. 
Carotid artery was cannulated for mean arterial pressure 
(MAP) monitoring. Mean portal fl ow (MPF) was assessed 
by perivascular fl owprobe. MAP and MPF were recorded at 
baseline, pre-repefusion and 4 h postreperfusion. Liver trans-
aminases, creatinine, pH, bicarbonate (BIC) and base excess 
(BE), potassium (K), glucose and lactate were measured at 
4 h postreperfusion.
Results: AST and ALT were decreased in the SEVO + IR 
group (12.118 ± 3.611 and 7.870 ± 1.586 U/L) compared to 
the IR group (16.890 ± 1.630 and 13.418 ± 1.088 U/L), p < 
0.05. BIC, and K were increased in the SEVO + IR group 
(11.20 ± 3.86 mmol/L and 6.1 ± 1.3 mEq/dL) compared to 
the IR (6.70 ± 3.32 mmol/L and 4.7 ± 0.7 mEq/dL), p < 0.05. 
There were no differences in MAP, MPF, creatinine, glucose, 
lactate, pH and BE; however glucose tended to be higher in 
the SEVO + IR group (50.8 ± 26.0 mg/dL) compared to the 
IR (35.0 ± 18.4 mg/dL).
Conclusion: In experimental warm liver ischemia/reperfu-
sion, sevofl urane preconditioning plus postconditioning 
reduced the hepatocellular injury demonstrated by lower 
levels of transaminases with a better behaviour of acid-base 
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variables and good hemodynamic recovery. These prelimi-
nary results are encouraging because postconditioning may 
have the advantage of being implemented at the moment of 
reperfusion, what is more feasible to be applied during liver 
transplantation surgery (FAPESP 2011/05214-3).
211
SEVOFLURANE PRECONDITIONING 
PROTECTS THE LIVER AGAINST 
WARM ISCHEMIA/REPERFUSION 
INJURY IN RATS
E. R. R. Figueira1, J. A. R. Filho2, B. B. Schimer3, 
M. Nakatani4, E. R. Tatebe5, M. J. C. Carmona2, 
P. A. Clavien3 and L. A. C. D’Albuquerque1
1Discipline of Digestive Organ Transplantation – LIM37, 
Department of Gastroenterology, Hospital das Clinicas, 
University of Sao Paulo School of Medicine, Sao Paulo, 
Brazil; 2Discipline of Anesthesiology, Department of 
Surgery, Hospital das Clinicas, University of Sao Paulo 
School of Medicine, Sao Paulo, Brazil; 3Department of 
Visceral and Transplant Surgery, University Hospital of 
Zurich, Switzerland; 4FAPESP 2011/09434-8 Scientifi c 
Initiation, University of Sao Paulo School of Medicine, Sao 
Paulo, Brazil; 5Discipline of Scientifi c Research in 
Medicine, University of Sao Paulo School of Medicine, Sao 
Paulo, Brazil
Discipline of Digestive Organ Transplantation, Department 
of Gastroenterology, Hospital das Clinicas, University of 
Sao Paulo School of Medicine, Sao Paulo, Brazil; Rua dos 
Ingleses, 586, apt 194, CEP 01329-000, Morro dos 
Ingleses, 1329 Sao Paulo, Brazil
Introduction: Preconditioning is a therapeutic strategy 
aimed to increase ischemic tissue tolerance and protection 
against ischemia/reperfusion (IR) injury. Recent studies 
demonstrated that volatile anaesthetics may improve post-
ischemic recovery by an ischemic preconditioning-like 
mechanism. We hypothesized that pharmacological precon-
ditioning with sevofl urane may reduce the hepatocellular 
damage in a rat model of warm liver IR.
Methods: Ten Wistar rats under mechanical ventilation 
were divided into 2 groups of 5 animals: I) IR: rats subjected 
to 45 min of warm liver ischemia of the left and median 
lobes, followed by resection of the non-ischemic lobes at 
early reperfusion; and II) SEVO + IR: rats were exposed to 
sevofl urane 2.5% for 15 min, followed by washout during 
5 min, before IR. The carotid artery was cannulated for mean 
arterial pressure (MAP) monitoring. The mean portal venous 
fl ow (MPF) was assessed by perivascular fl owprobe. MAP 
and MPF were recorded at baseline, pre reperfusion and 4 h 
post-reperfusion. Liver transaminases, creatinine, pH, bicar-
bonate (BIC) and base excess (BE), potassium (K), glucose 
and lactate were measured at 4 h post-reperfusion.
Results: AST and ALT were decreased in the SEVO + IR 
group (10.056 ± 5.830 and 8.586 ± 5.296 U/L) compared to 
the IR group (16.890 ± 1.630 and 13.418 ± 1.088 U/L), p < 
0.05. BIC, BE and K were increased in the SEVO + IR group 
(12.42 ± 4.39, −14.72 ± 4.46 mmol/L and 6.3 ± 0.9 mEq/dL) 
compared to the IR (6.70 ± 3.32, −20.48 ± 4.22 mmol/L and 
4.7 ± 0.7 mEq/dL), p < 0.05. MAP at 4 h post-reperfusion 
was decreased in the SEVO + IR group (65 ± 24 mmHg) 
compared to the IR (93 ± 14 mmHg), p < 0.05. There were 
no differences in MPF, creatinine, glucose and lactate; 
however glucose tended to be higher and lactate lower in the 
SEVO + IR group (54.0 ± 22.7 and 42.8 ± 18.6 mg/dL) 
compared to the IR (35.0 ± 18.4 and 66.8 ± 25.9 mg/dL).
Conclusion: In experimental warm liver ischemia/reperfu-
sion, sevofl urane preconditioning plus postconditioning 
reduced the hepatocellular injury demonstrated by lower 
levels of transaminases with a better behaviour of acid-base 
variables and good hemodynamic recovery. These prelimi-
nary results are encouraging because postconditioning may 
have the advantage of being implemented at the moment of 
reperfusion, what is more feasible to be applied during liver 
transplantation surgery. (FAPESP 2011/05214-3).
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HEMODYNAMIC ASSESSMENT OF THE 
PORTAL VENOUS SYSTEM IN WARM 
LIVER ISCHEMIA/REPERFUSION 
INJURY IN RATS
E. R. R. Figueira2, M. Nakatani1, J. A. R. Filho3, 
M. F. de S. Buto4, E. R. Tatebe4, A. R. de C. Martins3, 
T. Bacchella2 and L. A. C. D Albuquerque2
1FAPESP 2011/09434-8 Scientifi c Initiation, University of 
Sao Paulo School of Medicine, Sao Paulo, Brazil; 
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University of Sao Paulo School of Medicine, Sao Paulo, 
Brazil; 3Discipline of Anesthesiology, Department of 
Surgery, Hospital das Clinicas, University of Sao Paulo 
School of Medicine, Sao Paulo, Brazil; 4Discipline of 
Scientifi c Research in Medicine, University of Sao Paulo 
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Discipline of Digestive Organ Transplantation, Department 
of Gastroenterology, Hospital das Clinicas, University of 
Sao Paulo School of Medicine, Sao Paulo, Brazil; Rua dos 
Ingleses, 586, apt 194, CEP 01329-000, Morro dos 
Ingleses, 1329 Sao Paulo, Brazil
Introduction: Liver transplantation and resections require 
temporary interruption of the hepatic blood fl ow resulting in 
the ischemia/reperfusion (IR) injury. The hepatic microcir-
culatory impairment is related to the severity of the IR injury 
and may be refl ected in the liver macro hemodynamic. There 
is an inverse correlation between hepatic blood fl ow and the 
postoperative transaminases. The aim of the study was to 
evaluate the hemodynamic of the portal venous system after 
experimental warm liver IR injury.
Methods: Eighteen Wistar rats were divided into 3 groups: I) 
Control; II) sham: rats submitted to resection of right and 
caudate liver lobes; III) Ischemia (IR): rats subjected to 60 min 
of partial warm liver ischemia of the left and median lobes, 
followed by resection of non-ischemic lobes at reperfusion. 
Four hours after reperfusion rats were anesthetized and sub-
mitted to mechanical ventilation. The carotid artery was can-
nulated for mean arterial pressure (MAP) monitoring. The 
mean portal venous fl ow (MPF) was assessed by a perivascu-
lar fl owprobe. A micropressure probe was introduced into 
portal vein to assess the mean portal venous pressure (MPP). 
At the end blood was collected for AST and ALT analysis.
Results: The mean weigh of the rats was 229 ± 18 g. AST 
and ALT were increased in the IR group (6.675 ± 1.687 and 
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5.793 ± 1.119 U/L) compared to the sham (897 ± 303 and 
815 ± 433 U/L) and control groups (99 ± 28 and 64 ± 
27 U/L), p < 0.05. The MAP was decreased in the IR group 
(90 ± 17 mmHg) compared to the control group (114 ± 
9 mmHg), p < 0.05; but there is no difference when com-
pared to the sham group (106 ± 16 mmHg). The MPP was 
increased in the sham group (9.3 ± 1.8 mmHg) compared to 
the control (6.2 ± 1.7 mmHg) and IR (4.5 ± 1.7 mmHg) 
groups, p < 0.05. The MPF was decreased in the IR group 
(5.0 ± 2.2 mL/min) compared to the sham (12.3 ± 2.1 mL/
min) and control (12.2 ± 1.9 mL/min) groups, p < 0.05.
Conclusion: This experimental study showed that four 
hours after warm liver ischemia/reperfusion, the total hepatic 
blood fl ow is reduced, demonstrated by the decrease of 60% 
in mean portal fl ow and 21% in mean arterial pressure. These 
changes in the hepatic hemodynamics may be correlated with 
the severity of the liver ischemia/reperfusion injury. This 
model can be a tool to evaluate protective strategies against 
liver IR that impact hepatic macro hemodynamics (FAPESP 
2011/05214-3).
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METABOLIC DERANGEMENTS 
IN WARM LIVER ISCHEMIA/
REPERFUSION INJURY WITH PARTIAL 
HEPATECTOMY IN RATS
E. R. R. Figueira2, V. O. Andre1, J. A. R. Filho3, 
M. F. de S. Buto4, E. R. Tatebe4, T. Bacchella2, E. Chaib2 
and L. A. C. D’Albuquerque2
1FAPESP 2011/08759-0 Scientifi c Initiation, University of 
Sao Paulo School of Medicine, Sao Paulo, Brazil; 
2Discipline of Digestive Organ Transplantation – LIM37, 
Department of Gastroenterology, Hospital das Clinicas, 
University of Sao Paulo School of Medicine, Sao Paulo, 
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Sao Paulo School of Medicine, Sao Paulo, Brazil; Rua dos 
Ingleses, 586, apt 194, CEP 01329-000, Morro dos 
Ingleses, 1329 Sao Paulo, Brazil
Introduction: Liver ischemia/reperfusion (IR) is character-
ized by tissue injury associated with metabolic derangements 
as occurs in Liver transplantation (LT) and hepatic surgery. 
We hypothesized that a model reproducing whole liver isch-
emia may allow studying with more accuracy the metabolic 
derangements that follows particular clinical scenarios like 
LT.
Methods: Eighteen Wistar rats were divided into 3 groups 
of 6 animals: I) Control: normal rats not subjected to liver 
resection or IR; II) sham: rats submitted to resection of right 
and caudate liver lobes; III) Ischemia (IR): rats subjected to 
60 min of partial warm liver ischemia of the left lateral and 
median lobes, followed by resection of non-ischemic lobes 
at beginning of reperfusion. Four hours after reperfusion rats 
were anesthetized and submitted to mechanical ventilation. 
The carotid artery was cannulated and arterial blood was 
collected for analysis of lactate, potassium, glucose, hemo-
globin and liver transaminases. Then animals were killed by 
exsanguination.
Results: The mean weigh of the rats was 229 ± 18 g. AST 
and ALT were increased in the IR group (6.675 ± 1.687 and 
5.793 ± 1.119 U/L) compared to the sham (897 ± 304 and 
815 ± 433 U/L) and control groups (99 ± 28 and 64 ± 
27 U/L), p < 0.05. Glucose was decreased in the IR group 
(115 ± 30 mg/dL) compared to the sham (224 ± 101 mg/dL) 
and control (298 ± 115 mg/dL) groups, p < 0.05. Lactate was 
increased in the IR group (24.7 ± 10.2 mg/dL) compared to 
the sham group (14.8 ± 6.3 mg/dL), p < 0.05. There were no 
differences in potassium and hemoglobin between groups. 
However the potassium in the IR group tended to be higher 
than control and sham groups.
Conclusion: This experimental model of warm liver I/R 
showed that after 60 minutes of ischemia the hepatic metab-
olism is reduced. There was a decrease of 40% in the glucose 
and an increase of 60% in lactate serum levels. This impair-
ment of these metabolic variables was associated with an 
increase in liver transaminases indicating a correlation with 
the I/R injury. This model may be useful to study the meta-
bolic hepatic disorders that accompanies liver ischemia/
reperfusion (FAPESP 2011/05214-3).
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ANATOMICAL VARIATION OF THE 
RIGHT POSTERIOR SECTORAL BILE 
DUCT ORIGIN IN SAUDI POPULATION
H. Alghamdi, A. Alqourain, R. Souliman and M. Ismail
University of Dammam, King Fahad Hospital of the 
University
University of Dammam, King Fahad Hospital of the 
University, General Surgery, Pobox 4002031952 Alkhobar, 
Saudi Arabia
Introduction: It is well recognized that most hilar bile ducts 
anatomical variations stem from different right posterior sec-
toral bile duct (RPSBD) origin. Hjortsjo fi rst reported the 
characteristic crook sign of the RPSBD in cholangiography 
in 1951. This sign can be positive for the supraportal type. 
Recognition of this sign is helpful to achieve a safe liver 
resection and transplantation. Nakamura’s classifi es the 
supraportal RPSBD into the most commonly type I (65%: in 
which the right posterior.
Methods: Prospective study involves recruiting all patients 
undergoing indicated ERCP from 1st of March 2010 to 30th 
of May 2011, without a history of liver resection or biliary 
instrumentation.
Results: Around 223 ERCPs done in the study period. Only 
126 were eligible to be included in the study. The pattern of 
RPSBD origin found to be:
Type 1: 45% (positive Hjortsjo sign); type II: 30%; type 
III: 3%; type IV: 7%; type V: 15%.
Conclusion: We concluded that we have unfavorable ana-
tomical pattern of the RPSBD orgin in our community and 
Hepatobiliary and transplant surgeon should anticipate larger 
diffi culties during surgery if not diagnosed preoperatively.
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RHO INHIBITOR PREVENTS ISCHEMIC 
REPERFUSION INJURY IN RAT 
STEATOTIC LIVER
S. Kuroda, H. Tashiro, Y. Igarashi, J. Nambu, 
T. Kobayashi, H. Amano, T. Yuka and H. Ohdan
Department of Surgery, Division of Frontier Medical 
Science, Programs for Biomedical Research, Graduate 
School of Biomedical Sciences, Hiroshima University
Hiroshima University, Department of Surgery, Division of 
Frontier Medical Science, Programs for Biomedical 
Research, Graduate School of Biomedical Sciences, 1-2-3 
Kasumi, 734 Hiroshima, Japan
Introduction: Hepatic stellate cells are thought to play a 
role in modulating intrahepatic vascular resistance based on 
their capacity to contract via Rho signaling. We investigated 
the effect of a Rho-kinase inhibitor on ischemic reperfusion 
injury in the steatotic liver.
Methods: Steatotic livers, induced by a choline-defi cient 
diet in rats, were subjected to ischemic reperfusion injury. 
Hepatic stellate cells isolated from steatotic livers were ana-
lyzed for contractility and Rho signaling activity. The portal 
pressure of the perfused rat liver and the survival rate after 
ischemic reperfusion were also investigated.
Results: Hepatic stellate cells from steatotic livers showed 
increased contractility and upregulation of Rho-kinase 2 
compared with those from normal livers. Furthermore, endo-
thelin-1 signifi cantly enhanced the contractility and phos-
phorylation level of myosin light chain and cofi lin in hepatic 
stellate cells isolated from steatotic livers. A specifi c Rho-
kinase inhibitor, fasudil, signifi cantly suppressed the contrac-
tility and decreased the phosphorylation levels of myosin 
light chain and cofi lin. Rats with steatotic livers showed a 
signifi cant increase in portal perfusion pressure after isch-
emic reperfusion and a signifi cant decrease in survival rate; 
fasudil treatment signifi cantly reduced these effects.
Conclusion: Activation of Rho/Rho-kinase signaling in 
hepatic stellate cells isolated from steatotic livers is associ-
ated with an increased susceptibility to ischemic reperfusion 
injury. A Rho-kinase inhibitor attenuated the activation of 
hepatic stellate cells isolated from steatotic livers and 
improved ischemic reperfusion injury in steatotic rats.
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ORTHOTOPIC LIVER 
TRANSPLANTATION USING SELECTED 
ADVANCED AGE DONORS SHOULD 
BECOME A ROUTINE
T. Aoyagi1, F. Dondero1, S. Gaujoux1, D. Sommacale1, 
C. Francoz2, F. Durand2, C. Paugam-Burtz3 and J. Belghiti1
1Department of HPB Surgery and Transplantation, Beaujon 
Hospital; 2Department of Hepatology, Beaujon Hospital; 
3Department of Anesthesiology and Critical Care, Beaujon 
Hospital
Beaujon Hospital, HPB Surgery and Transplantation, 100 
Boulevard Du General Leclerc, 92110 Clichy, France
Introduction: Orthotopic liver transplantations (OLT) from 
advanced age donors have shown to provide acceptable 
results in short series. However, early synthetic function and 
outcome of these grafts have not been studied in large cohort.
Methods: Since 2004, from a prospectively maintained reg-
istry of 771 OLTS, 81 OLTs from selected (no cardiac arrest 
or moderate/severe steatosis) donors older than 75 years (75 
to 91) (ELD; Elderly Donor) were compared to 169 OLTs 
from donors between 40 and 60 years (UD; Usual Donor), 
in recipient with similar MELD score (17.9 vs 19.5; p = 0.2), 
with a specifi c attention to early postoperative liver function, 
vascular complication, and long-term outcome.
Results: With similar cold ischemia time (459 vs 
463 minutes; p = 0.83), ELD liver function test and their 
kinetic were superimposable when compared to UD. ELD 
short-term outcome was as good as UD one, without signifi -
cance in PNF (2.5% vs 3.6%; p = 0.67), EAD (11% vs 20%; 
p = 0.09), 30-day mortality (2.5% vs 5.6%; p = 0.24), or 
arterial thrombosis (1.2% vs 4.7%; p = 0.06). Long-term 
outcome were similar regarding 3-year graft (72.4% vs 
70.6%; p = 0.65) and patient survival (74.8% vs 72.3%; p = 
0.65) or retransplant rate (5.1 vs 7.7; p = 0.45).
Conclusion: This large single center study confi rms that 
selected advanced donor age provide excellent short and 
long-term outcome. These results should lead widely accept 
these selected grafts, and consider them as usual ones.
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URGENT PROCEDURES FOR 
ABDOMINAL HERNIA IN CIRRHOTIC 
PATIENT HAS HIGHER MORTALITY
W. Andraus, L. Haddad, L. Ducatti, B. Canedo, R. Pecora, 
L. Nacif, O. Ferro, L. A. D’albuquerque
Liver Transplantation Unit, Gastroenterology Department, 
São Paulo University School of Medicine
Liver Transplantation Unit, São Paulo University, 
Gastroenterology, St Dr. Enéas de Carvalho Aguiar, 255 
– 9º fl oor – room 9113/91145403 São Paulo, Brasil
Introduction: The incidence of abdominal wall hernias in 
cirrhotic patients is higher than general population, being up 
to 40% in those with ascites. Usually, “wait and see” approach 
is preferred, especially in those with refractory ascite and/or 
advanced cirrhosis (Child C). Therefore, hernia repair 
happens in an urgency situation, with high morbidity and 
mortality. The aim of this study was to compare elective and 
urgent hernia repair outcome in cirrhotic patients.
Methods: Sixty-seven cirrhotic patients underwent hernia 
repair between January 1998 and December 2009 at Sao 
Paulo University. Twenty patients were excluded because of 
loose in follow up and/or lack of information. The patients 
were divided in two groups: elective (ER) and urgent repair 
(UR). Data regarding patients demographic characteristics, 
cirrhosis etiology, hernia location and repair technique, pres-
ence of ascites, hospital length of stay, intensive care stay, 
morbidity and mortality were compared. Liver disease sever-
ity was evaluated using Child-Turcotte-Pugh (CTP) and 
MELD.
Results: Seventeen and 30 patients underwent ER and UR, 
respectively. The median MELD score was 12 for ER group 
and 14 for UR group (p = 0.30). UR was performed mostly 
in case of rupture (n = 14) and incarceration (n = 7). At ER 
group, 10 patients were CTP A, 6 CTP B and 1 CTP C, 
statistically different from UR group, which 4 were CTP A, 
17 CTP B and 9 CTP C (p < 0.001). Inguinal hernia (60%) 
and umbilical hernia (83%) were the most common type in 
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both groups. The median of hospital stay was 2 days in the 
ER group and 11 days in the UR group (p < 0.001). 
Postoperative complication was present in 17.6% in the ER 
group and 63.3% in the UR group. The most common com-
plication in both groups was acute renal failure. There was 
no difference in mortality.
Conclusion: Elective abdominal hernia repair in cirrhotic 
patients is safer and seems to lead to better outcomes than 
urgency repair. However, prospective randomized study, 
including all level of liver disease severity, is necessary in 
order to confi rm the safety and superiority of elective 
treatment.
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HEPATOCELLULAR CARCINOMA 
ASSOCIATED WITH CHRONIC 
SCHISTOSOMA MANSONI INFECTION: A 
CASE SERIES REPORT
R. Surjan1, L. Kikuchi1, A. Chagas1, I. Braghiroli2, 
J. Sabbaga, P. Hoff2, L. D’Albuquerque1 and F. Carrilho1
1Department of Gastroenterology, University of Sao Paulo 
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Introduction: HCC is related to liver cirrhosis in 60–90% 
of cases. Hepatitis B and C are the main etiology for liver 
disease, followed by NASH and alcohol abuse. Although 
chronic schistosomal infection, mainly in hepatosplenic 
form, evolves with important liver perisinusoidal fi brosis, 
progression to liver cirrhosis is not usual. The etiologic rela-
tionship of schistosomiasis and hepatocellular carcinoma has 
long been debated and we reported a case series in this 
context.
Methods: A prospective institutional database was used to 
identify all patient with HCC that could be related to chronic 
schistosomal infection. The inclusion criteria were patients 
with HCC and confi rmed schistosomiasis. The exclusion cri-
teria were the presence of other risk factor for HCC. All 
patients had to have negative serology for hepatitis C and B 
virus and negative history of excessive alcohol intake.
Results: We identifi ed six cases of HCC associated with 
Schistosomiasis mansoni. Five were man, age from 49 to 70 
months. Diagnosis of HCC was made by biopsy or associa-
tion of characteristic image + AFP > 200 ng/ml.
Schistosomal infection diagnosis was made by liver biopsy 
or association of positive epidemiology, typical image pattern 
on CT/Ultrasound, positive stools and/or serology for schis-
tosoma. All of them had signs of portal hypertension and in 
three of them with prior episode of esophageal variceal hem-
orrhage. All patients had negative serology for hepatitis C 
and B virus and denied excessive alcohol intake history. 
Markers of autoimmunity and risk factor for NASH were 
absent.
Number of nodes ranged from 1 to 5. Tumor size ranged 
from 40 to 110 mm (median: 61.5 mm). AFP at diagnosis 
ranged from 4 to 4692 ng/ml. All of them were Child-Pugh 
A. BCLC was B except for one (A). ECOG was 0 except for 
one (1). All patients received fi rst line treatment, three with 
transarterial chemoembolization and three with sorafenib. 
None were submitted to liver transplantation. At a median 
follow up of 22.2 months there were two deaths.
Conclusion: Chronic schistosomal infection could be 
related to HCC etiology. A greater number of cases is needed 
to better analyze the clinical characteristics of this 
population.
318
THE IMPACT OF MELD CRITERIA 
(MODEL FOR END-STAGE LIVER 
DISEASE) ON ALLOCATION OF GRAFTS 
FOR LIVER TRANSPLANTATION IN 
PATIENTS WITH HEPATOCELLULAR 
CARCINOMA IN BRAZIL
R. Surjan, A. Oliveira, L. Kikuchi, A. Chagas, R. Alencar, 
G. Cardoso, V. Pugliese and L. D’Albuquerque
University of São Paulo School of Medicine, Department 
of Gastroenterology, Liver Transplantation Service
University of Sao Paulo School of Medicine, Sao Paulo, 
Brazil; Department of Gastroenterology, Liver 
Transplantation Service, Rua João Moura 956, apt 151, 
Zip Code: 05412-0015412 São Paulo, Brazil
Introduction: MELD allocation criteria was fi rst intro-
duced in Brazil on August, 2006 and had clear effects on 
listing time for liver transplantation for patients with hepa-
tocellular carcinoma. The main objective of this paper is to 
evaluate the impact of MELD on the waiting list at the largest 
tertiary hospital in Brazil.
Methods: A retrospective analysis was performed on data 
of 582 sequential liver transplantations performed on The 
Clinics Hospital of The University of Sao Paulo School of 
Medicine from February 2002 to February 2011.
Results: When MELD was introduced, and patients with 
hepatocellular carcinoma within Milan criteria not prone to 
resection were granted with additional scores: 20 points at 
the time of listing, 24 points after three months and 29 points 
after 6 months, causing a signifi cative increase on the propor-
tion of tumor patients submitted to transplantation. This 
made it possible for many tumor patients to reach the trans-
plant. On October 2010, there was a determination that tumor 
patients listed for transplantation no longer received 29 
points, staying at 24 points. The impact came immediately: 
an abrupt decrease on the proportion of liver transplantations 
performed on cancer patients, while the mean MELD score 
remained the same since 2006.
Conclusion: The sudden reduction on MELD score of hepa-
tocellular carcinoma patients on liver transplantation waiting 
list made it more diffi cult for these patients to reach the 
transplant. Longer waiting times had impact on exclusion 
from transplant list for exceeding Milan criteria due to tumor 
enlargement and on mortality rates of patients listed for liver 
transplantation.
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DISPARITIES IN HEALTH INSURANCE 
STATUS AND COMMUNITY RESOURCES 
IMPACT LIVER TRANSPLANT 
RECIPIENTS’ HEALTH-RELATED 
QUALITY OF LIFE
L. A. Redhage, I. Feurer, D. Moore, L. Simmons and 
C. W. Pinson
Vanderbilt University Medical Center, Transplant Center
Vanderbilt University Medical Center, Transplant Center, 
801 Oxford House, 1313 21st Avenue South, 37232 
Nashville, United States of America
Introduction: Recently published cross-sectional data indi-
cate that patient characteristics such as employment, educa-
tional attainment and type of health insurance are related to 
post-transplant health-related quality of life (HRQOL). 
However, the relationship of patient and community-based 
characteristics to longitudinal HRQOL is unknown. The aim 
of this study was to test whether patient and community 
characteristics are associated with a variety of longitudinal 
HRQOL measures in liver transplant recipients.
Methods: HRQOL was measured using the SF-36 physical 
(PCS) and mental (MCS) components, Beck Anxiety 
Inventory (BAI), and CES-D depression scale. Patient char-
acteristics were months post-transplant at each HRQOL 
assessment, hepatitis C virus (HCV) infection, age, sex, race, 
and type of health insurance (private/public). Community 
characteristics by zip code of permanent residence using US 
census data were population, median household income and 
the proportion who were high school graduates. The National 
Center for Health Statistics urban-rural scale was used to 
classify zip codes (1 = large central metro, 6 = non-metro). 
Linear mixed models tested the effects of patient and com-
munity characteristics on longitudinal PCS, MCS, BAI and 
CES-D scores.
Results: 231 adult liver transplant recipients (69% male, 
95% white race, 78% private health insurance, 43% HCV-
positive, average follow-up = 29 ± 24 months) had one pre- 
and at least one post-transplant HRQOL assessment (>1,000 
assessments). Total population averaged 22,097 ± 14,973 
(range: 372–64,753) persons. All HRQOL outcomes 
improved (p < 0.001) after transplantation. After controlling 
for pre-transplant scores, HCV infection as the primary cause 
of liver failure was associated with increased post-transplant 
symptoms of anxiety (p = 0.043). Private health insurance 
was associated with better HRQOL in all four models (all p 
< 0.05). Living in a higher population area was associated 
with better PCS (p = 0.017), MCS (p = 0.016) and BAI (p = 
0.018) scores.
Conclusion: Liver transplant recipients with private health 
insurance living in more highly populated areas have supe-
rior health-related quality of life, which may be attributed to 
increased access to healthcare resources such as pharmacies, 
medical centers and rehabilitation facilities. Patients with 
fewer personal and community resources may be susceptible 
to increased symptoms of anxiety and depression post-trans-
plantation, warranting increased provider awareness and tar-
geted interventions.
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LIVING DONOR RIGHT HEPATECTOMY 
USING THE HANGING MANEUVER BY 
GLISSON’S APPROACH UNDER THE 
UPPER MIDLINE INCISION
Y.-K. Kim, S. H. Kim, T. S. You, S. D. Lee, S.-S. Han and 
S.-J. Park
Center for Liver Cancer, National Cancer Center
National Cancer Center, Center for Liver Cancer, 323 
Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 41076 
Goyang, Republic of Korea
Introduction: The purpose of this study was to introduce 
an advanced technique for the best living donor right hepa-
tectomy (LDRH) using the hanging maneuver by Glisson’s 
approach under an upper midline incision.
Methods: From January 2005 to February 2010, a total of 
196 consecutive LDRHs have been performed at the National 
Cancer Center, Korea. To assess the overall outcomes of 
LDRH done with two signifi cant technical developments-the 
upper midline incision and the initial Glisson’s approach-we 
performed a comparative analysis involving all consecutive 
living donors, who we divided into three groups based on the 
two technical modifi cations over 5 years.
Results: Compared with the previous two groups, the third 
group of 32 consecutive living donors, from September 2009 
to February 2010, demonstrated shorter operative time, 
shorter duration of hospital stay, and lower complication rate 
with no operative mortality, major morbidity, blood transfu-
sion, or reoperation. All donors were fully recovered and 
returned to their previous activities.
Conclusion: This LDRH using the hanging maneuver by 
Glisson’s approach can be completed safely and effectively 
with good outcomes through an upper midline incision above 
the umbilicus, which may be a new milestone toward the best 
LDRH that donor surgeons can pursue.
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LIVING DONOR HEPATECTOMIES IN 
SELECTIVE DONORS WITH THE 
RESIDUAL LIVER VOLUME LESS THAN 
30 PERCENT OF THE TOTAL LIVER 
VOLUME IN PREOPERATIVE CT 
VOLUMETRY: A SINGLE 
CENTER EXPERIENCE
Y.-K. Kim, S. H. Kim, T. S. You, S. D. Lee, S.-S. Han and 
S.-J. Park
Center for Liver Cancer, National Cancer Center
National Cancer Center, Center for Liver Cancer, 323 
Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 41076 
Goyang, Republic of Korea
Introduction: Recently, our center performed living donor 
hepatectomies in selective donors with RLV less than 30% 
of TLV in preoperative CT volumetry. The aim of this study 
is to investigate whether living donor hepatectomies in selec-
tive donors with RLV less than 30% of RLV in preoperative 
CT volumetry are acceptable in terms of donors’ safety.
Methods: From January 2005 to September 2011, consecu-
tive 302 living donor hepatectomies were performed in 
National Cancer Center, Korea. Among these donors, 2 
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donors were excluded due to donation of the left lobe and 12 
donors were excluded due to not performing preoperative CT 
volumetry. Remaining 288 donors were divided into 2 groups 
according to RLV of TLV in preoperative CT volumetry. 
General donor (GD) group (n = 260) was defi ned as that 
RLVs were ≥30% of TLV and selective donor (SD) group (n 
= 28) was defi ned as that RLVs were < 30% of TLV. Data of 
donors were collected based on medical record and were 
analyzed.
Results: Donation volume in CT volumetry was signifi -
cantly correlated with real graft weight (p < 0.01). There was 
no signifi cant difference between both groups in demograph-
ics and intraoperative factors. Postoperative factors were not 
signifi cantly different between both groups except peak bili-
rubin. Peak bilirubin was higher in SD group than GD group 
(p = 0.41).
Conclusion: The data from this study suggest that living 
donor hepatectomies could be safely performed in selective 
donors with RLV less than 30% of TLV in preoperative CT 
volumetry.
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INTRAOPERATIVE HEMODYNAMIC 
CHANGES IN LIVING DONOR PARTIAL 
LIVER GRAFTS
M. Shimazu1, Y. Kato2, M. Tanabe3, K. Hoshino3, 
S. Kawachi3, Y. Kitagawa3 and G. Wakabayashi4
1Department of Surgery, Hachioji Medical Center, Tokyo 
Medical University; 2Department of Surgery, School of 
Medicine, Fujita Health University; 3Department of 
Surgery, School of Medicine, Keio University; 4Department 
of Surgery, School of Medicine, Iwate Medical University
Hachioji Medical Center, Tokyo Medical University, 
Surgery and Transplantation, 1163 Tatemachi, Hachioji-
shi, 193-0998193-0 Tokyo, Japan
Introduction: The purpose of this study is to investigate the 
intraoperative hemodynamic changes in partial liver grafts 
and characterize their potential impact on post-transplant 
liver regeneration in LDLT.
Methods: We examined the portal venous fl ow (PVF) and 
hepatic arterial fl ow (HAF) to partial liver grafts by ultra-
sonic transit time fl owmetry of donors immediately before 
graft retrieval and of the corresponding recipients after vas-
cular reconstruction in 48 LDLT patients. We evaluated post-
transplant liver regeneration according to the changes in graft 
liver volume between the time of transplantation and the 7th 
post-transplant day.
Results: There was a signifi cant increase in PVF to the 
partial liver grafts in recipients compared with that in donors. 
In contrast, graft HAF in recipients signifi cantly decreased 
compared with that in donors. The PVF in recipients inversely 
correlated with graft weight-recipient body weight ratio 
(GRWR), while HAF volume showed no signifi cant correla-
tion. The PVF in recipients positively correlated with the rate 
of liver regeneration, which inversely correlated with GRWR. 
Full-size liver grafts showed a slight increase in PVF during 
transplantation and in graft volume following transplanta-
tion, and their increase rates were signifi cantly smaller than 
those in small-for-size grafts.
Conclusion: These results suggest that the intraoperative 
portal hemodynamic changes in partial liver grafts strongly 
affect their post-transplant regeneration. In particular, in 
small-for-size liver grafts, an immediate and remarkable 
increase in graft PVF may contribute to rapid liver regenera-
tion following LDLT if the increased PVF remains within a 
safe range.
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VALUE OF PEROPERATIVE CONTRAST-
ENHANCED ULTRASONOGRAPHY IN 
LIVER TRANSPLANTATION
F. Faitot1, E. Vibert2, N. Leo3, L. Ricca1, O. Ciacio1, 
M. Lewin3, R. Adam4 and D. Castaing4
1AP-HP Hopital Paul Brousse, Centre Hépato-Biliaire, 
F-94800 Villejuif, France; 2Inserm, Unit 785, F-94800 
Villejuif, France ; 3AP-HP hopital Paul Brousse, Service 
de Radiologie, F-94800 Villejuif, France; 4Univ Paris-Sud, 
Faculté de Médecine, F-94270 Le Kremlin-Bicêtre, France
AP-HP Hopital Paul Brousse, Centre Hépato-Biliaire, 
12-14 Avenue Paul Vaillant Couturier, 94800 Villejuif, 
France
Introduction: At the end of liver transplantation (LT), 
portal, arterial and hepatic veins fl ows are systematically 
evaluated by intraoperative ultrasound. Intraoperative con-
trast-enhanced ultrasonography (ICEUS) emphasizes the 
vessel visualization and liver parenchyma perfusion com-
paratively to classic US. The aim of this study was to evalu-
ate the clinical impact of using ICEUS at the end of liver 
transplantation.
Methods: On a 4 month period, at the end of LT, a periph-
eral venous injection of contrast media (2.5 ml SonoVue) 
was systematically made following a classic ultrasonography 
(US) in 40 consecutive transplanted patients (27 men/13 
women – mean age 50 ± 10) including 7 partial livers and 2 
retransplantations. Classic US in mode B studied arterial, 
portal and hepatic vein fl ow spectrum and ICEUS (Aloka 
Alpha 7) evaluated arterial and portal perfusion at the level 
of portal bifurcation then venous outfl ow in the caval anas-
tomosis. The additional value of ICEUS after classic ultra-
sonography was studied.
Results: The classic US did not detect arterial fl ow in 2/40 
patients (5%). In these two patients, ICEUS visualized intra-
hepatic arterial fl ow and arterial anastomosis was not recon-
structed. In patients with normal classic US, altered arterial 
perfusion was detected by ICEUS in 2/40 patients (5%) that 
were effi ciency treated, respectively, by an arcuate ligament 
section and splenic artery ligation. Outfl ow abnormalities 
were detected only by ICEUS in 4/40 patients (10%). Liver 
suspension or retrohepatic balloon placement corrected these 
abnormalities.
Conclusion: Contrast media injection at the end of LT had 
presented an additional value in 20% of the patients com-
paratively to classic US with a successful therapeutic impact 
in all cases. We advocate systematic use of this examination 
at the end of liver transplantation.
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PREDICTIVE FACTORS FOR ACUTE 
REJECTION AFTER LIVER 
TRANSPLANTATION
Y.-C. Wang, T.-J. Wu, T.-H. Wu, C.-F. Lee, H.-S. Chou, 
K.-M. Chan and W.-C. Lee
Chang-Gung Transplantation Institute, Department of 
Liver and Transplantation Surgery, Chang-Gung Memorial 
Hospital, Chang-Gung University Medical School, 
Taoyuan, Taiwan
Chang Gung Memorial Hospital, Chang Gung University, 
Chang-Gung Transplantation Institute, Department of 
Liver and Transplantation Surgery, 5 Fu-Hsing Street, 
Kwei-Shan, 333 Taoyuan, Taiwan
Introduction: Acute allograft rejection is still a common 
issue after liver transplantation (LT) although immunosup-
pressive agents are well-developed. The aim of this study is 
to evaluate the risk factors of acute cellular rejection (ACR) 
for adult liver transplantation patients.
Methods: A total of 110 consecutive patients undergoing LT 
were retrospectively reviewed between May 2007 and 
December 2010. Diagnosis of ACR was based on clinical 
presentation and biochemical fi ndings. Liver biopsy was 
considered only if clinical presentation was equivocal. The 
donors’ and recipients’ characteristics, peri-operative immune 
status, post-operative laboratory data were recorded and 
compared. Forty patients (36.4%) who suffered from clinical 
rejection and received pulsed or re-cycling steroid therapy 
were defi ned as R group, the other 70 patients (63.6%) 
without rejection as N group.
Results: The mean age of the recipients in R group was 
46.61 ± 9.97 year-old, which was younger than N group 
(51.86 ± 8.37, p = 0.005). Patients in R group had lower 
pre-orthotopic LT creatinine (p = 0.016) and higher ALT (p 
= 0.048). The Cox regression model showed recipient’s age 
was the only signifi cant factor to predict ACR (odds ratio = 
1.071, p = 0.003). Most optimal cut-point of recipient’s age 
to predict ACR was 46 year-old by ROC curve. Patients 
younger than 46 year-old had higher initial CD8+ T-cell 
counts than those older than 46 year-old (p = 0.038).
Conclusion: Recipient’s age is signifi cantly associated to 
ACR. Younger patients have more CD8+ lymphocyte counts 
than elder patients. Aggressive immunosuppression should 
be considered in the younger liver transplantation recipients 
to prevent ACR.
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HYPOTHERMIC OXYGENATED 
MACHINE PRESERVATION OF DONOR 
LIVERS AFTER PROLONGED ISCHEMIA 
IN A PORCINE MODEL OF DONATION 
AFTER CARDIAC DEATH
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T. Lisman1 and R. J. Porte2
1Surgical Research Laboratory, Department of Surgery, 
University Medical Center Groningen, The Netherlands; 
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Y2144, BA44 9713 GZ Groningen, The Netherlands
Introduction: Livers derived from donation after cardiac 
death (DCD) are increasingly accepted for transplantation. 
However, compared to donation after brain death, DCD 
livers suffer additional warm ischemic injury, leading to 
reduced viability and lower graft survival after transplanta-
tion. Oxygenated machine perfusion might allow resuscita-
tion of DCD livers and improve organ viability. In this study, 
we compared oxygenated hypothermic machine perfusion 
(HMP) with simple cold storage (SCS) of DCD pig livers.
Methods: Using standard procurement technique of in situ 
perfusion with cold UW solution (4°C), livers were obtained 
from Yorkshire pigs after 30 min of cardiac arrest. Donor 
livers were subsequently preserved for 4 hr by SCS (n = 4) 
or by 4 hr of oxygenated HMP (14°C; n = 4). To mimic 
transplantation, all livers were subsequently reperfused for 
2 hr at 37°C with oxygenated, heparinized porcine whole 
blood. The machine perfusion system used in this study is 
pressure-controlled and allows combined pulsatile arterial 
and continuous portal venous perfusion of the liver (Liver 
Assist®, Organ Assist, Groningen, Netherlands). During and 
after machine perfusion, liver and bile duct biopsies and 
samples from the perfusion fl uid or blood were collected.
Results: Biochemical markers of liver cell injury, alanine 
aminotransferase (ALT) en aspartate aminotransferase 
(AST), were signifi cantly higher after reperfusion of SCS 
livers, compared to HMP livers (248 vs 71 [p = 0.03] and 
4234 vs 956 [p = 0.03], respectively). Hepatic artery blood 
fl ow at 1 hour after reperfusion was higher in the HMP 
group, compared to the SCS group (269 [IQR 71–270] ml/
min vs 76 [IQR 22–128] ml/min), although this did not reach 
statistical signifi cance (p = 0.23). Gross appearance con-
fi rmed better preservation of HMP livers as these livers 
appeared more homogenously perfused after reperfusion. 
Histological evaluation of liver and bile duct biopsies, 
however, did not show major differences between SCS or 
HMP livers.
Conclusion: Oxygenated HMP of livers from DCD donors 
is associated with better restoration of hepatic artery blood 
fl ow upon graft reperfusion and a lower hepatic release of 
ALT and AST, compared to livers preserved by SCS. 
However, differences in histological injury were minimal 
and further optimization of machine preservation of DCD 
livers may require normothermic rather than hypothermic 
perfusion.
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LDLT COMBINED WITH 
INTERPOSITION GRAFT OF 
RETROHEPATIC IVC FOR THE HCC 
LOCATED IN THE CAUDATE LOBE 
AND RIGHT LIVER TO GET CURATIVE 
GOAL OVER MILAN AND WITHIN 
UCSF CRITERIA
Y. H. Kim1, K. S. Ahn1, H. T. Kim2, U. J. Park2, 
W. H. Cho2 and K. J. Kang1
1Division of HBP Surgery, Department of Surgery, 
Keimyung University School of Medicine; 2Division of 
Transplantation & Vascular Surgery, Department of 
Surgery, Keimyuing University School of Medicine
Keimyung University School of Medicine, Division of HBP 
Surgery, Department of Surgery, #56 Dalsung Ro, Jung Gu 
Daegu, South Korea
Introduction: Living donor liver transplantation (LDLT) 
for a big HCC located in the caudate lobe is an additional 
challenge in afraid of dissemination of cancer cells while 
doing recipient hepatectomy in Piggy-back technique for 
LDLT. To decrease a chance of disseminating cancer cells 
during recipient hepatectomy, en bloc resection of the liver 
including retrohepatic IVC and artifi cial venous graft may be 
a solution of this problem.
Methods: Case: A 50-years old male patient who had 
chronic hepatitis B cirrhosis developed HCC in the caudate 
lobe and segment 5. The diameters of the masses were 
4.5 cm & 2.5 cm respectively. There was neither metastatic 
lesion (intrahepatic or extrahepatic) nor vascular invasion. 
His INR was 1.68, bilirubin 3.6 mg/dl, albumin 2.7 gm/dl, 
ICG R15 59.7%, MELD score 17, a-FP and PIVKA II level 
was 15.8 ng/ml and 78.2 mAU/ml. He had moderate amount 
of ascites. He did not applied any kind of therapy including 
TACE or local ablative therapy of the HCC before 
transplantation.
Results: For the recipient hepatectomy, we did en bloc 
resection of the whole liver including retrohepatic vena cava 
with very limited manipulation or compression of the caudate 
lobe during resection and reconstructed IVC with rifampicin 
soaked Dacron graft (Hemashield®). We performed trans-
plantation a right lobe that was taken from living donor, with 
anastomosis of the right hepatic vein to the grafted Dacron. 
In order to prevent kinking or awkward anatomical position-
ing, we made a cuff to the right hepatic vein stump with great 
saphenous vein on the back table. We did not use veno-
venous bypass during entire procedure. Total anhepatic 
period was 84 minutes. The patient was stable and transfused 
2880 ml of packed RBC during entire surgical procedure.
Conclusion: In conclusion, the surgical technique is feasi-
ble in terms of safety of anatomical reconstruction and 
stability of the vital sign during entire procedure without 
veno-venous bypass. We should observe and evaluate long 
term safety for cancer recurrence and infection of artifi cial 
vascular graft in the milieu of immunosuppression after liver 
transplantation.
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RISK FACTORS FOR MORTALITY AND 
MINIMAL REQUIREMENT OF GRAFT 
RECIPIENT WEIGHT RATIO IN ADULT 
LIVING DONOR LIVER 
TRANSPLANTATION USING LEFT 
LOBE GRAFTS
A. Omori, H. Egawa, Y. Kotera, S.-ichi Ariizumi, 
Y. Takahashi, T. Kato, S. Katagiri and M. Yamamoto
Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University
Institute of Gastroenterology, Tokyo Women’s Medical 
University, Department of Surgery, 8-1, Kawada-cho, 
Shinjuku-ku, 16286 Tokyo, Japan
Introduction: The effectiveness of portal modulation to 
prevent small for size syndrome has been reported. On the 
other hand, 100% survival of adult living donor liver trans-
plantation (A-LDLT) using left lobe graft without portal 
modulation was recently reported. In this study, we analyzed 
risk factor for mortality after A-LDLT using left lobe grafts 
(Study 1) and to determine a benefi cial factor for patient 
survival in very small size grafts (Study 2).
Methods: Twenty-eight patients (age: 22 to 69 years, 10 
men and 18 women) underwent 28 LDLT. The indications 
were cirrhosis in 6, HCC in 6, PBC in 10, PSC in 1, and 
citrullinemia in 1. We used only left lobe grafts for safety of 
living donors regardless graft recipient weight ratio (GRWR: 
0.36 to 1.07 with a median of 0.65). A porto-systemic shunt 
anastomosis to decrease portal pressure or closure of preop-
eratively existing port-systemic shunts was not performed. 
We analyzed signifi cance of preoperative factors for mortal-
ity using JMP7 (SAS), such as age (Recipient and donor), 
gender (Recipient and donor), MELD, GRWR, preoperative 
shunt and gender mismatch.
Results: Major morbidity was intractable ascites (>2000 ml/
day) in 17, infection in 12, acute cellular rejection in 13. 
Overall 1 year patient survival was 54%. Ten of 14 mortality 
(71%) occurred within 4 months. Study 1: Signifi cant factors 
for overall mortality were recipient gender (1-year survival: 
female vs. male, 67% vs. 30%, p < 0.05), GRWR (>0.65 vs. 
<0.65, 73% vs. 31%, p < 0.05), and preoperative shunt (exis-
tence vs. absence, 90% vs. 18%, p < 0.005). Study 2: In 13 
patients with GRWR < 0.65, only preoperative shunt (exis-
tence vs. absence, 100% vs. 10%, p < 0.05) was a signifi cant 
factor.
Conclusion: Male recipients, GRWR <0.65, and preopera-
tive shunt absence were signifi cant risks for A-LDLT using 
left lobes. Effectiveness of intentional porto-systemic shunt 
in extra-small graft size was indicated.
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EARLY RE-OPERATION FOR 
BLEEDING FOLLOWING LIVER 
TRANSPLANTATION:  
PREDICTIVE FACTORS
R. Memeo1, C. Salloum1, A. Laurent1, C. Tayar1, 
C. Duvoux3, J. Y. Lauzet2, J. C. Merle2 and D. Azoulay1
1Hepato-Biliary and Liver Transplant Unit, Henri Mondor 
Hospital, Créteil, France; 3Department of Hepatology, 
Henri Mondor Hospital, Créteil, France; 2Anesthesiology 
and liver-ICU, Henri Mondor Hospital, Créteil, France
Hopital Henri Mondor, Service Chirurgie Digestive, 51 
Avenue du Maréchal de Lattre de Tassigny, 94000 Creteil, 
France
Introduction: Bleeding is a severe complication in the early 
postoperative period after liver transplantation impacting on 
morbidity, mortality and long term graft and patient survival. 
The objective of the study was to identify the risk factors of 
postoperative bleeding needing re-operation.
Methods: 372 consecutive LT performed at our centre since 
2005 were analysed. Reoperation for post-LT bleeding was 
considered when occurring within 30 days of LT.
We retrospectively analysed preoperative characteristics 
of donors, grafts, recipients and intraoperative data to iden-
tify the risk factors of postoperative bleeding needing 
re-operation.
Results: Only statistically signifi cant results are given. On 
univariate analysis, dosage of adrenaline (1.36 ± 3.6 vs 0.35 
± 1.3 mg/hr, p = 0.01) and transient heart failure in the donor 
(24% vs 10%, p = 0.02) were predictive of re-operation for 
bleeding. No other donor or graft data was predictive of 
reoperation including age of donor, donor risk index accord-
ing to Feng, cold ischemia time, BMI, duration of ICU stay 
and biological data. Concerning the recipients, only past 
history of laparotomy (p = 0.0001) and preoperative trans-
aminases (p < 0.01) were predictive of reoperation. All others 
factors were not predictive including age, sex, MELD and 
CHILD scores, indication for LT, presence of portal hyper-
tension and ascites. Concerning the LT procedure none of the 
factors was predictive of reoperation including the use of 
partial graft, transfusion, duration of surgery. Multivariate 
was not methodologically applicable.
Conclusion: Hemodynamically unstable donors, past 
history of laparotomy and high levels of transaminases are 
predictive of post LT reoperation for bleeding. These factors 
should be controlled as much as possible to improve LT 
results.
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MORBIDITY AND MORTALITY IN 200 
CONSECUTIVE LIVING DONOR 
HEPATECTOMIES FOR PEDIATRIC 
LIVER TRANSPLANTATION: A SINGLE-
CENTER EXPERIENCE
H. Sasanuma1, F. Takehito1, Y. Sakuma1, A. Shimizu, 
M. Hyodo1, K. Mizuta2, S. Naohiro1 and Y. Yasuda1
1Department of Surgery, Jichi Medical University; 
2Department of Transplant Surgery, Jichi Medical 
University
Jichi Medical University Surgery, 3311-1, Yakushiji, Zip 
Code: 3290498 Shimotsuke, Japan
Introduction: We assessed postoperative complication 
rates in living donor hepatectomies (LDH) for pediatric liver 
transplantation during the last decade (2001–2011).
Methods: We retrospectively analyzed the outcomes of 200 
consecutive LDHs during the period 2001–2011. 
Postoperative complications were classifi ed by the Clavien 
grading system. We defi ned Clavien grade more than or 
equal to 3 as major complications.
Results: Mean age at donation was 35 years (range 23–58), 
and body mass index was 22.1 (SD 2.6). Mean operating 
time was 320 min (SD 95) and blood loss was 859 ml (SD 
451). There was no perioperative mortality. A total of 12 
(6.0%) major and 84 (42.0%) minor complications were reg-
istered. Major complication was associated with age more 
than 40 years old (p = 0.004). Minor complications included 
gastric stasis, bile leakage and wound infection. Wound 
infection and bile leakage was associated with more than 
1000 ml blood loss (OR 5.53; 95% CI 1.73, 17.66) and 5 
hours of operating time (OR 5.28; 95% CI 4.41, 19.84). 
Prolonged hospitalization was associated with wound infec-
tion (OR 3.47; 95% CI 1.33, 9.10) and bile leakage (OR 15.6; 
95% CI 5.11, 47.66).
Conclusion: The risk of major complications related to 
LDH is low. Long hospitalization was mainly caused by 
wound infection and bile leakage in our study.
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INTERVENTIONAL RADIOLOGICAL 
PROCEDURES (IR) IN ORTHOTOPIC 
LIVER TRANSPLANTATION (OLT)
P. Tarazov, A. Granov, A. Polikarpov and D. Granov
Russian Scientifi c Center of Radiology and Surgical 
Technologies
Russian Scientifi c Center of Radiology and Surgical 
Technologies, St. Petersburg, Russia; Angio/Interventional 
Radiology, Leningradskaja 70, Pesocyny, 19776 St. 
Petersburg, Russia
Introduction: To study therapeutic modalities of IR before 
and after OLT.
Methods: Between 1998 and 2011, OLT was performed in 
102 pts with end-stage liver diseases (n = 92) or hepatocel-
lular carcinoma (HCC) on cirrhosis (n = 10). Pre-OLT IR 
procedures included TIPS (11 pts) and TACE (8 pts). Post-
OLT procedures were: dilatation or/and stenting of biliary 
strictures (10), stenting of IVC (4), balloon dilatation of 
cava-caval anastomosis (1), partial splenic embolization in 
splenic steel syndrome (2).
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Results: All IR procedures were technically successful. 
There was no mortality or serious complication. After TACE, 
partial tumor response in 7 and stabilization in 3 pts with 
HCC occurred. Four successfully transplanted pts are alive 
without recurrence in 8–54 mo. After TIPS, 6 pts received 
OLT, 3 are on the waiting list, and 2 died of liver failure 5 
and 7 mo later.
Satisfactory drainage was achieved in 10 pts with post-
OLT biliary strictures; in the remaining case hybrid interven-
tion (surgery with intraoperative IR stenting) was needed. 
Clinical symptoms and liver function improved in all 5 pts 
with venous strictures. After PSE, steal syndrome regressed 
rapidly. All pts are asymptomatic and well in 5–40 mo after 
IR treatment.
Conclusion: IR procedures play an important role before 
and after OLT.
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F. Galvao1, W. Soler2, D. Waisberg1, S. Catanozi1, 
V. Capelozzi1, W. Teodoro1, E. Chaib1 and 
L. D’Aluquerque1
1University of Sao Paulo; 2Santa Casa Sao Paulo
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Introduction: Multivisceral transplantation is indicated for 
diffuse abdominal tumor, portal thrombosis, gastrointestinal 
dismotility and diffuse gastrointestinal dysfunction (abdomi-
nal catastrophe); however, candidates for this transplantation 
accomplish high mortality in waiting list due to organ short-
age. Xenotransplantation, a proposal for this dilemma is 
impaired due to hyperacute rejection. We describe multivis-
ceral xenotransplantation and illustrate hyperacute rejection 
using immunoglobulin G marker.
Methods: We recovered from rabbits the liver, pancreas, 
distal esophagus, stomach, intestine, colon, and kidneys and 
implanted heterotopically in swine (n = 15) or rabbits (n = 
5). Three hours after graft reperfusion we collected samples 
from all xenograft organs for histology evaluation and immu-
noglobulin G (IGG) quantifi cation by immunofl uorescence 
as a marker for humoral immune response in the lesions.
Results: Endothelium of graft vessels were the main targets 
of hyperacute rejection for all organs. Histological evalua-
tion demonstrated prevalence of moderated lesions in esoph-
agus, and liver and severe in stomach, intestines spleen, 
pancreas and kidney. Intense IGG fi xation in the lesions 
confi rmed the humoral immune response, typical of hyper-
acute rejection.
Conclusion: The present model possibility experiments to 
control hyperacute rejection and generate stimulus to pros-
pect multivisceral xenotransplantation as a real therapeutic 
alternative. IGG expression in xenograft is a confi dent 
marker for hyperacute rejection.
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IMPACT OF BODY MASS INDEX 
ON THE OUTCOME OF LIVER 
TRANSPLANTATION IN CHILDREN
A. Hakeem, G. Marangoni, S. Chapman, R. Young, 
A. Nair, M. Attia, P. McClean and K R. Prasad
Department of Paediatric Transplantation, Leeds Teaching 
Hospitals NHS Trust
Leeds Teaching Hospital NHS Trust, Department of 
Paediatric Transplantation, St James’s University Hospital, 
NHS Trust, Beckett Street, Leeds LS9 7T, United Kingdom
Introduction: The impact of poor nutritional status on the 
outcome following liver transplantation in children is well 
recognised. Recently studies in adults and children have 
reported variable effects of obesity on post transplant mor-
bidity and mortality. This study examines the impact of pre-
transplant body mass index (BMI) on the outcome of liver 
transplantation in the current era in consecutive children 
from a single centre.
Methods: Data was retrieved from a prospectively main-
tained institutional database from 1994–2009. 146 paediatric 
liver transplants recipients were identifi ed, of which 132 
patients with height and weight data were included for analy-
sis. Patients were stratifi ed into 5 BMI categories established 
by the WHO according to their Z scores: severe thinness 
(−3), thinness (−2), normal weight (0), overweight (+2) and 
obese (+3). Primary outcome was to evaluate post-operative 
morbidity and secondary measures were overall patient and 
graft survival. Categorical variables were analysed by chi-
square, and continuous variables by one-way ANOVA (p < 
0.05 considered signifi cant). Kaplan-Meier curves were used 
to study the effect of BMI on patient and graft survival.
Results: 12.2% were underweight (UW: Z score −2 and −3), 
8.3% were overweight (OW: Z score +2 and +3) and 79.5% 
were normal weight (NW). The overall morbidity was higher 
in UW in comparison to NW (81.2% vs 42.8%, p = 0.006). 
Post-op septic events were common in UW in comparison to 
NW (75.0% vs 25.7%, p < 0.001). UW recipients had longer 
intensive care stay than NW (mean 5.6 vs 3.1 days, p = 
0.029). The length of ventilation period was longer in UW 
in comparison to NW (mean 3.4 vs 0.9 days, p = 0.001). 
There was no difference in the length of stay between UW 
and NW (mean 34.2 vs 30.9 days, p = 0.602). There was no 
difference in the morbidity between OW and NW. Overall 
graft (p = 0.949) and patient survival (p = 0.984) were no 
different between the three groups.
Conclusion: Despite current standards of peritransplant 
management we have demonstrated increased overall mor-
bidity in underweight patients, with increased rates of post-
operative septic complications, longer ventilatory period, 
and increased length of intensive care stay. However, unlike 
earlier studies, patient and graft survival were not affected. 
This study does not demonstrate any effect of obesity on post 
transplant morbidity or mortality.
486 Poster Presentation Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 288–699
536
DONOR MORBIDITY FOLLOWING 
LIVING DONOR LIVER 
TRANSPLANTATION (LDLT): 
OUTCOME FROM A SMALL 
VOLUME CENTRE
A. Hakeem, E. Hidalgo, M. Attia, S. Pollard, G. Toogood, 
C. Millson, J P. Lodge and K R. Prasad
Department of HPB and Liver Transplantation, St James’s 
University Hospital NHS Trust
Leeds Teaching Hospital NHS Trust, Department of HPB 
and Liver Transplantation, St James’s University Hospital 
NHS Trust, Beckett Street, Leeds LS9 7T, United Kingdom
Introduction: Living Donor Liver Transplantation (LDLT) 
has grown immensely in certain countries over the last few 
years, whereas in the West, the growth remains static and low 
volume. Donor morbidity following LDLT has been reported 
in the median range of 15–30%. One of the limiting factor 
for the growth of LDLT has been the concerns with morbidity 
and mortality during a centres initial experience. We report 
the donor outcome from a small volume centre, so as to 
assess the impact of volume on donor outcome.
Methods: Between June 2007 and December 2011, 25 
LDLT procedures were carried out in our unit. The criteria 
for donor selection included age, fi tness for surgery and 
remnant liver volume. Donor demographics, graft type, com-
plications, length of stay and overall survival were extracted. 
Donor morbidity was assessed objectively using the modi-
fi ed Clavien-Dindo classifi cation. Continuous variables were 
expressed as mean ± SD.
Results: The mean donor age was 38.4 ± 11.0 years and 
donor BMI was 23.9 ± 2.8 kg/m2. Two donors were aban-
doned on table due to complex arterial and biliary anatomy. 
The graft was right lobe (n = 12, 52.2%), left lateral lobe (n 
= 10, 43.5%) and left lobe (n = 1, 4.3%). The graft weight 
was 528.5 ± 260 gms. The morbidity was 21.7% (n = 5). 
There were three Clavien grade II complications (wound 
infection, urinary infection and unknown sepsis needing anti-
biotics). One patient needed laparotomy for haemorrhage 
(grade IIIb) and another patient had ultrasound guided drain-
age of subphrenic collection (grade IIIa). The length of hos-
pital stay was 7.9 ± 2.8 days. At the end of median follow-up 
of 21.4 months, all our donors were alive, with no long-term 
morbidity.
Conclusion: Our experience shows that donor hepatectomy 
for Live Donor Liver Transplantation is a safe procedure in 
a small volume unit. Our donor morbidity of 21.7% is com-
parable or better than most high volume centres across the 
world. Number of procedures performed by an unit should 
not be an impediment to the introduction of live donor liver 
programme.
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USABILITY OF RINGED 
POLYTETRAFLUOROETHYLENE 
GRAFTS FOR MIDDLE HEPATIC VEIN 
RECONSTRUCTION DURING LIVING 
DONOR LIVER TRANSPLANTATION
Y.-H. Park, S. Hwang, D.-H. Jung, T.-Y. Ha, C.-S. Ahn, 
D.-B. Moon, G.-W. Song and S.-G. Lee
Department of Surgery, Asan Medical Center, University of 
Ulsan College of Medicine, Seoul, Korea
Asan Medical Center, University of Ulsan College of 
Medicine, Department of Surgery, 38-1 Poongnap-dong, 
Songpa-gu, 13873 Seoul, Korea
Introduction: Large vein allografts are suitable for middle 
hepatic vein (MHV) reconstruction, but their supply is often 
limited. Although polytetrafl uoroethylene (PTFE) grafts are 
unlimitedly available, their long-term patency was relatively 
poor.
Methods: We intended to enhance the clinical usability of 
PTFE grafts for MHV reconstruction during living donor 
liver transplantation (LDLT). Two sequential studies were 
performed. First, PTFE grafts were implanted into dogs as 
inferior vena cava replacements. Second, in 1-year prospec-
tive clinical trial of 262 adults undergoing LDLT using modi-
fi ed right lobe, MHV reconstruction with PTFE grafts was 
compared with other types of reconstruction and outcomes 
were evaluated. In the animal study, PTFE grafts induced 
strong infl ammatory reactions and luminal thrombus forma-
tion, but the endothelial lining was well developed.
Results: In the clinical study, the reconstruction techniques 
were revised to make a composite PTFE graft with an artery 
patch according to the results of the animal study. MHVs 
were reconstructed using cryopreserved Iliac vein (n = 122), 
iliac artery (n = 43), aorta (n = 13) and PTFE (n = 84), yield-
ing 6-month patency rates of 75.3%, 35.2%, 92.3% and 
76.6%, respectively. Overall 6-month patency rates in iliac 
vein and PTFE grafts were similar (p = 0.922), but 6-month 
patency rates of segment 5 vein were 51.0% and 34.7%, 
respectively (p = 0.001). Overall graft and patient survival 
rates did not differ among these 4 groups.
Conclusion: In conclusion, ringed PTFE grafts combined 
with a small vessel patch showed a high patency rate com-
parable to that of iliac vein grafts, thus we suggest that this 
method can be reliably used for MHV reconstruction when 
other sizable vessel allograft is not available.
558
LIVER PRESERVATION LIQUID 
CONTAMINATION: AN EVIL 
NOT SO DISASTROUS
P. Pessaux, D. Ntourakis, T. Piardi, E. Marzano, 
H. Flicoteaux, M. Cantu, M. Audet and P. Wolf
Department of Hepato-Biliary Surgery and Liver 
Transplantation
Hopital Hautepierre, Hepotobiliary Surgery and Liver 
Transplantation, Avenue Molière, 67000 Strasbourg, 
France
Introduction: The microbial contamination of liver graft 
preservation liquid (PL) is not an uncommon event related 
to the procedure of organ harvesting. The aim of this study 
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was to evaluate the correlation between the contamination of 
PL and post transplantation morbidity and mortality.
Methods: An analysis of 179 prospective and consecutive 
patients who underwent whole liver transplantation (LT) was 
undertaken. PL contamination was identifi ed by routine bac-
teriologic analysis during the graft ex-vivo. All patients 
received perioperative antibioprophylaxy. When PL was con-
taminated with fungal or others microbes of Staphylococcus 
coag (−), patients received antibiotic treatment as for sys-
temic mycosis. Data regarding contamination of the PL of 
the other organs procured from the same donor were acquired 
from the National Organ Transplantation Agency. The con-
tamination of the PL was analysed in respect to postoperative 
one month morbidity and mortality defi ned by the Dindo’s 
classifi cation.
Results: The liver PL was contaminated in 80 donors 
(44.7%) and the PL of any organ procured was found con-
taminated in 120 donors (67%). The microbial fl ora isolated 
was poly-microbial in 18 (10%). The most frequently dis-
covered microbes were: Staphylococcus coag (−) 53%, E. 
coli 8%, Streptococcus sp. 5%, and Propionibacterium acnes 
4%. The pathogen was a fungus (Candida sp., Aspergilus sp.) 
in 5%. Contamination of the liver PL was not a risk factor 
for overall morbidity or mortality. However, liver PL con-
tamination was associated with a higher rate of biliary com-
plications (13.6% vs 4.5%, p = 0.045). The localisation of 
the organ procurement centre appears to be a risk factor for 
PL contamination (local vs regional vs national = 43% vs 
69.2% vs 37.8%, p = 0.021).
Conclusion: Contamination of graft PL is common during 
organ procurement and for the most part seems to be caused 
by skin germs due to breaches in the sterilisation during the 
operation or the graft manipulation. It is more frequent in 
organ procurements done at small regional hospitals. 
However it does not seem to increase post-operative morbid-
ity, mortality or infection rate at least in a context of antibio-
prophylaxis or antibiotic therapy based on the results of PL 
cultures.
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IMPACT OF TRANSJUGULAR 
INTRAHEPATIC PORTOSYSTEMIC 
SHUNTING ON LIVER 
TRANSPLANTATION: 12-YEAR 
SINGLE-CENTER EXPERIENCE
L. Barbier1,2, J. Hardwigsen1,2, N. Biance1,2, A. Dagfous1,2, 
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Introduction: Transjugular intrahepatic portosystemic 
shunt (TIPS) has been proposed in end-stage cirrhotic 
patients awaiting liver transplantation (LT). This study aims 
to assess the impact of TIPS on LT and early postoperative 
course.
Methods: This is a monocentric retrospective study from 
1996 to 2008 comparing patients with (n = 72) and without 
TIPS (n = 136) at the time of LT. Groups were matched based 
on age, gender and Child-Pugh score. Intraoperative criteria 
were: collateral venous circulation, ascites at opening, blood 
products transfusions, operative times, and requirement of 
portocaval anastomosis during surgery. Postoperative criteria 
were: ascites within the fi rst 7 days, laboratory tests (ALT 
and AST peaks, plasmatic creatinin level at day 7, prothrom-
bin time at day 5, day when factor V is above 60%), haemor-
rhage, graft rejection, renal failure, prolonged ascites, 
retransplantation, and 1-year mortality.
Results: 10% of TIPS were occluded and 32% displaced. 
Shunt removal was diffi cult in 17% with vena cava clamping 
in 10%. Collateral circulation was less extensive and porto-
caval anastomosis was more frequently required in TIPS 
group. No signifi cant difference in transfusion and operative 
times were observed between the two groups. Postoperatively, 
liver and renal function tests, in-hospital stay, graft rejection, 
retransplantation and 1-year mortality rates were not differ-
ent. Ascites volume in 1st week was greater in TIPS group 
(7.6 L vs. 6.9 L, p = 0.04). Within TIPS group, ascites and 
collateral circulation were greater if the shunt was occluded 
at the time of LT. Shunt displacement or occlusion were not 
associated with higher complication rates.
Conclusion: TIPS did not impair LT even in case of dis-
placement or thrombosis and can provide a safe bridge to LT 
in end-stage cirrhotic patients.
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PREVALENCE AND PROGNOSIS OF 
POST LIVER TRANSPLANT 
PERITONITIS DUE TO GI 
TRACT PERFORATION
L. Barbier2, L. khoy-Ear1, F. Dondero2, D. Sommacale2, 
A. Toussaint1, J. Mantz1, J. Belghiti2 and C. Paugam-Burtz1
1AP-HP, Hôpital Beaujon, Department of Anesthesiology 
and Critical Care, University Hospital, Clichy, F-92110, 
France; 2AP-HP, Hôpital Beaujon, Department of HPB 
Surgery and Liver Transplantation, University Hospital, 
Clichy, F-92110, France
Hôpital Beaujon, HPB Surgery and Liver Transplantation, 
100 bd Général Leclerc, 92110 Clichy, France
Introduction: Among patients who developed post liver 
transplantation (LT) abdominal sepsis, the subgroup in which 
peritonitis is due to gastro-intestinal perforation (perforation 
peritonitis, PP) has rarely been specifi cally described. We 
aimed to describe its incidence, characteristics and 
outcomes.
Methods: 699 adult liver transplants were performed in our 
centre between 2004 and 2011. 17 patients (2.4%) developed 
a surgically proven PP and were included. Patients’ charac-
teristics and postoperative data were retrieved from clinical 
fi les. Results are expressed in absolute numbers or percent-
ages and median with extremes in brackets.
Results: 71% of patients had a past history of abdominal 
surgery, including previous LT in 35%; 24% had combined 
kidney and LT for polycystic disease. 41% of patients had a 
bilio-enteric anastomosis. Delay LT/surgery for PP was 16 
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days (2–36). Perforation was located on small bowel (n = 9), 
duodenum (n = 6) and colon (n = 1). Fever was present in 
47% of patients, abdominal pain in 35% and white cells 
count >10 G/l in 71%. Preoperative abdominal CT-scan (n = 
8) showed pneumoperitoneum in 37% of patients. PP was 
diagnosed during reoperation for haemorrhage (n = 2) or 
retransplantation for primary non-function (n = 1). Peritoneal 
fl uid was polymicrobial in 53% and yeasts were isolated in 
35% of cases. Overall mortality was 47% and PP-related 
mortality was 35%.
Conclusion: Post liver transplant peritonitis due to gastro-
intestinal tract perforation is a rare complication, frequently 
associated with combined liver-kidney transplantation for 
polycystic disease and past history of abdominal surgery. Its 
diagnosis remains diffi cult and is sometimes fortuitous.
579
THE CLINICAL RELEVANCE OF SERUM 
GAMMA GLUTAMYL TRANSPEPTIDASE 
IN LIVER TRANSPLANT RECIPIENTS: 
A DIFFERENT ROLE AT DIFFERENT 
TIME POINTS
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Introduction: Gamma glutamyl transpeptidase (GGT) is a 
membrane bound enzyme that plays a key role in synthesis 
and degradation of the anti-oxidant glutathione. 
Epidemiological studies in the general population have 
shown that a high serum GGT is a risk factor of various 
clinical outcomes. However, the clinical signifi cance of ele-
vated GGT in liver transplantation (LT) recipients is not 
clear. We aimed to determine the clinical relevance of serum 
GGT levels in LT recipients early or long-term after LT.
Methods: A consecutive series of 522 adult patients who 
underwent LT between 1990 and 2009 were included in this 
study. Changes in serum GGT levels over time were com-
pared with changes in serum markers of hepatobiliary injury: 
ALT and AST. In addition, we compared GGT levels in 
short-term (90 days) and long-term (3 years) survivors and 
non-survivors.
Results: After LT, serum GGT levels gradually increased, 
reaching a peak at day 11, and slowly normalized thereafter. 
This pattern is different from that of hepatocellular injury 
markers AST and ALT, which have a peak immediately after 
LT and a rapid normalization thereafter. Serum GGT levels 
at day 7 were signifi cantly higher in patients who were still 
alive at day 90, compared to those who did not survive more 
than 90 days (median [IQR], 273 U/l [160–713] vs 164 U/l 
[80–213], p < 0.0001). In sharp contrast with this, serum 
GGT levels at 6 months after LT were inversely associated 
with 3-year survival: the higher the GGT level, the lower the 
survival.
Conclusion: Serum GGT levels early after LT are signifi -
cantly higher in 90-day survivors than in non-survivors. In 
contrast with this, but in accordance with the general popula-
tion, a high GGT at 6 months after LT is associated with 
lower 3-year survival. These fi ndings may be explained by 
the key role of GGT in glutathione metabolism by viewing 
GGT as a marker of an appropriate hepatic response in the 
early recovery phase and as a marker of chronic oxidative 
stress and increased mortality in the long-term.
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LIVER RE-TRANSPLANTATION IN A 
PATIENT WITH NASH RELATED 
CIRRHOSIS AFTER ROUX-EN-Y 
GASTRIC BYPASS
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C. A. F. Escanhoela, I. N. Santos, G. D. Calomeni 
and I. F. S. F. Boin
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Cep: 13087-75713087 Campinas, São Paulo, Brazil
Introduction: The increased incidence of morbid obesity 
and diabetes mellitus lead non-alcoholic fatty liver disease 
(NAFLD) the most common liver disease in the United 
States, ranging from steatosis to Non-alcoholic steatohepati-
tis (NASH). The evolution from NASH to cirrhosis is recog-
nized in the literature as well as the risk of developing 
hepatocellular carcinoma (HCC). Among the risk factors 
associated with progression of liver disease is associated 
viral hepatitis and even moderate alcohol consumption.
Methods: A 40 years old, male patient, with chronic hepa-
titis C virus infection, diagnosed in 2000, began monitoring 
in January 2011. It has a previous history of Roux-en-Y 
Gastric By-pass in mid-2006 by morbid obesity (BMI = 39) 
associated with hypertension and diabetes mellitus. Two 
years after surgery he developed jaundice and ascites, with 
MELD scores of 32, having undergone orthotopic liver trans-
plantation in January 2010 at another institution. The patho-
logical explant showed signs of non-alcoholic steatohepatitis. 
This patient developed in the late postoperative period (6 
months) with jaundice and was diagnosed with biliary anas-
tomotic stricture and repeated cholangitis.
Results: In December 2010 there was clinical worsening, 
having been hospitalized for decompensated infectious 
because of multiple hepatic abscesses treated by percutane-
ous drainage and antibiotic therapy. Developed with deterio-
rate liver function with ascites and acute renal failure. In the 
fi rst consultation in our clinic had MELD 34 and re-
transplantation were indicated. Second orthotopic liver trans-
plantation was performed in March 2011 with Piggyback 
technic. The patient had good postoperative evolution. The 
pathological analyses of liver explant demonstrated intrahe-
patic cholestasis and hepatocytic intense peri-vascular fi bro-
sis and areas of necrosis hepatocytes. It is not characterized 
chronic hepatitis interface.
Conclusion: The increased incidence of morbid obesity and 
diabetes mellitus lead non-alcoholic fatty liver disease the 
most common liver disease in the United States. Roux-en-Y 
Gastric bypass gives good results for control of obesity and 
diabetes mellitus and improvement of insulin resistance, 
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leading to improvement of NAFLD and NASH, as docu-
mented in prospective studies. Liver transplantation due 
NASH-related liver cirrhosis is expected to increase in 
coming decades because of rising global obesity.
587
OVARIAN ADENOCARCINOMA IN THE 
LATE POSTOPERATIVE PERIOD OF 
LIVER TRANSPLANTATION: 
A CASE REPORT
E. C. Ataide, A. P. Ramos, C. P. Reigada, F. A. Romani, 
R. S. B. Stucchi, G. D. Calomeni, C. A. F. Escanhoela 
and I. De F. S. F. Boin
State University of Campinas, Liver Transplantation Unit, 
Rua Zerillo Pereira Lopes 651, Casa 37, Alto Taquaral, 
Campinas, São Paulo, Brazil
Introduction: After any type of transplant is increased the 
risk of developing malignancy. This fact is mainly by the use 
of immunosuppressive agents that affect immunity against 
neoplastic cells and viruses which are major oncogenic 
factors. In addition, some immunosuppressive drugs are 
oncogenic by changing the DNA of cells and leading to 
proliferation.
The risk of death from cancer is higher among transplant 
recipients, especially after several years after procedure.
Methods: We report the case of female, 38 years, underwent 
orthotopic liver transplantation in February 1998 due to liver 
cirrhosis for hepatitis C. After 9 years of the liver transplanta-
tion patient developed with constipation, abdominal pain and 
weight loss. Investigation showed expansive pelvic lesion 
measuring 12.5 × 9.0 × 8.3 cm in contact with the uterine 
wall. Exploratory laparotomy was held, and frozen biopsy of 
ovarian tumor demonstrated undifferentiated malignant neo-
plasm. The patient was submitted to bilateral salpingo-
oophorectomy and hysterectomy, which showed a pathologic 
ovarian adenocarcinoma clear cell, stage IA. In the 3½ years 
follow-up, no evidence of recurrence was observed with 
tumor markers within normal limits.
Results: The development of malignancies after liver trans-
plantation is a frequent complication and is a major cause of 
death in these patients. There is no literature describing 
cases of ovarian adenocarcinoma in liver transplanted 
patients. With respect to gynecological tumors is well 
described the increase of tumors of the cervix and vulva due 
to immunity against HPV 13 be. High serum levels of 
immunosuppressive drugs is not indicated in this cases. The 
use of mTOR inhibitors seem to be associated with a lower 
incidence of cancer, but studies are still lacking to prove this 
benefi t.
Conclusion: In our center we have used sirolimus in cases 
of patients with hepatocellular carcinoma or when is present 
some type of cancer. Our patient is making use of sirolimus 
in a dose of 2 mg/day since the surgery with a serum level 
of 11.
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LIVER FAILURE AND THE NEED FOR 
TRANSPLANTATION IN SIX PATIENTS 
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J. R. De S. Almeida, T. Sevá-Pereira, C. A. F. Escanhoela 
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Cep: 13087-75713087 Campinas, São Paulo, Brazil
Introduction: Hepatoportal sclerosis (HPS), fi rst report by 
Mikkelsen et al. in 1965, is a clinic pathologic condition that 
causes no cirrhotic portal hypertension.
In HPS, the primary hepatic lesion is found in the portal 
vein branches. In general, hepatic synthetic function is pre-
served. Rarely patients with HPS need liver 
transplantation.
The Aim of this study is to present the clinical and patho-
logic features of six HPS cases that underwent liver trans-
plantation (LT).
Methods: From 1999 to 2008, 6 LT patients were diagnosed 
with HPS. Three patients with bleeding varices and four had 
concomitant ascites. Child-Pugh evaluation was B in four 
patients and C in two cases. MELD score was 18 in two 
cases, 20 in three patients and 22 in one patients.
Cirrhosis resulting from alcohol (1), autoimmune (2), 
cryptogenic cirrhosis (3) was the presumed diagnosis pre LT.
Results: On histological examination, there was marked 
phlebo-sclerosis in all cases, non occlusive portal vein 
thrombosis in 3 cases, intense portal fi brosis in one case, 
moderate portal fi brosis in 5 cases, moderate sinusoidal dila-
tation in all cases, none mega sinusoid formation, ductal 
biliar proliferation and ductal biliar fi brosis was observed in 
all cases, cholestasis was found in one case, incomplete 
septal cirrhosis was observed in 4 cases. None showed his-
tological features of the presumed underlying liver disease.
The overall survival of this group was no different to that 
seen in other LT patients underwent for other causes.
Conclusion: HPS can cause hepatic failure and may require 
liver transplantation. Signifi cant portal fi brosis and phlebo-
sclerosis may contribute to hepatic parenchyma loss and 
posterior synthetic loss.
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LIVER TRANSPLANTATION FOR HEPAR 
LOBATUM WITH CLINICAL 
MANIFESTATIONS OF 
CRYPTOGENIC CIRRHOSIS
E. Ataide, T. J. A. P. Mattosinho, G. D. Calomeni, 
A. R. Portes, J. R. De S. Almeida, T. Sevá-Pereira, 
C. A. F. Escanhoela and I. De F. S. F. Boin
State University of Campinas
State University of Campinas, Liver Transplantation of 
Campinas, Rua Zerillo Pereira Lopes 651, Casa 37, Alto 
Taquaral, Cep: 13087-75713087 Campinas, São Paulo, 
Brazil
Introduction: Hepar Lobatum (HL) is a chronic liver dis-
order mimicking cirrhosis, associated with liver metastases. 
Non-malignant causes can also result in HL, tertiary syphilis 
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and schistosomiasis described the most. May be associated 
with portal hypertension. The shrinkage of the hepatic paren-
chyma involving one or more lobes occurs in about 13% of 
cirrhotic livers, 50% of the livers courses with portal 
hypertension.
Methods: Female, 42 years old, diagnosed with cryptogenic 
cirrhosis started after an episode of frank hematemesis and 
melena in November 2010. Presented with ascites and 
encephalopathy grade I during follow up. She underwent 
orthotopic liver transplantation on May 16, 2011, MELD 24, 
by Piggy Back technique. During the surgery there was mod-
erate ascites, splenomegaly, other signs of portal hyperten-
sion, multi lobulated liver, size reduced, with structural 
changes consistent with hepar lobatum. Patient responded 
well to immediate postoperative. Because of the intraopera-
tive fi nding compatible with hepar lobatum, syphilis and 
other infectious diseases serology were requested, being all 
negative.
Results: The total hepatectomy product weighed 630 g, pre-
senting heavily anatomical deformities by the capsular 
surface, with presence of multiple nodular areas and deep 
grooves, sometimes pedunculated or totally detached from 
the body and wide variation in diameter. In microscopic 
examination, it was found intense variability of histological 
changes in liver parenchyma, no signs of cirrhosis and portal 
spaces expanded by fi brosis, with the issuance of septa and 
sketches of nodules. Intensely anomalous hyperplastic portal 
vessels were also commonly observed.
Conclusion: Currently, it is known that the hepar lobatum 
is associated with liver involvement in tertiary syphilis. 
Cases post- chemotherapy for metastatic carcinoma are also 
described, with fi brosis and retraction of the parenchyma. In 
this case, we observed morphological changes unrelated to 
infectious diseases or neoplasia. Due to the observation of 
peculiar form of distribution of portal vessels in this case, 
we question whether the same could not be among the 
primary events causing the hepar lobatum.
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AUTOMATED HEPATIC VOLUMETRY 
FOR ORTHOTOPIC LIVER 
TRANSPLANTATION, USING 
MULTIPHASE ACQUISITIONS ON 
MULTIDETECTOR COMPUTED 
TOMOGRAPHY (MDCT)
A. Luciani1, L. Rusko1, E. Pichon1, C. Duvoux2, 
J. T. V. Nhieu1, A. Rahmouni1, D. Azoulay2 and 
A. Luciani1
1Department of Radiology, Henri Mondor hospital, Créteil, 
France; 2Department of Hepatology, Henri Mondor 
hospital, Créteil, France; 3Department of HBP and Liver 
Transplantation Surgery, Henri Mondor hospital, Créteil, 
France
Hopital Henri Mondor, Magerie Medicale, 51 Avenue du 
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Introduction: To retrospectively evaluate a new algorithm 
for automated hepatic volumetry based on multi-phase com-
puted tomography (CT) acquisitions, by comparison with 
manual volumetry and the weight-derived volume of the 
excised liver following orthotopic liver transplantation 
(OLT).
Methods: The study was approved by our Institutional 
Review Board and the requirement for informed consent was 
waived. Forty patients (35 male, 5 female; mean age 57.5 
years; range 31–68) referred to our institution for OLT and 
imaged pre-operatively with multi-phase liver CT were 
studied. A level-set derived method for automated hepatic 
volumetry was implemented on a post-treatment worksta-
tion. The automated algorithm was tested using both single-
phase and multiphase images. The automated and manual 
volumes were compared with the weight-derived volume of 
the excised liver by using Pearson’s correlation. The times 
required for manual and automated liver volume measure-
ment were compared with Student’s t test.
Results: Both multiphasic automated and manual volume 
measurements correlated well with actual liver volume, with 
respective Pearson coeffi cients of 0.87 (p < 0.0001) and 0.90 
(p < 0.0001). Automated single-phase volume measurements 
was less highly correlated to calculated volume – Pearson 
coeffi cient 0.76; p < 0.0001. Automated segmentation was 
signifi cantly more rapid than manual segmentation, with 
respective mean times of 20 ± 13 s and 86 ± 3 s (p = 0.01).
Conclusion: Automated liver volumetry based on multi-
phase CT acquisitions is feasible and more rapid than manual 
segmentation.
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SOCIAL DEPRIVATION IS ASSOCIATED 
WITH A POORER OUTCOME 
FOLLOWING LIVER 
TRANSPLANTATION
S. McNally, C. Johnston and J. Powell
Scottish Liver Transplant Unit, Royal Infi rmary of 
Edinburgh, Edinburgh, UK
Royal Infi rmary of Edinburgh, Department of Surgery, c/o 
Ward 106, Royal Infi rmary of Edinburgh, 51 Little France 
Crescent, EH16 Edinburgh, UK
Introduction: Scotland has a high number of people 
living in deprivation. Deprivation is known to have a nega-
tive impact on health. The effect of deprivation on 
outcome after liver transplantation has not previously 
been established. This study investigates the impact of 
socio-economic deprivation on outcome following liver 
transplantation.
Methods: National registry data were obtained from UK 
Transplant for all primary liver transplants performed in 
Scotland from November 1992 to December 2009. 
Re-transplants, children and living donor transplants were 
excluded. Follow-up data collected to 1st October 2011 
included details of diagnosis, recipient co-morbidities, donor 
details, and graft and patient survival. The 2001 Carstairs 
index was used to measure socio-economic deprivation.
Results: 715 liver transplants were performed during the 
study period. 50.5% were male, and 94% were Caucasian. 
16.2% were for acute liver failure. Recipients were evenly 
distributed between Carstairs quintiles. Alcoholic liver 
disease and PBC were the two most common indications 
(20.1% and 19.7% respectively). There was no difference in 
disease preponderance rates between Carstairs groups. 
MELD and UKELD scores were similar across all back-
grounds (median 17 and 57 respectively). Deprivation had 
no effect on waiting time following listing (median 37 days). 
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Greater deprivation scores were associated with poorer graft 
and patient survival (p = 0.007 and p = 0.006 respectively). 
There was no difference in the prevalence of co-morbidities 
between groups.
Conclusion: This is the fi rst study to demonstrate a deleteri-
ous effect of social deprivation on outcome following liver 
transplantation. This effect appears independent of the 
primary diagnosis or associated co-morbidities. Whilst 
access to listing was not assessed in this study, deprivation 
had no bearing on UKELD or MELD scores or on waiting 
times following listing.
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RESOURCE UTILIZATION AND COSTS 
ASSOCIATED WITH PERI-OPERATIVE 
BLOOD LOSS DURING LIVER 
SURGERIES – A RETROSPECTIVE DATA 
ANALYSIS IN THE UNITED STATES
A. Ally, N. Parikh, L. Hashemi and M. Morseon
Covidien
Covidien Healthcare, Economic & Reimbursement 
Covidien, 4500 Parkway, Hampshire, PO15 Whiteley, UK
Introduction: Extensive peri-operative blood loss (PBL) in 
liver surgeries, especially during resections and transplanta-
tions can be associated with a range of complications and 
higher mortality. Apart from patient clinical outcomes, PBL 
and blood transfusions (BT) required to manage PBL may 
add signifi cant burden on hospital resources and overall 
costs. Aim of this study was to compare burden in terms of 
resource utilization and costs for liver surgery patients with 
PBL compared to those without PBL (NPBL).
Methods: Premier Perspective® Database (CY2009-
Q2CY2010) was used for this retrospective analysis. 
Inpatient discharges which had liver surgeries (ICD-9-CM: 
50.2×–50.6×) were identifi ed. These discharges were catego-
rized as PBL group if they had received at least one BT 
(ICD-9-CM: 99.02–99.07; CPTTM: 36,430, 35,455), else 
were included in NPBL group. BT was considered as an 
indicator for PBL. Groups were matched (1:1) on age, 
gender, race, CCI score, APR severity and elective admission 
type using propensity score. Adjusted estimates for days of 
length of stay (LOS), operating room (OR) time in minutes 
and costs (total and departmental) were compared between 
PBL and NPBL groups using generalized linear model 
(GLM) with gamma distribution and log link.
Results: A total of 4,237 liver surgery discharges were iden-
tifi ed of which 1,450 (32%) required BT peri-operatively. 
After matching, 1,203 discharges were retained in each 
group for the fi nal analysis. Compared to NPBL group, PBL 
group had higher adjusted mortality rate (9.0% vs. 6.7%, p 
= 0.04) and higher mean LOS (10 vs. 9, p = 0.02). Mean 
operating room (OR) time was 15 minutes more for PBL 
group, this difference was not signifi cant (p > 0.05). Adjusted 
mean total cost were signifi cantly higher for the BL group 
compared to NBL group ($58,599 vs. $48,310, diff = 
$10,289, p < 0.0001). For PBL group, mean adjusted costs 
associated with room & board, surgery, pharmacy, anesthesia 
and laboratory & pathology were higher (all p < 0.05) com-
pared to NPBL group.
Conclusion: Patients with peri-operative blood loss possi-
bly tend to stay signifi cantly longer in the hospital and may 
have a higher mortality rate compared to those who do not 
experience peri-operative blood loss. Peri-operative blood 
loss during liver surgeries may add signifi cant burden to 
hospital resources and costs. Adopting strategies aimed at 
minimizing peri-operative blood loss in liver surgery patients 
may help improve clinical and economic outcomes.
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HEAT STROKE AS A CAUSE OF LIVER 
FAILURE AND EVALUATION FOR 
LIVER TRANSPLANT
P. N. Martins1, J. Mcdaid1, M. Hertl1, T. Kawai1, R. Chung2 
and J. Markmann1
1Dept. of Surgery, Division of Transplantation, 
Massachusetts General Hospital, Harvard University; 
2Dept. of Gastroenterology, Massachusetts General 
Hospital, Harvard University
Massachusetts General Hospital, Harvard University, 
Dept. of Surgery, Division of Transplantation, 55 Fruit 
Street, 2114 Boston, USA
Introduction: Heat stroke is a multiple organ dysfunction 
syndrome of poorly understood pathogenesis. Potential com-
plications related to severe heat stroke are liver failure, acute 
renal failure, disseminated intravascular coagulation, rhab-
domyolysis, and acute respiratory distress syndrome. Acute 
hepatic failure is a rare complication of heat stroke with poor 
prognosis.
Methods: We retrospectively reviewed our electronic data-
base and report two cases of acute liver failure induced by 
heat stroke, and review the literature. There are less than 20 
cases of acute liver failure associated with heat stroke. In 2/3 
of cases there was spontaneously recovery and 1/3 died. 
There are only 4 previous cases of liver transplantation for 
heat stroke in the literature, and there are no guidelines avail-
able to guide transplantation. Out of 4 cases of liver trans-
plant, three of the patients died shortly after transplant.
Results: The fi rst patient is a 28-year-old man who col-
lapsed after running 15 Km. He presented with hyperthermia 
acute liver failure, kidney failure associated to rhabdomyoly-
sis, DIC, and change of mental status. The patient fulfi lled 
criteria for emergent liver transplantation. However, his 
clinical condition spontaneously improved. The second 
patient is a 27-year-old patient who collapsed after running 
2 Km. He presented with hyperthermia, acute liver failure, 
kidney failure, DIC, and change of mental status. The patient 
fulfi lled criteria for emergent liver transplantation, but we 
decided to wait for spontaneous clinical recovery. After 
failing conservative management, on day 24 post admission, 
he underwent combined kidney-liver transplantation.
Conclusion: Liver failure following heat-stroke is revers-
ible in many cases and conservative management can be 
successful. Conservative management appears to be justifi ed 
in heat-stroke-associated liver failure even in the presence of 
accepted criteria for emergency liver transplantation. In 
some cases, if the liver does not show signs of recovery 
despite optimal conservative treatment, and the liver shows 
massive necrosis, liver transplant should be performed. 
However, the results are in general poor.
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A NOMOGRAM FOR PREDICTING 
DROPOUT RISK AMONG PATIENTS 
ON THE LIVER TRANSPLANT 
WAITING LIST
C. Pulitanó, C. Sandroussi, D. Joseph, V. Deborah, 
G. Mccaughan and M. Crawford
Australian National Liver Transplantation Unit, Royal 
Prince Alfred Hospital
5401/8 Alexandria Drive, Camperdown, Sydney, NSW 
2050, Australia
Introduction: Allocation rules for patients with hepatocel-
lular carcinoma (HCC), waiting for liver transplantation 
under the Meld-based policy, remain controversial and still 
affected by inequity in access to liver transplant between 
HCC and not HCC patients. The aim of the present study 
was to develop a tool for predicting dropout risk in patients 
candidate to liver transplant. By using a nomogram we are 
trying to improve on the current practice of using HCC-Meld 
for evaluating risks of dropout.
Methods: All patients candidate to liver transplant at 
ANLTU for liver Transplant between January 2002 and 
January 2010 were included. A nomogram was developed as 
a graphical representation of a Cox proportional hazards 
regression model. The nomogram was verifi ed for discrimi-
nation and calibration. Predictions from this model were 
compared with those of HCC-Meld.
Results: Tumor size (summation of tumor diameter), alfa-
fetoprotein (value between 500–1000 ng/ml), response to 
bridge therapies, and Meld score were used. Extra points are 
given for every 3 months on the waiting list. The tumour size 
was recalculated with every scan and the score was upgraded. 
The nomogram achieved a concordance index of 0.69, sta-
tistically signifi cantly greater than chance. The nomogram 
also had very good calibration. Compared to HCC-Meld the 
normogram discriminated better (concordance index of 0.56 
vs. 0.72, P = 0.020).
Conclusion: This nomogram is a predictive tool that can be 
easily used to predict the risk of dropout among patients on 
the liver transplant waiting list, and can be applied to both 
HCC and not HCC patients. The nomogram may ensure a 
more equitable liver allocation in patients with HCC com-
pared to the actual score used in daily practice.
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PROGNOSTIC FACTOR FOR THE 
RECURRENCE OF PATIENTS WITH FAR 
ADVANCED HEPATOCELLULAR 
CARCINOMA AFTER LIVING DONOR 
LIVER TRANSPLANTATION
G. Hong1, K.-S. Suh1, H. Kim1, M.-su Park1, Y. Choi1, 
H. W. Lee2, N.-J. Yi1 and K.-W. Lee1
1Seoul National University Hospital; 2SNU Boramae 
Medical Center
Seoul National University Hospital, Department of 
Surgery, 101 Daehak-Ro Jongno-Gu, Seoul 110-744, South 
Korea
Introduction: We sometimes perform living donor liver 
transplantation for patients with far advanced hepatocellular 
carcinoma. Recurrence of transplant recipients with far 
advanced HCC including macrovascular invasion or huge 
HCC or numerous HCC is common and macrovascular inva-
sion is often considered as contraindication of liver trans-
plantation. The purpose of this study is to evaluate the 
predictive factor for recurrence of patients with far advanced 
HCC after LDLT.
Methods: We included 22 transplant recipients with HCC 
larger than 10 cm or more than 10 numbers or with macro-
vascular invasion preoperatively from January 2003 to 
October 2010. We investigated the preoperative tumor status 
and serum alpha-fetoprotein level. We investigated the recur-
rence and survival rates after living donor liver transplanta-
tion and the results after the use of TACE or resection or 
radiation therapy or chemotherapy and the effect of the siro-
limus use for patients with advanced HCC after LDLT.
Results: 1 year disease free survival (DFS) and 2 year DFS 
were 40.9% and 23.9%, respectively. 1 year survival rates 
(SR) and 2 year SR were 71.6% and 59.7%, respectively. 6 
patients were without tumor recurrence and the median sur-
vival duration was 25.4 (13–85) months and the median 
survival duration of 16 patients with tumor recurrence was 
12.37 (3–40) months. There were no statistical differences 
of DFS and SR according to macrovascular invasion (MVi) 
and 2 year SR were 68.2% (no MVi) and 50.9% (MVi). There 
were no signifi cant different outcome according to treatment 
modality. However, there was signifi cant different 2 yr DFS 
according to serum alpha-fetoprotein level, 54.5% (AFP < 
200 ng/mL) and 0.00% (AFP > 200 ng/mL) after LDLT 
(p = 0.023).
Conclusion: The patients with far advanced HCC have 
usually poor prognosis. However, the patients even with far 
advanced HCC can have better outcome after living donor 
liver transplantation if we select the candidates carefully by 
better selection criteria such as alpha-fetoprotein. They may 
have another chance for tumor free survival or comorbidity 
free survival or even long term survival after LDLT.
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LEFT GASTRIC VEIN USE AS AN 
ALTERNATIVE TECHNIQUE IN 
RECONSTRUCTION OF PORTAL 
VENOUS FLOW IN LIVER 
TRANSPLANTATION
F. Waechter1, J. Sampaio1, U. Teixeira2, P. Fontes1, 
T. Passarin2, L. Pereira-Lima1, M. Nectoux1 and 
J. Diedrich3
1Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS, Brazil; 2Hepato-Pancreato-
Biliary Surgery Resident, Universidade Federal de 
Ciências da Saúde de Porto Alegre, RS, Brazil; 3General 
Surgery Resident, Universidade Federal de Ciências da 
Saúde de Porto Alegre, RS, Brazil
Universidade Federal de Ciências da Saúde de Porto 
Alegre, Hepato-Pancreato-Biliary Surgery, Rua Sarmento 
Leite, 245. Zip Code: 90050-17090050 Porto Alegre, 
Brazil
Introduction: Portal vein obstruction is present in about 
10% of liver transplant candidates, making the procedure 
diffi cult or even impossible. When present, the dilation of 
the left gastric vein presents itself as an alternative technique 
for decompression of the splanchnic territory.
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Methods: Report of three cases in which were detected 
during the preoperative evaluation the presence of portal 
cavernoma and large left gastric vein draining the splanchnic 
territory. In all three cases, after dissection of this vein, its 
section was performed near the cardia with ligation of the 
cranial stump and anastomosis of the distal stump in the 
portal vein of the donor.
Results: Two patients had a favorable post-operative short 
hospital stay and good long-term outcome. The third patient 
died in the immediate postoperative period by multiple organ 
failure.
Conclusion: Anastomosis between the coronary and portal 
vein is an excellent technical option for revascularization in 
liver transplantation in the presence of portal thrombosis or 
hypoplasia, allowing proper drainage of the splanchnic ter-
ritory and direction of hepatotropic factors to the graft.
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UNREVEALING A NOVEL ASSOCIATION 
OF CHOLESTEROL ESTER STORAGE 
DISEASE (CESD) AND NON ALCOHOLIC 
FATTY LIVER DISEASE (NAFLD) – A 
SIMILAR CLINICAL SPECTRUM WITH 
DIFFERENT ETIOLOGY A PROSPECTIVE 
CLINICAL STUDY
P. Basu1, T. Nair2, S. Farhat2, S. Foustin2, L. Ang2 and 
N. J. Shah2
1Columbia University of Physicians and Surgeons, New 
York, USA; 2North Shore University Hospital, Forest Hills, 
New York, USA
Columbia University of Physicians and Surgeons, 
Hepatology and Liver Transplant, 5 Station Square, Forest 
Hills, 11375 New York, USA
Introduction: NAFLD is the most evolving global morbid-
ity progresses to cirrhosis, liver cancer and transplantation. 
Clinical spectrum is heterogeneous with biochemical and 
histological diversity. CESD is a part of metabolic storage 
disease with an intrinsic lysosomal acid lipase defi ciency 
(LAL) mimicking clinical overlap with NAFLD. This clini-
cal pilot study evaluates the clinical overlap of similar meta-
bolic syndromes with diverse etiology and outcome.
Methods: Three hundred (n = 300) patients with fatty liver 
disease with hepatomegaly, splenomegaly or both with mean 
BMI 27%, mean (anthropometric assay W/H ratio mean 0.9, 
HDL 28, LDL 148, triglyceride 187, HbA1c 5.9, HOMA 
Score 2.2, CRP 2.3, ALT 67, RBP 2.3, homocystein 11, leptin 
3.6, adiponectin 1.1, TNF-alfa 1.2, IL10 1.2, IL12 0.8, 
MELD 4). All under went abdominal sonogram and carotid 
artery Doppler. Serum fi bro sure, NASH score was measured 
and liver biopsy was performed in NASH group. Patients 
were divided into Group A (n = 100) control with mean BMI 
27.8% and no hepato-splenomegaly, Group B (n = 100) 
NAFLD with low BMI < 26%, and Group C, NASH (n = 
100) with NAFLD with BMI> 30%.
Results: Estimated prevalence of LAL 8.3% compared to 
the historical data (25 in 1 million).
Conclusion: Estimated prevalence of LAL 8.3% compared 
to the historical data (25 in 1 million). LAL has heterogeneity 
with an overlap with NAFLD and NASH. LAL defi ciency 
has peripheral atherogenic potential with signifi cant clinical 
morbidities with high steatotic, fi brogenic, and infl ammatory 
scores than NAFLA or NASH. CESD is an integral part of 
fatty liver disease.
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CAN PROPRANOLOL BE A VIABLE 
OPTION FOR TREATMENT OF SMALL-
FOR-SIZE SYNDROM? A CASE REPORT
Y.-D. Yu, D.-S. Kim, G.-Y. Byun and S.-O. Suh
Department of Surgery, Division of HBP Surgery & Liver 
Transplantation, Korea University Medical Center, Korea 
University College of Medicine, Seoul, Korea
Korea University Medical Center, Korea University 
College of Medicine, Seoul, Korea; Department of Surgery, 
Division of HBP Surgery & Liver Transplantation, 
Sungbuk-gu Anam-dong, 13670 Seoul, Korea
Introduction: Small-for-size (SFS) syndrome is defi ned as 
a syndrome characterized by several clinical symptoms after 
liver transplantation. Various methods of portal decompres-
sion using surgical or pharmacologic means have been 
described to prevent SFS syndrome. We present a case in 
which SFS syndrome persisted after splenic artery emboliza-
tion was successfully treated with propranolol in a LDLT 
patient.
Methods: A thirty-seven year old female diagnosed with 
liver cirrhosis due to hepatitis B underwent living donor liver 
transplantation.
Results: Thrombectomy and portal venoplasty was per-
formed before graft anastomosis due to severe and extensive 
portal vein thrombosis. Postoperatively small for size syn-
drome was suspected and splenic artery embolization was 
performed. After the procedure, due to continuing rise of 
bilirubin levels, propranolol was administered to lower the 
portal pressure. Patient condition improved after treatment 
with propranolol.
Conclusion: We suggest additional pharmacologic therapy 
including propranolol may further reduce portal pressure and 
improve graft function and patient condition.
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VASCULAR AND BILIARY ANATOMICAL 
CAUSES FOR REJECTION OF 
POTENTIAL LIVING LIVER DONORS 
IN PEDIATRIC AND ADULT 
LIVER TRANSPLANT
S. Iyer, W. B. Tan, K. Y. S. Chang, T. W. V. Lee and 
K. Madhavan
Division of Hepatobiliary and Pancreatic Surgery, National 
University Health System, Singapore
National University Health System, General Surgery, 
Department of Surgery, Level 8, Tower Block, 1E, Kent 
Ridge Road, 11922 Singapore
Introduction: The aim of this study is to report the outcome 
of the donor selection process for both adult and pediatric 
living donor liver transplant (LDLT), specifi cally looking 
into the rejection of donors due to unsuitable donor liver 
vascular and biliary anatomy.
Methods: 80 potential donors were evaluated for adult 
LDLT and 108 potential donors were evaluated for pediatric 
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LDLT from August 1996 to November 2011. Prospectively 
collected data regarding all the potential donors included 
demographics and the reasons for excluding unsuitable 
donors. Donor factors were classifi ed as steatosis, inadequate 
liver volume (graft or residual), unsuitable vascular or biliary 
anatomy, medical causes and others. 41 donors in adult group 
and 35 in pediatric group were rejected due to donor factors. 
6 (14.6%) donors in adult group and 14 donors (40%) in 
pediatric group were excluded on basis of unsuitable vascu-
lar and or biliary anatomy.
Results: In adult group vascular causes were segment 4 
branch from right hepatic artery, dual arterial supply to right 
lobe, right hepatic vein thrombus. Biliary causes were right 
posterior sectoral duct draining into left duct (2), right pos-
terior sectoral duct draining in hepatic duct. In the pediatric 
group the arterial causes were gastroduodenal arising from 
left hepatic artery (LHA), separate segment 2 and 3 arteries, 
segment 4 artery from right with insuffi cient segment 2/3 
volume, common trunk of anterior sectoral and LHA, thin 
LHA, segment 8 supply from LHA, accessory LHA from left 
gastric (4). The venous anomalies included short trunk of left 
portal vein, separate anterior and posterior sectoral vein and 
segment 3 draining into middle vein.
Conclusion: 14.6% of adult donors were rejected due to 
vascular and biliary variant anatomy and 40% of pediatric 
donors were rejected due to unsuitable vascular anatomy. 
With current level of experience 3 from adult group and 5 
from pediatric group could have been used as donors. With 
increasing experience in LDLT some of these rejected donors 
could have been used.
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CASE REPORT: 
LIVING DONOR LIVER 
TRANSPLANTATION IN PORTAL 
BILIOPATHY WIHT PORTAL 
VEIN THROMBOSIS
G. C. Park, D. B. Moon, T. Y. Ha, S. G. Lee and 
B. H. Jung
Asan Medical Center, Seoul, Korea
Asan Medical Center, Hepatobiliary and Liver 
Transplantation, 388-1 Pungnap-2 Dong, Songpa-gu, Seoul 
138-736, Korea
Introduction: Portal biliopathy refers to abnormalities of 
the entire biliary tract in patients with extrahepatic portal 
vein obstruction. Most of the patients are asymptomatic. The 
proposed therapies include endoscopic dilatation and stent-
ing of the common bile duct, portosystemic shunt with sple-
nectomy, meso Rex bypass, and occasionally, bilioenteric 
bypass. In patients with failed stenting and nonshuntable 
anatomy, liver transplant may be the only option.
Methods: We recently treated a 27-year-old Korean man 
who presented with recurrent episodes of cholangitis for the 
past 3 years and generalized weakness for the past 1 year. he 
underwent percutaneous transhepatic biliary drainage. 
Considering his young age, intractable symptoms, failure of 
endoscopic therapy, nonfeasibility of other treatment options, 
poor quality of life, and nonavailability of deceased-donor 
organ, the option of a living-donor liver transplant was given 
to him.
Results: Donor surgery was started after we identifi ed a 
2-cm wide anastomosable SMV. Using the Dacron graft, we 
performed the meso-portal anastomosis. The recipient hepa-
tectomy was accomplished without any splanchnic conges-
tion. A modifi ed right lobe graft was recovered from his 
21-year-younger brother. The graft weighed 640 grams, and 
there was a single right hepatic artery, and a hepatic duct. 
Doppler ultrasonography for the fi rst 5 postoperative days 
showed triphasic fl ow in the hepatic vein, and persistently 
well-maintained fl ow in the hepatic artery and the portal 
vein.
Conclusion: In patients with portal biliopathy, treatment 
should be determined by the individual patient characteris-
tics with a focus on management of portal hypertension and 
relief of obstructive jaundice. Living-donor liver transplant 
can be a viable option in young patients with a nonshuntable 
anatomy and multiple intrahepatic biliary strictures.
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VIDEO CLIP FOR CONTINUOUS 
MEDICAL EDUCATION (CME) OF 
OPERATION THEATER NURSE IN 
THE FIELD OF LIVING DONOR 
LIVER TRANSPLATATION
E. B. Lee, M. H. So and H. W. Lee
Asan Medical Center, Operating Nursing Team, 388-1 
Pungnap-2 Dong, Songpa-gu, Seoul 138-736, Korea
Introduction: Continuing medical education (CME) for 
nursing activity in operating theater has important role to 
enhance the safety of patient as well as work effi ciency. For 
CME, various types of program including lecture, test, pub-
lication, etc can be employed. However, well-made video 
clip can provide much enlightenment about the surgical pro-
cedure. It is an additional advantage of video clip in CME 
that it can be used for self-learning program.
Methods: In our institution, annual more than 300 cases of 
living donor liver transplantation (LDLT) have been per-
formed. Therefore, the number of nurse requiring education 
about became more and more. For the CME of operating 
theater nurse, we made video clip containing motion picture 
describing detail procedure of LDLT.
Results: In 2007, we made the video clip of LDLT for donor 
at fi rst. The clip for donor contains motion picture and ani-
mation which is divided into 7 steps including preparation 
of instrumental table, the procedure of hepatectomy, bench 
surgery, thawing of cryopreserved allograft vessel, measures 
for patient safety and the management of equipment. The 
running time was 43 minutes. In 2010, the video clip of 
recipient surgery was made. The running time is also 
43 minutes. It contains preparation of instrumental table, the 
procedure of recipient hepatectomy, implantation procedure 
and handling of extra-corporeal bypass pump machine. We 
handed out this video clip to operating theater nurses and 
visiting nurse from foreign country.
Conclusion: During 4 years, we have got feed-back from 
users of this video clip and plan to update contents. And we 
anticipate that this video clip will contributes to enhance the 
actual quality of nursing activity in operating theater.
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HEPATIC ARTERY RECONSTRUCTION 
USING RIGHT GASTROEPIPLOIC 
ARTERY IS A SUITABLE RESCUE 
THERAPY IN HEPATIC ARTERY 
THROMBOSIS BY CELIAC ARTERY 
STENOSIS AFTER LIVING DONOR 
LIVER TRANSPLANTATION
Y. S. Han, Y. O. Yoo, D. L. Choi and J. D. Kim
Division of Hepato-Biliary-Pancreas and Transplantation 
Surgery, Department of Surgery, Daegu Catholic 
University College of Medicine
Daegu Catholic Univerty College of Medicine, Division of 
Hepato-Biliary-Pancreas and Transplantation Surgery, 
Department of Surgery, 3056-6 Daemyung-4 Dong, 
Nam-gu, 70571 Daegu, Republic of Korea
Introduction: In liver transplantation, celiac artery stenosis 
may be a potential risk factor of graft loss by hepatic artery 
thrombosis. Various surgical procedures have been proposed 
to overcome this problem, but their impact is still ill-defi ned. 
We report our experience for management using right gas-
troepiploic artery in hepatic artery thrombosis by celiac 
artery stenosis after living donor liver transplantation.
Methods: A 27-year-old female was transferred to our hos-
pital for treatment of hepatitis A induced fulminant hepatic 
failure. She received urgent living donor liver transplantation 
using right lobe graft from her cousin. Arterial blood fl ow 
was satisfactory in the Doppler ultrasonography during 
immediate post-transplant period. But, she developed ele-
vated liver enzymes, persistent coagulopathy and signifi cant 
hyperbilirubinemia in post-transplant 14th day. On follow up 
Doppler ultrasonography, no arterial blood fl ow was detected. 
Hepatic artery thrombosis and celiac artery stenosis was con-
fi rmed by computed tomography and celiac angiography.
Results: During exploratory laparotomy, the anastomotic 
site of hepatic artery was not stenotic, but a thrombus was 
found from the recipient’s proper hepatic artery to the anas-
tomosis site. After ligation of common hepatic artery, hepatic 
artery reconstruction using the right gastroepiploic artery 
which was supplied from a superior mesenteric artery was 
performed.
The postoperative course of the patient was uneventful and 
the serial Doppler sonography showed adequate arterial 
blood fl ow.
Conclusion: Hepatic artery thrombosis caused by celiac 
artery stenosis is a rare situation in liver transplantation, but 
severe complications including graft failure can be devel-
oped. Hepatic artery reconstruction using the right gastroepi-
ploic artery may be considered as a suitable rescue therapy 
for the hepatic artery thrombosis by celiac artery stenosis.
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LIVING DONOR LIVER 
TRANSPLANTATION IN 
HEPATIC EPITHELIOID 
HEMANGIOENDOTHELIOMA PATIENTS
J.-M. Namgoong, S.-G. Lee, D.-B. Moon and G.-C. Park
Department of Surgery, Asan Medical Center, University of 
Ulsan College of Medicine, Seoul, Korea
Asan Medical Center, University of Ulsan College of 
Medicine, Department of Surgery, 388-1 Poongnap-dong, 
Songpa-gu, 13873 Seoul, Korea
Introduction: Malignant hepatic epithelioid hemangioen-
dothelioma (HEH) is a rare malignant tumor of vascular 
origin with unknown etiology and a variable natural course. 
The most common clinical manifestations were right upper 
quadrant pain, hepatomegaly, and weight loss. Most patients 
presented with multifocal tumor that involved both lobes of 
the liver. Lung, peritoneum, lymph nodes, and bone were the 
most common sites of extrahepatic involvement at the time 
of diagnosis.
Methods: The natural history of HEH is unpredictable, with 
a clinical course between benign hemangioma and angiosar-
coma. Metastases have been reported in 27% of patients and 
most commonly occur in the lungs. The mortality rate is 
reported at more than 65%. The most common management 
has been liver transplantation (44.8% of patients), followed 
by no treatment (24.8% of patients), chemotherapy or radio-
therapy (21% of patients), and liver resection (9.4% of 
patients). Liver resection has been the treatment of choice in 
patients with resectable HEH. However, Liver transplanta-
tion has been proposed as the treatment of choice because of 
the hepatic multicentricity of HEH.
Results: Now we have 2 patients of HEH who underwent 
liver transplantations.
Case 1: 40-year-old, otherwise healthy female who had no 
hepatitis virus infection underwent LDLT for HEH. Entire 
right lobe huge tumor and bilobular tumors were existed. 
Because of thrombosis of right hepatic vein, we had to do 
IVC replacement (using 30 mm PTFE).
Case 2: 38 year old female underwent LDLT due to HEH. 
Entire right lobe huge tumor and bilobular tumors were 
existed. Because there was no invasion to IVC and no throm-
bus, LDLT was routinely performed.
Conclusion: I will report these two cases with imaging 
studies, pictures of intraoperation, and pathologies.
By the Canadian multicentric study, The results of LT for 
HEH are encouraging, with a recurrence rate of 36.4% and 
a fi ve-year survival rate of 82%. We expect to meet with 
good prognosis of the patients.
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INCIDENCE AND MANAGEMENT OF 
POSTOPERATIVE ABDOMINAL 
BLEEDING AFTER LIVER 
TRANSPLANTATION
S. W. Jung, S. G. Lee, S. Hwang, K. H. Kim, C. S. Ahn, 
D. B. Moon and T. Y. Ha
Department of Hepatobiliary Pancreas Surgery and Liver 
Transplantation, University of Ulsan College of Medicine 
and Asan Medical Center, Seoul, Korea
Asan Medical Center, Department of Hepatobiliary 
Pancreas Surgery and Liver Transplantation, 388-1, 
Poongnap-dong, Songpa-Ku, 138-7 Seoul, South Korea
Introduction: : Most of liver transplantation (LT) recipients 
have serious coagulation disorders at the time of LT opera-
tion, thus postoperative bleeding complications occur much 
more frequently than in other major abdominal surgery. The 
objective of this study is to assess the incidence and manage-
ment of postoperative abdominal bleeding after LT operation 
and to identify its risk factors.
Methods: During a study period of 36 months between 
January 2008 and December 2010, 1,039 patients underwent 
LT operations at our institution. Medical records were retro-
spectively reviewed focused on post-transplant abdominal 
bleeding. Postoperative abdominal bleeding were defi ned as 
any hemorrhage requiring radiologic intervention or lapa-
rotomy bleeding control within the fi rst post-transplant 
month. Bleeding itself was identifi ed as drainage of blood 
from the abdominal drains in all patients and was also con-
fi rmed with dynamic phase enhanced computed tomography 
or percutaneous selective angiography.
Results: Of these 1039 patients, 94 (9%) (62 men and 32 
women; mean age 49 years) showed suffered from abdomi-
nal bleeding after LT operation. Post-transplant abdominal 
bleeding occurs after a mean of 6.1 days after LT (range: 
1–21 days). Active bleeding was completely controlled by 
endovascular interventional techniques in 37 (39%), by sur-
gical ligation or vascular reconstruction in 43 (46%), and by 
sequential combinations of endovascular intervention and 
surgery in 14 (15%). The bleeding sites indicated for endo-
vascular radiologic intervention were the right inferior 
phrenic artery (n = 14), right and left epigastric artery (n = 
7). The bleeding sites requiring laparotomy were the hepatic 
artery (n = 9), diaphragm (n = 8), inferior vena cava (n = 5).
Conclusion: Serious coagulopathy persists even after LT 
until the liver graft regain function suffi ciently. The risk of 
spontaneous bleeding from both coagulopathy and iatrogenic 
mechanical bleeding is very high during the early post-
transplant period, which can lead to worsening of recipient 
outcomes. To minimize the risk of post-transplant bleeding, 
meticulous surgical dissection and bleeding control should 
be emphasized.
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ROUTINE HEPATOBILIARY SCAN IN 
DONORS FOLLOWING PARTIAL 
HEPATECTOMY PREVENTS 
BILIARY MORBIDITY
A. Yadav, S. Gupta, N. Goyal, M. Wadhawan, 
K. R. VAsudevan and S. Agarwal
Centre For Liver and Biliary surgery Indraprastha Apollo 
Hospitals New Delhi
CLBS Indraprastha Apollo Hospitals, Liver 
Transplantation and HPB Surgery, Indraprastha Apollo 
Hospitals, Sarita Vihar, 11000 New Delhi, India
Introduction: Minor bile leak is a common problem follow-
ing donor hepatectomy in live related liver transplant. Most 
surgeons place a drain post hepatectomy. Due to formation 
of ascites in the initial post operative period, minor leaks can 
be missed. These subclinical bile leaks can present as delayed 
intra abdominal collections thus adding to donor morbidity. 
A HIDA scan may help in picking up minor bile leakages so 
that early drain removal will not result in delayed biloma 
formation, and thus prevent morbidity.
Methods: Between September 2006 and August 2011 we 
performed 565 donor hepatectomies. Since March 2009 we 
have performed routine HIDA scans in all donors on post 
operative day 7. If the HIDA scan showed no bile leak, then 
the drain was removed irrespective of the amount been 
drained. The study was divided into 2 parts: Group A – 
September 2006–March 2009 (N = 149) no HIDA scan was 
done and the abdominal drain was removed on post operative 
day 7 in the absence of a clinical bile leak. Group B – March 
2009–August 2011 (N = 416) when a routine Hepatobiliary 
study was performed on day 7, the abdominal drain was 
retained in those patients when HIDA showed evidence of 
bile leak or collection.
Results: 6.09% (n = 25) patients in group B had a positive 
HIDA scan for bile leak. The abdominal drain was retained 
in these patients for a mean duration of 15.7 ± 7.6 days. 
2.68% (n = 4) patients in group A developed delayed intra 
abdominal bilomas requiring a median of 1.93 ± 1.24 inter-
ventions, as compared to 1 major complication in group B 
(p < 0.05).
Conclusion: A routine HIDA scan performed in all patients 
following donor hepatectomy has a high sensitivity in detect-
ing minor bile leaks and hence preventing delayed donor 
morbidity.
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LIVING DONOR LIVER 
TRANSPLANTATION IN A JEHOVAH’S 
WITNESS-CASE REPORT
G.-S. Choi, H. C. Kim, J. C. Chung, H. J. Lee and 
K. D. Kim
Department of Surgery Soon Chun Hyang University 
Hospital Bucehon
Soon Chun Hyang University Hospital Bucheon, Surgery, 
1174 Jung dong, Wonmi-gu Bucheon city, Gyunggi-do, 
420-7 Bucheon, South Korea
Introduction:  Orthotopic liver transplantation is typically 
associated with large volume blood loss. Technological and 
pharmacological advances permit liver transplantation in 
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patients who formerly were not candidates for this surgery 
because of strict limitations on blood product administration. 
We describe a liver transplant in a Jehovah’s Witness with 
liver cirrhosis related with HBV infection.
Methods: A 52-year-old Jehovah’s Witness with liver cir-
rhosis related with HBV infection and end stage liver disease 
presenting with uncontrolled ascites underwent orthotopic 
liver transplantation. MELD score was 18. Recombinant 
human erythropoietin (10,000 IU sc every two days for 
four weeks, then 10,000 IU sc every day for one week) 
established a normal hemoglobin concentration preopera-
tively (>13.1 g/dL compared with 7.3 g/dL baseline). 
Intraoperatively, strategies for reducing risk of blood product 
transfusion included avoidance of hypothermia (T>35°C), 
minimal blood sampling (four 1 ml samples), normovolemic 
hemodilution (3 units) and return of blood (300 ml) scav-
enged from the operative fi eld.
Results: Estimated blood loss was 600 ml. The preoperative 
and postoperative hemoglobin concentration was 13.4 g/dL 
(hematocrit 0.38) and 11.4 g/dL (hematocrit 0.32), respec-
tively. No blood products were required and he was dis-
charged 15 days postoperatively without complication.
Conclusion: Technological and pharmacological advances 
allow patients to undergo surgery traditionally associated 
with large volume blood loss with reduced risk of blood 
product administration.
817
INFLUENCE OF INDUCTION 
IMMUNOSUPPRESSION ON OUTCOME 
AFTER HCV RECURRENCE IN LIVER 
TRANSPLANTATION. A 10-YEAR 
LONG EXPERIENCE
N. De Ruvo, F. Di Benedetto, V. Serra, G. Rompianesi, 
R. Ballarin, N. Cautero, R. Montalti and G. E. Gerunda
Liver and Multivisceral Transplantation Center, University 
of Modena, Modena, Italy
Liver and Multivisceral Transplantation Center, University 
of Modena, Modena, Italy; Centro Trapianti di fegato e 
multiviscerale, Policlinico di Modena, Via del Pozzo 71, 
41100 Modena, Italy
Introduction: Type of induction immunosuppression – with 
monoclonal antibodies anti-IL2, or with policlonal anti-
thymocyte globulins (RATG) – and related levels of immu-
nosuppressants can determinately infl uence the long term 
outcome after HCV recurrence in liver transplantation.
Methods: a retrospective analysis of clinical, virological 
and immunological data from 3 groups of patients – anti-IL2 
+ CyA; anti-IL2 + EVR; RATG + TAC in a period of 10 
year, comparing rates of ACR, levels of IS, rates of HCV 
recurrences, disease-related graft and patient survival.
Results: Rate of ACR was inferior with anti-IL2 vs RATG 
(6.6% vs 12, 40%) but levels of IS (CSA, EVR vs TAC) was 
notably more elevated; rate of HCV recurrence was superior 
with anti-IL2 (71.1% vs 66% RATG), with higher HCVRNA 
levels (13.1 vs 2.7 MUI/L), and worse histological grading 
and staging (G8, S3 vs G5, S2); disease-related graft and 
patient survival was inferior with RATG (7/32, 21.8%) than 
with anti-IL2 6/20 (30%) even at long-term period.
Conclusion: induction with RATG-TAC demonstrated a 
better infl uence on outcome after HCV recurrence in liver 
transplantation with respect to anti-IL2 + CSA/EVR, allow-
ing lesser IS exposition, better virological and histological 
characteristics, and longer disease related graft and patient 
survival.
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LIVER TRANSPLANTATION FROM 
DONORS OLDER THEN 60 YEARS 
DURING THE MELD-BASE ERA
K. Dudek1, O. Kornasiewicz1, R. Gryszkiewicz2, 
M. Sielska2, K. Zieniewicz1, T. Wróblewski1 and 
M. Krawczyk1
1Department of General, Transplant and Liver Surgery 
Medical University of Warsaw 1a, Banacha street 02-097 
Warsaw, Poland; 2Students’ Scientifi c Group, Department 
of General, Transplant & Liver Surgery of the Medical 
University of Warsaw 1a, Banacha street 02-097 Warsaw, 
Poland
Medical University of Warsaw, Department of General, 
Transplant and Liver Surgery, Banacha 1a, 02/09/2012 
Warsaw, Poland
Introduction: In the era of important shortage of organs for 
liver transplantation the use of older donors graft is justify.
The aim of present analysis is to assess the graft and patients 
outcomes from deceased donor older then 60 years.
Methods:  From January 2007 to January 2011, 329 sub-
jects after brain death were identifi ed as liver graft donors. 
From that group of donors 25% were <30 years, 39.5% were 
between 30–50 years, 29.8% were between 50–60 years and 
5.2% were >60 years old. We analyses: donors age, recipi-
ents age, MELD of the recipients in time of transplantation, 
earlier complication and mortality.
Results: The median time post LT follow up was 22 ± 15.5 
months. 3-year patients mortality receiving organs from 
donors grouped according to age was: (<30) 8.83%, (30–50) 
15.28%, (50–60) 10.91%, (>60) 13.34%. 3-years patients 
survival according donor age was: (<30) – 89.29%, (30–50) 
– 83.85%, (50–60) – 89.89% and (>60 years) – 87.20%. 
3-years patients survival according to MELD was: MELD I 
– 91.19%, MELD II – 85.37%, MELD III – 67.67%. Overall 
patients and graft survival rates of older donors were not 
signifi cantly worse to those then young donors (p > 0.1), but 
differences in graft and patients survivals according low 
MELD I and high MELD III were statistically signifi cant (p 
< 0.01).
Conclusion: Older donor age is not contraindications for 
LT. Liver graft from donor older then 60 years can be use 
safely in older recipients with relatively low MELD. High 
MELD before transplantation is important factor of grafts 
and patients survival.
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PORTOCAVAL SHUNT IN ORTHOTOPIC 
LIVER TRANSPLANTATION: 
IS IT STILL WORTHWHILE
J. Lubrano, P. Morati, P. Mathieu, B. Heyd and G. Mantion
Digestive and Liver Transplantation Unit, Besançon, 
University Hospital
Besançon University Hospital, Digestive Surgery and Liver 
Transplantation Unit, 1 boulevard Fleming, 25030 
Besançon, France
Introduction: Since the development of modifi ed piggy-
back in orthotopic liver transplantation (OLT), the need for 
portocaval shunt is still debated. Some authors are still advo-
cating its usefulness in order to preserve portal fl ow and 
maintain splanchnic venous drainage. However, improve-
ment in liver transplantation’s anaesthesiology and surgical 
procedure has led some liver transplantation centre to avoid 
its use.
The aim of our study was to identify the factors that may 
lead to perform a portocaval shunt.
Methods: During last decade 226 orthotopic liver transplan-
tations have been performed in our centre using the modifi ed 
piggyback technique systematically without portocaval 
shunt. The data of our patient were reviewed in order to fi nd 
out the perioperative factors that have lead us to perform 
portocaval shunt during OLT.
Results: Liver transplantation was performed for cirrhosis 
in 51% and for tumours in 34% of cases. Median age was 
51 years old. A portocaval shunt was performed in 2.5% of 
the patients. In multivariate analysis, an anhepatic duration 
up to 1 hour was statistically associated with the need of 
portocaval shunt during OLT (p < 0.001) whereas cirrhosis 
was not statistically associated. 1, 3 and 5 year survival after 
OLT were not statistically different.
Conclusion: Orthotopic liver transplantation can routinely 
be performed regardless underlying cirrhosis without the 
need of portocaval shunt except in case of an anhepatic phase 
up to 1 hour.
841
NEW EXPERIMENTAL MODEL NON 
HEART BEATING DONOR CARDIAC 
IN PIGS
L. Morais1, C. Quireze1, J. Duque1, A. Brasil1, J. Camarço1, 
S. Martins1 and P. Silva2
1Federal University of Goias; 2Federal University of South 
Mato Grosso
Federal University of Goias, Digestive Surgery, First 
Avenue Not Number District East Universitario, 74000 
Goiania, Brazil
Introduction: Describe a new experimental model of non-
heart beating donor, with possibilities of application in 
experimental transplantation of abdominal organs.
Methods: Technical-sample consisted of 12 pigs, male 
Landrace, weighing between 30 and 50 kg. We followed the 
international principles of animal research, the Brazilian 
College of Animal Experimentation, the surgeries being 
supervised by a veterinarian. All animals underwent the 
same anesthetic protocol. Operative technique: We per-
formed a wide median thoracoabdominal incision. Heparin 
(500 UI-kg) and given as a bolus 5 minutes before cardio-
plegia. A obtaining donor cardioplegia cardiac arrest was 
made with ventilator disconnection and suture block of left 
and right coronary arteries. Considering criteria of cardiac 
arrest: the central pulse, ECG isoelectric line and ventricular 
fi brillation.
Results: All results were expressed as means. It was valu-
ated the heart rate and electrocardiographic tracing, the sys-
tolic, mean and diastolic blood pressure, central venous 
pressure, pulse oximetry and CO2 concentration at the end 
of expiration, all by means of multiparameter monitor repre-
sented by graphs.
The concentration of CO2 in expired gas in relation to time 
after coronary ligation when there is an exponential increase 
with concentrations at the end of 7 minutes which accompa-
nies the heart there is a abrupt halt. In the blood pressure is 
a sharp drop demonstrating the failure of life. Shows the 
oxygen saturation due to the sharp fall in time with an 
average of 7 minutes. The evolution central venous pressure 
that has on average seven minutes demonstrating values 
incompatible life cardiac arrest. The fi nding by the data of 
death averaged 7 minutes.
Conclusion: The use of this technique is feasible to repro-
duce the model of cardiac arrest. Particularly absent from the 
stage made the agonizing animal that creates confl ict in the 
results of the experimental model.
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APPLICABILITY OF THE UP TO SEVEN 
CRITERIA TO THE PRE-TRANSPLANT 
EVALUATION: FEASIBLE BUT 
CAUTION IS WARRANTED IN PATIENTS 
WITH HIGH AFP LEVEL
R. Memeo, T. Decaens1, F. Roudot-Thoraval1, 
F. Pessione1, A. Mallat1, D. Cherqui2, D. Azoulay2 
and C. D. G. F. D’étude du CHC Transplanté
1Department of Hepatology, Henri Mondor hospital, 
Créteil, France; 2Department of HBP and Liver 
Transplantation Surgery, Henri Mondor hospital, Créteil, 
France
Hopital Henri Mondor, Service Chirurgie Digestive, 51 Av 
Lattre De Tassigny, 94000 Creteil, France
Introduction: The up to seven criteria have been proposed 
recently as expanded criteria for liver transplantation in HCC 
candidates but are based on the explant pathology. The aim 
of this study was to assess the validity of these criteria when 
applied to pre-LT tumor evaluation in a independent French 
cohort.
Methods: 391 patients transplanted for HCC between 2003 
and 2005 and followed prospectively for 5 years were 
studied. Tumors were classifi ed according to the up to seven 
criteria, based on pre-LT characteristics. Overall 5-year 
recurrence and survival rates were compared by the Log rank 
test and predictors of recurrence were identifi ed by multivari-
ate analysis.
Results: 347 patients were within the up to seven criteria 
and 44 beyond. Five year-recurrence rates statistically dif-
fered between these 2 groups (11.2 ± 2.1% and 31.4 ± 7.3%, 
p < 0.001). By multivariate analysis: HCC beyond up to 
seven criteria at listing (HR = 3.8; 95%CI: 2.0–7.3; p < 
0.001), AFP at listing in 3 classes: ≤ 100, 100–1000 ng/ml 
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(HR = 3.4; 95%CI: 1.7–7.0; p = 0.001) and >1000 ng/ml (HR 
= 19.9; 95%CI: 5.9–66.5; p < 0.001) were signifi cantly dif-
ferent. In patients within up to seven criteria, 5-year recur-
rence rate and 5-year overall survival were similar, whether 
patients were Milan in or out but differed signifi cantly 
according the AFP cut-off values (5-year recurrence rates: 
7.5 ± 1.7%, 40.9 ± 14.7% vs 60.0 ± 21.9%, respectively, p 
< 0.001) and 5-year overall survival (70.4% vs 37.8% vs 
20.0%, p < 0.001).
Conclusion: This study shows that an expansion of LT cri-
teria for HCC based on Up to seven criteria at listing is 
conceivable, provided AFP < 100 ng/mL. Great caution is 
warranted in patients with AFP >100 ng/ml and a strict 
down-staging policy should be encouraged in this setting.
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RESULTS OF SIMULTANEOUS LIVER-
KIDNEY TRANSPLANT: A SINGLE 
CENTER REVIEW
E. Maynard1, M. Henn2, Y. Lin1, J. Wellen1, J. Lowell1, 
S. Shenoy1, W. Chapman1 and M. B. Doyle1
1Washington University Department of Abdominal 
Transplantation; 2Washington University Department of 
General Surgery
Washington University, Abdominal Transplantation, 660 S. 
Euclid, Campus Box 8109, 63110 Saint Louis, MO, United 
States of America
Introduction: The purpose of this study was to analyze 
results of simultaneous liver-kidney transplantation, as well 
as, further defi ne those patients who will benefi t from simul-
taneous transplant (SLKT) versus liver alone (LTA).
Methods: A single institution retrospective review of dialy-
sis dependent patients undergoing liver transplant between 
2000 and 2011 was performed. Patients who received a 
kidney transplantation at the time of liver transplant were 
compared to those who received liver transplant alone. Log-
rank test was used to compare overall graft and patient sur-
vival. To identify factors of patients undergoing transplantation 
multiple logistic regression analysis were performed.
Results: The cohort was comprised of 80 patients, (35 had 
SLKT versus 45 LTA). Patient demographics were similar 
between both groups. Patients undergoing LTA had higher 
MELD than SLKT patients (p < 0.0001). Intraoperative 
blood loss, transfusions, hospital and ICU stay, and re-explo-
ration rates, were similar among the two groups. SLKT had 
improved patient survival at 1 and 5 years (94%, 85% vs 
68%, 65% respectively, p < 0.01). Patients undergoing SLKT 
also had better graft survival than LTA at 1 and 5 years (91%, 
82% vs 65%, 59% respectively, p < 0.01). Five patients who 
had SLKT required dialysis after transplant versus 24 patients 
after LTA (p < 0.0004). Eight patients who underwent LTA 
remained dialysis dependent versus one undergoing SLKT.
Conclusion: Patients with ESLD on dialysis who undergo 
liver transplant have better overall and graft survival when 
SLKT is performed compared to LTA. In properly selected 
patients SLKT is an appropriate utilization of a scarce 
resource. Better prognostic indicators to determine which 
patients will benefi t from SLKT are still needed.
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PROGRAMMED DEATH RECEPTOR 
(PD-1) IN MODULATION OF HEPATITIS 
C VIRUS SPECIFIC IFN-GAMMA AND 
IL-17 AND FIBROSIS AFTER HUMAN 
LIVER TRANSPLANTATION
W. Chapman1, V. Subramanian1, A. Seetharam2, 
N. Steward1, J. Crippin1, S. Shenoy1 and T. Mohanakumar1
1Department of Surgery, Washington University School of 
Medicine, St. Louis, MO, USA; 2Department of Medicine, 
Washington University School of Medicine, St. Louis, MO, 
USA
Washington University in St. Louis, Department of Surgery, 
660 S Euclid Ave, Campus Box 8109, 63110 St. Louis, USA
Introduction: The inhibitory co-receptor PD-1 downregu-
lates IFNγ in viral infections and tumors by negatively regu-
lating T-cell receptor signaling in virus specifi c and tumor 
specifi c immune cells. The aim of this study was to evaluate 
the role of PD-1 receptor and its ligand PD-L1 in the modula-
tion of Hepatitis C virus (HCV) specifi c T cells secreting 
IL-17 or IFNγ in HCV liver transplantation (LT) recipients.
Methods: Forty LT recipients (LTr) were enrolled – 20 
HCV and non-HCV. Peripheral blood mononuclear cells 
were isolated from whole blood by the fi coll gradient. PD1+ 
CD4 and CD8 cells in blood were enumerated by fl ow 
cytometry. Liver biopsy obtained at the time of blood collec-
tion was scored for fi brosis by Batts Ludwig scoring system. 
Expression of the ligand PD-L1 was assessed in Liver biop-
sies by immunohistochemistry. Mononuclear cells were 
stimulated with HCV core antigen with varying concentra-
tion of anti-PD1 antibody (0, 0.01, 0.1, 1, 10 mcg/mL) to 
neutralize PD-1 and IFN-g and IL-17 secreting cells were 
enumerated by ELISpot.
Results: Clinical demographics of HCV and non-HCV LTr 
were similar. HCV LTr had signifi cantly higher peripheral 
CD4+PD1+ and CD8+PD1+ cells compared to non-HCV 
LTr (p < 0.05). This correlated with the viral load in HCV 
LTr (r = 0.72, p < 0.001). HCV LTr with advanced fi brosis 
(Stage 3–4, n = 10) had higher CD4+PD1+ (29 ± 5 vs 21 ± 
4% of CD4+, p < 0.05) and CD8+PD1+ (p < 0.05) compared 
to those without (Stage 0–2, n = 10). Liver PD-L1 expression 
was increased in HCV LTr with fi brosis (MFI – 20.5 ± 2.3 
vs 14.5 ± 3.1, p < 0.05). Anti-PD1 signifi cantly increased 
frequency of cells secreting IFNγ in response to HCV core 
in dose-dependent manner in HCV LTr with fi brosis (r = 
0.48, p = 0.02) and without (r = 0.34, p = 0.03) and decreased 
frequency of IL17 cells (r = −0.49, p < 0.01).
Conclusion: Following LT in HCV LTr, there is induction 
of PD-1 expression on T cells and its ligand PD-L1 in the 
liver. This leads to modulation of HCV specifi c immune 
responses by decreasing HCV specifi c IFNγ and increased 
IL17 thus facilitating enhanced liver fi brosis. Blocking PD-1 
with its specifi c antibody restored HCV specifi c IFNγ and 
suppressed IL17. Thus, inhibition of the PD-1 receptor sig-
naling pathway may prevent HCV recurrence and develop-
ment of liver fi brosis in HCV LTr.
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LAPAROSCOPIC REPAIR MARKEDLY 
IMPROVES OUTCOMES OF HERNIA 
REPAIR AFTER LIVER TRANSPLANT
B. Samstein, J. Guarrera, T. Kato and J. Emond
New York Presbyterian Hospital, Columbia University, 
New York, USA
New York Presbyterian Hospital, Columbia University, 
Surgery, 622 West 168th Street, PH 14 Center Room 202, 
CLDT10032 New York, USA
Introduction: Clinicians are increasingly focusing on 
decreasing the morbidity of liver transplant complications. A 
frequent complication of liver transplant surgery is incisional 
hernia. We introduced laparoscopic repair as the primary 
technique in 2007. We reported improved patient outcomes 
with laparoscopic repair versus open repair of hernia after 
liver transplantation.
Methods: We performed a retrospective chart review of all 
patients who underwent DDLTx or LDLTx at our institute, 
between January 1998 and July 2011. Data included patient 
demographics, type of immunosuppression, length of stay, 
hernia complications, hernia recurrence and follow-up. For 
statistical comparison student’s t test was used. Between 
January 1998 to July 2011, 1358 liver transplantation has 
been performed in our institute and 69 patients (5.08%) were 
diagnosed with incisional hernia. A total of 50 patients under-
went primary open repairs. And a total of 19 patients under-
went laparoscopy incisional hernia repair. Composite mesh 
was used for all laparoscopic hernia repairs.
Results: The open and laparoscopic patients were not sig-
nifi cantly different in etiology of disease, sex, age, immuno-
suppression or BMI. The average time to repair was more 
than 2 years in each group.
There was signifi cant difference in surgical complications 
with a much higher incidence of complications after open 
repair than laparoscopic. Wound infections and hernia recur-
rence occurred in 28% and 34% of open repairs and 15% and 
5% of laparoscopic repairs. LOS of 128 (36–384) hours in 
the open group and 63 (16–178) hours in the laparoscopic 
group. 79% of the laparoscopic repairs were discharged 
without any complication while only 46% of the open repairs 
were complication free.
Conclusion: Hernias are frequent cause of patient morbidity 
after liver transplantation. Open repair has a very high inci-
dence of recurrence and infection. Many patients and provid-
ers may delay repair leading to increased patient discomfort. 
Laparoscopic repair appears to have lower risks and may 
allow for improved abdominal domain after liver 
transplantation.
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LIVER SPLITTING OR TRIPARTITION: 
MORPHOLOGICAL EVALUATION OF 
FEASIBILITY IN A SELECTED 
DONOR POOL
P. Compagnon, N. Sautot-Vial, M. Romano, B. Meunier 
and K. Boudjema
Département de Chirurgie Hépatobiliaire et Digestive, 
CHU Rennes, France
CHU Rennes, Département de Chirurgie Hépatobiliaire et 
Digestive, 2 Rue Henri Le Guilloux, 35033 Rennes, France
Introduction: Split liver transplantation represents a valid 
alternative to alleviate the current cadaver-organ shortage 
and reduce dependency upon living donation. Here we evalu-
ated for the fi rst time the feasibility of splitting a liver graft 
for transplantation in 2 adult patients on the basis of anatomi-
cal and volumetric criteria (morphological limit), from a pool 
of healthy and restrictively selected livers (qualitative limit). 
We also investigated the feasibility of liver tripartition.
Methods: A cohort of adult patients (>18 <60 years) that 
met the following criteria: weight >65 kg, BMI <26 kg/m2, 
normal liver function tests, and had a morphological explora-
tion by CT-Scan and MR Cholangiography during the previ-
ous year were analyzed. Vascular anatomy was analyzed on 
2D and 3D images obtained from axial CT slices. Liver volu-
metry and virtual partition was performed using OsiriX R 
image analysis software package. Biliary anatomy was 
assessed with T2-weighted MR cholangiography. All parti-
tions have been divided into ideal and non-ideal procedures 
depending on complexity of vasculobiliary reconstructions 
(1 or > 1 anastomosis in each anatomical system). Liver 
tripartition created left lobes, right anterior and right poste-
rior sectors.
Results: Thirty patients have been analyzed. By combining 
anatomical and volumetric constraints, the proportion of 
livers that could be split for transplantation in 2 adults with 
a recipient for the left lobe weighing 50, 55 and 60 kg was 
of 47, 40 and 37%, respectively. The implantation of the 
grafts was ideal in 43, 50 and 55% of cases, respectively. 
When non ideal, the diffi culty of the implantation depended 
in 70% of cases on only one anatomical system and mostly 
concerned the middle hepatic vein. From the same selected 
pool of donors, liver tripartition was possible in 10% of cases 
when considering a trio of adult recipients (<60 kg) and 67% 
for a trio of pediatric recipients (<30 kg), with all intermedi-
ate rates for mixed trio recipients.
Conclusion: By combining anatomical and volumetric cri-
teria, we showed for the fi rst time that splitting can increase 
the number of liver grafts from a selected donor pool from 
20% (ideal procedure) to 47% (more complex reconstruc-
tions). Otherwise, we could show that liver tripartition is 
theoretically possible.
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ACCIDENTLY DISCOVERED 
NEUROENDOCRINE TUMOUR OF THE 
APPENDIX DURING DECEASED DONOR 
MULTIORGAN PROCUREMENT: 
TO HARVEST OR NOT?
B. Hegab, F. Zarnaji, A. A. Tamimi, K. Abdullah, 
W. O’Hali, I. E. Sarrag, N. Marastani and 
A. A. Abdulkareem
Department of Hepatobiliary Sciences and liver 
Transpalnation, King Abulaziz Medical City, National 
Guard Health Affairs, Riyadh, Saudi Arabia
National Guard Health Affairs, Hepatobiliary Sciences and 
Liver Transplantation, King Abulaziz Medical City, 
1142622490 Riyadh, Saudi Arabia
Introduction: Cancer can be transmitted through organ 
donation and the risk of transmission, although in the order 
of 0.015%, cannot be fully eliminated. Carcinoid (also car-
cinoid tumor) is a slow-growing type of neuroendocrine 
tumor, originating in the cells of the neuroendocrine system. 
Neuroendocrine tumors are growths that look benign but that 
might possibly be able to spread to other parts of the body.
Methods: We report a case of 50-year-old man who was a 
potential deceased donor for multiorgan harvesting.
Results: Harvesting procedure was started with a Long 
midline incision extending from the suprasternal notch to 
symphysis pubis. Exploration showed 1.5 cm mass, hard in 
consistency at the middle of the appendix. Frozen section 
showed neuroendocrine (carcinoid) tumour extending to the 
mesoappendix and periappendicular fat. The harvesting team 
aborted the procedure because of the possibility of transmis-
sion of cancer to the recipients.
Conclusion: Donors and organs should be examined thor-
oughly at the time of retrieval and frozen sections taken of 
any suspect lesions. A donor will be excluded if they are 
confi rmed or suspected to have, or have had a diagnosis of 
cancer which may be transmitted to the recipient.
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THE ROLE OF MAGNETIC RESONANCE 
CHOLANGIOGRAPHY AND 
ANGIOGRAPHY IN SCREENING OF 
EARLY VASCULAR AND BILIARY 
COMPLICATIONS AFTER LIVER 
TRANSPLANTATION. A PROSPECTIVE 
STUDY IN 100 PATIENTS
C. Lyra1, F. P. Cotta1, J. Cazejust2, S. Zalinski1, 
A. Schielke1, F. Conti3, O. Soubrane3 and O. Scatton4
1Department of Hepatobiliary Surgery and Liver 
Transplantation, Saint-Antoine Hospital, Assistance 
Publique, Hôpitaux de Paris, Paris, France; 2Department 
of Radiology, Saint-Antoine Hospital, Assistance Publique, 
Hôpitaux de Paris, Paris, France; 3Department of 
Hepatobiliary Surgery and Liver Transplantation, Saint-
Antoine Hospital, Assistance Publique, Hôpitaux de Paris, 
Université Paris Descartes, Paris, France; 4Department of 
Hepatobiliary Surgery and Liver Transplantation, Saint-
Antoine Hospital, Assistance Publique, Hôpitaux de Paris, 
Université Pierre et Marie Curie, Paris, France
Saint-Antoine Hospital, Assistance Publique, Hôpitaux de 
Paris, Paris, France; Department of Hepatobiliary Surgery 
and Liver Transplantation, 7, Rue du Loing, Étage 475014 
Paris, France
Introduction: Objective – To evaluate the value of Magnetic 
Resonance Cholangio-Angiography (MRCA) in the screen-
ing of early (<90 days) vascular and biliary complications 
after liver transplantation (LT).
Methods: A prospective nonrandomized study was con-
ducted between November 2009 and July 2011 in 121 con-
secutive LT performed in 115 patients. The study protocol 
implied to perform a systematic MRCA between postopera-
tive days (POD) 10 and 15. 21 patients did not follow the 
protocol (clinical instability (n = 7), early retransplantation 
(n = 5), early death before postoperative day 10 (n = 3) and 
logistical problems (n = 4). Overall 100 patients were studied, 
among whom 89 underwent the complete sequence of the 
MRCA. 11 patients had only the biliary sequence (MRC).
Results: 20 patients experienced a biliary complication, 9 
of which were anticipated by MRC fi ndings whereas 11 
patients with biliary complications had a normal MRC. On 
the other hand, among 15 patients with abnormal MRC, only 
9 were clinically confi rmed. The sensitivity, specifi city, PPV 
and NPV were 45%, 92.5%, 40% and 87%. 11 patients were 
diagnosed with vascular complications: 9 arterial stenosis 
and 2 portal stenosis. 1 arterial stenosis was anticipated by 
MRCA fi ndings and was subsequently confi rmed by the arte-
riography whereas 10 patients with vascular complications 
had a normal MRCA. The arteriography was normal in 
another patient with abnormal MRCA. The sensitivity, speci-
fi city, PPV and NPV were 9%, 98%, 50% and 88% 
respectively.
Conclusion: Although MRCA provides imaging of the vas-
cular and biliary structures within one procedure, it may not 
be recommended as a routine screening protocol after adult 
OLT due to its poor intrinsic validity.
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ISCHEMIC PRECONDITIONING FAILS 
TO PROTECT TRANSPLANTED LIVER 
GRAFTS FROM NON HEART BEATING 
DONORS AGAINST WARM ISCHEMIC 
INJURY. AN EXPERIMENTAL STUDY
L. Morais1, C. Quireze1, J. Duque1, A. Brasil1, J. Camarço1, 
S. Martins1, P. Silva2 and L. Marinho3
1Federal University of Goias; 2Federal University of South 
Mato Grosso; 3Federal University of Brasilia
Federal University of Goias, Digestive Surgery, First 
Avenue Not Number East Universitario, 74000 Goiania, 
Brazil
Introduction: Improved liver function from non-heart-
beating donors seems to be related to short periods of warm 
ischemia; hence ischemia-reperfusion injury is a critical 
unsolved issue. Ischemic preconditioning (IPC) has been 
shown to protect the liver from ischemia-reperfusion injury. 
However little is known about the usefulness of ischemic 
precondition as a strategy to improve tolerance of non-heart-
beating liver grafts to warm ischemia. Therefore we designed 
an experimental study aiming the effects of ischemic precon-
ditioning on liver transplantation from non-heart-beating 
donors.
Methods: Protocol was approved by Federal University of 
Goias Ethics Committee. 24 Landrace pigs were assigned 
into 4 groups: I: after cardiac arrest livers were procured and 
transplanted; II: after IPC and cardiac arrest livers were pro-
cured and transplanted; III: after IPC and cardiac arrest, a 
15 min period of warm ischemia was observed before livers 
were procured and transplanted; IV: after IPC and cardiac 
arrest, a 30 min period of warm ischemia was observed 
before livers were procured and transplanted. Donors: 
cardiac arrest was obtained by ligation of coronary arteries 
and interruption of ventilation. IPC (10′ × 10′) and warm 
ischemia waiting time were observed accordingly. Livers 
were fl ushed with 4°C HTK solution cooled and procured. 
Recipients: standard technique was used. After one hour of 
reperfusion, blood and liver samples were collected and 
euthanasia was carried out.
Results: Non-parametrical statistical tests were applied. 
Results were expressed as medians. A value of p < 0.05 was 
considered statistically signifi cant. AST, ALT, lactic acid and 
factor V levels were similar for the different studied groups 
by the end of one hour of reperfusion. A trend towards a 
deteriorated liver function was observed in group IV. When 
histological variables were addressed, vacuolization of hepa-
tocytes and cell dropout scores were similar in all groups. 
Congestion score tended to be higher in animals from group 
IV, but with no statistical signifi cance.
Conclusion: Ischemic preconditioning showed no benefi ts 
to liver grafts from non-heart-beating donors. Even though 
it did not result in benefi ts, no prejudice could be noticed in 
this research, as well.
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LIVER MOBILISATION DURING LIVER 
RESECTION INDUCES PROFOUND 
HEPATIC INFLAMMATION: 
A MOUSE MODEL
J. Schreurs1, D. Dhar2, L. Mpabanzi3, R. Sverdlov1, 
T. Hendrikx1, M. Malagó2, C. Dejong3 and S. O. Damink4
1Department of Molecular Genetics, Maastricht University 
Medical Center+, Maastricht, The Netherlands; 
2Department of HPB Surgery and Liver Transplantation, 
Royal Free Hospital, University College London, London, 
UK; 3Department of Surgery, Maastricht University 
Medical Centre+, Maastricht, the Netherlands; 
4Department of Surgery, Maastricht University Medical 
Centre+, Maastricht, the Netherlands, and Department of 
HPB Surgery and Liver Transplantation, Royal Free 
Hospital, University College London, London, UK
Maastricht University, Department of Molecular Genetics, 
Jodenstraat 7B12, 6211ER Maastricht, The Netherlands
Introduction: Liver surgery requires mobilisation of the 
liver from its surrounding ligaments, and results in signifi -
cant squeezing of the organ. We recently showed that liver 
mobilisation is the predominant cause of hepatocyte damage 
during liver surgery and jeopardizes post-operative liver 
function. Thus, there is a critical need to investigate the 
mechanisms by which damage occurs during mobilisation. 
Our aim was to establish a mouse model to study the mecha-
nisms of mobilisation-induced liver damage.
Methods: C57BL/6 mice (n = 8) underwent surgery during 
which the liver was manipulated to mimic what occurs in 
humans during major abdominal surgeries including stan-
dard liver resection. Under inhalation anaesthesia the 
abdomen was opened by midline incision, and gentle manip-
ulation was carried out by the same surgeon touching, dis-
secting ligaments, retracting, and moving the liver lobes in 
situ for 15 minutes uniformly and intermittently with cotton-
wool applicators. Liver samples were obtained 2 hours after 
mobilisation. Controls for liver mobilisation were subjected 
to laparotomy only. The numbers of macrophages, neutro-
phils and T-cells were analyzed by immunohistochemistry, 
and gene expression of cytokines was quantifi ed by real-time 
RT-PCR.
Results: The amount of infl ammatory cells was increased 
after mobilisation (Mac1, p = 0.0008), (Nimp, p = 0.0002), 
(CD3, p = 0.0008), compared to control mice. Similar to the 
increase in infl ammatory cells, mRNA levels of some, but 
not all infl ammatory cytokines was higher in the mobilisation 
group than in control group (TNF, p = 0.0004), (IL-6, p = 
0.05), (MCP1, p = 0.007), (IL1b, p = 0.14), and (SAA1, p = 
0.22).
Conclusion: The current model provides an excellent 
opportunity to study the effects of liver mobilisation in vivo. 
Furthermore, this study showed that infl ammation is one of 
the important mechanisms of mobilisation-induced liver 
damage. These data produce insight into surgery related liver 
damage and post-resection liver failure, and facilitate design-
ing interventions aiming at decreasing mobilization-induced 
liver infl ammation. This will be benefi cial to improve the 
safety during liver surgery.
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LIVER TRANSPLANTATION WITH 
MODIFIED CAVOPORTAL 
HEMITRASPOSITION IN JAK 2 
MUTATION FOR BUDD-CHIARI 
SYNDROME COMPLICATED 
BY THROMBOSIS OF THE 
PORTAL-VENOUS SYSTEM
F. D’Amico, A. Vitale, A. Bertacco and U. Cillo
HPB Surgery and Liver Transplantation Unit, Padova 
University
Chirurgia Epatobiliare e Trapianti Epatici, Chirurgia 
Generale e Trapianti Addominali, Universita’ di PadovaVia 
Giustiniani, 235128 Padova, Italy
Introduction: Combined thrombosis of the inferior vena 
cava and portal-venous system is a rare and severe type of 
Budd Chiari syndrome. This combined thrombosis can 
involve both venous systems to a varying extent and can be 
either acute or chronic in nature. It is world wide accepted 
in the acute forms the use of liver transplantation with cavo-
portal hemitransposition as life-saving procedure or multi-
visceral transplantation.
Methods: In this study, the authors describe a case of 
chronic myeloproliferative syndrome related to JAK 2 muta-
tion determining acute liver failure due to combined throm-
bosis of the inferior vena cava and portal-venous system 
undergoing to liver transplantation. The authors perform also 
a systematic review of the literature on MEDLINE.
Results: This case was a 38 YO woman diagnosed with 
portal vein and spleno-superior mesenteric vein thrombosis. 
She was successfully treated using an in situ split right graft 
and a modifi ed Tzakis’ hemitransposition technique with 
porta-portal end to side anastomosis. In particular, we 
restored the outfl ow of the portal and mesenteric veins by 
using Urokinases bolus in recipient portal vein, followed by 
end to side anastomosis on portal vein of the donor.
The pre and post-transplant drug therapy was made with 
Oncocarbide and low molecular weight heparin.
This patient is alive with functioning graft after 3 months 
from the transplant. No bleeding from esophagus varices, no 
ascites, no limb edema and no portal thrombosis has been 
observed.
Conclusion: Based on an extremely rare case of combined 
thrombosis of the inferior vena cava and portal-venous 
system due to related to JAK 2 mutation requiring liver 
transplantation, we propose a modifi ed technique to perform 
cavoportal hemitransposition. In our systematic literature 
review we found only 7 cases of cavoportal hemitransposi-
tion for the simultaneous thrombosis of the caval and portal 
systems due to Budd Chiari syndrome. This is the fi rst case 
using such a modifi ed technique in this context.
934
PROSTATE CANCER AFTER LIVER 
TRANSPLANTATION: DO NOT FORGET
A. Doerfl er1, K. Guleryuz1, S. Herve2, H. Bensadoun1 and 
L. Chiche2
1Department of Urology; 2Department of Digestive Surgery
CHU Côte de Nacre, Urology, Avenue d ela Côte de Nacre, 
14033 Caen, France
Introduction: Improvements in immunosuppression and 
anti-infection drugs in liver transplantation (LT) have led to 
a signifi cant survival increase for patient and graft. 
Development of de novo cancer has emerged as one of the 
major complications following LT. As the most common 
tumor in men, combined with the increasing number of older 
male recipients, prostate cancer should show an increasing 
incidence in liver transplant recipients (LTR). The aim of this 
study is to analyze retrospectively our LTR cohort and 
extract patients with prostate cancer.
Methods: Between 1995 and 2011, we found 8 LTR with a 
prostate cancer. The mean ± SD (range) age at diagnosis was 
60.8 ± 5.9 (55–71) years and the mean interval from LT to 
diagnosis was 65.6 ± 43.8 (8–138) months. Mean PSA level 
was 20.55 ± 29.33 (0.55–80) ng/ml. Clinical stage was T1, 
T2 and T3 in respectively 3, 4 and 1 patients. Diagnosis was 
suspected because of screening (PSA level and/or digital 
rectal examination), prostatitis or bones pain in respectively 
5, 1 and 1 patients. In all patients, diagnosis was confi rmed 
on US-guided prostate biopsy.
Results: Five patients with a localized disease underwent 
retropubic radical prostatectomy. Histological fi ndings were 
3 pT2 and 2 pT3 without positive surgical margins. Gleason 
score was 3 + 3 in 4 cases and 5 + 2 in 1 case. With a follow-
up of 20.8 ± 16.7 (6–49) months, none of the patients had 
evidence of biochemical recurrence and all were continent. 
One patient with a clinical T1 prostate cancer, Gleason score 
3 + 2, was treated with HIFU without evidence of clinical or 
biochemical recurrence at 13 months. The patient with the 
prostatitis showed a T2 prostate cancer, Gleason score 4 + 3 
and was treated with external radiotherapy without recur-
rence at 52 months. The last patient with bones pain showed 
a metastatic prostate cancer, Gleason score 5 + 4, and died 
after 5 months in spite of hormonotherapy and CNI switch 
in mTOR inhibitor.
Conclusion: Nowadays, the prevalence of prostate cancer 
in LTR remains controversial, even though a signifi cant 
increase can be expected in the coming decades.
Indeed, the growing number of aged patients suited for LT 
and the increased graft survival result in a greater risk for 
prostate cancer among the LTR because this tumor is known 
to be more frequent in older patients. It is therefore recom-
mended to screen the male LTR after age 50 years because 
therapeutic outcomes are much better for cancers diagnosed 
and treated early. Radical prostatectomy or external radio-
therapy are usually considered for curative treatment. HIFU 
should be an alternative curative treatment for small local-
ized prostate cancer. In metastatic disease, hormonotherapy 
is recommended, but prognosis is usually poor, even if 
immunosuppressive agents are reduced.
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DOES LIVER GRAFT VOLUME 
CORRELATE TO TRANSAMINASES 
PEAK FOLLOWING WHOLE LIVER 
TRANSPLANTATION?
E. Boleslawski, G. Liddo, F. Corfi otti, S. Truant, 
S. Dharancy, G. Lebuffe, N. Declerck and F.-R. Pruvot
CHU, Univ Nord-de-France, Lille, France
CHRU De Lille, Chirurgie Digestive et Transplantations, 
Hôpital Huriez, Rue Michel Polonovski, 59037 Lille Cedex, 
France
Introduction: Early transaminases peak (TrP) after liver 
transplantation (LT) is usually regarded as a marker of graft 
quality, damage and function. We hypothesize that liver graft 
volume per se may correlate to serum transaminases levels 
and therefore may alter the interpretation of post-LT TrP.
Methods: Post-LT TrP were recorded in 48 consecutive 
adult recipients of whole cadaveric LT, excluding fulminant 
hepatic failure and early retransplantation. Post-LT TrP was 
defi ned as the maximal serum aspartate amino-transferases 
(AST) and alanine amino-transferases (ALT) levels mea-
sured within the fi rst two postoperative days. Liver graft 
volume was retrospectively determined on preoperative CT 
scan in all donors. Additionally, potential factors infl uencing 
post-LT TrP, such as cold ischemia time and liver pathology 
were analyzed.
Results: Median AST and ALT peaks were 783 UI/L (190–
6468) and 526 UI/L (159–4351) U/L, respectively. Univariate 
analysis showed that liver steatosis >20%, donor body mass 
index >30, donor umbilical perimeter and donor diabetes 
mellitus were associated with higher TrP. Liver graft volume 
and liver volume to recipient body weight ratio were not 
signifi cantly correlated to TrP (Rho = 0.236; P = 0.106 and 
Rho = 0.093; P = 0.536). There were 7 non steatotic grafts 
with liver volume >2000 ml. All but one of these grafts 
exhibits post-LT TrP < 1000 UI/L.
Conclusion: Post-LT TrP may refl ect liver quality and donor 
metabolic syndrome but is not correlated to liver graft 
volume per se. High post-LT TrP is not common in recipients 
of high volume non steatotic graft and should therefore indi-
cate further investigations.
944
THE FATE OF THE REMNANT SEGMENT 
4 OF DONOR AFTER PROCUREMENT OF 
LEFT LATERAL SECTION IN LIVING 
DONOR LIVER TRANSPLANTATION
Y. Choi, G. Hong, H. Kim, M.-S. Park, S. Mori, 
N.-J. Yi, K.-W. Lee and K.-S. Suh
Department of Surgery, Seoul National University College 
of Medicine, Seoul, Republic of Korea
Department of Surgery, Seoul National University College 
of Medicine, Surgery, 101 Daehak-ro, Jongno-gu, Seoul 
110-744, Korea
Introduction: Parenchymal atrophy and bile duct dilatation 
in remnant segment 4 after in living donor After procurement 
of left lateral section (LLS). We investigated donor’s liver 
function and the necessity of the medical procedures in these 
changes of the remnant liver.
Methods: We retrospectively analyzed consecutive 28 
living donors of LLS, 4 of extended LLS among 169 pedi-
atric liver transplantations from January 2004 to December 
2010. LLS graft was 28 cases and extended LLS 4 cases.
Results: Arterial supply for Segment 4 was from left hepatic 
artery (proper hepatic artery in 3 donors (9%) left hepatic 
artery in 23 (72%), right hepatic artery in 6 (19%). 
Postoperative bile duct dilatation was observed in 29 donors 
(90%) and most of remnant segment 4 became atrophied 
regardless of the arterial supply. Bile collection in the 
abdomen was conservative managed in 2 cases. However, 
fi nally Liver function test was normalized within postopera-
tive 4 months, although serum total bilirubin of donors was 
elevated on postoperative 3rd and 4th day.
Conclusion: After procurement of left lateral section in 
living donor liver transplantation, remnant segment 4 
has atrophied without any need of intensive medical 
procedures.
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RECIPIENT OBESITY ALONE HAS 
MINIMAL EFFECT ON LIVER 
TRANSPLANT OUTCOMES
E. Maynard1, K. Conzen2, C. Anderson3, S. Shenoy1, 
J. Lowell1, N. Vachharajani1, M. B. Doyle1 and 
W. Chapman
1Department of Abdominal, Washington University, 
Abdominal Transplantation, 660 S Euclid, Saint Louis, 
MO, USA; 2Department of General Surgery, Washington 
University, 660 S Euclid, Saint Louis, MO, USA; 
3University of Mississippi Medical Center, MS, USA
Introduction: Obesity is considered a relative contraindica-
tion to liver transplantation at most centers because of con-
cerns for increased technical diffi culty and post-operative 
complications. We hypothesized that obesity alone had 
minimal effect on the outcomes of liver transplantation.
Methods: A single institution retrospective review of all 
primary orthotopic liver transplants (OLT) between 1/1/2000 
and 10/31/2010 was conducted. OLT recipients were divided 
into six groups based on their pre-transplant body mass index 
(BMI): Group 1 (BMI <18), Group 2 (18–24.9), Group 3 
(25–29.9), Group 4 (30–35), Group 5 (35.1–40) and Group 
6 (>40). Pre- and post-transplant parameters were compared 
between groups. Differences in outcomes were determined 
using the log-rank test and student’s t-test; p-value < 0.05 
was considered signifi cant.
Results: 684 patients met the inclusion criteria. The numbers 
of patients in each group were: 1 (8), 2 (194), 3 (252), 4 
(151), 5 (62), 6 (17). Pretransplant demographics (race, age, 
MELD, ascites, and history of DM), were similar among 
groups. There was an increased incidence of HTN in groups 
5 and 6 (p = 0.001). Those with BMI >30 had longer waiting 
times (p = 0.002). There was no differences in operative time, 
ICU or hospital stay, hepatic artery thrombosis, portal vein 
thrombosis, bleeding, biliary complications, or infection. 
There was no difference in graft survival between groups. 
Patient survival was worse for recipients with BMI <18 (p = 
0.006), but there were no differences in the patient survival 
at 1-, 3-, 5-, or 7-years between the other groups.
Conclusion: Obesity has an increasing impact on the fi eld 
of liver transplantation and it is often considered a relative 
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contraindication. Although our data suffer the limitations of 
a single center study, they suggest that obesity alone does 
not signifi cantly affect short or long term outcomes follow-
ing liver transplantation. Further prospective analysis is indi-
cated to guide selection criteria for morbidly obese patients.
965
RIGHT-SIDED DIAPHRAGMATIC 
HERNIA AFTER LIVING DONOR 
RIGHT HEPATECTOMY: A RARE 
COMPLICATION AFTER LIVING 
DONOR OPERATION
C. Gyu-Seong, H. C. Kim, J. C. Chung, H. J. Lee and 
K. D. Kim
Department of Surgery, Soon Chun Hyang University 
Hospital Bucheon
Soon Chun Hyang University Hospital Bucheon, Surgery, 
1174, Jung-dong, Wonmi-gu Gyunggi-d0420-7, Bucheon, 
South Korea
Introduction: Right-sided diaphragmatic hernia after living 
donor Right hepatectomy has been rare complication. we 
report a Right-sided diaphragmatic hernia in a living donor.
Methods: A 26-year-old man underwent donor right hepa-
tectomy for living donor liver transplantation. Three months 
after liver donation, he presented with upper abdominal pain 
and vomitting. Computed Tomography revealed a diaphrag-
matic hernia of the right thorax with strangulation.
Results: He underwent laparotomy and a 3 cm defect in the 
right diaphragm was identifi ed and repaired with interrupted 
polypropylene suture, after operation, the patient remains 
well.
Conclusion: Throughout the expansion of living donor liver 
transplantion, the safety of the donor is most important thing. 
Diaphragmatic hernia is a rare complication of right donor 
hepatectomy but may occur. an early diagnosis and prompt 
management is needed for donor safety.
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CAN THE MODEL FOR END-STAGE 
LIVER DISEASE (MELD) SCORE AND 
MELD-SODIUM SCORES BE USED TO 
PREDICT PORTAL VEIN PRESSURE?
M. Molinari, A. Syed, K. Eltawil, M. Walsh and I. Alwayn
Dalhousie University, Halifax, Nova Scotia
Dalhousie University, Surgery, 1276 South Park Street, 
Room 6-302, Victoria General Hospital, b3h2y Halifax, 
Canada
Introduction: Portal venous pressure (PVP) measurement 
for cirrhotic patients with portal hypertension is invasive, 
costly and often not feasible. The goal of this study was to 
validate whether the Model for End-Stage Liver Disease 
(MELD) and the MELD-Sodium (MELD-Na) scores are pre-
dictive of portal pressure in cirrhotic patients.
Methods: A prospective cohort of 55 cirrhotic patients on 
the wait list for transplantation was recruited during the 
period of May 2009 to May 2011 at a tertiary Canadian 
university centre. At the time of transplant, MELD and 
MELD-Na were calculated and PVP was directly measured 
by cannulation of the portal vein with a 22 Gauge needle 
connected to a digital transducer during transplant surgery. 
For each patient, three consecutive readings of the PVP 
were obtained. Linear regression and receiver-operating 
curves (ROC) were generated to assess the correlation and 
discrimination functions of MELD/MELD-Na for portal 
hypertension.
Results: MELD had a poor predictive function for PVP (R2 
= 0.039, P = 0.151). MELD-Na was a better predictor 
although correlation with PVP was weak (R2 = 0.102, P = 
0.033). ROC curves revealed that the MELD-Sodium was 
only moderately accurate (AUROC = 0.73) at discriminating 
patients with PVP values equal or above 25 mmHg.
Conclusion: Our fi ndings would suggest that MELD and 
MELD-Na are inadequate instruments in predicting PVP 
measurement in cirrhotic patients.
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EXTRACORPOREAL MEMBRANOUS 
OXYGENATION IN A PORCINE NON-
HEART BEATING LIVER MODEL OF 
ORGAN PRESERVATION- 
HISTOLOGICAL OUTCOME
M. S. Noormohamed1,2, A. Kanwar2, C. Ray2, S. Stamp1, 
D. Talbot2, M. Wright1, A. Burt1 and S. White1
1Newcastle University, Institute of Cellular Medicine, 
Claremont Road, Newcastle upon Tyne, UK; 2Freeman 
Hospital, Newcastle upon Tyne, UK
Introduction: The aim of organ preservation is to maintain 
cellular viability and organ function. Apoptosis, a regulated 
form of cell death. The caspase family of proteases is acti-
vated in the apoptotic signaling pathway and is responsible 
for cellular destruction. To determine whether ECMO affects 
the viability of hepatocytes, we have used a porcine model 
of human organ donation and compared the viability of hepa-
tocytes which have undergone ischaemia typical in NHBD 
tissue with cold perfusion.
Methods: Female pigs were anaesthetised with propofol 
and alfentanyl and killed by a KCl injection followed by 
30 minutes of warm ischemia. Pigs were then subjected to 
either in situ intra-vascular cooling with HTK buffer and 
intra-peritoneal cooling for 2 hours (n = 5) or in situ ECMO 
at 37°C for 2 hours (n = 7). Livers were retrieved from both 
groups and were subjected to back table fl ush with HTK and 
then placed on a re-perfusion circuit with normo-thermic 
oxygenation for 2 hours. The liver tissues were then paraffi n 
embedded. H&E staining for analysis of tissue perfusion and 
caspase-3 (Asp 175) (Cell Signaling Technology) immuno-
histochemistry for apoptosis were carried out. Two indepen-
dent raters score the slides and output score were 
produced.
Results: The ECMO group had superior viability of hepa-
tocytes, mitochondrial function and seeding effi ciency com-
pared to the cooling group (p < 0.05) in addition to better 
seeding effi ciency. The ECMO group had signifi cantly better 
H&E tissue perfusion score and the caspase 3 apoptotic 
score. The intraclass correlation [ICC (1,1)] for R1, was 0.97 
[95% confi dence interval (CI) 0.94–0.99] and for R2, was 
0.95 (95% CI 0.90–0.98). The standard error of measurement 
was 1.09 and 1.44, respectively.
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Conclusion: This pre-clinical study suggests that ECMO is 
a viable technique for liver preservation that leads to an 
excellent yield of hepatocytes when isolated from an uncon-
trolled NHBD. ECMO group has also shown better tissue 
perfusion and apoptosis compared to conventional cooling 
group. It is also technically easier to institute and more effi -
cient than other methods of oxygenation.
980
LAPAROSCOPY-ASSISTED RECIPIENT 
OPERATION FOR LIVING-DONOR 
LIVER TRANSPLANTATION
T. Takahara, H. Nitta, Y. Hasegawa, Y. Kimura, K. Ootuka, 
K. Koeda, A. Sasaki and G. Wakabayashi
Iwate Medical University School of Medicine
Iwate Medical University School of Medicine, Surgery, 
19-1 Uchimaru, Morioka, Iwate 020-8505 Morioka, Japan
Introduction:  In our institute endoscopic surgery has been 
aggressively introduced for digestive tract surgery, and espe-
cially for liver surgery, the original procedure, laparoscopy-
assisted liver resection has been used since 2002. To reduce 
the wound size in laparoscopy-assisted hepatic lobectomies 
without compromising safety, we have performed laparo-
scopic-assisted donor hepatectomies for all living-donor 
liver transplantations.
Methods: Laparoscopy-assisted liver surgery was fi rst 
introduced to the recipient operation of living-donor liver 
transplantation after January, 2011. The major advantages of 
this procedure are as followings: (I) The minimization of 
body wall fractures by a 12 cm median incision; (II) The safe 
dissection of ligaments surrounding the liver by using the 
enlarged visualization of the laparoscope; and (III) The tissue 
removal surrounding the adrenal glands in the use of endo-
scopic surgery confi rming the correct layers. In this proce-
dure we fi rst mobilize the liver as wide range as we can, by 
using the various instruments for the laparoscopic liver 
surgery such as SoftWand™ (Olympus Corporation) and 
ultrasonic coagulation shears, et al.
Results: At this point, it becomes possible to dissect the 
collateral veins safely by using the enlarged visualization of 
the laparoscope. And from a small median incised wound, 
we can mobilize the liver completely, and perform the dis-
section of the hepatoduodenal ligament as well as the hepatic 
veins. Here, we propose the surgical procedure of laparos-
copy-assisted recipient operation with detailed technical 
description.
Conclusion: In summary, we can perform this surgical pro-
cedure safely for three consecutive cases (two right lobe graft 
and one left lobe graft), and the minimized operational 
wound is a clear benefi t for the recipient from the cosmetic 
point of view and other biological evaluation has been in 
progress. A clinical trial along with the establishment of the 
standardized procedure will be warranted.
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INFLUENCE OF STEATOSIS INFLUENCE 
ON LIVER GRAFT OUTCOME
L. Cezar1, R. Adam2, M. Sebagh3, E. Vibert4, O. Ciaccio4, 
C. Guettier3 and D. Castaing5
1Fellow Research, Centre Hépato-Biliaire CHB, Hôpital 
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Brousse, Assistance Publique-Hôpitaux de Paris, Faculte 
de Medicine Paris-Sud, Universites Paris XI Centre 
Hépato-Biliaire CHB, Hôpital Paul Brouss; 
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Faculte de Medicine Paris-Sud, Universites Paris XI 
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de Medicine Paris-Sud, Universites Paris XI Centre 
Hépato-Biliaire CHB, Hôpital Paul Brouss
Rua Espirito Santo, 748 Bairro Santa, 95600 Taquara, 
Brazil
Introduction: Steatosis is frequently present in liver grafts, 
and it is usually admitted that small grade (<30%) of mac-
rosteatosis is safe to transplant and is not advisable to use 
graft with severe (>60%) macrosteatosis. However there is 
no consensus about the real cut off for extent of macroste-
atosis and on the risk of microsteatosis. The aim of this study 
is to evaluate the steatosis infl uence on transplant outcome 
in a large unicentric cohort.
Methods: We performed a retrospective analysis of a pro-
spectively maintained database in a single center. Two thou-
sand seven hundred and six patients (2.706) were transplanted 
from December 3, 1984 to December 31, 2010. Among these 
grafts, 1132 had steatosis (924 macro, 782 micro, 458 macro 
and micro). Graft biopsies were available in 98% of the 
cases. Donor and recipient data and surgical factors were 
analyzed. The end-points were primary dysfunction, delayed 
graft function (aspartate aminotransferase level >2.000 and 
TP < 30%), 3-month, 1-year and 5-year survival. A multivari-
able analysis and logistic regression were performed to 
indentify the risk factors associated with the outcome.
Results: The presence of microsteatosis or macrosteatosis 
at any percentage is a risk factor for graft dysfunction or 
primary nonfunction (OR: 1.41 and 1.39; P = 0.01 and 0.02 
respectively). The 3-month and 1-year graft survival is only 
affected by macrosteatosis more than 30% (OR: 1.94, P = 
0.002 and OR: 1.41, p = 0.02 respectively). According to the 
grade of macrosteatosis, the 1 year graft survival was 81% 
for <30% macrosteatosis, 73% for 30–50% macrosteatosis, 
67% for 50–60% macrosteatosis, 58% for >60% macroste-
atosis; the 5 year graft survival was 67% for <30% macros-
teatosis, 66% for 30–50% macrosteatosis, 44% for 50–60% 
macrosteatosis, 38% for >60% macrosteatosis.
Conclusion: The presence of graft steatosis, (macro or 
micro) does affect the initial graft function. Only macroste-
atosis more than 30% does affect graft survival. With more 
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than 50% macrosteatosis risk of graft loss over-exceeds 50% 
and becomes prohibitive.
994
USE OF VASCULAR ALLOGRAFTS IN 
LIVER AND PANCREAS 
TRANSPLANTATION
P. A. Farinelli, J. M. Padin, H. Almau, M. Sandi, 
G. Pfaffen, D. Ramisch, P. B. Schelotto and G. Gondolesi
Multi-Organ Transplant Institute, University Hospital, 
Favaloro Foundation, Capital Federal, Buenos Aires, 
Argentina
University Hospital, Favaloro Foundation, Multi-Organ 
Transplant Institute, Belgrano Av, 17461093 Buenos Aires, 
Argentina
Introduction: Anatomic variations of the arterial supply 
and the need to obtain an adequate infl ow or an appropriate 
venous outfl ow occassionally mandates the use of complex 
vascular reconstructions in liver and pancreas transplantation 
using cadaveric vascular grafts. Our aim was to assess the 
long term patency of vascular allografts used after liver and 
pancreas transplantations.
Methods: Between September 2009 to December 2011, 117 
liver transplantations (LT) and 13 pancreas transplantations 
(PT) were performed. Iliac arteries and iliac veins from 
cadaveric donors were used for the vascular reconstructions. 
They were preserved with University of Wisconsin solution 
and storage at 4ºC. In all cases the anastomoses were per-
formed with polypropylene continuous suture. In order to 
evaluate graft patency intraoperative pulse-Doppler and 
color Doppler ultrasound were used, at 1, 2, 3 and 7 postop-
erative days. Statistical analysis was done using SPSS v17.0.
Results: From 117 LT, 21 transplants (17.9%) required 
arterial vascular grafts reconstruction. Seven of them were 
reconstructed anatomically with the celiac trunk and 14 with 
interposition graft to the aorta and the common hepatic 
artery. Venous grafts were used in 12 LT (10.2%) on portal 
and suprahepatic cava veins. Four patients (3.4%) had com-
bined arterial and venous reconstruction. In all pancreas 
transplantations (100%) the vascular reconstructions were 
performed with a “Y” iliac artery graft. Arterial thrombosis 
was observed in 4/117 (3.4%) LT, only one patient (0.8%) 
had vascular graft. Venous thrombosis was presented in 
2/117 LT (1.7%) but none patient had venous reconstruc-
tion. For PT, artery graft patency showed no complications 
(0%).
Conclusion: The arterial and venous reconstruction per-
formed with cadaveric iliac grafts is safe and still a valid 
option for revascularization of the graft avoiding thrombosis 
and need for tranplantectomy or emergency transplant.
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021
HEMANGIOMA RESECTION – 16 YEARS’ 
EXPERIENCE OF A SINGLE CENTER 
IN ISRAEL
J. Chen, J. Chen, E. Sharon, D. Maoz and F. Grief
Rabin Medical Center, Surgery A56 Kibutz Galuyot Street 
46247 Hertzelya, Israel
Introduction: Liver hemangiomas are the most common 
benign liver tumors. Because the use of imaging studies has 
increased, benign hepatic tumors, especially hemangiomas, 
are encountered more frequently. Liver resection is indicated 
for persistent symptoms, uncertainty regarding the diagnosis 
of possible malignancy but the indication for surgical resec-
tion of these lesions remains controversial. The aim of this 
study was to assess the indications for and outcome of 
hepatic resection for hemangioma liver lesion.
Methods: Records of the patients referred for evaluation of 
radiologically and/or histopathologically proven liver hem-
angiomas, from June 1995 to February 2008, were retrospec-
tively analyzed. Demographics, presentation, reason for 
referral, tumor characteristics, and results of imaging studies, 
surgical procedures, and outcome were analyzed.
Results: A total of 45 patients, including 29 women (64%) 
and 16 men, with a mean age of 49 years (range 26–84 years) 
underwent resection of liver hemangiomas. The hemangioma 
size was <5 cm in 14 patients (31%) and >5 cm in 31 patients 
(69%). The most common reason for referral was right upper 
abdominal pain in 42% (19/45) of the patients. Indications 
for operation included giant asymptomatic hemangioma (n 
= 4), suspicion of malignancy (16), persistent symptoms 
attributable to the lesion (19), chronic sepsis (2), or others 
(4). 15 patients (33%) underwent cholecystectomy with 9 
cases of chronic cholecystitis which may suggest a different 
cause for the RUQ abdominal pain. Only 6 patients (13%) 
required a median blood transfusion of 2.5 units.
Conclusion: Liver hemangiomas can be readily diagnosed 
by ultrasound or multiphase contrast-enhanced helical CT or 
even MRI. Hepatic resection can be safely recommended for 
selected patients with liver hemangiomas. A small group of 
patients undergo resection as a result of inability to rule out 
a malignant process, but the large majority will be operated 
because of progressive abdominal pain in combination with 
size >5 cm. According to our fi ndings gallbladder removal 
should be considered.
023
FIRST REPORT OF HEPATECTOMY 
WITHOUT ENDOTRACHEAL 
GENERAL ANESTHESIA
K. Yamamoto1, D. Fukumori2, R. Yamaguchi1, 
M. Yamamoto1, K. Yamashita1, H. Igimi1 and 
F. Yamamoto1
1Department of Surgery, Yamamoto Memorial Hospital; 
2Department of Hepato-Biliary-Pancreatic Surgery, 
Rigshospital, University of Copenhagen
Yamamoto Memorial Hospital, Surgery, Hachiyakarami 
88-4, Niri-cho, Imari City 848, Saga Prefecture, Japan
Introduction: Local anesthesia, including epidural anesthe-
sia, has much merit over general anesthesia in the reduction 
of perioperative cardiac and respiratory complications. Liver 
surgeries commonly require general anesthesia. This is the 
pioneering study report of liver surgery performed under 
epidural anesthesia with conscious sedation, thus avoiding 
general anesthesia with endotracheal intubation.
Methods: We devised the following protocol for hepatec-
tomy under epidural anesthesia with conscious sedation 
(Yamamoto Memorial Hospital method): The patient takes 
10 mg diazepam orally one hour before the surgery. An epi-
dural catheter is inserted via the Th7-9 interspaces. Just 
before the surgery, 10 mg diazepam and 15 mg pentazocine 
are injected intravenously. Intraoperatively, 7 mL of 2% 
mepivacaine is injected every 40 minutes through the epidu-
ral catheter. We assessed the effi cacy and safety in terms of 
the mortality rate, surgical time, amount of bleeding and 
central venous pressure (CVP) during the procedure.
Results: We conducted 2 cases of left hepatectomies, 1 case 
of left lateral sectorectomy and 4 cases of partial hepatecto-
mies. Every patient was managed without endotracheal intu-
bation and laryngeal masks. There was no perioperative 
mortality. Mepivacaine usage (median with range) was 46.0 
(23.0–61.0) mL. Intraoperative blood loss (median with 
range) was 614.0 (144.0–1292.0) mL and surgical time 
(median with range) was 242.0 (137.0–363.0) minutes. 
Intermittent Pringle maneuver cumulative time (median with 
range) was 30.0 (23.0–89.0) minutes. CVP values (median 
with inter-quartile range) pre-clamp and during the Pringle 
maneuver were 5.0 (1.5–8.3) mmHg and 2.0 (0.0–6.0) 
mmHg (P < 0.05), respectively. All patients were discharged 
with no complications.
Conclusion: It is usually believed that liver resection should 
be performed under general anesthesia. We report the world’s 
fi rst series of liver resections performed under epidural anes-
thesia with conscious sedation, avoiding general anesthesia 
with endotracheal intubation.
OTHER
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029
HEPATIC RESECTION IN THE ELDERLY: 
OUTCOMES FROM A REGIONAL 
ASIAN HOSPITAL
A. Chiow, L. S. Lee, C. Y. Ang, S. S. Tan, S. Ibrahim and 
S.-M. Tan
Department of General Sugery, Changi General Hospital, 
Eastern Health Alliance, Singapore
Changi General Hospital, Department of General Surgery, 
2 Simei Street 3, 529889 Singapore 52988
Introduction: With improvements in surgical techniques 
and ICU care, the boundaries extent of hepatic resection and 
surgical fi tness especially in the elderly are increasingly chal-
lenged. While earlier publications point to increased morbid-
ity and mortality in hepatic resection in the elderly, recent 
studies indicate that their outcomes may not be different 
from their younger cohort. We review our single institution 
experience in hepatic resection outcomes in the elderly.
Methods: A retrospective review of a prospectively main-
tained database of patients undergoing liver resection from 
the duration of Jan 2003 to Dec 2010 was done. Patients were 
stratifi ed according to age (elderly ≥70, young <70) and 
comorbidities, ASA status at time of operation, post-
operative morbidity, post-operative mortality (30 day), length 
of stay, intra operative blood loss and survival were collected. 
Patients who underwent open RFA only on laparotomy were 
excluded. Data analysis was by SPSS version 13.
Results: A total of 177 patients were analysed. Total of 100 
resections was for HCC, non-HCC malignancies (35) and 42 
was for benign liver disease. There were 134 patients who 
were below 70 year old and 43 who were 70 year old and 
above. The mean ASA did not differ between the young and 
the elderly (2.62 ± 1.03 vs 2.87 ± 0.99 respectively). The 
elderly had signifi cantly more comorbidities and had a longer 
mean length of stay (19.06 vs 10.78, p < 0.05). There was 
no signifi cant difference in intraoperative blood loss or peri-
operative morbidity. There was a slightly higher rate of mor-
tality in the elderly but did not reach statistical 
signifi cance.
Conclusion: The elderly who underwent hepatic resection 
while having larger number of comorbidities and longer 
length of stay, had similar outcomes in terms of mortality 
and morbidity compared to their younger counterparts.
031
IMAGING DIAGNOSIS AND POST-
THERAPEUTIC MONITORING OF 
IGG4-RELATED SCLEROSING DISEASE
B. Nguyen, V. Nguyen, P. Ram and M. Roarke
Mayo Clinic
Mayo Clinic, Radiology, 13400 E Shea Blvd, 85259 
Scottsdale, USA
Introduction: IgG4-related autoimmune disease is charac-
terized by lesions with lymphoplasmacytic infi ltrative fi bro-
sis. Also known as autoimmune pancreatitis due to the 
originally reported pancreatic involvement, this disorder also 
features lesions of different organ systems of the body. It may 
mimic malignant processes such as diffuse metastases or 
lymphoma based on conventional cross-sectional imaging. 
Functional PET/CT imaging is contributory to the correct 
identifi cation and evaluation of this disease.
Methods: The imaging of 5 patients with IgG4-related scle-
rosing disease is presented. This patient population com-
prises 4 men and 1 woman with the age range of 53–73 years. 
Anatomic and functional imaging was performed with 
ultrasound (US), computed tomography (CT), magnetic 
resonance imaging (MRI) and Fluorine-18-labeled 2-fl uoro-
2-deoxy-D-glucose positron emission tomography/computed 
tomography (F-18 FDG PET/CT) for the initial staging, 
imaging selection of site of tissue sampling and post-thera-
peutic surveillance.
Results: The sites of IgG4-related sclerosing disease include 
the pancreas, gallbladder, retroperitoneum, peri-aortic region, 
lymph nodes, lungs, airways, prostate, parotid glands, sali-
vary and submandibular glands, thyroid gland and retro-
orbital soft tissue. The functional imaging provides tissue 
sampling at the sites of high diagnostic yield with highest 
safety. Post-therapeutic imaging, especially with F-18 FDG 
PET/CT, shows resolution of IgG4-related disease with cor-
ticosteroid treatment.
Conclusion: This presentation raises the awareness of the 
important imaging impact in the diagnosis, biopsy guidance 
and corticosteroid treatment follow-up of IgG4-related scle-
rosing disease. The correct diagnosis of this autoimmune 
disorder obviates unnecessary surgery and its related 
morbidity.
038
LIVER HANGING MANEUVER IS 
USEFUL FOR VARIOUS ANATOMICAL 
LIVER RESECTIONS
A. Nanashima, T. Abo, T. Sawai and T. Nagayasu
Division of Surgical Oncology, Department of Surgery, 
Nagasaki University Hospital
Nagasaki University Hospital, Division of Surgical 
Oncology and Department of Surgery, 1-7-1 Sakamoto, 852 
Nagasaki, Japan
Introduction: To achieve complete anatomic hepatectomy, 
the Liver hanging maneuver (LHM) is a useful procedure for 
transection of adequate cut plane in anatomical liver resec-
tions, and reduce intraoperative bleeding and transection 
time. We report usefulness and application of standardized 
LHM for various anatomical hepatic resections.
Methods: LHM was conducted according to the Belghiti’s 
original method, which were modifi ed by author’s original 
devices. Naso-gastric tube is conventionally used, which 
were replaced following Kokudo’s repositioning technique. 
Vessel sealing devices are used for hepatic transection as a 
standard procedure.
Results: Intraoperative bleeding, blood transfusion, and 
operating time tended to be less in LHM group in comparison 
with non-LHM group, the time for parenchymal transection 
was signifi cantly shorter in the LHM group (36 ± 9 vs 48 ± 
13 min. P = .01). Rate of postoperative long-term ascites was 
less in LHM group (p = .03). In the left trisectionectomy, 
transection time tended to be shorter in the LHM group (32 
± 6 min). We applied the double LHM for central hepatec-
tomies in 8 patients and the dorsally fi xed LHM for the left 
hepatectomy with caudate resection in hilar bile duct carci-
nomas in 10 cases. In these series, blood loss and transection 
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time were similarly shorter in LHM group. LHM was applied 
in sectionectomy with combined resection of hepatic vein.
Conclusion: LHM can reduce the transection time at the cut 
plane in hepatic resections even in a large liver tumor or bile 
duct carcinomas. Our results emphasized the advantages and 
usefulness of LHM in anatomical liver resections.
047
NOVEL APPROACH OF PURE 
LAPAROSCOPIC POSTERIOR 
SECTIONECTOMY OF THE LIVER- 
CAUDAL APPROACH WITH 
LAPAROSCOPY-SPECIFIC VIEW
Z. Morise, N. Kawabe, H. Tomishige, H. Nagata, 
H. Ohshima, J. Kawase, S. Arakawa and R. Yoshida
Fujita Health University School of Medicine Banbuntane-
Houtokukai Hospital, Department of Surgery
Fujita Health University School of Medicine Banbuntane-
Houtokukai Hospital, Surgery, 3-6-10 Otobashi, 
Nakagawa-ku, Nagoya AICHI, 454-850945485 Nagoya, 
Japan
Introduction: The boundary plane between anterior and 
posterior sectors of the liver, the cutting plane of posterior 
sectionectomy, is horizontal in supine position. For the suc-
cessful laparoscopic posterior sectionectomy, the cutting 
plane should be well-opened in the small space of abdominal 
cavity. We fi gure out the new procedure, caudal approach 
pure laparoscopic posterior sectionectomy under the laparos-
copy-specifi c view.
Methods: Patients are put in left lateral position. Posterior 
sector is not mobilized and stayed to be fi xed to retroperito-
neum. Glissonian pedicle of the sector is encircled and 
clamped, and the cutting line of the liver is defi ned. Dissection 
of IVC behind the liver is started from caudal part. Liver 
transection is performed to search RHV branch from caudal 
edge. Dissection of IVC and transection of the liver with the 
exposure of RHV simultaneously proceed to the bifurcation 
of RHV/IVC in one direction from caudal to cranial. Since 
the remnant liver sinks down and the resected liver is fi xed 
to retroperitoneum, the cutting surface is well-opened. 
Dissection of the resected liver from retroperitoneum is per-
formed after completion of transection.
Results: The caudal approach pure laparoscopic posterior 
sectionectomy applied to a 63 years old woman with 1.5 cm 
metachronous colorectal liver metastasis in the segment 6 
close to RHV. She had undergone post operative adjuvant 
chemotherapy after open colorectal surgery and her liver had 
severe fatty change. Therefore, posterior sectionectomy 
applied to her lesion, not right hepatectomy. However, since 
the lesion is close to RHV, RHV exposure is required for R0 
resection of the lesion. The operation time was 341 minutes 
and operative blood loss was 1356 ml. Her postoperative 
hospital stay was uneventful and she is well without any 
signs of recurrences 3 months after surgery.
Conclusion: The caudal approach pure laparoscopic poste-
rior sectionectomy of the liver is feasible and useful approach 
especially for the patients with the tumor close to RHV 
through the use of laparoscopy-specifi c view.
057
LAPAROSCOPIC LEFT LIVER 
RESECTION FOR GIANT FOCAL 
NODULAR HYPERPLASIA
M. Jacobs and A. Kamyab
Providence Hospital and Medical Centers, Department of 
Surgery, Southfi eld, MI
Providence Hospital and Medical Centers, Surgery, 16001 
West Nine Mile Road, 48075 Southfi eld, USA
Introduction: Hepatectomy is used in the treatment of large 
or symptomatic focal nodular hyperplasia. An open hepatec-
tomy is the standard technique, but laparoscopic hepatec-
tomy is gaining wider acceptance. We present a laparoscopic 
liver resection of segments 2, 3 and 4.
Methods: The laparoscopic hepatectomy was performed 
with the patient in a supine position, with two 10 mm Hassan 
and two 5 mm Hassan trocars. The liver was resected with a 
LigaSure device, followed by an endo-GIA stapler across the 
vascularized pedicles and left hepatic vein. A Pringle maneu-
ver was not performed. There was no evidence of bile leak 
and hematostatis was assured.
Results: A 30 year old women underwent the above proce-
dure for a large hepatic mass emanating predominantly from 
segment 3, with imaging fi ndings suspicious for a focal 
nodular hyperplasia. OR time was 76 minutes, with an esti-
mated blood loss of 300 mL. The postoperative hospital stay 
was 4 days. There were no intraoperative or postoperative 
complications. Final pathology showed focal nodular hyper-
plasia measuring 12 × 9 × 7 cm.
Conclusion: Laparoscopic hepatectomy is a safe and viable 
technique, with the benefi ts of decreased blood loss and 
length of hospital stay compared to the open technique.
059
SEVERE LIVER BLUNT TRAUMA AND 
DIAPHRAGMATIC RUPTURE DUE 
TO BULLFIGHTING
J. M. Ramia1, R. De la Plaza1, J. Quiñones1, C. Benito2, 
C. García-Llorente1, C. Ramiro1, P. Veguillas1 and 
J. García-Parreño1
1HPB Unit, Department of Surgery, Hospital de 
Guadalajara, Guadalajara, Spain; 2ICU Service
Hospital de Guadalajara, Surgery, General Moscardo 26, 
5-1, 28020 Madrid, Spain
Introduction: The most frequent lesions produced by bulls 
in Spanish bullfi ghting festival are goring (open wounds 
caused by bull horns). Severe blunt liver trauma caused by 
a bull is extremely rare. We present an extreme case of blunt 
liver trauma and diaphragmatic rupture occurred in bullfi ght 
party.
Methods: A 72 year-old female was admitted in Emergency 
Department after severe blunt trauma during “encierro”: 
bull-running festival through the countryside. The bull hit 
her with the head and horns. Patient was admitted hypotense, 
hypotermic and with severe cutaneous paleness. GCS: 15. 
First haemoglobin: 8.1 g/dl. At exploration: a severe painful 
haematoma was seen in right hemithorax and peritonism in 
right hypochondrium. Thoraco-abdominal CT: Right rib 
fractures (7 to 10th), severe liver trauma with active bleed-
ing, liver herniation to thorax and hemoperitoneum.
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Results: We performed an exploratory laparotomy and 
observed a severe hemoperitoneum, a traumatic diaphrag-
matic rupture with intrathoracic herniation of right liver, 
retroperitoneal haematoma, a complete avulsion of segments 
VI and VII and partial avulsion of segments V and VII, a 
liver fracture in segments V and IVb, and multiples holes in 
anterior surface of inferior cava vein (ICV) due to pulling 
out of posterior veins of segments VI and VII draining to 
ICV (Grade V). We performed incomplete atypical right 
hepatectomy, suture of multiples holes in ICV, hepatorrhaphy 
of liver fracture affecting segments IVb-V, suture of right 
diaphragm and insertion of chest tube in right thorax. Due to 
poly-transfusion, we could not obtain a correct hemostasis 
so we decided to perform abdominal packing that we retired 
after 48 hours. No complication related to abdominal surgical 
procedures occurred. Patient presented multiple pulmonary 
complications: atelectasis, pleural effusion, pneumonia, pro-
longed orotracheal intubation and diaphragmatic paralysis 
that delayed ICU and hospital stay. Hospital stay: 50 days.
Conclusion: Bulls usually cause open bizarre wounds but 
exceptionally can provoke severe blunt liver trauma. A 
severe trauma causing acceleration/deacceleration in right 
fl ank can cause diaphragmatic rupture that can provoke a 
severe right liver avulsion and rupture of ICV. We present 
iconography of this exceptional case.
061
TOTALLY LAPAROSCOPIC 
ANATOMICAL HEPATECTOMY
G. Honda, M. Kurata, S. Kobayashi and K. Tsuruta
Dept of Surgery, Tokyo Metropolitan Cancer and Infectious 
Diseases Center Komagome Hospital
Tokyo Metropilitan Cancer and Infectious Diseases Center 
Komagome Hospital, Surgery, 3-18-22 Honkomagome, 
Bunkyo-ku, 11386 Tokyo, Japan
Introduction: Anatomical hepatectomy is the best option 
for curative treatment of hepatocellular carcinomas. 
Particularly in laparoscopic surgery, hepatectomy with 
aggressive exposure of the vessels, which is compatible with 
anatomical hepatectomy, is often useful to secure the surgical 
margin for other tumors, because the surgeon cannot explore 
the tumor by palpation. We present our standardized proce-
dure and our results.
Methods: During laparoscopic hepatectomy, we usually 
divide the liver parenchyma without precoagulation of the 
cutting plane, exposing the vessels aggressively by using 
CUSA. To control the bleeding, we often perform Pringle’s 
maneuver and increase the abdominal pressure temporarily. 
For 30 months until Oct. 2011, we have performed totally 
laparoscopic hepatectomy in 58 cases. We have performed 
anatomical hepatectomies or hepatectomies with aggressive 
exposure of the vessels in 29 out of 58 cases. These have 
included right hepatectomy in 1, left hepatectomies in 3, 
lateral sectorectomies in 5, medial sectorectomy in 1, ante-
rior sectorectomy in 1, posterior sectorectomies in 2, sectio-
nectomies in 14, and other methods in 2.
Results: The mean operation time was 358 minutes, and the 
mean amount of blood loss was 293 ml. The median length 
of hospital stay was 7 days. Perioperative complications 
were abscess formation beside the cutting edge in 1 case, 
port site infection in 2 cases and massive ascites in 2 cases. 
Mortality was zero, and we have not encountered CO2 embo-
lism during surgery so far.
Conclusion: Our standardized procedure has made the 
quality of the laparoscopic hepatectomy the same level as 
open hepatectomy. Laparoscopic anatomical hepatectomy or 
hepatectomies with aggressive exposure of the vessels can 
be performed safely, and provide several benefi ts for the 
patient.
062
IS RADICAL SURGERY FEASIBLE IN 
LIVER HYDATIDOSIS CYSTS 
CONTACTING WITH INFERIOR 
CAVA VEIN?
J. M. Ramia1, R. De la Plaza1, L. Gijón2, J. Quiñones1, 
C. Ramiro1, F. Adel1, P. Veguillas1 and J. Garcia-Parreño1
1HPB Unit, Department of Surgery, Hospital de 
Guadalajara, Guadalajara, Spain; 2Department of 
Radiology, Hospital de Guadalajara, Guadalajara, Spain
HPB Unit. Hospital de Guadalajara, Department of 
Surgery, General Moscardo 26, 5-128020 Madrid, Spain
Introduction: Radical surgery (RS) in liver hydatidosis has 
several advantages comparing with conservative surgery 
(CS) (less biliary morbidity, shorter hospital stay and fewer 
relapses). Main problem is feasibility in huge or complicated 
cysts. Cysts contacting with inferior cava vein (ICV) are a 
surgical challenge for HPB surgeons. Classically, they were 
treated with conservative techniques but more experienced 
surgeons have performed radical surgery (total cystectomy 
or liver resection plus partial/complete resection of ICV).
Methods: Retrospective study. Period: 2007–2010. We 
have attended 85 patients with liver hydatidosis. We have 
operated on 50 patients (active cysts (CE1 to CE3) and com-
plicated cysts). We made an abdominal CT and hydatidosis 
serology in every patient. 11 patients had a liver cyst contact-
ing with ICV. A study of epidemiological, clinical, surgical 
technique and morbidity of these patients was performed. On 
CT, we measured the length of contact and degree of involve-
ment of ICV.
Results: We have operated on 11 patients with 15 cysts. 6 
were male (54%). The mean age was 50.6 years (range: 
30–81). The mean size of the cyst was 11.3 cm (range: 5.5–
19). The median number of cysts was 1 (range: 1–3). Cysts 
were located on right liver (6 patients), affecting both lobes 
(4 p.), and left liver (1 p.). Main clinical symptom was: 
abdominal pain (7 patients), sepsis due to liver hydatid 
abscess (2 p.), obstructive jaundice (1 p.) and upper gastro-
intestinal bleeding (1 p). Three patients were relapsed cases. 
On CT, median length of contact was 37 mm (range: 13–100). 
The median degree of involvement was 90° (range: 45–180°). 
Only one patient had a real but asymptomatic obstruction of 
ICV with fl ow re-distribution to azygos system. No fi stula 
between cyst and ICV was observed. Five patients presented 
also a cysto-biliary communication. Same HPB team per-
formed every surgical procedure. Techniques were: near total 
cystectomy (6 p.), Lagrot (3 p.) and total cystectomy (2 p.) 
In one of two patients a direct suture of ICV was performed. 
In 5 patients treated by CS, surgical decision was made not 
only due to ICV contact but also for contacting portal or 
biliary system. Both cases treated radically had a contact of 
15 mm and 45° and 25 mm and 75°. Morbidity rate was 27% 
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(3 patients IIIb). One patient treated by RS (50%) and 2 cases 
of CS (22%). Mortality was 0%. In follow up, 22 months 
(range: 1–48) no relapsed and no problem related to ICV 
fl ow has been detected. Due to small number of cases no 
statistical relationship between length of contact and degrees 
of involvement of ICV and type of surgery was obtained.
Conclusion: Liver Hydatid cysts contacting con ICV are 
huge cysts (11.3 cm) located usually on right liver. They 
usually do not cause clinical symptoms related to ICV 
contact or compression.
- Radical surgery is feasible in some cases (20% in our 
series), but it is technically demanding. Near total cystec-
tomy is easier and results obtained are good. If the surgeon 
performing surgical procedure thinks that RS is too risky for 
a benign disease, it is a good option to leave a small wall of 
cyst contacting with ICV. Other concomitant local complica-
tions (biliary or portal system) not only ICV contact could 
lead to decide not to perform RS.
065
MINIMALLY INVASIVE ROBOT-
ASSISTED HEPATOBILIOPANCREATIC 
SURGERY: OUR EARLY EXPERIENCES
A. Scarinci, G. Castagnola, S. Di Filippo, M. Cosimelli, 
M. d’Annibale, P. Perri and G. L. Grazi
Regina Elena National Cancer Institute Rome Italy
Regina Elena National Cancer Institute, General and 
Hepatobiliopancreatic Surgery, Via Elio Chianesi, 53144 
Rome, Italy
Introduction: The laparoscopic approach in hepatobilio-
pancreatic (HPB) surgery is still limited because of the bidi-
mensional imaging and the challenging tools handling 
learning curve. Robotic surgical system allows working 
with the aid of 3D viewing and 360 degrees articulate instru-
ments. The aim of this study is to evaluate the feasibility of 
robotic surgery, based on the analysis of our preliminary 
experience.
Methods: From June 2010 to April 2011, 7 patients (4M/3F) 
were underwent to surgery using the ‘Da Vinci’ Surgical 
System (Intuitive Surgical, Mountain View, CA, USA). The 
mean age was 51 years (28–82). Five patients underwent 
liver resections: 3 for malignant lesions: metastatic colon 
ADK (S2--3), metastatic seminoma (S5--7), HCC (S6, 
HCV+ patient). Two cases for benign lesions: S6 adenoma, 
multiple haemangiomas (S4--5--6). Two patients underwent 
pancreatic resection, one for a benign lesion (insulinoma of 
the tail of the pancreas) and for a malignant lesion (neuro-
endocrine tumor of the tail of the pancreas). We evaluated 
transfusions, operative time, resection margins, postopera-
tive complications, morbidity, mortality, hospital stay.
Results: All operations were successfully completed. Two 
patients developed surgery related complications (bleeding) 
and required transfusions (1 autologous, 1 heterologous). 
Mean surgery duration was 307 minutes (240–405). Average 
hospital stay was 7 days (3–12). Positive resection margins 
were found in the only patient (16.7%) treated for adenoma, 
thus open radicalization was later performed. In one patients 
it was necessary to widen the laparotomic service access to 
complete hemostasis. In one case conversion to open surgery 
was inevitable.
Conclusion: The results of our study show the feasibility of 
robotic HPB surgery, that is reliable, requires a learning 
curve. In such preliminary experience, our data seems to 
show comparable results to conventional laparoscopic 
surgery. The robotic system has the advantages of 3D visu-
alization and better instruments maneuverability, on the other 
hand has some limitations such as high costs, diffi culty of 
conversion to open surgery, no organ tactile evaluation and 
technical issues.
086
MINIMALLY INVASIVE SURGEON IN 
HEPATOPANCREATOBILIARY SURGERY 
FELLOWSHIP: ONE ACADEMIC 
CENTER’S MODEL
N. Gusani, O. Hamed, J. Kaifi , E. Kimchi and 
K. Staveley-O’Carroll
Surgical Oncology, Department of Surgery, Penn State 
College of Medicine, Hershey, PA
Penn State College of Medicine, Department of Surgery, 
500 University Drive, P.O. Box 850, 17033 Hershey, 
Pennsylvania, United States
Introduction: Minimally Invasive Surgery (MIS) for 
Hepatopancreatobiliary (HPB) diseases is gaining increasing 
attention. MIS for complex HPB resections requires laparo-
scopic skills mastered during MIS fellowships, while 
complex HPB procedures require a signifi cant amount of 
knowledge and multidisciplinary management mastered 
during HPB fellowships.
Methods: HPB Surgery fellowship at our academic medical 
center has established a model to further advance the applica-
tion of MIS techniques in HPB diseases. Over the last 5 years 
this HPB surgery fellowship has trained 4 fellows with 
formal MIS fellowship training. To further assess the model 
we provided a survey to faculty and fellows with MIS train-
ing from this fellowship.
Results: Three out of four faculty had previous MIS training 
through Minifellowships only. Three faculty indicated that 
the number of MIS-HPB cases done increased to 25–50 
cases/year after adopting the model. This increase was due 
to the availability of MIS trained fellow, increase interest and 
marketing. All four faculty indicated that the best sequence 
for the fellowships is MIS followed by HPB. Three fellows 
choose to do 2 fellowships based on interest in MIS-HBP 
and one based on advice by a mentor, three fellows had done 
more MIS-HPB cases during the HPB fellowship compared 
to the MIS fellowship.
Conclusion: Lack of well established training programs for 
MIS-HPB procedures represents a challenge to the current 
HPB training paradigm. Performing two fellowships in MIS 
and HPB is a potential solution to master the technical skills 
required for MIS surgery and the knowledge and multidisci-
plinary approach of the HPB surgeon.
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INJECTION OF GLUE FOR BLEEDING 
UMBILICAL VARIX
S. Shah1, J. Kurien1 and R. Wadhwani2
1Division of GI Surgery, PD Hinduja Hospital, Mumbai 
400 016, India; 2Division of Radiology, PD Hinduja 
Hospital
PD Hinduja Hospital, GI Surgery, Veer Savarkar Marg, 
Mahim 16 Mumbai, India
Introduction: Caput medusae are varices formed around 
the umbilicus due to porto-systemic communication between 
the patent umbilical vein and the abdominal wall veins. 
Bleeding from this is rare and diffi cult to control.
Methods: We report a 26 year old lady with primary scle-
rosing cholangitis who presented to the emergency depart-
ment of another hospital with torrential external bleeding 
from an eroded varix at the umbilicus. Pressure dressing, 2 
packed cell transfusion and FFP was given, and she was 
shifted to us after stabilization. We performed an abdominal 
Doppler and injected n butyl cyanoacrylate glue into the 
patent umbilical vein just above the umbilicus under real 
time Doppler guidance.
Results: The fl ow in the umbilical varices promptly ceased. 
She complained of local discomfort over the thrombosed 
veins for a week and low grade fever. There was no further 
episode of bleeding from the umbilicus. She required vari-
ceal band ligation for esophageal varices. She was success-
fully transplanted 30 months later at which time the glue plug 
was excised from the falciform ligament.
Conclusion: We report a successful injection of bleeding 
umbilical varix with this minimally interventional technique. 
Previous reports recommend surgical ligation. The process 
of glue injection is far less morbid and its effi cacy can easily 
be checked by Doppler sonography.
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HEPATO-PANCREATO-BILIARY 
SURGERY IN ELDERLY PATIENTS
O. J. M. Torres1 and J. M. M. Junior2 and R. F. Neiva2
1Federal University of Maranhao, Professor Department of 
Surgery; 2Cancer Center, Department of Surgery
Federal University of Maranhao, Department of Surgery, 
Rua dos Bicudos 14/600 Ed. Aspen Renascença, II65075 
Sao Luiz, Brazil
Introduction: The risks of operating on elderly people are 
well known to surgeons and the challenge of obtaining 
results will increase. Malignant hepato-pancreatobiliary 
tumors have their highest incidence within the sixth to the 
eighth decades of life. Resection is the only potentially cura-
tive treatment option for the most of malignant hepato-
pancreatobiliary tumors. The aim of this is analyze the 
outcome of elderly patients who have undergone surgical 
resection of hepato-pancreatobiliary disease.
Methods: In the period from July 2010 to April 2011, 29 
patients age 65 years or older underwent surgery of the liver, 
biliary tract and pancreas for different etiologies. They were 
followed up for at least six months. There were 20 female 
(69%) and 9 male (32%) and the average age was 76.3 years 
(range 65–89 years old). Associated medical conditions were 
cardiovascular (6–20%), jaundice (5–17%), diabetes (2–7%), 
renal and pulmonary (1–3.5% each).
Results: The diagnosis were liver malignant (11 patients; 
primary 3 and secondary 8), liver abscess (1), benign liver 
tumor (1) gallbladder carcinoma (4), cholangiocarcinoma 
(2), bile duct stricture (4), ductal adenocarcinoma (5) and 
chronic pancreatitis (1). The resection performed were right 
hepatectomy (8–27.5%), hepatectomy IVb and V (4–14%), 
left lobectomy (3–10%), atypical resection (2–7%), pancre-
aticoduodenectomy (3–10%), distal pancreatectomy (2–7%), 
bile enteric anastomosis (6–20%), pancreatojejuno anasto-
mosis (1–3.5%). The majority of the complications were 
cardiopulmonary. There was no mortality. Twenty six patients 
(89.5%) required admission to the intensive care unit. 
Median hospital stay was 14.1 days (range 6–19 days).
Conclusion: Major hepato-pancreatobiliary surgery can be 
performed for the elderly with acceptable morbidity and 
mortality and possible long term survival. Chronological 
age alone is not a contraindication to this challenging 
procedure.
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THE EFFECT OF NK CELLS IN INSTANT 
BLOOD-MEDIATED INFLAMMATORY 
RESPONSE (IBMIR)--A MODEL OF ISLET 
XENOTRANSPLANTATION BETWEEN 
TILAPIA AND MICE
Z. X. Zhao, X. L. Jin, Y. K. Yong and T. G. You
Department of General Surgery, Shanghai East Hospital, 
Tongji University, Shanghai 200120, China
Shanghai East Hospital, Tongji University, Shanghai 
200120, China; Department of General Surgery, 150 Jimo 
Road, Pudong New District, Shanghai 200120, China
Introduction: The objetive of this study is to observation 
of the response of NK cells in instant blood-mediated infl am-
matory response of the islet xenograft rejection in the donor 
and recipient combination between tilapia and mice.
Methods: Tilapia islets were harvested, and isolated with 
the collagenase enzyme. The balb/c mice were made diabetic 
by intraperitoneal injection of STZ. Diabetic mice were 
divided randomly into two groups, which transplantation 
(islets) group (n = 18), and control (NS) group (n = 12). The 
blood glucose levels were tested and compared after trans-
plantation. The samples were evaluated and examined histo-
logically in HE and immunohistochemical staining.
Results: Mean blood glucose levels dropped to (9.34 ± 
3.05) mmol/L at 1h post-transplantation in transplantation 
group and kept decreased to (7.8 ± 2.10) mmol/L at 12h 
post-transplantation. That were signifi cantly lower than 
control group (P < 0.05). The blood glucose levels were 
rebound to (28.13 ± 1.56) mmol/L at 24h post-transplanta-
tion, which was no signifi cant difference in two groups (P > 
0.05). At 12h post-transplantation, mild infl ammatory 
response was found in transplantation group. Only partially 
necrotic islet tissue was observed. At 24h post-transplanta-
tion, globally necrotic islet was replaced by dense infl amma-
tory cells and fi brotic tissue. Immunocytochemical staining 
showed the surrounding of NKp46 cells. No infl ammation 
process was found in control group.
514 Poster Presentation Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 288–699
Conclusion: Tilapia islet grafts transplanted into diabetic 
mice were able to decrease temporarily the blood glucose 
levels. The instant blood-mediated infl ammatory response is 
the main reason to cause islet early death. NK cells seem to 
be involved in the rejection of islets transplantation in dis-
cordant tilapia-to- mice model.
114
SEVOFLUORANE REDUCES LIVER 
DAMAGE SECONDARY TO ISCHEMIC/
REPERFUSION INJURY BY A 
MECHANISM NOT RELATED TO A 
PRECONDITIONING EFFECT
A. M. Coelho, F. P. Cavalcante, M. Machado, 
S. Sampietre, E. Chaib and L. C. DAlbuquerque
Department of Gastroenterology (LIM/37), University of 
Sao Paulo, Sao Paulo, Brazil
University of Sao Paulo, Gastroenterology, R Joao Moura 
690 #41, Zip code: 054120015412 Sao Paulo, Brazil
Introduction: Previous studies have demonstrated that 
sevofl urane protects liver from ischemia/reperfusion (I/R) 
injury however it was not shown yet if this protection is by 
preconditioning or if it depends on a continuous administra-
tion of the anesthetic during the whole I/R period. In the 
present study we evaluated the mechanism of the protective 
effect of sevofl urane in I/R injury.
Methods: Wistar male rats underwent partial liver ischemia 
during an hour under mechanical ventilation. Rats were 
divided in 3 groups: Sevo Continued (n = 15): sevofl urane 
was administered during the whole I/R injury time and 
animals remained intubated during the whole I/R time, Sevo 
30 minutes (n = 15): sevofl urane was administered during 30 
minutes and discontinued before liver ischemia, and Control 
(n = 15): animals was submitted to I/R and no sevofl urane 
was administrated. Four hours after reperfusion blood was 
collected for determinations of AST, ALT. Liver tissues were 
assembled mitochondrial oxidation and phosphorylation 
and malondialdehyde (MDA) content. Pulmonary vascular 
permeability and myeloperoxidade (MPO) were also 
determined.
Results: Four hours after reperfusion Sevo Continued group 
presented elevation of AST and ALT serum levels signifi -
cantly lower than Sevo 30 minutes and Control groups (p < 
0.05). A signifi cant reduction on liver mitochondrial dys-
function and pulmonary vascular permeability was observed 
in Sevo Continued group compared to Sevo 30 minutes and 
Control groups (p < 0.05). No differences in liver MDA and 
pulmonary MPO activity were observed.
Conclusion: Sevofl urane attenuates liver ischemia/reperfu-
sion injury probably by a mechanism not related to a by 
preconditioning effect.
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DIAZOXIDE, A MITOK (ATP) CHANNEL 
OPENER, REDUCES LIVER DAMAGE 
SECONDARY TO ISCHEMIC/
REPERFUSION INJURY
M. Machado, M. Nogueira, A. M. Coelho, S. Sampietre, 
N. Molan and L. C. DAlbuquerque
Department of Gastroenterology (LIM/37), University of 
Sao Paulo, Sao Paulo, Brazil
University of Sao Paulo, Gastroenterology, Av Dr Arnaldo 
455 #3218, Zip Code: 012469031246 Sao Paulo, Brazil
Introduction: Diazoxide, a selective opener of mitochon-
drial adenosine-5’-triphosphatase (ATP)-sensitive potassium 
channels (mitoK (ATP)), blocks Ca (2+) infl ux and therefore 
may reduce ischemia/reperfusion injury. In the present study 
we evaluated the effect of diazoxide on local and systemic 
liver ischemia/reperfusion (I/R) process.
Methods: Wistar male rats underwent partial liver ischemia 
performed by clamping the pedicle from medium and left 
anterior lateral segments during an hour under mechanical 
ventilation. They were divided into 2 groups: Control Group 
(n = 26): rats received saline and Diazoxide Group (n = 26): 
rats received IV diazoxide (3.5 mg/kg) 15 minutes before 
liver ischemia. Four and 24 hours after reperfusion, blood 
were collected for determinations of AST, ALT, TNF-alpha, 
IL-6, and IL-10. Liver tissues were assembled for histologic 
analysis, malondialdehyde (MDA) content, and mitochon-
drial oxidation and phosphorylation. Pulmonary vascular 
permeability and myeloperoxidade (MPO) were also 
determined.
Results: Four hours after reperfusion Diazoxide Group pre-
sented elevation of AST, ALT, TNF-alpha, IL-6 and IL-10 
serum levels signifi cantly lower than Control Group (p < 
0.05). A signifi cant reduction on liver MDA content and on 
mitochondrial dysfunction were observed in Diazoxide 
Group compared to Control Group (p < 0.05). No differences 
in pulmonary vascular permeability and MPO activity were 
observed between groups. Twenty four hours after reperfu-
sion Diazoxide Group showed a reduction of AST and ALT 
serum levels when compared to Control group (p < 0.05).
Conclusion: Diazoxide attenuates liver ischemia/reperfu-
sion injury probably by a mechanism related to mitochon-
drial function preservation during liver ischemia.
124
FEASIBILITY OF LAPAROSCOPIC 
ORGAN-SAVING INTERVENTIONS 
IN PATIENTS WITH SPLEEN 
FOCAL LESIONS
D. Ionkin, V. Koubishkin, A. Kriger, S. Berelavichus, 
K. Shishin, O. Zhavoronkova and A. Shurakova
A.V.Vishnevsky Institute of Surgery, Moscow, Russia 
General Surgery B, Serpuchovskaya, 2711799 Moscow, 
Russia
Introduction: Relevance: Choice of optimal surgical treat-
ment is determined by the increasing number of patients with 
spleen focal lesions.
Aim: appropriate surgical treatment tactics determination in 
patients with spleen focal lesions.
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Methods: Materials and methods: Since 1976 more then 
300 patients with spleen focal lesions were monitored. 
Organ-saving interventions were in favor among others, oth-
erwise heterotopic spleen tissue autotransplantation was per-
formed. Open spleen resections were performed as well 
laparoscopic ones, 42 laparoscopic operations were success-
ful, including 4 robot-assisted. 26 patients undergone fenes-
trations (3 robot-assisted), 13 – resections (4 anatomic, 8 
atypical, 1 robot-assisted), 1 – echinococcectomy, 1 – sple-
nectomy due to echinococcosis, 1 – supplementary spleen 
lobe with true cyst removal, which was located in the hilus. 
Expect 42 successful procedures 3 laparoscopic interven-
tions were shifted into open due to signifi cant bleeding.
Results: Results: Once laparoscopic intervention was 
repeated after fenestration, US-guided puncture regarding 
residual cavities were performed in 8 cases. Urgent histologi-
cal study of cavity content and wall as well as routine histo-
logical study was performed in all cases.
Taking into account post-operative results apart from 
routine de-epithelialization residual wall part with argon and/
or coagulation we began to treat cavity with alcohol before 
cyst ablation.
Organ-saving operations, especially laparoscopic ones, 
showed statistically signifi cant less complications number 
and better long-term results, including lie quality assessment. 
Worst results were received after organ removal.
Conclusion: Conclusion. Diagnostics should include 
current non-invasive methods – US, CT and MRI. If benign 
character of the lesions is verifi ed, organ-saving operations 
are in favor with up-to-date hemostatic and appropriate tech-
nical maneuvers. Laparoscopic interventions are feasible 
depending on lesion localization.
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LAPAROSCOPIC ANATOMICAL 
LIVER RESECTION
I.-S. Choi, J.-I. Moon, Y.-M. Ra, S.-E. Lee, W.-J. Choi and 
D.-S. Yoon
Konyanf University Hospital, Dept of surgery
Konyang University Hospital, General Surgery, Gasoowon-
Dong, Seo-Gu 685, 302-718302-7 Daejeon, Korea
Introduction: Recently Laparoscopic liver resection (LLR) 
has been widely expanded in Liver surgery, but most proce-
dures are minor non-anatomical resection. So we introduce 
our experiences of laparoscopic anatomical liver resection 
(LALR).
Methods: Between December 2004 and October 2011, total 
of 78 patients who underwent LLR are reviewed. Among 
them, laparoscopic anatomical liver resection (LALR) have 
been performed in 36 patients. Female patients were 19, male 
patients were 17. Median age was 63 years old. In this study, 
the following factors were analyzed: Indications, operation 
types, operating time, bleeding amounts, hospital stay, 
complications.
Results: There were 20 cases of Intrahepatic stone, 8 cases 
of Hepatocellular carcinoma, one colorectal liver metastasis, 
one Gallbladder cancer, 2 cases of metastatic breast cancer 
and 4 cases of benign lesions. We performed 11 cases 
left hemihepatectomy, 14 cases left lateral sectionectomy, 
3 cases bisegmentectomy (one right posterior sectionectomy, 
2 cases S4a5a), and 8 cases monosegmentectomy (one S3, 
3 cases S4, 4 cases S5). Median operative time was 268 
minutes, blood loss was 450 ml, media hospital stay was 8 
days. Intraoperative transfusion was done in 9 cases. 
Complications was developed in 3 cases (one biloma, one 
pneumonia, one voiding diffi culty) There was no post opera-
tive mortality.
Conclusion: Laparoscopic liver resection (LLR) is increased 
in especially in malignancy. So for many surgeon easily 
perform LLR in liver surgery, we should make LLR easy and 
safe procedure through standard laparoscopic anatomical 
liver resection.
135
FLEJOU DISEASE
A. Frena1 and F. Martin2
1Hepato-Biliary Unit, Department of General Surgery, 
Central Hospital of Bolzano, Italy; 2Department of 
Generale Surgery, Central Hospital of Bolzano, Italy
Central Hospital of Bolzano, HB Unit, Dept. of General 
Surgery, Via Lorenz Boehler, 539100 Bolzano, Italy
Introduction: Liver adenomatosis (LA) can be defi ned a 
rare entity in which numerous (> 10) hepatocellular adeno-
mas occur in patients with a normal hepatic parenchyma 
without history of steroid use or glycogen storage disease.
Methods: In the last fi ve years we followed the cases of 3 
women (37, 43, and 51 yrs.) suffering from LA and treated 
by liver resection. In all cases an intraparenchymal hemor-
rhage of the greater lesion was present. According to the 
original Flejou’s description of the disease, all patients had 
only a serous increase of alkaline phosphatase and γGT.
Results: Up to the present, all patients are alive without 
signs of recurrence of the disease. Microscopic examination 
of the specimens revealed that all lesions were composed of 
benign hepatocytes arranged in irregularly thickened cords, 
separated by sinusoids. The histologic fi ndings were charac-
teristic of liver cell adenomas; in view of the large number 
of lesions pre-sent (in all cases > 20), the diagnosis of LA 
was established.
Conclusion: This report confi rms the existence of the 
unusual entity of LA. These lesions can be extremely vascu-
lar and prone to hemorrhage: this argues for removing large 
adenomas even in the presence of LA. The distinction 
between LA and well-differentiated hepatocellular carci-
noma (Edmonson I) is very diffi cult on histology alone. A 
long follow-up is essential to confi rm the diagnosis.
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THE POSSIBILITIES OF RADIO-
FREQUENT ABLATION IN PATIENTS 
WITH RECURRENT LIVER TUMORS
D. Panchenkov1, Y. Ivanov3, R. Alikhanov2, R. Izrailov1, 
A. Nechunaev1 and A. Baranov1
1Moscow State University of Medicine and Dentistry; 
3Federal Scientifi c Clinical Center of Specialized Medical 
Care and New Technologies FMBA; 2Lomonosov Moscow 
State University
Moscow State University of Medicine and Dentistry, 
Department of Surgery, FPDO127473 Delegatskaya str. 
20/1, Moscow, Russia
Introduction: The treatment of patients with recurrent liver 
tumors, who were earlier undergone liver resections is a dif-
fi cult problem of surgical hepatology. The possibilities of 
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radio-frequent ablation (RFA) in treatment of these patients 
are not completely investigated. There is no exhaustive 
system of indications and contraindications. The aim of our 
study was to estimate the possibilities of RFA in patients who 
were earlier undergone liver resections.
Methods: We have an experience of treatment of 12 patients 
with recurrent liver tumors after previous resections. There 
were 8 males and 4 females. In 5 patients previous surgery 
were anatomical resections, in 7 – atypical. In 2 cases patients 
had hepatocellular carcinoma, in 10 – colorectal metastases. 
The time from the previous liver resection was from 5 to 16 
months. During the period from the previous surgery till RFA 
all the patients were undergone chemotherapy. In all cases 
the size of recurrent tumor was not more than 40 mm. In 2 
cases RFA has been performed percutaneously under ultra-
sound control, in 2 cases under CT control, in 8 – during 
laparotomy with intraoperative ultrasound. RFA was per-
formed by RITA and FOTEC devices.
Results: Complications were noticed in two cases: in one 
patients there was a bleeding, which required repeated track 
ablation, another one had the abscess in the area of ablation 
of surface tumor. All the patient received chemotherapy in 
postoperative period. The longest time of observation was 16 
months, the median survival – 9 months.
Conclusion: RFA is the possible, safe and effective method 
of treatment of patients with recurrent liver tumors in 
patients, who were earlier undergone liver resections. This 
method is applicable in cases, when repeated liver resection 
is not indicated.
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LIVER INJURIES: OPERATIVE OR 
NON-OPERATIVE TREATMENT
A. Frena1, G. L. Guardia2 and F. Martin2
1Hepato-Biliary Unit, Department of General Surgery, 
Central Hospital of Bolzano, Italy; 2Department of 
Generale Surgery, Central Hospital of Bolzano, Italy
Central Hospital of Bolzano, HB Unit, Dept. of General 
Surgery, Via Lorenz Boehler, 539100 Bolzano, Italy
Introduction: Liver injuries are the most frequent cause of 
death in the fi eld of abdominal traumas. The increase in road 
accidents and sports injuries makes discussion of the treat-
ment modalities increasingly relevant in this area. In recent 
years we have witnessed an evolution in the therapeutic 
management of such injuries with the increasingly frequent 
use of non-operative procedures for the management of non-
complex lesions.
Methods: A retrospective study was conducted in 154 cases 
of liver injuries observed in our department over a 25-year 
period (1985–2010). The mean age of the patients was 31 
years. The most frequent causes were road accidents (48%), 
followed by sports injuries (23%) and occupational accidents 
(11%).
Results: 113 patients (73%) were treated surgically and 41 
conservatively. In 79 cases (35 of which treated surgically), 
the liver injury was isolated, while in the other 75 cases 
lesions were also present in other abdominal organs. The 
liver injuries, classifi ed according to the AAST, were grade 
I in 63 cases, grade II in 38 cases, grade III in 28 cases, grade 
IV in 13 cases, and grade V in 12 cases. Thirty-fi ve percent 
of grade I-II lesions were treated conservatively, while 94% 
of grade III-IV-V lesions received surgical treatment. The 
overall operative mortality was 12.5%.
Conclusion: The evolution of the management of liver inju-
ries has witnessed an increase in conservative treatment, 
particularly for grade I and II lesions. There is no alternative 
to surgical treatment when the injury involves the major 
hepatic vessels or substantial amounts of parenchyma. The 
mortality rate is high compared to that of elective liver 
surgery, but this is due to the frequent associated lesions in 
other organs and apparatuses.
140
HYDATIC CYST OF HEPATIC DOME 
BROKEN IN INTRAPERICARDIC 
VEINA CAVA
M. Bouziane and M. Soufi 
Surgery 17, Bd Ibn Khaldoune, 60000 Oujda, Morocco
Introduction: Hydatid cysts in the liver is usual, but broken 
one in intrapericadic inferior veina cava is ununsual and can 
pose serious operative problems.
Methods: The authors report a case of a hydatid cyst which 
had developed within the liver dome with lesion of intraperi-
cardic veina cava.
the cyst was detected from pains in the up of the abdomen, 
which was diagnosed by ultrasound and a CT scan.
Conclusion: The authors discuss the various possible clini-
cal and paraclinical contexts and recommend the safe tech-
nique of control of veina cava in this situation.
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ATTITUDES AND PERCEPTIONS OF 
GENERAL SURGERY PROGRAM 
DIRECTORS REGARDING 
HPB TRAINING
V. Mittal and N. Rehil
Providence Hospital and Medical Centers
Providence Hospital and Medical Centers, Surgery, 16001 
W. Nine Mile Rd., 48075 Southfi eld, USA
Introduction: OBJECTIVE: To understand the perceptions 
general surgery program directors (PDs) have regarding HPB 
training in the education of graduating residents.
Methods: A 22-question electronic survey was sent to 210 
general surgery PDs across the United States regarding the 
experience and competency of their graduating residents.
Results: 81 PDs responded (39% rate). Less than 5% of 
residents showed interest in applying to (67% of programs) 
or matched into HPB fellowships. Approximately 40% of 
PDs felt graduating residents performed 11–25 complex 
hepatic, pancreatic and biliary cases each. Moreover, 5–10 
PDs reported graduating residents were performing >40 
complex hepatic, pancreatic and biliary cases each. Two-
thirds of PDs were confi dent graduating residents could 
perform Whipples and liver resections. All were confi dent 
the residents could perform distal pancreatectomies and liver 
biopsies. Consequently, some PDs feel resident meeting 
certain HPB numbers should automatically be qualifi ed to 
perform HPB surgery with (26%) or without (33%) passing 
an examination.
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Conclusion: General surgery residents are getting more 
than the required number of cases in HPB categories. 
Residents performing >25 cases in each category should be 
qualifi ed to perform HPB surgery. Residents planning to 
practice HPB surgery predominantly as a career should com-
plete a formal HPB fellowship.
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PATHOLOGY AND PROGNOSIS OF 
GASTRIC CARCINOMA
N. A. Benamar, M. L. Achab, Z. Belkaid, F. M. Boudia, 
I. Haddam, M. Haoues, A. Mahindad and A. A. Benamar
Algiers Medical Institute, Medical Department, 8 Bachir 
Ibrahimi Street, Colonne Voirol, Hydra, 1608 Algiers, 
Algeria
Introduction: Gastric cancer is the second most common 
cancer worldwide with a frequency that varies greatly across 
different geographic locations. It was a major cause of death. 
The only proven effective therapy remains surgical resection 
though overall 5-year survival rates remain poor. The most 
important parameters predicting outcome of patients with 
gastric carcinoma are the depth of wall invasion and the 
status of lymph node metastasis, but the prognostic signifi -
cance of histologic type was unclear.
Methods: Histopathological fi ndings and outcomes of 111 
patients with gastric carcinoma were evaluated by Lauren 
classifi cation (well and poorly differentiated types). Well dif-
ferentiated gastric carcinoma (WGC) included papillary and 
tubular adenocarcinoma, medullary carcinoma and well 
differentiated mucinous carcinoma; whereas poorly differen-
tiated gastric carcinoma (PGC) included poorly differentiated 
scirrhous carcinoma, signet ring cell carcinoma, and poorly 
differentiated mucinous carcinoma. The aim of the study was 
to clarify the prognostic value of two histologic types, that is 
well and poorly differentiated types based on age, gender and 
tumors histologicals characters of gastric carcinoma (loca-
tion, size, lymph node status, serosal invasion).
Results: The overall 5-year survival rate for patients with 
WGC was higher than that for patients with PGC (48% vs 
28%, p = 0.08). Patients with WGC, when compared to those 
with PGC, were characterized by old age (58 vs 53 years, p 
= 0.04) and frequently were found in the lower third of the 
stomach (69.8% vs 50%, p = 0.13), treated by distal gastrec-
tomy, and small in size (5.68 cm vs 6 cm). The serosal inva-
sion were observed frequently in PGC (30.2% vs 12.5%, p 
= 0.027) and lymph node metastasis (54% vs 75%, p = 0.02). 
Multivariate analysis indicated that pathologic variables of 
the tumor (depth of wall invasion and status of lymph node 
metastasis) were independent prognostic factors, but histo-
logic type (WGC vs. PGC) was not a prognostic factor.
Conclusion: we want to emphasize that histologic type is 
important for assessing the tumor progression and outcomes 
of patients with gastric carcinoma.
In addition to the depth of wall invasion and status of 
lymph node metastasis, two main histologic types, well and 
poorly differentiated types, should be evaluated in the man-
agement of gastric carcinoma.
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HEPATIC RESECTION OF LIVER TUMOR 
AT COUINAUD SEGMENT IX WITH 
EXTENSION TO VIII THROUGH THE 
RIGHT DORSOCRANIAL APPROACH
M.-C. Lin, C.-C. Wu and C.-C. Yu
Taichung Veterans General Hospital
Taichung Veterans General Hospital, Department of 
Surgery, No. 160, Sec 3, Chung-Kang Road, 407 Taichung, 
Taiwan
Introduction: Hepatic resection of tumor at Couinaud 
segment IX with extension to VIII was rarely reported in 
literature. The aim of this study is to elucidate the hepatic 
resection of tumor at Couinaud segment IX with extension 
to VIII through the right dorsocranial approach.
Methods: In July 2011 two patients who had liver tumor 
located at Couinaud segment IX with extension to VIII 
received hepatic resection in our hospital through the right 
dorsocranial approach. After extensive mobilization of right 
liver, the extrahepatic right hepatic vein was looped. The 
right liver was rotated medially and cranially to create the 
right dorsocranial sector area bounded by the exposed IVC 
dorsally, elevated right hepatic vein ventrally, and merging 
of hepatic veins to IVC cranially. Through the right dorso-
cranial approach or “window”, hepatic wedge resection of 
tumor at segment IX with extension to VIII was performed 
under Pringle maneuver. The medial extremity of hepatec-
tomy was middle hepatic vein.
Results: One patient had tumor with pathological diagnosis 
of poorly differentiated carcinoma, the other patient had 
hepatocellular carcinoma. The indocyano green test was 10.4 
and 13.3% each and Ishak modifi ed staging was F4 and F1 
each. The maximal tumor diameter was 4.5 and 2.5 cm each. 
The hepatic resection time was 36 and 54 minutes each. The 
resected liver weight was 50 and 15 gm each with margin 
less than 1 mm. The operative blood loss was 700 and 
300 ml each without blood transfusion. There was no post-
operative complication and patients were discharged on the 
9th and 8th postoperative day each.
Conclusion: The right dorsocranial approach for hepatic 
resection of tumor at Couinaud segment IX with extension 
to VIII is safe and feasible in patients with cirrhotic liver.
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EFFICACY OF FIBRIN GLUE SPRAY AND 
POLYGLYCOLIC ACID SHEET FOR THE 
PROTECTION OF TRANSECTION 
SURFACE AFTER LIVER RESECTION
K. Imai, M. Taniguchi, K. Watanabe, T. Einama, 
H. Karasaki, T. Kono and H. Furukawa
Division of Gastoroenterologic and General Surgery 
Asahikawa Medical University
Asahikawa Medical University, Division of 
Gastoroenterologic and General Surgery, 2-1, 
Midorigaoka-higashi, 78 asahikawa, Japan
Introduction: Prophylactic abdominal drainage, in order to 
detect intra-abdominal hemorrhage or bile leakage and to 
drain fl uid collection in abdominal cavity for the patients 
with liver resection, has been performed routinely. To insert 
abdominal drain, however, may be associated with some 
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complications, such as increased rates of intra-abdominal 
and wound infection, abdominal pain, and abdominal fl uid 
loss. Therefore, the prophylactic drainage after liver resec-
tion is still controversial.
Methods: This study aimed to investigate the effi cacy of 
fi brin glue spray and polyglycolic acid sheet for the protec-
tion of transection surface after liver resection and explore 
the possibility of liver resection without prophylactic drain 
placement. Fifty two patients who underwent elective liver 
resection between May 2010 and August 2011, were divided 
into two groups, control group (N = 14) and fi brin glue/
polyglycolic acid sheet group (treatment group) (N = 38). 
Peri-operative factors, including total abdominal drainage 
volume, blood biochemical examination data, post-operative 
complications, and post-operative hospital stay, were com-
pared between the two groups.
Results: There was no difference between the two groups 
in pre-operative factors. Signifi cant difference was observed 
in serum albumin level at post-operative day 1(control group 
vs. treatment group; 2.48 vs. 2.75 P = 0.024) between the 
two groups. Total abdominal drainage volume (498 ml vs. 
324 ml), severe complication rate (Clavien’s grade IIIb or 
higher, 35.7% vs. 13.2%), and post-operative hospital stay 
(18 days vs. 15 days) are tend to be decreased in the treat-
ment group.
Conclusion: Use of fi brin glue spray and polyglycolic acid 
sheet for the protection of transection surface appears to be 
safe, and tend to reduce fl uid volume of abdominal drainage 
and severe post-operative complications, resulting in pre-
venting hypoproteinemia. So it will be feasible to perform 
liver resection without prophylactic drainage by using this 
treatment.
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FIRST HUMAN PREDICTIVE MODEL OF 
MICROWAVE ABLATION VOLUME
E. Hanna, K. Simo, J. Martinie, D. Iannitti and D. Sindram
Carolinas Medical Center, Department of General Surgery, 
Division of Hepatobiliary and Pancreatic Surgery, 
Charlotte, NC, USA
Carolinas Medical Center, Department of General Surgery, 
Division of Hepatobiliary and Pancreatic Surgery, 1025 
Moorehead Medical Drive, Suite 30028204 Charlotte, 
United States of America
Introduction: Animal models have been used previously to 
describe the relationship of energy applied to diameter of 
microwave ablation (MWA) zone achieved. Human models 
of energy applied to volume of MWA zone achieved are 
lacking. In liver surgery, computed tomography (CT) volu-
metrics have been used for operative planning and prediction 
of postoperative residual liver volume. Here we use CT volu-
metrics to evaluate the relationship of energy applied to 
volume of ablated liver parenchyma achieved.
Methods: Retrospective review was performed of all 
patients undergoing hepatic microwave ablation from 2007–
2011. Two subset groups of single application (2.45 GHz 
generator), single antenna MWA were identifi ed: patients 
with hepatocellular carcinoma (HCC) and known cirrhosis 
and those with other metastatic malignancies without cir-
rhosis. One month post ablation triphasic liver CT scans were 
used to calculate volume of liver ablated using three dimen-
sional rendering with Osirix® imaging software (Pixmeo, 
Geneva, Switzerland). Data subsets were evaluated for 
model fi tness using SAS v9.2 (SAS Institute Inc., Cary, NC, 
USA).
Results: During this time period, 192 patients underwent 
338 different tumor ablations. 16 patients were included with 
a total of 23 lesions which underwent single antenna, single 
application ablation. 14 treatments were included in the cir-
rhotic group, 9 in the non-cirrhotic group. Linear and non-
linear regression models were calculated for each subset. The 
best fi t model was observed in the cirrhotic group with HCC. 
Logarithmic regression yielded the best fi t model of energy 
applied to volume achieved in the cirrhotic group (mean 
squared error, MSE = 145, R² = 0.78). In the non-cirrhotic 
group, a predictive model could not be calculated (MSE = 
615, R² = 0.02).
Conclusion: For single antenna, single application abla-
tions, volume ablated to energy applied ratio in cirrhotic 
patients yielded a strongly correlated predictive model. No 
signifi cant correlation was identifi ed in non-cirrhotic patients. 
We speculate that increased rates of tissue repair and regen-
eration in non-cirrhotic patients may explain the reduced 
model correlation at one month post ablation. Further study 
is required to more accurately examine this relationship.
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GIANT LIVER HEMANGIOMA IN ONE 
CASE WITH MARFAN SYNDROME
J. Seoung and Y. H. Hur
Korean Association of HPB Surgery
Saint. Carollo Hospital, Hepato Biliary Surgery, St. 
Garolio Hospital, Sun Cheon-si, Jeonnam, 54071 
Sunchen-si, South Korea
Introduction: Lesions of greater than 4 cm have been 
referred to as giant hemangiomas, may produce a variety of 
symptoms and signs, including pain. Kasabach-Merritt syn-
drome, with thrombocytopenia secondary to platelet trapping 
within the hemangioma, also may occur. Marfan syndrome 
has more risk of bleeding, rupture and may have more size 
due to its complication. Surgical treatment can be diffi cult as 
a result of the high risk of intraoperative hemorrhage. But 
surgical resection was needed.
Methods: One patient with giant hepatic hemangioma 
underwent Right hepatectomy at the St. Carollo Hospital, 
Sun-chen, Korea. During November 2011, also had Marfan 
syndrome and one year ago received aortic valve replace-
ment due to Mitral valve prolapse. We applied a standard 
technique in which infl ow vessels were ligated, the liver 
hanging maneuver, and preparation for total vascular exclu-
sion. followed by ligation of hepatic veins and transection of 
parenchyma. For transection, we used a variety of devices 
including electrocautery, a cavitational ultrasonic surgical 
aspirator (CUSA; Valleylab). Silk or polypropylene ligatures 
were used for identifi ed blood vessels.
Results: The female patient’s age was 54 years. Ten years 
ago, hemangioma size was 4 cm by abdominal sono. But one 
year ago, she underwent mitral valve replacement and then 
size was 15 cm. after cardiac surgery, she was medicated 
warfarin. One year later, hemangioma size was greater than 
19 cm. on entire right lobe. Left lobe was collapsed due to 
mass effect. symptom was abdominal pain, an abdominal 
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mass, The hemangioma was single and had size of 20 × 
13 cm. resected right liver weight was 900 g. Blood loss was 
1200 cc, intraoperative transfusion was PRC 2U. Operation 
time was 350 min. There was no major morbidity or 
mortality.
Conclusion: Even if, hemangioma with Marfan syndrome 
was small. Size can increased rapidly. Early hepatic resection 
was necessary and safe.
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CURRENT APPROACH TO THE 
SURGICAL MANAGEMENT OF BENIGN 
(SOLID AND NON-PARASITIC CYSTIC) 
LIVER TUMORS. OUR EXPERIENCE
M. Secchi1, L. Rossi2, L. Quadrelli1, M. Cantaberta1 and 
E. Mateljan2
1Medical School, University Institute “IUNIR” and Italian 
Hospital of Rosario, Argentina; 2Surgical Division, Modelo 
Clinic, Rufi no, Argentina
IUNIR, Medical School and Italian Hospital of Rosario, 
Argentina General Surgery, HPB Unit, Virasoro, 12492000 
Rosario, Argentina
Introduction: Benign (solid and non-parasitic cystic) liver 
tumors are a very common condition in our setting. There 
are still issues for debate and updating: dubious diagnosis of 
the tumor, diagnostic approach, disabling symptoms or com-
plications, inability to exclude malignancy, complication of 
natural history (risk of rupture, hemorrhage or cancer). The 
purpose of this study is to evaluate the current tendency to 
diagnosis and management in our practice.
Methods: Benign tumors to be discussed include: hyperpla-
sia, adenomas, hamartomas, hemangiomas and non-parasitic 
cysts. Improvements in diagnosis and management can be 
defi ned as: better understanding of the natural history of each 
type of tumor, modern imaging techniques in assuring a 
precise diagnosis of tumor nature, new minimally invasive 
laparoscopic surgical approach: diagnostic and resectional 
procedures, and safer liver resections. The diffi culty in dif-
ferentiating an HCA from a well differentiated HCC (by 
imaging techniques and by biopsies) should be kept in mind.
We will present cases that underwent surgery: Resection 
(Res.) A tailored therapeutic strategy should be used from a 
conservative approach for hemangioma and FNH to Res. for 
HCA.
Results: Between 1990 and 2011, we diagnosed benign 
liver tumors in 76 patients in 2 specialized HPB units. 42 of 
these tumors (25 solid and 17 liquid) were operated (Res.) 
and 34 are clinically followed (F.Up).
(1) Focal Nodular Hiperplasia (FNH) Symptomatic and 
>10 cm: 3 Res., 4 F.Up in small FNH
(2) Hepatocellular Adenoma (HCA): 19 Res. and F.Up of 8 
asymptomatic with multiple HCA.
(3) Solid Mesenchymal Hamartoma: 1 Res.
(4) Hemangiomas: 2 Res. and 14 F.Up
(5) Benign Liquid: (5.1) Simple Biliary Cysts: Type 1: 9 
patients: 2 Res. (lobar cysts) and 7 laparoscopic Res. of 
the dome; (5.2) Policystosis (PLC): 4 Res.: 3 symptom-
atic type 2 PLC and 1 type 3 PLC, and 8 F.up
(6) Cystadenomas: 4 Res.
There was no mortality from surgical treatment. Morbidity 
was 14%
Conclusion: A close assessment is mandatory due to the 
natural history of HCA. In case of dubious diagnosis, a 
biopsy should be performed. Laparoscopic biopsy with intra-
operative frozen section study is the method of choice 
leading to appropriate decision about tumor nature. From a 
practical point of view, the key is to exclude a diagnosis of 
FNH (possible in 70% by MRI). Diagnosis and treatment of 
cystic tumors is simpler except in type 3 polycystosis where 
the approach is more complex.
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LIVER RESECTION WITH 
INTRAHEPATIC APPROACH 
GLISSONIAN APPROACH: 
PIG MODEL FOR TRAINING
P. Lima1, A. Martins1 and A. Ferraz2
1Instituto de Medicina Integral Professor Fernando 
Figueira; 2Universidade Federal de Pernambuco
Instituto de Medicina Integral, Professor Fernando 
Figueira, General Surgery, Rua Oscar Pinto, 293, Ap. 
140252051 Recife, Brazil
Introduction: The liver resections are considered the only 
potentially curative treatment for primary and metastatic 
liver tumors, which led to an increase in the number of indi-
cations for this procedure. Thus, there is a need for tech-
niques that give a greater preservation of hepatic parenchyma, 
as well as greater safety in performing these surgeries. The 
intrahepatic glissonian approach stands out as a technical 
approach to the pedicles that meet those goals.
Methods: Dissection was initially separated from pig livers 
to review the anatomy target. After the anatomical knowl-
edge proceeded to the isolation of liver segments by intrahe-
patic glissonian approach in eight anesthetized animals, 
associated with segmental resection.
Results: The isolation of segments 2, 3, 4, 5 and 6 was 
achieved in all animals. The segment one was not isolated in 
any animal. It, also, was not possible the isolation of the 
segment 8 individually. In two animals, there was failure in 
the isolation of segment 7.
Conclusion: It is concluded that the intrahepatic glissonian 
approach in pigs is simple and reproducible technique, which 
makes it a viable animal model for training in liver resections 
with such approach.
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SHUNT WITH GRAFT DISTAL RENAL 
ESPLEN FROM CADAVERS
R. M. A. Lenin, D. Boguetti, R. Maurette, M. Bregante, 
E. Porto
Hospital Britanico de Buenos Aires, Hepatobiliopancreas 
Department, General Surgery Service, Perdriel 74 y 
Caseros, Constitucion, 1254 Capital Federal, Argentina
Introduction: The variceal bleeding gastrointestinal bleed-
ing, is the most serious complication of portal hypertension, 
associated with a high mortality rate.
Methods: Descriptive.
Results: A 60 year old female patient, with cavernomatosis, 
portal vein thrombosis and portal hypertension and more 
than 5 episodes of variceal bleeding with hemodynamic 
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decompensation. Underwent an Esplen shunt using renal 
graft distal laterolateral deceased donor iliac vein.
Conclusion: It presents good POP evolution, it was found 
Shunt permeability and a Doppler follow up of 9 MONTHS. 
Reduction of bleeding varicose did not repeat.
The currently use of vein grafts from cadavers, prevent the 
use of own Graft by reducing the time and the operative 
injury, making this a valid option for these procedures.
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VALIDATION OF IMAGE OVERLAY 
ACCURACY IN A INSTRUMENT 
GUIDANCE SYSTEM FOR 
LAPAROSCOPIC LIVER SURGERY
M. Fusaglia1, M. Peterhans1, D. Wallach1, G. Beldi2, 
D. Candinas2 and S. Weber1
1ARTORG Center for Computer Aided Surgery, University 
of Bern; 2Department for Visceral Surgery and Medicine, 
Inselspital, University of Bern
ARTORG Center for Computer Aided Surgery, University 
of Bern, Stauffacherstrasse, 783014 Bern, Switzerland
Introduction: Benefi ts of laparoscopy include reduced 
patient trauma and blood loss and shorter hospital stay. 
Drawbacks such as limited orientation, due to the 2D repre-
sentation of the operative situs, can be overcome by instru-
ment guidance systems. By tracking the camera and 
instruments and registering the liver to an available data set, 
the camera image can be augmented with relevant medical 
image information. We propose the use of such a system and 
report on fi rst results regarding its implementation.
Methods: An instrument guidance system for open liver 
surgery (CAScination, CH) is extended to integrate a cali-
brated view of a laparoscopic camera. A standard laparo-
scopic optics with 30° inclination is used and connected to 
video camera module (Karl Storz Endoskope, GER). The 
video signal is integrated into the instrument guidance 
system. Instrument tracking is provided by an optical track-
ing system, tracking the distal ends of the laparoscopic 
instruments. MeVis planning data is used as medical image 
data input. After successful patient-to-image registration, the 
system displays the image of the laparoscopic camera on the 
computer screen.
Results: Since the pose of the camera image relative to the 
liver can be calculated (i.e. using transformations for camera 
calibration and patient registration), the camera image can 
be augmented with additional image information about the 
anatomy such as blood vessels or tumours, positions of 
instruments or information from the preoperative planning 
phase. An augmented reality display for the surgeon is pro-
vided. First tests indicate, that the accuracy of the image 
overlay is comparable to that in other applications.
Conclusion: We demonstrate, that instrument guided lapa-
roscopic surgery can be implemented based on existing con-
cepts for open liver surgery. Successful application of 
instrument guided laparoscopic system can potentially lead 
to better orientation for the surgeon, better identifi cation of 
structures at risk and ultimately to better outcomes.
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DIAGNOSIS, PATIENT MANAGEMENT 
AND TREATMENT OF 4017 BENIGN 
LIVER TUMORS
Y. Souza1, E. Chaib2, T. Marques2, M. Gomes1, 
A. Bernal-Filho2, F. Galvao2 and L. A. D Albuquerque2
1Universidade Nove de Julho; 2Liver and Pancreas 
Transplantation Surgery Unit, Department of 
Gastroenterology, University of Sao Paulo School of 
Medicine
University of Sao Paulo School of Medicine, Liver and 
Pancreas, Transplantation Surgery Unit, Department of 
Gastroenterology, Av. Dr Arnaldo 455, Level 3, 01246-903, 
1246 Sao Paulo, Brazil
Introduction: Benign liver tumors (BLT) include most fre-
quently liver hemangioma (LH), focal nodular hyperplasia 
(FNH), and hepatocellular adenoma (HA). LH is the most 
common BLT with an incidence ranging from 0.4% to 7.4%. 
Our aim is to report diagnosis, patient management, treat-
ment as well as natural history, rupture, bleeding, progres-
sion to malignancy of BLT.
Methods: A literature search was conducted using 
MEDLINE/PUBMED, with terms about BLT, LH, FNH and 
HA from 2000 to 2011. We have found 5050 papers but only 
43 articles were selected based on large casuistic and 5 years 
follow-up. 4017 patients with BLT were reviewed.
Results: LH and FNH diagnosis were made by CT and MRI 
in 45.5% and 35.3% respectively, whereas HA was done by 
the association of CT and histopathologic analysis in 50% of 
the cases. Hepatic surgery for LH was performed in 236 
(5.87%), FNH 202 (5.02%) and HA 1973 (49.11%). The 
most common postoperative complications was after HA 
surgery bleeding – 21% followed by pneumonia – 9.3%. In 
addition, malignant transformation has been showed in 179 
(9%) cases out of 1989 HA. Clinical follow-up was done for 
LH 1008 (25.09%), FNH 582 (14.5%) and HA 11 (0.275%). 
Alternative treatment for HA such as hepatic artery emboli-
zation was performed in 5 (0.12%) patients. Malignant trans-
formation of the HA was recorded in 179 (9%).
Conclusion: LH is often asymptomatic and incidentally 
found on abdominal imaging studies. Nevertheless, liver 
resection is implemented when it cause important symptoms 
or in superfi cial tumors larger than 10 cm because of the risk 
of rupture. FNH unusually progresses to rupture, bleeding or 
malignancy and fi nally as far as HA is concern the larger the 
tumor the greater the chance of bleeding (≥5 cm) or malig-
nancy (≥8 cm).
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LAPAROSCOPIC DRAINAGE OF 
LIVER ABSCESS
L. Tan, L. Tan, S. Krishnan, H. Zhou, I. Shridhar, 
M. Krishnakumar, S. Chang
National University Hospital, Hepatobiliary Surgery, 5 
Lower Kent Ridge, Singapore 11907
Introduction: The objective of this study is to compare the 
outcomes of percutaneously drained (PD) and laparoscopi-
cally drain (LD) abscesses.
Methods: Records of 85 patients from 2005 to 2011 with 
radiological evidence of liver abscesses measuring more than 
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3 cm were retrieved. Clinicopathologic variables were col-
lected and used to analyze the outcomes for each interven-
tion. Multivariable logistic regression was use to identify 
failures of intervention, complication associated with inter-
vention, length of antibiotic therapy and length of hospital 
stay.
Results: Eighty-fi ve patients received an intervention. 
Eighteen patients had LD and 67 patients had PD. Two 
patients (11.1%) in the LD group failed primary intervention 
compared to 27 (40.3%) in the PD group (p = 0.035). Two 
(3%) patients in the PD group died of progression of sepsis 
despite drainage. Percutaneous drainage of liver abscess is 
more likely to fail.
[OR 0.13; 95% CI 0.02–0.86; p = 0.035]. Complications 
related to intervention were not signifi cant between the two 
groups (p = 0.237). Mean length of antibiotics between the 
group were similar at 45.5 days in the PD group compared 
to 41.3 days in the LD group (p = 0.437). Mean length of 
hospital stay was also similar; PD at 15.3 days compared to 
11.2 in the LD group (p = 0.175).
Conclusion: Cryptogenic liver abscess have been treated 
successfully with both percutaneous and laparoscopic drain-
age. However, laparoscopic drainage results in earlier sepsis 
resolutions and should be considered as fi rst line therapy. 
Complication, length of antibiotic therapy and hospital stay 
are comparable between the two interventions.
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LASER SPECKLE IMAGING 
FOR ESTIMATING LIVER 
MICROCIRCULATION IN THE RAT
C. Sturesson1, D. MJ Milstein2, A. M Maas1, 
I. C. J. H. Post1 and T. M van Gulik1
1Department of Experimental Surgery, Academic Medical 
Center, University of Amsterdam, Amsterdam, The 
Netherlands; 2Department of Translational Physiology, 
Academic Medical Center, University of Amsterdam, 
Amsterdam, The Netherlands
Department of Experimental Surgery, Academic Medical 
Centre, IWO-1, Meibergdreef, 91105 Amsterdam, The 
Netherlands
Introduction: Measuring hepatic microcirculation is of 
interest in liver transplantation and resection, where damages 
are infl icted to liver vasculature by ischemia/reperfusion and 
preoperative chemotherapy. Laser speckle imaging (LSI) is 
a novel non-invasive technique for microcirculation estima-
tion not previously used in the liver, which provides non-
contact real time full-fi eld imaging. The aim of the present 
study was to evaluate LSI for estimating liver microcircula-
tion in the rat.
Methods: Six rats were used for the present study. The 
median liver lobe was exposed via a midline laparotomy. The 
portal vein and hepatic artery were encircled with thin rubber 
bands enabling occlusion of the individual vessels. Blood 
perfusion on the liver surface was measured during apnoea 
with LSI. Measurements were made during normal infl ow 
conditions and sequential temporary occlusions of the portal 
vein and the hepatic artery. Inter-individual variability 
depending on perfusion sampling areas was estimated by 
measuring perfusion over areas of either 1, 5 and 10 mm 
diameters.
Results: Occlusion of the hepatic artery, portal vein and 
total vascular occlusion resulted in a signifi cant decrease (p 
< 0.0048) in LSI signal to 71.2 ± 16.4%, 15.0 ± 5.6% and 
9.7 ± 2.1% of baseline values, respectively. During total 
infl ow occlusion, videomicroscopic imaging showed totally 
arrested fl ow in sinusoids and a back and forth movement of 
erythrocytes in postsinusoidal venules during respiration, 
which stopped completely during the periods of apnoea when 
perfusion measurements with the LSI were made. Baseline 
inter-individual variability when measuring in arbitrary per-
fusion units was 13% and decreased with increased region 
of interest.
Conclusion: LSI provides full-fi eld estimation in real time 
of liver microcirculation. Alterations in LSI signal during 
occlusion of infl ow vessels are in accordance with conven-
tional theories of hepatic hemodynamics in the rat. A small 
inter-individual variability enables comparison of arbitrary 
perfusion units between subjects without the need to depend 
on relative measurements.
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TENSILE STRENGTH OF 
BIOLOGICAL FIBRIN SEALANTS: 
A COMPARATIVE STUDY
M. Scotté1, L. Lacaze1, N. L. dem1, M. Bubenheim2, 
B. Tsilividis1, L. Schwarz1, A. François3 and 
M. B. d’Arc4
1Digestive Surgery department and INSERM U 1073, 
Rouen University Hospital; 2Biostatistics Department, 
Rouen University Hospital; 3Department of Pathology, 
Rouen University Hospital; 4Baxter BioSurgery, Maurepas
Service de Chirurgie Digestive, Hôpital Charles Nicolle, 1, 
Rue de Germont, 76000 Rouen, France
Introduction: Fibrin sealants are commonly used in liver 
surgery, although their effectiveness in clinical practice 
remains controversial. Individual sealant characteristics are 
based on haemostatic and adhesion properties that can be 
experimentally measured using the ‘rat skin test’. This study 
used a more relevant and realistic experimental canine model 
to compare the differences in the adhesive properties of four 
fi brin sealants in hepatectomy: Tachosil®, Tisseel/Tissucol®, 
Beriplast® and Quixil®.
Methods: A partial hepatectomy was performed in beagle 
dogs under general anaesthesia to obtain liver cross-sections. 
Fibrin sealants were allocated to dog livers using a Youden 
square design. The tensile strength measurement was per-
formed using a traction system to measure the rupture stress 
point of a small wooden cylinder bonded to the liver cross-
section. A biopsy was performed on the liver cross-section 
to allow pathological analysis (Day 0). One week later (Day 
8), the animals were sacrifi ced and pathological analysis of 
the cross-section and liver–sealant interface performed.
Results: Signifi cantly greater adhesion properties were 
observed with Tisseel/Tissucol® compared with Quixil® or 
Beriplast® (P = 0.002 and 0.001, respectively). Similarly, 
Tachosil® demonstrated signifi cantly greater adhesive prop-
erties compared with Beriplast® (P = 0.009) or Quixil® (P = 
0.014). No signifi cant differences were observed between 
Tisseel/Tissucol® and Tachosil® or between Beriplast® and 
Quixil®.
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Pathological analyses at Day 0 and Day 8 showed that 
Tisseel/Tissucol® and Beriplast® had lamellar/compact 
aspects at Day 0 and were totally or partially absorbed at Day 
8, whereas Tachosil® was compact and not resorbed at Day 
8 and Quixil® was compact or only partially resorbed.
Conclusion: The results of this comparative study demon-
strate that different fi brin sealants exhibit different adhesive 
properties. Tisseel/Tissucol® and Tachosil® provided greatest 
adhesion to liver cross-section in our canine model of hepa-
tectomy. These results may enable the optimal choice of 
fi brin sealants for this procedure in clinical practice.
229
THE ASSOCIATION FIBRIN GLUE-
COLLAGEN IS EFFICIENT ON 
LIVER CROSS SECTION 
FOLLOWING HEPATECTOMY
M. Scotté, L. Schwarz, L. Lacaze, E. Huet and 
J. Mezghani
Digestive Surgery Department and INSERM U1073, Rouen 
University Hospital
Service de Chirurgie Digestive, Hôpital Charles Nicolle, 1, 
Rue de Germont 76000 Rouen, France
Introduction: The use of fi brin sealant as an adjuvant hae-
mostatic device has been tested in several clinical trials with 
contradictory results. The association of fi brin glue and col-
lagen may act as a dressing on the liver section to prevent 
postoperative bleeding. The aim of this study was to analyze 
the effi ciency of this association following hepatectomy.
Methods: A prospective non randomized study was per-
formed in 350 patients (165 women and 185 men, with a 
median age of 55 years), who underwent a liver resection for 
malignant (n = 243) or benign (n = 107) tumour. Patients 
were separated in 2 groups according to the treatment of the 
liver cross section with collagen alone (group A, 90 patients) 
or with the association fi brin glue-collagen (group B, 260 
patients). The need for drainage, complication or reoperation 
rates, the need for blood transfusions and the length of hos-
pitalization have been compared in these 2 groups.
Results: Both groups were similar according to age and 
indications for liver surgery. Surgical procedures differed 
between 2 groups with a rate of major hepatectomy or 
pedicle clamping higher in group B as compared to group A. 
The need for drainage (41 vs 27%), RBC transfusions rates 
(41% vs 36%) and mean hospitalization stay (13.6j vs 11.5j) 
were signifi cantly decreased in group B (p < 0.05). Overall 
morbidity was similar in both groups but abdominal morbid-
ity (45% vs 22%) and reoperation rates (12% vs 8%) were 
decreased in group B (ns).
Conclusion: Our study shows that the use of fi brin sealant 
following liver resection is clinically effective. The system-
atic use of fi brin sealant leads to a decrease in drainage rate, 
blood transfusions and hospital stay. The association fi brin 
glue-collagen, acting as a dressing on the liver cross section 
should be tested in future randomized studies.
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SMALL SKIN INCISION 
HEMIHEPATECTOMY
F. Hirokawa, M. Hayashi, Y. Miyamoto, M. Asakuma, 
K. Komeda, Y. Inoue and K. Uchiyama
Osaka Medical College, Department of General and 
Gastroenterological Surgery
Osaka Medical College, General and Gastroenterological 
Surgery, 2-7 Daigaku-machi, Takatsuki city, Osaka 
569-8686, Japan
Introduction: Pure laparoscopic liver resection is thought 
to be a useful method in terms of cosmetic outcome and less 
invasiveness but this procedure has not yet become wide-
spread, presumably due to its high technical demands and 
profi ciency requirements. In order to achieve surgical safety 
and minimum invasiveness simultaneously, we recently 
implemented a small skin incision or laparoassisted hepatec-
tomy technique (SSIH).
Methods: In right hepatectomy, parenchymal transection is 
performed through a small skin incision with liver-hanging 
maneuver technique, followed by laparoscopic liver mobili-
zation. On the other hand, in left hepatectomy, fi rstly a small 
skin incision (8–10 cm) is put on the right subcostal region 
and Alexis  is attached to appropriately expand the wound. 
Board-shaped spatulae is used to spread the surgical fi eld and 
liver-hanging maneuver technique is used too. Furthermore, 
left hepatectomy cases were compared with conventional 
procedure, without vascular invasion and tumor diame-
ter<10 cm, during a recent 2-year period.
Results: 9 patients were performed SSIH (7 patients are left 
and 2 patients right hepatectmy) at our institutions. All cases 
didn’t have intra/postoperative complications. In left hepa-
tectomy, the median operative time, bleeding and postopera-
tive hospital stays were not different 295 vs 300 min, 400 vs 
435 ml and 10 vs 22 days respectively between SSIH and 
conventional group. But white blood cell counts on day 4, 7 
after hepatectomy were signifi cant lower in SSIH group than 
conventional group.
Conclusion: We believe that this technique can be intro-
duced immediately for experienced liver surgeons and would 
provide reasonable cosmetic results compared to the conven-
tional method, while not increasing the risk associated with 
pure laparoscopic hepatectomy.
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EVALUATION OF STAPLER 
HEPATECTOMY DURING 
LAPAROSCOPIC LIVER RESECTION
J. Buell1, B. Gayet2, HS Han3, G. Wakabayashi4, G. Belli5, 
A. Koffron6, H. Keneko7 and I. Dagher8
1Tulane Transplant Institute, Tulane University; 2Institute 
Mutualiste Motsouris, University Paris; 3Seoul National 
University Bundang Hospital; 4Hongo Bunkyo-ku Tokyo; 
5Loreto Nuovo Hospital; 6Oakland University William 
Beaumont School of Medicine; 7Toho University; 8Hôpitaux 
Universitaires Paris-Sud, Site Antoine Béclère
Tulane University Suregry, 1415 Tulane Ave TW35, New 
Orleans, LA 7012270122, USA
Introduction: Parenchymal transection has traditionally 
been the most challenging aspect of hepatectomy. Since the 
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inception of laparoscopic liver resection two techniques have 
evolved: electrosurgery and stapler hepatectomy. This study 
evaluates the benefi ts and defi ciencies of these approaches.
Methods: Methods: An international database of 1499 lapa-
roscopic liver resections was established and patient out-
comes were analyzed using univariate, and multivariate 
analysis.
Results: 735 electrosurgical resections (ER) were compared 
to 764 stapler hepatectomies (SH).
Age Male Cirrhosis Cancer Tumor size (cm)
Electro-ER 56.1 354 (47%) 245 (33.0%) 375 (51.5%) 4.89
Stapler-SH 54.3 308 (40%) 97 (12.6%) 282 (37.1%) 5.83
p-value 0.019 0.002 <0.0001 <0.0003 0.0006
outcomes:
Lobe OR-hr EBL Transfuse Convert Comp LOS Margin Recur Mort
ER 98 3.5 334 65 (9%) 16 (2%) 93 (12%) 8.9 1.28 137 (19%) 66 (8.9%)
SH 193 1.6 171 39 (5%) 12 (2%) 122 (16%) 3.2 1.02 81 (11%) 53 (6.9%)
p-value 0.01 <0.01 <0.01 <0.01 0.4 <0.06 <0.01 <0.01 <0.01 <0.01
SH group including bile leaks (26/735, 3.5% vs. 16/764, 2.1%: p = 0.09
Conclusion: Conclusions: SH had an overall reduced odds 
of tumor recurrence, after adjustment for age, gender, cir-
rhosis, tumor size, major lobe resection, transfusion (OR = 
0.34, 95% CI 0.19–0.60, p = 0.0002). SH provides several 
advantages: diminished blood loss, and shorter OR times. SH 
incurred a trend toward higher incidence of complications 
and statistically smaller margins. Despite this, SH demon-
strated an improved OR for recurrences suggesting tradi-
tional pathologic margins maybe underestimated.
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THE IMPLICATIONS OF CURRENT HPB 
SURGICAL TRAINING ON FUTURE 
PRACTICE WITHIN THE UNTIED 
KINGDOM
C. Jones, M. A Taylor and B. Clements
Department of HPB Surgery, Belfast Health and Social 
Care Trust, Belfast
Royal Victoria Hospital, Belfast Health and Social Care 
Trust, Department of HPB Surgery, 10 Breezemount Park, 
BT32 Banbridge, Northern Ireland
Introduction: The implementation of the European Working 
Time Directive has resulted in a reduction in working hours 
of surgical trainees, and in turn a reduction in training oppor-
tunities. This has caused many concerns regarding training 
competent surgeons within the allocated time. We therefore 
aimed to assess the current state of hepatopancreatobiliary 
training in the United Kingdom.
Methods: An e-mail survey of 175 Association of Upper 
Gastrointestinal Surgeons trainees, in which one third has a 
subspecialist interest in HPB, as identifi ed from the 
Association of Upper Gastrointestinal Surgeons database, 
was performed. Demographics, along with data on exposure 
to oncological planning and operative experience as defi ned 
by the national surgical training syllabus were assessed.
Results: 26.3% (n = 46) of trainees responded. 73.9% were 
senior trainees with most training regions represented. Of 
those who responded 32.6% had a subspecialist interest in 
hepatopancreatobiliary surgery. 86.6% were involved in 
oncological planning, however only 30.6% were confi dent 
to make the decision. 33.3% had exposure to microwave 
ablation, and 53.3% had exposure to radiofrequency abla-
tion. 23.1% had performed 1–10 hepatectomies and 7.7% 
greater than 10 in the past year, while 30.8% had performed 
1–5 pancreatic resections, and 7.7% greater than 5. No 
trainee was confi dent to perform either of these procedures 
unsupervised, while only one trainee was confi dent to mobil-
ise the liver unsupervised.
Conclusion: No trainee felt confi dent to perform key opera-
tions independently, despite the high proportion of senior 
trainees, raising concerns for the future. This could poten-
tially prevent the delivery of specialist care, affecting the 
training of a future generation.
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A CASE OF SCLEROSING 
ANGIOMATOID NODULAR 
TRANSFORMATION OF SPLEEN 
RELATED TO IGG4-RELATED 
SCLEROSING DISEASE
C. K. Cho, B. G. Choi, H. J. Kim, H. H. Kim, C. Y. Kim, 
Y. H. Hur, J. C. Kim and H. J. Kim
Chonnam National University Medical School, Gwangju, 
Korea
Chonnam National University Medical School, Surgery, 
160, Baekseo-ro, Dong-gu, Gwangju, 501-757, Korea
Introduction: Sclerosing angiomatoid nodular transforma-
tion of spleen (SANT) is a very rare infl ammatory tumor-like 
vascular lesion comprising of angiomatoid nodules in a fi bro-
sclerotic background. Since it was fi rst described by Martel 
in 2004, less than 100 cases of SANT have been reported in 
the literature. The pathogenesis of SANT still remains 
unclear and many authors have proposed various hypotheses 
about pathogenesis. Here, we report on a case of SANT 
which was diagnosed after laparoscopic splenectomy.
Methods: A 51-year-old woman visited our hospital com-
plaining of intermittent abdominal pain. In clinical review of 
the patients there was non-specifi c past or recent history of 
systemic infectious disease, tumorous condition or drug 
abuse. Abdominal computed tomography revealed a 5.1 × 
4.6 cm sized well-defi ned heterogenously enhanced nodular 
mass in the spleen. The routine laboratory data including 
tumor markers were all within normal limits. We thought the 
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splenic tumor to be benign nature and recommended follow-
up evaluation, but the patient strongly wanted to remove the 
tumor. Laparoscopic splenectomy was performed under the 
impression of splenic tumor such as hemangioma or 
hamartoma.
Results: In macroscopic examination, there was 4 × 4 cm 
in sized tumor with red-brown multi-nodular surface. 
Microscopically, the tumor was composed of multiple vas-
cular structures separated by fi brous connective tissue. An 
immunohistochemical examination showed positive staining 
for CD31, CD34, factor VIII, and IgG4. The proposed 
hypotheses about the pathogenesis of SANT are as follow; 
association with Epstein-Barr virus infection, unusual trans-
formation of red pulp in response to vascular blockage, dis-
turbance of intra-splenic blood circulation, and association 
with infl ammatory pseudotumors or IgG4-related sclerosing 
disease. The tumor of our case was diagnosed as SANT and 
which was thought to be related with IgG4-related sclerosing 
disease.
Conclusion: Although the etiology and pathogenesis of 
SANT is still unclear, some report suggest the connection of 
SANT to IgG4-related sclerosing disease. In our case, immu-
nohistochemical staining for IgG4 was positive. Thus, our 
data support the possibility that SANT is connected to IgG4-
related sclerosing disease. But further studies based on larger 
populations are necessary to clarify its pathogenesis.
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THE MANAGEMENT OF SEVERE 
LIVER INJURY, THE 
MARRAKESH’S EXPERIENCE
N. Ihfa1, Y. Narjis1, K. Rabbani1, Z. Semlani2, A. Diffaa2, 
A. Louzi1, R. Benelkhaiat1 and B. Finech1
1Service de Chirurgie Viscérale, CHU Mohamed VI, 
Faculté de Médecine et de Pharmacie de Marrakech, 
Université Cadi Ayyad, Marrakech; 2Service de Gastro-
entérologie, CHU Mohamed VI, Faculté de Médecine et de 
Pharmacie de MARRAKECH, Université Cadi Ayyad, 
Marrakech
CHU Mohamed VI, Universite Cadi Ayyad, Chirurgie 
Visceralebp: 7010, Sidi Abbad, 40000 Marrakech, Morocco
Introduction: Proposed early in children, nonoperative 
treatment (NT) of blunt trauma of the liver has become a 
genuine therapeutic method, and concerns at present over 
80% of cases. The availability of a technical performance, 
ensuring conditions for optimal surveillance and security, is 
traditionally one of the main conditions for the success of 
this attitude.
Methods: We report in a retrospective study, a series of 65 
hepatic trauma cases, 53 males and 12 females, mean age 
was 30 years, with extremes ranging from 13 to 71 years. 
The mechanism of injury was contusion in 100% of cases. 
The road accidents were the most frequent circumstance in 
our series with 56.9% (37 cases). 40% of patients admitted 
for trauma were hemodynamically unstable liver at their 
admission in emergency service. 48 (73.8%) patients were 
admitted in a poly trauma.
Results: Abdominal ultrasound was performed in 61 
patients on admission. It showed: a peritoneal liquid in 53 
patients (86.8%). 37 patients in our series had at least one 
CT (56.9%). 20 patients underwent emergency surgical treat-
ment, 30.5% of all patients in our series. 45 patients under-
went a nonoperative (conservative). In our series no death 
was reported.
Conclusion: The nonoperative management of blunt trauma 
of the liver should be adopted as a therapeutic method of 
reference, provided you have a technical performance, and 
an armed guard that is achievable only by a close interdisci-
plinary collaboration between surgeon, anesthetist and 
radiologist.
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A CASE OF GIANT HEMANGIOMA OF 
LIVER WITH KASABACH-MERRITT 
SYNDROME IN THE ADULT
B. G. Choi1, C. K. Cho1, H. J. Kim1, S. H. Cho1, 
C. Y. Kim1, J. C. Kim1, H. J. Kim1 and J. S. Seoung2
1Chonnam National University Medical School, Gwangju, 
Korea; 2Saint. Carollo Hospital, Suncheon, Korea
Chonnam National University Medical School, Department 
of Surgery, 160, Baekseo-ro, Dong-gu, Gwangju, 501-757, 
Korea
Introduction: Cavernous hemangioma is the most common 
benign tumor of liver and usually small and asymptomatic. 
But sometimes it can grows enormous size and causes 
various complications. Kasabach-Merritt syndrome (KMS) 
is one of serious complication of giant hemangioma. KMS 
is very rare and characterized by consumptive coagulopathy 
with mortality rate ranges between 10 and 37%. Majority of 
KMS develop in pediatric patient less than 1 year, but rarely 
adult KMS develop in association with giant hemangioma.
Methods: A 25-year-old woman was admitted to our institu-
tion because of abdominal discomfort, and low extremity 
edema that have been present for 1 month. Laboratory tests 
revealed prolonged PT (INR: 1.46), prolonged aPTT (44.8 
sec.; control 41.0 sec.), low fi brinogen (84 mg/dL; control 
180 mg/dL), and low platelet count (95 × 103/mm3), which 
suggested the consumptive coagulopathy. The patient did not 
administered oral contraceptives. Abdominal CT revealed a 
34.2 × 20.7 cm sized cystic mass containing enhanced inter-
nal septa and solid portion in right lobe of liver. The clinical 
impression was a malignant liver tumor, such as embryonal 
sarcoma of liver or biliary cystadenocarcinoma. Laparotomy 
was performed after careful preoperative preparation.
Results: In operative fi ndings, a huge liver tumor measuring 
more than 30 cm involving segments 5~8 containing old 
blood and hematoma was found and right hemihepatectomy 
was performed. After the operation the coagulation profi les 
were returned to within normal limits. The patient recovered 
uneventfully and discharged on 10 days after the operation. 
In macroscopic fi ndings, the specimen revealed a huge, well-
demarcated spongy tumor measured 22 × 12 cm with multi-
septation. The microscopic fi ndings showed blood-fi lled 
spaces lined by a single layer of fl at endothelial cells sup-
ported by a basement membrane. The fi nal pathologic diag-
nosis was cavernous hemangioma of the liver.
Conclusion: The present case was diagnosed that there was 
giant liver hemangioma which was complicated by spontane-
ous bleeding due to consumptive coagulopathy associate 
with KMS. KMS is usually developed in pediatric patients, 
but rarely it develops in the adult associated with giant hem-
angioma of liver. Here we report on a case of giant liver 
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hemangioma with adult KMS which was successfully treated 
with surgical resection.
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TOTALLY LAPAROSCOPIC LIVER 
RESECTIONS FOR MALIGNANCY IN 
THE ELDERLY: SAFETY, 
FEASIBILITY AND SHORT TERM 
ONCOLOGIC OUTCOMES
M. G. Spampinato1, L. Mandalà2, G. Quarta3, D. Traisci4, 
P. D. Medico5 and G. A. Baldazzi1
1HPB and Advanced Laparoscopic Surgical Unit, 
Department of General and Minimally Invasive Surgery, 
Policlinico of Abano Terme, Italy; 2HPB Unit, La 
Maddalena Cancer Center, Palermo, Italy; 3Unit of 
Medical Oncology, Gallipoli General Hospital, Italy; 4Unit 
of Medical Oncology, Villa Pini Clinical Institute, Italy; 
5Unit of Medical Oncology, Reggio Calabria General 
Hospital, Italy
Policlinico di Abano Terme, General and Advanced 
Minimally-Invasive Surgery, P.zza C.Colombo n°1 - 35031 
Abano, Terme, Italy
Introduction: Standard oncologic liver resections per-
formed on elderly patients (>70 years old) have been showed 
to be safe and effective. The aim of this study was to analyze 
the operative and oncologic short term outcome of totally 
laparoscopic liver resections (TLLR) performed in elderly 
patients for oncologic purpose by a single HPB team.
Methods: From October 2008 to October 2011 a total of 60 
TLLR were performed at our institution of which 21 (40%) 
were on elderly patients. Indication for surgery was primary 
malignancy in 8 (38%) cases and liver metastases in 13 
(62%) cases. There were 15 (71.4%) minor and 6 (28.6%) 
major liver resections. This is a retrospective cohort study 
analyzing prospectively recorded data. All values are pre-
sented as percentage (%) and median (range).
Results: There were 13 (62%) Men and 8 (38%) Female. 
Median age and BMI were 72 years (70–80) and 24.8 
(20–28) respectively. All cases but one were completed by a 
totally laparoscopic technique. Total operative time was 125 
(60–480) min. Estimated blood loss was 200 (40–600) ml 
and blood transfusion was required in 1 patient (4.8%). Total 
hospital stay was 4 (3–7) days with 9 patients (43%) requir-
ing one day of ITU admission. One patient (4.8%) had a 
grade A bile leak while peri-operative mortality rate was 
zero. All patients but one had an R0 resection with a clear 
margin distance of 1 (0.2–2.5) cm. At 23 (3–32) months 
follow-up, 19 patients were alive and without recurrence. 
Two patients (9.5%) died due to disease recurrence.
Conclusion: This small retrospective cohort study shows 
that TLLR performed for oncologic purposes on elderly 
patients are feasible and oncologic safe in the short term 
period. Larger prospective studies are needed to confi rm 
these results.
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LIVER INJURIES IN MODERN WAR 
CAUSED BY DIFFERENT FORMS OF 
ARMS AND WEAPONRY
M. Dimitrijevic1, M. Lazic1, S. Mihaljovic1 and D. Janjic2
1Department of Emergency Surgery, Clinic for General 
Surgery, Clinical Centre Nis; 2Department of Surgery, 
General hospital, Leskovac
Clinic for General Surgery, Clinical Cener Nis, Serbia 
Department of Emergency Surgery, Blv. dr Z.Djindjic 48 
18000 Nis, Serbia
Introduction: Experiences about injuries from modern war 
are not easily available to the wider professional public. The 
aim of the study was to evaluate the frequency and diffi culty 
as well as the surgical management of liver injuries within 
penetrating abdominal injuries caused by different forms of 
arms and weaponry in Sarajevo’s battlefi eld during the 
period 1992–1996 and to get acquainted with types of 
modern fi rearms and weaponry as well as with character, 
form and mutilateness of these injuries.
Methods: In the war fought in Sarajevo’s battlefi eld during 
the period 1992–1996. all kinds of modern conventional 
armaments known in the world today were used. In use were 
above all, various kinds of airplane bombs, artillery arma-
ments (grenade launchers, howitzer grenades, individual 
grenades that were “home made”, anti- infantry mines). 
Various kinds of hand-held armaments were used especially 
small caliber (under 5.56) ammunition and so called banned 
ammunitions (dum-dum bullets and cluster ammunition).
Study is based on series of 8123 wounded treated in hos-
pital “Zica” on Ilidza during the period 1992–1996. Work 
analyse cause, mechanism of injuries, number, associated 
injuries, surgical treatment, complications and rate of 
mortality.
Results: There were 8123 wounded patients. From that 
number 5605 (69%) were soldiers and 2518 (31%) were 
civilians, children were in 496 cases (19.6%) from the 
number of civilians. There were explosive wounds in 6060 
(74.6%) and sclopetar wounds in 2063 (25.4%) of the cases.
From total number of penetrating abdominal injuries (1249), 
injuries of the liver are in second place after intestinal inju-
ries with number of 241. Surgical treatment for liver injuries 
were suture in 94.2% and atypical resections in 5.8%. 
Complications appeared in 3.7% or 9 patients (4 with haem-
morhage, 2 with subhepatical abscess, 1 with subdiafragmal 
abscess and 2 with hepatic abscess). In 167 patients liver 
injuries were associated. Intrahospital mortality was 1.78%.
Conclusion: In liver injuries results showed that simple 
suture when possible is enough for healing without resection. 
Isolated or associated liver injuries are very frequent. 
Adequate and immediate fi rst aid and urgent surgical treat-
ment within “the golden hour” has reduced the frequence of 
postoperative complications and mortality. The massiveness 
and weight of injuries caused by modern fi rearms and weap-
onry are in direct proportion of development of war tech-
nologies with goal of even greater destruction.
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LAPAROENDOSCOPIC SINGLE SITE 
(LESS) SURGERY FOR LEFT LATERAL 
HEPATIC SECTIONECTOMY AS AN 
ALTERNATIVE TO TRADITIONAL 
LAPAROSCOPY. A CASE-MATCHED 
ANALYSIS FROM A SINGLE CENTRE
F. Ratti, F. Cipriani, F. Ferla, M. Catena, M. Paganelli and 
L. Aldrighetti
Hepatobiliary Surgery Unit, General Surgery Department, 
IRCCS H San Raffaele, Vita-Salute San Raffaele 
University, Via Olgettina 60, Milan, Italy
IRCCS H San Raffaele, Hepatobiliary Surgery Unit, 
General Surgery Department, Via Olgettina, 6020132 
Milano, Italy
Introduction: Laparoscopy is considered the gold standard 
to perform left lateral sectionectomy with results identical to 
those of open surgery, yielding decreased postoperative pain 
and disability, reducing hospital stay and shortening patient 
recovery time. As the emphasis on minimizing the 
invasiveness of surgical techniques continues, LESS 
(LaparoEndoscopic Single Site) surgery is quickly evolving.
Methods: Aim of this study was to compare the results of 
laparoscopic left lateral sectionectomy performed using the 
traditional approach or LESS approach with a case matched 
analysis for tumor size, type of resection and surgical indica-
tions. Thirteen patients who underwent LESS left lateral 
sectionectomy are considered the study group (LESS Group) 
and compared with 13 patients undergoing left lateral sectio-
nectomy with traditional laparoscopic approach (Conventional 
Group).
Results: There were no signifi cant differences between 
groups in length of surgery (165 min in Conventional Group 
vs 195 min in LESS Group), blood loss (150 mL in 
Conventional Group vs 175 mL in LESS Group), conversion 
to open surgery, histological tumor exposure, requirements 
of postoperative analgesics.
One patient in LESS Group died of cardiac failure due to 
an unknown severe aortic valve stenosis. No differences 
were recorded in postoperative complications (23.1% in both 
groups) and median length of postoperative stay (4 days in 
both groups).
Conclusion: In left lateral hepatic sectionectomy, LESS 
surgery is technically feasible and as safe as traditional lapa-
roscopic surgery in terms of intra and postoperative results 
even requiring both hepatobiliary and laparoscopic technique 
experience.
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TOTALLY LAPAROSCOPIC MAJOR-
COMPLEX LIVER RESECTIONS: IS 
THERE A LEARNING CURVE?
M. G. Spampinato1, L. Mandala’2, G. Quarta3, D. Traisci4, 
P. D. Medico5 and G. A. Baldazzi1
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Department of General and Advanced Minimally Invasive 
Surgery, Policlinico of Abano Terme, Italy; 2HPB Unit, La 
Maddalena Cancer Center, Palermo, Italy; 3Unit of 
Medical Oncology, Gallipoli General Hospital, Italy; 4Unit 
of Medical Oncology, Villa Pini Clinical Institute, Italy; 
5Unit of Medical Oncology, Reggio Calabria General 
Hospital, Italy
Policlinico of Abano Terme, General and Advanced 
Minimally Invasive Surgery, P.zza C. Colombo n°1 - 35031 
Abano Terme, Italy
Introduction: Laparoscopic major liver resections has had 
limited spread, mainly due to technical challenging issues 
and advanced laparoscopic skills required to perform it. 
Despite this, encouraging results have been reported in term 
of safety and oncologic results even for major (>3 segments) 
or complex for location (right posterior segments). The aim 
of this study was to analyze the learning curve in major-
complex totally laparoscopic liver resections (TLLR) per-
formed by a single HPB surgeon.
Methods: From October 2008 to October 2011 a total of 60 
TLLR were performed at our institution. Twenty (33.3%) 
were major-complex resections. Indication for surgery was 
malignancy in 17 (85%) cases and benign in 3 (15%) cases. 
The total series was divided in two groups: fi rst 10 cases 
(group A) and second 10 cases (group B). Perioperative out-
comes of the 2 groups were compared. All data were pro-
spectively recorded and values are presented as percentage 
(%) and median (range).
Results: Demographic data were similar in both groups 
Type of resection was as following:
– group A 6 Right Hepatectomy (RH), 3 Right Posterior 
Sectionectomy;
– group B 6 RH and 4 Left Hepatectomy (LH).
Comparing the two groups, results improved in terms of: 
Conversion 20% group A vs. 0% group B, operative time 
(min) 470 (240–600) vs. 330 (180–400) and blood loss (ml) 
550 (200–1200) vs. 375 (150–630). The number of cases 
requiring a Pringle’s manoeuvre was 10 (100% group A) vs. 
1 (10% group B). Patients requiring blood transfusion were 
6 (60% group A) vs. 0 (0% group B). Morbidity rate was 
20% on both groups while 1 patient in group A experienced 
an in-hospital dead. There were no difference in ITU admis-
sion, hospital stay and oncologic results.
Conclusion: This series of twenty consecutive cases of 
major-complex TLLR performed over a 3 years experience 
by a single HPB surgeon with advanced laparoscopic skills 
shows that a minimum of ten cases are needed to obtain a 
signifi cant improvement in peri-operative outcome. More 
studies are needed to clarify the minimum standard of train-
ing to perform safely this kind of surgery.
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INSULIN RESISTANCE AS PREDICTOR 
FOR ESOPHAGEAL VARICES IN 
HEPATITIS C VIRUS CIRRHOSIS
E. S. Ahmed1, S. Marzuk2, A. Yamany1 and M. Mahmud1
1Alexandria University, Faculty of Medicine Hepatology 
Unit, Alexandria, Egypt; 2Alexandria University, Faculty of 
Medicine Clinical Pathology, Alexandria, Egypt
Faculty of Medicine, Alexandria University, Alexandria, 
Egypt; Hepatolgy Department, Internal Medicine, 
Alexandria, Egypt; Faculty of Medicine, Alexandria 
University, Azzarita, Ramleh Station, Alexandria, Egypt
Introduction: Hepatitis C Virus (HCV) is a major global 
public health problem & is one of the main causes of cir-
rhosis, Egypt Specially has the highest rates all over the 
world. All patients with Cirrhosis should undergo diagnostic 
endoscopy to document the presence of esophageal varices 
(EVs). HCV infected subjects present a three fold increased 
risk of Insulin resistance (IR) which is considered a risk 
factor for EVs i HCV cirrhotic patients through its effects on 
hepatic fi brosis.
Methods: Our aim is evaluating the predictive value of IR, 
Splenic size, platelet count & PLT/Spleen longitudinal diam-
eter ratio for the presence of EVs in (Child A) Cirrhotic 
patients, thus twenty fi ve patients with Child A cirrhosis 
undergo evaluation for their HOMA score, platelet count, 
splenic diameter & upper gastrointestinal endoscopic study 
for development of esophageal varices.
Results: There was signifi cant positive correlation between 
the presence of esophageal varices (EVs) and the following 
parameters: AST/ALT, BMI, platelet count with cut of value 
115 000 cells/µl, spleen longitudinal diameter with cut of 
value 140 mm, HOMA score with cut off value of 3.39. 
There was a statistically signifi cant inverse relation between 
platelets/spleen longitudinal diameter ratio and esophageal 
varices (EVs) presence with a cut off value of 760.
Conclusion: HOMA score IR is closely associated with 
EVs presence in Child Pugh A HCV cirrhotic patients and 
can be considered as an important non invasive parameter 
for prediction of esophageal varices in those patients. Platelet 
count and splenic diameter showed strong correlation with 
presence of EVs in compensated cirrhotic patients.
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HARMONIC SCALPEL ‘FOCUS’ IS AN 
EFFECTIVE TECHNIQUE FOR LIVER 
RESECTION- A STUDY OF 29 CASES
G. Nagarajan, S. Mehta and K. Adayanthaya
Bombay Hospital and Medical Research Centre
Bombay Hospital and Medical Research Centre, Surgery, 
E5 Shri Tilak Complex, Eksar Road, Borivali west, 
400103103 Mumbai, India
Introduction: The ideal technique for liver transection is 
still a debated topic. The aim of our study was to objectively 
assess the peri-operative outcomes of 29 major hepatic resec-
tions with the FOCUS harmonic scalpel and thereby evaluate 
effi cacy of this technique.
Methods: We analyzed a prospectively maintained database 
of 29 anatomical liver resections performed at Bombay hos-
pital from October 2009 to November 2011. All surgeries 
were performed by the same surgeon (GN). We assessed the 
indications of surgery, demographic parameters, type of 
resection, blood loss, post operative morbidity, mortality, 
transection time and portal clamping time. Patients ranged 
from 39–70 years, 15 males, 14 females.
Results: Indications of surgery were HCC (10), intrahepatic 
cholangiocarcinoma (4), hilar cholangiocarcinoma (4), meta-
static disease (4), gall bladder cancer with liver invasion (4), 
benign disease (3). Resections included right hepatectomy 
(8), extended hepatectomy (3), classical left hepatectomy (6), 
left lateral (2), bisegmental resection (7), monosegmental 
resection (3). Mean blood loss was 560 cc. 11/28 resections 
were without transfusion. 13/28 patients were without portal 
clamping. Average clamping time in the other 15 patients 
was 17.5 min. Major complications were seen in 5 patients 
(17%) which included ascites (1), pneumonia (1), subacute 
intestinal obstruction, (1) liver failure (1), portal vein throm-
bosis (1). We had 1 mortality.
Conclusion: Our study proves that the harmonic scalpel is 
as effective and safe as other modalities. Though some 
studies have shown higher bile leak rates, we did not fi nd 
any such problem. Further randomized trials are required to 
compare the harmonic with other techniques.
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THE COUNTERMEASURE AGAINST OF 
SURGICAL SITE INFECTIONS AFTER 
HEPATECTOMY IN OUR HOSPITAL
R. Kawahara, G. Akasu, K. Fukuyo, H. Sakai, 
M. Yasunaga and H. Kinoshita
Department of Surgery, Kurume University School of 
Medicine, Kurume in Japan
Kurume University School of Medicine, Department of 
Surgery, 67 Asahi-machi, Kurume-shi, Fukuoka, 83000 
Kurume, Japan
Introduction: Surgical site infection (SSI) after hepatec-
tomy is relatively frequent postoperative complication. 
Understanding the status of SSI and planning and executing 
adequate preventive measures are considered to be extremely 
important issues to reduce the incidence of SSI.
Methods: Here, we conducted an SSI surveillance study of 
441 patients who had undergone hepatectomy between 
February 2007 and July 2011.
Results: We found that the rate of preoperative weight loss, 
preoperative anemia, preoperative albumin level, preopera-
tive alanine aminotransferase level, preoperative C-reactive 
protein level, number of preoperative days, hepatectomy 
larger than lobectomy, presence or absence of enteroanasto-
mosis, operative duration, and amount of intraoperative 
bleeding were risk factors for SSI. Multivariate analysis 
identifi ed the rate of preoperative weight loss, preoperative 
anemia and hepatectomy larger than lobectomy as signifi cant 
independent associated factors.
Conclusion: Prevention of weight loss, improvement of 
preoperative albumin level is possible to make improve-
ments in nutrition and immunonutrition as a Nutrition 
Support Team. Nutritional improvements were considered 
potentially benefi cial in preventing generation SSI.
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DEVELOPMENT OF A PATIENT-
SPECIFIC HEPATECTOMY 
SIMULATOR USING IMAGING DATA: 
A FEASIBILITY STUDY
K. Endo, N. Sata, M. Taguchi, H. Sasanuma, Y. Sakuma, 
A. Shimizu, A. Lefor and Y. Yasuda
Jichi Medical University, Department of Surgery
Jichi Medical University, Surgery, 3311-1 Yakushiji, 
Shimotsuke-shi, Tochigi-ken, 32904 Tochigi, Japan
Introduction: The development of effective treatment plans 
for hepatic surgery requires an understanding of tumor loca-
tion and individual anatomical differences, as this informa-
tion determines the type of resection carried out. Advances 
in diagnostic imaging have enabled accumulation of large 
amounts of patient-specifi c data. We developed a 3D visual-
ization technique using patient imaging data to create a 
virtual 3D liver model, as well as a patient-specifi c surgical 
simulator for hepatectomy.
Methods: A single healthy volunteer underwent imaging 
with a 64-MDCT scanner in this quadruple phase dynamic 
study using a routine protocol for preoperative evaluation. 
Each 1 mm thick contrast-enhanced image was used as 
DICOM data and saved in STL format. Synapse Vincent 
(Fujifi lm Medical, Tokyo, Japan) was used for segmentation 
of the portal vein, hepatic vein and hepatic parenchyma. 
FreeForm (Sensable, USA) was used for surface smoothing 
and reconstruction of the virtual 3D model. A 3D mouse was 
used to simulate right hepatectomy and left lateral segmen-
tectomy. In the virtual space, the 3D mouse can control a 
mouse pointer representing surgical devices three dimen-
sionally with haptic feedback.
Results: The virtual 3D liver model took approximately 150 
minutes to create. The model allowed simulation of a right 
hepatectomy and left lateral segmentectomy, and intuitive 
navigation was achieved with the tactile 3D mouse. The 
hepatic veins that should be seen in the resection plane were 
well visualized.
Conclusion: We developed a patient-specifi c surgical simu-
lator by creating a virtual 3D model based on preoperative 
patient imaging data. In addition to being useful for preop-
erative simulation, this method will be useful for medical 
education and patient communication.
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HAMARTOMA HEPATICO IN MEXICO
V. Carrillo-Maciel, O. M Solorzano-Pineda, 
R. Rangel-Rodarte, B. Rubio, Martinez, 
J. A Leal-Martinez, LI Gonzalez-Luna, 
F. J Rosales-Hernandez and Y. Jaramillo-Rodriguez
Social Security 71
Social Security 71, Department of Surgery, Calle Lobo No. 
224, Fracc. Los Viñedos, 27016 Torreon, Mexico
Introduction: Hepatic mesenchymal hamartoma (HMH) 
was described in 1903 and classifi ed in 1956 by Edmonson. 
It is the second benign liver tumor. The incidence is 0.7 per 
million per year, occurring in children under two years, the 
frequency varies by gender. Etiology, aneuploid cells has 
been investigated and Cromosoma 19, the growth factor as 
a cause. The tumor is a mixture of canalicular structures in 
mesenchymal stroma with septate cystic cavities of variable 
size, with areas of hemorrhage.
Methods: Case report: A case report of a boy 3 years old 
who underwent left hepatectomy for hamartoma of 15 cm in 
diameter.
Results: The patient presents with favorable postoperative 
course without any complications being graduated to 14th 
postoperative day until today still asymptomatic and without 
recurrence.
Conclusion: To ensure a successful outcome to the study, 
management and surgical treatment of such patients should 
be by expert personnel in the surgical management of liver, 
pancreas and biliary tract.
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SPATIAL ANATOMICAL VARIATIONS OF 
SEGMENTAL HEPATIC ARTERY AT 
HEPATIC HILUS
H. Sakai, K. Okuda, G. Akasu, H. Ishikawa, 
M. Yasunaga and H. Kinoshita
Department of Surgery, Kurume University School of 
Medicine
Kurume University School of Medicine, Department of 
Surgery, 67 Asahi-machi, Kurume-shi, Fukuoka, 83000 
Kurume, Japan
Introduction: Variant hepatic arterial anatomy not only dic-
tates the surgical technique but also increase the risk of 
hepatic arterial complications in hepatobiliary surgery. We 
investigate anatomical variations of the segmental hepatic 
artery including ramifi cation pattern and 3D relationship to 
the portal vein and bile duct, based on the integrated 3D 
images of MDCT and CT cholangiography.
Methods: 140 patients who underwent contrast enhanced 
multi-detector row CT (MDCT) and MDCT cholangiogra-
phy were enrolled. The course of the right posterior hepatic 
artery (RPHA) and the left hepatic artery (LHA) relative to 
the portal vein and bile duct was evaluated.
Results: An infraportal RPHA, which runs inferiorly to the 
right anterior portal vein, was observed in 118 cases. A supra-
portal RPHA, which runs superiorly to the right anterior 
portal vein, was observed in 22 (15.7%). The LHA ran the 
left side of the umbilical portal vein (UP) in 111 cases. On 
the other hand, in 29 cases (20.7%), the LHA located to the 
right side of the UP. In the LHA running right to the UP, an 
infraportal A2, which runs inferiorly to the UP, was observed 
in 20 (14.3%), a supraportal A2, which runs superiorly to the 
UP, was observed in 9 (6.4%). As risky variation for hepatic 
resection, in 4 cases A4 ramifi ed from the right anterior 
hepatic artery, GDA or SMA. Also as risky anomaly, A2 
independently ramifi ed from RHA in 2 cases.
Conclusion: “Supraportal” the right posterior hepatic artery 
and A2 are not unusual, when planning right or left sided 
hepatectomy, surgeons should pay attention to the course of 
the hepatic artery. Some had a risky variation for the ana-
tomical liver resection. To achieve safe resection, preopera-
tive understanding of the variants of the segmental arterial 
ramifi cation and 3D relationship is essential.
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SURGERY AS PRIMARY PROPHYLAXIS 
FROM VARICEAL BLEEDING IN 
PATIENTS WITH EXTRAHEPATIC 
PORTAL VENOUS OBSTRUCTION
S. Pal1, V. Mangla1, P Radhakrishna1, P. Sahni1, 
T. K. Chattopadhyay1, S. Acharya2, S. Nundy3 
and G. Pande4
1Dept. of Gastrointestinal Surgery and Liver 
Transplantation, All India Institute of Medical Sciences, 
New Delhi-110029, India; 2Dept of Gastroenterology, All 
India Institute of Medical Sciences, New Delhi-110029, 
India; 3Department of Surgical Gastroenterology, Sir 
Ganga Ram Hospital, New Delhi, India; 4Department of 
Hepatobiliary surgery, Lanceston, Tasmania, Australia
All India Institute of Medical Sciences, Dept. of 
Gastrointestinal Surgery and Liver Transplantation, Ansari 
Nagar, 110029 New Delhi, India
Introduction: In patients with extrahepatic portal venous 
obstruction (EHO), death is usually due to variceal bleeding. 
This is more so in developing countries where there are a 
lack of tertiary healthcare facilities and blood banks. 
Prophylactic operations in cirrhotics have been found to be 
deleterious. In patients with EHO liver function is well pre-
served and we therefore investigated the role of prophylactic 
surgery to prevent variceal bleeding.
Methods: Between 1976 and 2010, we operated on selected 
patients with EHO, who had no history of variceal bleeding 
but had ‘high risk’ oesophagogastric varices or severe portal 
hypertensive gastropathy, symptomatic hypersplenism and 
came from remote areas with poor access to tertiary health-
care. Following surgery these patients were prospectively 
followed up with regard to mortality, variceal bleeding, 
encephalopathy and liver insuffi ciency.
Results: A total of 114 patients (67 males; mean age: 19 
years) underwent prophylactic operations. Ninety-eight 
(86%) patients had proximal splenorenal shunts and 16 had 
oesophagogastric devascularization. One patient died post-
operatively (0.9%). Hypersplenism was reversed in all. No 
patient developed overwhelming post splenectomy sepsis. In 
89 (79%) patients who were followed up for a mean of 60 
months, late complications included 1 death (6 months), 1 
patient developed IgA nephropathy and 6 (5.3%) had vari-
ceal bleeding. Patients who bled (6) were managed success-
fully by endoscopic sclerotherapy. No patient developed 
encephalopathy and 90% were free of symptoms.
Conclusion: In patients with EHO, prophylactic surgery is 
fairly safe and prevents variceal bleeding in 95% of patients 
with no occurrence of encephalopathy. Patients with EHO 
who have not bled but have high-risk varices and/or hyper-
splenism and poor access to medical facilities should be 
offered prophylactic operations.
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THE MANAGEMENT OF LIVER 
ABSCESS; A SINGLE CENTER 
PROSPECTIVE EVALUATION
W. Otto, B. Najnigier, B. Cieslak, M. Krawczyk
Department General, Transplant & Liver Surgery, Warsaw 
Medical University, Banacha, 1a02/09/2012 Warsaw, 
Poland
Introduction: The prevalence of pyogenic liver abscess in 
surgical patients among polish population is not exactly 
known. They account probably less than 0.5% of all patients 
treated in surgical departments and remains unchanged over 
at least the last two decades. The approach changed, however; 
the abscess traditionally managed by antibiotics and open 
surgical drainage became be much more frequently treated 
by percutaneous USG guided procedures.
Methods: The objective of the study was to evaluate our 
experience in managing liver abscess over the last 15 years. 
The protocol consisted of systemic antibiotic therapy for 
single and multiple abscess, USG guided percutaneous drain-
age applied to all cases resistant to antibiotics and open surgi-
cal drainage for multiple abscess involving of both liver 
lobes. The approach was modifi ed according to patient’s 
status and the abscess localization. The data were prospec-
tively entered into the database of the Department. The 
analysis comprises of the results of treatment of 231 patients 
(M. 139, F. 92, m.a. 54) carried out from 1997 to 2011.
Results: Antibiotics alone applied to single and multiple 
abscess was successful in 110 (47.6%); failed in 84 (36.4%) 
who underwent USG guided drainage. USG procedure was 
successful in 76 (91.5%): 6 (7.9%) died, mean hospital stay 
21.3 days; not successful in 8 (9.5%). They underwent open 
surgical drainage: 2 (25%) died, mean hospital stay 27 days. 
Operative treatment was introduced to 37 (16%) with mul-
tiple and multiloculated abscess: 12 (32.4%) right hepatec-
tomy [died 4 (33.4%)]; 11 (29.6%) left bisegmentectomy + 
drainage of the right lobe [died 5 (45.4%)]; 14 (38.0%) open 
abscess drainage [died 8 (57.1%)]; hospital stay 26 days. The 
overall mortality was 10.8%.
Conclusion: Antibiotic therapy, percutaneous aspiration 
and open surgical drainage are the complementary methods 
of treatment. USG guided percutaneous drainage appeared 
to be effective and most helpful in successful treatment of 
cases either resistant or not suitable for antibiotics. Surgical 
intervention was the ultimate treatment for patients to whom 
percutaneous procedure failed and the treatment of the 
abscess involving both liver lobes.
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RISK FACTORS FOR SURGICAL SITE 
INFECTION AFTER LIVER RESECTION
K. Nakagawa, K. Tanaka, K. NOjiri, M. Sugita, K. Takeda, 
M. Ueda, T. Kumamoto and I. Endo
Department of Gastroenterological Surgery, Yokohama City 
University, Graduate School of Medicine, Yokohama, 
Japan
Yokohama City University, Graduate School of Medicine, 
Department of Gastroenterological Surgery, 3-9 Fukuura, 
Kanazawa-ku, 236 Yokohama, Japan
Introduction: Surgical site infection (SSI) is one of the 
major complications after liver resection. It leads to prolong 
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hospital stays and to increase medical expenses. This study 
aimed to clarify the incidence of SSIs after liver resection 
without biliary reconstruction and to investigate risk factors 
for SSI and to prevent the incidence of SSI.
Methods: This retrospective study involved 536 patients 
with liver diseases who underwent liver resection at our 
hospital between January 2000 and September 2011. 
Prophylactic antibiotics were given to just before skin inci-
sion and every 3 hours during the operations. These were 
usually continued until 72 to 120 hour after the completion 
of surgery. Intraoperatively, the bile leakage test was per-
formed as possible. Closed drain system was used in all 
patients. Clinicopathological factors were compared between 
patients who developed SSI and those without it.
Results: (1) The incidence of total SSI was 8.2% (n = 44). 
Incisional/deep SSI and space/organ SSI were 2.1% (n = 11) 
and 6.9% (n = 37), respectively.
(2) Risk factors for SSI: Among 536 patients, bile leakage 
(RR, 112.2; p < 0.01) was an independent risk factor for 
SSI by multivariate analysis.
(3) Risk factors for bile leakage : Multivariate analysis iden-
tifi ed the presence of intraoperative transfusion (RR, 3.1; 
p = 0.02) as an independent predictor for bile leakage in 
patients with normal background liver (n = 271). On the 
other hand, in patients with injured background liver 
induced by chronic hepatitis or liver cirrhosis (n = 257), 
serum albumin ≤3.5 g/dl (RR, 3.8; p = 0.01) was an 
independent risk factor for bile leakage by multivariate 
analysis.
Conclusion: Bile leakage frequently induced SSI after liver 
resection. Improved surgical procedures with less intraopera-
tive bleeding may prevent bile leakage in patients with 
normal liver. Preoperative administration of nutritional 
support or liver function support may prevent bile leakage in 
those with injured liver.
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EVALUATION OF THE EFFICACY OF 
ANGIOEMBOLIZATION IN THE 
MANAGEMENT OF SEVERE LIVER 
TRAUMA. HOSPITAL CLINIC 
BARCELONA CASE STUDIES
E. Pando1, J. Ferrer1, M. Burrel2, G. D. D. Gobbo1, 
M. Barrufet2, M. I. Real2, J. Fuster1 and 
J. C. García-Valdecasas1
1Department of Surgery. Hepatic Surgery and Liver 
Transplant Unit. ICMDM. Hospital Clinic Barcelona. 
University of Barcelona; 2Department of Vascular and 
Interventional Radiology. CDIC. Hospital Clinic 
Barcelona. University of Barcelona
ICMDM, Hospital Clinic Barcelona, Hepatic Surgery and 
Liver Transplant Unit, c/Villarroel, 1708036 Barcelona, 
Spain
Introduction: Hepatic angioembolization in the treatment 
of liver trauma patients continues to remain a viable thera-
peutic option in multidisciplinary management. However, for 
some authors, controversy prevails regarding its use, espe-
cially in severe liver injuries.
The aim of this study is to review Hospital Clinic experi-
ence and evaluate the role of angioembolization in liver 
trauma morbidity and mortality.
Methods: A retrospective study of patients undergoing 
angioembolization for liver trauma was conducted during a 
6-year period from 2005 to 2010. The severity of the liver 
injury was classifi ed according to AAST (American 
Association for the Surgery of Trauma), which is based on 
computerized tomography (CT) fi ndings. Other variables 
registered were: demographics, the “ISS” score (Injury 
Severity Score), the need for surgery, outcomes and post-
procedure morbidity/mortality.
Results: 32 patients with liver injury were evaluated; 9 
(28%) had hepatic angioembolization. The average of ISS 
was 26 ± 7.9. 89% of patients had sustained blunt trauma. 
The severity of liver injury was: Grade III (n = 1), Grade IV 
(n = 7) and Grade V (n = 1). Indications for angiography in 
hemodynamically stable patients were based on CT fi ndings: 
active bleeding (n = 7) and pseudoaneurysm (n = 2). Selective 
arterial embolization was performed in all cases. 2 patients 
required a second embolization (re-bleeding). Liver-related 
morbidity after embolization was 44.4% (liver necro-
sis).66.7% of patients required surgical intervention for: 
hemoperitoneum evacuation (elective surgery) (n = 3), com-
partment syndrome (n = 1), right hepatectomy (n = 1) and 
haemothorax (n = 1). No mortality occurred.
Conclusion: In our series, hepatic angioembolization is an 
effective procedure with no major liver complications 
arising. However, the need for surgery can not be fully ruled 
out. For the majority of trauma patients it remains one of the 
best options within a multidisciplinary approach.
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FULL HIGH VISION VIDEO SUPPORT 
SYSTEM IS ESSENTIAL TO EDUCATE 
TRAINEES OF SURGEONS AND 
OPERATIVE NURSES OF OPEN HEPATO-
PANCREATO-BILIARY SURGERY
N. Hroshi1, S.-I. Kobayashi2, S. Koizumi2, T. Asakura2 
and T. Otsubo2
1Deapartment of Gastroenterological Surgery, St. Marianna 
University Yokohama-City West Region Hospital; 
2Department of Gastroenterological Surgery, Stmarianna 
University, School of Medicine
St. Marianna University Yokohama-City West Region 
Hospital, Gastroenterological Surgery, 1197-1 Yasashi-cho, 
Asahi-ku, 241 Yokohama, Japan
Introduction: Usual and easier fi lming and recording all 
open surgeries of hepato-pancreato-biliary (HPB) now seems 
important and essential to educate trainees of surgeons and 
operative nurses of HPB surgery. However, recording system 
of surgical video usually costs a lot and needs assistants for 
fi lming. We here present an inexpensive full high vision 
video support system for recording HPB surgeries. This 
system does not always need assistant and can easily fi lm all 
HPB surgeries.
Methods: As examples, pancreaticoduodenectomy for pan-
creatic adenocarcinoma and left hepatectomy with caudate 
lobectomy for hilar cholangiocarcinoma were recorded using 
a Video-Support-System (VSS, Takasago Medical Co., 
Tokyo, Japan) which can place and fi x a video camera. The 
VSS is fi xed at the operating bed. The two surgeries were 
fi lmed with Full High Vision Video Camera, which is not one 
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for professional use (Everio GZ-HM1, Victor JVC, Tokyo, 
Japan).
Results: The two above-mentioned devices cost only 
approximately 4000 US dollars. The two surgeries were per-
formed by an operator and one assistant surgeon and fi lmed 
without a cameraman. The two surgeries were fi lmed in a 
fi ne full-high vision video within 40 Mega-bites, respec-
tively. The full high vision videos were easily edited by a 
computer software VideoStudio Pro X3 (Coreal Co., Tokyo, 
Japan), and were used for educating trainees of surgeons and 
operative nurses, especially instrumentists, of HPB surgery.
Conclusion: The above-mentioned Video System for open 
HPB surgeries is not costly and does not always need cam-
eramen, but can always offer satisfi ed full high vision fi ne 
videos of specialized HPB surgery.
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MOUSE LIVER VOLUMETRY BY 
MAGNETIC RESONANCE IMAGING – 
DEVELOPMENT AND VALIDATION OF A 
NEW PROTOCOL
E. Melloul, D. A. Raptis, R. Graf, P.-A. Clavien and 
M. Lesurtel
Department of Surgery and Transplantation, Swiss HPB 
center, University Hospital Zürich
University Hospital Zürich, Department of Surgery and 
Transplantation, Swiss HPB Center, Raemistrasse 1008091 
Zürich, Switzerland
Introduction: Assessment of liver volume in mice currently 
requires killing animals (measurement of liver volume and 
weight ex vivo). To allow repetitive liver volume assessment 
in a single mouse, we aimed to develop a protocol of liver 
volumetry using a small animal magnetic resonance imaging 
(MRI) and to confi rm the accuracy of MRI to assess changes 
of liver volume after partial hepatectomy (PH).
Methods: Mouse liver volumetry was assessed by a 4.7 
Tesla Magnet Unit specially dedicated for small animals. In 
a fi rst set of experiments, native liver volume measured at 
MRI with/without an extra-corporal gadolinium “bath” 
(±gado) were compared with the true liver weight/volume 
determinate at autopsy (n = 5 per group). In a second set of 
experiments, liver volumes were measured at MRI and at 
autopsy at different time points of regeneration after 70% PH 
(n = 5 at each time point). As a control group, volumetry of 
native liver were measured by MRI at the same time points 
in mice with sham surgery (laparotomy) (n = 5). All liver 
tissues were fi xed and stained for Ki-67, Histone 3 and 
PCNA to assess hepatocyte proliferation.
Results: Native liver volume measurement at MRI corre-
lated with true liver volume and weight, but gadolinium 
“bath” did not increase MRI accuracy (Pearson correlation 
0.90 [− gado] vs. 0.91 [+ gado] and 0.96 [− gado] vs. 0.92 
[+ gado], respectively). From days 0 to 14 after 70% PH, the 
overall MRI liver volumetry calculation was as accurate as 
true liver volume and weight measurements (Pearson cor-
relation 0.97 and 0.95, respectively). Analysis of liver 
volume hypertrophy after 70% PH showed that liver volume 
increased at day 1 (mean 0.68 + 0.04 ml) to reach 90% of 
its initial volume at day 14 (mean 1.16 + 0.15 ml). Finally, 
markers of hepatocyte proliferation correlated with volume 
increase measured at MRI.
Conclusion: MRI dedicated to small animals is an effective 
tool to assess liver volume in mice either for native liver or 
after PH. When available, this new tool should be used since 
it allows repetitive measurement of liver volume and pre-
vents per se killing animals.
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HEPATIC CAVERNOUS HEMANGIOMA: 
WHEN SHOULD BE IT RESECTED?
J. Grondona1, V. Ardiles2, R. Bracco1, V. Garay3, 
F. De Francesco1, V. Weinbaur2, J. Lendoire3 and 
E. De Santibañes2
1Hepato-Pancreato-Biliary Surgery Unit, UNACIR HPB de 
San Isidro, Buenos Aires, Argentina; 2Hepato-Pancreato-
Biliary Surgery and Liver Transplant Unit, Hospital 
Italiano de Buenos Aires, Argentina; 3Hepato-Pancreato-
Biliary Surgery Unit, Hospital Cosme Argerich, Buenos 
Aires, Argentina
Hepato-Pancreato-Biliary Surgery Unit, UNACIR HPB de 
San Isidro, Buenos Aires, Argentina; Centro Médico Martín 
y Omar de San Isidro, Arenales 24791640, Martínez, 
Provincia de Buenos Aires, Argentina
Introduction: Hepatic cavernous hemangioma (HCH) is a 
congenital vascular malformation and is the most frequent 
solid hepatic benign tumor. Because the use of cross-
sectional imaging studies HCH are frequently encountered. 
Surgeons and Physicians have to be familiar with the appro-
priated diagnostic method, management and outcome. The 
aim of this presentation is to assess surgical indications and 
outcome of resected patients.
Methods: Between January 1986 and July 2011 a total 
of 91 patients (17 males and 74 females) were resected 
in 4 different Hepato-Pancreato-Biliary Surgery Units in 
Argentina. The surgical indications were: pain (50.6%); pain 
plus other symptoms and/or signs (25.2%); uncertain diag-
nosis (10.9%), progressive tumor enhancement (6.6%) and 
spontaneous rupture (6.6%). The imaging studies employed 
were: Ultrasonography (US) in all patients; US plus dynamic 
Computed Tomography Scan (CT-scan) in 94.4% and US 
plus CT-scan plus Magnetic Resonance Imaging in 16.6%. 
A total of 44 hemangiectomies (48.3%) and 47 hepatecto-
mies (51.7%) were carried out.
Results: Morbidity rate was 17.6% and only one patient 
died (1.09%) due to a post-operative bleeding of a congenital 
brain aneurysm. Thorough follow-up was achieved in all the 
resected patients and all of them remain symptoms free after 
surgery.
Conclusion: Surgical treatment is only indicated in a 
select group of patients. The correlation between clinical 
fi ndings and the imaging studies obtained have to be accu-
rate. Resection therapy should accomplish complete 
removal of the lesion while maximizing preservation of the 
normal hepatic parenchyma. AsHCH is a benign liver 
tumor surgery must be done by HPB Surgeons with low 
morbidity rate.
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UTILITY OF XENOGRAFT MODELS 
USING NOG-EGFP MICE FOR A HIGH 
QUALITY SAMPLING SYSTEM OF 
PANCREATO-BILIARY CANCER CELLS
K. Shima1, M. Mizuma1, T. Rikiyama1, Y. Katayose2, 
S. Egawa1, N. Ishii3, A. Horii4 and M. Unno1
1Division of Hepato-Biliary-Pancreatic Surgery, 
Department of Surgery, Tohoku University Graduate 
School of Medicine, Sendai, Japan; 2Division of Integrated 
Surgery and Oncology, Department of Surgery, Tohoku 
University Graduate School of Medicine, Sendai, Japan; 
3Department of Microbiology and Immunology, Tohoku 
University Graduate School of Medicine, Sendai, Japan; 
4Department of Molecular Pathology, Tohoku University 
School of Medicine, Sendai, Japan
Tohoku University Graduate School of Medicine, Division 
of Hepato-Biliary-Pancreatic Surgery, Department of 
Surgery, 1-1 Seiryomachi, Aoba-ku, Sendai 980-8574, 
Japan
Introduction: If high-quality cancer cells are obtained from 
clinical samples more simply and quickly, it will be highly 
valuable for many analyses, possibly leading to personalized 
medicine. However, it is still technically diffi cult to harvest 
them with minimum amount of contaminated noncancerous 
cells. We hypothesized that xenograft models of NOG-eGFP 
mice, expressing eGFP ubiquitously, may be useful to obtain 
such high-quality cancer cells for detailed molecular and 
cellular analyses.
Methods: Mouse tumorigenicity of NOG-eGFP mice was 
evaluated compared with NOD/SCID mice by implanting 
pancreato-biliary cancer cell lines (500000 cells/mice) and 
clinical samples of resected pancreatic cancer in fi ve patients 
subcutaneously. To obtain high-quality cancer cells, the sub-
cutaneous tumors were harvested from the mice and enzy-
matically dissociated into a single-cell suspension. Then, the 
cells were sorted by fl uorescence-activated cell sorting 
(FACS) for separation of the host cells from the cancer cells. 
Thereafter, the contamination of host cells in collected 
cancer cells was quantifi ed by using FACS analysis. The 
viability of cancer cells after FACS sorting was evaluated by 
subcutaneous reimplantation on NOG mice.
Results: Tumorigenicity of NOG-eGFP mice were signifi -
cantly better than NOD/SCID mice in all of the analyzed 
cell lines (500000 cells/mice, p < 0.01). Also, NOG-eGFP 
mice showed better tumorigenicity in clinical specimens of 
pancreatic cancer than NOD/SCID mice. Sorting proce-
dures enabled an almost pure collection of cancer cells 
with minimum amount of contaminated host cells (0.4–
1.7%). Reimplantation of sorted cancer cells formed tumor 
again, which showed that cell viability after sorting was 
kept well.
Conclusion: NOG-eGFP mice have superior tumorigenicity 
and promise for expanding clinical tumor samples. Moreover, 
clear separation of cancer and stromal cells using fl uorescent 
mice is available for collection of high-quality cancer cells 
with minimum contamination of noncancerous cells. This 
method might provide a novel cancer sampling system for 
molecular and cellular analysis with high accuracy and 
contribute to cancer research that aims to personalized 
medicine.
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CONCEPT FOR IMAGE-GUIDED INTRA-
OPERATIVE HIGH-DOSE-RATE 
BRACHYTHERAPY (HDR-IOBT)
G. Toporek1, D. Wallach1, J. Vock2, D. Terribilini3, 
B. Isaak3, P. Manser3, D. M. Aebersold2 and S. Weber1
1Artorg Center for Computer Aided Surgery, University of 
Bern, Switzerland; 2Department of Radiation Oncology, 
Inselspital Bern, University Hospital, University of Bern, 
Switzerland; 3Division of Medical Radiation Physics and 
Department of Radiation Oncology, Inselspital Bern, 
University Hospital, University of Bern, Switzerland
University of Bern, Artorg Center for Computer Aided 
Surgery, Institute for Surgical Technology and 
Biomechanics, Stauffacherstrasse, 783014 Bern, 
Switzerland
Introduction: Intra-operative interstitial high-dose-rate 
brachytherapy (HDR-IOBT), that can be combined with sur-
gical resection of the resectable lesions in the same session, 
gains interest in the treatment of liver metastasis. As accu-
racy of the radiation source placement has a great impact on 
the delivered radiation dose, the diffi culty in HDR-IOBT is 
to precisely apply the treatment plan to the patient. We 
propose stereotactic instrument guidance to improve accu-
racy of needle placement during HDR-IOBT.
Methods: An existing instrument guidance system 
(CAScination AG, Bern, Switzerland) dedicated for open 
liver surgery and percutaneous interventions has been 
adjusted to the requirements of HDR-IOBT. The system 
comprises optical tracking of the surgical instruments and 
the patient as well as visual feedback during instrument 
guiding procedures. An interface (using the DICOM-RT 
standard) was added to display the target, 3D surface models 
of the organs at risk (OAR), planned catheter’s trajectories, 
radiation source positions as well as isodose maps according 
to the treatment plan.
Results: The system is capable of guiding needles precisely 
to an anatomical target based on available DICOM-RT data. 
3D renderings of the anatomy and dosimetry are reconstructed 
from the information available in the DICOM-RT with an 
average error of 0.9 mm and 0.2 mm respectively, represent-
ing 75% and 16% of the CT voxel size. The resulting dis-
placement error of the instrument guidance system (TRE – target 
registration error) measured in an animal model is 3.1 ± 
1.2 mm. Since the source positions and catheter’s trajectories 
from the RT plan were visualized as continuous lines, no 
precision was lost when transferring data to the navigation 
system. Additionally, adjustments of the radiation plan 
according to intra-operative fi ndings are available.
Conclusion: An instrument guidance system for open liver 
surgery has been successfully adapted to HDR-IOBT treat-
ments of the liver. In future, such guidance technology will 
increase the precision in the positioning of the radiation 
sources within the patient’s body. By improving local control, 
it might improve current treatment scenarios of nonresect-
able tumors and metastases occurring in the liver. Future 
work will be dedicated to the evaluation of the system’s 
workfl ow in ex-vivo and in-vivo experiments.
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PRESERVING HEPATIC ARTERY FLOW 
DURING HEPATIC INFLOW OCCLUSION 
REDUCES LIVER ISCHEMIA-
REPERFUSION INJURY IN RATS
D. Jiahong, Y. Chen, L. Chenghui, Z. Aiqun, S. Yang 
and W. Zhang
Hospital & Institute of Hepatobiliary Surgery, Chinese 
PLA General Hospital
Hospital & Institute of Hepatobiliary Surgery, Chinese 
PLA General Hospital, Fuxing Road, 2810085 Beijing, 
China
Introduction: Temporary portal triad clamping (Pringle 
maneuver) during liver resection can reduce intraoperative 
blood loss, but correlates with liver ischemia and reperfusion 
(I/R) injury. The hepatic artery supplies 20%-30% of total 
blood fl ow but more than 50% of oxygen requirements to the 
liver. In this study, we investigated whether the preservation 
of hepatic artery during hepatic infl ow occlusion could 
reduce liver I/R injury while not increasing the blood loss 
during liver resection.
Methods: Three groups of rats were created: Group SO 
(sham operation), Group OPT (Occlusion of portal triad 
under portal blood bypass), and Group OPV (Occlusion of 
portal vein under portal blood bypass). The cotton sticks 
were weighted before and after soaking blood to calculate 
the blood loss during liver resection. The blood fl ow was 
occluded for 90, 100, 110 and 120 min before reperfusion. 
Liver I/R injury was assessed by measuring the survival of 
rats within seven days after operation, serum alanine amino-
transferase (ALT), aspartate aminotransferase (AST), liver 
tissue malondialdehyde (MDA) and Na+-K+-ATPase, and 
liver histology.
Results: The seven-day survival of rats in group OPV was 
higher than in group OPT. The safe tolerance limit was 
90 min for group OPT and 110 min for group OPV. The 
amount of blood loss in both OPT and OPV groups were 
signifi cantly less than in group SO. However, no signifi cant 
difference was observed in the amount of blood loss between 
group OPT and group OPV. The group OPV had signifi cantly 
lower ALT, AST and MDA values on the fi rst hour and fi rst 
day post-reperfusion than in group OPT. The Na+-K+-
ATPase activity in OPV group was signifi cantly higher than 
in group OPT 1 h post-reperfusion. Hepatocyte injury was 
signifi cantly less in group OPV than in group OPT on 
histopathology.
Conclusion: The preservation of hepatic artery during 
hepatic infl ow occlusion can extend the tolerant time in nor-
mothermic hepatic ischemia, and induce less I/R injury while 
not increasing the blood loss during liver resection. It may 
become an alternative maneuver in liver surgery.
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SINGLE-INCISION LAPAROSCOPIC 
SPLENECTOMY: THE 
TECHNICAL REFINEMENTS
T. Misawa, H. Kitamura, R. Ito, H. Shiba, Y. Futagawa, 
S. Wakiyama, Y. Ishida and K. Yanaga
Department of Surgery, The Jikei University School of 
Medicine, Tokyo, Japan
The Jikei University School of Medicine, Department of 
Surgery, 3-25-8 Nishi-shinbashi, Minato-ku, 105 Tokyo, 
Japan
Introduction: Single-incision laparoscopic surgery has 
rapidly been introduced in a variety of operations and drawn 
a great deal of attention. However, application of this tech-
nique to splenectomy is still challenging, and little has been 
reported to date. We present the technical refi nements of our 
single-incision laparoscopic splenectomy (SILS) including 
the tug-exposure technique which is an innovative technique 
for providing a better exposure of the splenic hilum.
Methods: We performed SILS in 13 patients: 6 with ITP, 2 
each with liver cirrhosis, splenic aneurysm, and cyst, and 1 
with splenic tumor. A 2.5-cm intraumbilical laparotomy was 
made to place a SILS Port. A fl exible 5-mm laparoscope and 
an articulating grasper were used in addition to standard 
laparoscopic equipments. After splenic hilar dissection, a 
3–5 mm-wide cloth tape was introduced intraperitoneally to 
encircle and tug the splenic hilum. Both ends of the tape were 
extracted through an extra needle hole in the skin. Pulling of 
the tape in the appropriate directions provided excellent 
exposure of the splenic hilum. Under suffi cient tension and 
exposure by tugging the spleen, a linear stapler was intro-
duced for stapling the splenic vessels.
Results: The tug-exposure technique was successfully used 
in all patients and markedly improved the exposure of the 
splenic hilum. Only one patient with ITP required conver-
sions to open splenectomy due to bleeding from the splenic 
hilum. The intraoperative blood loss (mean ± S.D.) was 157 
± 304 ml. The operative time (mean ± S.D.) was 232 ± 81 
minutes, and the extracted spleen weight (mean ± S.D.) was 
337 g. The postoperative hospital stay (mean ± S.D.) was 7 
days. All patients were discharged uneventfully. Postoperative 
follow-up at 19 ± 8 months after surgery did not reveal any 
complications. The umbilical incision and the needle hole for 
tug exposure technique for the splenic hilum were com-
pletely invisible.
Conclusion: Using the tug-exposure technique and some 
technical refi nements, SILS performed by experienced sur-
geons is as safe as conventional laparoscopic splenectomy.
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ROUTINE AND SEAMLESS 3D LIVER 
LESION TARGETING FOR 
LAPAROSCOPIC ABLATION: 
ONE STEP CLOSER
K. Simo1, D. Sindram1, I. McKillop1, S. Razzaque2, 
J. Martinie1 and D. Iannitti1
1Section of Hepatobiliary and Pancreas Surgery, 
Department of General Surgery, Carolinas Medical Center, 
Charlotte, NC, USA; 2InnerOptic Technology, Inc., 
Hillsborough, NC, USA
Carolinas Medical Center, Charlotte, NC USA; Section of 
Hepatobiliary and Pancreas Surgery, Department of 
General Surgery, 1025 Morehead Medical Drive, Suite, 
30028204 Charlotte, USA
Introduction: To overcome challenges of targeting liver 
lesions, a novel 3D image guidance system (3D-IGS) was 
developed by InnerOptic (Hillsborough, NC). The aims of 
this study were to perform an in vivo evaluation of next 
generation magnetic position tracking systems for use with 
microwave antennae and radiofrequency ablation probes 
(MWA/RFA) while reviewing system performance under OR 
conditions.
Methods: Tumor mimics were placed intrahepatically in 
swine to compare conventional laparoscopic ultrasound-
guided ablation to 3D-IGS. The 3D-IGS was designed with 
position sensors built into (RF-probe) or bonded to (MWA-
antenna) laparoscopic ablation instruments in conjunction 
with a table top magnetic fi eld generator to track positioning. 
A fl exible laparoscopic ultrasound probe with snap-on posi-
tion sensor was employed to identify tumor mimics. After 
pneumoperitoneum was achieved and ports placed, ablations 
were performed.
Results: Operative workfl ow was not affected by fi eld gen-
erator location, position sensors or presence of a protective 
sleeve. Overall, tracking accuracy remained high with no 
interference detected between this system and essential OR 
instruments/equipment. Minor interference was detected 
with specifi c instruments (notably those with gold-plated 
handles) leading to warnings on the 3D-IGS. Using the 
3D-IGS ablation probe position sensors survived multiple 
stabs/ablations with 8/8 superfi cial targets hit on the fi rst 
attempt (mean = 43.7 seconds; range 24–76 seconds).
Conclusion: The new generation 3D-IGS solved many 
technical issues associated with its predecessor and per-
formed well and with high fi delity in an in vivo model under 
real-time OR conditions. We are proceeding with quantita-
tive validation and human trials.
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LIVER BENIGN TUMOUR IN MEN: 
IS THE PRESENTATION SIMILAR 
TO WOMEN?
M. Scotté1, L. Lacaze1, O. Goria2, G. Riachi2 and 
J. P. Lestrat3
1Department of Digestive Surgery; 2Department of 
Gastroenterology and Hepatology; 3Department of 
Radiology
Digestive Surgery, Hopital Charles Nicolle, 1, rue de 
Germont, 76000 Rouen, France
Introduction: Liver benign tumors are mainly represented 
by adenoma (Ad), focal nodular hyperplasia (FNH) and hae-
mangioma (Ha), that have different prevalence and compli-
cations. FNH and Ad are relatively common in women but 
rare in men. The main diffi culty in men is to distinguish these 
lesions from malignant tumours. The aim of this study was 
to investigate whether there were some differences between 
men and women based on the characteristics of these tumors.
Methods: We reported a retrospective surgical series of 203 
women and 28 men operated on for benign liver tumour 
between 1984 and 2008 in a single center. In this population, 
Ad represented 22% of resected tumours, HA 22% and FNH 
56%. Indications of liver resection for Ha and FNH were 
symptomatic lesions or lack of preoperative diagnosis, espe-
cially in men, patients with history of cancer and not typical 
imaging examinations or no-contributive biopsy. Clinical 
and radiological presentation, characteristics of tumours 
were compared in men and women.
Results: Repartition of tumours was different between men 
and women: Ad (7% vs 24%), Ha (57% vs 17%), FNH (36% 
vs 59%), respectively (p < 0.05). Men were older than 
women (55 years vs 42 years, p < 0.05). Main clinical symp-
toms were abdominal pain, observed in 36% of men vs 48% 
of women. Liver test functions were modifi ed in 14% of men 
vs 19% of women. Tumour was fortuitously discovered 
using ultrasound sonography in 21% of men and 29% of 
women. There was a history of cancer in 15% of patients, 
different in men (35%) than in women (12%). The concor-
dance between preoperative and pathological diagnosis was 
33% in all patients, lower in men (11%) than in women 
(36%). The mean diameter of tumor was larger in women 
(58 mm) than in men (40 mm).
Conclusion: Benign liver tumours in men differ from those 
in women in many clinical features. According to the risk of 
liver malignancy and the diffi culty of preoperative diagnosis, 
a systematic liver resection seems recommended in men pre-
senting with such tumours.
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LAPAROSCOPIC HABIB BIPOLAR 
RADIOFREQUENCY ABLATION 
FOR BLOODLESS LAPAROSCOPIC 
LIVER RESECTION
A. Belli1, V. Albino1, R. Palaia1, A. Amore1, C. Granata2, 
S. Setola2, A. Petrillo2 and F. Izzo1
1National Cancer Institute of Naples “G. Pascale”, 
Hepatobiliary Section, Naples, Italy; 2National Cancer 
Institute of Naples “G. Pascale”, Division of Radiology, 
Naples, Italy
National Cancer Institute “G. Pascale”, Naples, Italy; 
Department of Abdominal Oncology, Hepatobiliary Section 
and ‘Division of Radiology, Via Mariano Semmola 100, 
80131 Naples, Italy
Introduction: In recent years the progress of laparoscopic 
procedures and the development of new and dedicated tech-
nologies made laparoscopic hepatic surgery feasible and safe 
in selected cases. Never less laparoscopic liver resection 
remains a challenging surgical procedure because of the risk 
of massive bleeding during liver transection and the compli-
cated intra-hepatic biliary and vascular anatomy. A new lapa-
roscopic device could help and assist laparoscopic liver 
resection.
Methods: The laparoscopic Habib 4X (LH4X) is a bipolar 
radiofrequency device consisting of a 2 × 2 array of needles. 
It produces a coagulative necrosis of liver parenchyma 
sealing biliary and vascular structures. After liver mobiliza-
tion it can be iteratively introduced along the intended tran-
section line enabling an almost bloodless parenchymal 
transection.
Results: Four patients (1 for HCC and 3 for metastatic 
colorectal cancer) were submitted to laparoscopic liver 
resection with LH4X during the last 2 months. Surgical pro-
cedures consisted of 1 atypical resection of segment IV, 1 
segment VI resection, 1 left lateral sectionectomy and 1 
double atypical resection of segments IV and VIII. Pringle 
manoeuvre was never performed. None of the patients 
required intraoperative transfusion of red cells or blood prod-
ucts. Mean blood loss was 150 ml. Post-operative course was 
uneventful in all cases.
Conclusion: Laparoscopic liver resection can be safely per-
formed with laparoscopic Habib 4X with a signifi cant low risk 
of intraoperative bleeding or postoperative complications.
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INFLUENCE OF MAJOR HEPATIC VEIN 
INJURY ON TREATMENT OF BLUNT 
LIVER INJURY
G. O Jung, D. E. Park and K. M. Chae
Department of Surgery, Wonkwang University Hospital, 
Wonkwang University College of Medicine, Iksan, Korea
Wonkwang University Hospital, Wonkwang University 
College of Medicine, Surgery, Synyoung-dong, Iksan-city 
Jeonbuk, 344-7 Iksan, Korea
Introduction: Non-operative management of blunt liver 
injuries is highly successful in lower grade blunt liver injury 
(LI) patients. However, high grade blunt LI patients are 
shown higher rate of operation management than lower grade 
LI (grade I~II). Several factors such as contrast dye leak in 
CT, initial systolic blood pressure, and high grade of LI were 
known as risk of operative management. However, infl uence 
of major hepatic vein (MHV) injuries on management of 
blunt LI has not been well characterized. The purpose of this 
study was to analyze whether MHV injuries affect on choice 
of therapeutic modality of blunt LI and prognosis of patients.
Methods: From Jan. 2002 to Dec. 2009, 329 patients were 
treated after diagnosis as blunt LI. 90 of 329 patients were 
included to blunt LI grade III to V according to classifi cation 
of CT fi nding. We divided into three groups according to 
grade of LI. We reviewed medical record, retrospectively.
Results: Mean age of patients (n = 90) was 39.1 years old. 
63 of 90 patients were managed by non-operative treatment 
and 27 were treated by operative method. Morbidity and 
mortality of patients were 7 (7.8%) and 9 (11%), respec-
tively. In clinical and CT fi nding, initial systolic blood pres-
sure, initial diastolic blood pressure, transfusion amount, 
amount of hemoperitoneum, injury of major hepatic vein, 
and leakage of dye in CT showed signifi cant difference in 
each group. However, injury of major hepatic vein without 
injury of hepatic artery or portal vein did not showed signifi -
cance in multivariate analysis for operation risk and mortal-
ity risk. Vessel injury in CT fi nding showed signifi cance for 
risk of operation and mortality.
Conclusion: Direct application of CT based grading system 
for classifi cation of blunt liver injury may be predict the 
probable clinical outcome of attempted nonsurgical manage-
ment If contrast material leak in CT scan is caused by main 
hepatic injury, non-operative management is considered to 
be suffi cient because most of patients with this injury has 
been hemodynamic stable state. First of all, angiographic 
intervention may be apply to hemodynamic stable patient 
who show a extravasation of contrast material related arterial 
injury in the CT scan.
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EXPERIENCES OF LAPAROSCOPIC 
LIVER RESECTION IN VARIABLE 
LIVER DISEASE
I.-S. Song, S.-J. Han, K.-S. Chun
Chungnam National University Hospital, Department of 
Surgery, 33 Munhwaro, Jung-Gu, 30172 Daejoen, Korea
Introduction: To review and investigate the experiences of 
laparoscopic liver resection in variable liver disease.
Methods: From April 2008 to December 2010 in Chungnam 
national university, 49 cases of laparoscopic liver resection 
were performed among 157 liver resections. During formal 
one year, mainly laparoscopy assisted liver resections were 
performed and during later two years totally laparoscopic 
liver resections were main operative type. Surgery type is 
decided preoperatively by intension to treatment. Clinical 
data were collected retrospectively and comparatively ana-
lyzed by surgery type.
Results: 28 patients were diagnosed IHD stone with RPC, 
9 patients were HCC, 5 patients were colorectal cancer with 
liver metastasis and 7 patients were benign hepatic tumors. 
Laparoscopy assisted liver resection was 16 cases (32.7%) 
and totally laparoscopic liver resection was 33 cases (67.3%). 
Anatomic major liver resection was 40 cases (81.6%) and 9 
cases (18.4%) were nonanatomic resection. Open conversion 
was done in two cases. Complications were happened in 4 
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cases, two cases were bile leakage. Pulmonary atelectasis 
and indigestion were happened in one case each. All of them 
were recovered with conservative managements.
Conclusion: In this study, we conclude laparoscopic liver 
resection is safe and feasible operation but it needs to be 
carefully conducted when it comes to malignant tumors.
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USEFULNESS OF MODIFIED LIVER 
HANGING MANEUVER IN LEFT-SIDE 
MAJOR HEPATECTOMY
Y. Seyama, M. Matsuda, J. Shindoh, Y. Miyata and 
N. Umekita
Hepato-Biliary-Pancreatic Surgery Division, Department 
of Surgery, Tokyo Metropolitan Bokutoh Hospital
Tokyo Metropolitan Bokutoh Hospital, Hepato-Biliary-
Pancreatic Surgery Division, Department of Surgery, 
4-23-15 Koutoubashi, Sumida-ku, 130 Tokyo, Japan
Introduction: Liver hanging maneuver (LHM) is widely 
used technique in liver surgery to make hepatic transection 
safe and easy. However, LHM is not commonly used in 
left-side major hepatectomy, and has not been fully intro-
duced yet. Herein, we present the surgical techniques and 
results of left-side major hepatectomy using LHM with 
video-presentations.
Methods: We have performed fi ve cases of left-side major 
hepatectomy with caudate lobe resection since introduction 
of LHM (LHM group). The LHM was utilized when com-
bined resection of the middle hepatic vein (MHV) was 
needed for surgical margin, or in cases that full mobilization 
of the liver was diffi cult due to bulky lesions. Surgical tech-
nique included: The left lobe and the caudate lobe were 
mobilized fi rst to a maximum extent, and then a tape was 
placed behind the liver (modifi ed LHM). Liver transection 
of deeper part of the caudate lobe was done with LHM. The 
root of the middle and left hepatic vein was divided at the 
fi nal step. The outcomes were compared with previous four 
cases of left-side major hepatectomy without LHM (non-
LHM group).
Results: Operation comprised four extended left hepatec-
tomy (ELH) with MHV resection and one left trisectoriec-
tomy (L3H) in the LHM group, and 3 ELHs and 1 L3H in 
the non-LHM group. Resection of the extrahepatic bile duct 
was performed in three cases in both groups. The procedures 
were completed in four cases, however, in one patient ante-
rior approach was required because full mobilization of the 
liver was diffi cult due to adhesion. Blood loss of the LHM 
group (687 g in average, range, 499–1002 g) was less than 
that of the non-LHM group (2150 g in average, range, 842–
4757 g). Morbidity rate and postoperative stay were signifi -
cantly improved in the LHM group compared with the 
non-LEM group (0% vs. 75%, and 9 vs. 25 days in average, 
respectively).
Conclusion: Modifi ed LHM is safe and useful also in left-
side major hepatectomy, and has some advantages in techni-
cal demanding cases. Modifi ed LHM can be standardized for 
left-side major hepatectomy with combined resection of 
MHV.
459
CONTEMPORARY MANAGEMENT AND 
CLASSIFICATION OF HEPATIC 
LEIOMYOSARCOMA
K. Roberts1, M. Hamed1, W. Merchant2 and P. Lodge1
1Dept of Liver Surgery, St James Hospital, Leeds, UK; 
2Dept of Pathology, St James Hospital, Leeds, UK
St James University Hospital, Liver Surgery, 77 Three 
Acres Lane, Dickens Heath, Shirley B90 1NZ, UK
Introduction: Abdominal leiomyosarcoma (LMS) is rare. 
Furthermore the majority of tumours previously considered 
as LMS have been identifi ed as gastrointestinal stromal 
tumours (GIST). Consequently understanding the outcome 
of liver resection for true LMS is limited. An increasing body 
of evidence distinguishes subtypes of abdominal LMS. This 
study aims to present the outcome of liver resection for LMS 
and create an algorithm for their pathological assessment.
Methods: Cases were identifi ed from a departmental 
database. All tumours were negative for c-kit expression. 
Immunocytochemistry was performed to identify the pres-
ence of oestrogen or progesterone receptor (ER/PR) expres-
sion or Epstein Barr virus (EBV) relating to subtypes of 
LMS. Cases were stratifi ed according to this immunhisto-
chemistry (IHC) profi le and those negative for ER/PR and 
EBV expression classifi ed as LMS-NOS (not otherwise 
specifi ed).
Results: 8 subjects (7 females) with a median age of 64 
underwent a total of 10 liver resections over an 11 year 
period. The primary tumour was located in the mesentery, 
gynaecological organs or retroperitoneum in 4, 2 and 1 case 
respectively. Both cases of gynaecological origin stained 
positive for ER/PR. There was a single case of primary 
hepatic LMS. A single patient had previously undergone 
renal transplantation and this tumour was associated with 
EBV expression. The median survival was 40 months (range 
4–108) with 5 patients presently alive and disease free.
Conclusion: Hepatic resection of LMS is associated with an 
encouraging proportion of disease free cases though longer 
follow is required to confi rm disease free survival. An 
expected worse outcome compared to historical cohorts 
(partly comprising subjects with GIST) was not observed. 
Immunohistochemistry characterises subgroups of LMS: 
gynaecological, EBV related and LMS-NOS. The potential 
role of hormonal therapy or modulating immunosuppression 
in the fi rst two subtypes is yet to be fully explored.
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HEPATIC PORTAL VENOUS GAS A 
SINGLE INSTITUTE EXPERIENCE
S. Vasani, L. Rashidi, P. Thomas and K. Brown
University of Texas Medical Branch, Galveston, Texas, 
USA
University of Texas Medical Branch, General Surgery, 301 
University Boulevard, Galveston, Texas 77555, USA
Introduction: Portal venous gas (PVG) is a radiographic 
sign of underlying intra-abdominal pathology often associ-
ated with poor prognosis. With the added sensitivity and 
increased utilization of modern computed tomography (CT) 
PVG is being identifi ed more frequently. The goal of this 
study was to identify patients in need of urgent surgical 
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intervention based on their clinical presentation and distin-
guish them from those with benign PVG.
Methods: All reports on the abdominal CT scans and ultra-
sound (US) performed at our institution between December 
1995 and November 2010 were searched for the key words 
“portal venous gas” or “portal venous air”. Only patients 18 
years or older were included in the study. We performed a 
retrospective chart review of 52 patients with PVG thus 
identifi ed. Characteristics assessed included age, sex, clinical 
presentation, co-morbidities, radiological fi ndings, labora-
tory results, surgical fi ndings and clinical outcomes. We were 
able to identify four distinct clinical subgroups: acute mes-
enteric ischemia, mechanical causes, intra abdominal sepsis 
and benign idiopathic.
Results: Acute mesenteric ischemia group (n = 10) had 
elderly patients (average age 69.8 years) with co-morbidities, 
including coronary artery disease in 5 (50%) and peripheral 
arterial disease in 3 (30%). Surgical intervention was required 
in 6 and mortality was 50% (5/10). Mechanical causes group 
(n = 10) had a relatively younger population (average age 
54.5 years) with no co-morbidities. Nine patients required 
surgery, with no mortality. Intra abdominal sepsis was seen 
in 12 patients with an average age of 60.8 years with 3 (25%) 
requiring surgery and a mortality of 5 (42%). Benign idio-
pathic was the most common cause of PVG seen in 20 
patients (39%) with an average age of 57.9 years, 5 of whom 
were diagnosed by US. None required surgery and 3 (15%) 
died.
Conclusion: While PVG may be an ominous radiologic 
fi nding, it must be interpreted in the context of the underlying 
abdominal pathology. Mechanical causes are most likely to 
require surgery but have the best prognosis. Ischemic causes 
are associated with a poor prognosis. A clinical algorithm can 
identify subgroups to direct surgical intervention and assist 
surgeons in discussing prognosis with patients and 
families.
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SOLID PAPILLARY TUMOR AS 
PRIMITIVE LESION OF THE LIVER. 
CASE REPORT
R. D. Valle1, E. Thai2, C. B. Enrico3 and M. Silini2
1Dept. of Surgery, Azienda Ospedaliero-Universitaria Di 
Parma; 2Dept. of Pathology, Azienda Ospedaliero-
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Introduction: Solid papillary tumor (SPT) is an uncommon 
lesion of the pancreas, which origin and behavior are poorly 
understood. Rare cases of SPT have been described in extra-
pancreatic sites and only one has been described in the liver. 
Here we describe a case of a primitive SPT arising in the 
liver.
Methods: A 56-year-old Ukrainian woman came to the 
clinical attention for cholestasis with a bulky hepatic mass. 
A MR-cholangio-pancreatography revealed a polilobated 
mass measuring 20 cm, occupying the right liver (segments 
S4, S5, S6, S7 and S8), with inhomogeneous contrast-
enhancement due to hemorrhagic and fi brous areas. These 
features were deemed compatible with an angiomatous 
lesion. Neoplastic markers were within normal limits. Tests 
for HBV and HCV were negative. The patient underwent a 
percutaneous needle biopsy and needle aspiration of the 
lesion. As the morphology suggested an epithelial lesion, but 
all epithelial markers were negative, a diagnosis of poorly 
differentiated epitheliomorphic neoplasia or epithelioid 
sarcoma was suggested.
Results: The patient underwent a right hepatectomy 
enlarged to the IV segment. Histology revealed an epithelio-
morphic tumor formed by medium-size cells, with round and 
mildly atypical nuclei, granular chromatin, small nucleoli 
and rare mitosis. Vascular invasion by neoplastic emboli was 
observed. Immunohistochemically, the neoplastic cells were 
positive for vimentin, α1-antytrypsin, α1-antychymotrypsin, 
progesteron receptor, beta-catenin and NSE (neuron-spe-
cifi c-enolase). Histological, immunohistochemical and ultra-
structural features were coherent with the diagnosis of solid 
papillary tumor. Since the patient showed no other oncologi-
cally signifi cative lesions, the primitivity of this tumor could 
be confi rmed. No evidence of disease has been reported at 
one year follow-up.
Conclusion: Most SPTs are described as primitive lesions 
of the pancreas. Rare cases have been reported in extrapan-
creatic sites, including omentum, peritoneum and mesoco-
lon. Only one case has been described in the liver as a 
primary tumor, a possible site of metastatic spread in the rare 
aggressive forms. In our patient, both imaging and surgical 
exploration excluded other tumors outside the liver, making 
the present case, at best of our evaluation, the second case 
described so far in literature of primary SPT of the liver.
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LARGE SYMPTOMATIC TUMOR OF THE 
SPLEEN: A RARE ENTITY WITH A 
DISTINCT DIAGNOSIS!
A. S. Rajegowda, G. Shetty, P. Varty and J. Zaveri
Department of Surgical Gastroenterology, Lilavati Hospital 
& Research Centre, Bandra, Mumbai, Maharashtra, India
Lilavati Hospital & Research Centre, Surgical 
Gastroenterology, A-791, Bandra Reclamation, Bandra 
(W), 50 Mumbai, Maharashtra, India
Introduction: Splenic hamartoma is rare benign tumor with 
incidence 3 in 200000 splenectomies. It was fi rst described 
by Rokitansky in 1861. In the literature, there are fewer than 
200 cases published so far. It is often called splenoma or 
nodular hyperplasia or splenoadenoma. Most common 
tumors of spleen are lymphomatous tumors. Benign splenic 
tumors are exceedingly rare; amongst them most are 
either cysts or hemangiomas. Most hamartomas are 
asymptomatic.
Methods: 50 year old female, presented with left upper 
quadrant discomfort, for 2 months. The physical examination 
was non contributory. Ultrasound of the abdomen showed a 
8 × 10 cm lesion in the spleen with mixed echogenicity. A 
contrast enhanced CT scan revealed a strongly enhancing 
lesion. Lesion was nonhomogenous with no calcifi cation or 
cysts. MRI showed an isointense lesion on T1 image and a 
heterogenous hyperintense lesion on T2. Diagnosis of a 
malignant tumor could not be excluded completely. 
Splenectomy was done via a wide left subcostal incision.
Results: On gross examination, the cut surface showed an 
ill circumscribed dark red fi rm 8 × 10 cm lesion in the centre, 
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pushing the surrounding parenchyma. No necrosis or cysts 
or calcifi cation were evident. Microscopically, the lesion 
showed an expansive growth compressing the surrounding 
splenic tissue with the capsule. It consists of disorganized 
vascular channels lined by endothelial cells with red pulp 
without atypia. Immunohistochemistry was insignifi cant. 
The pathological diagnosis was a splenic hamartoma.
Conclusion: Splenic hamartoma is a rare benign tumor. 
Pathogenesis includes a congenital malformation of red pulp 
or a reactive lesion to prior trauma or neoplastic though 
nothing is proven so far. Histopathologically, splenic hamar-
tomas are of follicular (pulposal) type, or fi brous type. Large 
and symptomatic lesions are common in females, indicating 
a hormonal infl uence. Symptoms seem dependant on size. 
Symptomatic hamartomas are of the red pulposal type.
474
COMPARISON OF PREDICTED VERSUS 
EFFECTIVE MICROWAVE ABLATION 
VOLUMES IN AN EX-VIVO PORCINE 
LIVER MODEL
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Introduction: The liver is the most common site for 
colorectal cancer metastases. Not all patients are resectable 
as disease extent, tumor location or comorbidities prevent 
surgery. Microwave ablation (MWA) may prolong survival 
but local recurrence rates are problematic. This may partly 
be explained by patient analyses showing a discrepancy 
between predicted and effective ablation volumes. Here we 
compare effective ablation volumes after MWA with those 
predicted by the manufacturer in an ex-vivo porcine model.
Methods: In patients requiring MWA, predicted (according 
to protocols by Microsulis Medical) and effective ablation 
volumes were compared using CT analysis. Based on these 
results, a standardized porcine model was developed using 
freshly explanted livers, initially fl ushed with 4°C preserva-
tion solution (PS) with 25 000 IU heparin. During the abla-
tion, the liver was continuously perfused with warm PS via 
the portal vein (PV) at 1.6–1.8 l/min maintaining physiologi-
cal pressures in the PV and the vena cava while ensuring a 
constant temperature. MWA was carried with Microsulis 
ablation probes. Effective ablation volumes will be measured 
using CT-analysis and histological work-up.
Results: In patients treated with MWA for multiple metas-
tases, total predicted and effective ablation volumes were 
compared using postoperative CT evaluation, revealing 
signifi cant patient-specifi c differences of 154 to 468%. 
Preliminary results in the porcine liver model show the fea-
sibility of the experimental set-up with maintenance of phys-
iological conditions for ablation volume measurements. In 
particular, portal venous fl ow rates, venous pressures and 
liver temperature were maintained to mimic the in vivo 
setting. Initial results show reproducibility of ex vivo MWA 
using standard ablation needles (Microsulis Medical) used in 
human surgery.
Conclusion: To increase accuracy during MWA procedures, 
a more precise understanding of the effective ablation char-
acteristics is required. Using an advanced porcine model will 
enable the development of more accurate prediction models. 
In future, we intend to integrate MWA prediction into instru-
ment guidance systems, maximizing treatment effect (low 
local recurrence) without compromising patient safety. This 
is particularly important in patients with tumors located near 
the hepatic veins or biliary pedicle.
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INCIDENTALLY DISCOVERED GIANT 
TELENGIECTATIC ADENOMA OF LIVER
N. Kumar, S. Sasturkar and V. Pamecha
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Sciences, New Delhi. India.
Institute of Liver & Billiary Sciences, New Delhi. India; 
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Introduction: Telengiectatic adenoma (TA) is a rare benign 
liver tumor, a variant of liver cell adenoma (LCA). LCA may 
be complicated with rupture, hemorrhage and malignant 
degeneration. TA is predominantly found in young women 
(92%), strongly associated with oral contraceptive use and 
occurs in overweight or even obese patients. Initially 
described as the variant of FNH it now well recognized that 
it is more closely related to LCA. Defi nitive treatment is 
operative resection.
Methods: A 32-year male with liver mass on ultrasound was 
evaluated. CECT abdomen showed a large heterogeneously 
enhancing mass lesion in right lobe of liver in arterial phase, 
with more prominent enhancement in portal venous phase 
and no contrast washout in delayed phase. FNAC was nega-
tive for malignant cells. In view of uncertainty of diagnosis 
we performed right lobe hepatectomy. Intraoperatively an 
atypical highly vascular tumor without any central scar 
involving entire right lobe of liver was seen.
Results: On histopathology tumor show 1–2 cell thick cords 
of hepatocytes demarcated in places by thick fi brocollage-
nous tissue bands. Prominent areas of congestion, peliosis 
and sinusoidal dilatation are seen in the tumor. In few areas, 
blood vessels and remnants of portal areas devoid of bile 
ducts are noted.
The postoperative recovery of the patient was uneventful 
with highest serum bilirubin of 2.9 mg/dl. Patient was dis-
charged on day 8 of surgery and is asymptomatic at six 
months of follow-up.
Conclusion: Telengiectatic adenoma (TA) is a rare benign 
liver tumor with malignant potential. It is considered as the 
variant of liver cell adenoma, though earlier thought to be a 
variant of focal nodular hyperplasia. TA can present a diag-
nostic challenge despite of modern imaging techniques 
necessitating hepatic resection for confi rmation. Our patient 
required battery of investigation and subsequently surgery 
for confi rmation of diagnosis.
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OUR EARLY EXPERIENCES WITH 
SINGLE-INCISION LAPAROSCOPIC 
LIVER SURGERY : THE FIRST 
7 PATIENTS
C. Salloum, C. Tayar, A. Laurent, R. Memeo, F. Brunetti, 
P. Goyer, P. Bucur and D. Azoulay
Hepato-Biliary and Liver Transplant Unit, Henri Mondor 
Hospital, Créteil, France
Hopital Henri Mondor, Service Chirurgie Digestive, 51 
Avenue du Maréchal de Lattre de Tassigny, 94000 Creteil, 
France
Introduction: Laparoscopic surgery via a single-incision is 
an evolving technique that has been applied over the past 4 
years to laparoscopic cholecystectomy, nephrectomy, sple-
nectomy and obesity surgery. To the best of our knowledge, 
there has been few reports on transumbilical single-incision 
laparoscopic hepatectomy. We have performed 266 cases of 
laparoscopic hepatectomy since 1996. We present our initial 
experience of single-port laparoscopic liver surgery.
Methods: From October 2010 to September 2011, 7 patients 
were selected for single-incision laparoscopic liver surgery. 
The abdomen was approached through a 20 mm supraum-
bilical incision. Each procedure was performed through a 
single Triport. No supplemental ports were required. The 
liver was transected using a combination of Ligasure, har-
monic scalpels and staplers.
Results: The liver resection procedure was successfully 
completed for the 7 patients. The procedures consisted of 2 
partial resection of segment 3, 2 partial resection of segment 
5 and 3 partial resection of segment 6 in addition to concomi-
tant cholecystectomy (n = 1) and pulmonary wedge resection 
(n = 1) The mean operative time was 98.3 min (range, 
60–150 min) and the mean estimated blood loss was 57 ml 
(range, 25–150 ml). The postoperative courses were unevent-
ful and the mean hospital stay was 5.1 days (range, 1–13 
days). Pathology identifi ed 3 benign and 4 malignant liver 
tumors with a clear margin.
Conclusion: This preliminary experience suggests the tech-
nical feasibility and safety of liver wedge resection through 
single port access in terms of intra- and postoperative results 
respecting oncological principles concerning the width of the 
resection margin. However, this surgical technique requires 
relatively advanced laparoscopic skills and extensive surgi-
cal experience. Further studies are needed to determine the 
potential advantages of this technique, apart from the better 
cosmetic result, compared to the traditional laparoscopic 
technique.
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LAPAROSCOPIC DEVASCULARIZATION 
OF GASTRIC VARICES USING INTRA-
OPERATIVE DOPPLER SONOGRAPHY 
TO IMAGE VARICEAL BLOOD FLOW
Y. Sakuma, T. Zuiki, Y. Hosoya, H. Sasanuma, A. Shimizu, 
M. Hyodo, N. Sata and Y. Yasuda
Jichi Medical University, Department of Surgery
Jichi Medical University, Department of Surgery, 3311-1, 
Yakushiji, 329 Shimotsuke, Japan
Introduction: After the development of BRTO (balloon-
occluded retrograde transvenous obliteration of varices), the 
number of surgical procedures for gastric varices has 
decreased. Operative intervention may still be necessary if 
BRTO is unsuccessful. Laparoscopic surgery for portal 
hypertension is considered to have increased risk because of 
collateral venous drainage and excessive bleeding. In this 
study, we describe our results with laparoscopic devascular-
ization of gastric varices.
Methods: Between 2010 and 2011, we performed six cases 
of devascularization of gastric varices treated laparoscopi-
cally using intra-operative Doppler sonography to verify the 
disappearance of variceal blood fl ow to minimize the dissect-
ing area.
Results: Based on the intraoperative sonograhic fi ndings, 
pericardial devascularization was suffi cient to diminish fl ow 
in the gastric varices in every case. Postoperative endoscopic 
and CT fi ndings were also satisfactory. Two patients required 
mini-laparotomy to control intra-operative bleeding. The 
mean hospitalization time was 9.2 days (7–21 days). Peri-
operative complications included mild ascites in one patient 
and delayed gastric emptying in one patient. No mortality or 
rebleeding occurred.
Conclusion: Laparoscopic devascularization combined 
with intra-operative Doppler sonography is safe and effective 
in the treatment of portal hypertension. The keys to success 
include experienced laparoscopic skills and careful manipu-
lation of tissues.
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ROBOTIC-ASSISTED LEFT LATERAL 
HEPATIC SECTIONECTOMY: THE 
HENRI-MONDOR EXPERIENCE
C. Salloum, C. Tayar, A. Laurent, R. Memeo, F. Brunetti, 
P. Goyer, P. Bucur and D. Azoulay
Hepato-Biliary and Liver Transplant Unit, Henri Mondor 
Hospital, Créteil, France
Hopital Henri Mondor, Service Chirurgie Digestive, 51 
Avenue du Maréchal de Lattre de Tassigny, 94000 Creteil, 
France
Introduction: Laparoscopic hepatectomy remains techni-
cally challenging. The recent introduction of robotic surgical 
systems has revolutionized the fi eld of minimally invasive 
surgery in many different surgical specialties in regards to 
3-dimensional images and better instrumentations. It offers 
solutions to the fundamental limitations of conventional 
laparoscopic liver resection.
Methods: Between Mars 2011 and July 2011, we performed 
5 left lateral liver sectionectomy for both benign and malig-
nant lesions by robot-assisted laparoscopic approach. A Da 
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Vinci Robotic Surgical System (Intuitive Surgical, Mountain 
View, CA, USA) with three arms was used and two addi-
tional laparoscopic ports for the assistant surgeons were 
added. No Pringle maneuver was used. The dissection was 
carried out with the bipolar forceps on the left arm of the 
surgeon and the Harmonic curved shears on the right arm. 
The division of the vascular pedicles for segments II and III 
was performed with EndoGIA staplers. Prospectively col-
lected data was analysed retrospectively.
Results: Overall mean operative time was 139 ± 20.5 
minutes (range :120–170). Overall mean intraoperative 
blood loss was 240 ± 210 ml (range :100–600). One open 
conversion was needed. One patient (20%) had postoperative 
complication (thrombosis in the right anterior portal branch). 
There was no mortality and no reoperations. Mean hospital 
stay was 7 ± 5.2 days (range :3–16). All patients had R0 
resection.
Conclusion: In experienced hands, robot-assisted left lateral 
sectionectomy is feasible and safe. Further evaluation with 
clinical trials is required to assess for improvement in out-
comes and to validate its real benefi ts. Long-term oncologic 
outcomes are still pending. Further research on its cost-
effectiveness is required.
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LIVER HYDATIDOSIS: REASONED 
INDICATIONS OF SURGICAL 
TREATMENT. COMPARISON 
BETWEEN CONSERVATIVE AND 
RADICAL TECHNIQUES
G. Salamone, R. Tutino and G. Gulotta
Dipartimento di Discipline Chirurgiche ed Oncologiche-
Università degli Studi di Palermo
Università degli Studi di Palermo, Dipartimento di 
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Introduction: Hydatidosis is although a widespread para-
sitic disease and in Sicily the rate of incidence of this disease 
is elevated instead with vaccinations and measure of preven-
tion it is today less frequent. The surgery is nowadays the 
fi rst instrument for the eradication of this infestation in 
humans in our region.
The aim of this study was to fi nd indications for the surgi-
cal treatment of the liver hydatidic disease comparing the 
conservative and the radical techniques.
Methods: We have done a retrospective study where we 
analyzed 50 patients who underwent a surgical treatment for 
liver hydatidosis in the U.O. of General and Urgent Surgery 
of the Policlinico “Paolo Giaccone” of Palermo from 2000 
to 2011. Exclusion criteria were uncertain diagnosis with 
ultrasound, CT and MRI, laboratory analysis and pathologic 
anatomy. We divided the patients into two groups depending 
on the respective surgical technique. We have analyzed 
demographical data, clinical presentation, localization and 
characteristics of the liver cysts, hospital stay, occurrence of 
post-operative complications and relapse. Data were ana-
lyzed with the Fisher’s Exact Test.
Results: There were 50 patients in our study, 24 men and 
26 women. 78% of our patients were symptomatic. 29 
patients underwent conservative surgery, the radical tech-
niques were used in 21 patients. There was a relation between 
the situation of the cysts and chosen technique, in fact the 
fi sher’s exact test result was of p < 0.001. Radical techniques 
were used in cysts with a diameter less than 10 cm or local-
ized in the left lobe, even if of bigger diameter; those in the 
right lobe bigger than 10 cm, complex cysts with an intra-
biliary rupture, an intra-peritoneal rupture and in contiguity 
with major vascular and biliary structures underwent conser-
vative surgery. Post-operative morbidity was related with the 
conservative techniques (p < 0.004).
Conclusion: We recommend for the treatment of hydatidic 
liver cyst of the left lobe the use of radical surgery, even 
thanks to the use of liver resection, while for right lobe’s 
cysts, in particular if complex, we thought that the conserva-
tive treatment could be a possibility, even if this method 
brings an elevated rate of morbidity.
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CHALLENGE IN DIFFERENTIAL 
DIAGNOSIS OF A LIVER MASS 
HISTOLOGICALLY DEFINED AS A 
METASTATIC LESION FROM AN 
OCCULT PRIMARY INTESTINAL 
TUMOUR. THE IMPORTANCE OF THE 
CLINICAL FINDINGS AND THE 
LIMITATION OF HISTOLOGY AND 
MOLECULAR PROFILES
G. L. Barba1, A. Gardini2, L. Saragoni2, D. Calistri2, 
A. Casadei2, L. Serra2, L. Frassineti2 and D. Garcea2
1IHPBA EHPBA; 2Morgagni Pierantoni Hospital, General 
Surgery, Via Forlanini 3447100 Forli, Italy
Introduction: Differential diagnosis of liver lesion in 
absence of proved primary tumor is still a challenge. We 
experienced a case of an asymptomatic 14 cm lesion of right 
hemiliver, in a 67 year-old man submitted to right hepatec-
tomy in December 2010. One year before diagnosis patient 
underwent to curative and complete removal of polypoid 
lesion of right colon diagnosed as tubular adenoma with low 
grade dysplasia.
Methods: Preoperative endoscopy was negative. Preope-
rative diagnosis was supported by ultrasound, CT scan, PET 
and liver biopsy. Patient received 6 cycle of preoperative 
chemotherapy (FOLFOX). Resection margins were R0 and 
pathological report defi ned the lesion more compatible with 
a liver metastasis of intestinal mucinous adenocarcinoma. 
Immunohistochemistry showed positivity for cytocheratins 
19 and 20 (focal positivity), CEA, MUC-2 and negativity for 
Cytokeratin 7 and a-fetoprotein. Moreover, the neoplastic 
cells showed a focal positivity with lower intensity for 
MUC-1 and MUC-5AC.
Results: The immunohistochemical profi le suggested the 
possibility of a metastatic tumor from the large bowel, 
without excluding surely a primitive mucinous cholangiocar-
cinoma with intestinal phenotype. Biological markers could 
not add more useful information. During 6 months after 
operation the patient has been submitted to conventional 
chemotherapy for metastases from colon cancer (FOLFOX) 
without any relevant toxicity. Actually he’s in good condi-
tion, without radiological sign of recurrence. In the meantime 
the patient underwent more clinical diagnostic procedures 
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without any evidence of other tumors. Oncologists must 
evaluate the possible benefi ts of further adjuvant treatments.
Conclusion: In conclusion, a correct diagnosis of liver 
masses is mandatory and remain a challenge which can dif-
ferentiate either follow up or surgical and adjuvant treatment. 
Histology and immunohistochemistry must be related to 
clinical fi ndings because they cannot be always suffi cient to 
reach the correct fi nal diagnosis, but they can be even confus-
ing. Until now, molecular biology cannot be considered an 
helpful diagnostic methodic in these cases.
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VALUE OF MRI FOR THE DIAGNOSIS 
OF BENIGN LIVER TUMORS: 
CORRELATION OF UPDATED MRI 
CRITERIA WITH HISTOMOLECULAR 
ANALYSIS OF RESECTED SPECIMENS
A. Luciani1, L. Baranes1, J. T. V. Nhieu2, J. Zucman-Rossi2, 
M. Djabbari1, F. Pigneur1, A. Mallat2 and D. Azoulay3
1Department of Radiology, Henri Mondor hospital, Créteil, 
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transplantation surgery, Henri Mondor hospital, Créteil, 
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Hopital Henri Mondor, Imagerie Medicale, 51 Avenue du 
Maréchal de Lattre de Tassigny, 94000 Creteil, France
Introduction: To assess the sensitivity and specifi city of 
updated MRI criteria for the diagnosis of benign liver tumors 
(BLT) with histology and molecular biology of resected liver 
specimens as reference standard.
Methods: 35 patients with 41 liver nodules referred between 
2000 and 2008 for resection of a supra-centimetric BLT, and 
explored by a preoperative liver MRI were included. The 
resected specimens were analyzed by microscopy, immuno-
histochemistry and molecular biology including CTNNB1 
(coding for beta-catenin), HNF1A (coding for HNF1alpha), 
and IL6ST (codinggp130) gene sequencing and RT-PCR 
quantifi cation of GPR 49, GLUL, FABP1, UGT2B7, CRP, 
SAA2, ANGOT1, ANGOT2. The sensitivity and specifi city 
of updated MRI criteria and their combination were esti-
mated, and the unconformities were analyzed (Fisher exact 
test, Chi2, contingency table).
Results: The histo-molecular diagnosis was focal nodular 
hyperplasia (FNH) (13 cases), adenoma (22 cases -13 telan-
giectatic, 8 HNF1alpha-inactivated and 1 non-specifi c) and 
6 non-hepatocellular tumors. The correlation between MRI 
and histo-molecular diagnosis was 76.3%. The specifi city 
and sensitivity of MRI for the diagnosis of FNH were 100% 
and 53.8%. Marked hypersignal on T2W sequences associ-
ated with delayed persistent enhancement had a specifi city 
of 96.4% and a sensitivity of 53.8% for the diagnosis of 
telangiectatic adenoma. The specifi city and sensitivity of the 
homogeneous signal dropout on chemical shift images for 
the diagnosis of HNF1alpha-inactivated adenoma were 
100% and 75%.
Conclusion: The specifi city of MRI for the diagnosis of 
FNH is confi rmed. MRI features of liver adenoma appear to 
be correlated with molecular biology data in a population of 
BLT.
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SIGNIFICANCE OF EARLY ENHANCING 
≤1 CM LESIONS IN PATIENTS WITH 
HEPATOCELLULAR CARCINOMA
A. Luciani1, Z. Kourbane-Darugar1, L. Baranes1, 
J. T. V. Nhieu3, T. Decaens4, H. Kobeiter1, A. Rahmouni1 
and A. Laurent2
1Department of Radiology, Henri Mondor hospital, Créteil, 
France; 3Department of Pathology, Henri Mondor hospital, 
Créteil, France; 4Department of Hepatology, Henri 
Mondor hospital, Créteil, France; 2Department of HBP 
and liver transplantation surgery, Henri Mondor hospital, 
Créteil, France
Hopital Henri Mondor, Imagerie Medicale, 51 Avenue du 
Maréchal de Lattre de Tassigny, 94000 Creteil, France
Introduction: To evaluate the predictive positive value of 
≤10 mm early enhancing lesions (EEL) in patients with HCC 
on waiting list for liver transplantation (LT), taking the path-
ological analysis of the explanted liver as reference.
Methods: Among the 227 patients transplanted between 
2007 and 2010 at Mondor Hospital, 28 patients with ≥20 mm 
pathologically proved HCC and with at least one EEL less 
than 10 mm seen on preoperative CT scan (n = 11) or liver 
MRI (n = 17) performed less than three months prior to 
transplantation, were included retrospectively in the study. 
The kinetic of contrast enhancement and spontaneous signal 
intensity were analyzed in comparison to the pathology of 
the explanted livers taken as reference.
Results: 40 EEL ≤10 mm were identifi ed : 18 (45%) cor-
responded to HCC and 5 of them had a typical vascular 
profi le. 15 EEL ≤10 mm had no correlative pathologic fi nd-
ings, and 7 of them corresponded to infl ammatory nodules 
(n = 2), dysplastic nodules (n = 2), regenerative nodules (n 
= 2) and one biliary adenoma.
Conclusion: The predictive positive value of EEL ≤10 mm 
in patients with HCC over 20 mm is 45%, while it is less 
than 10% in cirrhotic population based on literature data.
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VOLUME MEASUREMENTS OF 
RESECTED LIVER SPECIMENS USING A 
SURGICAL NAVIGATION SYSTEM ARE 
VERY PRECISE
V. Banz1, M. Peterhans2, D. Inderbitzin1, S. Weber2 and 
D. Candinas1
1Department for Visceral Surgery and Medicine, 
Inselspital, University Hospital and University of Bern, 
Switzerland; 2Artorg Center for Computer Aided Surgery, 
University of Bern, Switzerland
Department for Visceral Surgery and Medicine, 
Department for Visceral Surgery and Medicine, Inselspital, 
University Hospital and University of Bern, 3010 Bern, 
Switzerland
Introduction: In patients requiring surgery for multiple 
liver metastases, careful perioperative planning is essential, 
particularly in the setting of reduced hepatic capacity (cir-
rhosis/post-chemotherapy). Intraoperative estimations of 
resected volumes are often imprecise. Computer-assisted, 
real-time intraoperative volume measurements may help the 
surgeon in the decision-making process of how much surgery 
542 Poster Presentation Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 288–699
is technically feasible without compromising postoperative 
liver function and patient safety.
Methods: The principle of intraoperative volume measure-
ment using a surgical navigation system was tested by mea-
suring the volume of resected liver specimens after surgery. 
Resected volume estimates were conducted by a) three expe-
rienced hepatobiliary surgeons (V_surg); b) Optical surface 
digitization and volume calculation using a commercial navi-
gation system for liver surgery (V_nav) (CAScination AG, 
Bern – CH); c) water displacement, V_H20 (Archimedes’ 
Principle). Measurements were carried out in a total of 15 
patients. Descriptive statistics were used to analyse the 
differences.
Results: A total of 15 patients underwent 19 resections 
between April and October 2010. Volume estimations by 
surgeons (V_surg) compared to gold standard V_H20 
revealed an absolute difference of 41.2 ± 191.2 ml. This was 
signifi cantly less accurate when compared to V_nav: 1.4 ± 
8.4 ml (p < 0.01). Results indicate, that the uncertainty of the 
human estimation directly correlates with the volume of the 
resected specimen: V_surg was within ± 60% of V_H20 in 
95% of all cases, whereas the human estimate was within ± 
16% in 95% of all cases for V_nav compared to V_H20.
Conclusion: Volume measurements of resected specimens 
using a surface digitization method (i.e. using a navigation 
system) were signifi cantly more precise than estimations 
given by experienced surgeons, particularly for larger resec-
tion volumes. We believe that in future, intraoperative digi-
tization of the remnant or resectable parts of the liver using 
the described navigation system may provide essential infor-
mation, helping the decision-making process and avoiding 
small-for size problems.
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AN INNOVATIVE DEVICE TO MANAGE 
PENETRATING WOUNDS OF THE LIVER
J. Jarry1, A. M. Gaudry2, P. Porcu3 and D. Blin3
1Department of Visceral Surgery, Desgenettes Hospital, 
Lyon; 2Clinical Investigate Center, Innovative Technology, 
Inserm 803, Grenoble; 3Cardiac Surgery Department, 
University Hospital Grenoble
Desgenettes Hospital, Digestive Surgery, 108 bd Pinel, 
69003 Lyon, France
Introduction: During elective or emergency surgery in both 
civilian military practice, surgeons can face major hepatic 
bleedings secondary to penetrating injuries of the liver. The 
control of bleeding can be particularly diffi cult because of 
its anatomical location or because of the fragility of the 
hepatic tissue. In such cases, conventional surgical tech-
niques may fail to achieve haemostasis.
Methods: We present an innovative device that was initially 
developed in cardiac surgery, but which reveals to be particu-
larly effi cient to achieve haemostasis in penetrating wounds 
of the liver. The device is composed of a peripheral vacuum 
chamber connected to an external aspirating device (Redon 
bottle). When the vacuum is created (600 to 700 mmHg), the 
vacuum chamber gets pulled onto the wound and stems the 
bleeding. It was successfully evaluated in 60 sheep present-
ing experimental, penetrating wounds of the liver.
Results: The device was clinically used for the fi rst time in 
a patient who sustained a iatrogenic wound of the liver 
during an emergency cardiac surgery. The patient had 
cirrhosis and no conventional technique was effi cient to stop 
the hepatic bleeding. Immediate hemorrhage control was 
obtained by applying the vacuum device over the wound, 
connected to a Redon bottle, enabling the surgeon to resume 
the cardiac surgery. The vacuum device was removed 40 min 
after its initial application. The wound was found dry and 
was therefore secured by application of a haemostatic com-
press. No hepatic complication neither recurrence of the 
bleeding was recorded during the follow-up of the patient.
Conclusion: The fi rst clinical results obtained with this new 
vacuum device looks extremely promising in human patients. 
This innovative concept proposes a simple and convenient 
solution for surgeons facing hemorrhagic, penetrating 
wounds of the liver for which they can sometimes lack 
resources.
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TOTAL CYSTECTOMY FOR LIVER 
HYDATID CYST
N. B. Serradj and N. Benmaarouf
Service de Chirurgie Hépatobiliaire et Greffe de Foie, 
EHU, Oran, Algerie
Service de Chirurgie Hépatobiliaire et Greffe de Foie, 
EHU, Oran (etablissement hospitalo-universitaire), Algeria
Introduction: Surgical treatment of hydatid cyst of the liver 
is by far the most effective treatment option. The pericystec-
tomy represents an ideal method of treatment of hydatid 
cysts of the liver to pericyste thick.
Methods: This is a 45-year-old patient, with a hydatid cyst 
of the liver segment VI, partially calcifi ed wall.
Results: (1) Making a total cyst pericystectomy closed; (2) 
Postoperative-simple; (3) Follow-up 3–6 months and 1 year 
without recurrence.
Conclusion: The hydatid cyst of the liver remains a public 
health problem in countries of the Maghreb.
The radical approach in the surgical treatment of hydatid 
cyst of the liver is a feasible method with good results in the 
hands of specialized teams.
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USE OF PREOPERATIVE 
PLANNING IN HEPATIC SURGERY. 
A TOOL TO IDENTIFY A PATIENT-
SPECIFIC APPROACH
A. Peloso1, J. F. di T. Vajana1, I. Fiorina2, E. Franchi1, 
L. Barbieri1, P. Quaretti2, P. Dionigi1 and M. Maestri1
1IRCCS Policlinico S. Matteo, Surgical Science 
Department; 2IRCCS Policlinico S. Matteo, Intervetional 
Radiology Department
IRCCS Policlinico San Matteo, Surgical Science, Piazzale 
Golgi, 27100 Pavia, Italy
Introduction: The preoperative planning is a paramount 
rule for a safe liver surgery. As of today it is mainly based 
on 2D imaging techniques (CT, US). However the sectional 
anatomy does not satisfy surgeon’s quest for spatial relation-
ships between disease and vessels in the complex parenchy-
mal structure of the liver. Recently the availability of 3D 
software packages has given an additional tool to the surgical 
diagnostic weaponry.
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Methods: Between January 2011 and December 2011 fi fty 
patients have been candidate for liver surgery (46 out of 50 
for liver cancer, 4 out of 50 for benign disease). Each patient 
had a preoperative CT-scan (slice: 1/1.5 mm; phases: basal, 
arterial time, portal time, late contrast). CT-scans were ana-
lyzed by open source software, which is freely available 
(Osirix®), and the standard DICOM images were converted 
to 3D navigable maps.
Such results were obtained in four steps:
1. Segmentation and volumetric rendering of the whole 
liver
2. Segmentation and volumetry of liver masses
3. Segmentation of the vascular tree
4. Evaluation of the liver remaining volume after surgical 
procedure
Results: Throughout this study, surgery was largely based 
upon the 3D reconstructions of the patient’s liver, which 
allowed depicting a virtual preoperative resection with a 
perspective defi nition of the expected specimen. Fifty out of 
50 patients had exactly the preoperatively planned proce-
dure. No complications were observed and the intraoperative 
blood losses were 200–400 ml (range). The average postop-
erative stay was 6 ± 3 days. Moreover, our study demon-
strated a strong correlation between reconstruction and the 
real anatomy, with a clear advantage for surgical procedure 
safety.
Conclusion: The use of a software for virtual reality in 
surgery is an appealing idea since many years ago. While 
some reports are available trough the literature, its real value 
is still questionable.
Recently, new hardware and ready available software pack-
ages has awakened new interest. Our study is based on 
instruments that are quite easy to obtain. The learning curve 
is easy and the results have a strong impact on the every-day 
surgical practice.
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EFFICACY OF LAPAROSCOPY-ASSISTED 
HEPATECTOMY
Y. Minami, H. Masui, R. Takagawa, K. Narui, T. Morita, 
T. Fukushima, M. Mogaki and K. Nagahori
Department of Surgery, Yokosuka Kyosai Hospital
Yokosuka Kyosai Hospital, Department of Surgery, 1-16 
Yonegahamadori, Yokosuka, Kanagawa, 238-8558 
Yokosuka, Japan
Introduction: The purpose of this study was to evaluate the 
effi cacy of laparoscopy-assisted liver surgery, especially 
laparoscopic surgery for hepatectomy.
Methods: Operative procedure: After the mobilization of 
the liver under the laparoscope, hepatectomy was performed 
using microwave tissue coagulation through a small skin 
incision; this procedure was the same as in conventional 
hepatectomy involving a wide incision with no 
laparoscope.
Method: Between 2009 and Jun 2011, 31 patients underwent 
laparoscopy-assisted hepatectomy (the Laparoscopic group). 
Twenty-seven patients who underwent conventional hepatec-
tomy provided a matched control group (the Open group). 
Operation time, operative blood loss, total amount of transfu-
sion and the short-term outcome were compared for the two 
groups.
Results: Operating time in the Laparoscopy group was sig-
nifi cantly longer than for the Open group. There were no 
signifi cant differences in other operating factors and postop-
erative complications. Mean hospital days after the hepatec-
tomy were not signifi cantly different because of the same 
clinical pathways in both groups.
Conclusion: Laparoscopy-assisted hepatectomy is feasible 
and well tolerated. It seemed to be minimal invasive and 
useful as the early stage of the introduction of laparoscopic 
surgery for hepatectomy.
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THE EFFECT OF HYPOXIC STRESS ON 
ACTIVATED HEPATIC STELLATE CELL 
CHEMOTAXIS IN-VITRO
A. Amer1, D. Manas1, M. Wright2 and S. White1
1Department of Hepato-Pancreatico-Biliary surgery, 
Freeman Hospital, Newcastle upon Tyne, United Kingdom; 
2Institute of Cellular Medicine, Newcastle University, 
Newcastle upon Tyne, United Kingdom
Freeman Hospital, Department of Hepato-Pancreatico-
Biliary Surgery, High Heaton, Newcastle upon Tyne NE7 
7DN, United Kingdom
Introduction: Hepatic stellate cells (HSC) are believed to 
be the most important precursor of matrix-producing myofi -
broblasts that promote fi brosis following liver injury. In their 
activated form, HSCs migrate towards infl ammatory foci in 
response to chemokines. When exposed to certain stresses, 
liver cells can express chemokines that control HSC migra-
tion. The aim of this study was to investigate the effect of 
hypoxia on chemokine expression by non-parenchymal liver 
cells using an in vitro model of ischaemia.
Methods: Human HSCs, biliary epithelial cells (BECs) and 
Kupffer cells (KC) were isolated from normal-appearing 
liver tissue obtained from liver resection specimens (n = 3). 
HSCs were cultured on either gel matrix or uncoated plastic 
in order to investigate both quiescent (qHSC) and activated 
(aHSC) phenotypes. Conditioned medium from each cell 
type was collected at various time points in culture after 
exposure to either normoxia (21% O2) or hypoxia (1% O2). 
For migration assays, fully activated human HSCs were used 
and were seeded on cell culture inserts exposed to condi-
tioned medium from each cell type added to the lower com-
partment. Cells were then incubated for 20 hours following 
which the migrated cells were fi xed, stained and counted.
Results: HSCs demonstrated greater migration towards 
medium obtained from HSCs cultured for 3 days under 
hypoxic conditions compared to normoxic HSCs (p = 0.06). 
This effect decreased with longer culture times, reaching 
levels signifi cantly lower than baseline by day 7 for both 
groups (P < 0.0001). In contrast, medium obtained from 
HSCs cultured on gel matrix under normoxic conditions 
stimulated signifi cantly higher HSC migration compared to 
hypoxic qHSCs, with a peak effect by day 5 (P < 0.0001). 
Similarly, normoxic KCs stimulated signifi cantly enhanced 
HSCs migration compared to hypoxic KCs (P < 0.0001). On 
the other hand, hypoxic BECs attracted signifi cantly more 
HSCs on day 1 compared to normoxia, an effect that contin-
ued to rise on day 7 (P = 0.002).
Conclusion: This study demonstrates that hypoxia in an in 
vitro model stimulates contrasting responses depending on 
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cell type and activation state. KCs and qHSCs in a relatively 
high O2 state similar to that of reperfusion during liver 
surgery can promote chemotaxis of aHSCs possibly through 
the formation of reactive oxygen species. BECs and aHSCs 
appear to produce factors that negatively affect HSC chemo-
taxis as evident by below-baseline migration responses. 
Hypoxia attenuates this negative effect in vitro.
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HEPATIC ATROPHY INDUCTION 
TREATMENT FOR ISOLATED INJURY 
OF THE HEPATIC SEMGENTAL DUCT 
FOLLOWING LAPAROSCOPIC 
CHOLECYSTECTOMY 
AND HEPATECTOMY
J.-M. Namgoong, S. Hwang, Y.-H. Park, C.-S. Park, 
H.-W. Park, G.-C. Park, D.-H. Jung and S.-G. Lee
Department of Surgery, Asan Medical Center, University of 
Ulsan College of Medicine, Seoul, Korea
Asan Medical Center, University of Ulsan College of 
Medicine, Department of Surgery, 388-1 Poongnap-dong, 
Songpa-gu, 13873 Seoul, Korea
Introduction: Laparoscopic cholecystectomy (LC) and 
resection of centrally located liver tumor can result in various 
bile duct injuries and their treatment is usually diffi cult and 
often leads to intractable clinical course. Since the clinical 
problem is intractable bile leak, induction of hepatic paren-
chyma atrophy would be benefi cial for cease of bile leak.
Methods: We present 3 types of unusual cases of isolated 
segmental duct injury following LC and central hepatectomy. 
The fi rst-type case was LC-induced right posterior sector 
duct injury, in which large biloma was detected 1 month after 
LC. The second-type case was LC-induced right anterior 
sector duct injury, in which bile leak continues a few days 
after LC. The third-type case was hepatectomy-induced bile 
leak from B3 duct after left medial sectionectomy for large 
hepatocellular carcinoma, which was detected 1 week later. 
Following procedures were applied to control intractable 
postoperative bile leak.
Results: First process was insertion of a pigtail to the bile 
leak site. The next was insertion of percutaneous transhepatic 
biliary drainage (PTBD) into the injured duct for biliary 
diversion. And then, percutaneous segmental portal vein 
embolization (PVE) was performed to induce parenchymal 
atrophy. After PVE, leaking bile became thin and its amount 
decreased. After 1–2 months, bile leak from the pigtail 
decreased much, implicating adhesive occlusion of the bile 
duct injury site. At this time, PTBD was clamped to acceler-
ate hepatic atrophy. With imaging study follow-up, the pro-
gressive atrophy process was monitored. After 4–6 months 
after operation, PTBD was successfully removed. On follow-
up for 2–5 years, no signifi cant complication occurred.
Conclusion: These fi ndings suggest that percutaneous seg-
mental portal vein embolization, followed by intentional 
clamping of external biliary drainage, can effectively control 
intractable bile leak from segmental bile duct injury follow-
ing LC or hepatectomy. Although this atrophy induction 
approach is not universally applicable, it can be considered 
a feasible option in some unique situations not facilitating 
reconstructive surgery.
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HISTORY OF LIVER ANATOMY: 
MESOPOTAMIAN LIVER CLAY 
MODELS IN 3D
A. C. de A. Martins1, C. Martins1 and J. Taylor2
1Instituto de Medicina Integral Prof. Fernando Figueira – 
IMIP; 2The british Museum
Instituto de Medicina Integral Prof. Fernando Figueira, 
IMIP, Surgery, Dep. Pedro Pires Ferreira, 325, Apt 1601 
Graças, 52050 Recife, Brazil
Introduction: The interest in human anatomy started with 
the study of the liver. Ancient Mesopotamian civilization 
used sheep liver to perform divinations that guided wars and 
political decisions. This prophetic reading of the liver surface 
was based on anatomical landmarks, taught through the use 
of anatomical clay models and is the oldest evidence of the 
starting interest in comparative and human anatomy.
Methods: Although Mesopotamian clay liver models are 
part of the history of liver anatomy, few have survived to our 
days. Model ME92668, held at the Middle East Department 
of British Museum is dated back to 2000BC. 3D images of 
the visceral and diaphragmatic surfaces of the model have 
been produced and nomenclature described has been com-
pared with anatomical terms in use today. W 3D Fuji camera, 
Japan and StereoPhoto Maker, Version 4.3 were used to 
produce anaglyphic 3D images.
Results: Although drawings and paintings existed in this 
period, the fact that a clay model was built attests on the 
importance given to the tridimensional qualities of the liver. 
Sulci and protrusions were well depicted and sometimes 
overexpressed – as happened with the caudate lobe. The 
Babylonians referred to the portal vein as strong. The right 
and left lobes were called wings. The term used for the gall-
bladder fossa and the umbilical fi ssure were the river of the 
edge of the liver and the river of the liver. The caudate was 
known as the middle of the liver and its papillary process, 
the fi nger of the liver. The gallbladder bore the appropriate 
name of bitter part. The hepatic duct was called the outlet 
and the choledocus, the yoke.
Conclusion: Because liver surgeons use surface anatomical 
landmarks on the liver to help perform procedures, ancient 
liver clay models should be considered part of the history of 
liver surgery. Furthermore, modern liver anatomical termi-
nology has its roots in the nomenclature used then.
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IMPACT OF LAPAROSCOPIC 
ULTRASONOGRAPHY IN ROBOTIC 
HPB SURGERY
H. Wang, W. Ji and J. Dong
Hospital & Institute of Hepatobiliary Surgery, Chinese 
PLA General Hospital, Beijing, China
Hospital & Institute of Hepatobiliary Surgery, Chinese 
PLA General Hospital, 28, Fuxing Road, 10085 Beijing, 
China
Introduction: Although the da Vinci surgical system was 
developed in response to some of the major challenges asso-
ciated with traditional laparoscopic techniques, haptic 
sensors have not yet been incorporated into the robot. 
Laparoscopic ultrasonography (LUS) can play an important 
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role in overcoming the lack of tactile palpation during lapa-
roscopic surgery. It should be helpful to precise robotic HPB 
surgeries which require extreme accuracy, fi ne dissection and 
localization of lesion.
Methods: Between 3, 2009 and 12, 2011, 51 patients under-
went robotic-assisted laparoscopic HPB surgeries. LUS was 
used for diagnosis and assessment in robotic surgery by 
providing a diagnostic impact on surgical decision making 
that allowed staging laparoscopy for malignancy and detec-
tion of small hepatic lesions (<10 mm) or CBD stones previ-
ously undetected by dynamic CT scans or MRI. Surgical 
dissection was also assisted and guided by LUS which can 
identify anatomic landmarks such as middle hepatic vein to 
accomplish safe anatomic hemihepatectomy or defi ne the 
location of the tumor and its transection margin to allow a 
better tumor clearance.
Results: LUS staging for pancreatico-biliary cancers and 
hilar cholangiocarcinomas was comparative with preopera-
tive assessment. No conversion to laparotomy occurred in all 
51 patients. Overall stones clearance in common bile duct 
and intrahepatic bile duct was obtained. All 24 hepatectomy 
procedures were performed anatomically with hilum dissec-
tion. The surgical margins in the patients with hepatic or 
pancreatic malignancy were negative.
Conclusion: A broad range of precise robotic HPB surgical 
procedures can be performed effi ciently and safely with the 
use of LUS.
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HEPATOBILIARYPANCREATIC 
SURGERY IN THE ELDERLY: SINGLE 
CENTER EXPERIENCE
S. Vaccarisi1, E. Bonaiuto1, V. Crocco1, V. Pellegrino1, 
M. Tortorella1, S. Rizzuti1, G. Cavallari2 and B. Nardo1
1Hepato-Biliary-Pancreatic and Transplant Organs Unit, 
Department of Surgery, Annunziata Hospital, Cosenza, 
Italy; 2Department of Surgery and Transplantation, S. 
Orsola-Malpighi Hospital, University of Bologna, Italy
Annunziata Hospital, Surgery, Hepato-Biliary-Pancreatic 
and Transplant Organs Unit, Via F. Migliori, 87100 
Cosenza, Italy
Introduction: The HPB district tumour includes a high inci-
dence between the 6th and the 8th decade of life. ISTAT 
informations of the 1st January 2011 confi rm that people 
over the age of 65 represent 20.3% of the population. In 
Calabria they represent 18.5% of the population, according 
with national tendency.
Methods: From January 2008 to December 2011, 961 
patients underwent hepatobiliopancreatic operations for 
benign and malignant diseases in our Institute. Among these, 
120 patients affected by neoplastic hepatobiliarypancreatic 
diseases, with more than 65 years, have been observed. The 
major indications for surgical intervention were 21 pancre-
atic tumours, 10 Vater papilla tumors, 8 neoplasm of the 
CBD, 5 bladder cancers, 1 cholangiocarcinoma, 28 HCC and 
47 liver metastases.
Results: Operative mortality, disease – free survival and 
overall survival are very similar to the deducible informa-
tions of the whole survey and they seem to be infl uenced by 
tactics and surgical technique.
As elderlies can present comorbidity, cognitive defects 
and minor expectation of life, appropriate therapeutical 
options require a signifi cant selection of the candidate for 
major resective surgery.
Conclusion: Our information indicates that elderly is not an 
aggravating risk for outcome, not only for the signifi cant 
patient selection but also for the surgeon experience and it 
doesn’t condition major surgical options.
The HPB resective surgery, in selected elderlies, can be 
done maintaining an acceptable morbidity and an appropriate 
survival rate.
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INITIAL HEPATO-BILIARY SURGERY 
SINGLE CENTER EXPERIENCE: 
A REVIEW
S. Vaccarisi1, E. Bonaiuto1, V. Crocco1, V. Pellegrino1, 
S. Rizzuti, M. Canonaco1, G. Cavallari2 and B. Nardo1
1Hepato-Biliary-Pancreatic and Transplant Organs Unit, 
Department of Surgery, Annunziata Hospital, Cosenza, 
Italy; 2Department of Surgery and Transplantation, S. 
Orsola-Malpighi Hospital, University of Bologna, Italy
Annunziata Hospital, Surgery, Hepato-Biliary-Pancreatic 
and Transplant Organs Unit, Via F. Migliori, 87100 
Cosenza, Italy
Introduction: Since 2007 November our 
Hepatobiliaryancreatic Surgery and Organ Transplant Unit 
was activated; aim of our study is to report our initial experi-
ence in these surgical fi elds.
Methods: Between 2008 January up to 2011 December, we 
performed 2921 general elective surgery interventions, 
included plastic surgery, mammary surgery and coloprocto-
logic surgery. In total 961 patients underwent hepato-biliary 
operations. Among these, we performed 484 laparoscopic 
cholecistectomies, 71 laparotomic cholecistectomies, 46 
bilio-digiunostomies, 175 hepatic resections. The main indi-
cation to hepatic resection was neoplastic disease and par-
ticularly 35 HCC, 10 cholecistic neoplasias, 101 metastases, 
28 of whom synchronic, 7 cholangiocarcinomas. The remain-
ing 22 cases were benign lesions.
Results: In the fi eld of major hepato-biliary surgery, the 
most numerous patients were those underwent an hepatic 
resection. Among the patients with oncologic tumours we 
observed 2 postoperative mortality, after extended liver 
surgery for neoplasia infi ltrating the vena cava in one case, 
and cholangiocarcinoma in the other one, due to cardiac 
complications. No severe post-operative complications were 
observed, except in one case of biliary leakage after left 
hepatectomy due to Caroli.
Conclusion: Our Hepatobiliaryancreatic Surgery Unit rep-
resents already a certainty completely satisfying activity, in 
treating patients affected by hepatobiliaryancreatic diseases 
requiring surgical intervention. Our hope is to continue our 
growth, encouraged by the target completed, and to further 
improve our practice by adding the liver transplant program 
at already current kidney transplant activity.
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A CASE OF SURGICAL PROCEDURE 
EFFECTIVE FOR HEMORRHAGE 
WITHOUT ENDOSCOPIC HEMOSTASIS 
CASED BY ENDOSCOPIC 
SPHINCTEROTOMY
R. Higuchi, T. Ota, N. Takeshita, H. Kajiyama, T. Yazawa, 
K. Onuki, S. Uemura and M. Yamamoto
Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University
Gastroenterology, Tokyo Women’s Medical University, 
Surgery 8-1 Kawada-cho, Shinjuku-ku, 162 Tokyo, Japan
Introduction: A 66-year-old man with past histories of 
chronic renal failure, prostate cancer, hyperparathyroidism 
and postoperative rectal cancer. He was referred to our hos-
pital due to onset of fever and acute abdominal pain.
Methods: From when, endoscopic therapy was undergone 
due to cholangitis accompany with biliary stones. At that 
time, Papilla of Vater was discovered at the anal and poste-
rior of a large diverticulum, middle endoscopic sphincterot-
omy (EST) was performed. The endoscopic nasobiliary 
drainage and dropped out type catheter pancreatic duct drain-
age were performed post pre-cutting procedure.
Results: Four days after EST, GI bleeding with hypovole-
mic shock was presented. Blood transfusion were given and 
emergent endoscopical hemostasis were performed three 
times but the treatments were in vain. The patient was then 
referred to our department. He was then underwent surgical 
hemostasis by transduodenal papilloplasty, lithotomy of the 
biliary stones, cholecystectomy and C tube drainage. His 
condition was improved postoperatively. He was discharged 
22 days after operation.
Conclusion: There are only few reports about surgical pro-
cedure effecting hemorrhage which was diffi cult to endo-
scopically hemostasis.
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INFLAMMATORY PSEUDOTUMOR OF 
THE LIVER TREATED BY HEPATIC 
RESECTION: REPORT OF THREE CASES
E. C. Ataide, G. D. Calomeni, C. R. Reigada, 
I. N. Santos, H. V. G. Lima, C. A. F. Escanhoela and 
I. De F. S. F. Boin
State University of Campinas, Campinas, São Paulo, Brazil 
130081-970
State University of Campinasliver Transplantation Unit, 
Rua Zerillo Pereira Lopes 651 Casa 37, Alto Taquaral, 
Cep: 13087-75713087 Campinas, São Paulo, Brazil
Introduction: Infl ammatory pseudotumor (IPT) is a rare 
injury with presence of infl ammatory cells and myofi bro-
blasts. Although most common in the lungs and orbits, such 
lesions are also found in the heart, liver, pancreas, spleen, 
stomach, small intestine, thyroid, urinary bladder and menin-
ges. Less than 300 cases of liver IPT was described in the 
literature. We report a series of three cases of liver IPT.
Methods: Of three cases of liver IPT
Results: Case 1. A male patient aged 64 was referred to our 
hospital with a history of chronic liver disease secondary to 
cholangitis sclerosants primary (MELD = 9) and an epigas-
tric palpable abdominal mass with hemobilia. Investigation 
revealed a heterogeneous lesion 62 × 50 mm in segments 2 
and 3, left hepatic artery aneurysm of 12 × 10 mm and mul-
tiple micro abscesses secondary to cholangitis. Aneurysm 
embolization and antibiotic therapy was performed. Hepatic 
lesion growth was observed and left hepatectomy was per-
formed. Pathologic examination of the lesion confi rmed the 
diagnosis of IPT. The patient progressed well in the early 
postoperative period but developed severe lung sepsis and 
died. Case 2. Male patient of 30 years was referred to our 
service with abdominal pain and fever. In an investigation 
with computed tomography (CT) was identifi ed a 5 cm mass 
in hepatic hilum. Antibiotic therapy was initiated. Was no 
clinical response and surgical resection was performed. 
Pathologic examination of the lesion confi rmed the diagnosis 
of IPT. This patient progressed well at this moment. Case 3. 
Female patient of 73 years was referred to our service with 
abdominal pain and fever. CT revealed a heterogeneous mass 
of 7 cm in the left hepatic lobe. Antibiotic treatment was 
unsuccessful, and left hepatectomy was chosen. Pathologic 
examination of the lesion confi rmed the diagnosis of IPT.
Conclusion: Liver IPT occurs more often in men around 30 
years. Association with other infl ammatory and autoimmune 
diseases is described. Abdominal pain, fever are the main 
signs and symptoms. When the diagnosis of IPT is estab-
lished with biopsy, simple observation or conservative 
therapy is preferred because of the possibility of regression. 
But if IPT was unresponsive to the conservative treatment, 
surgical resection should be considered and the evolution of 
these patients is usually favorable.
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HEMOADSORPTION OF HIGH-
MOBILITY GROUP BOX 1 IN SWINE 
ACUTE LIVER FAILURE MDOEL
M. Shinoda1, M. Tanabe1, R. Nishiyama1, G. Oshima1, 
K. Takano1, F. Yasushi2, I. Maruyama3 and Y. Kitagawa1
1Department of Surgery, Keio University School of 
Medicine; 2Department of Pediatric Surgery, Keio 
University School of Medicine; 3Department of Laboratory 
and Vascular Medicine, Kagoshima University Graduate 
School of Medicine and Dental Sciences
Keio University School of Medicine, Surgery, 35 
Shinanomachi, Shinjuku-ku, 160 Tokyo, Japan
Introduction: Despite recent therapeutic advances, acute 
liver failure remains a serious clinical condition that is asso-
ciated with a high mortality rate. High-mobility group box 1 
(HMGB1) is an infl ammatory mediator released from 
necrotic tissues and its release is associated with infl amma-
tory responses in various disease conditions including acute 
liver failure. We investigated if reducing plasma HMGB1 
levels using an adsorption column is feasible and benefi cial 
in a swine acute liver failure model.
Methods: i) Establishment of animal model. A swine acute 
liver failure model was developed injecting D-galactosamine 
intravenously at doses of 0, 0.2, 0.6, or 1.0 g/kg. ii) In vitro 
adsorption study. A HMGB1 adsorption column was newly 
developed. The swine plasma samples containing HMGB1 
were subjected to a 2 hour-incubation in vitro test with or 
without adsorbent. iii) Extracorporeal perfusion study. The 
acute liver failure swine (0.6 g/kg injection) were subjected 
to a 4 hour-extracorporeal hemoperfusion from 20 hours to 
 Poster Presentation Abstracts 547
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 288–699 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
24 hours after acute liver failure induction using a HMGB1 
adsorption column or empty column. An adsorption rate (%) 
was defi ned as follow: [adsorption rate] = [HMGB1 concen-
tration at the outlet]/[HMGB1 concentration at the inlet].
Results: i) The model of 0.6 g/kg injection had an increased 
plasma HMGB1 level and was selected for the hemoperfu-
sion study. ii) The developed adsorbent adsorbed 93% of 
HMGB1 after 2 hours incubation (before and after incuba-
tion, 25.9 ± 1.8 and 1.8 ± 0.4 ng/ml, respectively). iii) The 
HMGB1 adsorption rates were 94% and 53% at 20 hours and 
93% and 61% at 24 hours after acute liver failure induction 
in the control column and the HMGB1 adsorption column, 
respectively (p < 0.05 in both comparison). Plasma levels of 
HMGB1 were signifi cantly lower in the HMGB1 adsorption 
column group than the control group during perfusion. The 
hepatic enzymes were markedly suppressed and the survival 
showed a tendency of improvement in the HMGB1 adsorp-
tion column group.
Conclusion: It is possible that reducing plasma HMGB1 
levels are feasible performing hemoadsorption with the 
newly developed column. Hemoperfusion with this column 
seems benefi cial for the treatment of acute liver failure.
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GENE TRANSFER OF THE A BOX 
DOMAIN OF HIGH MOBILITY GROUP 
BOX 1 INTO THE LIVER IN RAT ACUTE 
LIVER FAILURE MODEL
M. Shinoda1, M. Tanabe1, A. Takayanagi2, R. Nishiyama1, 
G. Oshima1, H. Yagi1, I. Maruyama3 and Y. Kitagawa1
1Surgery, Keio University School of Medicine; 2Molecular 
Biology, Keio University School of Medicine; 3Kagoshima 
University
Keio University School of Medicine, Surgery, 35 
Shinanomachi, Shinjuku, 160 Tokyo, Japan
Introduction: One solution for severe hepatic failure may 
be a hybrid bioartifi cial liver device containing functioning 
hepatocytes (Shinoda M. J Surg Res. 2007). High mobility 
group box 1 (HMGB1) is known as a key mediator in acute 
liver failure (ALF) (Takano K. Shock. 2010). A domain of 
HMGB1, the A box, competes with HMGB1 for binding 
receptors and attenuates HMGB1-induced infl ammation. We 
established rat hepatocyte producing A box and investigated 
if gene transfer of A box is benefi cial for rat ALF.
Methods: i) In vitro study. We established three types of 
adenovirus vectors encoding A box (Adex-Abox) (a wild 
type of type W and 2 mutant types of type A and N). We 
transfected the vectors to primary cultured rat hepatocytes. 
The culture supernatant was subjected to western blot analy-
sis for A box protein, and was also subjected to an in vitro 
test of TNF release inhibition from macrophage; macrophage 
was cultured with recombinant HMGB1 or both recombinant 
HMGB1 and the supernatant containing A box protein. ii) In 
vivo study. We injected Adex-Abox (type A) or Adex-LacZ 
(control vector) into the portal vein of male SD rats. Twenty 
four hours after vector injection, D-galactosamine was 
injected into the penile vein to induce ALF.
Results: Western blot analysis showed a clear expression of 
A box protein in the culture supernatant of transfected rat 
hepatocytes in all types of vectors. The expressions were 
observed from 2 to 4 days after transfection. The expression 
was much stronger in type A and type N than in type W. TNF 
release from macrophage was signifi cantly suppressed in the 
culture of both HMGB1 and A box compared to that of 
HMGB1 only (401 ± 22 in A box (−) vs 248 ± 16 in A box 
(+), pg/mL, p < 0.05). Immunohistochemical staining of the 
liver injected with Adex-Abox showed an expression of A 
box. Survival was signifi cantly improved in the rats trans-
fected with Adex-A box compared to the rats transfected with 
Adex-LacZ.
Conclusion: Rat hepatocyte producing HMGB1 A box 
protein was established. Gene transfer of A box seems benefi -
cial for the treatment of ALF in rat model.
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ENHANCED RECOVERY PROGRAMMES 
IN HEPATOBILIARY AND PANCREATIC 
SURGERY: A SYSTEMATIC REVIEW
T. Hall, A. Dennison, D. Bilku, M. Metcalfe and G. Garcea
Department of Hepatobiliary and Pancreatic Surgery
Leicester General Hospital, Gwendolen Road, Leicester, 
Leicestershire LE5 4PW, United Kingdom
Introduction: ’Enhanced recovery after surgery’ or 
‘enhanced recovery programme’ (ERP) refers to multi-modal 
strategies aiming to streamline peri-operative care pathways, 
to maximise effectiveness and minimise costs. Whilst the 
results of ERP in colorectal surgery are well-reported; there 
have been no reviews examining if these concepts could be 
safely applied to Hepatobiliary and Pancreatic (HPB) surgery. 
This systematic review aims to appraise the current evidence 
for ERP in HPB surgery.
Methods: A Medline literature search was undertaken using 
keywords ‘enhanced recovery’, ‘fast-track’, ‘peri-operative’, 
‘surgery’, ‘pancreas’ and ‘liver’ and their derivatives such as 
‘pancreatic’ or ‘hepatic’. The primary end-point was length 
of postoperative hospital stay. Secondary end-points were 
morbidity, mortality and readmission rate.
Results: Ten articles were retrieved describing an ERP. ERP 
protocols varied slightly between studies. A reduction in 
length of stay was a consistent fi nding following the incor-
poration of ERP when compared to historical controls. This 
was not at the expense of increased rates of readmission, 
morbidity or mortality in any study.
Conclusion: The introduction of an ERP in HPB surgery 
appears safe and feasible. Currently, many of the principles 
of the multi-modal pathway are derived from the colorectal 
ERP and distinct differences exist which may impede its 
implementation in HPB surgery.
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IMPACT OF ANTICOAGULATION ON 
OUTCOMES IN NON-MALIGNANT AND 
NON-CIRRHOTIC PORTAL VEIN 
THROMBOSIS: A RETROSPECTIVE 
OBSERVATIONAL STUDY
T. Hall1, D. Bilku1, M. Metcalfe1, A. Rajesh2, A. Dennison1 
and G. Garcea1
1Department of Hepatobiliary and Pancreatic Surgery; 
2Department of Radiology
Leicester General Hospital, Gwendolen Road, Leicester, 
Leicestershire LE5 4PW, United Kingdom
Introduction: No defi nitive evidence exists regarding the 
treatment of acute portal vein thrombosis (PVT). The natural 
history is also poorly understood. Treatment modalities 
described include conservative management, anticoagula-
tion, thrombolysis and thrombectomy. This observational 
study examines the impact of anticoagulation on PVT.
Methods: The electronic radiology database was searched 
with keywords ‘portal vein’ and ‘thrombosis’. Relevant 
patient notes and imaging were reviewed to collect data from 
those with acute PVT. The primary end point was portal vein 
recanalisation. Secondary outcome measures were morbidity 
and the development of portal hypertension and its sequelae 
(including variceal bleeding). Data from patients with PVT 
in the context of cirrhosis, malignancy or liver transplant 
were excluded.
Results: Twenty two patients were included in the study. 
45.5% were male and median age was 58.5 years (range 
30–89). Acute pancreatitis was implicated as the precipitat-
ing cause in 50% of patients. 41.0% of patients were 
treated with anticoagulation. The remainder received no 
intervention.
Partial or complete recanalisation of the portal vein 
occurred in 81.8% of anticoagulated patients and 37.5% of 
the non-treatment group. 5 patients died, 1 was secondary to 
an intracranial haemorrhage whilst anticoagulated and 
another who was not treated secondary developed small 
bowel ischaemia and peritonitis. The remaining 3 died from 
the underlying pathology.
Conclusion: Spontaneous resolution of acute portal vein 
thrombosis is uncommon. Early anticoagulation results in a 
higher rate of recanalisation with minimal associated mor-
bidity when compared with no treatment.
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PRIMARY SQUAMOUS CELL 
CARCINOMA OF THE LIVER
D.-D. You1, Y.-S. Won1, I.-Y. Park2, K.-H. Kim3 and 
D.-G. Kim4
1Deparment of Surgery, St. Vincent’s Hospital, College of 
Mediciine, The Catholic University of Korea; 2Deparment 
of Surgery, Bucheon St. Mary’s Hospital, College of 
Mediciine, The Catholic University of Korea; 3Deparment 
of Surgery, Uijeongbu St. Mary’s Hospital, College of 
Mediciine, The Catholic University of Korea; 4Deparment 
of Surgery, Seoul St. Mary’s Hospital, College of 
Mediciine, The Catholic University of Korea
Deparment of Surgery, St. Vincent Hospital, College of 
Medicine, The Catholic University of Korea, Ji-Dong, 
Paldal-Gu, 442-7 Suwon, South Korea
Introduction: Primary squamous cell carcinoma (SCC) is 
an extremely rare in the liver and its prognosis is known to 
be dismal.
Methods: We report a case of SCC of the liver with no 
association with hepatic teratoma, hepatic cyst, or hepatoli-
thiasis. A 65-year-old man presented at our hospital with 
rectal mass on colonoscopy at local clinic. On routine 
work-up for suspicious rectal malignancy, multiple, variable 
sized hypodense hepatic nodular masses were noted on 
abdominopelvic computed tomography. He was chronic 
alcoholics and had no symptom associated with hepatic mass 
on initial presentation.
Results: On admission date, however, he had epigastric pain 
and tenderness. We performed left hemihepatectomy and 
transanal excision for hepatoma and retal mass. On operative 
fi ndings, multinodular lesion was distributed through the left 
lobe of the liver and distance of the tumor from surgical 
resection margin was 1.3 cm. Pathologic examination 
revealed a 12 × 7 cm size. Hepatic mass which was poorly 
differentiated carcinoma with central necrosis and microves-
sel invasion. The fi nal diagnosis of primary SCC of the liver 
was confi rmed by immunohistochemistry of positive immu-
nohistochemical staining with cytokeratin 34BE12 and nega-
tive hepatocyte-specifi c antigen staining.
Conclusion: He underwent an extensive workup to search 
for a primary squamous carcinoma, including a chest CT 
scan, gastroesophageal endoscopy, whole body positron 
emission tomography, all of which were negative. After 2 
months later, he had multiple hepatic and lung metastasis on 
CT scan.
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IN-VITRO-HEPATIC-PORTAL-BLOOD-
OCCLUSION TECHNOLOGY IN THE 
APPLICATION OF LAPAROSCOPIC 
LIVER RESECTION 
(VIDEO PRESENTATION)
F. Tao
Shaoxing People’s Hospital, Shaoxing, China
Shaoxing People’s Hospital, Department of General 
Surgery, Zhongxing North Street 568, Zhejiang, 31200 
Shaoxing, China
Introduction: To investigate a new in-vitro-hepatic-portal-
blood-occlusion (IVHPBO) technology for control of hepatic 
portal blood in laparoscopic liver resection (LLR).
Methods: Prepare a suction tube as a cannula (diameter of 
9 mm, length of 15 cm). Firstly, pull the hepatic pedicle by 
a 3 mm silicone tube through Winslow hole. Secondly, punc-
ture a hole in the middle of the upper abdomen with 1 cm 
troca. Then place half of the cannula into the abdominal 
cavity though this hole. Finally, extrude the silicone tube 
though the cannula in the process of promoting the cannula 
into the abdominal cavity. We can adjust the tightness of 
these tubes for control of hepatic portal blood in LLR. And 
we compare the blood loss, operation time and average post-
operative stay of IVHPBO with those of non-IVHPBO.
Results: Blood loss, operation time and average postopera-
tive stay of IVHPBO are less than those of non-IVHPBO.
Conclusion: IVHPBO is an easy, safe and effective way 
which improve the success rate of LLR.
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ROLE AND CAUSE OF BIOELECTRICAL 
IMPEDANCE CHANGE 
IN LIVER DURING ISCHEMIA-
REPERFUSION INJURY
Y. S. Su1, D. H. Lee1, D. S. Lee1, C. L. Mei2 and 
H. J. Kim1
1Department of Surgery, HBP Division, Yeungnam 
University Hospital, Daegu, Republic of Korea; 2Research 
Institute of Biomedical Engineering, Yeungnam University 
Hospital, Daegu, Republic of Korea
Yeungnam University Hospital, Surgery, Devision of HBP, 
317-1 Daemyung-dong, Nam-gu, 705-7 Daegu, Republic of 
Korea
Introduction: Ischemia and reperfusion (I/R) injury is a 
major cause of hepatic failure after liver surgery, but there is 
no direct method to monitor or predict it in a real-time 
manner during surgery. We measured bioelectrical imped-
ance (BEI) to assess the usefulness of BEI during I/R in rat 
liver and evaluated the mechanism underlying BEI changes.
Methods: A 70% partial rat liver ischemia model was used. 
Animals were allocated 30, 60 and 120 minutes I/R group (n 
= 5 at each group). BEI was measured at various frequencies 
(0.12, 1.2, 12, 62.5, and 100 KHz) with a multi-frequency 
LCR meter (GS-4311B, Ando, Japan) every 10 minutes. ATP 
contents, palmitic acid oxidation rate, cation changes in 
extracellular fl uid (ECF; determined using an in vivo intra-
cellular microdialysis technique), hepatocyte sizes, and his-
tological changes were examined to investigate the liver cell 
viability and mechanism of BEI change.
Results: BEI increased during ischemia and decreased sig-
nifi cantly after reperfusion at low frequency. BEI increased 
gradually during 60 minutes of ischemia and had a tendency 
to plateau thereafter. The ATP content decreased below 20% 
of the baseline level after 60 minutes ischemia and increased 
after reperfusion. [Na+] in ECF decreased from 150.4 ± 3.8 
to 97.8 ± 10.6 mmol/l, and [K+] in ECF increased from 7.5 
± 0.3 to 34.3 ± 5.5 mmol/l during the fi rst 60 minutes of 
ischemia. Hepatocyte diameter increased by ~20% during 
the fi rst 60 minutes of ischemia. After 24 hours of reperfu-
sion, the ATP contents decreased to below 50% in 30, 60 and 
120 minutes of ischemia and the palmitic acid metabolic 
rates decreased to 91%, 78%, and 74%, respectively.
Conclusion: BEI may be a good tool for monitoring I/R 
injury during liver surgery in a real time manner. BEI changes 
during I/R are probably caused by sodium and potassium 
concentration changes in the ECF due to reduced intracel-
lular ATP contents.
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IMMEDIATELY TRANSCRIPTED 
GENES IN VARIOUS HEPATIC 
ISCHEMIA MODELS
K. K. Choi1, S. H. Kim2, J. A Cho3, S. H. Kim4, 
S. W. Lee2, S. O. Min2 and K. S. Kim2
1Dept. of Surgery, Samsung Medical Center, Sungkyunkwan 
University School of Medicine; 2Dept. of Surgery, Yonsei 
University College of Medicine; 3Graduate School of 
Medicine of Gachon University; 4Dept. of Pathology, 
Yonsei University College of Medicine
Samsung Medical Center, Sungkyunkwan University School 
of Medicine, Department of Surgery, 50 Irwon-dong, 
Gangnam-gu, Seoul 135-710, Korea
Introduction: To elucidate the characteristic gene transcrip-
tion profi les of among various hepatic ischemia conditions, 
immediately transcribed genes and the degree of ischemic 
injury were compared among total ischemia (TI), intermit-
tent clamping (IC), and ischemic preconditioning (IPC).
Methods: Sprague-Dawley rats were equally divided into 
control (C; sham-operated), TI (ischemia for 90 min), IC 
(ischemia for 15 min and reperfusion for 5 min, repeated six 
times), and IPC (ischemia for 15 min, reperfusion for 5 min, 
and ischemia again for 90 min) groups. After occluding 
hepatic infl ow, hepatic tissues were obtained by partial hepa-
tectomy. Hematoxylin-eosin staining and terminal dUTP 
nick end labeling (TUNEL) were performed, followed by 
cDNA microarray analysis.
Results: (1) H-E staining : The C group exhibited little to 
no liver damage. The treatment groups exhibited mild liver 
damage. (2) TUNEL staining : The TI group had signifi -
cantly more TUNEL-positive hepatocytes than the C, IC, and 
IPC groups [57.0 ± 23.9 vs. 2.0 ± 1.4 (p < 0.001)/7.7 ± 9.4 
(p < 0.001)/21.0 ± 22.3 (p < 0.001)]. (3) cDNA microarray: 
IL-1β expression was 2-fold greater in the TI group than in 
the C group. In the IC group, IL-1α/β expression was 
increased by 2.5-fold, and Na+/K+ ATPase β1 expression 
was decreased by 2.4-fold. In the IPC group, interferon 
regulatory factor-1, osteoprotegerin, and retinoblastoma-1 
expression was increased by approximately 2-fold compared 
to that in the C group.
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Conclusion: The current fi ndings revealed characteristic 
gene expression profi les under various ischemic conditions. 
However, additional studies are needed to clarify the mecha-
nism of protection against IPC.
621
OUTCOME OF HEPATIC 
ANGIOEMBOLISATION IN BLUNT 
LIVER TRAUMA
Z. Y. Yan, U. Pua, V. Appasamy, M. T. Chiu, 
W. L. Woon and J. K. Low
General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan 
Tock Seng, Singapore
Introduction: The role of hepatic embolization in liver 
trauma has evolved over the past decade, due to improve-
ment in techniques and expertise. As such, more patients are 
now managed non-surgically with hepatic embolisation, with 
lower mortality rates. Our study aims to study the utility and 
outcome of hepatic angioembolisation in blunt trauma 
patients.
Methods: Retrospective review of patients admitted to our 
institution with liver trauma from October 2001 to November 
2010 was performed.
Patients underwent hepatic angiography with the intent for 
embolization were identifi ed. All these patients had prior 
computed tomography study (CT). Data including the demo-
graphics, mechanism of injury, admitting vital signs, Injury 
Severity Score (ISS), mortality, length of stay and intra-
abdominal complications were recorded.
Results: 381 patients who sustained blunt liver trauma were 
identifi ed in the study period. 22 patients (18 males, 4 
females), median age 34 (16–78) years underwent hepatic 
angiography after CT. 13 patients were found to have arterial 
injury and successfully angioembolised. 5 of these patients 
had grade 4 liver lacerations, 7 grade 3 liver lacerations and 
1 grade 2 liver laceration. These patients had a median ISS 
score of 26 (5–50). Angiography was negative in 9 patients. 
The mortality rate was 15% from the embolization group. 
The median length of stay for the 11 survivors was 22 (5–56) 
days. There were 3 embolization related complications: 1 
patient required laparotomy despite successful embolization, 
1 had hepatic necrosis on repeat CT and 1 had hepatic 
collection.
Conclusion: Our study shows that hepatic embolization can 
aid in achieving hemostasis with a high technical success 
rate. Although the mortality and complication rate are low, 
signifi cant complications can occur and close clinical sur-
veillance post-embolization is needed.
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WHAT IS AN OPTIMAL NUTRITIONAL 
INDEX FOR HEPATOCELLULAR 
CARCINOMA DURING EARLY 
PERIOPERATIVE PERIOD AFTER 
HEPATIC RESECTION?
K. H. Kwon1, S. H. Kim2, M. A. Seo2, S. J. Lee2, 
H. S. Lee3, J. G. Lee2, K. S. Kim2 and C. B. Kim2
1Dept. of Surgery, National Health Insurance Corporation 
Ilasn Hospital; 2Dept. of Surgery, Severance Hospital, 
Yonsei University College of Medicine; 3Nutritional 
Support Team, Severance Hospital
National Health Insurance Corporation, Ilasn Hospital, 
Surgery, 50 Yonseiro, Seodaemoon Ku, 12572 Seoul, Korea
Introduction: After hepatic resection, a synthetic liver 
function is often deteriorated, and ascites have been occa-
sionally developed. Because of these limitations, this study 
is designed to validate the optimal nutritional index.
Methods: We retrospectively reviewed medical records of 
sixty-fi ve patients who underwent hepatectomy for hepato-
cellular carcinoma. Body weight, Body Mass Index (BMI) 
and laboratory parameters were compared at preoperative 
day and postoperative day 7.
Results: Patients consist of fi fty-two males and thirteen 
females and average age is 56.2 ± 9.9 years old. Forty-four 
patients had resected more than three segments, and twelve 
had resected 2 segments and nine had resected only one 
segment or received a wedge resection. According to preop-
erative BMI, there were two underweight (BMI < 18.5), 
twenty-two normal, nineteen overweight, and twenty-two 
obese (BMI ≥ 27.5). After the surgery, lymphocyte count, 
total protein, albumin, BUN, Cholesterol, Prealbumin statis-
tically signifi cantly decreased, while WBC (5642 ± 1831 Vs. 
7149 ± 3069), CRP (2.98 ± 4.78 Vs. 25.69 ± 22.23) statisti-
cally signifi cantly increased (p = 0.00 & p = 0.00). However, 
BMI and change in Bwt do not show statistically signifi cant 
data (p = 1.91, p = 8.23).
Conclusion: The degree of infl ammation may have a sig-
nifi cant infl uence in nutrition evaluation scale. Therefore, a 
new method of nutritional evaluation that can adjust degree 
of infl ammation is needed to accurately evaluate the nutrition 
scale after hepatectomy.
627
HEPATIC RESECTION ACTIVITY IN 
SCOTLAND FROM 1990 TO 2007: 
PRACTICE AND OUTCOMES
S. McNally, S. Wigmore, R. Parks and J. Garden
Department of Surgery, Royal Infi rmary of Edinburgh, 
Edinburgh, UK
Royal Infi rmary of Edinburgh, Department of Surgery, c/o 
Ward 106, 51 Little France Crescent, EH16 Edinburgh, UK
Introduction: Hepatic resection has become better estab-
lished in the management of various hepatobiliary patholo-
gies over the past 20 years and guidance on regionalisation 
of service has been published. Changes in practice and 
outcome in Scotland have been assessed.
Methods: National registry data were obtained from the 
Information Services Division of NHS Scotland for all 
patients undergoing liver surgery from 1st April 1990 to 1st 
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April 2007. Follow-up data collected to 1st April 2010 
included details of diagnosis, the procedure undertaken, 
patient comorbidities and perioperative stay.
Results: 1663 procedures occurred in the study period. 
Activity increased annually (37 procedures in 1990; 179 in 
2007). 44% were major resections. Of the 5 main centres, 
one maintained a volume in excess of 40 cases per annum 
and accounted for 46% of total activity. Three centres per-
formed less than 20 cases per annum. 60% of cases were 
performed for metastatic disease, principally colorectal 
cancer (CRC), which accounted for an increasing proportion 
of activity over time (34% in 1990–1995; 57% in 2000–
2005). Perioperative outcomes improved over the study 
period with a reduction in length of stay (13 to 9 days) and 
thirty day mortality (3.7% to 2.2%). The three and fi ve year 
survival following resection for CRC was 72% and 65% 
respectively.
Conclusion: Hepatic resection activity has expanded sub-
stantially in Scotland over the past two decades. This has 
been associated with satisfactory outcomes which have 
shown continued improvement over time. The greatest 
increase in activity has been seen in metastatic colorectal 
cancer. At current activity levels, rationalisation of hepatic 
resection to fewer centres may be warranted.
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HEPATO-BILIARY -PANCREATIC 
TUBERCULOSIS
S. Pujari, C. Kantharia, R. Prabhu, R. Bapat and A. Supe
Department of Surgical Gastroenterology, Seth GS Medical 
College & King Edward Memorial Hospital
Seth GS Medical College & King Edward Memorial 
Hospital, Department of Surgical Gastroenterology, C-89, 
Snehdhara CHS, Dadabhai Cross Rd No. 3, Irla Vile Parle 
(West), Mumbai 400056, India
Introduction: Isolated hepatobiliary and pancreatic tuber-
culosis (TB) is rare and preoperative diagnosis is diffi cult. 
We report our experience this rare site of tuberculosis.
Methods: The records of patients with proven histological 
diagnosis of hepatobiliary and pancreatic tuberculosis were 
reviewed retrospectively. The demographic features, sign 
and symptoms, imaging, cytology/histopathology, proce-
dures performed, outcome and follow up data were obtained. 
The diagnosis of tuberculosis was based on granuloma with 
caseation necrosis on histopathology or presence of acid fast 
bacilli.
Results: Hepatic Tuberculosis: A 44 year old female patient 
who had isolated hepatic TB presented with jaundice and 
minimum ascites Based on clinical presentation and history 
a clinical diagnosis of autoimmune hepatitis was considered. 
However her AMA and ANCA test for autoimmune hepatitis 
were negative. She was subjected to Liver Biopsy which 
revealed presence of granuloma with caseation. She was 
started on 4 drugs AKT for six months. At the end of three 
months her jaundice subsided, and there was subjective 
improvement in increased weight and appetite. It is one and 
half year post AKT and she is doing well.
Biliary Tuberculosis: A 16 year old girl presented with chol-
angitis. Her imaging showed dilated CBD.
Conclusion: Tuberculosis should be considered as a dif-
ferential diagnosis, particularly in young patients, with atypi-
cal signs and symptoms coming from areas where tuberculosis 
is endemic and preoperative tissue and/or cytological diag-
nosis should be attempted before labeling them as hepatobili-
ary and pancreatic tuberculosis.
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ASSESSMENT OF ROLE OF SURGERY IN 
PORTAL HYPERTENSION
C. Kantharia, S. Pujari, R. Prabhu, R. Bapat and A. Supe
Seth GS Medical College & King Edward Memorial 
Hospital
Seth GS Medical College & King Edward Memorial 
Hospital, Department of Surgical Gastroenterology, C-89, 
Snehdhara CHS, Dadabhai Cross Rd No 3, Irla, Vile Parle 
(West), Mumbai 400056, India
Introduction: Surgery for Portal Hypertension is associated 
with high mortality, rebleeding rates and portosystemic 
encephalopathy. Though other effective therapeutic options 
are available for bleeding from portal hypertension, surgery 
has a defi nite role. The present study evaluates the mortality 
and morbidity, and factors affecting outcome of patients 
undergoing surgery.
Methods: Records of 29 patients operated between 2007 to 
2010 who underwent surgery were analyzed with particular 
attention to operative mortality, rebleeding, and encepha-
lopathy and factors affecting their outcome. Survival was 
calculated according to the Kaplan-Meier method.
Devascularization surgery included devascularisation of 
the greater curvature with splenectomy and stapled esopha-
geal transection.
Follow up period ranged from 12 months to 36 months.
Results: Of 29 patients subjected to surgery, 5 were 
Cirrhotic, 5 NCPF, 16 EHPVO and 3 BCS. 19 patients were 
of Child A (3-Cirrhotic, 4 NCPF and 12 EHPVO). 10 patients 
were Child B (2 Cirrhotic, 1 NCPF, 4 EHPVO and 3 BCS). 
DSRS was performed for 3 patients (Child A Cirrhotic). 
PSRS was performed for 12 patients (5 NCPF, 7 EHPVO). 
Mesocaval Shunt was performed for 3 patients (All patients 
of BCS). 11 patients underwent Devascularization (2 
Cirrhotic, 9 EHPVO), of which 1 was an emergency surgery 
(cirrhotic). 2 patients had rebleed (cirrhotic). 2 had ascites (1 
each of Cirrhotic and BCS). No patient had post operative 
encepahalopathy. Mortality was in three patients (2 Cirrhotic 
and 1 BCS). 26 patients are surviving.
Conclusion: Surgery is a one-time procedure with a low 
mortality rate and good long-term results. The two most 
important factors in predicting the results of surgery are The 
Childs score and the timing of the operation, with good 
results obtained in patients with good liver function and who 
had an elective operation.
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HEPATO-BILIARY PANCREATIC 
TUBERCULOSIS:
S. Pujari, C. Kantharia, R. Prabhu, R. Bapat and A. Supe
Seth GS Medical College & King Edward Memorial 
Hospital
Seth GS Medical College & King Edward Memorial 
Hospital, Department of Surgical Gastroenterology, C-89, 
Snehdhara CHS, Dadabhai Cross Rd No3, Irla, Vile parle 
(West), Mumbai 400056, India
Introduction: Isolated hepatobiliary and pancreatic tuber-
culosis (TB) is rare and preoperative diagnosis is diffi cult. 
We report our experience of this rare site of tuberculosis.
Methods: The records of patients with proven histological 
diagnosis of hepatobiliary and pancreatic tuberculosis were 
reviewed retrospectively. The demographic features, sign 
and symptoms, imaging, cytology/histopathology, proce-
dures performed, outcome and follow up data were obtained. 
The diagnosis of tuberculosis was based on granuloma with 
caseation necrosis on histopathology or presence of acid fast 
bacilli.
Results: Hepatic Tuberculosis: 44 year old patient of iso-
lated hepatic TB, presented with jaundice and ascites. A 
clinical diagnosis of autoimmune hepatitis was considered. 
Her AMA and ANCA test for autoimmune hepatitis were 
negative. Liver Biopsy performed revealed presence of gran-
uloma with caseation. She was started on 4 drugs AKT for 
six months. At the end of three months her jaundice subsided, 
with subjective improvement in increased weight and 
appetite.
Biliary Tuberculosis: 16 year old presented with cholan-
gitis. Her imaging showed dilated CBD hence diagnosis of 
Choledochal cyst was made. She was subjected to surgery, 
when Hepatico-dochojejunostomy was done. Histopathology 
of excised CBD revealed granuloma with presence of casea-
tion. Liver Biopsy done post operatively was normal. Patient 
was started on 4 drug AKT for six months, and patient is 
doing well.
Pancreatic Tuberculosis: 50 year patient presented with a 
palpable lump in the supraumbilical region. Imaging showed 
the lump in relation to the body of pancreas. Patient was 
subjected to exploratory laparotomy with excision of the 
lump. The lump contained pus, which was positive for AFB 
culture. Patient was started on 4 drug AKT, and patient is 
doing well.
Conclusion: Tuberculosis should be considered as a dif-
ferential diagnosis, particularly in young patients, with atypi-
cal signs and symptoms coming from areas where tuberculosis 
is endemic and preoperative tissue and/or cytological diag-
nosis should be attempted before labeling them as hepatobili-
ary and pancreatic tuberculosis.
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CLINICAL AND FINANCIAL OUTCOMES 
FROM THE COORDINATED 
TREATMENT OF PRIMARY AND 
METASTATIC HEPATOBILIARY 
MALIGNANCIES: EARLY EXPERIENCE 
OF A NEW CENTER
G. Tsoulfas, E. Kastanias, G. Georgantis, N. Mentesidou, 
S. Kalamaras, B. Tsiantzi, K. Soufl eris and D. Kiskinis
First Surgical Department, Papageorgiou General 
Hospital, Aristoteleion University of Thessaloniki, 
Thessaloniki, Greece
Aristoteleion University of Thessaloniki, Surgery, 66 
Tsimiski Street, 54622 Thessaloniki, Greece
Introduction: The treatment of hepatobiliary (primary or 
metastatic malignancies) requires a coordinated approach 
between different departments. The worldwide fi nancial 
crisis has direct implications on the practice of medicine. The 
goal of this paper is to describe the initial experience of a 
Hepatobiliary division at a University Surgical Department 
by analyzing both clinical and fi nancial outcomes.
Methods: A review of the record of the surgical department 
revealed 27 patients with hepatobiliary malignancies over 
the last 18 months. The age mean was 71 years old. The 
management and course of these patients were reviewed, as 
well as the fi nancial cost of the treatment rendered.
Results: The overall mean length of stay was 6.8 days, and 
operating time was 150.6 min. 15 had metastatic disease, 8 
hepatocellular carcinoma and 4 cholangiocarcinoma. Overall, 
13 patients underwent preoperative chemotherapy, 2 preop-
erative hepatic artery chemoembolization, 4 preoperative 
portal vein embolization, 10 treatment that included radio-
frequency ablation. Out of all these patients, 20 underwent 
an R0 resection, with 5 of these suffering from recurrence. 
Three patients passed away, but none in the immediate post-
operative period. The total mean cost per patient was € 5548. 
Patients were divided into three groups depending on whether 
they underwent (a) a major liver resection (group 1), (b) a 
simultaneous colon and hepatic metastatic disease resection 
(group 2) and (c) a palliative hepatobiliary procedure (group 
3). Patients in group 1 had the highest cost (€ 5989 vs. 
€4532 and €5227 in groups 2 and 3 respectively), because 
of the instruments required, but their hospital stay was the 
shortest (5.3 days vs. 7.8 and 7.3 in groups 2 and 3 respec-
tively) as a fast-track protocol was followed.
Conclusion: Considering the limitations of the small 
number of cases in this early effort, we believe that with the 
coordinated, protocol-based approach in the treatment of 
primary and metastatic hepatobiliary lesions, it is possible to 
achieve good results and to do that in a manner conscious of 
today’s fi nancial realities.
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MINIMIZING PORT SITES FOR TOTAL 
LAPAROSCOPIC LEFT LATERAL 
HEPATIC SEGMENTECTOMY USING 
“LESS” APPROACH
S. Fayek, D. Aranovish, R. Barth and B. Philosophe
University of Maryland School of Medicine, Baltimore, 
MD, USA
University of Maryland, School of Medicine, Division of 
Transplantation, Department of Surgery, 29 S Greene 
Street, Suite 20021201 Baltimore, USA
Introduction: With the expansion and development of min-
imally invasive surgery more liver resections are performed 
laparoscopically. Most segmental resections require multiple 
ports (5–6) in addition to a separate incision for specimen 
extraction. Our center has adopted LESS (Laparo-Endoscopic 
Single Site Surgery) technique for living donor nephrecto-
mies. With growing experience we applied the same approach 
to a patient requiring a liver resection.
Methods: Through a transumbilical longitudinal incision, 
GelPOINT was used in addition to two 5 mm ports to 
perform a total laparoscopic left lateral hepatic segmentec-
tomy for a 41 years old lady, with BMI of 30, who presented 
with a liver mass in which the non-invasive preoperative 
imaging was not diagnostic.
Results: Intraoperative laparoscopic ultrasound examina-
tion was completed. Totally laparoscopic left lateral hepatic 
segmentectomy was performed with no intra or post opera-
tive blood transfusion. The specimen was extracted intact 
through the GelPOINT without a need for a separate incision. 
Patient was discharged home on the 3rd post operative day. 
The fi nal visualized skin incision was 4 cm in length.
Conclusion: To our knowledge this is the fi rst report 
describing the use of LESS technology in a major segmental 
liver resection. Adopting LESS approach in hepatic resec-
tions is feasible and safe. In addition it offers minimization 
of port sites and elimination of a separate incision for speci-
men extraction.
645
HEPATIC TUMORS INVOLVING THE 
VENA CAVA AND THE ORIGIN OF THE 
HEPATIC VEINS
A. Karachristos1, A. Jain1, S. Munoz2 and J. Daly1
1Department of Surgery, Temple University School of 
Medicine and Hospital; 2Department of Medicine, Temple 
University School of Medicine and Hospital
Temple University School of Medicine and Hospital, 
Surgery, 6th Floor, Boyer Pavilion, 3509 N. Broad Street, 
19140 Philadelphia, USA
Introduction: The aim of this study is to review our experi-
ence with primary and metastatic hepatic tumors with 
involvement of the hepatocaval confl uence and those involv-
ing the vena cava. Although surgery is the only meaningful 
therapy, the location of these tumors has historically been 
considered a contraindication to resection.
Methods: This is a retrospective review of liver resections 
at our institution for primary or metastatic tumors over the 
last four years. We focused specifi cally on tumors at the 
origin of the hepatic veins or those involving the vena cava.
Results: 13 patients were identifi ed that fulfi lled the above 
criteria out of a total of 83 who underwent major hepatic 
resections. There were 9 females and 4 males. 9 of these 
tumors were primary liver tumors. 11 tumors were malig-
nant. Median follow up was 19 months. Partial resection of 
the vena cava along with liver resection was performed in 6 
(46%) patients, total vascular exclusion was used in 4 (31%) 
patients, and veno-veno bypass was used in one patient. 30 
day mortality was 7.7%; one patient died from liver failure. 
One patient died at 16 months due to progressive metastatic 
disease. Morbidity occurred in 38% of the patients classifi ed 
according to Clavien-Dido as: I (2 patients), III (1 patient), 
IIIb (1 patient), IVa (1 patient).
Conclusion: Resection of liver tumors at the hepatocaval 
confl uence and those involving the vena cava is feasible. 
Assessment of the liver remnant and patient selection is of 
paramount importance. Helpful technical points include ana-
tomic resections, identifi cation and control of hepatic veins, 
the supra and infrahepatic vena cava, resection of the vena 
cava near the end of the procedure and availability of veno-
veno bypass. Preoperative imaging cannot always identify or 
exclude vena cava involvement.
646
HEPATIC RUPTURE AS AN 
INITIAL PRESENTATION OF 
POLYARTERITIS NODOSA
S. MacKenzie, W. Dorman, J. Mehling and S. Timothy
Virginia Piper Cancer Institute, Abbott Northwestern 
Hospital, 800 East 28th Street, Minneapolis, Minnesota, 
55407
Virginia Piper Cancer Institute, Liver & Pancreas Surgery, 
800 East 28th Street, 55407 Minneapolis, USA
Introduction: Isolated hepatic involvement is an extremely 
rare manifestation of the systemic necrotizing vasculitis 
polyarteritis nodosa, which usually affects small and medium 
size arteries. Aneurysmal rupture of the damaged arteries 
may result in life-threatening hemorrhage. We present a case 
of spontaneous hepatic bleeding as an initial presentation of 
this rare demonstration of polyarteritis nodosa.
Methods: The case demonstrates an initial presentation of 
polyarteritis nodosa with as life-threatening hepatic rupture. 
The 39 year old male, born in Guyana, presented to the 
emergency department with abdominal pain located in the 
right upper quadrant. The patient ultimately became hypo-
tensive with decreased level of conscious, requiring intuba-
tion and transfer to the tertiary care facility. After stabilizing 
with aggressive resuscitation, an abdominal CT scan revealed 
hepatic rupture with extensive intra-abdominal clot and pos-
sible multiple hepatic lesions. Once stabilized from the initial 
trauma and appropriately evaluated for possible malignancy, 
the patient underwent an urgent right hepatectomy.
Results: Pathological evaluation of the specimen revealed 
diffuse patchy arterial damage and organizing micro-thrombi, 
associated with focal hepatic infarct with healing infl amma-
tion. These fi ndings are consistent with hepatic manifesta-
tions of polyarteritis nodosa. The patient was evaluated 
with a complete rheumatologic examination, including 
immunological studies (negative ANA, ASMA, and anti-
mitochondrial antibodies) and a complete arterial survey 
for additional pseudo-aneurysms. No additional systemic 
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manifestations of Polyarteritis nodosa were revealed. The 
multiple hepatic lesions appeared to be regenerative nodules, 
representing the chronicity of the disease. A tapering course 
of steroids was initiated, and the patient remains 
asymptomatic.
Conclusion: An exhaustive differential diagnosis for spon-
taneous hepatic rupture was considered, including hepatocel-
lular carcinoma, adenoma, hemangioma, budd-chiari, 
osler-weber-rendu syndrome, peliosis hepatis, infarction, 
passive congestion, HHT. Ultimately this case report dem-
onstrates hepatic rupture as a complication of polyarteritis 
nodosa.
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LAPAROSCOPIC LIVER RESECTION 
WITH SELECTIVE PRIOR 
VASCULAR CONTROL
H. Tranchart1, G. Di Giuro1, P. Lainas1, G. Pourcher1, 
N. Devaquet1, G. Perlemuter2, D. Franco1 and I. Dagher1
1Department of Abdominal and Minimally Invasive 
Surgery, Antoine Béclère Hospital, AP-HP, Clamart, 
F-92140, France; 2Department of Gastroenterology, 
Antoine-Béclère Hospital, AP-HP, Clamart, F-92140, 
France
Antoine Béclère Hospital, AP-HP, Department of 
Abdominal and Minimally Invasive Surgery, 157 Rue de la 
Porte de Trivaux, 92141 Clamart, France
Introduction: Selective control of vascular infl ow can 
reduce blood loss without inducing ischemic liver lesions in 
the future remnant liver. The aim of our study was to evaluate 
the effect of a selective prior vascular control (PVC) in 
patients undergoing laparoscopic liver resections (LLR) 
compared to laparotomy.
Methods: Fifty-two patients who underwent laparoscopic 
liver resection with PVC were compared in a case-match 
analysis to 52 patients selected from our open database. 
Variables evaluated were duration of intervention, blood 
loss, transfusion rate, resection margin, specifi c and overall 
morbidity, perioperative mortality and length of hospital stay.
Results: Patients were comparable regarding age, BMI, 
gender, ASA score, presence of liver disease, preoperative 
liver blood tests, tumour size, type of liver resection and 
histological type of resected tumour. There was no difference 
in operative time between the two groups (p = 0.7). Blood 
loss and transfusion rate were lower in the laparoscopic 
group (367 ml vs. 589 ml, p = 0.001; transfusions: 3.8% vs. 
17.3%, p = 0.05). Specifi c and general morbidity were not 
signifi cantly different between the two groups (specifi c: p = 
0.1 and general: p = 1.0). Hospital stay was longer in the 
open group (11.0 ± 8.9 vs. 7.4 ± 5.9 days, p = 0.001).
Conclusion: In this study we demonstrated the feasibility of 
PVC during LLR, which improved the intraoperative results. 
This prior vascular control was proved to be more effi cient 
than in open surgery. The effect of PVC is reinforced by the 
pneumoperitoneum that could play an additional hemostatic 
role.
648
LAPAROSCOPIC DRAINAGE AS FIRST 
LINE TREATMENT FOR PYOGENIC 
LIVER ABSCESS
L. Cioffi , P. Limongelli, A. Belli, G. Russo, A. D’agostino, 
C. Fantini and G. Belli
Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital
S.M. Loreto Nuovo Hospital, Department of General and 
Hepato-Pancreato-Biliary Surgery, Via A. Vespucci, 80142 
Naples, Italy
Introduction: The successful rate for percutaneous drain-
age in treating Pyogenic liver abscess is referred to be 66%, 
dwell time of 3–319 days, a signifi cant recurrence rate and 
a 64% rate of redo drainage.
The purpose of the current study was to report our experi-
ence in performing laparoscopic drainage of liver abscess 
over a 5-years period.
Methods: All cases of liver abscesses admitted to the 
General and HPB surgery of Loreto Nuovo Hospital Naples-
Italy over the last 5-years period and treated by laparoscopic 
drainage were retrospectively reviewed. Clinicopathologic 
variables, such as abscess location, presence of loculation, 
abscess size, drain dwell time, cultured organisms, and 
length of hospital stay were evaluated. Pre- and intra-opera-
tive imaging techniques were recorded.
Results: There were 10 patients with liver abscesses admit-
ted and treated by laparoscopic drainage.
Mean age was 51.5 years, (range 41–75 years) 7 males, 3 
females; the most frequent symptom at presentation was 
fever, chills with leukocytosis. Abscesses presented single in 
3 patients and multiple in 7. Primary abscess location was in 
the right lobe in 90% of patients and in the left lobe in 10% 
of patients.
Loculations were present in 7 abscesses. Abscess 
maximum diameter was less than 5 cm in 1 patient, between 
5 and 10 cm in 6 patients and more than 10 cm in 3 patients. 
Escherichia coli (22%) and Enterococci (34%) were the most 
frequent organisms isolated from the intra-operative cultures. 
Average hospital stay was 6.2 days (range 2–12 days).
Conclusion: In this study, pyogenic liver abscess was 
treated successfully in all patients with only one session of 
laparoscopic surgical drainage and without further treatment. 
No morbidity, mortality, or prolonged hospital stay were 
recorded. There was no recurrence at 2 year follow up. 
Laparoscopic drainage seems to be a safe and reproducible 
minivasive treatment of liver abscess. Large well-conducted 
comparative studies are necessary to support laparoscopic 
drainage as fi rst line treatment of pyogenic liver abscess.
649
THE ROLE OF PRINGLE’S MANOEUVRE 
IN LIVER RESECTION
C. Jones and M. A Taylor
Department of HPB Surgery, Mater Hospital, Belfast
Mater Hospital, Belfast Health and Social Care Trust, 
Department of HPB Surgery, 10 Breezemount Park, BT32 
Banbridge, Northern Ireland
Introduction: Liver resection can be associated with major 
blood loss and a high morbidity and mortality. Pringle’s 
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manoeuvre involves total clamping of the hepatic pedicle to 
reduce hepatic haemorrhage, but can alter cardiovascular 
dynamics and increase post-operative complications and 
mortality. This has led to variations in practice with the use 
of either intermittent or continuous clamping. The study aim 
was to review total infl ow occlusion as a method of vascular 
control in liver resection.
Methods: A literature search was carried out using the fol-
lowing databases – PubMed, Athens, Medline and Google 
scholar search engine. The following key words were used 
– liver resection, total infl ow occlusion, Pringle’s manoeu-
vre, continuous, intermittent, singly or in combination. To 
ensure an up-to-date literature search, the search was been 
restricted to the last fi ve years from 2006 to date inclusively. 
To maximize this search backward chaining of reference lists 
from retrieved papers was also undertaken, a total of 11 
papers were retrieved.
Results: Evidence regarding Pringle’s manoeuvre is incon-
clusive. One study compared 3 methods of vascular infl ow 
occlusion found Pringle’s manoeuvre was associated with a 
shorter operating time but a higher rate of complications. 
One study found continuous and intermittent clamping were 
equally protective against post-operative liver injury, while 
the continuous method was associated with reduced blood 
loss. Cellularly, an increase in oxidative stress with pro-
longed periods of clamping was found. Shorter clamp times 
were more benefi cial for this. No detrimental outcomes were 
reported, showing it is a safe method of vascular control. 
Some studies suggest other methods are associated with less 
intra-operative blood loss, and reduced mortality.
Conclusion: Although there are many methods of vascular 
control, Pringle’s manoeuvre is a safe option, and when 
applied intermittently the technique will minimize ischaemia 
– reperfusion injury especially in patients with liver cirrho-
sis. However, the literature is inconsistent in the role of 
Pringle’s manoeuvre in blood loss control and therefore no 
change in routine clinical practice can be made.
650
SERUM LEVELS OF ENDOTHELIN-1 
AFTER LIVER RESECTION IS AN EARLY 
PREDICTOR OF POSTOPERATIVE 
LIVER FAILURE
C. Pulitanó, F. Ratti, M. Catena, M. Paganelli and G. Ferla
Department of Surgery, Hepatobiliary Surgery Unit, 
Scientifi c Institute San Raffaele, Vita-Salute San Raffaele 
University
Via Delle Convertite n. 289125, Reggio Calabria, Italia
Introduction: Postoperative liver failure (PLF) remains a 
relatively frequent and life-threatening complication after 
liver resection. Recent studies have demonstrated that 
besides the residual liver volume, damage of the microcircu-
lation secondary to increased portal blood fl ow is a main 
determinant of PLF. Endothelin-1 (ET-1) is a multimodular 
mediator produced primarily by sinusoidal endothelial cells 
and is known to play a key role in the regulation of hepatic 
microcirculation.
Methods: Serial post-operative serum ET-1 levels in 
patients undergoing liver resections were correlated with 
indices of infl ammatory response, liver failure, and death. 
The aim of this study was to determine whether ET-1 levels 
has any prognostic utility in predicting PLF.
Results: A total of 65 patients were included. ET-1 levels in 
the patients who had a resection >40% of the remnant liver 
volume were signifi cantly higher than patients who had a 
resection <40% on POD 1 (P = 0.003), POD 2 (P = 0.0001), 
and POD 5 (P = 0.0001). Five patients developed PLF and 
ET-1 was signifi cantly higher compared to patients without 
PLF on POD 2 (P = 0.002) and POD 5 (P = 0.006). For all 
the patients who developed PLF, day 2 ET-1 concentrations 
were more than 28 pg/mL. Serum ET-1 concentration on 
POD 2 was an independent predictor of PLF in multivariate 
analysis.
Conclusion: ET-1 is as an early index of PLF and provides 
a rationale for therapeutic manipulation, a possibility with 
many clinical implications.
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THE ROLE OF LAPAROSCOPY AND 
TUMOUR BIOMARKERS IN 
POTENTIALLY RESECTABLE 
HEPATOBILIARY DISEASE; 
EXPERIENCE FROM A REGIONAL 
HEPATOBILIARY CENTRE
N. Misra1, C. Battersby1, S. Staettner1, N. Grimes2, 
E. McChesney2, G. Poston1, H. Malik1 and S. Fenwick1
1North Western Hepatobiliary Centre, University Hospital 
Aintree, Liverpool, UK; 2University of Liverpool, UK
University Hospital Aintree, Liverpool, North Western 
Hepatobiliary Centre, Lower Lane, Liverpool L9 7AL, UK
Introduction: The use of laparoscopy in the assessment of 
patients who are considered for major hepatobiliary resec-
tions is a recognised intervention. The role of tumour bio-
markers in the assessment of patients, with regards to 
prediction of the burden of disease or its aggressive biologi-
cal nature, is less well recognized. The aim of this study was 
to assess the potential combined role of tumour biomarkers 
and laparoscopic examination in the treatment algorithm of 
major hepatobiliary cancers.
Methods: A retrospective analysis of all the staging laparos-
copies conducted by the hepatobiliary unit between January 
2008 and August 2011 was undertaken. Operative details, 
patient demographics, fi nal post resectional histology and 
pre-laparoscopy tumour marker results, where available, 
were examined, as well as long term follow up. The correla-
tion of tumour marker levels and the probability of proceed-
ing to resection, as well as the risk of early tumour recurrence 
were analysed using Fishers exact t-test.
Results: 131 staging laparoscopies were conducted on the 
unit between January 2008 and August 2011.
Of these, 14 were for assessment of resectability in patients 
with metastatic ocular melanoma, 47 with cholangiocarci-
noma, and 34 with hepatocellular carcinoma.
In those patients with ocular melanoma, 7 patients (50%) 
proceeded to attempted resection after laparoscopy, and 6 
patients had a completed resection (43%). Of those patients 
who did not proceed to resection, 6 had bilobar multiple 
metastases and 2 patients had peritoneal disease diagnosed 
by laparoscopy.
In those patients with cholangiocarcinoma, 32 patients 
(68%) proceeded to an attempted resection after laparoscopy, 
and 28 patients had a completed resection (60%). In those 
who did not proceed to resection 5 patients had peritoneal 
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disease, 4 patients had locally advanced disease and 3 
patients had background liver disease. 4 patients proceeded 
to an attempted resection which was abandoned due to pro-
gression to peritoneal disease. 43% of patients with a signifi -
cantly raised CA 19-9 had oncologically operable disease, as 
compared to 68% with CA19-9 levels less than 200 (p = 
0.374). When all patients with resected cholangiocarcinoma 
were analysed, 50% of patients with a raised CA19-9 at the 
time of laparoscopy as compared to 85% with a CA19-9 less 
than 200 were alive at 6 months (p = 0.179). In terms of 
histology, 83% of patients with a CA 19-9 greater than 100 
had poor tumour characteristics, as opposed to 17% of 
patients with a CA 19-9 less than 100 (p = 0.04).
12 patients with hepatocellular carcinoma did not progress 
to resectional surgery after laparoscopy (36%), of which 6 
patients had advanced or multilobar disease, and 3 patients 
had previously undiagnosed background liver disease. In 
patients with an initial AFP level >1000, only 20% were 
found to have operable disease, as compared to 92% of 
patients with an AFP < 1000 (p = 0.003).
Conclusion: Laparoscopy changes the management in 
patients with potentially resectable hepatobiliary neoplastic 
disease in between 32–50% of patients, and thus has a sig-
nifi cant role to play.
A raised CA19-9 does not accurately predict resectability 
in patients with cholangiocarcinoma, nor does it correlate 
well with early post-operative mortality, but may suggest 
aggressive tumour biology.
A raised preoperative AFP > 1000 may predict potential 
resectability in patients with primary hepatocellular 
carcinoma.
This raises the possibility of a future predictive role for 
tumour markers in hepatobiliary disease.
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EXPERIMENTAL STUDY OF THE USE OF 
A SEALANT AND HEMOSTATIC SPONGE 
(TACHOSIL) FOR PRIMARY 
HEMOSTASIS IN HEPATECTOMIES
F. Waechter1, U. Teixeira2, J. Sampaio1, F. Paulo1, 
L. Pereira-Lima1, M. Nectoux1, T. Passarin2 and 
J. Diedrich3
1Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS, Brazil; 2Hepato-Pancreato-
Biliary Surgery Resident, Universidade Federal de 
Ciências da Saúde de Porto Alegre, RS, Brazil; 3General 
Surgery Resident, Universidade Federal de Ciências da 
Saúde de Porto Alegre, RS, Brazil
Universidade Federal de Ciências da Saúde de Porto 
Alegre, Hepato-Pancreato-Biliary Surgery, Rua Sarmento 
Leite, 245. Zip code: 90050-17090050, Porto Alegre, 
Brazil
Introduction: During last years, there has been an increase 
in indications of hepatic resections and the need of tech-
niques that enable the preservation of the liver parenchyma, 
allowing the removal of the liver in a fast, effective and safe 
way, with no complications or sequelae.
Methods: Ten pigs underwent laparotomy and total liver 
vascular exclusion with total resection of the right lobe by 
cold scalpel blade, generating a smooth and linear surface. 
The remaining blood in the left lobe was aspirated and an 
hemostatic sponge (Tachosil) was applied on and compressed 
for 5 minutes. After the release of the surface and also of the 
total vascular exclusion, the same liver area covered by the 
sponge was monitored for bleeding, presence of bile, 
opening, or bulging of the applied product, with records in 
the times: zero, 1, 5, and 30 minutes.
Results: The section time of the liver parenchyma ranged 
from 10 to 15 seconds. There was no active bleeding nor 
presence of bile along the surface covered by the hemostatic 
sponge and there were no opening or bulging of the applied 
product in the time control.
Conclusion: The use of the sealant and hemostatic sponge 
(Tachosil) on the surface of the remaining liver allows imme-
diate and adequate primary hemostasis of the hepatic vessels 
and bile ducts sealing. These results infer the feasibility of 
hepatectomies by simple section of the hepatic parenchyma 
with a cold blade.
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ROBOT-ASSISTED LAPAROSCOPIC 
LIVER RESECTION FOR BENIGN AND 
MALIGNANT HEPATIC PATHOLOGIES
E. C. H. Lai, C. N. Tang, G. P. C. Yang and O. C. Y. Chan
Department of Surgery, Pamela Youde Nethersole Eastern 
Hospital, Chai Wan, Hong Kong SAR, China
Department of Surgery, Pamela Youde Nethersole Eastern 
Hospital, Surgery, 3 Lok Man Road, Chai Wan, Hong Kong 
SAR, China
Introduction: The recent introduction of robotic surgical 
systems has revolutionized the fi eld of minimally invasive 
surgery. It was developed to overcome the disadvantages of 
conventional laparoscopic surgery. The role of robotic 
system in laparoscopic surgery was not well evaluated yet. 
The aim of this cohort study was to evaluate the outcome of 
robot-assisted laparoscopic liver resection for hepatic 
pathologies.
Methods: From May 2009 to December 2011, all patients 
with hepatic pathologies underwent robot-assisted laparo-
scopic liver resection in a surgical center were included. A 
prospectively collected data was analyzed retrospectively. 
During the study period, a total of 65 robot-assisted laparo-
scopic liver resections were performed for hepatic 
pathologies.
Results: The operated pathologies included: hepatocellular 
carcinoma, HCC, n = 35; combined HCC/cholangiocarci-
noma, n = 1; colorectal liver metastases, n = 18; incidental 
carcinoma of gallbladder, n = 1; biliary papillomatosis, n = 
1; recurrent pyogenic cholangitis, n = 5; adenoma, n = 1; 
hemangioma, n = 1; angiomyolipoma, n = 1; polycystic liver 
disease; n = 1. The mean operation time was 227 ± 90.3 min 
(SD). The mean blood loss during surgery was 314.2 (range, 
5–3500) ml. Two patients (3.1%) and 1 patient (1.5%) 
needed open conversion and hand-assisted approach conver-
sion, respectively. The morbidity rate was 9.2%. There was 
no procedure-related death. 86% of patients had R0 resection 
and 14% of patients had R1 resection. The mean hospital stay 
was 6.2 ± 3.3 days.
Conclusion: Robot-assisted laparoscopic liver resection of 
liver pathology was feasible and safe in selected patients. It 
was associated with a low complications rate.
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THE USEFULNESS OF PREOPERATIVE 
LIVER FUNCTIONAL TEST USING 
99TC-GALACOSYLHUMAN SERUM 
ALBUMIN SCINTIGRAPHY FOR 
SAFE HEPATECTOMY
A. Miki, Y. Sakuma, Y. Kawamura, N. Sata and Y. Yasuda
Department of Transplant Surgery, Jichi Medical 
University, Shimotsuke City, Tochigi, Japan
Introduction: The accurate preoperative estimation of liver 
function has been required for safety hepatectomy. However 
indocyanin green-based diagnosis is widely utilized in deter-
mination of hepatic resection volume, it only represents 
whole liver function.
99Tc-Galacosyl Human Serum Albumin (GSA) scintigra-
phy is liver function test that estimate the regional liver 
function. The aim of this study is to assess the clinical value 
of GSA scintigraphy as preoperative liver function test.
Methods: Consecutive forty patients who had major hepatic 
resection including right or left hepatectomy from August 
2008 to August 2010 were studied. Liver function was esti-
mated by both liver single photon emission computed tomog-
raphy (SPECT) using 99mTc-labelled diethylene triamine 
penta acetate galactosyl human serum albumin (GSA) and 
computed tomography (CT) scans. Preoperative remnant 
liver function was calculated by hepatic regional GSA clear-
ance using SPECT with fusion image of CT scan. Liver 
dysfunction was defi ned as acites, total bilirubin (more than 
3 mg/dl), or encephalopathy. SPSS was used for the statistic 
analysis and signifi cant difference was defi ned as P < 0.05.
Results: GSA clearance was correlated with LHL15, plate-
let count, total bilirubin, prothrombin time, and choline ester-
ase. Eleven patients of 40 patients developed liver 
dysfunction. All seven patients whose remnant liver function 
less than 75 ml/min developed liver dysfunction after hepa-
tectomy. Regression analysis of clearance of remnant liver 
correlated with postoperative max total bilirubin (R = 0.62, 
P < 0.01). Regression analysis of clearance of whole liver 
did not correlate with postoperative max total bilirubin (R = 
0.15, N.S.). Areas under the ROC curves for GSA clearance 
of remnant liver, whole liver, and LHL15 were 0.92, 0.62, 
and 0.58 respectively.
Conclusion: Remnant liver function test using GSA scintig-
raphy is useful tool and is of assistance in evaluating the risk 
of postoperative liver dysfunction, which might contribute 
selecting indication hepatectomy.
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SURGICAL TREATMENT OF BUDD-
CHIARI SYNDROME SECONDARY TO 
POLYCYSTIC LIVER DISEASE
F. Waechter1, U. Teixeira2, J. Sampaio1, P. Fontes1, 
M. Nectoux1, L. Pereira-Lima1, T. Passarin2 and 
J. Diedrich3
1Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS, Brazil; 2Hepato-Pancreato-
Biliary Surgery Resident, Universidade Federal de 
Ciências da Saúde de Porto Alegre, RS, Brazil; 3Surgery 
Resident, Universidade Federal de Ciências da Saúde de 
Porto Alegre, RS, Brazil
Universidade Federal de Ciências da Saúde de Porto 
Alegre, Hepato-Pancreato-Biliary Surgery, Rua Sarmento 
Leite, 245, Zip code: 90050-17090050 Porto Alegre, Brazil
Introduction: The polycystic liver disease is uncommon 
and often associated with autosomal dominant kidney poly-
cystosis. The liver complications are relatively common and 
may account for up to 10% of deaths. However, Budd-Chiari 
syndrome is an uncommon complication, with few cases 
reported in the literature.
Methods: Case Report: a 76-year-old female white patient, 
on hemodialysis due to polycystic kidney and liver disease. 
In the last 6 months started with progressive and diffi cult to 
control ascites, with repeated episodes of bacterial peritoni-
tis. Moreover, she had weight loss, worsening of general 
state and progressive loss of hepatic synthesis function trans-
lated by a decrease in albumin and prothrombin time. The 
angiotomographic liver study showed, in addition to multiple 
hepatic cysts, compression of the right hepatic vein with 
almost complete absence of left liver tissue.
Results: She underwent resection and drainage of multiple 
cysts located on the path of the hepatic vein, with good 
postoperative evolution and almost complete disappearance 
of ascites, and improvement of the nutritional and functional 
liver status. The postoperative angiotomographic study con-
fi rmed decompression of the right hepatic vein.
Conclusion: Surgical decompression of cysts that compress 
hepatic veins allows the restoration of adequate blood drain-
age of the liver, resulting in improved liver function, with 
resolution of ascites.
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HEAT SHOCK PROTEIN-70 (HSP-70) A 
NOVEL SURROGATE MARKER FOR 
HYPOXIA INDUCED LIVER INJURY 
(HILI) – A PROSPECTIVE OPEN LEVEL 
CONTROL CLINICAL PILOT STUDY
P. Basu1, T. Nair2, S. Farhat2, S. Foustin2, M. Jafri3, 
L. A. Niraj2 and J. Shah2
1Columbia University of Physicians and Surgeons, New 
York, USA; 2North Shore University Hospital, Forest Hills, 
New York, USA; 3NYMC Richmond university, Staten 
Island, New York, USA
Columbia University of Physicians and Surgeons, 
Hepatology and Liver Transplant, 5 Station Square, Forest 
Hills, 11375 New York, USA
Introduction: Hypoxic hepatopathy (HH) is a common 
entity in hospital with impaired hepatic perfusion secondary 
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to transient altered cardio pulmonary hemodynamics, mani-
festing with sharp rise of transaminases with perfusion injury 
rarely requiring transplantation. Transaminases are non-
specifi c index of reperfusion injury (IR). HSP are reperfusion 
signal proteins represent sheer stress. HSP-70 is one of spe-
cifi c signals of IR impacts on specifi c target. This study 
evaluates the utility of a novel marker of HILI.
Methods: sixty (n = 60) patients were recruited from 
Hospital. Group A control (n = 20) Group B (n = 20) HILI, 
Group C (n = 20) Acute Hepatitis [(Tylenol 8/20 (40%), 
Acute hepatitis B 8/20 (40%) herpes simplex 1/20 (5%) EBV 
1/20 (5%) acute hepatitis A 1/20 (5%) unknown 1/20 (5%). 
All groups underwent serial blood levels of HSP70, Liver 
and renal functions, MELD score, SOFA score, from day 0, 
4, 7 and 10. Exclusion; Cardio respiratory failure, Renal 
failure, Acute alcoholic hepatitis, sepsis, organ transplant, 
hemolytic Syndromes, CVA, MELD > 20, MAP < 90.
Results: Group A; HSP 70 was normal. Group B was inter-
mediate on day 0 and very high on day 4, 7 and reverting 
back to lower levels on day 10. Group C had a low level 
(mildly elevated) of HSP-70 on all days with the exception 
of the Tylenol group where it was intermediate levels.
Conclusion: HSP -70 is a relevant surrogate marker for 
hypoxia induced hepatopathy. HSP-70 levels strongly cor-
related with HILI and poorly with Tylenol induced liver 
injury. But negatively with other non-vascular liver injuries. 
Larger study needed to validate this fi nding.
755
UNEXPECTED INTERNAL HERNIATION 
OF THE SMALL BOWEL INTO THE 
DEAD SPACE AFTER RIGHT 
TRISECTIONECTOMY OF LIVER: 
A CASE REPORT
Y.-D. Yu, D.-S. Kim, G.-Y. Byun and S.-O. Suh
Department of Surgery, Division of HBP Surgery & Liver 
Transplantation, Korea University Medical Center, Korea 
University College of Medicine, Seoul, Korea
Korea University Medical Center, Korea University 
College of Medicine, Department of Surgery, Division of 
HBP Surgery & Liver Transplantation, Sungbuk-gu, 
Anamd-ong, 13670 Seoul, Korea
Introduction: Herniation of the intestine and its mesentery 
into openings or pouches in the visceral peritoneum is 
referred to as internal herniation. Intestinal obstruction due 
to internal herniation is rare, reported as 1% in the literature. 
We present a rare case in which the small bowel herniated 
into the dead space through an opening formed by the 
remnant liver, abdominal wall and right colon following right 
trisectionectomy with caudate lobectomy with associated 
imaging fi ndings.
Methods: A 32-year-old woman was admitted with a diag-
nosis of hepatic metastasis of sigmoid colon cancer. Patient 
underwent right trisectionectomy with caudate lobectomy 
without any signifi cant event. Sips of water were allowed on 
postoperative day 1, and a soft diet was started on postopera-
tive day 2. On the third postoperative day, she complained 
of nausea, vomiting, epigastric pain and tenderness over the 
whole abdomen. On abdominal computed tomography (CT) 
scan, marked fl uid-fi lled distension of the small bowel distal 
to the ligament of Treitz was observed and closed loop 
obstruction was suspected.
Results: Operative fi ndings revealed that the proximal 
jejunum was trapped in the dead space where the resected 
right trisection was located. A narrow opening to the dead 
space was created by the remnant left liver, abdominal wall 
and the relatively fi xed hepatic fl exure of the colon resulting 
in internal herniation and mechanical obstruction. Mild dis-
coloration of the herniated small intestine was observed, 
which might have been caused by ischemia due to kinking 
of the small bowel mesentery. The obstructed small intestine 
was reduced to its original location. To prevent future hernia-
tion, the right colon was mobilized down to the cecum and 
was fi xed to the posterior abdominal wall.
Conclusion: In conclusion, although rare, since an internal 
hernia can unexpectedly be caused by an opening created by 
the remnant liver, abdominal wall and the hepatic fl exure of 
the colon, we suggest that the right upper quadrant of the 
abdominal cavity should be inspected for potential causes of 
herniation before abdominal wall closure after major hepa-
tectomy, especially if the hepatectomy involves resection of 
the right lobe of the liver.
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INTRAOPERATIVE LIVER 
ULTRASONOGRAPHY: A PROSPECTIVE 
COMPARISON OF LAPAROSCOPIC VS. 
OPEN TECHNIQUE
L. Viganò, A. Ferrero, M. Amisano, N. Russolillo and 
L. Capussotti
Dept. HPB and Digestive Surgery, Ospedale Mauriziano 
Umberto I, Torino, Italy
Ospedale Mauriziano Umberto, Dept. HPB and Digestive 
Surgery, Largo Turati, 6210128 Torino, Italy
Introduction: Laparoscopic liver surgery must reproduce 
open surgical steps. Intraoperative ultrasonography (IOUS) 
is an essential tool for staging. Reliability of laparoscopic 
IOUS (L-IOUS) in comparison with open one (O-IOUS) has 
never been evaluated. To compare sensitivity (Se) and accu-
racy (Ac) of L-IOUS vs. O-IOUS in staging liver tumors.
Methods: Between September 2009 and March 2011, all 
patients scheduled for liver resection were considered. 
Inclusion criteria were primary or metastatic liver tumor. 
Exclusion criteria were hilar/gallbladder cholangiocarci-
noma, >10 lesions, re-resection, laparoscopic hepatectomy, 
adhesions precluding complete L-IOUS, and unresectability 
at exploration. Study protocol scheduled laparoscopy, 
L-IOUS, then laparotomy, O-IOUS and hepatectomy. 
Contrast-enhanced IOUS (CE-IOUS) was performed in dis-
cordant cases. Data were prospectively collected. Reference 
standards were fi nal pathology and 6-month follow-up.
Results: 65 patients were included (37 CRLM, 12 HCC, 12 
CCC, 4 non-CRLM). Median number of preoperative 
imaging studies was 3 (US/CT-scan 100%, CE-MRI 67%, 
PET-CT 54%). 119 lesions were diagnosed (median 1 per 
patient, >1 40%). L-IOUS detected 42 additional lesions 
(+35%) in 20 patients (31%), median diameter 6 mm (2–18). 
O-IOUS detected 2 additional lesions, while did not confi rm 
4 lesions (even after CE-IOUS): overall 40 lesions (+34%) 
in 16 patients. In comparison with O-IOUS, L-IOUS Se and 
Ac were 98.7% and 96.3%. Final pathology confi rmed 34 
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newly detected malignant nodules (+29%) in 14 patients 
(22%). After 6-month follow-up 10 new liver nodules were 
identifi ed in 6 patients. Se of L-IOUS and O-IOUS was 
93.2% and 93.8%; Ac was 88.4% and 90.8%.
Conclusion: L-IOUS is a reliable tool for staging liver 
tumors with performances similar to O-IOUS in detecting 
new nodules.
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EFFECTS OF LIDOCAINE 3% GEL 
DELIVERED RECTALLY IN ANO RECTAL 
DYSFUNCTION (ARD) INDUCED BY 
TELAPRAVIR THERAPY IN CHRONIC 
HEPATITIS C (CHC -C) A RANDOMIZED 
PLACEBO CONTROL STUDY
P. Basu1, T. Nair2, S. Farhat2, S. Foustin2, M. Jafri3, 
L. Ang2, N. J. Shah2 and A. Anwarullah2
1Columbia University of Physicians and Surgeons, New 
York, USA; 2North Shore University Hospital, Forest Hills, 
New york, USA; 3NYMC Richmond university, Staten 
Island, New York, USA
Columbia University of Physicians and Surgeons, 
Hepatology and Liver Transplant, 5 Station Square, Forest 
Hills, 11375 New York, USA
Introduction: Telapravir is a Potent Protease Inhibitor, 
which causes anorectal dysfunction (ARD) comprising 
Proctalgia, Rectal Ulcers, Hemorrhoids and rectal bleeding. 
Conventional therapy is suboptimal causing treatment 
Failure. This study evaluates 3% Topical Lidocaine gel rectal 
delivery to abate the drug related ARD to avoid treatment 
failure.
Methods: 52 Patients (mean age 51) were recruited under-
going therapy with Telapravir, Peg Interferon and Ribaviran 
for CHC-C. 45/52 (86%), with Rectalgia, 8/52 (15%) rectal 
ulcers, Hemorrhoids 19/52 (36%) with bleeding 6/19 (31%) 
without Bleeding 13/19 (68%). Group A (n = 17) placebo 
Group B (n = 17) hydrocortisone 2.5% Cream and Group C 
(n = 18) Lidocaine 3% Gel foam per rectally twice daily. All 
underwent Pre and post Proctoscopic evaluation and Ano-
rectal manometry.
Results: Rectalgia resolved in 3/17 (17%), 8/17 (47%) & 
7/18 (94%) for Group A, B & C respectively. Rectal ulcers 
healed in 0/2 (0%), 1/3 (33%) & 2/3 (66%) for all the above 
groups. Hemorrhoids resolved in 1/6 (16%), 2/6 (33%) & 5/7 
(71%) in all groups. Pre/Post Proctoscopy revealed normal 
mucosal integrity 4/17 (23%), 7/17 (41%) and 17/18 (94%) 
above groups. Results of Pre/Post Rx mean scores for pain, 
Itching and Burning. AR Manometry results showed 
Pre/Post treatment high sphincter tone >4 mm in Group A 
2/15 (8%) and no differences in pre and post treatment, 
Group B 7/15 (41%), 4/15 (22%) and Group C 5/15 (20%), 
2/15 (10%) respectively. Side events; Numbness, 4/17 (23%) 
in lidocaine.
Conclusion: Rectally delivered Lidocaine 3% gel is effi ca-
cious, tolerable compared to the SOC and placebo for ARD 
causing treatment failure, retention & SVR. Larger trial 
needs to validate this fi nding.
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CLIPLESS HEPATIC PARENCHYMAL 
TRANSECTION USING ENSEALTM IN 
LAPAROSCOPIC LIVER RESECTION
Y. Otsuka, T. Maeda, T. Katagiri, J. Ishii, Y. Kubota, 
A. Tamura, H. Shimada and H. Kaneko
Division of general and gastroenterological surgery, 
Department of surgery (Omori), Toho-university faculty of 
Medicine
Toho University Faculty of Medicine, Department of 
Surgery (Omori), 6-11-1 Omori-nishi, Ota-ku, 143 Tokyo, 
Japan
Introduction: Application of surgical instruments is quite 
important issues to achieve safe laparoscopic liver resection 
(LLR) and further development of minimally invasive 
surgery. EnSealTM (Ethicon Endo-Surgery, LLC., Cincinnati, 
OH, USA) is a bipolar tissue sealing device includes a blade 
for tissue division, and have been mainly used in laparo-
scopic gastro-intestinal surgery. We have been introducing 
EnSealTM in LLR, and report its usefulness for the reduction 
of clip-use in this paper.
Methods: We have used EnSealTM in 22 LLRs including a 
case of single-port LLR for 15 patients who had primary or 
metastatic liver tumor. In liver transection, veins smaller than 
4 mm in diameter and branches of glissonian pedicles 
smaller than 2 mm in liver parenchyma were isolated by 
clamp crushing method using laparoscopic forceps, and were 
divided after sealing using EnSealTM. Vessels larger than 
the former in liver parenchyma were clipped and divided 
using scissors. Division of main Glissonian pedicles or 
hepatic veins in anatomical hepatectomies was performed 
using laparoscopic linear staplers. The number of surgical 
clips used during the procedure and peri-operative clinical 
data of patients who received LLR were analyzed 
retrospectively.
Results: Averages of patient’s age, pre-operative ICGR15 
and tumor diameter were 62.6 year-old, 9.4% and 30.3 mm, 
respectively. Procedures of LLR were pure laparoscopic pro-
cedures in 16 (2 anatomical resections except left lateral 
sectionectomy, 4 left lateral sectionectomies, 10 partial 
resections), hand assisted procedure in 4 (4 partial resec-
tions) and laparoscopy assisted procedure in 2 (2 partial 
resections). Mean operative duration was 371.1 minutes, and 
mean blood loss was 291.5 cc. Average number of clips used 
was 2.0. However, no clips were used in 63.6% of LLRs (14 
LLRs; 3 left lateral sectionectomies, 11 partial hepatecto-
mies). Average of postoperative hospital stay was 7.2 days. 
No morbidity including bile leakage, or mortality was found.
Conclusion: Bipolar sealing device provides a favorable 
sealing effect to tissue and vessels in liver parenchymal tran-
section. LLR using EnSealTM is safe, and can contribute to 
the reduced usage of surgical clip. This technology is also 
applicable in single-port LLR for properly selected patients. 
Furthermore, a clipless procedure would help to improve the 
quality of diagnostic imaging for postoperative follow-up of 
liver tumor.
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AUTOLOGOUS STEM CELL 
TRANSPLANTATION FOR THE 
EXPANSION OF REMNANT LIVER 
VOLUME WITH EXTENSIVE 
HEPATECTOMY
K.-H. Ryu1, H.-S. Han2, S. K. Min3, H. K. Lee3, 
K. S. Ahn2, Y.-S. Yoon2 and J. Y. Cho2
1Department of Pediatrics, Ewha Womans University; 
2Department of Surgery, Seoul National University; 
3Department of Surgery, Ewha Womans University
Ewha Womans University, Pediatrics, Mok-dong 911-1, 
Yangcheon-Gu, 15871 Seoul, Korea
Introduction: Allogeneic liver transplantation remains the 
only effective treatment available for patients with liver 
failure. However, due to the serious shortage of liver donors, 
other alternative therapeutic approaches are urgently needed. 
Based on their ability for self-renewal and transdifferentia-
tion of bone marrow stem cells, we tried autologous stem 
cell transplantation via portal vein for rapid liver regenera-
tion in hepatocellular cancer patients.
Methods: Patients aged 20 to 75 years needing large exten-
sive hepatectomy due to hepatocelluar carcinoma with 
having signed informed consent were included. Patients were 
divided into one of three groups by use of a randomization 
table, such as control, mononuclear cells (MNC) and CD34+ 
cells according to infused cells. After portal vein emboliza-
tion (PVE), mobilized MNCs or CD34+ cells were then 
returned to the patient via portal vein on mobilization day 
without any manipulation. Comparison of liver volume, liver 
function, clinical score and ICG-R50 were performed to 
make an objective analysis before and after PVE.
Results: Ten patients have completed the 6 months follow-
up assessment; 4 from the MNC group, 3 from the CD34+ 
cell group, and 3 from control group. Infused cell numbers 
(MNCs, CD34+ cells and CD133+ cells) were satisfactory 
for body weight with only one leukaphereis. Total bilirubin, 
albumin and clinical score showed a signifi cant improvement 
(P < 0.05) at week post cell infusion, but there were no sig-
nifi cant difference between MNC group and CD34+ cell 
group. Four patients (control 1, MNC 1, CD34+ cell 2) were 
started at a status with over 18% of Indocyanine green R15 
(ICG-R15) which means inappropriate condition for exten-
sive hepatectomy, but possible hepatectomy after PVE. The 
daily hepatic volume growth (mL/day) in MNC group was 
2.5 and in CD34+ cel.
Conclusion: Based on improvement of the liver volume, 
liver function, clinical score and ICG R15 comparing with 
control group, we suggest that autologous stem cell trans-
plantation will be a new promising method for the treatment 
liver regeneration.
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A COST ANALYSIS: CYTOREDUCTIVE 
SURGERY AND HEATED 
INTRAPERITONEAL CHEMOTHERAPY 
VERSUS HEATED INTRAPERITONEAL 
CHEMOTHERAPY AND EARLY 
POSTOPERATIVE INTRAPERITONEAL 
CHEMOTHERAPY
R. Kirby, W. Liauw and D. Morris
UNSW Department of Surgery, Sydney, Australia
UNSW Department of Surgery, St. George Hospital, Level 
3 Pitney Building, Kogarah, Sydney, NSW 2217, Australia
Introduction: Peritoneal carcinomatosis is treated with 
Cytoreductive surgery (CRS) and Heated Intraperitoneal 
Chemotherapy (HIPEC) with or without Early Postoperative 
Intraperitoneal Chemotherapy (EPIC) depending on the 
pathology involved.
Since the beginning of 2010 heated intraperitoneal oxali-
platin has been utilised in our institution without the need for 
fi ve days of EPIC that requires High Dependency Unit 
(HDU) care.
Methods: Our aim was to determine if there was a signifi -
cant cost difference between patients receiving oxaliplatin 
and those requiring fi ve additional days of EPIC.
We retrospectively analysed to date 28 patients from a 
prospective database.
14 patients underwent CRS, heated intraperitoneal oxali-
platin (350 mg/m2) and 5-fl uorouracil (FU) intravenously 
administered intraoperatively.
We compared those patients with 14 patients who under-
went CRS, heated intraperitoneal mitomycin C (10–25 mg/
m2) as well as EPIC with 5-FU (600–800 mg/m2) on postop-
erative days 1 to 5.
Patients were matched for age, gender, pathology and peri-
toneal carcinomatosis index (PCI). A cost analysis was 
performed.
Results: There was no signifi cant difference between the 
two groups with regard to gender (10 female, 4 male) age (p 
= 0.4 student unpaired t-test) and PCI (p = 0.42).
The oxaliplatin group had a signifi cantly shorter length of 
stay with a mean of 18 versus 32 days (p = 0.001). There 
was no signifi cant difference between radiology (p = 0.3) and 
transfusion costs (p = 0.23). The chemotherapy costs in the 
oxaliplatin group were signifi cantly higher (p = 0.007) 
however overall bed costs including ward, HDU and ICU 
were signifi cantly lower in the oxaliplatin group (p = 0.029).
Conclusion: The overall costs involved including radiology, 
transfusion, chemotherapy and ward costs is signifi cantly 
lower in the oxaliplatin group when compared to the patients 
receiving mitomycin C and fi ve days of EPIC (p = 0.048).
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LAPAROSCOPIC ROBOT-ASSISTED 
MAJOR HEPATECTOMY
F. Caniglia, U. Boggi, M. A. Belluomini, S. Signori, 
N. De Lio, V. G. Perrone and F. Vistoli
Division of General and Transplant Surgery, University of 
Pisa, Pisa, Italy
University of Pisa, Pisa, Italy; Division of General and 
Transplant Surgery, Via Paradisa, 256124 Pisa, Italy
Introduction: Recent experience demonstrates that even 
major hepatectomy (HP) can be performed laparoscopically, 
despite the inherent technical limitations of this approach. 
The development of robotic technology provides the surgeon 
with the same dexterity experienced in open surgery and 
could be conveniently applied to major HP to enhance 
patients’ safety and/or allow performance of more complex 
operations.
Methods: Between 07/2010 and 11/2011, 10 patients under-
went robot-assisted major HP: 7 patients had a right HP, one 
an extended right HP, and two a left HP. All data were pro-
spectively entered into a computer database and were ana-
lyzed retrospectively.
Operative videos were reviewed to defi ne instrument 
traffi c (IT), defi ned as the time during which surgery is 
paused because the surgeon at the console is waiting for the 
action of the surgeon at the operating table. The analysis of 
IT included: crude IT time (CITT), relative IT time (RITT) 
(defi ned as the percentage of operative time spent for IT), 
number of robotic instruments changes (RIC), time spent for 
RIC (TRIC), number of pure laparoscopic actions (PLA), 
and time spent for PLA (TPLA).
Results: Mean operative time was 425 ± 66.35 minutes, 
421.87 ± 67.50 minutes for right HP and 440 ± 84.85 minutes 
for left HP. One patient needed open conversion because of 
diffi cult dissection and challenging management of right 
portal vein. There were no post-operative complications, 
only one patient required blood transfusions, and no patient 
died. Mean hospital stay was 9.4 ± 2.2 days.
Mean CITT was 56 ± 16.22 minutes, accounting for a 
RITT of 12.46%. Mean RIC was 127.43 ± 35.16 per opera-
tion accounting for a TRIC of 39.41 ± 10.97 minutes. A mean 
of 55 ± 9.50 PLA were required during each operation 
accounting for a TPLA of 11.09 ± 3.63 minutes. Camera 
cleaning required a mean of 3.31 ± 3.31 minutes per 
operation.
Conclusion: We have shown that in a center having exten-
sive experience with laparoscopic liver surgery, including 
laparoscopic live donor HP, robot-assisted major HP can be 
safely implemented. Operative time is longer than expected 
in open surgery, but could be signifi cantly reduced if IT was 
improved.
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IS IT POSSIBLE TO REDUCE BLEEDING 
IN HEPATECTOMIES WITHOUT 
MAKING PARTIAL OR TOTAL 
VASCULAR EXCLUSION? RESULTS 
OF THE USE OF BIPOLAR 
RADIOFREQUENCY COLD NEEDLES
F. Waechter1, U. Teixeira2, T. Passarin2, M. Nectoux3, 
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1Professor of Surgery, Universidade Federal de Ciências 
da Saúde de Porto Alegre, RS, Brazil; 2Hepato-Pancreato-
Biliary Surgery Resident, Universidade Federal de 
Ciências da Saúde de Porto Alegre, RS, Brazil; 3Professor 
of Surgery, Universidade Federal de Ciências da Saúde de 
Porto Alegre, RS, Brazil; 4Surgery Resident, Universidade 
Federal de Ciências da Saúde de Porto Alegre, RS, Brazil
Universidade Federal de Ciências da Saúde de Porto 
Alegre, Hepato-Pancreato-Biliary Surgery, Rua Sarmento 
Leite, 245, Zip code: 90050-170.90050, Porto Alegre, 
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Introduction: The development of techniques and appara-
tus for liver parenchymal transection aims to reduce the most 
feared complication during surgery, which is also the main 
cause of morbidity and mortality: the bleeding. An alterna-
tive technique was devised by this team – with cold bipolar 
radiofrequency needles – an equipment that bisects the 
hepatic parenchyma, reduces the intraoperative bleeding and 
enables a better hemostasis of the remnant liver.
Methods: A prospective analysis of 60 consecutive cases 
performed by the same team with the use of this 
equipment.
Results: It was performed Left/Right/Center hepatectomies; 
VI, VII, VIII, II, III and IV segmentectomies and atypical 
resections for hepatocellular carcinomas, liver metastases 
and adenomas. The medium bleeding was 58 ml (50–230 ml), 
without the use of maneuvers that control partial or total liver 
blood fl ow. There was no intraoperative mortality nor in late 
postoperative period (30 days).
Conclusion: The use of bipolar radiofrequency in hepatec-
tomies is a valid alternative. In comparison with current 
medical literature, we found that the mean bleeding with the 
use of bipolar radiofrequency is at least half of the other 
methods, with consequent impact on hospital expenses, need 
for transfusion and postoperative complications.
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LAPAROSCOPIC LIVER RESECTION 
FOR MALIGNANT LIVER TUMORS; 
WHY NOT MORE?
S. S. Yun, D. H. Lee, D. S. Lee, H. J. Kim and I. S. Kwun
Department of Surgery, Division of HBP, Yeungnam 
University Hospital
Yeungnam University Hospital, Department of Surgery, 
317-1 Daemyung-dong, Nam-gu, 705-7 Daegu, Republic of 
Korea
Introduction: Laparoscopic resection of liver malignancies 
remains controversial because of its oncologic safety. The 
purpose of the present study was to analyze the feasibility, 
safety, and outcome of 61 patients undergoing laparoscopic 
resection for liver malignancies.
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Methods: From January 2004 to March 2011, 111 patients 
were performed with laparoscopic liver resection.. Among 
the 111 patients, 61 patients with malignant liver tumors 
were included in this study. Variables analyzed included 
operating time, surgical margin, blood transfusion, conver-
sion to laparotomy, postoperative hospital stay, postoperative 
complication, operation related death, mean follow up 
period, overall survival and disease free survival. Survival 
curves were calculated according to the Kaplan-Meier 
method. P < 0.050 was considered statistically signifi cant.
Results: Mean operating time was 209.7 ± 108.9 minutes 
and mean surgical margin was 1.3 ± 1.2 cm. Blood transfu-
sion needed in 11 patients (18%). There were 2 conversion 
to laparotomy (3%) because of tumor rupture and bleeding. 
Mean postoperative hospital stay was 9.0 ± 4.4 days. 
Postoperative complication occurred in 9 patients (14%) 
including acute renal failure, wound infection, pleural effu-
sion, etc. At mean follow-up period of 18.9 ± 11.7 in HCC 
and 16.6 ± 7.5 in metastasis, 3-year overall survival rates 
were 87% in HCC and 95% in metastasis, and 3-year disease 
free survival rates were 57% in HCC and 90% in 
metastasis.
Conclusion: Even though laparoscopic liver resection needs 
learning curve and we have a limited number of patients, it 
is feasible with minimal surgical trauma even in patients who 
had malignant liver tumor especially in HCC and liver 
metastasis from colorectal cancer.
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PORTAL VEIN GAS: A REASON FOR 
PERFORMING AN URGENT 
EXPLORATORY LAPAROTOMY
X. Agrogianni2, I. Lintzeris1, T. Ziagos3, I. Pontikis3 and 
V. Ponirakos1
12nd Surgery Department, General Hospital of Tripolis, 
Arcadia, Greece; 2Postgraduate Medical Student, 
University of Athens, Greece; 3Radiology Department, 
General Hospital of Tripolis, Arcadia, Greece
Medicine School, University of Athens, Greece; 
Postgraduate Medical Student, 6 Birbili Street, Neos 
Kosmos, 11744 Athens, Greece
Introduction: Air in the portal venous system is a relatively 
rare but ominous sign, indicative of serious intra-abdominal 
pathology such as mesenteric vascular occlusion, bowel 
necrosis, abdominal sepsis.
Methods: We conducted a review of English medical litera-
ture searching the terms and conditions under which the 
radiographic fi nding of portal venous gas consists an indica-
tion for surgery intervention and performance of exploratory 
laparotomy.
Results:  Current data suggests that gas in the portal vein 
may be the outcome of several pathological conditions of 
ischaemic or not origin. It is not a specifi c diagnostic entity 
but a diagnostic clue in patients presenting with abdominal 
symptoms and signs. When it is the only fi nding, patients 
should be treated conservatively with antibiotics and it must 
act as a trigger for further assess the underlying disease. An 
emergent laparotomy is justifi ed only when this radiographic 
fi nding is combined with a deteriorating clinical state.
Conclusion: Finding gas in the portal vein during an ultra-
sound or computed tomography scan of the abdomen should 
be promptly evaluated along with concomitant signs and 
manifestations.
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SURGICAL TREATMENT OF GIANT 
HEPATIC HAEMANGIOMAS
M. Chinthakindi1, A. raj Saksena2, S. Komanduri2, 
V. kumar Jyothiprakasan3, N. R. Dvl4 and P. R. R.5
1Assistant Professor of Surgery, Department of Surgical 
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Professor, Department of Surgical Gastroenterology, 
Osmania General Hospital, Hyderabad, India; 5Professor 
And Head, Department of Surgical Gastroenterology, 
Osmania General Hospital, Hyderabad, India
Osmania General Hospital, Department of Surgical 
Gastroenterology, Flat no. 203, Samyukta Pride Enclave, 
Barkatpura Bus Depo Lane, Barkatpura, 27 Hyderabad, 
India
Introduction: Hepatic haemangiomas are the most common 
benign tumours of the liver. Surgical treatment (enucleation 
or resection) for symptomatic giant haemangioma carries 
high risk in view of intraoperative haemorrhage. However it 
is essential to minimize surgical morbidity and mortality for 
this benign condition. Enucleation is dangerous when the 
lesion is large occupying the entire lobe or deep seated. The 
present study highlights the need of safe hepatic resections 
for symptomatic giant haemangiomas.
Methods: 10 patients with symptomatic giant hepatic hem-
angiomas (>5 cm) underwent hepatic resections at the 
Osmania General Hospital, Hyderabad in India between July 
2007 and August 2011. Patient demographic, clinical, and 
surgical characteristics and outcomes were reviewed retro-
spectively. Inclusion criteria’s were symptomatic haeman-
giomas of >5 cm size, diagnostic uncertainty or presence of 
complications. Exclusion criteria’s were asymptomatic hae-
mangioma of any size or symptomatic haemangiomas <5 cm.
Results: 10 Patients were included in this retrospective 
study. 9 were female and 1 male with median age of 30 years 
(range, 3 to 60 years). Indications for surgical interventions 
were abdominal pain (60%), abdominal mass (30%) and 
diagnostic uncertainty (10%). The lesions were solitary in 
80%, multiple (10%) and bilobar (10%) and had a median 
size of 14.5 cm (range, 7 to 27 cm). All underwent anatomi-
cal hepatic resections (4 Right hepatectomy, 3 left hepatec-
tomy, 1 Right extended hepatectomy, 1 left extended 
hepatectomy and 1 monosegmentectomy), with early selec-
tive extra hepatic vascular control using the conventional 
hepatic transection method. Parenchymal transection done 
with harmonic scalpel. There was no mortality and morbidity 
was 25%.
Conclusion: Enucleation is dangerous and is not a ideal 
method when the lesion is very large involving entire lobe 
or when the lesion is deeply located in hepatic parenchyma. 
Resections were safe in large lesions. Early selective extra 
hepatic vascular control is essential for safe resection of large 
hepatic hemangiomas.
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EFFECT OF OBESITY ON 
PERIOPERATIVE OUTCOMES 
FOLLOWING LAPAROSCOPIC 
HEPATECTOMY
J. Buell2, R. Cannon1 and M. Killackey2
1University of Louisville, Dept of Surgery; 2Tulane 
Abdominal Transplant Insitute, Dept of Surgery, Tulane 
University
Tulane Abdominal Transplant Institute, Surgery, 1415 
Tulane Ave, TW 35, 70112 New Orleans, United States
Introduction: Obesity is generally considered to increase 
the risk of complications following surgery, although this 
risk may be mitigated through minimally invasive tech-
niques. This study was undertaken to evaluate the effect of 
obesity on perioperative outcomes following laparoscopic 
hepatectomy.
Methods: A retrospective review of 329 consecutive 
patients undergoing laparoscopic hepatectomy was per-
formed with IRB approval. Patients were divided into three 
weight classes: normal, obese (BMI > 30), and morbidly 
obese (BMI > 35). Comparisons were made on preoperative 
factors, operative variables, and perioperative outcomes. 
Continuous variables are presented as means and analyzed 
by ANOVA, while categorical variables are presented as 
count (percentage) and analyzed by chi-squared. Univariate 
and multivariate analysis of complications was also per-
formed using logistic regression.
Results: There were 329 total patients, with 255 (77.5%) 
normal, 57 (17.3%) obese, and 17 (5.2%) morbidly obese. 
The groups were equivalent with respect to age, presence of 
cirrhosis, segments resected, and operative blood loss and 
duration, while the mean ASA score was signifi cantly higher 
in the overweight groups (normal = 2.7, obese = 3.1, mor-
bidly obese = 3.1; p = 0.001). Length of stay was also statisti-
cally similar between groups. Complications were 
signifi cantly more common in the morbidly obese group 
(47.1%) than the obese (19.3%) and normal (17.7%; p = 
0.012) groups. In the multivariate model, morbid obesity 
remained signifi cantly associated with complications (OR 
3.125; p = 0.033), while BMI < 35 was not signifi cant (OR 
0.973; p = 0.945).
Conclusion: Weight does not appear to have any adverse 
effect on perioperative outcomes following laparoscopic 
hepatectomy until BMI exceeds 35.
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PLASMA BILE SALTS PREDICT LIVER 
REGENERATION IN A RABBIT MODEL 
OF PORTAL VEIN EMBOLIZATION
L. Hoekstra1, M. Rietkerk1, K. van Lienden2, 
J. van den Esschert1, F. Schaap3 and T. van Gulik1
1Department of Surgery, Academic Medical Center, 
University of Amsterdam, Amsterdam, the Netherlands; 
2Department of Radiology, Academic Medical Center, 
University of Amsterdam, Amsterdam, the Netherlands; 
3Tytgat Institute for Liver and Intestinal Research, 
Academic Medical Center, University of Amsterdam, 
Amsterdam, the Netherlands
Academic Medical Center, University of Amsterdam, 
Amsterdam, the Netherlands; Department of Surgery, 
IWO-A1-132, Meibergdreef 9, 1105 Amsterdam, The 
Netherlands
Introduction: Preoperative PVE is employed to increase 
the future remnant liver (FRL) volume through induction of 
hepatocellular regeneration in the non-embolized liver lobe. 
The regenerative response is commonly determined by CT 
volumetry after PVE. The aim of the study was to examine 
plasma bile salts and triglycerides in the prediction of the 
regenerative response following PVE.
Methods: PVE of the cranial liver lobe was performed in 
fi fteen rabbits, divided into 3 groups: NaCl (control), recon-
stituted collagen (short-term occlusion), and polyvinylalco-
hol particles with coils (PVAc, long-term occlusion). In all 
rabbits CT-volumetry and blood sampling were performed 
prior to PVE and on day 3 and 7 after PVE. Plasma bile salts 
and triglycerides were correlated with volume increase of the 
non-embolized, caudal liver lobe.
Results: After three and seven days, FRL volume was 
increased in both embolized groups with the largest hyper-
trophy response observed in the PVAc group. Plasma bile 
salt levels were increased after PVE, especially in the PVAc 
group at day 3 (p < 0.01 compared to reconstituted colla-
gen). Plasma bile salt levels at day three predicted volume 
increase of the FRL at day 7 showing a positive correlation 
of 0.838 (p < 0.001). Unlike bile salts, levels of triglycer-
ides were not signifi cantly altered in either of the PVE 
procedures.
Conclusion: Plasma bile salt levels early after PVE strongly 
correlated with the regenerative response in a rabbit model 
of PVE, showing more pronounced elevation with larger 
volume increase of the non-embolized lobe. Plasma bile salts 
therefore, but not triglycerides, can be used in the prediction 
of the regenerative response after PVE.
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SURGEONS’ VIEW ON MINIMAL ACCESS 
HBP SURGERY IN HONG KONG
C. CN Chong, S. Y. S. Cheung, J. Wong, K. F. Lee and 
P. B. S. Lai
Division of Hepato-biliary and Pancreatic Surgery, 
Department of Surgery, Prince of Wales Hospital, the 
Chinese University of Hong Kong
Prince of Wales Hospital, Department of Surgery, 4/F, 
Clinical Science Building, Prince of Wales Hospital, 
Shatin, Hong Kong
Introduction: Conventional laparoscopic hepato-biliary 
and pancreatic (HBP) surgery has progressed slowly when 
compared to the realm of the abdominal surgeries. Recent 
development of robotic surgery may overcome the diffi cul-
ties encountered in laparoscopic HBP surgeries. However, 
surgeons’ opinion on this issue is rarely explored. We convey 
this local survey to collect and review the opinion from 
surgeons interested in HBP surgery.
Methods: A survey on surgeons’ view on minimal access 
HBP surgery was given to every participant of an academic 
meeting organized by a local hepato-biliary and pancreatic 
surgery association. Information on surgeon’s experience in 
laparoscopic or robotic surgeries, opinions on the advantages 
and problems in development of laparoscopic or robotic sur-
geries, the reasons of not performing minimal access HBP 
surgeries was collected. The survey was anonymous. No 
reward for participation was given.
Results: A total of 25 of 48 surveys (52%) were returned. 
All of them were general surgeons with 57.1% were sub-
specialized in HBP surgery. More than 70% of the partici-
pants had experience in laparoscopic major HBP surgery. 
However, only one-third of them had experience in robotic 
surgery. For the surgical approach that is most worthwhile to 
develop further in major HBP surgery, 70% chose laparo-
scopic while another 40% chose robotic approach. Control 
of bleeding and cost were considered as the top problem that 
hindered the development of laparoscopic and robotic 
surgery respectively. While around 70% believed minimal 
access approach would replace open approach in the future 
HBP surgeries, only 55% believed robotic approach could do 
the same.
Conclusion: Further development in laparoscopic and 
robotic approaches would be worthwhile in future HBP 
surgery when compared with open, hand-assisted, single-
incision, or NOTES. Future technology in overcoming the 
diffi culties in control of bleeding laparoscopically and in 
reducing the cost of robotic surgery will facilitate the devel-
opment of minimally access HBP surgery.
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CLINICAL PARAMETERS, INJURY 
PATTERNS AND RADIOLOGICAL 
FINDINGS ASSOCIATED WITH LIVER 
TRAUMA IN EQUESTRIAN ACCIDENTS
A. Balakrishnan, K. Oakland, S. Jamdar, R. Al-Ghnaniem, 
N. V. Jamieson, E. L. Huguet, A. Jah and R. K. Praseedom
Hepatopancreaticobiliary Unit, Addenbrooke’s Hospital, 
Cambridge, United Kingdom
Hepatopancreaticobiliary Unit, Addenbrooke’s Hospital, 
Hills Road, CB2 Cambridge, United Kingdom
Introduction: Equestrian sports are common outdoor activ-
ities that may carry a risk of liver injury. Due to the relative 
infrequency of equestrian accidents the injury patterns and 
clinical parameters associated with liver trauma in these 
patients have not been well characterized.
Methods: We examined our experience of the management 
of equestrian liver trauma in our regional hepatopancreatico-
biliary unit at a tertiary referral center. The medical records 
of patients who sustained liver trauma secondary to eques-
trian activities were analysed for parameters such as demo-
graphic data, liver function tests, patterns of injury, 
radiological fi ndings and the need for intervention.
Results: 20 patients sustained liver trauma after falling from 
or being kicked by a horse. The median age was 22 (range 
5–48). The majority of patients were haemodynamically 
stable on admission. Alanine transaminase (ALT) levels were 
elevated in all patients, while bilirubin and alkaline phospha-
tase levels were predominantly unchanged. CT demonstrated 
laceration of the liver in 14 patients, contusion in 3 and 
subcapsular haematoma in 3. The right lobe of the liver was 
most commonly affected (segments 5–8) and right-sided rib 
fractures were a frequently associated fi nding. Only two 
patients required laparotomy and liver resection; the remain-
ing 18 were successfully managed conservatively.
Conclusion: The risk of liver injury following a horse kick 
or falling off a horse should not be overlooked. Early CT 
imaging is advised in these patients, particularly in the pres-
ence of high ALT levels and concomitant chest injuries such 
as rib fractures. Despite signifi cant liver trauma, laparotomy 
is only rarely warranted and conservative management in the 
form of close observation, ideally in a high-dependency 
setting, is often suffi cient.
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MORTALITY RELATED LIVER 
MORPHOLOGY IN SEVERE 
OBSTRUCTIVE JAUNDICE: 
A CASE CONTROL STUDY
A. Nugroho and T. Lalisang
Digestive Division, Department of Surgery, Faculty of 
Medicine, University of Indonesia, Cipto Mangunkusumo 
Hospital
Digestive Division, Department of Surgery, Faculty of 
Medicine, University of Indonesia, Cipto Mangunkusumo 
Hospital, Jl. Diponegoro 71, Central Jakarta 10430, 
Indonesia
Introduction: Changes in liver morphology will result in 
liver dysfunction, which is one of the surgical risk factors in 
severe obstructive jaundice that increase morbidity and mor-
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tality. The degree of liver injury as seen in its morphologic 
features is thought to be related to the mortality rate. The aim 
of this study was to investigate the relation between changes 
in liver morphology and mortality in severe obstructive jaun-
dice patients.
Methods: We did a case control study of 22 liver biopsy 
specimens taken during open biliary drainage surgery to 
relieve obstructive jaundice. A group of 11 cases who lived 
until the defi nitive surgery (Group A) was matched with the 
mortality group (Group B) according to age and sex. The 
biopsy specimens stained with Hematoxylin Eosin were 
scored with the use of a scale previously validated in a study 
of the treatment of primary biliary cirrhosis. Liver morphol-
ogy was assessed with regard to fi brosis, periportal infl am-
mation, ductal proliferations and cholestasis. Each of the 
item was graded 0 (none was observed) to 3 (severe). We 
analyze the mean difference of total histopathologic score 
and serum liver functions between groups.
Results: There were 9 male and 2 female in each group 
included in this study. The mean age was 50.68 ± 10.81 years 
old. The mean level of total bilirubin were 19.18 ± 9.96 in 
Group A and 28.41 ± 11.55 in Group B (p = 0.07), while the 
mean level of serum bile acid were 87.68 ± 53.32 in Group 
A and 121.04 ± 78.37 in Group B (p = 0.259). There were a 
statistically difference of the mean histopathologic score 
between group A and group B (5.73 ± 2.18 vs. 7.91 ± 2.46; 
p = 0.039).
Conclusion: The severe liver morphology impairment 
induced the mortality after bile duct decompression and con-
sistent with the degree of liver dysfunction as shown by the 
worsening of liver function markers.
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PELIOSIS HEPATIS: A RARE CAUSE OF 
MULTIPLE SPACE OCCUPYING LESIONS 
IN THE LIVER
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Introduction: Peliosis Hepatis is a rare benign vascular 
condition characterized by randomly distributed multiple 
blood-fi lled cavities throughout the liver which can be seen 
in a variety of settings. Image fi ndings often mimic true 
tumors and strongly enhance on arterial phase on CT/MRI. 
Persistant contrast uptake within the lesion is due to blood- 
pooled condition. We present a case report on this 
condition.
Methods: A 60 years female presented with pain upper 
abdomen of 2 days duration associated with vomitings. Past 
history of similar attack was present 8 years back, received 
symptomatic treatment in another hospital. On examination 
she found to be well built and well nourished. Abdominal 
examination revealed tenderness in right hypochondrium and 
epigastric area. Hepatomegaly was present. Blood investiga-
tions show leukocytosis and elevated serum lipase levels. 
Blood and urine cultures were negative. Viral screening was 
non reactive for HIV, HCV and HBV.
Results: Ultra sound abdomen was showing multiple well 
defi ned hypo echoic lesions in both lobes of liver. Doppler 
was showing increased vascularity. CT abdomen showing 
multiple well defi ned densely enhancing lesions in both lobes 
of liver. These lesions are isodense to liver on noncontrast 
CT and following contrast administration there was a arterial 
enhancement with no washout, the lesion remaining slightly 
hyper-attenuating compared to surrounding liver on portal 
venous phase. Magnetic resonance image (MRI) Findings: 
These lesions are not well visualized on MRI and are seen 
as faint hyper intensities on T2WI. Contrast MRI was not 
performed. Fine needle aspiration cytology from these 
lesions revealed only blood elements.
Conclusion: It is usually asymptomatic found incidentally 
on imaging or autopsy, but can present as hepatomegaly, 
jaundice, liver failure, hemoperitoneum. It is important to 
recognize the imaging characteristics of peliosis hepatis 
because these lesions mimic several different types of focal 
hepatic lesions. Most commonly identifi ed in the liver the 
same process may also involve kidney, spleen, lymph nodes, 
bone marrow and gut. It is associated with many conditions, 
and treatment involves underlying the cause.
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HYDATID DISEASE LIVER: EXPERIENCE 
AT A SINGLE SURGICAL UNIT IN A 
MULTISPECIALTY CENTRE
P. Puneet, S. Singh, D. Kumar, S. Tiwary and A. Khanna
Department of Surgery, Institute of Medical Sciences, 
Banaras Hindu University, Varanasi-221005, India.
Department of Surgery, Department of Surgery, Institute of 
Medical Sciences, Banaras Hindu University, 
Varanasi-221005, India
Introduction: This series discusses clinical, diagnostic and 
surgical experience with hydatid disease liver in a single 
surgical unit of a multispeciality hospital.
Methods: It is a retrospective study from January 2000 to 
September 2011. Data were collected from the hospital 
records. 51 patients admitted with diagnosis of hydatid 
disease liver were analysed.
Results: Female cases predominate (56.8%). Mean age of 
presentation was 41 years. USG abdomen was the most com-
monly used imaging modality for diagnosis supplemented by 
CT or MRI. Preoperative ERCP was done in cases of jaun-
dice and raised alkaline phosphatise (13.7%). Overall, 72.5% 
had isolated right hepatic lobe, 11.8% had isolated left and 
13.7% had bilateral lobe involvement. 67.8% cases had 
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positive IgG antibodies. Two patients had associated splenic 
hydatid cyst. Majority of the patients underwent enucleation 
alone (43.1%) or in combination with omentoplasty. 
Pericystectomy was done in 17.6% cases. 17.6% cases had 
cystobiliary communication. Post operative mortality was 
zero but minor complications occurred in 9.8% cases.
Conclusion: Hydatid disease is not an uncommon condition 
in India. Hydatid disease liver should be suspected in a case 
presenting with pain in right upper abdomen with a palpable 
mass. USG usually suffi ces for diagnosis. ELISA is a com-
plementary laboratory test (was positive in 74% of cases). 
Although resection of the whole cyst is the standard of care, 
but at our centre, we have carried out enucleation of the cyst 
with safe and reasonable results.
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LATE FOLLOW-UP OF PATIENTS 
SUBMITTED TO SUBTOTAL 
SPLENECTOMY
V. Resende and A. Petroianu
Department of Surgery, Alfa Institute of Gastroenterology, 
Hospital of Clinics of  the Federal University of Minas 
Gerais, Rua Sergipe 67/2401, 30130 Belo Horizonte, 
Brazil
Introduction: Over the past 24 years, we have performed 
more than 238 subtotal splenectomies, in which the upper 
splenic pole is preserved supplied only by the gastrosplenic 
vessels, to treat different pathologic conditions.
Methods: A total of 86 patients who had undergone surgery 
1 to 24 years ago were studied. Their pathological conditions 
were: portal hypertension due to schistosomiasis (n = 43), 
trauma (n = 31), Gaucher’s disease (n = 4), myeloid hepato-
splenomegaly due to myelofi brosis (n = 3), splenomegalic 
retarded growth and sexual development (n = 2), severe pain 
due to splenic ischemia (n = 2) and pancreatic cystadenoma 
(n = 1). Patients underwent a hematological exam, an immu-
nologic assessment, abdominal ultrasonography, computed 
tomography, scintigraphy and endoscopy.
Results: Increased white blood cell count and platelets were 
the only hematological abnormalities. No immunologic 
defi cit was found. Esophageal varices were still present 
although without rebleeding. The ultrasound, tomography 
and scintigraphy exams confi rmed the presence of functional 
splenic remnants without size alteration. This procedure was 
performed to treat other diseases in patients with chronic 
lymphocytic lymphoma (n = 2), Hodgkin disease (n = 1), 
splenic hemangioma (n = 1). Even not coming for the present 
study, we have contact with all these patients and they have 
had uneventful postoperative follow-up. In our experience 
we did not reoperate any patient due to complication related 
to the splenic remnant.
Conclusion: Subtotal splenectomy seems to be a safe pro-
cedure that can be useful in treating conditions involving the 
spleen.
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META-ANALYSIS OF FIBRIN BASED 
HAEMOSTATIC PRODUCTS IN 
LIVER RESECTION
C. W. (1), A. Amer, J. French, B. Jaques, D. Manas 
and S. White
Department of Hepatobiliary and Transplant Surgery, The 
Freeman Hospital, United Kingdom
Level 5 Liver Offi ce, The Freeman Hospital, High Heaton, 
Newcastle upon Tyne NE7 7DN, United Kingdom
Introduction: Fibrin Based Haemostatic Products (FBHP’s) 
are widely used in liver surgery and have been shown to aid 
biliostasis in experimental models. Various retrospective and 
observational studies across orthopaedic, vascular and car-
diothoracic surgery; as well as liver surgery have suggested 
that these translate into a real clinical benefi t. This meta-
analysis aimed to evaluate the randomised controlled trial 
(RCT) evidence of FBHP’s specifi c to liver surgery.
Methods: All RCT’s examining the use of FBHP’s were 
identifi ed by a combination of computer literature searches 
(MEDLINE, EMBASE, CENTRAL etc.), hand searching 
and personal communication. Quantitative data on the ben-
efi ts and harms of FBHP’s was then pooled using a random 
effects model. Data analysis was performed using RevMan 
Version 5.0 according to the principles of the Cochrane 
Collaboration.
Results: 11 RCT’s (1167 patients) fulfi lled the inclusion 
criteria and were suitable for analysis. The FBHP’s trialled 
clinically were Beriplast, Biocol, Quixil (Crosseal), CryoSeal, 
TachoSil, Tisseel (Tissucol). Only 3 small trials (169 patients) 
had a statistically positive effect on transfusion outcomes. 4 
trials (514 patients) reported on “time to haemostasis” 
and concluded that FBHP’s were benefi cial. Our meta-anal-
ysis of published data failed to identify a signifi cant 
clinical benefi t in transfusion, bile leaks or postoperative 
complications.
Conclusion: The number and range of commercial FBHP’s 
continues to proliferate. Although widely used there remains 
an absence of high grade clinical trial evidence. The majority 
of trials in this study were graded as low quality and there 
remains an urgent need for RCTs to guide their effective use.
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THE ONTOGENETIC BASIS OF LIVER 
HANGING MANOUVRE
S. Philip
Department of GastroIntestinal Surgery, Medical Trust 
Hospital, Kochi, Kerala, India
Medical Trust Hospital, Department of Gastrointestinal 
Surgery, Pulimootil, Guest House Road, Thiruvankulam, 
68230 Kochi, India
Introduction: The liver hanging maneuver (LHM) has been 
in vogue for 10 years. But the ontogenetic basis for it is not 
known. The Retrohepatic portion Inferior Venacava (IVC) 
develops during the 4th -8th week of Intrauterine life (IUL). 
This corresponds to Carnegie stages 13–23 in ontogenesis. 
The knowledge of embryological anatomy has rapidly 
increased over the past few years especially since the publi-
cation of data of the Kyoto collection of 1204 embryos.
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Methods: Medline and Cochrane database were searched 
for data on embryogenesis of IVC. Data was also acquired 
from the Kyoto Collection, the Digitally Reproduced 
Embryonic Morphologic (DREM) Project from the Carnegie 
collection including the HEIRLOOM collection and Arey-
Depana Pediatric Pathology Collection. The Kyoto collec-
tion data was analysed using a Super Parallel Magnetic 
Resonace (MR) Microscope and 3D MR Microscopic images 
acquired.
Results: Among the 6709 hits, 34 studies whose full data 
was available was chosen for analysis. Analysis was done for 
the development of Vitelline the posterior cardinal, the sub-
cardinal, and the supracardinal veins. Later, the subcardinal 
veins develop ventromedial to the posterior cardinal veins 
and ventrolateral to the aorta.. Anastomosesbetween the pos-
terior cardinal and subcardinal veins develop on each side at 
approximately the level of the intersubcardinal anastomosis. 
Simultaneously, union occurs between the right subcardinal 
vein and the hepatic segment of the IVC, which forms from 
the vitelline vein. No specifi c pattern was identifi ed in devel-
opment of the various hepatic venous branches to the IVC.
Conclusion: No ontogenetic basis could be made out for 
development of an embryonic avascular plane in retrohepatic 
region facilitating LHM.
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EXTENDED LEFT HEPATECTOMY IN A 
PATIENT WITH AN UNCLASSIFIED 
PORTAL VEIN ANOMALY
G. Shetty, R. A S, H. Mehta and P. Wagle
Department of Surgical Gastroenterology, Lilavati Hospital 
& Research Centre, Mumbai, India
Lilavati Hospital & Research Centre, Surgical 
Gastroenterology, A-791, Bandra Reclamation, Bandra 
West, Mumbai 400050, Maharashtra, India
Introduction: Intrahepatic vasculature has posted a chal-
lenge to many a hepatic surgeon in different scenarios. 
Variations in the ramifi cation of the portal vein have been 
previously described in many studies.
Methods: We present a case of a 60 year old lady who 
presented with a large intrahepatic tumor encroaching upon 
the hilum. The right portal vein however showed a non-
division into the anterior and posterior sectoral branches, 
which presented a challenge to the resection of the tumor.
Results: With essential preoperative planning and appropri-
ate intraoperative modifi cations we were able to perform a 
modifi ed extended left hepatectomy successfully resecting 
the tumor. The histopathology revealed a mucinous adeno-
carcinoma, with lymph nodal involvement.
Conclusion: We believe that this variation of the portal vein 
ramifi cation has not been classifi ed so far. With appropriate 
preoperative planning and intraoperative modifi cations, 
various complications can be averted and large tumors can 
be resected even in these rare situations.
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WANDERING STONES DESCENDING 
FROM HEPATOLITHIASIS CAUSED A 
MECHANICAL ILEUS INSIDE THE 
UNNECESSARILY LONG JEJUNAL LOOP 
FIFTEEN YEARS AFTER ROUX-EN-Y 
HEPATICOJEJUNOSTOMY: 
CASE REPORT
J. C. Woong1, H. J. Han2, S. B. Choi1, W. B. Kim1, T.-J. 
Song2 and S. Y. Choi1
1Department of Surgery, Korea University Guro Hospital, 
Seoul, South Korea; 2Department of Surgery, Korea 
University Ansan Hospital, Ansan City, South Korea
Korea University Guro Hospital, Department of Surgery, 
#97, Guro-dong Gil, Guro-gu, 15270 Seoul, Korea
Introduction: Roux-en-Y hepaticojejunostomy (HJ) is a 
routine procedure used to reconstruct bile drainage after bile 
duct resection. Though it might not be measured strictly, a 
recommended length for a Roux-en-Y jejunal loop is 40 to 
60 cm to prevent the refl ux of the bowel content. 
Hepatolithiasis is one of the common conditions which 
require a HJ with hepatectomy. However, postoperative 
stone recurrence still remains to be a challenge in the treat-
ment of hepatolithiasis. Here, we report a case that
Methods: A 62-year-old woman visited emergency room 
(ER) due to progressive abdominal pain and vomiting. The 
patient had a history of left hepatectomy with HJ for a hepa-
tolithiasis in a local hospital 15 years ago. The abdominal 
computed tomographic scans (CT) revealed that the jejunal 
loop was signifi cantly dilated with multiple stones. Because 
the patients was presented with symptoms of cholangitis, 
percutaneous transhepatic bile drainage (PTBD) was initially 
performed for decompression and antibiotics were also 
started. Five days after PTBD, patient was discharged with 
a plan to have an elective operation. However, three days 
after a discharge, patient re-visited ER with severe abdomi-
nal pain. At this time, we decided to perform an emergency 
operation.
Results: On an operation fi eld, the total length of the jejunal 
loop was approximately 105 cm and several stones were 
palpated inside the jejunal loop. The largest stone which was 
identifi ed at 10 cm below the colonic mesentery caused the 
complete obstruction. We manually pushed the stones up 
over the colonic mesentery and put an intestinal clamp just 
below the stones to prevent the stone form moving down 
during the operation. Then we opened the jejunal loop and 
retrieved the stones with stone forceps and manual squeezing 
with fi ngers. Then we irrigated the intra-hepatic duct and the 
jejunal loop with copious warm normal saline through PTBD 
catheter. Finally, after closing the jejunal loop, we made the 
omega loop to reduce the length of the jejunal loop.
Conclusion: Hepatectomy with HJ is one of the most 
common procedure used for hepatolithiasis. However, post-
operative stone recurrence still remains to be a challenge in 
the treatment of heptolithiasis. Mechanical ileus can be one 
of the rare clinical manifestations of stone recurrence and 
such condition could be prevented by keeping the appropri-
ate length of the jejunal loop.
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INFANTILE HEPATIC 
HEMANGIOENDOTELIOMA: 
A CASE REPORT
E. G. Anchante-Castillo1, V. H. Torres-Cueva2, 
C. M. Yeren-Paredes3, J. J. Nuñez-Ju3, J. Sumire-Umeres4, 
G. Chavez-Medina5 and K. Valdivia-Garcia5
1Chairman, Department of Surgery, Guillermo Almenara 
National Hospital, Lima, Peru; 2Chief, Hepatobiliary 
Surgery Service, Guillermo Almenara National Hospital, 
Lima, PERU; 3Staff, Hepatobiliary Surgery Service, 
Guillermo Almenara National Hospital, Lima, Peru; 4Staff, 
Department of Patology, Guillermo Almenara National 
Hospital, Lima, Peru; 5Staff, Pediatric Surgery Service 
Guillermo Almenara National Hospital Lima, Peru
Guillermo Almenara National Hospital, Es Salud General 
Surgery, Av. Grau 800, La Victoria, Lima 1313, Peru
Introduction: We report a newborn with unique palpable 
abdominal mass associated with heart failure and respiratory 
distress. She was born in Cusco, Peru. She was transferred 
to the pediatric ICU of Guillermo Almenara National 
Hospital – EsSalud, where she was treated for sepsis and 
abdominal mass.
Methods: In our hospital the patient had three episodes of 
cardiac arrest for complications of the tumor. So she under-
went sedation and endotracheal intubation with mechanical 
ventilation. Clinical fi ndings were systolic murmur II/VI, 
globular abdomen, enlarged liver and umbilical hernia.
Labs: Hb: 11 g/dl. PLT: 588000 mil/mm3. ALAT: 13 U/L, 
ASAT: 28 U/L, BT: 8.85 mg/dl, BD: 0.20 mg/dl, Alb: 3.9 g/
dl. AgSHVB (−). AFP: 1796 ng/ml.
Abdominal CT Scan: Right hepatic lobe with tumor of 70 
68 mm. Mass takes up contrast peripherally and has a 
necrotic center.
Echocardiography: moderate left ventricular dilatation, 
severe left ventricular dysfunction. FVI: 35%. Intracardiac 
shunts not present.
Results: She underwent an abdominal operation: We per-
formed Right Lateral segmental hepatectomy.(Segments VI 
– VII).
Labs Post Op3: Fosfate Alkaline: 119 U/L, ALAT: 95 U/L, 
ASAT: 59 U/L, Total bilirubine: 0.77 mg/dl, BD: 0.42 mg/
dl, Albumine: 4.9 g/dl. Hb: 9 g/dl. PLT: 347 000 mil/mm. 
AFP: 190 ng/ml.
Postoperative course was well. Heart problems were 
improving after Surgery and She was receiving medical 
treatment. The patient was discharged from clinical in patient 
at seven day Post Op with normal LFTs and better functional 
cardiac tests.
Our Pathologist confi rmed: Infantile liver hemangioen-
dothelioma and Inmunochemistry was: CD 31: (+); CD 34: 
(+); Factor VIII: (+); Alpha-fetoprotein (−) in tumor cells.
Conclusion: Infantile hepatic hemangioendotheliomas are 
vascular lesions that show a clinical course intermediate 
between a hemangioma and angiosarcoma. In this case, sur-
gical excision of single lesions, even in the face of congestive 
heart failure was successful.
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END STAGE LIVER DISEASE & STEM 
CELLS – WHERE ARE WE TODAY?
R. Pareek and S. Pareek
Pareek Hospital & Result Center (India) & Wishaw 
General Hospital (UK) GI Surgery 4/10, Bagh Farzana
Civil Lines, 28200 Agra, India
Introduction: Despite marked improvement in technique of 
liver transplant with subsequent improvement in outcome, 
there are still glitches and the results are not in any way 
perfect. There is also perpetual shortfall of Organ donations 
and the centers of excellence equipped to provide services 
are limited, especially in the developing world. Need of the 
hour is to fi nd means that are simpler and more readily avail-
able with fewer hazards, both to restore liver function ade-
quately or borrow time till liver transplant.
Methods: The aim of our work was to assess the present 
status of stem cell therapy for liver replacement, fi nd the 
ideal source of stem cells which produced functional 
improvement and fi nd a simple parameter to measure ade-
quacy of treatment. We enrolled 60 patients with end stage 
liver disease due to alcoholism & Hepatitis C who had no 
access to liver transplant due to fi nancial/social support 
reasons & had Childs C disease. We found Serum Albumin 
as a near ideal marker for functional liver capacity. After 
detailed, informed consent and explanation of procedure, 
they were divided into 2 groups of 30 each, for peripheral 
vein & US guided hepatic artery inj of adult marrow stem 
cells. Se albumin level was monitored 1, 3, 6 & 12 months 
as endpoint marker.
Results: Use of adult stem cells derived from patients own 
bone marrow was on balance found to be most versatile and 
simple source of stem cells.
Periferal vein injection of the stem cells, though easy and 
simple route, produced inadequate functional improvement 
in liver function, as determined by persistent improvement 
in Prothrombin time and serum albumin levels.
Of all the parameters used to monitor improvement in 
functional hepatic capacity, serum albumin level was the 
most reliable when compared to other liver function tests, 
which matched with improvement in symptoms and ascitis.
The time required to notice persistent improvement in 
albumin levels was 2 months in majority of cases (85%).
Conclusion: Although Liver transplant is today the gold 
standard for treatment of end stage liver disease, it has its 
share of pitfalls & hazards.
30% of functional hepatic capacity is adequate for healthy 
life. Stem cell transplantation is today maturing into an 
accessible therapy with better safety, adequate functional 
results and simpler follow up in patients with end stage liver 
disease (ESLD). This has the potential to change treatment 
of ESLD, the way coronary artery stents changed coronary 
artery bye.
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PATTERNS OF CARE FOR 
SYNCHRONOUS COLORECTAL LIVER 
METASTASES AT A COMMUNITY-BASED 
CANCER CENTER
S. Munireddy1, A. Schneider2, S. Katz1, N. J. Espat1 and 
P. Somasundar1
1Roger Williams Medical Center, Dept of Surgical 
Oncology, Providence, RI, USA; 2Hospital of St. Raphael, 
Department of Surgery, New Haven, CT, USA
Roger Williams Medical Center, Surgical Oncology, 825 
Chalkstone Avenue, Prior 4, Surgical Oncology, 2908 
Providence, USA
Introduction: At the time of initial presentation, 20–25% of 
patients with colorectal cancer have liver metastases 
(CRCLM). Much of the available literature regarding syn-
chronous CRCLM (sCRCLM) comes from large tertiary 
referral centers. This retrospective analysis examines how 
patients with sCRCLM are managed at a community cancer 
center (CCC).
Methods: A prospectively maintained database was used to 
analyze 201 patients treated for colorectal cancer between 
2006 and 2011 at the Roger Williams Cancer Center. Patients 
who had sCRCLM, confi rmed either radiologically or intra-
operatively, were included in the study.
Results: 22 patients with sCRCLM were identifi ed. Mean 
age was 64 yrs. The majority presented with T3/T4 tumors 
(82%) and nodal metastases (91%). Obstruction or bleeding 
led to urgent primary tumor resection in 9 patients. The mean 
number of liver lesions was 4.1 (range 1 -15). Three patients 
received neoadjuvant chemotherapy. 10 patients had liver-
directed therapy (resection and/or ablation) with primary 
tumor resection at initial operation. 5 out of 10 patients who 
underwent initial liver-directed surgery were managed with 
ablative therapy and 4 had surgical resection at the time of 
initial operation. With a median follow-up of 25.3 months, 
the 5 year overall survival (OS) for the whole group was 41% 
and median OS was 39 months.
Conclusion: In patients who presented with sCRCLM to 
our CCC, more than half (54.5%) of the patients underwent 
primary tumor resection only at initial operation. This was 
largely due to patients presenting with bleeding or obstruc-
tion and requiring primary tumor management at the initial 
operation. Despite patients presenting with advanced disease, 
long term survival was achieved in selected patients using a 
multimodal approach including surgical resection, tumor 
ablation, and systemic therapy.
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METHODS OF HAEMOSTASIS DURING 
LIVER RESECTION – A SURVEY OF UK 
LIVER SURGEONS
R. Lochan1, S. Robinson2, D. Kei-Hui2, B. Jaques1, 
J. French1, R. Charnley1, D. Manas1 and S. White1
1Dept of HPB & Transplantation Surgery; 2Dept of 
Cellular Medicine, Newcastle University
Freeman Hospital, Department of HPB and 
Transplantation Surgery, High Heaton, Newcastle upon 
Tyne NE7 7DN, United Kingdon
Introduction: Haemorrhage is a major cause of morbidity 
and mortality after liver surgery. Many techniques have been 
described to help minimize this risk. There has also been 
increasing interest amongst Bio-Surgical companies to 
develop haemostatic products for liver surgeons. The aim of 
this study was to evaluate the popularity of different methods 
of haemostasis amongst UK liver surgeons.
Methods: An online, 16 part questionnaire was developed 
detailing various aspects of liver surgery and methods of 
haemostasis. Surgeons listed as HPB specialists within the 
Association of Upper GI Surgeons of UK and Ireland 
(AUGIS) were contacted. Other UK livers surgeons who 
worked in major HPB centres who were not AUGIS members 
were also contacted.
Results: 70 liver surgeons were contacted and 36 individual 
responses were received. There were 34 non-responders. The 
most common method of parenchymal transection was by 
CUSA (n = 13, 46%). Pringle’s manoeuvre was used to 
reduce blood loss routinely by 11 (38%) surgeons. During 
major hepatectomy most surgeons suture/ligated the infl ow 
vessels (n = 16, 44%) but stapled the outfl ow (n = 15, 42%) 
vessels. Majority of surgeons (n = 22, 61%) used manufac-
tured haemostatic materials/adjuncts on liver resection 
margin whilst 33% (n = 12) used them occasionally. Most 
surgeons agreed that adjuncts played a major role in control-
ling haemorrhage from the hepatic parenchyma (n = 23, 
64%) whilst (n = 12, 33%) disagreed. Regarding individual 
products (users/responses to individual product); Tachosil 
(15/22; 68%), Quixil (11/21; 52%) and Tisseel (8/18; 44%) 
were most favourably rated.
Conclusion: Various techniques are used to control haemo-
stasis during liver surgery. Despite a lack of evidence con-
fi rming any benefi t from randomized controlled trials 
manufactured haemostatic adjuncts appear to be widely used 
amongst UK liver surgeons.
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EVALUATION OF THE RISK FACTORS 
FOR BLEEDING IN MAJOR 
LIVER RESECTION
I. Kozyrin, V. Vishnevsky, V. Subbotin, M. Efanov and 
R. Ikramov
Vishnevsky Institute of Surgery, Moscow, Russia
Vishnevsky Institute of Surgery, Hepatopancreatobiliary, 
Bolshaya Serpuchovskaya Street, 27 Moscow, Russia
Introduction: Major liver resections are still associated 
with high risk of massive blood loss. Up to now the exact 
defi nition of massive blood loss is not defi ned. The aim was 
to evaluate the prognostic factors for intraoperative bleeding 
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signifi cant for morbidity and mortality after major liver 
resections.
Methods: Design – a single-center retrospective cohort 
study. The results of major liver resections (removing 3 or 
more segments) in 230 patients with solid malignant and 
benign liver tumors and Klatskin’s tumor were evaluated. 
The blood loss was calculated in percentage of blood volume 
(BV). The complications rate was evaluated according to 
Dindo-Clavien. The variables were compared by the chi-
square test or odds ratio (OR) and 95% confi dence 
interval.
Results: The mean blood loss (BL) was 33% of blood 
volume (BV) (23; 54%). The rate of the moderate and severe 
complications was 43%, the mortality rate was 7.4%. BL > 
30% of BV increased the risk of liver insuffi ciency, OR 2.54 
(1.1, 5.6). BL > 40% of BV increased the major complica-
tions rate, OR 2 (1.2; 3.4). BL > 70% of BV impacted on 
mortality, OR 4.53 (1.5; 12.1). The signifi cant prognostic 
factors for blood loss were: liver cirrhosis (p = 0.04); preop-
erative chemotherapy, OR 3.1 (1.23, 3.94); prothrombine 
index <45% (p = 0.002); tumor size >7 cm, OR 5 (2, 12); 
the tumor involvement >3 liver segments, OR = 2.2 (1.3, 
3.9); the right lobe tumor location, OR, 2.7 (1.3, 5.8); tumor 
invasion into the main branches of the portal vein, OR = 4.4 
(1.1, 16.8) and into inferior vena cava (IVC), OR = 6 (1.2, 
29); the impairment of blood fl ow in IVC, right and middle 
hepatic veins, OR = 5.2 (1.8, 14.7).
Conclusion: Estimation of prognostic factors could help to 
calculate the risk of massive blood loss. It allows decreasing 
intraoperative bleeding, postoperative morbidity and mortal-
ity after major liver resections.
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TECHNOLOGY ASSISTED VERSUS 
CLAMP CRUSH LIVER RESECTION: 
A SYSTEMATIC REVIEW 
AND META-ANALYSIS
V. Alexiou1, T. Tsitsias2 and M. Mavros3
1Department of Hepatobiliary and Pancreatic Surgery, 
University Hospitals of Leicester, Leicester, UK; 
2Department of Thoracic Surgery, Glenfi eld Hospital, 
University Hospitals of Leicester, Leicester, UK; 3Alfa 
Institute of Biomedical Sciences (AIBS), Athens, Greece
University Hospitals of Leicester, Department of 
Hepatobiliary and Pancreatic Surgery, Leicester General 
Hospital, Portacabin Surgery Offi ces, Gwendolen Road, 
Leicester LE5 4P, United Kingdom
Introduction: We sought to systematically review the pub-
lished evidence on technology-assisted liver resection 
regarding operative time, intra-operative bleeding, mortality, 
hospital stay, post-operative bile leak, and other outcomes.
Methods: We performed a systematic search for clinical 
trials comparing liver resection performed using vessel 
sealing systems (VSS – LigaSure), Cavitron Ultrasonic 
Surgical Aspirator (CUSA), or Radiofrequency Dissecting 
Sealer (RFDS) with the conventional technique of crush 
clumping (CC), and estimated odds ratios (ORs) and 95% 
confi dence intervals (CIs), and weighted mean differences 
(WMD), as appropriate.
Results: 8 Randomised Controlled Trials (RCTs) and 6 non-
randomised studies with a total of 1450 patients were 
included. Compared with CC, the VSS group had signifi -
cantly lower blood loss by a mean of 149 mL (WMD −149; 
95% CI: −243.4, −56.2 mL; 494 patients), 2.2 times lower 
post-operative bile leak (ORs 0.45; 95% CI 0.21, 0.96; 559 
patients), and shorter total hospital stay by 2 days (WMD 
−2.04; 95% CI −3.50, −0.58 days; 340 patients); no differ-
ence was noted for surgical time and mortality. No difference 
was noted between CUSA or RFDS versus CC for any of the 
studied outcomes (in a total of 272 and 639 patients, respec-
tively). However, we noted a trend towards higher incidence 
of bile leak in the RFDS group (WMD 1.84; 95% CI: 0.92, 
3.69; 583 patients).
Conclusion: CUSA and RFDS do not seem to provide any 
signifi cant advantage over CC. Synthesis of the available 
data on VSS, as extracted from 3 RCTs and 3 non-ran-
domised studies, suggested a signifi cant benefi t over CC in 
3 important clinical outcomes, namely total blood loss, post-
operative bile leak, and total hospital stay. Large, well 
designed and implemented RCTs are warranted to further 
investigate the usefulness of the VSS in liver resection.
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BLOOD LOSS PREVENTION IN MAJOR 
LIVER RESECTION
I. Kozyrin, V. Vishnevsky, V. Subbotin, M. Efanov 
and R. Ikramov
Vishnevsky Institute of Surgery, Hepatopancreatobiliary, 
Bolshaya Serpuchovskaya Street, 27 Moscow, Russia
Introduction: Nowadays the numerous surgical (SM) and 
nonsurgical (NSM) methods for reducing blood loss in liver 
surgery are proposed. But their effi ciency and indications 
remain unclear. Aim of this study was to evaluate the effec-
tiveness of various methods to reduce blood loss during liver 
resection.
Methods: Design – a single-center retrospective cohort 
study. The results of major liver resections (removing 3 or 
more segments) in 230 patients with solid malignant and 
benign liver tumors and Klatskin’s tumor were evaluated. 
Mean blood loss was 33% of blood volume (BV) (23; 54%). 
During the resection we used no vascular exclusion, or 
Pringle maneuver, or total/hemi hepatic vascular exclusion 
with the vena cava fl ow preserved (HVE). The hepatic paren-
chyma was divided by clump-crush method, CUSA, 
Harmonic, RFA, GIA devices. Low central venous pressure 
(low CVP), preoperative autologous blood donation and cell-
saver were used as NSM. The variables were compared by 
the chi-square test or the odds ratio (OR) with 95% confi -
dence interval.
Results: HVE of the right lobe signifi cantly reduced blood 
loss (38% patients >40% BV) in comparison with the only 
Pringle maneuver (79% patients >40% BV) during right and 
extended right hemihepatectomy in presence of the follow-
ing risk factors: the tumor size >7 cm, compression of the 
right or middle hepatic veins and inferior vena cava, OR = 
6.2 (2.7, 14.3). The Pringle maneuver had not advantages in 
blood loss reduction in comparison with unilateral Glessonean 
pedicle clamping (p = 0.3). The methods of the liver paren-
chyma division had no signifi cant impact on the blood loss 
(p = 0.3). Low CVP methodic was effective in bleeding 
control during right and extended right hemihepatectomy 
(37% vs 55% > 40%), OR = 0.5 (0.2, 0.9). The preoperative 
autologous blood donation and the cell-saver signifi cantly 
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reduced the necessity of homologous blood cells transfusion, 
OR = 0.6 (0.3, 0.96).
Conclusion: Total and selective vascular exclusion with 
vena cava blood fl ow preserving, lowering of CVP, preopera-
tive autologous blood donation and cell-saver are effective 
in prevention of blood loss and homologous blood cells 
transfusion during major liver resection.
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CORRELATION BETWEEN THE 
VOLUME OF LIVER CELL NECROSIS 
AND CIRCULATING ALANINE 
AMINOTRANSFERASE LEVELS 
FOLLOWING ISCHEMIA/REPERFUSION 
IN THE RAT LIVER
A. R. Knudsen1, A.-S. Kannerup1, J. Nyengaard2 and 
F. Mortensen1
1Department of Surgical Gastroenterology L, Aarhus 
University Hospital, DK-8000, Aarhus C, Denmark; 
2Stereology & Electron Microscopy Laboratory, Centre for 
Stochastic Geometry and Advanced Bioimaging, Aarhus 
University Hospital, Aarhus, Denmark
Aarhus University Hospital, Surgical Gastroenterology L, 
Nørrebrogade 44, Bygning 1c, Lvn-Forskning, 8000 
Aarhus, Denmark
Introduction: Circulating liver enzymes are often used as 
markers of hepatocellular damages. Especially ALT, which 
is primarily located in liver cells, has been used to assess 
damages following ischemia/reperfusion (I/R) injuries, as 
ALT spills into the blood when liver cells are injured or dies. 
In this study we examined the correlation between circulat-
ing markers of ischemia/reperfusion (I/R) injuries and the 
volume of liver cell necrosis, using design-based stereologi-
cal methods.
Methods: 47 male Wistar rats were subjected to one hour 
of partial liver ischemia followed by either 4 or 24 hours of 
reperfusion. Within each group one third of the animals were 
subjected to ischemic preconditioning, one third to ischemic 
postconditioning and the remaining animals were not treated 
with hepatoprotective methods. Hepatoprotection was used 
to vary the extent of liver damages within each group. At end 
of reperfusion blood and liver samples were collected. Blood 
samples were analyzed for ALT, AP, bilirubin and acute 
phase protein α-2-makroglobolin. Liver specimens were 
handled using systematic uniform random sampling, enabling 
us to quantify the volume of necrotic liver and thus calculate 
the percentage of necrotic tissue in the liver.
Results: The circulating blood markers were tested for cor-
relation with the histological fi ndings using Pearson’s cor-
relation coeffi cient R. ALT peaked after 4 hours of 
reperfusion, however at this time-point only mild necrosis 
was observed, with Pearson’s correlation coeffi cient at 0.663 
(p = 0.001). None of the other circulating blood markers 
were found to correlate with the histological fi ndings at four 
hours of reperfusion. After 24 hours of reperfusion ALT was 
found to be highly correlated with the degree of hepatocel-
lular necrosis R = 0.836 (p = 0.000). Further AP R = 0.806 
and α-2-makroglobolin R = 0.655 were also correlated to the 
degree of necrosis.
Conclusion: We show for the fi rst time that there is a high 
correlation between the volume of hepatocellular necrosis 
and ALT in a model of I/R-injuries, especially after 24 hours 
of reperfusion, where 70% of the variation in ALT can be 
explained by the necrotic tissue. We also show that AP and 
α-2-makroglobolin can be used as markers of liver necrosis 
in the later phase of reperfusion.
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LAPAROSCOPIC HEPATECTOMY 
USING RADIOFREQUENCY
E. Gammeri, V. Resende, C. Xavier-Lima, M. D. Lisboa, 
E. Gammeri, M. M. Lusckal and J. R. Cunha-Melo
Alfa Institute of Gastroenterology, Hospital of Clinics of 
the Federal University of Minas Gerais, Surgical Rua 
Sergipe, 67/2401 Funcionários, 30130 Belo Horizonte, 
Brazil
Introduction: Laparoscopic liver resection has been gaining 
adherents among surgeons and patients, driven by both, the 
clinical and social benefi ts of a shorter hospital stay, quicker 
recovery, and better cosmetic results.
Methods: The laparoscopic radiofrequency device was fi rst 
used in Brazil for resection of hepatocellular carcinoma in 
segment six, in two cirrhotic patients.
Results:  Although the control of intraoperative bleeding 
during laparoscopic procedures remains the big challenge for 
surgeons, in both cases, the Pringle maneuver was not neces-
sary and there was no need for blood transfusion. The 
patients were discharged in the third postoperative day.
Conclusion: Laparoscopic liver resection assisted by radio-
frequency was performed safely with a signifi cantly low risk 
of intraoperative bleeding or postoperative complication.
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PRIMARY EXTRAMEDULLARY 
PLASMOCYTOMA OF THE LIVER: 
A CASE REPORT
M. Mirarchi, S. Vaccari, S. Palumbo, E. De Raffele 
and B. Cola
Dipartimento di Emergenza/Urgenza, Chirurgia Generale e 
dei Trapianti. Policlinico S. Orsola-Malpighi. Università 
degli Studi di Bologna. Bologna. Italy
Dipartimento di Emergenza/Urgenza, Chirurgia Generale e 
dei Trapianti, Policlinico S. Orsola-Malpighi, Università 
degli Studi di Bologna, Bologna, Italy; U.O. di Chirurgia 
Generale e di Urgenza, Padiglione 5, Policlinico S. 
Orsola-Malpighi, Via Massarenti, 940138 Bologna, Italy
Introduction: The extramedullary plasmacytoma (EMP) is 
a malignant proliferation of plasma cells in the absence of 
bone involvement, represents approximately 3% of all 
plasma cell neoplasms and is extremely rare in the liver as a 
primary solitary lesion; in these cases it determines mono-
clonal gammopathy in the serum and/or urine. We describe 
the case of a solitary hepatic EMP without evidence of 
myeloma elsewhere and without monoclonal gammopathy in 
the serum and/or urine.
Methods: A 89 year-old woman came to our observation for 
the appearance of a huge hepatic mass, palpable through the 
abdominal wall. The abdominal ultrasonography and the 
contrast-enhanced CT scan showed a huge hypervascular 
hepatic tumour measuring about 14 × 13 × 18 cm, located in 
segments S4-S8. At 18F-FDG PET-CT the hepatic mass had 
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an intense uptake (SUVmax 15.7). No distant metastasis was 
detected. The hematological indexes were normal, the liver 
and kidney function tests were within the normal limits; the 
plasma protein electrophoresis was normal; the viral markers 
were negative; the common tumour markers including the 
alpha-fetoprotein were not increased. A liver biopsy was not 
considered for the risk of tumour bleeding.
Results: The patient was admitted in our unit. The pulmo-
nary and the cardiac functions were evaluated and resulted 
substantially normal. In consideration of the risk of rupture 
in the peritoneum and of the reasonable operative risk, the 
patient was considered for liver resection. At abdominal 
exploration the tumour partially infi ltrated the right diafrag-
matic dome: a left hepatectomy partially extended to segment 
S8 with diafragmatic resection was performed; the diafragm 
was reconstructed with a goretex patch. The postoperative 
course was uneventful and the patient was discharged 14 
days later. The histological examination showed an EMP of 
the liver. Ten months later the patient is in excellent condi-
tions without evidence of recurrence.
Conclusion: In our patient, the diagnosis of EMP was anex-
pected, due to the absence of extrahepatic sites of disease 
and of monoclonal gammopathy in the serum and/or urine. 
In general, EMPs have a favourable prognosis and can be 
cured if accurately staged and treated. The treatment of 
choice is radiotherapy. However, for EMPs at sites other than 
head and neck the complete surgical removal should be con-
sidered if feasible. Liver resection is a safe option also in 
aged patients with isolated EMP of the liver.
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ENUCLEATION OF GIANT 
HEMANGIOMA UNDER SEGMENTAL 
VASCULAR EXCLUSION
M. C. Aguiar Junior, V. Resende, A. Dominho and 
M. M. Lusckal
Alfa Institute of Gastroenterology, Hospital of Clinics of 
the Federal University of Minas Gerais, Surgical Rua 
Sergipe, 67/2401 Funcionários, 30130 Belo Horizonte, 
Brazil
Introduction: Hemangioma is the most common solid 
benign hepatic lesion. Most are small and remain asynto-
matic. Diagnosis usually relies on imaging including ultra-
sonography, contrast-enhanced computed tomography and 
magnetic resonance. Liver hemangioma is a vascular malfor-
mation. For small and asyntomatic, conservative manage-
ment with periodic review is the recommended management 
strategy. For patients having symptomatic hemangiomas, 
enucleation is the usual recommended.
Methods: A 53 year-old woman was admitted with abdomi-
nal pain and a protrunding mass from the abdominal wall.
Computed tomography and magnetic resonance revealed 
a giant hemangioma that involved segments II and III.
Through bilateral subcostal incision left lateral segments 
were mobilized. Left artery was ligated preserving the artery 
for segment IV. The same procedure was performed for left 
portal vein. Left hepatic vein was dissected and ligated.
Under complete segmental vascular exclusion, the heman-
giona was separated from the healthy liver tissue by meticu-
lous dissection of the surgical plane between.
Results: The Pringle maneuver was not necessary and there 
was no need for blood transfusion. The patient were dis-
charged in the third postoperative day.
Conclusion: Left lateral giant hemangioma was performed 
safely under segmental vascular exclusion.
919
LAPAROSCOPIC LIVER RESECTIONS 
VERSUS OPEN APPROACH: 
A PROSPECTIVE INTRAOPERATIVE 
COST-EFFECTIVENESS ANALYSIS
R. Montalti, A. Verhaevert, L. De Gezelle, L. Louagie, 
X. Rogiers and R. I. Troisi
Dept. of General and Hepato-Biliary Surgery, Liver 
Transplantation Service, Ghent University Hospital 
Medical School, Ghent Belgium
Ghent University Hospital and Medical School, Dept. of 
General & Hepato-Biliary Surgery, Liver Transplantation 
Service, De Pintelaan 185, 9000 Ghent, Belgium
Introduction: The long learning curve and the common 
opinion that laparoscopic liver resections (LLRs) have higher 
costs are limiting the widespread utilization of this tech-
nique. Aim of the present study was to perform a cost-
effectiveness analysis of LLR vs liver resections with 
standard approach.
Methods: From August 2011 to November 2011, 25 liver 
resections were performed, 18 of them (72%) with a laparo-
scopic approach and 7 (28%) with an open approach. Hepatic 
resections requiring bile duct or vascular reconstruction or 
focal lesions not amenable to a parenchyma-sparing tech-
nique were not considered for laparoscopic approach. 
CUSA-Excel© was utilized as liver transecting device in 
open approach whereas Sonosurg© was utilized for LLRs. 
We prospectively collected the number and type of dispos-
able materials used for surgery such as: trocars, vascular 
staplers and refi lls, clips, stitches, sutures, irrigation suction, 
disposable materials for CUSA and Sonosurg, argon beamer, 
endobags.
Results: The mean operation time was 356 ± 123 min vs 
186 ± 75 min (p < 0.001) whereas the mean postoperative 
stay was 3.7 ± 2.6 days vs 8.7 ± 2.1 days for laparoscopic 
and open approach, respectively (p = 0.001). Type of resec-
tions in LLR vs open patients were respectively: 0 vs 3 right 
hepatectomy, 3 vs 1 left hepatectomy, 7 vs 2 segmentectomy, 
8 vs 1 wedge resection. According to the actual marketing 
price for Belgium, LLRs resulted in an average intraopera-
tive per/operation surplus costs of 310€ (1406 ± 96€ vs 
1096 ± 86€ for LLR and open approach respectively, p < 
0.001). The main costs for LLR were vascular stapler and 
refi lls (391€), trocars (351€), and clips (301€). The main 
costs for open approach were the disposable CUSA materials 
(426€) and sutures/stiches (202€). The cost of a day in 
hospital stay is 600 €, consequently the overall cost saving 
was 2690€.
Conclusion: LLRs require signifi cant higher intraoperative 
costs and longer operation time compared to the open 
approach. However the higher intraoperative costs are 
entirely compensated and overcome by the inferior costs of 
the shorter postoperative stay. A randomized prospective 
comparative study is necessary to avoid operation selection 
bias.
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MODIFIED HANGING MANEUVER 
USING THE GOLDFINGER© DISSECTOR 
IN LAPAROSCOPIC RIGHT AND 
LEFT HEPATECTOMY
R. Montalti and R. I. Troisi
Dept. of General & Hepato-Biliary Surgery, Liver 
Transplantation Service, Ghent University Hospital and 
Medical School
Ghent University Hospital and Medical School, Dept. of 
General & Hepato-Biliary Surgery, Liver Transplantation 
Service, De Pintelaan, 1859000 Ghent, Belgium
Introduction: The liver-hanging maneuver is a useful tech-
nique to transect the liver parenchyma in open approach 
while lifting it with a tape passed between the anterior 
surface of the inferior vena cava and the liver parenchyma. 
Due to the specifi c issue of the technique, the hanging 
maneuver during laparoscopic liver resection (LLR) is not 
routinely utilized.
Methods: We describe the technique and results of our 
experience on a modifi ed hanging maneuver in 13 right and 
5 left hepatectomies.
Results: This modifi ed hanging maneuver technique is 
based on the use of the “Goldfi nger©” dissector in several 
steps: (a) for the upper dissection of the space between right 
and middle hepatic veins, (b) to create the infero-superior 
arcade through the space between the anterior surface of the 
vena cava and the posterior surface of the liver, (c) to lift the 
cutting area of the liver from the posterior to the anterior 
direction during LLR, (d) to indicate the parenchymal tran-
section line.
Conclusion: The modifi ed hanging maneuver for laparo-
scopic right and left hepatectomy based on the use of 
Goldfi nger is safe, effi cient, reproducible, and can facilitate 
liver dissection during major hepatectomy.
930
SALVAGE PROCEDURE TO POSSIBLE 
SMALL FUTURE REMNANT LIVER 
VOLUME, LANG APPROACH VARIATION
A. Serrablo, P. Riverola, S. Saudi-Moro, V. Borrego-Estella 
and J. M. Ramia
Miguel Servet University Hospital, Surgery, Lasierra 
Purroy 25, 3ºD50007 Zaragoza, Spain
Introduction: Postoperative liver failure (PLF) is the most 
feared and severe complication after extensive liver resec-
tions. Sometimes liver surgeons have to take fast decisions 
in an unsuspected situation for instance when liver resection 
has to be more extensive that we planned previously for 
iatrogenic vascular or biliary injuries or for we discover more 
lesions in intraoperative explorations. The use of the lessons 
learned of Lang’s technique can be useful to avoid PLF in a 
complex case.
Methods: We present an unsuspected biliary posterior right 
duct injury with hepatic right posterior ligation in mesohepa-
tectomy for giant symptomatic haemangioma. The right pos-
terior hepatic artery could not be repaired so we did not 
perform posterior right hepaticojejunostomy. We used the 
principles of Lang technique, i.e., the complete liver transec-
tion let an inducing growth of future remnant liver (FRL). A 
40 years old woman was diagnosed with a giant haemangi-
oma in 2008. She suffered from upper right quadrant abdom-
inal pain more and more strong. Once AST and ALT were 
increased but the normal level was recovered spontaneously 
although the jaundice occurred in once but any interventional 
approach was not required.
Results: We performed a mesohepatectomy and we realized 
in intraoperative that posterior right hepatic artery and pos-
terior right biliary duct were been cut after inadvertent liga-
tion. S1-3 were very small, S6-7 were disconnected from S1 
parenchyma and they only had a right posterior portal vein 
and right hepatic vein. Both of them were encircled with 
small vaseloop which were fi xed with haemoclip. Right pos-
terior biliary duct was sutured. ERCP reported all left biliary 
duct was right and full. In7thPOD, CTscan reported that 
there was a clear S1-3 hypertrophy. FRL volume was 694 cc. 
Patient were discharged hospital on 8th POD. On 15th 
POD, she was undergone to S6-7 resection for biliary 
leakage. Op time was 45 min. 48 hours after resection she 
was discharged.
Conclusion: The Lang’s technique prevented PLF by induc-
ing rapid growth of the FRL. Although in our case the portal 
fl ow was preserved there were a inducing rapid growth 
(29%) without PLF. Despite the fact that the excluded liver 
has portal blood fl ow, it acts as an auxiliary liver that con-
tributes to the total liver function until the contralateral lobe 
has grown enough to tolerate the organ’s function. This is 
the fi rst report of this novel approach applied in the manage-
ment of iatrogenic intraoperative injury.
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DOES N-ACETYL CYSTEINE MODULATE 
RENAL FUNCTION AFTER 
MAJOR HEPATECTOMY?
R. R. Lochan, A. Boukas, S. Robinson, R. Saif, G. Sen, 
M. Derek and S. White
Department of HPB and Transplantation Surgery
Freeman Hospital, Department of HPB and 
Transplantation Surgery, High Heaton, Newcastle upon 
Tyne NE7 7DN, United Kingdom
Introduction: Acute kidney injury or deterioration in pre-
existing renal dysfunction following major hepatectomy is 
an important cause of morbidity and mortality. N-acetyl cys-
teine has been extensively utilised as a reno-protective agent 
to ameliorate contrast induced nephropathy. The aim of this 
study was to investigate its potential use for preserving renal 
function following major hepatectomy.
Methods: A prospective study to compare the impact of 
N-Acetyl cysteine (NAC) on liver function after hepatec-
tomy was undertaken in our Unit from 2004–2010.
A cohort of 44 patients received peri-operative NAC 
(10 g/24 hrs) for 5 days and were compared to a further 
cohort of 44 patients (matched for the extent of liver 
resection – all more than 3 segments), gender, age and 
chemotherapy use) who did not. Post-operative renal func-
tion was evaluated. Other variables known to infl uence renal 
function included associated co-morbidity, drugs, intra-
operative parameters (e.g. CVP and blood loss). In addition to 
calculating the renal risk index as described by Clavien et al. 
we also examined other outcome measures such as duration 
of renal support and long-term renal specifi c outcomes.
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Results: There were 3 patients with known CKD in the 
NAC group as compared to 1 in the control group. Mean 
(SD) pre-operative creatinine levels [93.9 (20.5), 92.5 (19.3) 
p = 0.7], BMI [26.9 94.5), 28.9 (13.1) p = 0.3], operating 
time (hrs) [6 (1.9), 5.5 (1.7), p = 0.9]. The mean renal risk 
index were also similar between the NAC and control group. 
Mean (SD) creatinine rise (delta creatinine) between days 1 
to 5 in the post-operative period, were also similar between 
the 2 groups [NAC 43.8 (82.9) vs Control 49.2 (63.5), p = 
0.72]. Renal support in the form of CVVH was needed in 3 
patients in the study group versus 1 in the control group (all 
known to have pre-existing CKD). All these patients went 
back to their pre-operative renal status at 3-months follow 
up.
Conclusion: In this study NAC does not appear to be reno-
protective in patients with known renal impairment who 
require a major liver resection. Its presumed renoprotective 
role in those at “high risk” needs to be further assessed in an 
adequately powered RCT.
937
EXTENDED LIVER RESECTIONS WITH 
IVC INVOLVMENT – EXPERIENCES OF 
ANNON TRANSPLANT UNIT
S. Stättner, N. Misra, R. Jones, V. Kalyiyaperumal, 
S. F. G. Poston and H. Malik
University Hospital Aintree, Liverpool, UK
University Hospital Aintree/NHS, Digestive Diseases, HB 
Unit, Lower Lane, Liverpool L9 7AL, UK
Introduction: Liver resection offers the chance of cure in a 
variety of malignant liver diseases. Therefore some centers 
push the boundaries towards more complex extended liver 
procedures. The reported mortality rate then often exceeds 
5%. We present data from a purely non transplant center in 
the Northwest of England.
Methods: Retrospective evaluation of a consecutive series 
of concomitant IVC and liver resections.
Results: From 6/2008 to 11/2011 11 patients required IVC 
and liver resections. 6 patients (55%) had colorectal metas-
tases all of whom were downsized with chemotherapy, 2 had 
cholangiocarcinoma, 1 had HCC and 2 had benign tumours 
on defi nitive histology. 1 patient required complete IVC 
clamping and prostethic replacement, 4 defects were closed 
using a bovine pericardial patch. Venovenous bypass was not 
used in any of the cases. There was no postoperative mortal-
ity, early reoperation was necessary for 1 patient, biliary 
leaks occurred in 2 and transient liver insuffi ciency due to 
prolonged warm ischemia in 1 patient. No complications in 
terms of IVC patency were seen.
Conclusion: Liver with IVC resection is feasible – even in 
a non transplant HB center. A meticulous technique, careful 
patient selection and an experienced anesthetic team are the 
key to low mortality.
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OVINE MODEL FOR ADVANCED 
SIMULATION TRAINING IN 
LAPAROSCOPIC LIVER SURGERY
F. Crovari, J. Varas, F. Moisan, J. Martínez, M. Sanhueza, 
C. Muñoz, C. Boza and N. Jarufe
Pontifi cia Universidad Católica de Chile
Pontifi cia Universidad Católica de Chile, Digestive 
Surgery, Marcoleta 350, Patio Interior, Santiago, Chile
Introduction: Surgical simulation may allow shortening the 
learning curve of highly complex technical procedures such 
as a laparoscopic hepatectomy. To fi nd a simple animal 
model for liver surgery is complex due to the different 
anatomy with human liver. Currently there are not known 
simulation-training programs validated for laparoscopic 
HPB surgery. Our aim is to develop and assess a simulation 
program to obtain the necessary surgical skills to perform a 
totally laparoscopic left hepatectomy (TLLH).
Methods: An adult, 30 kilograms, regular sheep model was 
used for all procedures. Two HPB surgeons performed all 
procedures on a live sheep with general anesthesia and anal-
gesia protocols at the experimental surgery laboratory during 
a one-year period. The registered variables assessed were: 
intraoperative blood loss, anatomical identifi cation of the left 
hepatic pedicle and outfl ow structures, hepatic transection 
performance, conversion to open surgery, operative time and 
intraoperative mortality. Each procedure was recorded on 
video and analyzed by 2 blinded HPB surgeon experts using 
global and specifi c rating scales. LC-CUSUM methodology 
was used to assess learning curves. Wilcoxon and Fisher tests 
were used for non-parametric variable analysis.
Results: A total of 12 procedures were done in the initial 
evaluation. A learning trend was observed in these fi rst 12 
sessions. LC-CUSUM curves indicated competency on intra-
operative mortality, correct identifi cation and dissection of 
the left portal vein, conversion to open surgery and hepatic 
transection performance, as from the seventh training session. 
After the eighth procedure, intraoperative bleeding remained 
less than 350cc and operative time maintained at 2h15m 
(±30 min). The median global rating score in the fi rst 3 and 
3 last procedures was of 12 and 24 respectively (p < 0.001). 
Not being able to perform the correct dissection of the left 
portal vein correlated to 100% intra-operative mortality.
Conclusion: The ovine model allows obtaining learning 
curves in HPB surgeons under real comparable conditions. 
Training, along with surgical experience in properly equipped 
facilities can lead to the implementation of complex proce-
dures such as a TLLH and its application to living donor.
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VASCULAR RECONSTRUCTION IN 
HEPATOPANCREATOBILIARY 
MALIGNANCY USING CADAVERIC 
VEIN GRAFTS
I. A Azodo, N. MacKenzie, J. J. Powell, O. J. Garden and 
S. J. Wigmore
Department of Clinical and Surgical Sciences, Royal 
Infi rmary of Edinburgh, University of Edinburgh, 
Edinburgh EH15 4SA, UK
Hepatopancreatobiliary Surgery, Transplantation Surgery 
(SLTU) Royal Infi rmary Edinburgh, 51 Little France 
Crescent, Ward 107/Room F3413 HPB, Edinburgh EH16 
4SA, United Kingdom
Introduction: Vascular reconstruction is sometimes indi-
cated in hepatopancreatobiliary (HPB) resection and often 
this can be achieved using autologous vein. Cadaveric veins 
surplus to transplantation requirements can also be used. Our 
experience in using cadaveric tissue is described below.
Abbreviations
HPB, hepatopancreatobiliary
IVC, inferior vena cava
PV, portal vein
NEC, neuroendocrine
PD, pancreatoduodenectomy
CRLM, colorectal liver metastases
DVT, deep-vein thrombosis
CCA, cholangiocarcinoma
Methods: Retrospective cohort
Results: From 2004–2011, 6 male and 3 female patients 
(median 46 years; range, 30–78) underwent resection of their 
tumors with vascular involvement. Two patients with meta-
static cancer (adrenocortical, CRLM), 2 CCA and 1 liver 
spindle cell tumor underwent liver resection (ext. right lobec-
tomy n = 3, caudate n = 1) with IVC (n = 3) and portal vein 
(n = 1) resections. One patient with pancreatic NEC tumor 
underwent PD and PV resection. Vascular only resections 
occurred in 3 patients. The PV and IVC (n = 4, each) were 
replaced with 8 iliac vein grafts. Iliac vein bifurcation and 
IVC cuff replaced the same for one vena cava sarcoma. No 
long term anticoagulation or immunosuppression was used. 
Patency at 1, 3 and 5 years were 67%, 55% and 22%, 
respectively.
Conclusion: Cadaveric vein is an alternate useful conduit 
for reconstructing vessels in HPB malignancy and has rea-
sonable vessel patency rates. In HPB surgery where exten-
sive vascular resection is required to achieve negative 
margins, cadaveric vessels may play the same role they do 
in transplantation surgery to bridge the gap between resected 
vessels and permit tension free anastomoses without addi-
tional undue patient morbidity.
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PREOPERATIVE PORTAL VEIN 
EMBOLIZATION BEFORE MAJOR 
HEPATECTOMY: AN UK SINGLE 
CENTRE EXPERIENCE
N. de’ L. Carino1, E. Bakir2, B. Ammori1, R. Deshpande1, 
D. J. Sherlock1 and D. A. O’Reilly1
1HPB Unit, North Manchester Hospital, Pennine Acute 
Trust, M8 5RB Manchester, UK; 2Interventional Radiology 
Unit, North Manchester Hospital, Pennine Acute Trust, M8 
5RB Manchester, UK
North Manchester Hospital, Pennine Acute Trust, HPB 
Unit, Delaunays Road, Crumpsall, Manchester M8 5RB, 
United Kingdom
Introduction: Transhepatic percutaneus portal vein embo-
lization (PVE) is an established radiological interventional 
procedure aiming to increase the volume of future liver 
remnant (FLR) before extensive hepatectomies.
Methods: Total Liver Volume (TLV) and FLR were derived 
using CT volumetry of the liver. FLR was calculated as FLR 
= FLR volume/TLV × 100. Six weeks following PVE, a CT 
scan of the liver was performed to asses response. This was 
obtained using the formula: FLR after PVE – FLR before 
PVE/TLV × 100. A cut off 27% was given as minimum FLR 
after PVE to allow resection.
Results: Between November 2007 and November 2011, 24 
right main branch PVE have been performed at our HPB 
Unit. There were 16 male and 8 female (ratio 2 : 1). 1 patient 
died of biliary sepsis before the 6th week follow-up CT scan. 
There were no periprocedure related complications. Mean 
FLR before PVE was 19.2% (7.6% to 26%). Mean FLR after 
PVE was 30.6% (12.7% to 56%). The procedure was suc-
cessful achieving a FLR after PVE ≥ 27% in 15 patients. 
Among these, 12 underwent the planned resection while in 
2 cases the planned procedure was abandoned due to disease 
progression. 1 patient was not offered major surgery due to 
deteriorated general conditions.
Conclusion: Success rate was 65.2% (15/23), bringing 12 
out of 24 (50%) initially inoperable patients, to successful 
major liver resection. PVE is a safe and effective procedure 
if FLR is below 25–30% prior to surgery. If liver is choles-
tatic, complete biliary drainage to increase success rate must 
be achieved before PVE.
957
POOR RESULTS WITH LAPAROSCOPIC 
FENESTRATION
H. Ramesh, M. Subramaniaiyer, M. Wani, K. P. Manjuraj, 
V. Lekha, B. Venugopal, D. Vaishnav and B. Abraham
Department of GI surgery, Lakeshore Hospital, Cochin, 
Kerala, India
31/543, Subash Nagar, Edappally, 68202 Cochin, India
Introduction: Laparoscopic fenestration is considered a 
standard treatment for “simple” liver cysts. This paper aims 
at analyzing retrospectively the results with management of 
liver cysts over the period 1999 to 2010.
Methods: There were 40 patients, 19 men and 21 women 
with liver cyst, without any clinical or radiologic evidence 
of complications. Their ages ranged between 21 and 80 
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years. 10 patients had undergone laparoscopic fenestration at 
another center earlier.
Results: The ten patients with surgery elsewhere were 
reviewed: one each had hydatid cyst with biliary leak and 
cystic squamous cell carcinoma, four patients had biliary 
cystadenoma, and 4 had residual infected biliary cysts (2 
biliary fi stulae). Of the 30 patients presenting to this center, 
2 patients had biopsy of the wall with biliary cystadenoma 
and underwent reoperationa and excision. 2 others had 
biliary fi stula treated by ERCP stenting. on the whole, 11 
required re-intervention: 5 cystadenomas, 2 biliary fi stulas, 
5 recurrent cysts with infection. Of the remaining 19 patients, 
7 have residual cysts of larger than 5 cm in size. Only 12 
patients had resolution of both symptoms and cysts after 
intervention.
Conclusion: Simple cysts are not often simple and laparo-
scopic fenestration may not provide relief. A more intensive 
preoperative evaluation for complicated cysts is warranted.
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MARGIN ACCENTUATION WITH 
IRREVERSIBLE ELECTROPORATION IN 
LOCALLY ADVANCED PANCREATIC 
CANCER: IMPROVED 
OVERALL SURVIVAL
R. Martin1, C. St Hill1, S. Ellis1 and V. Sharma2
1University of Louisville, Division of Surgical Oncology; 
2University of Louisville, Division of Medical Oncology
University of Louisville, Division of Surgical Oncology, 
315 East Broadway, Rm 31140207, Louisville, USA
Introduction: Locally advanced unresectable pancreatic 
adenocarcinoma (LAC) is characterized by poor survival 
despite chemotherapy and conventional radiation therapy. 
We have recently reported on the safety of the use of irrevers-
ible electroporation (IRE) in the management of LAC. The 
aim of this study was to evaluate the use of IRE to margin 
accentuate in patients with LAC undergoing resection.
Methods: A prospective multi-institutional evaluation of 20 
patients undergoing Pancreatic and en-bloc arterial resection 
with IRE for unresectable pancreatic cancer 12/2009 to 
10/2010 were evaluated for overall survival and compared 
to 60 matched stage III patients treated with standard therapy 
defi ned as chemotherapy and radiation therapy alone.
Results: A total of 20 LAC pts have successfully undergone 
IRE, with 11 women, 9 men, median age of 61 (45–80 years). 
Eight patients had pancreatic head primary and 12 with body 
tumors and while using IRE to accentuate the SMA or Aortic 
margin. 90% had pre-IRE chemotherapy alone or chemo-
radiation therapy for a median duration 5 months. 73% pts 
underwent post-IRE chemotherapy or chemoradiation. There 
have been no 90 day mortality. In a comparison of IRE 
patients to standard therapy we have seen a signifi cant 
improvement in Local progression free survival (14 vs 6 
months, P = 0.01), Distant progression free survival (15 vs 
9 months, p = 0.02), and overall survival (20 vs 13 months, 
p = 0.03).
Conclusion: IRE ablation of locally advanced pancreatic 
tumors remain safe and in the appropriate patient who has 
undergone standard neo-adjuvant therapy for a minimum of 
4 months can achieve greater local palliation and improved 
overall survival when compared to standard chemoradiation-
chemotherapy treatments. Validation of these early results 
will need to be validated in the current multi-institutional 
Phase 2 IDE study (G110102).
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20 YEARS EXPERIENCE IN 
HEPATECTOMY HIGHLY SPECIALIZED 
HOSPITAL IN MEXICO
V. Carrillo-Maciel, O. M Solorzano-Pineda, 
J. A Leal-Martinez, R. Rangel-Rodarte, S. Ramos-Linaje, 
B. Rubio-Martinez, B. Padilla-Guillen and E. Meza-Mata
Social Security 71
Social Security 71, Department of Surgery, Calle Lobo No. 
224, Fracc. Los Viñedos, 27016 Torreon, Mexico
Introduction: During the last two decades, an improved 
understanding of hepatic anatomy and advances in surgical 
technique have allowed hepatic resection to be performed 
safely with operative mortality rates between 1–5% and mor-
bidity 10–20%.
The indications are adenoma and symptomatic focal 
nodular hyperplasia, haemangioma or giant liver cysts and 
malignant lesions.
Objective: Evaluate retrospectively indications and patient 
outcomes of hepatic resections at a single center in Mexico.
Methods: Patient demographic, operative techniques, his-
topatological and patient outcomes were examined for all 
procedures performed between 1991–2011 at single center 
in Torreon, Mexico.
Results: In our experience we have no operative mortality 
or biliary fi stula, all patients have been discharged from 
hospital on average two weeks after surgery.
Conclusion: Liver surgery has become safer with the advent 
of technology and in the hands of surgeons experienced in 
liver, pancreas and biliary tract.
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WHICH TUMOR PATIENT POPULATION 
IS REFERRED TO AN ACTIVE HBP 
SERVICE? A PROSPECTIVE ANALYSIS 
OF PATIENT’S CHARACTERISTICS 
INCLUDING RESECTABILITY RATE
M. Petersen, J. M. Ceron, K.-J. Oldhaer, G. A. Stavrou, 
A. Stang, M. Petersen, J. M. Ceron, K. J. Oldhafer, 
G. Alexander and S. A. Stang
Asklepios Klinik Barmbek, Hamburg General Surgery, 
Rubenkamp 220, 22291 Hamburg, Deutschland
Introduction: Our HBP service’s active out-patient clinic is 
asked about indication for surgery regularly, with the major-
ity of consultations coming from gastroenterologists, hepa-
tologists, and oncologists presenting cases with a wide range 
of underlying diseases from benign to malignant tumors. 
However, at the end of each year, details of the patient popu-
lation being consulted remain unknown. The aim of this 
prospective study is to analyze patient’s characteristics, indi-
cation for surgery and resectability.
Methods: All patients referred to our service between 
1.5.2011 and 31.11.2011 were included. Patient’s sexes, 
age, underlying disease, data from CT and/or MRT and/or 
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sonography as well as co-morbidity were documented. In 
addition, we documented technical and medical 
resectability.
Results: 79 patients were referred. The patients were suffer-
ing from CRLM in 42/79 cases (53.2%), gallbladder/bile 
duct tumors including Klatskin tumors in 9/79 cases (11.4%), 
HCC in 6/79 cases (7.6%), NELMs in 3/79 cases (3.8%), 
different types of metastases in 11/79 cases (13.9%) and 
benign lesions in 7/79 cases (8.9%). The preoperative resect-
ability rate in CRLM was 78.6%. Resection was not possible 
due to extra hepatic tumor growth in 3 cases and non-
suffi cient liver reserve in 6 cases. 77.8% of gallbladder/bile 
duct tumors were interpreted as resectable on preoperative 
imaging, while only 57.1% were truly resectable intraopera-
tively. 83.3% of HCC patients were thought to be resectable 
preoperatively, while 80% were technically resectable after 
all.
Conclusion: This study shows clearly that the majority of 
patients are good candidates for surgery. The large variety of 
indications underlines the importance of HPB centers dealing 
with these patients and an effective interdisciplinary approach 
to metastatic disease.
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LAPAROSCOPIC LEFT LATERAL 
SECTIONECTOMY WITHOUT THE 
PRINGLE MANEUVER
Y. Hasegawa, H. Nitta, T. Takahara, M. Takahashi, N. Ito, 
D. Takeda, A. Sasaki and G. Wakabayashi
Department of Surgery, Iwate Medical University School of 
Medicine
Iwate Medical University School of Medicine, Japan; 
Department of Surgery, 19-1 Uchimaru, 20 Morioka, 
Japan
Introduction: Laparoscopic liver resection has been gaining 
popularity, and especially laparoscopic left lateral sectionec-
tomy has been considered the standard of care due to its 
anatomical accessibility. The aim of the present study was to 
assess the outcome of LLS in our procedure.
Methods: Between May 1997 and December 2011, 134 
patients underwent totally laparoscopic liver resection, and 
19 laparoscopic left lateral sectionectomies were performed. 
From 2007, the procedure of laparoscopic left lateral sectio-
nectomy has been unifi ed; using four trocars and liver resec-
tion is performed by a harmonic scalpel and staplers without 
the Pringle maneuver. Twelve patients were underwent this 
operation.
Results: The median operation time was 104 (85–130) min, 
and the median blood loss was 5 (2–27) ml. No conversion 
to laparotomy was recorded, and there was no morbidity and 
morbidity. The median hospital stay was 5.5 (4–11) days.
Conclusion: The laparoscopic left lateral sectionectomy can 
be performed safety in this series.
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PATIENT ELIGIBILITY CRITERIA FOR A 
SURGICAL TREATMENT THAT 
ENHANCES TISSUE SEALING BY 
USE OF A MEDICATED SPONGE: 
OBSERVATIONAL STUDY ELITE
F. Benabdallah2, P. Sockeel1, Y. Gangner3, J.-L. Paillasseur4 
and C. Raiffort5
1HIA Legouest, Abdominal Surgery Department, 27 avenue 
des plantieres, 57077 Metz cedex 03, France; 2Nycomed 
Group TAKEDA, Medical direction, 13 rue Watt, 75013 
Paris, France; 3CH Niort, Abdominal Surgery department, 
40 avenue Charles de Gaule, 79021 Niort Cedex, France; 
4ClinDataFirst, Biometrics, 85 Avenue Henri Barbusse, 
Clamart, France; 5CHU Lariboisière, General Surgery and 
Gynaecology department, 2 rue Amboise Paré, 75475 
Paris 10, France
Introduction: Tissue sealing in general surgery is the appli-
cation of an haemostatic agent providing a sealing and adhe-
sion in addition to its effect on bleeding. Some actions of 
resection and wide dissection or sometimes call the use of 
sponge drug without knowing, however, the eligibility crite-
ria of patients.
Methods: Observational study, from a surgeons selected 
from hospitals in France (abdominal, gynecology, urology 
and thoracic). The survey identifi ed the criteria use of the 
sponge TachoSil® in their surgical practice. The multiple 
correspondence analysis (MCA) and the ascending hierarchi-
cal classifi cation (AHC) were used to defi ne the eligibility 
criteria for the application of the sponge for haemostasis and 
tissue sealing. Initially, each patient forms a class. At each 
step, two classes were merged to have only one. The dis-
similarity is estimated using a criterion called aggregation 
criterion. The metric used is the euclidean distance and the 
rule is the minimization of the distance from Ward τ (or R 
squared mid partial).
Results: A total of 683 patients operated were included and 
52 surgeons: abdominal (69%), thoracic (15%), gynecology 
(7%) and urology (9%).
They were 9 groups of patients and the sponge was used 
during dissection:
G1 (retroperitoneal, 7%) including 96%, usually >5 cm 
(50% abdominal, 40% urology), G2 (circumscribed tumors 
simple resection, 22%), G3 (fl at/tortuous, 10%) of a visceral 
(70%), G4 (circumscribed tumor with tumor resection/dis-
section, 6%) resection was smaller (urological 54%), G5 
(adhesions/infl ammatory abdominal, 14%) mainly visceral 
(69%), G6 (other lesions, 10%) of a non-cancerous lesions 
and non-infl ammatory gynecological (27%), G7 (para-pedic-
ular, 9%) with lymph (64%) and pedicle (70%), G8 (adhe-
sions/ infl ammatory visceral,
Conclusion: ELITE observational study revealed that the 
sponge TachoSil® is used mainly during surgery requiring 
resection tissue reinforcement. The application of the sponge 
covers an area of about 5 cm2 in 50% of cases in each of the 
surgeries involved. These areas were located in parenchyma, 
fl at areas but also anfractuous pedicle. The expected objec-
tive was successful in 90% of cases in each of the 
surgeries.
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REVISITING DIAGNOSIS OF 
TELANGIECTATIC FOCAL NODULAR 
HYPERPLASIA BASED ON BORDEAUX 
METHOD FOR INFLAMMATORY 
HEPATOCELLULAR ADENOMA 
WITH GP130 MUTATION: 
THE BRISBANE EXPERIENCE
B. Manoharan1, N. O’Rourke1, C. Campbell2, C. Rosty1, 
P. Tessar1, R. Bryant1 and A. Clouston2
1Royal Brisbane & Women’s Hospital, Brisbane, Australia; 
2Envoi Specialist Pathologists, Brisbane, Australia
Royal Brisbane & Women’s Hospital, HPB/General 
Surgery 7 Camphorlaurel Court, McDowall 4053, 
Queensland, Australia
Introduction: Categorising benign liver tumours formerly 
called telangiectatic Focal Nodular Hyperplasia (TFNH) as 
either Hepatocellular Adenoma (HCA) or FNH was diffi cult 
due to morphological overlap and uncertain radiology. 
Evolution in genetic knowledge of HCA & FNH has shown 
that lesions formerly called TFNH have signifi cant morpho-
logical overlap with the Infl ammatory HCA subtype (IHCA; 
w/gp130 mutation; 45–60% HCA). Accurate diagnosis of 
TFNH or IHCA is essential for proper management.
Methods: New immunostaining techniques for the diagno-
sis of IHCAs (Serum Amyloid A (SSA) and C-Reactive 
Protein (CRP)) and malignant risk (nuclear beta-Catenin) 
were applied to human FNH specimens biopsied and surgi-
cally resected at The Royal Brisbane & Women’s Hospital 
(RBWH) from 2000–2011. Tissue sections were stained and, 
following microscopic analysis by specialist pathologists, 
data was analysed in conjunction with clinical (history, risk 
factors and criteria for operative decisions) and radiological 
(initial CT, USS and/or MRI scans and all subsequent sur-
veillance and preoperative studies information).
Results: 83 FNH cases (68% female; 61% female <50 yrs; 
average age 53 yrs), were identifi ed for this study. Preliminary 
evaluation indicates poor correlation between initial and sub-
sequent surveillance radiology diagnosis, especially in rela-
tion to reported pathological diagnosis. No defi nitive 
diagnosis was reported in a number of cases. Utilising immu-
nostaining has identifi ed a number of SSA & CRP positive 
samples which indicate misdiagnosis of IHCA as FNH. 
While current literature indicates 10% of IHCA also have a 
beta-Catenin activated mutation, indicating risk of malignant 
transformation, no samples are currently positive for nuclear 
beta-Catenin or Glutamine Synthatase, preventing us from 
defi ning a subset prone to higher risk of malignancy.
Conclusion: The study’s preliminary results indicate dif-
ferentiating between FNH & IHCA, while diffi cult micro-
scopically, is made more accurate using SSA & CRP immu-
nostains. At the RBWH, lesions formerly known as 
telangiectatic Focal Nodular Hyperplasia, are shown to actu-
ally be Infl ammatory HCA subtype. Testing for Serum 
Amyloid A & C-Reactive Protein in FNH specimens is rec-
ommended as best practice as it will allow better application 
of the different operative criteria for FNHs and HCAs.
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ONE HUNDRED ONE LAPAROSCOPIC 
LIVER RESECTION
P. B. Schelotto1, R. S. Claría2, R. Maurette3, E. Canepa4, 
M. Moro5, J. Pekolj2, D. Boghetti3 and G. Gondolesi1
1Multiorgan Trasplant Institute, Universitary Hospital 
Favaloro Foundation; 2Liver Transplant Unit, Hospital 
Italiano of Buenos Aires, Buenos Aires; 3Liver Transplant 
Unit, Hospital Britanico of Buenos Aires, Buenos Aires; 
4Hospital Privado de Comunidad, Mar del Plata, Buenos 
Aires; 5Liver Transplant Unit, Hospital Italiano of Bahia 
Blanca, Buenos Aires
Universitary Hospital Favaloro Foundation, Multiorgan 
Trasplant Institute, Balgrano Av 1748, 1093, Buenos Aires, 
Argentina
Introduction: laparoscopic liver resection (LLR) has been 
the last and probably the most controversial development in 
liver surgery. It evolved from limited non-anatomical resec-
tions to living liver donation worldwide. Our aim is to 
present as part of a multi center study the Argentinean experi-
ence with LLR.
Methods: A multi-center data base centralized by the 
CA-IHPBA web page was downloaded and fulfi ll by 5 HPB 
and transplant centers in Argentina. Data was sent to a PI 
that collect and analyzed the data from 101 patients who 
underwent LLR. Patient demographics, clinically relevant 
data, tumor characteristics, technical details of the operation, 
morbidity, mortality and long-term outcome and actuarial 
survival were analyzed.
Results: Median age was 52 years, 69 were female. There 
were totally laparoscopic approaches in 83 patients, hand-
assisted in 11 and hybrid technique in 7. 52 for malignant 
diseases. LLR included 65 wedge resections, 24 segmentec-
tomies and 11 major hepatectomies. Conversion rate was 
10.9%. Postoperative complications rate was 20.8%. There 
were statistical differences in the rates of complications 
between patients with only hepatic resections (12.8%) vs 
simultaneous resections (47.8%) p = 0.001 and patients with 
minor (17.8%) and major hepatectomies (45.5%) p = 0.03. 
Hospital stay was 3.9 days. For colorectal liver metastases, 
actuarial survival at 1 to 5 years was 88 and 45%. After a 
median of 14 months, all patients with HCC are alive.
Conclusion: In patients with benign and malignant diseases 
laparoscopic liver resection is a procedure safe and feasible, 
with the benefi ts of minimally invasive approach. In onco-
logic patients, the survivals rates were comparable to those 
reported after open surgery, in spite of the learning curve and 
being a multi-center study.
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EX SITU LIVER SURGERY FOR 
THE TREATMENT OF 
UNRESECTABLE TUMOURS: 
PADOVA EARLY EXPERIENCE
E. Gringeri1, D. Bassi1, M. Polacco1, F. E. D’Amico1, 
P. Bonsignore1, P. Feltracco2, G. Zanus1 and U. Cillo1
1Hepatobiliary and Liver transplant Unit, University 
Hospital of Padova, Italy; 2Department of Pharmacology 
and Anesthesiology, University Hospital of Padova, Italy
University of Padova, Hepatobiliary and Liver Transplant 
Unit, Via Giustiniani 3, 35100, Padova, Italy
Introduction: Hepatic resection is the gold standard for the 
treatment of primary and secondary liver tumours, but few 
patients are eligible for this procedure because of the extent 
of their neoplasm. Improvements in surgical experience on 
liver transplantation, hepatic resection and organ preserva-
tion have allowed to perform liver ex situ surgery for the 
treatment of tumours conventionally considered inoperable 
with safety.
We present our early experience with 3 cases of ex situ 
liver resection.
Methods: Case1: A 38 years old woman with unresectable 
liver metastases from pancreatoblastoma underwent an ex 
situ ex vivo liver resection without using veno-venous bypass 
and interposing a synthetic caval prosthesis during the anhe-
patic phase of the operation. Case2: A 51 Years old man with 
hilar cholangiocarcinoma preoperatively considered resect-
able underwent, using a veno-venous by pass, an ex situ ex 
vivo liver resection because of the extension of disease dis-
covered after the laparotomy. Case3: A 61 years man, after 
establishment of a veno-venous bypass, underwent a right 
nefrectomy, adrenalectomy and ante situm liver resection 
with caval replacement for adrenal cancer invadining the 
liver and retrohepatica vena cava.
Results: All patients were considered unresectable with 
conventional surgery. No perioperative mortality was 
observed. All patients received a R0 resection at the pathol-
ogy examination. One patient had an urinary fi stula, one 
patient a biliary bronchial fi stula successfully treated with 
sphincterotomy and one patient had a MDR Klebsiella 
Pneumoniae infection. The mean ICU stay was 21 days 
(range: 2–52 days). The mean hospital stay was 52 days 
(range 28–98 days). The mean follow-up is 4.6 months 
(range 2–9 months).
Conclusion: Ex situ liver surgery represents an extreme 
approach for the treatment of liver tumours. Although it is a 
complex technique with high morbidity, we believe that it 
will allow us to expand the indications for surgical treatment 
for primitive and secondary hepatic neoplasms.
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PORTAL VEIN LEIOMYOSARCOMA
M. P. Calvo, A. V. Lopez, M. G. Mateo, P. R. de Ordorica, 
J. G. Uriarte, A. V. Castiñeira, A. M. Sanz and 
J. O. de Urbina
Hepatobiliary Surgery and Transplant Unit, Department of 
General and Digestive Surgery, Cruces University Hospital
Cruces University Hospital, Hepatobiliary Surgery and 
Transplant Unit, Department of General and Digestive 
Surgery, Plaza de Cruces s.n. Barakaldo, Vizcaya, Spain
Introduction: Venous leiomyosarcoma is a rare entity. The 
vena cava is the location of 75% of the cases and only 9 cases 
originating in the porto-mesenteric vein have been described 
in the literature.
Methods: We report a case of leiomyosarcoma on portal 
vein which was operated at our institution.
Results: 44-year-old woman referring postprandial fullness. 
EUS, CT and MRI: Hypervascularized mass of 11 × 7 × 9 cm 
in portal vein (PV) with left PV thrombosis. During surgical 
procedure, large tumor located along the PV and superior 
mesenteric vein (SMV), attached to the head of the pancreas 
and two hepatic metastases were found. Surgical technique: 
Left hepatectomy, porto-mesenteric vein resection and 
pyloric-preserving duodenopancreatectomy. 10 mm Gore 
Tex graft was interposed between SMV and right PV. 
Pathological exam: PV High grade leiomyosarcoma. Patient 
developed a Grade I Dindo-Clavien complication (biliar 
fístula) and was discharged on postoperative day 22. No 
adjuvant therapy was indicated. The patient is alive with no 
recurrence 4 months after.
Conclusion: A very rare case of sarcoma originated in the 
PV is described. An aggressive surgical treatment of this 
disease is required. Adjuvant treatment with radiotherapy 
and/or quimiotherapy has low scientifi c evidence. Finally, 
the prognosis is limited mainly by R0 surgery and mitotic 
index.
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UPPER ABDOMINAL RESECTIONS IN 
GYNAECOLOGICAL MALIGNANCY 
– THE BARTS EXPERIENCE
J. Wat1, J. Butler2, E. Brockbank2, C. Pomel2, A. Jeyarajah2, 
A. Rosenthal2, K. Reynolds2 and H. Kocher1
1Barts Cancer Institute, London, UK; 2Barts and the 
London NHS Trust, London, UK
Barts Cancer Institute, London, UK; Tumour Biology Flat 
7, 5 Maples Place, E12EE, London, UK
Introduction: In order to improve rates of complete cyto-
reduction in gynaecological malignancy a team surgery 
approach has been developed involving hepatobilary (HPB) 
surgeons alongside gynaecological oncology (GO) surgeons. 
We report the procedures and outcomes in patients with 
gynaecological malignancies undergoing hepatobilary proce-
dures from 2007 to 2011.
Methods: Case note review was performed for all patients 
with a gynaecological malignancy where upper abdominal 
resections were performed. A database was constructed 
including full operative details, histology, stage and disease 
status.
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Results: 29 patients had combined GO HPB operations. 
Median age was 57 years (range, 24–70) and follow up was 
20 months (range, 1–58). 28 (97%) patients had ovarian 
cancer and 1 endometrial cancer (3%). HPB procedures 
included: Falciform ligament resection: 16 (55%); diaphragm 
peritonectomy: 11 (38%); full-thickness diaphragm resec-
tion: 8 (28%); splenectomy: 2 (7%); partial hepatectomy: 7 
(24%); cholecystectomy: 6 (21%); and porta hepatis tumour 
resection, 2 (7%). Complete cytoreduction was achieved in 
28 patients (97%), 1 patient (3%) had <1 cm residual bowel 
serosa disease. Four patients (14%) died: One (3%) of post-
operative complications at 2 months and three (10%) of 
disease at 6, 20 and 35 months. Nine (31%) are alive with 
disease 16 (55%) have no disease.
Conclusion: A surgical team approach combining HPB and 
GO expertise has increased the repertoire of procedures that 
we can offer GO patients at our institution. This has improved 
our ability to achieve complete cytoreduction – the most 
important predictor of survival in advanced ovarian cancer. 
Long term follow up is needed to assess morbidity and sur-
vival in this cohort.
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PROXIMAL SPLENORENAL SHUNT 
USING A SPLENIC ARTERY 
INTERPOSITION GRAFT: A NOVEL 
TECHNIQUE TO BRIDGE THE GAP
A. K. Agarwal
Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi 110002, India
Introduction: Extrahepatic portal venous obstruction 
(EHPVO) is an important cause of portal hypertention in the 
Indian subcontinent. A proximal splenorenal shunt (PSRS) 
has been used effectively for the management of variceal 
bleeding, hypersplenism and portal biliopathy due to non-
cirrhotic portal hypertension (NCPH). In an occasional 
patient the length of the splenic vein may be inadequate to 
achieve a tension-free anastomosis with the renal vein. We 
herein describe the use of an interposition splenic artery graft 
for creating an effective anastomosis in such situations.
Methods: Retrospective analysis of all patients of NCPH 
managed surgically with a PSRS at our centre between 
January 1999 and December 2011. The indication, technique, 
and outcomes following the use of splenic artery interposi-
tion graft were analyzed.
Results: During the study period 209 patients underwent a 
PSRS for NCPH. In 207 of these patients, the shunt was 
constructed by anastomosing the end of the splenic vein to 
the side of the renal vein/adrenal vein after performing a 
splenectomy. In 2 patients suffi cient length of splenic vein 
could not be mobilized due to dense adhesions of splenic 
vein to the posterior surface of pancreas in one patient and 
due to the need to sacrifi ce a portion of thin and friable 
distal splenic vein which did not appear suitable for shunt in 
another. The locally available distal splenic artery was 
mobilized along the superior border of the pancreas and a 
suffi cient length was procured and used as an interposition 
graft. A 1 cm tension-free anastomosis was achieved in both 
the cases. The operating time was 280 min and 330 min 
respectively with an estimated blood loss of 150 ml in each. 
A drop in portal pressure (10 mmHg and 13 mmHg respec-
tively) was recorded following construction of the shunt. 
Both patients had an uneventful postoperative course. At a 
follow up of 6 months, the Doppler ultrasound revealed a 
patent shunt and a reduction in the grade of the esophageal 
varices.
Conclusion: Splenic artery interposition graft is a locally 
available, effective conduit to bridge the gap between splenic 
vein and left renal vein and can be used in situations wherein 
suffi cient length of splenic vein is not available.
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TOTAL LAPAROSCOPIC 
PANCREATICODUODENECTOMY: 
EARLY SINGLE INSTITUTION 
EXPERIENCE
M. Jacobs, A. Kamyab and K. Khatlani
Department of Surgery, Providence Hospital and Medical 
Centers, Southfi eld, MI
Providence Hospital and Medical Centers, 16001 West 
Nine Mile Road, 48075, Southfi eld, USA
Introduction: Total laparoscopic pancreaticoduodenec-
tomy (TLPD) remains one of the most advanced laparo-
scopic procedures. The vast majority of the initial reluctance 
pertained to the long operative times and technical dif-
fi culties. With evolution in laparoscopic technology and 
instrumentation in the last decade, laparoscopic pancreatico-
duodenectomy is beginning to achieve wider acceptance. 
Our aim was to describe the outcome of total laparoscopic 
pancreaticoduodenectomy at our institution.
Methods: Data was collected for all patients who under-
went a TLPD at our institution from March until July 2011. 
Preoperative evaluation consisted of CT scan with pancreatic 
protocol, and selective use of MRI and/or endoscopic 
ultrasound. The TLPD was done with 6 ports on three 
patients, and 5 ports on one patient, and included a celiac, 
periportal, peripancreatic and periduodenal lymphadenec-
tomy. Pancreatic stents were used in all 4 cases, and intestinal 
continuity was reestablished by intracorporeal anastomoses.
Results: Four patients underwent a TLPD for suspicion of 
a periampullary tumor. There were 3 females and 1 male with 
a mean age of 65 years and mean BMI of 30.5. Intraoperatively, 
the mean operative time was 9 hours and 31 minutes with a 
mean blood loss of 120 mL. Postoperatively there were no 
complications with a mean length of stay of 6.5 days. Mean 
follow up time was 4 months. There was no lymph node 
involvement in any of the 4 specimens. The pathologies 
included IPMN in two, pancreatic adenocarcinoma in one 
(R0 resection), and benign 4 cm periampullary adenoma in 
one.
Conclusion: TLPD is a safe and viable alternative to the 
standard Whipple procedure. Our early experience suggests 
decreased length of stay, quicker recovery, and improved 
quality of life. Complication rates appear to be improved or 
equivalent.
002
PANCREATIC AND PERIAMPULLARY 
MIXED TUMORS
Y.-M. Shyr, S.-E Wang and C.-H. Su
Taipei Veterans General Hospital, Surgery, 201, Shih-Pai 
Road, 112, Taipei
Introduction: There is no data regarding the tumor inci-
dence by histological type and biological behavior in terms 
of number of malignancy inside the mixed tumors, tumor 
location, and histopathology. With analysis of the pooled 
data, we tried to clarify the characteristics and survival out-
comes of the pancreatic and periampullary mixed tumors.
Methods: Data of mixed tumors in the pancreas and peri-
ampullary region from our prospectively-collected computer 
database and cases reported in the English literature were 
included for analysis together.
Results: There were 43 mixed tumors. The mixed tumor 
composed of adenocarcinoma and neuroendocrine neoplasm 
was most common (42%). Thirty-two (74%) mixed tumors 
were malignant, and 28% were composed of double malig-
nancies. The most common histolopathological diagnosis 
was neuroendocrine neoplasm (43%) including 36% neuro-
endocrine tumor and 7% neuroendocrine carcinoma. The 
median tumor size was 3 cm, and larger in the benign group 
(6.3 vs. 2.5 cm, P = 0.038). There was no signifi cant survival 
difference between malignant mixed tumors with double vs. 
single malignancy, pancreatic vs. non-pancreatic origin, and 
adenocarcinoma vs. non-adenocarcinoma.
Conclusion: Neuroendocrine neoplasms are the most 
common histolopathological diagnosis in pancreatic and 
periampullary mixed tumors. There is no signifi cant survival 
difference in terms of number of malignancy, tumor location 
and histolopathology.
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PANCREATICODUODENECTOMY FOR 
PANCREATIC AND PERIAMPULLARY 
LESIONS IN THE YOUNG
S.-E Wang, Y.-M. Shyr and C.-H. Su
Taipei Veterans General Hospital, Surgery, 201, Section 2, 
Shih-Pai Road, 112, Taipei
Introduction: The purpose of this study was to clarify sur-
gical outcomes and to assess the biological behavior of peri-
ampullary malignancy after pancreaticoduodenectomy (PD) 
in the young. PD remains a formidable challenge to many 
pancreatic surgeons. There is no literature report regarding 
PD in the young.
Methods: Data on patients undergoing PD were retrieved 
for study. Demographics, disease patterns, clinical presenta-
tions, operative fi ndings, surgical risks, tumor pathologic 
characteristics, and survival outcomes were evaluated in the 
young patients less than 60 years old and compared with 
those in the older population.
Results: There were 585 pancreatiocoduodenectomy 
patients, including 172 younger than 60 years. There were 
more neuroendocrine neoplasms (7.6% vs 1.9%), and less 
ampullary adenocarcinoma (32% vs 23.8%) and distal CBD 
adenocarcinoma (8.5% vs 2.9%) in the young, as compared 
to the old. In the young group patients, lower surgical mortal-
ity (2.3% vs 8%), shorter hospital stay (21 days vs 27 days) 
and an overall less advanced stage (11.4% vs 19.4%) were 
found. The survival of periampullary malignancy between 
the young and old showed signifi cant difference with a better 
5-year survival in the young (29.5%) as compared to the old 
(25.1%). Similar fi nding was also found in pancreatic head 
adenocarcinoma (13.5% vs 7.7%).
Conclusion: PD does not carry more surgical morbidity or 
pancreatic leakage in the young, whereas it is associated with 
less surgical mortality, as compared to the old. Young age 
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patients after PD have better 5 year survival in periampullary 
malignancy and pancreatic head adenocarcinoma.
004
REAPPRAISAL OF PANCREATIC 
ADENOCARCINOMA UNDERGOING 
PANCREATICODUODENECTOMY
S.-E Wang, Y.-M. Shyr and C.-H. Su
Taipei Veterans General Hospital, Surgery, 201, Section 2, 
Shih-Pai Road, 112, Taipei, Taiwan
Introduction: This study is to present our experience in the 
management of pancreatic head adenocarcinoma at a single 
large institute with high volume in pancreaticoduodenec-
tomy. We reappraise the clinical presentations, surgical risks 
and survival outcomes for patients with exclusive pancreatic 
head adenocarcinoma undergoing pancreaticoduodenectomy 
before and after 1997.
Methods: Data of pancreatic head adenocarcinomas under-
going pancreticoduodenectomy were reappraised and com-
pared between period 1 (1984–1996) and period 2 
(1997–2009).
Results: Surgical mortality was 3.6% in period 2 and 5.0% 
in period 2. The surgical morbidity was 35.7% in period 1, 
35.3% in period 2. Pancreatic leakage is signifi cantly lower 
(3.4%) in pancreaticogastrostomy group, as compared to 
11.7% in pancreaticojejunostomy. There were 57.5% posi-
tive lymph node involvement and 77.4% perineural invasion. 
More patients underwent adjuvant or palliative chemother-
apy in period 2 (42.2%) than in period 1 (14.8%). The 5-year 
survival for resected pancreatic head adenocarcinoma was 
3.7% in period 1 and 11.1% in period 2. The 5-year survival 
after curative resection in period 1 was signifi cantly lower 
than that in period 2 (4.2% vs. 14.7%).
Conclusion: Although surgical mortality has signifi cantly 
decreased recently, pancreaticoduodenectomy continues to 
be a complex and technically-demanding procedure with 
high and unchanged surgical morbidity. The poor survival 
outcome of pancreatic head adenocarcinoma might be a com-
bined refl ection of diffi culty in early detection, aggressive 
biological behavior of tumor itself and complex surgical 
anatomy for resection.
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TECHNICAL APPROACH TO 
TOTAL LAPAROSCOPIC 
PANCREATICODUODENECTOMY
M. J. Jacobs and A. Kamyab
Providence Hospital and Medical Centers
Providence Hospital and Medical Centers, Surgery, 16001, 
West Nine Mile Road, 48075, Southfi eld, USA
Introduction: Total laparoscopic pancreaticoduodenec-
tomy (TLPD) is one of the most advanced laparoscopic pro-
cedures. With advancements in laparoscopic technology and 
instrumentation, laparoscopic pancreaticoduodenectomy is 
beginning to achieve wider acceptance.
Methods: Data was collected for all patients who under-
went a TLPD at our institution from March until July 2011. 
The TLPD was done with 6 ports on three patients, and 5 
ports on one patient, and included a standard lymphadenec-
tomy. Pancreatic stents were used in all 4 cases, and intestinal 
continuity was reestablished by intracorporeal anastamoses 
with radially oriented interrupted sutures similar to the open 
technique.
Results: Four patients underwent a TLPD for suspicion of 
a periampullary tumor. The mean operative time was 9 hours 
and 31 minutes with a mean blood loss of 120 mL. A single 
surgical assistant was required in addition to the surgical 
scrub technologist. Visualization was greatly improved in the 
setting of laparoscopy with no apparent technical limitations. 
There were no hand ports or conversions, and there were no 
postoperative complications with a mean length of stay of 
6.5 days and a mean follow up time of 5 months.
Conclusion: TLPD is a safe and viable alternative to the 
standard Whipple procedure, with the added advantage of 
improved visualization. Mastery of laparoscopy and hepato-
biliary anatomy is essential. The benefi ts as suggested by our 
early experience include decreased length of stay, quicker 
recovery, and improved quality of life. Complication rates 
appear to be improved or equivalent.
009
LAPAROSCOPIC THREE PORT 
SPLEEN PRESERVING DISTAL 
PANCREATECTOMY
M. Jacobs and A. Kamyab
Providence Hospital and Medical Centers
Providence Hospital and Medical Centers, Surgery, 16001, 
West Nine Mile Rd, 48075, Southfi eld, USA
Introduction: Historically, a three-port laparoscopic distal 
pancreatectomy has been previously described. A three-port 
spleen-preserving laparoscopic distal pancreatectomy 
(LSPDP) however has not been previously described. We 
present a three-port spleen preserving laparoscopic distal 
pancreatectomy.
Methods: The three-port LSPDP was performed with the 
patient in a modifi ed left thoracoabdominal position, with a 
10 mm Hassan in the anterior axillary line, and two 5 mm 
Hassan trocars in the epigastrium and the posterior axillary 
line. The pancreas was divided using a 3.5 mm endo-GIA 
stapler. The specimen was removed from the 10 mm port 
site.
Results: A 56 year old women underwent the above proce-
dure for a pancreatic tail cystic lesion. OR time was 98 
minutes, with an estimated blood loss of 50 mL. The post-
operative hospital stay was 3 days. There were no intraopera-
tive or postoperative complications. Final pathology showed 
intraductal papillary mucinous neoplasm.
Conclusion: A three-port LSPDP is a safe and viable tech-
nique. Our early experience suggests a decreased length of 
hospital stay compared to the open technique, and a compa-
rable operative time and outcome to four or greater ports.
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PANCREATICODUODENECTOMY: 
22 YEAR COMPARATIVE OUTCOME 
ANALYSIS IN A SINGLE INSTITUTION 
AND THE EFFECT OF ACQUIRING A 
FELLOWSHIP TRAINED 
HEPATOPANCREATICOBILIARY 
SURGEON
M. Jacobs, A. Kamyab and L. Bolo
Providence Hospital and Medical Centers
Providence Hospital and Medical Centers, Surgery, 16001, 
West Nine Mile Road, 48075, Southfi eld, USA
Introduction: Pancreaticoduodenectomy (PD) outcome 
prior to and subsequent to acquiring a hepatopancreaticobili-
ary (HPB) surgeon has not been previously studied. We com-
pared our single-institution data prior to procuring a HPB 
surgeon, to the data that ensued.
Methods: A retrospective review was performed of patients 
that underwent a PD at our institution between January 1990 
and August 2011. Data acquired included demographic data, 
operative time, blood loss, length of stay, and pathology. A 
HPB surgeon started in 2003; the data was therefore divided 
into those performed between January 1990 and December 
2002 (Group 1), and those performed between January 2003 
and July 2011 (Group 2).
Results: Thirty-nine patients underwent a PD in Group 1, 
compared to 86 patients in Group 2. The average age was 
68.5 vs. 67, the median operating time was 7.5 hours vs. 5.3 
hours, median blood loss was 950 vs. 400 mL, median length 
of stay (LOS) was 21 vs. 10 days, and overall complication 
rates were 62.5% vs. 22.1% (group 1 vs. group 2 respec-
tively), of which gastric emptying was the most common in 
both groups. When excluding PDs performed by general 
surgeons in group 2, 66 PDs (76.7%) were performed by the 
HPB surgeon, with a median operative time unchanged at 
5.3 hours, however median blood loss decreased to 300 mL, 
median LOS decreased to 9 days, and complication rates 
decreased to 15.1%.
Conclusion: Pancreaticoduodenectomies performed since 
acquiring a HPB surgeon were performed more effi ciently, 
with decreased operating time, blood loss, complication 
rates, and length of stay.
013
UNDERSTANDING THE SEVERITY 
AND THE MANAGEMENT OF 
ACUTE PANCREATITIS, 
A SIMPLIFIED GUIDELINE
N. N. Ganguly
Gauhati Medical College, Guwahati, AssamSurgery 
‘NAMAN’, 12 J.P. Agarwalla Bye Lane, Bishnurabha Path, 
Beltola, 78102878108, Guwahati, Assam, India
1. Bradley EL. A clinically based classifi cation system for 
acute pancreatitis: summary of the International 
Symposium on Acute Pancreatitis, Atlanta, GA, September 
11–13, 1992. Arch Surg. 1993;128:58
Introduction: Acute pancreatitis at times can be a severe 
and life threatening illness. However, only 20% of this 
disease is severe. Out of this 20% of the severe diseases again 
20–30% patients may die of the disease.
Till today various scoring methods are tried to understand 
the severity and the course of the disease. But none of these 
are truly satisfactory. We had Ranson’s scoring, followed by 
APACHE I and APACHE II thereafter. Then Added Glasgow 
Score to make it something like APACHE III. We have 
Balthazar’s scoring. A new severity score called the BISAP 
is expected to predict mortality in acute pancreatitis within 
the fi rst 24 hours of admission. This is a fi ve point scoring 
system. It was found to have a similar prediction value with 
the APACHE II scoring. The components of BISAP include 
BUN of >25 mg/100 ml, deranged mental status (Glasgow 
coma scale score, <15), SIRS score of ≥2, age >60 years, and 
lastly Pleural effusion. This scoring is applicable at the sec-
ondary level care giving institutes too.
The Panc 3 score (hematocrit, >44; BMI, >30 kg/m2; and 
pleural effusion on x-ray) is another recently developed 
severity assessment tool, in which presence of all 3 compo-
nents was found to predict severity quite accurately.
The new Japanese Severity Score (JSS) is another scoring 
system that includes 9 components and a score of 3 or more 
indicates severe disease. This scoring can predict the severity 
of the disease as that of Ranson’s score, Glasgow score, and 
APACHE II score. This scoring is only can be tried in the 
tertiary care level Institutes.
The Harmless Acute Pancreatitis score (HAPS) is the most 
recently published severity assessment scoring system; it 
looks into the severity assessment from a different angle. Its 
components include absence of rebound tenderness and/or 
guarding, normal hematocrit, and normal serum creatinine. 
A combination of these 3 components was found to predict 
a mild course of AP with 98% accuracy within 30 minutes 
of admission. This system can be used in even the basic 
health centre and with confi dence.
Some of the recently described individual markers of 
severity in AP include urinary trypsinogen activation peptide 
(TAP), procalcitonin, anti-thrombin III, interleukin-6, intra-
abdominal hypertension (>15 mmHg), and immunoparalysis 
(reduced HLA-DR expression).
The utility of artifi cial neural networks (ANNs) to predict 
severity of AP has been frequently studied in recent years. 
ANN is a nonlinear pattern recognition technique that con-
tains a set of processing units that simulate human neurons 
in that it can learn from the data presented, thereby improvis-
ing their predictive capability. In a recent systematic review 
of 11 studies, ANN was found to predict prolonged hospital 
stay with 75% sensitivity and was comparable to APACHE 
II and Ranson’s score.
In addition there is the concept of the Cytokine storm to 
predict the severity of acute pancreatitis.
In this back ground we present our observations to sim-
plify the understanding and the management of acute pan-
creatitis on Admission and manage them with this fi rst 
impression only.
It had been our passion to tackle this condition fro over a 
decade and half now. We have presented our newer fi ndings 
periodically in various national, regional and international 
meets. This work is based on our experience on managing 
acute pancreatitis in a simpler way and we must say that the 
only death we have faced is not due to the disease.
Methods: One Hundred patients were observed over the last 
15 years. 30% of these was APACHE II above 7 on admis-
sion. 99 survived, one died but not really due to Acute 
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Pancreatitis. It was noted that the severity scoring did not 
predict death. We primarily follow Ranson’s and APACHE 
II scores for all the patients admitted with acute Pancreatitis 
along with Glasgow severity scoring for our severe cases. 
We found that these complicated scoring systems were not 
making our jobs easier and so simultaneously started devel-
oping a local score to understand the severity on admission 
and there by developing a guideline for the management of 
acute pancreatitis. The points we considered for better under-
standing of the disease were simple physiological fi ndings at 
admission but they have worked well for our patients.
The following points are considered in our practice.
Here we present our fi ndings. The following points were 
recorded for each patient at admission and the importance 
given to each point is shown underneath:
• Age <12–>50 Serious
• Sex Female Better
• Biliary Acute Normal risk
• Alcohol >180 ml/day Serious
• TC >12000 Serious
• Dehydration Dry Tongue Serious
• Early signs of Sepsis <48 Hours  Serious
• MODS/SRS <48 Hours Serious
• Co existing Dm, Hypertension,  Serious
 Diseases COAD
• Amylase >4 fold rise Serious
• Lipase >1000 units Serious
• ASO >4 fold rise Serious
• CRP >4 fold rise Serious
• Calcium <7 Serious
• Sodium >150 Serious
• Potassium <3 Serious
Balthazar’s scoring is noted but we could not associate it 
with our work.
We have also followed up our serious patients with ABG 
analysis time to time to maintain the homeostasis. It guided 
us for early oxygenation of the severe and hypoxic patients.
Results: Patients having three serious points were consid-
ered to be serious and were managed energetically. We had 
practically two groups of patients, First, the Serious and the 
second, not serious. The moment we received a serious 
patient as per our scoring we started a standard course of 
therapy. The mainstay of our treatment is Hydration. Patients 
received apprx. 6 (six) liters of fl uid per 24 hours and all 
these serious patients received I.V Ofl oxacin or Ceftazidime 
as the fi rst line of management, We maintained normother-
mia in these patients. Enteral feeding was always encour-
aged. We inserted Ryle’s tube to decompress the stomach 
only in those patients who had vomited six times in an hour. 
One Controversial point in our management was the use of 
Octreotide. Although many works suggest that this is of no 
use, we used it in all of our serious patients at the dose of 
100 mcg subcutaneously 8 hourly. As per our observation we 
have noticed that patients having more than six of the serious 
points needed longer time to stabilize and needed longer 
hospital stay. Average 7–10 days in less than six points to 
3–4 weeks for having six and more points. The not serious 
patients, as per our scoring, were managed routinely and 
were discharged from 7 to 10 days of admission. Simplifying 
the scoring mechanism has brought confi dence to our unit 
and as a result we could develop a disciplined approach to 
the treatment of Acute Pancreatitis in our working environ-
ment. Although we still follow scoring systems to conduct 
studies but the above mentioned scoring system works well 
for us. As H. Ramesh and M. Buchler have suggested simpler 
grading system for the chronic pancreatitis we are trying to 
simplify the scoring for the severity of acute pancreatitis. The 
Direct benefi ts will be the ease with which these patients can 
be managed.
The point of consideration in our experience is that many 
of our patients, who were considered mild pancreatitis as per 
the other scoring system especially APCHE II, <7, were in 
the serious group as per our scoring and received the similar 
treatments with those of the patients considered serious by 
APACHE II scoring (>7).
The only mortality was due to Dehydration as the patient 
did not receive the ordered amount of fl uid in the ICCU.
Conclusion: Acute pancreatitis, when severe, is a dreaded 
disease. The scoring systems presently followed or are being 
offered including ANN are too cumbersome and produces 
diffi culty in a high volume centers like ours. Making it 
simple increases the confi dence amongst the residents and 
trainees. As a result patients are better treated. So we suggest 
that these simple risk factors be followed to score Acute 
Pancreatitis and manage them successfully as we have 
managed them. Our No mortality speaks about the success 
of this system.
Another point needs to be added in our scoring is Increased 
BMI. We are getting obese patients more and more recently. 
Obesity along with its attached co-morbid conditions add 
burden on these patients, so in our future scoring we would 
be adding BMI above 32 as an additional serious point.
016
ROBOT ASSISTED LAPAROSCOPIC 
PANCREATICODUODENECTOMY IN A 
PATIENT WITH REPLACED COMMON 
HEPATIC ARTERY
G. Gunasekaran1, S. Chalikonda2, C. Miller2, J. Fung2 and 
M. Walsh2
1New York Medical College/Westchester Medical Center, 
Valhalla, NY 10601; 2Cleveland Clinic, Cleveland, OH 
44195
New York Medical College/Westchester Medical 
CenterIntra-abdominal Transplantation/HPB Surgery, 100, 
Woods Road, BHC-A wing Lower level, Valhalla, NY 
10595, Valhalla, USA
Introduction: Currently pancreaticoduodenectomy (PD) is 
uncommonly being performed using laparoscopy. Even with 
the improvements in minimally invasive techniques, safety 
of laparoscopic PD has been controversial. Robotic surgery, 
which was developed in response to the limitations and 
drawbacks of laparoscopic surgery has gained increased 
acceptance over the last few years. We describe a case of 
pancreatic head mass with replaced common hepatic artery 
(CHA) managed by robotic assisted laparoscopic PD.
Methods: A fi fty three year old female presented following 
an episode of pancreatitis. On further evaluation by endo-
scopic ultrasonogram, it revealed a 1 to 2 cm mass on the 
pancreatic head. The biopsy revealed it to be an ampullary 
carcinoid. The imaging studies showed no evidence of 
metastasis instead showed a replaced CHA from the superior 
mesenteric artery. We performed the PD laparoscopically. 
After the resection, we used the da Vinci robot for the recon-
struction. We performed this hybrid technique as the robot 
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enabled us to perform the pancreatic and biliary anastamosis 
with more precision and accuracy.
Results: The patient tolerated the procedure very well and 
had an uneventful post-operative course and was discharged 
from the hospital on post-operative day 5.
Conclusion: Complex pancreatic surgery requires recogni-
tion of anatomic variants. Appropriate recognition and treat-
ment can be performed similarly with laparoscopic or open 
resection. The enhanced precision and the angle of dissection 
provided by the Robotic arm can be helpful in performing 
reconstruction after pancreaticoduodenectomy.
020
HHV-8 ASSOCIATED 
LYMPHADENOPATHIC KAPOSI’S 
SARCOMA MIMICKING PTLD AFTER 
PANCREAS TRANSPLANT
S.-E Wang, Y.-M. Shyr and C.-H. Su
Taipei Veterans General Hospital, Surgery, 201, Section 2, 
Shih-Pai Road, 112, Taipei, Taiwan
Introduction: Kaposi’s sarcoma currently comprises more 
than 5% of all de novo neoplasms in this group. The average 
time to development of Kaposi sarcoma following transplan-
tation is 15–30 months. Human herpesvirus 8 (HHV-8) 
genomic sequences have been identifi ed by polymerase 
chain reaction in more than 90% Kaposi sarcomas.
Methods: From 2003 to 2011, Kaposi’s sarcoma was identi-
fi ed for study from 64 patients with 68 pancreas transplants 
performed at Taipei Veterans General Hospital. Literature 
review was also done.
Results: Only one case of Kaposi’s sarcoma was identifi ed. 
The patient suffered from varicellar zoster Infection (chicken 
pox) 11 months after pancreas transplant alone (PTA). Four 
months later (15 months after PTA), lymphadenopathy with 
enlargement of multiple lymph nodes in neck, around celiac 
trunk, along the superior mesenteric artery and abdominal 
aorta, which mimicked posttransplant lymphoproliferative 
disorder (PTLD). The biopsy for pathology turned out to be 
Kaposi’s sarcoma. HHV-8 viral gene was detected by the 
molecular (PCR) assay. The lymphadenopathic Kaposi’s 
sarcoma regressed 3 months after treatment by adding siro-
limus, reducing the dose of tacrolumus and discontinuing 
mycophenolate mofetil.
Conclusion: This is an unusual HHV-8 associated Kaposi’s 
sarcoma mimicking PTLD presenting as lymphadenopathic 
form, instead of usual cutaneous form. Sirolimus is recom-
mended for the treatment of Kaposi’s sarcoma, in addition 
to reduction, cessation or modifi cation of immunosuppres-
sive regimen.
022
VASCULAR RESECTION AND 
RECONSTRUCTION FOR A REPLACED 
RIGHT HEPATIC ARTERY CAN BE 
AVOIDED DURING A 
PANCREATICODUODENECTOMY 
PROCEDURE
J. Zakhary2, H. Shokouh-Amiri2, H. D’Agostino1, 
G. Zibari2 and Q. Chu1
1Louisiana State Health Science Center Shreveport; 2Willis 
Knighton Medical Center
Louisiana State University Health Science Center 
Shreveport, Surgery, 193, Hallette Dr. 71115, Shreveport, 
USA
Introduction: There is a paucity of literature on the man-
agement of a replaced right hepatic artery (RRHA) during a 
Whipple. It is believed that up to 9% of patients with RRHA 
will require a vascular resection/reconstruction. Whether this 
is avoidable has not been well described. Except for an artery 
that has penetrated through the tumor, we believe that, with 
careful identifi cation and meticulous dissection of this 
variant, a Whipple can safely be performed without a vascu-
lar resection/reconstruction.
Methods: From 2008 to 2011, a retrospective review of 100 
consecutive patients who underwent a pancreaticoduodenec-
tomy was performed. Patients’s demographics, fi nal pathol-
ogy, size of tumor, and the presence or absence of a RRHA 
were recorded. A preoperative evaluation included an endo-
scopic ultrasound, MRI, and/or CT scans.
Results: There were 13 patients (13%) who had an intraop-
eratively identifi ed RRHA. Seventy-seven percent of patients 
had a malignancy. The average tumor size was 2.4 cm (range, 
1.0 to 4.5 cm) and all had a negative resection margin. None 
of the variants penetrated the tumor and therefore, none of 
the 13 patients required a vascular resection/reconstruction.
Conclusion: A preoperative CT/MRI can help identify a 
replaced right hepatic artery in patients undergoing a pancre-
aticoduodenectomy. Surgeons can be cognizant of such an 
anomaly during the dissection. The presence of a RRHA that 
does not penetrate the tumor does not necessitate a vascular 
resection/reconstruction as long as a meticulous dissection is 
performed.
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THE DETECTION OF CIRCULATING 
TUMOR CELLS IS A NEGATIVE 
PROGNOSTIC FACTOR IN 
PANCREATIC CANCER
D. Klos1, J. Srovnal2, A. Benedikova2, L. Radova2, 
M. Hajduch2, M. Lovecek1, R. Havlik1 and C. Neoral1
1Department of Surgery, Faculty of Medicine and Dentistry, 
Palacky University and Teaching Hospital, I.P. Pavlova 6, 
77520 Olomouc, Czech Republic; 2Laboratory of 
Experimental Medicine, Institute of Molecular and 
Translational Medicine, Faculty of Mediciny and Dentistry, 
Palacky University, Puskinova 6, 77520 Olomouc, Czech 
Republic
Palacky University and Teaching Hospital Olomouc, 
Surgery, I.P. Pavlova 6, 77520 Olomouc, Czech Republic
Introduction: We tested the hypothesis that the presence 
CTC is a negative prognostic factor in patients with pancre-
atic cancer. Pancreatic cancer is one of the most aggressive 
malignancies with the poor prognosis. Assessment of the 
circulating tumour cells (CTC) in patients with this highly 
malignant disease could prevent burdensome surgery in 
patients with systemic dissemination.
Methods: This was a prospective study to test for the pres-
ence of CTC in systemic blood, portal blood, bone marrow 
and peritoneal lavage in 90 pancreatic cancer patients at the 
time of surgery using real-time RT-PCR for carcinoembry-
onic antigen (CEA), epidermal growth factor receptor 1 
(EGFR1) and human telomerase (hTERT). Absolute gene 
expressions of tested markers were correlated with clinical/
pathological characteristics and survival parameters.
Results: Overall, 51 of 90 (56.6%) pancreatic cancer 
patients died, the overall survival median was 8.8 months. 
We found a statistically signifi cant association between 
EGFR and hTERT expression levels in the portal blood and 
clinical stage. We also showed high expression of EGFR and 
CEA in the peritoneal lavage of patients with metastatic 
disease, in contrast to patients without the presence of the 
metastases. CTC positive patients measured as hTERT in 
tumor draining blood and CEA in bone marrow showed 
signifi cantly poorer overall survival (OS) (p = 0.005/p = 
0.001). We also found statistically signifi cant shorter OS in 
patients with EGFR positive peritoneal lavage (p = 0.01).
Conclusion: The results of this study demonstrate a high 
sensitivity and specifi city of the real-time RT-PCR method 
for CTC detection in pancreatic cancer. Detection of CTC 
seems to be negative prognostic factor for overall survival in 
pancreatic cancer and can infl uence the radical surgery 
decision.
030
OUR INVENTIONS FOR SECURE 
SURGERY OF LAPAROSCOPIC 
SPLENIC VESSEL-PRESERVING 
DISTAL PANCREATECTOMY
K. Suzuki1, O. Itano2, M. Inoue1, M. Kaneda1, M. Osaku1, 
F. Asanuma1 and Y. Yamada1
1Department of Surgery, Kitasato Institute Hospital; 
2Department of Surgery, Keio University School of 
Medicine
Kitasato Institute Hospital, Department of Surgery, 5-9-1, 
Shirogane, Minato-ku 10886, Tokyo, Japan
Introduction: Recently, laparoscopic operation technique 
has improved, especially in the fi eld of hepato-biliary pan-
creatic surgery, due to the remarkable development of several 
energy-based surgical devices. Laparoscopic splenic vessel-
preserving distal pancreatectomy (Lap-SVPDP) has spread 
quite rapidly. Here we present our inventions and associated 
surgical cases to perform Lap-SVPDP safely.
Methods: Five patients with benign tumors in the pancre-
atic body underwent Lap-SVPDP in 2011 from January to 
August at our hospital. The average age was 64.8, ranging 
between 50 and 78 years-old. These patients consisted of one 
man and four women. Two patients had mucinous cyst ade-
nomas (MCA) and three patients had intraductal papillary 
mucinous adenomas (IPMA) in their pancreatic body. Lap-
SVPDP was performed in the lithotomy position with a slight 
head-up position. We used the vessel sealing system regu-
larly when detaching the pancreatic body from the greater 
omentum. BiClamp of VIO System was very useful for 
hemostasis of pancreatic parenchyma bleeding. The pancre-
ases were dissected by Endo GIA DUET TRS 60-4.8.
Results: The operation time ranged from 185~382 min, 
with a mean of 275.2 min. Blood loss amount during Lap-
SVPDP was between 50~500 cc, with a mean of 181 cc. 
Number of days after operation ranged from 15~23; with a 
mean of 17.2 days. We could not fi nd any bleeding from 
preserved splenic vessels after surgery. Two cases had pan-
creatic fi stula: grade A and grade B, respectively. However, 
they recovered shortly after with conservative treatment. 
There may arise some diffi culty in the hemostasis of splenic 
artery bleeding. In this situation, it is useful to clamp both 
the proximal and distal sides of the bleeding point by lapa-
roscopic vascular clamps, then suture securely with an atrau-
matic needle such as PROLENE.
Conclusion: The benefi ts of Lap-SVPDP were: 1) reduction 
of infectious risk from bacteria with bacterium capsule such 
as Haemophilus infl uenzae; 2) prevention of thrombocytosis 
and thrombosis; 3) maintenance of gastric blood fl ow by 
preserving short gastric arteries. Lap-SVPDP should be per-
formed limitedly on patients with benign or low grade malig-
nant tumors which do not require lymph node dissection. 
Lap-SVPDP will become a standard procedure that will 
spread more widely because of its easiness to learn.
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RESULTS OF 
PANCREATODUODENECTOMY OF A 
LOW VOLUME SURGEON; A 
RETROSPECTIVE ANALYSIS
S. Subramanian, S. Gavini and S. Gopal
Department of Surgical Gastroenterology, Sri 
Ramachandra Medical College & Research Institute, Sri 
Ramachandra University, Porur, Chennai, Tamilnadu, 
India 600116
Sri Ramachandra Medical College & Research Institute, 
Chennai, TN, India; Surgical Gastroenterology, Room No 
10, D-2 Private Clinic, Sri Ramachandra Medical Center, 
Porur, Chennai 60011, India
Introduction: The outcome of pancreatoduodenectomy has 
vastly improved in the last few decades. Operative mortality 
has reduced and morbidity achieved a plateau. Improvement 
in surgical technique, anaesthesia, perioperative care, experi-
ence and centralized management are some of the reasons 
for the better outcome. The concept of high volume centers 
and high volume surgeons has a major bearing on this 
improved outcome. The craft of pancreatoduodenectomy is 
learned by a surgeon through a training sequence compr
Methods: The study period was from June 2007 to May 
2011. The author was privileged to perform pancreatoduode-
nectomy independently (as primary surgeon) from June 2007 
and hence that constituted the beginning of the study. All 
pancreatoduodenectomy performed by the senior author and 
assisted by residents were included for the study. The study 
was conducted at Sri Ramachandra Medical Center, an uni-
versity hospital attached to Sri Ramachandra University 
located in Chennai. The study was a retrospective analysis 
of prospectively collected data. All patients underwent pre-
operative evaluation with pancreatic protocol CECT with 
volume rendering to assess the arterial anomalies. 
Preoperative biliary drainage was not done routinely.
Results: The study consist of twenty patients, male 16 and 
female 4. The oldest patient was 81 years and the youngest 
was 29 years. The indication for pancreatoduodenectomy 
were periampullary carcinoma 8 cases, pancreatic head 
cancer in 6, chronic pancreatitis with IPMN 1, pancreatic 
neck cancer 1, neuroendocrine carcinoma 1 and duodenal 
carcinoma 3 cases. Two patients were obese (BMI 30 & 32) 
and one patient was morbidly obese (BMI of 50). Interestingly 
all the three patients with BMI of more than 30 had duodenal 
carcinoma. One third of patients underwent preoperative 
stenting, indications being bilirubin value more than 20 mg%, 
albumin less than 2.5 gms%. The average operating time was 
320 minutes (240 to 480). Four patients did not received 
blood.
Conclusion: The study demonstrates low volume surgeon 
operating independently in the beginning of their carrier as 
pancreatic surgeon can produce short term outcomes that are 
comparable with experienced centers, provided they adopt 
same standards and pathways.
033
ACCURACY OF ENDOSCOPIC 
ULTRASOUND IN THE EVALUATION OF 
SUSPECTED PANCREATIC 
MALIGNANCY: A COMMUNITY 
HOSPITAL EXPERIENCE
G. Wright1, M. Shaheen2, L. Baatenburg3, J. B. Morrow3 
and M. Chung4
1Grand Rapids Medical Education Partners/Michigan State 
University General Surgery Residency Program, Grand 
Rapids, MI; 2Michigan State University College of Human 
Medicine, Grand Rapids, MI; 3Grand River 
Gastroenterology PC, Grand Rapids, MI; 4Spectrum Health 
Medical Group, Grand Rapids, MI
Grand Rapids Medical Education Partners, Department of 
Surgery, 1000 Monroe NW49503, Grand Rapids, MI, USA
Introduction: Endoscopic ultrasound (EUS) has played a 
role in the diagnostic evaluation of pancreatic lesions for 
nearly 30 years. Reports on the utility of EUS in differentiat-
ing benign, pre-malignant, and malignant pancreatic lesions 
have been variable, particularly with cystic neoplasms. 
Furthermore, the few large series reported have originated 
from tertiary academic centers. This study refl ects our expe-
rience with EUS in the evaluation of suspected pancreatic 
malignancy in a community hospital setting.
Methods: All patients who underwent EUS for suspected 
pancreatic malignancy by a single examiner from 2007 to 
2010 were reviewed. Variables included patient demograph-
ics, year of exam, type and location of lesion, cyst size, and 
fl uid amylase and CEA. A fi nal EUS diagnosis was deter-
mined based on the examiner’s impression and fi ne-needle 
aspiration results if applicable. Lesions were stratifi ed as 
benign, pre-malignant, or malignant. For patients undergoing 
surgical resection, the diagnosis was compared with surgical 
pathology. For suspected benign lesions, follow-up imaging 
was monitored and accuracy was determined based on no 
changes in size or character over time.
Results: A total of 422 EUS exams were reviewed, of which 
298 patients had follow-up data available for study. There 
were 180 (60.4%) solid and 118 cystic (39.6%) lesions. 
Diagnoses included 127 benign (42.6%), 26 pre-malignant 
(8.7%), and 145 malignant lesions (48.7%). One hundred 
four (34.9%) underwent surgery, 123 (41.3%) were moni-
tored with imaging, and 71 (23.8%) were unresectable malig-
nancies. Median duration of follow-up imaging for benign 
lesions was 315 (59–1298) days. Four (3.3%) suspected 
benign lesions showed change on imaging and underwent 
resection. Age, sex, BMI, race, year of exam, location of 
lesion, and performance of FNA were not signifi cant con-
tributors to accuracy. Accuracy was higher for solid versus 
cystic lesions (p < 0.001).
Conclusion: This study represents the largest patient series 
investigating the accuracy of endoscopic ultrasound in sus-
pected pancreatic malignancy. Though regionalization of 
pancreatic cancer care to tertiary academic centers has been 
advocated, high volume community cancer centers with 
appropriate resources may offer a comparable level of care. 
Endoscopic ultrasound is a highly accurate diagnostic modal-
ity in the evaluation of suspected pancreatic malignancy in 
a community hospital setting.
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IMPROVING QUALITY OF CARE 
FOR PANCREATIC CANCER: 
DEVELOPING EVIDENCE 
BASED CLINICAL PATHWAYS 
FOR PATIENTS UNDERGOING 
PANCREATIC CANCER SURGERY
K. Devitt, A. Ramjaun, S. Gallinger and A. Wei
Department of Surgery, University Health Network, 
University of Toronto, Toronto, Canada
University Health Network, Surgery, 200, Elizabeth Street, 
M5G2C, Toronto, Canada
Introduction: To date, the most effective treatment of pan-
creatic cancer is surgical resection with chemotherapy. 
Unfortunately, pancreatic surgery is underutilized and the 
quality of care is highly variable. We postulate that surgical 
process improvement tools can be an important method of 
closing the gap between evidence and practice. The objective 
of this study was to understand the quality improvement 
needs of surgical health care teams and to develop a clinical 
pathway for pancreatic surgery in Ontario.
Methods: Nominal group workshops were held at desig-
nated hepato-pancreato-biliary (HPB) centres in Ontario to 
determine the quality improvement needs in pancreatic 
surgery. These multidisciplinary multi-institutional groups 
identifi ed and ranked key concepts and interventions in the 
proposed clinical pathway. Data was collected using ranking 
questionnaires and by recording deliberations. Quantitative 
ranking of options has been reported as frequencies. 
Qualitative results were assembled thematically to summa-
rize deliberations. A literature review was completed to 
evaluate best evidence for recommendations on key elements 
of the clinical pathway.
Results: A total of 66 stakeholders participated in the work-
shops. Participants included nurses (39%), allied health 
(26%), HPB surgeons and fellows (26%), anesthesiology 
(8%), and a surgical resident (2%). An average of 88% of 
participants agreed with the primary domains on the clinical 
pathway. The quantitative results showed the participants 
agreed with the majority of assessments and interventions on 
the proposed clinical pathway. Elements of the clinical 
pathway were excluded based on participant responses. 
Themes that emerged from the discussions were incorporated 
into the clinical pathway and the implementation plan.
Conclusion: Clinical pathways are an important quality 
improvement and knowledge translation tool that can be used 
to improve quality of care. Using a multidisciplinary multi-
institution approach we engaged stakeholders to aid in the 
development of a clinical pathway for pancreatic surgery. We 
will work to implement this instrument throughout the prov-
ince of Ontario at designated HPB centres as a quality 
improvement initiative to improve the quality of care for 
patients undergoing pancreatic cancer surgery.
045
MANAGEMENT OF CELIAC AXIS 
STENOSIS IN PATIENTS UNDERGOING 
PANCREATICODUODENECTOMY
H. Urakami1, S. Iida1, S. Seki1, A. Shimada1, T. Ohishi1, 
Y. Isobe1, Y. Isobe2 and S. Matsumoto1
1Department of Surgery, National Hospital Organization 
Tokyo Medical Center; 2Department of Radiology, National 
Hospital Organization Tokyo Medical Center
National Hospital Organization Tokyo Medical Center, 
General Surgery, 2-5-1, Higashigaoka, 15289, Tokyo, 
Japan
Introduction: Celiac axis (CA) stenosis is relatively 
common and it can lead to a fatal hepatic ischemia after 
pancreaticoduodenectomy (PD) unless a simultaneous revas-
cularization of the celiac circulation is performed because of 
the requirement for intraoperative division of the gastroduo-
denal arteries (GDA). The etiology of CA stenosis includes 
atherosclerotic plaques in the celiac trunk as well as com-
pression by extrinsic masses originating in the pancreas, 
lymph nodes and median arcuate ligament (MAL).
Methods: We had three cases of CA stenosis, all of which 
had histologically diagnosed carcinoma of head of pancreas 
or papilla Vater. We evaluated the cause of CA stenosis by 
the multi-detector row computed tomography (MDCT). 
Some of the cases underwent angiography as well as CT. All 
patients underwent PD as curative surgery. The fl ow volume 
of common hepatic artery (CHA) and proper hepatic artery 
(PHA) are measured as well as the fl ow direction such as 
afferent or efferent to the liver by the pulse Doppler ultraso-
nography (US) before or after test clamping of GDA and 
releasing of CA stenosis. Postoperative complications related 
with procedure of releasing of CA stenosis were recorded.
Results: In case 1 and 2, supra mesenteric artery (SMA) 
arteriography revealed GDA, CHA, CA and splenic artery 
(SPA) through the highly-developed collaterals from SMA, 
and suspected CA stenosis. Interventional radiology (IVR) 
of balloon dilation failed to release CA stenosis before 
surgery. MDCT showed the highly developed dorsal pancre-
atic artery (DPA) and small aneurysm of DPA in case 3, 
however, collaterals from SMA did not develop unlike other 
cases. CA stenosis due to MAL compression was observed 
in all cases. After releasing CA stenosis, Doppler US showed 
afferent arterial fl ow to the liver in CHA and PHA with test 
clamping of GDA and DPA. We have successfully performed 
three cases of PD without major complications during post-
operative course.
Conclusion: Although CA stenosis is usually a benign con-
dition, it may cause fatal gut and liver ischemia when surgery 
necessitates division of collaterals from SMA. Preoperative 
MDCT appears to be a sensitive and objective diagnostic 
method for detecting CA stenosis. Doppler US can provide 
important information about collateral circulation, and intra-
operative Doppler US before and after test clamping of GDA 
can assess the adequacy of revascularization for CA stenosis 
during PD.
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RECURRENT GNAS MUTATIONS DEFINE 
AN UNEXPECTED PATHWAY FOR 
PANCREATIC CYST DEVELOPMENT
H. Matthaei1, J. Wu2, A. Maitra2, P. J. Allen3, 
C. M. Schmidt4, R. D. Schulick2, B. Vogelstein2 and 
R. H. Hruban4
1University of Bonn; 2Johns Hopkins University; 3Memorial 
Sloan-Kettering Cancer Center; 4Indiana University
University of Bonn, Department of General, Visceral, 
Thoracic and Vascular Surgery, Sigmund-Freud-Str. 
2553105, Bonn, Germany
Introduction: More than 2% of the adult U.S. population 
harbors a pancreatic cyst. These often pose a diffi cult man-
agement problem because conventional criteria cannot 
always distinguish cysts with malignant potential from those 
that are innocuous. One of the most common cystic neo-
plasms of the pancreas, and a bona fi de precursor to invasive 
adenocarcinoma, is called intraductal papillary mucinous 
neoplasm (IPMN).
Methods: To help reveal the pathogenesis of these lesions, 
we purifi ed the DNA from IPMN cyst fl uids from 19 patients 
and searched for mutations in 169 genes commonly altered 
in human cancers.
Results: In addition to the expected KRAS mutations, we 
identifi ed recurrent mutations at codon 201 of GNAS. A 
larger number (113) of additional IPMNs were then analyzed 
to determine the prevalence of KRAS and GNAS mutations. 
In total, we found that GNAS mutations were present in 66% 
of IPMNs and that either KRAS or GNAS mutations could 
be identifi ed in 96%. In eight cases, we could investigate 
invasive adenocarcinomas that developed in association with 
IPMNs containing GNAS mutations. In seven of these eight 
cases, the GNAS mutations present in the IPMNs were also 
found in the invasive lesion. GNAS mutations were not 
found in other types of cystic neoplasms of the pancreas or 
in invasive adenocarcinomas not associated with IPMNs.
Conclusion: In addition to defi ning a new pathway for pan-
creatic neoplasia, these data suggest that GNAS mutations 
can inform the diagnosis and management of patients with 
cystic pancreatic lesions.
054
IS IT POSSIBLE TO PREDICT 
MICROSCOPIC INVOLVEMENT OF 
PERI-ARTERIAL MARGIN ON 
COMPUTED TOMOGRAPHY IN 
PRIMARY RESECTABLE 
ADENOCARCINOMA OF THE 
PANCREATIC HEAD?
J.-M. Regimbeau, D. Fuks, T. Yzet, D. Chatelain, 
C. Mouly and B. Robert
Federation of Medico-Surgical Digestive Diseases, Amiens 
University Hospital, Amiens, France
Amiens University Hospital, Amiens, France; Federation of 
Medico-Surgical Digestive Diseases, Place Victor Pauchet, 
80000 Amiens, France
Introduction: We aimed to establish whether fi ndings on 
pre-operative CT scans in patients with primary resectable 
pancreatic carcinoma (PRPC) who underwent pancreatico-
duodenectomy (PD) were associated with microscopic (R1) 
infi ltration of the peri-arterial margin.
Methods: Data of patients who underwent PD between 
2005 and 2010 for PRPC were retrospectively reviewed. 
Patients with macrovascular contact with superior mesen-
teric artery (SMA) were excluded. In order to identify risk 
factors for R1 resection in patients with PRPC, pre-operative 
CT scans (<1 month) were analyzed according to predefi ned 
criteria (tumor size, location of the tumor center, distance 
between the posterior limit of the pancreas and the SMA) by 
two radiologists blinded to the patients’ margin status. 
Associations between R1 resection and radiologic fi ndings 
were assessed. All pancreaticoduodenectomies were per-
formed by a single surgeon and the peri-arterial margin was 
located by 2 threads.
Results: Twenty-fi ve patients were included (19 males, 6 
females, median age: 58 ± 10). Tumors were classifi ed as 
pT1, pT2 and pT3 in 2 (8%), 7 (28%) and 16 (64%) respec-
tively. The overall rate of margin involvement (R1) was 48% 
(12 R1 cases out of 25), with the most commonly involved 
margin being the periarterial margin (7 cases; 58%), fol-
lowed by the peri-venous margin (4 cases; 33%). Neither the 
tumor size (21.5 vs. 24.3 mm, p = 0.47), nor the location of 
the tumor within the pancreatic head (p = 0.52), nor the 
distance between the tumor and the SMA (15.2 vs. 15.1, p = 
0.97) were associated with R1 resection on the defi nitive 
pathological analysis.
Conclusion: Preoperative multidetector CT-scan doesn’t 
seem to predict microscopic invasion of peri-arterial margin 
before pancreaticoduodenectomy for pancreatic carcinoma 
in our series.
056
MODIFICATION OF PARTINGTON-
ROCHELLE AND FREY PROCEDURES 
WITH A LONGITUDINAL 
PANCREATICO-GASTROSTOMY
L. Fernández-Cruz, M.-A. López-Boado, J. Ferrer and 
J. Hidalgo
Hospital Clínic de Barcelona
Hospital Clínic de Barcelona, Surgery, Villarroel, 1708036 
Barcelona, Spain
Introduction: The suitable indication for the Partington-
Rochelle operation in chronic pancreatitis is an isolated dila-
tation of the pancreatic duct without an infl ammatory mass 
in the head of the pancreas. A longitudinal pancreatico-
jejunostomy of the body and tail of the pancreas, combined 
with a limited duodenum-preserving excision of the pancre-
atic head was introduced by Frey and Smith. A modifi cation 
of these drainage procedures with pancreatico-gastrostomy 
preserves gastrointestinal tract integrity.
Methods: Four patients with chronic pancreatitis were 
managed three by a simple drainage procedure and another 
by a local resection of the pancreatic head according with 
the Frey technique. In our modifi cation the dilated pancreatic 
duct or the locally excised head of the pancreas is covered 
with the opened longitudinally segment of the stomach after 
gastric partition.
Results: The side-to-side longitudinal pancreatico-gastros-
tomy resulted in a safe operation. During the follow-up both 
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patients were pain free 26, 20, 12 and 6 months respectively 
with good endocrine function.
Conclusion: The potential benefi t of the lateral pancreatico-
gastrostomy includes construction of a single anastomosis, 
potentially shorter operative time and physiologically recon-
struction method which preserves gastrointestinal tract integ-
rity, in which the operative fi eld is confi ned to the region 
above the transverse colon.
060
ACUTE PANCREATITIS – IS SERUM 
AMYLASE STILL REQUIRED?
D. Gomez, A. Addison, A. De Rosa, A. Brooks and 
I. Cameron
Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust, Nottingham, United Kingdom
Queen’s Medical Centre, Department of Hepatobiliary and 
Pancreatic Surgery, E Floor, West Block, Queen’s Medical 
Centre, Derby Road, Nottingham NG7 2UH, United 
Kingdom
Introduction: To assess the role of serum amylase and 
lipase in the diagnosis of pancreatitis. Secondary aims were 
to perform a cost analysis of these enzyme assays in patients 
admitted to the surgical admissions unit.
Methods: Patients admitted with pancreatitis to the acute 
surgical admissions unit from January–December 2010 were 
included in the study. Data collated included demographics, 
laboratory results and aetiology. The cost of measuring 
a single enzyme assay was £0.69 and both assays were 
£0.99.
Results: Of the 151 patients, 117 patients had acute pancre-
atitis with gallstones (n = 51) as the most common cause. 
Most patients with acute pancreatitis had raised levels of 
both amylase and lipase. Raised lipase levels only were 
observed in additional 12% and 23% of patients with gall-
stone- and alcohol-induced pancreatitis, respectively. 
Overall, raised lipase levels were seen in between 95–100% 
of patients based on aetiology. Sensitivity and specifi city of 
lipase in the diagnosis of acute pancreatitis was 96.6% and 
99.4%, respectively, while the sensitivity and specifi city of 
amylase was 78.6% and 99.1%. Single lipase assay in all 
patients presenting with abdominal pain to the admission unit 
would result in a potential saving of £893.70/year.
Conclusion: Determining serum lipase level alone is suffi -
cient to diagnose pancreatitis and substantial savings can be 
made if measured alone.
068
SURGICAL RESECTION AFTER 
CHEMORADIOTHERAPY AND/OR 
CHEMOTHERAPY IN PATIENTS WITH 
UNRESECTABLE PANCREATIC 
DUCT CARCINOMA
S. Saeki, S. Saeki, W. Takiyama, N. Hirabayashi, 
M. Okajima, H. Mukaida, Y. Suguyama, M. Yoshimitu 
and J. Taomoto
Hiroshima City Asa Hospital Surgery, 1-2-3 Kabe-Minami 
Asaminami-Ku Hiroshima City, 73102 Hiroshima, Japan
Introduction: The use of chemoradiotherapy and/or che-
motherapy for pancreatic cancer has been advocated in unre-
sectable pancreatic cancer for palliation. This article reports 
our experience with chemoradiotherapy and/or chemother-
apy for patients with unresectable pancreatic cancer (with 
metastasis or locally advanced: superior mesenteric artery or 
celiac axis encasement).
Methods: Since April 1999, 19 patients with radiographi-
cally unresectable pancreatic cancer have received chemora-
diotherapy (54 Gy, 2 Gy/day Gemcitabine (GEM) 800 mg/
body 1 d/wk) and/or chemotherapy (GEM or GEM/S-1). 
There were reviewed retrospectively. Patients with tumor 
response at restaging CT scan or MRI underwent surgical 
exploration to determine whether the tumor was resectable.
Results: Fifteen of 19 restaged patients demonstrated a 
disease progression fi nally. Four patients had downstaged 
and underwent surgical resection after chemoradiotherapy 
and/or chemotherapy. Two patients underwent distal pancre-
atectomy, one patient underwent total pancreatectomy, one 
patient underwent pancreatoduodenectomy. Two of 4 patients 
died of ditant metastasis: lung metastasis or pleural effuision 
etw. Median survival for the resected patients was 34 months, 
Median survival was 8 months in the group who not received 
surgical resection.
Conclusion: Surgical intervention should be considered for 
patients with initially-unresectable pancreatic duct carci-
noma who demonstrate long-term favorable responses to 
chemoradiotherapy and/or chemotherapy. Surgical resection 
(especially R0 resection) may signifi cantly contribute to 
cure, especially in patients with initially locally-advanced 
disease. Large cohort prospective studies will be necessary 
to demonstrate the effi cacy of this strategy.
075
MALIGNANT PREDICTORS FOR 
BRANCH DUCT TYPE INTRADUCTAL 
PAPILLARY MUCINOUS NEOPLASMS
S. Hirono, M. Tani, M. Kawai, K.-ichi Okada, 
M. Miyazawa, A. Shimizu, Y. Kitahata and H. Yamaue
Wakayama Medical University, School of Medicine
Wakayama Medical University, School of Medicine, Second 
Department of Surgery, 811-1 Kimiidera, 641-8, 
Wakayama, Japan
Introduction: In general, intraductal papillary mucinous 
neoplasm (IPMN) has a favorable prognosis, however, once 
IPMN progresses to invasive carcinoma, it becomes aggres-
sive and is associated with a poor prognosis. Main duct type 
IPMN has been recommended for resection. However, the 
indications for resection of the branch duct type IPMN have 
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been controversial. Therefore, in this study, we identifi ed 
predictors of malignancy to determine indications for surgery 
for the patients with branch duct type IPMN.
Methods: We retrospectively analyzed the clinicopathologi-
cal factors of 134 patients who underwent resection for 
branch duct type IPMN, excluding main duct type IPMN, at 
Wakayama Medical University Hospital, from July 1999, to 
February 2011, to identify predictors of the malignant behav-
ior of this neoplasm. The cut-off values of tumor size, main 
pancreatic duct (MPD) size, mural nodule size, and carcino-
embryonic antigen (CEA) level in the pancreatic juice 
obtained during preoperative endoscopic retrograde pancrea-
tography (ERP) were analyzed using receiver-operator char-
acteristic curves.
Results: We found 7 signifi cant predictors for malignancy 
in the branch duct type IPMN in a univariate analysis; jaun-
dice, tumor occupying the pancreatic head, MPD size 
>5 mm, mural nodule size >5 mm, serum CA19-9 level, 
positive cytology in the pancreatic juice, and CEA level in 
the pancreatic juice >30 ng/ml. In a multivariate analysis, a 
mural nodule size >5 mm and a CEA level in the pancreatic 
juice >30 ng/ml were independent factors associated with 
malignancy. When the combination of a mural nodule size 
>5 mm and a CEA level in the pancreatic juice >30 ng/ml is 
used, the positive predictive value was 100%, and the nega-
tive predictive value was 96.3%.
Conclusion: We identifi ed two useful predictive factors for 
malignancy in branch duct type IPMN; a mural nodule size 
>5 mm and a CEA level in the pancreatic juice obtained by 
preoperative ERP >30 ng/ml. Branch duct type IPMN with 
a mural nodule size >5 mm and a CEA level in the pancreatic 
juice >30 ng/ml would be recommended for resection, and 
then, that with a mural nodule size ≤5 mm and a CEA level 
in the pancreatic juice ≤30 ng/ml might be better treated by 
strict observation.
080
PANCREATICODUODENECTOMY FOR 
PANCREAS HEAD CANCER IN A 
PATIENT WITH ADVANCED 
MULTIPLE SCLEROSIS
H. Haider, H. Hayati, A. Taqi and A. Sadeq
Amiri Hospital, Kuwait City, Kuwait
Amiri Hospital, Kuwait City, Kuwait, Surgery, P.O. Box 
1128035153, Al-Dasmah, Kuwait
Introduction: There are no reports in the literature, up to 
our knowledge, on the outcome of major abdominal surgery 
in patients with multiple sclerosis (MS). In this case report, 
we present the outcome of pancreaticoduodenectomy surgery 
(Whipple’s operation) for pancreatic head cancer in a patient 
with advanced progressive MS.
Methods: A 48-year-old Kuwaiti female diagnosed with 
progressive MS in 1996. Her neurological manifestations 
included quadriplegia and unilateral facial palsy. She has 
been bedridden since 1999. The patient has intact cognitive 
abilities and swallowing function. She does not have history 
of chest infection in the past. T2 brain MRI showed wide 
spread variable MS plaques.
She presented with painless jaundice that led to further 
workup, which detected resectable peri-ampullary adenocar-
cinoma with no evidence of distal metastasis. The case was 
discussed in multidisciplinary team meeting and the main 
worry was post-operative ventilator dependency.
Results: Patient underwent uneventful Whipple’s operation 
and was successfully extubated shortly after transfer to ICU. 
The histopathology of the specimen showed the adenocarci-
noma to be arising from the head of the pancreas (stage pT3, 
N1, Mx). Her post-operative course was complicated by a 
pancreatic leak on day 7 managed conservatively by existing 
intra-abdominal drain and additional placement of transhe-
patic biliary drain to divert the bile away from the leak site 
at pancreaticojejunostomy anastomosis. Patient then did well 
and was discharged from hospital on post-operative day 60. 
Adjuvant therapy for the tumor included a single agent 
Gemcitabine chemotherapy. Twenty-one month follow-up 
patient is still alive, but with metastatic disease.
Conclusion: Major abdominal surgery is feasible in patients 
with MS. Multidisciplinary team approach is recommended 
in the management of such diffi cult cases.
083
CONTRAST-ENHANCED ULTRASOUND 
IN THE DIAGNOSIS OF MASS-FORMING 
PANCREATITIS
I. Di Carlo2, F. Loria1, G. Loria1, S. Basile1, G. Crea1, 
D. Randazzo3, L. Frosina3 and P. Rodoni4
1Dept. of Radiology Palmi, ASP 5 Reggio Calabria; 2Dept. 
of Surgical Sciences, University of Catania; 3School of 
Medicine, University of Messina; 4Dept. of Radiology 
Mendrisio, EOC Bellinzona
University of Catania, Surgical Sciences, Cannizzaro 
Hospital, via Messina 82695126, Catania, Italy
Introduction: The aim of this work is to assess the utility 
of contrast-enhanced ultrasound (CEUS) with a second gen-
eration contrast medium in the differential diagnosis between 
mass-forming pancreatitis (MFP) and pancreatic carcinoma 
(PC).
Methods: From our database, we retrieved all patients 
affected by MFP or PC who underwent CEUS, between 
March 2002 and November 2011. We evaluated the results 
of CEUS in the study of 173 pancreatic masses (35 MFP and 
138 PC), considering the possibilities of a differential diag-
nosis between MFP and PC. The presence of a slight continu-
ous enhancement inside the masses during dynamic phase of 
CEUS, was defi ned as parenchymographic enhancement, 
which was considered diagnostic for MFP. The enhancement 
pattern of the lesions was compared to the normal adjacent 
parenchyma. The lesions were classifi ed as hypoechoic/
hypovascular, isoechoic/isovascular or hyperechoic/
hypervascular.
Results: During dynamic phase at CEUS, 94% of the MFP 
showed intralesional parenchymographic enhancement 
assuming hyperechogenicity compared to the adjacent paren-
chyma, 91% of the PC were hypovascular assuming 
hypoechogenicity compared to the adjacent parenchyma.
CEUS allowed diagnosis of MFP with sensitivity of 
88.6%, specifcity of 97.8%, positive predictive value of 
91.2%, negative predictive value of 97.1% and overall accu-
racy of 96%.
CEUS signifi cantly increased the diagnostic confi dence in 
the differential diagnosis between MFP and PC, with receiver 
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operating characteristic curve areas from 0.557 (P = 0.1608) 
for baseline sonography to 0.956 (P < 0.0001) for CEUS.
Conclusion: MFP and PC may present with the same symp-
toms and signs and the differential diagnosis is a crucial point 
for the correct management of patients. Several clinical and 
imaging features have been proposed to be helpful for the 
differential diagnosis. CEUS allowed diagnosis of MFP with 
diagnostic accuracy of 96% and signifi cantly increases the 
diagnostic confi dence with respect to baseline sonography in 
discerning MFP from PC.
085
DIAGNOSIS AND STAGING OF 
PANCREATIC CANCER: ROLE OF 
CONTRAST-ENHANCED MAGNETIC 
RESONANCE IMAGING
I. Di Carlo2, F. Loria1, G. Loria1, D. Randazzo3, 
L. Frosina3, G. Crea1, A. Haghighi4 and P. Rodoni4
1Dept. of Radiology Palmi Hospital, ASP 5 Reggio 
Calabria; 2Dept of Surgical Sciences, University of 
Catania; 3School of Medicine, University of Messina; 
4Dept. of Radiology Mendrisio Hospital, EOC Bellinzona
University of Catania, Surgical Sciences, Cannizzaro 
Hospital, via Messina 82695126, Catania, Italy
Introduction: Despite the poor prognosis of patients with 
pancreatic cancer, surgical resection is still the only poten-
tially curative treatment for the disease. Early diagnosis and 
the assessment of tumor resecability are the important tasks 
for diagnostic imaging. The purpose of this study is to 
asseess the utility of contrast-enhanced magnetic resonance 
imaging (CEMRI) in the diagnosis and staging of pancreatic 
cancer and in the differentiation between cancer and focal 
pancreatitis.
Methods: 42 patients with suspected pancreatic masses 
underwent CEMRI at 1.5 tesla. The image were assessed for 
the presence or absence of tumors; characterization of 
massess; and presence of vascular invasion, lymph nodes or 
liver metastases. The imaging fi ndings were correlated with 
fi ndings at laparotomy, laparoscopy, biopsy o follow-up.
To assess vascular invasion the attention was focused on 
main portal vein, portal-venous confl uence, superior 
mesenteric artery and vein and celiac trunk. The short axis 
of enlarged lymphnodes and peritoneal implants were 
recorded.
Tumors were deemed unresectable when enlarged distant 
lymph-nodes (non peripancreatic), liver or peritoneal metas-
tases were present.
Results: Focal masses were present in 36/42 patients (cancer 
26, focal pancreatitis 7, other 3). The sensitivity for lesion 
detection of CEMRI was 100%. For the diagnosis of tumor 
nonresecability the sensitivity of CEMRI was 90%. Liver 
metastases were missed on CEMRI in 1/8 patients. For the 
differentiation between adenocarcinoma-nonadenocarci-
noma the sensitivity of CEMRI was 100% (PPV 90%, NPV 
100%).
Receiver operating characteristic analysis revealed that the 
mean area under the curve for CEMRI was 0.920.
Conclusion: CEMRI is an accurate imaging modalities for 
the detection and staging of pancreatic cancer and offers 
advantages in the detection of small pancreatic malignancies 
and of liver metastases compared with others imaging 
modalities as computed tomoraphy and contrast-enhanced 
sonography.
089
THE USE OF TACHOSIL® IN 
PREVENTING PANCREATIC 
LEAKS FOLLOWING 
PANCREATICO-DUODENECTOMY
D. Gomez, I. C. Cameron and A. Brooks
Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust, Nottingham, United Kingdom
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust, Nottingham, United Kingdom
Department of Hepatobiliary and Pancreatic Surgery, 
Department of Hepatobiliary and Pancreatic Surgery, E 
Floor, West Block, Queen’s Medical Centre, Derby Road, 
Nottingham, NG7 2UHNG72U, Nottingham, United 
Kingdom
Introduction: Pancreatic leaks following Whipple’s proce-
dure are associated with high morbidity and prolonged hos-
pital stay. Tachosil is a collagen sponge coated with thrombin 
and fi brinogen that is primarily used as an absorbable hameo-
static agent, however it is recognized to have sealant proper-
ties. The aim was to assess whether the application of 
TachoSil® following construction of pancreatico-jejunos-
tomy in patients undergoing a Whipple’s procedure reduced 
the incidence of pancreatic anastomotic leak.
Methods: Patients that underwent a Whipple’s procedure 
and had TachoSil® applied around the pancreatico-
jejunostomy anastamosis were included. Data collected 
included demographics, drain amylase and length of 
hospital stay.
Results: There were three patients included in this initial 
study, of which 2 were female. Patients were discharged 
within 10 days following Whipple’s procedure. In all patients, 
pancreatico-jejunostomy anastamosis was performed with a 
2-layer technique. The inner layer (pancreatic duct to small 
bowel mucosa) with 5/0 prolene, while the outer layer (pan-
creatic parenchyma to small bowel serosa) 4/0 polydioxa-
none (PDS) was used. Following this, TachoSil® was wrapped 
around the outer layer of the pancreatico-jejunostomy anasta-
mosis effectively sealing it. All patients had their drain 
amylase measured; none were greater than 30 U/L, prior to 
drain removal. No pancreatic anastomotic leak was observed 
in all patients.
Conclusion: TachoSil® may be of value as a sealant of the 
pancreatico-jejunostomy anastamosis and reduce the inci-
dence pancreatic leaks and further work needs to be done to 
assess the value of the technique.
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SURGERY FOR INFECTIOUS 
COMPLICATIONS OF SEVER 
ACUTE PANCREATITIS
T. Yasuda1, T. Ueda1, Y. Nakata1, K. Kamei2, 
M. Yamazaki1, H. Ishikawa1, T. Nakai1 and T.1
1Department of Surgery, Kinki University Faculty of 
Medicine; 2Department of Surgery, Sakai Hospital, Kinki 
University Faculty of Medicine
Kinki University Faculty of Medicine, Department of 
Surgery, 377-2 Ohno-higashi, 589, Osaka-sayama, Japan
Introduction: In severe acute pancreatitis (SAP), infectious 
complications are main contributors to high mortality. Once 
infectious complications occur, conservative treatment is not 
effective and drainage procedure is considered. Especially 
when infected pancreatic necrosis is proven, surgical inter-
vention is adapted. The aim of this study is to review our 
cases and consider the indication and timing of surgical 
intervention.
Methods: A total of 7 patients (4 males and 3 females) with 
infectious complications from SAP were treated at the 
Department of Surgery, Kinki University hospital, Japan, 
between January 2007 and October 2011, and were analyzed 
retrospectively. Etiology of SAP was presumed to be alcohol 
in 4 patients (all male patients), gallstone in one patient, 
idiopathy in one patient, and others in one patient.
Results: Among 7 patients, infected pancreatic necrosis was 
occurred in 3 patients, and peripancreatic & retroperitoneal 
infection was occurred in 4 patients. The timing of surgical 
intervention was from 35 days to 120 days after onset of 
SAP. Among the patients with infected pancreatic necrosis, 
we performed necrosectomy & drainage in 2 cases, and 
endoscopic necrosectomy in one case. Among the patients 
with peripancreatic & retroperitoneal infection, we per-
formed laparotomy & drainage in 3 cases, and percutaneous 
drainage in one case. In all cases, abscess-gut fi stula was 
identifi ed during hospitalization, and in 5 cases, enterostomy 
was added during surgery. Three patients died after the surgi-
cal intervention due to multiple organ failure.
Conclusion: In SAP, the mortality of infectious complica-
tions is still high. It is important to perform surgical proce-
dure at the late phase, and to choose the adequate procedure 
according to the patient’s conditions.
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SYNCHRONOUS MULTIFOCAL 
BILIOPANCREATIC TUMOURS
S. Shah and N. Jain
Division of GI Surgery, PD Hinduja Hospital, Mumbai 400 
016, India
PD Hinduja Hospital, GI Surgery, Veer Savarkar Marg, 
Mahim, 16, Mumbai, India
Introduction: Synchronous cancer of biliary tract and 
cancer of pancreas is well known. Anomalous pancreatico-
biliary disjunction (APBDJ) is shown to be associated with 
synchronous tumours. We report a case of synchronous 
involvement of biliary tract and pancreas in a middle aged 
lady in the absence of APBDJ.
Methods: 55 years lady with incidentally detected stage Ia 
adenonocarcinoma of gall bladder post laparoscopic chole-
cystectomy presented with pain in abdomen after four years. 
On investigations she had dilated intrahepatic biliary radi-
cles, enhancing mass in common heptic duct and diffusely 
enlarged pancreas with multifocal lesions within without 
dilated pancreatic duct. Staging PET scan showed signifi cant 
uptake in common hepatic duct and pancreas. Percutaneous 
biopsy of pancreas performed elsewhere showed adenocar-
cinoma. MRCP did not reveal an APBDJ.
Results: She underwent total pancreatectomy and radical 
excision of biliary tract with Roux en y heapticojejunostomy. 
Histology showed well differentiated papillary neoplasm 
in the biliary system and well differentiated multifocal 
adenocarinomas in the pancreas. There was no nodal 
involvement.
Conclusion: To best of our knowledge this is the fi rst case 
of synchronous invlolvement of biliary tract and pancreas 
discontinuously. We need further exploration to answer this 
synchronicity.
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CENTRAL PANCREATECTOMY 
FOR IPMN
S. Shah and N. Jain
Division of GI Surgery, PD Hinduja Hospital, Mumbai 400 
016, India
PD Hinduja Hospital, GI Surgery, Veer Savarkar Marg, 
Mahim, 16, Mumbai, India
Introduction: Intraductal papillary mucinous neoplasms 
(IPMN) are have been increasingly recognized. Surgical 
management depends upon site, size, type of duct involve-
ment and intraoperative resection margin status. Sophisticated 
imaging leads to early diagnosis in asymptomatic stage. 
Extensive pancreatic resections are often advocated for 
IPMN because of extensive duct involvement.
Methods: We report two cases of symptomatic side branch 
IPMN located in the neck of pancreas treated with central 
pancreatectomy. One was 2 cm in diameter and the other 
showed progression from 1.8 to 2.5 cm in a six month period. 
The excised specimen was submitted for frozen section. The 
duodenal end of the duct was sutured closed and the tail end 
was anastomosed to a Roux loop of jejunum with a duct-
mucosa anastomosis.
Results: Both patients recovered uneventfully and were dis-
charged at 7 days. There is no evidence of exocrine or endo-
crine insuffi ciency over a follow up of 9 months and 4 years.
Conclusion: Central pancreatectomy may offer a safe, 
parenchyma preserving alternative in selected cases of 
IPMN.
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HORMONE SECRETING PANCREATIC 
NEUROENDOCRINE TUMOURS
S. Shah, P. Chauhan and N. Shah
Division of GI Surgery, PD Hinduja Hospital, Veer 
Savarkar Marg, Mahim, Mumbai 400 016, India
Introduction: Pancreatic neuroendocrine tumors (PNET) 
are rare. We present our experience with hormone secreting 
PNETs, excluding carcinoid tumours.
Methods: Retrospective review between 2004–2011 of 8 
patients with hormone secreting PNETs. This included 5 with 
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insulinoma, 2 with gastrinoma and one glucagonoma. 
Hormone assays were measured. CECT was imaging of 
choice. All were operated upon.
Results: CECT showed the primary lesion in all except 2 
insulinomas which were detected by intraoperative ultraso-
nography. Surgery was successful in all. Three patients had 
MEN 1 syndrome. 4 gastrinomas were enucleated from one, 
one required radical total pancreatectomy and one had an 
insulinoma removed. The remaining insulimomas were enu-
cleated. The patient with glucagonoma had radical distal 
pancreatectomy and liver metastatectomy. Resurgery was 
required in one. All are currently symptom free over a 
median follow up of 4 years (2 months–7 years).
Conclusion: Surgery is effective in the treatment of secre-
tory pancreatic neuroendocrine tumours.
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CLINICAL USEFULNESS OF FDG-PET 
FOR PANCREATIC CANCER
Y. Mataki1, H. Shinchi1, K. Maemura1, H. Kurahara1, 
T. Kuwahata1, S. Ueno1, S. Takao2 and S. Natsugoe1
1Department of Digestive, Breast and Thyroid Surgery, 
Kagoshima University; 2Frontier Science Research Center, 
Kagoshima University
Kagoshima University, Department of Digestive, Breast 
and Thyroid Surgery, Sakuragaoka, 8-35-189085, 
Kagoshima City, Japan
Introduction: The purpose of this study was to estimate the 
usefulness of positron emission tomography (PET) in divid-
ing between the uptake in the main tumor and except the 
main tumor for the treatment of patients with pancreatic 
cancer.
Methods: 168 patients with primary pancreatic cancer were 
evaluated with 18F-FDG-PET. For the main tumor, the 
maximum standardized uptake value (SUVmax) levels were 
compared with clinicopathological factors and analyzed. For 
the exception of main tumor, we examined the site of accu-
mulation and the rate of malignancy. For the accumulation 
of FDG to the main tumor, high SUVmax level was signifi -
cantly correlated with T, N, M category in TNM classifi ca-
tion (P < 0.001, respectively), tumor size (>3 cm) (P < 
0.001), CA19-9 levels (>37 U/ml) (P = 0.007).
Results: Prognostic factors were determined by multivariate 
analysis using Cox’s proportional hazard model. CEA level 
was an independent prognostic factors. The overall survival 
of the group in which SUVmax was less than 7.5 was better 
than that of the group in which SUVmax was more than 7.5 
(P = 0.03). Meanwhile, as for hepatic metastasis, sensitivity, 
specifi city, PPV were 72%, 99%, 100% for FDG-PET, 92%, 
99%, 94% for MD-CT. As for lymph node metastasis, a 
curative operation was performed in 42 patients (59%), 62% 
among them had lymph node metastasis in the fi nal pathol-
ogy. Sensitivity, specifi city, PPV were 4.2%, 100%, 100% 
for FDG-PET, 8.3%, 100%, 100% for MD-CT.
Conclusion: We conclude that FDG-PET is a useful tool for 
predicting the prognosis in pancreatic cancer, but not useful 
for detection of lymph node metastasis and hidden malignant 
disease. FDG-PET has an important clinical impact on the 
selection of proper treatment.
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ARTERIOR STIMULATION VENOUS 
SAMPLING (ASVS) IS AN ESSENTIAL 
METHOD FOR THE PREOPERATIVE 
LOCALIZATION OF PANCREATIC 
INSULINOMA
K. Megumi1, H. Shinchi1, K. Maemura1, Y. Mataki1, 
H. Kurahara1, S. Ueno1, S. Takao2 and S. Natsugoe1
1Department of Digestive, Breast and Thyroid Surgery, 
Kagoshima University; 2Frontier Science Research Center, 
Kagoshima University
Kagoshima University, Department of Digestive, Breast 
and Thyroid Surgery, Sakuragaoka, 8-35-189085, 
Kagoshima City, Japan
Introduction: The therapy for the pancreatic insulinoma 
needs to be resected completely. That’s why we have to 
identify the exact tumor localization of pancreatic insulin-
oma preoperatively. We reviewed the accuracy of each 
methods such as computed tomography (CT), ultrasonogra-
phy (US), endoscopic ultrasonography (EUS), arteriography, 
arterial stimulation venous sampling (ASVS).
Methods: Ten patients (3 male, 7 female) diagnosed pan-
creatic insulinoma, aged 18–79 years, were studied retro-
spectively. Tumor location was pancreatic head in 4 patients, 
body in 2, and tail in 4. Preoperatively we performed CT, 
US, EUS, arteriography, and ASVS. The results were com-
pared with the post operative fi ndings.
Results: The average size of removed insulinoma was 16.2 
± 9.3 mm. All except one who admitted multiple liver metas-
tasis were cured by the surgery. Operative method was PD 
in 2 patients, distal pancreatectomy in 4, and tumor enucle-
ation in 4. Sensitivities of preoperative localization methords 
were 100% by ASVS, 80% by CT, 70% by US, 70% by 
arteriography, 40% by EUS. And they were free from hypo-
glycemic symptoms caused by pancreatic insulinoma.
Conclusion: We identifi ed the difference of the sensitivities 
by each moderlities for the detection of pancreatic insulin-
oma. But ASVS showed 100% accuracy. The reasons why 
tumor was not detected in the other modalities were tumor 
localization, tumor sizes, and patient’s bodies. ASVS is a 
very important modality for preoperative detection of pan-
creatic insulinoma.
102
THE IMMUNOLOGICAL MONITORING 
OF CIRCULATING CD4+CD25+ 
REGULATORY T CELLS IN PATIENTS 
WITH PANCREATIC CANCER
S. Hirooka, S. Satoi, T. Yamamoto, H. Yanagimoto, 
H. Toyokawa, S. Yamaki, R. Yui and A-H. Kwon
Department of Surgery, Kansai Medical University
Kansai Medical University, Surgery, 2-3-1 Shin-Machi, 
57311, Hirakata, Japan
Introduction: Regulatory T cells (Treg) can inhibit immune 
responses mediated by T cells. The aim of this study was to 
evaluate the prevalence of Treg in peripheral blood mono-
nuclear cells (PBMCs) from patients with pancreatic cancers 
in relation to their clinical outcomes.
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Methods: Among a total of 100 patients with ductal adeno-
carcinoma of the pancreas, 40 underwent pancreatectomy 
and 60 had unresectable disease. Their PBMCs were evalu-
ated to determine the proportion of CD4+CD25+ (FoxP3+) 
T cells, as a percentage of the total CD4+ cells, by fl ow 
cytometric analysis.
Results: The percentage of Treg in pancreatic cancer 
patients was signifi cantly lower than in healthy volunteers (p 
= 0.048), and patients who underwent surgical resection had 
lower Treg levels that those with unresectable disease (p = 
0.040). Patients in the resected group with a higher percent-
age of Treg in their peripheral blood survived longer (p = 
0.021). Treg in patients who remained disease free at post-
operative 12 months signifi cantly decreased compared to that 
of the postoperative period (p = 0.009). In contrast, Treg in 
the recurrent group did not decrease at 12 months after surgi-
cal resection.
Conclusion: A relative increase in Treg may be related to 
immunosuppression and tumor progression in patients with 
pancreatic cancer. The immunological monitoring of Treg 
may be useful to predict the prognosis for patients with 
pancreatic cancer.
105
‘ARTERY FIRST’ 
PANCREATO-DUODENECTOMY
S. Pandanaboyana and J. Windsor
Department of HPB Surgery, Auckland City Hospital, 
Auckland, New Zealand
Auckland City Hospital, HPB Surgery, Surgical Offi ces, 
ACH Support Building, Park Road, Grafton, 1010, 
Auckland, New Zealand
Introduction: The technique of pancreatoduodenectomy 
(PD) has evolved. Previously irresectability was determined 
by involvement of the portal-superior mesenteric vein. 
Because venous resection can be achieved safely and with 
greater awareness of the prognostic signifi cance of the status 
of the postero-medial resection margin, irresectability is now 
determined by involvement of the superior mesenteric artery. 
This change in focus, the desire for an early determination 
of resectability.
Methods: An electronic search was performed of the 
MEDLINE, EMBASE, PubMed databases from 1960 to 
2011 using both subject headings (MeSH) and truncated 
word searches to identify all articles published that related 
to this topic.
Results: The search revealed 6 different surgical approaches 
that can be considered as ‘artery fi rst’. These involve 
approaching the SMA from the retroperitoneum (posterior 
approach), the uncinate process (medial uncinate approach), 
infracolic region medial to the duodeno-jejunal fl exure (infe-
rior infracolic or mesenteric approach), infracolic retroperi-
toneum lateral to the DJ fl exure (left posterior approach), the 
supracolic region (inferior supracolic approach) and through 
the lesser sac (superior approach). Illustrations were derived 
from the original descriptions and purported advantages and 
disadvantages noted.
Conclusion: The six approaches described in this review 
provide a range of options for the early determination of 
arterial involvement, depending on the location and size of 
the tumour, and before the ‘point of no return’. Whether these 
approaches will achieve an increase in the proportion of 
patients with negative margins, improve loco-regional 
control and increase long-term survival has yet to be deter-
mined. Clarifi cation of the options may assist that task.
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AGING IS RELATED TO INCREASED 
INTESTINAL DAMAGE AND BACTERIAL 
TRANSLOCATION IN ACUTE 
PANCREATITIS IN RATS
A. M. Coelho1, M. Machado1, S. Sampietre1, N. Molan1, 
I. Heijden2, J. Cunha1 and L. C. D’Albuquerque1
1Department of Gastroenterology (LIM/37), University of 
Sao Paulo, Sao Paulo, Brazil; 2Department of Infectious 
Disease (LIM/54), University of Sao Paulo, Sao Paulo, 
Brazil
University of Sao Paulo, Gastroenterologia, R Joao Moura 
690 #41, Zip Code: 054120015412, Sao Paulo, Brazil
Introduction: Acute pancreatitis (AP) in elderly patients is 
followed by a substantial increase in multiple organ failure 
possibly due to increased bacterial translocation. Intestinal 
fatty acid binding protein (I-FABP), a protein located at the 
intestinal mucosa may leak out of damaged intestinal mucosal 
cells and levels of I-FABP may be an indication of bacterial 
translocation. The aim of the present study was to evaluate 
the effect of aging on intestinal damage, bacterial transloca-
tion, and organ failures in AP.
Methods: AP was induced in male Wistar rats by intraductal 
2.5% taurocholate injection and divided into 2 experimental 
groups: GI (n = 20): Young (3 month old rats), and GII (n = 
20): Older (18 month old rats). Two and 24 hours after AP 
blood were collected for determinations of plasma ileal fatty 
acid binding protein (I-FABP), and biochemical markers: 
amylase, AST, ALT, urea, creatinine, and glucose. Pulmonar 
myeloperoxidade (MPO) activity was also performed. 
Bacterial translocation was evaluated by bacterial cultures of 
pancreas expressed in colony-forming units (CFU) per gram.
Results: A signifi cant increase in plasma amylase, AST, 
ALT, urea, creatinine, and I-FABP levels was observed in the 
older group compared to the young group (p < 0.05). 
Pulmonar myeloperoxidade (MPO) activity was also 
increased in the older group compared to the young group (p 
< 0.05). Compared to young rats, rate of positive bacterial 
cultures obtained from pancreas cultures in the older rats was 
signifi cantly increased.
Conclusion: This study demonstrated that aging is associ-
ated to an increased distant organ damaged and bacterial 
translocation, and that plasma level of I-FABP is an impor-
tant marker of bacterial translocation.
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A CLINICAL ROLE OF A CRITICAL 
PATHWAY IMPLEMENTATION FOR 
PANCREATICODUODENECTOMY IN 
179 PATIENTS
S. Yamaki, S. Satoi, H. Toyokawa, H. Yanagimoto, 
T. Yamamoto, S. Hirooka, R. Yui and A-H. Kwon
Kansai Medical University, Department of Surgery
Kansai Medical University, Department of Surgery, 10-15 
Fumizono-cho Moriguchi-city Osaka, Japan
Introduction: In June 2004, a critical pathway for patients 
undergoing pancreaticoduodenectomy (PD) was introduced. 
The objective of this study is to determine the clinical role 
of critical pathway implementation.
Methods: From January 2000 to January 2010, 256 con-
secutive patients who underwent PD were divided into 4 
groups by date of operation. Group A (pre-pathway group) 
comprised 77 patients. Group B comprised 51 patients who 
were managed according to departmental guidelines. Group 
C comprised 78 patients who had no biliary and pancreatic 
duct stenting in reconstruction of PD. Group D comprised 
50 patients who had reinforcement of pancreaticojejunos-
tomy. The success rate of the clinical outcomes, were ana-
lyzed between each group, year by year and every 50 patients.
Results: The success rate of the clinical outcomes, includ-
ing rate of nasogastric tube removal, timing of discontinua-
tion of prophylactic anti-microbial agent, drain removal, and 
starting oral intake, and patient discharge from hospital were 
signifi cantly improved in group B relative to group A, and 
in group C relative to group B. There were no signifi cant 
increases in mortality and morbidity among any group. All 
clinical outcomes reached the plateau at 2–3 years or 100–150 
patients’ operations after clinical pathway implementation.
Conclusion: The long time use of a critical pathway is asso-
ciated with improved clinical outcomes. A certain period of 
time, or volume of patients is needed for this good rate for 
the clinical outcomes to reach a plateau, indicating standard-
ization of peri-operative management.
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LESS MAJOR MORBIDITY FOLLOWING 
DISTAL PANCREATECTOMY AFTER 
IMPLEMENTATION OF THE NEW 
DEPARTMENTAL GUIDELINE
R. Yui, S. Satoi, H. Toyokawa, H. Yanagimoto, 
T. Yamamoto, S. Hirooka, S. Yamaki and A-H. Kwon
Department of Surgery, Kansai Medical University
Kansai Medical University, Department of Surgery, 10-15 
Fumizono-cho Moriguchi-city Osaka, Japan
Introduction: The aim of this study is to retrospectively 
compare morbidity and mortality before and after implemen-
tation of the new departmental guideline.
Methods: We have introduced a use of ultrasonically acti-
vated device on distal pancreatectomy, early removal of 
drains and peri-operative management using clinical pathway 
since May 2006. Group A consisted of 57 consecutive 
patients from 2006 to 2010. Group B consisted of 52 con-
secutive patients from 2000 to 2006.
Results: There were no differences in operative mortality, 
overall morbidity, and rate of re-operation between groups A 
and B. The rate of intra-abdominal abscess in group A was 
signifi cantly lower than that in group B (p = 0.012). The rate 
of pancreatic fi stula (PF), Grade B/C PF and surgical site 
infection in group A had the lower tendency relative to group 
B, but signifi cantly differences were not found. The rate of 
grade 3/4 of Clavien classifi cation in group A was signifi -
cantly lower than that in group B (p = 0.039). Moreover, 
timing of drain removal (3 days vs 8 days) and in-hospital 
stay (8 days vs 17 days) in group A were signifi cantly shorter 
than those in group B (p < 0.001).
Conclusion: This retrospective study showed that imple-
mentation of the new departmental guideline for distal pan-
createctomy was closely associated with low frequency of 
intra-abdominal abscess and grade 3/4 of Clavien score, 
resulting in shorter in-hospital stay.
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IS THE TYPE OF POST-OPERATIVE PAIN 
CONTROL RELATED TO PANCREATIC 
FISTULA FORMATION AFTER OPEN 
DISTAL PANCREATECTOMY?
H. Bach, E. Pappano, E. Bock, M. Shoup and G. Aranha
Loyola University Medical Center, Maywood, IL, USA
Loyola University Medical Center, General Surgery, 2160 
S. First Ave., Building 110, 3rd Floor, 60153, Maywood, 
IL, USA
Introduction: The most common complication after distal 
pancreatectomy (DP) is pancreatic fi stula (PF). We sought to 
determine if post-operative patient controlled analgesia 
(PCA) or patient controlled epidural analgesia (PCEA) has 
any relation to PF formation post DP. PCA introduces narcot-
ics into the bloodstream, which may act directly on the 
ampulla, causing spasm and increasing pancreatic ductal 
pressure, whereas PCEA does not. Therefore, we hypothe-
sized PCA patients are more likely to develop PF post DP.
Methods: Our database identifi ed 153 patients. Measuring 
drain amylase, PF was defi ned as none, Grade A, B, or C 
according to the severity classifi cation system of the ISGPS. 
Other factors studied were gender, patient age, body mass 
index (BMI), ASA class, albumin, creatinine, estimated 
blood loss (EBL), texture of pancreatic remnant, and type of 
closure (oversewn, stapled, or both). Data were analyzed 
with Chi Squared test, Fisher’s Exact Test, and ANOVA, 
where appropriate.
Results: The two analgesia groups were found to be similar 
in terms of age, sex, ASA class, preoperative albumin and 
creatinine level, intraoperative estimated blood loss, type of 
closure used, and post-operative pathology results. There 
were a total of 41 pancreatic leaks observed, 24 of which 
were patients who employed PCA and 17 of which patients 
employed PCEA (p = 0.10, Chi-Square).
Conclusion: These data from this small pilot study show 
that there is no statistical signifi cance, but a trend (p = 0.10) 
favoring PCEA over PCA in decreased formation of PF after 
DP. A randomized, prospective trial may provide a defi nitive 
answer whether type of analgesia effects PF formation after 
open DP.
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BENEFIT FROM ANTERIOR APPROACH 
IN RADICAL DISTAL 
PANCREATECTOMY FOR LEFT 
PANCREATIC CANCER
Y. Cui, X. Zhong, Z. Wang, S. Zhao and H. Wang
Second Affi liated Hospital of Harbin Medical University, 
Department of Biliary-Pancreatic Surgery, 246#, Xuefu 
Road, Nangang District, Harbin, China
Introduction: Dissection of the superior mesenteric artery 
(SMA) and celiac axis (CA) is the crucial part of radical 
distal pancreatectomy for left pancreatic cancer.
Methods: Since 2009, we have used anterior approach in 
which SMA and superior mesenteric vein (SMV) are dis-
sected fi rst and pancreatic neck is cut and than radical distal 
pancreato-splectomy from right to left is performed for pan-
creatic body and tail cancer, other than traditionally distal 
pancreato-splectomy from left to right.
Results: 21 patients with pancreatic body and tail cancer 
was operated in radical distal pancreatectomy by this tech-
nique without some life-threatening complications. 
Postoperative chemotherapy is used regularly in Gemcitabin 
as the effective treatment for tumor-resected patients, and the 
follow-up time is in 2–27 months.
Conclusion: Anterior approach for left pancreatic cancer 
can fi rst identify the possibility of resection by seeing inva-
sion of SMA or not, match the no touch and en bloc skill for 
cancer lesion and improve R0 rate for pancreatic cancer.
119
A NOVEL TRIPLE SECURED 
TECHNIQUE OF PANCREATIC 
RECONSTRUCTION FOLLOWING 
PANCREATICODUODENECTOMY FOR 
SOFT PANCREAS
Y. Suzuki, K. Okano, K. Kakinoki, M. Oshima, S. Yachida, 
H. Suto, H. Kashiwagi and N. Yamamoto
Kagawa University, Kagawa, Japan
Kagawa University, Gastroenterological Surgery, 1, 750-1 
Ikenobe, Miki-cho, Kita, Kagawa, Japan
Introduction: Soft pancreases are susceptible to pancreatic 
fi stula (PF) or leakage following pancreaticoduodenectomy 
(PD). To reduce PF after PD in patients with a soft pancreas, 
we developed a triple secured technique. In this study we 
described details of this triple secured technique and reported 
the postoperative outcomes.
Methods: This triple secured technique consisted of the fol-
lowing 3 steps. First, we used an ultrasonic dissector for 
pancreatic transection, with skeletonizing and ligating small 
pancreatic branch ducts and vessels. Second, the main pan-
creatic duct was anastomosed to the jejunum with duct-
invagination or duct-to-mucosa technique. Finally, four to 
fi ve large stitches with 3-0 polypropylene sutures were 
placed between pancreatic stump parenchyma and jejunal 
seromuscular layer to prevent pancreatic minor leakage from 
pancreatic stump. 28 consecutive patients with a soft pan-
creas who underwent an elective PD using our technique 
were included in this study.
Results: Postopetrative complication occurred in 16 patients 
(57.1%). Grade B PF developed in a total of 6 patients 
(21.4%). However, no grade C PF occurred in this series. In 
5 of 6 patients complicated with grade B PF, the drain could 
be removed and discharged by 30 days after surgery. There 
was no in-hospital mortality in this series.
Conclusion: Our triple secured pancreatic reconstruction 
technique after PD was feasible and safe with an acceptable 
rate of grade B PF and no grade C PF for patients with a soft 
pancreas.
122
BOWEL COMPLICATION FOLLOWING 
PANCREATIC NECROSECTOMY
S. S. Virk, S. Singla and P. Sihag
Department of Gastroenterology Surgery, Dayanand 
Medical College & Hospital, Ludhiana, India
Dayanand Medical College & Hospital, Ludhiana, India; 
Gastroenterology Surgery, 35-B, Udham Singh Nagar, Civil 
Lines, Ludhiana, India
Introduction: Signifi cant number of patients require some 
form of intervention for necrotizing pancreatitis. Open pan-
creatic necrosectomy followed by continuous lavage is well 
recognized form of treatment for infected pancreatic necro-
sis. Bowel complications are frequent and fatal sequel of this 
procedure. This report provides data on outcome of bowel 
fi stula following open necrosectomy in a tertiary referral 
center.
Methods: During the period January, 2003 to July, 2011, 
131 patients were subjected to open pancreatic necrosec-
tomy. Appearance of gut contents in the drains or in wound 
was taken as enterocutaneous fi stula and it was localized on 
the basis of nature of contents, transit study and or radiologi-
cal methods, before any further intervention. Twenty fi ve 
patients (19%) developed bowel fi stula. Thirteen patients 
(52%) developed small bowel fi stula (10 patients duodenum 
and three patients jejunum) while 12 patients (48%) devel-
oped a transverse colon fi stula.
Results: Twenty fi ve percent (n = 6) of the fi stulas were 
recognized intraoperatively, in 2 cases of colonic fi stula loop 
ileostomy was added to the procedure and in duodenal fi stu-
las primary closure followed by good drainage was estab-
lished and feeding jejunostomy was added to the procedure. 
In seventy fi ve percent (n = 19) of the patients the fi stulas 
were recognized post operatively. All the patients in whom 
small bowel was involved were managed conservatively and 
were kept feeding through naso-jejunal tube while 2 patients 
with large bowel involvement were managed conservatively 
and remaining 6 underwent proximal loop ileostomy as a 
second procedure. Overall mortality in this group was 33%.
Conclusion: Pancreatic necrosectomy is associated with 
bowel fi stula in signifi cant number of patients. Small bowel 
and large bowel are involved in equal frequency. Most of 
small bowel fi stula will heal spontaneously provided it is 
controlled and adequate nutrition is maintained. Large bowel 
fi stula require proximal diversion without repair of the rent 
in majority of the patients. Mortality in these patients is more 
as compared to patients without enterocutaneous fi stula.
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141
PRIMARY RETROPERITONEAL 
MALIGNANT MELANOMA
Z. Aziz1, K. Sair2 and M. A. Ali3
1Aziz Zentar; 2Ait Ali Mounaim; 3Sair Khalid
Hopital militaire d instruction med V Rabat Service de 
Chirurgie General Hopital Militaire Hay Ryad Rabat, 
10100, Morocco
Introduction: Primary retroperitoneal malignant melanoma 
is extremely rare and only a few descriptions of this presenta-
tion have been found in the medical literature only 6 cases.
Methods: The present case was initially suspected as 
sarcoma on the basis of the CT scan fi ndings, as the rest of 
the retroperitoneal tissues, the adrenal gland and kidney were 
within normal limits.
Malignant melanomas show many variations in the cyto-
morpholigical architecture and the stromal components 
[3–9]. Immunohistolchemical study leads to the correct 
diagnosis.
Results: Primary retroperitoneal malignant melanoma is 
extremely rare and only a few descriptions of this presenta-
tion have been found in the medical literature only 6 cases.
Conclusion: Primary retroperitoneal malignant melanoma 
is extremely rare and only a few descriptions of this presenta-
tion have been found in the medical literature only 6 cases.
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OUTCOME OF COLORECTAL 
PANCREATIC METASTASES
L. Morley1, K. Roberts1, C. Verbeke2, G. Morris-Stiff1 and 
A. Smith1
1Pancreatic Surgery Unit, St James’s University Hospital, 
Leeds; 2Department of Histopathology, St James’s 
University Hospital, Leeds
Leeds Teaching Hospitals Trust, Histopathology, 
Department of Histopathology, Bexley Wing, St James’s 
University Hospital, Beckett Street, LS97T, Leeds, England
Introduction: Colorectal pancreatic metastases (CRPM) 
are uncommon, thus the role of surgical resection remains 
uncertain. It is therefore prudent to establish whether the 
surgical management of CRPM is associated with successful 
outcomes. This case series compares the outcomes and long-
term survival of patients with CRPM who were managed 
surgically or with palliative intent.
Methods: The patients in this series were managed at a 
tertiary referral centre for hepatopancreatobiliary disease. 
Using the electronic records server at our institution, all 
patients with colorectal cancer (n = 8228) were searched for 
evidence of CRPM. A retrospective analysis of each case was 
undertaken by scrutinising the patient notes. Patients assigned 
to 1 group had undergone surgical management of their pan-
creatic disease. A 2nd group comprised of patients diagnosed 
with CRPM on cross-sectional imaging but did not undergo 
surgery. This group was used to compare the demographic 
details, site and stage of disease, interval between primary 
disease and metastases and overall survival outcomes.
Results: Four cases of CRPM underwent resection at our 
institution. The interval between diagnosis of colorectal car-
cinoma and CRPM was 1, 6, 7 and 7 years. CRPM were 
identifi ed on routine CT surveillance in asymptomatic 
patients. Extra-pancreatic metastases were present in every 
patient. An additional 5 patients were managed palliatively.
In the surgical cohort, the median survival was 4 years. 
One patient remains disease-free 4 years and 3 months post-
surgery. Three patients developed disease recurrence, of 
which 1 is alive with progressive disease 3 years 11 months 
post-operatively. The other 2 patients passed away at 18 
months and at 5 years 1 month post-surgery. Median survival 
in the palliate group from the CRPM diagnosis was 11 
months.
Conclusion: When resection of CRPM is possible, there is 
a survival advantage compared to non-operated patients. 
CRPM arise late in the disease course, with extra-pancreatic 
metastases frequently diagnosed in the interim. Surgeons 
outside of pancreatic units should refer cases to their local 
pancreatic MDT for consideration of surgical resection.
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PANCREATIC THICKNESS AS A 
PREDICTIVE FACTOR FOR 
POSTOPERATIVE PANCREATIC FISTULA 
AFTER DISTAL PANCREATECTOMY 
WITH AN ENDOPATH STAPLER
J. Uemura, K. Okano, N. Yamamoto and Y. Suzuki
Department of Gastroenterological Surgery, Kagawa 
University
Kagawa University, Gastroenterological Surgery, 1750-1, 
Ikenobe, Kita-gun, Miki-cho, Kagawa, Japan
Introduction: A consistent risk factor for pancreatic fi stula 
(PF) development after distal pancreatectomy (DP) with a 
stapler has not yet been established.
Methods: A total of 31 consecutive patients underwent DP 
with an endopath stapler between June 2006 and December 
2010 by using a slow parenchymal fl attening technique. The 
risk factors for PF after DP with an endopath stapler were 
identifi ed using univariate and multivariate analyses.
Results: Clinical PF developed in 7 of 31 (22%) patients 
who underwent DP with a stapler. The pancreas were signifi -
cantly thicker at the transection line in patients with PF (19.4 
± 1.47 mm) as compared to patients without PF (12.6 ± 
0.79 mm) (p = 0.0003). A 16-mm cut-off for pancreatic 
thickness was established based on the receiver operating 
characteristic (ROC) curve; the area under the ROC curve 
was 0.875 (p = 0.0215). Pancreatic thickness (p = 0.0006) 
and blood transfusion (p = 0.028) were associated with post-
operative PF in univariate analysis. Pancreatic thickness was 
the only independent signifi cant factor (odds ratio, 9.99; p = 
0.036) in multivariate analysis with a specifi city of 72%, 
sensitivity of 85%.
Conclusion: Pancreatic thickness is an independent signifi -
cant risk factor for PF development after DP with an endo-
path stapler. In patients with a pancreatic thicknesses of 
<16 mm, a suffi cient result could be provided by stapler 
technique.
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HIGH READMISSION RATES DUE TO 
DELAYED CHOLECYSTECTOMY 
FOLLOWING GALLSTONE 
PANCREATITIS
D. Gomez, A. Addison, A. De Rosa, D. N. Lobo and 
I. C. Cameron
Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust, Nottingham, United Kingdom
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust, Nottingham, United Kingdom
Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Department of Hepatobiliary and Pancreatic 
Surgery, E Floor, West Block, Queen’s Medical Centre, 
Derby Road, Nottingham, NG7 2UHNG72U, Nottingham, 
United Kingdom
Introduction: The aim of this study was to assess the re-
admission rates following discharge with acute gallstone 
pancreatitis and their subsequent defi nitive treatment. 
Secondary aims were to evaluate factors that infl uenced re-
admission rates.
Methods: Patients admitted with acute pancreatitis to the 
surgical admissions unit from January 2010 to December 
2010 were included in this study. Data collated included 
demography, laboratory studies, radiological investigations, 
underlying aetiology and timing of surgery.
Results: 117 patients were admitted with pancreatitis, of 
which 51 patients had gallstone-related pancreatitis. Of the 
30 admissions with primary gallstone presentation, 20 were 
placed on the cholecystectomy waiting list. 11 (55%) patients 
were re-admitted, and 6 patients underwent emergency cho-
lecystectomy. The remaining 5 patients were discharged with 
interval cholecystectomy. Of the 21 patients with previous 
admission for gallstone related complications, 1 patient had 
an emergency cholecystectomy while 15 patients had inter-
val cholecystectomy. 5 patients re-presented with 3 patients 
then undergoing an emergency cholecystectomy. The overall 
re-admission rate was 45.7%. On univariate analysis, only 
female gender predicted re-admission (p = 0.006).
Conclusion: High re-admission rates following gallstone 
pancreatitis are a result of non-adherence to the British 
Society of Gastroenterology guidelines, especially in female 
patients.
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INDICATIONS FOR ERCP AND EUS IN 
ACUTE PANCREATITIS
D. Gomez, A. Addison, A. De Rosa, D. N. Lobo and 
I. C. Cameron
Department of Hepatobiliary Surgery and Pancreatic 
Surgery, Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust, Nottingham, United Kingdom
Queen’s Medical Centre, Nottingham University Hospitals 
NHS Trust, Nottingham, United Kingdom; Department of 
Hepatobiliary and Pancreatic Surgery, Department of 
Hepatobiliary and Pancreatic Surgery, E Floor, West 
Block, Queen’s Medical Centre, Derby Road, Nottingham, 
NG7 2UH, United Kingdom
Introduction: With increase sub-specialization, the avail-
ability of endoscopic retrograde cholangiopancreatography 
(ERCP) and endoscopic ultrasound (EUS) has increased. 
Current guidelines suggest that ERCP should be performed 
in patients with gallstone-induced pancreatitis in the pres-
ence of cholangitis, jaundice or a dilated common bile duct 
(CBD) within 72 hours. The aim of this study was to evaluate 
the utilisation of ERCP and EUS in patients with gallstone 
pancreatitis.
Methods: Patients admitted with acute pancreatitis to the 
surgical admissions unit from January 2010 to December 
2010 were included in this study. Data collated included 
demography, laboratory studies, radiological investigations, 
underlying aetiology and timing of surgery.
Results: Of 117 patients admitted with acute pancreatitis, 
51 patients had gallstones as their cause. 21 patients had 
previous admissions with pancreatitis or gallstone-related 
complications. 15 patients were predicted to have severe 
pancreatitis. The majority of patients had at least one 
deranged liver function tests. Raised bilirubin was observed 
in 32 patients and a dilated CBD and/or CBD stones was 
seen in 10 patients. ERCP was performed in 4 patients for 
suspected CBD stones, none within 72 hours. EUS was per-
formed in 3 patients. In 1 patient, EUS was performed to rule 
out CBD stones. Following repeated admission with improv-
ing LFTs, EUS was performed to assess the CBD. The 
remaining patient had a pancreatic collection drained.
Conclusion: ERCP should be used as a therapeutic modality 
for CBD stones, and not for all acute pancreatitis patients 
with deranged LFTs. EUS can be used to assess the 
CBD for gallstones when other investigations have been 
inconclusive.
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HAND-ASSISTED LAPAROSCOPIC 
LIVING DONOR NEPHRECTOMY AND 
DISTAL PANCREATECTOMY FOR 
SIMULTANEOUS PANCREAS AND 
KIDNEY TRANSPLANTATION
M. Maruyama, T. Kenmochi, N. Akutsu, C. Iwashita, 
K. Otsuki, T. Ito, I. Matsumoto and T. Asano
Chiba-east National Hospital, Department of Surgery
Chiba-east National Hospital, Department of Surgery, 673 
Nitona, Chuo-ku, 26087, Chiba, Japan
Introduction: The simultaneous transplantation of pancreas 
and kidney from live donors (LDSPK) is performed in select 
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countries. One of the reasons for this reduced applicability 
is the invasiveness of the donor operation. We propose the 
method of hand-assisted laparoscopic operation to be per-
formed on live donors with minimal invasion.
Methods: Since January 2004 we performed 16 cases of 
LDSPK and the hand-assisted laparoscopic operation was 
performed in the last 8 donors. The donor was placed in the 
right lateral decubitus position. A 7-cm upper midline inci-
sion was taken, and a handport was installed in addition to 
2 or 3 12-mm ports. After the removal of the left kidney graft, 
the spleen and the distal part of the pancreas were completely 
mobilized. The splenic vein and artery were identifi ed and 
mobilized. The donor was then rotated to a supine position. 
Dissection of the pancreatic parenchyma using ultrasound 
shears and ligation of the splenic vessels were performed 
through midline incision under direct vision. The distal part 
of the pancreas and the spleen were extracted.
Results: Total operative time was 476 ± 41 minutes (mean 
± SD). Time to removing kidney graft and pancreas graft 
were 173 ± 30 minutes and 402 ± 39 minutes, respectively. 
Intraoperative blood loss was 495 ± 304 mL. Warm ischemic 
time of the kidney and the pancreas were 2.3 ± 0.5 minutes 
and 4.3 ± 1.1 minutes, respectively. Except of one case of 
grade B pancreatic fi stula, the postoperative course was 
uneventful and both the renal and pancreatic grafts func-
tioned well. No diabetes occurred in all donors.
Conclusion: Since 2000 we performed over 250 retroperi-
toneoscopic donor nephrectomies in living donor kidney 
transplantation. The advantage of this scopic technique is 
obvious. Thus we introduced the hand-assisted laparoscopic 
live donor nephrectomy and distal pancreatectomy for SPK. 
This technique is minimally invasive and safe and may 
become the standard method of live donor operation for 
simultaneous pancreas-kidney transplantation.
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INDICATION OF DISTAL 
PANCREATECTOMY WITH EN-BLOC 
CELIAC AXIS RESECTION IN 
PATIENTS WITH PANCREATIC 
BODY/TAIL CARCINOMA
K.-ichi Okada, H. Yamaue, M. Tani, M. Kawai, S. Hirono, 
M. Miyazawa, A. Shimizu and Y. Kitahata
Second Department of Surgery, Wakayama Medical 
University
Wakayama Medical University, Second Department of 
Surgery, 811-1 Kimiidera, 64185, Wakayama, Japan
Introduction: The most important predictor for long-term 
survival of patients with locally advanced pancreatic carci-
noma is whether radical surgical resection (R0) might be 
possible. However the impact of DP-CAR in the surgical 
strategy still remains controversial. The aim of the present 
study was to clarify the indication of distal pancreatectomy 
with en-bloc celiac axis resection (DP-CAR) in pancreatic 
body/tail carcinoma.
Methods: The medical records of 52 consecutive patients 
who underwent distal pancreatectomy with D2 node dissec-
tion, including 36 standard distal pancreatectomy (standard 
DP) and 16 DP-CAR, for pancreatic body/tail carcinoma 
were reviewed retrospectively.
Results: The microscopic positive margins were identifi ed 
at the dissection sites around cut-margin of splenic arteries 
and were more frequently detected in the patients with tumor 
situated within 10 mm distance from the root of splenic 
artery in standard DP (13.9%), whereas those were identifi ed 
in periarterial nerve plexuses and retropancreatic tissue 
around celiac artery in DP-CAR (62.5%). The overall 1-year, 
2-year survival rates after standard DP/DP-CAR were 
80.5/81.3%, 51.8/52.5%, and the median survival time 32/25 
months respectively with no signifi cant differences. There 
was no signifi cant difference in mortality rate and the inci-
dence of each complication between two groups except for 
delayed gastric emptying.
Conclusion: DP-CAR was feasible and safe procedure, 
similar with standard DP, and the survival of DP-CAR was 
as same as that of standard DP. For improvement of the R0 
resection rate, the indication of DP-CAR could be extended 
for potentially resectable pancreatic carcinoma near the root 
of splenic artery, and for borderline resectable pancreatic 
body/tail carcinoma, we should perform precise neoadjuvant 
multimodal therapy to perform R0 surgery for the future.
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DIAGNOSIS AND MANAGEMENT OF 
THE SOLID PSEUDOPAPILLARY 
TUMOUR OF THE PANCREAS
D. Kostov1, B. Manevska2 and G. Kobakov3
1Naval Hospital of Varna, Varna, Bulgaria; 2Medical 
University of Varna, Varna, Bulgaria; 3Specialized Hospital 
for Oncologic Diseases of Varna, Varna, Bulgaria
Naval Hospital of Varna, Varna, Department of Surgery, 3 
Hristo Smirnenski Street, 9002, Varna, Bulgaria
Introduction: There is rising evidence that Gruber-Frantz 
tumour or solid pseudopapillary tumour of the pancreas 
(SPTP) (according to WOS defi nition (1996) is no more any 
extraordinarily rare pathology worldwide. The diagnosis 
requires comprehensive clinical, histological, immunohisto-
chemical and CAT examinations to exclude malignant pan-
creatic diseases. Timely surgery is, usually, effective. Our 
purpose was to review the recent literature on SPTP and to 
present three own cases of the disease.
Methods: Three young female patients aged 17, 19, and 24 
years presented with periodic acute low-abdominal or epi-
gastric pains, nausea, vomiting and anemia of several-month 
duration prior to hospitalization in the Naval Hospital of 
Varna. CAT established solitary cysts of 8, 12, and 17 cm 
involving the head, the body, and the tail of the pancreas, 
respectively. The histological assessment of the cysts 
revealed solid areas of small vessels surrounded by medium-
sized tumour cells with light or eosinophilic cytoplasm 
located among the loose connective tissue. A strong vimentin 
expression was immunohistochemically proved in the 
tumour cells.
Results: Both type and volume of the surgical intervention 
differed in these patients. In the fi rst patient, a pylorus-saving 
pancreato-duodenal resection was performed. In the second 
patient, a corporo-caudal resection of the body of the pan-
creas was accomplished with ligation of a. lienalis and v. 
lienalis and preservation of the distal part of the tail of the 
pancreas and spleen as well. In the third patient, a resection 
of the tail of the pancreas and a preservation of the spleen 
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were done. This intervention resulted in a postoperative dia-
betes mellitus. There were no complications in the other 
patients 12 months after the operation at all. The possibilities 
for individualized and timely diagnosis and surgical treat-
ment of SPTP were discussed.
Conclusion: Our results demonstrate that nowadays SPTP 
does not occur very rarely among the patients with pancreatic 
diseases. It should be suspected in young females presenting 
with atypical gastrointestinal complaints. Both CAT and 
immunohistochemistry provide reliable information about 
the nature of the lesions. Timely diagnosis warrants an effec-
tive surgical behaviour which should be individualized 
because of the extent of affection of the pancreas and neigh-
bouring abdominal organs.
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DOUBLE BYPASS FOR INOPERABLE 
PANCREATIC MALIGNANCY AT 
LAPAROTOMY: POSTOPERATIVE 
COMPLICATIONS AND 
LONG-TERM OUTCOME
F. Ausania, A. Vallance, D. Manas, C. Snowden, S. White, 
R. Charnley, J. French and B. Jaques
Freeman Hospital, Newcastle Upon Tyne, UK
Freeman Hospital, HPB Surgery, High Heaton, Newcastle 
Upon Tyne, NE77DN, UK
Introduction: Between 4 and 13% of patients with operable 
pancreatic malignancy are found unresectable at the time of 
surgery. Double bypass is a good option for fi t patients but 
it is associated with high risk of postoperative complications 
and mortality. The aim of this study is to defi ne if it is pos-
sible to identify patients at high risk of complications and to 
assess the long term outcome of these patients.
Methods: All 50 patients who underwent a double bypass 
procedure for pancreatic malignancy between January 2006 
and July 2011 were identifi ed from a prospectively held 
database. Demographic data, risk factors for postoperative 
complications and preoperative anesthetic assessment data 
including P-Possum and Cardiopulmonary Exercise Testing 
(CPET) were collected.
Results: Fifty (33 male and 17 female) patients were 
included in the study; median age was 64 (39–79) years. 
Complication rate was 50% and in hospital mortality rate 
was 4%. P-Possum physiology score and low Anaerobic 
Threshold at CPET were signifi cantly associated with post-
operative complications (P = 0.005 and 0.016 respectively) 
but they were unable to predict them. Overall long-term 
survival was signifi cantly shorter in patients with postopera-
tive complications (9 vs 18 months). Postoperative complica-
tions were independently associated with poorer long-term 
survival (P = 0.003, OR 3.261).
Conclusion: P-Possum and CPET are associated with post-
operative complications but the possibility of using them for 
risk prediction requires further research. However, postop-
erative complications following double bypass have a sig-
nifi cant impact on long-term survival and therefore this type 
of surgery should be only performed in specialised centers.
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HEMORRHAGIC COMPLICATIONS 
AFTER CEPHALIC 
PANCREATICODUODENECTOMY: 
WHICH STRATEGY?
P. Duconseil1, L. Beyer1, O. Turrini2, J. Ewald2, S. Berdah1, 
C. Brunet1, J.-R. Delpero2 and V. Moutardier1
1General and Digestive Surgery, North Hospital, Marseille, 
France; 2Oncologic Surgery, Paoli-Calmettes Institute, 
Marseille, France
50 rue Edouard Delanglade, 13006, Marseille, France
Introduction: Hemorrhagic complications (HC) after pan-
creaticoduodenectomy (PD) can be treated either by surgery 
or by endovascular techniques proposed by radiologists. The 
aims of the study was to defi ne the place of iterative surgery 
(IS) and radiologic intervention (RI) in the management of 
HC after PD.
Methods: Between September 2005 and June 2011, 345 PD 
were performed in two centers [center A (CA): n = 199, 
center B (CB): n = 14]. RI was available only in center B. 
HC were divided into immediate (IHC, before the 72nd post-
operative hour) and late (LHC, after the 72nd post-operative 
hour).
Results: A HC concerned 42 patients (12%) within 14 days: 
CA: 20, CB: 22, 7 IHC (CA: n = 3; CB: n = 4) and 35 LHC 
(CA: n = 17, CB: n = 18). Ten patients (29% of LHC) expe-
rienced a sentinel bleeding (SB), prior to a HC within 8 days. 
LHC was caused by gastro-duodenal artery rupture in 48.5% 
and a pancreatic fi stula existed in 22 cases (63%). The man-
agement was: CA: 16 (80%) IS (3 IHC and 13 LHC) with 
additional pancreatectomy (AP) in 7 cases; 3 RI; 2 patients 
required a simple monitoring. CB: 5 (22%) IS (4 IHC and 1 
LHC) with 1 AP; 15 RI (68%), 2 monitorings. Hospitalization 
stay (HS) and mortal rate (MR) were: CA: 42 days and 10%; 
CB: 44 days and 4%. All the IHC had an IS (n = 7: 17%) 
with a MR of 0%. MR of LHC was of 6.6%. MR was: IS 
(19%), RI: 0% (p = 0.22 NS).
Conclusion: IS is the optimal treatment for IHC. LHC are 
half the time due to gastro-duodenal artery rupture, 2 out of 
3 times linked to a pancreatic fi stula, and is preceded by a 
SB in a quarter of cases. There is no signifi cant difference 
between IS and RI in terms of results when treating a LHC, 
but performing a IS leads to an additional pancreatectomy in 
more than half the cases.
168
LAPAROSCOPIC DISTAL 
PANCREATECTOMY FOR 
BENIGN CONDITIONS
A. Slepavicius
Klaipeda University Hospital, Lithuania
Klaipeda University Hospital, Abdominal and Endocrine, 
Liepojos 4192288, Klaipeda, Lithuania
Introduction: Advanced laparoscopic techniques have been 
adapted to various surgical pathologies, including pancreatic 
tumors, with potential benefi ts of attenuated surgical trauma, 
faster recovery, and improved cosmesis. Laparoscopic pan-
creatic surgery is technically demanding, and thus has not 
yet gained widespred acceptance. The aim of this study was 
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to review our preliminary experience with laparoscopic 
distal pancreatectomy for benign pancreatic pathology.
Methods: Since 2006, 15 patients have undergone laparo-
scopic distal pancreatectomy for benign pathology at our 
institution. The indication for surgery were solid tumors 
(n-10), cystic lesions (n-3), and chronic pancreatitis (n-2). 
The lesions varied in size from 1.8 cm. to 9.7 cm and were 
located in the body and tail of pancreas. Laparoscopic ultra-
sonography was used to localise the lesion in the pancreas. 
The site of pancreatic transection was determined by the 
pathology in the individual case. EndoGIA stapler was used 
to transect the pancreas.
Results: Five males and ten females in the age range of 
28–82 years underwent operation. Splenic preservation was 
possible in 7 patients. The mean operating time was 208 min 
(ranged from 167 min to 460 min). The mean length of inci-
sion required for specimen retrieval was 4 cm. All patients 
were started on a liquid diet on the fi rst operation day. The 
median hospital stay was 6.2 days. Three patients developed 
pancreatic fi stulas that were managed conservatively.
Conclusion: Laparoscopic distal pancreatectomy is a safe 
procedure, with minimal morbidity, rapid recovery, and short 
hospital stay. In appropriate cases, splenic preservation is 
feasible.
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SURGICAL MANAGEMENT OF 
NEUROENDOCRINE PANCREATIC 
TUMORS; AN OBSERVATIONAL STUDY
R. Moldovanu1, G. Pavy2, C. Lupascu1, N. Vlad1, 
G. Dimofte1, S. Georgescu1, G. Raileanu1 and 
E. Tarcoveanu1
1First Surgical Unit; 2Hopital Arras les Bonnettes, Unite de 
Chirurgie Viscerale, Digestive et Oncologique
Hopital Arras les Bonnettes, Unite de Chirurgie Viscerale, 
Digestive et Oncologique, 2 rue Dr. Forgeois, BP 
2099062012, Arras, France
Introduction: Neuroendocrine Pancreatic Tumors (NEPT) 
are rare neoplasms with an estimated incidence of 3–10 to 
1 000 000 inhabitants. Due to heterogeneous clinical, biologi-
cal and imagery data their management is usually diffi cult.
Methods: We performed a retrospective study, evaluating 
the NEPTs management. Clinical, biological, imagery, oper-
ative and postoperative data are reviewed. The pathological 
fi ndings were presented according to the 2010 WHO clas-
sifi cation system. We enrolled 23 patients diagnosed with 
NEPT.
Results: The women/men ratio was 16/7 with a mean age 
of 49.79 ± 3.39 years old (range: 27–71). The tumors were 
secreting in 56.5%: insulinomas (43.5%), gastrinomas 
(8.7%) and ACTH-oma (4.3%). In three patients (13%) 
NEPTs were associated with others endocrine tumors (MEN 
type I). The 56.5% of the tumors were located into pancreatic 
body/tail and the others 43.5% into the pancreatic head/
isthmus. The mean tumor diameter was 33.05 ± 4.38 mm 
(range 6–90). Different surgical procedures have been per-
formed: tumor resection 26.1%; left pancreatectomies 
39.1%; pancreaticoduodenectomies 17.4%; Beger operation 
4.3%; total pancreatectomy 4.3%; biopsies 8.7%. Histological 
classifi cation: 39.1% NET G1, 13% NET G2 and 47.8% 
NEC G3.
Conclusion: NEPTs are rare tumors, and their management 
is always challenging. To establish the diagnosis, it is neces-
sary to recognize the clinical signs of the secreting tumors 
and to carefully explore the patients. The choice of surgical 
procedure depends of the tumor site and staging.
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LONG TERM RESULTS AND 
QUALITY OF LIFE AFTER 
PANCREATICODUODENECTOMY
R. Moldovanu1, G. Dimofte1, N. Vlad1, D. Ferariu2 and 
E. Tarcoveanu1
1First Surgical Unit; 2Pathology Department
Hopital Arras les Bonnettes, Unite de Chirurgie Viscerale, 
Digestive et Oncologique, 2 rue Dr. Forgeois, BP 
2099062012, Arras, France
Introduction: The short term results after pancreaticoduo-
denectomy (PD) were well known, but the long term results 
and especially the quality of life after PD were less studied. 
Apparently the pylorus preserving PD allow better results.
Methods: We enrolled 17 patients in whom a PD has been 
performed. We designed two groups: group A, patients with 
Whipple PD (WPD), 58.8% (N = 10) and respectively group 
B, patients with pylorus preserving PD (PPPD), 41.2% (N = 
7). An investigation protocol was established. The quality of 
life was studied using FACT-Hep questionnaire. The clinical, 
biological and imagery data were included into a MS Access 
data base and statistically analyzed.
Results: Men/women ratio was 11/6, with a mean age of 
56.29 ± 2.43 years old (range 40–74). No differences con-
cerning demographic data were reported between the groups. 
The BMI was also similar: 21.79 ± 1 vs 21.94 ± 0.96 kg/m2 
(p = 0.92). Diarrhea associated with steatorrhea was a higher 
incidence in group A (30% vs 14% in group B) but without 
statistical signifi cance (p = 0.58). A higher level of total 
serum proteins was noticed in group B: 77.17 ± 1.62 vs 68.62 
± 3.04 g/L (p = 0.04). The gastro esophageal refl ux had a 
similar incidence in the two groups: 60% in group A vs 
57.14% in group B (p = 0.56). The biliary-gastric refl ux was 
noted in 92.3% from the patients with equal distribution 
between the two groups. The FACT scores were also similar 
between the groups.
Conclusion: There is no difference between PPPD and 
WPD from point of view of long term results and the quality 
of life. However a better nutritional status is apparently asso-
ciated with PPPD.
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A SINGLE INSTITUTION EXPERIENCE 
WITH CENTRAL PANCREATECTOMY 
AND ROUX-EN-Y 
PANCREATICOJEJUNOSTOMY
P. Roberts1, R. Hart2 and P. Szasz2
1University of the West Indies, Mona, Jamaica; 2University 
of Toronto, Toronto, Canada
University Hospital of the West Indies, Department of 
Surgery, Mona, St. Andrew, Jamaica, Kgn 7, Kingston, 
Jamaica
Introduction: The incidence of non-cancerous pancreatic 
lesions has been increasing. Central pancreatectomy allows 
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the resection of benign and low grade malignant tumor of 
the pancreatic neck and proximal pancreatic body with the 
preservation of pancreatic parenchyma and pancreatic 
function.
Methods: Between January 2004 and September 2011, nine 
central pancreatectomies were performed with Roux-en-Y 
pancreaticojejunostomy. There were eight women and one 
man with a mean age of 58.2 years. Three resections were 
performed for mucinous cystadenoma, two were performed 
for pancreatic endocrine tumors, and one each performed for 
intraductal papillary mucinous neoplasm, metastatic renal 
cell carcinoma, solid pseudopapillary neoplasm, and serous 
cystadenoma. Pancreatic endocrine function was assessed by 
glucose level.
Results: The median operative time was 4.1 hrs. The mean 
blood loss was 417 mls. The mean postoperative hospital 
stay was 8.5 days. All resection margins were negative. 
Postoperative complications occurred in 55% of patients; 
however there was no pancreatic leak. One patient developed 
an abscess requiring drainage by interventional radiology. 
One patient died in the perioperative period at 14 days from 
a ruptured splenic artery pseudoaneurysm. With a mean 
follow up of 36.9 months, eight patients are alive without 
any evidence of exocrine or endocrine pancreatic insuffi -
ciency. There was no clinical or radiological evidence of 
disease recurrence.
Conclusion: Central pancreatectomy with Roux-en-Y pan-
creaticojejunostomy in selected patients is a viable surgical 
option for patients with benign or low grade malignant 
tumors of the pancreas in high-volume centers. Long-term 
function exocrine and endocrine function of the pancreas 
may be preserved.
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THE INFLUENCE OF THE DRAIN 
INFECTION AROUND THE 
PANCREATICOJEJUNOSTOMY UPON 
THE SEVERITY OF POST OPERATIVE 
PANCREATIC FISTULA
K. Watanabe, M. Taniguchi, T. Einama, K. Imai, 
H. Karasaki and H. Furukawa
Asahikawa Medical University
Asahikawa Medical University, Surgery, 2-1 Midorigaoka 
Higashi, 78, Asahikawa, Japan
Introduction: Postoperative pancreatic fi stula (POPF) is a 
most striking complication after pancreaticoduodenectomy 
(PD). The objective of this study is to reveal the infl uence of 
the drain infection around the pancreaticojejunostomy (PJ) 
upon the severity of POPF.
Methods: PD was performed for 76 patients between 01/06 
and 04/11, and the bacteriological examination of the drain-
age fl uid around the PJ was achieved on day 3, 5, 7.
Results: POPF was found in 48 (63.1%) patients; grade A 
group (GrA) by international defi nition in 27 (35.5%), grade 
B and C group (GrBC) in 21 (27.6%). The number of the 
infection by intestinal bacterium on day 3 in GrBC; 9/21 
(42.9%) was signifi cantly higher than in non pancreatic 
fi stula group (no PF); 2/28 (7.1%) and in GrA; 2/27 (7.4%): 
(P < 0.01). The number of the infection by non-intestinal 
bacterium in no PF and GrA were increased from day 3; 0/28 
(0%), 5/27 (19%) to day 7; 10/21 (48%), 7/21 (33%), respec-
tively, however, in GrBC remained unchanged from day 3; 
1/12 (5%) to day 7; 0/18 (0%), (P < 0.01).
Conclusion: Endogenous infection around the PJ on day 3 
was a risk factor for grade B or C POPF after pancreatico-
duodenectomy. However retrograde infection was not sig-
nifi cantly associated with grade B or C POPF. Early 
prophylaxis against endogenous infection around the PJ 
might be advantageous for the reduction of severe POPF.
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HOW DO WE PREDICT THE 
CLINICALLY RELEVANT 
PANCREATIC FISTULA AFTER 
PANCREATICODUODENECTOMY? 
– AN ANALYSIS IN 244 
CONSECUTIVE PATIENTS
M. Miyazawa, M. Tani, M. Kawai, S. Hirono, K. Okada 
and H. Yamaue
Wakayama Medical University, School of Medicine, Second 
Department of Surgery
Wakayama Medical University, School of Medicine, Second 
Department of Surgery, 811-1 Kimiidera, Wakayama, 641, 
Wakayama, Japan
Introduction: The most important problem in pancreatic 
fi stula is whether one can distinguish clinical pancreatic 
fi stula, grade B+C fi stula by the International Study Group 
on Pancreatic Fistula (ISGPF) and transient pancreatic fi stula 
(grade A) in the early period after pancreaticoduodenectomy 
(PD). It remains still unclear what predictive risk factors can 
precisely predict which clinical relevant or transient pancre-
atic fi stula when diagnosed pancreatic fi stula on POD3 by 
ISGPF criteria.
Methods: We analyzed the predictive factors of clinical 
pancreatic fi stula by logistic regression analysis in 244 con-
secutive patients who underwent PD. Pancreatic fi stula was 
classifi ed into three categories by ISGPF.
Results: The rate of pancreatic fi stula was 69 of 244 con-
secutive patients (28%) who underwent PD. Of these, 47 of 
244 patients (19%) had grade A by ISGPF criteria, 17 patients 
(7.0%) had grade B, and 5 patients (2.0%) had grade C. The 
independent risk factor of incidence of pancreatic fi stula is 
soft pancreatic parenchyma. However, soft pancreatic paren-
chyma did not predict underlying clinical relevant pancreatic 
fi stula. The independent predictive factors of clinical rele-
vant pancreatic fi stula were serum albumin level ≤3.0 g/dL 
on POD 4 and leukocyte counts >9.800/mm3 on POD 4. 
Positive predictive value of the combination of two predic-
tive factors for clinical relevant pancreatic fi stula was 88%.
Conclusion: The combination of two factors on POD 4, 
serum albumin level ≤3.0 g/dL and leukocyte counts >9.800/
mm3, is predictive of clinical relevant pancreatic fi stula when 
diagnosed pancreatic fi stula on POD 3 by ISGPF criteria.
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TRAUMATIC PANCREATIC 
TRANSECTION: DO WE ALWAYS HAVE 
TO RESECT: AN EXPERIENCE
M. Khare, T. Naik, M. Dewangan, S. Tiwari and G. Kohli
Jawahar Lal Nehru Hospital & Research Centre, Bhilai, 
India
J.L.N Hospital & Research Centre, Bhilai, India; General 
Surgery, House 40/247, Near Sahu Sadan, Kelabadi Durg, 
C.G, India
Introduction: In this era of high speed vehicular accidents, 
incidence of pancreatic trauma has risen. Commonly present-
ing as pancreatic duodenal complex injuries whereas isolated 
pancreatic trauma is less common. Incidence has been esti-
mated to be between 1% to 2%. Management comprises 
simple drainage to more resectional procedures. Presently 
organ/parenchymal preservation is stressed upon. This is not 
a designed study; we wish to share our experience with 
management of pancreatic transection with good results.
Methods: 3 patients were admitted in fall of 2010 with 
pancreatic injuries. 1st case had duodeno-pancreatic injuries, 
for which primary repair of duodenum was done over a 
controlled fi stula and pancreas was repaired as after median 
Pancreatictomy with duct to mucosa anastamosis over 16G 
cannula as stent. 2nd & 3rd cases had isolated pancreatic 
transection in the line of SMV for which an end to end ductal 
anastomosis was done over a 18 G and 16 G Epidural cath-
eter which was used to stent the pancreatic duct. The paren-
chyma was repaired over the anastomosis
Results: 1st Case: Feeding started by feeding jejunostomy 
on the 3rd post-operative day and graduated to oral feeds by 
6th post-operative day. Discharged on 14th post-operative 
day with blocked controlled fi stula. This fi stula T tube was 
removed on the 28th day after contrast study.
2nd Case: Uneventful post-op course. Discharged on 9th 
post-operative day. CECT abdomen after 12 weeks showed 
a healed pancreatic parenchyma with ductal continuity.
3rd Case: Uneventful post-op. Discharged on 10th post-op 
day. MRI after 8 weeks showed parenchyma and ductal con-
tinuity with no demonstrable stricture
Conclusion: All injuries were grade 5. We salvaged viable 
pancreatic parenchyma. Early intervention in stable patient 
could make vital difference. All patients belonged to young 
age group. All patients have a F/U of 18 months, with no 
exo/endo defi ciency.
Why we did it:
1. Early Intervention, Young Patients, No other organ injury 
(in two cases)
2. Clean transection of parenchyma without any crushing 
with good vascularity (parenchymal preservation)
3. With patience Undilated duct could be identifi ed and 
cannulated.
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DETERMINATION OF PANCREATIC 
CANCER EXTENT USING CT AND MRI: 
IMPLICATIONS FOR NEOADJUVANT 
TREATMENT PLANNING
O. Zakharova, V. Egorov and G. Karmazanovsky
Vishnevsky Institute of Surgery, Radiology, B. 
Serpukhovskaya Street, Moscow, Russia
Introduction: A complete R0 resection is dependent on 
accurate preoperative imaging of tumor and its relationship 
to vital structures. Preoperative staging is generally achieved 
by MDCT or MRI. There is no consensus on the single best 
diagnostic modality. The inverse relationship of tumor size 
and prognosis has been noted in many studies; 80–85% of 
patients are treated palliatively or neoadjuvantly. High rate 
of pathologic duodenal invasion – risk of duodenal under-
coverage with highly conformal radiotherapy.
Methods: To analyze the accuracy of CT and MRI in detect-
ing pancreatic cancer and determining its extent, we per-
formed a retrospective analysis of CT and MRI scans and 
pathohistological reports of 174 cases of pancreatic ductal 
adenocarcinoma’s after pancreatoduodenectomies (2006–
2011). We compared tumor size measurements of pancreatic 
cancer evaluated on CT and MRI with those in the pathologi-
cal reports.
Results: In a series of 174 patients with a suspected pancre-
atic tumor, our study demonstrated sensitivity, specifi city, 
and accuracy of contrast enhanced MDCT of 86%, 75%, and 
83.3%, respectively. With a PPV of 96% and NPV of 100%. 
The sensitivity, specifi city, and accuracy in tumor detection 
by MRI reaches approximately 75%, 50%, and 74.3%, 
respectively. With a PPV of 98.1% and NPV of 94.4%. In 
124 patients (71.3%) tumor size reported by pathologist sur-
passed one claimed by CT and MRI studies (p < 0.001).
Conclusion: The values of sensitivity, specifi city and accu-
racy in PC detection, speak in favor of MDCT as the single 
best diagnostic modality. The goal is to improve selection of 
patients who may benefi t from tumor resection and those 
who might fi rst need neoadjuvant radiotherapy, so that 
unnecessary laparotomies can be avoided. Surgeons and 
oncologists need to keep in mind that MDCT and MRI have 
a tendency to underestimate the size of PC. This has impor-
tant implications for neoadjuvant treatment planning.
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PANCREATIC CANCER
S. Takahashi, M. Konishi, T. Kinoshita, N. Gotohda, 
Y. Kato and T. Kinoshita
Department of Hepato-Biliary Pancreatic Surgery, 
National Cancer Center Hospital East, Kashiwanoha 
6-5-1, Kashiwa, Chiba, Japan
Introduction: Invasion to celiac axis (CA) or common 
hepatic artery (CHA) usually means locally advanced disease 
beyond surgical indication in pancreatic cancer. On the other 
hand, distal pancreatectomy with celiac axis resection (DP-
CAR) is a treatment option for pancreatic body cancer with 
CA or/and CHA invasion. Purpose of this study was to evalu-
ate early and late results after DP-CAR.
Methods: A total of 10 patients who underwent DP-CAR 
between 1994 and 2010 for pancreatic cancer were examined 
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retrospectively. Clinicopathological fi ndings, surgical results, 
and prognosis were evaluated.
Results: Operation time and intraoperative blood loss was 
350 min and 2452 ml. Reconstruction of CHA was per-
formed in the former 3 pts whose pulsation was faint after 
clamping CA. Portal vein resection was carried out in 4 pts. 
There was no treatment-related death, but 8 (80%) pts devel-
oped complications. Six pts experienced pancreatic fi stula, 
and 2 pts suffered delayed gastric emptying. Arterial inva-
sion was shown in only 3 pts, however, frequent neural 
plexus invasion was observed (6 pts) pathologically. R0 was 
achieved in 80%. Median survival and disease-free survival 
were 14 and 7 months. Two pts survived more than 2 years 
after resection. Recurrence involved liver in 7 pts, locore-
gional site in 5, peritoneum in 3, and others in 2.
Conclusion: Considering relatively poor prognosis and fre-
quent occurrence of postoperative complications, pancreatic 
cancer patients who would receive DP-CAR may be candi-
dates for neoadjuvant therapy.
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HIGH PLATELET COUNT IS A 
SENSITIVE INDICATOR OF ABDOMINAL 
FLUID COLLECTION IN EARLY 
POSTOPERATIVE PERIOD AFTER 
PANCREATODUODENECTOMY
A. Kobayashi, T. Oda, A. Takahashi, S. Hashimoto, 
K. Fukunaga, R. Sasaki and N. Ohkohchi
Department of Surgery, University of Tsukuba
1-1-1 Tennodai, 305, Tsukuba, Japan
Introduction: Postoperative complication rate after pancre-
atoduodenectomy (PD) ranges from 30% to 60%, and 
decreasing this rate remains a signifi cant challenge in pan-
creatic surgery. Postoperative pancreatic fi stula, incidence of 
which ranges from 2% to more than 30%, represents the most 
common major complication after PD. The goal of this study 
is to review the correlation between undrained abdominal 
fl uid collection after PD due to pancreatic fi stula and clinical 
factors.
Methods: One hundred and twenty-two patients who had 
undergone PD between 2005 and 2010 at University of 
Tsukuba were selected from the database for analysis. 
Correlation between clinical factors (white blood cell count, 
C-reactive protein, platelet count and body temperature 
higher than 38 degrees C) and undrained abdominal fl uid 
collection due to postoperative pancreatic fi stula were 
analyzed.
Results: Postoperative pancreatic fi stula, according to the 
ISGPF defi nition, was occurred in 41 patients. Of these, 
patients, 31 were performed ultrasonography, computed 
tomographic scan, or drain radiographic contrast study. 
Twenty-one patients out of these 31 patients revealed und-
rained abdominal fl uid collection around the pancreato-jeju-
nostomy, and minimal invasive drainage was performed. The 
sensitivity/specifi city of abnormal level of white blood cell 
count, C-reactive protein, platelet count, and body tempera-
ture higher than 38 degrees C detecting undrained abdominal 
fl uid collection were 70%/42.8%, 70%/36.4%, 89.4%/66.6%, 
and 0%/30%, respectively. Only the platelet count was sta-
tistically correlated to the undraind fl uid.
Conclusion: High platelet count is the sensitive predictor of 
undrained abdominal fl uid collection after PD.
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IMPROVEMENT IN 
PANCREATICODUODENECTOMY (PD) 
OUTCOMES AT BARTS AND THE 
LONDON: AN 11 YEAR REVIEW
R. Lahiri, S. Mukherjee, H. Kocher, A. Abraham, 
R. Hutchins and S. Bhattacharya
Barts and the London HPB Centre, Royal London 
Hospital, Whitechapel Road, London E1 1BB
Barts and the London HPB Centre, Digestive Diseases, 
The Blizard Institute of Cell and Molecular Science, Barts 
and The London School of Medicine and Dentistry, 4 
Newark Street, London E1 2A, UK
Introduction: Pancreaticoduodenectomy (PD) is a complex, 
major operation with a signifi cant risk of morbidity and mor-
tality. Cancer Outcome Guidelines (COG) was implemented 
in the UK in 2003, which led to the centralisation of pancre-
atic and upper GI cancer services at designated tertiary units. 
As a tertiary pancreatic centre in the UK, we reviewed 311 
PDs performed at Barts and the London HPB Centre over a 
ten year period to assess the effect of implementation of 
COG.
Methods: Patients requiring PD at Barts and the London 
from July 1999 to June 2011 were identifi ed from a prospec-
tively maintained departmental database. Clinical and patho-
logical data were retrieved from electronic records and 
patients’ case notes. The annual caseload for PD and corre-
sponding outcomes for length of hospital stay, morbidity and 
mortality were analysed. Three distinct groups were anal-
ysed: Pre-COG (1999–2002, n = 41), early post-COG (2003–
2007, n = 138) and late post-COG (2008–2011, n = 132). 
Peri-operative mortality was defi ned as death within 30 days 
of the procedure. In-hospital mortality was defi ned as death 
before discharge from hospital and after 30 days following 
the procedure.
Results: 311 patients (male to female ratio: 1.09:1; median 
age was 65 (range 25–86) underwent PD between 1999 and 
2011. The median hospital stay was 15 days (range 7–316). 
The majority of resections were for pancreatic ductal adeno-
carcinoma (41%). The peri-operative mortality was 3.5% and 
overall in-hospital mortality was 5.2%. Overall morbidity 
was 40.5%. Pancreatic anastomotic leak rate was 8.9%, 
although over 70% of these were grade A fi stulae managed 
conservatively. Over the 11 year period there was a fi vefold 
increase in the volume of PDs per year from 12 cases in 2000 
to over 50 cases in 2011. There was a trend in reduction of 
in-hospital mortality over time; pre-COG group 9.7%, early 
post-COG group 5.1%, late post-COG group 3.0% (p = 
0.55).
Conclusion: Our results demonstrate that centralisation led 
to increasing PD volume at Barts and the London, which in 
turn, led to improved overall mortality rates. Although length 
of hospital stay remained relatively unchanged over the study 
period, this may be due to an increasing age of patients 
undergoing PD (median age 62 in pre-COG group versus 65 
in late post-COG group). As evidence of on-going improve-
ment, in the last 100 consecutive cases performed in the unit, 
the overall mortality was 1%.
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RECURRENCE AND ADJUVANT 
CHEMOTHERAPY AFTER RESECTION 
FOR INVASIVE DUCTAL CARCINOMA 
OF PANCREAS TREATED 
WITH NEO-ADJUVANT 
CHEMO-RADIATION THERAPY
S. Kobayashi, G. Honda, M. Kurata, Y. Okuda and 
K. Tsuruta
Cancer and Infectious Disease Center Tokyo Metropolitan 
Komagome Hospital, Tokyo, Japan
Cancer and Infectious Disease Center Tokyo Metropolitan 
Komagome Hospital, Hepato-Biliary-Pancreatic Surgery, 
3-18-22 Honkomagome, Bunkyo-ku, Tokyo, Japan
Introduction: Neo-adjuvant chemo-radiation (nCRT) 
therapy has been increasingly applied for treatment of inva-
sive ductal carcinoma of pancreas (IDC).
Methods: Since 2008, nCRT has been applied to IDC at the 
Cancer and Infectious Disease Center Tokyo Metropolitan 
Komagome Hospital, Tokyo, Japan. Mode of recurrence and 
adjuvant chemotherapy were retrospectively analyzed in 
patients who underwent R0 or R1 resection for IDC after 
nCRT.
Results: From July 2008 to August 2011, 16 patients under-
went R0 or R1 resection for IDC after nCRT. There were two 
males and 14 female cases, and the mean age was 69 years. 
Protocols for nCRT included weekly gemcitabine and daily 
S-1 with concurrent extra-body radiation therapy 50.4 Gy 
(GS-RT) (n = 11) and daily S-1 with concurrent extra-body 
radiation therapy 50.4 Gy (S-RT) (n = 5). Clinical stages 
before nCRT were as follows; UICC stage IIA (n = 9), stage 
IIB (n = 1), and stage III (n = 6). Resection included pancre-
aticoduodenectomy (PD) (n = 12) and distal pancreatectomy 
(DP) (n = 4). Recurrences were indentifi ed in seven cases as 
follows; liver (n = 6), peritoneum (n = 4), lymph node (n = 
2), remnant pancreas (n = 2), lung (n = 1), and local neural 
plexus (n = 1). Median follow-up time was 21 months, and 
median disease-free and overall survivals were 13 and 27 
months, respectively. Time to start adjuvant chemotherapy 
with gemcitabine was shorter with S-RT than GS-RT (45 
days vs 84 days, p = 0.38), while adjuvant chemotherapy 
could not be started in three cases with GS-RT. Mean cycles 
of adjuvant gemcitabine within six months after surgery were 
9.5 with S-RT and 5.0 with GS-RT (p = 0.38). No signifi cant 
difference was identifi ed between cases with PD and DP 
(time to start adjuvant chemotherapy: 68 days vs 78 days, 
p = 0.90) (mean cycles of adjuvant gemcitabine; 7.3 vs 9.0, 
p = 0.78).
Conclusion: Since all recurrent cases developed distant 
organ metastases, it was clearly demonstrated that adjuvant 
chemotherapy was an essential part of treatment strategy 
with nCRT against IDC. Adjuvant gemcitabine could be 
administered earlier and more continuously in cases with 
S-RT than those with GS-RT, therefore S-RT was considered 
as more feasible than GS-RT as an nCRT protocol. Further 
discussion is necessary in regard to optimal nCRT 
protocol.
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PYLORUS-RESECTING 
PANCREATICODUODENECTOMY (PRPD) 
VS. PPPD&#65293; THE PROSPECTIVE 
RANDOMIZED CONTROLLED TRIAL IN 
WAKAYAMA MEDICAL UNIVERSITY
H. Yamaue, M. Kawai, M. Tani, S. Hirono, K.-ichi Okada, 
M. Miyazawa, Y. Kitahata and M. Ueno
Second Department of Surgery, Wakayama Medical 
University
Wakayama Medical University, Second Department of 
Surgery, 811-1 Kimiidera, 64185, Wakayama, Japan
Introduction: Delayed gastric emptying (DGE) after pylo-
rus-preserving pancreatoduodenectomy (PpPD) may be 
attributed to denervation and devascularization of the pylorus 
ring. One should consider to develop the new surgical pro-
cedure with resection of only pylorus ring with preservation 
of nearly total stomach in PD; pylorus-resecting pancreato-
duodenectomy (PrPD). We conducted this prospective ran-
domized controlled trial (RCT) to confi rm the hypothesis that 
PrPD reduces the incidence of DGE compared to PpPD.
Methods: Between October 2005 and March 2009 at 
Wakayama Medical University Hospital (WMUH), 130 
patients with pancreatic or periampullary lesions were ran-
domized to 64 PpPD and to 66 PrPD. This RCT was regis-
tered at Clinical Trials Gov NCT00639314. Primary endpoint 
is the incidence of DGE. DGE was defi ned by the interna-
tional study group of pancreatic surgery (ISGPS). Quality of 
life (QOL) by Functional Assessment of Cancer Therapy-
Gastric (FACT-Ga) questionnaire, the 13C-acetate breath 
tests, and nutritional status at 1, 3, and 6 months after surgery 
were performed to compare gastric emptying between PpPD 
and PrPD.
Results: The overall incidence of DGE was signifi cantly 
lower in PrPD (4.5%) than PpPD (17.2%) (P = 0.0244). The 
proposed clinical grading classifi ed 11 cases of DGE in 
PpPD into grades A (n = 6), B (n = 5), and C (n = 0), and 
one case in PrPD into each of the three grades. Tmax (the 
time of peak 13CO2 content in 13C-acetate breath test) at 
1.3, and 6 months after surgery in PpPD was signifi cantly 
delayed than PrPD (34.3 ± 24.6 min vs. 18.7 ± 11.8 min, 
26.5 ± 21.1 min vs. 17.3 ± 11.7 min, 26.7 ± 18.8 min vs. 
17.4 ± 13.2 min, respectively). PrPD had comparable out-
comes compared to PpPD in the assessment at 1, 3, and 6 
months after surgery concerning to QOL, postoperative body 
weight loss, nutritional status.
Conclusion: This study clarifi ed that PrPD can lead to a 
signifi cant reduction in the incidence of DGE compared with 
PpPD. The patients enrolled in this study will follow care-
fully in terms of nutritional status and QOL for 2 year post-
operatively, and evaluated the better procedure.
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EMERGENT 
PANCREATICODUODENECTOMY: 
A DUAL INSTITUTION EXPERIENCE
Z. Dambrauskas2, A. Pupine2, E. L. Rosato2, 
E. P. Kennedy1, J. Pundzius2, G. Barauskas2, C. J. Yeo1 
and H. Lavu1
1Department of Surgery, Thomas Jefferson University 
Hospital, Philadelphia, PA; 2Department of Surgery, 
Medical Academy, Lithuanian University of Health 
Sciences, Kaunas, Lithuania
Lithuanian University of Health Sciences, Kaunas, 
Lithuania; Department of Surgery, Eiveniu Str. 250009, 
Kaunas, Lietuva
Introduction: Emergent pancreaticoduodenectomy (PD) is 
an uncommon surgical procedure used to treat patients with 
acute pancreaticoduodenal trauma, bleeding, or perforation. 
This study presents the experience of two university hospi-
tals on emergent PD.
Methods: Clinical data on emergent PD in trauma and non-
trauma patients from 2002–2009 were extracted from the 
HPB surgery databases at Thomas Jefferson University 
(TJUH) and Kaunas Medical University Hospitals (KMUH). 
Data on indications, operative variables, clinical course, 
morbidity and mortality rates were evaluated.
Results: Ten single stage emergent PD patients were identi-
fi ed (5 – classic Whipple resections, 5 – PPPDs). Six patients 
had traumatic indications for PD (2 – multiple gunshot 
wounds, 4 – blunt high energy injuries: 2 falling from height, 
2 direct assaults on the abdomen). Four cases of non-trauma 
patients had PD surgery for massive GI hemorrhage. The 
median age of the emergent PD cohort was 49 years, while 
the trauma subgroup had a signifi cantly lower median age of 
30 years (p value = 0.3214). The median operating time and 
estimated blood loss (EBL) was 6 hours and 1750 ml, 
respectively. All ten patients recovered and were discharged 
with a median ICU stay of 3 days, and a median postopera-
tive hospital length of stay of 25 days.
Conclusion: No signifi cant differences in postoperative out-
comes between groups or institutions were found. Despite a 
high morbidity rate, emergent PD can serve as a life saving 
procedure, in both the trauma and non-trauma settings, 
however, this procedure preferably has to be performed in a 
center with a suffi cient patiens volume, experience and high 
level of postoperative care.
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HOW BIG OF AN OBSTACLE IS FAT? 
THE FIRST QUANTITATIVE, VALIDATED 
FAT ANALYSIS IN WHIPPLE PATIENTS
K. Simo, D. Sindram, J. Martinie and D. Iannitti
Section of Hepatobiliary and Pancreatic Surgery, 
Department of Surgery, Carolinas Medical Center, 
Charlotte, NC, USA
Carolinas Medical Center, Section of Hepatobiliary and 
Pancreas Surgery, Department of Surgery, 1025 Morehead 
Medical Drive, Suite 30028204, Charlotte, USA
Introduction: The infl uence of abdominal fat distribution 
on estimated blood loss (EBL) and operative time (OT) 
remains unclear. In specifi c regard to the Whipple procedure 
(pancreaticoduodenectomy), multiple attempts to defi ne 
cut-off values and ratios of abdominal fat distribution mea-
surements have fallen short in the establishment of a standard 
method to defi ne this relationship. In this study, evaluation 
and validation of multiple quantitative obesity measurements 
on computed tomography (CT) imaging and determination 
of impact on EBL, OT, and complications in patients under-
going a Whipple procedure was undertaken.
Methods: Retrospective analysis of all patients who under-
went a Whipple at a single institution from 10/2006 to 
4/2011. CT imaging measurements were performed using 
OsiriX® Imaging Software (Pixmeo, Geneva, Switzerland) 
and included total fat area (TFA), visceral fat area (VFA), 
retrorenal fat thickness (RRF), anterior abdominal wall fat 
thickness (AAWF), and hip girdle fat thickness (HGF). 
Principal component analysis (PCA) and principal compo-
nent regression (PCR) were employed to analyze measure-
ments and body mass index (BMI). As a representative 
example of these linear combinations of obesity measure-
ments, principal component (PC) #4 (value) = −0.181(BMI) 
+ 0.045(VFA) + 0.089(RRF) + −0.511 (AAWF) + 0.811(HGF) 
+ −0.193(TFA).
Results: Of 194 patients who underwent a Whipple and had 
a CT available for review mean BMI = 26.34 kg/m2 (16–48; 
43 pts >30). CT measurements mean values: TFA = 
656.61 cm2, VFA = 272.22 cm2, RRF = 1.37 cm, AAWF = 
2.62 cm, HGF = 5.42 cm. Mean EBL = 789 cc and OT = 295 
minutes. Due to incomplete CT data 126 patients (79% car-
cinoma) were used for PCA and PCR. In order to ensure 
values were not skewed secondary to carcinoma in this popu-
lation, they were compared to those of 30 randomly selected 
trauma patients with no statistical differences found. 
Univariate analysis revealed a signifi cant association between 
EBL and AAWF (p = 0.0209) and TFA (p = 0.028) via simple 
linear regression. BMI (p = 0.0092), VFA (p = 0.0017), 
AAWF (p = 0.0124), and TFA (p = 0.0003) were signifi cantly 
associated with OT. Due to the high correlation of these 
variables, PCA yielded 2 principal components with rela-
tively good distribution of variance that explained 81% of 
the overall variance (OV). PCR revealed PC4 (5% OV) had 
a signifi cant association with EBL (p = 0.0011) and PC1 and 
PC4 had a signifi cant association with OT (p = 0.0014 and 
p = 0.0312, respectively). Analysis of 51 patients with 
Clavien grade complications yielded insignifi cant results.
Conclusion: For the fi rst time a model is established and 
validated in patients undergoing a Whipple procedure to 
evaluate CT obesity measurements. Further, this model dem-
onstrates a signifi cant association between EBL and OT, but 
not complications in relation to BMI and quantitative CT 
obesity measurements.
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HOW BIG OF AN OBSTACLE IS FAT? 
THE FIRST QUANTITATIVE, VALIDATED 
FAT ANALYSIS IN WHIPPLE PATIENTS
K. Simo1, R. Swan1, A. Walters2, E. Hanna1, J. Martinie1, 
D. Iannitti1 and D. Sindram1
1Section of Hepatobiliary and Pancreas Surgery, 
Department of General Surgery, Carolinas Medical Center, 
Charlotte, NC, USA; 2Division of Gastrointestinal and 
Minimally Invasive Surgery, Department of General 
Surgery, Carolinas Medical Center, Charlotte, NC, USA
Carolinas Medical Center, Section of Hepatobiliary and 
Pancreas Surgery, Department of General Surgery, 1025 
Morehead Medical Drive, Suite 300, 28204, Charlotte, 
USA
Introduction: Infl uence of abdominal fat distribution on 
estimated blood loss (EBL) and operative time (OT) remains 
unclear. In regard to the Whipple procedure (pancreaticoduo-
denectomy), multiple attempts to defi ne abdominal fat mea-
surement cut-off values/ratios have fallen short and no 
standard method exists to defi ne this relationship. Evaluation 
and validation of quantitative obesity measurements on CT 
imaging and determination of impact on EBL, OT, and com-
plications in Whipple patients (pts) was undertaken.
Methods: Retrospective analysis of all pts who underwent 
a Whipple at a single institution from 10/2006 to 4/2011. CT 
imaging measurements were performed using OsiriX® 
Imaging Software (Pixmeo, Geneva, Switzerland) and 
included total fat area (TFA), visceral fat area (VFA), retro-
renal fat thickness (RRF), anterior abdominal wall fat thick-
ness (AAWF), and hip girdle fat thickness (HGF). Principal 
component analysis (PCA) and principal component regres-
sion (PCR) were employed to analyze measurements and 
body mass index (BMI) due to the high correlation of these 
variables. As a representative example of these linear com-
binations of obesity measurements, principal component 
(PC) #4 (value) = −0.181(BMI) + 0.045(VFA) + 0.089(RRF) 
+ −0.511(AAWF) + 0.811(HGF) + −0.193(TFA).
Results: 194 pts underwent Whipple with CT for review: 
mean BMI = 26.34 kg/m2 (16–48; 43 pts >30), EBL = 789 cc 
and OT = 295 min. CT mean values: TFA = 656.61 cm2, VFA 
= 272.22 cm2, RRF = 1.37 cm, AAWF = 2.62 cm, HGF = 
5.42 cm. Due to incomplete CT data 126 pts (79% carci-
noma) used for PCA/PCR. To ensure values were not skewed 
due to carcinoma, comparison with 30 trauma pts performed 
and no differences found. Univariate analysis: association 
between EBL and AAWF (p = 0.02) and TFA (p = 0.03). 
BMI (p = 0.009), VFA (p = 0.002), AAWF (p = 0.01), TFA 
(p = 0.0003) were associated with OT. PCA: 2 PCs that 
explained 81% of overall variance (OV). PCR: PC4 (5% OV) 
association with EBL (p = 0.0011) and PC1 and PC4 with 
OT (p = 0.001 and p = 0.03, respectively). Complication 
analysis yielded insignifi cant results.
Conclusion: For the fi rst time a model is established and 
validated in patients undergoing a Whipple procedure to 
evaluate CT obesity measurements. Further, this model dem-
onstrates a signifi cant association between EBL and OT, but 
not complications in relation to BMI and quantitative CT 
obesity measurements.
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TOTAL PANCREATECTOMY FOR 
METASTATIC MELANOMA: IS IT 
WORTH IT?
A. M. D. Roch, K. Vychnevskaia, E. Lermite and 
J.-P. Arnaud
CHU Angers, 4 rue Larrey, 49933 Angers, France
University Hospital of Angers, Digestive Surgery, 4 rue 
Larrey, 49933, Angers, France
Introduction: Metastatic melanoma spread to solitary 
organs specifi cally to the pancreas is extremely rare (<2%) 
with less than 15 cases reported in the literature. The choice 
to resect M1c melanoma metastases is still widely debated, 
this stage being considered a terminal condition with a 
median survival up to 9 months.
Methods: We present the case of a 62-year old woman who 
developed isolated pancreatic metastases from a choroïdal 
malignant melanoma which was treated with enucleation 4 
years before. The patient underwent a total pancreatectomy 
with spleen preservation. Preoperative imaging showed no 
peritoneal seeding or other sites of metastatic disease and no 
other metastatic foci were found in the abdomen at laparot-
omy. Final histological examination of the resected specimen 
was consistent with 13 secondary melanoma deposits and 
clear excision margins.
Results: The patient remained disease-free 22 months later. 
Only complete surgical resection of limited pancreatic 
metastases seems to be associated with improved overall and 
disease-free survival. Indeed, there is currently no effective 
non-surgical treatment, response rates to chemotherapy, 
immunotherapy and radiation being low with little effect on 
survival.
Conclusion: Despite the signifi cant mortality and morbidity 
of total pancreatectomy, we advocate reconsidering this kind 
of aggressive surgery as a curative treatment option in 
selected patients for pancreatic melanoma metastases with 
disease spread over the whole gland.
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THE TREATMENT OF 
PANCREANECROSIS 
OPERATIONS COMPLICATIONS
V. Glabai, A. Arharov, A. Keshishev, B. Yunusov and 
A. Aliev
First Moscow State Medical University, Surgery, 8-2, 
Trubetskaya Street, 11999, Moscow, Russia
Introduction: During the period from 1991 until 2011, 277 
patients were operated for infected necrotising pancreatitis, 
25 for sterile pancreatitis with organ failure, 102 of them 
developed different complications in early and late periods. 
The mortality was 26.4%.
Methods: The only serious complication after the opera-
tions for necrotising pancreatitis was blood vessel erosion 
and bleeding (29 pts). Timely operations of 25 patients 
proved to be successful. Other complication during the early 
periods were: external fi stula of colon (12 pts), of duodenum 
(5 pts), and of stomach (7 pts). Only one patient with exter-
nal fi stula of colon was operated. 3 patients developed inter-
nal fi stulae, cystoduodenum (2 pts), stomach cyst fi stula 
(3 pts), pleura cyst fi stula (3 pts), colon-pancreatic fi stula 
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(2 pts), pancreatic fi stula (18 pts), jejunal fi stula (3 pts). And 
other complications such as acute cholecystitis, abscess, 
pleuritis, thrombosis were observed.
Results: During the late periods the most common compli-
cation was the pancreatic cyst – 26 patients (in 3 cases – with 
the development of pancreatic ascites). 33 patients, after 
open packing operation developed ventral hernias, and 2 
patients had external pancreatic fi stula.
In 3 cyst patients the US-puncture method was used. The 
other 23 required surgical treatment. 5 patients had distal 
resection of pancreas, 18 had different types of internal 
drainage. Internal drainage was also performed for external 
pancreatic fi stula patients. Also, 33 patients were operated 
for ventral hernias.
Conclusion: In conclusion, the early complications seldom 
occur as a result of ‘open packing’ and, we also, believe that 
the treatment of different types of infected pancreatic necro-
sis operation complications demand early diagnosis, and its 
type should be selected on a case-by-case basis.
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SURGICAL TREATMENT OF SEVERE 
ACUTE PANCREATITIS
A. Arharov, V. Glabai, A. Keshishev, B. Yunusov and 
A. Aliev
First Moscow State Medical University, Surgery, 8-2, 
Trubetskaya Street, 11999, Moscow, Russia
Introduction: During the period from 1991 to 2011, 2990 
patients with acute pancreatitis were observed. 277 of them 
were operated for severe acute pancreatitis treated in the 
course of 3–27 days from the onset of the disease. The signs 
of this complication were palpable mass in the upper 
abdomen (90%), fever (100%) and intra- and/or peripancre-
atic cavities and fl uid collections in US and CT examinations 
(100%). The diagnosis of infected or sterile pancreatitis with 
organ failure was an indication to surgery.
Methods: Were also revealed: acute necrotising pancreatitis 
without any signs of improvement, despite the intensive 
treatment (25 pts); pancreatic abscess (27 pts); acute infected 
pseudocyst (52 pts); infected pancreatic and parapancreatic 
necrosis, peritonitis (177 pts). 4 out of 77 patients with 
infected pancreatic pseudocyst and abscess died.
Results: In 177 patients with the widespread infected pan-
creatic and peripancreatic tissues necrosis ventral open 
packing was used. Abdominal cavity was opened by wide 
bilateral subcostal incision, the gastrocolicum ligament was 
cut, and right and left colonic fl exures were fallen down, and 
the posterior surface of the pancreas was mobilized. Thereby, 
removal of pus and debridement of non-fi xing devitalized 
tissues were easily achieved. The closely fi xed necroses were 
never removed because of bleeding hazard. The peripancre-
atic and retrocolic spaces were packed with wads of gauze, 
abdominal wall was closed by temporary sutures. The wads 
replacements were performed every two days, with 3 to 18 
times frequency. The mortality was 26.4%.
Conclusion: In conclusion, we believe that the ventral open 
packing appears to be the operation of choice in the treatment 
of widespread infected and peripancreatic necrosis.
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THE IMPACT OF CHRONIC 
PANCREATITIS ON PANCREATIC 
RESECTIONS: IS THERE A 
NEGATIVE CORRELATION?
J. Onesti1, P. Attawala2, D. Jain1, G. Wright1, 
A. Siripong1 and M. Chung3
1Grand Rapids Medical Education Partners, Grand 
Rapids, MI USA; 2Michigan State University College of 
Human Medicine, Grand Rapids, MI USA; 3Spectrum 
Health Medical Group, Grand Rapids, MI USA
Grand Rapids Medical Education Partners, General 
Surgery, 221 Michigan St NE, Suite 200A, Grand Rapids, 
MI, USA
Introduction: Pancreatic fi stulas following pancreatic 
resections can be a highly morbid complication. The fi rm 
texture of the pancreas in patients with chronic pancreatitis 
has been associated with fewer incidence of pancreatic fi s-
tulas and leaks, yet anecdotal dogma suggest a more chal-
lenging operation in dissecting the pancreas and diffi culty in 
estimating a negative margin resection. Despite these obser-
vations, the specifi c impact of chronic pancreatitis on an 
oncologic resection has not been studied.
Methods: We retrospectively analyzed all patients undergo-
ing partial pancreatectomies, including Whipple procedures 
or distal pancreatectomies, by a single surgeon at our institu-
tion from June 1, 2005 to July 1, 2011. Chronic pancreatitis 
was defi ned on fi nal pathology report. Pancreatic leak was 
confi rmed by laboratory testing. Data analyzed included pre-
operative risk factors, operating time, estimated blood loss 
(EBL), need for re-excision to achieve negative margins, 
fi nal negative margins, pancreatic leaks, postoperative com-
plications, duration of ileus, duration of surgical drain and 
length of stay (LOS). Paired t-test and chi square analyses 
were performed accordingly. P value less than 0.05 was 
considered signifi cant.
Results: Chronic pancreatitis (CP) was found in 84 (32.4%) 
of 259 patients. Preoperative factors were not different 
between CP patients versus those without (NL). Neither pan-
creatic leak rate (CP 4.8% v NL 6.3%, p = 0.616), nor fre-
quency of positive margin (CP 23.8% v NL 24.0%, p = 
0.973) were affected. No signifi cant differences were noted 
among intraoperative factors, including EBL (p = 0.103), 
re-excision rates (p = 0.121) or OR time (CP = NL). 
Postoperative outcomes also showed no difference in days 
until tolerating a diet (p = 0.663) or LOS (p = 0.775). Only 
gastroparesis showed a difference (CP 20% v NL 9%, p = 
0.017), likely due to a higher proportion of Whipple resec-
tions in the CP cohort.
Conclusion: Our data suggest that chronic pancreatitis does 
not necessarily protect against pancreatic leaks following 
pancreatectomies. However, chronic pancreatitis does not 
seem to increase positive margin resection rate, OR time or 
length of hospital stay. Chronic pancreatitis should not deter 
the surgeon from performing a standard pancreatic resection 
in appropriately selected patients.
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LAPAROSCOPIC ROUX-EN-Y SINGLE-
BYPASS IN PANCREATIC HEAD 
CANCER PALLIATION
G. F. Bonsanto2, E. V. de Carvalho1, E. P. Vilela2 and 
O. P. Vaz1
1Department of Surgery, Ipanema Federal Hospital, Rio de 
Janeiro, Brazil; 2Surgery Resident, Ipanema Federal 
Hospital, Rio de Janeiro, Brazil
Introduction: Pancreatic cancer is responsible for approxi-
mately 227.000 deaths per year worldwide, the majority of 
patients present with locally advanced and or metastatic 
disease, where the most common symptoms are abdominal 
pain, obstructive jaundice, weight loss, and gastric outlet 
obstruction. At this point, where median survival is approxi-
mately 8 months, palliation becomes an important part of the 
treatment, improving the quality of live.
Methods: Patients presenting with pancreatic head cancer 
were evaluated and stratifi ed. Those with locally advanced 
or unresectable disease were ellegible for the laparoscopic 
Roux-en-y single-bypass and subsequent follow-up.
Results: Seven patients were ellegible for the study. With 
the exception of one patient, we were able to safely perform 
a choledochojejuno and a gastrojejunal anastomosis. The 
mean operative time was 360 min (range 200–460 min). In 
one case the surgery had to be converted to a laparotomy due 
to neoplastic involvement of the hepatic hilum. There were 
no deaths or intraoperative complications. No patient 
required blood transfusion or ICU admissions. Two patients 
died after 5 and 4 months. The remaining patients presented 
no postoperative complications within the fi rst 30 days and 
during the follow up period, none developed billiary obstruc-
tion or gastric outlet syndrome. Two patients still refer 
abdominal pain and are being treated with opiate.
Conclusion: Results were compared to literature data on 
traditional surgery and endoscopic biliary and digestive 
bypass, and provide evidence that the laparoscopic approach 
a feasible option for palliation in pancreatic head cancer, 
especially for patients with a longer predicted survival.
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HOXB7 RNA EXPRESSION IS 
INCREASED IN PANCREATIC 
ADENOCARCINOMAS AND IN 
PANCREATIC ADENOCARCINOMA CELL 
LINES BUT ITS KNOCKDOWN DOES 
NOT MODULATE CELL PROLIFERATION
R. R. Giorgi1, T. Chile1, M. A. Z. Fortes1, 
M. L. C. C. Giannella1, H. P. Brentani2, M. S. Kubrusly3 
and M. C. C. Machado4
1Laboratory for Cellular and Molecular Endocrinology 
(LIM-25), University of São Paulo Medical School, São 
Paulo, Brazil; 2Department of Psychiatry, Medical School 
of University of Sao Paulo, Sao Paulo, Brazil; 3São Paulo 
University, School of Medicine, Department of 
Gastroenterology (LIM-37), Brazil; 4Liver and Pancreas 
Transplantation Surgery Unit and LIM 37, Department of 
Gastroenterology, University of São Paulo School of 
Medicine, São Paulo, Brazil
Laboratory for Cellular and Molecular Endocrinology 
(LIM-25), University of São Paulo Medical School, São 
Paulo, Brazil; Laboratory for Cellular and Molecular 
Endocrinology (LIM-25) Av. Dr. Arnaldo 455 – Cerqueira 
Cesar São Paulo Brazil
Introduction: Pancreatic adenocarcinoma (PA) is the fourth 
leading cause of cancer deaths. HOX genes are a family of 
homeodomain-containing transcription factors whose aber-
rant expression has been implicated in abnormal develop-
ment and malignancy. The aim of the present study was to 
evaluate the magnitude of HOXB7 mRNA expression in PAs 
and in the PA cells lines BxPC-3, MiaPaca2 and Capan1 and 
to investigate the potential role of HOXB7 mRNA inhibition 
in cell proliferation of these lineages.
Methods: Real time RT-qPCR (Taqman) was employed to 
assess HOXB7 mRNA expression and qPCR (SYBR Green) 
was used to evaluate gene copy number in 29 PAs, 10 normal 
pancreatic tissues and the 3 cell lines. siRNA was used to 
knockdown HOXB7 mRNA expression in the PAs cells lines 
and its consequence on cell proliferation was measured by 
MTT assay. In order to identify signaling pathways related 
to the knockdown of HOXB7, cDNA microarrays were per-
formed with total RNA extracted from the siRNA treated cell 
lines as well as from the parental cell lines.
Results: HOXB7 mRNA expression was signifi cantly 
higher in the PAs and in the 3 cell lines in comparison to 
normal pancreatic tissue but its knockdown by siRNA did 
not infl uence the proliferation of the cell lines. No gene 
amplifi cation was detected in the PAs samples. Comparative 
analyses of the microarray results of MiaPaca2, BxPC3 and 
Capan 1 siRNA treated cell lines in comparison to the cor-
responding parental cell line identifi ed, respectively, 14, 47 
and 138 genes as upregulated and 964, 2948 and 35 genes 
as downregulated.
Conclusion: Our fi ndings demonstrate that HOXB7 mRNA 
expression is augmented in PAs and in PA cell lines and that 
this overexpression is not determined by an increase in the 
number of gene copies. The siRNA assays suggest that 
HOXB7 is not directly involved in PA cell proliferation 
although RNA knockdown has resulted in the modulation of 
several genes. Further studies are necessary to evaluate 
whether hypomethylation of the promoter region of the 
HOXB7 is the cause of its overexpression.
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LAPAROSCOPIC TRANSGASTRIC 
ENDOLUMENAL CYSTGASTROSTOMY 
AND PANCREATIC DEBRIDEMENT
K. Simo, R. Swan, D. Sindram, J. Martinie and D. Iannitti
Section of Hepatobiliary and Pancreas Surgery, 
Department of General Surgery, Carolinas Medical Center, 
Charlotte, NC, USA
Carolinas Medical Center, Section of Hepatobiliary and 
Pancreas Surgery, Department of General Surgery, 1025 
Morehead Medical Drive, Suite 30028203, Charlotte, USA
Introduction: Cystgastrostomy is commonly performed for 
internal drainage of pancreatic pseudocysts (PP) and con-
comitant pancreatic debridement for walled-off pancreatic 
necrosis (WOPN). While approaches to cystgastrostomy 
continue to evolve, an optimal minimally invasive technique 
has not yet been well-established.
Methods: Retrospective review of patients (pts) with symp-
tomatic PP/WOPN treated with laparoscopic transgastric 
endolumenal cystgastrostomy (Lap-TEC) and pancreatic 
debridement (PD) was performed. The ten steps of this oper-
ation are: 1) intra-abdominal access and placement of 4 ports, 
2) transgastric laparoscopic ultrasound of PP/WOPN, 3) 
Insuffl ation of the stomach via gastroscope, 4) creation of 3 
small gastrotomies and transgastric placement of balloon 
trocars, 5) endolumenal ultrasonic confi rmation of PP/
WOPN cavity, 6) posterior gastrostomy creation, 7) cystgas-
trostomy anastomosis performed with linear stapler and 
suture reinforcement, 8) debridement of PP/WOPN cavity, 
9) placement of nasogastric tube into cavity and 10) closure 
of gastrostomy sites.
Results: From 10/06 to 4/11, 10 Lap-TEC/PD were per-
formed; 7 laparoscopically. Cohort had a median age of 52 
years (39–71), 50% were female, average BMI was 30 kg/
m2 and 90% had an ASA score ≥3. Gallstones were the most 
common etiology (50%). Half of the PP/WOPN were chronic 
and median time between initial presentation and operation 
was 65 days (0–360). Median operative time and EBL were 
178 minutes and 75 cc, respectively. 40% of pts admitted to 
the ICU postoperatively, average length of hospital stay was 
12 days (4–48); median follow-up was 3 months with 3 pts 
having non-procedural related complications within the 30 
day postoperative period. There were no reoperations, late 
complications, or mortalities. All pts had resolution of their 
symptoms.
Conclusion: Our technique of internal drainage via 
Lap-TEC and pancreatic debridement has been successful 
in achieving primary drainage and relieving symptoms of 
PP and WOPN with no mortality and minimal morbidity. 
Strong consideration should be given to the utilization of 
this straightforward and successful minimally invasive 
technique.
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MICRORNAS AS POTENTIAL 
MEDIATORS OF HMGA1-NETWORK IN 
PANCREATIC ADENOCARCINOMA
S.-S. Liau1, R. Praseedom1, N. Jamieson1, A. Jah1, 
P. Gibbs1 and E. Whang2
1HPB Unit, Department of Surgery, Addenbrooke’s 
Hospital, Cambridge, UK; 2Pancreatic Cancer Laboratory, 
Department of Surgery, Brigham and Women’s Hospital 
(BWH), Harvard Medical School, Boston, MA, USA
Addenbrooke’s Hospital and University of Cambridge, 
UKHPB Unit, Department of Surgery, University 
Department of Surgery, Level 9, Addenbrooke’s Hospital, 
Hills Road, Cambridge CB2 0QQ, United Kingdom
Introduction: High mobility group A1 (HMGA1) proteins 
are ‘AT-hook’ promoter-binding, architectural transcrip-
tional factors. Increasingly, HMGA1 is recognized as the 
‘hub of nuclear function’ in cancer. We previously verifi ed 
the clinical signifi cance of HMGA1 in pancreatic adenocar-
cinoma (PDA). Importantly, HMGA1 performs major onco-
genic roles in PDA progression in vitro and in vivo. Given 
the overarching roles of HMGA1, we hypothesized that 
HMGA1 may regulate oncogenic microRNA (miRNA) 
expression.
Methods: We carried out comparative microRNA expres-
sion profi ling in human PDA (versus normal pancreas, NP). 
Tumour RNA (Ambion, USA) from 3 PDA specimens 
(HMGA1 + PDA1-3) was verifi ed for HMGA1 expression. 
High-throughput microRNA microarray analysis was per-
formed (590 probes covering Sanger miRbase Release 7.1, 
LC Sciences, Houston, USA).
Results: The PDA tumour RNA showed varying levels of 
HMGA1 overexpression, compared to low expression in NP. 
We found 55 microRNAs to be differentially expressed (p < 
0.05) in HMGA1 + PDA compared to NP. Of these, 16 
microRNAs were overexpressed whilst 39 microRNAs 
showed signifi cant repression. Interestingly, the miR-29(a–c) 
family is repressed in HMGA1 + PDA compared to NP (see 
Table 1). miR-29c showed the highest fold-change increase 
in HMGA1 + PDA. In some microRNAs, a HMGA1-dose 
dependency was observed.
Conclusion: Differential expression of HMGA1-related 
miRNAs in human PDA may be exploited as novel biomark-
ers and potential therapeutic targets.
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GROOVE PANCREATITIS MIMICKING 
PERIAMPULLARY CANCER
K. Hyun-Jong, C.-K. Cho, J.-C. Kim, Y.-S. Koh, Y.-H. Hur, 
H.-J. Kim, H.-H. Kim and B.-G. Choi
Division of Hepato-Pancreato-Biliary Surgery, Department 
of Surgery, 42, Jebong-ro, Dong-gu, Chonnam National 
University Medical School, 501-7, Gwang-ju, Republic of 
Korea
Introduction: Groove pancreatitis is a form of segmental 
chronic pancreatitis affecting the groove between the pan-
creas head, duodenum, and common bile duct. Sometimes, 
it is diffi cult to differentiate groove pancreatitis from peri-
ampullary cancer. We describe a case of groove pancreatitis 
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in a 46-year-old man presenting with obstructive jaundice 
and pancreatic mass, mimicking malignancy.
Methods: A 46-year-old man was referred to out hospital in 
September 2011. He had a two-week history of jaundice, and 
abdominal pain. He had a chronic alcohol abuse history. 
Serum pancreatic enzymes and bilirubin were elevated 
(amylase 354 IU/L, lipase 588 U/L. total bilirubin 17.4 mg/
dL, direct bilirubin 13.3 mg/dL), and CA 19-9 was mildly 
elevated (107.2 U/mL). Abdominal CT and MRI revealed a 
ill-defi ned soft tissue mass measuring about 70 × 50 mm in 
diameter between pancreatic head and duodenal 2nd portion 
which was enhanced. The mass was abutting to common bile 
duct (CBD), superior mesenteric vein (SMV), and mesen-
teric root. Intrahepatic biliary dilatation and a dilated CBD 
of 33 mm were noted. The pancreatic duct appeared to be 
prominent.
Results: A preoperative diagnosis of periampullary cancer 
was made. To decompress the biliary system, percutaneous 
transhepatic biliary drainage (PTBD) was performed. After 
resolving the jaundice, he underwent pancreaticoduodenec-
tomy. Histologic examination of the resected mass revealed 
extensive fi brosis without malignant features. He was 
discharged 18 days after the operation without any 
complication.
Conclusion: Groove pancreatitis is an important diagnostic 
consideration in any cystic lesion between pancreas and 
duodenum, particularly when a patient has clinical history 
of alcohol abuse. Although preoperative recognition is 
important to avoid unnecessary operation, pancreatico-
duodenectomy still may be required to relieve obstructive 
symptoms.
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NOVEL FLUORESCENT AGENTS 
ENABLING REAL-TIME 
IDENTIFICATION OF PANCREATIC 
JUICE VIA VISUALIZATION OF 
ACTIVITY OF PROTEASE
S. Yamashita1, T. Ishizawa1, Y. Sakamoto1, T. Aoki1, 
Y. Sugawara1, K. Hasegawa1, Y. Urano2 and N. Kokudo1
1Department of Surgery, Graduate School of Medicine, 
University of Tokyo; 2Graduate School of Pharmaceutical 
Sciences, University of Tokyo
Graduate School of Medicine, University of TokyoHepato-
Biliary-Pancreatic Surgery Division, Department of 
Surgery, 7-3-1 Hongo, Bunkyo-ku11386, Tokyo, Japan
Introduction: Despite advances in recent surgical tech-
niques, the morbidity and mortality rate after pancreatic 
resection remain high. Although several strategies have been 
described to manage the pancreatic fi stula (PF), the complete 
assessing and preventing method of the PF has been unknown. 
The objective of this study is to develop the probe labelling 
pancreatic juice specifi cally and to evaluate the labelling 
ability on the drained fl uids and resected specimen for the 
purpose of clinical application.
Methods: Hydroxymethylrhodamine green (HMRG) has 
already been applied as a platform for fl uorescence probes. 
We synthesized glutamyl-phenylalanine (gPhe-)HMRG to 
detect chymotrypsin specifi cally. In the 1st examination, we 
investigated amylase concentration and fl uorescence inten-
sity by gPhe-HMRG for abdominal drained fl uids after pan-
creatic surgery (n = 76). In the 2nd examination, we 
investigated the fl uorescence intensity of the stump of the 
main pancreatic duct (MPD) by using gPhe-HMRG (n = 30). 
And we investigated the relationship between the fl uores-
cence intensity and occurrence of PF ≥ grade B defi ned by 
international study group of pancreatic fi stula (ISGPF) 
classifi cation.
Results: In the fi rst examination, the fl uorescence intensi-
ties were correlated with the amylase concentration of each 
sample (n = 76, r = 0.6784, p < 0.001). In the second exami-
nation, the fl uorescence intensity at the MPD were correlated 
with the amylase concentration of pure pancreatic juice 
obtained from external fi stula at fi rst operative day (n = 24, 
r = 0.6643, p < 0.001). The patients who had positive fl uo-
rescence at MPD represented PF ≥ ISGPF grade B more 
frequently than those who had negative fl uorescence at 
whole pancreatic stump (p = 0.008).
Conclusion: We developed novel fl uorescent agents 
enabling real-time identifi cation of pancreatic juice. In the 
future they will contribute to safe pancreatic surgery.
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POST-OPERATIVE PANCREATIC 
FISTULA AFTER PROXIMAL AND 
DISTAL PANCREATECTOMY. A 
COMPARATIVE STUDY
S. Mario1, L. Rossi2, L. Quadrelli1, M. Cantaberta1 and 
J. M. Torre1
1Medical School, University Institut ‘Iunir’ and Surgical 
Division, Italian Hospital of Rosario, Argentina; 2Modelo 
Clinic, Rufi no
Medical School-IUNIR, and Italian Hospital of Rosario, 
HPB Surgery, Virasoro 12492000, Rosario, Argentina
Introduction: The rate of post-operative pancreatic fi stula 
(POPF) in pancreatic surgery (PS) is between 4% and 35%, 
depending on the type of pancreatectomy (PCT). An all-
inclusive defi nition of POPF is a drain output of any measur-
able volume of fl uid on or after post-operative day 3, with 
amylase content greater than 3 times the serum amylase 
activity. Three different grades of POPF (grades A, B, C) are 
defi ned according to the clinical impact on the patient’s hos-
pital course. (Surgery 2005;138:8–13)
Methods: A multidisciplinary approach to POPF was used 
based on optimal patient management, nutrients, reduced 
loss of fl uid, reduced fi stula output with pharmacotherapy, 
reduced risk of intra-abdominal infection and reoperation, 
improved quality of life for the patient and reduced (direct 
and indirect) costs to fi stula treatment with a shorter hospital 
stay. χ2 and Student’s t test were used to compare POPF 
between proximal pancreaticoduodenectomy (PD) (G1) and 
distal PCT (DPCT): body and tail (G2).
Our personal experience from 212 PCTs (tumors, cysts 
and chronic pancreatitis), 143 PDs (G1) and 69 DPCTs (G2) 
includes 32 patients (15%) with POPF. 24 PDs (G1) and 8 
DPCTs (G2).
Results: In 14 patients with Grade A POPF (G1:9 vs. G2:5: 
NS), the use of somatostatin or analogues (SMT) was insti-
tuted exceptionally (n = 2). The drains were always main-
tained in place. No mortality.
9 patients with Grade B POPF (G!:7 vs. G2:2: p < 0.05) 
were supported with partial or total parenteral or enteral 
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nutrition. The drains were always maintained in place, IV 
antibiotics (ATB) were administered, and the use of SMT 
was often instituted (n = 7). No mortality.
There were 9 patients with Grade C POPF (G!:8 vs. G2:1 
p > 0.01)). All required aggressive clinical intervention and 
nutrition. Reoperation were used in 7 of 9 cases; the use of 
SMT and IV ATB was always instituted (n = 9) in an ICU 
setting. 2 patients died (25%).
Conclusion: We had 32 POPFs in 212 patients with proxi-
mal and distal pancreatectomy, that is, 15%, with a mortality 
rate by POPFs of 0.9% (2/212) after management by this 
multidisciplinary approach. POPF is more frequent and more 
severe in proximal pancreatectomies (PD) than in distal ones 
(p < 0.01).
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TUMOR LOCATION IN PANCREATIC 
CANCER INFLUENCES LYMPH 
NODE POSITIVITY
V. Siripurapu, E. Liu, A. Khithani, A. Mejia, R. Dickerman 
and D. Jeyarajah
Methodist Dallas Medical Center, 221 West Colorado 
Blvd., Suite 100, 75208, Dallas, TX, USA
Introduction: Pancreatic cancer mortality is dependent on 
node positivity, margin status and overall stage of tumor. We 
aim to assess whether equivalent tumor (T) sizes for distal 
pancreatectomy (DP) or pancreaticoduodenectomy (PD) for 
pancreatic cancer have varying nodal positivity ratios related 
to tumor location.
Methods: 622 patients with pancreatic surgery treated in 
2005–2011 under 6 surgeons, inclusive for operative type, 
patient co-morbidities, tumor pathology, nodal status includ-
ing a calculated nodal ratio (node positive/total nodes) were 
analyzed. Patients with T3 tumors were examined to study 
the hypothesis that location affected pattern of nodal spread.
Results: 113 patients with PD and 18 patients with DP were 
identifi ed with pathologic T3 pancreatic adenocarcinomas. 
No pre-operative treatment was administered to the groups. 
Mean age for these two groups was 67.8 ± 2.48 yrs (PD) and 
72.4 yrs (DP) (p < 0.05). No signifi cance is noted in co-
morbid index or BMI. Nodal positivity was 77% in PD 
versus 56% in DP group (p < 0.05). Lymphatic invasion was 
signifi cantly higher in the PD group (p < 0.05) as was the 
lymph node ratio (p < 0.05), compared to the DP group. 
Mean number of nodes examined was 16 for PD versus 13 
for DP (p > 0.05).
Conclusion: With an equivalent T stage between the two 
operative groups, nodal positivity and nodal ratio was higher 
in the PD group compared to the DP group. This suggests 
that tumor location does have a bearing on ease of nodal 
spread despite equivalent tumor size.
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A SURGEONS LEARNING EXPERIENCE 
OF PANCREATICODUODENECTOMIES 
(PD): IT CONTINUES DESPITE A 
DECADE LONG EXPERIENCE
V. Siripurapu, E. Liu, A. Khithani, T. Winston and 
D. Jeyarajah
Methodist Dallas Medical Center, 221 West Colorado 
Blvd., Suite 10075208, Dallas, TX, USA
Introduction: Pancreatic surgery outcomes are well docu-
mented to be better at high volume institutions with high 
volume surgeons. We aim to see if a single experienced high 
volume surgeon still improves over the years with this pro-
cedure at the same institution.
Methods: A retrospective database of 245 patients undergo-
ing pancreaticoduodenectomy under a single between 2005–
2011 was interrogated, identifying co morbidities, operative 
parameters, morbidity and mortality to answer the question 
of whether learning continues after substantial experience.
Results: Two years were chosen at random to be fi ve years 
apart from each other, with the fi rst year of analysis to be a 
decade after the designated surgeon started performing pan-
creaticoduodenectomies (PD). A threshold number of 40 PD/
year was chosen. 2006 and 2010 were the years resulting in 
analysis. 41 patients (pts) underwent a PD in 2006, compared 
to 48 pts in 2010. No patients received preoperative therapy, 
with 63% being operated for adenocarcinoma in 2006 versus 
43% in 2010 (P = NS). There was signifi cance between 2006 
(4.12 hours) and 2010 (3.33 hours) for mean operative time 
(P = 0.023) and signifi cance between 2006 (16.2 days) and 
2010 (12.2 days) for mean hospital length of stay (P < 0.05).
Conclusion: With PD performed on similar comorbid 
patients between years investigated, by a single surgeon at 
single institution, we note the operative procedure is per-
formed more effi ciently and with decreased length of stay. 
We believe that an experienced surgeon does continue to 
have a signifi cant learning curve even a decade after practic-
ing the art of pancreaticoduodenectomy.
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REFERRAL PATTERNS IN PANCREATIC 
CANCER TO A HIGH VOLUME CENTER; 
THE GASTROENTEROLOGIST REMAINS 
YOUR FRIEND
V. Siripurapu, T. Winston, E. Liu and D. Jeyarajah
Methodist Dallas Medical Center, 221 West Colorado 
Blvd., Suite 10075208, Dallas, TX, USA
Introduction: Pancreatic cancer referral to surgeons has 
been dominated by gastroenterology through fare. With a 
recent push to perform pancreatic surgery at high volume 
centers, we investigate whether surgeon to surgeon referrals 
has increased over time from a lower volume to a high 
volume institution.
Methods: Retrospective data was collected on patients 
diagnosed with pancreatic cancer who were referred from 
August 2005 through August of 2011, to ascertain the number 
of referrals from gastroenterologists, medical oncologists, 
surgeons, and primary care physicians and notate pattern 
change over the years.
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Results: 348 patients were identifi ed in analysis. Nine 
patients were excluded for either emergency room admission 
or direct transfer from outside institution. Patients were 
grouped by referral from gastroenterology, oncology, surgery, 
and primary care physicians. There were two other specialty 
doctors referring patients including two radiologists and one 
gynecologist. The gastroenterologist referred the highest 
number, totaling 221 patients. Over the six year period, the 
percentages of referrals for the gastroenterologists ranged 
from 51% to 73%, oncologists and primary care physicians 
10% to 25%, surgeons 2–8%, with, radiologists and gynecol-
ogy referring 2–4%.
Conclusion: Although there has been a minimal increase in 
the number of surgeon to surgeon referrals over the last 
several years, the gastroenterologist still dominate as the 
highest referring physician, which may indicate an estab-
lished pattern of referral to a high volume institution.
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EXTENDING THE CRITERIA FOR 
SURGERY ON ‘UNRESECTABLE’ 
PANCREATIC CANCER
R. Lewis1, J. Drebin1, M. Callery2, D. Fraker1, T. Kent2, 
J. Gates1 and C. Vollmer1
1The Universtiy of Pennsylvania School of Medicine, 
Philadelphia, USA; 2Beth Israel Deaconess Medical 
Center, Harvard Medical School, Boston, USA
The University of Pennsylvania School of Medicine, 
Department of Surgery, Silverstein Pavilion, 4th Floor, 
3400 Spruce Street, 19104, Philadelphia, USA
Introduction: Resection criteria for pancreatic malignan-
cies have gradually expanded in the past three decades, to 
the point where vascular resection, multivisceral resection 
and even total pancreatectomy are considered selectively 
acceptable. However, locally advanced tumors and meta-
static disease are still widely considered as contraindications. 
In this study, we assess the perioperative outcomes and ulti-
mate survival of patients who received resection despite 
these indications of advanced disease.
Methods: A database containing 424 resections performed 
for pancreatic ductal adenocarcinoma at two institutions over 
a decade (2001–2011) was studied. Twenty patients were 
identifi ed with advanced disease: locally advanced tumors 
(LA; n = 9), metastases (M1; n = 10), or both (n = 1). LA 
patients, initially with inoperable vascular involvement, were 
resected if there was demonstrable tumor response to preop-
erative downstaging chemoradiation therapy. All M1 disease 
was unsuspectedly discovered at laparotomy, indicative of 
limited tumor burden. Kaplan Meier survival analysis and 
descriptive statistics were employed using physiologic, oper-
ative, postoperative, and tumor features to compare these 
advanced disease resections to all others.
Results: Advanced disease patients had no 90 d mortalities 
and demonstrated similar survival compared to all others 
(17.8 m vs 22.1 m; p = 0.15). M1 patients had features of 
less demanding operations (short OR times, limited EBL, no 
vascular resection), no major complications, and survived 
17.8 m (3.8–47.6 m). Hepatic/omental disease fared better 
than peritoneal spread. LA patients survived 16.6 m post-
resection, but 28.1 m from diagnosis. Despite only one vein 
resection, they had higher EBL (1350 mL vs 400 mL, p < 
0.001), more transfusions, and more major complications 
(30%). Final pathology revealed 10% N1, 60% R1, and 90% 
T3, with only one complete response. There was no survival 
segregation based on margins or tumor grade, nor were there 
any 5-yr survivors.
Conclusion: These data suggest selected resection of pan-
creatic cancer with advanced locoregional disease (Metastatic 
disease with low burden, hepatic/omental sites, and decreased 
operative complexity; Downstaged locally advanced tumors) 
can be performed safely and may contribute to real survival 
gains compared with historical cohorts of unresectable 
locally advanced and metastatic disease.
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REDEFINING RESECTION MARGINS IN 
PANCREATIC SURGERY
C. Jones1, S. A. Badger1, M. Verma2, T. Diamond1, 
M. A. Taylor1, L. D. McKie1 and M. Loughrey
1Department of HPB Surgery, Mater Hospital, Belfast; 
2Department of Pathology, Royal Victoria Hospital, Belfast
Mater Hospital, Belfast Health and Social Care Trust, 
Department of HPB Surgery, 10 Breezemount Park, BT32, 
Banbridge, Northern Ireland
Introduction: A British Society of Gastroenterology survey 
of pathologists found a range of practice for reporting of 
Whipples specimens, and therefore a greater need for con-
formity. As a result, R0 and R1 resection margins have been 
redefi ned. The aim of the study was to determine the effect 
of the implementation of a new pathology reporting protocol 
on histological fi ndings.
Methods: The new protocol was introduced incrementally 
in 2007. The pathology reports of all patients who underwent 
Whipples resection between 2004 and 2006 (Group 1) were 
compared to those in 2008 to 2010 (Group 2). No change in 
surgical technique or personnel occurred in this timeframe. 
Results are expressed as median (IQR) and comparison 
between groups using Chi squared test.
Results: 34 patients (25 male) were in Group 1 and 53 (30 
male) in Group 2. They had similar age, with larger tumours 
in Group 2 (25.0 (16.0–33.0) vs. 30.0 (20.0–35.0) mm; p = 
0.19). Most tumours were in the head of pancreas (22 and 
35) in both groups, with adenocarcinoma being the predomi-
nant type (29 and 43). R0 resection was achieved in 19 of 
34 (55.9%) patients in Group 1, compared to 24 of 53 
(45.3%) patients in Group 2 (p = 0.46). This difference was 
most noticeable in head of pancreas tumours (57.1% vs. 
29.6%; p = 0.42). The distribution of T stages was similar 
between groups (p = 0.41). Although the average number of 
resected lymph nodes remained steady (p = 0.80), the propor-
tion of involved nodes increased (p = 0.004).
Conclusion: The new protocol, and trends towards spe-
cialised pathology reporting have resulted in a higher rate of 
detection of disease in lymph nodes and at resection margins. 
Further studies are however required to assess the implica-
tions on prognosis and overall survival.
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INTRAARTERIAL THERAPY AND 
OXIDATIVE STRESS PARAMETERS IN 
ACUTE PANCREATITIS PATIENTS
S. Chooklin and O. Hranat
Medical University, Lviv, Ukraine
Medical University, Pasichna 38/1079038, Lviv, Ukraine
Introduction: One of principal causes of lethality of patients 
with severe acute pancreatitis (SAP) is multiorgan dysfunc-
tion. Continuous regional arterial infusion (CRAI) was pro-
posed as special therapy for SAP.
Methods: 55 patients with severe acute pancreatitis were 
studied. The patients were divided into two groups: one 
received the protease inhibitor, antioxidant and the antibiotic 
by continuous regional arterial infusion (group A – 27 
patients) during 12–14 days and the other received protease 
inhibitors, antioxidant, and antibiotics by intravenous infu-
sion (group B – 28 patients). Advanced oxidation protein 
products (AOPP), peroxides, total antioxidant capacity in 
plasma were determined by using standard commercial kits.
Results: The combination of antioxidant (quercetin), a pro-
tease inhibitor and antibiotics in intraarterially, decreases the 
frequency of infection, limit the destructive process, reduced 
the number of surgical interventions and mortality. After 
CRAI function of kidneys and liver much more quickly 
improved, the pulmonary complications decreased. In 
patient, who received intravenous therapy, AOPP and perox-
ides not show signifi cant changes. In contrast, a signifi cant 
reduction was noted after 7 days of treatment in the patients 
given continuous regional arterial infusion.
Conclusion: In complex management of acute necrotizing 
pancreatitis we include intraarterial therapy. Continuous 
regional arterial infusion in acute pancreatitis inhibits the 
oxidative stress.
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OUTCOMES OF 
PANCREATODUODENECTOMY WITH 
RESECTION OF THE PORTAL 
VEIN FOR PANCREATIC CANCER: 
INSTITUTIONAL EXPERIENCE
Y. Puri1, O. Damrah1, R. Gillmore2, N. Woodward3, 
G. Fusai1, D. Sharma1, B. Davidson1 and S. Rahman1
1Centre for HPB Surgery & and Liver Transplantiotion, 
Royal Free Hospital Hampstead; 2Department of Oncology, 
Royal Free Hospital Hampstead; 3Department of 
Radiology, Royal Free Hospital Hampstead
Royal Free Hospital Hampstead, Centre for HPB Surgery 
and Liver Transplantiotion, Pond Street, London UKNW3, 
UK
Introduction: Utilization of portal vein resection is becom-
ing increasingly popular and has resulted in improved resec-
tion rates for pancreatic cancer. This study investigates the 
outcome of portal vein resection in patients with pancreatic 
cancer, and the accuracy of pre-operative radiological assess-
ment of portal vein tumour infi ltration.
Methods: The clinical data of 26 patients with pancreatic 
cancer requiring resection in combination with portal/supe-
rior mesenteric vein resection and reconstruction was retro-
spectively analyzed. Radiological classifi cation of venous 
infi ltration was based on the Ishikawa classifi cation.
Results: Pre-operatively, 39% of patients were classifi ed as 
Ishikawa grade I, 31% as grade II, 15% as grade III and 15% 
as grade IV. Postoperative histopathological analysis con-
fi rmed R0 resection in 12% of patients, and R1 resection in 
88%. Morbidity and mortality were 35% and 0% respec-
tively. The overall survival rate was 36 months and disease 
free survival was 30 months. Ten patients had disease recur-
rence after a mean time of 16 months. Pre-operative evalua-
tion of portal vein showed tumour infi ltration in 61% of 
patients, whereas postoperative histopathological analysis 
revealed that 35% of patients had portal vein involvement, 
with poor correlation between pre-operative, intra-operative 
evaluation, and post-operative histological results.
Conclusion: Portal vein resection and reconstruction for 
pancreatic cancer is a relatively safe procedure in specialised 
centres. Pre-operative radiological evaluation and intra-oper-
ative assessment do not accurately correlate with postopera-
tive fi nal specimen analysis in this cohort of patients.
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THE DETRIMENTAL EFFECT OF THE 
EPIDURAL ANESTHESIA AND 
ANALGESIA AFTER 
PANCREATICODUODENECTOMY
H. Ryota, S. Satoi, H. Toyokawa, H. Yanagimoto, 
T. Yamamoto, S. Hirooka, S. Yamaki and A-H. Kwon
Kansai Medical University, Hirakata Hospital, Department 
of Surgery
Kansai Medical University, Surgery, 2-3-1, Shinmachi, 
Hirakata-shi, Osaka, Japan
Introduction: It has been reported that epidural anaesthesia 
and analgesia (EAA) after pancreatic resection was associ-
ated with hemodynamic instability and complications. The 
objective of this study is to retrospectively analyze the effect 
of EAA on the postoperative course and complications after 
pancreaticoduodenectomy (PD).
Methods: 160 consecutive patients who underwent PD 
from January 2006 to May 2010 were analyzed. The patients 
who underwent the EAA were divided into 2 groups accord-
ing to development of hypotension (<90 mmHg) or not 
during postoperative 3 days. Demographics, surgical details, 
and postoperative complications were compared between 
two groups.
Results: Ninety-three patients did not have postoperative 
hypotension (Group A). Fifty-four patients suffered from 
postoperative hypotension (Group B). The frequency of 
patients in group B (48%) whose pre-operative hemoglobin 
level were less than 11 mg/dl were signifi cantly higher than 
in group A (26%, p = 0.0065). Allogenic blood transfusion 
rate (44%) in group B was signifi cantly higher than in group 
A (22%) (p = 0.004). Rate of surgical sight infection (SSI), 
wound infection, pneumonia in group B were signifi cantly 
higher than in group A (SSI: 12% in group A vs. 28% in 
group B, wound infection: 9% vs. 28%, pneumonia: 0% vs. 
7%, p < 0.05).
Conclusion: It was suggested that postoperative hemody-
namic instability due to EAA may lead to increase postopera-
tive complications.
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PANCREATICODUODENECTOMY FOR 
PANCREATIC CANCER, THE 
MARRAKESH’S EXPERIENCE
Y. Narjis1, K. Rabbani1, N. Ihfa1, Z. Semlani2, A. Diffaa2, 
A. Louzi1, R. Benelkhaiat1 and B. Finech1
1Service de chirurgie viscérale, CHU Mohamed VI, Faculté 
de médecine et de pharmacie de Marrakech, Université 
Cadi Ayyad, Marrakech; 2Service de gastro-entérologie, 
CHU Mohamed VI, Faculté de médecine et de pharmacie 
de Marrakech, Université Cadi Ayyad, Marrakech
CHU Mohamed VI, Universite Cadi Ayyadchirurgie 
Visceralebp: 7010, Sidi Abbad, 40000, Marrakech, 
Morocco
Introduction: The pancreaticoduodenectomy is a compli-
cated surgical technique, multi-operating times. His tech-
nique has developed over several years, since its fi rst 
description by classical Whipple in 1935 until today with its 
various solutions.
Methods: This retrospective study examined 21 cases of 
pancreaticoduodenectomy collected in department of general 
surgery of the Mohamed VI universitary hospital of 
Marrakesh. The average age of our patients was 58.85 years 
with male predominance (sex ratio = 1.62).
Results: The indication for pancreaticoduodenectomy was: 
adenocarcinoma of the pancreatic head: 76.19%, of the 
Vater’s ampulla: 19.04% and serous cystadenoma: 4.76%. 
The anastomoses were done according to Child in 38.10% 
patients, while the pancreato-gastric anastomosis was 
performed in 61.90% patients. In our series, we found a 
mortality rate of 4.76%. The complications after pancreati-
coduodenectomy was about 38.10% and include: pancreatic 
fi stula: 9.52%, gastroplégie: 4.76% and biliary fi stula: 4.76%.
Conclusion: It has been suggested by several studies that 
the experience of the teams seemed the best way not only 
decrease morbidity and perioperative mortality, but also 
increase the chances of patient survival.
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MANAGEMENT OF ACUTE 
PANCREATITIS, EXPERIENCE OF 
MARRAKECH (ABOUT 150 CASES)
N. Ihfa1, Y. Narjis1, K. Rabbani1, Z. Semlani2, A. Diffaa2, 
A. Louzi1, R. Benelkhaiat1 and B. Finech1
1Service de chirurgie viscérale, CHU Mohamed VI, Faculté 
de médecine et de pharmacie de Marrakech, Université 
Cadi Ayyad, Marrakech; 2Service de gastro-entérologie, 
CHU Mohamed VI, Faculté de médecine et de pharmacie 
de Marrakech, Université Cadi Ayyad, Marrakech
CHU Mohamed VI, Universite Cadi Ayyadchirurgie 
Visceralebp: 7010, Sidi Abbad, 40000, Marrakech, 
Morocco
Introduction: Acute pancreatitis (AP) is a medico-surgical 
pathology, which continues to pose diffi culties for aetiologi-
cal diagnosis, prognostic and therapeutic approaches. 
Through a retrospective study on 150 cases of PA collected 
at the service of General Surgery of Mohamed VI universi-
tary hospital of Marrakech, we tried to trace the epidemio-
logical, clinical, biological, morphological, and therapeutic 
profi le of AP.
Methods: The study period was 5 years, the average age 
was 50 years with a marked female predominance (75%). 
Abdominal pain was the main symptom. The amylasemia 
was done in 94% of cases. The Ranson score was classifi ed 
14% of our cases, such as severe PA, 6 cases were hospital-
ized in the ICU. Ultrasound has displayed a lithiasis of the 
gallbladder (LVB) in 83 patients and in the common bile duct 
(VBP) in 41 cases.
Results: CT was performed in 93% of cases. The cause of 
AP was biliary (76.6%), alcohol (6.6%), hydatid (2%), 
trauma (2%) and idiopathic (13.3%). After improvement, 62 
patients were operated during the same hospitalization (7 
days on average). For simple LGB (84 cases), cholecystec-
tomy was done under laparoscopy in 56% of cases. Patients 
with lithiasis in the bile duct (31 cases) underwent choledo-
chotomy: cholédoco-duodenal anastomosis (55.5%) and 
kehr drain (44.4%). The pancreatic pseudocyst was a com-
plication encountered in 3%. The mortality rate in our series 
reached 2% and the average length of hospital stay was 10 
days.
Conclusion: Based on the analysis of results from the litera-
ture and cases in our series, we proposed a schema for diag-
nosis, prognosis and treatment; which seems to us that is the 
most coherent to a suspicion of acute pancreatitis.
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MALIGNANT FUNCTIONAL EXTRA-
ADRENAL PANCREATIC 
PARAGANGLIOMA; CASE REPORT AND 
LITERATURE REVIEW
B. O. Al-Jiffry1, Y. Alnemary1 and S. H. Khayat2
1Surgery, Taif University, Taif, Saudi Arabia; 2Surgery, 
AlHada Military Hospital, Taif, Saudi Arabia
Taif University, Surgery, Po Box 88821947, Taif, Saudi 
Arabia
Introduction: Paragangliomas are rare tumours of neural 
crest origin. There malignancy rate is 10% with a 5 year 
survival of less than 50%. Extra-adrenal pancreatic paragan-
gliomas are exceptionally rare. The average age reported in 
the literature of extra-adrenal pancreatic paragangliomas is 
67 (42 to 85 years).
Case report: A 19-year-old female came complaining of on 
& off abdominal pain for one year. She has been seen in 
multiple hospitals with no conclusive diagnosis and increas-
ing pain.
Methods: Physical examination was unremarkable except 
for a palpable mass in the right upper abdomen. Initial labo-
ratory investigation was within normal range. Tumor markers 
(CEA, AFP and CA19-9) were negative. Abdominal and 
pelvic C.T. scan showed a well defi ned retroperitoneal para-
aortic mass. This lesion measured 9 × 5 × 9.5 cm with rela-
tive central hypo-dense pattern and abundant vascularity. 
The lesion was seen at the level of the head and neck of the 
pancreas, anterior to the aorta and IVC, abutting the fundus 
of the gall bladder reaching the level of porta hepatis. No 
surrounding lymph nodes were seen on CT, but the liver 
showed evidences of parenchymal infi ltration. At surgery in 
March 2010, there was a large hard tumor pushing the 
caudate
Results: and the IVC, originating from the head of pancreas. 
The tumor was resected through a pancreateco-dudenectomy, 
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segment VI of the liver and a small segment of the IVC. The 
blood pressure spiked during the operation when the tumor 
was manipulated (>220 mmHg). Final pathology report 
showed a 9 cm paraganglioma with lymphovascular inva-
sion. All resection margins were negative, with the closest in 
the liver of 5 mm. There was one lymph node positive for 
metastasis out of 15. Post-operative recovery was unremark-
able except for an abdominal collection that was drained 
under CT guidance. She received a therapeutic dose of I-131 
MIBG. Follow up MIBG scan done in November 2011 
showed no recurrence. She is currently disease free for 20 
months.
Conclusion: Conclusion: Pancreatic paragangliomas are 
rare tumors, with only 15 cases reported up to date. None of 
these cases were malignant functional pancreatic paragan-
glioma with this degree of marked invasion. At 19 yrs of age, 
our patient was an extraordinary example of a rare tumor. 
Even more remarkable was that it was functional. We 
couldn’t fi nd any similar case reported in the literature.
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TYPE IIIC3-RARE CAUSE OF 
RECURRENT ACUTE 
PANCREATITIS; CASE REPORT 
AND LITERATURE REVIEW
B. O. Al-Jiffry1,2, A. Khorshed2, T. Chundrigar2 and 
Y. Alnemary1
1Department of Surgery, Taif University, Taif, Saudi 
Arabia; 2Department of Surgery, Al-Hada Armed Forces 
Hospital, Taif, Saudi Arabia
Taif University, Surgery, Po Box 88821947, Taif, Saudi 
Arabia
Introduction: Choledochal cyst is a rare congenital dilata-
tion of the CBD that is known to be associated with 
Anomalous Union of the Pancreaticobile Duct (AUPBD). 
AUPBD is a well described though uncommon, often unrec-
ognized, cause of acute pancreatitis, especially in young 
patients. Komi et al. in his new classifi cation described 51 
cases of AUPBD. Type III was sub-divided into three types 
(A, B and C). Type C is further divided into three sub-types 
(1, 2, and 3).
Methods: Case Report: A 19 years old Saudi girl presented 
with three recent episodes of acute biliary pancreatitis. She 
had repeated episodes of abdominal pain since childhood. 
At the age of three, she was diagnosed to have acute pan-
creatitis and a pancreatic congenital anomaly was suggested 
but was not actively pursued, even with several visits to 
hospitals over several years. Ultrasound showed dilated 
intra- and extra-hepatic ducts with the CBD measuring 
about 2.5 cm. MRCP revealed dilated extra-hepatic duct 
down to the lower end. At ERCP both the major and minor 
papilla were separately cannulated. Injection of either 
papilla demonstrated the same complex network of dilated 
ducts, with these ducts opening eventually into each other 
and to the CBD.
Results: and pancreatic duct. The lower end of the CBD was 
markedly narrowed, with a choledochal cyst shown more 
proximally. After reviewing the literature and comparing the 
pictures we found that she fi ts into type IIIC3. This subtype 
is treated by pancreatectodudenectomy. She underwent 
surgery after much discussion with the family. The immedi-
ate post operative course was complicated by wound infec-
tion, which responded to appropriate treatment. She is 
currently symptom free. Her last visit was in November, 
2011 (26 month post surgery).
Conclusion: In young patients, AUPBD should be consid-
ered as a cause of recurrent acute pancreatitis. Our patient 
had two papilla, communicating with each other and with 
dilatation of the ducts which makes it type IIIC3. Only type 
IB, IIB and IIIC3 are associated with recurrent pancreatitis 
and are treated surgically. The treatment of choice for type 
IIIC3 is pancreatectodudenectomy. Out of Japan the two 
reported cases of type III are type IIIa of all AUPBD types. 
Komi et al. didn’t mention the numbers of the each subtype 
of type III C. Our case therefore is the only reported case of 
type IIIC3 in the literature.
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TWO CASES OF UNUSUAL 
INTRADUCTAL PAPILLARY MUCINOUS 
CARCINOMA OF THE PANCREAS
H. J. Kim, E. K. Park, H. J. Kim, B. G. Choi, S. H. Cho, 
C. Y. Kim, J. C. Kim and C. K. Cho
Chonnam National University Medical School, Gwangju, 
Korea
Chonnam National University Medical School, Surgery, 
160, Baekseo-ro, Dong-gu, Department of Surgery, 
Chonnam National University Medical School, Gwangju, 
501-757, Korea
Introduction: Intraductal papillary mucinous carcinoma 
(IPMC) is usually characterized by cystic mass with papil-
lary projection or mural nodule and dilated pancreatic duct 
fi lled with mucin. But its clinical and radiologic manifesta-
tions may be variable and rarely very unusual type of IPMC 
can be developed which was very diffi cult to diagnose pre-
operatively. Recently, we experienced two cases of IPMC of 
the pancreas with unusual clinical features, and here on we 
report the cases.
Methods: (Case 1) A 71-year-old woman presented with 
abdominal pain and jaundice. Abdominal CT and MRI 
showed marked dilatation of main pancreatic duct and biliary 
tract, with multifocal papillary soft tissue mass lesions in 
pancreatic head. And fi stulous communications were shown 
between duodenum second portion and main pancreatic duct 
in head, and between gastric body and pancreatic duct in tail. 
(Case 2) A 63 year-old man visited because of incidentally 
detected pancreatic mass by abdominal CT. Abdominal CT 
and MRI revealed a 1.5-cm sized nodular lesion without any 
enhancement in the pancreatic body. Distal pancreatic duct 
was slightly dilated and there was no cystic lesion in the 
mass.
Results: (Case 1) Whipple’s operation and resection of 
gastro-pancreatic fi stula tract were performed under the 
impression of IPMC. The pathologic diagnosis was invasive 
IPMC with pancreato-duodenal and gastro-pancreatic fi stula. 
There was no tumor cell in the resected gastro-pancreatic 
fi stula tract.
(Case 2) Distal pancreatectomy with splenectomy was per-
formed and 1.5 cm sized whitish hard nodular mass without 
cystic component was found in the pancreas body. In micro-
scopic examination, tumor cells were spread along the pan-
creatic duct diffusely and the size of tumor was 9 × 2 × 
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1.6 cm. The fi nal pathologic diagnosis was confi rmed to be 
main duct type-invasive IPMC, well-differentiated.
Conclusion: Here, we report on two cases of unusual type 
of IPMC. The fi rst case shows unusually marked dilated bile 
duct and pancreatic duct with multiple fi stula formation with 
stomach and duodenum. In the second case, the tumor was 
detected as only small nodular lesion with mild distal pan-
creatic duct dilatation without cystic component in imaging 
studies which was thought to be ductal adenocarcinoma, but 
in pathologic examination, IPMC was confi rmed with diffuse 
ductal involvement.
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CLINICOPATHOLOGICAL FEATURES OF 
THE SUBTYPES OF IPMN
T. Hisaka, H. Horiuchi, H. Isihkawa, S. Uchida, 
R. Kawahara, Y. Kawashima, H. Kinoshita and K. Shirozu
Department of Surgery, Kurume University, Kurume, Japan
Kurume University, School of medicine, Depatment of 
Surgery, 67 Asahi-machi, Kurume City, 830-0011, Japan
Introduction: The clinicopathological signifi cance of four 
distinct subtype-gastric, intestinal, pancreatobiliary and 
oncocytic of IPMN was assessed.
Methods: We retrospectively analysed from 50 patients 
with IPMN who underwent surgical resection between 1996 
and 2010 at the Dept. Surg, Kurume University.
Results: There were 20 tumors of the gastric type, 23 intes-
tinal, 6 pancreatobiliary, 1 oncocytic. The tumor size was 
signifi cantly larger in pancreatobiliary type-IPMNs than in 
the other type-IPMN. In the pancreatobiliary type-IPMN, 
there were 6 invasive carcinoma (100%) was signifi cantly 
greater than in the other type-IPMN.
Patients with panccreatobiliary type-IPMN had poorer prog-
nosis than those with gastric type or intestinal type.
We also analyzed the survival curves of patients with inva-
sive carcinoma from IPMNs of the intestinal and pancreato-
biliary types. Mean survival periods in the intestinal and 
pancreatobiliary types were very different, although not to a 
statistically signifi cant degree.
Conclusion: Pancreatobiliary type had more malignant 
potential than the gastric and intestinal types. The morpho-
logical type of IPMN is related to prognosis.
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A NOMOGRAM FOR PREDICTING THE 
PROBABILITY OF CARCINOMA IN 
PATIENTS WITH INTRADUCTAL 
PAPILLARY-MUCINOUS NEOPLASM 
(IPMN) – EXTERNAL VALIDITY IN 
RECENT RESECTED CASES AND LONG-
TERM FOLLOW-UP CASES
Y. Shimizu, T. Sano, Y. Senda and Y. Nimura
Department of Gastroenterological Surgery Aichi Cancer 
Center Hospital, Nagoya, Japan
Aichi Cancer Center Hospital, Gastroenterological 
Surgery, Kanokoden 1-1, Chikusa-ku, 46486, Nagoya, 
Japan
Introduction: We developed a model for predicting the 
presence of carcinoma in patients with IPMN using clinical 
and laboratory data, which were collected from 81 patients 
with IPMN who underwent a pancreatic resection between 
1989 and 2008 at our hospital. We reported the area under 
the receiver operating characteristic curve (AUC) for the 
model was 0.903 (World J Surg 2010). The objective of the 
current study was to validate this predictive nomogram with 
an external data set.
Methods: 1. External validity was assessed using an exter-
nal data set of 26 IPMN patients who underwent surgery after 
2009 at our hospital. 2. The nomogram was validated with 
the data set of 43 IPMN patients who received a meticulous 
examination and were followed up without a change for 
more than 3 years. External validity was assessed using their 
fi rst examination fi ndings.
Results: 1. 18 patients had malignant tumors (non-invasive 
Ca. in 9 and invasive Ca. in 9) and 8 had adenoma. AUC for 
the model was 0.875. The sensitivity and specifi city of the 
model were 89% and 63%, respectively, in the validation 
study for which the predictive probability of >10% was used 
to indicate the presence of Ca. 2. During observation periods 
(median 8 years), mean diameter of the main pancreatic duct 
varied 4.3 mm to 4.2, size of the branch pancreatic duct 
17 mm to 20, and mural nodules were detected in 11 to 13 
patients. With the exception of one death from other disease, 
42 patients are in good health. Using their fi rst examination 
data, nomogram showed the predictive probability of the 
presence of Ca. <5% in 41 (95%) of 43 patients.
Conclusion: The nomogram has a high diagnostic predict-
ability for carcinoma in patients with IPMNs and for indi-
vidual cancer probability. It is also useful for determining the 
operative indication and the schedule for follow-up.
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SURGICAL BYPASS IS OPTION OF 
CHOICE IN UNRESECTABLE 
PANCREATIC HEAD CANCER
S. Deshpande, V. Borgaonkar and V. Borgaonkar
Seth Nandalal Dhoot Hospital, Aurangabad, India
Seth Nandalal Dhoot Hospital, Department of Surgery and 
HPB Unit, Plot A-1, MIDC, Chikalthana, 43121, 
Aurangabad, India
Introduction: In developed countries Pancreatic cancers 
are 4th of 5 most common causes of cancer mortality. Mostly 
the patients present in advanced stage and only 15% of them 
are eligible for curative resection. So almost 85% patients 
need a palliative procedure which would improve quality of 
life with minimum morbidity. Presenting herewith our expe-
rience in management of such unresectable patients with 
locally advanced Pancreatic cancers.
Methods: In our hospital we treated 124 patients of 
Pancreatic cancer in last 7 years.
All these patients were evaluated thoroughly and on MDCT 
for either curative resection/palliative procedure.
In this series 24 patients (19%) qualifi ed for curative 
surgery and underwent Whipple’s pancreaticoduodenectomy. 
Palliative bypass procedures (Cholecystojejunostomy – 68, 
Choledochojejunostomy – 12) were performed in 80 patients 
(65%) and 20 patients (16%) underwent endoscopic stenting. 
Elective Gastroenterostomy was performed in all the patients.
Results: Whipple’s procedure is the ideal treatment for 
resectable pancreatic head cancers.
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In this series unresectable patients were considered for 
surgical bypass procedures. Few of the patients found unre-
sectable at laparotomy were also considered for surgical 
bypass. The mortality in our series was 2.94% and morbidity 
was 11.7%.
Patients not qualifying for surgical option and predicted 
shorter life expectancy were considered for Endoscopic 
stenting.
Conclusion: All patients found to be advanced stage of pan-
creatic cancer and also those who were found to be unresect-
able on laparotomy should undergo palliative surgical 
bypass. We found Cholecystojejunostomy to be a good pal-
liative procedure having less morbidity and mortality. This 
procedure is also technically less demanding and can be 
safely performed by average general surgeon having no 
formal HPB training. Endoscopic stenting even though less 
morbid initially, needs repeated admissions.
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THE ANALYSIS OF SURGICAL 
TREATMENT FOR SOLID-
PSEUDOPAPILLARY NEOPLASM 
IN THE PANCREAS
T. Einama, H. Karasaki, K. Watanabe, K. Imai, 
M. Taniguchi and H. Furukawa
Division of Gastroenterological and General Surgery, 
Department of Surgery Asahikawa Medical University, 
Hokkaido, Japan
Asahikawa Medical University, Division of 
Gastroenterological and General Surgery, Department of 
Surgery, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido, 
078-8510, Japan
Introduction: Solid pseudopapillary neoplasm (SPN) of the 
pancreas is a rare tumor. It has a relatively low malignant 
potential and are mostly diagnosed in young women. The 
prognosis after surgical resection seems generally favorable. 
The aim of this study is to summarize our experience with 
surgical treatment of SPN of the pancreas and to clarify the 
characteristics of this rare condition.
Methods: The retrospective date was analyzed on the clini-
cal presentation, radiologic imaging, pathology and opera-
tive records of patients with SPN of the pancreas who were 
diagnosed between January 1994 and November 2011.
Results: All 6 patients were women, and the mean age was 
36 years old. Abdominal imaging showed solid and cystic 
masses in 2 cases at the head of pancreas and in 4 cases at 
the body and tail of pancreas. The mean diameter of the 
tumor was 30.9 mm (range 6.7–76.0 mm). All 6 patients 
underwent surgical exploration, 1 pylorus preserving pancre-
aticoduodenectomy, 1 enucleation, and 4 distal pancreatec-
tomy. Pathological fi nding showed local invasion of the 
pancreas in 1 case, splenic artery invasion in 1 case, and 
perineural invasion in 3 cases. Median follow-up periods 
were 79 months, and all of patients were alive with no evi-
dence of recurrence.
Conclusion: SPN of the pancreas is a low-grade malignant 
tumor but have a potential of local invasion. Considering our 
date, it is essential for favorable prognosis to perform com-
plete surgical resection.
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ANALYSIS OF LONG-TERM SURVIVORS 
OF PANCREATIC CANCER
H. Shimamura1, S. Ishiyama2, Y. Narushima1, G. Yunome1 
and K. Takeda1
1Department of Surgery, Sendai Medical Center; 
2Department of Surgery, Sendai Kosei Hospital
Sendai Medical Center, Department of Surgery, 2-8-8 
Miyagino, Miyagino-ku, Sendai, Miyagi pref. 98385, 
Sendai, Japan
Introduction: It is not easy to obtain 5-year survivors of 
pancreatic cancer (invasive ductal carcinoma; IDC), because 
of delayed diagnosis and rapid progression. Tough, recent 
developments of diagnosis modalities and newly introduced 
chemotherapeutic drugs, such as gemcitabine (Gem), have 
been contributed to long-term survival of IDC. In recent 
years, the number of 5-y survivors of IDC operated in our 
institute is increasing. Here we analyze our pts and elucidate 
factors for long-term survival of IDC.
Methods: Between January 2000 and December 2010, 145 
patients (pts) were diagnosed as pancreatic cancer and intro-
duced to our institute. Among them, 103 cases were resected 
with mortality rate of 2.9%. In resected cases, 85 pts histo-
logically confi rmed as IDC were retrospectively analyzed in 
terms of long-term survival factors such as lymph node (LN) 
metastasis, respectability, adjuvant chemotherapy and so on. 
Survival rates were calculated using Kaplan-Meier method, 
and compared by Generalized Wilcoxon or Logrank test.
Results: In 85 resected cases, 13 pts have survived for 5 or 
more years (7 M and 6 F, average age: 65.5). According to 
the UICC staging, most of these survivors belonged to stage 
2A, and there was no case belonging to stage 3 or higher. 
When LN met negative and positive groups were compared, 
pts in LN met negative group obtained signifi cantly longer 
survival. Tough, there were 2 LN positive pts in long term 
survivors. Although some long term survivors underwent 
portal vein (PV) resection and/or plexus clearance, both of 
them did not correspond to prognostic factors. R0 resection 
pts obtained signifi cantly longer survival, and so did all of 
our cases. On the other hand, there was no signifi cant differ-
ence in terms of chemotherapy.
Conclusion: LN met turns out to be the independent prog-
nostic factor of IDC. Adjuvant chemotherapy had not yet 
contributed to improve survival rate so far, whereas R0 
resection is necessary to obtain long-term survival for IDC. 
PV resection and/or arterial plexus clearance are allowed 
only to achieve R0 resection.
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FULMINANT EMPHYSEMATOUS 
PANCREATITIS
J. Y. Jeon, M. J. Kim, J. S. Lee and I.-G. Kim
Hallym University Scared Heart Hospital
Hallym University Sacred Heart Hospita, lGeneral 
Surgery, 896 Pyungchon-Dong, Dongan-Gu, Anyang-City, 
Kyungki-Do, 431-0, Anyang, South Korea
Introduction: A 78-year-old man was admitted with wors-
ening continuous abdominal pain 18 h after onset. He had 
history of alcohol abuse (one & half bottle/day). He showed 
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jaundice, oliguria, and slight fever (37.4_C) with tachypnea 
and tachycardia. Laboratory analysis revealed high levels of 
s-amylase (1281 U/L), WBC (2100/µL), T-Bil (1.8 mg/dL), 
AST (37 IU/L), ALT (16 IU/L), alk-p (63 IU/L), γ-GT 
(67 IU/L), BUN (25.5 mg/dL) and Cr (1.25 mg/dL), sug-
gesting acute pancreatitis.
Methods: Ranson’s criteria at admission were 2 (age in 
years >55 years, serum LDH >350 IU/L), and the APACHE 
II score was 11 points. Chest X-ray revealed small free air. 
Abdominal X-ray depicted paralytic small intestine. 
Abdominal CT showed intraparenchymal mottled gas 
throughout the pancreas. Extensive pneumoretroperitoneum 
in left anterior pararenal space, peripancreatic area, trans-
verse mesocolon, and mesenteric root and a small amount of 
peritoneal free air in upper abdominal cavity, Morrison’s 
pouch and portal vein gas in periphery of both lobes of the 
liver and SMV gas and high density ascites were detected in 
the abdominal cavity. We guessed the patient as massive 
emphysematous pancreatitis. Because there was no biliary 
dilatation.
Results: Because there was no biliary dilatation or biliary 
stone on CT scan. Therefore, we did not perform endoscopic 
sphincterotomy or biliary stenting. We consider explo-
laparotomy seriously to rule out duodenal perforation. 
Operation fi eld revealed multiple hemorrhagic necrosis in 
left anterior pararenal space, peripancreatic area, transverse 
mesocolon, and mesenteric root. Ascites were reddish black 
colored. But there was no perforation of duodenum & proxi-
mal jejunum. After irrigation multiple cigar drain was placed 
into the lesser sac. He remained stable hemodynamically in 
the intensive care unit immediately after explo-laparotomy 
including suffi cient fl uid supply, intravenous administration 
of antibiotics, protease inhibitor.
Conclusion: However 8 hours after surgery, circulatory, 
respiratory and renal failure occurred. Dopamine & norepi-
nephrine were administered. Intubation was made and CRRT 
was started. However, the patient died at 54 h after surgery 
(72 h after onset). Whereas conservative management has 
been thought to be appropriate in selected cases of emphy-
sematous pancreatitis, when there is pancreatic emphysema 
in the early phase, a fulminant course tends to develop. 
Recently, we experienced a fatal case of EP.
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THE PROPER SURGICAL INDICATIONS 
AND METHODS FOR INTRADUCTAL 
PAPILLARY MUCINOUS NEOPLASMS OF 
THE PANCREAS
A. Kaito, Y. Kato, N. Gotohda, T. Kinoshita, S. Takahashi, 
M. Konishi and T. Kinoshita
National Cancer Center Hospital East, Division of 
Hepatobiliary-Pancreatic Surgery
National Cancer Center Hospital East, Division of 
Hepatobiliary-Pancreatic Surgery, 6-5-1, Kashiwano-ha, 
Kashiwa, Japan
Introduction: The surgical indications for intraductal papil-
lary mucinous neoplasms (IPMNs) of the pancreas have been 
decided based on international consensus guidelines for 
management of IPMNs (Pancreatology, 2006) in our hospi-
tal. The indications are a) main duct and mixed IPMNs: all 
case, b) branch duct IPMNs: tumor size >30 mm or increas-
ing, main duct dilation (>6 mm), presence of mural nodules. 
The cases with less possibility of invasiveness have occa-
sionally been performed limited pancreatic resection.
Methods: To investigate proper surgical indications, proce-
dure and lymph node dissection (LND) for IPMNs, We ret-
rospectively assessed the 139 IPMN cases surgically resected 
between May 1994 and Nov 2011 in our hospital.
116 cases were conventionally resected with D2 LND and 
limited resection was performed in 23 cases. 43 cases had 
main duct and mixed IPMNs (M group) and other 96 cases 
had branch duct IPMNs (B group). Adenoma/Non-invasive/
minimally-invasive/invasive carcinomas were 8/15/6/14 
cases in M group and 46/11/10/29 cases in B group respec-
tively. M group/B group: Malignant cases (carcinoma 
in situ, invasive carcinoma) were 81.4%/52.1%, invasive 
cases (minimally-invasive and invasive carcinoma) were 
46.5%/40.6% respectively.
Results: The cases with metastatic lymph nodes were 
14.0%/15.6% (all cases were invasive cases), the cases with 
the mural nodule were 65.1%/45.8% (66.7% of cases were 
invasive cases), PCM positive (PanIN2/3) cases were 
9.3%/27.1% respectively. Predictive factors for malignancy 
were tumor size >30 mm (p = 0.02, OR14.6) in M group and 
the mural nodule (p < 0.01, OR17.3), tumor size >30 mm (p 
< 0.01, OR5.3) in B group respectively, while predictive 
factors for invasive cases were tumor size >30 mm (p = 0.02, 
OR14.6) in M group and the mural nodule (p < 0.01, 
OR17.3), tumor size >35 mm (p < 0.01, OR5.3) in B group 
respectively in multivariate analysis. Tumor size of invasive 
cases without mural nodule exceeded 30 mm in M group and 
35 mm in B group respectively.
Conclusion: All cases of M group and the cases with mural 
nodule or tumor size >30 mm in B group are recommended 
to have dissected surgically because of high proportion of 
malignancy. The cases with mural nodule are highly possible 
to have invasive carcinoma. Limited resection can be done 
in the cases of tumor size <30 mm without mural nodule in 
M group and tumor size <35 mm without mural nodule in B 
group.
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IMPACT OF TJ-137 ADMINISTRATION 
FOR THE PREVENTION OF ADVERSE 
EVENTS DURING CHEMOTHERAPY IN 
PATIENTS WITH ADVANCED 
PANCREATIC CANCER PATIENTS
D. Ishikawa, M. Shimada, T. Utsunomiya, S. Imura, 
Y. Morine, T. Ikemoto and H. Miyake
Department of Digestive and Trasnplant Surgery, 
Tokushima University
Tokushima University, Department of Digestive and 
Trasnplant Surgery, 2-50-1 Kuramoto-cho, 77085, 
Tokushima, Japan
Introduction: We have already reported that Japanese 
herbal medicine, TJ-48 can reduce the leucocytopenia during 
Gemcitabine (GEM)-based chemotherapy for advanced pan-
creatic cancer patients (ASCO-GI 2010), however, thrombo-
cytopeina is still hard to prevent thus this is the one of the 
major adverse events for the termination of chemotherapies 
for such patients. Therefore we looked upon TJ-137 
which was reported for the effects of splenomegaly, and 
 Poster Presentation Abstracts 621
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 288–699 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
investigated that the clinical aspects for advanced pancreatic 
patients with GEM-based chemotherapy.
Methods: Twelve patients who undergone full dose sys-
temic GFP (GEM + 5-FU + CDDP, intravenous infusion) 
with clinical stage III and IV (TNM classifi cation). Patients 
were divided into two groups; TJ-48 administration group 
(7.5 g/day oral administration) and TJ-48 + TJ-137 (both 
7.5 g/day oral administration). Their immunological param-
eters and clinicopathological factors were investigated 
retrospectively.
Results: CD4/CD8 ratio and peripheral Foxp3 + CD4 + 
CD25 + regulatory T cell populations signifi cantly decreased 
near the healthy control level (P < 0.05). The fi rst day with 
the usage of G-CSF for leucocytopenia, and the fi rst day of 
the dose reduce or the termination due to thrombocytopenia 
were signifi cantly prolonged in TJ-48 + TJ-137 group (20.3 d 
vs. 66.8 d, P < 0.01 and 23.9 d vs. 71.5 d, P < 0.01, respec-
tively). Moreover, patients in TJ-48 + TJ-137 group contin-
ued signifi cantly more cycles of chemotherapy compared to 
TJ-48 group (120 d vs 203 d, P < 0.05).
Conclusion: We here showed TJ-137 plus TJ-47 orally 
administration lead immunoaugumentation for the advanced 
pancreatic cancer patients with chemotherapy. Moreover, it 
is considered that this effect prevented adverse events espe-
cially pancytopenia and lead the continuous chemotherapy 
for these patients.
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HISTOPATHOLOGICAL INVESTIGATION 
OF PROGNOSTIC FACTORS IN STAGE I 
PANCREATIC CANCER
G. Akasu, K. Fukuyo, Y. Nomura, H. Sakai, M. Yasunaga 
and H. Kinoshita
Department of Surgery, Kurume University School of 
Medicine, Kurume in Japan
Kurume University School of Surgery, Department of 
Surgery, 67 Asahi-machi, Kurume-shi, Fukuoka, 83000, 
Kurume, Japan
Introduction: Currently, the prognosis of patients with even 
stage I pancreatic cancer is poorer, with a 5-year-survival rate 
of 52.5% (1991–2000) in Japan, than that of other cancer 
patients. Therefore, to select patients with pancreatic cancer 
who can expect a longer survival, we examined the correla-
tion between the prognosis and histopathological fi ndings in 
patients with stage I pancreatic cancer treated in our 
hospital.
Methods: Total of seven patients with stage I pancreatic 
cancer (excluding IPMC) who underwent surgical resection 
in our hospital between January 2000 and December 2009 
and who had been successfully followed-up for at least 3 
years were included in this study. They consisted of 5 men 
and 2 women, with a mean age of 70.7 years. The tumor was 
located in the Ph in 2 patients, and in the Pbt in 5. One, 5, 
and 1 patient underwent PD, DP, and TP, respectively. 
Postoperative histopathological examination revealed a 
residual tumor (R1) in 1 patient. Three patients, including 1 
with R1, died of a recurrence of pancreatic cancer within 3 
years after surgery. The overall MST was 1099 days, with a 
3-year survival rate of 57.1%.
Results: One, 5, and 1 patient had well, moderately, and 
well-moderately differentiated adenocarcinomas, respec-
tively. One, 3, and 3 tumors had medullary, intermediate, and 
scirrhous stroma, respectively. The tumor infi ltration pattern 
(INF) was INF B in 5 patients, and INF C in 2. Lymphatic 
(ly), venous (v), and intrapancreatic neural invasion (ne) 
were observed in 7, 6, and 4 patients, respectively. Intraductal 
growth into the main pancreatic duct (MPD) was noted in 1 
patient. No difference was observed in the histological type, 
amount of stroma, INF, ly, v, ne, or MPD between the patients 
who survived and those who died of recurrence. The differ-
ence in tumor diameter, ≤15 mm or >15 mm, was noted 
between these two groups of patients (P ≤ 0.05).
Conclusion: The prognosis of stage I pancreatic cancer 
patients in our hospital was not necessarily favorable. 
However, the results of this study suggest that those with 
pancreatic cancer of 15 mm or less in diameter can expect a 
long-term survival, and that R0 resection is essential for 
long-term survival even in patients with stage I pancreatic 
cancer.
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SOLID PSEUDOPAPILLARY TUMOR OF 
THE PANCREAS: ANALYSIS OF 
CLINICOPATHOLOGICAL FEATURES 
AND SURGICAL OUTCOME IN A 
SINGLE INSTITUTION
A. El-Gendi1, S. El-Gendi2 and M. El-Gendi1
1Department of Surgery, Faculty of Medicine, Alexandria 
University, Egypt; 2Department of Pathology, Faculty of 
Medicine, Alexandria University, Egypt
Faculty of Medicine, Alexandria University, Surgery, 440 
El-Horreya Street, Roushdy, 21311, Alexandria, Egypt
Introduction: Solid-pseudopapillary tumor (SPT) of the 
pancreas is an uncommon pancreatic neoplasm with a low-
grade malignancy that occurs mainly in young women. This 
study was undertaken to examine the clinico-pathological 
characteristics of the disease and to evaluate the outcome of 
surgical intervention in a tertiary referral cancer centre.
Methods: A prospectively maintained database of the char-
acteristics of 14 patients (13 females and 1 male), with a 
mean age of 21.6 years (range 17–34 years) who underwent 
surgical resection in our institution with a defi nitive histo-
logical diagnosis of SPT between 2002 and 2011 was devel-
oped and analyzed.
Results: 5 cases (37%) presented with dull aching pain, 
palpable mass in 3 cases (21%) with incidental detection in 
3 cases (21%). The tumor was located in the body/tail in 12 
cases and in the head in 2 patients. Mean tumor diameter was 
6.7 cm (range 3.5–19). Tumors of the head were smaller 
(average 5.4 cm) but more symptomatic than those in the 
body-tail (average 8.8 cm). None of the patients had metas-
tases at presentation. 2 cases underwent pancreaticoduode-
nectomy, 2 enucleations, while 10 patients had left 
pancreatectomy. Overall morbidity rate was 22% with no 
mortality. At a median follow-up of 62 months (range 9–110), 
all patients are alive without evidence of local recurrence, 
metastasis, but one case of diabetes developed.
Conclusion: SPT is an indolent neoplasm with low grade 
biological aggressiveness, making surgical resection possi-
ble despite its large size and patients can survive a long 
period after the operation.
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CAN POSTOPERATIVE PANCREATIC 
FISTULA BE PREDICTED BY SIMPLE 
CLINICAL MEASURE?
H. Baba1, T. Sanada1, H. Kuwabara1, N. Goseki1, S. Arii2 
and H. Ishida3
1Shuwa General Hospital; 2Tokyo Medical and Dental 
University; 3Saitama Medical Center, Saitama Medical 
University
Shuwa General Hospital, Surgery, 1200 Yaharashinden, 
344, Kasukabe, Japan
Introduction: Postoperative pancreatic fi stula (POPF) is 
one of the major complications experienced after pancreatic 
surgery. It may be life-threatening that careful observation is 
necessary. However, various measures were learned by expe-
rience at each individual institution. We investigated whether 
simple measures used in daily practice can be effective for 
predicting post-operative fi stula.
Methods: Thirty nine consecutive patients were enrolled for 
the study. They all received pancreatico-jejunal anastomosis 
with duct to mucosa anastomosis (modifi ed Blumgart 
method) at operation. Enteral nutrition was started on the 
fi rst postoperative day. Amylase level of the pancreatico-
jejunostomy drain output and various serum measures were 
recorded every three days. Patients were grouped as POPF 
and non-POPF for discussion.
Results: Thirty nine consecutive patients were enrolled for 
the study. Pancreatic head cancer, bile duct cancer and cancer 
of ampulla of Vater were seventeen, ten and eight, respec-
tively. POPF occurred in eleven patients, seven Grade A 
patients and four Grade B patients (according to the ISGPF 
grading). The average amylase level within the drain output 
on the third postoperative day of the POPF patients were 
16973 IU/l whereas 1027 IU/l in non-POPF patients (p < 
0.05). At the same time, average serum C-reactive protein 
level of POPF patients were 17.42 mg/dl, whereas 6.08 mg/
dl in non-POPF patients (p < 0.05). Other serum measures 
did not show any signifi cant difference.
Conclusion: Under steady surgical procedure and postop-
erative management, POPF can be predicted by amylase 
level of the drain output together with serum C-reactive 
protein on the third postoperative day. To nip in the bud is 
crucial for POPF in order to avoid turning into lethal 
complication.
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SHORT TERM OUTCOME OF LARGE 
TUMOURS REQUIRING PANCREATIC 
RESECTION: DOES SIZE MATTERS?
H. K. Yeong, A. Kow, C. Chia, C. Y. Chan, K. H. Liau and 
C. K. Ho
Department of Surgery, Digestive Disease Centre, Tan Tock 
Seng Hospital, Singapore
Tan Tock Seng Hospital, Singapore, Department of Surgery, 
Digestive Disease Centre, 11 Jalan Tan Tock Seng, 
Singapore 30843330843
Introduction: Large abdominal tumours involving pancreas 
are usually challenging to operate upon as they are located 
deep in the retroperitoneum and closely related to many 
important anatomical structures. However, recent advances 
in surgical techniques and operative care have improved the 
outcome of pancreatic surgery. In this study, we examine the 
short term outcome of patients with large abdominal tumours 
requiring pancreatic resection.
Methods: A retrospective analysis of 123 patients with 
tumour requiring pancreatic resection between January 2003 
to May 2010 was performed. Initial comparison used 3 cm 
as the cut-off as it was the median tumour size (Group A: 
Tumour <3 cm vs Group B: Tumour >3 cm). We also per-
formed subgroup analysis using 5 cm (Group C: Tumour 
<5 cm vs Group D: Tumour >5 cm) and 10 cm (Group E: 
Tumour <10 cm vs Group F: Tumour >10 cm) as cut-off. 
Outcome parameters that were examined included duration 
of operation, operative blood loss, morbidity rate and mortal-
ity rate. We also reviewed the post-operative length-of-stay.
Results: The median duration of operation, estimated blood 
loss, intra-operative blood transfusion was comparable 
between Group A and B. The rate of chronic pancreatitis, 
PANin status and lymphovascular invasion status were com-
parable. Subgroup analysis with 5 cm as cut-off did not fi nd 
any difference in terms of duration of operation and intra-
operative blood transfusion. There was signifi cantly more 
lymph node harvested in Group D compared to Group C. 
Post-operative morbidity and length of stay were compara-
ble. Similarly, subgroup analysis with 10 cm as cut-off found 
similar results in terms of duration of operation and intra-
operative blood transfusion. However, there was signifi -
cantly higher median estimated blood loss in Group E 
compared to Group F.
Conclusion: Large tumour size does not negatively infl u-
ence the short term operative outcome of patients requiring 
pancreatic resection. Careful selection of appropriate cases 
with good pre-operative imaging and optimization of surgi-
cal care are essential to ensure best surgical outcome in such 
cases. New ISGPS defi nition overestimated the rate of mor-
bidity in this study when clinically insignifi cant POPF and 
DGE were included.
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EARLY NASO-JEJUNAL FEEDING IN 
SEVERE ACUTE PANCREATITIS
S. Kumar1, V. Singla1, S. Budhiraja1 and N. P. Jain2
1Dept. of Surgery, Dayanand Medical College & Hospital, 
Ludhiana; 2Dept. of Internal Medicine, Dayanand Medical 
College & Hospital, Ludhiana
Dayanand Medical College & Hospital, Department of 
Surgery, Civil Lines, 14100, Ludhiana, India
Introduction: Early enteral nutrition in patients with severe 
acute pancreatitis (SAP) has been shown to be safe and 
effi cacious in reducing the morbidity and mortality. Though 
the role of nasogastric feeds has been disputed, nasojejunal 
feeds are better tolerated. But there are limited studies to 
prove effi cacy of nasojejunal feeds. We present our early 
experience with nasojejunal feeds in patients of SAP.
Methods: Thirty patients aged 23–65 years, who met the 
inclusion criteria were planned for NJFT (Naso-jejunal 
feeding tube) insertion under fl uoroscopy and feeds were 
started within 48 hours from admission through the NJFT. 
Morbidity and feasibility of this nutritional route were evalu-
ated by the frequency of complications, gastrointestinal 
symptoms, and abdominal pain.
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Results: All the patients included had APACHE II score 
>8. Early enteral nutrition via NJFT was tolerated in 90% 
patients. After initiation of feeds there was improvement in 
serum Calcium, albumin and leucocyte count. Average ICU 
stay was 6 days and average hospital stay was 15 days 
(Range 10–36). Patients who tolerated the feeds were satis-
factorily discharged. Out of the 2 patients who did not tol-
erate the feed, one patient expired due to complications of 
severe acute pancreatitis. The major complications encoun-
tered were acute fl uid collection (10), acute renal failure 
(6), sterile necrosis (6), infected pancreatic necrosis (1), 
gastrointestinal bleed (3), respiratory failure (3). No com-
plications related to NJFT insertion were encountered.
Conclusion: In predicted SAP, early enteral nutrition was 
feasible via naso-jejunal tube and was tolerated in the major-
ity of patients. Outcome was favourable in those patients 
who tolerated the feed.
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TWO LAYER OPEN 
PANCREATICOGASTROSTOMY. 
TOWARD AN EASY AND SAFE 
ANASTOMOSIS? PRELIMINARY 
EXPERIENCE
R. D. Valle and N. De’angelis
University of Parma, Italy
University of Parmasurgeryvia Gramsci 1443123, Parma, 
Italia
Introduction: Pancreatic fi stula (PF) is the main cause of 
morbidity and mortality after pancreaticoduodenectomy 
(PD). It mostly occurs when anastomosis is performed in soft 
pancreatic tissue. Pancreaticogastrostomy (PG) seems actu-
ally to be preferred to Pancreaticojejunostomy (PJ) in pres-
ence of soft residual parenchyma. The aim of the study is to 
compare the PG and PJ in a consecutive series of patients 
submitted to PD.
Methods: From January 2009 to September 2011 61 patients 
were submitted to two different surgical reconstructive tech-
nique, PG and PJ. 31 patients received PJ (duct to mucosa 
pancreaticojejunostomy) and 30 PG (two layer open pancre-
aticogastrostomy). All the procedures were performed by the 
same surgeon. PF was defi ned in according to the International 
Study Group on Pancreatic Fistula Classifi cation. 53 patients 
underwent a Whipple procedure whereas 7 patients were 
submitted to a pylorus-preserving operation.
Results: In the PJ group (18 male/13 female, average age 
69 years) we observed 5 PF (16.1%), 3 grade A, 1 grade B 
and 1 grade C. This latter case required a relaparotomy for 
completion pancreatectomy. In all these 5 PF the residual 
parenchyma was soft. In the PG group (14 male/16 female, 
average age 68 years) we registered 4 grade A PF (13.3%) 
all in presence of soft pancreatic tissue. In this group of 
patients we observed also 1 bleeding from the pancreatic 
anastomosis and 1 postoperative pancreatitis with a minimal 
leak of the gastrojejuneal anastomosis. All complications 
were treated conservatively. In the two groups mortality were 
0%. The mean hospitalization time was 15.6 days in PJ group 
and 12.2 days in PG group. Histological examination led to 
the diagnosis of 36 ductal adenocarcinomas, 15 carcinomas 
of the papilla, 6 duodenal carcinoma, 3 chronic pancreatitis 
and 1 duodenal polyposis (Spigelmann stage IV).
Conclusion: In our experience the incidence of PF seems to 
be lower in the PG group especially in presence of soft pan-
creatic tissue. The anterior gastrotomy makes easier the anas-
tomosis whereas the two layer technique increases its safety. 
These initial results appear encouraging but must be con-
fi rmed in a larger group of patients.
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PINCH INFLUENCES PANCREATIC 
CANCER CELLS SENSITIVITY 
TO GEMCITABINE
J. Shea, K. Hewitt and C. Scaife
University of Utah, Department of Surgery
University of Utah, Surgery, 30N 1900 E84132, Salt Lake 
City, USA
Introduction: Current chemotherapeutic treatments for 
pancreatic adenocarcinoma (PDA) have had little impact on 
improving patient survival. Sensitivity to chemotherapeutic 
agents is mediated in part by focal adhesions, which includes 
the integrin-associated protein PINCH. We have previously 
shown greater PINCH expression is associated with poorer 
PDA patient survival. The goal of the present investigation 
was to determine if alterations in PINCH expression change 
PDA cells sensitivity to gemcitabine.
Methods: To examine how PINCH affects PDA growth and 
sensitivity to gemcitabine, we exposed PDA cell lines 
(MiaPaCa-2 and AsPC1) to increasing concentrations of 
gemcitabine and compared the cell growth of PINCH 
expressing PDA cell lines (PINCH+/+) to those that do not 
express PINCH (PINCH−/−) (shRNA; Sigma). Cell growth 
was determined every 24 hours for 72 hours via an 
AlamarBlue assay. The IC50, the drug concentration for 50% 
growth inhibition, was calculated for each cell line 
(Calcusyn).
Results: There were no growth differences between the 
non-gemcitabine treated PINCH expressing (PINCH+/+) 
and non-expressing cell lines (PINCH−/−) over the 72-hour 
time frame. However the PINCH−/− cells were statistically 
more sensitive gemcitabine, with MiaPaCa-2 PDA PINCH−/− 
cells lines having an IC50 of 20 ± 3 nM compared with 30 
± 2 nM for the PINCH (+/+) group (p < 0.05). We observed 
similar results with the AsPC-1 PINCH−/− cell line having 
a smaller IC50 than the PINCH+/+ cells.
Conclusion: The PINCH expressing PDA cell lines were 
consistently more resistant to gemcitabine compared to 
PINCH−/− PDA cells. Thus, our data suggests that targeting 
signaling molecules, such as PINCH, that are important com-
ponents of focal adhesions and thus tumor cell attachment to 
the extracellular matrix, may enhance the effectiveness of 
chemotherapeutics by making tumor cells more susceptible 
to treatment.
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CAN MODIFIED 
PANCREATICOJEJUNOSTOMY REDUCE 
THE PANCREATIC FISTULA AFTER 
PANCREATICODUODENECTOMY?
K. Y. Paik
The Catholic University of Korea, Yeouido St. Mary’s 
Hospital
The Catholic University of Korea, Yeouido St. Mary’s 
Hospital, HPB Surgery, #62 Yeouido-dong, 
Yeongdeungpo-gu, Seoul, Korea
Introduction: Pancreatic fi stula (PF) has traditionally been 
a source of signifi cant morbidity and mortality after pancre-
aticoduodenectomy. External drainage of pancreatic duct 
with stent has been reduced PF after pancreaticoduodenec-
tomy in many study. Recently, Blumgart anastomosis 
(transpancreatic U-suture technique) which reduce leakage 
rates has been introduced. We applied compounding 
described two methods for pancreaticojejunostomy during 
pancreaticoduodenectomy.
Methods: We performed the review of consecutive eight 
patients who underwent pancreaticojejunostomy using the 
described two techniques. Pancreaticojejunostomy after pan-
creaticoduodenectomy was performed using outer transpan-
creatic U-suture technique for pancreas-to-seromuscular 
jejunal anastomosis and an inner duct-to-mucosa anastomo-
sis with stenting external drainage.
Results: There was no PF, and JP (Jackson-Pratt) drain 
amylase was nearly normal range until removal of drain. 
There was no postoperative mortality, and delayed gastric 
emptying in two patients. External drain of pancreas were 
removed two month after surgery.
Conclusion: Our experience was too short and very limited 
for only eight patients. In the future, the novel pancreatico-
jejunostomy will be applicable to all patients in whom per-
formed pancreaticojejunostomy during pancreatectomy. 
We hope for reduction of PF through this modifi ed 
pancreaticojejunostomy.
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ENDOSCOPIC DRAINAGE OF 
PANCREATIC PSEUDO-CYST
P. T. A. Arias
Fundación Clínica Valle del Lili
Fundación Clínica Valle del Lili, Gastrointestinal – HPB 
Surgery, Av. Simón Bolívar. Cra 98 # 18-49, Offi ce 
34572003, Cali, Colombia
Introduction: Pancreatic pseudo cyst is a complication of 
acute pancreatitis (AC), about 2% of patients with AC. Most 
common drainage is by cysto-gastrostomy. With endoscpy 
it´s possible to perform this procedure, avoiding surgery. 
Using ultrasound guide punction the collection is identifi ed, 
but this device is not common in all gastrointestinal units. In 
our institution cysto-gastrostomy is an option using a biliary 
stents to maintain the patence of perforation to ensure total 
drainage of cyst.
Methods: Since January 2009 to November 2011 5 patients 
with pancreatic pseudocyst were treated by endoscopic 
drainage. CT-scan previous procedure was done to view that 
pseudocyst is in contact with posterior wall of the stomach. 
Using video-gastroscope a punction is performed by electro-
cautery on the posterior wall of the stomach, draining the 
collection. After fl uid appears one or two biliary plastic 
stents are introduced in the gastric wall incision. After one 
month a CT-scan ensure that pseudocyst has been completely 
drained and by endoscopy the stents are removed.
Results: No complications as bleeding, severe pain, infec-
tion or recurrence were observed. All fi ve patients were 
treated as a one day hospitalization with follow up. No 
migration of the stent were observed.
Conclusion: Endoscopic drainage of pseudocyst if a good 
option to treat patients with this complications, in trained 
hands this procedure is safe, accessible to hospitals with 
conventional endoscopy unit.
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CYSTADENOMA OF PANCREAS: 
PRESENTATION OF A CASE, STUDY 
AND MANAGEMENT
V. Carrillo-Maciel, O. M. Solorzano-Pineda, 
M. Hurtado-Guerra, V. M. Velasco-Rodriguez, 
B. Rubio-Martinez, R. Vega-Hernandez, 
Y. Jaramillo-Rodriguez and M. Sanchez
Social Security 71
Social Security, Department of Surgery, Calle Lobo No. 
224, Fracc. Los Viñedos, 27016, Torreon, Mexico
Introduction: Pancreatic serous cystadenoma is a cystic 
tumor of serous fl uid, with a ratio of 2 to 1 on the woman 
and nonspecifi c symptoms in 50% are located in head of 
pancreas, plain abdominal radiograph shows calcifi cations, 
the series gastro-duodenal arcade opening in the abdominal 
arteriography is hypervascularity, U.S. mixed pattern, the 
abdominal CT cystic lesions are well defi ned. The treatment 
of choice is Distal pancreatectomy.
Methods: Objective: To report a case of a patient with pan-
creatic serous cystadenoma, study and treatment.
Case report: Women 33 years of age, no signifi cant back-
ground, his condition started 4 months before admission with 
epigastric discomfort.
Physical examination: Vital signs within the normal range, 
lung fi elds with good ventilation, normal heart sounds, 
abdominal tenderness, epigastric discomfort to deep palpa-
tion, normal peristalsis,
This complements studies and distal subtotal pancreatec-
tomy is performed 90% more splenectomy and was dis-
charged after two weeks.
Results: The patient has diabetes mellitus, remaining 
asymptomatic.
Discussion: The serous cystadenoma of the pancreas is a 
disease with nonspecifi c symptoms, once the diagnosis is 
suspected should undertake complementary studies to arrive 
at an accurate diagnosis in highly specialized hospital and 
operated on by surgeons trained and experienced in handling 
pancreatic pathology.
Conclusion: The management of these patients should be 
effected in high specialty hospitals have all the resources and 
trained personnel in pancreatic surgery.
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PANCREATIC PSEUDOCYST: 
INVOLUTION POST 
CYSTO-YEYUNO ANASTOMOSIS: 
RADIOLOGICAL CONTROL
V. Carrillo-Maciel, O. M. Solorzano-Pineda, 
S. Ramos-Linaje, J. A. Leal-Martinez, A. Guitron-Cantu, 
B. Sandoval-Enriquez, R. Rangel-Rodarte and 
A. Salas-Rodriguez
Social Security 71
Social Security 71, Department of Surgery, Calle Lobo No. 
224, Fracc. Los Viñedos, 27016, Torreon, Mexico
Introduction: Acute pancreatitis is a non-bacterial infl am-
mation of the pancreas characterized by insterticial release 
and digestion of the gland by its enzymes, the etiology is: 
alcoholism, gallstones, trauma, and hyperlipidemia. Of the 
patients with severe acute pancreatitis over 50% in pancreas 
pseudocysts develop if they are over 6 cms require surgery.
Methods: Objective: Radiological monitoring to determine 
the time it takes to regress in pseudocyst after cysto-jejunal 
anastomosis latero-lateral ‘Y’ Roux.
Material and methods: Patients who were admitted to our 
department with diagnosis of pancreatic pseudocysts who 
underwent internal referral and placed a feeding tube into the 
cavity 6 of the French psudoquiste, taking serial radiological 
controls.
Results: The pseudocyst regresses to 100% at 3 months 
postoperative.
Conclusion: In our study the involution pseudocyst 100% 
in three months but should consider increasing the number 
of patients to be able to say that the average time of involu-
tion of the pseudocyst of pancreas.
360
THE INFLUENCE OF STANDARDIZED 
HISTOPATHOLOGICAL WORKUP ON 
REPORTING OF THE RESECTION 
MARGIN STATUS IN PANCREATIC 
HEAD CANCER
A. El-Gendi1 and S. El-Gendi2
1Department of Surgery, Faculty of Medicine, Alexandria 
University, Egypt; 2Deaptment of Pathology, Faculty of 
Medicine, Alexandria University, Egypt
Faculty of Medicine, Alexandria University, Egypt; 
Surgery, 440 El-Horreya Street, Roushdy, 21311, 
Alexandria, Egypt
Introduction: Resection margin (RM) status in pancreatic 
head adenocarcinoma is assessed histologically, but patho-
logical examination is not standardized. Our aim was to 
determine the infl uence of the technique of histopathological 
examination of pancreaticoduodenectomy specimens on the 
reporting of the RM status and to develop a standardized 
histopathological workup to test prospectively the hypothesis 
that current histopathological reports underestimate the pro-
portion of R1 pancreatic head resections.
Methods: Towards this goal, we fi rstly implemented a stan-
dardized protocol (SP) for pancreaticoduodenectomy speci-
men examination, involving fi ve color margin staining, axial 
slicing and extensive tissue sampling. Starting October 2009, 
a prospective series of 14 patients with pancreatic ductal 
adenocarcinoma patients reported according to this protocol 
was compared with our conventional bivalve slicing in which 
a non-standardized protocol was used. Then, we carefully 
reevaluated the different sites of R1 resections according to 
the color code and demonstrate the most frequent site of 
incomplete tumor resection.
Results: Applying our conventional protocol, 12 cancers 
were curatively (R0) resected (85.7%), while 2 cases were 
R1 resections (14.2%) based on infi ltration of pancreatic 
neck margin. Applying the standardized histopathological 
workup, an additional set of 7 specimens were considered 
R1 resections (64.2%), reducing the rate of R0 resection to 
35.7%. An additional 12 sites of tumor infi ltration were 
detected; uncinate margin (n = 6), posterior surface (n = 4), 
anterior surface (n = 1), SMV groove (n = 1). 35% of R1 
resections exhibited multifocal margin involvement. 
Interestingly, the uncinate margin was the commonest site of 
infi ltration in 6 (56.4%) of these R1 specimens either alone 
(n = 3) or in combination (n = 3).
Conclusion: Standardization of the histopathological exam-
ination of pancreaticoduodenectomy specimens infl uences 
the reporting of RM status. Our study seems to indicate that 
resection margin involvement is signifi cantly more frequent 
than commonly reported. A standard pathological practice is 
a more important determinant of R1 classifi cation in pancre-
atic cancer than operative expertise.
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DIFFERENTIAL DIAGNOSIS BETWEEN 
BENIGN OR MALIGNANT 
INTRADUCTAL PAPILLARY MUCINOUS 
NEOPLASMS (IPMNS) BY CONTRAST-
ENHANCED PET/CT
K. Ohta, M. Tanada and H. Iguchi
Shikoku Cancer Center
Shikoku Cancer Center, Surgery, Minamiumenomoto-chou 
kou 160, 79102, Matsuyama, Japan
Introduction: IPMNs are characterized by cystic dilatation 
of the main and/or branch pancreatic duct. IPMNs do not 
progress even over a long period of time, thus, it is important 
to diagnose benign or malignant for the treatment decision. 
Contrast-enhanced PET/CT has been routinely carried out 
for detailed examination of pancreatic tumorous lesions in 
our hospital. Therefore, we evaluated the utility of contrast-
enhanced PET/CT in the differential diagnosis between 
benign and malignant IPMNs.
Methods: PET/CT imaging was conducted on 21 patients 
with IPMNs, who underwent an operation. Preoperative fi nd-
ings on PET/CT imaging were compared with the histologi-
cal fi ndings of the resected specimens in order to determine 
the diagnostic accuracy rate of PET/CT imaging for evalua-
tion in the differential diagnosis between benign and malig-
nant IPMNs. We classifi ed 4 Groups due to PET/CT fi ndings. 
Group A (n = 7) has neither mural nodule nor solid tumor 
with FDG-uptake on IPMNs. Group B (n = 1) has mural 
nodule without FDG-uptake and no solid tumor on IPMNs. 
Group C (n = 6) has mural nodule with FDG-uptake and no 
solid tumor on IPMN. Group D (n = 7) has no mural nodule 
on IPMNs but solid tumor with FDG-uptake close to IPMNs.
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Results: Group A patients were 6 IPMAs and 1 IPMC, who 
had main pancreatic duct dilatation. Group B patient was 1 
IPMC. Group C patients were 4 IPMCs and 2 invasive car-
cinomas with IPMNs. Type D patients were 7 invasive car-
cinomas with IPMNs. FDG accumulation was noted in 12 of 
14 malignant IPMNs, suggesting that FDG accumulation is 
a new indicator for the high risk stigmata of IPMNs. The 
SUVmax values were signifi cantly higher in invasive carci-
noma (4.0 ± 1.3), followed by IPMC (3.7 ± 1.4) and IPMA 
(1.3 ± 0.4) in order. However, the SUVmax values in malig-
nant IPMNs overlapped those in benign IPMNs, suggesting 
that the SUVmax-based differential diagnosis between 
benign and malignant cases is diffi cult.
Conclusion: Contrast-enhanced PET/CT is not only a less-
invasive imaging modality but also able to cover the whole 
procedure, including existence diagnosis, qualitative diagno-
sis, local diagnosis, and metastasis detection. So, it seems to 
be the most appropriate imaging modality for the clinical 
management of IPMNs.
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THE DEVELOPMENT OF A COMPOSITE 
ENDPOINT FOR PANCREATIC SURGERY
S. Clermonts1, M. Coolsen1, A. Wilt, van der1, R. Dam, 
van1, C. Dejong1 and C. Dejong2
1Department of surgery, Maastricht University Medical 
Centre, The Netherlands; 2Nutrim School for Nutrition, 
Toxicology and Metabolism
Maastricht University Medical Centre, The Netherlands; 
Department of Surgery, P.O. Box: 8500, P.Debyelaan 25, 
Zip Code: 6202 AZ6202, Maastricht, The Netherlands
Introduction: In nowadays pancreatic surgery, event rates 
are low, so large amounts of patients are needed to show 
signifi cant differences. Trials on pancreatoduodenectomy 
suffer from this problem. When large amounts of patients are 
not available the combination of relevant endpoints to one 
specifi c endpoint is a solution. This way sample sizes will be 
drastically reduced, and comparability of outcomes improved. 
The aim of this study was to develop a pancreatoduodenec-
tomy-specifi c composite endpoint (CEP).
Methods: A three-step approach was undertaken to develop 
a CEP specifi c for pancreatic surgery. First, a systematic 
review of literature was conducted to identify single-compo-
nent clinical endpoints of RCTs in pancreatic surgery, pub-
lished between 2006 and 2011. Second, a web survey based 
on the selected endpoints was developed to be completed by 
pancreatic surgeons. This survey will lead to consensus on 
which endpoints are specifi c for pancreatic surgery and 
which components should be eventually included in the CEP.
Results: A systematic search on PubMed, EMBASE and 
The Cochrane Trial Register produced a total of 154 studies 
of which 33 RCT’s were included. Primary endpoints were 
dichotomous in 22 and continuous in 11 of the studies. Only 
one RCT used a composite endpoint as primary endpoint 
composed of pancreatic fi stula formation and anastomotic 
leakage. Of the included trials 33% reported simultaneously 
on pancreatic fi stula, delayed gastric emptying as on leakage 
of the gastrojejunostomy (and post pancreatectomy hemor-
rhage). The 17 different primary endpoints reported in de 
studies were incorporated in the websurvey. The websurvey 
was send to an expert group of international pancreatic 
surgeons
Conclusion: This study shows a wide variety in endpoints 
of RCT’s concerning pancreatoduodenectomy. This stresses 
the need for a composite endpoint specifi cally designed for 
this type of surgery to reduce sample sizes. It is of impor-
tance that international consensus on the components is 
reached before the pancreatic-duodenal surgery specifi c CEP 
can be used in clinical practice.
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GASTROINTESTINAL BLEEDING AS 
THE INITIAL MANIFESTATION OF 
PANCREATIC ADENOCARCINOMA 
SUCCESSFULLY TREATED 
BY EMERGENCY 
PANCREATICODUODENECTOMY: 
CASE REPORT
K. Keiko1, T. Yasuda2, Y. Nakata2, M. Yamazaki2, 
H. Ishikawa2, T. Nakai2 and Y. Takeyama2
1Department of Surgery, Sakai Hospital, Kinki University 
Faculty of Medicine; 2Department of Surgery, Kinki 
University Faculty of Medicine
Sakai Hospital, Kinki University Faculty of Medicine, 
Department of Surgery, 377-2 Ohno-higashi, 589, Osaka-
sayama, Japan
Introduction: Pancreatic adenocarcinoma is a rare cause of 
gastrointestinal bleeding, and it is extremely rare that the 
initial symptom of pancreatic adenocarcinoma is hematoche-
zia, melena, or hematemesis. Moreover, there have been a 
few reports of successful treatment by emergency pancreati-
coduodenectomy to control bleeding in such cases. The clini-
cal course of this unusual case is reviewed.
Methods: We report the case of a 55-year-old man with 
melena who was found to have pancreatic adenocarcinoma 
directly invading the duodenum by histopathological 
examination.
Results: In this case, preoperative diagnosis of pancreatic 
adenocarcinoma was diffi cult. The endoscopic hemostatic 
procedure failed and emergency pancreaticoduodenectomy 
was performed successfully to stop bleeding. His postopera-
tive course was uneventful, but he died 8 months after the 
operation of recurrence of pancreatic adenocarcinoma.
Conclusion: It is important to keep in mind that pancreatic 
adenocarcinoma may cause gastrointestinal bleeding as an 
initial symptom, and once occurred, emergency pancreatico-
duodenectomy is one of the treatment options for severe and 
unremitting bleeding.
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LONG-TERM ADMINISTRATION OF 
CHEMOTHERAPY FOR POSITIVE 
PERITONEAL WASHING CYTOLOGY IN 
PATIENTS WITH RESECTABLE 
PANCREATIC CANCER
O. Kainuma, H. Yamamoto, A. Cho, S. Park and 
H. Arimitsu
Chiba Cancer Center, Gastroenterological Surgery
Chiba Cancer Center, Gastroenterological Surgery, 666-2 
Nitona, Chuo-ku, 260, Chiba, Japan
Introduction: The prognostic signifi cance of positive peri-
toneal washing cytology (Cy+) remains controversial in 
resectable pancreatic cancer. Strategy of treatment for Cy+ 
patients has not yet established. Recent progress of chemo-
therapy has improved survival in patients with pancreatic 
cancer. Multidisciplinary therapy has a possibility to improve 
the prognosis in Cy+ patients. The aim of this study is to 
investigate the effi cacy of long-term administration of che-
motherapy after resection in Cy+ patients.
Methods: Between January 2006 and August 2011, a total 
of 105 patients with pancreatic cancer were explored perito-
neal washing cytology at the time of pancreatic resection. 
Malignant cells were identifi ed in 13 patients (12.4%). 
Curative intent operation was performed irrespective of Cy 
status. Eighty-three of all patients were postoperatively 
treated using gemcitabine (n = 63), or S-1 (n = 15), or a 
combination of both agents (n = 5) in adjuvant setting. The 
duration of the adjuvant chemotherapy was ordinarily 6 
months in Cy− patients. However, we prospectively contin-
ued postoperative chemotherapy as long as possible until 
recurrence was noticed in Cy+ patients. Clinicopathological 
parameters and survival were compared between Cy− and 
Cy+ patients.
Results: Location (body/tail), serosa invasion, other organ 
involvement, and preoperative value of CA19-9 (1000≤) 
were signifi cantly correlated with Cy+ status. Of the patients 
who received adjuvant chemotherapy, the average duration 
was signifi cant longer in Cy+ patients than in Cy− patients 
(19.2 m vs 6.9 m). The longest survivor with Cy+ underwent 
gemcitabine therapy for 59 months without recurrence. 
Toxicity was mild during the entire treatment period in long-
term survivor. The 2y- and 4y-survival rates in Cy− and Cy+ 
patients were 59, 48% and 46, 23%, respectively. There was 
no statistical difference (p = 0.27) between the two groups. 
Peritoneal recurrence was observed in 3 (20%) of CY+ 
patients and in 13 (14%) of Cy− patients (p = 0.42).
Conclusion: Peritoneal cytologic status is not a predictor of 
poor prognosis in resectable pancreatic cancer. Long-term 
administration of chemotherapy could be effective in 
Cy+ patients after radical resection. We should not exclude 
Cy+ patients from surgical treatment. In Cy+ patients 
of pancreatic cancer without other non-curative factors, 
radical resection and long-term adjuvant chemotherapy is 
recommended.
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LAPAROSCOPIC SPLEEN-PRESERVING 
TOTAL PANCREATECTOMY AND 
CONCURRENT LAPAROSCOPY-
ASSISTED DISTAL GASTRECTOMY FOR 
A PATIENT WITH A PANCREATIC 
CANCER IN ASSOCIATION WITH IPMN 
AND A SYNCHRONOUS GASTRIC 
CANCER: A CASE REPORT
C. Takishita, G. Honda, M. Kurata, Y. Okuda, 
S. Kobayashi and K. Tsuruta
Dept of Surgery, Tokyo Metropolitan Cancer and infectious 
Diseases Center Komagome Hospital
Tokyo Metropolitan Cancer and infectious Diseases Center 
Komagome Hospital, Surgery, 3-18-22 Honkomagome, 
Bunkyo-ku, 11386, Tokyo, Japan
Introduction: In this case, because we had to divide the left 
gastric artery in order to dissect regional lymph-nodes of a 
gastric cancer, we attempted to preserve the spleen and the 
splenic vessels through which blood is supplied to remnant 
stomach. Here we report our successful strategy for a cura-
tive and feasible surgery for a patient with pancreatic cancer 
in association with intraductal papillary mucinous neoplasm 
(IPMN) and synchronous gastric cancer.
Methods: A 76-year-old man was pointed out a dilation of 
the main pancreatic duct (MPD) without obvious tumor 
during preoperative examination for gastric cancer. ERCP 
showed a stenosis of MPD in the pancreatic head and a dila-
tion of the MPD in the tail side of this stenosis. And adeno-
carcinoma derived from IPMN was detected by exfoliative 
cytodiagnosis of the pancreatic juice. We diagnosed a mini-
mally infi ltrative pancreatic cancer of the pancreas head, an 
IPMN of the pancreatic body-tail and a gastric cancer invad-
ing submucosal layer (T1b). We attempted laparoscopic 
spleen-preserving total pancreatectomy and laparoscopy-
assisted distal gastrectomy with regional lymph-node dissec-
tion (D2).
Results: Firstly, we isolated the pancreatic body-tail, pre-
serving the splenic artery and vein and the spleen. After 
completing preservation of them, we performed distal gas-
trectomy with D2, which contains division of the left gastric 
artery. Finally, we isolated pancreatic head in the same way 
as our usual laparoscopic pancreaticoduodenectomy. The 
hepatichojejunostomy was performed laparoscopically and 
the gastrojejunostomy was performed extracorporeally 
through the upper middle incision of 4 cm. The operation 
time was 668 minutes, and the blood loss was 800 g. He 
started oral intake on POD 3 and was discharged on 
POD 24. Postoperatively, a temporal delayed gastric-empty 
occurred but was improved by fasting alone.
Conclusion: We could achieve laparoscopic spleen-preserv-
ing total pancreatectomy and concurrent laparoscopy-assisted 
distal gastrectomy with D2. If we could not have completed 
preserving the splenic vessels, we would have preserved the 
left gastric artery in order to keep blood fl ow into remnant 
stomach. The outcome depending on insuffi ciency of lymph-
node dissection for T1b gastric cancer is better than that 
depending on losing both a secretory property of insulin and 
a whole stomach at the same time.
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PERCUTANEOUS EMBOLIZATION OF 
PANCREATIC TRANSPLANT 
ARTERIOVENOUS FISTULA: 
REPORT OF A CASE
J. Ferrer1, M. Barrufet2, M. Burrel2, M. I. Real2, 
R. Gilabert2, M. A. López-Boado1, E. Astudillo1 and 
L. Fernández-Cruz1
1Department of Surgery, ICMDM, Hospital Clinic 
Barcelona, University of Barcelona; 2Imaging Diagnosis 
Center (CDIC), Hospital Clinic Barcelona, University of 
Barcelona
ICMDM, Hospital Clinic Barcelona, Department of 
Surgeryc/Villarroel, 1708036, Barcelona, Spain
Introduction: Simultaneous pancreas-kidney transplant is 
the treatment to choose for patients with type 1 diabetes 
mellitus and end-stage renal disease (ESRD). Vascular com-
plications are not uncommon, but are the main cause of loss 
of the graft. Angiography is used to confi rm or exclude the 
diagnosis and for the management of a known vascular 
abnormality.
Methods: We report the clinical case of a 42-year-old 
woman, with a 12-year history of type 1 diabetes and ESRD. 
A simultaneous kidney-pancreas transplant was performed. 
Pancreas technique was enteric-portal drainage. On the back 
table, the arterial anastomosis of the graft was created end-
to-end between splenic artery (SA) and distal superior mes-
enteric artery (SMA). In the recipient, the arterial anastomosis 
was done end-to-side between the proximal SMA and the 
right iliac artery.
Results: After 10 months to the surgery, the patient was 
admitted in our hospital due to a pancreas graft rejection. The 
ultrasound carried out showed a transplanted kidney with 
preserved structure and a transplanted pancreas with normal 
size and arterial vascularization at a very high speed due to 
arteriovenous fi stula (AVF). Angio-CTscan confi rmed that 
diagnostic. An arteriography of the pancreatic graft and AVF 
embolization was performed. Digital subtraction arteriogram 
obtained via the SMA demonstrated occlusion of the AVF 
after embolization with an Amplatzer, with preservation of 
the main arteries and branches supplying the pancreas. After 
complete embolization, fl ow within the donor splenic artery 
and vein returned.
Conclusion: Interventional radiology could be a useful 
tool to treat the arteriovenous fi stula after pancreas 
transplantation.
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MANAGEMENT AND OUTCOMES OF 
PATIENTS WITH INSULINOMA: 
A RETROSPECTIVE ANALYSIS 
OF 51 PATIENTS
S. Pal1, G. Choubal1, P. Sahni1, S. Gamangatti2, 
N. Tandon3, R. Sharma2, P. Garg4 and 
T. K. Chattopadhyay1
1Dept. GI Surgery & Liver transplantation, AIIMS, New 
Delhi-110029, India; 2Dept. Radiology, AIIMS, New 
Delhi-110029, India; 3Dept. of Endocrinology and 
Metabolism, AIIMS, New Delhi-110029, India; 4Dept. of 
Gastroentrology, AIIMS, New Delhi-110029, India
All India Institute of Medical Sciences, Dept. GI Surgery & 
Liver Transplantation, Ansari Nagar, New Delhi-
11002911002, India
Introduction: Although Insulinomas are the commonest 
islet cell tumors of the pancreas, their localisation can be 
challenging. Of late, successful preoperative localisation 
with advanced techniques has become possible. We present 
our experience with insulinomas with special emphasis on 
effi cacy of localization techniques and surgical outcome.
Methods: We studied all patients operated for hyperinsulin-
emic hyperglycemia (1992–2010). Their demographic 
parameters, symptoms, biochemical profi le, imaging studies, 
intra-operative ultrasound and type of surgery, histopathol-
ogy and postoperative outcome were analyzed. Since 2008, 
endoscopic ultrasound (EUS), DOTATOC-PET-CT and intra 
arterial calcium stimulation tests (IACS) have also been used 
for preoperative localisation. Enucleation, distal pancreatec-
tomy (DP) or pancreatoduodenectomy (PD) was done based 
on intraoperative localisation with IOUS, palpation and size 
of the tumour.
Results: 51 cases (28 M), symptomatic for a mean of 4.6 
yrs were studied. Biochemical diagnosis was made in 56% 
cases, ‘72-hour fast’ was positive in 43%. Dual phase CECT 
could localize in 55% cases, intraop. localisation was suc-
cessful in 91%. Pick-up rates of EUS and IACS were 85.7% 
(6/7) and 75% (3/4) respectively. Insulinomas were located 
in the pancreatic head, body and tail in 15 (29.4%), 13 
(25.4%) and 23 (45%) respectively. Two patients had mul-
tiple tumours, 3 had malignant lesions (1 had MEN syn-
drome). Enucleation, DP and PD were done in 25, 24 and 2 
cases respectively. 2 patients had recurrence of hypoglycae-
mia, of which 1 was successfully reoperated, 4 patients 
developed transient pancreatic fi stulae and 2 died of postop-
erative sepsis.
Conclusion: Accurate perioperative localization of insulin-
omas was achieved in 91% and surgery was successful in 
94% cases. Selective use of EUS and IACS has the potential 
to improve localization.
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MAIN DUCT AND MIXED PANCREATIC 
INTRADUCTAL PAPILLARY MUCINOUS 
NEOPLASM: ANALYSIS OF 
CLINICOPATHOLOGICAL FEATURES 
AND SURGICAL OUTCOMES
A. El-Gendi1, S. El-Gendi2, A. Zeid3 and M. El-Gendi1
1Department of Surgery, Faculty of Medicine, Alexandria 
University, Egypt; 2Department of Pathology, Faculty of 
Medicine, Alexandria University, Egypt; 3Department of 
Internal Medicine, Faculty of Medicine, Alexandria 
University, Egypt
Faculty of Medicine, Alexandria University, Surgery, 440 
El-Horreya Street, Roushdy, 21311, Alexandria, Egypt
Introduction: Intraductal papillary mucinous neoplasms 
(IPMNs) are increasingly recognized entities, whose man-
agement remains sometimes controversial, due to the high 
rate of benign lesions and on the other side to the good sur-
vival after resection of malignant ones. We present our expe-
rience with resected pancreatic tumors found to be IPMN, 
with the aim to underline the clinical problems they set, 
related both to the diagnostic procedures and to the therapeu-
tic indication including extent of surgical resection.
Methods: Between March 2007 and September 2011, 25 
patients presented with operable non metastatic pancreatic 
cystic tumors. 10/25 were resected and diagnosed as IPMN 
and were subject to further analysis of clinicopathologic 
data, diagnostic procedures, extent of surgical resection, his-
topathology, disease free survival and recurrence.
Results: 80% of patients were symptomatic; the cholangio-
MRI diagnostic accuracy was 90%. One patient underwent 
pancreaticoduodenectomy, 9 total pancreatectomies with 
morbidity of 40 and 0% hospital mortality with median hos-
pital stay of 8 days. Main duct and mixed type were found 
in 7.3 patients respectively; this corresponded to the preop-
erative imaging classifi cation in 70%. 6/10 resected lesions 
were malignant (3 in situ and 3 invasive carcinoma) which 
corresponds to preoperative diagnostic accuracy of 66.6%. 
2/6 malignant patients had metastatic nodes and had a relapse 
after 14 months and deceased 17 months after the operation. 
The mean follow-up was 18 months (range 9–32); 6/10 
patients are alive and disease-free, 2 died from cardiac 
condition.
Conclusion: IPMN especially the main duct or mixed type 
warrants complete resection due to its signifi cant malignant 
potential and multifocal pattern. Therapeutic indication for 
IPMNs is mainly based upon radiological evaluation of the 
risk of malignancy. Total pancreatectomy was tolerated in all 
patients with minimal morbidity and mortality and produces 
excellent long-term survival for both noninvasive and inva-
sive tumors.
374
SURGICAL OUTCOME OF 
PANCREATICODUODENECTOMY AT A 
LOW-VOLUME COMMUNITY HOSPITAL 
IN JAPAN
M. Ikeda, E. Daisuke and A. Nobuyoshi
Kohnodai Hospital, National Center for Global Health and 
Medicine, Department of Surgery
Kohnodai Hospital, National Center for Global Health and 
Medicine, Department of Surgery, 1-7-1, Kohnodai, 
Ichikawa-shi, 272, Chiba, Japan
Introduction: In Clinical Practice Guidelines for Pancreatic 
Cancer published by the Japan Pancreas Society, patients 
with pancreatic cancer are recommended to receive pancre-
atic surgery in so-called high volume centers, because of low 
incidence of postoperative complications and excellent skills 
in management of those. However, not all patients can 
receive pancreatic surgery only in high volume centers. We 
would like to report out results of PD in an average Japanese 
community hospital.
Methods: Twenty-three patients performed PD in our hos-
pital from January 1998 to December 2011. These cases are 
retrospectively analysed including background characteris-
tics of patients, operative procedures and perioperative 
outcomes.
To reduce surgical complication, we change the way of 
reconstruction from double Roux-Y to modifi ed Child in 
2008. Anastomosis between pancreatic duct to mucosal layer 
of the jejuna loop with drainage tube has been used since 
2006, and Kakita method have been used since 2008. 
Omental fl ap was placed behind the stump of pancreas in 
almost all cases.
Results: Mean age was 69 years old (41–89). Pancreas head 
carcinoma and carcinoma of the ampulla of Vater were each 
seven cases, distal cholangiocarcinoma was six. PD was per-
formed sixteen cases, pylorus preserving PD was seven, 
combined portal vein resection was four. Mean operative 
time was 540 min. (426–1133), intraoperative blood loss was 
945 ml (489–5368), nine patients were received intraopera-
tive blood transfusion. Mean length of hospital stay was 45 
days (18–100). There is no mortarity. About morbidity, pan-
creas juice fi stula or infection were seen eleven cases (50%) 
including one case which needed re-laparotomy for drainage. 
Appetite loss or delayed gastric emptying were seen nine 
case.
Conclusion: The biggest advantage of community hospital 
is that patients can be taken care consistently in the same 
hospital from surgery to chemotherapy. This gives patients 
convenience and confi dence especially in elderly. We believe 
that the quality of PD depends on personal experience and 
skills of each surgeons as well as volume of institutions. If 
the surgeon is specialist of pancreatic surgery and can secure 
quality of PD, to perform PD in low volume hospitals is 
medically and socially acceptable.
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SHORT TERM RESULTS AND LONG 
TERM SURVIVAL IN 168 CONSECUTIVE 
PATIENTS TREATED WITH RFA 
ABLATION FOR STAGE III PANCREATIC 
CANCER: RESULTS FROM A 
SINGLE INSISTUTION
R. Girelli1, I. Frigerio1, P. Regi1, A. Giardino1, R. Salvia2 
and C. Bassi2
1Hpb Surgical Unit, Pederzoli Clinic, Peschiera Del 
Garda, Verona
2Surgical Department, University Of Verona
Hpb Surgical Unitvia Molte Baldo 2437019, Peschiera del 
Garda, Italy
Introduction: Radiofrequency ablation (RFA) is an 
accepted procedure for unresectable solid tumors and we 
previously demonstrated its applicability in Stage III pancre-
atic carcinoma where the gold standard therapies lead to a 
survival rate of 12–14 months depending on series. Here we 
present our series of 167 patients consecutively treated in a 
single institution.
Methods: Patients with Stage III ductal carcinoma were 
prospectively enrolled for the study. RFA was performed 
during laparotomy and associated to palliative surgery when 
needed. Pancreatic fi stula, duodenal injuries and thrombosis 
of portal vein or SMV were considered as RFA-related com-
plications. After surgery all patients were sent to the oncolo-
gist to receive chemo and radiotherapy (CTRT) and follow 
up was updated every three months. Progression free sur-
vival (PFS) and overall survival (OS) were evaluated only in 
patients with a minimum follow up (FU) of 12 months.
Results: Between February 2007 and November 2011, 167 
patients were treated with RFA in our institution. Males were 
95 and the median age was 64 yrs (range 36–80). Tumor was 
located in the head/uncinate process in 123 cases (73.6%) 
and palliative surgery was associated in 78 pts (47.5%). RFA 
as up front treatment was carried out in 67 cases (40%) and 
128 pts completed the adjuvant CTRT after RFA. RFA-
related morbidity occurred in 22 pts (13%) and 9 pts expe-
rienced multiple complications (5.3%). Mortality rate due to 
the procedure was 2.3%. Median FU was 11 months (IQR: 
5–20) and 133 pts were eligible for survival statistics: in this 
group median overall survival was 19 months (IQR: 10–27) 
with a PFS of 12 months.
Conclusion: RFA might be a new option to treat patients 
with Stage III pancreatic cancer and must be associated with 
chemo and radiotherapy. Promising results in term of pro-
longed survival is a strong push to pursue with a randomized 
study.
383
ARTERIAL INFUSION OF A SUSPENSION 
OF HYDROCORTISONE IN THE 
BLOODSTREAM OF THE 
PANCREAS IN PATIENTS WITH 
CHRONIC PANCREATITIS
A. Mikhaylov, V. Gervaziev, V. Lubyanskii and 
T. Kharlamova
Barnaul, Altai State Medical University
Altai State Medical University, Department of Hospital 
Surgery, Malakhova Street 79-a-33, 65603, Barnaul, Altay 
Region, Russian Federation
Introduction: Hypertension in terminal pancreatic ducts 
due to mikroautolisis destroys functionally active cells. It 
brings up a chronic infl ammation with multifocal or diffuse 
lymphocytic infi ltration of the lobules, the interlobular 
stroma, leading to activation of connective tissue cells, fi bro-
sis, and forms a small compression of the outfl ow tracts. 
Surgical treatment of Frey and Beger has no effect on func-
tional status, the drainage function and infl ammation in the 
remaining parenchyma of the pancreas.
Methods: The clinic of hospital surgery ASMU used a pat-
ented the method of organ drug treatment on the pancreas by 
means of long-term (5 days) infusion of a suspension of 
hydrocortisone 50 mg/day in the gastroduodenal artery to 19 
patients with chronic pancreatitis. The method provides an 
impact on chronic infl ammation and autoimmune processes 
during dissolution and diffusion of the glucocorticoid in 
breast tissue. Purpose: To provide prolonged anti-infl amma-
tory, immunosuppressive, and antifi brotic effects of anes-
thetic into the tissue of the pancreas. For indirect control of 
organ blood fl ow of the pancreas using our proposed method 
and reoarteriogastrografi i reoarteriogepatografi i.
Results: All patients had better clinical condition and bio-
chemical parameters as well as the reduction of pain. 
According to reoarteriografi i the blood supply practically 
didn’t change. For 2–3 days a little more pain in the epigas-
trium was indicated. This can be explained by saturation of 
the arterial bed of organ crystals hydrocortisone, relative 
ischemia and requires the arterial administration of antispas-
modics (procaine). After treatment and discharge patients 
note stabilization of the clinical condition, weight gain, and 
better quality of life.
Conclusion: When treating patients with chronic pancreati-
tis it is necessary to follow the concept of the free recovery 
of capillary drainage of pancreatic juice directly from the 
gland lobules, which is achieved by elimination of the 
infl ammation, including autoimmune limiting of the fi brosis 
expansion, leading to parenchymal, ductal compression.
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ONE LAYER END-TO-SIDE 
PANCREATICOJEJUNOSTOMY USING 
REINFORCEMENT SUTURE ON 
PANCREATIC STUMP
Y. J. Kwon, H. K. Park, K. S. Lee and K. G. Lee
Department of Surgery, College of Medicine, Hanyang 
University, 17 Haengdang-dong, Seongdong-gu, Seoul, 
Korea
College of Medicine, Hanyang University, Department of 
Surgery, 17 Haengdang-dong, Seongdong-gu, Seoul, Korea
Introduction: Pancreaticoduodenectomy is associated with 
a high incidence of postoperative morbidity and pancreatic 
fi stula is the most important complication. The incidence of 
a pancreatic fi stula did not change in the past decade. So we 
designed modifi ed method of pancraticojejunosotmy using 
reinforcement suture on pancreatic stump that prevent 
serious complication of pancreatic fi stula.
Methods: All surgical procedures were performed by one 
surgeon. This procedure is performed as follow: fi rst, insert 
a soft rubber catheter in pancreatic duct, then reinforcement 
sutures are performed with 3-0 vicryl. This sutures are paral-
lel with cut edge of the pancreatic stump, and 5 mm apart 
form cut edge. The whole layer of jejunum is sewed to the 
pancreas including reinforcement suture.
Results: Between July 2002 and November 2011, 52 con-
secutive cases of pancreaticoduodenectomy were performed 
using this method. The median operative time were 441 
minutes. One patient underwent a relaparotomy on day 6 for 
anastomosis leakage of transverse colon. One patient devel-
oped pancreatic leakage and died of sepsis. We used The 
International Study Group for Pancreatic Surgery (ISGPS) 
severity grading for postoperative pancreatic fi stula (POPF) 
and delayed gastric emptying (DGE). There were 1 grade A 
fi stula (1.9%), 16 grade B fi stulas (30.8%), and 2 grade C 
fi stulas (3.8%). The rate of grade B and C fi stula was 34.6%. 
There were 5 clinically relevant grade B and C DGE (9.6%).
Conclusion: This method is one layer anastomosis that is 
simple and easy to perform, so it is possible to save operative 
time. And this method is not much affected by surgical tech-
nique. Even though this method can’t prevent pancreatic 
fi stula itself, it can prevent life-threatening complete break-
down of pancreaticojejunostomy especially for soft pancreas, 
because posterior wall of anastomosis is stable in this 
method.
390
THE NUMBER OF FAILED ORGANS AND 
THE REPONSE TO THERAPY 
DETERMINES OUTCOME IN PATIENTS 
WITH ACUTE PANCREATITIS 
REQUIRING LEVEL 1 ORGAN SUPPORT
S. Farid1, G. M. Stiff1, A Baker1, G. Bonney1, A. Khan1, 
A. Breen2 and A. Smith1
1Department of HPB/Transplant Surgery; 2Department of 
Intensive Care Medicine
St James University Hospital, HPB/Transplant Surgery, St 
James University Hospital, Beckett St, Leeds LS9 7TF, 
United Kingdom
Introduction: To establish if the number of organs failing 
at admission to the ICU, and response to support had a 
bearing on outcome in patients with severe acute pancreatitis 
(SAP).
Methods: Only SAP patients requiring organ support were 
included in the analysis. Gallstones (55%) and alcohol were 
the commonest aetiologies. The proportion of patients with 
1, 2 or 3 system failure at baseline, 24, 48, and 72 hours were 
calculated and related to outcome.
Results: 123 patients (85 male and 38 female) with a mean 
age of 58 years met the study criteria. Numbers presenting 
with 1, 2 and 3 organ failure were 29, 70 and 24 of which 6 
(21%), 29 (41%), and 14 (48%) respectively died. Subsequent 
fi gures were: 24, 57 and 39 with mortalities of 4 (17%), 19 
(33%), and 24 (62%) at 24 hours; 21, 53 and 43 with mortali-
ties of 2 (10%), 18 (34%), and 26 (60%) at 48 hours; and 17, 
49 and 45 with mortalities of 0 (0%), 16 (33%), and 28 (62%) 
at 72 hours.
Conclusion: This data allows prognostication of patients 
with SAP requiring organ support. At 72 hrs, the prognosis 
of patients with single organ failure is excellent and that of 
patients with 3-organ failure remains poor.
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ASSESSING THE POTENTIAL OF NOTCH 
AS A BIOMARKER FOR PANCREATIC 
DUCTAL ADENOCARCINOMA
M. Masood1, C. Mann1, C. Neal1 and D. Berry2
1University Hospitals of Leicester NHS Trust; 2University 
Hospital of Wales
University Hospitals of Leicester NHS Trust, Hepatobiliary 
and Pancreatic Surgery, Leicester General Hospital, 
Gwendolen Road, Leicester, LE54P, UK
Introduction: Pancreatic cancer is an aggressive malig-
nancy with low survival rates mainly due to late presentation. 
Novel biomarkers are urgently required to improve patient 
outcomes. Abnormal Notch signalling has been implicated 
in pancreatic intraepithelial neoplasia. Notch signalling 
involves several sequential cleavages. S4 cleavage results in 
a peptide fragment being secreted into extracellular fl uid. 
Our aim is to detect this peptide fragment in patients with 
resectable pancreatic adenocarcinoma.
Methods: Solid Phase Extraction was performed on pancre-
atic cancer cell culture medium. The purifi ed samples were 
further enriched by immunoprecipitation using a validated 
antibody against the Notch 1 peptide bound to dynabeads. 
The enriched solution was analysed by MALDI-MS and 
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Notch 1 peptide was detected. This same procedure was 
repeated on healthy human plasma and no Notch 1 peptide 
was detected. Next, healthy human plasma was spiked with 
synthetic Notch 1 peptide which was then detectable. The 
limit of detection was determined, and plasma from 20 
PDAC patients and 5 healthy volunteers were analysed.
Results: The limit of detection for the Notch 1 peptide frag-
ment was 167 Fm/µL. However, Notch 1 peptide was not 
detected in any patient samples or in those from healthy 
volunteers. Using an antibody against the Notch 3 peptide, 
we were able to detect this fragment in 5/5 patient samples 
and 5/5 healthy volunteers.
Conclusion: MALDI-MS did not detect the Notch 1 peptide 
in plasma to enable its use as a potential biomarker for 
PDAC. Other methods of detection, such as ELISA need to 
be considered. More work also needs to be done on Notch 3 
using MALDI-MS to determine its potential usefulness in a 
panel of biomarkers for PDAC.
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RESULTS OF SURGICAL TREATMENT 
WITHOUT POSTOPERATIVE 
STEROID THERAPY FOR 
AUTOIMMUNE PANCREATITIS
T. Hatsuno, K. Kondo, M. Kataoka, H. Nakayama, 
S. Shimoyama, N. Takano, H. Tanaka and H. Ishihara
National Hospital Organization Nagoya Medical Center
National Hospital Organization Nagoya Medical Center, 
Surgery, 4-1-1 Sannomaru Naka-ku, 460, Nagoya, Japan
Introduction: Since the revision of Clinical Diagnostic 
Criteria for Autoimmune Pancreatitis (AIP) 2006, many 
cases of localized AIP have been reported. But postoperative 
results of these cases have been reported rarely.
Methods: We present two cases of result of surgical treat-
ment without postoperative steroid therapy for AIP in our 
hospital.
Results: Case 1: A 52-year-old man was diagnosed as 
having pancreatic double cancer in the pancreatic body. 
Therefore, distal pancreatectomy was performed. Pathological 
diagnosis was AIP. The appearance of intraductal pancreatic 
stone is recognized at the pancreatic head and the image of 
MPD on MRCP is changing from normal to bead-like dilata-
tion during a 4-year-follow-up.
Case 2: A 69-year-old man was diagnosed as having pan-
creatic head carcinoma. Therefore, PpPD was performed. 
Pathological diagnosis was AIP and IgG4-related sclerosing 
cholangitis. The relapse of AIP is not recognized at the pan-
creatic body and tail during a 3-year-follow-up.
Conclusion: We have to clarify long-term postoperative 
prognosis of AIP. Some patients with AIP show exocrine and 
endocrine disfunction, and develop DM. In some cases, 
steroid therapy improves these abnormalities. So, we have to 
treat some cases with surgical treatment by postoperative 
steroid administration.
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PERCUTANEOUS NECROSECTOMY IN 
INFECTED PANCREATIC NECROSIS
I. Khomyak, V. Kopchak and K. Kopchak
National Institute of Surgery and Transplantology named 
after O. Shalimov
National Institute of Surgery and Transplantology named 
after O. Shalimov, Pancreatic and Bile Ducts Surgery, 
Yablonskoi Str. 2, 773058, Kyiv, Ukraine
Introduction: Treatment of acute necrotizing pancreatitis 
(ANP) is a challenging medical and social problem, while 
the disease could cause serious complications and death.
Methods: We have analyzed the results of treatment of 231 
patients with ANP, treated in our clinic in the period of 
2006–2010 years. Infected necrosis with septic complica-
tions was diagnosed in 111 (48.05%) patients. There were 56 
(24.24%) female patients and – 175 (75.76%) male patients, 
with an age, ranging from 18 to 79 years. Main group com-
prised of 14 patients with ANP, mainly with separated necro-
sis, in which percutaneous necrosectomy was done. In all 
patients ultrasound-controlled draining of peripancreatic 
fl uid collections was done. Indications for the procedure was 
insuffi cient drainage of the peripancreatic fl uid collection. In 
all patients drainages were put in the retroperitoneal space. 
In 13 patients necrosectomy was done in cases of left peri-
pancreatic fl uid collections, in 1 patient – in case of right 
retroperitoneal abscess. Drainages were taken away after 
complete stop of fl uid output.
Results: Retroperitoneal necrosectomy was successful in 14 
patients. In 2 patients reoperation was needed 8 and 12 days 
after procedure due to the progression of the disease. 
Drainages were taken away in patients on 5–34 postoperative 
days. No postoperative mortality and no procedure-depend-
ing complications were observed in this group of patients. In 
the late postoperative period pancreatic pseudocyst occurred 
in 1 patient and chronic pancreatic fi stula was formed in 1 
patient.
Conclusion: Percutaneous necrosectomy could be success-
fully applied in a selective group of patients and let surgeon 
to avoid unnecessary traumatic laparotomies and generaliza-
tion of the infection process.
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FDG-PET INCIDENTAL DETECTION 
OF SECOND CANCER DURING 
INVESTIGATION FOR 
PANCREATIC DESEASES
C. Pasquali1, C. Sperti1, V. Beltrame1, B. Bellamio1, 
S. Bissoli2, F. Chierichetti2 and T. Morbin3
1Pancreatic and Endocrine Digestive Surgical Unit, Clinica 
Chirurgica IV, University of Padua; 2Nuclear Medicine, 
Castelfranco General Hospital, Castelfranco Veneto, 
Treviso; 3Clinica Chirurgica I, University of Padua
Clinica Chirurgica IV, University of Padua, Medical and 
Surgical Sciencesvia Giustiniani 235128, Padova, Italy
Introduction: Positron Emission Tomography/computed 
tomography (PET/CT) is currently used for cancer staging, 
including pancreatic neoplasms. In the course of performing 
whole-body FDG-PET, an unexpected region of FDG uptake 
may be identifi ed: this raises the possibility of a new malig-
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nancy which may require further evaluation. This study 
evaluated our fi ndings of second primary cancer incidentally 
discovered during PET/CT examination of patients initially 
investigated or followed-up for pancreatic disease.
Methods: We performed a retrospective evaluation of a pro-
spectively collected data base of 305 patients with pancreatic 
pathology who were evaluated by whole body PET/CT 
imaging from January 2004 to October 2010. In this series, 
274 patients were scanned before treatment and 31 during 
the course of their follow-up (pancreatic cancer). Median 
follow-up time was 29 months (range 14–124).
Results: Twenty-nine patients (9.5%) had pathologic uptake 
of FDG in their organs, and 24 (7.8%) had second primary 
cancers revealed by PET/CT imaging. Of these, 15 tumors 
(62.5%) were synchronous (found at initial evaluation). 
Pancreatic disease included: pancreatic cancer (n = 5), 
IPMNs (n = 9), mucinous cystadenoma (n = 1). Second 
cancer was located in the colon (n = 12), right ureter (n = 1), 
duodenum (n = 1) and breast (n = 1): 13 patients underwent 
surgical resection and 2 endoscopic excision (colonic 
adenoma with high grade dysplasia). Second cancer involved 
the colon (n = 5), lung (n = 3) and larynx (n = 1). All but 
one second tumor were resected: 2 patients died for pancre-
atic cancer progression, 7 are alive and free from disease 
from 6 to 101 months.
Conclusion: Synchronous or metacronous second primary 
cancer may be identifi ed by PET/CT in a small, but signifi -
cant proportion of patients with pancreatic diseases. An addi-
tional diagnostic work-up is essential when abnormal 
fi ndings, indicative for a second primary cancer, are obtained 
on PET/CT images to rule out the presence of second 
malignancy.
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CRITICAL CARE RESOURCE USE AND 
MORTALITY FROM SEVERE ACUTE 
PANCREATITIS IN SCOTLAND: 
2008 TO 2010
D. Mole1, C. Haddow2, B. Cook3, R. Ravindran5, 
D. W. McKeown4, M. S. Duxbury1, O. J. Garden1 
and R. W. Parks1
1Clinical Surgery, University of Edinburgh; 2Scottish 
Intensive Care Society Audit Group (SICSAG), Information 
Services Division NHS Scotland; 3SICSAG and Anaesthesia 
and Critical Care, Royal Infi rmary of Edinburgh; 
4Anaesthesia and Critical Care, Royal Infi rmary of 
Edinburgh; 5General Surgery, Royal Infi rmary of Edinburgh
Clinical Surgery, University of Edinburgh, Royal Infi rmary 
of Edinburgh, 51 Little France Crescent, Edinburgh EH16 
4SA, United Kingdom
Introduction: Acute pancreatitis (AP) remains an important 
healthcare problem with signifi cant morbidity and mortality. 
When AP leads to extrapancreatic organ dysfunction or local 
complications, patients often require monitoring and support 
in a critical care environment. The aim of this study was to 
document the extent of critical care resource utilisation 
resulting from AP in Scotland.
Methods: The Scottish Intensive Care Society Audit Group 
prospectively collects information on all high-dependency 
unit (HDU) and intensive care unit (ICU) admissions on a 
national basis. Using this resource, all patients with AP who 
required critical care support from 2008 to 2010 inclusive 
were identifi ed. Episodes and outcomes were analysed taking 
into account continuous stays within one unit, readmissions 
to critical care within one hospital, inter-hospital transfers 
and cumulative critical care stays. Record linkage with the 
Scottish Information Services Division database SMR01 was 
used to enhance the accuracy of outcome analysis.
Results: During the study period 2235 critical care episodes 
due to AP were identifi ed. Median continuous length of stay 
in HDU was 3.0 days and in ICU was 5.0 days. AP or its 
complications accounted for 2.6% of all available HDU bed 
occupancy and 3.2% of all available ICU bed occupancy in 
Scotland. Mortality during a single critical care episode due 
to AP was 10.0%. When calculated for a single hospital 
admission due to AP (when patients may have had one or 
more than one critical care episode), mortality was 19.2%. 
When calculated for all patients with AP requiring critical 
care, including those transferred between critical care units 
at different hospitals, mortality was 20.9%. No major differ-
ences were seen between the individual years studied.
Conclusion: AP is a serious condition which utilises a sig-
nifi cant proportion of critical care resources. Mortality for 
those patients with severe AP who require critical care 
admission remains high.
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DO MULTIPLE DEPRIVATION INDEX 
SCORES CORRELATE WITH THE 
PREVALENCE AND OUTCOME OF 
PANCREATIC AND PERIAMPULLARY 
CANCER IN WEST YORKSHIRE?
M. Hamed, J. Pine, A. M. Smith and G. Morris-Stiff
Pancreatic Surgery Unit, St James’s University Hospital, 
Leeds, England
St James’s University Hospital, Pancreatic Surgery, Beckett 
Street, LS9 7TF, Leeds, England
Introduction: Pancreatic cancer is associated with both 
smoking and heavy alcohol consumption both of which are 
linked with social deprivation. The aim of this study was to 
assess whether the prevalence of pancreatic/periampullary 
carcinomas was related to multiple deprivation index (MDI) 
scores.
Methods: Patients discussed at pancreatic MDT during the 
period 2006–2010 were identifi ed from a departmental 
database and postcode data extracted for MDI score 
calculation.
Results: 782 patients, with MDI scores calculable for 766 
(97.9%). The MDI scores were grouped into quintiles [1 
most and 5 least affl uent]: 1 (n = 164); 2 (n = 175); 3 (n = 
137); 4 (n = 135); and 5 (n = 155). 122 (15.7%) patients 
underwent resection. Signifi cant differences existed in 
gender distribution: a male predominance in 1&2 
(186M/153F) and a female predominance in 3&4 (123M/67F). 
Mean age at presentation was higher in 1&2 quintiles at 69.4 
vs 67.8 years. More patients in 1&2 quintiles underwent 
surgery (19.2% vs 11.7%). The overall median survival of 
the 1&2 quintiles was better at 6.4 months [IQR: 2.4–12.7] 
vs 4.6 months [IQR: 1.9–11.3], however, there was no sig-
nifi cant difference following resection (14.8 [IQR: 7.4–24.5] 
vs 14.3 [IQR: 7.9–24.8].
634 Poster Presentation Abstracts
© 2012 The Authors
HPB © 2012 Americas Hepato-Pancreato-Biliary Association HPB 2012, 14 (Suppl. 2), 288–699
Conclusion: Signifi cant differences in demographic profi les 
in relation to MDIs were noted, survival being a little better 
for quintiles 1&2 although this disappears for patients under-
going resection.
415
LYMPHOEPITHELIAL CYSTS OF THE 
PANCREAS: A MANAGEMENT DILEMMA
J. Martin1, K. J. Roberts1, G. Morris-Stiff1, G. Falk2, 
M. Sheridan3, C. Verbeke4, R. M. Walsh2 and 
A. M. Smith1
1Pancreatic Surgery Unit, St James’s University Hospital, 
Leeds, England; 2Section of Surgical Oncology/HPB, 
Cleveland Clinc, Cleveland, USA; 3Department of 
Radiology, St James’s University Hospital, Leeds, England; 
4Department of Histopathology, Karolinska Institute, 
Stockholm, Sweden
St James’s University Hospital, Pancreatic Surgery, Beckett 
Street, LS9 7TF, Leeds, England
Introduction: Pancreatic lymphoepitheilal cysts are rare, 
benign lesions and as such they are often an unexpected 
histopathological fi nding following excision of a cystic 
lesion. The aims of this study were to review the experience 
in management of lymphoepithelial cysts in order determine 
if a specifi c profi le exists that may allow their pre-operative 
diagnosis.
Methods: The histopathology databases of 2 large volume 
pancreatic centers were searched to identify all cases of lym-
phoepithelial cyst undergoing resection. Notes were reviewed 
to determine patient demographic details, mode of presenta-
tion, investigations, treatment and outcome.
Results: Six male patients were identifi ed with a median age 
of 60.5 years. Four were asymptomatic fi ndings, and 2 
reported abdominal pain. All patients underwent CT scans, 
3 of 6 MRI and 5 of 6 EUS. Five patients had lesions in the 
tail and one in the body of the pancreas. 5 of 6 had single 
cysts and 1 had 2 closely approximated cysts. The median 
cyst size was 5 cm. There were no characteristic features 
identifi ed on cross-sectional imaging, EUS or cyst fl uid 
analysis. The pre-operative diagnosis was mucinous cystic 
neoplasm in all cases. All patients were treated by means of 
distal pancreatectomy and splenectomy at which point the 
diagnosis was established.
Conclusion: Pancreatic lymphoepithelial cysts appear to be 
more common in males in the 6th and 7th decades of life, 
are usually large, single and asymptomatic, being located in 
the tail of the pancreas. However, the lack of diagnostic 
radiological features means that they are likely to continue 
to be a histopathological diagnosis.
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THE MULTIDISCIPLINARY 
MANAGEMENT OF INDIVIDUALS WITH 
NEOPLASTIC PANCREATIC CYSTS 
FREQUENTLY ALTERS DIAGNOSIS AND 
TREATMENT IN COMPARISON TO 
SINGLE PROVIDER CARE
L. Manos, V. Kiswani, N. Ahuja, E. Fishman, R. Hruban, 
M. of T. M. P. C. Program, C. Wolfgang and 
A. M. Lennon
Johns Hopkins Medical Institutions
Johns Hopkins Medical Institutions, Surgery, 600 N. Wolfe 
St., Halsted 60021287, Baltimore, MD, USA
Introduction: Incidental pancreatic cysts are a diverse 
group of neoplasms that range from completely benign to 
precancerous or cancerous. Improper management may 
potentially result in unnecessary surgery or under-treatment 
of a potentially curable malignancy. In light of the known 
benefi t of multidisciplinary cancer management, we sought 
to determine whether a multidisciplinary program for cystic 
neoplasms has the potential to improve care for these 
individuals.
Methods: The records of all patients seen at our 
Multidisciplinary Pancreatic Cyst Program Clinic (MDC) 
from 01/01/2010 to 12/01/2011 were reviewed, and the clini-
cal, radiologic diagnoses and management recommendations 
from the patient’s previous treating institution/referring phy-
sician were documented and compared to the diagnosis and 
management plan of the MDC. Alterations in diagnosis and/
or management between the previous treating institution/
referring physician and the MDC were recorded. Patient 
outcomes were also assessed.
Results: 306 patients were seen at MDC. 291 patients had 
a diagnosis documented prior to MDC evaluation. 127 
patients (43.6%; p ≤ 0.001) had a change in diagnosis fol-
lowing review at the MDC. The presumptive diagnosis fol-
lowing MDC evaluation was: IPMN (n = 204), serous 
cystadenoma (n = 14), pancreatic neuroendocrine tumor (n 
= 6), pseudocyst (n = 3), mucinous cystic neoplasm (n = 2), 
adenocarcinoma (n = 4), solid pseudopapillary tumor (n = 
1), and other (n = 52). In 5 patients no cyst was present. 283 
patients had an outside management plan, which was altered 
in 69 individuals (24.4%; p < 0.001). 36% of those with a 
diagnosis change also had a treatment change compared to a 
change in treatment in 16% of those without a change in 
diagnosis (p = 0.0001).
Conclusion: A multidisciplinary approach signifi cantly 
alters the diagnosis and management of individuals with 
pancreatic cysts. To our knowledge this is the fi rst study to 
report results on the impact of an MDC approach to the 
management of neoplastic pancreatic cysts. Long-term fol-
low-up will be needed to determine if this approach trans-
lates into improved outcomes.
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POST-OPERATIVE DAY ONE 
C-REACTIVE PROTEIN AS A POTENTIAL 
MARKER FOR PANCREATIC LEAK POST 
PANCREATICODUODENECTOMY
R. Storey, I. Anderson, Z. Hamady, G. Marangoni, 
K. Menon, A. Aldoori and S. Andrew
Division of Hepatobilary & Pancreatic Surgery, 
Department of Surgery, St. James’s University Hospital, 
Leeds, United Kingdom
St. James’s University Hospital, Leeds, United Kingdom
Division of Hepatobilary & Pancreatic Surgery, St James 
University Hospital, Beckett Street, West Yorkshire, Leeds 
LS9, England
Introduction: Pancreaticoduodenectomy is a major proce-
dure associated with 5% mortality and 30% morbidity. Post-
operative pancreatic fi stula, with an incidence between 5 & 
20% has been reported as one of the most serious complica-
tions. The use of CRP as a marker for developing infl amma-
tory complications remains unclear. It remains diffi cult to 
differentiate a normal post-operative infl ammatory response 
from developing infl ammatory complications.
Methods: Data was collected from 368 patients who had 
undergone pancreaticoduodenectomy over an 8-year period 
(June 2002–Dec 2010). Pancreatic fi stula was defi ned as per 
the International Study Group for Pancreatic Fistula, as any 
measurable volume of fl uid on or after post-operative day 3 
with amylase content greater than 3 times the serum activity. 
CRP levels taken on day-1 were documented and analysed 
for there use as a potential marker for developing pancreatic 
fi stula.
Results: Overall median follow up was 32-months with a 
44-month median survival (95%CI = 25.8–62.8). 30-day 
mortality was 2.6% with an overall 33% morbidity. Pancreatic 
fi stula occurred in 9% (n = 32) patients. Patients who devel-
oped a pancreatic fi stula compared to those without had a 
median hospital stay of 27 versus 14 days. A CRP >100 on 
day one, was found to be associated with developing pancre-
atic fi stula (p = 0.024).
Conclusion: CRP may have a potential role in the 
early prediction of developing pancreatic leak post 
pancreaticoduodenectomy.
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PANCREATODUODENECTOMY 
PERFORMED BY MEDICAL RESIDENTS 
OF THE DIGESTIVE SURGERY. 
CASE SERIES
E. Ettinger1, P. Amaral1, R. Santan1, P. V. Soares3, 
F. Silano2 and L. Dias3
1Staff of Digestive Surgery, Hospital São Rafael, Salvador, 
Brazil; 3Medical Resident of General Surgery, Hospital São 
Rafael, Salvador, Brazil; 2Medical Resident of Digestive 
Surgery, Hospital São Rafael, Salvador, Brazil
Hospital São Rafael, Digestive Surgery, Av. São Rafael, 
2152, São Marcos. 41253, Salvador, Brazil
Introduction: Pancreatoduodenectomy have high rates of 
morbidity and mortality even in referral centers, therefore the 
training of surgeons is a challenge. The objective of 
this study is to analyze surgeries performed by residents, 
compared with surgeries performed by expert surgeons in the 
period 2008 to 2010.
Methods: Nineteen pancreatoduodenectomies were held by 
residents of the service in three years. The data were cata-
loged through standardized forms during hospitalization of 
patients, and compared with results of expert surgeons found 
at literature in the last 5 years. The data were statistically 
analyzed using SPSS, version 15.0.
Results: In all cases the pylorus was preserved and feeding 
jejunostomy were made. The reconstruction of digestive tract 
was performed with single handle trans-meso-colic duode-
nojejunostomy and choledochojejunostomy; pancreaticoje-
junostomy were duct-to-mucosa with prosthesis. The etiology 
of the disease involved both benign and malignant lesions. 
Complications related to surgery occurred: gastroparesis in 
10.5%, pancreatic fi stula in 10.5%, gastrointestinal bleeding 
15.8%, surgical site infection in 21%, liver abscess in 5.2% 
and sepsis without focus set at 5.2%. The average stay in 
hospital was 16 days. There were two deaths (10.5%) in the 
sample, with a focus on respiratory sepsis to septic shock and 
another source not established.
Conclusion: We present a series of private hospital in pan-
creatoduodenectomy held by training surgeons of gastroin-
testinal surgery, rates of morbidity and mortality consistent 
with the literature.
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ANTERIOR AND LATERAL APPROACHS 
TO VIDEOLAPAROSCOPIC DISTAL 
PANCREATECTOMY WITH 
SPLEEN PRESERVATION
P. Amaral1, E. Ettinger1, R. Santana1, F. Silano2, 
P. V. Soares3 and A. Bacelar3
1Staff of Digestive Surgery, Hospital São Rafael, Salvador, 
Brazil; 2Medical Resident of Digestive Surgery, Hospital 
São Rafael, Salvador, Brazil; 3Medical Resident of General 
Surgery, Hospital São Rafael, Salvador, Brazil
Hospital São Rafael, Digestive Surgery, Av. São Rafael, 
2152, São Marcos. 41253, Salvador, Brazil
Introduction: The surgical approach of the pancreas is still 
associated to high morbidity and mortality as a result of the 
complex nature of this organ. Its retroperitoneal topography, 
anatomical relations and peculiarities of the tissue makes 
pancreatic surgery a challenge. The objective of this study is 
to present two surgical laparoscopic techniques – anterior 
and lateral – for pancreatic lesions resection.
Methods: We analyzed data from nine patients who under-
went videolaparoscopic distal pancreatectomy between the 
period of 2005 to 2010. The data were cataloged through 
standardized forms during hospitalization of patients and 
statistically analyzed by SPSS version 15.0.
Results: Nine patients underwent laparoscopic distal pan-
createctomy, fi ve by the anterior technique (opening epí-
ploon retrocavity), whose lesion was in the pancreatic body, 
and four by lateral technique (release of the splenic angle of 
the left colon), whose injury was in the pancreatic tail. Two 
patients had a BMI > 35 kg/m², one underwent anterior pan-
createctomy and the other lateral pancreatectomy. The mean 
duration of surgery was of 150 minutes by the lateral tech-
nique and of 270 minutes by the anterior technique. There 
was no injury to adjacent organs, intra-operative bleeding or 
need for blood transfusion.
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Conclusion: In this series, both techniques were effective 
in addressing the laparoscopic distal pancreatectomy. The 
anterior technique was used in lesions of the pancreatic body 
and lateral in lesions of the tail.
430
LYMPH NODE RATIO AS A MARKER 
OF PROGNOSIS FOLLOWING 
PANCREATICODUODENECTOMY 
FOR ADENOCARCINOMA
R. Storey, Z. Hamady, G. Marangoni, K. Menon, 
A. Aldoori and A. Smith
St. James’s University Hospital, Leeds, United Kingdom
St. James’s University Hospital, Leeds, United Kingdom; 
Division of Hepatobilary & Pancreatic Surgery, St James 
University Hospital, Beckett Street, West Yorkshire, Leeds 
LS9, England
Introduction: The lymph node ratio (LNR) rather than the 
absolute number of lymph nodes (LN’s) involved with meta-
static tumour is known to be a more accurate prognostic 
marker following pancreaticoduodenectomy for adenocarci-
noma. The LNR threshold for prognostic signifi cance and its 
relationship to other prognostic markers is less clear.
Methods: Data was collected from 368 patients who had 
undergone pancreaticoduodenectomy over an 8-year period 
(June 2002–Dec 2010). 270 (73%) were performed for ade-
nocarcinoma of the pancreas, common bile duct or ampulla. 
The patients who underwent surgery for adenocarcinoma 
were categorized into three groups according to the LNR 
(<0.05, 0.05–0.15 and >0.15). Kaplan–Meier and Cox pro-
portional hazard models were used for analysis.
Results: Median survival among the 270 patients was 
21-months with a 5-year survival of 24%. 23% (n = 61) were 
LN negative (N0). 33% had clear margins (RO) versus 67% 
with microscopic disease at the resection margin (R1). LN 
metastasis versus total lymph nodes sampled, on univariate 
analysis was statistically signifi cant as a marker of prognosis. 
LNR of 0.05–0.15 versus <0.05 was not statistically signifi -
cant (p = 0.092). LNR > 0.15 versus 0.05–0.15 was signifi -
cant (median survival 18 months versus 26 months; p = 
0.039). On multivariate analysis LNR failed to remain an 
independent predictor of survival (p = 0.11; HR 1.47). 
Completeness of resection (>1 mm) was the most important 
predictor of disease free survival (p = 0.001; HR 3.02).
Conclusion: Lymph node ratio is an important predictor of 
survival following pancreaticoduodenectomy for adenocar-
cinoma. On univariate analysis a LNR > 0.15 was statisti-
cally signifi cant for poorer prognosis. On multivariate 
analysis however, completeness of resection among our 
patient cohort was the most signifi cant marker of 
prognosis.
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ALVIMOPAN PATIENTS SHOW 
SIGNIFICANT IMPROVEMENT 
IN RECOVERY POST 
PANCREATICODUODENECTOMY 
SURGERIES
V. Siripurapu, E. Liu, V. Siripurapu and T. W. D. Jeyarajah
Methodist Dallas Medical Center, 221 West Colorado Blvd, 
Suite 10075208, Dallas, TX, USA
Introduction: In recent publications, Alvimopan has been 
shown to improve gastrointestinal recovery in patients who 
are undergoing bowel resections. We intend to see if patients 
undergoing Pancreaticoduodenectomies and who were 
administered Alvimopan, fi rst dose immediately preopera-
tively, demonstrate a signifi cant improvement in bowel 
movement recovery, fi rst intake of clear liquid diet, and fi rst 
intake of soft/solid food diet; compared to patients not 
administered with Alvimopan.
Methods: From a retrospective review of 255 pancreatico-
duodenectomy patients under a single surgeon between years 
2005–2011, 23 patients in 2011 were given Alvimopan. After 
excluding patients who received narcotics within 7 days 
before their surgery and after excluding Whipple-pylorus 
preserving, 15 Whipple-standard patients were left to 
analyze. For every one patient who was given Alvimopan, 
we found 2 patients who shared similar age, BMI, and 
pathology diagnosis and same Co-Morbidity and pT stage. 
We collected 30 patients ranging from years (2005–2011) 
who met these criteria, were not given Alvimopan, and who 
underwent a Whipple-standard procedure. We also excluded 
patients who received narcotics within 7 days before their 
surgery in this group.
Results: When comparing the two groups, signifi cance was 
noted for the mean length of hospital stay (P = 0.0483), mean 
time to fi rst clear liquid diet (P = 0.00212), and mean time 
to fi rst soft/solid food diet (P = 0.0406). There was no sig-
nifi cant difference noted between age, BMI, Co-morbidity, 
and mean time to fi rst bowel movement.
Conclusion: With a comparison between the Alvimopan 
and non-Alvimopan group, we recognize a signifi cant 
decrease in the length of hospital stay with a possible cost 
benefi t, due to a signifi cantly earlier intake of diet in the 
Alvimopan’s group. We believe with a radical procedure, 
such as pancreaticoduodenectomy, Alvimopan results in 
earlier recovery.
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SURGERY FOR PANCREATIC 
CARCINOMA IN THE ELDERLY
M. Oliverius1, M. Kucera1, M. Kocik1, Z. Kala2 and 
M. Varga1
1Transplant Surgery Department, Institute for Clinical and 
Experimental Medicine, Prague, Czech Republic; 
2Department of Surgery, University Hospital, Brno 
Bohunice, Czech Republic
Institute for Clinical and Experimental Medicine Prague, 
Transplant Surgery Department, Videnska 195814000, 
Prague 4, Czech Republic
Introduction: Pancreatic carcinomas have a dim prognosis. 
The fi ve-year survival does not exceed 5%. Approximately 
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60% occur in those over 65. With the increasing life expec-
tancy the number of patients is increasing. No evidence-
based recommendations regarding the surgical treatment in 
the elderly are available. The aim of our study was to evalu-
ate the morbidity and mortality of patients aged 65 and over 
after surgery for pancreatic carcinoma in two surgical centers 
in Czech Republic.
Methods: Sixty consecutive patients aged 65 and over 
(range 65–85; median 70; mean 71 year) operated on from 
2000 to 2007 were included in the study. All for pancreatic 
lesion confi rmed by using at least two imaging techniques 
CT or MRI, endoscopic ultrasound in all cases and FDG-
PET. Preoperative FNAB was performed in a smaller propor-
tion (27 out of 60; 45%). All had screening to rule out 
generalization (chest x-ray, CT or CT/PET). Patients with 
metastatic disease were excluded. The principal indication 
criterion was general status, as assessed by ECG, laboratory, 
chest x-ray, spirometry and, when indicated, exercise testing. 
Final histology proved pancreatic carcinoma in all patients.
Results: HPD was carried out in 43 out of 60 (72%) with 4 
portomesenteric vein resection. Twelve patients (20%) had 
distal pancreatectomy and 5 (8%) underwent total pancre-
atectomy. Majority patients (35 out of 60; 58%) had advanced 
disease (stages IIB and III). Overall hospital mortality was 
7% (4 out of 60), 2 death for pancreatic leak and 2 due to 
cardiovascular events. Overall morbidity was 17 patients 
(28%) with 5 (8%) pancreatic leaks. The mean survival time 
was 24.9 months (median 14.5 months). The one- and two-
year overall survival rate was 62.8% and 38.4% respectively. 
Age of patients itself had no signifi cant effect on survival 
time (p = 0.350). Stage of the disease was the only statisti-
cally signifi cant factor regarding long-term survival.
Conclusion: Our results show that surgery should be offered 
to all elderly patients with pancreatic carcinoma in good 
general condition having no metastatic disease. The morbid-
ity below 30% and mortality 7% is acceptable in comparison 
with overall survival rate higher than the reported for 
untreated patients. Four patients (the oldest being 85) had 
vascular resection with no death. The only independent 
factor affecting long-term survival in our group was an early 
stage of the disease.
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RADIOLOGY DIAGNOSTICS OF 
INTRADUCTAL PAPILLARY MUCINOUS 
NEOPLASMS AT THE STAGES OF 
SURGICAL TREATMENT
Y. Stepanova, G. Karmazanovsky and A. Shchegolev
Vishnevsky Institute of Surgery
Vishnevsky Institute of Surgery, Radiology, B. 
Serpukhovskaya St., 2711799, Moscow, Russian Federation
Introduction: Intraductal papillary mucinous neoplasms 
(IPMN) was defi ned by the World Health Organization as 
‘an intraductal papillary mucin-producing neoplasm, arising 
in the main pancreatic duct or its major branches’. IPMN 
represents a spectrum of disease ranging from benign 
adenoma, through IPMN borderline, to malignant noninva-
sive and invasive lesions. It has been recognized and diag-
nosed with increasing frequency in recent years.
Methods: Preoperative radiology data of 24 patients (16 
men, 8 women; 38–80 years) the majority from which had 
undergone surgical resection and had a pathologic diagnosis 
of IPMN were retrospectively assessed. Radiology methods 
were the next: ultrasonography, bolus contrast-enhanced CT 
and MRI. Type of ductal involvement (main pancreatic duct 
(MPD) type, branch ducts (BD) type, combined type), loca-
tion, the diameter of MPD, tumor size, mural nodules, tumor 
structure and solid appearance of the lesion were assessed 
and correlated with pathologic fi ndings. 22 (91.7%) patients 
were operated on, 2 patients with BD type are under follow-
up radiological examination. Postoperative (p/o) monitoring 
of patients carried out on contrast-enhanced CT.
Results: Presurgical IPMN diagnostics 75.0%. False nega-
tive results: mucinous cystic tumor, adenocarcinoma, pseu-
docyst. MRI is preferable in diagnostics.
Intraoperative US (6) allowed to correct intervention 
tactic.
MPD type (12): borderline (3), malignant (9); BD type (7): 
benign (2), borderline (2), malignant (1); combined type (5): 
borderline (3), malignant (2). Carcinomas characteristic: 
mural nodules, tumor size >3 sm, MPD expansion 
>11–12 mm.
P/o monitoring: spread disease progression – 3 (lethal 
outcome); relapse – 2 (surgery). CT performs well in detect-
ing local recurrence. Optimized pancreatic imaging should 
be performed when examining for tumor recurrence, com-
parison with earlier scans help to distinguish early recurrence 
from p/o changes.
Conclusion: MRI and CT combination is the most effective 
in IPMN diagnostics. IPMN is necessary to differentiate with 
mucinous cystic tumor, pancreatic adenocarcinoma and 
pseudocyst. Intraoperative ultrasound can correct the course 
of operative intervention. BD IPMN type is more benign. 
The preoperative radiology determination of the benign or 
malignant nature of IPMN is important because it can guide 
the surgical approach and determine prognosis.
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CLOSURE OF PANCREATOENTERIC 
FISTULA WITH VASCULAR OCCLUDING 
COIL EMBOLIZATION AND FIBRIN 
GLUE INJECTION
K. Choi1, J. Lee2 and Y. Kim3
1Dept of Surgery, Gangneung Asan Hospital, Univ of 
Ulsan, Coll of Medicine; 2Dept of Radiology, Gangneung 
Asan Hospital, Univ of Ulsan, Coll of Medicine; 3Dept of 
Internal Medicine, Gangneung Asan Hospital, Univ of 
Ulsan, Coll of Medicine
Gangneung Asan Hospital, Univ of Ulsan, Coll of 
Medicine, Dept of surgery, 38, Bangdong-gil, Sacheon-
myeon, Gangneung-si, Gangwon-do,201-711, Republic of 
Korea
Introduction: Pancreatoenteric fi stulas and the pancreatic 
abscess are rare complications of severe acute pancreatitis. 
Traditional management with aggressive surgery or percuta-
neous drainage catheter placement has been associated with 
increased surgery-related morbidity and mortality, and a 
longer hospitalization. We report the case where a pancreato-
enteric fi stula which remained open after the percutanous 
catheter drainage of pancreatic abscess is successfully closed 
by using vascular coil embolization and fi brin glue 
injection.
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Methods: A 79 years old female patient presented initially 
with acute biliary pancreatitis and cholecystitis and subse-
quently underwent uneventful laparoscopic cholecystec-
tomy. Three days after the hospital discharge, she presented 
with epigastric pain and diarrhea and admitted. Abdominal 
CT scan on admission revealed a new air containing peripan-
creatic abscess, while the pancreas swelling and infi ltration 
were signifi cantly improved, when compared with her previ-
ous CT scan. While inserting a percutaneous catheter to drain 
the abscess, we detected two fi stulous tracts between a pan-
creatic abscess and the duodenum. The subsequent EGD 
confi rmed a fi stulous hole with pus draining into the duode-
nal wall. After a week of catheter drainage, the follow-up 
tubogram and CT scan revealed that the fi stulous tract 
remained open while the size of abscess was reduced 
signifi cantly.
Results: We attempted to close the fi stula tract initially with 
the injection of 0.5 mL of tissue adhesive glue mixed with 
0.5 mL of iodized oil, but did not succeed. At the third week 
of the catheter placement, when the drainage was decreased 
5–10 cc daily, we placed two vascular occluding coils and, 
in succession, injected 2 mL of fi brin glue as fi lling. The 
patient tolerated the procedure well without any complica-
tions. On the third day after coil embolization, the follow up 
tubogram showed that the fi stulous tract was successfully 
closed. The patient discharged without a catheter at the 
fourth week of hospitalization and has been monitored after 
discharge with CT scan and EGD regularly up to 6 months. 
The patient remained asymptomatic.
Conclusion: A vascular occluding coil embolization with 
fi brin glue injection may be a less invasive, more effective, 
and better tolerated strategy for the management of fi stulous 
tract which remained open after the catheter drainage of 
abscess resulted from severe acute biliary pancreatitis in a 
selected group of high risk patients, and needs further 
investigation.
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THE EFFECT OF AGE ON SHORT-TERM 
AND LONG-TERM OUTCOMES AFTER 
PANCREATIC RESECTION
Y. Egashira, N. Chiba, A. Shimada, T. Nakamura, 
S. Ishikawa, Y. Arisawa and M. Hashimoto
Department of Surgery, Kawasaki Municipal Ida Hospital
Kawasaki Municipal Ida Hospital, Department of Surgery, 
2-27-1 Ida Nakahara-ku, Kawasaki, 21100, Kanagawa, 
Japan
Introduction: Pancreatic cancer usually has an unfavorable 
prognosis and radical resection is the only potential cure for 
pancreatic malignancies. Over the last two decades, medical 
and surgical improvements have drastically changed the 
postoperative outcome of elderly patients undergoing pan-
creatic resection, but pancreatic resection still carries signifi -
cant risk. Appropriate treatment for elderly potential 
candidates for pancreatic resection has become an important 
issue.
Methods: Thirty-eight consecutive patients over Stage III 
undergoing radical pancreatic resection against pancreatic 
cancer between 2000 and 2011 were considered and divided 
into two age groups, i.e., over 75-years-olds (group 1, 15 
patients) and under 75-year-olds (group 2, 23 patients). The 
two groups were compared as regards demographic features, 
comorbidities, surgical procedure, blood loss during surgery, 
postoperative mortality and morbidity, and overall survival.
Results: There were no signifi cant differences between the 
two groups concerning median survivals and 3-years sur-
vival rates (group 1; 1.45 years and 34.9%, gourp2; 0.77 
years and 14.3%). Complications such as pancreatic fi stulas, 
wound infections, and pneumonia were more frequent in the 
older group (incidence of complications on group 1; 50%, 
group 2; 32%), and the duration of hospital stay was same 
as before (group 1; 59 days, group 2; 37 days), but the dif-
ferences were not statistically signifi cant.
Conclusion: In the light of these fi ndings, age alone is not 
a contraindication to pancreatic resection. However, the 
complex nature of pancreatic surgery and the relatively low 
survival rates following pancreatic resection for pancreatic 
cancer make decisions regarding surgery in the elderly popu-
lation diffi cult.
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TREATING PANCREATIC 
ARTERIOVENOUS MALFORMATION 
WITH TOTAL PANCREATECTOMY AND 
ISLET AUTOTRANSPLANTATION
N. Sakata1, M. Goto2, F. Motoi1, H. Hayashi1, 
K. Nakagawa3, M. Mizuma1, S. Satomi4 and M. Unno1
1Division of Hepato-Biliary-Pancreatic Surgery, 
Department of Surgery, Tohoku University Graduate 
School of Medicine, Sendai, Miyagi 980-8574, Japan; 
2New Industry Creation Hatchery Center, Tohoku 
University Graduate School of Medicine, Sendai, Miyagi 
980-8574, Japan; 3Division of Integrated Surgery and 
Oncology, Department of Surgery, Tohoku University 
Graduate School of Medicine, Sendai, Miyagi 980-8574, 
Japan; 4Division of Advanced Surgical Science and 
Technology, Department of Surgery, Tohoku University 
Graduate School of Medicine, Sendai, Miyagi 980-8574, 
Japan
Tohoku University Graduate School of Medicine, Division 
of Hepato-Biliary-Pancreatic Surgery, Department of 
Surgery, 1-1 Seiryomachi, Aobaku, 980, Sendai, Japan
Introduction: Pancreatic arteriovenous malformation 
(AVM) is defi ned as a vascular anomaly which builds up via 
an aberrant bypass anastomosis of the arterial and venous 
systems. Some of the AVM are correlated with acute pancre-
atitis. AVM is an indication for surgical therapy, and total 
pancreatectomy (TP) cannot be prevented in some cases, 
subsequently causing severe diabetes mellitus. We have per-
formed TP with islet autotransplantation (IAT) to 3 AVM 
patients and evaluated the effectiveness and safety.
Methods: Three AVM patients have been performed TP 
with IAT. The age of them was 39 to 59 years old. All of 
them were male, had episode of alcohol abuse and had 
attacks of pancreatitis. The case 2 (a 52 years-old man) has 
a past history of DM. Computed tomography examination 
revealed that conglomeration of the small vessels in pancreas 
and pancreatic psuedocyst was detected in all of them. All 
of them had episodes of bleeding in the psudocyst. We under-
went distal pancreatectomy fi rst, and then pancreaticoduode-
nectomy for severe infl ammation in all the cases. The warm 
ischemia times were within 10 minutes and the cold ischemia 
times were less than 2 hours. After islet isolations were 
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completed in our institution, IATs were performed via portal 
vein.
Results: The number acquired islets were 230 000–360 000 
islet equivalents (IEQs). Total cell volumes were 1–16 mL. 
The purities of the islets were over 30%, however substantial 
amount of larger clusters were detected in the case 2. 
Preoperative portal vein pressures in all cases were normal 
and no or slight increase was detected after islet infusion in 
the case 1 (a 59 years-old man) and 3 (a 39 years-old man). 
The case 2 had a severe portal vein hypertension and throm-
bosis that was needed emergency operation. Other two cases 
had a good blood glucose control with a little insulin injec-
tions and no severe complications including hypoglycemic 
shock. Especially, the blood glucose levels in the case 1 have 
been stably controlled for more than 1 year.
Conclusion: TP with IAT is mainly performed to chronic 
pancreatitis, but there have been no reports regarding AVM. 
AVM is a rare disease, but is considered as the ideal indica-
tion for TP with IAT. We succeeded TP with IAT in the two 
cases in preserving endocrine function, but also experienced 
severe complications of portal vein hypertension and throm-
bosis with liver dysfunction in other one case. Further opti-
mization of the protocol is necessary for improving the 
outcome and safety of this treatment.
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LAPAROSCOPIC SPLENIC 
VESSEL-PRESERVING 
DISTAL PANCREATECTOMY
S. Baba, A. Sasaki, H. Nitta, T. Takahara, K. Otsuka, 
Keisuke, Koeda, M. Mizuno and G. Wakabayashi
Department of Surgery, Iwate Medical University School of 
Medicine
Iwate Medical University School of Medicine, Surgery, 
19-1 Uchimaru, 20, Morioka, Japan
Introduction: Although the spleen is often routinely 
resected during both open and laparoscopic distal pancreatec-
tomy, splenectomy can increase the risk of postoperative and 
complications involving life-long infections. Laparoscopic 
splenic vessel-preserving distal pancreatectomy (LSVPDP) 
is a technically challenging procedure because the splenic 
vein is often embedded in the pancreatic parenchyma. The 
aim of the present study was to evaluate the outcomes of 
LSVPDP.
Methods: This retrospective study included a prospective 
database of patients treated in a single institution. Between 
March 2003 and December 2011, eight patients with benign 
pancreatic tumors underwent LSVPDP. Many branches of 
the splenic vessels from the pancreatic tail toward the body 
were divided using a tissue sealing device, and the pancreatic 
parenchyma was transected using a 4.8-mm endoscopic 
linear stapler. The perioperative data and surgical outcomes 
were analyzed.
Results: LSVPDPs were successfully completed in all 
patients. The median operating time and blood loss were 161 
(range, 105–230) min and 13 (range, 1–71) ml, respectively. 
The median tumor size was 22 (10–55) mm. The patients 
resumed a regular diet at a median of 2 (range, 1–3) days, 
and the median length of hospital stay was 8.5 (range, 7–11) 
days. The median drain amylase level reached a peak of 1225 
(range, 93–3700) IU/l at postoperative day 1 and dropped 
to 165 (range, 33–846) IU/l at postoperative day 3. No 
clinical pancreatic fi stulas or postoperative hemorrhages 
were observed. The fi nal pathological diagnosis included 
three intraductal papillary-mucinous adenomas, three insuli-
nomas, one solid pseudopapillary tumor, and one serous 
cystadenoma.
Conclusion: LSVPDP is a safe and feasible treatment for 
benign or low-grade malignant tumors in the distal pancreas 
that can be administered without compromising splenic 
function.
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(INVITED PAPER) BINDING 
PANCREATIC ANASTOMOSES
S. Y. Peng and J. T. Li
Department of Surgery, Second Affi liated Hospital, School 
of Medicine, Zhejiang University, Hangzhou, China, 
310009
Second Affi liated Hospital, School of Medicine, Zhejiang 
University, Department of Surgery, No. 88 Jiefang Road, 
Hangzhou, China
Introduction: Binding pancreaticojejunostomy (BPJ) is a 
safe and effective technique that avoids the primary compli-
cation of pancreatic anastomosis leakage. There are two 
problems with BPJ: a high discrepancy in the size of pan-
creas stump and the jejunal lumen; sutures on to the pancreas 
for fi xation might cause exudation of pancreatic juice into 
the abdominal cavity.
Methods: To deal with these two problems, Binding 
PancreaticoGastrostomy (BPG); End-to-Side Binding 
PancreaticoJejunostomy (ESBPJ) as well as Binding pancre-
atic Duct to Mucosa anastomosis (BDM) are designed and 
successfully performed clinically.
Results: There is no anastomotic leakage occurred although 
parenchymal pancreatic leak might occur in BDM.
Conclusion: Binding pancreatic anastomoses can be used to 
reliably prevent leakage even though when the pancreatic 
texture is soft and the duct is not dilated. Both BPG and 
ESBPJ are good for accommodating a large stump. The 
essential advantage of BDM is no need to isolate the stump. 
This is especially important when the stump is densely 
adhered to its bed. The problem with BDM is that although 
the anastomotic leak can be avoided, it is hard to prevent the 
parenchymal pancreatic leak.
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PANCREATIC NECROSECTOMY WITH 
ABSCESS WALL AND JEJUNUM 
ANASTOMOSIS – A NEW SURGICAL 
OPTION FOR TREATMENT FOR 
INFECTED NECROTIZING 
PANCREATITIS AND ABSCESS
T. Shikano, T. Mori, T. Kinoshita, N. Kurata, 
M. Tsutsuyama, S. Umeda, A. Yarita and M. Miyauchi
Yokkaichi Municipal Hospital, Yokkaichi, Japan
Yokkaichi Municipal Hospital, Surgery, 2-2-37 Shibata, 
Yokkaichi, Japan
Introduction: Infected necrotizing pancreatitis and abscess 
represents a serious and therapeutically challenging compli-
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cation. Percutaneous drainage of infected pancreatic necrosis 
is often unsuccessful. Alternatively, open necrosectomy is 
associated with high morbidity, endoscopic approach is not 
readily available at all facilities and minimally invasive 
necrosectomy frequently necessitate multiple sessions. To 
solve these problems, we performed pancreatic necrosec-
tomy with abscess wall-jejunum anastomosis.
Methods: Five patients presenting infected pancreatic 
necrosis and abscess during course of acute pancreatitis and 
not responding to radiological drainage were offered pancre-
atic necrosectomy with abscess wall-jejunum anastomosis 
from April 2008 to December 2011. After the abdominal 
cavity is opened, the gastrocolic and the duodenocolic liga-
ments are divided close to the greater curvature of the 
stomach, and the pancreas is exposed. Once the focus of 
necrosis is exposed, debridement is carried out. After loose 
debris has been removed, abscess wall and jejunum is anas-
tomosed in Roux-Y fassion without drainage tube in abscess 
cavity.
Results: No operative complications were recorded with a 
mean operative time of 208 minutes. No blood transfusions 
were needed. No surgical postoperative morbidity and mor-
tality were recorded. Postoperative ICU/hospital stay is 1/17 
day. None required complementary surgical or radiological 
treatment.
Conclusion: Pancreatic necrosectomy with abscess wall-
jejunum anastomosis has been safe and highly effi cient for 
infected pancreatic necrosis in our series of patients. Our 
method is a promising technique for infected necrotizing 
pancreatitis and should be regarded as a valid therapeutic 
option for necrotizing pancreatitis.
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3-YEAR EXPERIENCE OF NO-TOUCH 
PANCREATICODUODENECTOMY (PD). 
SINGLE CENTER EXPERIENCE
K. Kopchak, V. Kopchak, I. Khomiak, O. Duvalko, 
D. Cheverdiuk, A. Zelinskiy, L. Pererva and S. Andronik
National Institute of Surgery and Transplantology
National Institute of Surgery and Transplantology, 
Pancreatic and Bile Ducts Surgery, Geroev Sevastopolia 
303680, Kiev, Ukraine
Introduction: The long-term results of pancreatic tumors 
resections are still disappointing. Main problems of the post-
operative course of the patient are liver metastasis and peri-
toneal dissemination. In order to increase postoperative 
survival after resections by surgical control of liver metasta-
sis and peritoneal dissemination no-touch techniques of PD 
were proposed.
Methods: We investigated the results of no-touch PD for 
malignant periampullary tumors in 29 patients, treated in our 
clinic in the period of 2008–2011 years. In 13 patients tumors 
of papilla of Vater (PV) were diagnosed, in 12 patients – 
tumors of the head of the pancreas, including 1 neuroendo-
crine tumor, in 3 patients – tumors of the common bile ducts 
(CBD), and in 1 patient – gastrointestinal stromal tumor 
(GIST) of the duodenum. In 18 patients pylorus-preserving 
resections were done, in 11-standard Whipple procedure, 
including antrumectomy. In 3 patients additional resections 
of the affected portal or superior mesenteric vein were done.
Results: Duration of the operation was 440.4 ± 77.4 minutes 
(from 340 to 745). Mean blood loss was 575.0 ± 320.1 ml 
(from minimal to 1800 ml). Early postoperative morbidity 
was 20.7% (6 patients). Postoperative mortality was zero. In 
the groups of patients with tumors of PV and pancreatic 
cancer (PC) we did not reached median survival. Median 
survival in group of CBD cancer was 21.5 month. 1- and 
2-year survival in PC patients was 63.5%, maximal follow-
up – 26 months. 1- and 2-year survival for PVC patients was 
100%, 3-year survival – 85.7% and disease free 3-year sur-
vival – 57.1%. Patient with GIST is alive 34 months after 
procedure with metastatic disease from second postoperative 
year. Patient with neuroendocrine tumor is alive 26 months.
Conclusion: No-touch PD is as safe procedure as standard 
and could be applied in clinical practice. Further investiga-
tions should be done to evaluate potential benefi t of the 
procedure.
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THE CAPTURE OF PANCREATIC CTC 
FOR CYTOLOGICAL, MOLECULAR AND 
CELL CULTURE EVALUATION
B. Kulemann1, A. Liss1, N. Valsangkar1, 
C. Fernandez-del Castillo1, A. Warshaw1, K. Lillemoe1, 
M. Pitman2 and S. Thayer1
1Department of Surgery & Warshaw Institute, 
Massachusetts General Hospital, Harvard Medical School, 
Boston, MA; 2Department of Pathology, Massachusetts 
General Hospital, Harvard Medical School, Boston, MA
Massachusetts General Hopsital, Harvard Medical School, 
Department of Surgery & Warshaw Institute, 15 Parkman 
Street, WAC 4602114, Boston, USA
Introduction: Circulating Tumor cells (CTC) likely are the 
mechanism of metastasis. However, their capture and analy-
sis on microfl uidic systems has been limited by high cost, 
technical diffi culty, and by the inability to capture whole 
cells for genomic analysis or culture. Here we evaluate a 
low-cost, technically easy fi ltration method to capture pan-
creatic cancer cells from peripheral blood for cell culture, 
cytological and molecular analysis.
Methods: 1000, 100, 10, and 2 cells/ml of orange-tagged 
(Invitrogen®) and non-tagged PANC-1 cells with a known 
KRASG12D mutation were spiked into healthy blood. Three 
ml for cytology and six ml for both DNA extraction and cell 
culture (1000 cells/ml) were processed through ScreenCell® 
fi ltration devices according to manufacturer’s instructions. 
The capture rate of the tagged PANC-1 cells was evaluated 
by fl uorescence microscopy. To validate the molecular sig-
nature and cytological evaluation, molecular analysis of 
KRAS mutations was performed on the DNA isolated from 
the CTC and the parent tumor. The cytological specimens, 
stained with routine methods, and blindly evaluated by a 
cytopathologist (M.B.P.), were categorized as malignant, 
atypical or negative. Atypical cells were epithelioid but not 
overtly malignant appearing cells. The growth of captured 
cells in cell culture was assessed 8 days after fi ltration. Blood 
from one patient with metastatic PDAC was tested.
Results: CTC were identifi ed in samples spiked with as few 
as 2 cells/ml. The recovery of cancer cells was ~50% in 
spiked samples containing ≥10 cells/ml (≥50% in 1000 cells/
ml, 49.5% in 100 cells/ml, 46.5% in 10 cells/ml and 7.5% in 
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2 cells/ml). Cytological analysis of the patient specimen 
showed the presence of atypical cells. Genomic analysis 
identifi ed the known KRASG12D mutation in all spiked 
samples, thereby validating the captured cells as CTC. In the 
one patient case there was a KRASG12V mutation; the same 
genotype was found in the primary tumor. Captured CTC 
could successfully be grown in vitro.
Conclusions: This study confi rms a low-cost, low-tech 
method for rapid isolation of proven pancreatic cancer cells 
from peripheral venous blood for cell culture, cytological 
and molecular evaluation. Capture of circulating tumor cells 
matching the genome of the primary tumor may allow us 
screening of patients for PDAC, genomic characterization of 
a tumor from a blood sample, and monitoring for effect of 
therapy.
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POST-PANCREATICODUODENECTOMY 
HEMORRHAGE IN PERI-AMPULLARY 
CARCINOMA: RESULTS AND 
OUTCOME ACCORDING TO THE 
ISGPS CLASSIFICATION
R. Singh, J. Reddy, A. Tank, A. Prakash, A. Behari, 
A. Kumar, V. Kapoor and R. Saxena
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Sanjay Gandhi Post Graduate Institute of Medical 
SciencesSurgical Gastroenterology, Dept of Surgical 
Gastroenteology, SGPGIMS, Raebareli Road, 22601, 
Lucknow, India
Introduction: Post-pancreaticoduodenectomy hemorrhage 
(PPH) is a serious complication that has been classifi ed by 
ISGPS (International Study Group of Pancreatic Surgery) in 
2007. However the prognostic utility of this unifi ed classifi -
cation is not clearly known. We report our experience with 
factors predicting PPH, mortality associated with PPH and 
outcome using the ISGPS classifi cation.
Methods: Retrospective analysis of a prospectively main-
tained database was done (from January 2003 to September 
2010). Pancreaticoduodenectomy was done for 302 patients 
of periampullary carcinoma. PPH incidence was 17.2% (52 
patients); Early onset – 8 patients (15.3%) & late onset – 44 
patients (84.6%); Mild hemorrhage – 18 patients (34.6%) & 
severe hemorrhage – 34 patients (65.3%). Fishers test, 
Mann–Whitney test and multivariate analysis (SPSS) were 
done for factors associated with PPH and post-PPH 
mortality.
Results: ISGPS PPH grade was A, B and C in 6 (11.5%), 
30 (57.6%) and 16 (30.7%) patients respectively. PPH was 
managed with conservative treatment, surgery alone, trans-
vascular embolization or both in 26 (50%), 16 (30.7%), 3 
(5.7%) and 7 (13.4%) patients respectively. The overall mor-
tality after PPH was 13.4% (7 patients), all with ISGPS grade 
C hemorrhage.
Multivariate analysis showed that intra-abdominal abscess 
(p = 0.007) and overall postoperative major complications (p 
= 0.001) independently predicted occurrence of PPH. Though 
multivariate analysis did not reveal any of the evaluated 
factors to independently predict mortality after PPH, all 7 
deaths occurred in ISGPS grade C hemorrhage.
Conclusion: Intra-abdominal abscess and postoperative 
major complications predict PPH in multivariate analysis. 
Morality following PPH is signifi cantly associated ISGPS 
grade C hemorrhage. The ISGPS PPH classifi cation is useful 
for triage and improved multimodality management in order 
to achieve a low mortality after PPH.
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SURGICAL OUTCOMES OF 
NEUROENDOCRINE TUMOR OF THE 
PANCREAS FROM TAIWAN
C.-T. Cheng, J.-T. Hsu, T.-S. Yeh, T.-L. Hwang and 
Y.-Y. Jan
Department of Surgery, Chang Gung Memorial Hospital at 
Linkou, Chang Gung University College of Medicine, 
Taoyuan, Taiwan
Chang Gung Memorial Hospital at Linkou, Chang Gung 
University College of Medicine, Taoyuan, Taiwan; 
Department of Surgery, 5 Fu-Hsing Street, Kwei-Shan, 
Taoyuan, 333, Taoyuan, Taiwan
Introduction: Neuroendocrine tumors (NETs) of the pan-
creas are rare neoplasms arising from endocrine cells of the 
pancreas with favorable prognosis even in face of metastasis. 
Surgery is the mainstay treatment for resectable tumor. The 
aim of the study is to report the surgical results of pancreatic 
NETs from a single medical center in Taiwan.
Methods: Between 1992 and 2008, medical records of 76 
patients with pancreatic NETs were retrospectively reviewed. 
Carcinoma was defi ned using mitotic count, Ki-67 index and 
presence of adjacent organ invasion lymph node/vascular 
involvement or distant metastasis Analysis of clinicopatho-
logical data and prognostic factors was performed.
Results: The median age of patients is 59 years (range, 
16–84). The patients included 49 women and 27 men. Most 
patients (53.9%) with pancreatic NETs are nonfunctional. 
Fifty three patients (69.7%) had well-differentiated tumors 
(WDTs) and 23 (30.3%) had carcinomas. Pancreatic NETs 
with well differentiation were associated with higher propor-
tions of functional disease, enucleation procedure and tumor 
size less than 2 cm as compared with pancreatic carcinomas. 
The overall survival rates of patients with pancreatic NETs 
were 77.6% and 77.3% at 5 and 10 years after surgery, 
respectively. Patients with WDTs had favorable prognoses 
than those with carcinomas (p < 0.0001).
Conclusion: The prognosis of pancreatic NETs is favorable 
than that of common pancreatic adenocarcinoma. Patients 
with pancreatic WDTs have signifi cantly better survival than 
those with neuroendocrine carcinomas.
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HEMATOLOGICAL INDEXES IN 
DIAGNOSIS OF THE SEVERE ACUTE 
PANCREATITIS AND PROGNOSIS OF 
ITS OUTCOME
V. Syplyviy, V. Robak, K. Kon, D. Ievtushenko and 
P. Petiunin
Kharkiv National Medical University
Kharkiv National Medical University General Surgery & 
#8470;235 Lenina av., apt. 3061072, Kharkiv, Ukraine
Introduction: The course of the severe acute pancreatitis is 
accompanied by the expressed system immune response. The 
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purpose of our research was to defi ne hematological markers 
of the severe acute pancreatitis, refl ecting affection of a pan-
creas and parapancreatic fat.
Methods: The results of surgical treatment of 125 patients 
with the severe acute pancreatitis were analyzed. 34 patients 
have died. 24 hematological indexes were studied in dynam-
ics of treatment of the patients. One of these hematological 
indexes – the intoxication indicator – offered by us for 
revealing an acute infl ammatory process.
Results: The signifi cantly prognostic hematological indexes 
for outcome of the severe acute pancreatitis were: index of 
organism’s resistance, leukocyte intoxication index, reactive 
neutrophilic response index and intoxication indicator. It is 
established that at decrease of the index of organism’s resis-
tance more than 31.59, lethality rate was 50%, at higher 
values – 2.7%. At increase of the leukocyte intoxication 
index more than 8.18, lethality rate was 70.0%, at values 
below 8.18–18.3%. At increase of the reactive neutrophilic 
response index more than 40.77, lethality rate was 42.11%, 
at values more low 40,77–6,06%. At values of an intoxica-
tion indicator more than 1.14 lethality rate was 46.67%, at 
values below 1.14–9.76% (p < 0.05).
Conclusion: Hematological indexes – index of organism’s 
resistance, the leukocyte intoxication index, the reactive neu-
trophilic response index and the intoxication indicator are 
prognostic indicators in diagnosis of the severe acute pan-
creatitis and prognosis of its outcomes.
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SINGLE CENTER EXPERIENCE OF 
GROOVE PANCREATITIS
G. Marangoni, K. Dickinson, S. Bokhari, A. Hakeem, 
Z. Hamady, R. Storey, G. Morris-Stiff and A. Smith
St James’ Hospital, HPB and Transplant Unit, Beckett 
Street, LS9 7TF, Leeds, UK
Introduction: Groove pancreatitis (GP) is a form of chronic 
segmental pancreatitis. Due to increased awareness of the 
condition, a greater number of cases have been reported in 
recent years. Clinical symptoms are heterogeneous, with 
abdominal pain and gastric outlet obstruction considered the 
most common, and can mimic pancreatic adenocarcinoma. 
Most of the published literature is represented by small 
series. Aim of the study is to describe our experience in the 
management of this condition.
Methods: From Jan 2005 to Dec 2011, 47 patients with GP 
were treated in our Unit. 33 males (M : F = 2.3:1); mean age 
was 50 (31–84), average number of hospital admissions was 
4 (0–20), mean hospital stay was 10 days (1–82). 8 patients 
needed HDU/ICU support. Aetiology was alcohol in 41 
(87%) and 13 were abstinent for more than 6 months at last 
follow-up. Amylase was elevated (3xN) on admission in 22. 
The most common feature was abdominal pain (n = 40, 85%) 
and 50% (n = 20) required daily use of opioids. Gastric outlet 
obstruction (n = 7), jaundice (n = 11) and acute renal failure 
(n = 5) were less frequent. Exocrine insuffi ciency was present 
in 23 (49%). 13 had a dilated pancreatic duct (>5 mm) and 
6 developed portal hypertension. Median follow-up was 34 
months.
Results: There were 5 deaths, one due to GP. 29 patients 
were treated conservatively; 11 required enteral feeding. 4 
had ERCP and biliary stenting, 2 of which subsequently 
underwent biliary reconstruction. One patient had a pancre-
atic stent and then a Berne’s procedure. Endoscopic drainage 
for pseudocyst (n = 2), cholecystectomy (n = 6) for sludge/
stones, gastric bypass (n = 3), Puestow procedure (n = 1), 
Whipple’s operation (n = 4, 2 of which later required thora-
coscopic splanchnicectomy – TS), TS (n = 3), celiac plexus 
block (n = 2) were the other interventions. Overall 28 (66%) 
patients are well with no or occasional use of analgesia, 6 
patients still experience recurrent hospital admissions and 8 
require regular use of analgesia but with improved 
symptoms.
Conclusion: The majority of GP is caused by alcohol 
excess. GP can be effectively treated conservatively and pain 
(the most common symptom) managed with simple analge-
sia. Despite good support the majority remain addicted to 
alcohol. Radical surgery should be reserved for complex 
cases, as it is not always effective for pain relief, and when 
there is a diagnostic dilemma.
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‘PARADUODENAL PANCREATITIS’: THE 
CONS OF THE TERM OUTWEIGH THE 
PROS. OUR EXPERIENCE WITH 
DUODENAL DYSTROPHY AND 
BRUNNER’S GLAND HAMARTOMA 
TREATMENT: A REPORT OF 52 CASES
V. Egorov, A. Vankovich, N. Yashina, N. Kurushkina and 
R. Petrov
Vishnevsky Institute of Surgery
Vishnevsky Institute of Surgery, HPB, Bolshaya 
Serpukhovskaya Str, 2711799, Moscow, Russia
Introduction: The term ‘paraduodenal pancreatitis’ was 
coined to cover cystic dystrophy in heterotopic pancreas 
(DD), paraduodenal cyst and groove pancreatitis, by reason-
ing that these conditions mimic pancreatic head tumors and 
share certain histological evidences. Merging different enti-
ties into one defi nition makes sense if their differentiation 
presents an unnecessary challenge and/or their detection 
entails applying the same therapeutic approach.
Methods: To judge the advisability of amalgamating the 
above-mentioned pathologies 1. prospective analysis of 50 
cases of DD and 2 cases of brunneroma (2004–2011), com-
paring preoperative and histopathological fi ndings in 32 sur-
gical specimens; 2. assessment of clinical presentation and 
the results of DD treatment were performed.
Results: No case of groove pancreatitis was revealed 
throughout the observation. Correct diagnosis was made in 
all the cases except onesuspected cystic tumor of the pancre-
atic head (1.9%). Patients presented with abdominal pain 
(100%), weight loss (76%), vomiting (30%) and jaundice 
(18). CT, MRI and endoUS were the most useful diagnostic 
modalities. Patients underwent 20 pancreatoduodenectomies 
(PD), pancreatico- and cystoenterostomies (7), Nakao proce-
dures (4), duodenum-preserving pancreatic head (DPPH) 
resections (4), partial gastrectomy (1) and 6 pancreas-pre-
serving duodenal resections (PPDR). No mortality. Full pain 
control was achieved after PPRDs in 83%, PDs in 85%, and 
after PPPH resections and draining procedures in 18% of 
cases. 3 DM cases after PDs.
Conclusion: 1. The diagnosis of DD can be confi dently 
determined with the aid of modern-day techniques prior to 
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surgery. 2. The effectiveness of PPDR provides compelling 
proof that DD is an entity distinct from tumors, groove and 
orthotopic pancreatitis. 3. Reliable diagnostics and differing 
treatment modalities of the paraduodenal pancreatitis com-
ponents motivate the abandonment of this term.
482
THE UTILITY OF THE SANDWICH TYPE 
FORCEPS WHICH WAS EASY FOR A 
HEMOSTASIS OF THE LINEAR STAPLER 
TRANSECTION PANCREAS 
TAIL BLEEDING IN THE 
LAPAROSCOPIC SURGERY
M. Yamazaki, K. Koda, M. Suzuki, T. Tezuka, C. Kosugi, 
K. Imai, A. Hirano and H. Yasuda
Department of Surgery Teikyo University Chiba Medical 
Center, Ichihara City, Chiba, Japan
Teikyo University Chiba Medical Center, Surgery, 3426-3 
Anesaki Ichihara City, Chiba Japan
Introduction: Because a bleeding site is not exposed, the 
hemostasis from the linear stapler transection pancreas tail 
bleeding with the clip is diffi cult. The hemostasis with the 
energy device is in danger of the pancreatic injury. Therefore, 
a suture ligature maneuver is necessary to stop bleeding 
securely. However, a transfi xing suture in the laparoscopic 
surgery is a diffi cult procedure. We report the case that a new 
type of sandwich forceps was useful in a hemostasis of the 
pancreas tail bleeding.
Methods: The reasons why a needle grasp was diffi cult in 
the laparoscopic surgery with a conventional forceps are next 
points. First, under the two dimensional optical view, it is 
diffi cult to confi rm the state of the grasp in the laparoscopic 
surgery. Second, it is diffi cult to hold a needle at a suitable 
angle for suturing. Finally, a needle moves during a suture 
because the state of a grasp is labile. We developed a new 
type of a needle-holder (sandwich forceps) putting a needle 
between parallel planes (like a sandwich) to solve above-
mentioned distresses. We report a bleeding case from the 
pancreas tail transection in a laparoscopic splenectomy that 
a sandwich forceps was useful in a hemostasis.
Results: A 73-year-old women came to our hospital suffer-
ing from right lower abdominal pain. The multiple cystic 
lesions of the spleen were detected at a right inguinal hernia 
diagnosis accidentally. The spleen was resected at the same 
time of hernia repair by the hope of the patient. After the 
removal of the spleen from retroperitoneum, a splenic hilum 
was divided by a linear stapler. The hemostasis was kept for 
a while. After some procedures, the bleeding from a splenic 
artery began. There was not the site with a clip over a bleed-
ing artery and a suture hemostasis was required. We were 
able to suture and ligature the bleeding of several points 
using the sandwich forceps in a laparoscopic surgery safely.
Conclusion: We can sew up and ligature easily, precisely 
and safely by the sandwich forceps in the laparoscopic 
surgery. Therefore, the sandwich forceps seems to be 
useful in laparoscopic surgery needing a suture hemostasis 
procedure.
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DOES DEBULKING SURGERY IMPROVE 
SURVIVAL IN NON-FUNCTIONING 
PANCREATIC NEUROENDOCRINE 
TUMORS WITH HEPATIC METASTASES?
P. Bhalla, R. C. Shah and P. Jagannath
Department of Surgical Oncology, Lilavati Hospital & 
Research Centre
Lilavati Hospital & Research Centre, Department of 
Surgical Oncology, Department of Surgical Oncology, 
Lilavati Hospital & Research Centre, A-791, Bandra 
Reclamation, Bandra (W), Mumbai-400050, India
Introduction: Pancreatic non-functioning neuroendocrine 
tumors (NFPNETs) are uncommon & usually present late 
with metastatic disease, most often to liver. Many nonsurgi-
cal options are now available for treatment for metastatic 
NFPNETs. The role of debulking surgery in non-functioning 
tumors along with multimodal treatment (MMT) is unclear. 
A prospective study comparing debulking surgery with non-
surgical treatment versus nonsurgical treatment alone in 
NFPNETs is presented.
Methods: A prospective analysis was carried out of 39 
patients presenting with NFPNETs with liver metastases 
(LM) between January 2003 and January 2011. Patients were 
divided into two groups. Group A patients underwent resec-
tion of pancreatic and liver lesions (≥90% of LM). On follow 
up, those who developed disease progression & had resect-
able LM underwent surgery/Radio Frequency Ablation. In 
patients with multiple metastatic sites & good uptake on 
somatostatin scintigraphy (SRS), Sandostatin LAR or 
Peptide receptor Radionuclide Therapy (PRRT) with 
Lutetium DOTATE was used. Chemotherapy was used in 
those with low uptake. Group B patients underwent either 
palliative surgery (By pass) followed by nonsurgical treat-
ment or nonsurgical treatment.
Results: There was no signifi cant difference in age or tumor 
size between the two groups (Group A n = 22, Group B n = 
17). In Group A, the median follow up in patients who were 
alive was 47.5 (9–90) months. Eight (36.36%) out of the 15 
patients (68.2%) who developed disease progression during 
postoperative follow up expired. The median progression-
free survival was 21 (12–35) months. In Group B, 4 patients 
(23.5%) had expired at the time of last follow up with the 
remaining having a median follow up of 14 (10–24) months. 
The mean time to death was signifi cantly longer in group A 
than in group B (21.13 versus 9.25 months, p = 0.0006). But 
the mean time to progression was not signifi cantly different 
between the groups (17.4 versus 14.17 months, p = 0.0628).
Conclusion: The therapy for patients with pancreatic non-
functioning neuroendocrine tumors with liver metastases 
must be individually tailored. Aggressive adequate (≥90%) 
surgical debulking with multimodal treatment can be offered 
to selected patients as surgical treatment can prolong pro-
gression free and overall survival. Nonsurgical treatment can 
be offered to patients where debulking could not be done, as 
these prevent the progression of disease.
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LONG-TERM RESULTS OF FREY 
PROCEDURE IN THE TREATMENT OF 
CHRONIC PANCREATITIS
F. Paye1, F. Cauchy1, J.-M. Regimbeau2, P. Balladur1, 
D. Fuks2, E. Tiret1 and L. Arrivé3
1Department of Digestive Surgery, Saint Antoine Hospital, 
Paris; 2Department of Digestive Surgery, Hopital Nord, 
Amiens; 3Department of Radiology, Saint Antoine Hospital, 
Paris
Saint Antoine Hospital, Digestive Surgery, 184 rue du 
Faubourg Saint-Antoine, 75012, Paris, France
Introduction: To evaluate the long-term outcome for 
patients undergoing Frey procedure in the treatment of 
chronic pancreatitis (CP) regarding pain, quality of life 
(QOL) and endocrine/exocrine function in order to identify 
predictive factors of poor results.
Methods: From 1999 to 2010, 33 patients included in two 
centers underwent a Frey procedure for CP. Assessment of 
pain was based on the consumption of analgesics and grading 
of symptoms. QOL was evaluated using the EORTC QLQ-30 
questionnaire. Endocrine function was explored considering 
the deterioration of pre-existing diabetes with the assessment 
in the changes in haemoglobin A1c levels and antidiabetic 
medications.
Results: From 1999 to 2010, 33 patients were operated 
including 31 (94%) for intractable pain. Mean duration of 
symptoms was 5 +/− 3.3 years. Twenty patients (61%) had 
an associated procedure including 17 biliary bypasses. 
Operative mortality was nil and 16 (49%) patients had a 
complicated postoperative course including 13 (40%) with 
major complications. Post-operative fi stula and gastroparesis 
rates were 15% and 6% respectively. After a mean follow-up 
of 56 +/− 39 months, 91% of the patients had either a partial 
or complete relieve of their symptoms and 12 (36%) had a 
deterioration of endocrine function. On univariate analysis, 
a biliary stenosis was associated to both resurgence of pain 
(p = 0.039) and deterioration of endocrine function (p = 
0.008).
Conclusion: Frey procedure for the treatment of CP offers 
excellent long-term results with low operative risk. An asso-
ciated biliary compression is related to a more severe disease 
with increased risk of long-term pain recurrence and endo-
crine insuffi ciency.
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PANCREATIC RESECTION FOR 
METASTASES FROM RENAL CANCER: 
LONG TERM OUTCOME AFTER 
SURGERY AND IMMUNOTHERAPY 
APPROACH – SINGLE 
CENTER EXPERIENCE
A. Gardini, G. La Barba, P Morgagni, A. Riccobon, 
L. Saragoni, C. Milandri, D. Amadori and D. Garcea
IHPBA EHPBA; Morgagni Pierantoni Hospital, General 
Surgery, Via Forlanini 3447100, Forli, Italy
Introduction: Natural history of renal cell carcinoma 
includes metastases to the Pancreas. The literature reports 
that selected patients may have benefi ts by pancreatic resec-
tion in terms of long term survival. We report patients 
outcome and considerations on immunotherapy approach.
Methods: From September 2001 to July 2010 eight patients 
underwent pancreatic resection for metastases from renal 
cancer. We reviewed surgical outcome and following 
treatment (conventional chemotherapy: 5FU-Vindesine; 
Immunotherapy: Interleukin 2 [IL2]- Interferon [IFN] – 
Dendritic cells [DC: prepared from peripheral blood mono-
cytes pulsed with autologous tumor lysate]) of these patients.
Results: All patients underwent radical pancreatic resection 
(7 spleno-pancreasectomy; 1 segmental pancreatic resection) 
and were R0 after surgery. No postoperative mortality is 
reported. Morbidity was 37% (2 distal leakage; 1 pneumoni-
tis). Two patients did not received any further treatment; 2 
patients conventional chemotherapy; 2 patients: immuno-
therapy (interleukin2 + interferon); 2 patients: Dendritic 
Cells (DC) interleukin-2 infusion. 3 years overall survival 
rate was 55%. Disease free survival after 3 years was 30%.
Conclusion: Our data confi rm that pancreatic resection 
should be offered to selected patients with no mortality and 
low morbidity. Long term survival is achievable, but recur-
rence rate after surgery is high. Immunotherapy could be 
effective to control tumour progression especially in selected 
cases where DC may be used.
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PANCREATICO-DUODENECTOMY 
PERFORMED BY SENIOR SURGEONS: 
IS IT MORE DANGEROUS?
U. Marchese2, O. Turrini1, J. Ewald1, P. Orsoni2, 
C. Brunet2, S. Berdah2, V. Moutardier2 and J.-R. Delpero1
1Service de Chirurgie Oncologique, Institut Paoli-
Calmettes, Marseille; 2Service de Chirurgie Digestive, 
Hôpital Nord, Marseille
Hopital Nord, Service de Chirurgie Digestive, 37 rue Saint 
Leon, 13012, Marseille, France
Introduction: PD is a complex surgical procedure where 
each detail may infl uence the post-operative outcomes. In 
expert centers, mortality rates decrease but morbidity rates 
still remain high. We wanted to know if surgical experience 
could impact on PD morbi-mortality rate.
Methods: between January 2010 and July 2011, 135 PD 
have been performed at two medical centers. 68 PD were 
done by two experienced surgeons (more than 100 PD each 
– senior group) and 67 by two less experienced surgeons 
(less than 50 PD each – junior group). Operative (transfu-
sion, veinous resection and operating time) and post-opera-
tive outcomes (pancreatic fi stulae, hemorragiae, death, 
length of stay) were studied.
Results: Of these 135 patients, there were 30 pancreatic 
fi stulae (22%), 9 hemorragiae (6.8%) and 3 patients died 
(2.2%). There was more malignant tumors in the junior 
group (91% vs. 76%; p = 0.03). There was no signifi cant 
difference between senior and junior group concerning 
veinous resection (15% vs. 27%, p = 0.09), operating time 
(413 vs. 409 min; p = 0.7) and number of transfusion (0.8 
vs. 0.7; p = 0.6). There was also no signifi cant difference 
between groups concerning global pancreatic fi stulae rates 
(24% vs. 21%; p = 0.8), neither for the grade B and C fi stulae 
(10% vs. 12%; p = 0.4), hemorragiae (9% vs. 4%; p = 0.2), 
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length of stay (24.6 days vs. 22.5, p = 0.2) and number of 
death (1.5% vs. 3%, p = 0.6).
Conclusion: less experienced surgeons can perform PD 
without increasing the morbidity and mortality rate when 
compared to senior surgeons. However the patient volume 
of the center as well as the supervision and presence of an 
experienced surgeon are probably necessary to obtain these 
results.
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CLINICOPATHOLOGIC FEATURES AND 
PROGNOSIS OF MUCINOUS CYSTIC 
NEOPLASMS (MCNS) WITH 
OVARIAN STROMA
E. Gil, S. H. Choi, D. W. Choi, J. S. Heo, M. J. Kim, 
H. J. Park and K. K. Choi
Department of Surgery, Samsung Medical Center, 
Sungkyunkwan University of Medicine, Seoul, Korea
Surgery, Department of Surgery, Samsung Medical Center, 
Sungkyunkwan University School of Medicine, 50 Irwon-
dong, Gangnam-gu, Seoul, 135-710, Korea
Introduction: Mucinous cystic neoplasms (MCNs) are gen-
erally considered low-grade malignant tumors with good 
prognosis. Despite the increase in the frequency, its natural 
history and long term surgical result remains unclear. The 
aim of this study was to elucidate the clinicopathological 
features and prognosis of MCN.
Methods: By using the presence of ovarian stroma as a 
requisite criterion for diagnosis of MCN, medical records of 
48 MCN patients among 285 mucin-producing neoplasms 
were reviewed. All the patients underwent curative resection 
in Samsung Medical Center between 1994 and April 2011.
Results: MCN was confi rmed in 48 cases, including 38 
low-grade (79.2%), 4 intermediate-grade (8.3%), 1 high-
grade dysplasia (2.1%) and 5 invasive carcinomas (10.4%). 
The patients were exclusively women (44, 91.7%) with the 
mean age of 48.1 years. Most tumors were located in the 
pancreatic body/tail (43, 89.6%) with a mean size of 5.5 cm. 
The most frequent presenting symptom was abdominal pain 
(12, 25%). More than half were asymptomatic. There was no 
lymph node metastasis in 27 lymph node dissected cases. 
None of the 43 patients with non-invasive MCNs recurred. 
However 2 out of 5 patients with invasive MCNs recurred 
and 1 died within 5 years.
Conclusion: The prognosis of the non-invasive MCN is 
excellent when curative resection was performed. Early cura-
tive surgical resection is recommended even in the cases of 
recurrence.
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PROGNOSTIC SIGNIFICANCE OF 
ANEUPLOIDY LEVELS IN PANCREATIC 
INTRAEPITHELIAL NEOPLASIA
A. Morhan1, P. Griffi ths2, S. Doak1, T. Brown3, 
B. Al-Sarireh3 and G. Jenkins1
1Institute of Life Science, College of Medicine, Swansea, 
UK; 2Histopathology Dept, Morriston Hospital, Swansea, 
UK; 3Pancreatic Unit, Morriston Hospital, Swansea, UK
Institute of Life Science, College of Medicine, Molecular 
Biology of Cancer, 3 Castle Street, Mumbles, Swansea SA3 
4BH, UK
Introduction: Pancreatic ductal adenocarcinoma has the 
highest cancer mortality rate (survival <4% at 5 years). 
Carcinogenesis is initiated in precursor lesions like pancre-
atic intraepithelial neoplasias (PanINs 1-3) and is marked by 
progressive accumulation of genetic abnormalities, including 
chromosome copy numbers anomalies (aneuploidy).
Methods: This is a retrospective 2-year study using archival 
tissue samples of pancreatic adenocarcinoma containing 
intraductal premalignant lesions of all stages as well as 
normal ducts. The technique involves fl uorescence in situ 
hybridization (FISH) to quantify chromosome copy numbers 
for chromosomes 1, 6, 9 and 18 (probes Vysis, UK) using a 
Zeiss Axio Imager Z1 Fully Motorised Upright microscope 
with MetaSystems Isis FISH imaging software, equipped 
with DAPI, Spectrum Green and Spectrum Orange fi lters. 
The fi nal aneuploidy scores corresponding to each stage are 
included in multivariate analysis alongside biochemical, 
staging and survival data. They are also proccessed to reveal 
a potential critical stage in carcinogenesis.
Results: Up to date the study included 40 samples with dif-
ferent histological stages, hybridized with dual probes of 
chromosome 1 and 6 and chromosome 9 and 18 respectively. 
Over 100000 cells have been scored: the deletions levels are 
subject to bias from tissue sectioning techniques but they are 
increased for chromosome 6 and 9 in PanIN 3 (mean 
35.124%, 20.014% respectively) compared to PanIN 1 
(mean 10.112%, 12.754% respectively); the level of ampli-
fi cations are predominant for chromosome 1 and 18 in 
PanIN3 (mean 9.025%, 11.231% respectively) compared to 
PanIN1 (mean 3.256%, 2.145% respectively). Further prog-
ress aims to expand the number of samples, analyze the most 
signifi cant aneuploidy variations and perform multivariate 
analysis.
Conclusion: The carcinogenesis in pancreatic cancer is an 
intricate process. The analysis of abnormal chromosome 
copy numbers can provide vital information towards prog-
nosis and survival.
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EVALUATION OF THE 18F-FDG 
PETSCAN FOR THE DIAGNOSIS OF 
DEGENERATION OF THE INTRADUCTAL 
PAPILLARY MUCINOUS TUMORS OF 
THE PANCREAS (IPMT)
C. Péry1, A. Sauvanet2, O. Turrini3, F. Cauchy2, 
J.-R. Delpero3 and N. Regenet4
1Service de Chirurgie Hépato-biliaire et Digestive, CHU de 
Rennes, France; 2Service de Chirurgie Hépatique et 
Pancréatique, Hôpital Beaujon, Assistance Publique-
Hopitaux de Paris, Clichy-la-Garenne; 3Service de 
Chirurgie Oncologique, Institut Paoli-Calmettes, Marseille, 
France; 4Service de Chirurgie Digestive et Endocrinienne, 
CHU de Nantes, France
Centre Hospitalier Univeritaire de Rennes, Service de 
chirurige hépato-biliaire et Digestive, 2 rue Henri Le 
Guilloux, 35033, Rennes Cedex 9, France
Introduction: IPMT can degenerate. Currently, imagery is 
insuffi ciently sensitive and specifi c to evaluate the malig-
nancy. The aim of this study is to assess the effi cacy of the 
PETscan in the diagnosis of malignant IPMT.
Methods: Patients reached by an IPMT with surgical deci-
sion who had underwent CTscan, MRI and/or endoscopic 
ultrasonography and 18F -FDG PETscan before the surgery, 
were retrospectively studied. They were operated between 
October 2005 and November 2011 at the Hospitals of Nantes, 
Beaujon (Paris) and at the Paoli Calmettes institute of 
Marseille.
Results: Sixty-seven patients were studied, 32 males and 35 
females. The median age was 58.6 years [34–81]. Sensitivity, 
specifi city, positive (PPV) and negative predictive values 
(NPV) of traditional imagery for the diagnosis of malignancy 
(high grade dysplasia and adenocarcinoma) were respec-
tively 86.1%, 48.3%, 65.9% and 75%. The radiological signs 
considered as suggesting malignancy were: main duct dila-
tion >10 mm, branch ducts dilation >30 mm, mural nodes or 
a mass syndrome. These values with PETscan were respec-
tively 61.1%, 80.6%, 78.5% and 64.1%.
Conclusion: Traditional imagery is sensible to detect malig-
nant IPMT but not specifi c enough, generating a risk of 
radical surgery whereas a limited resection could be per-
formed. PETscan is more specifi c and then could help for the 
surgical decision. However, its negative predictive value is 
not suffi cient to decide a simple following. But a limited 
resection as enucleation or medial pancreatectomy could be 
performed in case of no FDG uptake. PETscan is also useful 
for searching metastases.
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LONG-TERM SURVIVAL OF STRAIGHT 
OFF RESECTABLE PANCREATIC 
ADENOCARCINOMA FURTHER 
RECUSED DURING PEROPERATIVE 
SURGERY PROCEDURE
D. J. Birnbaum1, O. Turrini1, J. Ewald1, 
L. Moureau-Zabotto2, J.-L. Raoul2 and J.-R. Delpero1
1Department of Surgical Oncology, Institut Paoli-Calmettes 
and Université de la Mediterranée, Marseille, France; 
2Department of Medical Oncology, Institut Paoli-Calmettes 
and Université de la Mediterranée, Marseille, France
Institut Paoli-Calmettes, Department of Surgical Oncology, 
Department of Surgical Oncology, Institut Paoli-Calmettes 
and Université de la Mediterranée, 232, boulevard 
Sainte-Marguerite, BP 156, 13273 Marseille cedex 09, 
France
Introduction: Only 10 to 15% of patients with a pancreatic 
adenocarcinoma (PA) can benefi t of a curative resection. The 
median survival of these patients is about 20 months with a 
5 years survival ranging between 15 to 20%. Unresectable 
PA survival is about approximately 6 months, with a 5-years 
survival almost non-existent. We were thus interested in the 
survival of patients with a resectable PA in preoperative, 
while the surgery was rejected during the preoperative surgi-
cal act.
Methods: A total of 45 patients with PA were cared at the 
hospital, from January 1999 to June 2011. All patients were 
programmed for a curative surgery but none benefi ted from 
it. The reasons were the peroperatory discovery of a locally 
advanced (LA) disease, the presence of hepatic metastases 
(HM) or peritoneal carcinosis (PC). The median and overall 
survival (OS) of these patients, according to the peroperative 
observations, were analyzed.
Results: The median age of the population was of 67 years. 
38% of the patients were female. In 71% of the cases, the 
tumor was localized at the head of the pancreas. The median 
size of tumors was of 30 mm (19–90 mm). 53% of the 
patients benefi ted from a neo-adjuvant treatment by radio 
chemotherapy (RCT). During the preoperative procedure, we 
found that the tumor was LA in 23 patients (51%), HM were 
present in 10 patients (22%) and PC were found in 12 
patients (27%). A palliative treatment was proposed in 64% 
of patients (CT n = 23 and RCT n = 6). The median of the 
OS was of 14 months (mo) (0–44) all patients confounded, 
18 mo (0–41) in patients with LA disease, 13 mo (3–46) in 
patients with HM and 9 mo (2–18) in patients presenting PC.
Conclusion: With this study we found quite surprisingly 
that the median survival of straight off resectable pancreatic 
adenocarcinoma further recused during peroperative surgery 
procedure was extremely close to the median survival 
observed in patients with effective resection of the pancreatic 
adenocarcinoma.
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LIMITS OF RADICALITY IN 
PANCREATECTOMY
M. Levy, V. Visokai and L. Lipska
Surgical Department, Thomayer Hospital, First Faculty of 
Medicine, Charles University
Thomayer Hospital, First Medical Faculty, Charles 
University Prague, Surgical Department, Videnska 800, 
14059, Prague 4, Czech Republic
Introduction: Pancreatic cancer is one of leading causes of 
cancer-related death in the world. Surgery remains the only 
potential currative method of treatment. Many patients in the 
time of diagnosis presents with advanced disease. This 
cancer invades the retropancreatic neural tissue, duodenum, 
portal vein, and superior mesenteric vein, or regional lymph 
nodes. For this reason, surgeons have attempted to obtain a 
complete resection by extending the limits of conventional 
resection.
Methods: The aim of this study was to review the outcome 
of the extended pancreatectomy for carcinoma. Studies pub-
lished in the last 10 years on pancreatectomy with portal 
vein/superior mesenteric vein resection, multivisceral resec-
tion and resection of metastatic ductal pancreatic carcinoma 
were retrieved from the Medline database and reviewed.
Results: The mortality in pancreatectomy with portal vein/
superior mesenteric vein resection varied between 0% and 
15%, postoperative complication between 6% and 65%. 
Median survival was 15 months and ranged from 1.6 to 250 
months, and 3 and 5-year survival ranged from 0 to 60 and 
0 to 24% according to the studies reviewed.
Morbidity following multivisceral resections varied 
between 35%–68% while mortality ranged from 0%–3%. 
5-year survival varied between 16%–22%.
The mortality and morbidity of pancreatic resections for M1 
disease was 0% and 24.1%.
Conclusion: In properly selected patients, portal vein/supe-
rior mesenteric vein resection combined with pancreatec-
tomy is a safe and feasible procedure that increases the 
number of patients who undergo curative resection with a 
survival benefi t.
From the limited data of multivisceral resections it can be 
concluded that such resections are feasible and when per-
formed in high volume centres. Pancreatic resections with 
M1 disease can be performed with acceptable safety in 
highly selected patients.
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PERIAMPULLARY TUMORS, 
TREATMENT AND 
PROGNOSTIC FACTORS
M. Levy, L. Lipska and V. Visokai
Surgical Department, Thomayer Hospital, First Faculty of 
Medicine, Charles University
Thomayer Hospital, First Medical Faculty, Charles 
University Prague, Surgical Department, Videnska 
80014059, Prague 4, Czech Republic
Introduction: Periampullary tumors originate from ampul-
lary, duodenal, biliary, or ductal pancreatic epithelium. These 
cancers vary in outcome after surgical resection. Overall 
survival after pancreaticoduodenectomy is best for patients 
with ampullary and duodenal cancers, intermediate for 
patients with bile duct cancer, and worst for patients with 
pancreatic cancer. Tumor biology rather than anatomic 
factors probably causes these differences in survival.
Methods: In Surgical Department, Thomayer Teaching 
Hospital, Prague between 1996–2010, 95 patients underwent 
pancreatic resection for periampullary cancer. In this group, 
carcinoma of papilla Vateri was in 29 cases, in 66 cases 
ductal carcinoma. Due to different biologic entities and 
different clinical manifestation, different results were 
suspected.
Results: In the group of carcinoma of papilla Vateri 19 
pylorus preserving pancreatoduodenectomies (PPPD) and 10 
Whipple procedures were performed. Mortality was 8%, 
morbidity 39%. In the group of ductal adenocarcinoma 36 
Whipple procedures were performed, in 7 cases with mesen-
teric vein resection, in 1 case with hepatic resection for 
metastasis, in 30 cases PPPD were performed. Mortality was 
9%, morbidity 45%. Overall 5-year survival in the group of 
carcinoma of papilla Vateri was 59%, in the group of ductal 
carcinoma was 18%. Pancreatic ductal carcinomas expressed 
MUC1 (pan-epithelial membrane-associated mucin) but did 
not express MUC2 (intestinal-type secreted mucin), which is 
expressed in tumors with indolent behavior and a favorable 
outcome.
Conclusion: Our results confi rm different biological behav-
iour of these two types of pancreatic cancer. We declare there 
is no place for therapeutic nihilism especially in non-ductal 
cancer. Mucin expression monitoring should have a potential 
as a prognostic factor.
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PHASE II TRIAL OF GEMCITABINE 
PLUS INTRAVENOUS OMEGA-3 
FISH OIL IN ADVANCED 
PANCREATIC CANCER
A. Arshad1, D. Al-Lewas1, T. Hall1, W.-Y. Chung1, 
C. Pollard1, W. Steward2, M. Metcalfe1 and A. Dennison1
1Department of Hepatobiliary and Pancreatic Surgery, 
University Hospitals of Leicester; 2Department of Medical 
Oncology, University Hospitals of Leicester
University Hospitals of Leicester, Hepatobiliary and 
Pancreatic Surgery, Gwendolen Road, Leiester LE54P, 
United Kingdom
Introduction: Advanced pancreatic cancer (APC) carries a 
dismal prognosis. The anti-infl ammatory and anti-angiogenic 
properties of omega-3 rich fatty acids (n-3FA) have been 
well demonstrated in the laboratory setting. Clinical 
trials with oral preparations in cancer patients have shown 
a tendency to improved quality of life but are not 
conclusive possibly due to limited bioavailability and poor 
compliance.
Methods: A phase II single-arm trial of weekly gemcitabine 
plus intravenous n-3FA rich lipid emulsion was administered 
to patients with APC. Inclusion criteria were identical to 
those for single-agent gemcitabine. Tumour evaluation by 
RECIST CT and serum CA19-9 was carried out every 2 
cycles. A cohort of historical controls (HC) with a signifi -
cantly lower proportion of metastatic disease was examined 
to determine institutional results. Adverse events were 
recorded by CTCAE v4.0 criteria.
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Results: Thirty four patients were enrolled of whom 32 
received treatment. 24 were evaluable for response. 
Proportion of patients with all-site metastatic disease in 
experimental group (EG) vs HC was 24/32 (75%) vs 13/27 
(48%). Median overall and progression free survival for EG 
vs HC were 5.4 vs 4.1 months (p = 0.48) and 3.7 vs 2.35 
months (p = 0.01) respectively. Minor response rate was 
17/24 (70.8%). Partial response (PR) rate was 3/24 (12.5%). 
PR of liver metastases (LM) was 6/12 (50%). Disease control 
rate was 19/24 of EG (79.2%) vs 6/17 of HC (35.3%) (p = 
0.01). 10/19 (47%) patients had a 50% or greater decrease 
in CA19-9. Adverse events were: Grade 3 thrombocytopae-
nia – 6.3%, grade 3/4 neutropaenia – 12.5% and grade 3 
nausea – 6.3%.
Conclusion: Intravenous n-3FA may have a synergistic 
effect with gemcitabine in APC. Larger randomised clinical 
trials are necessary to assess this further and to clarify the 
independent contribution of n-3FA to this effect.
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INTRAVENOUS OMEGA-3 FISH OIL 
PLUS GEMCITABINE AMELIORATES 
TUMOUR CACHEXIA AND STABILISES 
QUALITY OF LIFE AND PAIN SCORES IN 
PATIENTS WITH ADVANCED 
PANCREATIC CANCER
A. Arshad1, D. Al-Lewas1, D. Bilku1, W.-Y. Chung1, 
C. Pollard1, W. Steward2, M. Metcalfe1 and A. Dennison1
1Department of Hepatobiliary and Pancreatic Surgery, 
University Hospitals of Leicester; 2Department of Medical 
Oncology, University Hospitals of Leicester
University Hospitals of Leicester, Hepatobiliary and 
Pancreatic Surgery, Gwendolen Road, Leiester LE54P, 
United Kingdom
Introduction: Tumour cachexia in patients with advanced 
pancreatic cancer (APC) is almost universal and a major 
contributor to decreasing quality of life (QoL). It is driven 
by highly potent infl ammatory cytokines which may be 
modulated by omega-3 rich fatty acids (n-3FA).
Methods: A phase II single-arm trial of Gemcitabine 
(1000 mg/m3 weekly for 3 weeks followed by a rest week) 
plus intravenous -3FA rich lipid emulsion (Lipidem® 
BBraun, Melsungen 200 mg/ml) (up to 100 g/500 mls over 
4 hours) in patients with histologically confi rmed, locally 
advanced or metastatic pancreatic cancer. Clinically vali-
dated (EORTC QLQ-C30/PAN26) QoL and brief pain inven-
tory (BPI) questionnaires were completed by patients during 
treatment each week, and scored according to internationally 
agreed guidelines. Rates of clinical benefi t response (CBR), 
defi ned by an improvement in any one of Global QoL score, 
BPI score or weight sustained for ≥4 weeks without decline 
in any of the other criteria were recorded.
Results: Thirty two patients received at least one treatment 
with 24 assessable over at least 8 weeks period. 16/24 
(66.7%) gained weight at some point during treatment. 
Median duration of weight gain response was 16 weeks. 
12/17 (70.6%) of patients completing at least 16 weeks, and 
7/10 (70%) completing 24 weeks had stable or increased 
weight. Global QoL scores were improved or static in 14/24 
(58.3%) and pain scores improved or were static in 16/24 
(66.7%) of patients after 8 weeks of treatment. 7/24 (29.2%) 
and 5/24 (20.8%) of patients had >10% or >20% increase in 
global QoL respectively. CBR was demonstrated in 10/24 
patients (41.6%).
Conclusion: Intravenous n-3FA may be a useful adjunct to 
existing regimens in stabilising weight and QoL in patients 
with advanced pancreatic cancer.
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BASELINE INTERLEUKIN 6 AND 8 
PREDICT CLINICAL OUTCOME IN 
PATIENTS WITH ADVANCED 
PANCREATIC CANCER TREATED WITH 
GEMCITABINE AND INTRAVENOUS 
OMEGA-3 FISH OIL
A. Arshad1, W.-Y. Chung1, T. Hall1, D. Al-Leswas1, 
C. Pollard1, W. Steward2, M. Metcalfe1 and A. Dennison1
1Department of Hepatobiliary and Pancreatic Surgery, 
University Hospitals of Leicester; 2Department of Medical 
Oncology, University Hospitals of Leicester
University Hospitals of Leicester, Hepatobiliary and 
Pancreatic Surgery, Gwendolen Road, Leiester LE54P, 
United Kingdom
Introduction: Pro-infl ammatory cytokines such as 
Interleukin (IL) 6 and 8 may contribute to tumour cachexia, 
reducing quality of life and ultimately survival in patients 
with advanced pancreatic cancer (APC). Omega-3 fatty acids 
(n-3FA) have been shown to inhibit pro-infl ammatory cyto-
kine production both in vivo and in vitro.
Methods: As part of a phase II clinical trial of weekly gem-
citabine plus intravenous n-3FA in patients with APC, serum 
samples were collected from patients immediately prior to 
treatment. Concentrations of 14 pro-infl ammatory cytokines 
and pro-angiogenic growth factors were evaluated using a 
multiplex ELISA cytokine array (Aushon biosystems), and 
low or high expressors around the median concentration of 
each factor correlated with overall and progression free 
survival.
Results: High expressors of IL-6 and IL-8 had signifi cantly 
shorter median overall survival than low expressors (IL-6: 
3.1 vs 7.0 months – p = 0.01, IL-8: 3.1 vs 7.3 months – p = 
0.01). Low expressors of Receptor Activator of Nuclear 
Kappa beta factor Ligand (RANKL) had signifi cantly shorter 
median overall survival than high expressors (2.7 vs 7.0 
months – p = 0.04). High expressors of IL-8 had signifi cantly 
shorter progression free survival than low expressors (2.8 vs 
5.6 months, p = 0.002). No other factors had any signifi cant 
differences in survival between low or high expressors.
Conclusion: Baseline IL-6, IL-8 and RANKL predicted 
overall survival, and IL-8 progression free survival in this 
cohort. Further investigations in larger randomised clinical 
trials are warranted to determine the independent effect of 
the n-3FA component of treatment.
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EXPRESSION OF CIRCULATING PRO-
ANGIOGENIC AND PRO-
INFLAMMATORY FACTORS IS 
REDUCED IN PATIENTS WITH 
ADVANCED PANCREATIC CANCER 
TREATED WITH GEMCITABINE AND AN 
INTRAVENOUS OMEGA-3 RICH 
LIPID EMULSION
A. Arshad1, W.-Y. Chung1, T. Hall1, D. Al-Leswas1, 
C. Pollard1, W. Steward2, M. Metcalfe1 and A. Dennison1
1Department of Hepatobiliary and Pancreatic Surgery, 
University Hospitals of Leicester; 2Department of Medical 
Oncology, University Hospitals of Leicester
University Hospitals of Leicester, Hepatobiliary and 
Pancreatic Surgery, Gwendolen Road, Leiester LE54P, 
United Kingdom
Introduction: Omega-3 rich fatty acids (n-3FA) reduce 
expression of pro-angiogenic and pro-infl ammatory circulat-
ing factors (CAF’s) in vitro and in vivo. These factors may 
contribute to tumour cachexia, reducing quality of life and 
tumour progression in advanced pancreatic cancer (APC).
Methods: As part of a phase II clinical trial of gemcitabine 
plus intravenous n-3FA in patients with APC, serum samples 
were collected each week. Patients were treated weekly for 
3 weeks with a rest week in week 4 for a total of up to 6 
months. Concentrations of fourteen CAF’s were evaluated 
using a multiplex ELISA cytokine array. Changes with time 
were evaluated using univariate logistic regression.
Results: TNF-alpha Related Apoptosis Inducing Ligand 
(TRAIL): p = 0.009, Fibroblast Growth Factor (FGF): p = 
0.03 and Platelet-derived Growth Factor (PDGF): p = 0.05, 
all displayed signifi cantly reduced expression with patient 
treatment. PDGF showed highly signifi cant decreased 
expression when analysed on a per-cycle basis (p ≤ 0.001 for 
cycles 1–5). The effect in PDGF reduction was lost during 
the rest week but reinstated after resumption of treatment.
Conclusion: Signifi cantly reduced expression of CAF in 
APC may be achieved using the combination of intravenous 
n-3FA and gemcitabine. PDGF reduction in particular 
appears to be highly correlated with treatment. Randomised 
clinical trials are required to assess the independent contribu-
tion of n-3FA to this effect.
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RESTORATION OF MANNOSE-BINDING 
LECTIN PATHWAY ACTIVITY IS 
RELATED TO IMPROVED OUTCOME IN 
PATIENTS WITH ADVANCED 
PANCREATIC CANCER TREATED WITH 
GEMCITABINE AND INTRAVENOUS 
OMEGA-3 FISH OIL
A. Arshad1, W.-Y. Chung1, D. Bilku1, D. Al-Leswas1, 
C. Pollard1, W. Steward2, M. Metcalfe1 and A. Dennison1
1Department of Hepatobiliary and Pancreatic Surgery, 
University Hospitals of Leicester; 2Department of Medical 
Oncology, University Hospitals of Leicester
University Hospitals of Leicester, Hepatobiliary and 
Pancreatic Surgery, Gwendolen Road, Leiester LE54P, 
United Kingdom
Introduction: Omega-3 rich fatty acids (n-3FA) have 
proven anti-infl ammatory and anti-angiogenic properties in 
vitro and in vivo. These properties in addition to their low 
cost and excellent safety profi le make them attractive poten-
tial adjuncts in cancer therapy. Complement activates 
myeloid derived suppressor cells, in combination with pro-
infl ammatory cytokines which together may block host 
immune response against tumour cells.
Methods: As part of a phase II trial of gemcitabine plus 
intravenous n-3FA in patients with advanced pancreatic 
cancer, serum samples were collected prior to treatment each 
week and assessed for complement activity in the Mannose 
binding lectin (MBL) pathway using an ELISA assay. 
Patients with <70% activity at baseline which was restored 
to positive control or greater during treatment were classifi ed 
as responders. Overall and progression free survival (PFS) 
for responders versus non-responders was assessed.
Results: 23 patients were assessable for complement activ-
ity over at least an 8 week period. There was no difference 
in OS or PFS between low and high MBL activity at baseline. 
However MBL responders had signifi cantly prolonged PFS 
vs non responders (8.6 vs 2.0 months p = 0.01).
Conclusion: Restoration of MBL activity may refl ect 
decreased consumption of complement and is related to 
improved outcome in this cohort. This may be related to 
reduction in circulating myeloid derived suppressor cells 
with enhanced anti-tumour immunity. Further work to clarify 
the mechanisms of action is required in addition to assessing 
the independent anti-tumour effect of n-3FA.
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ALTERNATIVE VASCULAR 
RECONSTRUCTION FOR BORDERLINE 
RESECTABLE PANCREATIC CANCER 
AND REGIONAL VESSEL DAMAGE 
AFTER NEOADJUVANT RADIOTHERAPY
E. Akaishi1, V. M. Jr1, A. C. Buzaid2, F. Busnardo1, 
F. Gaiotto1, N. Mizumoto1, T. A. Lima1 and M. Katayama3
1Hospital das Clinicas, University of Sao Paulo School of 
Medicine, Brazil; 2Hospital Sao Jose, Sao Paulo, Brazil; 
3Hospital Sirio Libanes, Sao Paulo, Brazil
Hospital das Clinicas, University of Sao Paulo School of 
Medicine, Brazil; Department of General Surgery, Surgical 
Oncology Group, R. Barata Ribeiro, 414 cj 461308, Sao 
Paulo, Brazil
Introduction: Neoadjuvant chemoradiation for pancreatic 
adenocarcinoma is a key component of current treatment 
regimens for borderline resectable lesions. Hepatic artery 
abutment or encasement is still considered unresectable in 
the scope of this disease. The aim of this study is to describe 
a surgical alternative for deeming resectable patients with 
hepatic artery abutment.
Methods: A 56-year-old man, diagnosed with pancreatic 
adenocarcinoma in May 2010 through CT scan and staged 
with endoscopic ultrasound (US) and fi ne needle biopsy. The 
CT showed the celiac trunk, hepatic artery and superior mes-
enteric vein involved by the tumor. Staging workup showed 
clinical stage III (cT3cN1cM0) disease. The tumor was con-
sidered unresectable. The patient underwent neoadjuvant 
chemotherapy: Gemcitabine + Capecitabine (2 cycles), 
Oxaliplatin + Irinotecan-based regimen (6 cycles), followed 
by chemoradiotherapy (30 Gy + Capecitabine, 28 days). In 
January 2011, he underwent a gastropancreatoduodenectomy 
with intraoperative radiotherapy.
Results: The preoperative treatment regimen resulted in a 
radiologic downstaging of the lesion but persistent abutment 
of superior mesenteric vein and common hepatic artery. An 
en bloc Whipple procedure with superior mesenteric vein 
and 4-cm common hepatic artery resections were carried out. 
Vascular reconstruction was made with an autologous jugular 
vein graft for replacement of SMV. Arterial reconstruction 
was fi rstly made by splenic artery transposition to remnant 
hepatic artery (after splenectomy). Splenic artery presented 
very thick wall, probably caused by radiation, and few 
minutes after anastomoses the thrombosis was observed in 
this artery, with no arterial perfusion to the liver. Therefore 
we used saphenous vein for arterial reconstruction.
Conclusion: Saphenous vein graft for arterial reconstruc-
tion in cases of advanced vascular damage by neoadjuvant 
chemoradiation was a feasible and safe surgical technique 
for the treatment of a patient with borderline resectable pan-
creatic tumor.
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LONG-TERM SURVIVAL FOLLOWING 
PANCREATODUODENECTOMY FOR 
PANCREATIC ADENOCARCINOMA
G. Falk, D. Joyce, G. Morris-Stiff, S. Chalikonda and 
R. M. Walsh
Section of Surgical Oncology/HPB, Cleveland Clinic, 
Euclid Avenue, 44195, Cleveand, USA
Introduction: Pancreatic ductal adenocarcinoma frequently 
presents at an advanced stage, and even after potentially 
curative pancreatoduodenectomy, outcomes are frequently 
poor. As a result, some authors have suggested that the 
majority of patients have a diagnosis other than that of ade-
nocarcinoma. The aim of this study was to review the long-
term results of pancreatoduodenectomy and to determine the 
histopathology of those surviving in excess of 5 years.
Methods: The departmental database was reviewed to iden-
tify all patients undergoing pancreatoduodenectomy during 
the period January 2000 to December 2005, such that the 
minimal potential follow-up was 5 years. For all patients 
within this cohort, the histopathology was reviewed to deter-
mine the tumor type present.
Results: During the study period 195 patients underwent 
pancreatoduodenectomy and 96 patients survived at least 5 
years. Data for the primary adenocarcinomas of the peri-
ampullary region are summarized below. The number of 
5-year survivors for each histopathological subtype as: 
Ampullary 18/35 (51%); CBD 4/8 (50%); 10/15 (67%); 
20/78 (26%). The 5-year actual survival of patients with 
pancreatic ductal adenocarcinoma (29%) was signifi cantly 
less than that of other periampullary neoplasms (p < 0.05) 
despite a similar stage profi le at presentation. Of those with 
pancreatic ductal adenocarcinoma, the initial disease staging 
was: IA (n = 4); IB (n = 13); IIA (n = 8); IIb (n = 52); III (n 
= 0) and IV (n = 1). Of stages of those surviving 5 years was: 
IA (n = 4 [100%]); IB (n = 8 [63%]); IIA (n = 2 [25%]); IIb 
(n = 11 [21%]); and IV (n = 0 [0%]).
Conclusion: Whilst the prognosis of patients with pancre-
atic adenocarcinoma undergoing resection is not as good as 
that of other periampullary neoplasms, the actual survival 
rate of 26% at 5 years indicates that success can be achieved. 
Furthermore, whilst prognosis is signifi cantly better for stage 
I disease, patients with stage II disease exhibit survival of 
greater than 20%.
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OUTCOMES OF 
PANCREATODUODENECTOMY IN THE 
21ST CENTURY: A SINGLE SERIES 
EXPERIENCE OF 591 PATIENTS
G. Falk, D. Joyce, G. Morris-Stiff, S. Chalikonda and 
R. M. Walsh
Section of Surgical Oncology/HPB, Cleveland Clinic, 
Euclid Avenue, 44195, Cleveand, USA
Introduction: Pancreatoduodenectomy (PD) is the treat-
ment of choice for resectable periampullary carcinomas, and 
for selected patients with benign pathologies within the peri-
ampullary region, in particular those with a malignant poten-
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tial. The aim of this study is to report the outcomes of all 
patients undergoing PPD at a single centre and to examine 
the evolution of the service.
Methods: All patients undergoing PD during the period 
January 2000 to December 2010 were identifi ed from the 
departmental database. Pre-, peri- and post-operative data 
were reviewed. The more common pathologies for which 
survival was calculated included: ampullary carcinoma; 
ampullary adenoma; CBD carcinoma; duodenal carcinoma; 
duodenal adenoma: pancreatic carcinoma; pancreatic neuro-
endocrine tumours; IPMN; IPMN carcinoma; and chronic 
pancreatitis.
Results: During the period covered by the study, 591 
patients underwent PD. There were 320 men and 271 women 
with a mean age of 64 ± 12 years. The number of resections 
performed per year increased steadily from 12 in 2000 to 85 
in 2010. Final pathology revealed 53 (9%) benign, 81 (14%) 
pre-malignant, and 457 (77%) malignant pathologies. The 
30-day mortality was 2.7%. The median survival for the 
cohort as a whole was 55.3 months. Median survivals for 
the common identifi ed were: 45.9; 102.2; 69.4; 74.5; 199.3; 
40.7; 77.7; 96.6; 63.6; and 58.4 months respectively. The 
survival of duodenal adenomas was signifi cantly greater than 
the group as a whole (p < 0.05) whilst that of pancreatic 
adenocarcinoma is worse (p < 0.05). There were no statisti-
cally signifi cant differences in survival for the remaining 
pathologies.
Conclusion: The resection volume increased signifi cantly 
during the decade. The majority of resections were per-
formed for malignant/pre-malignant lesions. Whilst there 
were differences in median survival rates of the common 
indications for PD, the outcomes of the majority of lesions 
encountered were comparable.
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NATURAL HISTORY OF ASYMPTOMATIC 
PANCREATIC CYSTIC NEOPLASMS
G. Morris-Stiff, F. Gavin, S. Chalikonda and R. M. Walsh
Section of Surgical Oncology/HPB, Cleveland Clinic, 
Cleveand, USA
Cleveland Clinic, Section of Surgical Oncology/HPB9500 
Euclid Avenue, 44195, Cleveland, USA
Introduction: Management of asymptomatic pancreatic 
cysts is controversial, with need for excision based on pathol-
ogy and natural history. The aim of this study was to examine 
the outcome of asymptomatic lesions using our protocol 
based on size and cyst fl uid analysis.
Methods: A prospective database was queried to identify 
asymptomatic pancreatic cysts. Sequential cross-sectional 
imaging studies were assessed, and for those ≥1.5 cm, results 
of endoscopic ultrasound-guided aspiration were co-anal-
ysed. Defi nitive histopathology was available for resected 
specimens.
Results: From 1998–2008, 338 patients underwent evalua-
tion. 84 cysts were <1.5 cm and 254 were ≥1.5 cm in diam-
eter. Median patient follow-up was 5.1 years (IQR: 4.1–6.9). 
In the <1.5 cm group, median cyst size at presentation was 
1 cm (IQR: 0.6–1.2) increasing to 1.2 cm (0.7–1.6) during 
follow-up. 5 (6.0%) patients underwent resection, all within 
2 months of presentation, 4 of these also underwent cyst 
aspiration which was positive for mucin. In the ≥1.5 cm 
group, the median cyst size at presentation was 2.5 cm (IQR: 
2.0–3.4) increasing to 2.7 cm (IQR: 3.0–4.2). 63 (24.8%) 
patients underwent resection. 53 (84.1%) cases were per-
formed within 2 months, 4 (6.3%) within 12 months, and 6 
(9.6%) >12 months post presentation. Histopathology of 
resected specimens revealed 71% were malignancies or had 
malignant potential.
Conclusion: Asymptomatic cysts <1.5 cm can safely be fol-
lowed only by imaging with little change expected. A quarter 
of all asymptomatic cysts ≥1.5 cm are appropriately resected 
based on imaging and cyst fl uid analysis.
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ADENOCARCINOMA ARISING IN 
INDRADUCTAL PAPILLARY MUCINOUS 
NEOPLSMS (IPMN): A DIFFERENT 
BIOLOGICAL PROFILE AND 
CLINICAL OUTCOME
G. Morris-Stiff, F. Gavin, S. Chalikonda and R. M. Walsh
Section of Surgical Oncology/HPB, Cleveland Clinic, 
Cleveand, USA
Cleveland Clinic, Section of Surgical Oncology/HPB9500 
Euclid Avenue, 44195, Cleveland, USA
Introduction: The rate of malignant transformation in 
patients with IPMN is high, in particular for disease affecting 
the main pancreatic duct. The aim of this study was to evalu-
ate a subset of patients with pancreatic adenocarcinoma 
arising in IPMN.
Methods: The pancreatic cyst database was reviewed to 
identify patients with a histopathological diagnosis of pan-
creatic adenocarcinoma arising within an IPMN. Their pre-
sentation, histopathological characteristics and outcome 
were recorded.
Results: 30 patients were identifi ed. The commonest modes 
of presentation included: jaundice (n = 10); pain (n = 7); 
asymptomatic (n = 5); and pancreatitis (n = 4). Only 1 patient 
had a pre-operative diagnosis of carcinoma, the rest being 
histopathological fi ndings. 22 patients had main duct IPMN, 
5 had side branch IPMN and 3 had combined disease. 5 had 
foci of invasive carcinoma and 25 had mass lesions varying 
from 1.1 to 12 cm. Disease stage was: IA (n = 4); IB (n = 
7); IIA (n = 5) and IIB (n = 14). Lymphovascular and nural 
invasion were each seen in 11 patients. 16 patients died, 15 
of recurrent carcinoma. The median actuarial survival is 24.9 
months (range: 0.8–84.4 months) and the median time to 
death for those not surviving was 20.8 months (range: 0.8–
65.8 months).
Conclusion: Despite an intensive pre-operative work-up, 
IPMN-related adenocarcinoma is rarely identifi ed pre-oper-
atively. The data would support resection of all symptomatic 
and asymptomatic main duct IPMN and side-branch disease 
being followed very closely.
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ADENOCARCINOMA ARISING IN 
INDRADUCTAL PAPILLARY MUCINOUS 
NEOPLASMS (IPMN): A DIFFERENT 
BIOLOGICAL PROFILE AND 
CLINICAL OUTCOME
G. Morris-Stiff, G. Falk, S. Chalikonda and R. M. Walsh
Section of Surgical Oncology/HPB, Cleveland Clinic, 
Cleveand, USA
Cleveland Clinic, Section of Surgical Oncology/HPB9500 
Euclid Avenue, 44195, Cleveland, USA
Introduction: The rate of malignant transformation in 
patients with IPMN is high, in particular for disease affecting 
the main pancreatic duct. The aim of this study was to evalu-
ate a subset of patients with pancreatic adenocarcinoma 
arising in IPMN.
Methods: The pancreatic cyst database was reviewed to 
identify patients with a histopathological diagnosis of pan-
creatic adenocarcinoma arising within an IPMN. Their pre-
sentation, histopathological characteristics and outcome 
were recorded.
Results: 30 patients were identifi ed. Modes of presentation 
included: jaundice (n = 10); pain (n = 7); asymptomatic (n 
= 5); and pancreatitis (n = 4). Only 1 patient had a pre-
operative diagnosis of carcinoma, the rest being histopatho-
logical fi ndings. 22 patients had main duct IPMN, 5 had side 
branch IPMN and 3 had combined disease. 5 had foci of 
invasive carcinoma and 25 had mass lesions varying from 
1.1 to 12 cm. Disease stage was: IA (n = 4); IB (n = 7); IIA 
(n = 5) and IIB (n = 14). Lymphovascular and neural invasion 
were each seen in 11 patients. 16 patients died, 15 of recur-
rent carcinoma. The median actuarial survival was 24.9 
months (range: 0.8–84.4 months) and the median time to 
death for those not surviving was 20.8 months (range: 0.8–
65.8 months).
Conclusion: Despite an intensive pre-operative work-up, 
IPMN-related adenocarcinoma is rarely identifi ed pre-oper-
atively. The data would support resection of all symptomatic 
and asymptomatic main duct IPMN and side-branch disease 
being followed very closely.
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INCIDENCE AND IMPLICATIONS OF 
IMPAIRED GLYCEMIC CONTROL 
FOLLOWING DISTAL 
PANCREATECTOMY
G. Falk1, M. Rogers1, G. Morris-Stiff1, S. Chalikonda1, 
L. Yerian2 and R. M. Walsh1
1Section of Surgical Oncology/HPB, Cleveland Clinic, 
Cleveand, USA; 2Anatomic Pathology, Cleveland Clinic, 
Cleveland, USA
Cleveland Clinic, Section of Surgical Oncology/HPB9500 
Euclid Avenue, 44195, Cleveland, USA
Introduction: The development of diabetes mellitus (DM) 
is an important long-term consequence of distal pancreatec-
tomy. The aim of this study was to document the prevalence 
of DM and assess its relationship to potential etiological risk 
factors.
Methods: Frequency and follow-up data was obtained from 
The National Cancer Institute’s Surveillance, Epidemiology, 
End Results (SEER) database for the period 1973–2006. The 
survival of patients with ductal adenocarcinoma (ICD 
[International classifi cation of disease] codes: 8010, 8140–
8147, 8500) were compared to: adenocarcinoma in IPMN 
(ICD: 8453); mucinous cystadenocarcinoma (ICD: 8470–
8471); endocrine/islet cell carcinoma (8240–8249, 8150–
8157); and mucinous adenocarcinoma 8480–8481). 
Carcinomas classifi ed as malignant neoplasms and those of 
other histopathological subtypes were excluded.
Results: 137 patients underwent resection including 26 
(19.0%) that had DM pre-operatively. New-onset DM was 
identifi ed in 27/111 patients (24.3%) at a mean of 6.4 months 
post-operatively. DM was more common in patients with 
chronic pancreatitis (5/13; 38.5%) and adenocarcinoma 
(7/22, 31.8%), but was not seen in patients undergoing resec-
tion for serous cystadenoma (0/8), or IPMN (0/9). Patients 
developing diabetes were older (63.4 vs. 55.1, p = 0.01) but 
there was no difference in gender or ethnic distributions. DM 
was not linked to the volume of parenchyma resected: lower 
volumes of tissue were resected in those with diabetes 
(119.2 cm3 vs 192.7 cm3; p = 0.314); or related to patient 
body mass index [BMI] (29.3 KgM-2 vs 28.1 KgM-2; p = 
0.51). Of the 26 patients with pre-resection diabetes, 9 were 
taking insulin. In the remaining 17, 8 (47%) deteriorated and 
required insulin postoperatively. The development of post-
operative impaired glycemic control was associated with 
prolonged hospital stay (12.6 days vs. 7.7 days; p = 0.001).
Conclusion: Impaired glycemic control is common follow-
ing distal pancreatectomy, especially in those resected for 
chronic pancreatitis or cancer. In patients requiring distal 
pancreatectomy for chronic pancreatitis, improved outcome 
may include islet replacement.
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THE RETROPANCREATIC FUSION 
FASCIA PLAYS AS A BARRIER AGAINST 
THE INFILTRATION OF THE 
PANCREATIC CARCINOMAS
H. Kitagawa1, H. Tajima1, H. Nakagawara1, I. Makino1, 
Y. Hayashi1, H. Takamura1, H. Ikeda2 and T. Ohta1
1Department of Gastroenterologic Surgery, Graduate 
School of Medical Science, Kanazawa University; 
2Department of Pathology, Graduate School of Medical 
Science, Kanazawa University
Kanazawa University, Gastroenterologic Surgery, 13-1 
Takaramachi, 920, Kanazawa, Japan
Introduction: We often experience that the pancreatic car-
cinoma infi ltrate toward posterior beyond the parenchyma, 
however the involvement of the IVC or the adrenal grand is 
rare. The pancreas is fi xed at the posterior side and the fusion 
fascia exists between the pancreatic parenchyma and the 
retroperitoneal organ. The retropancreatic dissection plane 
and the concomitant resection of retroperitoneal organ are 
controversial.
Methods: We studied 140 pancreatic carcinomas which 
were resected in our institute from 1997 to 2011. Ninety-four 
cases were performed PD and 46 cases were performed DP. 
Resected specimens were cut consecutively into 5 mm slices. 
Specimens after PD were cut perpendicularly to the body 
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axis, and the specimens after DP were cut perpendicularly to 
the apsis of specimens. The retropancreatic infi ltration was 
divided three grades; Grade 0: carcinoma confi ned within the 
parenchyma, Grade 1: carcinoma infi ltrate beyond the paren-
chyma but respect the fusion fascia (include abut to the 
fusion fascia), Grade 2: carcinoma infi ltrate retroperitoneal 
tissues beyond the fusion fascia.
Results: The retropancreatic infi ltration was assessed by the 
grades. Grade 0 was verifi ed in 22%, 28%, 24% of PD, DP, 
total patients, respectively. Grade 1 was verifi ed in 76%, 
68%, 73% of PD, DP, total patients, respectively. Grade 2 
was verifi ed in 2%, 4%, 3% of PD, DP, total patients, 
respectively.
Conclusion: We divided the degree of retropancreatic infi l-
tration in 3 grades. The carcinomas infi ltrate beyond the 
parenchyma at the posterior site are revealed over 70% in 
our series. On the contrary, the Grade 2 was very rare (3%). 
The carcinoma infi ltration confi ned to the upper side of the 
fusion fascia in almost cases, even if the pancreatic carci-
noma abut to the IVC or adrenal grand by MDCT or MRI. 
The fusion fascia plays a role of a barrier against the infi ltra-
tion of the pancreatic carcinomas.
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VOLUMETRIC ASSESSMENT FOR NEW-
ONSET DIABETES AFTER DISTAL 
PANCREATECTOMY IN 
NON-DIABETIC PATIENTS
S. Shirakawa, I. Matsumoto, H. Toyama, M. Shinzeki, 
S. Asari, T. Ajiki, T. Fukumoto and Y. Ku
Division of Hepato-Biliary-Pancreatic Surgery, Kobe 
University Graduate School of Medicine
Kobe University Graduate School of Medicine, Hepato-
Biliary-Pancreatic Surgery, 7-5-2 Kusunoki-cho, Chuo-ku, 
65000, Kobe, Japan
Introduction: One major concern after distal pancreatec-
tomy (DP) is the risk of long-term disturbances in glucose 
metabolism. However, the risk factors remain unclear. 
Although the extent of pancreatic volume reduction is 
thought to be a major factor for postoperative glucose metab-
olism, the volumetric assessment is lacking to date. To deter-
mine functional consequence of the endocrine pancreas after 
DP in preoperatively non-diabetic patients with imaging 
volumetry using multidetector row computed tomography 
(MDCT).
Methods: This study included 52 non-diabetic patients 
undergoing DP from 2005 to 2010. Clinical data on the pre- 
and postoperative status were obtained. Diabetes was defi ned 
according to the World Health Organization (WHO) criteria, 
or under treatment with antidiabetics or insulin. The resec-
tion volume ratio (RVR) of the pancreas was determined by 
MDCT imaging volumetry. The resection lines of the pan-
creas were obtained from the operation records and postop-
erative CT images. The borders of pancreatic parenchyma 
and resection lines were outlined on every slice excluding 
tumors, dilated pancreatic duct, bile duct and vessels. Total 
volume of resected and remnant pancreatic parenchyma were 
computed by summing the volume of each slice.
Results: Mean fasting plasma glucose and serum hemoglo-
bin A1c (HbA1c) level signifi cantly increased after DP even 
in patients without new-onset diabetes. Fourteen (27%) 
patients developed new-onset diabetes. CT volumetry 
revealed that the mean RVR was 41% and the variables 
ranged from 9.2 to 85%. There was a signifi cant inverse 
correlation between the time for the onset of diabetes and 
RVR (r = −0.60, P = 0.037). By the receiver operating char-
acteristic curve, 44% reduction of normal pancreatic volume 
was determined as the cut-off level to predict postoperative 
new-onset diabetes. A multivariate logistic regression analy-
sis identifi ed preoperative serum HbA1c level (Odds ratio, 
35.7; P = 0.006) and RVR > 44% (Odds ratio, 9.08; P = 
0.027) as independent risk factors for new-onset diabetes 
after DP.
Conclusion: DP causes disturbances in glucose metabolism 
in all non-diabetic patients and noteworthy is the fact that 
patients undergoing DP are in the prediabetic state. The 
resection volume of the pancreatic parenchyma strongly 
impacts long-term outcome of the endocrine pancreas. 
Preoperative HbA1c level is another predictive indicator of 
new-onset diabetes after DP. Parenchyma-sparing pancre-
atectomy should be performed for better preservation of 
endocrine function when indicated.
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THE CLINICAL ROLE OF POSITRON 
EMISSION TOMOGRAPHY WITH F-18-
FLUORODEOXYGLUCOSE (FDG-PET) IN 
DIAGNOSIS AND STAGING IN PATIENTS 
WITH PANCREATIC DUCTAL 
ADENOCARICINOMA
I. Matsumoto, M. Shinzeki, H. Toyama, S. Asari, T. Goto, 
T. Ajiki, T. Fukumoto and Y. Ku
Division of Hepato-Biliary-Pancreatic Surgery, Department 
of Surgery, Kobe University Graduate School of Medicine
Kobe University Graduate School of Medicine, Division of 
Hepato-Biliary-Pancreatic Surgery, Department of Surgery, 
7-5-2 Kusunoki-cho, Chuo-ku, 65000, Kobe, Japan
Introduction: The use of positron emission tomography 
with F-18-fl uorodeoxyglucose (FDG-PET) in patients with 
pancreatic ductal adenocarcinoma (PDA) has been increased. 
However, the effi cacy of FDG-PET in patients with PDA is 
still controversial and has not been well evaluated in the 
clinical settings. The purpose of this study is to investigate 
the effi cacy of additional routine FDG-PET in diagnosis and 
staging in PDA and the ability of FDG-PET to distinguish 
between PDA and tumor-forming pancreatitis (TFP).
Methods: We retrospectively reviewed consecutive 209 
patients who were referred to our department from January 
2006 to June 2011 for highly suspected PDA without distant 
metastasis by US and/or CT in referral centers. All patients 
were reevaluated for diagnosis and staging by imaging 
studies and FDG-PET. The routine imaging study included 
abdominal ultrasonography, multidetector computed tomog-
raphy (MDCT), magnetic resonance imaging (MRI) and 
endoscopic ultrasonography (EUS). SPIO-enhanced MRI 
was performed for the detection of liver metastasis. 
Endoscopic retrograde cholangiopancreatography (ERCP) 
was performed when required. FDG-PET images were ana-
lyzed visually. The fi nal diagnosis of the patients were as 
follows: 196 PDAs (81 resected cases and
Results: 1) The sensitivity of FDG-PET was 93% (183/196) 
in the detection of primary tumor in all PDAs. In resected 
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cases with histological measurement of tumor size, the sen-
sitivities were 69% (11/16) in tumors <20 mm, 92% (46/50) 
in >20 and <40 mm, and 93% (14/15) in >40 mm. The sen-
sitivities of the primary tumor were signifi cantly affected by 
tumor size (p = 0.04). The sensitivity of primary tumor of 
UICC stage 0, IA/B, IIA/B, III, IV with FDG-PET were 50% 
(1/2), 50% (4/8), 92% (60/65), 100% (35/35), 97% (83/86), 
respectively. The sensitivity of metastasis of para-aortic 
lymph nodes (n = 39) with FDG-PET, MDCT and MRI were 
64% (25/39), 42% (13/31) and 51% (20/39), respectively.
Conclusion: In the diagnosis of PDA, although primary 
tumor was highly detectable with FDG-PET, low sensitivity 
was noted in tumor diameter ≤20 mm and early stages. 
FDG-PET had no benefi t for the detection of metastases to 
distant lymph nodes and liver comparing to MDCT and MRI. 
We concluded that FDG-PET could not provide the defi nitive 
assessment of clinical diagnosis and staging of PDA or dif-
ferential diagnosis between PDA and TFP.
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TREATMENT OF PANCREATIC CANCER 
BEYOND WHIPPLE PROCEDURE
Y. Luo, J. Spiers, W. Taylor, I. Peer, R. Bacchus and 
S. Misra
Hotel-Dieu Grace Hospital, Windsor, Ontario, Canada
Hotel-Dieu Grace Hospital, General Surgery, 1106 
Ouellette Avenue, #202, Windsor, ON, N9A 1C9, Canada
Introduction: Whipple procedure was described more than 
100 years ago. It has been used for treatment of cancer in the 
pancreatic head regularly. Although signifi cant improvement 
was seen regarding surgery and peri-operative care and surgi-
cal mortality has been signifi cantly decreased to below 5% 
over last 20–30 years, long-term outcome of pancreatic 
cancer was still not as good. Further effective strategies in 
pancreatic cancer management are certainly to be 
identifi ed.
Methods: A total of 106 pancreatic resection were per-
formed by a single surgeon in our institution over last 7 
years, including Whipple procedure (n = 71), total pancre-
atectomy (n = 6), and distal pancreatectomy (n = 29). Forty-
eight Whipple procedures and total pancreatectomies for 
pancreatic cancer with at least one year follow-up were ana-
lyzed retrospectively. Postoperative chemo-radiation therapy 
was conducted according to Cancer Ontario Guideline. All 
patients were followed up after surgery regularly once every 
three months for 2 years, once very six months up to 5 years 
and then once every year. Mortality and morbidity were 
reviewed.
Results: One patient died within one month after srugery, 
due to repeated myocardiac infarction (surgical mortalily, 
2.1%). One-, Three- and fi ve-years actual survival were 69%, 
39% and 33%, respectively. Postoperative gastroparesis and 
biliary/pancreatic leak happened in 4 (8.3%) and 4 (8.3%) 
patients, respectively. Two patients had simultaneous liver 
resection. One patient, who had distal pancreatectomy and 
nephrectomy 4 years after Whipple procedure, is still alive 
without recurrence for more than 6 years. Among those who 
succumbed within one year after surgery (n = 15, 31.3%), 
53.3% were due to cancer metastasis, mostly in liver and 
lungs, and 47.7% from other reasons, e.g. pneumonia, pul-
monary embolization.
Conclusion: Enhancing pre-operative assessment, i.e. accu-
rate, updated imaging or intra-operative U/S may help in 
better patient selection for radical surgery, while pre-opera-
tive treatment, i.e. neo-adjuvant chemotherapy, may be 
needed and thus avoid early recurrence or metastasis. Closer 
postoperative follow-up would reduce non-cancer mortality 
in early postoperative period. Re-resection and simultaneous 
other organ resection in selected patients could prolong 
survival.
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Introduction: With the emerging reports of minimally inva-
sive surgery for infected pancreatic necrosis (IPN), the devel-
opment of evidence-based guidelines for managing IPN 
requires a balance of data from laparoscopic and open necro-
sectomy series. To analyse outcomes of delayed single-stage 
necrosectomy after early conservative management of 
patients with IPN in severe acute pancreatitis (SAP).
Methods: Between January 1998 and December 2009, data 
of patients with SAP who developed IPN and were managed 
by pancreatic necrosectomy, was analysed.
Results: Fifty nine of 61 pancreatic necrosectomies were 
performed by open surgery and 2 laparoscopically. In 55 
patients, single-stage necrosectomy could be performed 
(90.2%). Patients underwent surgery at a median of 29 days 
(range 13–46) after diagnosis of AP. Sepsis and multiple 
organ failure accounted for the 9.8% mortality rate. Pancreatic 
fi stulae (50.8%) predominantly accounted for the morbidity. 
The median hospital stay was 23 days, and the median inter-
val for return to regular activities was 110 days.
Conclusion: This series provides further support to the 
concept of delayed single-stage open pancreatic necrosec-
tomy for IPN. Advances in critical care, effective antibiotic 
therapy with carbapenems, the availability of interventional 
radiology and good supportive care have played a comple-
mentary role to surgery in improving outcomes in IPN.
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THREE LEVEL RISK ASSESSMENT FOR 
PANCREATIC FISTULA FORMATION 
AFTER DISTAL PANCREATECTOMY
N. Doctor and R. Gomes
Department of Surgical Gastroenterology Jaslok Hospital 
and Research Centre, 15, Dr G Deshmukh Marg, Mumbai, 
Maharashtra, India 400026
Jaslok Hospital and Research Centre, 15, Dr G Deshmukh 
Marg, Mumbai, Maharashtra India 400026; Department of 
Surgical Gastroenterology, 9, Dani Sadan, 113 Walkeshwar 
Road, Mumbai, India
Introduction: Distal pancreatectomy (DP) has a high post-
operative morbidity predominantly due to pancreatic fi stula 
though mortality is very low. Data on distal pancreatectomy 
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was reviewed to analyse the risk factors that contribute to 
this morbidity.
Methods: Thirty three patients underwent distal pancreatec-
tomy with sutured closure of the remnant over a 5 year period 
between May 2006 and April 2011. Pancreatic fi stula (PF) 
was defi ned according to the International Study Group on 
Pancreatic Fistula defi nition. Patient and surgical risk factors 
were subdivided as those refl ecting a poorer premorbid 
status, those associated with increased complexity of surgery 
and those related to pancreas gland and were analyzed for 
incidence of pancreatic fi stula.
Results: Indications for DP included 16 (51.5%) pancreatic 
tumours, 13 (39.4%) chronic pancreatitis and 3 (9.1%) 
trauma. Spleen was preserved in 12 patients (36.4%). There 
was no mortality while the morbidity rate was 45.5% (n = 
15). Incidence of pancreatic fi stula was 30.3% (n = 10); 8 
were grade A (80%) and 2 were grade C (20%). Incidence 
of clinically signifi cant pancreatic fi stulas was 6.1%. PF was 
signifi cantly more in those aged >50 years (p = 0.036) and 
if the pancreatic duct was not identifi ed (p = 0.024). PF was 
signifi cantly less with extensive peripancreatic adhesions 
(p = 0.036).
Conclusion: Improving premorbid status and identifi cation 
and ligation of main pancreatic duct can help reduce the 
incidence of pancreatic fi stulas. The identifi cation of patients 
at high risk of developing a PF helps to implement preven-
tion strategies.
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NECROTIZING PANCREATITIS 
OUR EXPERIENCE FROM 
UNIVERSITY HOSPITAL
S. A. Elavarasan, S. Subramanian, S. Karuparthi, 
B. Elangovan, S. Gavini, Sathiyavelavan and Niranjan
Sri Ramachandra University, Surgical Gastroenterology, G 
864 Sri Ramachandra Gents Hostel, Porur, 116, Chennai, 
India
Introduction: Necrotizing pancreatitis is a surgical chal-
lenge and is associated with considerable morbidity and mor-
tality. The indications, timing of surgical intervention and 
type of procedure continue to be debated in an effort to 
improve the outcome of this devastating disease process. 
This retrospective study is aimed at analyzing our experience 
(single university hospital) in managing such patients.
Methods: A retrospective analysis of a series of 452 con-
secutive patients diagnosed with acute pancreatitis admitted 
between Jan 2006 and Sep 2011, were studied. Subset of 
acute necrotizing pancreatitis n = 54, 11.95%) (44 men, 10 
women, median age 42.5, range 13–74 years) was analyzed 
with regard to etiology, presentation, management and com-
plications encountered.
Results: Etiology causing necrotizing pancreatitis were 
ethanol related (n = 17, 31.48%), idiopathic (n = 22, 40.74%), 
biliary aetiology (n = 15, 27.78%). 37 (68.57%) patients 
underwent surgical intervention. 13 (35.14%) patients devel-
oped post operative pancreatic fi stulas, 5 patients underwent 
successful ERCP and stenting, 3 patients underwent spinc-
terotomy, 5 patients were managed conservatively. Colonic 
complications occurred in 4 patients. Duodenal leak occured 
in 2 patients. Haemorrhage occurred in 3 patients, 2 patients 
were conservatively managed & 1 patient had GDA aneu-
rysm which was managed by angioembolism. 17 patients 
(31.48%) were treated conservatively. 5 patients had radio-
logical evidence of infected necrosis (Retroperitoneal air) 
were treated conservatively.
Conclusion: In our series, idiopathic pancreatitis contrib-
uted to the major cause of necrotizing pancreatitis.(n = 54) 
11.95% constitutes necrotizing pancreatitis in our series of 
(n = 452) acute pancreatitis. Among (n = 54) 11.95% cases 
of necrotizing pancreatitis (n = 37) 68.52% needed surgery. 
Overall mortality of necrotizing pancreatitis is 8 (5 cases on 
fi rst week of pancreatitis & 3 cases after post necrosectomy). 
Pancreatic fi stula, colonic involvement and duodenal leaks 
where the major causes of morbidity.
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PANCREATICODUODENECTOMY IN 
ELDERLY PATIENTS OVER 75 YEARS: 
AGE INCREASE MORTALITY AND 
PANCREATIC FISTULA RATES
L. Sulpice1, M. Rayar1, P. N. D’Halluin2, Y. Harnoy1, 
A. Merdrignac1, B. Meunier1 and K. Boudjema1
1Service de chirurgie hépatobiliaire et digestive, CHU 
Pontchaillou, Université de Rennes 1, France; 2Service des 
maladies de l’appareil digestif, CHU Pontchaillou, 
Université de Rennes 1, France
CHU Pontchaillou, Rennes, Université de Rennes 1, 
Service de chirurgie hépatobiliaire et digestive, 2 rue 
Henri Le Guilloux, 35033, Rennes cedex, France
Introduction: While the peak incidence of pancreatic 
cancers occurs during the seventh decade of life, there is little 
data about the risk associated with pancreaticoduodenectomy 
(PD) in elderly patients. The aim of our study was to assess 
the incidence of death and postoperative complications fol-
lowing PD and identify risk factors in patients aged over 75 
years.
Methods: All patients who underwent PD between January 
2000 and September 2009 were analyzed retrospectively. 
Patients were divided into two groups according to age 
(Group 1: patients aged <75 years, and Group 2: patients 
aged >75 years). Postoperative mortality was defi ned as 
death occurring within 30 days of surgery. Morbidity and 
mortality risk factors were analyzed using univariate and 
multivariate analyses.
Results: Among the 314 patients, 273 were included in 
Group 1 (sex ratio 1 : 4) and 41 in Group 2 (sex ratio 1 : 1). 
Median patient age was higher in Group 2 than Group 1 (79 
vs. 59 years, p < 0.001). Group 2 was associated with 
increased postoperative deaths (24.4% vs. 3.66%, p < 0.001) 
and pancreatic fi stulas (26.8% vs. 13.2%, p = 0.041), espe-
cially Grade C fi stulas (4.4% vs. 14.6%, p = 0.023), when 
compared to Group 1. In multivariate analyses, only postop-
erative hemorrhage proved to be an independent predictive 
factor for mortality (OR 12.9 [1.07–155.5] p = 0.04).
Conclusion: PD in the elderly patients aged over 75 years 
was associated with an increased risk of postoperative death 
and pancreatic fi stula. No single preoperative factor allowed 
for predicting this risk.
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PATIENT SATISFACTION FOLLOWING 
TOTAL PANCREATECTOMY (WITH 
OR WITHOUT ISLET CELL 
TRANSPLANTATION) FOR 
CHRONIC PANCREATITIS
G. Garcea, C. Pollard and D. Ashley
Department of Hepatobiliary and Pancreatic Surgery, 
University Hospitals of Leicester
University Hospitals of Leicester, Department of 
Hepatobiliary and Pancreatic Surgery, Leicester General 
Hospital, Gwendolen Road, LE5 4, Leicester, United 
Kingdom
Introduction: Total pancreatectomy (TP) is the last resort 
in pain control for patients with chronic pancreatitis. This 
study polled patients who had undergone a previous total 
pancreatectomy (+/− autologous islet cell transplantation) to 
evaluate their outcome.
Methods: Questionnaires were sent out by post to all 
patients alive following TP. Reponses were collated and 
assessed. Questions asked related to patients’ pain scores pre 
and post surgery; insulin requirements and overall quality of 
life.
Results: 77 patients were polled (60 ‘islets’ & 17 ‘non-
islets’), return rates were 45% for islet and 35.3% for non-
islet patients. 97% reported that they were pleased with their 
operation with over 90% reporting that their pancreas pain 
had gone completely. Median visual analogue scores for pain 
(VAS) were 10 pre-operatively and 2 post-operatively. 25.9% 
of islet patients were insulin in-dependent and those on 
insulin had lower daily insulin requirements than non-islet 
patients (39 versus 60 units). The majority of patients 
reported that the surgery had improved their quality of life 
and they would recommend it to somebody (97.0% and 
100%).
Conclusion: Total pancreatectomy is effective in reducing 
pain and improving quality of life in patients with chronic 
pancreatitis. The addition of autologous islet cell transplanta-
tion results in the chance of being insulin independent and 
reduces insulin requirements in those who are not.
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CYSTIC DYSTROPHY OF THE 
PANCREAS: A TWO CASE 
REPORT WITH DIFFERENT 
THERAPEUTIC MANAGEMENT
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A. N. Garrini1, M. Tortorella1, G. Cavallari2 and B. Nardo1
1Hepato-Biliary-Pancreatic and Transplant Organs Unit, 
Department of Surgery, Annunziata Hospital, Cosenza, 
Italy; 2Department of Surgery and Transplantation, S.
Orsola-Malpighi Hospital, University of Bologna, Italy
Annunziata Hospital, Surgery, Hepato-Biliary-Pancreatic 
and Transplant Organs Unitvia F. Migliori, 87100, 
Cosenza, Italy
Introduction: Cystic dystrophy of the heterotopic pancreas 
is a rare benign condition characterized by presence of aber-
rant pancreatic tissue in the wall of the digestive tract associ-
ated with chronic infl ammation and fi brosis. The disease can 
be associated with signs of upper digestive obstruction, signs 
of acute pancreatitis and jaundice. Alcohol and mechanical 
obstruction of heterotoptic pancreatic ducts have been impli-
cated in its pathogenesis. Therapeutic management is still 
under debate.
Methods: We described a two case of cystic dystrophy of 
the duodenal wall in heterotopic pancreas. The patients were 
admitted with upper abdominal pain of several months dura-
tion, periodic nausea, vomiting after meals, weight loss and 
chronic alcoholic pancreatitis. The fi rst case regards a 
39-year-old man with a history of alcohol, tobacco abuse and 
drug addiction. The second patient was a 71-year-old man 
with a long history of alcohol. The diagnosis was performed 
with CT, MRI and EUS.
We decided to treat the patients with different approaches. 
The fi rst patient underwent to gastrointestinal bypass, 
instead, the second patient, was treated with 
pancreaticoduodenectomy.
Results: In the fi rst case we performed a gastrointestinal 
bypass because his poor general conditions. The post-opera-
tive was characterized by abdominal pain within three 
months after surgery. Then he was treated for bleeding from 
a duodenal ulcer NSAID abuse related. After 14 months from 
surgery, the patient is free to abdominal pain, with improve-
ment of general conditions and increased body weight. He 
presents diabetes for chronic alcoholic pancreatitis. In the 
second patient we performed a cephalic pancreaticoduode-
nectomy. At this moment, after 10 months from surgery, his 
general conditions are good with increased body weight and 
no surgery complication related.
Conclusion: As described in literature, the treatment of 
cystic dystrophy in heterotopic pancreas is controversial. 
Symptomatic improvement can be obtained with medical 
treatment. The indications for surgery include persistent 
severe symptoms, relapse after medical treatment and suspi-
cion of malignancy. We believe that surgical treatment pro-
vides the best long-lasting results. When surgery is needed a 
cephalic pancreaticoduodenectomy is preferred, reserving 
by-pass procedure for high risk patients.
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WHIPPLE OPERATION DUE TO 
DUODENAL METASTASIS FROM 
KIDNEY CARCINOMA WITH LONG 
TERM SURVIVAL: CASE REPORT
E. Bonaiuto1, S. Vaccarisi1, N. Spadafora1, V. Crocco1, 
A. N. Garrini1, V. Pellegrino1, G. Cavallari2 and B. Nardo1
1Hepato-Biliary-Pancreatic and Transplant Organs Unit, 
Department of Surgery, Annunziata Hospital, Cosenza, 
Italy; 2Department of Surgery and Transplantation, S.
Orsola-Malpighi Hospital, University of Bologna, Italy
Annunziata Hospital, Surgery, Hepato-Biliary-Pancreatic 
and Transplant Organs Unitvia F. Migliori, 87100, 
Cosenza, Italy
Introduction: Kidney carcinoma represents 2–3% of 
tumors of the adult and results in terms of frequency, the third 
genitourinary neoplasia. It involves preferentially the males 
and occurs typically in the adult age with a peak of incidence 
between 50 and 70 years of age.
Methods: A male patient, 56 years old, affected by diabetes 
mellitus, already undergone right nephrectomy for clear cells 
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carcinoma, was admitted to our Unit in November 2008 with 
endoscopic diagnosis of ‘ulcerated infi ltrating neoformation, 
with apical-bulbar localization on the anterior wall of the 
duodenal knee’. He reported anorexia, abdominal pain and 
melena. At the admission he showed sideropenic anemia. 
The patient underwent surgical operation of Whipple 
duodenocefalopancreasectomy.
Results: The histology showed duodenal metastasis of 
kidney clear cells neoplasia. Resection borders, gallbladder, 
pancreas and stomach without metastasis evidence and neo-
plastic invasion. The post-operative course was without com-
plications. The patient was discharged in 12th day after 
operation. At 36 months follow-up, the patient is alive, well 
and disease-free.
Conclusion: Renal tumor determines metastasis in 25% of 
cases (0.3% at duodenum); generally they appear years later 
from nephrectomy for the primitive tumor. This case report 
allows us important considerations: the sideropenic anemia 
accompanied by melena, in patients underwent nephrectomy, 
should induce the suspect of secondary intestinal localiza-
tion, not always detectable by traditional endoscopic tech-
niques. Regarding our demolitive therapeutic option, the 
literature shows comforting data, reporting a considerable 
improvement of the quality of life of these patients (about 
15% at 5-years) despite further studies are required, consid-
ering this rare disease.
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ASSOCIATION OF PANCREATIC 
NEUROENDOCRINE TUMORS AND 
MESENCHIMAL NEOPLASMS OF 
GI TRACT
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C. Sperti1 and S. Pedrazzoli1
1Clinica Chirurgica IV, Pancreatic and Digestive 
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Surgical Unit, University of Padova, Via Giustiniani 
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Introduction: Neuroendocrine pancreatic tumors (NPT) 
are occasionally associated with mesenchimal tumors in 
Neurofi bromatosis type 1 but rarely in sporadic cases. We 
report fi ve cases of NPT associated with other rare mesenchi-
mal neoplasms of GI tract.
Methods: We reviewed clinical data of patients observed in 
our Department for pancreatic neuroendocrine tumors asso-
ciated with mesenchimal neoplasms of GI tract from 2003 to 
2011. All fi ve patients (3M/2F, averaging 67 years) had pre-
operative diagnosis of NPT: in two cases the NPT was an 
incidental fi nding, one patients presented with abdominal 
pain, one presented hypoglicemia, and another one a 
Zollinger–Ellison syndrome. In all cases the mesenchimal 
neoplasms were incidental fi ndings during surgery. All 
patients underwent surgical resection: 1 middle pancreatec-
tomy, 2 left pancreatectomy and 2 pancreaticoduodenec-
tomy. The mesenchimal neoplasms were in all cases small 
size and low-risk tumors and they had been treated with 
enucleations.
Results: The following associations were observed: 1 
benign insulinoma with a jejeunal leiomyoma, 2 non func-
tioning NPT with a gastric GIST and two duodenal GISTs 
respectively, 1 non functioning metastatic NPT with a cecal 
GIST, 1 malignant metastatic gastrinoma with one jejunal 
and two duodenal GISTs. In all cases the mesenchimal 
lesions were low-risk neoplasms. Postoperatively we had 
three pancreatic fi stula (one C grade) and one abdominal 
fl uid collection. Mean follow-up was 48.7 months. Two 
patients are still alive without disease 26 and 57 months after 
surgery. One patient died postoperatively for sepsis due to a 
C grade pancreatic fi stula, two patients died for progression 
of metastatic disease 18 and 94 months after surgery.
Conclusion: The association of NPT and mesenchimal GI 
tumor is rare. In our experience all mesenchimal tumors of 
the GI tract were incidental fi ndings, small size and low-risk 
neoplasms. In no case they recurred after excision or infl u-
enced the prognosis of the NPT.
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INITIAL PANCREATIC SURGERY 
SINGLE CENTER EXPERIENCE: 
A REVIEW
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Orsola-Malpighi Hospital, University of Bologna, Italy
Annunziata Hospital, Surgery, Hepato-Biliary-Pancreatic 
and Transplant Organs Unitvia F. Migliori, 87100, 
Cosenza, Italy
Introduction: Pancreatic cancer is a disease that deserves a 
perfect diagnostic management and a complex therapeutic 
treatment feasible only in centers of reference. We report 
the initial experience on pancreatic surgery in our 
Hepatobiliarypancreatic Unit from January 2008 until 
December 2011.
Methods: From January 2008 until December 2011, 79 
patients, affected by pancreatic tumors, were admitted to our 
Unit. They were 44 males and 35 females; mean age was 
64.1 years (range 30–80). The indications for surgery were: 
cefalopancreatic neoplasia in 42 patients, Vater papilla tumor 
in 15, distal biliary duct neoplasia in 15, body-caudal tumor 
in 7. In 47 patients we performed oncologic radical opera-
tions (37 Whipple procedures, 4 total pancreatectomy, 6 en 
bloc distal pancreatectomy with splenectomy) and in 7 
patients also a liver resection was required for liver metasta-
sis. In 26 patients we performed an exploratory laparotomy 
with derivation and biopsies for peritoneal tumor dissemina-
tion. In 6 we performed a Roux-en-Y hepaticojejunostomy.
Results: No postoperative mortality was observed. The 
post-operative complications were 4 pancreatic fi stulas and 
5 biliary fi stulas treated conservatively, 1 ischemic stenosis 
of the bilio-digestive anastomosis treated by percutaneous 
dilatation. The disease-free survival in patients who under-
went radical surgery is 56% at 2 years.
Conclusion: The resective pancreatic surgery for neoplasia 
has strict indications due the severity of the pathology, 
already at the moment of diagnosis, then should be encour-
age to perform it only in specialized units. However, in our 
experience, the results in terms of disease-free survival and 
post-operative complications, are comparables with the lit-
erature data and encourage us to go on with our work.
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580
THE SHORT-TERM 
OUTCOMES FOLLOWING 
PANCREATODUODENECTOMY WITH 
PANCREATICOGASTRIC ANASTOMOSIS
H. Ikoma, Y. Yamamoto, R. Morimura, H. Fujiwara, 
K. Okamoto, T. Ochiai, Y. Kokuba and E. Otsuji
Division of Digestive Surgery, Department of Surgery, 
Kyoto Prefectural University of Medicine
Kyoto Prefectural University of Medicine, Surgery, 465 
Kajii-tyou Kamigyou-ku, 602, Kyoto, Japan
Introduction: To determine short-term outcomes following 
pancreatoduodenectomy with pancreaticogastric anastomo-
sis in our institute.
Methods: From April 2008 through to December 2011, 52 
patients were submitted for PD reconstructed by pancreati-
cogastrostomy. The study consisted of 34 men and 18 
women, with a median age of 65.6 years. The main indica-
tions for PD were cholangiocarcinoma in 20 patients, pan-
creatic ductal carcinoma in 16 patients, IPMN in 8 patients, 
pancreatic Neuroendocrine tumor in 3 patients. Reconstruction 
by pancreatogastrostomy was performed, the stump of pan-
creas was invaginated into the posterior wall of the stomach 
by using a pancreatic stent.
Results: The average of duration of operation was 542 
minute, and the amount of blood loss 963 ml. The overall 
in-hospital morbidity and mortality rate was 48% and 0%, 
respectively. Pancreatic fi stula at the grade B/C in ISGPF 
occurred in four (7.69%) patients and three patients at the 
grade B was treated conservatively with good outcome. One 
patient at the grade C reoperated to drainage abdominal 
abscesses due to pancreatic fi stula with good outcome, too. 
No patients developed postoperative new or worsening endo-
crine or exocrine insuffi ciency.
Conclusion: Pancreatoduodenectomy with pancreaticogas-
tric anastomosis in our method offers a safe alternative to the 
pancreaticojejunostomy and may be technically simpler.
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A NOVEL SOLUTION FOR SHIPPING OF 
ISOLATED PANCREATIC ISLETS
N. Kasahara1, T. Teratani2, J. Doi3, Y. Fujimoto3, 
S. Uemoto3, N. Sata1, Y. Yasuda1 and E. Kobayashi2
1Division of Development of Advanced Therapy, Center for 
Development of Advanced Medical Technology, Jichi 
Medical University; 2Department of Surgery, Jichi Medical 
University; 3Division of Hepato-Pancreato-Biliary Surgery 
and Transplantation, Department of Surgery, Kyoto 
University Graduate School of Medicine
Jichi Medical University, Division of Development of 
Advanced Therapy, Center for Development of Advanced 
Medical Technology, 3311-1, Yakushiji, 32904, Shimotsuke, 
Japan
Introduction: Islet transplantation is a promising treatment 
for type 1 diabetes. However, chronic shortage of donor 
organs and poor equipment of supply prohibit the progress. 
In this study, we focus on the capacity for tissue regenerative 
effect of the mesenchymal stem cells derived from adipose 
tissue (ADMSCs). ADMSCs have so far been applied to 
some clinical conditions already. We devise a new means to 
preserve islets by combining the conditioned medium of 
MSCs and existing organ preservation solutions.
Methods: We have already established the luciferase-
transgenic Lewis rat (Luc-Tg rat) visualization system to 
detect intracellular ATP levels in viable cells. The islets were 
isolated from Luc-Tg rat pancreas. ADMSC was established 
from wild type Lewis rat. When the cells were 80% confl u-
ent, culture solution was changed to low concentration of 
FBS. After 24 hrs of incubation, supernatants were divided 
into 5 fractions by molecular weight. Islets were cultured in 
organ preservation solution at 4°C, each fraction was added 
to them up to 5% to 20%. Luciferase imaging was performed 
using the bioimaging system IVIS, the signal intensity of 
islets was quantifi ed every 24 hrs. Islet morphology was 
examined by DTZ and insulin staining.
Results: Preservation with conditioned medium (CM) of 
ADMSCs resulted in higher signal intensity rate than control 
group suggesting that improved preservative effect. DTZ and 
insulin staining also revealed better maintenance of islet 
structure in CM group.
Conclusion: ADMSCs secreting factors added to existing 
organ preservation solution improved isolated islet preserva-
tion. We will identify the active component by protein array 
analysis in the next stage. This improvement may be appli-
cable to other transplantable organs in a similar way, further 
investigation is needed simultaneously.
584
EARLY CONTINUOUS VENO-VENOUS 
HAEMOFILTRATION IN THE 
MANAGEMENT OF SEVERE ACUTE 
PANCREATITIS COMPLICATED WITH 
INTRA-ABDOMINAL HYPERTENSION. 
RETROSPECTIVE REVIEW OF 
10 YEAR EXPERIENCE
H. Plaudis, G. Pupelis, K. Zeiza, N. Drozdova, M. Mukans 
and I. Kazaka
Riga East Clinical University Hospital ‘Gailezers’, 
Department of General and Emergency Surgery, Riga, 
Latvia
Riga East Clinical University Hospital ‘Gailezers’, 
Department of General and Emergency Surgery, Hipokrata 
St. 21038, Riga, Latvia
Introduction: Formation of intra-abdominal/retroperitoneal 
fl uid collections and visceral oedema secondary to systemic 
infl ammation may lead to development of intra-abdominal 
hypertension (IAH) in patients with severe acute pancreatitis 
(SAP). Deterioration of visceral perfusion as a consequence 
of IAH increases risk of multiple organ dysfunction. 
Continuous veno-venous hemofi ltration (CVVH) is one of 
the treatment modalities for control of fl uid sequestration and 
maintenance of optimal fl uid balance.
Methods: Retrospective analysis of 130 SAP patient treat-
ment experience in Riga East Clinical University hospital 
‘Gailezers’ during the period from January 2000 to June 2010 
was done. Intra-abdominal pressure was measured indirectly 
through the urinary bladder. Patients with IAH who under-
went CVVH were included in CVVH group, those who were 
managed without CVVH were included in no-CVVH group. 
Recorded measurements of intra-abdominal pressure were 
analysed in parallel with dynamics of C-reactive protein, 
 Poster Presentation Abstracts 659
© 2012 The Authors
HPB 2012, 14 (Suppl. 2), 288–699 HPB © 2012 Americas Hepato-Pancreato-Biliary Association
SOFA score and fl uid balance. Complication rate and main 
outcomes were analysed comparing patients with and without 
IAH and whether they underwent CVVH or not.
Results: IAH was observed in 89 (68.5%) patients. Average 
intra-abdominal pressure at admission was similar in both 
groups 15.4 ± 4.3 vs. 14.5 ± 3.7 mmHg. On day 2 after 
admission intra-abdominal pressure reached 19.6 ± 
7.1 mmHg in CVVH group comparing to 16.3 ± 5.5 mmHg 
in no CVVH group, p = 0.05. Comparing fl uid balance in 
CVVH and no-CVVH groups it was possible to achieve 
negative fl uid balance in CVVH receiving patients starting 
from day 3 until day 7 and it improved abdominal perfusion 
pressure. Signifi cantly lower infection rate and shorter hos-
pital stay characterised CVVH group, 26.7% vs. 37.9%, p = 
0.02, and 27.3 ± 16.4 vs. 32.5 ± 21.2 days, p = 0.05, compar-
ing CVVH vs. no-CVVH group. Mortality rate reached 
11.7% in CVVH group and 13.8% in no-CVVH group.
Conclusion: Early application of CVVH facilitates achieve-
ment of negative fl uid balance and reduction of IAH in 
patients with severe acute pancreatitis, is not associated with 
increased infection and mortality rate and may reduce hos-
pital stay.
585
PREOPERATIVE CT SCAN HELPS TO 
PREDICT THE OCCURRENCE OF 
SEVERE PANCREATIC FISTULA AFTER 
PANCREATICODUODENECTOMY
S. Gaujoux1, H. Tranchart1, M.-P. Vullierme2, S. Dokmak1, 
P. Levy1, A. Couvelard3, J. Belghiti1 and A. Sauvanet1
1Department of HPB Surgery, PMAD, Beaujon Hospital, 
AP-HP; 2Department of Radiology, PMAD, Beaujon 
Hospital, AP-HP; 3Department of Pathology, PMAD, 
Beaujon Hospital, AP-HP
Beaujon Hospital, AP-HP, Department of HPB Surgery, 
PMAD, 100 Bd du General Leclerc, 92110, Clichy, France
Introduction: Pancreatic fatty infi ltration is a predictive 
factor of PF, but accurate preoperative assessment is chal-
lenging. We hypothesized that it could be associated with an 
increased visceral obesity, and assessed preoperatively. The 
aim of the study was assess the infl uence of body fat distribu-
tion, estimated by a preoperative CT scan, on pancreatic 
fi stulas (PF) risk after pancreaticoduodenectomy (PD).
Methods: Over 18 months, 103 consecutive patients with 
PD and pancreaticogastrostomy were studied. Demographic, 
radiologic, and pathologic data were correlated to PF occur-
rence. Radiologic data included on a non-enhanced CT 
acquisition: pancreas, spleen, and liver density measures 
(Dpancreas, Dspleen, and Dliver respectively), retro-renal fat 
thickness, and at the level of the umbilicus, total, visceral, 
and subcutaneous fat area (TFA, VFA, and SFA respec-
tively). Pancreatic fatty infi ltration was graded histologically. 
Logistic regression analysis was used to identify independent 
predictors of PF graded B and C according to the ISGPF.
Results: Among the 103 patients, 37% (n = 38) developed 
a PF (47.4% grade A, 39.5% B, and 13.1% C). PF risk was 
correlated with pancreatic fatty infi ltration (p = 0.017). In 
univariate analysis male gender (p = 0.023), BMI over 25 kg/
m2 (p = 0.02), Dliver/Dspleen, retro-renal fat thickness over 
15 mm (p = 0.006), TFA over the median (>233 cm2; p = 
0.023), and VFA over the median (>84 cm2; p < 0.0001) were 
signifi cantly associated with an increased risk of symptom-
atic PF (grade B and C). In multivariate analysis, VFA > 
84 cm2 (OR = 8.16, p = 0.002) was the only independent 
predictive factor of grade B or C PF. Using the same model, 
a VFA > 84 cm2 was the only independent factor associated 
with the presence of fatty pancreas on pathologic 
examination.
Conclusion: Preoperative assessment of body fat distribu-
tion by a CT scan, as a surrogate for fatty pancreas infi ltra-
tion, can help to predict the occurrence of clinically signifi cant 
PF after PD.
593
INDICATION OF THE LIMITED 
PANCREATIC RESECTION FOR CYSTIC 
NEOPLASMS OF THE PANCREAS
N. Ooshima1, T. Hatori1, A. Kimijima1, T. Furukawa2 and 
M. Yamamoto1
1Department of Gastroenterological Surgery, Tokyo 
Women’s Medical University, Tokyo, Japan; 2Institute for 
Integrated Medical Sciences, Tokyo Women’s Medical 
University, Tokyo, Japan
Tokyo Women’s Medical University, Gastroenterological 
Surgery, 8-1, Kawadacho, Shinjuku-ku, Tokyo, 162, Japan
Introduction: Limited pancreatic resection can be selected 
for benign, low-grade or non-invasive malignant neoplasms 
of the pancreas. However, limited pancreatic resection has 
its problems, including technical diffi culty, a higher inci-
dence of postoperative complications including pancreatic 
fi stulae, and the risk of recurrence from potentially residual 
neoplasm. The aim of this study is to evaluate the indication 
of the limited pancreatic resection for cystic neoplasms of 
the pancreas.
Methods: A total of 510 patients who underwent pancre-
atectomy for cystic neoplasms of the pancreas between 1981 
and 2010 were reviewed retrospectively. 386 patients were 
IPMN, 47 patients were MCN, 44 patients were serous cystic 
neoplasm (SCN) and 33 patients were solid-pseudopapillary 
neoplasm (SPN). Limited pancreatic resection was per-
formed in 137 patients (DPPHR 28, ventral pancreatectomy 
15, Dorsal pancreatectomy of the pancreatic head 1, middle 
pancreatectomy 58, spleen-preserving DP 35, enucleation 2).
Results: In the IPMN, although lymph node metastasis was 
observed in 51% of the patients with an associated invasive 
carcinoma, no lymph node metastasis was observed in the 
patients with high-grade dysplasia. As the results of the 
pathological examination in the IPMN patients who under-
went limited pancreatic resection, an associated invasive 
carcinoma or an invasive ductal carcinoma was revealed in 
9% of the patients. In the MCN, SCN and SPN, the incidence 
rate of malignancy was 6% (non-invasive 4%, invasive 2%), 
and there was no recurrence in the patients who underwent 
limited pancreatic resection. The incidence rates of the post-
operative pancreatic fi stulae were observed in 15% of the 
137 patients who underwent limited pancreatic resection.
Conclusion: Limited pancreatic resection can be selected 
for benign, low-grade or non-invasive malignant cystic neo-
plasms if there is no fi nding of invasion on imaging diagno-
sis. However, it should be pay attention of the risk of the 
invasive neoplasms, especially in IPMN.
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GASTRODUODENAL ARTERY 
PSEUDOANEURYSMS COMPLICATING 
CHRONIC PANCREATITIS
V. Gupta1, K. Rakesh2, J. Wig1, N. Khandelwal3, T. Yadav1 
and K. Singh2
1Department of Surgery, Postgraduate Institute of Medical 
Education and Research; 2Department of Gastroenterology, 
Postgraduate Institute of Medical Education and Research; 
3Department of Radiodiagnosis and Imaging, Postgraduate 
Institute of Medical Education and Research
Postgraduate Institute of Medical Education and Research, 
Surgery, Additional Professor, Department of Surgery, 
Postgraduate Institute of Medical Education and Research, 
16001, Chandigarh, India
Introduction: To analyse our experience with management 
of gastroduodenal artery (GDA) pseudoaneurysms associ-
ated with chronic pancreatitis using a multi-disciplinary 
approach.
Methods: Between April 1998 and December 2011, we 
treated nine patients (all men, age 24–62 years) of GDA 
pseudoaneurysms. All had presented with recent hemeteme-
sis and/or melena. All the patients were initially subjected to 
aneurysmal embolisation or radiologically guided thrombin 
injection. Recurrence of bleeding within 48 hours was taken 
as failure. Emergency surgery was done for recurrent bleed-
ing and elective surgery was carried out as per specifi c 
indications.
Results: Nine interventional procedures were performed. 
Angioembolisation was done in 4 patients with success in 3, 
and thrombin injection in 5 (including 1 with embolisation 
failure) with success in 4. Five patients underwent surgery, 
two on emergency basis for hemodynamic instability in one 
and recurrent bleeding in another and 3 for defi nitive treat-
ment of pancreatitis/associated complication. One patient 
died while the other eight survived and all of them are well 
with no recurrence of bleeding for 6 months to 8 years.
Conclusion: A multidisciplinary approach can be success-
fully used in a majority of patients of GDA pseudoaneu-
rysms. Judicious use of non-surgical methods can obviate the 
need for surgery in some patients.
671
CLINICAL FEATURES AND LONG TERM 
SURVIVAL OF THE PACNREATIC 
NEUROENDOCRINE TUMORS
Y. Hwang1, S. Kim1, J. Chun2, H. Kwon1 and Y.K. Yun2
1Department of Surgery, Kyungpook National University 
Medical Center; 2Department of Surgery, Kyungpook 
National University School of Medicine
Kyungpook National Universtiy Medical Center, 
Department of Surgery, 807 Hogukno, Buk-gu, Daegu 
Metropolitan City, Republic of Korea
Introduction: The clinical features of Pancreatic 
Neuroendocirne Tumors (PET) varied according to the 
hormone secreted and heredity of the tumor. Malignant PETs 
are common in nonfunctioning PET (NFT) whereas majority 
of functioning PET (FT) is benign. We aimed to determine 
the clinical features and prognosis of the PET according to 
the WHO classifi cation and AJCC-UICC 7th TNM staging.
Methods: Thirty patients of PET including one case of 
nesidiolastosis from April, 1992 to June, 2010 were selected. 
Clinico-pathological features were studied retrospectively. 
The PETs were classifi ed into benign, uncertain malignant, 
low grade, and high grade malignant by WHO classifi cation. 
For statistic analysis, T-test, Chi-square test, and Kaplan-
Meier method were utilized.
Results: Nine cases were FT and twenty one cases were 
NFT. The Size of FT was smaller than NFT (1.71 Vs 4.33 P 
= 0.04). The head of pancreas was most commonly involved 
(33.3% and 47.6%) but the locations of tumor were not dif-
ferent between both tumors. Insulinoma was most common 
(66.7%, 6/9) in FT. The incidence of malignant tumors was 
33.3% and 55.0% in FT and NFT. 5-year disease free sur-
vival rate of patients with benign PET (FT and NFT), and 
low grade malignant FT was 100%. However, 5-year disease 
free survival rates of patients with low grade and high grade 
malignant NFT were 66.7% and 0%.
Conclusion: Malignant tumor was more common in NFT 
compared to FT. High grade malignant NFT showed worst 
prognosis while all FT of any WHO classifi cation did not 
show any recurrence.
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PREDICTIVE FACTORS FOR INVASIVE 
INTRADUCTAL PAPILLARY MUCINOUS 
NEOPLASM OF THE PANCREAS
J. Chun1, H. Kwon2, S. Kim2, Y. Hwang2 and Y.K. Yun1
1Department of Surgery, Kyungpook National University 
School of Medicine; 2Department of Surgery, Kyungpook 
National University Medical Center
Kyungpook National University Hospital, Department of 
Surgery, 130 Dongdukro, Jung-gu, Daegu Metropolitan 
City, Republic of Korea
Introduction: Intraductal papillary mucinous neoplasm 
(IPMN) of the pancreas has malignant potential. Predicting 
invasive IPMN has proven diffi cult and controversial. We 
tried to identify predictive factors for invasive IPMN.
Methods: Thirty six patients underwent resection for IPMN 
from February 2001 to July 2011. Clinicopathological fea-
tures including demographic, imaging, microscopic, and 
serological fi ndings were retrospectively reviewed. Receiver 
operating characteristic (ROC) curve analysis was used to 
analyze sensitivity and specifi city of all possible cut-off 
values for the diameter of the main pancreatic duct and mass 
size predicting invasive IPMN. T-test, chi-square test, and 
logistic regression were used for univariate and multivariate 
analysis.
Results: Non-invasive IPMNs were present in 80.6% 
(29/36), whereas invasive IPMNs were present in 19.4% 
(7/36). In univariate analysis, tumor location (p = 0.036), 
Kuroda classifi cation (p = 0.048), mural nodule (p = 0.016), 
and main duct dilatation (8 mm and more) (p = 0.006) were 
statistically signifi cant variables. ROC curve analysis showed 
that a value of 8 mm for the main duct dilatation and a value 
of 35 mm for the size of the mass lesion have 80% sensitivity 
and 75% specifi city and 100% sensitivity and 82.6% speci-
fi city, respectively. However, in multivariate analysis, main 
ductal dilatation (8 mm and more) was identifi ed to be the 
only independent factor for invasive IPMN (p = 0.049).
Conclusion: Main duct dilatation is a useful indicator for 
predicting invasive IPMN.
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THE OUTCOMES OF 
INVERTED MATTRESS 
PANCREATICOJEJUNOSTOMY ON 
POSTOPERATIVE PANCREATIC FISTULA 
(POPF) – A VARIANT TYPE OF 
DUNKING METHOD
S. G. Kim, H. J. Kwon, J. M. Chun, Y. J. Hwang and 
Y. K. Yun
Department of Surgery, Kyungpook National University 
Medical Center, 807 Hogukno, Buk-gu, Daegu 
Metropolitan City, Republic of Korea
Introduction: Pancreaticoduodenectomy (PD) is standard 
surgery for malignant disease and severe injury involving 
periampullary regions. Postoperative pancreatic fi stula 
(POPF) remains a common and potentially most lethal mor-
bidity after PD. Various techniques of pancreaticojejunos-
tomy (PJ) were devised to minimize the rate of POPF. We 
presents a modifi cation of Mattress PJ (a type of end to side 
dunking PJ) and compares its effect on POPF to historic 
consecutive cases with duct to mucosa PJ.
Methods: From June, 2003 to Oct, 2009, 130 patients (76 
men and 54 women) underwent a PD consecutively by a 
single surgeon. Inverted mattress PJ (IM) was utilized for the 
later 78 patients group since Jun, 2007. The former consecu-
tive 52 patients underwent conventional duct to mucosa PJ 
(DM) and was utilized as a historic control. Clinical features 
and surgical outcomes including POPF of both groups were 
compared.
Results: The mean age of both groups was 60.3 and 62.9 
(16–81) years respectively. Female to Male ratio was not 
different between both groups (1.44 Vs 1.36). The diseases 
include 115 malignant and 15 benign diseases. The indica-
tions of PD were not different between both groups. The 
average duration of surgery was shorter in IM group (578 Vs 
490 min, p < 0.000). Grade B and C POPF defi ned by ISGPF 
occurred less frequently in IM group (17.3%, 9/52 Vs 10.3% 
8/78, p = 0.06) and Grade C POPF did not occur in IM group. 
Three cases of mortality occurred (1/52 in DM, 2/78 in IM). 
The causes of death were arrhythmia in two cases and 
Candida sepsis in one case.
Conclusion: The inverted mattress end-to-side pancreatico-
jejunostomy is simple and safe technique with no incidence 
of Grade C POPF.
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SURGICAL OUTCOMES AND RISK 
FACTORS FOR RECURRENCE IN 
PATIENTS WITH NONFUNCTIONING 
PANCREATIC NEUROENDOCRINE 
TUMORS
N. Yazawa1, T. Nakagohri1, H. Kijima2, K. Kato1, 
D. Furukawa1, K. Murakami1, M. Tanaka3 
and S. Inokuchi3
1Tokai University School of Medicine, Department of 
Surgery; 2Hirosaki University Graduate School of 
Medicine, Department of Pathlogy and Bioscience; 3Tokai 
University School of Medicine, Department of Critical 
Care and Emergency Medicine
Tokai University School of Medicine, Department of 
Surgery, 143 Shimokasuya, Isehara, Kanagawa, Japan
Introduction: Few studies have reported risk factors for 
recurrence of resected nonfunctioning pancreatic neuroendo-
crine tumors (PNETs).
Methods: We retrospectively reviewed medical records of 
29 patients with nonfunctioning PNETs who underwent cura-
tive surgery at Tokai University Hospital. All tumors were 
reclassifi ed according to the 2010 WHO classifi cations.
Results: The tumors were reclassifi ed into 11 cases of NET 
G1, 17 cases of NET G2, and 1 case of neuroendocrine 
carcinoma (NEC). Tumor recurrence occurred in 5 of 29 
cases (17.2%). Three- and 5-year relapse-free survival rates 
were 83.9% and 73.5%, respectively. Five-year relapse-free 
survival rates were not signifi cantly different between 
patients with NET G1 and those with NET G2 (100% vs. 
62.2%, p = 0.078). In univariate analysis, tumor growth 
pattern (expanding vs. intermediate, infi ltrating), lymphatic 
permeation score (ly0, 1 vs. ly2, 3), and Ki-67 labeling index 
were signifi cantly associated with recurrence. However, 
these factors were not independently associated with recur-
rence in multivariate analysis.
Conclusion: Intermediate or infi ltrating growth pattern, 
lymphatic permeation scores of 2 or 3, and high Ki-67 label-
ing index could be good indicators for close follow-up after 
surgical resection for nonfunctioning PNETs.
680
PLECTIN – A NOVEL MARKER FOR 
PANCREATIC CANCER
S. Steigen, T. Keck, U. T. Hopt and D. Bausch
Department of General and Visceral Surgery, University of 
Freiburg, Germany
University of Freiburg, Department of General and 
Visceral Surgery, Hugstetter Str. 5579106, Freiburg, 
Germany
Introduction: The diagnosis of PDAC is challenging due to 
its similarity to benign lesions. No single commercially 
available marker has proven entirely specifi c for PDAC. 
Plectin may be such a potential biomarker. It is specifi c for 
PDAC and not expressed in benign pancreatic disease.
However, no data on its use on fi ne needle biopsies (FNB) 
is currently available. The aim of this study was to determine 
if Plectin is also capable to detect PDAC in FNB compared 
to the respective resection specimen.
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Methods: FNB and resection samples from formalin fi xed 
primary pancreatic cancer and FNB were stained for Plectin-1 
using Immunohistochemistry. For comparison samples from 
primary colon cancers were also stained. Staining was con-
sidered positive if more than 1/3 of the cells were at least 
moderately or strongly stained. Nerves, which showed strong 
staining served as internal control.
Results: All of the tumors in the fi ne needle biopsies and 
their respective resection samples from PDAC were Plectin-1 
positive. In contrast, primary colon cancers only showed 
diffuse cytoplasmic staining in the tumor cells with only one 
case considered Plectin-1 positive.
Conclusion: Plectin-1 is a specifi c diagnostic marker for 
PDAC in FNB and in resections specimen while the majority 
of colon cancer does not express the protein. Plectin-1 may 
thus be useful to evaluate FNB as well as resection margins 
for the presence of cancer cells in pancreatic cancer.
681
HOW PARA-AORTIC LYMPH NODE 
SAMPLING SHOULD IMPACT SURGICAL 
MANAGEMENT IN PANCREATIC 
HEAD ADENOCARCINOMA?
F. Paye1, L. Schwarz1, R. Lupinacci1, M. Svrcek1, 
M. Lesurtel2, H. Vuarnesson1 and P. Balladur1
1Department of Digestive Surgery, St Antoine University 
Hospital, Paris, France; 2Department of Surgery, Swiss 
Hepato-Pancreato-Biliary Center, UniversitätsSpital 
Zürich, Zürich, Switzerland
St Antoine University Hospital, Department of Digestive 
Surgery, 184 rue du Faubourg Saint-Antoine, 75012, Paris, 
France
Introduction: Para-aortic lymph nodes (PALN) involve-
ment in pancreatic head adenocarcinoma, is usually consid-
ered as precluding surgery to be curative. However, few 
studies have assessed the prognostic impact of PALN metas-
tasis after pancreaticoduodenectomy, and PALN sampling is 
not routinely performed in most of the centers. This prospec-
tive study aims to assess the prevalence and prognostic value 
of PALN involvement in patients who underwent pancreati-
coduodenectomy for pancreatic head cancer.
Methods: Between 2000 and 2010, 110 consecutive patients 
(median age: 64 (42–76) years) years with a pancreatic head 
adenocarcinoma, without suspected distal nodal involvement 
on preoperative assessment, underwent pancreaticoduode-
nectomy with standard lymphadenectomy and PALN sam-
pling with frozen section. Sampling of PALN harvested 5 cm 
of the cellulo-lymphatic tissue located between the aorta and 
the vena cava downwards to the left renal vein. The surgeon 
was blinded for the results of frozen section which did not 
interfere with the decision to perform pancreaticoduodenec-
tomy. PALN were thereafter studied by standard pathological 
examination after fi xation and staining.
Results: PALN metastasis (PALN+) were found in 17 
patients (15%). Tumor size and surgical margin status did 
not differ in PALN+ and PALN− patients. Despite similar 
numbers of analyzed nodes (excluding PALN) (22.6 vs. 23.7, 
p = 0.7), the number of positive nodes was higher in case of 
PALN+ (9.2 +/− 1.2 vs 2.8 +/− 0.3; p < 0.0001). PALN+ 
patients had always positive nodes on the specimen. With a 
median follow up of 18 (2–124) months, 1-year and 3 years 
disease free survival rates for PALN− and PALN+ patients 
were 56 vs 29% and 26 vs 12% respectively (p = 0.02). One-
year and 3 years overall survival rates for patients PALN− 
and PALN+ were 78 vs 64% and 43 vs 34% (p = 0.19) 
respectively. Two PALN+ patients were alive without recur-
rence at 30 and 47 months.
Conclusion: Involvement of PALN in pancreatic head ade-
nocarcinoma is a witness of extended lymphatic tumorous 
spread. It signifi cantly alters disease free survival but a few 
recurrence free long term survivors are observed. PALN 
sampling should be therefore only considered as an addi-
tional intra-operative tool for the decision to perform pan-
creaticoduodenectomy. PALN+ might be not an absolute 
contra-indication to pancreatic resection in patients without 
other adverse prognostic factor.
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LAPAROSCOPIC DISTAL 
PANCREATECTOMY. ANALYSIS OF 
57 PATIENTS
R. Jureidini1, T. Bacchella2, G. N. Namur1, 
T. C. Ribeiro2, E. R. R. Figueira2, W. M. Pollara2, 
U. R. Jr1 and I. Cecconello1
1Instituto Do Câncer do Estado de Sao Paulo – FMUSP/
SP; 2Hospital das Clínicas da Fac. Medicina da USP/SP
Instituto do Cancer do Estado de São Paulo – FMUSP, 
Gastroenterology/University of Sao Paulo, Rua Jose Maria 
Lisboa 331 ap 22. Jardim Paulista, Sao Paulo/SP1423, 
Brazil
Introduction: The use of laparoscopy has not been fully 
established in pancreatic resections, especially by the techni-
cal complexity of these operations. Since 2006, 57 laparo-
scopic distal pancreatic resections were carried out for solid 
and cystic pancreatic neoplasms. This is the largest series in 
Brazil.
Methods: The occurrence of pancreatic fi stula, abscess, 
bleeding, operative time, conversion rate and mortality were 
evaluated. The patients were divided into Group 1 (G1), 
spleen preserving distal pancreatectomy and Group 2 (G2) 
distal pancreatectomy with splenectomy.
Results: The fi stulas were classifi ed according to the 
International Group for the Study of Pancreatic Fistula. In 
G1 (n = 23) there were six grade A fi stulas and two grade B. 
One patient had a splenic infarction. In G2 (n = 34), there 
were 13 grade A, three grade B and one grade C fi stula. The 
mean operative time was 3.0 h and splenic preservation was 
about one hour faster. In group G2 there was a percutaneous 
drainage of a peripancreatic abcess and two conversions. The 
conversions were observed after the fi rst 40 cases were oper-
ated and were related to a more liberal indication of the lapa-
roscopic approach including malignancies. There was no 
blood transfusions and no mortality. The average length of 
hospital stay was fi ve days.
Conclusion: Distal pancreatectomy can be performed with 
low mortality and acceptable morbidity rates. The results of 
this approach are similar to those of conventional distal pan-
createctomy regarding the incidence of fi stula and other com-
plications, but there was better results in operative time, fast 
recovery, pain scores and better cosmesis.
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ANTIOXIDANT THERAPY FOR 
CHRONIC PANCREATITIS: THE FINAL 
RESULTS OF A RANDOMISED, DOUBLE-
BLIND, PLACEBO-CONTROLLED TRIAL 
(THE ANTICIPATE STUDY)
A. Siriwardena1, J. Mason2, A. Sheen1, A. Makin2 and 
N. Shah1
1Regional Hepatobiliary Surgery Unit, Manchester Royal 
Infi rmary; 2School of Health, University of Durham
Manchester Royal Infi rmary, Regional Hepatobiliary Surgery 
Unit, Oxford Road, Manchester M13 9WL, United Kingdom
Introduction: The aim of this study is to test whether anti-
oxidant therapy reduces pain and improves quality of life in 
patients with painful chronic pancreatitis.
Methods: The study was a double-blind, randomised con-
trolled trial comparing antioxidant therapy to placebo. 
Patients provided one month of baseline data and were fol-
lowed for 6 months while receiving either Antox version1.2 
or matched placebo (2 tablets t.i.d.). Of 141 eligible patients 
approached, 92 consented of whom 22 withdrew before 
completion; 70 patients completed the trial providing data to 
the analysis. The primary analysis was baseline-adjusted 
change in clinic pain score at 6 months (VAS 10-point scale). 
Secondary analyses included alternative analyses of clinic 
and diary pain scores; quality of life scores (EORTC-
QLQ-C30, QLQ-PAN28, EuroQOL EQ-5D and EQ-VAS); 
antioxidant levels; opiate usage and adverse events.
Results: Clinic reported pain scores were reduced in both 
groups (change from baseline at 6 months, placebo: −1.97; 
antioxidant: −2.33), but were similar between groups (−0.36, 
95%CI: −1.44 to 0.72, p = 0.509). Diary scores were also 
similar (average daily pain score over 6 months, placebo: 
3.05; antioxidant: 2.93, difference: −0.11, 95%CI: 1.05 to 
0.82, p = 0.808). Measures of quality of life were similar 
between groups, as were opiate use, hospital admissions and 
outpatient visits. Blood levels of vitamin C, E, β-carotene 
and selenium were signifi cantly increased in the antioxidant 
group.
Conclusion: In patients with painful chronic pancreatitis of 
predominantly alcoholic origin, antioxidant therapy did not 
reduce pain or improve quality of life, despite a sustained 
increase in blood antioxidant levels.
Trial Registration: ISRCTN-21047731.
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NOTCH3 AND HEY-1 AS PROGNOSTIC 
BIOMARKERS IN PANCREATIC 
ADENOCARCINOMA
C. Mann1, C. Bastianpillai2, C. Neal1, D. Jones2, 
M. Masood1, E. Karpova2, M. Manson2 and D. Berry3
1Leicester General Hospital; 2University of Leicester; 
3University Hospital of Wales
Leicester General Hospital, Department of HPB Surgery, 
Gwendolen Road, Leicester LE54P, United Kingdom
Introduction: In order to achieve better outcomes for pan-
creatic cancer patients, reliable molecular biomarkers are 
required to enable earlier diagnosis, as well as improved 
determination of individual prognosis. In addition, such bio-
markers may represent novel avenues for therapeutic inter-
vention. Recent data have suggested that members of the 
Notch family of proteins may be implicated in the develop-
ment and progression of pancreatic cancer.
Methods: Expression of Notch proteins (Notch1, Notch3, 
Notch4) and their putative downstream proteins HES-1 and 
HEY-1 was examined by immunohistochemistry in resect-
able (n = 42) and non-resectable (n = 50) pancreatic cancers, 
as well as their matched lymph node and liver metastases, 
using appropriate positive and negative controls. Slides 
were independently scored in a blinded fashion by two 
observers. Protein expression was correlated with clinico-
pathological characteristics including tumour stage and long-
term survival.
Results: All Notch family members were signifi cantly ele-
vated in tumour tissue, compared to uninvolved pancreas, 
with expression maintained within matched metastases. 
Furthermore, signifi cantly higher nuclear expression of 
Notch1, -3 and -4, HES-1, and HEY-1 (all P </= 0.001) was 
noted in locally advanced and metastatic tumours compared 
to resectable cancers. In survival analyses, nuclear Notch3 
and HEY-1 expression were signifi cantly associated with 
reduced overall and disease-free survival following tumour 
resection with curative intent, with nuclear HEY-1 maintain-
ing independent prognostic signifi cance in multivariable 
analyses for both overall and disease-free survival (P = 0.023 
and P = 0.005 respectively).
Conclusion: These data further support a central role for 
Notch signalling in pancreatic cancer and suggest that 
nuclear Notch3 and its target gene Hey-1 may prove useful 
in biomarker panels for diagnosis, prognosis and treatment 
effi cacy.
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‘AN ANNULAR PANCREAS WITH 
CHOLEDOCHAL CYST IN ADULT: A 
RARE PHENOMENON’
K. Anand
HCG Medisurge Hospital, Surgical Gastroenterology and 
HPB Surgery, C-304, Devdarshan Apartement, opp. IOC 
petrol Pump, Bopal, Ahmedabad, Gujarat, India
Introduction: Annular pancreas is a less common anomaly 
of the hepato-pancreatio-biliary structures and most com-
monly associated with duodenal obstruction. Annular pan-
creas with choledochal cyst is not reported in literature in a 
single case in adult. Annular pancreas without duodenal 
obstruction or recurrent pancreatitis is also a rare presenta-
tion. I present a unique case of this kind in 37 yrs female.
Methods: a 37 yrs female presented with recurrent pain in 
upper abdomen and low grade fever with chills which 
improves with oral antibiotics and analgesics. She does not 
have vomiting, weight loss, anorexia or jaundice. She was 
non diabetic, non hypertensive. On evaluation – ultrasonog-
raphy revealed choledochal cyst, which further evaluated by 
CECT abdomen with MRCP – showed a choledochal cyst 
type 1 with an incidental annular pancreas without duodenal 
obstruction/chronic pancreatitis/pancreatic divisum. Blood 
investigation suggestive of low grade cholangitis. She under-
went choledochal cyst excision with roux en y hepaticojeju-
nostomy without duodeno-duodenalplasty. Post operative 
course remained uneventful.
Results: Choledochal cyst excision and roux en y 
hepaticojejunostomy is a standard procedure and with least 
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complications. In this patient lower end of choledochal cyst 
was diffi cult to dissected due to surrounding pancreatic 
parenchyma. Bipolar dissection helps for the same. A small 
cut placed on right border of pancreatic tissue to facilitate 
cyst dissection taking care not to injure pancreatic duct to 
prevent pancreatic ductal fi stula. Post operative stay of the 
patient was 7 days with intravenous antibiotics for the 5 day 
only. Follow up for this patient is of 14 months and she is 
having normal life.
Conclusion: Annular pancreas with Choledochal cyst in 
adult is a rare case with non symptomatic annular pancreas 
(no duodenal obstruction or pancreatic divisum-chronic 
pancreatitis).
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PANCREATOBILIARY CARCINOMA 
COMPLICATING CHRONIC 
PANCREATITIS: ARE INDICATIONS OF 
PANCREATODUODENECTOMY 
CORRECTLY ASSESSED?
A. Merdrignac1, L. Sulpice1, M. Rayar1, T. Rohou2, 
E. Quéhen2, K. Boudjema1 and B. Meunier1
1Service de chirurgie hépatobiliaire et digestive, CHU 
Pontchaillou, Université Rennes 1, Rennes, France; 
2Service d’imagerie médicale, CHU Pontchaillou, 
Université Rennes 1, Rennes, France
CHU Pontchaillou, Service de chirurgie hépatobiliaire et 
digestive, 2 rue Henri Le Guilloux, 35033, Rennes, France
Introduction: Chronic pancreatitis (CP) is a risk factor for 
pancreatobiliary carcinoma (PC). During follow-up of 
patient with CP, the occurrence of a cephalic nodule is 
suspect and indicates a pancreatoduodenectomy (PD). The 
diagnosis of carcinoma is diffi cult in this context. The indica-
tion of PD results of a multidisciplinary discussion. The aims 
of our study were to evaluate conventional imaging and to 
identify risk factors of carcinoma complicating CP.
Methods: Between January 2000 to December 2010 in our 
department, 18 patients with CP underwent PD for suspicion 
of PC. Indication of PD was decided by multidisciplinary 
meeting (MM) with systematic review of conventional 
imaging. We compared retrospectively the histopathological 
data with the MM conclusion. The pre- and post-operative 
clinical and biological data were compared between the PC 
+ CP group and the CP group to identify risk factors of PC. 
The imaging data (CT scan, MRI and ERCP) were submitted 
independently to a second reading of 2 specialized radiolo-
gists (senior and junior). The radiologists had to conclude for 
benign or malignant lesion.
Results: The mean patient age was 50.5 +/− 8.2 years with 
a sex ratio = 3.5. The main symptoms were: pain n = 17 
(94.4%), weight loss n = 13 (72.2%) and jaundice n = 8 
(44.4%). Imaging data were based on CT scan n = 16 
(88.8%), EUS n = 12 (66.6%), MRI n = 7 (38.8%) and ERCP 
n = 5 (27.7%). The pathologist confi rmed the diagnosis of 
carcinoma for 5 patients (27.7%). 4 patients without carci-
noma underwent surgical reoperation for complications 
(hemorrhage or fi stula). Only total bilirubin was signifi ca-
tively higher in patients with carcinoma (318 vs. 98 µmol/l, 
p = 0.04). The sensibility and sensitivity of the senior radi-
ologist review were both 100%, and were 100% and 80% 
respectively for the junior radiologist review.
Conclusion: Our results show that the diagnosis of PC com-
plicating CP is diffi cult, despite a collegiate surgical indica-
tion. However, a careful review by senior radiologist raises 
awareness and corrects diagnosis. Presence of senior radiolo-
gist, during each MM, economizes major pancreatic resec-
tion and its complications for patients who could benefi t 
from other less invasive treatment.
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LAPAROSCOPIC AND OPEN SURGICAL 
TREATMENT OF LEFT–SIDED 
PANCREATIC LESIONS: 
CLINICAL OUTCOMES AND 
COST-EFFECTIVENESS ANALYSIS
A. Belli, P. Limongelli, G. Russo, L. Cioffi , A. D’agostino, 
C. Fantini and G. Belli
Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital
S.M. Loreto Nuovo Hospital, Department of General and 
Hepato-Pancreato-Biliary Surgery, Via A. Vespucci, 80142, 
Naples, Italy
Introduction: Previous studies comparing open distal pan-
createctomy (ODP) and laparoscopic distal pancreatectomy 
(LDP) have found advantages related to minimal-access 
surgery. Few studies have compared direct and associated 
costs after LDP versus ODP. The purpose of the current study 
was to compare perioperative outcomes of patients undergo-
ing LDP and ODP and to assess if LDP was a cost-effective 
procedure when compared to the traditional ODP.
Methods: A retrospective analysis of a prospectively main-
tained database of 52 distal pancreatic resection performed 
over a ten years period was performed.
Results: Patients included in the analysis were 16 in the in 
the LDP group and 29 in the ODP. Morbidity (25% vs. 41%; 
P = 0.373) and pancreatic fi stula (18% vs. 20%; P = 0.600) 
rates were similar after LDP and ODP, as was thirty day-
mortality (0% vs. 2%; P = 0.565). LDP had a shorter mean 
length of hospital stay than ODP (6.4 (2.3) versus 8.8 (1.7) 
days; P < 0.0001). Operative cost for LDP was higher than 
ODP (€2889 versus €1989; P < 0.0001). The entire cost of 
the associated hospital stay was higher in the ODP group 
(€8955 versus €6714; P < 0.043). The total cost was com-
parable in LDP and ODP groups (€ 9603 versus 10944; P = 
0.204).
Conclusion: Laparoscopic distal pancreatectomy for left-
sided lesions can be performed safely and effectively in 
selected patients, with reduced hospital stay and operative 
blood loss. Major complications including pancreatic leak 
were not reduced whereas total cost was comparable between 
LDP and ODP. A selective use of LDP seems to be an effec-
tive and cost-effi cient alternative to ODP.
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MANAGEMENT OF PRIMARY 
HYDATID CYST OF PANCREAS: 
A RETROSPECTIVE 
MULTICENTRIC STUDY
M. Soufi 1, M. Bouziane1, H. Mohammadine2, R. Mssrouri2, 
M. K. Lahlou2, J. Mdaghri2, A. Settaf2 and B. Chad2
1Oujda Department of Surgery, Faculty of Medicine, 
University Mohammed First Morocco; 2Rabat Surgery B 
Department Avicenne Hospital Morocco
Faculty of Medicine, University Mohammed First Morocco, 
Oujda Department of Surgery, bp 4847 oujda université, 
60049, Oujda, Morocco
Introduction: The pancreas is a rare localization of hydatid 
disease, during the last 30 years, less than 50 cases have been 
reported in journals on review.
Objective: This study aims at giving better insight into the 
diagnostic and management approach to the disease.
Methods: 13 (three men, ten women) ranged in age from 
18 to 60 years. Abdominal pain, vomiting, abdominal mass 
and dyspeptic symptoms were seen in cysts involving the 
body and tail. Eight patients having cysts in the head of the 
pancreas presented with obstructive jaundice. An indirect 
hemagglutination test and an enzyme-linked immunoabsor-
bent assay were positive for the presence of specifi c hydatid 
antibodies in six patients. Abdominal ultrasonography, com-
puted tomography successfully imaged the cysts and also 
defi ned the relationship of the lesion with the pancreatic duct. 
All patients underwent surgical exploration.
Results: In 7 cases, the diagnosis was made intraoperatively 
and confi rmed on histopathological examination. Patients 
with cysts located in the tail underwent a distal pancreatec-
tomy without a splenectomy. Cysts of the head were treated 
with evacuation, partial cystectomy and tube drainage. 
Morbidity rates were 46%. Conservative approach was asso-
ciated with high rate of morbidity (p: 0.001) and pancreatic 
fi stula was the dreaded complication and assoiated with high 
rate of long stay hospital p: 0.001. There were no death and 
no evidence of cyst recurrence was observed during the 
follow-up period. All the patients were followed up at six-
month intervals with a mean follow-up time of 62 months 
(rang: 6–120 months); no patient had cyst recurrence.
Conclusion: A hydatid cyst is an uncommon cause of cystic 
lesions in the pancreas and should be included in the dif-
ferential diagnosis of cystic lesions of the pancreas, espe-
cially in endemic areas. Preoperative diagnosis is diffi cult. 
Pancreatctomy without splenectomy is the treatment of 
choise in body or tail’s localization. Whereas, for those 
in the head region, a cystectomy with simple drainage is 
a simple, quick and effective solution but with high 
morbidity.
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PANCREATIC TEXTURE STUDY (PA.TE.
ST) I. PRELIMINARY RESULTS OF 
INTRAOPERATIVE ASSESSMENT
G. Malleo1, G. Marchegiani1, R. Ballarin2, M. Paini1, 
R. Salvia1, G. Butturini1, P. Capelli3 and C. Bassi1
1General Surgery B, Pancreas Unit, G.B. Rossi Hospital, 
Department of Surgery, University of Verona, Italy; 
2General and Transplant Surgery, Department of Surgery, 
University of Modena e Reggio Emilia, Italy; 3Department 
of Pathology, G.B. Rossi Hospital, University of Verona, 
Italy
General Surgery B, Pancreas Unit, G.B. Rossi Hospital, 
Department of Surgery, University of Verona, P.Le L.A. 
Scuro 1037134, Verona, Italy
Introduction: Pancreatic texture has been identifi ed as one 
of the most important risk factors for postoperative pancre-
atic fi stula. Texture defi nition (classically soft/hard) is 
however subjective and based on intraoperative gland palpa-
tion. The aim of this prospective study was to develop a 
reproducible method to assess pancreatic texture by using 
elastic module measurement.
Methods: Study population consisted of 140 patients who 
underwent pancreatic resections at our institution from 
November 2010 to November 2011. Before pancreatic tran-
section, a calibrated coiled valve was employed to test pan-
creatic resistance to compression. Texture was expressed by 
using pancreatic elastic module (Newton/mm2). Measurements 
were then correlated with a pathologic score (0–100) based 
on percentage of fi brosis, pancreatic acini and fat infi ltration 
of the resection margin. Furthermore, the pancreas was pal-
pated by an experienced surgeon (blinded to the elastic 
module measurement) who subjectively assessed texture on 
a 1-to-10 scale.
Results: There was a signifi cant correlation between pan-
creatic elastic module and pathologic score (p = 0.005). In 
order to defi ne ‘soft’ and ‘hard’ texture, an arbitrary cut off 
was set at the 75th percentile for pathological score (Total 
amount of fi brosis >45%). Mean values of elastic modules 
for soft/hard pancreas were signifi cantly different (p < 
0.001). Surprisingly, surgeons’ evaluation correlated with 
both elastic module and pathological assessments.
Conclusion: Pancreatic texture can be assessed using elastic 
module. This is a reproducible method which may represent 
a common framework for future multicentric studies. The 
next step of this analysis will be the correlation pancreatic 
texture assessed by elastic module and the development of 
postoperative pancreatic fi stula.
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WHIPPLE PROCEDURE FOR 
GASTROINTESTINAL STROMAL TUMOR 
OF THE PANCREATICODUODENAL 
COMPLEX: REPORT OF TWO CASES
M. Soufi 1, M. Bouziane1, H. Mohammadine2, A. Essadel2, 
S. Benamer2, J. Mdaghri2, A. Settaf2 and B. Chad2
1Oujda Department of Surgery, Faculty of Medicine, 
University Mohammed First Morocco; 2Rabat Surgery B 
Department Avicenne Hospital Morocco
Faculty of Medicine, University Mohammed First Morocco, 
Oujda Department of Surgery, Bp 4847 oujda université, 
60049, Oujda, Morocco
Introduction: Gastrointestinal stromal tumors (GISTs) are 
one of the most common mesenchymal neoplasms of the 
human gastrointestinal tract. Duodenal and pancreatic GISTs 
are very rare and constitute less than 5% of all kind of GISTs. 
We report two rare cases treated by Whipple procedure.
Methods: Case n1: This is a report of a rare gastrointestinal 
stromal tumor of the duodenum in a 25-year-old female who 
was presented as an acute pancreatitis and treated by Whipple 
procedure.
Case n 2: We report a case of a EGIST in a 39-year-old 
male who presented an subocclusif syndrome and an abdom-
inal pain. A computerized tomography demonstrated a 9 cm 
pancreatic mass, without liver lesions. A Whipple procedure 
with segmental colectomy was performed with success. At 
the 18 months follow up, the patient is doing well and 
disease-free.
Results: All patients underwent a Whipple procedure with 
segmental colectomy in one case was. At the 18, 24 months 
follow up, the patients are well and disease-free.
Conclusion: GISTs are uncommon intra-abdominal tumors. 
In fewer than 5% of cases, they originate primarily from 
extra-gastrointestinal tumors (EGIST). Gastrointestinal 
stromal tumors of the duodenopancreas simplex are very 
rare. Only few cases have been published. In this essay, we 
report two rare cases. The originality of the fi rst case is that 
the tumor involves the colon with concomitant pancreas 
divisum, and in the second case the mode of revelation by 
pancreatitis is exceptional.
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GLYCOLYTIC REGULATION OF 
CALCIUM HOMEOSTASIS IN 
PANCREATIC CANCER
A. Siriwardena1, A. Chan1 and J. Bruce2
1Regional Hepatobiliary Surgery Unit, Manchester Royal 
Infi rmary; 2Faculty of Life Sciences, University of 
Manchester
Manchester Royal Infi rmary, Regional Hepatobiliary 
Surgery Unit, Oxford Road, Manchester M13 9WL, United 
Kingdom
Introduction: Pancreatic ductal adenocarcinoma (PDAC) 
has abysmal survival. The Warburg Effect describes a switch-
ing in cancer cells of ATP production away from the pre-
dominant mitochondrial oxidative phosphorylation towards 
cytosolic glycolysis. Inhibiting glycolysis can therefore limit 
the supply of ATP and affect cancer cell viability. This study 
tests the hypothesis that inhibiting glycolysis will reduce 
Plasma-membrane calcium ATPase (PMCA) causing cyto-
solic Ca2+ overload and cell death.
Methods: Two PDAC cell lines (Panc-1 and Mia-PaCa) 
were cultured in Dulbecco’s modifi ed Eagle’s medium (with 
10% FBS and 1% penicillin/streptomycin) and treated gly-
colytic and mitochondrial inhibitors. Cytoscolic Ca2+ was 
monitored using Fura-2 imaging.
Results: Characterization of Panc-1 cells shows calcium 
clearance is independent of Na+/Ca2+ exchange and reliant 
on PMCA. Treatment with glycolytic inhibitors 3-bromopy-
ruvate (500 µM) and iodoacetate (5 mM) reduced PMCA 
activity to 71.7% and 65.8% of normal respectively (p < 
0.05). Mitochondrial inhibitors oligomycin (10 µM) and car-
bonyl cyanide m-chlorophenyl hydrazone (4 µM) had no 
signifi cant effect (113.5% and 97.7% respectively, p > 0.5). 
More profound effects were seen in the Mia-PaCa cell line, 
whereby 3-bromopyruvate impairs the PMCA’s ability to 
fully restore cytosolic Ca2+ concentration.
Conclusion: These data suggest that the Warburg Effect is 
present in pancreatic cancer cells, and glycolysis may be an 
effective therapeutic target for selectively killing pancreatic 
cancer cells whilst sparing healthy cells.
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PREOPERATIVE DIABETES MELLITUS 
DOES NOT IMPACT ON 
POSTOPERATIVE MORBIDITY AFTER 
PANCREATIC RESECTIONS FOR 
DUCTAL ADENOCARCINOMA
G. Malleo, F. Mazzarella, A. Malpaga, G. Marchegiani, 
C. Bassi and G. Butturini
General Surgery B, Pancreas Unit, G.B. Rossi Hospital, 
Department of Surgery, University of Verona, Italy
General Surgery B, Pancreas Unit, G.B. Rossi Hospital, 
Department of Surgery, University of Verona, P.Le L.A. 
Scuro 1037134, Verona, Italy
Introduction: The prevalence of diabetes mellitus (DM) in 
patients with pancreatic ductal adenocarcinoma (PDAC) 
ranges from 20% to 80%. In patients amenable of resection, 
it is unclear whether DM represents a risk factor for postop-
erative morbidity and pancreatic fi stula (PF).
Methods: To address this issue, 631 consecutive patients 
who underwent pancreatic resections for PDAC at the 
General Surgery B Unit, University of Verona from 2000 
through 2010 were analyzed using univariate and multivari-
ate models. A set of variables including (among the others) 
sex, BMI, DM, preoperative weight loss, jaundice, type of 
resection and of pancreatic anastomosis, length of surgery, 
blood transfusions, pancreatic texture, postoperative collec-
tions, delayed gastric emptying, post-operative pancreatitis, 
post-pancreatectomy haemorrhage, pulmonary, cardiac and 
renal complications was used for the analysis.
Results: 130 patients (20.6%) had DM. 95 had longstanding 
DM, 35 had a new-onset DM. Diabetics were older, had a 
greater BMI, and lost more weight preoperatively (all p = 
0.01). Postoperative morbidity was similar, but the rate of PF 
was greater in non-diabetics (16.6% vs 8.3%, p = 0.03), who 
were also more likely to have a hard pancreatic texture 
(p = 0.02). Postoperative stay was longer in non-diabetics 
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(p = 0.01). All these variables did not differ when stratifying 
by DM type. On multivariate analysis, DM was associated 
with PF (OR = 0.46 (95%CI 0.21–0.95, p = 0.04). Additional 
variables signifi cantly associated with PF formation were 
male sex (p = 0.037), BMI (p = 0.043), weight loss (p = 
0.003), soft pancreatic texture (p = 0.03), abdominal collec-
tion (p = 0.001).
Conclusion: Preoperative DM is not a risk factor for 
increased postoperative morbidity after pancreatectomy for 
ductal adenocarcinoma. The decreased incidence of PF in 
diabetics is likely to be a consequence of a harder pancreatic 
texture, although there was no difference in PF rate or pan-
creatic texture between patients with a new-onset or long-
standing DM.
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LAPAROSCOPIC VERSUS OPEN 
LEFT PANCREATECTOMY: 
SHORT-TERM OUTCOME AND 
COST-BENEFIT ANALYSIS
N. Pecorelli, M. R. Angiolini, G. Capretti, G. Balzano, 
R. Castoldi, V. Di Carlo and M. Braga
San Raffaele Scientifi c Institute, Milano, Italy
San Raffaele Scientifi c Institute, Surgery, Via Olgettina 
6020132, Milano, Italy
Introduction: To date, no randomized trials comparing 
laparoscopic (LLP) with open (OLP) left pancreatectomy are 
available. Existing data derived from single-institution series 
or heterogeneous multicenter comparisons reported shorter 
hospital stay after LLP, but no data about economic analysis 
have been published.
The aim of this study was to compare short-term outcome 
and hospital costs of LLP versus OLP in a high-volume 
center.
Methods: Between 2009 and 2011, 53 consecutive patients 
underwent LLP. The fi rst 10 cases were excluded as part of 
the learning curve. Each of the remaining 43 patients was 
matched with one control patient who underwent OLP, 
selected from our prospective electronic database. Match 
criteria were: gender, age (±5 years), ASA score (1–2, 3–4), 
BMI (<24, 24–30, >30), lesion site, type of disease. All 
patients were treated according to an enhanced recovery after 
surgery protocol. Hospital costs were calculated for each 
patient in both groups.
Results: No mortality occurred. Conversion rate in LLP 
group was 18.6%. Mean operative time (min) was 216 ± 61 
for LLP, 214 ± 73 for OLP (p = 0.885), blood loss (mL) was 
slightly reduced in LLP group (388 ± 371 vs. 571 ± 599, p 
= 0.092) without affecting transfusion rate. No difference 
was found in overall morbidity (44.2% in both groups). 
Mean length of stay (days) was 7.37 ± 3.0 in LLP group vs. 
7.81 ± 2.8 in OLP group (p = 0.481). Median time (weeks) 
to return to preoperative performance was signifi cantly lower 
in LLP group (3 vs. 5, p < 0.001). Additional cost for lapa-
roscopic instruments was €767 per patient. Overall savings 
in the LLP group were €168 (€155 due to shorter LOS, €13 
due to reduced cost of complications). Net balance resulted 
in €599 extra-cost per LLP patient.
Conclusion: Short-term outcome was similar in the two 
groups, however LLP was associated with a faster recovery 
of preoperative performance. The extracharge for LLP 
patients was almost equivalent to laparoscopic instrument 
costs.
720
DOES INTRAOPERATIVE INFUSION 
MANAGEMENT REALLY MATTER IN 
PANCREATIC SURGERY?
G. Capretti, N. Pecorelli, D. Corti, G. Balzano, C. Martani, 
R. Ariotti, L. Beretta and M. Braga
San Raffaele Scientifi c Institute, Milano, Italy
San Raffaele Scientifi c Institute, Surgery, Via Olgettina 
6020132, Milano, Italy
Introduction: Literature shows a correlation between intra-
operative infusion volume and short-term outcome in gastro-
intestinal surgery. No data is currently available for pancreatic 
surgery.
The objective of this study was to assess the impact of intra-
operative fl uid management on short-term outcome after 
major pancreatic resection.
Methods: Prospectively collected data on 199 patients who 
underwent pancreaticoduodenectomy (PD) (n = 115) or 
distal pancreatectomy (DP) (n = 84) from January 2010 to 
September 2011 in our Institution have been analysed. 
Intraoperative infusions were graded as ml/kg/hour, and were 
analysed as continuous value and different categorical values 
according to the 33rd and 66th percentile. Primary endpoint 
was postoperative morbidity (Clavien grade III–V identifi ed 
major complications); secondary endpoints were PONV, 
recovery of both oral feeding and gut function. Uni and 
multivariate analyses were performed considering different 
risk factors. Values are reported as median (interquartile 
range).
Results: Median infusion rate (ml/kg/h) was 12.1 (5.0) and 
13.3 (5.9) for PD and DP patients respectively, with a median 
crystalloid/colloid ratio of 2.9 (3.3) and 2.9 (2.2). Overall 
morbidity was 57.1% and major complication rate was 
18.3% and 4.8% after PD and DP respectively. In both 
groups intraoperative infusion rate did not represent an inde-
pendent risk factor for overall morbidity and pancreatic 
fi stula in univariate or multivariate analysis. Interestingly, 
after PD pulmonary complications progressively increased 
with higher fl uid infusion rate (<10 ml/kg/h 3.3%, 10–14 ml/
kg/h 9.8%, >14 ml 11.1%; 0%). No signifi cant correlation 
was found between intraoperative infusion and any of the 
secondary end points.
Conclusion: No correlation between intraoperative fl uid 
infusion and overall morbidity was found after major pan-
creatic resection. However, an increasing rate of pulmonary 
complications was found in patients with higher intraopera-
tive fl uid infusion. A restrictive fl uid regimen in this kind of 
surgery should be further investigated.
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MODIFIED EARLY WARNING SCORE 
(MEWS): A SENSITIVE PREDICTOR OF 
POOR OUTCOME IN ACUTE
D. J. Malde, A. Suppiah, T. Arab, M. Hamed, 
G. Morris-Stiff and A. M. Smith
The HPB and Transplant Unit, St James University 
Hospital, Leeds, UK
St James University Hospital, The HPB and Transplant 
Unit, Beckett Street, Leeds LS17 7DR, UK
Introduction: Assess accuracy of Modifi ed Early Warning 
Score (MEWS) and determine optimal MEWS value in pre-
dicting poor prognosis in acute pancreatitis (AP). The valida-
tion of the optimal MEWS value is described. MEWS is 
compared with Imrie score, and other scores in a review of 
current prognostic scoring systems.
Methods: MEWS and Imrie scores in fi rst 72 hours for 
predicting poor prognosis (pancreatitis complications, necro-
sis, surgery, intensive care, death) in 142 sequential AP 
admissions, and review of other scoring systems.
Results: Highest MEWS in any 24 hours ≥3 was more accu-
rate than ≥2, and mean daily MEWS >1 was more accurate 
than mean ≥1. Sensitivity, specifi city, NPV, PPV & Accuracy 
of highest MEWS ≥3 was 95.5%, 90.8%, 99%, 65.6% & 
92% (Day 1), 86.4%, 96.7%, 97.5%, 82.6% & 95% (Day 2) 
and 77.3%, 99.2%, 96%, 94.4% & 95.7% (Day 3); and for 
daily Mean MEWS >1 was 95.5%, 87.5%, 99%, 58.3% & 
88.7% (Day 1), 90.9%, 82.5%, 98%, 45.8% & 88% (Day 2) 
and 95.5%, 94.2%, 99.1%, 75% & 93.6% (Day 3). The 
optimal mean MEWS was 1.125–1.625 with 91.5–92.3% 
accuracy but low sensitivity (72.7−86.4%). Mean MEWS >1 
is recommended as has greater clinical utility. All MEWS 
cut-offs values used were more accurate than Imrie (93.6% 
vs. 83.5%).
Conclusion: MEWS provides an easy instant repeatable 
reliable prognostic score which is superior to Imrie, and 
comparable to other scoring systems.
724
SURGICAL APPROACH IN BORDERLINE 
RESECTABLE PANCREATIC CANCER 
WITH PREOPERATIVE 3D-CT 
COMPUTER-ASSISTED 
SURGERY PLANNING
Y. Abe, K. Takano and M. Shimazu
Department of Surgery, Tokyo Medical University Hachioji 
Medical Center
Tokyo Medical University Hachioji Medical Center, 
Department of Surgery, 1163 Tatemachi Hachioji, 193, 
Tokyo, Japan
Introduction: Although surgery is still the only one that can 
achieve complete cure, surgery alone is not enough. Thus we 
suggest that neoadjuvant therapy in combination with 
defi nitive R0 surgery could improve survival. We report 
the surgical approach in four cases of locally advanced pan-
creatic cancer with neoadjuvant chemoradiotherapy and 
preoperative 3D-CT computer-assisted surgery planning 
(3D-CASP).
Methods: We have six patients who had locally advanced 
pancreatic cancers that was found to have invaded the SMV 
and tumor abutment of the SMA or CHA. They were treated 
with radiation (2.0 Gyx25) and the combination chemother-
apy of S-1 plus gemcitabine (S-1: 40 mg/m2/day day 1–14 
and day 22–35, gemcitabine 400 mg/m2 iv, day 1, 8, 22 and 
29). Five weeks later, a reduction of the tumor markers and 
no progressive disease were observed by diagnostic imaging 
in fi ve cases. 3D-CASP were performed to determine resect-
ability and plan operative strategy.
Results: Five of six patients underwent surgery. One of 
them had peritoneal dissemination so that radical surgery 
was withheld. 3D-CASP clarifi ed the anatomical relation-
ships between tumor and vessels and enabled determination 
of the transection line. Frozen sections in dissection line were 
negative for cancer invasion so that R0 surgery were con-
fi rmed in all four cases. Appropriate vessel reconstructions 
were performed according to plan by 3D-CASP. They are 
disease free (median 468 days) and undergoing adjuvant 
chemotherapy except one case (died of gastrointestinal 
bleeding six months after surgery).
Conclusion: Although benefi t from surgery in the manage-
ment of locally advanced pancreatic adenocarcinoma remains 
controversial, we suggest such an approach be considered 
particularly following completion of neoadjuvant therapy 
without systemic progression. 3D-CASP was particularly 
helpful in patient with borderline resectable pancreatic 
cancer to reduce risk for a margin-positive resection.
725
INTERMITTENT NEGATIVE PRESSURE 
EXTERNAL DRAINAGE OF THE 
PANCREATIC DUCT IN 
PANCREATICODUODENECTOMY
N. Minagawa, T. Tamura, S. Kanemitsu, K. Shibao, 
A. Higure and K. Yamaguchi
Department of Surgery 1, School of Medicine, University 
of Occupational and Environmental Health
1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Japan, 80785
Introduction: Pancreatic fi stula is still one of serious mor-
bidity after pancreaticoduodenectomy. This study is focused 
on the effectiveness of intermittent negative pressure exter-
nal drainage for pancreaticojejunostomy in pancreaticoduo-
denectomy patients.
Methods: Forty-three patients were scheduled for pancre-
aticoduodenectomy at our hospital from May of 2008 to 
August of 2011. Negative suction drainage group (n = 23) 
and no negative suction drainage group (n = 24) were com-
pared by patient characteristics, parameters related to opera-
tion, and postoperative complications.
Results: There were no statistical differenced between two 
groups in patient demographics (except sex ratio), laboratory 
data and parameters related to operation. The male rate was 
signifi cantly higher in no negative suction drainage group (p 
= 0.045). The volume of pancreatic juice was higher in nega-
tive suction drainage group. The complication rates were 
signifi cantly lower in negative suction drainage group in 
terms of pancreatic fi stula (p = 0.009) and intra abdominal 
abscess (p = 0.028). Moreover, the mean hospital stay was 
signifi cantly shorter in negative suction drainage group (p = 
0.041).
Conclusion: This retrospective study showed that external 
stenting with intermittent negative pressure suction drainage 
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of the pancreatic duct has signifi cantly reduced the rate of 
pancreatic fi stula and intraabdominal abscess, and also short-
ened mean hospital stay.
729
ENTERAL NUTRITION IN ACUTE 
PANCREATITIS: NASOGASTRIC 
OR NASOJEJUNAL?
D. J. Malde, A. Suppiah, T. Arab, K. V. Menon and 
A. M. Smith
The HPB and Transplant Unit, St James University 
Hospital, Leeds, UK
St James University Hospital, The HPB and Transplant 
Unit, Beckett Street, Leeds LS17 7DR, UK
Introduction: Enteral feeding is benefi cial in patients with 
severe acute pancreatitis. A published series suggests 100% 
can be fed via the nasogastic (NG) route.
Methods: 146 consecutive patients (January–December 
2010) admitted with acute pancreatitis (AP) were reviewed 
to assess the safety and tolerance of NG feed. In all severe 
AP patients nutrition was initially delivered via an NG tube, 
if there were not absorbing an Nasojejunal (NJ) tube was 
inserted.
Results: 29 patients were identifi ed as having poor outcome. 
127 (87%) patients were able to commence oral intake within 
72 hours of admission. 19 (13%) patients required additional 
enteral or parenteral nutritional support. 16 patients were 
commenced on NG feed but 2 patients needed conversion to 
NJ feed. 3 patients were directly commenced on NJ feed but 
one needed conversion to parenteral feed. Only 1 patient had 
been commenced on parenteral feed prior to transfer. Need 
for nutritional support was a signifi cant indicator of poor 
outcome; morbidity 13/19 vs 12/127 (p < 0.0001) and mor-
tality 6/19 vs 1/127 (p < 0.0001).
Conclusion: Nasogastric feeding is is well tolerated in the 
majority (73.7%) of patients with severe AP. NG feeding 
should be fi rst line, but if failing a rapid change to the NJ 
route instituted.
730
LAPAROSCOPIC 
PANCREATODUODENECTOMY 
FOR LARGE-SIZED IPMN
H. Sunagawa and N. Oshiro
Nakagami Hospital
Nakagami Hospital, Surgery, 6-25-5 Chibana, Okinawa 
904-2195, Japan
Introduction: Nowadays, laparoscopic pancreatoduode-
nectomy can be performed with similar short term outcomes 
to open method. And many surgeons have shown that this 
procedure is feasible in patients with benign and low-grade 
malignant pathology. Although intraductal papillary muci-
nous neoplasms (IPMN) is adapted for this procedure, ideas 
are needed in some locations and size of tumor.
Methods: A 29-year-old female was referred to our hospital 
for abdominal discomfort. Computed tomography and endo-
scopic retrograde cholangiopancreatography revealed a 
branched-type IPMN, measuring 7 cm in diameter, adjacent 
to the superior mesenteric vein. This tumor was widely press-
ing, but not invading the supra mesenteric vein. This type of 
tumor is low grade malignancy and this patient is young lady. 
So we tried a laparoscopic pancreatoduodenectomy. A 
Kocher maneuver was performed from the left side. Although 
the large tumor deteriorated the vision, we could see enough 
the right side of the duodenum with this approach.
Results: Laparoscopic pancreatoduodenectomy was suc-
cessfully performed without adverse events during surgery. 
The operation time was 470 minutes. The patient started oral 
intake on the 4th postoperative day. Recovery was unevent-
ful and she was discharged on the 19th postoperative day.
Conclusion: Although laparoscopic pancreatoduodenec-
tomy for large-sized tumor with adjacent to the supra mes-
enteric vein is a technically diffi cult challenging operation, 
we completed safely in addition to some ideas.
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ARTERY FIRST PPPD – CLINICAL 
OUTCOME AND STAGING 
USING A STANDARDISED 
PATHOLOGY PROTOCOL
D. J. Malde, G. Morris-Stiff, C. Verbeke and A. M. Smith
The HPB and Transplant Unit, St James University 
Hospital, Leeds, UK
St James University Hospital, The HPB and Transplant 
Unit, Beckett Street, Leeds LS17 7DR, UK
Introduction: With increased numbers of borderline locally 
advanced patients undergoing resection due to the accep-
tance of portal vein (PV) resection, early dissection of the 
superior mesenteric artery (SMA) allows defi nitive assess-
ment of the tumour/SMA relationship and improved control 
when PV resection is required.
Methods: The lymph node yield, resection margins, mor-
bidity and mortality data were compared between patients 
undergoing Artery fi rst technique of pancreaticoduodenec-
tomy (January 2009 to December 2010) and previous resec-
tions (January 2000 to December 2008).
Results: 42 resections were carried out using the artery fi rst 
technique were age, sex and pathology matched with 182 
previous resections. Although higher, the increase in the 
overall R0 resection margins (28.6% vs 36.3%, p = 0.375) 
and the posterior resection margins (42.9% vs 36.3%, p = 
0.481) didn’t meet signifi cance. The mean lymph node yield 
was signifi cantly increased (19 vs 27, p < 0.05) but there was 
no signifi cant difference in the post-operative morbidity and 
mortality rates between the 2 groups. The actuarial 1 and 2 
year survival was 72% and 49.4% for earlier resections and 
71.8% and 56.8% for Artery fi rst PPPD respectively. The 1 
and 2 year disease free survival was 65.2% and 47% for 
earlier resections and 67.6% and 64.4% for Artery fi rst 
PPPD.
Conclusion: Artery fi rst resection enhances the clearance at 
the SMA (a common site for R1 resection) with increased 
lymph node yield. The 2 year follow up with Artery fi rst 
PPPD shows a trend towards improving overall and disease 
free survival.
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RESULTS OF PANCREATIC SURGERY IN 
THE ELDERLY: AGE IS NOT A BARRIER
D. J. Malde, M. Oliveira-Cunha, A. Aldouri, 
G. Morris-Stiff, K. V. Menon and A. M. Smith
The HPB and Transplant Unit, St James University 
Hospital, Leeds, UK
St James University Hospital, The HPB and Transplant 
Unit, Beckett Street, Leeds LS17 7DR, UK
Introduction: By 2033 the number of people aged 85 and 
over in the UK is projected to double, accounting for 5% of 
the total population. Therefore, it is important to understand 
the surgical outcome in the elderly to assist decision making.
Methods: 428 consecutive pancreatic resections over a 
9-year period (Jan 2000–Aug 2009) were reviewed. Data 
were collected on mortality, complications, length of stay 
and survival. Patients were divided into two groups (younger 
than 70 and older than 70 years old) and outcomes were 
analysed.
Results: 119 cases were ≥70 years and 309 cases were <70 
years. The median length of stay for the older and younger 
group was 15 days (range 3–91) and 14 days (range 3–144) 
respectively. The overall mortality was 3.4% in the older 
group and 2.6% in the younger group (P = 0.75). The older 
cohort had a cumulative median survival of 57.3 months 
(range 0–119), compared to 78.7 months (range 0–126) in 
the younger cohort (P < 0.0001). In patients undergoing 
pancreatic resection for ductal adenocarcinoma, the older 
cohort had a median survival of 26.5 months compared to 
47.6 months (P = 0.043), for cholangiocarcinoma the younger 
group had a median survival of 43.9 months compared to 
16.3 months (P = 0.003) and for ampullary adenocarcinoma 
the older group (n = 22) had a median survival of 47.1 
months compared to 68.3 months (P = 0.194).
Conclusion: Our results suggest that elderly patients can 
safely undergo pancreatic resection and that age alone should 
not preclude pancreatic resection.
733
SURGICAL TECHNIQUE IN THE 
INCIDENCE OF PANCREATIC 
FISTULA AFTER LAPAROSCOPIC 
DISTAL PANCREATECTOMY
A. Meyer, P. Alonso, L. Guimarães and E. Berger
Department of General Surgery, Edmundo Vasconcelos 
Hospital, São Paulo, Brasil
Edmundo Vasconcelos Hospital, Department of General 
Surgery, Jaguaribe, 584 ap. 71, Vila Buarque, 01224-
0001224, São Paulo, Brasil
Introduction: Distal pancreatectomy with en-bloc splenec-
tomy has been considered the standard technique for man-
agement of benign and malignant pancreatic disorders with 
a rate of resectability of tumors of the body and tail around 
10%. However, splenic preservation has recently been advo-
cated. The technique is usually not performed in the same 
way by all surgeons.
In the literature the incidence of pancreatic fi stula after 
pancreatic left resection is highly variable, ranging from 3% 
to 34%.
Methods: Cross-sectional study was conducted from May 
to October 2011, in which four patients were evaluated, three 
females and one male, mean age 66 years (43–68) who 
underwent laparoscopic distal pancreatectomy: three 
Warshaw’s technique and one distal pancreatectomy with 
en-bloc splenectomy. The pancreatic resection was per-
formed with linear stapler and usually is used two vascular 
charge (white).
We used TachoSil® patch in the pancreatic remaining to 
achieving fast and reliable haemostasis and sealing of soft 
tissues.
Results: We assessed age and sex of patients, operative 
time, conversion to open technique, length of stay and post-
operative complications. The average operating time was 
154 minutes. Three patients were discharged on the fourth 
day after surgery and one on the fi fth day.
To date there has been no postoperative complications, all 
outpatient treatment patients remain in control with ultra-
sonography, and there were no evidence of fi stula or abdomi-
nal collections.
The pathologic fi ndings varied among patients: mucinous 
cystadenoma, macrocystic serous adenoma, neuroendocrine 
and adenocarcinoma.
Conclusion: Lessons learnt from patients with malignant 
neoplasms in the body-tail of the pancreas suggest that sple-
nectomy has a negative infl uence on long-term survival after 
resection.
Spleen salvage should be preferable because it eliminates 
the rare but potentially fatal complications of overwhelming 
infection with encapsulated bacterial organisms.
The incidence of pancreatic fi stula may be related to the 
type of device used and surgical technique.
734
OUTCOME OF MINIMALLY INVASIVE 
PANCREATIC NECROSECTOMY 
WITHOUT IRRIGATION
D. J. Malde, S. S. Raza, N. Khan, A. Aldouri and 
A. M. Smith
The HPB and Transplant Unit, St James University 
Hospital, Leeds, UK
St James University Hospital, The HPB and Transplant 
Unit, Beckett Street, Leeds LS17 7DR, UK
Introduction: Necrotizing Pancreatitis with secondary 
infection of the pancreatic tissue is associated with signifi -
cant morbidity and mortality. Current evidence suggests that 
a minimally invasive retroperitoneal necrosectomy (MIRP) 
is feasible, well tolerated and benefi cial for the patient when 
compared with open surgery.
Methods: A total of 16 patients who underwent MIRP from 
September 2007 till April 2011 were included in the study. 
Current minimal access techniques all recommend routine 
irrigation but we aim to show that comparable results can be 
achieved without irrigation.
Results: The mean age was 52.5 years with 13 patients 
transferred from other centers. The etiology was gallstones 
(13), alcohol (1), idiopathic (1) and hyperlipidemia (1). The 
average time before 1st necrosectomy was 50.2 days. The 
mean number of procedures was 3.3 (range 1–7) with one 
patient requiring an open procedure. 1 patient required post-
necrosectomy ICU admission. 13 patients had nasojejunal 
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feed and 4 patients started with parenteral feed which was 
later converted to nasojejunal. 5 patients developed a pan-
creatic fi stula, 3 patients developed colonic fi stula and 2 
patients died. Mean inpatient stay was 82.6 days (range 
31–182).
Conclusion: This series suggests that doing MIRP without 
irrigation has results comparable to other centers carrying out 
routine irrigation.
735
PALLIATIVE DOUBLE BYPASS IN 
UNRESECTABLE PANCREATIC 
CARCINOMA: SINGLE 
CENTRE EXPERIENCE
D. J. Malde, R. Brown, K. V. Menon and A. M. Smith
The HPB and Transplant Unit, St James University 
Hospital, Leeds, UK
St James University Hospital, The HPB and Transplant 
Unit, Beckett Street, Leeds LS17 7DR, UK
Introduction: For distinct locally unresectable or metasta-
sised advanced pancreatic cancer, treatment of bile duct and 
duodenal obstruction is an essential part of the comprehen-
sive palliative therapy. The objective was to determine mor-
bidity and outcome associated with palliative double bypass 
and identify factors predicting unresectability in patients 
who would benefi t from pre-operative laparoscopy.
Methods: A single centre retrospective analysis of all 
patients undergoing palliative double bypass after an 
attempted resection of pancreatic cancer.
Results: From January 2006 to March 2011, 213 patients 
were considered for pancreaticoduodenectomy. 48 patients 
(19 female and 29 male), were found to have unresectable 
disease during attempted surgery. 29 (60.4%) patients had 
pre-operative biliary drainage (27 plastic and 2 metal stents). 
Multidisciplinary review had identifi ed 19 (40%) patients as 
borderline resectable. Reasons for inoperability were locally 
advanced disease (36), liver metastasis (10) and peritoneal 
metastasis (2); they were equally distributed between patients 
considered to be borderline resectable or operable by MDT. 
Post operative morbidity rate was 22.9% and 25 (52.1%) 
patients underwent palliative chemotherapy. Median post 
operative hospital stay was 15 days (range 8–43) and the 
median survival was 3.5 months (range 0–17). 12 (25%) 
patients with liver and peritoneal metastases may have ben-
efi ted from a pre-operative laparoscopy.
Conclusion: Despite advances in preoperative investiga-
tion, surgical exploration is often the only way to determine 
whether a pancreatic cancer is curatively resectable. Pre-
operative laparoscopy may prevent unnecessary exploration 
in a quarter of patients, who could be palliated endoscopi-
cally, as post operative morbidity is high.
736
PANCREATICODUODENECTOMY WITH 
PORTAL VEIN RESECTION IS SAFE AND 
RESULTS IN COMPARABLE SURVIVAL
D. J. Malde, M. Oliveira-Cunha, A. Aldouri, K. V. Menon 
and A. M. Smith
The HPB and Transplant Unit, St James University 
Hospital, Leeds, UK
St James University Hospital, The HPB and Transplant 
Unit, Beckett Street, Leeds LS17 7DR, UK
Introduction: Combined vascular and pancreatic resection 
improves long-term survival of patients suffering from ductal 
adenocarcinoma of the pancreatic head.
Methods: From September 2006 to January 2011, there 
were 39 (27.1%) portal vein resections carried out during 144 
pancreaticoduodenectomies for malignancy. Data was ana-
lysed to look at morbidity, mortality and survival to evaluate 
the safety of portal vein resection.
Results: There were 20 female and 19 male patients with a 
mean age of 60.4 years (median 63). 20 (51.3%) patients had 
pre-operative biliary drainage (ERCP 19 and PTC 1). Post-
operative complications occurred in 5 (12.8%) patients with 
a 30-day mortality of 1 (2.6%). The type of portal vein resec-
tion was a wedge resection, with or without a patch, in 27 
(69.2%) and complete resection with end to end anastomosis 
in 11 (28.2%) patients respectively. An interposition vein 
graft was used in 1 (2.6%) patient. There was no evidence 
of portal vein thrombosis in any patients during follow up. 
The median follow up in this study was 13 months (range 
0−39). The actuarial 1 and 3 year survival was 35.5% and 
4.8% respectively, with median disease free survival of 10 
months (range 0–38.5).
Conclusion: Vascular resection combined with pancrea-
toduodenectomy for pancreatic cancer increases local 
resectability without increasing mortality and morbidity rates 
in the setting of a tertiary referral centre and should not be a 
contraindication to surgery.
752
RESOURCE UTILIZATION AND COSTS 
ASSOCIATED WITH PERI-OPERATIVE 
BLOOD LOSS DURING PANCREATIC 
SURGERIES – A RETROSPECTIVE DATA 
ANALYSIS IN THE UNITED STATES
A. Ally, N. Parikh and M. M. L. Hashemi
Covidien
Covidien, Healthcare Economic & Reimbursement, 4500 
Parkway, Hampshire, PO15, Whiteley, UK
Introduction: Pancreatic surgeries carry risk of massive 
blood loss which can lead to prolonged operation time (OR) 
and hospital stay (LOS), and higher mortality and morbidity 
in patients. Peri-operative blood loss (PBL) requiring blood 
transfusion (BT) in these patients could potentially consume 
excessive hospital resources and these patients may have 
high costs. The aim of this study is to compare hospital 
resource use and costs in pancreatic surgery discharges in 
PBL group v/s no PBL group (NPBL).
Methods: For the purpose of this retrospective analysis, 
inpatient discharges who had undergone pancreatic surgeries 
(ICD-9-CM: 52.2X–52.9) were identifi ed using Premier 
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Perspective® Database (CY2009-Q2CY2010). PBL was 
defi ned as presence of at least one BT (ICD-9-CM: 99.02-
99.07; CPTTM: 36430, 35455). Based on this defi nition, 
pancreatic surgery discharges were categorized into PBL 
group and NPBL group. These groups were matched (1 : 1) 
on age, gender, race, CCI score, APR severity and elective 
admission type using propensity score. Adjusted estimates 
for LOS in days, OR time in hours and costs (total and 
departmental) were compared between these groups using 
generalized linear model (GLM) with gamma distribution 
and log link.
Results: A total of 6333 discharges with pancreatic surgery 
were identifi ed of which 1560 (24.6%) required at least one 
peri-operative BT. All patients in PBL group were matched 
to NPBL group. Compared to NPBL group, PBL group had 
higher adjusted mortality rate (7.3 vs. 6.2%, p = 0.04) and 
higher mean LOS days (11 vs. 15, p < 0.0001) compared to 
NPBL discharges. Mean OR time was 11.3 minutes more for 
PBL group but was not signifi cant between the groups (p = 
0.26). Adjusted mean total cost were signifi cantly higher for 
the BL group compared to NBL group ($60 782 vs. $45 740, 
p < 0.0001). For PBL group, mean adjusted costs associated 
with room & board, surgery, pharmacy, anesthesia and labo-
ratory & pathology were higher (all p < 0.05) compared to 
NPBL group.
Conclusion: Pancreatic surgery patients with peri-operative 
blood loss are likely to stay longer in the hospital and might 
have higher mortality rates and costs compared to those who 
do not experience peri-operative blood loss. Peri-operative 
blood loss during pancreatic surgeries may add signifi cant 
burden to hospital resources and costs. Adopting strategies 
aimed at minimizing peri-operative blood loss in pancreatic 
surgeries may help improve clinical and economic 
outcomes.
756
PYLORUS-PRESERVING 
PANCREATODUODENECTOMY 
WITH GASTROINTESTINAL 
RECONSTRUCTION BY THE IMANAGA 
METHOD ENABLE THE ENDOSCOPIC 
EXAMINATION OF 
PANCREATOJEJUNOSTOMY OR 
CHOLEDOCHOJEJUNOSTOMY 
ANASTOMOSIS
M. Kitago1, J. Matsui2, M. Tanabe1, S. Kawachi1, O. Itano1, 
M. Shinoda1, H. Yagi1 and Y. Kitagawa1
1Department of Surgery, School of Medicine, Keio 
University; 2Department of Surgery, Tokyo Dental College 
Ichikawa General Hospital
School of Medicine, Keio University, Surgery, 35 
Shinanomachi, Shinjuku-ku, Tokyo, Japan
Introduction: We have favored PPPD with gastrointestinal 
reconstruction by the Imanaga method (PPPD-Imanaga), 
which consists of duodenojejunostomy (DJ), pancreatojeju-
nostomy (PJ), and choledochojejunostomy (CJ), performed 
in that order, because the PPPD-Imanaga provides a physi-
ologic mixture of food, pancreatic juice, and bile in the 
upper portion of the jejunum and PJ and CJ are observed by 
endoscopy after surgery. We present our PPPD-Imanaga and 
evaluate anastomoses of PJ and CJ by endoscopy.
Methods: From April 2007, 24 patients underwent PPPD-
Imanaga at our hospital. As part of the PPPD-Imanaga, the 
pancreatic duct was sewn directly to the jejunal mucosa and 
lost tube stent was inserted. Outer layer sutures were placed 
between the pancreas and seromuscular layer of the jejunum 
after spraying of fi brin glue on the pancreatic stump. CJ was 
done with single layer sutures without biliary drainage tube. 
DJ was anastomosed by layer-to-layer anastomosis.
Results: Of 24 patients 5 developed pancreatic fi stula; grade 
A in 4 patients, grade B in 1. 7 occurred delayed gastric 
emptying. The median duration of hospital stay after surgery 
was 21 days. Follow-up endoscopy performed 3 months after 
surgery showed a patent anastomosis of PJ and CJ in all 
patients. Stent removal was performed in 1 patient and local 
recurrence was diagnosed in 1 patient by endoscopy 8 
months after surgery.
Conclusion: PPPD by the Imanaga method is quite safe and 
convenient reconstruction and enable the useful endoscopic 
examination.
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MANAGING PANCREATIC TRAUMA: 
TERTIARY CARE CENTRE EXPERIENCE
R. P. S. Babra, S. S. Virk and S. Budhiraja
Dayanand Medical & Hospital Ludhiana Punjab India
Dayanand Medical College & Hospital Ludhiana Punjab 
India; Department of Surgery, 86 Maya Nagar, Near Rose 
Garden, Ludhiana 141001, Punjab, India
Introduction: Pancreatic trauma isolated or not carries sig-
nifi cant morbidity and mortality because of the delay in rec-
ognition and consequent treatment. This study reviews our 
experience of managing pancreatic trauma at a tertiary refer-
ral centre.
Methods: From Jan 2004 to Sept 2011, forty eight patients 
were treated as cases of pancreatic trauma after they had 
sustained blunt and penetrating abdominal trauma.
Results: Forty eight patients (39 males and 9 females) 
with median age of 38 years (range 19–64 years) were 
identifi ed. Three groups were categorized, Group A (24 
patients) those which presented within 48 hours of injury, 
Group B (14 patients) those which presented with time 
period between 48 hours to two weeks, Group C (10 
patients) presented after two weeks of sustaining injury. In 
Group A fourteen patients underwent surgical procedure 
which included distal spleenopancreatectomy (7 patients), 
spleen preserving distal pancreatectomy (4 patients), Roux-
en-Y pancreaticojejunostomy (3 patients), while ten patients 
had laceration of pancreatic tissue which was managed by 
drainage. Group B patients were treated and had 70% mor-
tality. Thirty four patients developed complication includ-
ing abdominal collection (n = 19), pancreatic fi stulae (n = 
10), and pseudocyst (n = 5). At median follow up of 8 
months (range 3–38 months) 30 of 48 patients were 
asymptomatic.
Conclusion: Successful treatment of pancreatic injuries 
depends largely on initial correct assessment and appropriate 
treatment. Presence of pancreatic duct disruption accounts 
for most of complications and timely intervention minimizes 
the incidence of morbidity and mortality.
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A NEWLY SAFE LYMPHADENECTOMY 
IN PANCREATICODUODENECTOMY 
USING INTRAOPERATIVE DOPPLER 
ULTRASONOGRAPHY-GUIDED 
NAVIGATION
K. Maemura1, H. Shinchi1, Y. Mataki1, H. Kurahara1, 
K. Maeda1, S. Ueno1, S. Natsugoe1 and S. Takao2
1Department of Digestive Surgery, Kgoshima University; 
2Frontier Science Reserch Center, Kagoshima University
Kagoshima University, Department of Digestive Surgery, 
8-35-1 Sakuragaoka, Kagoshima, Japan
Introduction: We assessed the utility and safety of an intra-
operative Doppler ultrasonographic navigation for critical 
vessel treatments during lymphadenectomy in pancreati-
coduodenectomy (PD).
Methods: Fifty-three patients who underwent PD for pan-
creatic head cancer were analyzed for prognostic factors of 
surgical treatment. The consecutive last 10 patients of this 
series were subjected to the intraoperative Doppler ultra-
sonography for visualization of the pancreas head arterial 
arcade. Following ultrasonography, real-time vessel naviga-
tion using the Doppler blood fl ow meter guidance (Dop-
Navi) was performed. The effect of Dop-Navi procedure to 
operative status was evaluated.
Results: The median survival time was signifi cantly higher 
in patients with no residual tumor (R0 operation) than in 
patients with microscopic residual tumor (R1 operation). 
Compared with conventionally treated 43 patients, the 10 
Dop-Navi patients had signifi cantly reduced operating time 
(647 vs. 529 min) and bleeding volume (1560 vs. 974 ml), 
resulting in no postoperative complication following PD.
Conclusion: The vessel navigation procedure using the 
intraoperative Doppler ultrasonography combined with real-
time Doppler fl ow meter guidance is an effective and safe 
lymphadenectomy in PD.
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CREATION OF A REFERENCE CENTER 
FOR PANCREATIC SURGERY BY TEAM 
RELOCATION – IS SURGICAL 
EXPERTISE TRANSFERABLE?
M. Erkan, C. W. Michalski, C. Reiser-Erkan, R. Gertler, 
C. Jäger, M. Hartel, H. Friess and J. Kleeff
Department of General Surgery, Klinikum rechts der Isar, 
Technische Universität München, Munich, Germany
Klinikum rechts der Isar, Technische Universität München, 
Surgery, Ismaningerstrasse 2281675, Munich, Germany
Introduction: Pancreatic resection for malignancy can be 
performed with low morbidity and mortality rates in tertiary 
reference centres. To analyze if such results are transferable 
by surgical team relocation; fi rst 4 years of the new team 
experienced in pancreatic surgery in a new university clinic 
was compared with a) actual publications of other tertiary 
reference centres world-wide, b) with the last 4 years of the 
same university clinic before specialization in pancreatic 
surgery.
Methods: All operations were performed in the Klinikum 
rechts der Isar – Technische Universität München (TUM). 
Data registered prospectively into a database was retrospec-
tively analyzed. All operations were performed or assisted 
by three senior surgeons trained previously in a tertiary 
reference centre for pancreatic surgery. Frequency of 
major morbidities (MM: fi stula, abscess or bleeding) neces-
sitating re-intervention and mortality-rate were endpoints. 
Stratifi cation of complications were made according to 
Clavien-Dindo classifi cation.
Results: MM and mortality rates less than 36% and 5%, 
respectively can be achieved in tertiary reference centres. In 
the 1st period, 126 resections were performed in the TUM 
(77 classical Whipples, 34 pp-Whipples, 13 left- and 2 total-
pancreatectomies). Pancreatic resections tripled in the 2nd 
period with 381 operations (19 classical Whipples, 185 pp-
Whipples, 98 left- and 46 total-pancreatectomies). 
Complicated operations like ampullectomy (6), segmental 
pancreatectomy (7), pancreas-preserving duodenum resec-
tion (3) and multiviscreal- (39) or vascular-resetions (51) 
were routinely performed only in the 2nd period. MM 
(Clavien-Dindo Grade III & IV) was 19% and 35.7% (p < 
0.001), and mortality was 3.2% and 4.7% (p = 0.459) for the 
1st and the 2nd periods.
Conclusion: Extended surgical operations can be performed 
in tertiary reference centres with facilities of multidiscipli-
nary approach without increasing mortality. Pancreatic refer-
ence centres with a high case load performing routine and 
complicated pancreatic resections with acceptable morbidity 
and mortality rates can be created by surgical team 
relocation.
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SIGNIFICANCE OF CD133 AS A CANCER 
STEM CELL MARKERS FOCUSING ON 
THE TUMORIGENICITY OF 
PANCREATIC CANCER CELL LINES
D.-D. You1, H. J. Lee2, D. W. Choi3, Y. S. Choi2, 
S. J. Kim3, Y. S. Won1 and H. J. Moon4
1Department of Surgery, St. Vincent’s Hospital, College of 
Medicine, The Catholic University of Korea; 2Samsung 
Biomedical Research Institute; 3Department of Surgery, 
Samsung Medical Center, Sungkyunkwan University School 
of Medicine; 4Department of Surgery, Kwandong 
University College of Medicine Myongi Hospital
St. Vincent’s Hospital, College of Medicine, The Catholic 
University of Korea, Surgery, Ji-dong paldal-gu, 442-7, 
Suwon, South Korea
Introduction: The cancer stem cell hypothesis states that 
the capacity of a cancer to grow and propagate is dependent 
on a small subset of cells. To determine the signifi cances of 
the cancer stem cell markers CD133, CD44, and CD24 using 
a comparative analysis with a focus on tumorigenicity.
Methods: Four pancreatic cancer cell lines, Capan-1, Mia-
PACA-2, Panc-1, and SNU-410 were analyzed for the 
expressions of CD133, CD44, and CD24 by fl ow cytometry. 
The tumorigenicity was compared using tumor volumes and 
numbers of tumors formed/numbers of injection in nonobese 
diabetic severe combined defi ciency mice. Fluorescence-
activated cell sorting (FACS) analysis was used to confi rm 
that xenograft explants originated from human pancreatic 
cancer cells.
Results: CD133 was positive in only Capan-1, CD44 posi-
tive in all, CD24 partially positive in Panc-1. After injecting 
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2 × 106 cells, all mice administered Capan-1 or Mia-Paca-2 
developed tumors, 3 of 5 administered Panc-1 developed 
tumors, but no mouse administered SNU-410 developed any 
tumors. The volumes of Capan-1 tumors were seven times 
larger than those of Mia-Paca-2 tumors. When 2 × 105 or 2 
× 104 of Capan-1 or Mia-Paca-2 was injected, tumors devel-
oped in all Capan-1 treated mice, but not in Mia-Paca-2 
treated mice. Furthermore, xenograft explants of Capan-1 
expressed CD133+CD44+ and Capan-1 injected mice devel-
oped lung metastasis. FACS analysis showed that xenograft 
explants originated from human pancreatic cancer cell lines.
Conclusion: CD133 positive cells have higher tumorigenic 
and metastatic potential than CD44 and CD24 positive cells, 
which suggests that CD133 might be a meaningful cell 
surface marker of pancreatic cancer stem cells.
This research was published in the Journal of the 
Korean Surgical Society (J Korean Surg Soc. 2011 
Oct;81(4):263–70).
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DESMOID TUMOR OF THE REMNANT 
PANCREAS AFTER PANCREATICO-
DUODENECTOMY: ELEVENTH CASE 
REPORTED IN THE LITERATURE
V. Tonini and M. Cervellera
Department of Surgery and Transplantation, University of 
Bologna Italy
University of Bologna, Department of General Surgery and 
Transplantation, Via Parigi 1640121, Bologna, Italy
Introduction: Desmoids are rare benign tumors of connec-
tive tissue. Despite their inability to metastasize, desmiod 
tumors (DTs) are frequently locally invasive. DTs may occur 
sporadically or in association with familiar adenomatous 
polyposis (FAP) or Gardner’s Syndrome (GS). The sporadic 
intra-abdominal DTs are very rare. Fewer than 100 cases of 
sporadic intra-abdominal DTs have been reported in the lit-
erature. Pancreatic localization is exceptional. This is the 
eleventh case reported in the literature.
Methods: We report a 42-year old woman with a mass in 
the remnant pancreas after pancreatico-duodenectomy for 
solid pseudo-papillary tumor. A mass appeared in the remnant 
pancreas 3 years after surgery. She underwent operation with 
the presumed diagnosis of pancreatic tumor recurrence. A 
pancretectomy of the remnant pancreas with splenectomy 
was performed. The patient recovered well without compli-
cations and she was discharged on post-operative day 10. 
Pathological analysis was a surprise. The diasnosis of DT 
was confi rmed by immuno-cytochemical analysis and the 
assessment of beta-catenin gene mutation. The association 
with FAP and GS was escluded post-operatively. The patient 
remains disease free 45 months after surgery.
Results: While intra-abdominal DTs are mostly associated 
with FAP, this association was found in only one patient of 
the ten patients with pancreatic DT reported in the literature. 
More frequent is the association with pancreatic biopsy (1 
case) or surgery (4). One case occurred after previous spleno-
pancreatectomy, 1 case after pylorus-preserving pancreatico-
duodenectomy, 2 cases after pancreatico-duodenectomy. 
Surgical trauma is considered an important etiologic factor 
for DTs in patients with FAP. However, although complica-
tions of pancreatic surgery are not uncommon, occurrence of 
pancreatic DTs is very rare. In a report of the John Hopkins 
Medical Institution of Baltimora, only one case of pancreatic 
DT was observed after 2650 pancreatico-duodenectomy.
Conclusion: The high rate of post-operative recurrence for 
DTs in patients with FAP, differs completely from the low 
rate of recurrence after resection of pancreatic sporadic 
tumors. The only reported case of pancreatic recurrence was 
in the single patient with FAP. In conclusion, pancreatic DTs 
are very rare and their diagnosis can be very diffi cult. When 
a mass in encountered in the remnant pancreas after pancrea-
tectomy for tumor of the pancreas, DT should be condidered 
in the differential diagnosis.
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SIGNET RING CELL CARCINOMA OF 
THE AMPULLA OF VATER
Y. S. Han, Y. O. Yoo, D. L. Choi and J. D. Kim
Division of Hepato-Biliary-Pancreas and Transplantation 
Surgery, Department of Surgery, Daegu Catholic 
University School of Medicine
Daegu Catholic University School of Medicine, Division of 
Hepato-Biliary-Pancreas and Transplantation Surgery, 
Department of Surgery, 3056-6 Daemyung-4 Dong, 
Nam-gu, 70571, Daegu, Republic of Korea
Introduction: Signet ring cell carcinoma of the Ampulla of 
Vater (AOV) is less frequent, even rare. So, additional 
reports are necessary to determine an adequate surgical strat-
egy and prognosis.
Methods: We present a case of advanced signet ring cell 
carcinoma of the AOV, with invasion of the duodenum, pan-
creas and distal common bile duct. 62-year-old female 
without abdominal discomfort was hospitalized because of 
further evaluation for the elevation of aminotransferase and 
bilirubin. Computed tomography (CT) revealed an 1.2 cm 
sized calcifi ed mass with bile duct dilatation and endoscopic 
retrograde cholangiopancreatography (ERCP) showed a pro-
truding mass on the AOV.
Results: Pancreaticoduodenectomy was performed. A 
nodular mass in the AOV invaded the adjacent duodenum 
and pancreas, and histological examination identifi ed signet 
ring cell carcinoma. But, there was no regional lymph node 
metastasis. The postoperative course was uneventful. Our 
patient has survived for follow up of 12 months.
Conclusion: In conclusion, although the detailed clinico-
pathological features and prognosis are not enough, long-
term survival is possible following a curative resection in 
selected patients.
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SURGICAL TREATMENT FOR THE 
LUNG METASTASIS FROM THE 
PANCREATIC CANCER
A. Kimijima1, T. Hatori1, N. Ooshima1, T. Furukawa2, 
T. Onuki3 and M. Yamamoto1
1Department of Gastroenterological Surgery, Tokyo 
Women’s Medical University; 2Institute for Integrated 
Medical Sciences, Tokyo Women’s Medical University; 
3Department of Surgery I, Tokyo Women’s Medical 
University
Tokyo Women’s Medical University, Department of 
Gastroenterological Surgery, 8-1 Kawada-cho, 
Shinjuku-ku, Tokyo, 162, Japan
Introduction: Lung metastasis is one of the recurrent modes 
of the pancreatic cancer after surgery. In case of the solitary 
metastasis or long-term survivor, a surgical resection for the 
lung metastasis is an effective treatment even if the primary 
lesion is a pancreatic cancer. The aim of this study is to 
evaluate the surgical treatment for the lung; metastasis from 
the pancreatic cancer.
Methods: Six patients who underwent a surgical resection 
for the lung metastasis from the invasive ductal adenocarci-
noma of the pancreas after pancreatectomy were chosen in 
this study.
Results: There were fi ve females and one male with a mean 
age of 67.8 years. A pancreaticoduodenectomy was per-
formed in three patients, distal pancreatectomy in two 
patients and p total pancreatectomy in one patient. The mean 
follow-up period to the surgical resection of the lung metas-
tases was 53.2 (31–106) months. The lung metastases were 
located in the right lobe by fi ve patients and in the left lobe 
by one patient. There were four patients with solitary metas-
tasis and one patient with multiple metastases with a mean 
size of 9.2 (7–10) mm in diameter. Five patients underwent 
partial resection and one patient underwent lobectomy of the 
right upper lobe. All patients are alive with a mean follow-up 
period of 86.5 (38–169) months from pancreatectomy.
Conclusion: Even if the primary lesion is a pancreatic 
cancer, a surgical resection of the lung metastasis should be 
considered in case of the solitary metastasis, more than 
2-year survivor and no recurrence in the abdomen.
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NEUROENDOCRINE TUMORS 
OF PANCREAS
I. Lintzeris1, X. Agrogianni2, K. Giovanakis3, C. Dimakis1, 
T. Argyrakos4 and D. Rontoyianni4
1Surgery Department, General Hospital of Tripolis, 
Arcadia, Greece; 2Postgraduate Medical Student, 
University of Athens, Greece; 3Surgery Department, 
General Hospital of Athens ‘Evangelismos’, Greece; 
4Pathology Department, General Hospital of Athens 
‘Evangelismos’, Greece
Surgery Department, General Hospital of Tripolis, Arcadia, 
Greece; Surgery Department, 6 Birbili Street, Neos 
Kosmos, Athens, Greece
Introduction: Pancreatic neuroendocrine tumors are rare 
neoplasms, compared to the commonest ones that arise from 
the rest pancreatic tissue. Their annual incidence is estimated 
at 1–2 in 100000 individuals and 1–2% of primary pancreatic 
tumors, according to current data. Our study is attempting an 
estimation of the incidence of this rare and poorly understood 
disease in the Hellenic-Mediterranean population.
Methods: We conducted a 7 year old retrospective, mono-
centered study, in our 3rd level hospital. We searched thor-
oughly medical records, pathology examination results and 
surgery reports of all patients that were diagnosed and treated 
of pancreatic neoplasms. We registered all cases that involved 
neuroendocrine pancreatic tumors – PNETs, gender, age and 
histology type.
Results: In the study period, 266 cases of primary pancre-
atic neoplasms were registered. From these, 19 cases of 
PNETs were histologically identifi ed, that referred to 4 
insulinomas, 6 somatostatinomas, 4 VIPomas, 1 gastrinoma, 
1 glucagonoma and 3 silent tumors that expressed neuroen-
docrine markers. As far as gender is concerned there is a 
small predominance of females – 10 female patients and 9 
males – with median age the 7th decade of life. It is worth-
noticing that VIPomas and somatostatinomas that are the 
rarest among the PNETs seem to be frequent in our popula-
tion study.
Conclusion: Clinicians should be aware of the incidence, 
the histology types and the natural course of the disease in 
order to approach diagnose and treatment in the most effi ca-
cious way. Therefore, a wide, multi-centered research involv-
ing PNETs epidemiology characteristics and a prospective 
registry of every new case are required so that a proper 
estimation and clarifi cation of incidence of every type can 
be achieved.
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PARAGANGLIOMA RETRODUODENAL
Z. Aziz and K. Sair
Service de chirurgie hopital militaire med V Rabat 
Morocco
Introduction: Paragangliomas are rare tumors arising from 
extra-adrenal chromaffi ne tissue, that is, the paraganglia, 
which are widely distributed near or within the autonomic 
nervous system in a variety of retroperitoneal sites and in the 
sympathetic ganglia of various viscera; all paragangliomas 
are believed to derive from the neural crest and can synthe-
size and store catecholamines.
Methods: A 40 year old woman who presented for fi ve 
months of right upper quadrant pain without other signs. Our 
patient had a temperature of 37°C and blood pressure of 12/7. 
Her abdominal examination was normal. An abdominal com-
puted tomography scan showed a pre-aortic retroperitoneal 
tumor in contact with the duodenopancreatic region (Fig 1). 
The laboratory blood tests were normal and the results of 
tests for methoxyl derivatives were negative.
Results: We proceeded out right subcostal laparotomy. The 
tumor was located in inter aorto caval, under the left renal 
vein behind the duodenum and the pancreatic head. The 
cleavage plane well individualized and few feeding vessels 
that required ligature. The complete resection of the tumor 
was performed without vascular sacrifi ce (Figs 2,3).
The histological study of the tumor was in favor of a 
paraganglioma.
Conclusion: Treatment of paraganglioma needs a multidis-
ciplinary management. Surgery is the only curative treatment 
provided that it is complete (11,12,13). It allows survival 
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rates of 75 and 45 percent to 5 and 10 years respectively (12). 
In our patient, although the tumor was in close contact with 
the aorta and inferior vena cava, the resection was complete. 
The diagnosis of paraganglioma was done in postoperative 
by histological study of the tumor.
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UNDIFFERENTIATED HEAD OF 
PANCREAS ADENOCARCINOMA WITH 
OSTEOCLAST GIANT CELLS, 
PRESENTING AS A CYSTIC MASS 
FOLLOWING ACUTE PANCREATITIS: 
CASE REPORT
G. Glantzounis1, G. Georgiou1, G. Lianos1, C. Bali1, 
A. Mantelou1, V. Siozopoulou2, E. Balasi2 
and M. Fatouros1
1Department of Surgery, University Hospital of Ioannina, 
Greece; 2Department of Histopathology, University 
Hospital of Ioannina, Greece
University Hospital of Ioannina, Greece University; 
Department of Surgery, Medical School, University of 
Ioannina, Department of Surgery, 45110, Ioannina, Greece
Introduction: Pancreatic giant cell tumors are a rare entity, 
which represents less than 1% of all non-endocrine pancre-
atic tumors. There is an eterogenicity in the clinical picture 
of presentation and it seems that chronic pancreatitis is 
related with them. There is also controversy for the histologi-
cal nature of these tumours. We present a case of undiffer-
entiated head of pancreas carcinoma with osteoclast giant 
cells with an unusual clinical presentation, which led to late 
diagnosis.
Methods: Female patient 75 years old was referred to our 
department by another hospital, with a diagnosis of giant cell 
tumour of the head of pancreas, for surgical evaluation. She 
developed an episode of acute pancreatitis three years prior 
to her admission to our hospital. 18 months after the episode 
of acute pancreatitis developed abdominal pain and steator-
rhea. CT abdomen showed a cystic mass in the head of the 
pancreas with a maximum diameter of 4 cm. The initial 
diagnosis was pancreatic pseudocyst; however as the mass 
was gradually increased in size, a CT-guided biopsy was 
performed. Histological examination revealed an osteoclast-
like giant cell pancreatic tumor.
Results: The patient underwent laparotomy in our hospital. 
A large encapsulated heterogeneous mass (9 cm) was found 
which was partially invading the common hepatic artery. A 
pancreaticoduodenectomy was performed with excision of 
the part of the common hepatic artery which was involved. 
Blood fl ow was restored with the placement of a graft from 
the major saphenous vein. Post-operative course was une-
ventful. Histological examination revealed an undifferenti-
ated pancreatic adenocarcinoma with osteoclast-like giant 
cells. The patient declined the option of chemotherapy. She 
died 10 months after the operation.
Conclusion: Pancreatic giant cell tumors are rare neoplasms 
and can present with an atypical clinical picture. Early diag-
nosis and aggressive surgical treatment is the only way to 
prolong survival.
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BIOCHEMICAL MARKERS OF 
BILIARY PANCREATITIS
F. Anderson
University of Kwazulu Natal
IALCH, Surgery, P/Bag X03, Mayville, 4058, Durban, 
South Africa
Introduction: Establishing a gallstone aetiology for acute 
pancreatitis at presentation is vital as there are specifi c inter-
ventions which may alter the course and outcome of the 
disease. Transabdominal ultrasound is able to detect gall-
stones in some cases and Endoscopic ultrasound and ERCP 
are complementary usually establishing stones in all cases.
Methods: A retrospective review of a prospective data base 
was performed from the period May 2001 to November 
2010. Diagnosis of acute pancreatitis was based on clinical 
features associated with elevation of serum amylase of 
greater than 2 times the upper limit of normal or elevated 
urine amylase. A diagnosis of a gallstone aetiology was by 
transabdominal ultrasound, endoscopic retrograde cholangi-
ography and endoscopic ultrasound. Liver function tests 
were routinely performed at admission. Cholestasis was 
defi ned as alkaline phosphatase, bilirubin and gamma 
glutamyl transferase greater than 121 U/L, 21 µmol/L and 
64 U/L respectively. Clinical jaundice was determined by a 
bilirubin level >51 µmol/L. Isolated elevations of ALT and 
GGT greater than 150 were sought. The sensitivity and spe-
cifi city of these tests for a diagnosis of gallstone related 
pancreatitis were assessed.
Results: There were 623 admissions in the period and 118 
had gallstone related pancreatitis. A gallstone aetiology was 
made by transabdominal US in 101 (86%), endoscopic ultra-
sound 6 (5%) and ERCP (9%). In the 17 confi rmed by ERCP 
and EUS, 9 (53%) had cholestasis and GGT > 150 U/L. 
Eighty one (68%%), 72 (61%), 52 (44%) and 33 (28%) of 
the admissions with gallstone related pancreatitis were asso-
ciated with cholestasis, GGT > 150 U/L, ALT > 150 U/L and 
clinical jaundice with a sensitivity and specifi city of 0.69 
(0.59–0.77) and 0.91 (0.88–0.93), 0.61 (0.52–0.70) and 0.73 
(0.69–0.77), 0.44 (0.35–0.53) and 0.93 (0.91–0.95), and, 
0.28 (0.20–0.37) and 0.94 (0.91–0.96) respectively. All 4 
markers were present in 88 (75%) episodes of biliary 
pancreatitis.
Conclusion: Cholestasis and raised GGT are usefull predic-
tors of a gallstone aetiology. They are helpfull in patients 
with a negative ultrasound examination and limited early 
access to ERCP and EUS.
800
PREDICTORS OF EARLY OR LATE 
MORTALITY IN ACUTE PANCREATITIS
F. Anderson
University of Kwazulu Natal
IALCH, Surgery, P/Bag X03, Mayville, 4058, Durban, 
South Africa
Introduction: Mortality in acute pancreatitis is either an 
early (within 2 weeks) or a late (after 2 weeks) event. Early 
mortality is associated with a severe systemic infl ammatory 
response whereas later mortality is characterized by septic 
necrosis and secondary organ failure. The management strat-
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egies differ in the 2 phases. We sought to defi ne factors 
predictive of early or late mortality.
Methods: A retrospective analysis of a prospective data 
base was performed of patients admitted with acute pancrea-
titis May 2001 to November 2010. A diagnosis of acute 
pancreatitis was made by clinical features in association with 
serum amylase greater than 2 times the upper limit of normal 
(20–104 U/L) or urine amylase greater than 760 U/L. 
Aetiology was determined by history for alcohol and transab-
dominal ultrasound for a gallstone aetiology. Prognostication 
was by the Glasgow criteria and Organ failure (Atlanta cri-
teria). In hospital mortality was either early (within 2 weeks) 
and late (>2 weeks).
Results: There were 623 admissions with acute pancreatitis 
in the period. Forty-two patients died, 19 (45%) female and 
23 (55%) male, and, 67% early and 33% late. The mean age 
of the early mortalities was 46 (22–79) and the late 42 (27–
67). Of the common aetiologies, 75% of alcohol related 
mortalities were early and 70% of gallstone related mortali-
ties were in the late group. Five of the 6 mortalities associ-
ated with HIV were early. A base defi cit of −4 had a sensitivity 
0.71 (0.51–0.86) and a specifi city of 0.79 (0.49–0.94) for 
early mortality whereas organ failure and a Glasgow score 
≥3 had a sensitivity and specifi city of 0.68 (0.48–0.83) and 
0.57 (0.30–0.81), and, 0.46 (0.28–0.66) 0.36 (0.14–0.64) 
respectively. The Glasgow score had a sensitivity and spe-
cifi city of 0.64 (0.36–0.86) and 0.53 (0.34–0.72) for late 
mortality.
Conclusion: Most deaths in our experience are early and 
associated with a gallstone aetiology. A base defi cit of −4 is 
more sensitive and specifi c than organ failure for determin-
ing early mortality whereas a Glasgow score (≥3) was more 
helpful in predicting late mortality.
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LAPAROSCOPIC LATERAL 
PANCREATICOJEJUNOSTOMY AND 
BEGER’S PROCEDURE IN PATIENTS 
WITH CHRONIC PANCREATITIS
Y. Khaled and B. Ammori
The University of Manchester and the Department of 
Hepato-Pancreato-Biliary Surgery, North Manchester 
General Hospital, Delaunays Road, Crumpsall, 
Manchester, M8 5RB, UK
North Manchester General Hospital, Department of 
Hepato-Pancreato-Biliary Surgery, Delaunays Road, 
Crumpsall, M85RB, Manchester, UK
Introduction: Pancreatic resection and/or ductal drainage 
are common surgical options in the management of unremit-
ting abdominal pain of chronic pancreatitis (CP). We describe 
the results of the laparoscopic approach to pancreatic duct 
drainage and head resection for CP.
Methods: Patients with CP and intractable abdominal pain 
requiring Beger’s or Puestow procedure were offered laparo-
scopic surgery by a single surgeon. The results shown rep-
resent median (range).
Results: Five patients (3 males) with CP (alcohol induced, 
n = 4; idiopathic, n = 1) underwent laparoscopic surgery 
between 2009 and 2011. The pancreatic duct diameter 
was 7.5 (6–11) mm. Four patients have had lateral pancrea-
ticojejunostomy (LPJ) and one patient underwent Beger’s 
procedure, all of which were completed laparoscopically. 
The operating time was 285 (250–360) minutes. There were 
no deaths and one patient was readmitted and had laparot-
omy for pancreatic bleeding following LPJ (morbidity, 20%). 
The hospital stay was 5 (5–8) days. At a follow-up of 18 
months (12–25) four of the patients were pain-free whereas 
one patient required one-third of the pre operative oral opioid 
dose for pain control.
Conclusion: The laparoscopic approach to pancreatic duct 
drainage and limited head resection in carefully selected 
patients and in experienced hands is feasible and safe with 
good short-term results and potential advantages. Further 
expansion of experience and longer follow up is required.
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PROGNOSTIC VALUE OF 
POST OPERATIVE CA19-9 IN 
PATIENTS UNDERGOING 
PANCREATICODUODENECTOMY FOR 
PANCREATIC ADENOCARCINOMA
D. J. Malde, E. Jeans, N. De Liguori, R. Deshpande, 
B. Ammori, D. Sherlock and D. O’Reilly
The HPB Unit, North Manchester General Hospital, 
Manchester, UK
North Manchester General Hospital, The HPB Unit, 
Delaunays Road, Manchester M8 5RB, UK
Introduction: Pancreatic Adenocarcinoma accounts for 
over 90% of Pancreatic malignancy with overall survival 
being <5% at 5 years. CA 19-9 is a commonly used tumor 
marker with levels in excess of 200 U/ml being 90% sensi-
tive for pancreatic malignancy. Pre-operative CA 19-9 has 
been used as a prognostic marker with higher levels being 
associated with poorer outcomes. The purpose of this study 
was to see if post operative Ca19-9 was an independent 
prognostic factor.
Methods: A retrospective analysis of a prospectively col-
lected database from January 2005 to December 2010. 
Inclusion criteria was a normal preoperative bilirubin and pre 
and postoperative Ca 19-9 measurements (n = 76). The 
primary endpoint was death or recurrence of disease. Data 
was also analysed for TNM staging, resection margin status 
and overall survival.
Results: 70 patients with pancreatic ductal adenocarcinoma 
were in the study. An elevated post operative CA19-9 (n = 
33) had a signifi cantly poor mean survival of 26.8 months 
compared to patients with normal levels (n = 37) who had a 
mean survival of 45.5 months (p = 0.004). For patients with 
a postoperative value ≥200 U/ml (n = 13) mean survival was 
19.8 months compared with levels <200 U/ml (n = 57) being 
43.9 months (p = 0.001). A less than 75% fall in post opera-
tive ca19-9 levels in comparison to preoperative levels (45 
vs 25 patients) resulted in poor mean survival of 34.9 vs 45.9 
months but did not reach statistical signifi cance (p = 0.218).
Conclusion: In patients who have undergone pancreati-
coduodenectomy for ductal adenocarcinoma having a normal 
postoperative Ca 19-9 is a marker for improved outcome 
where as a level in excess of 200 U/ml is a negative predic-
tive factor. A <75% fall in post operative readings of CA19-9 
results in poor survival (11 months) but was not statistically 
signifi cant.
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NEW EXPERIMENTAL MODEL OF COLD 
PANCREATIC ISCHEMIA-REPERFUSION 
IN RATS
V. Rocha-Santos, O. Ferro, M. Povlovitsch-Seixas, 
L. Ducatti, R. Arantes, F. H. F. Galvão, E. Chaib and 
L. A. Dalbuquerque
Abdominal Transplantation Unit, Medical Investigation 
laboratory n 37, Gastroenterology Department, Hospital 
das Clínicas, University of São Paulo Medical School, São 
Paulo, Brazil
Abdominal Transplantation Unit, Medical Investigation 
laboratory n 37, Gastroenterology Department, Hospital 
das Clínicas, University of São Paulo Medical School, 
Gastroenterology, Av. Dr. Enéas de Carvalho Aguiar, 255 
– Cerqueira César –5403, Sao Paulo, Brazil
Introduction: The syndrome of ischemia-reperfusion (I/R) 
is often found in clinical and surgical practice, especially in 
organ transplants, including pancreas transplantation that is 
extremely susceptible to I/R injury. The aim of the present 
study was to perform a new experimental model of cold 
pancreatic I/R, intending to keep the temperature of the organ 
as close to 4.5°C.
Methods: The wistars male rats were anesthetized and the 
surgery was performed via median laparotomy. The pancreas 
was carefully (no-touch technique) separated from the 
stomach, and the short gastric vessels were ligated. All peri-
pancreatic tissues were removed of the pancreas, isolating 
this portion along with the spleen. The pancreatic ischemia 
was performed by a total occlusion of the splenic artery and 
vein with a vascular microclamp for a period of 60 minutes. 
The caudal portion of the pancreas was placed out the 
abdominal cavity and then, the abdominal wall was partially 
closed. The outside pancreas was surrounded by a thin sheet 
of plastic and small pieces of ice were placed around the 
organ. A small digital thermometer was positioned.
Results: There was 41 rats underwent cold pancreatic I/R. 
We had 2 deaths (4.8%). The variation of the temperature 
during the 60 minutes of ischemia was between 3.5°C to 
4.7°C in all 39 animals.
Conclusion: We performed a new and effective model of 
cold pancreatic I/R keeping the temperature as close to 
4.5°C. This experimental model increase the possibility to 
study the atenuation of the pancreatic I/R injury in pancreas 
transplantation.
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ANALYSIS OF RECURRENCE AFTER 
RESECTION OF PANCREATIC 
NEUROENDOCRINE TUMORS
P. Shen1, N. Newman1, G. Mann2, M. Shukla1, 
K. Geisinger1, J. Park2, J. Bergquist2 and J. Sham2
1Department of General Surgery, Surgical Oncology 
Section, Wake Forest University Baptist Medical Center, 
Medical Center Boulevard, Winston-Salem, NC 27157, 
USA; 2Division of General Surgery, Section of Surgical 
Oncology, University of Washington Medical Center 1959 
NE Pacifi c Street, Box 356410 Seattle, WA 98195
Wake Forest University Baptist Medical Center, 
Department of General Surgery, Surgical Oncology 
Section, Department of General Surgery, Surgical 
Oncology Section, Wake Forest University Baptist Medical 
Center, Medical Center Boulevard, 27157, Winston-Salem, 
USA
Introduction: Outcomes after recurrence of resected pan-
creatic neuroendocrine tumor (PNET) are not well described. 
Our aim is to assess the rate and sites of recurrence as well 
as the treatment of recurrence and its effect on clinical 
outcomes.
Methods: Retrospective chart review of patients (n = 83) 
who underwent surgical resection of PNETs at two institu-
tions. Patients were treated from September 2002 to July 
2010. Charts were reviewed for disease recurrence, date, site, 
and treatment of recurrence.
Results: There were a total of 12 (14.5%) recurrences. The 
most common site of recurrence was the liver (10 patients, 
83%). The most common treatment of recurrences was 
chemotherapy (5 patients, 35.7%). The 1, 3, and 5 year 
disease-free survival (DFS) was 88.5%, 78.6%, and 68.9% 
respectively. The median follow-up for all PNET patients 
was 33.7 months (range 2.3 to 65 months). Multivariate 
analysis found both lymph node positivity (p = 0.01) and 
AJCC stage (p = 0.004) to be independent predictors for 
DFS. Local, distant, and combined recurrences occurred in 
3.9%, 9.2%, and 1.3% of all patients, respectively. Mean 
overall survival for those with and without recurrence was 
44.9 and 48.3 months, respectively (p = 0.3).
Conclusion: Lymph node metastases and AJCC stage are 
signifi cant predictors of recurrence after resection of PNETs 
with hepatic metastases being most common. Survival of 
patients with recurrence is not signifi cantly different from 
patients without recurrence and is likely due to the indolent 
nature of the disease and the relatively rare recurrences.
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ARE THERE ADVANTAGES FOR 
RESORBABLE INNER DRAINAGE OF 
THE PANCREATICO-JEJUNOSTOMY 
AFTER PANCRATIC HEAD RESECTION?
C. M. Krueger, A. Schulz, U. Adam and H. Riediger
Vivantes, Humboldt Klinikum, Dept. of Surgery, Berlin, 
Germany
Vivantes, Humboldt Klinikum, Dept. of Surgery, Visceral & 
Vascular Surgery, Am Nordgraben 2, 13509, Berlin, 
Germany
Introduction: Pancreatic fi stulae are important for periop-
erative outcome, morbidity and mortality after pancreatic 
head resection. We analysed the benefi t of an internal drain-
age technique by a resorbable monofi lament suture when 
performing a two layer duct mucosa pancreatojejunostomy 
(Warren-Cattell).
Methods: From 2006 to 2010, 138 pancreatic head resec-
tions were performed (123 pylorus preserving, 15 Whipple). 
Indications for surgery were pancreatic head cancer (n = 67), 
periampullary cancer (n = 27), chronic pancreatitis (n = 21) 
or other (n = 23). Postoperative morbidity was classifi ed by 
ISGPF (international study group for pancreatic fi stula, type 
A–C) and Accordion (classifi cation of postoperative compli-
cations, degree 1–6).
Results: In 97 cases pancreatojejunostomy and in 41 pan-
creatogastrostomy was performed. Morbidity (Accordion 
(Ac.) 1–6) was 48%, and mortality (Ac. 6) was 5.7%. 
Pancreatic fi stula occurred in 8.5%, while only one patient 
died of a type C fi stula after pylorus preserving pancreatic 
head resection and pancreatogastrostomy. Pancreatic fi stula 
contributed to morbidity in 17% and to mortality in 8%.
When performing a Warren-Cattell anastomosis with 
internal drainage by a resorbable monofi l suture (n = 62), 
pancreatic fi stula occurred in 8% (n = 5). Analogous to 
ISGPF and Ac. classifi cation, there were type A (n = 2, Ac. 
1), type B (n = 2, Ac. 2) and type C (n = 1, Ac. 4). In this 
subgroup, morbidity (Ac. 1–6) was 54% (n = 34) and mortal-
ity (Ac. 6) was 6.4% (n = 4).
Conclusion: Pancreatic fi stula occurred in 8% of all groups 
and subgroups. Internal drainage by a resorbable monofi l 
suture could not reduce the perioperative morbidity and 
mortality.
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MEDIAN ARCUATE LIGAMENT 
SYNDROME: IDENTIFICATION AND 
MANAGEMENT DURING 
PANCREATICODUODENECTOMY
A. Pai
Head Department of Surgical Oncology, MIOT Hospitals, 
Chennai, India
Miot Hospitalssurgical Oncologyd-3, Sneha Sadan 
Apartments, Karpagam Avenue, 94 Santhome High Road, 
Ra Puram, Chennai-60002860028, India
Introduction: The median arcuate ligament is a fi brous arch 
that unites the diaphragmatic crura across the aortic hiatus. 
In 10% of people, a low insertion compresses the coeliac 
artery origin, which may result in symptoms. The presence 
of such an occlusion creates problems during the Whipple 
operation [PD]. The incidence of signifi cant coeliac artery 
stenosis in patients for PD varies from 2% to 10%. We 
present a case diagnosed preoperatively and successfully 
managed at surgery for a pancreatic cancer.
Methods: A 54-year-old male presented to our unit with 
obstructive jaundice of 2 months duration. Evaluation with 
triple phase computerized tomography demonstrated a 4 cm 
mass in the pancreatic head, without involvement of the 
superior mesenteric vessels. 3D CT angiogram demonstrated 
a sharp cut-off of the coeliac artery origin – the characteristic 
‘hook’ appearance. Endoscopic Retrograde Cholangio 
Pancreaticography [ERCP] with biliary stenting and an 
endoultrasound guided Fine needle aspiration of the mass 
were performed, confi rming an adenocarcinoma of the head 
pancreas. Angioplasty failed to open the coeliac artery, and 
he underwent exploration, release of the median arcuate liga-
ment, and a modifi ed Whipple procedure.
Results: At surgery, the hepatic artery was fl accid. The 
coeliac axis was exposed and the fi brotic arcuate ligament 
divided till the aortic wall was reached. The stump pressure 
in the hepatic artery before and one hour after division of the 
arcuate ligament were 30 and 88 mmHg respectively. Once 
the hepatic artery fi lled up, pylorus preserving pancreatico-
duodenectomy was performed in the standard manner. The 
patient made an uneventful recovery and CT angiograms 
performed at 4 weeks, 8 months and 1 year, revealed opening 
up of the coeliac axis. The patient remains free of recurrence 
or symptoms of coeliac axis occlusion, at last follow up 13 
months from surgery.
Conclusion: Coeliac artery occlusion in patients for pan-
creaticoduodenectomy is uncommon, and due to Median 
arcuate ligament syndrome, more so. Its presence should be 
looked for in every patient for a Whipple with a preoperative 
CT angiogram. Revascularization of the coeliac axis may be 
possible with angioplasty, surgical release or reconstruction. 
Performing a Whipple procedure in an untreated coeliac 
artery occlusion jeopardizes the anastomosis and the patients 
life and there should be no case for this.
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ANALYSIS OF CLINICAL OUTCOMES IN 
PATIENTS WITH UNRESECTABLE 
ADVANCED PANCREATIC CANCER
Y. Endou, H. Shimamura, Y. Narushima, G. Yunome and 
K. Takeda
Department of Surgery, Sendai Medical Center
Sendai Medical Center, Department of Surgery, 2-8-8 
Miyagino, Miyagino-ku, Sendai, Miyagi pref. 98385, 
Sendai, Japan
Introduction: Prognosis of pancreatic cancer (PC) is very 
poor, because of its rapid progression and high frequency of 
recurrence. Since gemcitabine (Gem) was applied to chemo-
therapy for PC, clinical outcomes have been getting better. 
In Japan, S-1 (tegafur/gimeracil/oteracil potassium) has 
become another expected chemotherapeutic drug against PC. 
Here we report our clinical outcomes of chemotherapy, using 
Gem and/or S-1, against unresectable advanced PC.
Methods: Since April 2001, when Gem became available in 
Japan to PC, we had 39 patients who were diagnosed 
as ‘unresectable’ advanced PC before or during the opera-
tion. Thirty-fi ve pts, excluding 4 non-operated cases, were 
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retrospectively reviewed in terms of chemotherapy. Although 
standard dose of Gem administration was 1000 mg/m2, we 
reduced the dose for most pts. Dose reduction was also con-
sidered in the case of S-1 administration. Survival rates were 
calculated using Kaplan-Meier method, and compared by 
Generalized Wilcoxon or Logrank test.
Results: All pts were tried to apply Gem and/or S-1 admin-
istration. But, 14 pts (40%) could not continue chemotherapy 
due to allergic reaction or severe hematological toxicity. 
When these pts (incomplete group) were compared with the 
pts who could continue Gem and/or S-1 (continuous group), 
overall survival of continuous group was signifi cantly better 
than that of incomplete group. In continuous group, admin-
istration dose and interval of Gem/S-1 were fl exibly changed. 
Two pts in continuous group survived more than 30M 
(maximum: 55.8M). Tumor location did not affect the prog-
nosis, whereas the presence of liver metastases seemed to 
badly infl uence the prognosis.
Conclusion: When chemotherapy is applied to unresectable 
advanced PC, continuity of drug administration should be 
preferentially considered rather than compliance with dosage 
and interval regimen. Usage of Gem and S-1 seemed to 
contribute to longer survival of unresectable advanced PC.
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LAPAROSCOPIC MEDIAN 
PANCREATECTOMY – AN IDEAL WAY 
TO PRESERVE PARENCHYMAL 
FUNCTION FOR MID BODY TUMORS
P. Senthilnathan, C. Palanivelu, P. S. Rajan, 
S. Rajapandian, P. P. Raj, K. V. Jayganesh, J. Singh 
and N. A. V.
GEM Hospital & Research Centre
GEM Hospital and Research Centre, HPB Surgery, 45, 
Pankaja Mill Road, Ramanathapuram, 45, Coimbatore, 
India
Introduction: Pancreatic body lesions are diffi cult to treat, 
one for the late presentation and other being removal of 
major portion of parenchyma. Distal Pancreatectomy for 
benign tumors results in endocrine disturbances particularly 
development of Diabetes Mellitus. Median or central pan-
createctomy is an option for centrally located tumors but is 
technically diffi cult to perform. We present our experience 
of Minimally Invasive approach to treat these tumors.
Methods: Since 2001, we have performed 5 median pan-
createctomy, 3 of them were for females and 2 males. Those 
patients who were planned for median pancreatectomy but 
could not be completed for technical reasons were excluded 
from this study. The mean age is 36 years and the size of the 
lesion is 3 cms. Malignant tumors, borderline resectable 
tumours and large lesions more than 3 cm were excluded.
Results: The mean operating time is 240 mins and blood 
loss is 160 ml (range 30–320 ml). Mean ICU stay was 1 day 
and hospital stay was 4.5 days. Return of bowel function is 
on the second day. There was no leak and all margins were 
negative. Four of those were done for mucinous cystade-
noma and one for serious cystadenoma. Follow up ranges 
from 8 years to 2 months and till now no recurrence is being 
reported.
Conclusion: Laparoscopic Median pancreatectomy is an 
ideal procedure for selected small lesions situated in the body 
of pancreas which preserves both exo and endocrine function 
of pancreas.
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LYMPH NODE SIZE AS A PROGNOSTIC 
FACTOR TO PREDICT SURVIVAL IN 
RESECTABLE ADENOCARCINOMA OF 
THE PANCREATIC HEAD
S. Vyas, J. John, P. Naik, D. Yu, G. Fusai, D. Sharma, 
B. R. Davidson and S. H. Rahman
Royal Free Hospital, London, UK
HPB and Liver Transplant Surgery, Royal Free Hospital 
NHS Trust, Royal Free Hospital, Pond Street, London 
NW3 2QG, United Kingdom
Introduction: The Lymph node ratio (number of positive 
lymph nodes/total lymph nodes examined) and number of 
positive lymph nodes have been prognostic indicators of 
outcome in pancreatic adenocarcinoma. However not much 
litereture exists on the relation between the lymph node size 
irrespective of status and survival outcomes following resec-
tion for adenocarcinoma of the pancreatic head. We looked 
at the association between the lymph node involvement – 
irrespective of whether benign/involved and outcome.
Methods: Retrospective case records of all patients who 
underwent a pancreaticoduodenectomy for adenocarcinoma 
of the pancreatic head were analysed. Specifi cally apart from 
the demographics, radiologic and histology data was ana-
lysed for size of enlarged lymph nodes, number of enlarged 
nodes and radiological characteristics to determine possible 
metastatic nodes. All scans were reviewed by a single radi-
ologist with a specifi c interest in pancreatic radiology.
Results: We found that lymph node size more than 1 cm 
irrespective of lymph nodal status strongly correlated with 
survival and was found to be an important prognostic factor. 
(p = 0.025; 19.37 +/− 2.71 months v/s 27.44 +/− 2.74 months; 
HR = 2.70 (1.09–6.68 95% CI) (Figure 2). However we did 
not fi nd any correlation between lymph node size and lymph 
node status. Increase in lymph node size did not necessarily 
correlate with lymph node status. This affi rms the concept 
the increasing lymph node size of >1 cm may be due to 
infl ammatory change. However as would be expected pres-
ence of positive lymph node was associated with poor sur-
vival and was highly signifi cant for survival outcomes.
Conclusion: Lymph nodal size >1 cm irrespective of lymph 
nodal status are independent prognostic markers of overall 
survival in pancreatic cancer.
These should be added to the list of other more conven-
tional indicators in determining the prognosis in resected 
patients. More prospective studies would be required to 
determine the precise infl uence of lymph nodal size in deter-
mining long term survival.
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BILIARY BACTERIAL CONTAMINATION 
DUE TO PREOPERATIVE STENTING IS 
CORRELATED WITH POSTOPERATIVE 
INFECTIOUS COMPLICATIONS IN 
PANCREATIC SURGERY
F. Gavazzi, C. Ridolfi , B. Fiore, A. Zerbi and M. Montorsi
Pancreatic Unit, Department of General Surgery, 
University of Milan, IRCCS Humanitas-Rozzano (MI), Italy
Istituto Clinico Humanitas IRCCS, Departimento di 
Chirurgia GeneraleVia Manzoni 5620089, Rozzano 
(Milano), Italy
Introduction: The role of preoperative biliary stenting in 
jaundiced patients undergoing pancreatic surgery is still con-
troversial. We evaluated in our series of patients affected by 
periampullary diseases the infl uence of preoperative biliary 
stenting and the type of bacterial contamination on postop-
erative outcome.
Methods: From January 2010 to November 2011 we pro-
spectively enrolled 120 patients undergoing surgery for 
periampullary diseases. Surgical procedures were: 91 pan-
creaticoduodenectomies, 15 biliary bypasses, 7 total pan-
createctomies, 7 ampullectomies. In all patients intraoperative 
bile sampling for culture was performed; perioperative 
prophylaxis with Cefazolin 2gr was administered. 59 patients 
(49%, group A), underwent preoperative biliary stenting (52 
endoscopic prostheses, 88% and 7 percutaneous drainages, 
12%), whereas 61 (51%, group B, of which 7 jaundiced, 
11%), did not.
Results: All patients of group A had positive intraoperative 
bile cultures, whereas only 24% of group B had infected bile 
(p < 0.00001). In group A there were 143 isolated germs (61 
gram+, 76 gram−, 6 fungi), whereas in group B 24 bacteria 
(10 gram+, 14 gram−). Enterococcus was the most prevalent 
gender. Cefazolin was effective against only 10% isolated 
bacteria. Overall complication rate in group A was 68% 
while in group B 32% (p = 0.018). According to Clavien-
Dindo classifi cation in group A 61% complicated patients 
had grade <III, while in group B 48% (p = 0.4). Wound 
infection rate was in group A 24% and in group B 8% (p = 
0.038). 34% of germs isolated from drainages of patients 
with abdominal infection were already present in the intra-
operative bile.
Conclusion: The patients with biliary stenting have 100% 
of positive bile culture. Preoperative biliary intervention 
increases signifi cantly overall morbidity. Wound infection 
rate is higher in patients with biliary stent. Cefazolin is effec-
tive against very few bacteria isolated in bile cultures. The 
germs responsible for abdominal infection were in one third 
already isolated from intraoperative bile culture.
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MULTIDETECTOR CT (MDCT) 
DETERMINATION OF RESECTABILITY 
IN LOCALLY ADVANCED PANCREATIC 
DUCTAL ADENOCARCINOMA: 
ASSESSMENT OF SURVIVAL 
PROGNOSTIC FACTORS
C. Carla1, L. Novaria1, N. De Lio2, N. Funel3, S. Mazzeo1, 
D. Campani3, U. Boggi2 and C. Bartolozzi1
1Diagnostic and Interventional Radiology, University of 
Pisa; 2General and Transplant Surgery, University of Pisa; 
3Surgical Pathology III, University of Pisa
Diagnostic and Interventional Radiology, Department of 
Oncology, Transplants and New Technologies in Medicine, 
Via Paradisa, 256100, Pisa, Italy
Introduction: An adequate pre-operative evaluation is man-
datory in order to select resectable patients among patients 
affected by locally advanced pancreatic cancer. Aims of our 
study were to evaluate the predictive value of CT in assessing 
resectability in patients with locally advanced pancreatic car-
cinoma and to compare local staging parameters with sur-
vival in order to identify possible prognostic factors of 
survival at CT.
Methods: We included 54 patients with locally-advanced 
pancreatic carcinoma submitted to surgery with vascular 
resection. At CT we evaluated: vascular involvement, fat 
tissue infi ltration (mesenteric and transverse mesocolon root, 
fat corresponding to the SMA margin). Patients were divided 
into 3 groups: resectable, borderline resectable (peripancre-
atic and venous infi ltration liable to resection, likely R0) and 
palliative resectable (arterial or venous infi ltration associated 
to peripancreatic infi ltration, liable to resection likely R+). 
All CT fi ndings and the overall resectability judgement were 
compared to histopathological results. Each CT fi nding and 
judgement of resectability were related to survival.
Results: In the evaluation of vascular and fat tissue infi ltra-
tion CT showed diagnostic accuracy of 81% and 91% respec-
tively; 7 patients were judged as resectable, 23 borderline 
resectable and 24 palliative resectable. CT/histology agree-
ment was reached in 72% of cases. In judging resectability-
unresectability, diagnostic accuracy was 72%–83%. Survival 
was 84% (6 months) and 57% (1 year); 1 year survival was 
100% for resectable cases, 75% for borderline resectable and 
28% for palliative resectable. A signifi cant correlation with 
survival was obtained by considering type of vessel infi l-
trated, SMA margin and mesenteric/mesocolic root infi ltra-
tion at CT, histological SMA margin infi ltration and overall 
judgement of resectability at CT (p = 0.0008).
Conclusion: MDCT is accurate in evaluating local staging 
parameters, that, moreover, can be related to survival, thus 
confi rming the strong contribution of MDCT in the therapeu-
tic planning.
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FEASIBILITY OF CONTINUOUS WOUND 
ANALGESIA (CWA) WITH ROPIVACAINE 
TO CONTROL PAIN AFTER PANCREATIC 
SURGERY
C. Ridolfi , F. Gavazzi, B. Fiore, S. De pascale, N. Leone, 
M. Montorsi and A. Zerbi
Pancreatic Unit, Department of General Surgery, 
University of Milan, IRCCS Humanitas-Rozzano (MI), Italy
Istituto Clinico Humanitas IRCCS, Dipartimento di 
Chirurgia Generale, Via Manzoni 5620089, Rozzano 
(Milan), Italy
Introduction: CWA by pre-peritoneal catheter is used in 
various surgical settings and several studies had demon-
strated a satisfactory pain control, reduction of opioids 
requirements and earlier return to normal bowel function. 
The use of CWA for pancreatic surgery is not widely reported, 
while epidural analgesia or intravenous morphine infusion 
are used. We evaluate the feasibility of CWA and its effi cacy 
to control post-operative pain versus epidural analgesia (EA) 
and opioids after pancreatic surgery.
Methods: From October 2010 to June 2011 78 patients 
undergoing elective subcostal laparotomy for pancreatic 
surgery received post-operative analgesia: 31 with CWA of 
ropivacaine 2%, 16 with continuous EA of ropivacaine 2% 
plus fentanyl 3 mg, 31 with continuous intravenous mor-
phine infusion. We evaluated the following clinical variables: 
quality of analgesia by static and dynamic VAS, use of rescue 
drugs, post-operative nausea and vomiting, time of fi rst 
bowel movement, procedure complications.
Results: We didn’t register statistically signifi cant differ-
ence in rest or dynamic VAS among the 3 groups. In the fi rst 
postoperative day, 22% with CWA needed other analgesic 
drugs, while 43%with EA (p = NS). There wasn’t statistic 
difference among the 3 groups for nausea and vomiting. The 
median time of fi rst fl atus in CWA group was 64.7 ± 22 h, 
in EA group 78 ± 18 h and in morphine group 78.6 ± 27 h 
(p = 0.5); CWA allowed a more rapid stool canalization 
(mean 88 h) than morphine (117 h) and EA (110 h) (p < 
0.05). In CWA group 9% had therapeutic failure, while 25% 
of patients with EA. The rate of wound infection and 
hematoma was similar in the 3 groups. In EA an inferior limb 
paresthesia was observed. No other specifi c complications 
were reported.
Conclusion: Local anaesthesia infusion of ropivacaine at 
the fascial plane is an effective analgesia in pancreatic 
surgery alternative to epidural or opioids infusions. CWA is 
a safe procedure that doesn’t increase local complication. 
The patients with CWA have a more rapid bowel canalization 
that improves their post-operative recovery.
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RADIOLOGICAL TUMOUR DENSITY 
COULD PREDICT OUTCOME IN 
PATIENTS WITH RESECTABLE 
ADENOCARCINOMA OF THE HEAD 
OF PANCREAS
S. Vyas, B. J. John, D. Yu, J. Watkins, S. H. Rahman, 
G. Fusai, D. Sharma and B. R. Davidson
Royal Free Hospital, HPB and Liver Transplant 
Surgeryroyal Free Hospital NHS Trust, Royal Free 
Hospital, Pond Street, London NW3 2QG, UK
Introduction: Enhancement tumour patterns on CT scan-
ning has been variably associated with tumour size and 
degree of tumour differentiation. As yet, its exact role in the 
diagnosis, prognosis or preoperative planning of patients 
with tumours of the Head of the Pancreas (HOP) is unde-
fi ned. We evaluated the impact of radiological tumour vari-
ables on outcome.
Methods: Retrospective analysis of patients undergoing 
pancreaticoduodenectomy for adenocarcinoma HOP from 
2006–2009. Triple phase contrast enhanced helical CT scans 
were re-interpreted to document tumour variables including 
size and density. The background pancreatic density was also 
evaluated. Post operative histopathological variables includ-
ing degree of differentiation and nodal status and, outcome 
was documented. The relationship between tumour variables 
and outcome was analyzed.
Results: Complete data was available on 25 patients. 
Increasing tumour density was signifi cantly associated with 
adverse outcome (p = 0.042, HR 1.034, 1.002–1.067 95% 
CI). There was no association between radiological tumour 
size, pancratic density or the ratio of the tumour to back-
ground pancreatic density and outcome. Patients with well 
differentiated tumour had a signifi cantly lower tumour 
density as compared to those with moderately differentiated 
tumours (39.00 ± 26.00 vs 71.13 ± 21.03, p = 0.05). Although 
well differentiated tumours had a lower tumour density com-
pared to poorly differentiated tumours, it did not reach sta-
tistical signifi cance (39.00 ± 26.00 vs 61.83 ± 13.35, p = 
0.19) No association between tumour density and histopatho-
logical lymph node involvement was found.
Conclusion: Increasing tumour density adversely affects 
survival. Well differentiated tumours seem to have a lower 
tumour density than dedifferentiated tumours. Tumour 
density as measured on enhanced helical CT could be used 
as a preoperative prognostic marker for outcome. Further 
research is warranted.
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DEFINING THE RESECTION MARGIN IN 
PANCREATIC RESECTION: THE ROLE 
OF INTRAOPERATIVE 
ULTRASONOGRAPHY (IOUS)
M. Mirarchi, E. De Raffele, S. Palumbo, S. Vaccari and 
B. Cola
Dipartimento di Emergenza/Urgenza, Chirurgia Generale e 
dei Trapianti, Policlinico S.Orsola-Malpighi, Università 
degli Studi di Bologna, Bologna, Italy
Dipartimento di Emergenza/Urgenza, Chirurgia Generale e 
dei Trapianti, Policlinico S.Orsola-Malpighi, Università 
degli Studi di Bologna, Bologna, Italy; U.O. di Chirurgia 
Generale e di Urgenza, Padiglione 5, Policlinico S.
Orsola-Malpighi, Via Massarenti, 9, 40138, Bologna,Italy
Introduction: Partial pancreatic resection for solid and 
cystic tumours of the pancreas require accurate evaluation of 
the resection margin (RM) to avoid unappropriate resection 
and recurrence. Segmental resections are increasingly per-
formed for lesions with low malignant potential, but are 
usually considered at higher risk of residual tumour on the 
margin. The aim of the study was to defi ne the usefulness of 
IOUS in defi ning the RM in candidates to partial pancreatic 
resection for neoplasia.
Methods: Thirty-three pts who received IOUS-guided pan-
creatic resection for neopasia in our unit were included in 
this study: the indication was adenocarcinoma (PDAC) in 
5 pts, PDAC associated with intraductal papillary mucinous 
neoplasm (IPMN) in 2, ampullary cancer in 4, IPMN in 12, 
serous cystadenoma in 3, neuroendocrine tumour in 2, and 
other tumours in 5. IOUS was performed after exposure of 
the anterior aspect of the pancreas to explore the paren-
chyma, the tumour and the peripancreatic vessels, and then 
before pancreatic division to defi ne resection margins (RM). 
RM were submitted for intraoperative frozen section analysis 
(FSA) in all cases. Low dysplasia was not considered an 
indication to extend the resection, except for main duct 
IPMN.
Results: Nineteen pts underwent pancreaticoduodenectomy 
(1 with MV resection), 9 distal splenopancreatectomy (1 with 
MV resection), 3 spleen-preserving distal pancreatectomy, 1 
mesopancreatectomy and 2 enucleoresection. FSA of the RM 
revealed low dysplasia in 1/7 pts (14%) with adenocarci-
noma and in 5/12 (42%) with IPMN (2 had foci of moderate 
dysplasia at defi nitive examination); the RM was free in all 
the other cases. A total of 6 pts (18%) had low dysplasia at 
the intraoperative FSA and were not reresected intraopera-
tively; two of them (6%) had foci of moderate dysplasia at 
defi nitive examination: both had partial pancreatic resection 
for IPMN with in situ carcinoma and were not reresected.
Conclusion: In our experience, IOUS was very useful to 
defi ne the RM in patients with solid tumours, since in no case 
the margin was neoplastic. In 42% of pts with IPMN the RM 
showed low dysplasia, which was not an indication to extend 
the resection in our policy, even though in 17% of this group 
foci of moderate dysplasia were evident at defi nitive exami-
nation. IOUS should be routinely used in partial pancreatic 
resections to reduce the risk of inappropriare resection and 
early neoplastic recurrence.
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NEURAL INVASION IS NOT A 
PROGNOSTIC FACTOR IN COLON 
CANCER DUE TO MISSING NEURO-
CANCER CELL AFFINITY AS IN 
PANCREATIC CANCER
F. Liebl1, I. E. Demir1, R. Rosenberg1, A. Boldis1, 
T. Schuster2, K. Becker3, H. Friess1 and G. O. Ceyhan1
1Department of Surgery, Klinikum rechts der Isar, TU 
Munich, Germany; 2Institute of Medical Statistics and 
Epidemiology, Klinikum rechts der Isar, TU Munich, 
Germany; 3Institute of Pathology, Klinikum rechts der Isar, 
TU Munich, Germany
Klinikum rechts der Isar, TU Munich, Germany; 
Department of Surgery, Ismaninger Str. 2281675, Munich, 
Germany
Introduction: Neural invasion (NI) is a neglected his-
topathological feature of colon cancer (CC). The slight clini-
cal consideration may be due to the low prevalence of NI in 
CC compared to other gastrointestinal malignancies like pan-
creatic cancer (PCa). The aim of this study was to perform 
a comprehensive morphological and functional characteriza-
tion of NI in CC and to assess its actual role in CC biology.
Methods: NI was detected in H&E-stained tissue sections 
of 673 patients with CC. The localization and the severity of 
NI was determined and related to patient’s prognosis and 
survival. To determine a potential affi nity between CC cells 
(HT29, HCT-116) and neurons, a recently established in-
vitro 3D-neural-migration assay was utilized, and the migra-
tory behaviour of CC cells was compared to that of the PCa 
cell-line T3M4 via live-cell-imaging-analysis.
Results: NI was detected in 210 of 673 patients (31.2%). 
Although increasing NI severity scores were associated with 
a signifi cantly poorer survival, multivariate analysis includ-
ing gender, age, pTNM stage, grading, lymphatic invasion, 
CEA-level, resection status and tumor location did not reveal 
NI as an independent prognostic factor in CC. In the 3D 
migration assay, CC cells did not demonstrate any neurite-
targeted migration behavior in contrast to the clearly observed 
one in T3M4 cells.
Conclusion: NI is not an independent prognostic factor in 
CC. The lack of a considerable biological affi nity between 
CC cells and neurons and the predominantly intraperitoneal 
localization of colon segments may explain the low preva-
lence and impact of NI in CC compared to PCa.
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PANCREATIC INSULINOMAS – ORGAN 
PRESERVATION IS POSSIBLE
S. Vyas, M. Druce, W. Drake, A. McLean, E. Frediman, 
S. Preston, J. C. Aleong and S. Bhattacharya
Royal Free Hospital, HPB Surgery, Soumil Vyas, Division 
of HPB Surgery, Royal Free Hospital, Pond Street, London 
NW3 2QG, United Kingdom
Introduction: A major challange in the management of 
insulinomas, is the pre-operative localization, which helps 
identify the lesion and also plans surgical management. 
We retrospectively reviewed our data with respect to insuli-
nomas with an aim to identify the accuracy of different 
imaging modalities (CT/MRI/Octreotide scanning/EUS) to 
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pre-operatively localize insulinomas. Also to assess the fea-
sibility and possibility of organ preservation for insulinoma 
surgery.
Methods: Retrospective study of case records of 27 patients 
with insulinomas over an 10 year period. Investigative fi nd-
ings were compared against Intra-Operative assessment of 
the lesion, which was considered as the gold standard.
The imaging fi ndings were individually compared to the 
intra-operative assessment and detection of the lesion.
Surgical outcomes were analysed with respect to kind 
of surgery performed, post-operative outcomes, and 
recurrences.
The sensitivity, specifi city and accuracy of the individual 
imaging modalities was also calculated based on the data 
obtained. The diagnostic accuracy of different imaging 
modalities were compared.
Results: 28 surgical procedures in 27 patients were carried 
out. 25 patients had sporadic insulinomas while 2 patients 
had insulinomas as a part of MEN1. CT scan, MRI, EUS, 
Octreotide scanning were found to have accuracies of 
78.57%, 69.56%, 75% and 52.63% respectively. Venous 
sampling was highly accurate in localizing the lesion in 
95.83% patients. IOUS was accurate up to 85.71% of 
patients. In 1 patient the lesion could not be detected at 
surgery, leading to a failed exploration. In 50% (n = 14) of 
patients pancreatic parenchymal preservation was achieved. 
We also carried out resections preserving the spleen and 
duodenum in other patients. A formal pancreaticoduodenec-
tomy was needed in only 5 patients (17.86%), including in 
the single patient with a recurrence following ennucleation. 
Overall morbidity of pancreatic surgery for insulinomas was 
17.85% and we had a single post-operative mortality (3.57%).
Conclusion: Insulinomas are a rare condition and hence 
centralized management of this condition at a tertiary referral 
centre, in close coordination between the endocrinologists 
and an experienced ‘insulinoma’ surgeon, is mandatory for 
optimum management. Judicious use of different investiga-
tive modalities should be made to obtain an accurate 
pre-operative localization. We have shown conservative 
pancreatic resections are possible and feasible with an 
acceptable morbidity and mortality.
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COMPARISON BETWEEN 
MULTIDETECTOR CT (MDCT) POST-
CONTRASTOGRAPHIC PATTERN AND 
MICROVASCULAR DENSITY (MVD) IN 
PANCREATIC NEUROENDOCRINE 
TUMORS: CORRELATION WITH THE 
NEOPLASM NATURE
C. Carla1, L. Novaria1, N. Funel3, N. De Lio2, S. Mazzeo1, 
D. Campani3, U. Boggi2 and C. Bartolozzi1
1Diagnostic and Interventional Radiology, University of 
Pisa; 2General and Transplants Surgery, University of 
Pisa; 3Surgical Pathology III, University of Pisa
Diagnostic and Interventional Radiology, Department of 
Oncology, Transplants and New Technologies in Medicine, 
Via Paradisa, 256100, Pisa, Italy
Introduction: Pre-operative suspicion of neuroendocrine 
pancreatic lesions nature arises both from clinical (presence 
and the type of secreted hormone) and imaging fi ndings. 
However, imaging suggestion of lesion nature is based quite 
only on nodular dimension and on the presence of local and 
distant spreading. Aim of the study was to determine the 
nature of neuroendocrine pancreatic lesions by analysing 
lesions enhancement pattern at MDCT and by comparing it 
with histological fi ndings, including the MVD.
Methods: We included 45 patients submitted to surgical 
resection for pancreatic neuroendocrine tumor. All preopera-
tive CT examinations were performed by a multidetector CT. 
Post-contrastographic study included 4 phases: early arterial 
(delay 15–20’’), pancreatic (delay 35’’), venous (delay 70’’) 
and late phases (delay 180’’). Two different patterns of 
enhancement were defi ned: pattern A, including lesions 
showing early enhancement (during early arterial or pancre-
atic phase) and a rapid wash-out; pattern B, including lesions 
with wash-in in the early arterial or pancreatic phase with no 
wash-out nor in the late phase (pattern B1), and lesions 
showing enhancement only in the venous and/or late phases 
(pattern B2).
Results: 66 lesions were detected (30 pattern A, 26 B1 and 
10 B2). At pathology 28 lesions were adenomas, 14 border-
line and 24 carcinomas: 24/30 lesions showing pattern A 
were benign, 5 borderline and 1 carcinoma; 23/36 lesions 
showing pattern B were carcinomas, 9 borderline and 4 
adenomas. Among the 26 B1 lesions, 13 were carcinomas, 9 
borderline and 4 adenomas, while all 10 B2 lesions were 
malignant. Pattern A showed PPV of benignancy of 80%, and 
pattern B NPV of benignancy of 89%. MVD was evaluated 
in 20 lesions obtaining signifi cant differences among the 3 
histological and the 3 enhancement pattern. Signifi cant dif-
ferences between B1 and B2 malignant lesions existed by 
considering metastases (only B2 lesions) and fi brosis (all B2 
lesions).
Conclusion: The enhancement pattern at CT is related to 
MVD and the histological type, thus representing a further 
criterium for suggesting nature of neuroendocrine lesions. 
The low MVD of B2 lesions, associated with the presence of 
fi brosis, may justify the delayed enhancement of these lesions.
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FREY’S PROCEDURE FOR TREATMENT 
OF CHRONIC PANCREATITIS
V. Resende1 and J. R. Cunha-Melo2
1Vivian Resende; 2José Renan da Cunha-Melo
Alfa Institute of Gastroenterology, Hospital of Clinics of 
the Federal University of Minas Gerais, Surgical, Rua 
Sergipe 67/240130130, Belo Horizonte, Brazil
Introduction: Chronic pancreatitis is often accompanied by 
severe and disabling pain that requires surgery, although the 
most appropriate means of intervention, varying from highly 
aggressive procedures to more conservative management, 
remains to be established. Only limited prospective data are 
available regarding the long-term outcome of local resection 
of the pancreatic head in combination with lontidudinal pan-
creaticojejunostomy in patients with chronic pancreatitis.
Methods: From January 2006 to December 2009, 16 
patients affected by chronic pancreatitis were subjected to 
the Frey’s procedure. Preoperative selection criteria included 
confi rmed diagnosis of chronic pancreatitis, dilation of 
Wirsung’s duct to a diameter greater than 6 mm, the absence 
of neoplasia and obstructive chronic pancreatitis secondary 
to fi brotic stenosis at the pancreatic body or tail.
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Results: The median age of the patient cohort (n = 16) was 
40 years. There were 8 males and 8 females. Diabetes mel-
litus was present in two patients. Pain and pancreatic calci-
fi cations was present in all patients. There were no pancreatic 
fi stulae or postoperative deaths. The median of surgical time 
was 300 min and postoperative hospitalization time 6 days. 
No blood transfusion was necessary. Concomitant surgical 
procedures were hepaticojejunostomy (n = 2) and cholecys-
tectomy (n = 4). Quality of life showed improvement at 
follow-up interval.
Conclusion: Whenever surgery is indicated, the short-term 
outcomes confi rm that Frey’s procedure is an appropriate 
means of management for patients with chronic pancreatitis 
in the absence of doubts of neoplasia and/or distal ductal 
obstruction.
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DOUBLE STAPLED ROUX EN Y GASTRO-
JEJUNAL ANASTOMOSIS AFTER 
PANCREATECTOMY: FAST, SIMPLE, 
SAFE AND FUNCTIONAL
G. L. Greca, M. Sofi a, S. Latteri, F. Cannemi, A. Ricotta, 
R. Bonaccorso, R. Lombardo and D. Russello
Department of Surgical Sciences Organ Transplantations 
and Advanced Tecnologies
University of Catania, Department of Surgical Sciences 
Organ Tranplantations and Advanced Technologiesvia 
Messina 82995126, Catania, Italy
Introduction: Many studies have been performed to opti-
mize the technical aspects of reconstruction after pancreati-
coduodenectomy (PD). The aim of the study is to evaluate a 
new technical solution to simplify the mechanical Roux en 
Y gastro-jejunal anastomosis, trying to improve the func-
tional outcome.
Methods: In fi ve consecutive patients submitted to Whipple 
PD the gastro-jejunal anastomosis was performed con-
structed on a separate Roux-en-Y loop as functional end to 
end. A fi rst the end to side jejuno-jejunal anastomosis was 
performed by circular stapler (21–25 mm) introduced 
through the open jejunal loop. On the proximal end of this 
loop a second purse string was applied. The stapler 
(29–31 mm) was now introduced into the previously com-
pletely stapled stomach through an opening on the right of 
the lesser curve. The needle of the stapler passed through the 
stapled line on the left edge of the large curve. The opening 
on the stomach was closed by a linear stapler.
Results: The construction of both these anastomoses by cir-
cular stapler takes a mean of 9 minutes if mechanical purse 
string are used, 2–3 minutes more with manual purse string. 
This Roux en Y anastomosis is technically simple, fast and 
the gastro-jejunal anastomosis reproduces functionally an 
end-to-end anastomosis like a Billoroth 1. Only one patient 
with a pancreatic fi stula with a retrogastric collection, devel-
oped post-operatively problems in gastric empting. After a 
mean follow-up of 7 months none of the remnant patients 
present any problems of gastric empting.
Conclusion: This Roux en Y gastro-jejunal anastomosis is 
technically simple, fast and functionally as an end to end 
anastomosis. It reproduces the normal gastric anatomy, 
favouring the food transit and minimizing number and length 
of suture lines, and decreasing post-gastrectomy symptoms. 
This anastomosis may have a useful application after PD, 
especially for laparoscopic approach. Future randomized 
control trials are recommended to further evaluate the effi -
cacy of this technique.
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THE INFECTION ANASTOMOTIC 
FISTULA, LEAK, AND 
ABSCESS FOLLOWING 
PANCREATICODUODENECTOMY
H. Ikoma, Y. Yusuke, R. Morimura, D. Ichikawa, 
K. Okamoto, T. Ochiai, Y. Kokuba and E. Otsuji
Division of Digestive Surgery, Department of Surgery, 
Kyoto Prefectural University of Medicine
Kyoto Prefectural University of Medicine, Surgery, 465 
Kajii-tyou kamigyou-ku, 602, Kyoto, Japan
Introduction: There is a case for critical situation associ-
ated with anastomotic fi stula, leak, and abscess, which are 
common complications of pancreaticoduodenectomy. 
Furthermore, the effective prophylactic approach is not 
established yet. However, it is considered that the critical 
situation is involved in infection complication.
The aim of this study is investigate the prognostic value 
of the bacteria isolated from the culture of post operative 
pancreatic fi stula.
Methods: Review of a retrospectively maintained database 
identifi ed 132 patients who underwent pancreaticoduodenec-
tomy between April 2003 and December 2011. Complication 
data were retrospectively entered into a validated postopera-
tive complication database. Patients were included if they 
were identifi ed as having a clinically signifi cant (≥grade B 
or C ISGPF) pancreatic fi stula, leak, or abscess. The cultiva-
tion test results from post operative pancreatic fi stula, and 
the clinicopathological factors, including isolated bacteria, 
were investigated using both univariate and multivariate 
analysis in these patients.
Results: From April 2008 through to December 2011, 
Pancreatic anastomotic leakage occurred in 42 of 132 patients 
(31.8%) following pancreaticoduodenectomy.
Two or more kinds of bacteria were isolated from 15 
among 42 patients. Enterococcus faecalis were isolated from 
21 patients and then MRSA from 13 patients, Klebsiella 
pneumonia form 12 cases, Pseudomonas aeruginosa form 8 
patients, were also isolated respectively. The overall in-hos-
pital mortality rate was 5.3% (7 cases). The mortality rate in 
the group, including patients whom MRSA was isolated 
from, was 38.5% (5 of 13 cases). In the univariate analysis, 
it was signifi cantly higher than in the other groups (p = 
0.011). However, the isolation of MRSA was not signifi -
cantly predictors of mortality.
Conclusion: Most of the bacteria isolated from anastomotic 
fi stula, leak, and abscess, were drug resistant.
MRSA infection in the abdominal drain fl uid may increase 
its risk and therefore aggressive treatment of MRSA and high 
index of suspicion are indicated.
In addition, it was considered that a hospital ward manage-
ment is necessary to prevent a resistant bacteria infection.
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INHIBITION OF HIF PROLYL 
HYDROXYLASE ENZYMES 
ATTENUATES ACUTE PANCREATITIS 
IN MICE
M. Mollenhauer, T. Hank, J. Kiss, J. Kirchberg, J. Werner, 
J. Weitz, M. Schneider and O. Strobel
Department of General, Visceral and Transplantation 
Surgery, University of Heidelberg, Germany
University of Heidelberg, Germany; Department of 
General, Visceral and Transplantation Surgery, INF 
11069120, Heidelberg, Germany
Introduction: Acute pancreatitis (AP) is characterized by 
leukocyte invasion and related infl ammatory tissue injury. 
Hypoxia Inducible Factors (HIFs) are crucially involved in 
the maintenance of leukocyte-mediated infl ammation. HIF 
stabilization in the infl ammatory setting is regulated by HIF 
prolyl hydroxylase enzymes (PHD1, PHD2, PHD3). Specifi c 
functions of PHD enzymes in AP have however remained 
elusive. Here, we aimed to investigate whether inhibition or 
loss of PHD enzymes affects the course of AP.
Methods: Mice were pre-treated with the pharmacological 
PHD-inhibitor EDHB (100 mg/kg) or vehicle control for 3 
days, and subsequently subjected to AP induced by repetitive 
injection of cerulein (50 µg/kg). Furthermore, AP was 
induced in mice specifi cally lacking PHD1 (PHD1−/−) or 
PHD3 (PHD3−/−), or in corresponding wild type (WT) mice. 
Subsequently, serum levels of p-amylase- and lipase were 
assessed as markers for acinar cell injury. Histochemical 
analyses comprised assessment of pancreatic necroses (HE), 
leukocyte invasion (CD45-, F4/80- and MPO staining), and 
cell proliferation (PCNA staining).
Results: Pharmacologic inhibition of PHD enzymes caused 
a signifi cant decrease in plasma levels of p-amylase and 
lipase when analyzed at 6 h or 12 h following induction of 
AP. Consistently, histological analysis revealed attenuated 
necrotic tissue damage and less invasion by leukocytes and 
macrophages in the pancreas of EDHB-treated mice. Cell 
proliferation in the regenerating pancreas following AP was 
not signifi cantly affected by PHD-inhibition. Strikingly, 
studies in PHD-defi cient mice revealed that similar effects 
could be induced by specifi c deletion of the PHD3 enzyme, 
but not by depletion of PHD1 in mice.
Conclusion: Pharmacologic inhibition of HIF Prolyl 
hydroxylase enzymes signifi cantly decreases pancreatic cell 
injury in a murine model of AP. This effect seems to rely 
specifi cally on impaired function of the PHD3 enzyme. 
PHD3 might therefore represent a therapeutic target in AP.
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AUTOIMMUNE PANCREATITIS TYPE 2: 
FIRST REPORTED CASE FROM INDIA
G. Shetty1, C. Tampi2, P. Varty1 and P. Wagle1
1Department of Surgical Gastroenterology, Lilavati 
Hospital & Research Centre, Mumbai, India; 2Department 
of Histopathology, Lilavati Hospital & Research Centre, 
Mumbai, India
Lilavati Hospital & Research Centre, Surgical 
Gastroenterology, A-791, Bandra Reclamation, Bandra 
West, Bandra, Mumbai 400050, Maharashtra, India
Introduction: Autoimmune pancreatitis has recently 
received increasing attention. Recent consensus meetings 
have categorized and defi ned criteria to diagnose and type 
autoimmune pancreatitis.
Methods: We hereby report a case of a 50 year old gentle-
man with a history of multiple attacks of pancreatitis in the 
past, who presented with pain in the abdomen and vomiting. 
Investigations revealed a large pancreatic head mass with a 
dilated pancreatic duct. In view of a high possibility of the 
lesion being a tumor (absence of calcifi cations and pseudo-
cyst in the head of the pancreas) the patient was taken up for 
a pancreatoduodenectomy. However, multiple intraoperative 
biopsies done were negative for malignancy. Finally, a Freys 
head coring procedure was done.
Results: The patient tolerated the procedure well and the 
postoperative period was uneventful.
The histopathology revealed features of chronic pancrea-
titis, with prominent ductocentric lymphoplasmacytic infl am-
mation (grade 3). Ductal mucosal hyperplasia, ulceration and 
squamous metaplasia was seen. Several neutrophilic aggre-
gates were seen within the ducts (GELs). Perilobular fi brosis 
and mild intraacinar infl ammation was also seen. The plasma 
cells were positive for IgG4. No inspissated secretions, 
calculi, or fat necrosis, stigmata of alcoholic pancreatitis 
were present. No dysplasia or malignancy was seen. The 
histology was consistent with autoimmune pancreatitis 
Type 2.
Conclusion: Autoimmune pancreatitis is a unique but dis-
tinct form of chronic pancreatitis. It has specifi c biochemical 
and radiological features. However, the confi rmatory diag-
nosis is made histopathologically. Type 2 Autoimmune pan-
creatitis is a much more recent distinction and more awareness 
about this type of pancreatitis is required to enhance the 
diagnostic and therapeutic capabilities of multidisciplinary 
teams and curtail major surgeries in such cases.
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SURGERY FOR SEROUS AND MUCINOUS 
CYSTIC NEOPLASMS OF THE 
PANCREAS: SINGLE 
CENTER EXPERIENCE
K. Saribeyoglu, S. Pekmezci, E. Aytac, G. Cancan, 
M. Kapan and S. Erguney
Istanbul University, Cerrahpasa Medical Faculty, 
Department of General Surgery, Istanbul, Turkey
Istanbul University, Cerrahpasa Medical Faculty, 
Department of General Surgery, Istanbul, Turkey; 
Cerrahpasa Tip Fakultesi Genel Cerrahi Anabilim Dali, 
Fatih, 34098, Istanbul, Turkey
Introduction: Serous and mucinous cystic neoplasms are 
common cystic tumors of the pancreas.
Hereby in this study, we aimed to evaluate the outcomes 
and follow up details including oncological results of pan-
creatic resection for serous and mucinous cystic 
neoplasms.
Methods: We retrospectively reviewed the medical records 
of the patients undergoing pancreatectomy with curative 
intent, between 1997–2011, for the treatment of cystic neo-
plasms of the pancreas in our clinic. Demographics, histopa-
thology of the tumors and postoperative outcomes, mortality, 
morbidity and oncological follow up were evaluated.
Results: Thirty-nine of 56 cases whose data were compat-
ible with the methods were included to the study. Median 
age and follow up time were 55 and 15 months respectively. 
Whipple procedure (n = 19), distal pancreatectomy (n = 19), 
total panreatectomy (n = 1) were performed. 38.5% of the 
cases were malignant. Median tumor size and lymph node 
number were 4.8 cm and 11. A patient was re-operated on 
postoperative day four. Complications were wound infection 
(18%), ileus (7.7%), leak (5.1%), pulmonary embolus 
(2.6%), stroke (2.6%), evisceration (2.6%), intraabdominal 
abscess (2.6%). Early mortality was 2.6%. 46.7% of cancer 
cases received adjuvant chemotherapy. Survival rate of the 
cancer cases was 66.7%. There was no dead in non-malig-
nant patients.
Conclusion: Although advanced preoperative assessment 
techniques which give us an opportunity about the cancer 
involvement of serous and mucinous cystic neoplasms of the 
pancreas, radical surgery is still only reliable option present-
ing a curative treatment and an exact diagnosis. Pancreatecomy 
could also be performed with low postoperative mortality 
and mortality in experienced centers for benign cystic lesions 
considering its size and further status.
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TOTAL LAPAROSCOPIC 
PANCREATEDUODENECTOMY. 
ANALYSIS OF FIVE CASES
R. Jureidini1, T. Bacchella2, G. N. Namur1, T. C. Ribeiro2, 
E. R. R. Figueira, W. M. Pollara2, U. R. Jr1 and 
I. Cecconello2
1Instituto do Cancer do Estado de São Paulo – FMUSP; 
2Hospital das Clínicas da Fac. Medicina USP/SP
Instituto do Câncer do Aparelho Digestivo, Faculdade de 
Medicina da Universidade de São Paulo, Rua Jose Maria 
Lisboa 331 ap 22 Jardim Paulista, 1423, Sao Paulo, Brazil
Introduction: Total laparoscopic pancreaticoduodenec-
tomy is one of the most advanced laparoscopic procedures. 
The viability of this procedure has already been established 
in small series. The surgical techniques described are not 
standardized. Several surgeons use hand ports or small auxil-
liary incisios for reconstruction. At the present time, onco-
logic margins and number of ressected limphnodes are on 
evaluation.
Methods: This is a series of fi ve cases operated at our 
University since December 2009. Preoperative analysis 
included CT scan with pancreatic protocol and endoscopy. 
The operation was carried out with 6 ports and included a 
celiac, hepatic, periportal lymphadenectomy. Intestinal con-
tinuity was reestablished by intracorporeal anastomoses with 
a single Roux en Y loop to the pancreas.
Results: The mean operative time was 480 min with esti-
mated blood loss of 100 ml. Patients were discharged at the 
seventh postoerative day. One biliary and two pancreatic 
fi stulas type A ISGPF were observed. Pathological analises 
confi rmed papilla adenocarcinoma in four patients with neg-
ative margins, one patient had a 11 cm solid pseudo papillary 
pancreatic tumor. Mean lymphnodes recovered was 20.
Conclusion: The videolaparoscopic pancreatoduodenec-
tomy is feasible and safe. The results in selected cases are 
comparable to the conventional surgical treatment including 
oncologic goals. Further studies will demonstrate the benefi ts 
of the minimally invasive approach.
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RENAL CELL CARCINOMA 
METASTASES TO THE PANCREAS: 
A WORTHWHILE INDICATION 
FOR RESECTION
K. Westesson1, G. Falk2, G. Morris-Stiff2, S. Campbell1, 
M. Gong1 and M. Walsh2
1Glickman Urologic and Kidney Institute, Cleveland Clinic, 
Cleveland OH, USA; 2Department of Surgery, Section of 
Surgical Oncology/HPB, Cleveland Clinic, Cleveland OH, 
USA
Cleveland Clinic, Glickman Urologic and Kidney Institute, 
9500 Euclid Ave. Q1044195, Cleveland, USA
Introduction: Metastatic lesions are an uncommon but 
growing indication for pancreatic resection. Renal cell car-
cinoma (RCC) is the most common primary pathology, 
however the majority of the published literature reports small 
series and case reports. The aim is to review the institutional 
experience of the management and outcome of resectable 
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RCC metastases to the pancreas in a large tertiary referral 
centre.
Methods: The institutional RCC database was reviewed to 
identify all patients who developed pancreatic metastases 
and subsequently underwent resection of these lesions. Data 
was recorded in relation to patient demographics, the histo-
logical features of the primary lesion, and those of the pan-
creatic metastases. Outcome data were also recorded.
Results: 27 patients were identifi ed of which are 20 males, 
median age of 63 years (range: 34–81 years). One resection 
was synchronous and the rest were metachronous with a 
median interval between nephrectomy and pancreatic resec-
tion of 82.6 months (range: 1–278.4 months). 18 patients 
underwent distal pancreatectomy and 9 pancreatoduodenec-
tomy. All lesions were solitary with a median size of 2.2 cm 
(range: 1.6–5.5 cm). The median follow-up was 88.1 months 
(range: 14.2–238.0 months). 16 patients are alive with an 
overall survival of 89 months (range: 32–142 months). 4 are 
disease-free, 4 on active surveillance of known metastasis 
and one undergoing therapy. 11 patients died with a median 
interval 100.8 months (16–150 months) after pancreatic 
resection.
Conclusion: In this series, multiple patients were selected 
with favorable characteristics for which surgical resection 
could be performed. The overall survival of these patients 
suggests that metastasis to the pancreas often occurs in a 
delayed manner and resection provides a signifi cant chance 
of cure.
887
UNUSUAL INDICATIONS 
FOR AND UNCOMMON 
HISTOPATHOLOGIES FOLLOWING 
PANCREATODUODENECTOMIES
G. Shetty, A. S. Rajegowda, D. Kulkarni, P. Varty, 
H. Mehta and P. Wagle
Department of Surgical Gastroenterology, Lilavati Hospital 
& Research Centre, Mumbai, India
Lilavati Hospital & Research Centre, Surgical 
Gastroenterology, A-791, Bandra Reclamation, Bandra 
West, Mumbai 400050, Maharashtra, India
Introduction: Following decades of innovations and 
improvisations, pancreatoduodenectomy has now been 
standardized. Previously published studies have set stand-
ards for this complex surgery performed for periampullary 
cancers including pancreatic cancers and chronic pancreati-
tis. There is widely available data setting standards for high 
volume centres, techniques for resection and pancreatic anas-
tomosis and subsequently the complication rates and even 
the mortality rates following pancreatoduodenectomies.
Methods: We accumulated data of all unusual indications 
along with rare pathologies following 330 pancreatoduo-
denectomies done from 1996 to 2011. The authors provided 
prospectively collected data. We included data of all pancrea-
toduodenectomies that were done as part of another surgery 
or as a part of a multivisceral resection wherein R0 resections 
were achieved. We also included pancreatoduodenectomies 
done for secondary disease in the pancreas. We expanded this 
study to also include all uncommon histopathologies reported 
from pancreatoduodenectomies. We evaluated a total of 24 
pancreatoduodenectomies done over a 15 year period. We 
excluded standard indications like carcinoma of the pancreas 
and chronic pancreatitis.
Results: The indications included carcinoma of the stomach 
or colon, colorectal or renal cell carcinoma metastases, a 
large bleeding duodenal ulcer and a nodal recurrence. The 
uncommon pathologies revealed following pancreatoduo-
denectomies included ampullary carcinoid, ectopic pancre-
atic tissue in the ampulla, duodenal GIST, autoimmune 
pancreatitis type 1, cystic dystrophy of heterotopic pancreas, 
clear cell carcinoma of the lower bile duct, villous adenoma 
of the pancreatic duct, and infl ammatory pseudotumor of 
ampulla. The clinical presentation varied from obstructive 
jaundice, pancreatitis, pain, vomiting, hematemesis and inci-
dental fi ndings. The morbidity rate was 41.6% and there was 
one mortality (4.16%) postoperatively in this study group.
Conclusion: The overall survival of these patients depended 
on whether the primary disease was benign or malignant in 
nature. Our results indicate that pancreatoduodenectomies 
done in a high volume centre are relatively safe showing 
permissible rates of morbidity and mortality even in cases 
well beyond the usual indications.
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PANCREATIC FISTULA AFTER DISTAL 
PANCREATECTOMY FOR THE 
PANCREAS DISEASE
N. Kurauchi1, M. Tahara1, I. Tsuda2, M. Kato1, S. Emoto1, 
S. Suzuki1, S. Toyama1 and J. Kimura1
1Hakodate Municipal Hospital; 2Megumino Hospital
Institute of Surgery, Department of Gastroenterology, 
1-10-1, Minato-Cho, 40, Hakodate, Japan
Introduction: There is instrumental or hand-sewn suture 
closure for stump processing at the pancreas parenchyma 
cutting in distal pancreatectomy, but even a recent report is 
frequent around 30% without the superiority and inferiority 
(Lancet 377:1514–22, 2011).
[Purpose] The purpose is to evaluate a tendency of our 
postoperative pancreatic fi stula (POPF), the safety of the 
early drain removal, and the effectiveness the patch method 
that the round ligament of the liver sewed on the pancreas 
stump.
Methods: For 13 distal pancreatectomies for pancreas dis-
eases from January, 2007 to November, 2011, To estimate I: 
ISGPF classifi cation for 13 cases after 3rd, 7th, and 10th days 
after operation, II: the results of the cases of early drain 
removal within seven days after the operation from the waste 
fl uid property just before the removal, III: the outcome of the 
fi ve cases of the patch method.
Results: No pancreatic fi stula occurred in seven cases, 
Grade A in two cases, and Grade B in 4 (30%; two cases that 
needed drain exchange, two cases of formation of pseudo-
cyst). B: There were eight early drain removals. It developed 
in a stump pseudocyst in two of three of Grade A. In these 
two pseudocyst formation cases; cyst became small in the 
case where drain amylase was 1621 IU/L on the fi fth day, 
but the cyst became large in the case where drain amylase 
was 8694 IU/L on the seventh day and needed percutaneous 
drainage.
We tried the patch method that the round ligament of 
the liver sewed to pancreas stump in fi ve cases. Grade B of 
the transient cyst formation was in one case, and fi nally 
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pancreatic fi stula incidence was 20% (37.5% in the cases 
without path method).
Conclusion: The ISGPF classifi cation on the third day 
would be useful, but a lot of Grade changes after third day 
indicated that the early drain removal should have carefully 
considered in the case of the high amylase output. The patch 
method of the round ligament of the liver sewed to the stump 
of the pancreas was worth doing a further examination.
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EXTENDED 
PANCREATODUODENECTOMY WITH 
RECONSTRUCTION MIZUMOTO 
JAPANESE TYPE IN MEXICO, 
CLINICOPATHOLOGICAL 
CORRELATION. 20 YEARS EXPERIENCE
V. Carrillo-Maciel, O. M. Solorzano-Pineda, 
J. A. Leal-Martinez, S. R. Linaje, R. Rangel-Rodarte, 
J. Garza-Sanchez, R. Castillo-Soriano and E. Meza-Mata
Social Security 71
Social Security 71, Department of Surgery, Calle Lobo No. 
224, Fracc. Los Viñedos, 27016, Torreon, Coahuila
Introduction: Pancreatic cancer is the fi fth most common 
in the West, with an incidence of 9 per 100 000 inhabitants. 
20% of patients survive 1 year after diagnosis and survival 
at 5 years is only 3%. The procedure is the cephalic pancrea-
ticoduodenectomy, described by Whipple in 1935, of which 
there have been a number of modifi cations. We perform the 
modifi cations made Mizumoto Mie University in Japan in 
1979.
Objective: Clinicopathological correlation, results and evo-
lution according to the stage.
Methods: A retrospective study of patients operated on in 
January 1991 to December 2011 with pancreatic cancer 
Mizumoto technique, evolution, complications and results as 
well as survival with Kaplan-Meier.
Results: All patients underwent pancreaticoduodenectomy 
with extended double omega reconstruction Braun, two had 
biliary fi stula, two deaths, one myocardial infarction and 
other acute respiratory failure secondary to chronic obstruc-
tive pulmonary disease, pancreatic fi stula none present. A 
patient with ac ampulla of Vater has 13 years of survival 
without chemotherapy or radiotherapy.
Conclusion: The extended pancreaticoduodenectomy with 
reconstruction in double omega Braun is a safe surgery with 
regard to pancreatic and biliary fi stula successfully by sur-
geons experienced in liver surgery pancreas and biliary tract.
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ANALYSIS OF INSTRUMENT 
TRAFFIC DURING LAPAROSCOPIC 
ROBOT-ASSISTED 
PANCREATICODUODENECTOMY
E. F. Kauffmann1, N. Napoli1, S. Signori2, N. De Lio2, 
V. G. Perrone2, F. Costa1, A. Gennai1 and U. Boggi2
1First Division of General Surgery, University of Pisa, 
Pisa; 2Division of General and Transplant Surgery, 
University of Pisa, Pisa
First Division of General Surgery, University of Pisa, Pisa, 
Via Paradisa, 256124, Pisa, Italy
Introduction: Robotic surgery entails specifi c issues that 
are not present, or are not equally relevant, in open surgery 
or conventional laparoscopy. Instrument traffi c (IT) is one of 
such issues. IT is the time during which surgery is paused 
because the surgeon at the console is waiting for the action 
of the surgeon the table (e.g. instrument change, camera 
cleaning, introduction/withdrawal of needles). We herein 
provide the fi rst objective evaluation of IT during robotic 
pancreaticoduodenectomy (PD).
Methods: The operative videos of 12 robot-assisted PD 
were reviewed to defi ne IT. The analysis included: crude IT 
time (CITT), relative IT time (RITT) (defi ned as the percent-
age of operative time spent for IT), number of robotic instru-
ments changes (RIC), time spent for RIC (TRIC), number of 
pure laparoscopic actions (PLA), and time spent for PLA 
(TPLA). Figures were estimated for the entire operation as 
well as for dissection and reconstruction phases. Details on 
pancreaticojejunostomy (PJ) or hepaticojejunostomy (HJ) 
were related to IT to defi ne their relative impact on operative 
time.
Results: Mean operative time was 517 min (range 420–
600). Mean CITT was 3681.6 sec (RITT 11.89%). Mean RIC 
or PLA was 315.7. Each RIC or PLA paused surgery for 
11.8 sec. Mean RIC was 184.4 (TRIC 2633.8 sec). Mean 
PLA was 131.4 (TPLA 1039.5 sec). Mean dissection time 
was 326.9 min. Mean CITT was 2095.1 sec (RITT 10.68%). 
Mean RIC was 105.8 (TRIC 1645.2 sec). Mean PLA was 
35.7 (TPLA 382.5 sec). Each RIC or PLA paused surgery for 
14.4 sec. PJ was made by invaginating technique or duct-to-
mucosa. The last one required fewer stitches, but did not 
reduced CITT or RIC. HJ was performed using either 4 half 
running sutures or interrupted external stitches plus inner 
half running sutures. Despite similar CITT the former tech-
nique was associated with fewer RIC.
Conclusion: Some 12% of operative time of laparoscopic 
robot-assisted PD is wasted because of IT. Since in this series 
operative time of robotic PD averaged 517 minutes, IT pro-
longed surgery of more than one 1 hour. Technology improve-
ments and/or refi nements in surgical technique are expected 
to reduce IT during robotic PD.
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GROOVE PANCREATITIS: A CASE 
REPORT AND REVIEW OF LITERATURE
M. Serradilla1, E. Daban1, A. Palomares2, B. Sanchez1, 
L. Vazquez1, F. Ramos3 and M. Medina2
1Division of Hepato-Pancreatic-Biliary Surgery, 
Department of Surgery, Complejo Hospitalario de Jaen; 
2Department of Surgery, Complejo Hospitalario de Jaen; 
3Department of Pathology, Complejo Hospitalario de Jaen
Complejo Hospitalario de Jaen, Division of Hepato-
Pancreatic-Biliary Surgery, Department of Surgery, Avda. 
del Ejercito Español, 1023007, Jaen, Spain
Introduction: Groove pancreatitis is a rare type of segmen-
tal pancreatitis characterized by fi brous scars of the anatomic 
space between the dorsocranial part of the head of the pan-
creas, the duodenum and the common bile duct. Most patients 
with groove pancreatitis are males aged 40–50 years with a 
history of alcohol abuse and smokers. In about 20% of 
patients undergoing pancreaticoduodenectomy to treat 
chronic pancreatitis, groove pancreatitis is detected.
Methods: A 55-years-old man, with a personal history of 
chronic alcohol consumption and type 2 diabetes mellitus 
presented with epigastric pain radiating to the back, oral 
intolerance and vomiting and a weight loss of 12 kg. An 
abdominal CT showed swelling of the pancreatic head, a 
hypodense mass and duodenal wall thickening with luminal 
narrowing. Upper gastrointestinal endoscopy revealed an 
edematous and reddish raised mucosa with narrowing of the 
second portion of the duodenum. Histological examination 
of the duodenal biopsy specimens showed preservation of 
the crypt-villus ratio and the submucosa showed Brunner 
gland hyperplasia. All these fi ndings appeared consistent 
with the diagnosis of groove pancreatitis.
Results: A pancreatoduodenectomy was performed in June 
2011. The fi fteenth postoperative day the patient required 
ICU admission for hypertensive crisis and acute respiratory 
failure by aspiration. One month after surgery the patient 
presented a decrease in hematocrit, abdominal pain and dis-
tension. CT showed a necrosis of the pancreatic stump and 
a large hematoma in the pancreatic handle. A distal pancrea-
tectomy was performed. The patient was discharged two 
weeks after relaparotomy with no more complications.
Conclusion: Groove pancreatitis often masquerades as pan-
creatic head carcinoma. This condition should be kept in 
mind when making the differential diagnosis between pan-
creatic masses and duodenal stenosis. In all cases of focal 
pancreatitis involving the head or uncinate process of the 
pancreas with involvement of the adjacent duodenum, the 
possibility of groove pancreatitis should be considered.
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INVASIVE IPMN: SAME PROGNOSIS AS 
PANCREATIC ADENOCARCINOMA?
M. Charvin1, V. De Franco1, E. Frampas2, C. Brient1, 
M. F. Heymann3 and N. Regenet1
1IMAD Clinique de Chirurgie Digestive et Endocrinienne 
Hotel Dieu CHU Nantes; 2Radiologie centrale Hotel Dieu 
CHU Nantes; 3Anatomopathologie Hotel Dieu CHU 
Nantes
CHU Nantes, CCDE1 place Alexis Ricordeau, 44000, 
Nantes, France
Introduction: The aim of this study is to compare the prog-
nosis of patients with invasive Intraductal Papillary Mucinous 
Neoplasm of the pancreas (IPMN) to that of patients with 
pancreatic adenocarcinoma after pancreactectomy.
Methods: This is a retrospective study. In this study, 117 
patients with pancreatic adenocarcinomas and 28 patients 
with invasive IPMN (20 intestinal type, 3 colloid type, 3 
oncocytic type and 2 undefi ned type) were made of a pan-
createctomy with curative intent between 1991 and 2009 at 
the Nantes University Hospital.
Results: There was no signifi cant difference in terms of 
preoperative items (age, BMI, ASA score, CA 19.9 level), in 
terms of operative items.(during of surgery, portal vein resec-
tion, blood transfusion), anatomopathologic characteristics 
(tumoral stage, perineural invasion, lymph node invasion) 
and postoperative items (during of hospitalization, parenteral 
nutrition, pancreatic fi stula). There was no signifi cant differ-
ence in terms of three and fi ve year’s survival (p = 0.85) 
between pancreatic adenocarcinoma and invasive IPMN. 
There was no signifi cant difference in terms of three and fi ve 
year’s survival (p = 0.29) between IPMN subtypes.
Conclusion: With advances in medical imaging, IPMN is 
an entity increasingly diagnosed. The poor prognosis of this 
lesion from stage I, similar to the prognosis of pancreatic 
adenocarcinoma, leads to surgical treatment of these lesions 
at a very early stage.
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NINETY PERCENT DISTAL 
PANCREATECTOMY
N. De Lio1, M. A. Belluomini2, S. Signori1, F. Costa2, 
D. Tartaglia2, A. Gennai2, F. Mosca2 and U. Boggi1
1Division of General and Transplant Surgery, University of 
Pisa, Pisa, Italy; 2First Division of General Surgery, 
University of Pisa, Pisa, Italy
Division of General and Transplant Surgery, University of 
Pisa, Pisa, Italy
Introduction: Brittle diabetes typically plagues the quality 
of life of patients after total pancreatectomy. Sparing even a 
small amount of endocrine tissue avoids extreme glycemic 
fl uctuations, by maintaining a source of servo-regulated 
endogenous production of all pancreatic hormones (insulin, 
glucagon, somatostatiin and pancreatic polypeptide). We 
herein report on the outcome of a selected group of patients 
undergoing ninety percent distal pancreatectomy (90%DP).
Methods: From April 2000 to July 2011, 90%DP was per-
formed in 25 patients: 7 males (28%) and 18 females, 
with a mean age of 68 yrs (range 40–79). Twenty-two 
patients underwent conventional open resection while 3 had 
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a laparoscopic operation (robot-assisted in 2 of them). 
Splenectomy was associated in 23 patients (92%), while 2 
had a multivisceral resection. Segmental resection of peri-
pancreatic vessels was associated in 4 patients (1 celiac 
trunk-hepatic artery, and 3 superior mesenteric/portal vein).
Results: Sixteen patients were diagnosed with ductal adeno-
carcinoma (64%), 3 with well-differentiated endocrine tumor 
(12%), 3 with a serous cystadenoma, 1 with a mucinous 
cystoadenocarcinoma (4%), 1 with carcinoma on IPMN, and 
1 patient with chronic pancreatitis. Mean operative-time was 
330 minutes (range 180–535 minutes). There was no post-
operative mortality with a morbidity of 40%. Pancreatic 
fi stula was recorded in 8 patients (32%) and was always 
managed conservatively. Thirteen patients developed insulin 
dependent diabetes mellitus (52%) and 15 developed exocrine 
insuffi ciency (60%) requiring enzyme supplementation.
Conclusion: 90%DP may be considered in patients with 
centrally located pancreatic lesions to avoid the complica-
tions due to pancreatic exocrine and endocrine insuffi ciency. 
In selected patients 90%DP may be performed laparoscopi-
cally, especially if robotic assistance is available. Careful 
patient selection and sound experience in pancreatic surgery 
are crucial to achieve the best results.
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LAPAROSCOPIC DISTAL 
PANCREATOMY FOR LARGE CYSTIC 
NEOPLASMS: DOES SIZE MATTER?
G. Jain, B. Murgatroyd and A. G. Patel
Institute of Minimal Access Surgery, King’s College 
Hospital, London, UK
Institute of Minimal Access Surgery, King’s College 
Hospital, London, UK; Department of Minimal Invasive 
and HPB Surgery, King’s College Hospital, Denmark Hill, 
SE59R, London, UK
Introduction: Laparoscopic distal pancreatectomy is an 
established alternate approach to open surgery. However, 
tumour size, location and underlying pathology are important 
determinants in the feasibility of a laparoscopic approach. To 
date, a laparoscopic technique has commonly been reserved 
for small benign tumours, less than 5 cm.
Methods: A retrospective analysis was performed to assess 
the feasibility and safety of laparoscopic distal pancreatec-
tomy for tumours more than 10 cm in size. Between 2009 
and 2011 four patients with large cystic neoplasms under-
went a laparoscopic distal pancreatectomy. Splenic preserva-
tion was performed in two of the four patients, one using a 
Warshaw technique, the other with splenic vessel preserva-
tion. The surgical technique involved transaction of the pan-
creas followed by a medial to lateral dissection. The 
specimens were removed using a retrieval bag through a 
pfannensteil incision.
Results: Four female patients presented with abdominal 
pain or swelling and were found to have large cystic tumours 
in the pancreas. Median age was 38.5 years. Median 
tumour size was 11.5 cm (range 10–12.5 cm). All patients 
underwent successful laparoscopic removal of the cystic 
neoplasm. There were no intra-operative complications. 
One patient developed a small pancreatic leak, which settled 
conservatively. Histology of all tumours was mucinous 
cystadenoma.
Conclusion: Laparoscopic distal pancreatectomy is safe and 
feasible for large cystic tumour; size does not matter.
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ABDOMINAL DRAINAGE IS 
NOT NECESSARY AFTER 
PANCREATICODUODENECTOMY IN 
PATIENTS WITH LOW RISK 
OF PANCREATIC FISTULA: 
A CASE-CONTROL ANALYSIS
S. Dokmak, C. Lim, B. Aussilhou, J. Belghiti and 
A. Sauvanet
Department of Hepato-Biliary and Pancreatic Surgery and 
Liver Transplantation, Hôpital Beaujon, AP-HP, Clichy, 
France
Hôpital Beaujon, Department of Hepato-Biliary Surgery, 
Hôpital Beaujon, Assistance Publique Hôpitaux de Paris 
(AP-HP), Université Paris 7, 100 Boulevard du Général 
Leclerc, 92118, Clichy, France
Introduction: Routine abdominal drainage is a standard 
procedure after pancreaticoduodenectomy (PD), but this 
policy has been challenged recently. The aim of this study 
was to test the hyposthesis whether abdominal drainage (AD) 
is necessary after PD in patients with low risk (with hard 
pancreatic texture and a diameter of wirsung >3 mm) of 
pancreatic fi stula (PF).
Methods: From 2009 to 2011, 27 consecutive patients 
underwent PD without AD. They were compared with 27 
patients who had PD with prophylactic drainage and were 
matched one-to-one in terms of demographic data (gender, 
BMI, ASA grade), preoperative weight loss >10% within 6 
months, preoperative biliary drainage, underlying diseases 
[adenocarcinoma, n = 17 vs 18; malignant intraductal papil-
lary and mucinous neoplasm (IPMN), n = 2 vs 1; benign 
IPMN, n = 3 vs 3; endocrine tumor, n = 3 vs 3 and chronic 
pancreatitis, n = 1 vs 1], and main predictive risk factors of 
PF (pancreatic texture, main duct size). Postoperative mor-
bidity and mortality in the 2 groups were compared.
Results: Overall morbidity (no drain = 56% vs 70%; p < 
0.4), intensive care unit stay (3 days vs 4; p < 0.57), and 
operative mortality (1 vs 1) rates were similar in both groups. 
There was no difference in terms of delayed gastric emptying 
(no drain = 15% vs 11%; p = 1), and chylous ascitis (4% vs 
15%; p = 0.35). Hospital stay (12 d. vs 20; p = 0.0043) and 
PF rate (no drain = 0% vs 6%, p = 0.0229) were signifi cantly 
reduced in the non-drainage group than in the drainage 
group. Radiological or surgical interventions for surgical 
complications were required in 2 patients in the non-drainage 
group and 2 patients in the drainage group. Readmission rate 
was similar in both groups (no drain = 7% vs 3.7%; p = 1).
Conclusion: These results suggest that abdominal drainage 
should not be considered routinely after PD in highly-
selected patients (hard pancreatic texture and dilated pancre-
atic main duct). A no-drain policy reduced hospital stay 
after PD.
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SINGLE INCISION LAPAROSCOPIC 
DISTAL PANCREATECTOMY FOR 
TUMORS IN THE BODY AND TAIL OF 
THE PANCREAS. PRESENTATION OF A 
SINGLE CENTER EXPERIENCE WITH 
VIDEO DEMONSTRATION
B. Røsok1, A. Fretland1, A. Waage1, A. Rosseland1 and 
B. Edwin2
1Department og gastrointestinal and HPB Surgery, Oslo 
University Hospital, Oslo, Norway; 2The Interventional 
Center, Oslo University Hospital, Oslo, Norway
Oslo University Hospital, Gastrointestinal and HPB 
Surgery, Sognsvannsveien 2027, Oslo, Norway
Introduction: Laparoscopic surgery through a single inci-
sion has been shown be safe and feasible compared to con-
ventional laparoscopy for a variety of surgical procedures but 
there are few reports on pancreas resections using this tech-
nique. In our institution, the laparoscopic approach has been 
the preferred method for distal resections of the pancreas for 
more than a decade and the single port access was introduced 
in selected patients in 2010.
Methods: Between June 2010 and September 2011 4 
females and 2 males with tumors in the body and tail of the 
pancreas were included in the study. Median tumor diameter 
was 20 mm. An OlympusQuad-port was used in all cases and 
conventional laparoscopic principles were followed.
Results: Two patients were operated by distal resections and 
concommittant splenectomy while 4 patients had spleen pre-
serving procedures. Median operative time was 162 minutes 
and blood loss was 200 ml and. Histology revealed 3 neu-
roendocrine tumors, 2 fi brotic lesions and 1 serous cystade-
noma. One patient had drain fl uid containing elevated 
amylase content for more than 5 days and was classifi ed with 
a grade B fi stula. One patient had a superfi cial wound infec-
tion and one patient complained of transient odynophagia. 
No other complications were noted and the median hospital 
stay was 5 days.
Conclusion: Single port laparoscopic resections for lesions 
in the body and tail of the pancreas is safe and feasible in 
selected cases. Potential advantages to conventional laparos-
copy is unclear and merits further investigations. A video 
showing technical conciderations and potential pitfalls will 
be presented.
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MANAGEMENT OF COMPLICATIONS OF 
PANCREATODUODENECTOMY
E. A. M. de Oliveira1, F. Mrue1, F. Amorim1, M. Alves2, 
R. Anne1, M. A. Barbosa2 and M. V. Chalar2
1Federal University of Goias, Clinic’s Hospital, Goiânia, 
Brazil; 2Santa Genoveva’s Hospital, Goiânia, Brazil
Federal University of Goias, Surgery, 1a Avenida Q, 68 
– S Lest Universitário, 7460, Goiânia, Brazil
Introduction: Pancreatoduodenectomy is the most impor-
tant therapeutic approach for cure en pancreatic and periam-
pullar cancer. It is a major surgical procedure which carry 
out high morbidity. Recently, mortality rate is lower than 5% 
in reference centers. Therefore, post-operative complications 
is a challenge for surgical team.
Methods: The aim of this work is to report a case of a 
56-year-old man presented with clinic and image fi ndings 
suggestive of periampullar cancer that was underwent pan-
creatoduodenectomy without intra-operative complications, 
but with post-operative severe complications. The main goal 
of this work is to describe the management of complications 
related to this procedure.
Results: The patient fi rst presented with cholangitis and was 
treated by percutaneous biliary drenage and antibiotics. After 
infection control he underwent pancreatoduodenectomy with 
extended lymphadenectomy. At the fi rst post-operative week 
he developed pancreatitis and pancreatic fi stula with clinical 
management. At the end of the fi rst week he presented with 
severe haemathemesis with active bleeding at the stappler 
suture line at endoscopy, treated by surgery with suture rein-
forcement. At the second week new severe bleeding, now 
managed by arteriography which showed an active bleeding 
at the left gastric artery branch which was embolizated with 
success. Next, billiar fi stula was treated by serial laparotomy. 
He recovery well and was discharged.
Conclusion: The post-operative complications of a pancrea-
toduodenectomy must be expected for a early and adequate 
management, and the institution must have all conditions 
needed to treat and improve the results.
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STUDY OF THE METABOLIC 
RESPONSE WITH PET IN RESECTED 
ADENOCARCINOMA OF PANCREAS 
AFTER NEOADJUVANT TREATMENT; 
GEMCITABINE AND 
ABRAXANE REGIMEN
H. Duran1, B. Ielpo1, E. Diaz1, I. Fabra, R. Puga, 
J. C. Plaza, Y. Quijano and E. Vicente
1General and Digestive Surgery Service
Madrid Norte Sanchinarro Hospital, ‘Clara Campal’ 
Oncological Center, San Pablo University, CEU, General 
Surgery Service, C/Oña nº1028050, Madrid, Spain
Introduction: Positron emission tomography (PET) is used 
to measure the tumoral response to neo adjuvant treatment. 
Overall pancreas cancer (PC) survival is very poor. These 
poor results of neo adjuvant treatment could be due to the 
tissue area around PC that reduces adsorption of the anti 
tumoral drug.
We aimed to fi nd the effect of neo adjuvant treatment of 
Gemcitabine combined with Abraxane on the SUV on 
patients affected by resectable PC, measuring it after and 
before chemotherapy administracion. It is expected that a 
decrease in SUV values correlates with an improved TRR.
Methods: We enrolled 15 patients prospectively form 
March 2011 to December 2022. Untill now 7 patients under-
went surgery, one patient had systematical progression of 
malignancy after treatment and 7 patients are waiting for 
surgery.
Results: The anatomo pathological results of the 7 specimen 
were: 1 well differentiate neuroendocrine tumor; 5 adenocar-
cinoma; 1 pan IN-2?
Case 1: SUV decreased of 55%; Case 2: SUV decreased of 
100%; Case 3: SUV unchanged (biliar stent needed); Case 
4: SUV decreased of 75%; Case 5: SUV decreased of 37% 
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(biliar stent needed). For among fi ve patients shows the best 
high effi cacy of tumoral regression rate (TRR 1 of Ryan 
escale).
Conclusion: PET shows to be useful on measure the 
decrease metabolic activity of pancreas adenocarcinoma 
after Gemcitabine and Abraxane treatment. The best TRR 
confi rm this data. The two lower SUV decrease can be due 
to the biliar stent setting during treatment.
940
EXTRAPANCREATIC VIPOMA 
(WDHA-SYNDROME). CASE REPORT
F. R. A. Torrez, R. I. Beron, M. Trivino, E. J. Lobo, 
A. Goldenberg and T. Trivino
Department of Hepatobiliary and Pancreas Surgery, 
Federal University of Sao Paulo, Napoleao de Barros 
Street, #715, Vila Clementino, PO BOX 04024-0024024, 
Sao Paulo, Brazil
Introduction: Pancreatic neuroendocrine tumors are rare 
neoplasms accounting for aproximately 2% of all pancreas 
tumors. Moreover, due to recent advances in imaging 
methods and radioimmune analysis, the diagnose of such 
tumors has become more frequent. Among functional tumors 
the VIPoma also known as Werner Morrison syndrome, it´s 
even a more infrequent tumor, mainly characterized by pro-
found diarrhea and consequently hydroelectrolyte distur-
bances. We report a case of extrapanextrapancreatic VIPoma.
Methods: We present a case of a 54 year-old male, with a 
four-month past history of watery diarrhea, every 3 hours for 
the last 15 days. He was fasting and lose 14 kg over this 
period. Lethargy, adynamia, anorexia, muscle weakness and 
cramps were also present. Physical examination showed a 
thin patient with no other remarks. Laboratory exams 
revealed a high VIP: 242 pg/ml (<75). Abdominal ultrassound 
showed a 4.2 cm hypoechogenic in segment IV, later con-
fi rmed by abdominal CT that showed multiple hypervascular 
images in segments IV, III and II. Image guided biopsy of 
one of the nodules revealed a neuroendocrine carcinoma 
metastasis by immunehistochemistry.
Results: The patient was then submitted to surgical explora-
tion where intraoperative US revealed a nodule in the 
pancreas body. Distal pancreatectomy and left threesegmen-
tectomy was performed. The pancreas parenchyma was 
spared but the peripancreatic nodule confi rmed the neuroen-
docrine neoplasm. The patient had an uneventful recovery 
and presented no more diarrhea and electrolyte 
disturbances.
After 12 months the patients symptoms recurred. 
Abdominal CT scan showed diffuse nodular images in the 
remaining liver. The patient was submitted to somatostatin 
analogues and target therapy (Everolimus). He showed sat-
isfactory imaging and clinical response to the treatment and 
is now under oncologic surveillance.
Conclusion: Neuroendocrine tumors that produce vasoac-
tive intestinal peptide, have good response to multidiscipli-
nar approach and deserve aggressive investment such as 
debulking surgery procedures even in advanced disease 
cases.
943
NEW GENERATION MICROWAVE IN 
THE TREATMENT OF AN UNUSUAL 
CASE OF MALIGNANT AND LOCALLY 
ADVANCED RARE TUMOR OF 
PANCREAS IN ASA IV PATIENT
F. D’Amico, A. Vitale, A. Bertacco, D. Bassi and 
G. Zanus, U. Cillo
HPB Surgery and Liver Transplantation Unit, Padova 
University
Chirurgia Epatobiliare e Trapianti Epatici, Chirurgia 
Generale e Trapianti Addominali, Universita’ di Padovavia 
Giustiniani 235128, Padova, Italy
Introduction: The Intraductal papillary-mucinous tumor 
of pancreas, is a rare primary neoplasm of unknown 
pathogenesis.
This kind of tumor represents 0.2 to 2.7% of all pancreatic 
cancers and is considered a low grade malignant tumor (bor-
derline tumor) that in association with nuclear atipia can 
shown metastases (malignant tumor).
No increase of tumor markers (CEA, Ca 19-9) has been 
related with the malignancy of the tumor.
Methods: In this study the authors describe a case of intra-
ductal papillary-mucinous tumor of pancreas (4.3 cm in the 
head) with nuclear atipia, percutaneous FNA-citology 
proven, associate with a GIST of the gastric wall detected in 
OR at the extemporaneous pathological report.
The authors perform also a systematic review of the litera-
ture on MEDLINE and they found only one relevant study 
that in a period between 2004–2006 used the old generation 
microwave ablation in 15 patients for the palliative treatment 
of the tumor in the pancreas.
Results: We describe the case of a 70 YO male that after a 
generalized jaundice (Oct. 2010), diagnosed a pancreas 
tumor with biliary tree dilatation.
The patient performed a CT-scan, a percutaneous FNAB 
and an endoscopic positioning of a protesis in the biliary tree 
to reduce the bilirubin level and resolve the biliary-tree 
dilatation.
In consideration of the ASA IV status we perform a micro-
wave in open surgery, in the head of pancreas combined with 
palliative bile and gastric bypass. No complications was seen 
in relation with surgical procedure. The hospitalization was 
of 11 days after surgery, with normal liver and pancreatic lab 
test at the dismission. The patient follow an adiuvant chemo-
therapy for 6 months with a complete response for 8 months.
Conclusion: New generation of microwave ablation, in our 
case report has demonstrated to be feasible and safe without 
complications. It can be used as a phase of a multimodality 
treatment, in the advance pancreatic cancer and in the ASA 
IV patients. (First case reported with new generation MW in 
this context) At the 1 year follow up visit, the patient is in 
very good general condition with an increase of tumor 
markers (Ca 19-9 since September 2011) without modifi ca-
tion of tumor size in the pancreas-head.
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THE PANCREATIC TRAUMA: 
EXPERIENCE OF THE DEPARTMENT OF 
UCV BETWEEN 2000–2010
B. Serji, M. E. Ounani, M. Amraoui, A. Rougani and 
R. Chkoff
University Mohamed V Department of the Emergency 
Surgery (UCV) Ibn Sina Hospital Rabat Morocco
Faculty of Medecine and Pharmacy of Rabatservice des 
UCV125, Amal 6, Hay El Montalak, CYM10150, Rabat, 
Morocco
Introduction: The traumas of pancreas are rare but can be 
fatal due to diffi culties in diagnosing and treatment.
Methods: It is a retrospective study of all patients hospital-
ized in the UCV for management of pancreatic trauma 
between 2000 and 2010. Were collected: clinical, paraclini-
cal, treatment and follow established data.
Results: Twenty three pancreatic traumas were supported 
during this period. The abdominal contusion is the most 
common mechanism. Diagnosis was based on CT in 80% of 
cases with an intraoperative diagnosis in 2 cases. Surgical 
treatment was recommended in 21 patients, 15 underwent 
conservative surgery. The overall morbidity rate was 17%. 
We deplore a death.
Conclusion: The management of pancreatic trauma is dif-
fi cult. Reference Exams are ERCP and the scanner to accu-
rately determine the status of the main pancreatic duct to 
defi ne an appropriate therapeutic approach.
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MALIGNANT FIBROUS HISTIOCYTOMA 
OF THE PANCREAS
A. E. Padilla-Rosciano, M. G. Serna-Thomé, G. C. Ruiz, 
I. V. Sarmiento and A. H. Gomez
Instituto Nacional de Cancerología México
Nogales num 42 jardines de San Mateo, 53240, Mexico, 
Mexico
Introduction: Sarcomas of the pancreas represent less than 
1% of all pancreatic tumors. Less of 50 cases of malignant 
fi brous histiocytoma primary of pancreas have been reported 
in the literature.
Methods: Female 27 years old with few days of evolution 
with abdominal pain and burning epigastric discomfort at 
physical examination with Karnofsky of 90% and pain in the 
epigastrium without palpable mass, jaundice ascitis or weight 
loss. The computed tomography showed a pancreatic tumor 
of 6 cms of diameter in the body of pancreas without involve-
ment or abutment of the celiac axis, superior mesenteric vein 
and artery, portal and splenic vein, the serum carbohydrate 
antigen 19-9 was normal. Endoscopic ultrasound guided fi ne 
needle biopsy reports mesenchymal tumor. Distal pancreate-
ctomy with splenectomy without lymphadenectomy was 
performed, no complications. Received adjuvant radiother-
apy is alive two years after surgery.
Results: The fi nal histopathological report vas a tumor of 
6.5 × 5.5 centimeters. Malignant fi brous histiocytoma giant 
cell type, the pancreatic limit was negative with 7 mm of 
margin, the spleen was normal.
Conclusion: Primary mesenchymal tumors of the pancreas 
are rare, however mesenchymal tumors from neighboring 
sites may secondarily involve the pancreas in particular ret-
roperitoneal sarcomas and gastrointestinal stromal tumors. 
The primary sarcomas reported are schwannoma, leiomyosa-
rcoma and malignant fi brous histiocytoma. The treatment is 
surgery with pancreatoduodenectomy or distal pancreatec-
tomy to achieve complete resection. Adjuvant radiotherapy 
increase local control.
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CURATIVE RESECTION OF THE 
PANCREATIC CANCER WITH MAJOR 
VENOUS RESECTION/REPAIR IS A 
SAFE PROCEDURE
H. Shokouh-Amiri1, A. H. Jahromi1, E. Jafarimehr1, 
Q. Chu1, H. D’Agostino2, G. Wellman3, R. Shi4 and 
G. B. Zibari1
1Department of Surgery, Louisiana State University Health 
Sciences Center-Shreveport, LA, United States; 
2Department of Radiology, Louisiana State University 
Health Sciences Center-Shreveport, LA, United States; 
3Department of Pathology, Willis Knighton Medical 
Center-Shreveport, LA, United States; 4Department of 
Medicine and Feist-Weiller Cancer Center, Louisiana State 
University Health Sciences Center-Shreveport, LA, United 
States
Louisiana State University Health Sciences Center-
Shreveport, Department of Surgery, Louisiana State 
University Health Sciences Center-Shreveport, 1501 Kings 
Highway, Shreveport, LA, United States 71130
Introduction: Pancreatic cancer is the fourth leading cause 
of cancer death in the United States, with a 5-year overall 
survival (5-Yr-OS) of only 9–18%. Patients who have locally 
advanced disease may benefi t from a more radical surgery if 
an R-0 resection can be achieved. We assessed the safety of 
combined curative resection (CR) of pancreas and major 
venous repair in the management of locally advanced pan-
creatic malignancy.
Methods: This is a retrospective IRB approved cohort study 
of patients who had pancreatic surgery (N = 207) between 
1998 and 2011. Malignant causes were present in 132 
patients, of which 117 underwent CR. Sixteen patients with 
major vascular involvement (portal vein/superior mesenteric 
vein) who required vascular resection/repair (G-1) during the 
CR were compared with 101 patients without vascular 
involvement (G-2). Demographics, operative and follow-up 
data were reviewed. Short and long-term morbidity and mor-
tality were compared between the groups.
Results: Seventy seven percent of patients had adenocarci-
noma and 11.1% had neuroendocrine tumors. The operations 
were: Whipple (N = 50), pylorus sparing Whipple (N = 34), 
distal pancreatectomy (N = 18), total pancreatectomy (N = 
8), and other (N = 7). Among resectable cases, 71.8% had 
R-0 resection and 52.1% had lymph node involvement. The 
5-Yr-OS for N0 and N (+) was 38.3% and 24.3% (p < 0.05) 
respectively, and for R0 and R1 was 37.9% and 19.5% (p < 
0.05) respectively. In G-1, venous involvement was excised 
and either primarily repaired/re-anastomosed (N = 11), or 
repaired using other veins (N = 5) or synthetic patch (N = 
1). The median-overall-survival was not signifi cantly differ-
ent between the two groups (p = 0.11).
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Conclusion: In patients with a locally advanced pancreatic 
malignancy, with major venous involvement, but without 
tumor thrombi, a pancreatic curative resection should be 
considered. In our experience the most important factors in 
predicting long term survival were age of the patient, stage 
and grade of the disease, and lymph-node and margin status.
952
CHARACTERIZING THE EXTENSIVE 
USE OF INTERVENTIONAL RADIOLOGY 
PROCEDURES IN PATIENTS 
READMITTED AFTER 
PANCREATICODUODENECTOMY
B. Goslin1 and M. Chung2
1Grand Rapids Medical Education Partners, General 
Surgery Residency; 2Spectrum Health, Surgical Oncology
Grand Rapids Medical Education Partners, Surgery, 100 
Michigan NE, 49503, Grand Rapids, USA
Introduction: The pancreaticoduodenectomy (Whipple 
procedure) is historically known as a procedure with a 
high morbidity and mortality. Interventional radiology has 
a growing role after complex surgical procedures that 
help limit morbidity associated with anastomotic leak, 
abscess formation, or biliary procedures. We sought to deter-
mine the role that interventional radiology has played in 
patients readmitted with perioperative complications after 
pancreaticoduodenectomy.
Methods: This was a retrospective cohort study of patients 
who underwent traditional or extended pancreaticoduo-
denectomy at a single high-volume institution. Trained 
general surgeons or a surgical oncologist performed all pan-
creaticoduodenectomies. All procedures were performed 
between July 2005 and March 2010. Postoperative readmis-
sion data was collected for one year.
Results: The Whipple procedure was performed on 130 
patients over the study period. Fifty-seven patients were 
readmitted within the one-year follow-up period and 71.9% 
of patients underwent at least one interventional radiology 
procedure. A total of 159 procedures were performed on 
patients who were readmitted (range 1–15). The most fre-
quent procedures included abscess drain placement and repo-
sitioning, 45, and enteric tube placement/repositioning/
replacement, 32. Other common procedures included para-
centesis, chemotherapy port placements, and percutaneous 
transhepatic and biliary procedures.
Conclusion: Our study has demonstrated that recidivism 
remains high after pancreaticoduodenectomy. Patients are 
often readmitted with complications or disease progression 
requiring interventional radiology procedures. We advocate 
for patients to be readmitted to tertiary centers with trained 
interventional radiologists who routinely perform a multi-
tude of procedures.
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PANCREATICOPLEURAL FISTULA: 
AN UNUSUAL COMPLICATION 
OF PANCREATITIS
H. J. Jang, J. H. Kwak, K. J. Cheon, J. H. Ahn and 
D. U. Um
University of Ulsan, Gangneung Asan Hospital, Surgery, 
Gangneung Asan Hospital
415 Bandong-ri Sacheon-myeon, Gangneung-si, 
Gangwon-do 210-711, Korea
Introduction: Pancreaticopleural fi stula is a rare complica-
tion of pancreatitis. Pleural effusion resulting from a pan-
creaticopleural fi stula is extremely rare and accounts for less 
than 1% of cases. Due to non-specifi c clinical presentations 
of a pancreaticopleural fi stula, imaging plays an important 
role. Magnetic resonance cholangiopancreatography (MRCP) 
is very useful in depicting parenchymal and ductal structural 
changes along with direct visualization of a pancreaticopleu-
ral fi stula.
Methods: We present two cases of 39 and 45-year-old male 
with moderate left and rigrt pleural effusion who had a 
history of pancreatitis.
Results: Chest X-ray showed massive left and right sided 
pleural effusion, and a thoracocentesis revealed amylase 
content of 2935, 21710 U/L. MRCP showed chronic pan-
creatitis with a pancreaticopleural fi stula. The patients under-
went and exploratory laparatomy during which a direct 
pancreatic ductogram demonstrated the PPF tract. Fistula 
was outlined by the methylene blue injection into the main 
pancreatic duct. A drainage procedure (side to side pancrea-
tojejunostomy), to provide decompression of the pancreatic 
duct as well as fi stula tract excision were performed. 
Postoperative course was uneventful. The patients subse-
quently completely recovered.
Conclusion: Pancreaticopleural fi stula is an uncommon 
complication of chronic pancreatitis occurring as a result of 
disruption of the main pancreatic duct and tracking of pan-
creatic fl uid through the retroperitoneum into thoracic cavi-
ties. The optimal treatment strategy for pancreaticopleural 
fi stula is unknown; it has traditionally been medical manage-
ment followed by operative therapy for patients who fail to 
respond to conservative treatment. We report herein two 
patients underwent a drainage procedure.
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A CASE MATCHED COMPARATIVE 
STUDY OF LAPAROSCOPIC VERSUS 
OPEN CYSTGASTROSTOMY FOR 
PANCREATIC PSEUDOCYSTS
D. J. Malde, Y. Khaled, T. Fox, P. Laftsidis, D. O’Reilly, 
D. J. Sherlock and B. J. Ammori
The HPB Unit, North Manchester General Hospital, 
Manchester, UK
North Manchester General Hospital, The HPB Unit, 
Delaunays Road, Manchester, M8 5RB, UK
Introduction: Whilst large and persistent pancreatic pseu-
docysts are amenable to internal drainage by laparoscopic 
techniques, the benefi ts of this minimally invasive approach 
remain to be demonstrated. The aim of this study was to 
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compare the open and laparoscopic approaches for internal 
drainage of large and persistent pancreatic pseudocysts.
Methods: Patients who underwent cystgastrostomy were 
selected, and those who had the surgery performed laparo-
scopically were matched to those who had open surgery 
for age, sex and size of the pseudocyst. The two approaches 
were compared on an intention-to-treat basis. Between 1997 
and 2010, 42 patients (15 female and 27 male) underwent 
46 surgical internal drainage procedures for pancreatic 
pseudocysts. 36 procedures performed via the laparoscopic 
approach (2 open conversions) and 10 by open approach 
respectively.
Results: The laparoscopic and open groups were compara-
ble for age (52 vs. 59 years, p = 0.227), sex distribution, and 
size of pseudocyst (12 vs. 13.3 cm, p = 0.287). Although 
laparoscopic surgery was associated with signifi cantly longer 
operating time (95 vs. 60 minutes, p = 0.02), it carried a 
signifi cantly lower risk of post-operative morbidity (22% vs. 
63%, p = 0.01) and shorter postoperative hospital stay (2 vs. 
8.5 days, p < 0.0001). A more rapid resumption of dietary 
intake (median 4 vs. 6 days, p = 0.065) and shorter hospital 
stay (6 vs. 11 days, p = 0.001) was noted.
Conclusion: The laparoscopic approach to cystgastrostomy 
for large and persistent retrogastric pancreatic pseudocysts is 
associated with a smoother and more rapid recovery and a 
shorter hospital stay compared with open surgery.
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A REPLACED COMMON HEPATIC 
ARTERY ORIGINATING FROM THE SMA 
DURING PANCREATODUODENECTOMY
H. J. Jang, J. H. Kwak, K. J. Cheon, J. H. Ahn and 
D. U. Um
University of Ulsan, Gangneung Asan Hospital, Surgery, 
Gangneung Asan Hospital
415 Bandong-ri Sacheon-myeon, Gangneung-si, 
Gangwon-do 210-711, Korea
Introduction: A replaced common hepatic artery (RCHA) 
originating from the superior mesenteric artery (SNA) is a 
rare anomaly.
Methods: We herein report such a case in a 80-year-old man 
who was scheduled to undergo a pancreatoduodenectomy for 
pancreas head cancer.
Results: Computed tomography (CT) showed the RCHA to 
run along within the pancreas and the mass was invaded to 
the artery. Abdominal angiography showed an RCHA origi-
nating from the SMA, which communicated with from the 
left and right gastric artery. No gastroduodenal artery was 
observed. The RCHA was confi rmed to course along within, 
the pancreas. Clamping of the RCHA infl uence the arterial 
fl ow in the liver, the arterial fl ow was weak and the RCHA 
infl uence the arterial fl ow in the liver, the arterial fl ow was 
weak and the RCHA was subsequently divided with recon-
struction (left gastric artery and RCHA).
Conclusion: A combination of CT and angiographic fi nd-
ings can help in both the diagnosis of an anomalous RCHA 
coursing within the pancreas as well as in selecting optimal 
operative procedures. Pancreatoduodenectomy with arterial 
reconstruction was performed with a curative resection.
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USE OF BOVINE PERICARDIUM PATCH 
TO REPAIR THE PORTAL VEIN IN 
PANCREATICODUODENECTOMY 
PROCEDURE
A. E. Padilla-Rosciano, M. G. Serna-Thomé, 
A. G. Pedraza, A. Takahashi, G. C. Ruíz and 
A. H. Gómez
Instituto Nacional de Cancerología México Department of 
Surgical Oncology
Nogales num 42 jardines de San Mateo, 53240 Mexico
Introduction: Pancreaticoduodenectomy procedure is the 
standard surgery for cancer of pancreatic head. To achieve 
complete tumor resection, venous resection with reconstruc-
tion has become routine for advanced pancreatic cancer. If 
separation of the tumor from portal vein is not possible a 
venous tangential wedge resection or segmental resection is 
necessary, the options of reconstruction are patch of autolo-
gous vein or prosthetic patches, we report the use of bovine 
pericardium patch.
Methods: 47 years old man diagnosed with pancreatic head 
adenocarcinoma, the endoscopic ultrasound showed contact 
of the tumor with the portal vein, the splenic and superior 
mesenteric vein without involvement. In the laparotomy a 
tumor of the 4 × 3 cm attached to the pancreas head with 
invasion of the 2 × 1 cm on the outer side wall of the portal 
vein was found, we performed pylorus-preserving pancrea-
ticoduodenectomy and limited tangential wedge resection of 
the portal vein wall with placement of bovine pericardium 
patch to repair the portal vein. The intraoperative and post-
operative period arose without major complications. 
Histopathologic examination revealed cancer invasion of the 
vein and negative resection margins.
Results: In Mexico, the bovine pericardium treated with 
glutaraldehyde has been used to treat incisional, inguinal and 
diaphragmatic hernias and repair vascular defects with good 
results low cost and no allergic reaction. We report this case 
to show a successful result in the use of bovine pericardium 
to repair the portal vein defect after pancreaticoduodenec-
tomy for pancreatic cancer with vascular invasion. The use 
of bovine pericardium patch is indicated in small defects for 
limited tangential wedge resections and not for segmental 
resections o major defects.
Conclusion: The use of bovine pericardium patch is effec-
tive to repair limited vein defects after tangential wedge 
resection in the pancreaticoduodenectomy procedure when 
the primary lateral venorrhaphy is not possible with low cost, 
could be use in portal vein and superior mesenteric vein. 
Resection of the superior mesenteric or portal vein to achieve 
macro and microscopic tumor clearance can be performed 
safely with acceptable morbidity and mortality in pancreatic 
cancer surgery.
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POSTERIOR PANCREATOTOMY 
FOR PANCREATOLITHIASIS: 
A NOVEL APPROACH
G. Shetty, A. S. Rajegowda and H. Mehta
Department of Surgical Gastroenterology, Lilavati Hospital 
& Research Centre, Bandra, Mumbai, Maharashtra, India
Lilavati Hospital & Research Centre, Surgical 
Gastroenterology, A-791, Bandra Reclamation, Bandra 
West, Mumbai 400050, Maharashtra, India
Introduction: Pancreatolithiasis has presented itself to pan-
creatic surgeons in various forms and degrees. The sheer 
variety of surgeries performed, innovations made and modi-
fi cations carried out to treat them are a testimony to the 
above. We report 2 cases with a large solitary pancreatic duct 
stone in the head of the pancreas.
Methods: The patients had a similar history of multiple 
attacks of pancreatitis in the past. Investigations revealed a 
solitary large calculus in the head of an atrophic pancreas 
with massive upstream ductal dilatation. The sizes of the 
stones made them not amenable to endoscopic extraction 
warranting surgical intervention. On kocherisation the stone 
was palpated in the head very close to the posterior pancre-
atic capsule and extracted via a posterior pancreatotomy. In 
the fi rst case we closed the pancreatotomy primarily and 
performed an anterior drainage along the length of the pan-
creas. However, in the second we had enough mobility and 
access to perform a posterior pancreaticojejunostomy in the 
head of the pancreas for ductal drainage.
Results: Both patients tolerated the procedures well and the 
postoperative course was uneventful. There was no evidence 
of a pancreatic fi stula in the postoperative period. 
Investigations revealed that the anastomoses functioned well 
in both cases. Both patients had relief of symptoms and no 
attacks of pancreatitis thereon till the time of the last follow 
up. One patient however did require external enzyme sup-
plementation to control symptoms of steatorrhea initially.
Conclusion: We have not found any reference in literature 
for a posterior pancreatotomy for a pancreatic head stone 
extraction. We believe that this procedure can be easily done 
in well selected cases. The posterior approach if selected well 
can avoid excess manipulation of the pancreas and prevent 
unnecessary bleeding as the parenchyma in the head is 
transgressed to reach the main pancreatic duct as it dips 
posteriorly.
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AGGRESSIVE SURGICAL 
MANAGEMENT OF ACINAR CELL 
CARCINOMA OF THE PANCREAS
K. Tan, R. Finch, L. Nathanson and N. O’Rourke
Royal Brisbane & Women’s Hospital, Brisbane, Australia
Royal Brisbane & Women’s Hospital, Butterfi eld Street, 
Herston, 4006, Brisbane, Australia
Introduction: Acinar cell carcinoma (ACC) is a rare cancer 
of the pancreas accounting for approximately 1% of pancre-
atic tumours. Surgical resection is known to benefi t these 
patients. The aim of this study is to analyse the clinicopatho-
logical characteristics and presentation of ACC.
Methods: Retrospective review of prospectively collected 
data from 2008 to 2011 included all patients who underwent 
pancreatic resections for histologically proven ACCs. All 
specimens of ACC were reviewed by an expert pathologist. 
Patient demographic factors, outcomes and tumour charac-
teristics have been examined.
Results: Six patients were identifi ed between 2008 and 
2011. Two were female and four were male, with the average 
age at diagnosis being 66.5 years (51–75 years). Tumour size 
ranged between 2 to 12 cm (median 5 cm). After thorough 
staging, all patients were determined to have local disease 
only. Two patients underwent open pancreaticoduodenec-
tomy and one patient required reconstruction of the portal 
vein. Four patients were treated with distal pancreatectomy. 
Two patients had a laparoscopic approach and one had a 
spleen-preserving procedure (Warshaw). Two patients under-
went open distal pancreatectomy because of tumour rupture 
in one case and the need for en-bloc total gastrectomy and 
adrenalectomy in the other. Clear margins were obtained.
Conclusion: The outcomes of resection for ACC of the pan-
creas are more favourable compared to the more common 
ductal adenocarcinoma. R0 resection can be achieved even 
in the presence of large tumour size at time of presentation 
and nodal metastases are less common. Aggressive surgical 
management is indicated. There is no consensus regarding 
the optimal management of these patients. All patients should 
be discussed in a multidisciplinary forum as the histological 
diagnosis is often challenging.
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AGGRESSIVE SURGICAL 
MANAGEMENT OF ACINAR CELL 
CARCINOMA OF THE PANCREAS
N. O’Rourke, K. Tan, R. Finch, L. Nathanson and 
E. Sieling
Wesley Medical Centre, 40 Chasely St, Auchenfl ower, 4065, 
Brisbane, Australia
Introduction: Acinar cell carcinoma (ACC) is a rare cancer 
of the pancreas accounting for 1% of pancreatic tumours. 
Surgical resection is thought to benefi t these patients, with 
survival better than for ductal cell cancers.
Methods: A review of prospectively collected data from 
2007 to 2011 at Royal Brisbane Hospital, included all 
patients who underwent pancreatic resections for ACCs. All 
specimens of ACC were reviewed by an expert pathologist. 
Patient demographic factors, outcomes and tumour charac-
teristics have been examined.
Results: Six patients were identifi ed. Two female, age at 
diagnosis of 66 years (51–75). Tumour size – 2 to 12 cm 
(median 5 cm). Two patients underwent open pancreaticodu-
odenectomy. Four patients had distal pancreatectomy. Two 
had a laparoscopic approach, one had a spleen-preserving 
procedure (Warshaw). Two patients underwent open distal 
pancreatectomy because of tumour rupture in one case and 
the need for en-bloc total gastrectomy and adrenalectomy in 
the other. Clear margins were obtained in all cases. Only one 
case had lymph node metastasis. One patient died at 18 
months, but their presentation was with rupture of a 12 cm 
tail tumour. All others are alive without disease with 6–40 
month follow-up.
Conclusion: Large tumours of the pancreas may not always 
be of ductal origin. With ACC, R0 resection can be achieved 
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even in the presence of large tumour size, and nodal metas-
tases are less common. Aggressive surgical management is 
indicated. The potential for alpha-fetoprotein as a marker for 
these tumours requires further investigation.
981
PANCREATIC NEUROENDOCRINE 
TUMOURS AND THEIR MANAGEMENT
S. Noory, G. Noory and A. Prachalias
King’s College Hospital
King’s College Hospital, Institute of Liver Studies, 
Research & Transplantation, 27 Fordington House 
Sydenham Hill, London, SE26, UK
Introduction: Gastroenteropacreatic neuroendocrine 
tumours (GEP-NETs) are a group of tumours originating in 
the neuroendocrine system of the gastrointestinal tract. GEP-
NETs are categorised as either ‘functional’ (F-NETs) or ‘non-
functional’ neuroendocrine tumours (NF-NETs). F-NETs are 
normally affi liated with a clinical syndrome corresponding 
to the hormone which the tumour secretes. The most common 
types of neoplasms in this category are insulinoma, gastri-
noma, glucagonoma as well as somatostatinoma.
Methods: NF-NETs have no associated clinical syndromes 
as a result of hormone hyper-secretion.
Pancreatic neuroendocrine tumours (PNETs) are a sub-
category of GEP-NETs. PNETs are distinctive because they 
have unique tumour biology, natural history and clinical 
management from other GEP-NETs. Less than 5% of primary 
pancreatic malignancies are caused by neuroendocrine 
tumours.
Results: Asian and European based studies report incidence 
of PNETs to be <1 in 100 000.
Certain malignant gastrinomas as well as malignant 
NF-PNETs are affi liated to a number of other neoplasms 
such as, ovarian, breast, endometrial, bladder or prostate 
cancer. Potentially any pancreatic cell type may lead to a 
PNET. Apart from insulinoma, 50 to 60% of PNETs are 
metastasised by the time they are diagnosed.
Transabdominal ultrasound is commonly used in clinical 
practice because of its low cost and availability. Its sensitiv-
ity for detecting PNETs is 9 to 64%.
Conclusion: Survival in patients with Zollinger-Ellison 
syndrome following surgical resection is reported as high as 
86%. Surgical methods used include a enucleation, distal 
pancreatectomy and pancreticoduodenectomy. Even cases 
where metastasis has reached lymph nodes, long-term sur-
vival rates are high. However quality of life after the surgical 
procedure remains to be evaluated.
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CARCINOMA IN THE PANCREATIC 
HEAD CORED OUT BY A FREY 
PROCEDURE: MANAGEMENT
H. Ramesh, M. Wani, B. Abraham and S. Mahesh
Lakeshore Hospital, Cochin, Kerala, India
31/543, Subash Nagar, Edappally, 68202, Cochin, India
Introduction: The distinction between chronic pancreatitis 
and pancreatic cancer is not always easy to establish, and this 
may be further complicated by the fact that carcinoma may 
coexist/superimpose on chronic pancreatitis.
Methods: The aim of this study was to retrospectively 
analyze the prevalence of histologically proven carcinoma in 
chronic pancreatitis treated by a Frey procedure, and to 
analyze the outcomes in these patients. There were 6 cases 
among 540 Frey procedures (1.1%). 4 of these were male, 
and 2 female and their ages ranged from 37 to 52 years 
(median 47). 4 of the 6 patients had biliary obstruction with 
jaundice, and 3 had raised CA 19-9 levels above 300 units/
ml.
Results: The fi rst three cases were counseled and given best 
supportive care. Case 4 underwent chemotherapy (gemcitab-
ine 6 cycles) and thereafter since he was well, was offered 
surgery and a Whipple procedure was performed 13 months 
after the fi rst operation. The patient lived a further 21 months.
Cases 5 and 6 underwent reoperation and a conversion to 
Whipple procedure. They are alive and well 36 and 41 
months after surgery.
Conclusion: Carcinoma discovered in the pancreatic head 
on histopathological examination of the Frey specimen must 
be treated aggressively. Reoperation can produce good 
results.
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ERCP AND EPT IN ACUTE 
COMPLICATED PANCREATITIS: 
A CASE REPORT
D. Janjic1, M. Lazic2, S. Mihajlovic2, M. Dimitrijevic2 and 
V. Petrovic3
1General Hospital Leskovac, Department of Surgery, 
Leskovac, Serbia; 2Clinic of Surgery, Clinical Center Niš, 
Niš, Serbia; 3Health Center Vršac, Department of Internal 
Medicine, Vršac, Serbia
General Hospital, Department of Surgery str. Rade 
Koncara 9, 16000 Leskovac, Serbia
Introduction: Ultrasound is the modality of choice for the 
diagnosis of cholelithiasis and for the evaluation of the intra- 
and extrahepatic biliary tree in the patient with jaundice, but 
its role in the diagnosis of choledocholithiasis is less certain. 
Endoscopic retrograde cholangiopancreatography (ERCP) 
with endoscopic papillotomy (EPT) is a safe diagnostic and 
therapeutic procedure.
Methods: ERCP/EPT
Results: We report a case of a 69-year-old man who was 
admitted to our hospital with epigastric pain, vomiting and 
jaundice. The patient had a cholecystectomy 15 years ago. 
Abdominal ultrasound imaging was normal. Enhanced 
abdominal computed tomography revealed dilatation of a 
common bile duct and infl ammatory change of the pancreas 
with two cystic lesions. ERCP/EPT was performed. The 
patient made a satisfactory recovery by conservative medica-
tion treatment for acute pancreatitis and cystic lesions disap-
peared in parallel with pancreatitis.
Conclusion: In the postcholecystectomy patient population, 
ultrasound assessment of biliary duct size is not a useful 
predictor of biliary disease. For symptomatic postcholecys-
tectomy patients, we recommend ERCP as the initial diag-
nostic modality. ERCP plays a role in complicated acute 
pancreatitis. Symptomatic pseudocysts, essentially walled-
off pancreatic or peripancreatic fl uid collections seen in 
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either acute or chronic pancreatitis, may be drained via the 
papilla if they connect with the pancreatic duct. ERCP with 
EPT is appropriately becoming a therapeutic rather than 
diagnostic tool in the management of acute pancreatitis and 
its complications.
997
A ‘LIMITED INCISION’ TECHNIQUE TO 
PERFORM CYSTOGASTROSTOMY FOR 
LARGE PANCREATIC PSEUDOCYSTS
A. K. Agarwal
Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi 110002, India
Introduction: Management of symptomatic and unresolv-
ing pancreatic pseudocyst involves draining them into the 
lumen of adjacent viscera. In the majority, the cyst bulges 
anteriorly into the stomach and a cystogastrostomy provides 
an effective drainage. This can be accomplished by a variety 
of techniques (endoscopic, laparoscopic, or conventional 
open). Laparoscopic transgastric & intragastric approaches 
are the most often used techniques. The current article 
describes a simple an effective limited incision technique of 
cystogastrostomy for large pseudocysts, palpable on the 
anterior abdominal wall.
Methods: Patients with large pseudocysts reaching the 
abdominal wall were considered.
Technique: A small 3 to 5 cm incision is sited at over the 
maximum bulge (of the pseudocyst). After opening the 
abdomen, the anterior wall of the stomach is identifi ed & 
fi xed to the skin (temporary gastrocutaneopexy). An anterior 
gastrotomy is made and deep sutures are taken through the 
bulging cyst on the posterior wall to approximate the cyst 
wall to the posterior wall of the stomach and a posterior 
gastrotomy is made. The cyst fl uid is evacuated using wide 
bore suction. The technique effectively prevents any perito-
neal spillage of the cyst fl uid and contents. A part of the cyst 
wall is excised for histopathology and a cystogastrostomy is 
performed using a side to side stapler. A telescope is inserted 
to inspect the cyst cavity for any debris or necrotic tissue 
which if present is easily removed. The cavity is irrigated 
with saline and the anterior gastrotomy is suture closed. In 
patients with biliary pancreatitis a 10 mm port is inserted via 
this incision which is approximated around it. The remaining 
ports are inserted (as for a conventional laparoscopic chole-
cystectomy) and the cholecystectomy completed.
Results: Four patients, 2 male & 2 female (aged 14, 15, 23 
& 44 years) of pancreatic pseudocyst, following an attack of 
acute pancreatitis (gall stone pancreatitis-2 and idiopathic 
pancreatitis-2). A transverse incision of size 3 cm in one & 
5 cm in the other three patients’ at the most prominent part 
of bulge was given. Stapled cystogastrostomy was performed 
and a stoma of 4.5 cm was created. A laparoscopic cholecys-
tectomy was added in 2 patients. The average duration of 
surgery was 45 minutes and the blood loss was minimal. All 
patients were started on liquid diet on 2nd and discharged on 
4th post operative day. Excellent cosmetic results were 
achieved in all 4 patients.
Conclusion: Limited incision cystogastrostomy is an alter-
native technique for large pseudocyst of the pancreas. 
Gastrocutaneopexy prevents spillage of cyst contents and the 
procedure has a shorter operative time and gives excellent 
cosmetic results.
